PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fernando, N; Wickremesinghe, S; Niloofa, R; Rodrigo, C; Karunanayake, L; de Silva, HJ; Wickremesinghe, AR; Premawansa, S; Rajapakse, S; Handunnetti, SM				Fernando, Narmada; Wickremesinghe, Shalini; Niloofa, Roshan; Rodrigo, Chaturaka; Karunanayake, Lilani; de Silva, H. Janaka; Wickremesinghe, A. R.; Premawansa, Sunil; Rajapakse, Senaka; Handunnetti, Shiroma M.			Protein Carbonyl as a Biomarker of Oxidative Stress in Severe Leptospirosis, and Its Usefulness in Differentiating Leptospirosis from Dengue Infections	PLOS ONE			English	Article							CONFIRMED LEPTOSPIROSIS; CLINICAL PRESENTATION; LIPID-PEROXIDATION; THROMBOCYTOPENIA; OUTBREAK; VITAMINS; DISEASE; NITRITE; HAWAII; ASSAY	Pathogenesis of disease severity in leptospirosis is not clearly understood whether it is due to direct damage by pathogen or by adverse immune responses. Knowledge on biomarkers of oxidative stress which could be used in identifying patients with severe illness has shown to be of great value in disease management. Thus, the main aim of this study was to assess the damage to serum proteins and lipids, and their significance as biomarkers of oxidative stress in severe leptospirosis. In regions endemic for both leptospirosis and dengue, leptospirosis cases are often misdiagnosed as dengue during dengue epidemics. Therefore, the second aim was to assess the potential of the oxidative stress markers in differentiating severe leptospirosis from critical phase dengue. We measured serum antioxidants (uric acid and bilirubin), total antioxidant capacity (AOC), protein carbonyl (PC) and lipid hydroperoxide (LP) in patients with severe leptospirosis (n = 60), mild leptospirosis (n = 50), dengue during the critical phase (n = 30) and in healthy subjects (n = 30). All patient groups had similar total antioxidant capacity levels. However, the presence of significantly high uric acid and total bilirubin levelsmay reflect the degree of renal and hepatic involvement seen in severe leptospirosis patients (p<0.02). Serum PC and LP levels were significantly higher in leptospirosis patients compared to critical phase dengue infections (p<0.005). Moreover, high serum PC levels appear to differentiate SL from DC [area under the curve (AUC) = 0.96; p<0.001]. SerumPC may be a reliable biomarker of oxidative damage to serum proteins to identify severe leptospirosis patients (AUC = 0.99) and also to differentiate severe leptospirosis from mild cases (AUC = 0.78; p<0.005) indicating its contribution to pathogenesis. Use of serum PC as an indicator of leptospirosis severity and as an oxidative stress biomarker in differentiating leptospirosis from dengue would provide the opportunity to save lives via prompt patient management.	[Fernando, Narmada; Wickremesinghe, Shalini; Niloofa, Roshan; Handunnetti, Shiroma M.] Univ Colombo, Inst Biochem Mol Biol & Biotechnol, Colombo 03, Sri Lanka; [Rodrigo, Chaturaka; Rajapakse, Senaka] Univ Colombo, Trop Med Res Unit, Fac Med, Colombo 08, Sri Lanka; [Karunanayake, Lilani] Med Res Inst, Natl Reference Lab Leptospirosis, Colombo 08, Sri Lanka; [de Silva, H. Janaka; Wickremesinghe, A. R.] Univ Kelaniya, Fac Med, Kelaniya, Sri Lanka; [Premawansa, Sunil] Univ Colombo, Fac Sci, Colombo 03, Sri Lanka	University of Colombo; University of Colombo; Medical Research Institute Sri Lanka (MRI); University Kelaniya; University of Colombo	Fernando, N (corresponding author), Univ Colombo, Inst Biochem Mol Biol & Biotechnol, Colombo 03, Sri Lanka.	narfernando@gmail.com	Rodrigo, Chaturaka/A-8400-2011; Niloofa, Roshan/AAF-2507-2019; Rajapakse, Senaka/A-8404-2011	Rodrigo, Chaturaka/0000-0003-2189-9177; Niloofa, Roshan/0000-0002-6972-9858; Fernando, Narmada/0000-0001-5899-9564; Rajapakse, Senaka/0000-0003-1965-6678; Karunanayake, Lilani/0000-0001-6014-1671	National research Council, Sri Lanka [NRC-12-077]	National research Council, Sri Lanka	This study was supported by grant no. NRC-12-077, National research Council, Sri Lanka, http://www.nrc.gov.lk/. The study was funded for the data collection and analysis.	Abiles J, 2006, CRIT CARE, V10, DOI 10.1186/cc5068; Abu-Zidan FM, 2002, EUR J SURG, V168, P119, DOI 10.1080/11024150252884359; [Anonymous], 2011, 2 M LEPT BURD EP REF; [Anonymous], 2003, HUM LEPT GUID DIAGN; Araujo AM, 2014, AM J TROP MED HYG, V90, P719, DOI 10.4269/ajtmh.13-0667; Arguelles S, 2004, BBA-GEN SUBJECTS, V1674, P251, DOI 10.1016/j.bbagen.2004.06.023; Arumugam P, 2006, ASIA PAC J CLIN NUTR, V15, P119; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Butterfield DA, 2003, AMINO ACIDS, V25, P419, DOI 10.1007/s00726-003-0027-7; Daher EF, 2010, BRAZ J INFECT DIS, V14, P3, DOI 10.1590/S1413-86702010000100002; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dean RT, 1997, BIOCHEM J, V324, P1; Dotan Y, 2004, PROG LIPID RES, V43, P200, DOI 10.1016/j.plipres.2003.10.001; Ellis T, 2008, VECTOR-BORNE ZOONOT, V8, P541, DOI 10.1089/vbz.2007.0241; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652; Girotti AW, 1998, J LIPID RES, V39, P1529; GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011; Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543, DOI 10.4037/ajcc2002.11.6.543; Gunaratna RI, 2012, ASIAN PAC J TROP MED, V5, P75, DOI 10.1016/S1995-7645(11)60250-2; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Halliwell Barry, 1993, American Journal of Clinical Nutrition, V57, p715S, DOI 10.1093/ajcn/57.5.715S; Heyland DK, 2005, INTENS CARE MED, V31, P327, DOI 10.1007/s00134-004-2522-z; HUDSON L, 1989, PRACTICAL IMMUNOLOGY; Kalugalage T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-206; Kambayashi Y, 2009, J CLIN BIOCHEM NUTR, V44, P46, DOI 10.3164/jcbn.08-162; Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084; Kumar A BV, 2012, ANN TROPICAL MED PUB, V5, P4; LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212; Maciel EAP, 2006, ACTA TROP, V100, P256, DOI 10.1016/j.actatropica.2006.11.006; McGrowder D, 2010, RES REP TROP MED, V1, P59, DOI 10.2147/RRTM.S14118; Mourao MPG, 2007, PLATELETS, V18, P605, DOI 10.1080/09537100701426604; Narsaria N, 2012, J TROP PEDIATRICS, V58, P147, DOI 10.1093/tropej/fmr043; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411; Programme for Research and Training in Tropical Diseases, 2009, Dengue: guidelines for diagnosis, treatment, prevention and control; Rajapakse S, 2015, T ROY SOC TROP MED H, V109, P710, DOI 10.1093/trstmh/trv079; Rajapakse Senaka, 2010, J Emerg Trauma Shock, V3, P213, DOI 10.4103/0974-2700.66519; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Soundravally R, 2008, ACTA TROP, V106, P156, DOI 10.1016/j.actatropica.2008.03.001; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2	44	36	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156085	10.1371/journal.pone.0156085	http://dx.doi.org/10.1371/journal.pone.0156085			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280281	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000013
J	Klushkina, VV; Kyuregyan, KK; Kozhanova, TV; Popova, OE; Dubrovina, PG; Isaeva, OV; Gordeychuk, IV; Mikhailov, MI				Klushkina, Vitalina V.; Kyuregyan, Karen K.; Kozhanova, Tatiana V.; Popova, Oksana E.; Dubrovina, Polina G.; Isaeva, Olga V.; Gordeychuk, Ilya V.; Mikhailov, Mikhail I.			Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia	PLOS ONE			English	Article							S-GENE; CHILDREN; MUTANTS	Vaccination of newborns against hepatitis B (HB) was introduced in Russia in 1998. Since then the incidence of acute HB has rapidly declined. However, prevalence of chronic HB remains stable. The aim of this study was to estimate the effect of vaccination on HBV-associated morbidity, and to assess the prevalence of HBV immune escape variants after 10 years of vaccination. Methods 6,217 sera samples collected from volunteers in six epidemiologically different regions of Russia were tested for serological and molecular markers of HBV infection. A mathematical model developed by the U.S. Centers for Disease Control and Prevention was used to estimate the effect of vaccination and birth dose coverage on the incidence of HB and adverse outcomes of infection. Results Prevalence of HBsAg in the study population varied from 1.2% to 8.2%; anti-HBc detection rates were 13.0-46.2%. HBsAg detection rates in epidemiologically significant cohorts were 0.6-10.5% in women of childbearing age; 0-2.4% in children <= 5 years old; 1.9-8.1% in adults >= 30 years old. Mathematical modeling demonstrated that the current 96.1-99.6% level of birth dose coverage increased the effectiveness of vaccination 10-21 times compared to 50% and 0% birth dose coverage scenarios. HBV DNA was detected in 63 sera samples. The frequency of amino acid substitutions in HBsAg was 38% (24/63). Only in 3% (2/63) the mutations were within the a-determinant of HBsAg (M133T and G145S, one case each). None of the identified mutations eluded HBsAg detection, since all these samples tested positive for HBsAg by commercial ELISA. Conclusion Despite a significant decline in acute HB incidence after the introduction of universal vaccination, many undiagnosed potential sources of infection remain. Low prevalence of HBV immune escape variants is a favorable predictor of vaccine effectiveness in the future.	[Klushkina, Vitalina V.; Kyuregyan, Karen K.; Kozhanova, Tatiana V.; Popova, Oksana E.; Dubrovina, Polina G.; Isaeva, Olga V.; Gordeychuk, Ilya V.; Mikhailov, Mikhail I.] Chumakov Inst Poliomyelitis & Viral Encephalitide, Dept Viral Hepatitis, Moscow, Russia; [Klushkina, Vitalina V.] IM Sechenov First Moscow State Med Univ, Minist Heath Russian Federat, Prophylact Med Fac, Dept Epidemiol & Evidence Based Med, Moscow, Russia	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Sechenov First Moscow State Medical University	Gordeychuk, IV (corresponding author), Chumakov Inst Poliomyelitis & Viral Encephalitide, Dept Viral Hepatitis, Moscow, Russia.	lab.gord@gmail.com	Mikhailov, Mikhail Ivanovich/AAD-6917-2022; Gordeychuk, Ilya/AAD-6017-2022; Kyuregyan, Karen/D-6300-2014; Gordeychuk, Ilya V/D-6515-2014; Mikhailov, Mikhail/E-3531-2014	Mikhailov, Mikhail Ivanovich/0000-0002-6636-6801; Gordeychuk, Ilya/0000-0002-4551-7535; Kyuregyan, Karen/0000-0002-3599-117X; Gordeychuk, Ilya V/0000-0002-4551-7535; Klushkina, Vitalina/0000-0001-8311-8204	Chumakov Institute of Poliomyelitis and Viral Encephalitides	Chumakov Institute of Poliomyelitis and Viral Encephalitides	The work was funded by the Chumakov Institute of Poliomyelitis and Viral Encephalitides without any involvement of additional grants.	Basuni AA, HBV VACCINE ESCAPE V, P115, DOI [10.1385/1-59259-669-X:115, DOI 10.1385/1-59259-669-X:115]; Federal Center of Hygeine and Epidemiology,, 2010, INF PAR DIS MORB RUS; Federal Center of Hygeine and Epidemiology, 2010, INF GROUPS CHILDR AD; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; Ngui SL, 1997, J INFECT DIS, V176, P1360, DOI 10.1086/514133; OON CJ, 1995, VACCINE, V13, P699, DOI 10.1016/0264-410X(94)00080-7; Petersen KM, 2004, PEDIATR INFECT DIS J, V23, P650, DOI 10.1097/01.inf.0000130952.96259.fd; Plotkin SA, 2013, VACCINES; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; Torresi J, 2002, VIROLOGY, V299, P88, DOI 10.1006/viro.2002.1448	11	12	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157161	10.1371/journal.pone.0157161	http://dx.doi.org/10.1371/journal.pone.0157161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280884	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000099
J	Zhu, YJ; Cui, HW; Xia, YF; Gan, H				Zhu, Yongjun; Cui, Hongwang; Xia, Yunfeng; Gan, Hua			RIPK3-Mediated Necroptosis and Apoptosis Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease Progression in Rats	PLOS ONE			English	Article							PROTEIN-KINASE 1; INTERSTITIAL FIBROSIS; SDS-PAGE; RECEPTOR; NECROSIS; INJURY; PROLIFERATION; MECHANISMS; DEATH; MICE	Tubulointerstitial fibrosis (TIF) is caused by the progressive loss of renal tubular cells and the consequent replacement of the extracellular matrix. The progressive depletion of renal tubular cells results from apoptosis and necroptosis; however, the relative significance of each of these cell death mechanisms at different stages during the progression of chronic kidney disease (CKD) remains unclear. We sought to explore the mechanisms of renal tubular cell death during the early and intermediate stages of chronic renal damage of subtotal nephrectomied (SNx) rats. The results of tissue histological assays indicated that the numbers of necrotic dying cells and apoptotic cells were significantly higher in kidney tissues derived from a rat model of CKD. In addition, there was a significant increase in necroptosis observed by transmission electron microscopy (TEM) and an increase in the proportion of TUNEL-positive cells in kidney tissues from SNx rats compared with control rats, and necrostatin-1 (Nec-1) could inhibit necroptosis and reduce the proportion of TUNEL-positive cells. More importantly, we observed a significant increase in the incidence of necroptosis compared with apoptosis by TEM in vivo and in vitro and a significant increase in the proportion of TUNEL-positive tubular epithelial cells that did not express caspase-3 compared with those expressing cleaved caspase-3 in vitro. Furthermore, treatment with Nec-1 and zVAD strongly reduced necroptosis- and apoptosis-mediated renal tubular cell death and decreased the levels of blood urea nitrogen and serum creatinine and tubular damage scores of SNx rats. These results suggest that necroptotic cell death plays a more significant role than apoptosis in mediating the loss of renal tubular cells in SNx rats and that effectively blocking both necroptosis and apoptosis improves renal function and tubular damage at early and intermediate stages of CKD.	[Zhu, Yongjun; Xia, Yunfeng; Gan, Hua] Chongqing Med Univ, Affiliated Hosp 1, Dept Nephrol, Chongqing, Peoples R China; [Zhu, Yongjun] Hainan Med Coll, Affiliated Hosp, Dept Nephrol, Haikou, Peoples R China; [Cui, Hongwang] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China	Chongqing Medical University; Hainan Medical University; Chongqing Medical University	Zhu, YJ; Gan, H (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Nephrol, Chongqing, Peoples R China.; Zhu, YJ (corresponding author), Hainan Med Coll, Affiliated Hosp, Dept Nephrol, Haikou, Peoples R China.	zyj418207195@yeah.net; zgxxchw@sina.com			Chinese National Science and Technology Support Plan [2011BAI10B01]	Chinese National Science and Technology Support Plan	This study was supported by the Chinese National Science and Technology Support Plan (2011BAI10B01).	Amann K, 1996, NEPHROL DIAL TRANSPL, V11, P1003, DOI 10.1093/oxfordjournals.ndt.a027447; Baumann M, 2009, ACTA PHYSIOL, V196, P231, DOI 10.1111/j.1748-1716.2008.01916.x; Bazzi C, 1997, AM J KIDNEY DIS, V29, P27, DOI 10.1016/S0272-6386(97)90005-6; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Dworkin LD, 2004, KIDNEY INT, V65, P409, DOI 10.1111/j.1523-1755.2004.00417.x; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Joo KW, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-98; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Lopez AD, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0200-8; MACKENSENHAEN S, 1981, CLIN NEPHROL, V15, P167; Mene P, 1998, NEPHROL DIAL TRANSPL, V13, P1936, DOI 10.1093/ndt/13.8.1936; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Piecha G, 2008, AM J PHYSIOL-RENAL, V294, pF748, DOI 10.1152/ajprenal.00220.2007; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Sugiyama H, 1996, KIDNEY INT, V49, P103, DOI 10.1038/ki.1996.14; Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530; Thomas GL, 1998, NEPHROL DIAL TRANSPL, V13, P2216, DOI 10.1093/ndt/13.9.2216; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Truong LD, 1996, KIDNEY INT, V50, P200, DOI 10.1038/ki.1996.303; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; WOO KT, 1991, CLIN NEPHROL, V36, P6; Yang B, 2001, KIDNEY INT, V60, P1765, DOI 10.1046/j.1523-1755.2001.00013.x; Yang B, 2001, J AM SOC NEPHROL, V12, P275, DOI 10.1681/ASN.V122275; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhu YJ, 2015, BIOCHEM BIOPH RES CO, V461, P575, DOI 10.1016/j.bbrc.2015.03.164	34	40	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156729	10.1371/journal.pone.0156729	http://dx.doi.org/10.1371/journal.pone.0156729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281190	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000041
J	Hsu, CL; Hsu, CW; Chang, PC; Huang, WH; Weng, CH; Yang, HY; Liu, SH; Chen, KH; Weng, SM; Chang, CC; Wang, IK; Tsai, AI; Yen, TH				Hsu, Chia-Lin; Hsu, Ching-Wei; Chang, Pei-Ching; Huang, Wen-Hung; Weng, Cheng-Hao; Yang, Huang-Yu; Liu, Shou-Hsuan; Chen, Kuan-Hsing; Weng, Shu-Man; Chang, Chih-Chun; Wang, I-Kuan; Tsai, Aileen I.; Yen, Tzung-Hai			Oral Tori in Chronic Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CLINICAL CHARACTERISTICS; PREVALENCE; PALATINUS; MANDIBULARIS; CONCURRENCE; ASSOCIATION; POPULATION; EXOSTOSES	Background The pathogenesis of oral tori has long been debated and is thought to be the product of both genetic and environmental factors, including occlusal forces. Another proposed mechanism for oral tori is the combination of biomechanical forces, particularly in the oral cavity, combined with cortical bone loss and trabecular expansion, as one might see in the early stages of primary hyperparathyroidism. This study investigated the epidemiology of torus palatinus (TP) and torus mandibularis (TM) in peritoneal dialysis patients, and analyzed the influences of hyperparathyroidism on the formation of oral tori. Method In total, 134 peritoneal dialysis patients were recruited between July 1 and December 31, 2015 for dental examinations for this study. Patients were categorized into two subgroups based on the presence or absence of oral tori. Demographic, hematological, biochemical, and dialysis-related data were obtained for analysis. Results The prevalence of oral tori in our sample group was high at 42.5%(57 of 134), and most patients with oral tori were female (61.4%). The most common location of tori was TP (80.7%), followed by TP and TM (14.0%), then TM (5.3%). All 54 TP cases were at the midline, and most were <2 cm (59.3%), flat (53.7%), and located in the premolar region (40.7%). Of the 11 TM cases, all were bilateral and symmetric, mostly <2 cm (81.9%), lobular (45.4%), and located at premolar region (63.6%). Interestingly, patients with oral tori had slightly lower serum levels of intact parathyroid hormones than those without oral tori, but the difference was not statistically significant (317.3 +/- 292.0 versus 430.1 +/- 492.6 pg/mL, P = 0.126). In addition, patients with oral tori did not differ from patients without tori in inflammatory variables such as serum high sensitivity C-reactive protein levels (6.6 +/- 8.2 versus 10.3 +/- 20.2 mg/L, P = 0.147) or nutritional variables such as serum albumin levels (3.79 +/- 0.38 versus 3.77 +/- 0.45 g/dL, P = 0.790). Furthermore, there were no differences between patients with and without oral tori in dialysis adequacy (weekly Kt/V-urea, 2.14 +/- 0.39 versus 2.11 +/- 0.33, P = 0.533; weekly creatinine clearance rate, 59.31 +/- 17.58 versus 58.57 +/- 13.20 L/1.73 m(2), P = 0.781), or peritoneal membrane transporter characteristics (P = 0.098). Conclusion Secondary hyperparathyroidism does not contribute to the formation of tori in peritoneal dialysis patients. Further studies are warranted.	[Hsu, Chia-Lin; Chang, Pei-Ching; Tsai, Aileen I.] Chang Gung Mem Hosp, Dept Pediat Dent, Linkou, Taiwan; [Hsu, Ching-Wei; Huang, Wen-Hung; Weng, Cheng-Hao; Yang, Huang-Yu; Liu, Shou-Hsuan; Chen, Kuan-Hsing; Weng, Shu-Man; Yen, Tzung-Hai] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan; [Hsu, Ching-Wei; Huang, Wen-Hung; Weng, Cheng-Hao; Yang, Huang-Yu; Liu, Shou-Hsuan; Chen, Kuan-Hsing; Weng, Shu-Man; Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Linkou, Taiwan; [Huang, Wen-Hung; Weng, Cheng-Hao; Yang, Huang-Yu; Liu, Shou-Hsuan; Chen, Kuan-Hsing; Yen, Tzung-Hai] Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan; [Chang, Chih-Chun] Far Eastern Mem Hosp, Dept Clin Pathol, New Taipei, Taiwan; [Wang, I-Kuan] China Med Univ, China Med Univ Hosp, Dept Nephrol, Taichung, Taiwan; [Wang, I-Kuan] China Med Univ, Coll Med, Taichung, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Far Eastern Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital	Tsai, AI (corresponding author), Chang Gung Mem Hosp, Dept Pediat Dent, Linkou, Taiwan.; Yen, TH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan.; Yen, TH (corresponding author), Chang Gung Univ, Coll Med, Linkou, Taiwan.; Yen, TH (corresponding author), Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan.; Yen, TH (corresponding author), Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan.	ait001@adm.cgmh.org.tw; m19570@adm.cgmh.org.tw	huang, wen/GXW-0661-2022; Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505; YANG, HUANG-YU/0000-0001-6826-9717	Ministry of Science and Technology, Taiwan (MST) [104-2221-E182A-003]; Chang Gung Memorial Hospital, Linkou, Taiwan (CMRP) [G3D0012, G3E0361, G3D0072, G3F0601, C3F1161, G3F0371]	Ministry of Science and Technology, Taiwan (MST); Chang Gung Memorial Hospital, Linkou, Taiwan (CMRP)	Support was provided by the Ministry of Science and Technology, Taiwan (MST 104-2221-E182A-003) and Chang Gung Memorial Hospital, Linkou, Taiwan (CMRP G3D0012, G3E0361, G3D0072, G3F0601, C3F1161, G3F0371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Quran Firas A M, 2006, J Contemp Dent Pract, V7, P112; Al-Bayaty HF, 2001, INT DENT J, V51, P300, DOI 10.1002/j.1875-595X.2001.tb00842.x; Antoniades DZ, 1998, ORAL SURG ORAL MED O, V85, P552, DOI 10.1016/S1079-2104(98)90290-6; Auskalnis A, 2015, MEDICINA-LITHUANIA, V51, P228, DOI 10.1016/j.medici.2015.07.001; Bruce I, 2004, INT DENT J, V54, P78, DOI 10.1111/j.1875-595X.2004.tb00259.x; Chao PJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/897674; Chiang ML, 2014, J DENT SCI, V9, P69, DOI 10.1016/j.jds.2013.06.004; EGGEN S, 1994, SCAND J DENT RES, V102, P60; EGGEN S, 1986, SCAND J DENT RES, V94, P233; EGGEN S, 1994, SCAND J DENT RES, V102, P54; Garcia-Garcia AS, 2010, MED ORAL PATOL ORAL, V15, pE353, DOI 10.4317/medoral.15.e353; Gorsky M, 1996, ARCH ORAL BIOL, V41, P623, DOI 10.1016/0003-9969(96)00149-5; Gorsky M, 1998, AM J MED GENET, V75, P138, DOI 10.1002/(SICI)1096-8628(19980113)75:2<138::AID-AJMG3>3.0.CO;2-P; HAUGEN LK, 1992, ACTA ODONTOL SCAND, V50, P65, DOI 10.3109/00016359209012748; Hiremath VK, 2011, J INT SOC PREV COMMU, V1, P60, DOI 10.4103/2231-0762.97704; Hsu CW, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-17; Jainkittivong A, 2007, SURG RADIOL ANAT, V29, P125, DOI 10.1007/s00276-007-0184-6; Jorgetti V, 2009, NEPHROLOGY, V14, P404, DOI 10.1111/j.1440-1797.2009.01148.x; Lin JL, 2010, NEPHROL DIAL TRANSPL, V25, P1627, DOI 10.1093/ndt/gfp663; Miller PD, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.44; Padbury AD, 2006, J CLIN ENDOCR METAB, V91, P3439, DOI 10.1210/jc.2005-2282; Rai Sachin, 2012, Indian J Dent Res, V23, P384, DOI 10.4103/0970-9290.102236; REICHART PA, 1988, COMMUNITY DENT ORAL, V16, P61, DOI 10.1111/j.1600-0528.1988.tb00557.x; Romanos Georgios E, 2013, N Y State Dent J, V79, P25; Sathya K, 2012, J Oral Biol Craniofac Res, V2, P15, DOI 10.1016/S2212-4268(12)60005-0; Sawair FA, 2009, SAUDI MED J, V30, P1557; Simunkovic SK, 2011, COLLEGIUM ANTROPOL, V35, P637; Sisman Y, 2012, J DENT SCI, V7, P154, DOI 10.1016/j.jds.2012.03.012; Sisman Yildiray, 2008, Eur J Dent, V2, P269; Sprague SM, 2016, AM J KIDNEY DIS, V67, P559, DOI 10.1053/j.ajkd.2015.06.023; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Wang TY, 2011, NEPHROLOGY, V16, P225, DOI 10.1111/j.1440-1797.2010.01366.x; Yildiz E, 2005, SURG RADIOL ANAT, V27, P368, DOI 10.1007/s00276-005-0003-x; Yoshinaka M, 2010, J ORAL REHABIL, V37, P848, DOI 10.1111/j.1365-2842.2010.02100.x; Yoshinaka M, 2014, GERODONTOLOGY, V31, P117, DOI 10.1111/ger.12017	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156988	10.1371/journal.pone.0156988	http://dx.doi.org/10.1371/journal.pone.0156988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275607	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700054
J	Shukla, A; Moussa, A; Singh, TR				Shukla, Ankita; Moussa, Ahmed; Singh, Tiratha Raj			DREMECELS: A Curated Database for Base Excision and Mismatch Repair Mechanisms Associated Human Malignancies	PLOS ONE			English	Article							DNA; METHYLATION	DNA repair mechanisms act as a warrior combating various damaging processes that ensue critical malignancies. DREMECELS was designed considering the malignancies with frequent alterations in DNA repair pathways, that is, colorectal and endometrial cancers, associated with Lynch syndrome (also known as HNPCC). Since lynch syndrome carries high risk (similar to 40-60%) for both cancers, therefore we decided to cover all three diseases in this portal. Although a large population is presently affected by these malignancies, many resources are available for various cancer types but no database archives information on the genes specifically for only these cancers and disorders. The database contains 156 genes and two repair mechanisms, base excision repair (BER) and mismatch repair (MMR). Other parameters include some of the regulatory processes that have roles in these disease progressions due to incompetent repair mechanisms, specifically BER and MMR. However, our unique database mainly provides qualitative and quantitative information on these cancer types along with methylation, drug sensitivity, miRNAs, copy number variation (CNV) and somatic mutations data. This database would serve the scientific community by providing integrated information on these disease types, thus sustaining diagnostic and therapeutic processes. This repository would serve as an excellent accompaniment for researchers and biomedical professionals and facilitate in understanding such critical diseases. DREMECELS is publicly available at http://www.bioinfoindia.org/dremecels.	[Shukla, Ankita; Singh, Tiratha Raj] JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India; [Moussa, Ahmed] Abdelmalek Essaadi Univ, ENSA Tangier, LabTIC Lab, BP1818 Route Ziaten, Tangier 90000, Morocco	Jaypee University of Information Technology; Abdelmalek Essaadi University of Tetouan	Singh, TR (corresponding author), JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India.; Moussa, A (corresponding author), Abdelmalek Essaadi Univ, ENSA Tangier, LabTIC Lab, BP1818 Route Ziaten, Tangier 90000, Morocco.	amoussa@uae.ac.ma; tiratharaj@gmail.com	Singh, Tiratha Raj/AAL-4256-2020; Moussa, Ahmed/AAI-1351-2020	Moussa, Ahmed/0000-0003-1628-8179; Shukla, Ankita/0000-0003-1520-755X	Department of Biotechnology and Bioinformatics, JUIT	Department of Biotechnology and Bioinformatics, JUIT	The authors would like to thank the Department of Biotechnology and Bioinformatics, JUIT for providing financial support and technical assistance.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bejjani BA, 2006, J MOL DIAGN, V8, P528, DOI 10.2353/jmoldx.2006.060029; Chen X, 2009, DRUG DISCOV TODAY, V14, P754, DOI 10.1016/j.drudis.2009.05.005; Chow E, 2004, LANCET ONCOL, V5, P600, DOI 10.1016/S1470-2045(04)01595-5; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Forbes S.A., 2008, CURR PROTOC HUM GENE; Ford BN, 2000, CARCINOGENESIS, V21, P1977, DOI 10.1093/carcin/21.11.1977; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; He XM, 2008, NUCLEIC ACIDS RES, V36, pD836, DOI 10.1093/nar/gkm730; Huebert DJ, 2006, METHODS, V40, P365, DOI 10.1016/j.ymeth.2006.07.032; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Kumps FSC, 2009, COPY NUMBER ALTERATI, V182, P176; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martin-Lopez JV, 2013, FAM CANCER, V12, P159, DOI 10.1007/s10689-013-9635-x; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Shilpa V, 2014, MOL MECH MISMATCH RE, V1, P1; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Strafford J Craig, 2012, Rev Obstet Gynecol, V5, P42; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Yano K, 2006, NUCLEIC ACIDS RES, V34, P1532, DOI 10.1093/nar/gkl058	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157031	10.1371/journal.pone.0157031	http://dx.doi.org/10.1371/journal.pone.0157031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276067	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700058
J	Casey, NP; Fujiwara, H; Tanimoto, K; Okamoto, S; Mineno, J; Kuzushima, K; Shiku, H; Yasukawa, M				Casey, Nicholas Paul; Fujiwara, Hiroshi; Tanimoto, Kazushi; Okamoto, Sachiko; Mineno, Junichi; Kuzushima, Kiyotaka; Shiku, Hiroshi; Yasukawa, Masaki			A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy	PLOS ONE			English	Article							ENHANCED ANTITUMOR-ACTIVITY; HEMATOPOIETIC STEM-CELLS; ZINC-FINGER NUCLEASES; TCR GENE-TRANSFER; CANCER REGRESSION; HUMAN-LYMPHOCYTES; DISULFIDE BOND; IN-VIVO; THERAPY; POPULATION	Aurora Kinase A is a cancer-associated protein normally involved in the regulation of mitosis. Being over-expressed in a range of cancers, it is a suitable target for cell-based immunotherapy. Gene transfer of T-cell receptor sequences cognisant of HLA-A*0201-restricted Aurora Kinase A antigen has previously been shown to transfer specific immunoreactivity against the target peptide in a Human Lymphocyte Antigen-restricted manner. While T cell receptor gene-transfer has great potential in overcoming the difficulties of isolating and expanding tumour-reactive lymphocytes from a patient's own cells, one hurdle is potential mispairing and competition between exogenous and endogenous T cell receptor chains. We have used a retroviral vector design bearing a short-interfering RNA that downregulates endogenous T cell receptor chains, without affecting expression of the transgenic T cell receptor sequences. The T cell receptor expression cassette also includes a 2A self-cleaving peptide, resulting in equimolar expression of the T cell receptor alpha and beta chains, further enhancing formation of the desired T cell receptor. Via a simple, modular cloning method, we have cloned the alpha and beta chains of the anti-Aurora Kinase A-reactive T cell receptor into this 'siTCR' vector. We then compared the activity of this vector against the original, 'conventional' vector across a panel of assays. T cell receptors expressed from the siTCR-vector retained the cytotoxic functionality of the original vector, with evidence of reduced off-target reactivity. The rate of expression of correctly-formed T cell receptors was superior using the siTCR design, and this was achieved at lower vector copy numbers. Maintaining T cell receptor efficacy with a reduced vector copy number reduces the risk of genotoxicity. The siTCR design also reduces the risk of mispairing and cross-reactivity, while increasing the functional titre. Such improvements in the safety of T cell receptor gene-transfer will be crucial for clinical applications of this technology.	[Casey, Nicholas Paul; Fujiwara, Hiroshi; Tanimoto, Kazushi; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Hematol Clin Immunol & Infect Dis, Matsuyama, Ehime 790, Japan; [Okamoto, Sachiko; Mineno, Junichi] Takara Bio Inc, CDM Ctr, Shiga, Japan; [Kuzushima, Kiyotaka] Aichi Canc Ctr, Div Immunol, Nagoya, Aichi, Japan; [Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Canc Vaccine & Immunogene Therapy, Tsu, Mie, Japan	Ehime University; Takara Bio Inc.; Aichi Cancer Center; Mie University	Fujiwara, H; Yasukawa, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Hematol Clin Immunol & Infect Dis, Matsuyama, Ehime 790, Japan.	yunarief@m.ehime-u.ac.jp; yasukawa@m.ehime-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKEN 15H04858, 15K09506]; Project for Development of Innovative Research on Cancer Therapeutics; Ministry of Health, Labor and Welfare; Takeda science Foundation; Uehara Memorial Foundation; Princess Takamatsu Cancer Research Fund	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Princess Takamatsu Cancer Research Fund	This work was supported in part by grants from the following: Ministry of Education, Culture, Sports, Science and Technology of Japan (https://www.jsps.go.jp/jgrantsinaid/), grant numbers KAKEN 15H04858 (MY) and 15K09506 (HF); Project for Development of Innovative Research on Cancer Therapeutics (http://www.amed.go.jp/en/program/list/01/03/010.html) (MY); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare (MY); a grant from Takeda science Foundation (MY); a grant from the Uehara Memorial Foundation (MY); and a grant from Princess Takamatsu Cancer Research Fund (MY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two of the authors are employed by Takara Bio Inc. This funder provided support in the form of salaries for these authors (S.O. and J.M.). This funder also provided the original siTCR vector (as noted in the Materials and Methods), and provides research funding to co-author HS for work not related to this study. This funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Takara Bio Inc. provided the salaries for these two employees, and provided the original siTCR vector, but played no role in study design, data collection or analysis, the decision to publish, nor the preparation of the manuscript.	Baldini E, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/816430; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Dropulic Boro, 2005, Curr Hematol Rep, V4, P300; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grube M, 2004, CLIN CANCER RES, V10, P1047, DOI 10.1158/1078-0432.CCR-03-0075; Hamada M, 2003, BRIT J HAEMATOL, V121, P439, DOI 10.1046/j.1365-2141.2003.04311.x; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Ho WY, 2003, CANCER CELL, V3, P431, DOI 10.1016/S1535-6108(03)00113-2; Ikezoe T, 2007, MOL CANCER THER, V6, P1851, DOI 10.1158/1535-7163.MCT-07-0067; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kim Yonghyun, 2009, Int J Stem Cells, V2, P109; Kitzen JJEM, 2010, CRIT REV ONCOL HEMAT, V73, P99, DOI 10.1016/j.critrevonc.2009.03.009; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Kobayashi H, 2010, CANCER IMMUNOL IMMUN, V59, P1029, DOI 10.1007/s00262-010-0826-0; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Miyazaki Y, 2013, BLOOD, V121, P4894, DOI 10.1182/blood-2012-11-465971; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Nagai K, 2012, BLOOD, V119, P368, DOI 10.1182/blood-2011-06-360354; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Ochi T, 2009, BLOOD, V113, P66, DOI 10.1182/blood-2008-06-164889; Okamoto S, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.52; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Preffer FI, 2002, STEM CELLS, V20, P417, DOI 10.1634/stemcells.20-5-417; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sadelain M, 2004, GENE THER, V11, P569, DOI 10.1038/sj.gt.3302243; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SCHWARTZENTRUBER DJ, 1994, J CLIN ONCOL, V12, P1475, DOI 10.1200/JCO.1994.12.7.1475; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; SIEMANN DW, 1986, CANCER RES, V46, P3556; Sommermeyer D, 2006, EUR J IMMUNOL, V36, P3052, DOI 10.1002/eji.200636539; Stauss HJ, 2007, MOL THER, V15, P1744, DOI 10.1038/sj.mt.6300216; Thomas S, 2007, J IMMUNOL, V179, P5803, DOI 10.4049/jimmunol.179.9.5803; Voss RH, 2008, J IMMUNOL, V180, P391, DOI 10.4049/jimmunol.180.1.391; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	55	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156896	10.1371/journal.pone.0156896	http://dx.doi.org/10.1371/journal.pone.0156896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271876	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000043
J	Kumordzi, BB; Gundale, MJ; Nilsson, MC; Wardle, DA				Kumordzi, Bright B.; Gundale, Michael J.; Nilsson, Marie-Charlotte; Wardle, David A.			Shifts in Aboveground Biomass Allocation Patterns of Dominant Shrub Species across a Strong Environmental Gradient	PLOS ONE			English	Article							ECOSYSTEM PROPERTIES; ISLAND AREA; PLANTS; SHOOT; ROOT; VARIABILITY; PLASTICITY; RESPONSES; NITROGEN; CAPTURE	Most plant biomass allocation studies have focused on allocation to shoots versus roots, and little is known about drivers of allocation for aboveground plant organs. We explored the drivers of within-and between-species variation of aboveground biomass allocation across a strong environmental resource gradient, i.e., a long-term chronosequence of 30 forested islands in northern Sweden across which soil fertility and plant productivity declines while light availability increases. For each of the three coexisting dominant understory dwarf shrub species on each island, we estimated the fraction of the total aboveground biomass produced year of sampling that was allocated to sexual reproduction (i.e., fruits), leaves and stems for each of two growing seasons, to determine how biomass allocation responded to the chronosequence at both the within-species and whole community levels. Against expectations, within-species allocation to fruits was least on less fertile islands, and allocation to leaves at the whole community level was greatest on intermediate islands. Consistent with expectations, different coexisting species showed contrasting allocation patterns, with the species that was best adapted for more fertile conditions allocating the most to vegetative organs, and with its allocation pattern showing the strongest response to the gradient. Our study suggests that co-existing dominant plant species can display highly contrasting biomass allocations to different aboveground organs within and across species in response to limiting environmental resources within the same plant community. Such knowledge is important for understanding how community assembly, trait spectra, and ecological processes driven by the plant community vary across environmental gradients and among contrasting ecosystems.	[Kumordzi, Bright B.; Gundale, Michael J.; Nilsson, Marie-Charlotte; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden; [Kumordzi, Bright B.] Univ Laval, Dept Sci Bois & Foret, Pavillon Abitibi Price,2405 Rue Terrasse, Quebec City, PQ G1V 0A6, Canada	Swedish University of Agricultural Sciences; Laval University	Kumordzi, BB (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden.; Kumordzi, BB (corresponding author), Univ Laval, Dept Sci Bois & Foret, Pavillon Abitibi Price,2405 Rue Terrasse, Quebec City, PQ G1V 0A6, Canada.	brightkumordzi@yahoo.com	Hegethorn, Marie-Charlotte Nilsson/B-1802-2017; Wardle, David A./F-6031-2011; Gundale, Michael J/O-1265-2013	Hegethorn, Marie-Charlotte Nilsson/0000-0002-9254-2223; Wardle, David A./0000-0002-0476-7335; Gundale, Michael J/0000-0003-2447-609X	Swedish Research Council (Vetenskapsradet); Wallenberg Scholars award	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Wallenberg Scholars award	This work was funded by a grant from the Swedish Research Council (Vetenskapsradet, http://www.vr.se) and a Wallenberg Scholars award (http://www.wallenberg.com/kaw/) to DAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON WG, 1979, EVOLUTION, V33, P517, DOI 10.1111/j.1558-5646.1979.tb04705.x; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; [Anonymous], 1994, WHOLE PLANT PERSPECT; Bazzaz FA, 2000, SEEDS ECOLOGY REGENE; BROUWER R., 1963, Jaarboek. Instituut voor biologisch en scheikundig Onderzoek van Landbouwgewassen 1963, P31; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; CRICK JC, 1987, NEW PHYTOL, V107, P403, DOI 10.1111/j.1469-8137.1987.tb00192.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Freschet GT, 2015, J VEG SCI, V26, P431, DOI 10.1111/jvs.12259; Freschet GT, 2013, ECOL EVOL, V3, P1065, DOI 10.1002/ece3.520; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Gundale MJ, 2012, ECOLOGY, V93, P1695, DOI 10.1890/11-1877.1; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; Jackson BG, 2013, J ECOL, V101, P1409, DOI 10.1111/1365-2745.12155; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Kruse J, 2010, PLANT SOIL, V332, P387, DOI 10.1007/s11104-010-0305-6; Kumordzi BB, 2015, J VEG SCI, V26, P32, DOI 10.1111/jvs.12218; Kumordzi BB, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00339.1; Lagerstrom A., 2013, PLANT SOIL, P1; Le Bagousse-Pinguet Y, 2014, J ECOL, V102, P466, DOI 10.1111/1365-2745.12201; Li LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089063; Li LP, 2014, AQUAT BOT, V112, P84, DOI 10.1016/j.aquabot.2013.08.002; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Niklas KJ, 2003, EVOL ECOL RES, V5, P79; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Poorter L, 2003, PLANT ECOL, V166, P295, DOI 10.1023/A:1023295806147; R-Core Development Team, 2013, R LANG ENV STAT COMP; Siefert A, 2012, OECOLOGIA, V170, P767, DOI 10.1007/s00442-012-2351-7; Taneda H, 2004, AM J BOT, V91, P1949, DOI 10.3732/ajb.91.12.1949; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Wardle DA, 2012, ECOLOGY, V93, P521, DOI 10.1890/11-0930.1; Wardle DA, 2009, FUNCT ECOL, V23, P442, DOI 10.1111/j.1365-2435.2008.01513.x; Yagi T, 2000, J PLANT RES, V113, P171, DOI 10.1007/PL00013928	44	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157136	10.1371/journal.pone.0157136	http://dx.doi.org/10.1371/journal.pone.0157136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270445	Green Submitted, gold, Green Published			2022-12-27	WOS:000377561000066
J	Pukancsik, M; Orban, A; Nagy, K; Matsuo, K; Gekko, K; Maurin, D; Hart, D; Kezsmarki, I; Vertessy, BG				Pukancsik, Maria; Orban, Agnes; Nagy, Kinga; Matsuo, Koichi; Gekko, Kunihiko; Maurin, Damien; Hart, Darren; Kezsmarki, Istvan; Vertessy, Beata G.			Secondary Structure Prediction of Protein Constructs Using Random Incremental Truncation and Vacuum-Ultraviolet CD Spectroscopy	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SYNCHROTRON-RADIATION; SOLUBLE EXPRESSION; BINDING; DOMAIN	A novel uracil-DNA degrading protein factor (termed UDE) was identified in Drosophila melanogaster with no significant structural and functional homology to other uracil-DNA binding or processing factors. Determination of the 3D structure of UDE is excepted to provide key information on the description of the molecular mechanism of action of UDE catalysis, as well as in general uracil-recognition and nuclease action. Towards this long-term aim, the random library ESPRIT technology was applied to the novel protein UDE to overcome problems in identifying soluble expressing constructs given the absence of precise information on domain content and arrangement. Nine constructs of UDE were chosen to decipher structural and functional relationships. Vacuum ultraviolet circular dichroism (VUVCD) spectroscopy was performed to define the secondary structure content and location within UDE and its truncated variants. The quantitative analysis demonstrated exclusive alpha-helical content for the full-length protein, which is preserved in the truncated constructs. Arrangement of alpha-helical bundles within the truncated protein segments suggested new domain boundaries which differ from the conserved motifs determined by sequence-based alignment of UDE homologues. Here we demonstrate that the combination of ESPRIT and VUVCD spectroscopy provides a new structural description of UDE and confirms that the truncated constructs are useful for further detailed functional studies.	[Pukancsik, Maria; Nagy, Kinga; Vertessy, Beata G.] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Pukancsik, Maria; Orban, Agnes; Kezsmarki, Istvan] Budapest Univ Technol & Econ, Dept Phys, H-1111 Budapest, Hungary; [Pukancsik, Maria; Orban, Agnes; Kezsmarki, Istvan] MTA BME Lendulet Magnetoopt Spect Res Grp, H-1111 Budapest, Hungary; [Matsuo, Koichi; Gekko, Kunihiko] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Higashihiroshima 724, Japan; [Maurin, Damien; Hart, Darren] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38044 Grenoble, France; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1111 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Budapest University of Technology & Economics; Budapest University of Technology & Economics; Hiroshima University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Budapest University of Technology & Economics	Pukancsik, M; Vertessy, BG (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.; Pukancsik, M (corresponding author), Budapest Univ Technol & Econ, Dept Phys, H-1111 Budapest, Hungary.; Pukancsik, M (corresponding author), MTA BME Lendulet Magnetoopt Spect Res Grp, H-1111 Budapest, Hungary.; Vertessy, BG (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1111 Budapest, Hungary.	p_marcsi@enzim.hu; vertessy@mail.bme.hu	Vertessy, Beata G/H-6202-2012; Hart, Darren/C-4858-2015	Hart, Darren/0000-0002-3502-2002; Vertessy, Beata G./0000-0002-1288-2982	National Research, Development and Innovation Office, Hungary [OTKA K 109486, 84008, OTKA K 108918]; FRISBI [ANR-10-INSB-05-1102]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]; P-CUBE [INFRA-2008-227764]	National Research, Development and Innovation Office, Hungary; FRISBI; GRAL within the Grenoble Partnership for Structural Biology (PSB); P-CUBE	National Research, Development and Innovation Office, Hungary (OTKA K 109486 and 84008 to BGV, OTKA K 108918 to IK).; The ESPRIT platform is part of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-1102) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB) and funded access was provided by the P-CUBE (INFRA-2008-227764).	Alagna L, 1998, PHYS REV LETT, V80, P4799, DOI 10.1103/PhysRevLett.80.4799; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bekesi A, 2007, BIOCHEM BIOPH RES CO, V355, P643, DOI 10.1016/j.bbrc.2007.01.196; Bekesi A, 2011, FEBS J, V278, P295, DOI 10.1111/j.1742-4658.2010.07951.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Chin DH, 2002, P NATL ACAD SCI USA, V99, P15416, DOI 10.1073/pnas.232591399; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hart DJ, 2006, ACTA CRYSTALLOGR D, V62, P19, DOI 10.1107/S0907444905036097; Hussain R, 2012, COMPREHENSIVE CHIRAL, V8, P438; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Matsuo K, 2005, J BIOCHEM, V138, P79, DOI 10.1093/jb/mvi101; Matsuo K, 2004, J BIOCHEM, V135, P405, DOI 10.1093/jb/mvh048; Matsuo K, 2003, ANAL SCI, V19, P129, DOI 10.2116/analsci.19.129; Matsuo K, 2002, CHEM LETT, P826, DOI 10.1246/cl.2002.826; Matsuo K, 2008, PROTEINS, V73, P104, DOI 10.1002/prot.22055; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Ojima N, 2000, CHEM LETT, P832, DOI 10.1246/cl.2000.832; Ojima N, 2001, CHEM LETT, P522, DOI 10.1246/cl.2001.522; Ostermeier M, 1999, NAT BIOTECHNOL, V17, P1205, DOI 10.1038/70754; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; Pukancsik M, 2010, FEBS J, V277, P1245, DOI 10.1111/j.1742-4658.2009.07556.x; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stephens PJ, 2008, CHIRALITY, V20, P643, DOI 10.1002/chir.20477; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yumerefendi H, 2011, METHODS, V55, P38, DOI 10.1016/j.ymeth.2011.06.007; Yumerefendi H, 2010, J STRUCT BIOL, V172, P66, DOI 10.1016/j.jsb.2010.02.021	39	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156238	10.1371/journal.pone.0156238	http://dx.doi.org/10.1371/journal.pone.0156238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27273007	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000377561000010
J	Tsai, TH; Chang, HT; Ho, YL				Tsai, Tsai-Hsuan; Chang, Hsien-Tsung; Ho, Yi-Lun			Perceptions of a Specific Family Communication Application among Grandparents and Grandchildren: An Extension of the Technology Acceptance Model	PLOS ONE			English	Article							INTERGENERATIONAL RELATIONSHIPS; SELF-EFFICACY; FIT INDEXES; OLDER; PEOPLE; INTERNET; PARTICIPATION; INFORMATION; LONELINESS; INTENTION	Many studies have noted that the use of social networks sites (SNSs) can enhance social interaction among the elderly and that the motivation for the elderly to use SNSs is to keep in contact with remote friends and family or the younger generation. Memotree is designed to promote intergenerational family communication. The system incorporates the Family Tree design concept and provides family communication mechanisms based on the Family Communication Scale. In addition, the system optimizes hardware and interface use to conform to the specific needs of older and substantially younger individuals. Regarding the impact of variables on SNS with respect to the interaction of usability variables in the construction of a cross-generational communication platform, we adopted the TAM model and Chung et al.'s suggestions to promote user acceptance of the proposed Memotree system. A total of 39 grandchildren and 39 grandparents met the criteria and were included in the study. The elderly and young respondents revealed substantial willingness to use and/or satisfaction with using the Memotree system. Empirical results indicate that technology affordances and perceived ease of use have a positive impact on perceived usefulness, while perceived ease of use is affected by technology affordances. Internet self-efficacy and perceived usefulness have a positive impact on the user's behavioral intention toward the system. In addition, this study investigated age as a moderating variable in the model. The results indicate that grandchildren have a larger significant effect on the path between perceived usefulness and behavioral intention than grandparents. This study proposes a more complete framework for investigating the user's behavioral intention and provides a more appropriate explanation of related services for cross-generational interaction with SNS services.	[Tsai, Tsai-Hsuan; Ho, Yi-Lun] Chang Gung Univ, Dept Ind Design, Taoyuan, Taiwan; [Chang, Hsien-Tsung] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Chang Gung University; Chang Gung University	Tsai, TH (corresponding author), Chang Gung Univ, Dept Ind Design, Taoyuan, Taiwan.	ttsai@mail.cgu.edu.tw	Chang, Hsien-Tsung/E-7511-2012	Chang, Hsien-Tsung/0000-0003-4987-5943	National Science Council, Taiwan, ROC [NSC102-2221-E-182-053]; Chang Gung University	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Chang Gung University	This work was supported by the National Science Council, Taiwan, ROC under Contract NSC102-2221-E-182-053, and Chang Gung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Del-Amo M-D-C, 2012, AFRICAN J BUSINESS M, V6, P8609, DOI DOI 10.5897/AJBM11.2664; Asis M M, 1995, J Cross Cult Gerontol, V10, P145, DOI 10.1007/BF00972034; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; BARNES HL, 1985, CHILD DEV, V56, P438, DOI 10.1111/j.1467-8624.1985.tb00118.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Boyd Danah, 2008, MACARTHUR FDN SERIES, P119; Brandtzaeg PB, 2009, LECT NOTES COMPUT SC, V5621, P143, DOI 10.1007/978-3-642-02774-1_16; Brandyberry AA, 2010, AMCIS 2010 P; Brandyberry AA, 2010, DETERMINANTS PERCEIV; Braun MT, 2013, COMPUT HUM BEHAV, V29, P673, DOI 10.1016/j.chb.2012.12.004; Chadwick-Dias A, 2003, ACM SIGCAPH COMPUTER; Chen X, 2000, RES AGING, V22, P43, DOI 10.1177/0164027500221003; Chung JE, 2010, COMPUT HUM BEHAV, V26, P1674, DOI 10.1016/j.chb.2010.06.016; Constantinides E, 2013, STUD COMPUT INTELL, V444, P221; Cornejo R, 2013, COMPUT SUPP COOP W J, V22, P309, DOI 10.1007/s10606-012-9166-2; DEVOS S, 1993, ECON DEV CULT CHANGE, V41, P377, DOI 10.1086/452016; Dhume SM, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON TECHNOLOGY ENHANCED EDUCATION (ICTEE 2012); Ding L, 1995, STRUCT EQU MODELING, V2, P119, DOI 10.1080/10705519509540000; Eastin M.S., 2000, J COMPUT-MEDIAT COMM, V6, pJCMC611, DOI [10.1111/j.1083-6101.2000.tb00110.x, DOI 10.1111/J.1083-6101.2000.TB00110.X]; Ellison N, 2006, INT COMMUNICATION AS, V36; Gangad H., 2008, J INTERACTIVE ADVERT, V8, P5, DOI DOI 10.1080/15252019.2008.10722138; Gibson L, 2010, DESIGNING SOCIAL NET; Hagestad G. O., 2006, Z FAMILIENFORSCH, V18, P315; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Hair Jr JF, 1986, MULTIVARIATE DATA AN; Hampton K, 2011, SOCIAL NETWORKING SI; Harwood J, 2000, J COMMUN, V50, P56, DOI 10.1111/j.1460-2466.2000.tb02863.x; Hatton Yeo A, 2006, INTERGENERATIONAL PR; Hawthorn D, 2000, INTERACT COMPUT, V12, P507, DOI 10.1016/S0953-5438(99)00021-1; Hill Rebecca, 2008, Information Technology & People, V21, P244, DOI 10.1108/09593840810896019; Hu T, 2011, COMMUN ASSOC INF SYS, V29; Huberman BA, 2008, 1 MONDAY, V14, P1, DOI [DOI 10.5210/FM.V14I1.2317, 10.2139/ssrn.1313405]; Igbaria M, 1995, OMEGA-INT J MANAGE S, V23, P587, DOI 10.1016/0305-0483(95)00035-6; Jacoby LL, 2005, J EXP PSYCHOL GEN, V134, P131, DOI 10.1037/0096-3445.134.2.131; Jaeger PT, 2008, J DISABILITY POLICY; Kim Y, 2013, COMPUT HUM BEHAV, V29, P1421, DOI 10.1016/j.chb.2013.01.018; Lehtinen V, 2009, P 23 BRIT HCI GROUP; Leng GS., 2011, J INTERNET BANKING C, V16, P1; Liaw SS, 2003, COMPUT HUM BEHAV, V19, P751, DOI 10.1016/S0747-5632(03)00009-8; Lin HF, 2008, CYBERPSYCHOL BEHAV, V11, P138, DOI 10.1089/cpb.2007.0003; Liu K.P.A.C., 2000, ELECTRON MARK, V10, P120, DOI [10.1080/10196780050138173, DOI 10.1080/10196780050138173]; MacCallum J., 2006, COMMUNITY BUILDING I; Marcoulides GA., 2013, ADV STRUCTURAL EQUAT; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; MORGAN SP, 1983, AM SOCIOL REV, V48, P269, DOI 10.2307/2095111; Morrell RW, 2000, HUM FACTORS, V42, P175, DOI 10.1518/001872000779656444; Munoz D, 2014, FUTURE GENERATION CO; Murata A, 2005, HUM FACTORS, V47, P767, DOI 10.1518/001872005775570952; Murphy M, 2010, INT STUD POPUL, V8, P263, DOI 10.1007/978-90-481-3553-0_11; Noh MJ, 2016, INF SYST E-BUS MANAG, V14, P273, DOI 10.1007/s10257-015-0283-6; Olson DH, 2000, J FAM THER, V22, P144, DOI 10.1111/1467-6427.00144; Park N, 2010, J COMMUN, V60, P40, DOI 10.1111/j.1460-2466.2009.01440.x; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Routasalo PE, 2006, GERONTOLOGY, V52, P181, DOI 10.1159/000091828; Ruhleder K, 2002, INFORM RES, V7, P7; Ryan T, 2011, COMPUT HUM BEHAV, V27, P1658, DOI 10.1016/j.chb.2011.02.004; Ryu MH, 2009, COMPUT HUM BEHAV, V25, P619, DOI 10.1016/j.chb.2008.08.013; Sanchez M, 2007, INTERGENERATIONAL PR; Scott J., 1995, ACM SIGNS DATABASE, V26, P43, DOI DOI 10.1145/206476.206484; Selwyn N, 2004, J AGING STUD, V18, P369, DOI 10.1016/j.jaging.2004.06.008; Seyal AH, 2002, BEHAV INFORM TECHNOL, V21, P71, DOI 10.1080/01449290210123354; Sharma S, 2005, J BUS RES, V58, P935, DOI 10.1016/j.jbusres.2003.10.007; Silverstein M, 2006, J GERONTOL B-PSYCHOL, V61, pS256, DOI 10.1093/geronb/61.5.S256; Smock AD, 2011, COMPUT HUM BEHAV, V27, P2322, DOI 10.1016/j.chb.2011.07.011; Stevens N, 2001, AGEING SOC, V21, P183, DOI 10.1017/S0144686X01008108; Suki NM, 2012, UNIVERSAL ACCESS INF, V11, P223, DOI 10.1007/s10209-011-0248-6; Taylor AC, 2005, J ADULT DEV, V12, P33, DOI 10.1007/s10804-005-1280-7; THORNTON A, 1984, DEMOGRAPHY, V21, P475, DOI 10.2307/2060911; Tsai T-H, 2011, LECT NOTES COMPUTER, V6778, P277; United Nations, FOLL UP 2 WORLD ASS; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 1996, DECISION SCI, V27, P451, DOI 10.1111/j.1540-5915.1996.tb01822.x; Venkatesh V, 2008, DECISION SCI, V39, P273, DOI 10.1111/j.1540-5915.2008.00192.x; Yang SC, 2011, AFR J BUS MANAGE, V5, P9014; Zickuhr K., 2012, OLDER ADULTS INTERNE	76	15	15	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156680	10.1371/journal.pone.0156680	http://dx.doi.org/10.1371/journal.pone.0156680			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27270915	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000030
J	Kang, JO; Lee, JB; Chang, J				Kang, Jung-Ok; Lee, Jee-Boong; Chang, Jun			Cholera Toxin Promotes Th17 Cell Differentiation by Modulating Expression of Polarizing Cytokines and the Antigen-Presenting Potential of Dendritic Cells	PLOS ONE			English	Article							RECEPTOR; ACTIVATION; RESPONSES; IMMUNITY; IL-17; DEGRADATION; GENERATION; FAMILY; ALPHA; STAT5	Cholera toxin (CT), an exotoxin produced by Vibrio cholera, acts as a mucosal adjuvant. In a previous study, we showed that CT skews differentiation of CD4 T cells to IL-17-producing Th17 cells. Here, we found that intranasal administration of CT induced migration of migratory dendritic cell (DC) populations, CD103(+) DCs and CD11b(hi) DCs, to the lung draining mediastinal lymph nodes (medLN). Among those DC subsets, CD11b(hi) DCs that were relatively immature had a major role in Th17 cell differentiation after administration of CT. CT-treated BMDCs showed reduced expression of MHC class II and CD86, similar to CD11b(hi) DCs in medLN, and these BMDCs promoted Th17 cell differentiation more potently than other BMDCs expressing higher levels of MHC class II and CD86. By analyzing the expression of activation markers such as CD25 and CD69, proliferation and IL-2 production, we determined that CT-treated BMDCs showed diminished antigen-presenting potential to CD4(+) T cells compared with normal BMDCs. We also found that CT-stimulated BMDCs promote activin A expression as well as IL-6 and IL-1 beta, and activin A had a synergic role with TGF-beta 1 in CT-mediated Th17 cell differentiation. Taken together, our results suggest that CT-stimulated DCs promote Th17 cell differentiation by not only modulating antigen-presenting potential but also inducing Th polarizing cytokines.	[Kang, Jung-Ok; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lee, Jee-Boong] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, Kyunggi Do, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU)	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2060008]; Korean Health Technology R& D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0826]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korean Health Technology R& D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2060008) and by a grant of the Korean Health Technology R& D Project, Ministry of Health & Welfare, Republic of Korea (Grant number: HI13C0826) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fang R, 2007, INFECT IMMUN, V75, P3112, DOI 10.1128/IAI.00007-07; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Mather JP, 1997, P SOC EXP BIOL MED, V215, P209; Mattsson J, 2015, MUCOSAL IMMUNOL, V8, P815, DOI 10.1038/mi.2014.111; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Murata T, 1997, ENDOCR J, V44, P35, DOI 10.1507/endocrj.44.35; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shiner EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100175; Simms PE, 1996, CLIN DIAGN LAB IMMUN, V3, P301, DOI 10.1128/CDLI.3.3.301-304.1996; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Waithman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066136; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yu J, 1997, CYTOKINES CELL MOL T, V3, P169	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157015	10.1371/journal.pone.0157015	http://dx.doi.org/10.1371/journal.pone.0157015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271559	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200028
J	Cosma, G; Acampora, G; Brown, D; Rees, RC; Khan, M; Pockley, AG				Cosma, Georgina; Acampora, Giovanni; Brown, David; Rees, Robert C.; Khan, Masood; Pockley, A. Graham			Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model	PLOS ONE			English	Article							RISK; CLASSIFICATION; RECURRENCE; NOMOGRAMS; NETWORKS; SYSTEM; TABLES	The prediction of cancer staging in prostate cancer is a process for estimating the likelihood that the cancer has spread before treatment is given to the patient. Although important for determining the most suitable treatment and optimal management strategy for patients, staging continues to present significant challenges to clinicians. Clinical test results such as the pre-treatment Prostate-Specific Antigen (PSA) level, the biopsy most common tumor pattern (Primary Gleason pattern) and the second most common tumor pattern (Secondary Gleason pattern) in tissue biopsies, and the clinical T stage can be used by clinicians to predict the pathological stage of cancer. However, not every patient will return abnormal results in all tests. This significantly influences the capacity to effectively predict the stage of prostate cancer. Herein we have developed a neuro-fuzzy computational intelligence model for classifying and predicting the likelihood of a patient having Organ-Confined Disease (OCD) or Extra-Prostatic Disease (ED) using a prostate cancer patient dataset obtained from The Cancer Genome Atlas (TCGA) Research Network. The system input consisted of the following variables: Primary and Secondary Gleason biopsy patterns, PSA levels, age at diagnosis, and clinical T stage. The performance of the neuro-fuzzy system was compared to other computational intelligence based approaches, namely the Artificial Neural Network, Fuzzy C-Means, Support Vector Machine, the Naive Bayes classifiers, and also the AJCC pTNM Staging Nomogram which is commonly used by clinicians. A comparison of the optimal Receiver Operating Characteristic (ROC) points that were identified using these approaches, revealed that the neuro-fuzzy system, at its optimal point, returns the largest Area Under the ROC Curve (AUC), with a low number of false positives (FPR = 0.274, TPR = 0.789, AUC = 0.812). The proposed approach is also an improvement over the AJCC pTNM Staging Nomogram (FPR = 0.032, TPR = 0.197, AUC = 0.582).	[Cosma, Georgina; Acampora, Giovanni; Brown, David] Nottingham Trent Univ, Sch Sci & Technol, Comp & Technol, Nottingham, England; [Rees, Robert C.; Pockley, A. Graham] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England; [Khan, Masood] Univ Hosp Leicester NHS Trust, Dept Urol, Leicester, Leics, England	Nottingham Trent University; Nottingham Trent University; University Hospitals of Leicester NHS Trust; University of Leicester	Cosma, G (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Comp & Technol, Nottingham, England.	georgina.cosma@ntu.ac.uk	Pockley, Alan G/I-4704-2015; Brown, David J/A-1777-2009; Cosma, Georgina/G-3508-2019	Pockley, Alan G/0000-0001-9593-6431; Cosma, Georgina/0000-0002-4663-6907; brown, david/0000-0002-1677-7485; Acampora, Giovanni/0000-0003-4082-5616	NHS Nottingham City Clinical Commissioning Group's allocation of NIHR Research Capability Funding [CCG/NTU/02/RCF/13-14]; John and Lucille van Geest Foundation; Healthcare and Bioscience iNet, an ERDF	NHS Nottingham City Clinical Commissioning Group's allocation of NIHR Research Capability Funding; John and Lucille van Geest Foundation; Healthcare and Bioscience iNet, an ERDF	This study was funded from the NHS Nottingham City Clinical Commissioning Group's allocation of NIHR Research Capability Funding (Contract Number: CCG/NTU/02/RCF/13-14). The authors would also like to acknowledge the financial support of the John and Lucille van Geest Foundation and the Healthcare and Bioscience iNet, an ERDF funded initiative managed by Medilink East Midlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, J CLIN PATHOL; Benecchi L, 2006, UROLOGY, V68, P357, DOI 10.1016/j.urology.2006.03.003; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; BLUTE ML, 1989, J UROLOGY, V142, P1262, DOI 10.1016/S0022-5347(17)39051-1; Boehm K, 2015, EUROPEAN UROLOGY; Brawer K, 2013, J CLIN ONCOL, P31; Briganti Alberto, 2009, Eur Urol, V55, P743, DOI 10.1016/j.eururo.2008.11.038; Burford D., 2009, PROSTATE CANC RISK M; Castanho MJP, 2013, EXPERT SYST APPL, V40, P466, DOI 10.1016/j.eswa.2012.07.046; Chun FKH, 2007, BJU INT, V99, P794, DOI 10.1111/j.1464-410X.2006.06694.x; Cinar M, 2009, EXPERT SYST APPL, V36, P6357, DOI 10.1016/j.eswa.2008.08.010; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Cristianini N, 2000, INTRO SUPPORT VECTOR; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dotan ZA, 2009, EUR UROL SUPPL, V8, P721, DOI 10.1016/j.eursup.2009.06.013; Edge SB, 2010, AJCC CANC STAGING MA; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y; Falzarano S., 2010, DIAGN HISTOPATHOL, V16, P432, DOI DOI 10.1016/J.MPDHP.2010.06.010; Han J., 2011, DATA MINING CONCEPTS, V2nd; Hastie T.J., 2001, ELEMENTS STAT LEARNI; Heijnsdijk E, 2012, J UROLOGY, V187, pE491, DOI 10.1016/j.juro.2012.02.1502; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jang JSR, 1996, FUZZ-IEEE '96 - PROCEEDINGS OF THE FIFTH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P1493, DOI 10.1109/FUZZY.1996.552396; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Keles A, 2007, COMPUT BIOL MED, V37, P1617, DOI 10.1016/j.compbiomed.2007.03.006; Lujan M, 2012, ACTAS UROL ESP, V36, P403, DOI 10.1016/j.acuro.2011.10.013; Makarov DV, 2007, UROLOGY, V69, P1095, DOI 10.1016/j.urology.2007.03.042; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Saritas I, 2010, EXPERT SYST APPL, V37, P6646, DOI 10.1016/j.eswa.2010.03.056; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Shariat SF, 2009, FUTURE ONCOL, V5, P1555, DOI [10.2217/fon.09.121, 10.2217/FON.09.121]; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Sugeno M., 1993, IEEE Transactions on Fuzzy Systems, V1, P7, DOI 10.1109/TFUZZ.1993.390281; Tamblyn DJ, 2011, BJU INT, V108, DOI 10.1111/j.1464-410X.2011.10687.x; Tewari A, 2001, MOL UROL, V5, P147, DOI 10.1089/10915360152745812; Tsao CW, 2014, J CHIN MED ASSOC, V77, P513, DOI 10.1016/j.jcma.2014.06.014; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	40	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155856	10.1371/journal.pone.0155856	http://dx.doi.org/10.1371/journal.pone.0155856			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258119	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700022
J	Mariani, E; Canella, V; Cattini, L; Kon, E; Marcacci, M; Di Matteo, B; Pulsatelli, L; Filardo, G				Mariani, Erminia; Canella, Valentina; Cattini, Luca; Kon, Elizaveta; Marcacci, Maurilio; Di Matteo, Berardo; Pulsatelli, Lia; Filardo, Giuseppe			Leukocyte-Rich Platelet-Rich Plasma Injections Do Not Up-Modulate Intra-Articular Pro-Inflammatory Cytokines in the Osteoarthritic Knee	PLOS ONE			English	Article							SYNOVIAL-FLUID; GROWTH-FACTOR; SURGICAL-TREATMENT; FORMULATIONS; PROFILES; BLOOD	Introduction The presence of leukocytes in platelet concentrates is deemed to cause deleterious effects when injected intra articularly. The aim of this study is to analyse both local and systemic effects induced by leukocyte-rich Platelet-rich Plasma (PRP) injections through a proteomic characterization of serial synovial fluid and blood samples obtained from subjects treated for knee OA. Secondary aim was to compare the effects on knee homeostasis and systemic response with those obtained with visco-supplementation. Methods Thirty-six OA patients treated either by autologous L-PRP or HA intra-articular knee injections, administered in series of three at one-week intervals, were analyzed. Just before the injection, 1 ml of synovial fluid was collected through the same needle way. In the same time, a peripheral blood sample was obtained and plasma separated. A further peripheral blood sample was collected at 2, 6, and 12 months. L-PRP, plasma and synovial fluid were tested by multiplex bead-based sandwich immunoassay by means of the Bio-Plex suspension array system (Bio-Rad Laboratories) for the presence of pro-and anti-inflammatory cytokines (IL-1beta, IL-6, IL-8, IL-17 and IL-4, IL-10, IL-13) and growth factors (FGF-b, HGF, PDGF-AB/BB). Results In general, pro-inflammatory cytokine levels were similar at basal condition and after treatment whereas anti-inflammatory ones were nearly undetectable. L-PRP administration did not modulate significant changes of cytokine concentrations either in synovial fluid or plasma, whatever the time points analyzed. No different trend was observed between L-PRP and HA administration in terms of pro- and anti-inflammatory cytokines, as well as growth factors. Conclusions In contrast with the evidence reported by "in vitro" studies, where a cellular pro-inflammatory response appears to be induced by the presence of leukocytes, these results suggest that the presence leukocyte-rich PRP doesn't induce a relevant in vivo up regulation of proinflammatory mediators.	[Mariani, Erminia; Canella, Valentina; Cattini, Luca; Pulsatelli, Lia] Rizzoli Orthopaed Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy; [Mariani, Erminia] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Kon, Elizaveta; Marcacci, Maurilio; Di Matteo, Berardo; Filardo, Giuseppe] Rizzoli Orthopaed Inst, Orthopaed & Traumatol Clin 2, Lab Biomech & Technol Innovat NABI, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Di Matteo, B (corresponding author), Rizzoli Orthopaed Inst, Orthopaed & Traumatol Clin 2, Lab Biomech & Technol Innovat NABI, Bologna, Italy.	bdimatteo@biomec.ior.it	Mariani, Erminia/AAE-8110-2021; Pulsatelli, Lia/D-4092-2019; Mariani, Erminia/C-6881-2019; Filardo, Giuseppe/K-5088-2016	Mariani, Erminia/0000-0002-4407-6707; Pulsatelli, Lia/0000-0003-3031-170X; Mariani, Erminia/0000-0002-4407-6707; MARCACCI, MAURILIO/0000-0002-7484-1246; Di Matteo, Berardo/0000-0002-9807-0271; Filardo, Giuseppe/0000-0002-8136-0977; KON, ELIZAVETA/0000-0003-0649-2336	Rizzoli Orthopaedic Institute (Ricerca Corrente); University of Bologna (RFO funds); Italian Ministry of Health (Project RF) [1498841]; Emilia-Romagna Region (Region-University Program: Regenerative Medicine of Cartilage and Bone)	Rizzoli Orthopaedic Institute (Ricerca Corrente); University of Bologna (RFO funds); Italian Ministry of Health (Project RF); Emilia-Romagna Region (Region-University Program: Regenerative Medicine of Cartilage and Bone)	This work was supported by grants from Rizzoli Orthopaedic Institute (Ricerca Corrente), "5x1000" funds, University of Bologna (RFO funds to EM), Italian Ministry of Health (Project RF-2009 grant no. 1498841) and Emilia-Romagna Region (Region-University Program 2010-2012: Regenerative Medicine of Cartilage and Bone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2014, J BIOMED MAT RES A; Anitua E, 2013, ANN ANAT, V195, P461, DOI 10.1016/j.aanat.2013.04.004; Assirelli E., 2014, KNEE SURG SPORTS TRA; Braun HJ, 2014, AM J SPORT MED, V42, P1204, DOI 10.1177/0363546514525593; Browning Shawn R, 2012, J Bone Joint Surg Am, V94, pe1721, DOI 10.2106/JBJS.K.01501; Cavallo C, 2014, J BONE JOINT SURG AM, V96A, P423, DOI 10.2106/JBJS.M.00726; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Filardo G, 2015, AM J SPORT MED; Filardo G., 2013, KNEE SURG SPORTS TRA; Filardo G, 2013, AM J SPORT MED, V41, P95, DOI 10.1177/0363546512463675; Filardo G, 2012, KNEE SURG SPORT TR A, V20, P2078, DOI 10.1007/s00167-011-1837-x; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P468, DOI 10.1007/s00167-011-1714-7; Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; Johnson VL, 2014, BEST PRACT RES CL RH, V28, P5, DOI 10.1016/j.berh.2014.01.004; Kaneko S, 2000, CYTOKINES CELL MOL T, V6, P71, DOI 10.1080/13684730050515796; Kon Elizaveta, 2013, Open Orthop J, V7, P120, DOI 10.2174/1874325001307010120; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Liu-Bryan R, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0323-5; Mabey T, 2014, INT ORTHOP, V38, P1885, DOI 10.1007/s00264-014-2406-y; Mariani E, 2008, EXP GERONTOL, V43, P462, DOI 10.1016/j.exger.2007.12.003; Mariani E, 2006, BIOGERONTOLOGY, V7, P449, DOI 10.1007/s10522-006-9060-8; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; Perut F, 2013, CYTOTHERAPY, V15, P830, DOI 10.1016/j.jcyt.2013.01.220; Poole A Robin, 2012, HSS J, V8, P4, DOI 10.1007/s11420-011-9248-6; Rios DL, 2015, CYTOKINE, V76, P505, DOI 10.1016/j.cyto.2015.07.008; Smyth NA, 2013, ARTHROSCOPY, V29, P1399, DOI 10.1016/j.arthro.2013.03.004; Sundman EA, 2011, AM J SPORT MED, V39, P2135, DOI 10.1177/0363546511417792; Textor JA, 2013, VET J, V198, P217, DOI 10.1016/j.tvjl.2013.07.020; Tschon Matilde, 2011, Front Biosci (Elite Ed), V3, P96	33	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156137	10.1371/journal.pone.0156137	http://dx.doi.org/10.1371/journal.pone.0156137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258008	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700039
J	Abdalrhim, AD; Marroush, TS; Austin, EE; Gersh, BJ; Solak, N; Rizvi, SA; Bailey, KR; Kullo, IJ				Abdalrhim, Ahmed D.; Marroush, Tariq S.; Austin, Erin E.; Gersh, Bernard J.; Solak, Nusret; Rizvi, Syed A.; Bailey, Kent R.; Kullo, Iftikhar J.			Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEART-FAILURE; EXPRESSION; ATHEROSCLEROSIS; SEVERITY; MARKER	Osteopontin (OPN) is a secreted glycophosphoprotein that has a role in inflammation, immune response and calcification. We hypothesized that plasma OPN levels are associated with adverse cardiovascular outcomes in patients with stable coronary artery disease (CAD) and preserved ejection fraction (EF) enrolled in the PEACE trial. We measured plasma OPN levels at baseline in 3567 CAD patients (mean age 64.5 +/- 8.1 years, 81% men) by a sandwich chemiluminescent assay (coefficient of variation = 4.1%). OPN levels were natural log (Ln) transformed prior to analyses. We assessed whether Ln OPN levels were associated with the composite primary endpoint of cardiovascular death, non-fatal myocardial infarction and hospitalization for heart failure using multiple event multivariable Cox proportional hazards regression. Adjustment was performed for: (a) age and sex; (b) additional potential confounders; and (c) a parsimonious set of statistically significant 10 variates. During a median follow-up of 4.8 years, 416 adverse cardiovascular outcomes occurred in 366 patients. Ln OPN was significantly associated with the primary endpoint; HR (95% CI) = 1.56 (1.27, 1.92); P < 0.001, and remained significant after adjustment for age and sex [1.31 (1.06, 1.61); P = 0.01] and after adjustment for relevant covariates [1.24 (1.01, 1.52); P = 0.04]. In a secondary analysis of the individual event types, Ln OPN was significantly associated with incident hospitalization for heart failure: HR (95% CI) = 2.04 (1.44, 2.89); P < 0.001, even after adjustment for age, sex and additional relevant covariates. In conclusion, in patients with stable CAD and preserved EF on optimal medical therapy, plasma OPN levels were independently associated with the composite incident endpoint of adverse cardiovascular outcomes as well as incident hospitalization for heart failure.	[Abdalrhim, Ahmed D.; Marroush, Tariq S.; Austin, Erin E.; Gersh, Bernard J.; Solak, Nusret; Kullo, Iftikhar J.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA; [Rizvi, Syed A.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Bailey, Kent R.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kullo, IJ (corresponding author), Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA.	Kullo.Iftikhar@mayo.edu		SOLAK, NUSRET/0000-0002-0352-8711	National Institutes of Health USA	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health USA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeez HAH, 2010, J CLIN LAB ANAL, V24, P201, DOI 10.1002/jcla.20378; [Anonymous], 2014, R LANG ENV STAT COMP; Arnlov J, 2006, HEART, V92, P1514, DOI 10.1136/hrt.2005.081406; Bjerre M, 2013, EUR J PREV CARDIOL, V20, P922, DOI 10.1177/2047487313487083; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Chen J, 2014, INT J CLIN EXP MED, V7, P1122; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Ford ES, 2000, AM HEART J, V139, P371, DOI 10.1067/mhj.2000.102907; Georgiadou P, 2010, EUR J CLIN INVEST, V40, P288, DOI 10.1111/j.1365-2362.2010.02257.x; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grau JB, 2012, ANN THORAC SURG, V93, P79, DOI 10.1016/j.athoracsur.2011.08.036; Kassebaum NJ, 2014, LANCET, V384, P2209, DOI 10.1016/S0140-6736(14)62425-9; Lorenzen JM, 2010, ATHEROSCLEROSIS, V209, P184, DOI 10.1016/j.atherosclerosis.2009.09.009; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Minoretti P, 2006, EUR HEART J, V27, P802, DOI 10.1093/eurheartj/ehi730; Nunohiro T, 1997, HEART VESSELS, P201; Ohmori R, 2003, ATHEROSCLEROSIS, V170, P333, DOI 10.1016/S0021-9150(03)00298-3; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Sabatine MS, 2012, CIRCULATION, V125, P233, DOI 10.1161/CIRCULATIONAHA.111.063842; Singh K, 1999, HYPERTENSION, V33, P663, DOI 10.1161/01.HYP.33.2.663; Soejima H, 2007, CIRC J, V71, P1879, DOI 10.1253/circj.71.1879; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Wolak T, 2014, ATHEROSCLEROSIS, V236, P327, DOI 10.1016/j.atherosclerosis.2014.07.004; Zahradka P, 2008, CIRC RES, V102, P270, DOI 10.1161/CIRCRESAHA.107.170555	27	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156965	10.1371/journal.pone.0156965	http://dx.doi.org/10.1371/journal.pone.0156965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284698	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000034
J	Gadeberg, HC; Bond, RC; Kong, CHT; Chanoit, GP; Ascione, R; Cannell, MB; James, AF				Gadeberg, Hanne C.; Bond, Richard C.; Kong, Cherrie H. T.; Chanoit, Guillaume P.; Ascione, Raimondo; Cannell, Mark B.; James, Andrew F.			Heterogeneity of T-Tubules in Pig Hearts	PLOS ONE			English	Article							RAT ATRIAL MYOCYTES; VENTRICULAR MYOCYTES; CA2+ RELEASE; TRANSVERSE TUBULES; CONTRACTION; MYOCARDIUM; CELLS; SYSTEM; ULTRASTRUCTURE; MUSCLE	Background T-tubules are invaginations of the sarcolemma that play a key role in excitation-contraction coupling in mammalian cardiac myocytes. Although t-tubules were generally considered to be effectively absent in atrial myocytes, recent studies on atrial cells from larger mammals suggest that t-tubules may be more numerous than previously supposed. However, the degree of heterogeneity between cardiomyocytes in the extent of the t-tubule network remains unclear. The aim of the present study was to investigate the t-tubule network of pig atrial myocytes in comparison with ventricular tissue. Methods Cardiac tissue was obtained from young female Landrace White pigs (45-75 kg, 5-6 months old). Cardiomyocytes were isolated by arterial perfusion with a collagenase-containing solution. Ca2+ transients were examined in field-stimulated isolated cells loaded with fluo-4-AM. Membranes of isolated cells were visualized using di-8-ANEPPS. T-tubules were visualized in fixed-frozen tissue sections stained with Alexa-Fluor 488-conjugated WGA. Binary images were obtained by application of a threshold and t-tubule density (TTD) calculated. A distance mapping approach was used to calculate half-distance to nearest t-tubule (HDTT). Results & Conclusion The spatio-temporal properties of the Ca2+ transient appeared to be consistent with the absence of functional t-tubules in isolated atrial myocytes. However, t-tubules could be identified in a sub-population of atrial cells in frozen sections. While all ventricular myocytes had TTD >3% (mean TTD = 6.94 +/- 0.395%, n = 24), this was true of just 5/22 atrial cells. Mean atrial TTD (2.35 +/- 0.457%, n = 22) was lower than ventricular TTD (P<0.0001). TTD correlated with cell-width (r = 0.7756, n = 46, P<0.0001). HDTT was significantly greater in the atrial cells with TTD <= 3% (2.29 +/- 0.16 mu m, n = 17) than in either ventricular cells (1.33 +/- 0.05 mu m, n = 24, P<0.0001) or in atrial cells with TTD >3% (1.65 +/- 0.06 mu m, n = 5, P<0.05). These data demonstrate considerable heterogeneity between pig cardiomyocytes in the extent of t-tubule network, which correlated with cell size.	[Gadeberg, Hanne C.; Bond, Richard C.; Kong, Cherrie H. T.; Cannell, Mark B.; James, Andrew F.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol Cardiovasc, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England; [Chanoit, Guillaume P.] Univ Bristol, Sch Vet Sci, Langford House, Langford BS40 5DU, England; [Ascione, Raimondo] Univ Bristol, Sch Clin Sci, Bristol Royal Infirm, Upper Maudlin St, Bristol BS2 8HW, Avon, England	University of Bristol; University of Bristol; Bristol Royal Infirmary; University of Bristol	Cannell, MB; James, AF (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol Cardiovasc, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England.	mark.cannell@bristol.ac.uk; a.james@bristol.ac.uk	Chanoit, Guillaume P/GSD-3137-2022; Chanoit, Guillaume/AAC-4836-2022; Chanoit, Guillaume PA/T-3702-2017	Chanoit, Guillaume/0000-0002-7414-6403; Chanoit, Guillaume PA/0000-0002-7414-6403	British Heart Foundation [RG/12/10/29802]; British Heart Foundation Clinical Research Training Fellowship [FS/10/68/28492]; British Heart Foundation [PG/14/65/31055, PG/10/40/28369, FS/10/68/28492] Funding Source: researchfish; Medical Research Council [MR/L012723/1] Funding Source: researchfish; MRC [MR/L012723/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation Clinical Research Training Fellowship; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the British Heart Foundation Programme grant RG/12/10/29802, CHTK MBC AFJ, and British Heart Foundation Clinical Research Training Fellowship FS/10/68/28492, RCB AFJ.	AYETTEY AS, 1978, J ANAT, V127, P125; BERLIN JR, 1995, AM J PHYSIOL-HEART C, V269, pH1165, DOI 10.1152/ajpheart.1995.269.3.H1165; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Brette F, 2002, AM J PHYSIOL-HEART C, V283, pH1720, DOI 10.1152/ajpheart.00347.2002; Cannell MB, 2012, J MOL CELL CARDIOL, V52, P298, DOI 10.1016/j.yjmcc.2011.04.014; CANNELL MB, 1984, BIOPHYS J, V45, P913, DOI 10.1016/S0006-3495(84)84238-1; Cannell MB, 2006, HDB BIOL CONFOCAL MI, P488, DOI DOI 10.1007/978-0-387-45524-2_25; CHENG H, 1994, PFLUG ARCH EUR J PHY, V428, P415, DOI 10.1007/BF00724526; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; DOLBER PC, 1994, AM J PHYSIOL-HEART C, V267, pH1279, DOI 10.1152/ajpheart.1994.267.4.H1279; Silva FFE, 2013, GENET MOL BIOL, V36, P520, DOI 10.1590/s1415-47572013005000042; FORBES MS, 1990, J STRUCT BIOL, V103, P266, DOI 10.1016/1047-8477(90)90045-E; FORBES MS, 1988, ANAT RECORD, V222, P362, DOI 10.1002/ar.1092220409; FORSSMAN.WG, 1970, J CELL BIOL, V44, P1, DOI 10.1083/jcb.44.1.1; Frisk M, 2014, AM J PHYSIOL-HEART C, V307, pH609, DOI 10.1152/ajpheart.00295.2014; Garger JC, 2011, GUIDE FOR THE CARE A; GOTOH T, 1983, ACTA ANAT, V115, P168; Greiser M, 2011, CARDIOVASC RES, V89, P722, DOI 10.1093/cvr/cvq389; He JQ, 2001, CARDIOVASC RES, V49, P298, DOI 10.1016/S0008-6363(00)00256-X; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; HIBBS RG, 1969, AM J ANAT, V124, P251, DOI 10.1002/aja.1001240302; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; IIDA H, 1989, CELL TISSUE RES, V257, P325, DOI 10.1007/BF00261836; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Kawai M, 1999, AM J PHYSIOL-HEART C, V277, pH603, DOI 10.1152/ajpheart.1999.277.2.H603; Kockskamper J, 2001, BIOPHYS J, V81, P2590, DOI 10.1016/S0006-3495(01)75903-6; LEGATO MJ, 1973, CIRCULATION, V47, P178, DOI 10.1161/01.CIR.47.1.178; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Lipp P, 1996, J PHYSIOL-LONDON, V497, P599, DOI 10.1113/jphysiol.1996.sp021793; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; MCNUTT NS, 1969, J CELL BIOL, V42, P46, DOI 10.1083/jcb.42.1.46; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; Mitcheson JS, 1996, PFLUG ARCH EUR J PHY, V431, P814, DOI 10.1007/BF02332165; Orchard CH, 2013, J PHYSIOL-LONDON, V591, P4141, DOI 10.1113/jphysiol.2013.254540; Orchard CH, 2009, EXP PHYSIOL, V94, P509, DOI 10.1113/expphysiol.2008.043984; REILAND S, 1978, ACTA RADIOL DIAGN, P15; Richards MA, 2011, AM J PHYSIOL-HEART C, V301, pH1996, DOI 10.1152/ajpheart.00284.2011; RUBIO D, 1989, J VET MED A, V36, P64, DOI 10.1111/j.1439-0442.1989.tb00703.x; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; TIDBALL JG, 1991, CELL TISSUE RES, V264, P293, DOI 10.1007/BF00313966; Trafford AW, 2013, CARDIOVASC RES, V98, P192, DOI 10.1093/cvr/cvt018; Walters EM, 2011, ANN NY ACAD SCI, V1245, P63, DOI 10.1111/j.1749-6632.2011.06345.x; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Woo SH, 2002, J PHYSIOL-LONDON, V543, P439, DOI 10.1113/jphysiol.2002.024190; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186	49	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156862	10.1371/journal.pone.0156862	http://dx.doi.org/10.1371/journal.pone.0156862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281038	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000050
J	Haronikova, L; Coufal, J; Kejnovska, I; Jagelska, EB; Fojta, M; Dvorakova, P; Muller, P; Vojtesek, B; Brazda, V				Haronikova, Lucia; Coufal, Jan; Kejnovska, Iva; Jagelska, Eva B.; Fojta, Miroslav; Dvorakova, Petra; Muller, Petr; Vojtesek, Borivoj; Brazda, Vaclav			IFI16 Preferentially Binds to DNA with Quadruplex Structure and Enhances DNA Quadruplex Formation	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN; CIRCULAR-DICHROISM SPECTROSCOPY; RELEVANT G-QUADRUPLEX; INNATE IMMUNE SENSOR; NUCLEIC-ACID; PROVIDES INSIGHTS; PROMOTER REGION; ACTIVATION; GENE; RNA	Interferon-inducible protein 16 (IFI16) is a member of the HIN-200 protein family, containing two HIN domains and one PYRIN domain. IFI16 acts as a sensor of viral and bacterial DNA and is important for innate immune responses. IFI16 binds DNA and binding has been described to be DNA length-dependent, but a preference for supercoiled DNA has also been demonstrated. Here we report a specific preference of IFI16 for binding to quadruplex DNA compared to other DNA structures. IFI16 binds to quadruplex DNA with significantly higher affinity than to the same sequence in double stranded DNA. By circular dichroism (CD) spectroscopy we also demonstrated the ability of IFI16 to stabilize quadruplex structures with quadruplex-forming oligonucleotides derived from human telomere (HTEL) sequences and the MYC promotor. A novel H/D exchange mass spectrometry approach was developed to assess protein interactions with quadruplex DNA. Quadruplex DNA changed the IFI16 deuteration profile in parts of the PYRIN domain (aa 0-80) and in structurally identical parts of both HIN domains (aa 271-302 and aa 586-617) compared to single stranded or double stranded DNAs, supporting the preferential affinity of IFI16 for structured DNA. Our results reveal the importance of quadruplex DNA structure in IFI16 binding and improve our understanding of how IFI16 senses DNA. IFI16 selectivity for quadruplex structure provides a mechanistic framework for IFI16 in immunity and cellular processes including DNA damage responses and cell proliferation.	[Haronikova, Lucia; Coufal, Jan; Kejnovska, Iva; Jagelska, Eva B.; Fojta, Miroslav; Brazda, Vaclav] Acad Sci Czech Republ, Inst Biophys, Kralovopolska 135, CS-61265 Brno, Czech Republic; [Haronikova, Lucia] Masaryk Univ, Fac Sci, Dept Biochem, Kotlarska 2, CS-61137 Brno, Czech Republic; [Dvorakova, Petra; Muller, Petr; Vojtesek, Borivoj] Masaryk Mem Canc Inst, RECAMO, Zluty Kopec 7, Brno 65653, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; Masaryk Memorial Cancer Institute	Brazda, V (corresponding author), Acad Sci Czech Republ, Inst Biophys, Kralovopolska 135, CS-61265 Brno, Czech Republic.	vaclav@ibp.cz	Brazda, Vaclav/ABH-9460-2020; Muller, Petr/AAK-5014-2021; Kejnovska, Iva/G-9767-2014; Muller, Petr/F-7762-2015; Václav, Brázda/F-9582-2011; Haronikova, Lucia/A-1530-2018	Brazda, Vaclav/0000-0003-2837-4226; Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Václav, Brázda/0000-0003-2837-4226; Haronikova, Lucia/0000-0002-4903-2404	Grant Agency of the Czech Republic [15-21855S, P206/12/G151];  [MEYS-NPSI-LO1413]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); 	This work was supported by the Grant Agency of the Czech Republic: 15-21855S (LH, JC, EBJ, VB), P206/12/G151 (MF, PM, BV) and by MEYS-NPSI-LO1413 (PD).	Aglipay JA, 2003, ONCOGENE, V22, P8931, DOI 10.1038/sj.onc.1207057; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ansari MA, 2013, J VIROL, V87, P8606, DOI 10.1128/JVI.00805-13; Booiman T, 2014, INT J IMMUNOGENET, V41, P518, DOI 10.1111/iji.12157; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Brazda V, 2012, BIOCHEM BIOPH RES CO, V422, P716, DOI 10.1016/j.bbrc.2012.05.065; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Costa S, 2011, BRIT J DERMATOL, V164, P282, DOI 10.1111/j.1365-2133.2010.10097.x; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DAWSON MJ, 1995, BIOCHEM BIOPH RES CO, V214, P152, DOI 10.1006/bbrc.1995.2269; DAWSON MJ, 1995, J CELL BIOCHEM, V57, P39, DOI 10.1002/jcb.240570106; Egistelli L, 2009, J CELL BIOCHEM, V106, P666, DOI 10.1002/jcb.22053; Fekete A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042690; Fujiuchi N, 2004, J BIOL CHEM, V279, P20339, DOI 10.1074/jbc.M400344200; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; GRAY DM, 1995, METHOD ENZYMOL, V246, P19; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13; Johnstone RW, 1998, J BIOL CHEM, V273, P17172, DOI 10.1074/jbc.273.27.17172; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Ni XM, 2016, J MOL CELL BIOL, V8, P51, DOI 10.1093/jmcb/mjv053; Nissen SK, 2014, CLIN EXP IMMUNOL, V177, P295, DOI 10.1111/cei.12317; Ouchi M, 2008, FRONT BIOSCI-LANDMRK, V13, P236, DOI 10.2741/2673; Palacky J, 2013, NUCLEIC ACIDS RES, V41, P1005, DOI 10.1093/nar/gks1135; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Prakash A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/896947; Prakash A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/529828; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quante T, 2012, CELL CYCLE, V11, P3290, DOI 10.4161/cc.21646; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Renciuk D, 2009, NUCLEIC ACIDS RES, V37, P6625, DOI 10.1093/nar/gkp701; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Singh VV, 2013, J VIROL, V87, P4417, DOI 10.1128/JVI.03282-12; Song LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008569; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Tosoni E, 2015, NUCLEIC ACIDS RES, V43, P8884, DOI 10.1093/nar/gkv897; Trcka F, 2014, J BIOL CHEM, V289, P9887, DOI 10.1074/jbc.M113.526046; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Veeranki S, 2012, MOL IMMUNOL, V49, P567, DOI 10.1016/j.molimm.2011.11.004; Virno A, 2007, NUCLEOS NUCLEOT NUCL, V26, P1133, DOI 10.1080/15257770701521854; Vorlickova M, 2012, CHIRALITY, V24, P691, DOI 10.1002/chir.22064; Wang Q, 2011, NUCLEIC ACIDS RES, V39, P6229, DOI 10.1093/nar/gkr164; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Yan HY, 2008, BBA-PROTEINS PROTEOM, V1784, P1087, DOI 10.1016/j.bbapap.2008.04.004; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	64	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157156	10.1371/journal.pone.0157156	http://dx.doi.org/10.1371/journal.pone.0157156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280708	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000097
J	Toyoda, Y; Takada, T; Miyata, H; Ishikawa, T; Suzuki, H				Toyoda, Yu; Takada, Tappei; Miyata, Hiroshi; Ishikawa, Toshihisa; Suzuki, Hiroshi			Regulation of the Axillary Osmidrosis-Associated ABCC11 Protein Stability by N-Linked Glycosylation: Effect of Glucose Condition	PLOS ONE			English	Article							MEDIATED PROTEASOMAL DEGRADATION; HUMAN EARWAX-TYPE; TRANSPORTER ABCC11; CYSTIC-FIBROSIS; BREAST-CANCER; EFFLUX PUMP; CELLS; GENE; EXPRESSION; SECRETION	ATP-binding cassette C11 (ABCC11) is a plasma membrane protein involved in the transport of a variety of lipophilic anions. ABCC11 wild-type is responsible for the high-secretion phenotypes in human apocrine glands, such as that of wet-type ear wax, and the risk of axillary osmidrosis. We have previously reported that mature ABCC11 is a glycoprotein containing two N-linked glycans at Asn838 and Asn844. However, little is known about the role of N-linked glycosylation in the regulation of ABCC11 protein. In the current study, we investigated the effects of N-linked glycosylation on the protein level and localization of ABCC11 using polarized Madin-Darby canine kidney II cells. When the N-linked glycosylation in ABCC11-expressing cells was chemically inhibited by tunicamycin treatment, the maturation of ABCC11 was suppressed and its protein level was significantly decreased. Immunoblotting analyses demonstrated that the protein level of the N-linked glycosylation-deficient mutant (N838Q and N844Q: Q838/844) was about half of the ABCC11 wild-type level. Further biochemical studies with the Q838/844 mutant showed that this glycosylation-deficient ABCC11 was degraded faster than wild-type probably due to the enhancement of the MG132-sensitive protein degradation pathway. Moreover, the incubation of ABCC11 wildtype-expressing cells in a low-glucose condition decreased mature, glycosylated ABCC11, compared with the high-glucose condition. On the other hand, the protein level of the Q838/844 mutant was not affected by glucose condition. These results suggest that N-linked glycosylation is important for the protein stability of ABCC11, and physiological alteration in glucose may affect the ABCC11 protein level and ABCC11-related phenotypes in humans, such as axillary osmidrosis.	[Toyoda, Yu; Takada, Tappei; Miyata, Hiroshi; Suzuki, Hiroshi] Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan; [Ishikawa, Toshihisa] RIKEN Ctr Life Sci Technol, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN	Toyoda, Y (corresponding author), Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan.	ytoyoda-tky@umin.ac.jp	Toyoda, Yu/S-9802-2019	Toyoda, Yu/0000-0002-7411-0531	Japan Society for the Promotion of Science (JSPS) KAKENHI [12J03163, 15H05610]; Grants-in-Aid for Scientific Research [15H05610] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/) KAKENHI grant number 12J03163 and 15H05610 to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The NGO Personalized Medicine & Healthcare (founder and president: Dr. Toshihisa Ishikawa) did not take any role of fund provider in the present study at all. In addition, this non-governmental organization did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Ishikawa only contributed to the writing of the manuscript as a critical reviewer and scientific adviser. In other words, Dr. Ishikawa contributed scientifically, but not financially, to this research.	Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Bortfeld M, 2006, NEUROSCIENCE, V137, P1247, DOI 10.1016/j.neuroscience.2005.10.025; Bronsveld I, 2000, GASTROENTEROLOGY, V119, P32, DOI 10.1053/gast.2000.8524; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen GP, 2011, FASEB J, V25, P4531, DOI 10.1096/fj.11-185991; Chen ZS, 2005, MOL PHARMACOL, V67, P545, DOI 10.1124/mol.104.007138; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Dray-Charier N, 1999, HEPATOLOGY, V29, P1624, DOI 10.1002/hep.510290634; Emi Y, 2011, J BIOCHEM, V149, P177, DOI 10.1093/jb/mvq131; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; George A. M., 2016, ABC TRANSPORTERS 40; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Inoue Y, 2010, J PLAST RECONSTR AES, V63, P1369, DOI 10.1016/j.bjps.2009.06.029; Ishikawa Toshihisa, 2013, Frontiers in Genetics, V3, P306, DOI 10.3389/fgene.2012.00306; Ito N, 2015, PHARM RES; Kruh GD, 2007, PFLUG ARCH EUR J PHY, V453, P675, DOI 10.1007/s00424-006-0114-1; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Martin A, 2010, J INVEST DERMATOL, V130, P529, DOI 10.1038/jid.2009.254; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Miura K, 2007, HUM GENET, V121, P631, DOI 10.1007/s00439-007-0356-9; Muthusamy S, 2015, AM J PHYSIOL-CELL PH, V308, pC964, DOI 10.1152/ajpcell.00023.2015; Nakagawa H, 2011, J PHARM SCI-US, V100, P3602, DOI 10.1002/jps.22615; Nakagawa H, 2009, FEBS J, V276, P7237, DOI 10.1111/j.1742-4658.2009.07423.x; Nakano M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-42; Nies AT, 2015, ADV CANCER RES, V125, P217, DOI 10.1016/bs.acr.2014.10.007; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Reginato AM, 2012, NAT REV RHEUMATOL, V8, P610, DOI 10.1038/nrrheum.2012.144; Sasaki M, 2002, J BIOL CHEM, V277, P6497, DOI 10.1074/jbc.M109081200; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Stiburkova B, 2016, RHEUMATOLOGY, V55, P191, DOI 10.1093/rheumatology/kev350; Sugiura T, 2011, J PHARM SCI-US, V100, P3620, DOI 10.1002/jps.22575; Suzuki S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04258; Takada T, 2005, PHARM RES-DORDR, V22, P458, DOI 10.1007/s11095-004-1884-9; Tammur J, 2001, GENE, V273, P89, DOI 10.1016/S0378-1119(01)00572-8; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Toyoda Y, 2013, PHARMACOGENOMICS HUM, P387; Toyoda Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep24586; Toyoda Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7670483; Toyoda Y, 2012, DRUG METAB DISPOS, V40, P169, DOI 10.1124/dmd.111.041137; Toyoda Y, 2010, ANTI-CANCER AGENT ME, V10, P617, DOI 10.2174/187152010794473975; Toyoda Y, 2009, FASEB J, V23, P2001, DOI 10.1096/fj.09-129098; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Wakabayashi-Nakao K, 2010, METHODS MOL BIOL, V648, P139, DOI 10.1007/978-1-60761-756-3_9; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Yabuuchi H, 2001, BIOCH BIOPHYS RES CO, V288; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733	55	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157172	10.1371/journal.pone.0157172	http://dx.doi.org/10.1371/journal.pone.0157172			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281343	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000102
J	Vene, N; Mavri, A; Gubensek, M; Tratar, G; Cuderman, TV; Perme, MP; Blinc, A				Vene, Nina; Mavri, Alenka; Gubensek, Mirjam; Tratar, Gregor; Cuderman, Tjasa Vizintin; Perme, Maja Pohar; Blinc, Ales			Risk of Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation After Dabigatran or Rivaroxaban Discontinuation - Data from the Ljubljana Registry	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; CLINICAL-OUTCOMES; WARFARIN; MANAGEMENT; INTERRUPTION; APIXABAN; STROKE	Background and Aim Interruption of anticoagulant treatment with warfarin or non-vitamin K antagonist oral anticoagulants (NOAC) represents a vulnerable period with an increased risk of thromboembolic events. What is the incidence of thromboembolic events in real-life patients with non-valvular atrial fibrillation treated with NOAC who had a discontinuation or cessation of treatment in comparison to patients on continuous treatment? Patients and Methods Registry data from 866 patients with non-valvular atrial fibrillation, aged 74.3 (SD 9.8) years, with an average CHADS2 score of 2.1 (SD 1.2), who were started on dabigatran or rivaroxaban, were analysed for thromboembolic events and survival. Patients who had temporary or permanent discontinuation of NOAC were compared to patients on continuous NOAC treatment. Results Among 866 patients started on NOAC, 705 were treated without interruption, 84 patients had temporary interruption (69 because of planned invasive procedures, 10 due to bleeding, 5 for other causes) and 77 had permanent cessation of NOAC treatment. In patients without interruptions, the incidence of thromboembolic events was 1.0 (95% CI 0.4-2.1) per 100 patient-years, while in patients with interruption/cessation the rate of thromboembolic events was 21.6 (95% CI 10.3-45.2) per 100 patient-years, p < 0.001. There was a distinct clustering of thromboembolic events in the first weeks of NOAC discontinuation with the median occurring on day 14 (range 1-37 days) after discontinuation. Conclusion Dabigatran and rivaroxaban offered good protection against thromboembolic events during treatment, but interruption of NOAC treatment increased the short-term thromboembolic risk more than 20-fold.	[Vene, Nina; Mavri, Alenka; Gubensek, Mirjam; Tratar, Gregor; Cuderman, Tjasa Vizintin; Blinc, Ales] Univ Med Ctr Ljubljana, Dept Vasc Dis, Ljubljana, Slovenia; [Mavri, Alenka; Tratar, Gregor; Cuderman, Tjasa Vizintin; Blinc, Ales] Univ Ljubljana, Fac Med, Div Internal Med, Ljubljana, Slovenia; [Perme, Maja Pohar] Univ Ljubljana, Fac Med, Inst Biomed Informat, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana	Blinc, A (corresponding author), Univ Med Ctr Ljubljana, Dept Vasc Dis, Ljubljana, Slovenia.; Blinc, A (corresponding author), Univ Ljubljana, Fac Med, Div Internal Med, Ljubljana, Slovenia.	ales.blinc@kclj.si		Blinc, Ales/0000-0002-7538-1595	University Medical Centre Ljubljana [20120086]	University Medical Centre Ljubljana	This work was funded as a part of the industry-independent tertiary research and development project "Hospital Registry of Patients on Anticoagulation Treatment" of the University Medical Centre Ljubljana, grant No. 20120086, primary investigator Doc. Dr. Alenka Mavri.	Beyer-Westendorf J, 2014, EUR HEART J, V35, P1888, DOI 10.1093/eurheartj/eht557; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P1864; Garcia D, 2014, BLOOD, V124, P3692, DOI 10.1182/blood-2014-08-595496; Garcia DA, 2008, ARCH INTERN MED, V168, P63, DOI 10.1001/archinternmed.2007.23; Gonsalves WI, 2013, MAYO CLIN PROC, V88, P495, DOI 10.1016/j.mayocp.2013.03.006; Granger CB, 2015, AM HEART J, V169, P25, DOI 10.1016/j.ahj.2014.09.006; Healey JS, 2012, CIRCULATION, V126, P343, DOI 10.1161/CIRCULATIONAHA.111.090464; Held C, 2015, EUR HEART J, V36, P1264, DOI 10.1093/eurheartj/ehu463; Kikkert WJ, 2013, CIRC-CARDIOVASC INTE, V6, P391, DOI 10.1161/CIRCINTERVENTIONS.113.000425; Patel MR, 2013, J AM COLL CARDIOL, V61, P651, DOI 10.1016/j.jacc.2012.09.057; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perzborn E, 2014, J THROMB HAEMOST, V12, P1054, DOI 10.1111/jth.12591; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Qureshi W, 2014, AM J CARDIOL, V113, P662, DOI 10.1016/j.amjcard.2013.10.044; Raunso J, 2012, EUR HEART J, V33, P1886, DOI 10.1093/eurheartj/ehr454; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Schulman S, 2015, CIRCULATION, V132, P167, DOI 10.1161/CIRCULATIONAHA.115.015688; Sherwood MW, 2014, CIRCULATION, V129, P1850, DOI 10.1161/CIRCULATIONAHA.113.005754; Thorne KM, 2012, BMJ-BRIT MED J, V345, P4469; Weiler Bethany, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-203910; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261	24	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156943	10.1371/journal.pone.0156943	http://dx.doi.org/10.1371/journal.pone.0156943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280704	Green Submitted, gold, Green Published			2022-12-27	WOS:000377563000057
J	Wang, L; Zhou, R; Zhao, Y; Dong, ST; Zhang, JW; Luo, YH; Huang, N; Shi, M; Bin, JP; Liao, YL; Liao, WJ				Wang, Lin; Zhou, Rui; Zhao, Yang; Dong, Shaoting; Zhang, Jingwen; Luo, Yuhao; Huang, Na; Shi, Min; Bin, Jianping; Liao, Yulin; Liao, Wangjun			MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway	PLOS ONE			English	Article							GROWTH-FACTOR; TUMOR ANGIOGENESIS; VASCULOGENIC MIMICRY; VEGF-A; MESENCHYMAL TRANSITION; BREAST-CANCER; IN-VIVO; METASTASIS; EXPRESSION; TWIST1	Endothelium-dependent angiogenesis is thought to be a crucial step in cancer progression. We previously reported that metastasis-associated in colon cancer-1 (MACC1) contributed to the vasculogenic mimicry in gastric cancer (GC), but it remains unknown whether MACC1 promotes endothelium-dependent angiogenesis of GC and whether TWIST1 is involved in this process. In the present study, we detected MACC1 expression and microvessel density (MVD) by immunohistochemistry in 159 patients with stage I-III GC, and investigated the role of TWIST1 and vascular endothelial growth factor A (VEGF-A) in MACC1-induced endothelium-dependent angiogenesis using nude mice with GC xenografts, and human umbilical vein endothelial cells (HUVECs) that were co-cultured with conditioned media from overexpression and interference MACC1 GC cells. We found that MACC1 expression was positively correlated with an increased MVD and tumor recurrence in GC patients. In GC xenograft models, MACC1 elevated MVD and upregulated the expression of VEGF-A as well as accelerated tumor growth. In addition, MACC1 obviously increased the expression of TWIST1 and induced tube-like formation of HUVECs, whereas attenuation of TWIST1 suppressed the protein expression of VEGF-A and repealed the effect of MACC1 on tube formation. Our findings shed light on the function of MACC1 in endothelium-dependent angiogenesis of GC and suggest potential prognostic and therapeutic value.	[Wang, Lin; Zhou, Rui; Zhao, Yang; Dong, Shaoting; Zhang, Jingwen; Luo, Yuhao; Huang, Na; Shi, Min; Liao, Wangjun] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Bin, Jianping; Liao, Yulin] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liao, WJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	nfyyliaowj@163.com	Zhang, Jing/GWZ-7332-2022; Liao, Yulin/AAP-6315-2021	Wangjun, Liao/0000-0002-1364-8442	National Natural Science Foundation for Young Scientists of China [81302155]; National Natural Science Foundation of China [31271564]; President Foundation of Nanfang Hospital [2015B007]; key Clinical Specialty Discipline Construction Program of China	National Natural Science Foundation for Young Scientists of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); President Foundation of Nanfang Hospital; key Clinical Specialty Discipline Construction Program of China	This study was funded by the National Natural Science Foundation for Young Scientists of China (No. 81302155), the National Natural Science Foundation of China (No. 31271564), the President Foundation of Nanfang Hospital (No. 2015B007), and the key Clinical Specialty Discipline Construction Program of China (to The Department of Oncology, Nanfang Hospital).	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Banerjee AN, 2012, J NANOMATER, V2012, DOI 10.1155/2012/201492; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Che N, 2011, HUM PATHOL, V42, P840, DOI 10.1016/j.humpath.2010.03.010; Chen HX, 2014, ONCOTARGET, V5, P11873, DOI 10.18632/oncotarget.2662; Dehghanian Fariba, 2014, Avicenna Journal of Medical Biotechnology, V6, P192; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Foy KC, 2012, ONCOIMMUNOLOGY, V1, P1048, DOI 10.4161/onci.20708; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Huang N, 2015, ONCOTARGET, V6, P15222, DOI 10.18632/oncotarget.3835; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; Lederer A, 2015, HEPATOLOGY, V62, P841, DOI 10.1002/hep.27885; Li CW, 2016, CANCER RES, V76, P1451, DOI 10.1158/0008-5472.CAN-15-1941; Lin L, 2015, ONCOGENE, V34, P2700, DOI 10.1038/onc.2014.204; Liu TJ, 2013, J CELL MOL MED, V17, P116, DOI 10.1111/j.1582-4934.2012.01653.x; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; MAEDA K, 1995, J CLIN ONCOL, V13, P477, DOI 10.1200/JCO.1995.13.2.477; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Meng FH, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-179; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Qian LW, 2003, INT J CANCER, V104, P542, DOI 10.1002/ijc.10997; Roudnicky F, 2013, CANCER RES, V73, P1097, DOI 10.1158/0008-5472.CAN-12-1855; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Sun L, 2015, CANCER LETT, V357, P242, DOI 10.1016/j.canlet.2014.11.035; Sun T, 2011, HEPATOLOGY, V54, P1690, DOI 10.1002/hep.24543; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; Wang G, 2012, ONCOL LETT, V4, P783, DOI 10.3892/ol.2012.784; Wang L, 2015, ONCOTARGET, V6, P11492, DOI 10.18632/oncotarget.3416; Wang L, 2013, INT J CANCER, V133, P1419, DOI 10.1002/ijc.28140; Wang XL, 2013, INT J CLIN EXP PATHO, V6, P586; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang SW, 2006, ONCOL REP, V15, P15	38	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157137	10.1371/journal.pone.0157137	http://dx.doi.org/10.1371/journal.pone.0157137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280289	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000093
J	Chen, GF; Wei, L; Chen, J; Duan, ZP; Dou, XG; Xie, Q; Zhang, WH; Lu, LG; Fan, JG; Cheng, J; Wang, GQ; Ren, H; Wang, JP; Yang, XX; Jia, ZS; Fu, QC; Wang, XJ; Shang, J; Zhang, YX; Han, Y; Du, N; Shao, Q; Ji, D; Li, F; Li, B; Liu, JL; Niu, XX; Wang, C; Wu, V; Wong, A; Wang, YD; Hou, JL; Jia, JD; Zhuang, H; Lau, G				Chen, Guo-Feng; Wei, Lai; Chen, Jing; Duan, Zhong-Ping; Dou, Xiao-Guang; Xie, Qing; Zhang, Wen-Hong; Lu, Lun-Gen; Fan, Jian-Gao; Cheng, Jun; Wang, Gui-Qiang; Ren, Hong; Wang, Jiu-Ping; Yang, Xing-Xiang; Jia, Zhan-Sheng; Fu, Qing-Chun; Wang, Xiao-Jin; Shang, Jia; Zhang, Yue-Xin; Han, Ying; Du, Ning; Shao, Qing; Ji, Dong; Li, Fan; Li, Bing; Liu, Jia-Liang; Niu, Xiao-Xia; Wang, Cheng; Wu, Vanessa; Wong, April; Wang, Yu-Dong; Hou, Jin-Lin; Jia, Ji-Dong; Zhuang, Hui; Lau, George			Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; VIROLOGICAL RESPONSE; LIVER-DISEASE; UNITED-STATES; CHRONIC HCV; ALL-CAUSE; SOFOSBUVIR; LEDIPASVIR; MORTALITY; REGIMENS	Background Little is known on the cost-effectiveness of novel regimens for hepatitis C virus (HCV) compared with standard-of-care with pegylated interferon (pegIFN) and ribavirin (RBV) therapy in developing countries. We evaluated cost-effectiveness of sofosbuvir/ledipasvir for 12 weeks compared with a 48-week pegIFN-RBV regimen in Chinese patients with genotype 1b HCV infection by economic regions. Methods A decision analytic Markov model was developed to estimate quality-adjusted-life-years, lifetime cost of HCV infection and incremental cost-effectiveness ratios (ICERs). SVR rates and direct medical costs were obtained from real-world data. Parameter uncertainty was assessed by one-way and probabilistic sensitivity analyses. Threshold analysis was conducted to estimate the price which can make the regimen cost-effective and affordable. Results Sofosbuvir/ledipasvir was cost-effective in treatment-experienced patients with an ICER of US$21,612. It varied by economic regions. The probability of cost-effectiveness was 18% and 47% for treatment-naive and experienced patients, and it ranged from 15% in treatment-naive patients in Central-China to 64% in treatment-experienced patients in Eastern-China. The price of 12-week sofosbuvir/ledipasvir treatment needs to be reduced by at least 81% to US$18,185 to make the regimen cost-effective in all patients at WTP of one time GDP per capita. The price has to be US$105 to make the regimen affordable in average patients in China. Conclusion Sofosbuvir/ledipasvir regimen is not cost-effective in most Chinese patients with genotype 1b HCV infection. The results vary by economic regions. Drug price of sofosbuvir/ledipasvir needs to be substantially reduced when entering the market in China to ensure the widest accessibility.	[Chen, Guo-Feng; Shao, Qing; Ji, Dong; Li, Fan; Li, Bing; Liu, Jia-Liang; Niu, Xiao-Xia; Lau, George] 302 Hosp, Liver Cirrhosis Diag & Treatment Ctr 2, Beijing, Peoples R China; [Wei, Lai] Peking Univ, Beijing Key Lab Hepatitis & Immunotherapy Liver D, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China; [Chen, Jing; Wang, Cheng; Wu, Vanessa; Wong, April; Wang, Yu-Dong; Lau, George] Humanity & Hlth Med Ctr, Div Gastroenterol & Hepatol, Hong Kong, Hong Kong, Peoples R China; [Duan, Zhong-Ping] Capital Univ Med, Beijing Youan Hosp, Translat Hepatol Inst, Beijing, Peoples R China; [Dou, Xiao-Guang] China Med Univ, Dept Infect Dis, Shengjing Hosp, Shenyang 110001, Peoples R China; [Xie, Qing] Jiao Tong Univ, Dept Infect Dis, Shanghai Ruijin Hosp, Sch ofMedicine, Shanghai 200030, Peoples R China; [Zhang, Wen-Hong] Fudan Univ, Key Lab Med Mol Virol, Huashan Hosp, China Inst Biomed Sci,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Lun-Gen] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Fan, Jian-Gao] Shanghai Jiao Tong Univ, Dept Gastroenterol, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Cheng, Jun] Capital Univ Med, Liver Dis Ctr, Beijing Ditan Hosp, Beijing, Peoples R China; [Wang, Gui-Qiang] Peking Univ, Dept Infect Dis, Ctr Liver Dis, Hosp 1, Beijing 100871, Peoples R China; [Ren, Hong] Chongqing Univ Med Sci, Inst Viral Hepatitis, Affiliated Hosp 2, Chongqing, Peoples R China; [Wang, Jiu-Ping] Fourth Mil Med Univ, Dept Infect Dis, Xijing Hosp, Xian 710032, Peoples R China; [Yang, Xing-Xiang] Sichuan Prov Peoples Hosp, Dept Infect, Chengdu, Sichuan, Peoples R China; [Jia, Zhan-Sheng] Fourth Mil Med Univ, Ctr Diag & Treatment Infect Dis Chinese PLA, Tangdu Hosp, Xian 710032, Peoples R China; [Fu, Qing-Chun] Nanjing Mil Command, Shanghai Liver Dis Res Ctr, Shanghai, Peoples R China; [Wang, Xiao-Jin] Shanghai Jiao Tong Univ, Peoples Hosp, Sch Med, Shanghai 200030, Peoples R China; [Shang, Jia] Zhengzhou Univ, Dept Infect Dis, Henan Prov Peoples Hosp, Zhengzhou 450052, Peoples R China; [Zhang, Yue-Xin] Xinjiang Med Univ, Dept Infect Dis, Affiliated Hosp 1, Urumqi, Peoples R China; [Han, Ying] Fourth Mil Med Univ, Dept Digest Dis, Xijing Hosp, Xian 710032, Peoples R China; [Du, Ning] 302 Hosp, Liver Dis Ctr Combined Tradit Chinese Med & Weste, Beijing, Peoples R China; [Wang, Cheng; Hou, Jin-Lin] Southern Med Univ, State Key Lab Organ Failure Res, Guangdong Prov Key Lab Viral Hepatitis Res, Dept Infect Dis,Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Jia, Ji-Dong] Capital Med Univ, Beijing Friendship Hosp, Liver Dis Ctr, Beijing, Peoples R China; [Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China; [Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Ctr Infect Dis, Beijing 100871, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Peking University; Capital Medical University; China Medical University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Capital Medical University; Peking University; Chongqing Medical University; Air Force Military Medical University; Sichuan Provincial People's Hospital; Air Force Military Medical University; Shanghai Jiao Tong University; Zhengzhou University; Xinjiang Medical University; Air Force Military Medical University; Fifth Medical Center of Chinese PLA General Hospital; Southern Medical University - China; Capital Medical University; Peking University; Peking University	Lau, G (corresponding author), 302 Hosp, Liver Cirrhosis Diag & Treatment Ctr 2, Beijing, Peoples R China.; Lau, G (corresponding author), Humanity & Hlth Med Ctr, Div Gastroenterol & Hepatol, Hong Kong, Hong Kong, Peoples R China.	gkklau@netvigator.com	ji, dong/AAF-6364-2019; Lau, George/AAQ-2085-2021	ji, dong/0000-0001-8214-462X; Chen, Jing/0000-0001-5972-3623	Cheng Si-Yuan (China-International) Hepatitis Research Foundation; Humanity and Health Medical Group, HKSAR, China	Cheng Si-Yuan (China-International) Hepatitis Research Foundation; Humanity and Health Medical Group, HKSAR, China	This study was supported by the Cheng Si-Yuan (China-International) Hepatitis Research Foundation and Humanity and Health Medical Group, HKSAR, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; [Anonymous], 2015, LIFE TABLES CONTRY C; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Cure S, 2015, J VIRAL HEPATITIS; Duan ZP, 2012, 6 ISPOR AP C SEPT 7; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Grishchenko M, 2009, INT J TECHNOL ASSESS, V25, P171, DOI 10.1017/S0266462309090229; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Kohli A, 2015, LANCET, V385, P1107, DOI 10.1016/S0140-6736(14)61228-9; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lau G, 2015, AASLD LIV M SAN FRAN; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Leleu H, 2015, J VIRAL HEPATITIS, V22, P376, DOI 10.1111/jvh.12311; Manos MM, 2013, J MANAGE CARE PHARM, V19, P438, DOI 10.18553/jmcp.2013.19.6.438; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984; Rein DB, 2015, CLIN INFECT DIS, V61, P157, DOI 10.1093/cid/civ220; Saab S, 2014, ALIMENT PHARM THER, V40, P657, DOI 10.1111/apt.12871; San Miguel R, 2014, GUT; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Thein HH, 2005, AM J GASTROENTEROL, V100, P643, DOI 10.1111/j.1572-0241.2005.40976.x; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; United Nations, 2015, ESAPWP241 UN; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vgl. etwa Gold, 1996, COST EFFECTIVENESS H; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; WHO Commission on Macroeconomics and Health, 2002, REP WHO COMM MACR HL; World Health Organization, 2015, WHO MOD LIST ESS MED; World Health Organization and Health Action International, 2003, MED PRIC NEW APPR ME; Younossi ZM, 2015, ALIMENT PHARM THER, V41, P544, DOI 10.1111/apt.13081; Yu H, 2015, HEALTH POLICY, V119, P1145, DOI 10.1016/j.healthpol.2015.07.008	39	21	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155934	10.1371/journal.pone.0155934	http://dx.doi.org/10.1371/journal.pone.0155934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276081	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700010
J	Renault, AL; Lesueur, F; Coulombe, Y; Gobeil, S; Soucy, P; Hamdi, Y; Desjardins, S; Le Calvez-Kelm, F; Vallee, M; Voegele, C; Hopper, JL; Andrulis, IL; Southey, MC; John, EM; Masson, JY; Tavtigian, SV; Simard, J				Renault, Anne-Laure; Lesueur, Fabienne; Coulombe, Yan; Gobeil, Stephane; Soucy, Penny; Hamdi, Yosr; Desjardins, Sylvie; Le Calvez-Kelm, Florence; Vallee, Maxime; Voegele, Catherine; Hopper, John L.; Andrulis, Irene L.; Southey, Melissa C.; John, Esther M.; Masson, Jean-Yves; Tavtigian, Sean V.; Simard, Jacques		Breast Canc Family Registry	ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MISSENSE SUBSTITUTIONS; GERMLINE MUTATIONS; BRCA1; PROTEIN; RARE; COMPLEX; CCDC98; SITE; CONTRIBUTE	Approximately half of the familial aggregation of breast cancer remains unexplained. This proportion is less for early-onset disease where familial aggregation is greater, suggesting that other susceptibility genes remain to be discovered. The majority of known breast cancer susceptibility genes are involved in the DNA double-strand break repair pathway. ABRAXAS is involved in this pathway and mutations in this gene impair BRCA1 recruitment to DNA damage foci and increase cell sensitivity to ionizing radiation. Moreover, a recurrent germline mutation was reported in Finnish high-risk breast cancer families. To determine if ABRAXAS could be a breast cancer susceptibility gene in other populations, we conducted a population-based case-control mutation screening study of the coding exons and exon/intron boundaries of ABRAXAS in the Breast Cancer Family Registry. In addition to the common variant p.Asp373Asn, sixteen distinct rare variants were identified. Although no significant difference in allele frequencies between cases and controls was observed for the identified variants, two variants, p.Gly39Val and p.Thr141Ile, were shown to diminish phosphorylation of gamma-H2AX in MCF7 human breast adenocarcinoma cells, an important biomarker of DNA double-strand breaks. Overall, likely damaging or neutral variants were evenly represented among cases and controls suggesting that rare variants in ABRAXAS may explain only a small proportion of hereditary breast cancer.	[Renault, Anne-Laure; Gobeil, Stephane; Soucy, Penny; Hamdi, Yosr; Desjardins, Sylvie; Vallee, Maxime; Simard, Jacques] Ctr Hosp Univ Quebec, Genom Ctr, Quebec City, PQ, Canada; [Renault, Anne-Laure; Gobeil, Stephane; Soucy, Penny; Hamdi, Yosr; Desjardins, Sylvie; Vallee, Maxime; Simard, Jacques] Univ Laval, Quebec City, PQ, Canada; [Lesueur, Fabienne] INSERM, U900, Mines ParisTech, Inst Curie, Paris, France; [Coulombe, Yan; Masson, Jean-Yves] Ctr Hosp Univ Quebec Res Ctr, Oncol Axis, Genome Stabil Lab, HDQ Pavillon, Quebec City, PQ, Canada; [Le Calvez-Kelm, Florence; Vallee, Maxime; Voegele, Catherine] Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France; [Hopper, John L.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [John, Esther M.] Stanford Univ, Sch Med, Fremont, MA USA; [John, Esther M.] Stanford Canc Inst, Fremont, MA USA; [John, Esther M.; Breast Canc Family Registry] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Masson, Jean-Yves] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Tavtigian, Sean V.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Laval University; Laval University; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Laval University; World Health Organization; International Agency for Research on Cancer (IARC); University of Melbourne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Melbourne; Stanford Cancer Institute; Laval University; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Simard, J (corresponding author), Ctr Hosp Univ Quebec, Genom Ctr, Quebec City, PQ, Canada.; Simard, J (corresponding author), Univ Laval, Quebec City, PQ, Canada.	Jacques.Simard@crchudequebec.ulaval.ca	Andrulis, Irene L./E-7267-2013; Lesueur, Fabienne/R-2178-2017	Lesueur, Fabienne/0000-0001-7404-4549; Renault, Anne-Laure/0000-0001-6321-3458; Vallee, Maxime/0000-0002-3616-9508; Hamdi, Yosr/0000-0002-2815-1834; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Masson, Jean Yves/0000-0002-4403-7169; Southey, Melissa/0000-0002-6313-9005; Durocher, Francine/0000-0001-8012-4641; Simard, Jacques/0000-0001-6906-3390	Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program [CRN-87521]; Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-701]; Government of Canada through Genome Canada; Canadian Institutes of Health Research [GPH-129344]; Ministere de l'Economia, de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation for the PERSPECTIVE project; National Cancer Institute (NCI); National Institute of Health (NIH) [R01 CA121245]; National Cancer Institute [UM1 CA164920]	Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade; Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de l'Economia, de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation for the PERSPECTIVE project; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program - grant # CRN-87521, the Ministry of Economic Development, Innovation and Export Trade - grant # PSR-SIIRI-701 and by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research (GPH-129344), the Ministere de l'Economia, de la Science et de l'Innovation du Quebec through Genome Quebec, the Quebec Breast Cancer Foundation for the PERSPECTIVE project, the National Cancer Institute (NCI) and the National Institute of Health (NIH) grant R01 CA121245. This work was also supported by grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. J-Y.M. is a FQRS chercheur national investigator and was supported by a Canadian Institutes of Health Research operating grant. I.L.A is the Anne and Max Tanenbaum Chair in Molecular Medicine at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; BORRESEN AL, 1992, CANCER RES, V52, P3234; Castillo A, 2014, CELL REP, V8, P807, DOI 10.1016/j.celrep.2014.06.050; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Damiola F, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3669; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dever SM, 2011, AGING-US, V3, P515, DOI 10.18632/aging.100325; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Feunteun J, 1996, BBA-REV CANCER, V1242, P177, DOI 10.1016/0304-419X(95)00016-9; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenberg RA, 2008, CHROMOSOMA, V117, P305, DOI 10.1007/s00412-008-0154-8; Harris JL, 2011, AGING-US, V3, P461, DOI 10.18632/aging.100334; Hu X, 2011, J BIOL CHEM, V286, P11734, DOI 10.1074/jbc.M110.200857; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Mok MTS, 2012, TRAFFIC, V13, P800, DOI 10.1111/j.1600-0854.2012.01355.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Novak DJ, 2009, BREAST CANCER RES TR, V117, P453, DOI 10.1007/s10549-008-0134-y; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Pinheiro J, 2020, R PACKAGE VERSION 31; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Solyom S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003223; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Tischkowitz M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/humu.22022; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Werner Thomas, 2002, In Silico Biology, V2, P249; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	46	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156820	10.1371/journal.pone.0156820	http://dx.doi.org/10.1371/journal.pone.0156820			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270457	gold, Green Published			2022-12-27	WOS:000377561000040
J	Garbers, C; Wachtler, T				Garbers, Christian; Wachtler, Thomas			Wavelength Discrimination in Drosophila Suggests a Role of Rhodopsin 1 in Color Vision	PLOS ONE			English	Article							R8 PHOTORECEPTOR CELLS; PSYCHOMETRIC FUNCTION; RECEPTOR NOISE; MELANOGASTER; EXPRESSION; HONEYBEE; R7; SENSITIVITY; THRESHOLDS; BEHAVIOR	Among the five photoreceptor opsins in the eye of Drosophila, Rhodopsin 1 (Rh1) is expressed in the six outer photoreceptors. In a previous study that combined behavioral genetics with computational modeling, we demonstrated that flies can use the signals from Rh1 for color vision. Here, we provide an in-depth computational analysis of wildtype Drosophila wavelength discrimination specifically considering the consequences of different choices of computations in the preprocessing of the behavioral data. The results support the conclusion that Drosophila wavelength discrimination behavior can best be explained by a contribution of Rh1. These findings are corroborated by results of an information-theoretical analysis that shows that Rh1 provides information for discrimination of natural reflectance spectra.	[Wachtler, Thomas] Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany; Bernstein Ctr Computat Neurosci Munich, Munich, Germany	University of Munich	Wachtler, T (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany.	wachtler@biologie.uni-muenchen.de	Wachtler, Thomas/K-3714-2014	Wachtler, Thomas/0000-0003-2015-6590	Bundesministerium fur Bildung und Forschung [01GQ1004A]; Bernstein Center Munich (BMBF grant) [01GQ1004A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bernstein Center Munich (BMBF grant)	This work was supported by Bundesministerium fur Bildung und Forschung grant 01GQ1004A (https://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Hiromu Tanimoto and Christopher Schnaitmann for fruitful discussions, as well as Franziska Hellmundt and Christian Kellner for their valuable comments on the manuscript. This works was supported by Bernstein Center Munich (BMBF grant 01GQ1004A).	Arnold SEJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014287; BACKHAUS W, 1987, BIOL CYBERN, V55, P321, DOI 10.1007/BF02281978; BARLOW HB, 1982, VISION RES, V22, P635, DOI 10.1016/0042-6989(82)90099-2; Brandt R, 1997, VISION RES, V37, P425, DOI 10.1016/S0042-6989(96)00195-2; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; DESALOMON CH, 1983, J COMP PHYSIOL, V150, P31, DOI 10.1007/BF00605285; DEVALOIS RL, 1974, VISION RES, V14, P69, DOI 10.1016/0042-6989(74)90117-5; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Garbers C, 2015, J VISION, V15, DOI 10.1167/15.1.13; HARDIE RC, 1983, BIOPHYS STRUCT MECH, V9, P171, DOI 10.1007/BF00537814; Hardie RC, 1985, FUNCTIONAL ORG FLY R; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Jones E., 2001, SCIPY OPEN SOURCE SC; Kelber A, 2001, ENTOMOL EXP APPL, V99, P231, DOI 10.1023/A:1019244619503; Kelber A, 2013, CURR BIOL, V23, pR1043, DOI 10.1016/j.cub.2013.10.025; KIRSCHFE.K, 1968, KYBERNETIK, V5, P47, DOI 10.1007/BF00272694; KIRSCHFELD K, 1983, BIOPHYS STRUCT MECH, V10, P81, DOI 10.1007/BF00535544; Klockner A, 2012, PARALLEL COMPUT, V38, P157, DOI 10.1016/j.parco.2011.09.001; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; Kotel'nikov VA, 2006, PHYS-USP+, V49, P736, DOI 10.1070/PU2006v049n07ABEH006160; Lewis A, 2006, J VISION, V6, P285, DOI 10.1167/6.3.8; Lunau K, 2014, J COMP PHYSIOL A, V200, P497, DOI 10.1007/s00359-014-0895-1; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MENNE D, 1977, J COMP PHYSIOL, V114, P301, DOI 10.1007/BF00657325; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Prins N, 2012, J VISION, V12, DOI 10.1167/12.6.25; Rister J, 2013, DEVELOPMENT, V140, P493, DOI 10.1242/dev.079095; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salcedo E, 2003, J NEUROSCI, V23, P10873; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; STILES WS, 1946, P PHYS SOC LOND, V58, P41, DOI 10.1088/0959-5309/58/1/305; TROJE N, 1993, Z NATURFORSCH C, V48, P96; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Vorobyev M., 1997, COSTS BENEFITS INCRE, P280; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wright WD, 1934, P PHYS SOC, V46, P459, DOI 10.1088/0959-5309/46/3/317; YEH T, 1995, J OPT SOC AM A, V12, P456, DOI 10.1364/JOSAA.12.000456	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155728	10.1371/journal.pone.0155728	http://dx.doi.org/10.1371/journal.pone.0155728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258000	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700019
J	Jang, H; Ngunjiri, JM; Lee, CW				Jang, Hyesun; Ngunjiri, John M.; Lee, Chang-Won			Association between Interferon Response and Protective Efficacy of NS1-Truncated Mutants as Influenza Vaccine Candidates in Chickens	PLOS ONE			English	Article							AVIAN INFLUENZA; A VIRUS; IMMUNE-RESPONSES; STIMULATED GENES; INFECTION; OUTBREAK; EXPRESSION; CELLS; PCR; H5	Influenza virus mutants that encode C-terminally truncated NS1 proteins (NS1-truncated mutants) are attractive candidates for avian live attenuated influenza vaccine (LAIV) development because they are both attenuated and immunogenic in chickens. We previously showed that a high protective efficacy of NS1-truncated LAIV in chickens corresponds with induction of high levels of type I interferon (IFN) responses in chicken embryonic fibroblast cells. In this study, we investigated the relationship between induction of IFN and IFN-stimulated gene responses in vivo and the immunogenicity and protective efficacy of NS1-truncated LAIV. Our data demonstrates that accelerated antibody induction and protective efficacy of NS1-truncated LAIV correlates well with upregulation of IFN-stimulated genes. Further, through oral administration of recombinant chicken IFN alpha in drinking water, we provide direct evidence that type I IFN can promote rapid induction of adaptive immune responses and protective efficacy of influenza vaccine in chickens.	[Jang, Hyesun; Ngunjiri, John M.; Lee, Chang-Won] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Jang, Hyesun; Lee, Chang-Won] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ngunjiri, JM; Lee, CW (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.; Lee, CW (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	ngunjiri.1@osu.edu; lee.2854@osu.edu	Ngunjiri, John/AAB-3798-2021; Jang, Hyesun/AAG-7814-2021	Ngunjiri, John/0000-0002-2131-1698; Jang, Hyesun/0000-0002-8142-8222	SEEDS fund [2012009]; Ohio Agricultural Research and Development Center, The Ohio State University	SEEDS fund; Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University)	This study was supported by the SEEDS fund (2012009) and other funds from the Ohio Agricultural Research and Development Center, The Ohio State University.	BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bracci L, 2006, VACCINE S2, V24, pS2; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Cyranoski D, 2001, NATURE, V412, P261, DOI 10.1038/35085715; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Elaish M, 2015, VACCINE, V33, P4901, DOI 10.1016/j.vaccine.2015.07.049; Feng L, 2014, EURO SURVEILL, V19; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hvistendahl M, 2015, SCIENCE, V348, P741, DOI 10.1126/science.348.6236.741; Ibrahim M, 2015, VACCINE, V33, P2670, DOI 10.1016/j.vaccine.2015.04.023; Jang H, 2013, POULTRY SCI, V92, P2290, DOI 10.3382/ps.2013-03116; Kapczynski DR, 2014, METHODS MOL BIOL, V1161, P217, DOI 10.1007/978-1-4939-0758-8_18; Kim Y, 2011, ANTIVIR RES, V89, P165, DOI 10.1016/j.antiviral.2010.11.016; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lee Chang-Won, 2005, Animal Health Research Reviews, V6, P1, DOI 10.1079/AHR2005101; Lee CW, 2014, METHODS MOL BIOL, V1161, P37, DOI 10.1007/978-1-4939-0758-8_4; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; Liang JF, 2013, POULTRY SCI, V92, P2651, DOI 10.3382/ps.2013-03193; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Marcus PI, 2007, EMERG INFECT DIS, V13, P1608, DOI 10.3201/eid1310.061552; Marcus PI, 2010, J VIROL, V84, P10974, DOI 10.1128/JVI.00502-10; Menachery VD, 2014, MBIO, V5, DOI 10.1128/mBio.01174-14; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Nagao Y, 1998, J INTERF CYTOK RES, V18, P661, DOI 10.1089/jir.1998.18.661; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nfon C, 2012, VACCINE, V30, P7187, DOI 10.1016/j.vaccine.2012.10.021; Ngunjiri JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118934; Ngunjiri JM, 2012, J INTERF CYTOK RES, V32, P280, DOI 10.1089/jir.2011.0102; Pawar SD, 2015, J VIROL METHODS, V222, P28, DOI 10.1016/j.jviromet.2015.05.004; Penski N, 2011, J VIROL, V85, P7730, DOI 10.1128/JVI.00063-11; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pulit-Penaloza JA, 2012, VIROLOGY, V425, P82, DOI 10.1016/j.virol.2012.01.006; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Sasaki S, 2014, J INFECT DIS, V210, P865, DOI 10.1093/infdis/jiu190; SEKELLICK MJ, 1994, J INTERFERON RES, V14, P71, DOI 10.1089/jir.1994.14.71; Sen GC, 2007, ADV VIRUS RES, V70, P233, DOI 10.1016/S0065-3527(07)70006-4; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; STONE HD, 1987, AVIAN DIS, V31, P483, DOI 10.2307/1590728; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Tang RB, 2013, J CHIN MED ASSOC, V76, P245, DOI 10.1016/j.jcma.2013.04.003; Wang L, 2008, VACCINE, V26, P3580, DOI 10.1016/j.vaccine.2008.05.001; Wang YF, 2014, VIROLOGY, V468, P621, DOI 10.1016/j.virol.2014.09.010; Wright P.F., 2013, FIELDS VIROLOGY, P1186	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156603	10.1371/journal.pone.0156603	http://dx.doi.org/10.1371/journal.pone.0156603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257989	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700088
J	Kelman, I; Luthe, T; Wyss, R; Tornblad, SH; Evers, Y; Curran, MM; Williams, RJ; Berlow, EL				Kelman, Ilan; Luthe, Tobias; Wyss, Romano; Tornblad, Silje H.; Evers, Yvette; Curran, Marina Martin; Williams, Richard J.; Berlow, Eric L.			Social Network Analysis and Qualitative Interviews for Assessing Geographic Characteristics of Tourism Business Networks	PLOS ONE			English	Article							GLOBAL PIPELINES; CLIMATE-CHANGE; INNOVATION; KNOWLEDGE; PROXIMITY; TRIANGULATION; COMMUNITIES; SPILLOVERS; RESILIENCE; PLACE	This study integrates quantitative social network analysis (SNA) and qualitative interviews for understanding tourism business links in isolated communities through analysing spatial characteristics. Two case studies are used, the Surselva-Gotthard region in the Swiss Alps and Longyearbyen in the Arctic archipelago of Svalbard, to test the spatial characteristics of physical proximity, isolation, and smallness for understanding tourism business links. In the larger Surselva-Gotthard region, we found a strong relationship between geographic separation of the three communities on compartmentalization of the collaboration network. A small set of businesses played a central role in steering collaborative decisions for this community, while a group of structurally 'peripheral' actors were less influential. By contrast, the business community in Svalbard showed compartmentalization that was independent of geographic distance between actors. Within towns of similar size and governance scale, Svalbard is more compartmentalized, and those compartments are not driven by geographic separation of the collaboration clusters. This compartmentalization in Svalbard was reflected in a lower density of formal business collaboration ties compared to the communities of the Alps. We infer that the difference is due to Svalbard having higher cultural diversity and population turnover than the Alps communities. We propose that integrating quantitative network analysis from simple surveys with qualitative interviews targeted from the network results is an efficient general approach to identify regionally specific constraints and opportunities for effective governance.	[Kelman, Ilan] UCL, Inst Global Hlth, London, England; [Kelman, Ilan] UCL, Inst Risk & Disaster Reduct, London, England; [Kelman, Ilan] Univ Agder, Kristiansand, Norway; [Luthe, Tobias] Univ Appl Sci HTW Chur, Living Environm Dept, Chur, Switzerland; [Luthe, Tobias] MonViso Inst, Bozen Ostana, Italy; [Wyss, Romano] Ecole Polytech Fed Lausanne, Lab Human Environm Relat Urban Syst HERUS, CH-1015 Lausanne, Switzerland; [Tornblad, Silje H.] Univ Oslo, ARENA Ctr European Studies, Oslo, Norway; [Evers, Yvette] Forest Trust, Nyon, Switzerland; [Curran, Marina Martin] Business Sch Lausanne, Chavannes, Switzerland; [Williams, Richard J.; Berlow, Eric L.] Vibrant Data Inc, San Francisco, CA USA	University of London; University College London; University of London; University College London; University of Agder; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Oslo	Kelman, I (corresponding author), UCL, Inst Global Hlth, London, England.; Kelman, I (corresponding author), UCL, Inst Risk & Disaster Reduct, London, England.; Kelman, I (corresponding author), Univ Agder, Kristiansand, Norway.	ilan_kelman@hotmail.com	Williams, Richard J/B-8344-2011	Williams, Richard J/0000-0001-8847-3213; Luthe, Tobias/0000-0002-4748-3885; Kelman, Ilan/0000-0002-4191-6969	Swiss Network of International Studies (SNIS); Vibrant Data Inc.	Swiss Network of International Studies (SNIS); Vibrant Data Inc.	This study is part of the ArcAlpNet project (Comparative social network governance of climate resilience in the Arctic and the Alps) funded by the Swiss Network of International Studies (SNIS). Coauthors Richard J. Williams and Eric L. Berlow are employed by Vibrant Data Inc. Vibrant Data Inc. provided support in the form of salaries for authors RJW and ELB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alber K, 2011, CLIMALP TOUR CLIMATE; [Anonymous], 2000, TOURISM DEV MOUNTAIN; [Anonymous], 2015, B SOC METHOD, V125, P3; [Anonymous], 2014, B SOC METHOD, V124, P3; Audretsch DB, 1996, AM ECON REV, V86, P630; Baldacchino G, 2012, EXTREME HERITAGE MAN; Balland PA, 2015, REG STUD, V49, P907, DOI 10.1080/00343404.2014.883598; Bathelt H, 2004, PROG HUM GEOG, V28, P31, DOI 10.1191/0309132504ph469oa; Beck T, 2006, J BANK FINANC, V30, P2931, DOI 10.1016/j.jbankfin.2006.05.009; Bellotti E., 2015, QUALITATIVE NETWORKS; Beritelli P., 2007, Journal of Travel Research, V46, P96, DOI 10.1177/0047287507302385; BfS, 2013, POP SIZ POP COMP DAT; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Boschma RA, 2005, REG STUD, V39, P61, DOI 10.1080/0034340052000320887; Boschma R, 2010, HANDBOOK OF EVOLUTIONARY ECONOMIC GEOGRAPHY, P120; Breschi S, 2001, PAP REG SCI, V80, P255, DOI 10.1007/PL00013627; Breschi S., 2001, IND CORP CHANGE, V10, P975, DOI DOI 10.1093/ICC/10.4.975; Broekel T, 2012, J ECON GEOGR, V12, P409, DOI 10.1093/jeg/lbr010; Carrington P. J., 2011, SAGE HDB SOCIAL NETW, DOI 10.4135/9781446294413; Conover MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055957; Crona BI, 2006, ECOL SOC, V11; de Vet E, 2013, AREA, V45, P198, DOI 10.1111/area.12019; Esser JK, 1998, ORGAN BEHAV HUM DEC, V73, P116, DOI 10.1006/obhd.1998.2758; Freel M., 2000, ENTREP REGION DEV, V12, P245, DOI DOI 10.1080/089856200413482; Freel MS, 2003, RES POLICY, V32, P751, DOI 10.1016/S0048-7333(02)00084-7; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; GALASKIEWICZ J, 1993, SOCIOL METHOD RES, V22, P3, DOI 10.1177/0049124193022001001; Garcia-Rosell JC, 2007, TOURISM, V55, P445; Getz D, 2005, ANN TOURISM RES, V32, P237, DOI 10.1016/j.annals.2004.07.006; Graci S., 2010, SUSTAINABLE TOURISM; Grossetti M, 2008, EUR PLAN STUD, V16, P630, DOI 10.1080/09654310802049133; HESTA, 2013, OV STAYS HOT CAMPGR; Ingold K, 2010, LOCAL ENVIRON, V15, P651, DOI 10.1080/13549839.2010.498811; JICK TD, 1979, ADMIN SCI QUART, V24, P602, DOI 10.2307/2392366; Jina Prem Singh, 1994, TOURISM LADAKH HIMAL; Kelman I, 2012, NORTH REV, P96; Langhout RD, 2003, AM J COMMUN PSYCHOL, V32, P229, DOI 10.1023/B:AJCP.0000004744.09295.9b; Laudel G, 2003, SCIENTOMETRICS, V57, P215, DOI 10.1023/A:1024137718393; LIEVROUW LA, 1987, SOC NETWORKS, V9, P217, DOI 10.1016/0378-8733(87)90021-9; Luthe T, 2013, ITF FORSCHUNGSBERICH; Luthe T, 2016, ECOL SOC, V21, DOI 10.5751/ES-08234-210127; Luthe T, 2014, TOURISM MANAGE, V44, P161, DOI 10.1016/j.tourman.2014.03.011; Luthe T, 2012, REG ENVIRON CHANGE, V12, P839, DOI 10.1007/s10113-012-0294-5; Maskell P, 2007, J ECON GEOGR, V7, P603, DOI 10.1093/jeg/lbm020; McCall G, 1996, GEOGR Z, V84, P74; MIZRUCHI MS, 1994, ACTA SOCIOL, V37, P329, DOI 10.1177/000169939403700403; Morgan K, 2004, J ECON GEOGR, V4, P3, DOI 10.1093/jeg/4.1.3; Morrison A, 2013, ECON GEOGR, V89, P77, DOI 10.1111/j.1944-8287.2012.01167.x; Onnela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016939; Prell C, 2009, SOC NATUR RESOUR, V22, P501, DOI 10.1080/08941920802199202; Sandstrom A, 2008, POLICY STUD J, V36, P497, DOI 10.1111/j.1541-0072.2008.00281.x; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Scott N, 2008, NETWORK ANAL TOURISM; Sin CH, 2003, AREA, V35, P305, DOI 10.1111/1475-4762.00179; Sorensen F., 2007, Tourism Geographies, V9, P22, DOI 10.1080/14616680601092857; Stark D, 2006, AM J SOCIOL, V111, P1367, DOI 10.1086/499507; Stark D, 2012, AM SOCIOL REV, V77, P700, DOI 10.1177/0003122412453921; Teaiwa Teresia, 2007, WORLD ISLANDS ISLAND, P514; Ter Wal ALJ, 2014, J ECON GEOGR, V14, P589, DOI 10.1093/jeg/lbs063; Ter Wal ALJ, 2009, ANN REGIONAL SCI, V43, P739, DOI 10.1007/s00168-008-0258-3; Terrell JE, 2010, ANN HUM GENET, V74, P211, DOI 10.1111/j.1469-1809.2010.00575.x; Wasserman S, 1994, SOCIAL NETWORK ANAL; Wellman B., 1988, SOCIAL STRUCTURES NE, P19; Whittington KB, 2009, ADMIN SCI QUART, V54, P90, DOI 10.2189/asqu.2009.54.1.90; Wyss R, 2015, LOCAL ENVIRON, V20, P908, DOI 10.1080/13549839.2013.879289; Zitt M, 2000, SCIENTOMETRICS, V47, P627, DOI 10.1023/A:1005632319799	67	17	18	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156028	10.1371/journal.pone.0156028	http://dx.doi.org/10.1371/journal.pone.0156028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258007	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700029
J	Kim, JE; Yoo, HJ; Gu, JY; Kim, HK				Kim, Ji Eun; Yoo, Hyun Ju; Gu, Ja Yoon; Kim, Hyun Kyung			Histones Induce the Procoagulant Phenotype of Endothelial Cells through Tissue Factor Up-Regulation and Thrombomodulin Down-Regulation	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; EXTRACELLULAR HISTONES; CIRCULATING NUCLEOSOMES; THROMBIN GENERATION; C ACTIVATION; RISK-FACTORS; MECHANISMS; PHOSPHATIDYLSERINE; INFLAMMATION; COAGULATION	The high circulating levels of histones found in various thrombotic diseases may compromise the anticoagulant barrier of endothelial cells. We determined how histones affect endothelial procoagulant tissue factor (TF) and anticoagulant thrombomodulin (TM). Surface antigens, soluble forms, and mRNA levels of TF and TM were measured by flow cytometry, ELISA, and real-time RT-PCR, respectively. TF and TM activity were measured using procoagulant activity, thrombin generation, or chromogenic assays. Involvement of the toll-like receptor (TLR) was assessed using the neutralizing antibodies. Histones dose-dependently induced surface antigens, activity and mRNA levels of endothelial TF. Histone-treated endothelial cells significantly shortened the lag time and enhanced the endogenous thrombin potential of normal plasma, which was normalized by a TF neutralizing antibody. Histones induced phosphatidylserine and protein-disulfide isomerase expression in endothelial cells. Histones also reduced the surface antigen, activity, and mRNA levels of endothelial TM. Polysialic acid and heparin reversed the histone-induced TF up-regulation and TM down-regulation. Activated protein C did not affect the TF up-regulation, but interrupted TM down-regulation. TLR2, and TLR4 inhibitors partially blocked the TF up-regulation. Histones induced the endothelial procoagulant phenotype through TF up-regulation and TM down-regulation. The effects of histones were partly mediated by TLR2, TLR4. Strategies to inhibit the harmful effects of histones in endothelial cells may be required in order to prevent a thrombotic environment.	[Kim, Ji Eun] Seoul Natl Univ, Bundang Hosp, Dept Hematooncol, Healthcare Innovat Pk, Gyeonggi Do, South Korea; [Yoo, Hyun Ju; Gu, Ja Yoon; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Yoo, Hyun Ju; Gu, Ja Yoon; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	lukekhk@snu.ac.kr			Korea Health Industry Development Institute (KHIDI) [HI13C0954]; National Research Foundation of Korea (NRF) [2013-068572]	Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by the Korea Health Industry Development Institute (KHIDI), grant number HI13C0954, and the National Research Foundation of Korea (NRF), grant number 2013-068572.	Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Arai Y, 2013, BIOL BLOOD MARROW TR, V19, P1683, DOI 10.1016/j.bbmt.2013.09.005; Bode M, 2014, VASC PHARMACOL, V62, P57, DOI 10.1016/j.vph.2014.05.005; Borissoff JI, 2013, ARTERIOSCL THROM VAS, V33, P2032, DOI 10.1161/ATVBAHA.113.301627; Carestia A, 2013, THROMB HAEMOSTASIS, V110, P1035, DOI 10.1160/TH13-02-0174; Chen QX, 2012, INT J INFECT DIS, V16, pE558, DOI 10.1016/j.ijid.2012.03.007; Chen VMY, 2013, SEMIN THROMB HEMOST, V39, P40, DOI 10.1055/s-0032-1333311; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Ekaney ML, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0543-8; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Henriksson CE, 2005, THROMB HAEMOSTASIS, V94, P1236, DOI 10.1160/TH05-07-0463; Kim JE, 2015, THROMB RES, V135, P1064, DOI 10.1016/j.thromres.2015.03.014; Kowalska MA, 2014, ARTERIOSCL THROM VAS, V34, P120, DOI 10.1161/ATVBAHA.113.302236; Langer F, 2014, THROMB HAEMOSTASIS, V111, P590, DOI 10.1160/TH13-09-0802; LE DT, 1994, THROMB HAEMOSTASIS, V72, P848; Levi M, 2012, SEMIN THROMB HEMOST, V38, P506, DOI 10.1055/s-0032-1305782; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; PAL PK, 1983, THROMB RES, V31, P69, DOI 10.1016/0049-3848(83)90008-7; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Rao LVM, 2012, J THROMB HAEMOST, V10, P2242, DOI 10.1111/jth.12003; Regnault V, 2003, THROMB HAEMOSTASIS, V89, P208, DOI 10.1055/s-0037-1613433; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; van Montfoort ML, 2013, ARTERIOSCL THROM VAS, V33, P147, DOI 10.1161/ATVBAHA.112.300498; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Wolberg AS, 2000, BIOCHEM BIOPH RES CO, V272, P332, DOI 10.1006/bbrc.2000.2783; Wu HL, 2008, BIOCHEM BIOPH RES CO, V367, P162, DOI 10.1016/j.bbrc.2007.12.135; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95	35	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156763	10.1371/journal.pone.0156763	http://dx.doi.org/10.1371/journal.pone.0156763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258428	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700122
J	Zhou, FF; Fang, KY; Zhang, F; Dong, ZP; Chen, D				Zhou, Feifei; Fang, Keyan; Zhang, Fen; Dong, Zhipeng; Chen, Dan			Climate-Driven Synchronized Growth of Alpine Trees in the Southeast Tibetan Plateau	PLOS ONE			English	Article							RING GROWTH; TEMPERATURE RECONSTRUCTION; SPATIOTEMPORAL VARIABILITY; RESPONSES; MOUNTAINS; DROUGHT; PRECIPITATION; MOISTURE; REGION; ALASKA	Knowledge about the spatiotemporal tree growth variability and its associations with climate provides key insights into forest dynamics under future scenarios of climate change. We synthesized 17 tree-ring width chronologies from four tree species at the high-elevation sites in the southeast Tibetan Plateau (SETP) to study the regional tree growth variability and climate-growth relationships. Despite of diverse habitats and different physiological characteristics of these species, these tree-ring chronologies shared a significant common variance in SETP. An unprecedented increase in the shared variance is found along the latter half of the 20th century, coinciding with the enhancement of the frequency of extreme rings among chronologies. It is found that minimum winter temperature tends to be the dominant climate for trees in this region. The site-specific responses in cold (1965-1980) and warm (1990-2005) intervals by means of Fuzzy Cmeans (FCM) clustering reveal that the remarkable enhancement of growth synchrony among trees mainly occur in warm conditions. This is different from previous findings indicating that increased consistence among temperature sensitive tree rings in cold periods. This may be related to the reduced temperature sensitivity of regional tree growth as winter minimum temperature is lower than a certain threshold, which is in agreement with the "principle of ecological amplitude". In addition, it is worth noting that precipitation in June have started to restrain the tree growth since the beginning of the 1980s, which is possibly an important contributor for synchronized growth among trees in SETP.	[Zhou, Feifei; Fang, Keyan; Dong, Zhipeng; Chen, Dan] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc MOE, Fuzhou 350007, Peoples R China; [Fang, Keyan] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China; [Zhang, Fen] Lanzhou Univ, Key Lab Western Chinas Environm Syst MOE, Lanzhou 730000, Peoples R China	Fujian Normal University; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Lanzhou University	Fang, KY (corresponding author), Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc MOE, Fuzhou 350007, Peoples R China.; Fang, KY (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China.	kfang@fjnu.edu.cn	dong, zhipeng/AFN-4971-2022; Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034	National Natural Science Foundation of China [41471172, U1405231, 41404047]; Fujian Province [2014R1034-2, 2015J06008]; fundamental research funds for the central universities [lzujbky-2014-114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province; fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities)	This work is funded by the National Natural Science Foundation of China (No. 41471172, No. U1405231 and No. 41404047) (http://www.nsfc.gov.cn/), non-profit research funds of Fujian Province (2014R1034-2) (http://www.fjkjt.gov.cn/), the Fellowship for Distinguished Young Scholars of Fujian Province (2015J06008) and the fundamental research funds for the central universities (No. lzujbky-2014-114) (http://kyc.lzu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andreu L, 2007, GLOBAL CHANGE BIOL, V13, P804, DOI 10.1111/j.1365-2486.2007.01322.x; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Carrer M, 2013, PLOS ONE, V7; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cook E.R., 2013, METHODS DENDROCHRONO; Cook E. R., 1985, TIME SERIES ANAL APP; Cook ER, 2001, ECOL APPL, V11, P883, DOI 10.1890/1051-0761(2001)011[0883:IFGOTI]2.0.CO;2; Deng Y, 2014, TIBET PLATEAU Q RES, V18, P513; Driscoll WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024258; Duan JP, 2012, CLIM DYNAM, V39, P919, DOI 10.1007/s00382-011-1232-9; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; EQUIHUA M, 1990, J ECOL, V78, P519, DOI 10.2307/2261127; Ettinger AK, 2011, ECOLOGY, V92, P1323, DOI 10.1890/10-1639.1; Fan ZX, 2008, INT J CLIMATOL, V28, P1879, DOI 10.1002/joc.1689; Fang KY, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034010; Fang KY, 2012, CLIM DYNAM, V39, P1697, DOI 10.1007/s00382-012-1371-7; Fang KY, 2012, TREES-STRUCT FUNCT, V26, P1471, DOI 10.1007/s00468-012-0721-8; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Fang KY, 2009, IAWA J, V30, P443, DOI 10.1163/22941932-90000231; Fritts H., 1976, TREE RINGS CLIMATE; Gershunov A, 2001, J CLIMATE, V14, P2486, DOI 10.1175/1520-0442(2001)014<2486:LFMOTE>2.0.CO;2; Gou X., 2013, NW CHINA BIOGEOSCI D, V10, P9969, DOI [10.5194/bgd-10-9969-2013, DOI 10.5194/BGD-10-9969-2013]; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; Holmes R.L., 1994, DENDROCHRONOLOGY PRO; Ji F, 2014, NAT CLIM CHANGE, V4, P462, DOI [10.1038/nclimate2223, 10.1038/NCLIMATE2223]; Liang EY, 2009, THEOR APPL CLIMATOL, V98, P9, DOI 10.1007/s00704-008-0085-6; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Liang E, 2014, ECOLOGY, V95, P2453, DOI 10.1890/13-1904.1; Liang E, 2010, CAN J FOREST RES, V40, P200, DOI 10.1139/X09-186; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Ni FB, 2002, INT J CLIMATOL, V22, P1645, DOI 10.1002/joc.804; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Shao XM., 1999, QUATERNARY SCI, V19, P81, DOI DOI 10.3321/j.issn:1001-7410.1999.01.010; Shi JF, 2013, PALAEOGEOGR PALAEOCL, V381, P92, DOI 10.1016/j.palaeo.2013.04.018; Solberg BO, 2002, ECOSCIENCE, V9, P79, DOI 10.1080/11956860.2002.11682693; Tardif J, 2003, ECOL MONOGR, V73, P241, DOI 10.1890/0012-9615(2003)073[0241:SVITGI]2.0.CO;2; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wilson R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008318; Woodhouse CA, 2001, J AM WATER RESOUR AS, V37, P561, DOI 10.1111/j.1752-1688.2001.tb05493.x; Wu XC, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024016; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Zhang Q, 2015, NATURE COMMUNICATION, V6; Zhang QB, 2000, FOREST SCI, V46, P229; Zhang YX, 2009, PLANT ECOL, V201, P39, DOI [10.1007/s11258-008-9478-y, 10.1007/978-90-481-2795-5_4]; Zhu HF, 2009, CLIM PAST, V5, P661, DOI 10.5194/cp-5-661-2009	54	6	6	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156126	10.1371/journal.pone.0156126	http://dx.doi.org/10.1371/journal.pone.0156126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257971	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700038
J	Candela, ME; Wang, C; Gunawardena, AT; Zhang, KR; Cantley, L; Yasuhara, R; Usami, Y; Francois, N; Iwamoto, M; van der Flier, A; Zhang, YJ; Qin, L; Han, L; Enomoto-Iwamoto, M				Candela, Maria Elena; Wang, Chao; Gunawardena, Aruni T.; Zhang, Kairui; Cantley, Leslie; Yasuhara, Rika; Usami, Yu; Francois, Noelle; Iwamoto, Masahiro; van der Flier, Arjan; Zhang, Yejia; Qin, Ling; Han, Lin; Enomoto-Iwamoto, Motomi			Alpha 5 Integrin Mediates Osteoarthritic Changes in Mouse Knee Joints	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; ALPHA-5-BETA-1 INTEGRIN; FIBRONECTIN FRAGMENTS; GENE-EXPRESSION; CARTILAGE; PROLIFERATION; HISTOPATHOLOGY; CHONDROLYSIS; COOPERATE; PROTEIN	Osteoarthritis (OA) is one of most common skeletal disorders and can affect synovial joints such as knee and ankle joints. alpha 5 integrin, a major fibronectin receptor, is expressed in articular cartilage and has been demonstrated to play roles in synovial joint development and in the regulation of chondrocyte survival and matrix degradation in articular cartilage. We hypothesized that alpha 5 integrin signaling is involved in pathogenesis of OA. To test this, we generated compound mice that conditionally ablate alpha 5 integrin in the synovial joints using the Gdf5Cre system. The compound mice were born normally and had an overall appearance similar to the control mice. However, when the mutant mice received the OA surgery, they showed stronger resistance to osteoarthritic changes than the control. Specifically the mutant knee joints presented lower levels of cartilage matrix and structure loss and synovial changes and showed stronger biomechanical properties than the control knee joints. These findings indicate that alpha 5 integrin may not be essential for synovial joint development but play a causative role in induction of osteoarthritic changes.	[Candela, Maria Elena; Gunawardena, Aruni T.; Zhang, Kairui; Cantley, Leslie; Usami, Yu; Francois, Noelle; Iwamoto, Masahiro; Enomoto-Iwamoto, Motomi] Childrens Hosp Philadelphia, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA; [Wang, Chao; Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Zhang, Kairui] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China; [Yasuhara, Rika] Showa Univ, Sch Dent, Dept Oral Diag Sci, Div Pathol, Tokyo 142, Japan; [van der Flier, Arjan] MIT, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Cambridge, MA USA; [Zhang, Yejia] Univ Penn, Perelman Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA; [Qin, Ling] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Drexel University; Southern Medical University - China; Showa University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Enomoto-Iwamoto, M (corresponding author), Childrens Hosp Philadelphia, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA.	iwamotom1@email.chop.edu	Lin, Han/GRF-1081-2022; Han, Lin/D-2602-2014	Han, Lin/0000-0003-4180-1288; Yasuhara, Rika/0000-0003-2282-6295; van der Flier, Arjan/0000-0002-6911-9291	Arthritis Foundation [6389]; NIH [RO1AR061758, RO1AR046000]; Japanese government: MEXT KAKENHI [15K11050]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062908, R01AR046000, R21AR066824] Funding Source: NIH RePORTER	Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese government: MEXT KAKENHI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Arthritis Foundation (http://www.arthritis.org/?utm_source=google&utm_medium=cpc), Innovative Research Award #6389. NIH Funds: RO1AR061758, RO1AR046000 Grant-in-Aid for Scientific Research, Japanese government: MEXT KAKENHI, 15K11050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte-Becerril M, 2014, J ORTHOP RES, V32, P1161, DOI 10.1002/jor.22649; Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684; Batista MA, 2014, MATRIX BIOL, V38, P84, DOI 10.1016/j.matbio.2014.05.008; BROWN RA, 1990, J RHEUMATOL, V17, P65; Buschmann MD, 1999, ARCH BIOCHEM BIOPHYS, V366, P1, DOI 10.1006/abbi.1999.1197; Candela ME, 2014, MATRIX BIOL, V39, P44, DOI 10.1016/j.matbio.2014.08.015; Davey G, 1999, J CELL SCI, V112, P4663; EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Garciadiego-Cazares D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127166; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Homandberg GA, 1998, OSTEOARTHR CARTILAGE, V6, P231, DOI 10.1053/joca.1998.0116; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P381, DOI 10.1053/joca.2002.0524; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; LUST G, 1987, J RHEUMATOL, V14, P28; Murphy PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120872; Ohta Y, 2015, ARTHRITIS RHEUMATOL, V67, P2679, DOI 10.1002/art.39243; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Pulai JI, 2002, ARTHRITIS RHEUM, V46, P1528, DOI 10.1002/art.10334; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Tanaka N, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4307; Turner CJ, 2015, DEVELOPMENT, V142, P797, DOI 10.1242/dev.117572; van der Flier A, 2010, DEVELOPMENT, V137, P2439, DOI 10.1242/dev.049551; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; Wenham CYJ, 2010, THER ADV MUSCULOSKEL, V2, P349, DOI 10.1177/1759720X10378373; WOODS VL, 1994, ARTHRITIS RHEUM, V37, P537, DOI 10.1002/art.1780370414; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yasuda T, 2003, LAB INVEST, V83, P153, DOI 10.1097/01.LAB.0000056999.08437.B2; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824	39	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156783	10.1371/journal.pone.0156783	http://dx.doi.org/10.1371/journal.pone.0156783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280771	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000048
J	Fischer, W; Franke, H; Krugel, U; Muller, H; Dinkel, K; Lord, B; Letavic, MA; Henshall, DC; Engel, T				Fischer, Wolfgang; Franke, Heike; Kruegel, Ute; Mueller, Heiko; Dinkel, Klaus; Lord, Brian; Letavic, Michael A.; Henshall, David C.; Engel, Tobias			Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure Models	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; P2X(7) RECEPTOR; STATUS EPILEPTICUS; PHARMACOLOGICAL CHARACTERIZATION; PURINERGIC RECEPTOR; ANTIEPILEPTIC DRUGS; NERVOUS-SYSTEM; EPILEPTOGENESIS; BRAIN; MICE	The ATP-gated P2X7 receptor (P2X7R) is a non-selective cation channel which senses high extracellular ATP concentrations and has been suggested as a target for the treatment of neuroinflammation and neurodegenerative diseases. The use of P2X7R antagonists may therefore be a viable approach for treating CNS pathologies, including epileptic disorders. Recent studies showed anticonvulsant potential of P2X7R antagonists in certain animal models. To extend this work, we tested three CNS-permeable P2X7R blocker (Brilliant Blue G, AFC-5128, JNJ-47965567) and a natural compound derivative (tanshinone IIA sulfonate) in four well-characterized animal seizure models. In the maximal electroshock seizure threshold test and the pentylenetetrazol (PTZ) seizure threshold test in mice, none of the four compounds demonstrated anticonvulsant effects when given alone. Notably, in combination with carbamazepine, both AFC-5128 and JNJ-47965567 increased the threshold in the maximal electroshock seizure test. In the PTZ-kindling model in rats, useful for testing antiepileptogenic activities, Brilliant Blue G and tanshinone exhibited a moderate retarding effect, whereas the potent P2X7R blocker AFC-5128 and JNJ-47965567 showed a significant and long-lasting delay in kindling development. In fully kindled rats, the investigated compounds revealed modest effects to reduce the mean seizure stage. Furthermore, AFC5128- and JNJ-47965567-treated animals displayed strongly reduced Iba 1 and GFAP immunoreactivity in the hippocampal CA3 region. In summary, our results show that P2X7R antagonists possess no remarkable anticonvulsant effects in the used acute screening tests, but can attenuate chemically-induced kindling. Further studies would be of interest to support the concept that P2X7R signalling plays a crucial role in the pathogenesis of epileptic disorders.	[Fischer, Wolfgang; Franke, Heike; Kruegel, Ute] Univ Leipzig, Fac Med, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany; [Mueller, Heiko; Dinkel, Klaus] Lead Discovery Ctr GmbH, Dortmund, Germany; [Dinkel, Klaus] Affectis Pharmaceut AG, Dortmund, Germany; [Lord, Brian; Letavic, Michael A.] Janssen Res & Dev LLC, Neurosci Therapeut Area, San Diego, CA USA; [Henshall, David C.; Engel, Tobias] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland	Leipzig University; Lead Discovery Center GmbH (LDC); Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Royal College of Surgeons - Ireland	Fischer, W (corresponding author), Univ Leipzig, Fac Med, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany.	fisw@medizin.uni-leipzig.de		Engel, Tobias/0000-0001-9137-0637; Henshall, David/0000-0001-6237-9632; Krugel, Ute/0000-0002-2317-2302	German Research Foundation (DFG) [SCHU 1672/3-3]; Universitat Leipzig; Science Foundation Ireland [13/SIRG/2098]	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors acknowledge support from the German Research Foundation (DFG: SCHU 1672/3-3) and Universitat Leipzig within the program of Open Access Publishing. This study was partly supported by funding from Science Foundation Ireland (13/SIRG/2098) to TE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Amhaoul H, 2016, NEUROPHARMACOLOGY, V105, P175, DOI 10.1016/j.neuropharm.2016.01.018; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Barros-Barbosa AR, 2016, EPILEPSIA, V57, P99, DOI 10.1111/epi.13263; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Baulac M., 2009, EPILEPSIA, V50, P571, DOI 10.1111/j.1528-1167.2008.01811.x; Bedner P, 2015, BRAIN, V138, P1208, DOI 10.1093/brain/awv067; Bhattacharya A, 2013, BRIT J PHARMACOL, V170, P624, DOI 10.1111/bph.12314; Bos M, 2009, Patent WO, Patent No. [2009118175A1, 2009118175]; Chen Z, 2002, ACTA PHARMACOL SIN, V23, P361; Cherubini E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00019; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Choi HK, 2012, NEUROL SCI, V33, P515, DOI 10.1007/s10072-011-0740-z; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Chrovian CC, 2014, PROGR MED CHEM, V53, P65, DOI 10.1016/B978-0-444-63380-4.00002-0; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; CORDA MG, 1992, J PHARMACOL EXP THER, V262, P792; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Di Maio R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00029; Di Virgilio F, 2015, CURR MED CHEM, V22, P866; Dona F, 2009, EPILEPSY RES, V83, P157, DOI 10.1016/j.eplepsyres.2008.10.008; Duan SM, 2006, GLIA, V54, P738, DOI 10.1002/glia.20397; Engel T, 2016, NEUROPHARMACOLOGY, V104, P140, DOI 10.1016/j.neuropharm.2015.11.001; Engel Tobias, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P174; Engel T, 2012, FASEB J, V26, P1616, DOI 10.1096/fj.11-196089; Fernandes M, 2010, OPEN NEUROSCI J, V4, P35; Ferrari D, 2007, J IMMUNOL, V179, P8569, DOI 10.4049/jimmunol.179.12.8569-b; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fischer W, 1998, J NEURAL TRANSM, V105, P1129, DOI 10.1007/s007020050117; Fischer W, 2002, SEIZURE-EUR J EPILEP, V11, P285, DOI 10.1053/seiz.2001.0644; Fischer W, 2015, ABSTRACT HDB U HAMBU, P85; Fischer W, 2014, PURINERG SIGNAL, V10, P313, DOI 10.1007/s11302-013-9392-1; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Franke H, 2001, PHARMACOL BIOCHEM BE, V70, P291, DOI 10.1016/S0091-3057(01)00612-8; Franke H, 2014, ADV NEUROBIOL, V11, P213, DOI 10.1007/978-3-319-08894-5_11; Henshall DC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00237; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jiang LH, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00055; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Pacheco A, 2013, EPILEPSIA, V54, P1551, DOI 10.1111/epi.12257; Kaiser M, 2014, J PHARMACOL EXP THER, V350, P531, DOI 10.1124/jpet.114.214569; Kaminski RM, 2014, NEUROTHERAPEUTICS, V11, P385, DOI 10.1007/s13311-014-0266-1; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Kim JE, 2009, NEUROL RES, V31, P982, DOI 10.1179/174313209X389811; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lam BYH, 2003, PHYTOMEDICINE, V10, P286, DOI 10.1078/094471103322004776; Letavic MA, 2013, ACS MED CHEM LETT, V4, P419, DOI 10.1021/ml400040v; Li TF, 2008, J CLIN INVEST, V118, P571, DOI 10.1172/JCI33737; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; Lord B, 2015, EUR J PHARMACOL, V765, P551, DOI 10.1016/j.ejphar.2015.09.026; Lourbopoulos A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00054; Marin-Garcia P, 2008, NEUROSCIENCE, V151, P361, DOI 10.1016/j.neuroscience.2007.10.038; Maroso M, 2011, J INTERN MED, V270, P319, DOI 10.1111/j.1365-2796.2011.02431.x; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Mesuret G, 2014, CNS NEUROSCI THER, V20, P556, DOI 10.1111/cns.12272; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; Noe FM, 2013, NEUROBIOL DIS, V59, P183, DOI 10.1016/j.nbd.2013.07.015; Ono J, 1990, NEUROLOGY, V5, P345; Padrao R. A., 2011, PURINERG SIGNAL, V7, P127, DOI [10.1007/s11302-010-9208-5, DOI 10.1007/S11302-010-9208-5]; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Perucca E, 2014, EPILEPSIA, V55, P1326, DOI 10.1111/epi.12725; RAMANJANEYULU R, 1984, EUR J PHARMACOL, V98, P337, DOI 10.1016/0014-2999(84)90282-6; Rappold PM, 2006, BRAIN RES, V1089, P171, DOI 10.1016/j.brainres.2006.03.040; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Rodrigues RJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00148; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Romagnoli R, 2008, EXPERT OPIN THER TAR, V12, P647, DOI 10.1517/14728222.12.5.647 ; Roseti C, 2015, NEUROBIOL DIS, V82, P311, DOI 10.1016/j.nbd.2015.07.003; Ryu JK, 2008, NEUROREPORT, V19, P1715, DOI 10.1097/WNR.0b013e3283179333; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Soni N, 2015, EPILEPSY BEHAV, V48, P4, DOI 10.1016/j.yebeh.2015.04.056; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; Steinhauser C, 2012, JASPERS BASIC MECH E, P1; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Suttkus Anne, 2012, Am J Neurodegener Dis, V1, P122; Uludag IF, 2015, SEIZURE-EUR J EPILEP, V26, P22, DOI 10.1016/j.seizure.2015.01.009; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Vezzani A, 2015, EXPERT OPIN DRUG SAF, V14, P583, DOI 10.1517/14740338.2015.1010508; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vianna EPM, 2002, EPILEPSIA, V43, P227, DOI 10.1046/j.1528-1157.43.s.5.26.x; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Xu D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00195; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Yuen ESM, 2015, SEIZURE-EUR J EPILEP, V24, P21, DOI 10.1016/j.seizure.2014.11.006	104	41	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156468	10.1371/journal.pone.0156468	http://dx.doi.org/10.1371/journal.pone.0156468			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281030	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000030
J	Lu, P; Li, JX; Jin, CG; Jiang, BW; Bai, YM				Lu, Ping; Li, Jingxin; Jin, Chenggong; Jiang, Baiwen; Bai, Yamei			Different Growth Responses of an Invasive Weed and a Native Crop to Nitrogen Pulse and Competition	PLOS ONE			English	Article							SOYBEAN GLYCINE-MAX; PIGWEED AMARANTHUS-RETROFLEXUS; PLANT INVASION; USE EFFICIENCY; MOJAVE DESERT; N-2 FIXATION; INTERFERENCE; ABILITY; CHINA; COMMUNITIES	Resource pulses are a common event in agro-ecosystems. A pot experiment was conducted to assess the effects of nitrogen (N) pulses and competition on the growth of an invasive weed, Amaranthus retroflexus, and a native crop, Glycine max. A. retroflexus and G. max were planted in pure culture with two individuals of one species in each pot and in mixed culture with one A. retroflexus and one G. max individual and subjected to three N pulse treatments. The N treatments included a no-peak treatment (NP) with N applied stably across the growing period, a single-peak treatment (SP) with only one N addition on the planting date, and a double-peak treatment (DP) with two N additions, one on the planting date and the other on the flowering date. N pulse significantly impacted biomass and height of the two species across the whole growing season. However, only the relative growth rate (RGR) of A. retroflexus was significantly affected by N pulse. A. retroflexus had the greatest biomass and height in the SP treatment at the first harvest, and in the DP treatment at the last three harvests. Pure culture G. max produced the greatest biomass in the DP treatment. In mixed culture, G. max produced the greatest biomass in the NP treatment. Biomass production of both species was significantly influenced by species combination, with higher biomass in mixed culture than in pure culture at most growth stages. Relative yield total (RYT) values were all greater than 1.0 at the last three harvests across the three N treatments, suggesting partial resource complementarity occurred when A. retroflexus is grown with G. max. These results indicate that A. retroflexus has a strong adaptive capacity to reduce interspecific competition, likely leading to its invasion of G. max cropland in China.	[Lu, Ping; Jin, Chenggong; Jiang, Baiwen; Bai, Yamei] Northeast Agr Univ, Coll Resources & Environm Sci, Harbin, Peoples R China; [Li, Jingxin] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China	Jiang, BW (corresponding author), Northeast Agr Univ, Coll Resources & Environm Sci, Harbin, Peoples R China.	neauecology@126.com			National Natural Science Foundation of China [30900218, 31370546]; Science Technology Foundation of Heilongjiang Education Office [12541021]; China Postdoctoral Special Science Foundation [200902368]; Heilongjiang Postdoctoral Science-Research Foundation [LBH-Q11161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Foundation of Heilongjiang Education Office; China Postdoctoral Special Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Science-Research Foundation	PL received the funding of the National Natural Science Foundation of China (contract No. 30900218, 31370546), http://www.nsfc.gov.cn/; PL received the funding of the Science Technology Foundation of Heilongjiang Education Office (contract No. 12541021), http://www.hlje.net; PL received the funding of the China Postdoctoral Special Science Foundation (contract No. 200902368), http://res.chinapostdoctor.org.cn/BshWeb/index.shtml; PL received the funding of the Heilongjiang Postdoctoral Science-Research Foundation (contract No. LBH-Q11161), www.hljbsh.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Relva MA, 2010, BIOL INVASIONS, V12, P303, DOI 10.1007/s10530-009-9623-0; Angonin C, 1996, WEED RES, V36, P175, DOI 10.1111/j.1365-3180.1996.tb01813.x; BASKIN JM, 1977, OECOLOGIA, V30, P377, DOI 10.1007/BF00399768; Bensch CN, 2003, WEED SCI, V51, P37, DOI 10.1614/0043-1745(2003)051[0037:IORPAR]2.0.CO;2; Blackshaw RE, 2003, WEED SCI, V51, P532, DOI 10.1614/0043-1745(2003)051[0532:DROWST]2.0.CO;2; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Clements DR, 2004, AGR ECOSYST ENVIRON, V104, P379, DOI 10.1016/j.agee.2004.03.003; Cong X, 2013, CROPS, V1, P73; Cowan P, 1998, WEED SCI, V46, P533, DOI 10.1017/S0043174500091050; Cramer MD, 2007, J ECOL, V95, P1123, DOI 10.1111/j.1365-2745.2007.01285.x; Crotser MP, 2000, WEED SCI, V48, P20, DOI 10.1614/0043-1745(2000)048[0020:EOGMCC]2.0.CO;2; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Di W, 2010, J NUCL AGR SCI, V24, P612; DIELEMAN A, 1995, WEED SCI, V43, P612, DOI 10.1017/S0043174500081728; Esque TC, 2010, OECOLOGIA, V164, P253, DOI 10.1007/s00442-010-1617-1; FORCELLA F, 1984, AUST J EXP AGR, V24, P421, DOI 10.1071/EA9840421; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Gan YB, 2003, FIELD CROP RES, V80, P147, DOI 10.1016/S0378-4290(02)00171-5; Glauninger J., 1982, Biology and ecology of weeds [Holzner, W. and Numata, M. (Editors)], P149; Harper J. L, 1977, POPULATION BIOL PLAN; Harrison S, 1999, OECOLOGIA, V121, P99, DOI 10.1007/s004420050910; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; James JJ, 2006, J ARID ENVIRON, V67, P528, DOI 10.1016/j.jaridenv.2006.02.014; KIGEL J, 1994, AMARANTH BIOL CHEM T, P39; KNEZEVIC SZ, 1994, WEED SCI, V42, P568, DOI 10.1017/S0043174500076967; LeBrun EG, 2012, J ANIM ECOL, V81, P884, DOI 10.1111/j.1365-2656.2012.01954.x; LEGERE A, 1989, WEED SCI, V37, P84, DOI 10.1017/S0043174500055909; Li X.J., 2004, PESTIC SCI ADM, V25, P13; Li ZY, 2002, INVASIVE ALIEN PLANT, P106; Lindquist JL, 1998, AGRON J, V90, P787, DOI 10.2134/agronj1998.00021962009000060012x; Liu X, 2008, FIELD CROP RES, V105, P157, DOI 10.1016/j.fcr.2007.09.003; Lu ZJ, 2005, WEED SCI, V53, P600, DOI 10.1614/WS-04-188R2.1; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; NAGATA TADAO, 1959, PROC CROP SCI SOC JAPAN, V28, P79; Niu SL, 2008, J PLANT ECOL-UK, V1, P103, DOI 10.1093/jpe/rtn003; Olson BE, 2003, PLANT SOIL, V254, P457, DOI 10.1023/A:1025536100535; ORWICK PL, 1979, WEED SCI, V27, P665, DOI 10.1017/S0043174500046117; PATTERSON DT, 1995, WEED SCI, V43, P483, DOI 10.1017/S0043174500081510; Puricelli EC, 2003, WEED TECHNOL, V17, P446, DOI 10.1614/0890-037X(2003)017[0446:SAACCI]2.0.CO;2; Qin RM, 2013, NEW PHYTOL, V197, P979, DOI 10.1111/nph.12071; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; SAUER JONATHAN D., 1967, ANN MO BOT GARD, V54, P103, DOI 10.2307/2394998; SHURTLEFF JL, 1985, WEED SCI, V33, P654, DOI 10.1017/S004317450008303X; TODD CE, 2010, OECOLOGIA, V164, P253, DOI DOI 10.1007/S00442-010-1617-1; Van Delden A, 2002, WEED RES, V42, P429, DOI 10.1046/j.1365-3180.2002.00303.x; Vasquez E, 2008, INVAS PLANT SCI MANA, V1, P287, DOI 10.1614/IPSM-08-062.1; Vila M, 2004, BIOL INVASIONS, V6, P59, DOI 10.1023/B:BINV.0000010122.77024.8a; Vitta JI, 1999, WEED RES, V39, P259, DOI 10.1046/j.1365-3180.1999.00142.x; WILSON SD, 1986, ECOLOGY, V67, P1236, DOI 10.2307/1938679; Wu JT, 2013, ECOTOXICOLOGY, V22, P608, DOI 10.1007/s10646-013-1052-2; Xu BC, 2013, ECOL RES, V28, P781, DOI 10.1007/s11284-013-1061-x; Xu HG, 2006, BIOL INVASIONS, V8, P1495, DOI 10.1007/s10530-005-5841-2; Zhang DY, 2010, BRIEF INTRO SOYBEAN	55	9	12	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156285	10.1371/journal.pone.0156285	http://dx.doi.org/10.1371/journal.pone.0156285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280410	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000024
J	Betancourth-Cundar, M; Lima, AP; Hodl, W; Amezquita, A				Betancourth-Cundar, Mileidy; Lima, Albertina P.; Hodl, Walter; Amezquita, Adolfo			Decoupled Evolution between Senders and Receivers in the Neotropical Allobates femoralis Frog Complex	PLOS ONE			English	Article							DART-POISON FROG; EPIPEDOBATES-FEMORALIS; MAXIMUM-LIKELIHOOD; CALL FREQUENCY; BEHAVIOR; RECOGNITION; PREFERENCES; COMMUNICATION; DENDROBATIDAE; INTERFERENCE	During acoustic communication, an audible message is transmitted from a sender to a receiver, often producing changes in behavior. In a system where evolutionary changes of the sender do not result in a concomitant adjustment in the receiver, communication and species recognition could fail. However, the possibility of an evolutionary decoupling between sender and receiver has rarely been studied. Frog populations in the Allobates femoralis cryptic species complex are known for their extensive morphological, genetic and acoustic variation. We hypothesized that geographic variation in acoustic signals of A. femoralis was correlated with geographic changes in communication through changes in male-male recognition. To test this hypothesis, we quantified male call recognition using phonotactic responses to playback experiments of advertisement calls with two, three and four notes in eight localities of the Amazonian basin. Then, we reconstructed the ancestral states of call note number in a phylogenetic framework and evaluated whether the character state of the most recent common ancestor predicted current relative responses to two, three and four notes. The probability of a phonotactic response to advertisement calls of A. femoralis males was strongly influenced by the call mid-frequency and the number of notes in most populations. Positive phonotaxis was complete for calls from each individual's population, and in some populations, it was also partial for allotopic calls; however, in two populations, individuals equally recognized calls with two, three or four notes. This evidence, in conjunction with our results from phylogenetic comparative methods, supports the hypothesis of decoupled evolution between sender and receiver in the male-male communication system of the A. femoralis complex. Thus, signal recognition appears to evolve more slowly than the calls.	[Betancourth-Cundar, Mileidy; Amezquita, Adolfo] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Lima, Albertina P.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Pesquisas Biodiversidade, Manaus, Amazonas, Brazil; [Hodl, Walter] Univ Vienna, Dept Integrat Zool, Vienna, Austria	Universidad de los Andes (Colombia); Institute Nacional de Pesquisas da Amazonia; University of Vienna	Betancourth-Cundar, M (corresponding author), Univ Los Andes, Dept Biol Sci, Bogota, Colombia.	cm.betancourth2026@uniandes.edu.co		Lima, Albertina Pimentel/0000-0003-4586-5633	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas'' - COLCIENCIAS [617]; Faculty of Sciences at the Universidad de los Andes - Colombia [2012-2]; Austrian Science Foundation [FWF-P15345, FWF-P25612]	Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas'' - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Faculty of Sciences at the Universidad de los Andes - Colombia; Austrian Science Foundation(Austrian Science Fund (FWF))	This work was supported by Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas'' - COLCIENCIAS (Grant Jovenes investigadores e innovadores No. 617, 2013 to MBC) the Faculty of Sciences at the Universidad de los Andes - Colombia (Proyecto Semilla 2012-2 to CMB) and two grants to W. Hodl from the Austrian Science Foundation (FWF-P15345 and FWF-P25612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2005, ANIM BEHAV, V70, P1377, DOI 10.1016/j.anbehav.2005.03.012; Amezquita A, 2006, EVOLUTION, V60, P1874; Amezquita A, 2011, P NATL ACAD SCI USA, V108, P17058, DOI 10.1073/pnas.1104773108; Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Andersson S, 1999, TRENDS ECOL EVOL, V14, P174, DOI 10.1016/S0169-5347(99)01615-8; [Anonymous], 2014, TRACER V1 6; ARAK A, 1993, PHILOS T R SOC B, V340, P207, DOI 10.1098/rstb.1993.0059; Bernal XE, 2009, P R SOC B, V276, P1323, DOI 10.1098/rspb.2008.0935; Bioacoustics Research Program, 2014, RAV PRO INT SOUND AN; BLAIR WF, 1958, AM NAT, V92, P27, DOI 10.1086/282007; Bradbury Jack W., 1998, pi; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dawkins MS, 1996, AM NAT, V148, P937, DOI 10.1086/285964; de Luna AG, 2010, ANIM BEHAV, V79, P739, DOI 10.1016/j.anbehav.2009.12.031; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekstrom C, 2013, MESS MISCELLANEOUS E; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Erdtmann LK, 2011, BEHAVIOUR, V148, P485, DOI 10.1163/000579511X565754; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gerhardt H. C, 1988, EVOLUTION AMPHIBIAN, P253; Gerhardt H. Carl, 1995, Amphibian Biology, V2, P603; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Green S., 1979, SOCIAL BEHAV COMMUNI, P73, DOI DOI 10.1007/978-1-4615-9116-0_3; Hastie T., 1986, STAT SCI, V1, P297; Hodl W, 2004, J COMP PHYSIOL A, V190, P823, DOI 10.1007/s00359-004-0536-1; Hodl W, 1983, WISSENSCHAFTLICHER F, V30, P12; Hoke KL, 2010, J EXP BIOL, V213, P3463, DOI 10.1242/jeb.043992; HOLM S, 1979, SCAND J STAT, V6, P65; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison WP, 2009, MESQUITE MODULAR SYS; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PENGILLEY RK, 1971, J ZOOL, V163, P73; Prohl H, 1999, BEHAV ECOL SOCIOBIOL, V46, P215, DOI 10.1007/s002650050612; Prohl Heike, 1997, Amphibia-Reptilia, V18, P437, DOI 10.1163/156853897X00495; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Read M., 2000, FROGS OF THE ECUATOR; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; ROBERTSON JGM, 1986, ANIM BEHAV, V34, P773, DOI 10.1016/S0003-3472(86)80061-6; ROITHMAIR ME, 1994, HERPETOL J, V4, P77; ROITHMAIR ME, 1992, ETHOLOGY, V92, P331, DOI 10.1111/j.1439-0310.1992.tb00970.x; Rojas B, 2006, ETHOLOGY, V112, P564, DOI 10.1111/j.1439-0310.2005.01190.x; Ron SR, 2008, ANIM BEHAV, V76, P1783, DOI 10.1016/j.anbehav.2008.07.024; Ryan M.J., 1988, P637; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; RYAN MJ, 1992, AM NAT, V139, P1370, DOI 10.1086/285391; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Ryan MJ, 2003, ACTA ZOOL SINICA, P713; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schneider H., 2006, AMPHIBIAN BIOL, V7, P2892; Schwartz JJ, 1998, ANIM BEHAV, V56, P55, DOI 10.1006/anbe.1998.0737; SCHWARTZ JJ, 1985, COPEIA, P27; SCHWARTZ JJ, 1984, BEHAV ECOL SOCIOBIOL, V14, P211, DOI 10.1007/BF00299621; Silverstone PA., 1976, NAT HIST MUS LOS ANG, V27, P1; Simoes PI, 2008, BIOTROPICA, V40, P607, DOI 10.1111/j.1744-7429.2008.00416.x; Simoes PI, 2010, ZOOTAXA, P1; Simoes PI, 2014, TROP CONSERV SCI, V7, P811, DOI 10.1177/194008291400700416; Simoes PI, 2012, CONSERV GENET, V13, P1145, DOI 10.1007/s10592-012-0362-x; SUMMERS K, 1992, ANIM BEHAV, V43, P907, DOI 10.1016/0003-3472(92)90004-S; Summers K, 2000, BEHAVIOUR, V137, P7, DOI 10.1163/156853900501845; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ursprung E, 2011, MOL ECOL, V20, P1759, DOI 10.1111/j.1365-294X.2011.05056.x; Velez A, 2012, ETHOLOGY, V118, P377, DOI 10.1111/j.1439-0310.2012.02021.x; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vitt L. J., 2013, HERPETOLOGY INTRO BI; Weary D, 1993, ANIM BEHAV, V45, P417, DOI [10.1006/anbe.1993.1051, DOI 10.1006/ANBE.1993.1051]; WELLS KD, 1980, BEHAV ECOL SOCIOBIOL, V6, P199, DOI 10.1007/BF00569201; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; WILCZYNSKI W, 1993, J COMP PHYSIOL A, V172, P425, DOI 10.1007/BF00213524; Wiley R. Haven, 1994, P157; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2006, GEN ADDITIVE MODELS	79	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155929	10.1371/journal.pone.0155929	http://dx.doi.org/10.1371/journal.pone.0155929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276054	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700009
J	Buonanno, M; Stanislauskas, M; Ponnaiya, B; Bigelow, AW; Randers-Pehrson, G; Xu, YP; Shuryak, I; Smilenov, L; Owens, DM; Brenner, DJ				Buonanno, Manuela; Stanislauskas, Milda; Ponnaiya, Brian; Bigelow, Alan W.; Randers-Pehrson, Gerhard; Xu, Yanping; Shuryak, Igor; Smilenov, Lubomir; Owens, David M.; Brenner, David J.			207-nm UV Light-A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. II: In-Vivo Safety Studies	PLOS ONE			English	Article							PERCUTANEOUS-ABSORPTION; ULTRAVIOLET-RADIATION; VISIBLE CHANGES; SKIN; EXPRESSION; RESPONSES; CONTAMINATION; IRRADIATION; INVITRO; MARKERS	Background UVC light generated by conventional germicidal lamps is a well-established anti-microbial modality, effective against both bacteria and viruses. However, it is a human health hazard, being both carcinogenic and cataractogenic. Earlier studies showed that single-wavelength far-UVC light (207 nm) generated by excimer lamps kills bacteria without apparent harm to human skin tissue in vitro. The biophysical explanation is that, due to its extremely short range in biological material, 207 nm UV light cannot penetrate the human stratum corneum (the outer dead-cell skin layer, thickness 5-20 mu m) nor even the cytoplasm of individual human cells. By contrast, 207 nm UV light can penetrate bacteria and viruses because these cells are physically much smaller. Aims To test the biophysically-based hypothesis that 207 nm UV light is not cytotoxic to exposed mammalian skin in vivo. Methods Hairless mice were exposed to a bactericidal UV fluence of 157 mJ/cm(2) delivered by a filtered Kr-Br excimer lamp producing monoenergetic 207-nm UV light, or delivered by a conventional 254-nm UV germicidal lamp. Sham irradiations constituted the negative control. Eight relevant cellular and molecular damage endpoints including epidermal hyperplasia, pre-mutagenic UV-associated DNA lesions, skin inflammation, and normal cell proliferation and differentiation were evaluated in mice dorsal skin harvested 48 h after UV exposure. Results While conventional germicidal UV (254 nm) exposure produced significant effects for all the studied skin damage endpoints, the same fluence of 207 nm UV light produced results that were not statistically distinguishable from the zero exposure controls. Conclusions As predicted by biophysical considerations and in agreement with earlier in vitro studies, 207-nm light does not appear to be significantly cytotoxic to mouse skin. These results suggest that excimer-based far-UVC light could potentially be used for its anti-microbial properties, but without the associated hazards to skin of conventional germicidal UV lamps.	[Buonanno, Manuela; Ponnaiya, Brian; Bigelow, Alan W.; Randers-Pehrson, Gerhard; Xu, Yanping; Shuryak, Igor; Smilenov, Lubomir; Brenner, David J.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA; [Stanislauskas, Milda; Owens, David M.] Columbia Univ, Dept Dermatol, Med Ctr, New York, NY 10027 USA; [Owens, David M.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Brenner, DJ (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	djb3@cumc.columbia.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	Columbia University Medical Center; NIH NIAMS Skin Disease Research Center pilot project [5P30AR044535-13]; Ushio Inc. (Tokyo, Japan)	Columbia University Medical Center; NIH NIAMS Skin Disease Research Center pilot project; Ushio Inc. (Tokyo, Japan)	This was funded through internal funding at Columbia University Medical Center. This work was also supported by the NIH NIAMS Skin Disease Research Center pilot project 5P30AR044535-13 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Lynn Shostack for her support and advice. GR-P receives royalty payments from Ushio Inc. (Tokyo, Japan) pursuant to exclusive license and research agreements with Columbia University.	Athar M, 2004, TOXICOL APPL PHARM, V195, P370, DOI 10.1016/j.taap.2003.09.030; BISSETT DL, 1987, PHOTOCHEM PHOTOBIOL, V46, P367, DOI 10.1111/j.1751-1097.1987.tb04783.x; BISSETT DL, 1989, PHOTOCHEM PHOTOBIOL, V50, P763, DOI 10.1111/j.1751-1097.1989.tb02907.x; BRONAUGH RL, 1982, TOXICOL APPL PHARM, V62, P481, DOI 10.1016/0041-008X(82)90149-1; Buonanno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076968; COLE CA, 1983, PHOTOCHEM PHOTOBIOL, V37, P623, DOI 10.1111/j.1751-1097.1983.tb04531.x; Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50; COOHILL TP, 1986, PHOTOCHEM PHOTOBIOL, V44, P359, DOI 10.1111/j.1751-1097.1986.tb04676.x; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; Dawson DV, 2013, INT J COSMETIC SCI, V35, P220, DOI 10.1111/ics.12038; GOLDFARB AR, 1951, SCIENCE, V114, P156, DOI 10.1126/science.114.2954.156; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; GREEN H, 1987, CANCER RES, V47, P410; Haley VB, 2012, INFECT CONT HOSP EP, V33, P565, DOI 10.1086/665710; HAWK JLM, 1988, BRIT J DERMATOL, V118, P27, DOI 10.1111/j.1365-2133.1988.tb01746.x; Hayashi L. C., 1998, Asia-Pacific Journal of Public Health, V10, P57, DOI 10.1177/101053959801000201; Hitzschke L, 2001, P 9 INT S SCI TECHN, P411; HORIO T, 1993, BRIT J DERMATOL, V128, P10, DOI 10.1111/j.1365-2133.1993.tb00139.x; IKAI K, 1985, J INVEST DERMATOL, V85, P82, DOI 10.1111/1523-1747.ep12275365; JOSE JG, 1985, EXP EYE RES, V41, P545, DOI 10.1016/S0014-4835(85)80011-7; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010; LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5; LORIAN V, 1985, DIAGN MICR INFEC DIS, V3, P433, DOI 10.1016/0732-8893(85)90082-3; McDevitt JJ, 2012, APPL ENVIRON MICROB, V78, P1666, DOI 10.1128/AEM.06960-11; Metz M, 2006, AM J PATHOL, V169, P815, DOI 10.2353/ajpath.2006.060037; Metzler DE., 2001, BIOCH CHEM REACTIONS; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Rao BK, 2011, OSTOMY WOUND MANAG, V57, P46; Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Russell LM, 2008, EUR J PHARM BIOPHARM, V69, P861, DOI 10.1016/j.ejpb.2008.02.002; Sander CS, 2002, J INVEST DERMATOL, V118, P618, DOI 10.1046/j.1523-1747.2002.01708.x; Sano T, 2009, ARCH DERMATOL RES, V301, P227, DOI 10.1007/s00403-008-0914-6; SATO K, 1991, J PHARM SCI, V80, P104, DOI 10.1002/jps.2600800203; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schweintzger NA, 2015, EXP DERMATOL; Setlow J., 1966, CURR TOP RADIAT RES, P195; SETLOW RB, 1966, J MOL BIOL, V17, P237, DOI 10.1016/S0022-2836(66)80105-5; SODERBERG PG, 1988, ACTA OPHTHALMOL, V66, P141; Sosnin EA, 2005, INSTRUM EXP TECH+, V48, P663, DOI 10.1007/s10786-005-0118-7; Stocks GW, 2011, J ARTHROPLASTY, V26, P771, DOI 10.1016/j.arth.2010.07.001; Sun T T, 1983, Curr Probl Dermatol, V11, P277; U.S. Department of Health and Human Services, 2000, REP CARC BACKGR DOC; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; VARGHESE AJ, 1969, NATURE, V223, P299, DOI 10.1038/223299a0; Volkova G. A., 1984, Journal of Applied Spectroscopy, V41, P1194, DOI 10.1007/BF00659516; Vollkommer F., 1998, Proceedings of 8th International Symposium on the Science and Technology of Light Sources (LS-8), P51; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; Yin R, 2013, CURR OPIN PHARMACOL, V13, P731, DOI 10.1016/j.coph.2013.08.009	52	59	61	8	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0138418	10.1371/journal.pone.0138418	http://dx.doi.org/10.1371/journal.pone.0138418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275949	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700001
J	Fu, CH; Tsai, WC; Lee, TJ; Huang, CC; Chang, PH; Pang, JHS				Fu, Chia-Hsiang; Tsai, Wan-Chun; Lee, Ta-Jen; Huang, Chi-Che; Chang, Po-Hung; Pang, Jong-Hwei Su			Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; UPPER AIRWAY DISEASE; ALLERGIC-ASTHMA; MURINE MODEL; INFLAMMATION; PROTEIN; DIFFERENTIATION; STATINS; EOTAXIN; HL-60	IL-5-induced chemotaxis of eosinophils is an important feature of allergic airway inflammatory diseases. Simvastatin, a lipid lowering agent, has been shown to exhibit anti-inflammatory and anti-allergic effects. Our aim was to investigate the effect of simvastatin on IL-5-induced eosinophil chemotaxis and its regulatory mechanisms. Eosinophils were derived by treating HL-60 clone 15 (HC15) cells with butyric acid (BA) in an alkaline condition or through direct isolation from human peripheral blood. The expressions of CC chemokine receptor 3 (CCR3) and interleukin (IL)-5 receptors (IL5R alpha and beta) were analyzed using RT/real-time PCR. The granular proteins were stained using fast green. Eotaxin-induced chemotaxis was measured using a transwell migration assay. CCR3 protein expression was revealed by immunocytochemistry. An animal model of allergic rhinitis was established by challenging Sprague-Dawley (R) rats repeatedly with ovalbumin. Butyric acid significantly increased the expression of IL5R alpha and IL5R beta, CCR3 and granular proteins in HC15 cells, indicating the maturation of eosinophils (BA-E cells). IL-5 further enhanced the CCR3 expression at both the mRNA and protein levels and the eotaxin-induced chemotaxis of BAE cells. Simvastatin inhibited the effects of IL-5 on BA-E cells, but not in the presence of mevalonate. Similar results were also exhibited in human primary eosinophils. In vivo animal studies further confirmed that oral simvastatin could significantly suppress the infiltration of eosinophils into turbinate tissues of allergic rats. Therefore, simvastatin was demonstrated to inhibit IL-5-induced CCR3 expression and chemotaxis of eosinophils mediated via the mevalonate pathway. We confirmed that simvastatin also reduced eosinophilic infiltration in allergic rhinitis.	[Fu, Chia-Hsiang; Tsai, Wan-Chun; Huang, Chi-Che; Chang, Po-Hung; Pang, Jong-Hwei Su] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Fu, Chia-Hsiang; Lee, Ta-Jen; Huang, Chi-Che; Chang, Po-Hung] Chang Gung Mem Hosp, Dept Otolaryngol, Taoyuan, Taiwan; [Tsai, Wan-Chun] Chang Gung Univ, Coll Med, Dept Resp Therapy, Taoyuan, Taiwan; [Pang, Jong-Hwei Su] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Pang, JHS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.; Pang, JHS (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan.	jonghwei@mail.cgu.edu.tw		Lee, Ta-Jen/0000-0003-0508-1359; PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Memorial Hospital [CMRPG392311, CMRPG3C1941]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the Chang Gung Memorial Hospital (CMRPG392311 and CMRPG3C1941).	Akuthota P, 2010, CURR OPIN ALLERGY CL, V10, P14, DOI 10.1097/ACI.0b013e328334f693; Bachert C., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P209; Bystrom J, 2012, CURR OPIN ALLERGY CL, V12, P18, DOI 10.1097/ACI.0b013e32834eccaf; Cowan DC, 2010, THORAX, V65, P891, DOI 10.1136/thx.2010.138990; Desai F, 2009, INT IMMUNOPHARMACOL, V9, P153, DOI 10.1016/j.intimp.2008.10.019; Dursun E, 2003, OTOLARYNG HEAD NECK, V129, P526, DOI 10.1016/S0194-5998(03)01576-6; FISCHKOFF SA, 1984, J EXP MED, V160, P179, DOI 10.1084/jem.160.1.179; FISCHKOFF SA, 1986, BLOOD, V68, P185; FISCHKOFF SA, 1988, LEUKEMIA RES, V12, P679, DOI 10.1016/0145-2126(88)90103-8; Folli C, 2008, EUR ANN ALLERGY CLIN, V40, P84; Fortin M, 2010, CYTOKINE, V52, P194, DOI 10.1016/j.cyto.2010.07.005; Foster CA, 1996, J ALLERGY CLIN IMMUN, V98, pS270, DOI 10.1016/S0091-6749(96)70075-1; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Graziano FM, 1999, ALLERGY ASTHMA PROC, V20, P141, DOI 10.2500/108854199778553055; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Huang CC, 2011, EUR J CLIN INVEST, V41, P507, DOI 10.1111/j.1365-2362.2010.02434.x; Kampen GT, 2000, BLOOD, V95, P1911, DOI 10.1182/blood.V95.6.1911; Kenji I, 2005, INT ARCH ALLERGY  S1, V137, P77, DOI [10.1159/000085436, DOI 10.1159/000085436]; Kim DY, 2007, EUR J PHARMACOL, V557, P76, DOI 10.1016/j.ejphar.2006.11.027; Kim MA, 2014, CURR OPIN ALLERGY CL, V14, P49, DOI 10.1097/ACI.0000000000000028; Lampinen M, 2004, ALLERGY, V59, P793, DOI 10.1111/j.1398-9995.2004.00469.x; Leckie Maggie J, 2003, Am J Respir Med, V2, P245; Liu JN, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.55; Maneechotesuwan K, 2013, CLIN EXP ALLERGY, V43, P212, DOI 10.1111/cea.12067; Maneechotesuwan K, 2010, J ALLERGY CLIN IMMUN, V126, P754, DOI 10.1016/j.jaci.2010.08.005; Matthew WR, 2008, OTOLARYNGOL CLIN N A, V41, P283, DOI [10.1016/j.otc.2007.11.005, DOI 10.1016/J.OTC.2007.11.005]; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Michael AD, 2011, OTOLARYNGOL CLIN N A, V44, P685, DOI [10.1016/j.otc.2011.03.005, DOI 10.1016/J.OTC.2011.03.005]; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Montecucco F, 2009, RHEUMATOLOGY, V48, P233, DOI 10.1093/rheumatology/ken466; Nakahara Y, 2001, RESPIRATION, V68, P389, DOI 10.1159/000050532; Park IH, 2012, AM J RHINOL ALLERGY, V26, P7, DOI 10.2500/ajra.2012.26.3679; Qiu ZJ, 2009, J BIOL CHEM, V284, P13099, DOI 10.1074/jbc.M807307200; Robinson AJ, 2009, CLIN EXP ALLERGY, V39, P1866, DOI 10.1111/j.1365-2222.2009.03334.x; Saigusa Hanako, 2006, Nihon Jibiinkoka Gakkai Kaiho, V109, P774; Shen HH, 2006, ACTA PHARMACOL SIN, V27, P1594, DOI 10.1111/j.1745-7254.2006.00446.x; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Tulbah AS, 2014, AAPS PHARMSCITECH, V15, P956, DOI 10.1208/s12249-014-0127-6; Wang WH, 2011, OTOLARYNG HEAD NECK, V144, P982, DOI 10.1177/0194599811400367; Wardlaw AJ, 1999, J ALLERGY CLIN IMMUN, V104, P917, DOI 10.1016/S0091-6749(99)70069-2; Wickert LE, 2014, J LEUKOCYTE BIOL, V95, P951, DOI 10.1189/jlb.0713413; Xu L, 2012, INT IMMUNOPHARMACOL, V12, P556, DOI 10.1016/j.intimp.2012.01.012; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zhu YM, 2011, J IMMUNOL, V186, P516, DOI 10.4049/jimmunol.1000955	45	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157186	10.1371/journal.pone.0157186	http://dx.doi.org/10.1371/journal.pone.0157186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275740	Green Submitted, gold, Green Published			2022-12-27	WOS:000377561700083
J	Wooddell, LJ; Kaburu, SSK; Rosenberg, KL; Meyer, JS; Suomi, SJ; Dettmer, AM				Wooddell, Lauren J.; Kaburu, Stefano S. K.; Rosenberg, Kendra L.; Meyer, Jerrold S.; Suomi, Stephen J.; Dettmer, Amanda M.			Matrilineal Behavioral and Physiological Changes following the Death of a Non-Alpha Matriarch in Rhesus Macaques (Macaca mulatta)	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL ACTIVITY; PAPIO-HAMADRYAS-URSINUS; CORTISOL CONCENTRATIONS; CHACMA BABOONS; HAIR CORTISOL; KILLER WHALES; WILD BABOONS; SOCIAL RANK; MONKEYS; DOMINANCE	In many species, the loss of alpha matriarchs is associated with a number of negative outcomes such as troop fission, eviction, wounding, and reduced vitality. However, whether the dramatic consequences of their loss are due to their role as an old experienced figure or to their alpha status remains unclear. We tested the hypothesis that in a semi-free ranging colony of rhesus macaques (Macaca mulatta), the death of a non-alpha matriarch, who had a large set of kin, would lead to changes in behavior and physiological stress within her matriline. Following her death, her matriline increased in aggression, vigilance, and social grooming. Additionally, hierarchical stability, measured by levels of rank changes, decreased within her matriline, and levels of intense aggression by high-ranking animals were more frequent, as well as matrilineal wounding. Although ordinal rank was positively associated with higher chronic hair cortisol concentrations (HCCs) in the months before the matriarch's death, following her death, only those who experienced large increases in rank within her matriline displayed higher HCCs. Changes in matrilineal stability, aggression, behavior, and HCCs within the other two matrilines in the troop were not evident, although caution is needed due to the small sample sizes. We conclude that the death of the non-alpha matriarch led to matrilineal instability, characterized by higher levels of aggression and subsequent vigilance, rank changes, physiological stress, and grooming. We suggest that non-alpha matriarchs with a large number of kin and social support can be integral to the stability of matrilines.	[Wooddell, Lauren J.; Suomi, Stephen J.; Dettmer, Amanda M.] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Poolesville, MD USA; [Kaburu, Stefano S. K.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Rosenberg, Kendra L.; Meyer, Jerrold S.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Davis; University of Massachusetts System; University of Massachusetts Amherst	Wooddell, LJ (corresponding author), NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Poolesville, MD USA.	lauren.wooddell@nih.gov	Kaburu, Stefano SK/O-5055-2019	Kaburu, Stefano SK/0000-0001-7456-3269; Meyer, Jerrold/0000-0002-8382-7075	Division of Intramural Research, National Institute of Child Health and Human Development [1ZIAHD001107-32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Division of Intramural Research, National Institute of Child Health and Human Development, 1ZIAHD001107-32, awarded to SJS, https://www.nichd.nih.gov/about/org/dir/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barrett L, 2012, PHILOS T R SOC B, V367, P2108, DOI 10.1098/rstb.2012.0113; Beehner JC, 2005, ANIM BEHAV, V69, P1211, DOI 10.1016/j.anbehav.2004.08.014; Beisner BA, 2016, AM J PHYS ANTHROPOL, V160, P102, DOI 10.1002/ajpa.22945; Beisner BA, 2014, AM J PRIMATOL, V76, P111, DOI 10.1002/ajp.22214; Beisner BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077369; Beisner BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016365; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; BERNSTEIN IS, 1985, AM J PRIMATOL, V8, P37, DOI 10.1002/ajp.1350080105; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Brent LJN, 2015, CURR BIOL, V25, P746, DOI 10.1016/j.cub.2015.01.037; Clarke FM, 1997, P ROY SOC B-BIOL SCI, V264, P993, DOI 10.1098/rspb.1997.0137; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; Croft DP, 2015, TRENDS ECOL EVOL, V30, P407, DOI 10.1016/j.tree.2015.04.011; Czoty PW, 2009, J NEUROENDOCRINOL, V21, P68, DOI 10.1111/j.1365-2826.2008.01800.x; Davenport LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011385; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Dettmer AM, 2014, PSYCHONEUROENDOCRINO, V42, P59, DOI 10.1016/j.psyneuen.2014.01.002; Dettmer AM, 2016, AM J PRIMATOL, V78, P238, DOI 10.1002/ajp.22503; Dettmer AM, 2015, AM J PRIMATOL, V77, P346, DOI 10.1002/ajp.22350; DEWAAL F, 1982, CHIMPANZEE POLITICS; Douglas-Hamilton I.O., 1975, ELEPHANTS, V113, P72; Douglas-Hamilton I, 2006, APPL ANIM BEHAV SCI, V100, P87, DOI 10.1016/j.applanim.2006.04.014; Elo A. E., 1978, RATING CHESSPLAYERS; Engh AL, 2006, P ROY SOC B-BIOL SCI, V273, P707, DOI 10.1098/rspb.2005.3378; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Foster EA, 2012, SCIENCE, V337, P1313, DOI 10.1126/science.1224198; Fox HE, 1997, J NEUROSCI, V17, P6463; Franz M, 2015, P R SOC B; GUST DA, 1993, HORM BEHAV, V27, P318, DOI 10.1006/hbeh.1993.1024; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Jennings DJ, 2009, ANIM BEHAV, V77, P343, DOI 10.1016/j.anbehav.2008.10.006; Judge PG, 2006, AM J PRIMATOL, V68, P993, DOI 10.1002/ajp.20290; Kaburu SSK, 2015, ANIM BEHAV, V99, P61, DOI 10.1016/j.anbehav.2014.10.018; Kaburu SSK, 2013, AM J PRIMATOL, V75, P789, DOI 10.1002/ajp.22135; Kachel AF, 2011, P ROY SOC B-BIOL SCI, V278, P384, DOI 10.1098/rspb.2010.1247; Koren L, 2008, HORM BEHAV, V54, P212, DOI 10.1016/j.yhbeh.2008.02.020; Lindburg D. G., 1971, PRIMATE BEHAV, V2, P2; MALLOW GK, 1980, AGGRESSIVE BEHAV, V6, P217, DOI 10.1002/1098-2337(1980)6:3<217::AID-AB2480060303>3.0.CO;2-V; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; McComb K, 2011, P ROY SOC LOND B BIO; Meyer JS, 2014, ILAR J, V55, P347, DOI 10.1093/ilar/ilu023; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Nieuwenhuijsen K., 1982, Zoo Biology, V1, P5, DOI 10.1002/zoo.1430010103; Novak MA, 1998, AM J PRIMATOL, V46, P213, DOI 10.1002/(SICI)1098-2345(1998)46:3&lt;213::AID-AJP3&gt;3.0.CO;2-L; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Oates-O'Brien RS, 2010, J AM ASSOC LAB ANIM, V49, P196; Pannozzo PL, 2007, ETHOLOGY, V113, P881, DOI 10.1111/j.1439-0310.2007.01392.x; Qin Dong-Dong, 2013, Zoological Research, V34, pE42, DOI 10.3724/SP.J.1141.2013.E02E42; Qin DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11267; RUEHLMANN TE, 1988, AM J PRIMATOL, V14, P125, DOI 10.1002/ajp.1350140203; SADE DS, 1972, FUNCTION EVOLUTIONAR; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1993, RECENT PROG HORM RES, V48, P437; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Soma T, 2012, LEAPING AHEAD, P137; Southwick C. H., 1996, P95; Vessey SH, 1984, POLIT PSYCHOL, P623; Watts DP, 1998, PRIMATES, V39, P71, DOI 10.1007/BF02557744; Wenyuan Qu, 1993, International Journal of Primatology, V14, P607, DOI 10.1007/BF02215450; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wooddell LJ, 2015, AM J PRIMATOL, V77, P80	72	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157108	10.1371/journal.pone.0157108	http://dx.doi.org/10.1371/journal.pone.0157108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275743	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700069
J	Flores-Martinez, A; Zanello, G; Shankar, B; Poole, N				Flores-Martinez, Artemisa; Zanello, Giacomo; Shankar, Bhavani; Poole, Nigel			Reducing Anemia Prevalence in Afghanistan: Socioeconomic Correlates and the Particular Role of Agricultural Assets	PLOS ONE			English	Article							NUTRITION OUTCOMES; WOMEN; INTERVENTIONS; STRATEGIES; HOUSEHOLDS; GOODNESS; BURDEN; HEALTH; MODEL; RISK	This research aims to examine the socio-economic correlates of anemia in women, and potential sources of iron in household diets in Afghanistan. It also examines whether ownership of agricultural (particularly livestock) assets and their use in food production has a role in alleviating anaemia, especially where local markets may be inadequate. We analyse data from the 2010/11 Afghanistan Multiple Indicator Cluster Survey, estimating a logistic regression to examine how anemia status of women is associated with socio-economic covariates. A key result found is that sheep ownership has a protective effect in reducing anemia (prevalence odds ratio of sheep ownership on anemia of 0.83, 95% confidence interval (CI): 0.73-0.94) after controlling for wealth and other covariates. This association is found to be robust to alternative model specifications. Given the central role of red meat in heme iron provision and absorption of non-heme iron, we hypothesise that sheep ownership promotes mutton consumption from own-production in a setting where market-sourced provision of nutritious food is a challenge. We then use the 2011/12 National Risk and Vulnerability Assessment household data to understand the Afghan diet from the perspective of dietary iron provision, and to understand interactions between own-production, market sourcing and mutton consumption. Sheep ownership is found to increase the likelihood that a household consumed mutton (odds ratio of 1.27, 95% CI: 1.15-1.42), the number of days in the week that mutton was consumed (prevalence rate ratio of 1.24. 95% CI: 1.12-1.37) and the quantity of mutton consumed (7 grams/person/week). In the subsample of mutton consumers, households sourcing mutton mostly from own production consumed mutton 1.5 days more frequently on average than households relying on market purchase, resulting in 100 grams per person per week higher mutton intake. Thus this analysis lends support to the notion that the linkage between sheep ownership and anemia risk is at least partly due to consumption arising from own-production in the presence of market incompleteness.	[Flores-Martinez, Artemisa; Shankar, Bhavani; Poole, Nigel] Univ London, SOAS, London, England; [Flores-Martinez, Artemisa; Shankar, Bhavani; Poole, Nigel] Leverhulme Ctr Integrat Res Agr & Hlth, London, England; [Zanello, Giacomo] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	University of London; University of London School Oriental & African Studies (SOAS); University of Reading	Shankar, B (corresponding author), Univ London, SOAS, London, England.; Shankar, B (corresponding author), Leverhulme Ctr Integrat Res Agr & Hlth, London, England.	b.shankar@soas.ac.uk		Poole, Nigel/0000-0002-2157-7883; Zanello, Giacomo/0000-0002-0477-1385; Shankar, Bhavani/0000-0001-8102-321X	UK aid from the UK Government (Department for International Development); UK aid from the UK Government	UK aid from the UK Government (Department for International Development); UK aid from the UK Government(CGIAR)	This article is part of the research generated by the Leveraging Agriculture for Nutrition in South Asia Research (LANSA) research consortium, and is funded by UK aid from the UK Government (Department for International Development).; This article is part of the research generated by the Leveraging Agriculture for Nutrition in South Asia Research (LANSA) research consortium, and is funded by UK aid from the UK Government. The views expressed do not necessarily reflect the UK Government's official policies. We gratefully acknowledge the detailed comments provided by two anonymous referees that have resulted in significant improvements to the paper. We are also grateful for comments provided by an anonymous reviewer as part of an internal review of the paper within the LANSA consortium, and by participants at the iHEA congress Milan, 2015. We thank the Central Statistics Organization, Government of Afghanistan, for access to the NRVA dataset and UNICEF/MICS for access to the AMICS data.	Abbaspour N, 2014, J RES MED SCI, V19, P164; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akhter P, 2005, NUTR FOOD SCI, V35, P109, DOI 10.1108/00346650510585895; [Anonymous], 2015, HUM DEV REP 2015 WOR; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Azzarri C., 2014, 7111 WORLD BANK; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bentley ME, 2003, EUR J CLIN NUTR, V57, P52, DOI 10.1038/sj.ejcn.1601504; Berti PR, 2004, PUBLIC HEALTH NUTR, V7, P599, DOI 10.1079/PHN2003595; Central Statistics Organization, 2014, NAT RISK VULN ASS 20; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; CSO & UNICEF, 2012, AFGH MULT IND CLUST; D'Souza A, 2013, FOOD POLICY, V42, P32, DOI 10.1016/j.foodpol.2013.06.007; D'Souza A, 2012, J DEV STUD, V48, P282, DOI 10.1080/00220388.2011.635422; Dangour AD, 2012, P NUTR SOC, V71, P222, DOI 10.1017/S0029665112000213; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Du SF, 2000, J NUTR, V130, P193, DOI 10.1093/jn/130.2.193; Dwivedi A, 2014, SCN NEWS, V31, P19; Engle-Stone R, 2005, J AGR FOOD CHEM, V53, P10276, DOI 10.1021/jf0518453; *FAO, 1982, 26 FAO; Food and Agriculture Organization, 2008, AFGH LIV CENS 2002 0; GILLESPIE S, 1998, MAJOR ISSUES CONTROL; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P205, DOI 10.1111/j.1365-3016.2012.01282.x; Government of Pakistan, 2011, NAT NUTR SURV PAK; Hallberg L, 1998, AM J CLIN NUTR, V68, P3, DOI 10.1093/ajcn/68.1.3; Hoddinott J, 2013, 63 IFPRI; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Huber D, 2010, B WORLD HEALTH ORGAN, V88, P227, DOI 10.2471/BLT.08.059410; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; HURTADO A, 1945, ARCH INTERN MED, V75, P284, DOI 10.1001/archinte.1945.00210290007002; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; KORN EL, 1990, AM STAT, V44, P270, DOI 10.2307/2684345; Leroy JL, 2007, J NUTR, V137, P2311, DOI 10.1093/jn/137.10.2311; Levitt E, 2011, MALNUTRITION AFGHANI; Levitt EJ, 2009, FOOD SECUR, V1, P177, DOI 10.1007/s12571-009-0018-y; Masset E., 2012, BMJ-BRIT MED J, V344; Ministry of Public Health and UNICEF, 2013, NAT NUTR SURV AFGH 2; Otte J, 2008, 13 AN SCI C AS AUSTR, P22; Paul P, 2013, STAT MED, V32, P67, DOI 10.1002/sim.5525; Rammohan A, 2012, ADDRESSING FEMALE IR, P1; Rawlins R, 2014, FOOD POLICY, V44, P202, DOI 10.1016/j.foodpol.2013.12.003; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruel M. T., 2001, CAN FOOD BASED STRAT; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Thomson EF, 2005, PRODUCTION MAR UNPUB; United Nations, 2015, EC SOC SURV AS PAC 2; Varkey S, 2015, LANCET GLOB HEALTH, V3, pE13, DOI 10.1016/S2214-109X(14)70362-6; World Bank, 2014, TEL STAT END SEPT 20; World Bank, 2015, AFGH POV STAT UPD OV; World Bank and Islamic Republic of Afghanistan, 2012, POV FOOD INS AFGH; World Health Organization, 1992, PREV AN WOM TAB AV I; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS	56	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156878	10.1371/journal.pone.0156878	http://dx.doi.org/10.1371/journal.pone.0156878			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1SU	27271735	Green Published, gold, Green Accepted			2022-12-27	WOS:000377560200025
J	Sarkar, S; Dell'Acqua, F; Walsh, SF; Blackwood, N; Scott, S; Craig, MC; Deeley, Q; Murphy, DGM				Sarkar, Sagari; Dell'Acqua, Flavio; Walsh, Sean Froudist; Blackwood, Nigel; Scott, Stephen; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.			A Whole-Brain Investigation of White Matter Microstructure in Adolescents with Conduct Disorder	PLOS ONE			English	Article							EARLY-ONSET; STRUCTURAL CONNECTIVITY; SEX-DIFFERENCES; FEARFUL FACES; FRONTAL-LOBE; IN-VIVO; ABNORMALITIES; CHILDREN; BOYS; CEREBELLUM	Background The biological basis of severe antisocial behaviour in adolescents is poorly understood. We recently reported that adolescents with conduct disorder (CD) have significantly increased fractional anisotropy (FA) of the uncinate fasciculus (a white matter (WM) tract that connects the amygdala to the frontal lobe) compared to their non-CD peers. However, the extent of WM abnormality in other brain regions is currently unclear. Methods We used tract-based spatial statistics to investigate whole brain WM microstructural organisation in 27 adolescent males with CD, and 21 non-CD controls. We also examined relationships between FA and behavioural measures. Groups did not differ significantly in age, ethnicity, or substance use history. Results The CD group, compared to controls, had clusters of significantly greater FA in 7 brain regions corresponding to: 1) the bilateral inferior and superior cerebellar peduncles, cortico-pontocerebellar tract, posterior limb of internal capsule, and corticospinal tract; 2) right superior longitudinal fasciculus; and 3) left cerebellar WM. Severity of antisocial behavior and callous-unemotional symptoms were significantly correlated with FA in several of these regions across the total sample, but not in the CD or control groups alone. Conclusions Adolescents with CD have significantly greater FA than controls in WM regions corresponding predominantly to the fronto-cerebellar circuit. There is preliminary evidence that variation in WM microstructure may be dimensionally related to behaviour problems in youngsters. These findings are consistent with the hypothesis that antisocial behaviour in some young people is associated with abnormalities in WM 'connectivity'.	[Sarkar, Sagari; Dell'Acqua, Flavio; Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Kings Coll London, Sackler Inst Translat Neurodev, London WC2R 2LS, England; [Sarkar, Sagari; Dell'Acqua, Flavio; Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London WC2R 2LS, England; [Sarkar, Sagari] Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Dell'Acqua, Flavio] Kings Coll London, Natbrainlab, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Kings Coll London, NIHR Biomed Res Ctr Mental Hlth South London, London WC2R 2LS, England; [Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Maudsley NHS Fdn Trust, London, England; [Blackwood, Nigel; Craig, Michael C.; Deeley, Quinton; Murphy, Declan G. M.] Inst Psychiat Psychol & Neurosci, London, England; [Walsh, Sean Froudist] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Scott, Stephen] Kings Coll London, Dept Child & Adolescent Psychiat, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust; Icahn School of Medicine at Mount Sinai; University of London; King's College London	Sarkar, S (corresponding author), Kings Coll London, Sackler Inst Translat Neurodev, London WC2R 2LS, England.; Sarkar, S (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London WC2R 2LS, England.; Sarkar, S (corresponding author), Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England.	Sagari.Sarkar@kcl.ac.uk	Dell'Acqua, Flavio/I-1407-2012; craig, michael/AAG-6641-2020; Froudist-Walsh, Sean/AAY-2567-2020	craig, michael/0000-0002-5311-8673; Deeley, Quinton/0000-0001-5306-0769; Blackwood, Nigel/0000-0002-5909-203X; Sarkar, Sagari/0000-0002-4898-4657; Murphy, Declan/0000-0002-6664-7451; Froudist Walsh, Sean/0000-0003-4070-067X; Dell'Acqua, Flavio/0000-0001-5313-5476	Medical Research Council (MRC, United Kingdom); AIMS Network [G0400061/69344]; MRC [G0800298/87573]; National Institute Health Research (NIHR) Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry; South London & Maudsley NHS Foundation Trust; Medical Research Council (MRC, UK) AIMS Network [G0400061/69344]; MRC [MR/N026063/1, G0400061] Funding Source: UKRI; Medical Research Council [G0400061, MR/N026063/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045] Funding Source: researchfish	Medical Research Council (MRC, United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AIMS Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute Health Research (NIHR) Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry; South London & Maudsley NHS Foundation Trust; Medical Research Council (MRC, UK) AIMS Network(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a private donation (to DGMM), together with infrastructure support from the Mortimer D. and Theresa Sackler Foundation (to DGMM), the Medical Research Council (MRC, United Kingdom), AIMS Network (G0400061/69344, DGMM, principle investigator), an ongoing MRC funded study of brain myelination in neurodevelopmental disorders (G0800298/87573)(to DGMM), and the National Institute Health Research (NIHR) Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry and South London & Maudsley NHS Foundation Trust (to DGMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was generously funded by a private donation; together with infrastructure support from the Mortimer D and Theresa Sackler Foundation, the Medical Research Council (MRC, UK) AIMS Network (G0400061/69344, DGMM, principle investigator), an ongoing MRC funded study of brain myelination in neurodevelopmental disorders (G0800298/87573), and the NIHR Biomedical Research Centre for Mental Health at King's College London, Institute of Psychiatry and South London & Maudsley NHS Foundation Trust.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596]; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Berns GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006773; BERNTSON GG, 1973, PHYSIOL BEHAV, V11, P81, DOI 10.1016/0031-9384(73)90126-1; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P42; Catani M., 2012, ATLAS HUMAN BRAIN CO, DOI DOI 10.1093/MED/9780199541164.001.0001/MED-9780199541164; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; De Bellis Michael D, 2005, Alcohol Clin Exp Res, V29, P1590, DOI 10.1097/01.alc.0000179368.87886.76; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Descoteaux M, 2008, BIOMEDICAL OPTICS ME; Donnellan MB, 2000, J ABNORM PSYCHOL, V109, P396, DOI 10.1037/0021-843X.109.3.396; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fahim C, 2011, AGGRESSIVE BEHAV, V37, P326, DOI 10.1002/ab.20396; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Finger EC, 2008, ARCH GEN PSYCHIAT, V65, P586, DOI 10.1001/archpsyc.65.5.586; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Forth A.E., 2003, HARE PSYCHOPATHY CHE; Fortier CB, 2014, ALCOHOL CLIN EXP RES, V38, P2925, DOI 10.1111/acer.12568; Frick PJ., 2001, ANTISOCIAL PROCESS S; Gelhorn HL, 2007, COMPR PSYCHIAT, V48, P529, DOI 10.1016/j.comppsych.2007.04.009; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; GOODMAN R, 1995, J CHILD PSYCHOL PSYC, V36, P409, DOI 10.1111/j.1469-7610.1995.tb01299.x; Haney-Caron E, 2014, J PSYCHIATR RES, V48, P111, DOI 10.1016/j.jpsychires.2013.09.015; Herpertz SC, 2008, J CHILD PSYCHOL PSYC, V49, P781, DOI 10.1111/j.1469-7610.2008.01905.x; Hoppenbrouwer SS, 2013, PLOS ONE, V8, P8; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jang SH, 2012, NEUROSCI LETT, V506, P146, DOI 10.1016/j.neulet.2011.10.069; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2002, HUM BRAIN MAPP, V15, P216, DOI 10.1002/hbm.10018; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kessler RC, 1996, AM J ORTHOPSYCHIAT, V66, P17, DOI 10.1037/h0080151; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Kruesi MJP, 2004, PSYCHIAT RES-NEUROIM, V132, P1, DOI 10.1016/j.pscychresns.2004.07.002; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; LYNSKEY MT, 1995, J ABNORM CHILD PSYCH, V23, P281, DOI 10.1007/BF01447558; Maier-Hein KH, 2013, BIOL PSYCHIAT; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Marcus DK, 2006, PSYCHOL MED, V36, P1571, DOI 10.1017/S0033291706008245; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nicolas JM, 2000, QJM-MON J ASSOC PHYS, V93, P449, DOI 10.1093/qjmed/93.7.449; Okugawa G, 2006, PROG NEURO-PSYCHOPH, V30, P1408, DOI 10.1016/j.pnpbp.2006.05.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson M, 2008, NORD J PSYCHIAT, P1; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Pfefferbaum A, 1997, ALCOHOL CLIN EXP RES, V21, P521, DOI 10.1111/j.1530-0277.1997.tb03798.x; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Ramnani N, 2006, CEREB CORTEX, V16, P811, DOI 10.1093/cercor/bhj024; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sterzer P, 2005, BIOL PSYCHIAT, V57, P7, DOI 10.1016/j.biopsych.2004.10.008; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; TOMASCH J, 1969, BRAIN RES, V13, P476, DOI 10.1016/0006-8993(69)90261-3; Toritsuka M, 2015, NEURAL PLAST, V2015, P6; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Vloet TD, 2008, BEHAV SCI LAW, V26, P99, DOI 10.1002/bsl.794; Wang YY, 2012, BRAIN RES, V1478, P1, DOI 10.1016/j.brainres.2012.08.038; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weinstein M, 2010, ABNORMAL WHITE MATTE; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Zhang J.-M., 2014, BIOMED RES INT, V2014; Zhang JB, 2014, J AM ACAD CHILD PSY, V53, P466, DOI 10.1016/j.jaac.2013.12.015	92	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0155475	10.1371/journal.pone.0155475	http://dx.doi.org/10.1371/journal.pone.0155475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271503	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200002
J	Chang, J; Zhou, YF; Liu, ZL				Chang, Jennifer; Zhou, Yifeng; Liu, Zili			Limited Top-Down Influence from Recognition to Same-Different Matching of Chinese Characters	PLOS ONE			English	Article							IMAGE; AREA	We investigated the extent to which recognition of Chinese characters influenced same-different matching performance that did not require recognition. In each experimental trial, two partially occluded characters were shown sequentially, and participants decided whether or not they were the same. The two characters were either both upright or both inverted and mirror-reflected. The participants' Chinese reading fluency spanned the full range, from not knowing any characters to native speakers. The participants who could recognize some characters (defined as readers) were subsequently tested with character recognition in a naming task. Interestingly, although the readers' recognition accuracies well correlated with their years of Chinese language schooling, they were uncorrelated with the matching accuracies in the same-different task with upright characters. The only indication of top-down influence was the readers' higher accuracy in matching upright than inverted and reflected characters. However, the magnitude of this effect was small, to the extent that the average same-different accuracies were comparable for readers and non-readers alike. This small effect was further confirmed with native speakers in China, who should give rise to the largest possible effect. We conclude that top-down influence from character recognition was present but very limited, at least with the task and stimuli used.	[Chang, Jennifer; Liu, Zili] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	University of California System; University of California Los Angeles; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liu, ZL (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	zili@psych.ucla.edu			US National Science Foundation (NSF) [BCS 9817979]; China Natural National Science Foundation (NSF) [NSFC 31228009, NSFC 31230032]	US National Science Foundation (NSF)(National Science Foundation (NSF)); China Natural National Science Foundation (NSF)	This work was supported by the following sources of funding: ZL: US National Science Foundation (NSF)(BCS 9817979); ZL, YZ: China Natural National Science Foundation (NSF)(NSFC 31228009)(NSFC 31230032).	Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Houpt JW, 2014, ACTA PSYCHOL, V145, P118, DOI 10.1016/j.actpsy.2013.10.013; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KERSTEN D, 1987, J OPT SOC AM A, V4, P2395, DOI 10.1364/JOSAA.4.002395; Lu HJ, 2006, J VISION, V6, P75, DOI 10.1167/6.1.7; Lu HJ, 2009, J VISION, V9, DOI 10.1167/9.4.4; Lu HJ, 2008, J VISION, V8, DOI 10.1167/8.7.31; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; Pelli DG, 2009, COGN NEUROPSYCHOL, V26, P36, DOI 10.1080/13546800802550134; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Sekuler AB, 2004, CURR BIOL, V14, P391, DOI 10.1016/j.cub.2004.02.028; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Tse PU, 2000, COGNITION, V74, pB27, DOI 10.1016/S0010-0277(99)00065-7; Ullman S., 1996, HIGH LEVEL VISION OB; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946	22	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156517	10.1371/journal.pone.0156517	http://dx.doi.org/10.1371/journal.pone.0156517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258366	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700072
J	Zhang, L; Jiang, W; Wang, QJ; Zhao, H; Zhang, HX; Marcec, RM; Willard, ST; Kouba, AJ				Zhang, Lu; Jiang, Wei; Wang, Qi-Jun; Zhao, Hu; Zhang, Hong-Xing; Marcec, Ruth M.; Willard, Scott T.; Kouba, Andrew J.			Reintroduction and Post-Release Survival of a Living Fossil: The Chinese Giant Salamander	PLOS ONE			English	Article							BODY CONDITION; ANDRIAS-DAVIDIANUS; RADIO TRANSMITTERS; AMPHIBIANS; TRANSLOCATION; EXTINCTIONS; BEHAVIOR; REPTILES; GROWTH	Captive rearing and reintroduction / translocation are increasingly used as tools to supplement wild populations of threatened species. Reintroducing captive-reared Chinese giant salamanders may help to augment the declining wild populations and conserve this critically endangered amphibian. We released 31 captive-reared juvenile giant salamanders implanted with VHF radio transmitters at the Heihe River (n = 15) and the Donghe River (n = 16) in the Qinling Mountains of central China. Salamanders were monitored every day for survival from April 28th 2013 to September 3rd 2014. We attempted to recapture all living individuals by the end of the study, measured their body mass and total body length, and checked for abnormalities and presence of external parasites. Two salamanders at the Heihe River and 10 animals at the Donghe River survived through the project timeline. Nine salamanders were confirmed dead, while the status of the other 10 animals was undetermined. The annual survival rate of giant salamanders at the Donghe River (0.702) was 1.7-fold higher than that at the Heihe River (0.405). Survival increased as individuals were held longer following surgery, whereas body mass did not have a significant impact on survival rate. All salamanders recaptured from the Donghe River (n = 8) increased in mass (0.50 +/- 0.13 kg) and length (5.5 +/- 1.5 cm) after approximately 11 months in the wild, and they were only 7% lighter than wild animals of the same length (mean residual = -0.033 +/- 0.025). Our results indicate that captive-reared Chinese giant salamanders can survive in the wild one year after release and adequate surgical recovery time is extremely important to post-release survival. Future projects may reintroduce older juveniles to achieve better survival and longer monitoring duration.	[Zhang, Lu; Marcec, Ruth M.; Willard, Scott T.] Mississippi State Univ, Biochem Mol Biol Entomol & Plant Pathol Dept, Mississippi State, MS 39762 USA; [Zhang, Lu; Kouba, Andrew J.] Memphis Zool Soc, Conservat & Res Dept, Memphis, TN USA; [Jiang, Wei; Wang, Qi-Jun; Zhao, Hu; Zhang, Hong-Xing] Shaanxi Inst Zool, Xian, Shaanxi, Peoples R China; [Kouba, Andrew J.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Kouba, AJ (corresponding author), Memphis Zool Soc, Conservat & Res Dept, Memphis, TN USA.; Kouba, AJ (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.	a.kouba@msstate.edu		Zhang, Lu/0000-0002-1795-9563	U.S. Forest Service International Programs (Asia-Pacific Office); Ocean Park Conservation Foundation, Hong Kong; Shaanxi science and technology plan projects [2013KW20]; Shaanxi Institute of Zoology; Mississippi State University; Memphis Zoo; Los Angeles Zoo; Omaha Henry Doorly Zoo	U.S. Forest Service International Programs (Asia-Pacific Office); Ocean Park Conservation Foundation, Hong Kong; Shaanxi science and technology plan projects; Shaanxi Institute of Zoology; Mississippi State University; Memphis Zoo; Los Angeles Zoo; Omaha Henry Doorly Zoo	Funding was provided by 1) the U.S. Forest Service International Programs (Asia-Pacific Office) (http://www.fs.fed.us/about-agency/international-programs); 2) Ocean Park Conservation Foundation, Hong Kong (http://www.opcf.org.hk/en/); 3) the Shaanxi science and technology plan projects (2013KW20); 4) the Shaanxi Institute of Zoology (http://sxdws.xab.cas.cn/en/); and 5) Mississippi State University (http://www.msstate.edu/). In addition, the following zoos contributed funds to support the project including: 1) Memphis Zoo (http://www.memphiszoo.org/); 2) Los Angeles Zoo (http://www.lazoo.org/); and 3) Omaha Henry Doorly Zoo (http://www.omahazoo.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NS, 1998, T AM FISH SOC, V127, P128, DOI 10.1577/1548-8659(1998)127&lt;0128:EOSAGI&gt;2.0.CO;2; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Bodinof CM, 2012, COPEIA, P150, DOI 10.1643/CH-11-024; Browne Robert K., 2012, Amphibian & Reptile Conservation, V5, P1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Dervo B, 2010, AMPHIBIA-REPTILIA, V31, P229, DOI 10.1163/156853810791069128; DODD CK, 1991, HERPETOLOGICA, V47, P336; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; GASCON C, 2007, AMPHIBIAN CONSERVATI; Geng Y, 2011, J COMP PATHOL, V145, P95, DOI 10.1016/j.jcpa.2010.11.012; Germano JM, 2009, CONSERV BIOL, V23, P7, DOI 10.1111/j.1523-1739.2008.01123.x; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Liang G, 2004, ANDRIAS DAVIDIANUS; Luo Qinghua, 2009, Shengwu Duoyangxing, V17, P310, DOI 10.3724/SP.J.1003.2009.08041; Marcec R, 2016, J ZOO WILDLIFE MED, V47, P187, DOI 10.1638/2015-0044.1; Martin Steven W., 1995, North American Journal of Fisheries Management, V15, P494, DOI 10.1577/1548-8675(1995)015<0494:COSGDA>2.3.CO;2; Matsui M, 2008, MOL PHYLOGENET EVOL, V49, P318, DOI 10.1016/j.ympev.2008.07.020; NEWTON SF, 1993, J ZOOL, V229, P561, DOI 10.1111/j.1469-7998.1993.tb02657.x; PETERSON CL, 1983, COPEIA, P225, DOI 10.2307/1444718; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reimer A, 2014, ANIM CONSERV, V17, P235, DOI 10.1111/acv.12085; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Schmutz JA, 1999, J WILDLIFE MANAGE, V63, P1239, DOI 10.2307/3802841; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Souza MJ, 2012, J WILDLIFE DIS, V48, P560, DOI 10.7589/0090-3558-48.3.560; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Wang XMM, 2004, ORYX, V38, P197, DOI 10.1017/S0030605304000341; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5; Zhang L, 2014, HERPETOLOGICA, V70, P369, DOI 10.1655/HERPETOLOGICA-D-14-00011R1; Zhao E., 1998, CHINA RED DATA BOOK; Zheng HX, 2010, ASIAN HERPETOL RES, V1, P31, DOI 10.3724/SP.J.1.245.2010.00031; Zhou Z. Y., 2012, African Journal of Biotechnology, V11, P15130	38	16	17	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156715	10.1371/journal.pone.0156715	http://dx.doi.org/10.1371/journal.pone.0156715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258650	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700113
J	Haddi, K; Mendes, MV; Barcellos, MS; Lino-Neto, J; Freitas, HL; Guedes, RNC; Oliveira, EE				Haddi, Khalid; Mendes, Marcos V.; Barcellos, Marcelo S.; Lino-Neto, Jose; Freitas, Hemerson L.; Guedes, Raul Narciso C.; Oliveira, Eugenio E.			Sexual Success after Stress? Imidacloprid-Induced Hormesis in Males of the Neotropical Stink Bug Euschistus heros	PLOS ONE			English	Article							WEEVIL SITOPHILUS-ZEAMAIS; NICOTINIC ACETYLCHOLINE-RECEPTORS; STAL HEMIPTERA DELPHACIDAE; CINNAMON ESSENTIAL OILS; MAIZE WEEVIL; COLEOPTERA-CURCULIONIDAE; DROSOPHILA-MELANOGASTER; INSECTICIDE RESISTANCE; BEHAVIORAL AVOIDANCE; CARAUSIUS-MOROSUS	Environmental stress in newly-emerged adult insects can have dramatic consequences on their life traits (e.g., dispersion, survival and reproduction) as adults. For instance, insects sublethally exposed to environmental stressors (e.g., insecticides) can gain fitness benefits as a result of hormesis (i.e., benefits of low doses of compounds that would be toxic at higher doses). Here, we experimentally tested whether sublethal exposure to the insecticide imidacloprid would hormetically affect the sexual fitness of newly-emerged adults of the Neotropical brown stink bug Euschistus heros (Hemiptera: Heteroptera: Pentatomidae), which is the most abundant and prevalent insect pest in Neotropical soybean fields. We evaluated the sexual fitness of four couple combinations: unexposed couples, exposed females, exposed males, and exposed couples. Sublethal exposure to dry residues (i.e., contact) of imidacloprid (at 1% of recommended field rate) did not affect insect survival, but led to higher mating frequencies when at least one member of the couple was exposed. However, the average mating duration was shortened when only females were exposed to imidacloprid. Moreover, exposed males showed higher locomotory (walking) activity, lower respiration rates and induced higher fecundity rates when mated to unexposed females. Although the reproductive tracts of exposed males did not differ morphometrically from unexposed males, their accessory glands exhibited positive reactions for acidic and basic contents. Our findings suggest that males of the Neotropical brown stink bug hormetically increase their sexual fitness when cued by impending insecticidal stress in early adulthood.	[Haddi, Khalid; Mendes, Marcos V.; Freitas, Hemerson L.; Guedes, Raul Narciso C.; Oliveira, Eugenio E.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Haddi, Khalid] Univ Fed Vicosa, Programa Posgrad Entomol, BR-36570900 Vicosa, MG, Brazil; [Barcellos, Marcelo S.; Lino-Neto, Jose] Univ Fed Vicosa, Dept Biol Geral, BR-36570900 Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Haddi, K; Oliveira, EE (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.; Haddi, K (corresponding author), Univ Fed Vicosa, Programa Posgrad Entomol, BR-36570900 Vicosa, MG, Brazil.	khalid.haddi@ufv.br; eugenio@ufv.br	Haddi, Khalid/K-6387-2018; de Oliveira, Eugenio Eduardo/ABE-8935-2021; de Oliveira, Eugênio Eduardo/F-4045-2016; Guedes, Raul Narciso Carvalho/L-3924-2013	Haddi, Khalid/0000-0002-2655-4365; de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Guedes, Raul Narciso Carvalho/0000-0001-6229-7549	CAPES Foundation; National Council of Scientific and Technological Development (CNPq); Minas Gerais State Foundation for Research Aid (FAPEMIG); Arthur Bernardes Foundation (FUNARBE)	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Foundation for Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Arthur Bernardes Foundation (FUNARBE)	Grants from the CAPES Foundation, the National Council of Scientific and Technological Development (CNPq), the Minas Gerais State Foundation for Research Aid (FAPEMIG), and the Arthur Bernardes Foundation (FUNARBE) supported this work.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Borges M, 2008, METODOLOGIAS CRIACAO, P18; BURGER JM, 2004, SCI AGING KNOWLEDGE, pPE30, DOI DOI 10.1126/SAGEKE.2004.28.PE30; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Cordeiro EMG, 2013, CHEMOSPHERE, V93, P1111, DOI 10.1016/j.chemosphere.2013.06.030; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Correa AS, 2014, ANN APPL BIOL, V165, P137, DOI 10.1111/aab.12127; Correa AS, 2011, CROP PROT, V30, P1655, DOI 10.1016/j.cropro.2011.08.022; Costantini D, 2014, EARLY LIFE HORMESIS, P39; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Droge-Young EM, 2015, BEHAV ECOL, DOI [10.1093/beheco/arv1191, DOI 10.1093/BEHECO/ARV1191]; Duffield KR, 2015, J EVOLUTION BIOL, V28, P1872, DOI 10.1111/jeb.12703; Farias LR, 2014, NEOTROP ENTOMOL, V43, P106, DOI 10.1007/s13744-013-0187-4; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gatehouse AG, 1997, ANNU REV ENTOMOL, V42, P475, DOI 10.1146/annurev.ento.42.1.475; Ge LQ, 2010, PESTIC BIOCHEM PHYS, V98, P279, DOI 10.1016/j.pestbp.2010.06.019; Ghimire N, 2013, ECOL ECON, V89, P73, DOI 10.1016/j.ecolecon.2013.02.003; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Correa YDG, 2015, PESTIC BIOCHEM PHYS, V125, P31, DOI 10.1016/j.pestbp.2015.06.005; Green K, 2009, ANIM BEHAV, V77, P887, DOI 10.1016/j.anbehav.2008.12.017; Guedes NMP, 2009, J APPL ENTOMOL, V133, P524, DOI 10.1111/j.1439-0418.2009.01391.x; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guedes RNC, 2009, J ECON ENTOMOL, V102, P170, DOI 10.1603/029.102.0124; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; Haddi K, 2015, J ECON ENTOMOL, V108, P2815, DOI 10.1093/jee/tov255; Haddi K, 2015, J ECON ENTOMOL, V108, P362, DOI 10.1093/jee/tou049; Harano T, 2015, J EVOLUTION BIOL, V28, P320, DOI 10.1111/jeb.12563; Jeschke P, 2013, ANGEW CHEM INT EDIT, V52, P9464, DOI 10.1002/anie.201302550; KESTLER P, 1991, COMP BIOCHEM PHYS C, V100, P207, DOI 10.1016/0742-8413(91)90155-M; Kivimagi I, 2013, EUR J ENTOMOL, V110, P47, DOI 10.14411/eje.2013.006; Le Bourg E, 2011, EXP GERONTOL, V46, P345, DOI 10.1016/j.exger.2010.08.003; Lee CY., 2000, J BIOSCIENCES, V11, P107, DOI DOI 10.5772/66461; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Lopez-Martinez G, 2012, J EXP BIOL, V215, P2150, DOI 10.1242/jeb.065631; Mallqui KSV, 2014, J ECON ENTOMOL, V107, P860, DOI 10.1603/EC13526; Matsumura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127042; Morales JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067283; Nicodemo D, 2014, ENVIRON TOXICOL CHEM, V33, P2070, DOI 10.1002/etc.2655; Noguera JC, 2011, FUNCT ECOL, V25, P1144, DOI 10.1111/j.1365-2435.2011.01856.x; Oliveira EE, 2005, NEOTROP ENTOMOL, V34, P981, DOI 10.1590/S1519-566X2005000600015; Oliveira EE, 2007, CHEMOSPHERE, V69, P17, DOI 10.1016/j.chemosphere.2007.04.077; Oliveira EE, 2011, INSECT BIOCHEM MOLEC, V41, P872, DOI 10.1016/j.ibmb.2011.08.001; Oliveira EE, 2010, J NEUROPHYSIOL, V103, P2770, DOI 10.1152/jn.00963.2009; Panizzi AR, 2014, SOJA MANEJO INTEGRAD, P335; Pereira CJ, 2009, CROP PROT, V28, P168, DOI 10.1016/j.cropro.2008.10.001; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Qu YY, 2015, ECOTOXICOLOGY, V24, P479, DOI 10.1007/s10646-014-1396-2; Rix RR, 2015, J PEST SCI, P1; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Salmon AB, 2001, EVOLUTION, V55, P1600, DOI 10.1111/j.0014-3820.2001.tb00679.x; Saluso A, 2011, NEOTROP ENTOMOL, V40, P704, DOI 10.1590/S1519-566X2011000600011; Santos MF, 2016, J PEST SCI, V89, P231, DOI 10.1007/s10340-015-0666-y; Silva CC, 2008, PESQUI AGROPECU BRAS, V43, P575, DOI 10.1590/S0100-204X2008000500004; Silva FAC, 2011, NEOTROP ENTOMOL, V40, P35, DOI 10.1590/S1519-566X2011000100005; Sosa-Gomez DR, 2009, J ECON ENTOMOL, V102, P1209, DOI 10.1603/029.102.0346; Sosa-Gomez DR, 2010, PESQUI AGROPECU BRAS, V45, P767, DOI 10.1590/S0100-204X2010000700019; Sousa AH, 2012, J ECON ENTOMOL, V105, P2187, DOI 10.1603/EC12218; Szczepaniec A, 2013, EXP APPL ACAROL, V59, P307, DOI 10.1007/s10493-012-9614-1; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Unkiewicz-Winiarczyk A, 2012, B ENVIRON CONTAM TOX, V89, P960, DOI 10.1007/s00128-012-0814-5; Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x; Vidau C, 2009, TOXICOL IN VITRO, V23, P589, DOI 10.1016/j.tiv.2009.01.017; Yu YL, 2012, CROP PROT, V34, P59, DOI 10.1016/j.cropro.2011.08.026; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zanuncio TV, 2003, CROP PROT, V22, P941, DOI 10.1016/S0261-2194(03)00094-2	73	40	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156616	10.1371/journal.pone.0156616	http://dx.doi.org/10.1371/journal.pone.0156616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284906	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000017
J	Hong, MG; Jung, E; Yang, S; Jung, W; Seong, YJ; Park, E; Bramos, A; Kim, KE; Lee, S; Daghlian, G; Seo, JI; Choi, I; Choi, IS; Koh, CJ; Kobielak, A; Ying, QL; Johnson, M; Gardner, D; Wong, AK; Choi, D; Hong, YK				Hong, Mingu; Jung, Eunson; Yang, Sara; Jung, Wonhyuek; Seong, Young Jin; Park, Eunkyung; Bramos, Athanasios; Kim, Kyu Eui; Lee, Sunju; Daghlian, George; Seo, Jung In; Choi, Inho; Choi, In-Seon; Koh, Chester J.; Kobielak, Agnieszka; Ying, Qi-Long; Johnson, Maxwell; Gardner, Daniel; Wong, Alex K.; Choi, Dongwon; Hong, Young-Kwon			Efficient Assessment of Developmental, Surgical and Pathological Lymphangiogenesis Using a Lymphatic Reporter Mouse and Its Embryonic Stem Cells	PLOS ONE			English	Article							SECONDARY LYMPHEDEMA; GFP REPORTER; VESSELS; PROX1; EXPRESSION; VISUALIZATION; REGENERATION; METASTASIS; PATTERNS; MICE	Several lymphatic reporter mouse lines have recently been developed to significantly improve imaging of lymphatic vessels. Nonetheless, the usage of direct visualization of lymphatic vessels has not been fully explored and documented. Here, we characterized a new Prox1-tdTomato transgenic lymphatic reporter mouse line, and demonstrated how this animal tool enables the researchers to efficiently assess developmental, surgical and pathological lymphangiogenesis by direct visualization of lymphatic vessels. Moreover, we have derived embryonic stem cells from this reporter line, and successfully differentiated them into lymphatic vessels in vivo. In conclusion, these experimental tools and techniques will help advance lymphatic research.	[Hong, Mingu; Jung, Eunson; Yang, Sara; Jung, Wonhyuek; Seong, Young Jin; Park, Eunkyung; Bramos, Athanasios; Kim, Kyu Eui; Lee, Sunju; Daghlian, George; Seo, Jung In; Choi, Inho; Johnson, Maxwell; Gardner, Daniel; Wong, Alex K.; Choi, Dongwon; Hong, Young-Kwon] Univ So Calif, Div Plast & Reconstruct Surg, Dept Surg, Keck Sch Med, Los Angeles, CA 90033 USA; [Hong, Mingu; Jung, Eunson; Yang, Sara; Jung, Wonhyuek; Seong, Young Jin; Park, Eunkyung; Kim, Kyu Eui; Lee, Sunju; Daghlian, George; Seo, Jung In; Choi, Dongwon; Hong, Young-Kwon] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Choi, Inho] Hoseo Univ, Dept Pharmaceut Engn, Asan, South Korea; [Choi, In-Seon; Koh, Chester J.] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Urol, Houston, TX 77030 USA; [Kobielak, Agnieszka] Univ Warsaw, Ctr New Technol, S Banacha 2c,Room 2107, Warsaw, Poland; [Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Hoseo University; Baylor College of Medicine; University of Warsaw; University of Southern California	Choi, D; Hong, YK (corresponding author), Univ So Calif, Div Plast & Reconstruct Surg, Dept Surg, Keck Sch Med, Los Angeles, CA 90033 USA.; Choi, D; Hong, YK (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	dongwcho@usc.edu; young.hong@usc.edu	Bramos, Athanasios/N-2119-2019; Koh, Chester J./M-8373-2017	Koh, Chester J./0000-0001-8696-5193; Kobielak, Agnieszka/0000-0002-9293-0787; Daghlian, George/0000-0002-4921-0442; Wong, Alex/0000-0002-4068-5230	American Heart Association [13GRNT17060131]; National Institute of Health [R01HL121036, R21HL119583]; Southern California Clinical and Translational Science Institute (SC-CTSI) [KL2TR000131]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL119583, R01HL121036] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southern California Clinical and Translational Science Institute (SC-CTSI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by American Heart Association (13GRNT17060131 to YKH), National Institute of Health (R01HL121036 & R21HL119583 to YKH) and Southern California Clinical and Translational Science Institute (SC-CTSI, KL2TR000131 to AKW).	Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Bianchi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122976; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Choi I, 2012, CIRCULATION, V125, P872, DOI 10.1161/CIRCULATIONAHA.111.030296; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hagerling R, 2011, BIOCHEM SOC T, V39, P1674, DOI 10.1042/BST20110722; Iljin K, 2001, FASEB J, V15, P1028, DOI 10.1096/fj.00-0383com; Martinez-Corral I, 2012, P NATL ACAD SCI USA, V109, P6223, DOI 10.1073/pnas.1115542109; Masood R, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.33; Mendez U, 2012, AM J PHYSIOL-HEART C, V302, pH2250, DOI 10.1152/ajpheart.01159.2011; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; PHILIPS FREDERICK S., 1961, CANCER RES, V21, P1577; Raju A, 2015, ANN SURG, V261, P1013, DOI 10.1097/SLA.0000000000000763; Ramirez MI, 1999, DEV DYNAM, V215, P319, DOI 10.1002/(SICI)1097-0177(199908)215:4<319::AID-AJA4>3.0.CO;2-B; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Saban MR, 2004, BLOOD, V104, P3228, DOI 10.1182/blood-2004-04-1428; Seth A, 2014, DEVELOPMENT, V141, P538, DOI 10.1242/dev.099481; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Truman LA, 2012, AM J PATHOL, V180, P1715, DOI 10.1016/j.ajpath.2011.12.026	24	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157126	10.1371/journal.pone.0157126	http://dx.doi.org/10.1371/journal.pone.0157126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280889	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000090
J	Khoramshahi, M; Shukla, A; Raffard, S; Bardy, BG; Billard, A				Khoramshahi, Mahdi; Shukla, Ashwini; Raffard, Stephane; Bardy, Benoit G.; Billard, Aude			Role of Gaze Cues in Interpersonal Motor Coordination: Towards Higher Affiliation in Human-Robot Interaction	PLOS ONE			English	Article							EYE-HAND COORDINATION; JOINT ACTION; EMOTION RECOGNITION; SOCIAL COGNITION; HUMAN LIKENESS; SCHIZOPHRENIA; ATTENTION; DIRECTION; FACES; REAL	Background The ability to follow one another's gaze plays an important role in our social cognition; especially when we synchronously perform tasks together. We investigate how gaze cues can improve performance in a simple coordination task (i.e., the mirror game), whereby two players mirror each other's hand motions. In this game, each player is either a leader or follower. To study the effect of gaze in a systematic manner, the leader's role is played by a robotic avatar. We contrast two conditions, in which the avatar provides or not explicit gaze cues that indicate the next location of its hand. Specifically, we investigated (a) whether participants are able to exploit these gaze cues to improve their coordination, (b) how gaze cues affect action prediction and temporal coordination, and (c) whether introducing active gaze behavior for avatars makes them more realistic and human-like (from the user point of view). Methodology/Principal Findings 43 subjects participated in 8 trials of the mirror game. Each subject performed the game in the two conditions (with and without gaze cues). In this within-subject study, the order of the conditions was randomized across participants, and subjective assessment of the avatar's realism was assessed by administering a post-hoc questionnaire. When gaze cues were provided, a quantitative assessment of synchrony between participants and the avatar revealed a significant improvement in subject reaction-time (RT). This confirms our hypothesis that gaze cues improve the follower's ability to predict the avatar's action. An analysis of the pattern of frequency across the two players' hand movements reveals that the gaze cues improve the overall temporal coordination across the two players. Finally, analysis of the subjective evaluations from the questionnaires reveals that, in the presence of gaze cues, participants found it not only more human-like/realistic, but also easier to interact with the avatar. Conclusion/Significance This work confirms that people can exploit gaze cues to predict another person's movements and to better coordinate their motions with their partners, even when the partner is a computer-animated avatar. Moreover, this study contributes further evidence that implementing biological features, here task-relevant gaze cues, enable the humanoid robotic avatar to appear more human-like, and thus increase the user's sense of affiliation.	[Khoramshahi, Mahdi; Shukla, Ashwini; Billard, Aude] Ecole Polytech Fed Lausanne, Sch Engn, Learning Algorithms & Syst Lab, CH-1015 Lausanne, Switzerland; [Raffard, Stephane] CHRU, Univ Dept Adult Psychiat, Montpellier, France; [Raffard, Stephane] Lab Epsylon, EA 4556, Montpellier, France; [Bardy, Benoit G.] Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France; [Bardy, Benoit G.] Inst Univ France, Paris, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; Institut Universitaire de France	Khoramshahi, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, Learning Algorithms & Syst Lab, CH-1015 Lausanne, Switzerland.	mahdi.khoramshahi@epfl.ch	Raffard, Stéphane/K-9822-2013; Raffard, Stephane/M-3926-2019; Bardy, Benoît/AAU-3078-2021	Raffard, Stephane/0000-0001-5563-0323; 	EU [600010]	EU(European Commission)	This research was supported by EU project AlterEgo under grant agreement number 600010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrist S, 2014, ACMIEEE INT CONF HUM, P25, DOI 10.1145/2559636.2559666; Bailenson JN, 2006, PRESENCE-VIRTUAL AUG, V15, P359, DOI 10.1162/pres.15.4.359; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; Bente G, 2007, LECT NOTES COMPUT SC, V4563, P185; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; BYRNE D, 1961, J ABNORM SOC PSYCH, V62, P713, DOI 10.1037/h0044721; Cazzato D, 2015, LECT NOTES ARTIF INT, V9388, P124, DOI 10.1007/978-3-319-25554-5_13; Coen-Cagli R, 2009, VISION RES, V49, P810, DOI 10.1016/j.visres.2009.02.016; Combs DR, 2008, SCHIZOPHR RES, V105, P68, DOI 10.1016/j.schres.2008.05.018; D'Entremont B, 1997, INFANT BEHAV DEV, V20, P569, DOI 10.1016/S0163-6383(97)90048-5; Drusch K, 2014, SCHIZOPHR RES, V159, P485, DOI 10.1016/j.schres.2014.09.003; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Engell AD, 2007, NEUROPSYCHOLOGIA, V45, P3234, DOI 10.1016/j.neuropsychologia.2007.06.022; Fitzpatrick P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00021; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Fu Y, 2008, IEEE T CIRC SYST VID, V18, P467, DOI 10.1109/TCSVT.2008.918441; Garau M, 2001, P SIGCHI C HUM FACT, P309; Garau Maia, 2003, SYSTEMS P SIGCHI C H, P529, DOI DOI 10.1145/642611.642703; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Hooker CI, 2012, SCHIZOPHR RES, V139, P53, DOI 10.1016/j.schres.2012.05.009; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Ishiguro H, 2007, SPR TRA ADV ROBOT, V28, P118; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Jayasekera A. I., 1996, Schizophrenia Research, V18, P218, DOI 10.1016/0920-9964(96)85674-X; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; Khoramshahi M, 2014, 2014 IEEE INT C SYST; Kipp M, 2008, LECT NOTES COMPUT SC, V5208, P191; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Langdon RA, 2012, SCHIZOPHR RES, V136, pS362, DOI 10.1016/S0920-9964(12)71058-7; Lazzari S, 2009, J MOTOR BEHAV, V41, P294, DOI 10.3200/JMBR.41.4.294-304; Liesker H, 2009, EXP BRAIN RES, V197, P395, DOI 10.1007/s00221-009-1928-9; LYDON JE, 1988, SOC COGNITION, V6, P269, DOI 10.1521/soco.1988.6.4.269; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Mason MF, 2005, PSYCHOL SCI, V16, P236, DOI 10.1111/j.0956-7976.2005.00809.x; Meadows MS, 2007, I AVATAR CULTURE CON; Minato T, 2004, LECT NOTES COMPUT SC, V3029, P424; Minato T, 2005, INT C DEVEL LEARN, P106; Minato T, 2006, ADV ROBOTICS, V20, P1147, DOI 10.1163/156855306778522505; Mori M, 2012, IEEE ROBOT AUTOM MAG, V19, P98, DOI 10.1109/MRA.2012.2192811; Mutlu B., 2012, ACM T INTERACT INTEL, V1, P1, DOI [10.1145/2070719.2070725, DOI 10.1145/2070719.2070725]; Mutlu Bilge, 2009, P 4 ACM IEEE INT C H, P61, DOI DOI 10.1145/1514095.1514109; Noris B, 2011, COMPUT VIS IMAGE UND, V115, P476, DOI 10.1016/j.cviu.2010.11.013; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Pattacini U., 2011, THESIS; PAUS T, 1991, SCHIZOPHR RES, V5, P145, DOI 10.1016/0920-9964(91)90041-O; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Rae I., 2013, HRI 07, V15, P36, DOI 10.1145/2470654.2466253; Raffard S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08156; Ramaiah MS, 2013, P IEEE VIRT REAL ANN, P95, DOI 10.1109/VR.2013.6549379; Roux P, 2014, SCHIZOPHR RES, V157, P78, DOI 10.1016/j.schres.2014.04.031; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Silverstein SM, 2001, SCHIZOPHRENIA BULL, V27, P247, DOI 10.1093/oxfordjournals.schbul.a006871; Steptoe W, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P197; Tikhanoff V., 2008, P 8 WORKSHOP PERFORM, P57, DOI [DOI 10.1145/1774674.1774684, 10.1145/1774674.1774684]; Tomasello M., 1995, JOINT ATTENTION ITS, P103; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; Varlet M, 2013, PRESENCE-TELEOP VIRT, V22, P202, DOI 10.1162/PRES_a_00151; Varlet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029772; Volcic R, 2009, PERCEPTION, V38, P174; Yoshikawa Y, 2006, ROBOTICS SCI SYSTEMS; Zhao X, 2015, HRI, P133	71	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156874	10.1371/journal.pone.0156874	http://dx.doi.org/10.1371/journal.pone.0156874			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281341	Green Submitted, gold, Green Published			2022-12-27	WOS:000377563000052
J	Pedersen, MJB; Gjerland, A; Rund, BR; Ekeberg, O; Skogstad, L				Pedersen, May Janne Botha; Gjerland, Astrid; Rund, Bjorn Rishovd; Ekeberg, Oivind; Skogstad, Laila			Emergency Preparedness and Role Clarity among Rescue Workers during the Terror Attacks in Norway July 22, 2011	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PROFESSIONALS; EXPOSURE	Background Few studies address preparedness and role clarity in rescue workers after a disaster. On July 22, 2011, Norway was struck by two terror attacks; 77 people were killed and many injured. Healthcare providers, police officers and firefighters worked under demanding conditions. The aims of this study were to examine the level of preparedness, exposure and role clarity. In addition, the relationship between demographic variables, preparedness and exposure and a) role clarity during the rescue operations and; b) achieved mastering for future disaster operations. Methods In this cross-sectional study, healthcare providers (n = 859), police officers (n = 252) and firefighters (n = 102) returned a questionnaire approximately 10 months after the terror attacks. Results The rescue personnel were trained and experienced, and the majority knew their professional role (healthcare providers M = 4.1 vs. police officers: M = 3.9 vs. firefighters: M = 4.2, p < .001, [scale 1-5]). The police officers reported significantly more lack of control (p < .001). In the multivariable analysis, being female (OR 1.4, p < .05), having more years of work experience (OR 2.3, p = < .001), previous training (OR 1.6, p < .05) and the experience of an event with > 5 fatalities (OR 1.6, p < .05) were all associated with role clarity, together with a feeling of control, not being obstructed in work and perceiving the rescue work as a success. Moreover, independent predictors of being more prepared for future operations were arousal during the operation (OR 2.0, p < .001) and perceiving the rescue work as a success (OR 1.5, p < .001). Conclusion Most of the rescue workers were experienced and knew their professional role. Training and everyday-work-experience must be a focal point when preparing rescue workers for disaster.	[Pedersen, May Janne Botha] Vestre Viken Hosp Trust, Ringerike Hosp, Dept Gen Surg, Drammen, Norway; [Pedersen, May Janne Botha] Vestre Viken Hosp Trust, Ringerike Hosp, Dept Orthoped Surg, Drammen, Norway; [Pedersen, May Janne Botha] Vestre Viken Hosp Trust, Ringerike Hosp, Dept Anesthesia, Drammen, Norway; [Pedersen, May Janne Botha] Vestre Viken Hosp Trust, Ringerike Hosp, Dept Emergency Care, Drammen, Norway; [Pedersen, May Janne Botha] Vestre Viken Hosp Trust, Ringerike Hosp, Dept Intens Care, Drammen, Norway; [Pedersen, May Janne Botha] Vestre Viken Hosp Trust, Ringerike Hosp, Dept Obstet, Drammen, Norway; [Gjerland, Astrid] Vestre Viken Hosp Trust, Baerum Hosp, Dept Anesthesia, Drammen, Norway; [Gjerland, Astrid] Vestre Viken Hosp Trust, Baerum Hosp, Dept Intens Care, Drammen, Norway; [Gjerland, Astrid] Vestre Viken Hosp Trust, Baerum Hosp, Dept Emergency, Drammen, Norway; [Rund, Bjorn Rishovd] Univ Oslo, Dept Psychol, Drammen, Norway; [Rund, Bjorn Rishovd] Vestre Viken Hosp Trust, Drammen, Norway; [Ekeberg, Oivind] Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Behav Sci Med, Oslo, Norway; [Ekeberg, Oivind; Skogstad, Laila] Oslo Univ Hosp, Dept Acute Med Res & Dev, Oslo, Norway; [Skogstad, Laila] Oslo & Akershus Univ Coll, Paramed Sci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet)	Skogstad, L (corresponding author), Oslo Univ Hosp, Dept Acute Med Res & Dev, Oslo, Norway.; Skogstad, L (corresponding author), Oslo & Akershus Univ Coll, Paramed Sci, Oslo, Norway.	laila.skogstad@ous-hf.no			South-Eastern Norway Regional Health Authority [2012108]	South-Eastern Norway Regional Health Authority	This work was supported by grant number 2012108 from the South-Eastern Norway Regional Health Authority (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burstein JL, 2006, ANN EMERG MED, V47, P50, DOI 10.1016/j.annemergmed.2005.11.023; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Fattah S, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-40; Fernandez AR, 2011, ACAD EMERG MED, V18, P403, DOI 10.1111/j.1553-2712.2011.01030.x; Gaarder C, 2012, J TRAUMA ACUTE CARE, V73, P269, DOI 10.1097/TA.0b013e31825a787f; Gabriel R, 2007, EUR PSYCHIAT, V22, P339, DOI 10.1016/j.eurpsy.2006.10.007; Harrington T, 2007, ADDICT BEHAV, V32, P2788, DOI 10.1016/j.addbeh.2007.04.016; Hsu Edbert B, 2004, Prehosp Disaster Med, V19, P191; Jensen TK, 2015, SCAND J PSYCHOL, V56, P45, DOI 10.1111/sjop.12182; Kristiansen T, 2010, INJURY, V41, P444, DOI 10.1016/j.injury.2009.05.027; National Health Emergency Plan, 2014, VIS COR CONC 2012; Perry RW, 2003, DISASTERS, V27, P336, DOI 10.1111/j.0361-3666.2003.00237.x; Reason J., 1997, MANAGING RISK ORG AC; Saver Cynthia, 2014, OR Manager, V30, P16; Skogstad L, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0104-4; Skogstad M, 2013, OCCUP MED-OXFORD, V63, P175, DOI 10.1093/occmed/kqt003; Slepski Lynn A, 2007, Disaster Manag Response, V5, P99, DOI 10.1016/j.dmr.2007.08.001; Sollid SJM, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-3; Thoresen S, 2009, DISASTERS, V33, P353, DOI 10.1111/j.1467-7717.2008.01078.x; Utsi Risten, 2008, Tidsskr Nor Laegeforen, V128, P1057; Waage S, 2013, BRIT J SURG, V100, P1198, DOI 10.1002/bjs.9203; Weathers F, 1993, SCI PRACTICE, V2007, P290; Weisaeth L, 2011, LEADERSHIP CRISES PR; Williams J, 2008, ANN EMERG MED, V52, P211, DOI 10.1016/j.annemergmed.2007.09.030; Wisborg T, 2008, J TRAUMA, V64, P1613, DOI 10.1097/TA.0b013e31812eed68; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004	26	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156536	10.1371/journal.pone.0156536	http://dx.doi.org/10.1371/journal.pone.0156536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280520	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000036
J	Ren, W; Zuo, R; Wang, YN; Wang, HJ; Yang, J; Xin, SK; Han, LY; Zhao, HY; Han, SY; Gao, B; Hu, H; Hu, YJ; Bian, BL; Si, N				Ren, Wei; Zuo, Ran; Wang, Yao-Nan; Wang, Hong-Jie; Yang, Jian; Xin, Shao-Kun; Han, Ling-Yu; Zhao, Hai-Yu; Han, Shu-Yan; Gao, Bo; Hu, Hao; Hu, Yuan-Jia; Bian, Bao-Lin; Si, Nan			Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; PERFORMANCE LIQUID-CHROMATOGRAPHY; RADIX-SCUTELLARIAE EXTRACT; TANDEM MASS-SPECTROMETRY; TYPE-2 DIABETIC-RATS; DU-TANG HLJDT; LOW BIOAVAILABILITY; INTEGRATED PHARMACOKINETICS; LIPOXYGENASE PATHWAY; BIOACTIVE COMPONENTS	Huang-Lian-Jie-Du Decoction (HLJDD) is a classical Traditional Chinese Medicine (TCM) formula with heat-dissipating and detoxifying effects. It is used to treat inflammation-associated diseases. However, no systematic pharmacokinetic (PK) and pharmacodynamic (PD) data concerning the activity of HLJDD under inflammatory conditions is available to date. In the present study, the concentration-time profiles and the hepatic clearance rates (HCR) of 41 major components in rat plasma in response to the oral administration of a clinical dose of HLJDD were investigated by LC-QqQ-MS using a dynamic multiple reaction monitoring (DMRM) method. Additionally, the levels of 7 cytokines (CKs) in the plasma and the body temperature of rats were analyzed. Furthermore, a PK-PD model was established to describe the time course of the hemodynamic and anti-inflammatory effects of HLJDD. As one of the three major active constituents in HLJDD, iridoids were absorbed and eliminated more easily and quickly than alkaloids and flavonoids. Compared with the normal controls, the flavonoids, alkaloids and iridoids in inflamed rats exhibited consistently changing trends of PK behaviors, such as higher bioavailability, slower elimination, delays in reaching the maximum concentration (T-max) and longer substantivity. The HCR of iridoids was different from that of alkaloids and flavonoids in inflamed rats. Furthermore, excellent pharmacodynamic effects of HLJDD were observed in inflamed rats. The levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), IL-1 beta, IL-10, and macrophage inflammatory protein-2 (MIP2) and body temperature significantly decreased after the administration of HLJDD. Based on PK-PD modeling with the three-phase synchronous characterization of time-concentration-effect, flavonoids exhibited one mechanism of action in the anti-inflammatory process, while iridoids and alkaloids showed another mechanism of action. Taken together, the results demonstrated that HLJDD may restrain inflammation synergistically via its major constituents alkaloids, flavonoids and iridoids). A correlation between the exposure concentration of different types of compounds and their anti-inflammatory effects in the body was shown. This study provides a comprehensive understanding of the anti-inflammatory activity of HLJDD.	[Ren, Wei; Wang, Hong-Jie; Yang, Jian; Xin, Shao-Kun; Han, Ling-Yu; Zhao, Hai-Yu; Bian, Bao-Lin; Si, Nan] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China; [Ren, Wei; Wang, Yao-Nan; Xin, Shao-Kun] Capital Med Univ, Beijing 100069, Peoples R China; [Zuo, Ran] Li Kang Hosp, Beijing 102609, Peoples R China; [Hu, Hao; Hu, Yuan-Jia] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Zhuhai, Macao, Peoples R China; [Han, Shu-Yan] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Integrat Chinese & Western Med, Minist Educ,Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100142, Peoples R China; [Gao, Bo] Anhui Jinchan Biochem Co Ltd, Huaibei 235000, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Capital Medical University; University of Macau; Peking University	Zhao, HY; Si, N (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.	hyzhao@icmm.ac.cn; nsi@icmm.ac.cn	Wei, Ren/J-7185-2019; HU, Hao/H-7813-2018; Hu, Yuanjia/AAW-7721-2021	Wei, Ren/0000-0002-5245-451X; HU, Hao/0000-0001-9441-106X; yuanjia, Hu/0000-0001-5244-8577	National Natural Science Fund Project [81202904]; National Basic Research Program of China [2014CB543003]; Fundamental Research Funds for the Central public welfare research institutes [ZZ070832]; Key Project at Central Government Level for Regulating Funds [2060302]	National Natural Science Fund Project(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central public welfare research institutes; Key Project at Central Government Level for Regulating Funds	The work was aided financially by National Natural Science Fund Project (NO. 81202904), National Basic Research Program of China (NO. 2014CB543003), Fundamental Research Funds for the Central public welfare research institutes (NO. ZZ070832) and Key Project at Central Government Level for Regulating Funds (NO. 2060302). Anhui Jinchan Biochemistry Company Ltd. had a role in data collection and analysis and preparation of the manuscript. Anhui Jinchan Biochemistry Company Ltd. has no role in the study design or decision to publish. The other funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621; Akao T, 2007, J PHARM PHARMACOL, V59, P87, DOI 10.1211/jpp.59.1.0012; Bae SK, 2009, J PHARM SCI-US, V98, P1587, DOI 10.1002/jps.21511; Cai ZX, 2008, J CHROMATOGR A, V1200, P144, DOI 10.1016/j.chroma.2008.05.095; Chaudhry H, 2013, IN VIVO, V27, P669; Chung HJ, 2006, EUR J PHARM SCI, V27, P363, DOI 10.1016/j.ejps.2005.11.008; Dai Y, 1999, LIFE SCI, V66, P19, DOI 10.1016/S0024-3205(99)00557-3; Deng YT, 2008, J CHROMATOGR B, V863, P195, DOI 10.1016/j.jchromb.2007.12.028; Deng YX, 2006, BIOMED CHROMATOGR, V20, P1098, DOI 10.1002/bmc.649; Deng YX, 2012, FITOTERAPIA, V83, P1435, DOI 10.1016/j.fitote.2012.08.007; Dou SS, 2009, CHROMATOGRAPHIA, V69, P659, DOI 10.1365/s10337-008-0945-3; Durairajan SSK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092954; Fang HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/245357; Flierl MA, 2008, FASEB J, V22, P2198, DOI 10.1096/fj.07-105221; He MY, 2014, J ETHNOPHARMACOL, V155, P334, DOI 10.1016/j.jep.2014.05.033; Hu YH, 2013, J ETHNOPHARMACOL, V150, P1137, DOI 10.1016/j.jep.2013.10.038; Jiang HQ, 2009, GUANGMING J CHIN MED, V24, P480; Jin Dan, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P541, DOI 10.3736/jcim20070513; Kang HE, 2009, XENOBIOTICA, V39, P465, DOI 10.1080/00498250902890151; Kim J, 1997, J PHARM PHARMACOL, V49, P878, DOI 10.1111/j.2042-7158.1997.tb06129.x; Lan MH, 2001, J HENAN COLL TRADIT, V16, P58; Li CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067530; Li Guofu, 2011, Zhongguo Zhong Yao Za Zhi, V36, P644; Lin Liang-Tzung, 2013, J Tradit Complement Med, V3, P227, DOI 10.4103/2225-4110.119732; Lin SC, 1996, AM J CHINESE MED, V24, P219, DOI 10.1142/S0192415X96000281; Liu GJ, 2005, JIANGXI J TRADIT CHI, V36, P19; Liu L, 2010, PLANTA MED, V76, P70, DOI 10.1055/s-0029-1185946; Lu J, 2011, J ETHNOPHARMACOL, V134, P911, DOI 10.1016/j.jep.2011.01.049; Lu T, 2007, J ETHNOPHARMACOL, V110, P412, DOI 10.1016/j.jep.2006.09.036; Ma ST, 2015, CHIN J NAT MEDICINES, V13, P30, DOI 10.1016/S1875-5364(15)60004-8; Ma Z, 2005, BLOOD, V105, P3312, DOI 10.1182/blood-2004-10-3915; Ma ZT, 2014, J ASIAN NAT PROD RES, V16, P483, DOI 10.1080/10286020.2014.913577; Miura N, 2007, BIOL PHARM BULL, V30, P495, DOI 10.1248/bpb.30.495; Nishigaki J, 1998, BIOL PHARM BULL, V21, P735; Ohura K, 2012, J PHARM SCI-US, V101, P3264, DOI 10.1002/jps.23182; Penney M, 2014, BRIT J CLIN PHARMACO, V77, P740, DOI 10.1111/bcp.12225; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Sun Jian, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1526; Sun Jian, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1461; Swartz ME, 2005, J LIQ CHROMATOGR R T, V28, P1253, DOI 10.1081/JLC-200053046; Tang YH, 2006, BIOMED CHROMATOGR, V20, P1116, DOI 10.1002/bmc.655; Tsai TH, 2002, BRIT J PHARMACOL, V137, P1314, DOI 10.1038/sj.bjp.0704959; Wang LM, 1997, J PHARM PHARMACOL, V49, P102, DOI 10.1111/j.2042-7158.1997.tb06760.x; Wang N, 2015, J ETHNOPHARMACOL, V164, P309, DOI 10.1016/j.jep.2015.02.025; Wang PR, 2014, J PHARMACEUT BIOMED, V88, P106, DOI 10.1016/j.jpba.2013.08.025; Wei YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/909624; Wen T, 2012, ARTHRITIS RHEUM-US, V64, P2896, DOI 10.1002/art.34528; Wu YH, 2012, J ETHNOPHARMACOL, V140, P55, DOI 10.1016/j.jep.2011.12.002; Xiao Yan-ling, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1767; Xing J, 2005, LIFE SCI, V78, P140, DOI 10.1016/j.lfs.2005.04.072; Yang Y, 2013, LISHIZHEN MED MAT ME, V24, P1599; Yang Y, 2013, J CHROMATOGR A, V1321, P88, DOI 10.1016/j.chroma.2013.10.072; Yi Q, 2012, CURR THER RES CLIN E, V73, P174, DOI 10.1016/j.curtheres.2012.09.002; Yu KH, 2009, J PHARM PHARMACOL, V61, P1197, DOI 10.1211/jpp/61.09.0009; Yue RC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/439690; Yue RC, 2013, J ETHNOPHARMACOL, V145, P465, DOI 10.1016/j.jep.2012.11.010; Zeng HW, 2011, J ETHNOPHARMACOL, V135, P561, DOI 10.1016/j.jep.2011.03.055; Zeng H, 2009, J PHARM PHARMACOL, V61, P1699, DOI [10.1211/jpp/61.12.0016, 10.1211/jpp.61.12.0016]; Zeng MF, 2010, FITOTERAPIA, V81, P490, DOI 10.1016/j.fitote.2010.01.004; Zhang HW, 2014, J ETHNOPHARMACOL, V154, P55, DOI 10.1016/j.jep.2014.03.007; Zhang L, 2005, PHARM RES-DORDR, V22, P1050, DOI 10.1007/s11095-005-5303-7; Zhang XJ, 2014, PHYTOMEDICINE, V21, P615, DOI 10.1016/j.phymed.2013.11.004; Zhu Hua-Xu, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2033; Zhu HX, 2013, PHYTOMEDICINE, V20, P767, DOI 10.1016/j.phymed.2012.11.012; Zhu HX, 2012, J ETHNOPHARMACOL, V141, P158, DOI 10.1016/j.jep.2012.02.014; Zuo R, 2016, XENOBIOTICA, V46, P65, DOI 10.3109/00498254.2015.1048541; Zuo Ran, 2014, Yaoxue Xuebao, V49, P237	67	18	22	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156256	10.1371/journal.pone.0156256	http://dx.doi.org/10.1371/journal.pone.0156256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280291	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000023
J	Zhang, WQ; Jin, X; Zhu, XL; Shan, BQ				Zhang, Wenqiang; Jin, Xin; Zhu, Xiaolei; Shan, Baoqing			Characteristics and Distribution of Phosphorus in Surface Sediments of Limnetic Ecosystem in Eastern China	PLOS ONE			English	Article							SHALLOW EUTROPHIC LAKE; ORGANIC PHOSPHORUS; WATER; EXTRACTION; ALUMINUM; PH; SPECIATION; SORPTION; TAIHU; RIVER	Phosphorus (P) is an essential nutrient for aquatic organisms; however, excessive P inflow to limnetic ecosystems can induce eutrophication. P concentrations in the rivers, wetlands and lakes of Eastern China have been amplified by fertilizer and sewage inputs associated with the development of industry and agriculture. Yet, knowledge of the distribution and speciation of P is lacking at the regional scale. We determined the distribution and speciation of P in limnetic ecosystems in Eastern China using Standards, Measurements and Testing (SMT) and phosphorus nuclear magnetic resonance (P-31-NMR). The results indicate that P pollution in surface sediments was serious. Inorganic P (Pi) was the primary drive of variation in total P (TP) among different river systems, and Pi accounted for 71% to 90% of TP in surface sediment in Eastern China. Also, the concentrations of TP and Pi varied among watersheds and Pi primarily drove the variation in TP in different watersheds. Sediments less than 10-cm deep served as the main P reservoir. Environmental factors affect the speciation and origin of P. NaOH-Pi, HCl-Pi and organic P (Po) were related to pH accordingly at the regional scale. The physicochemical properties of sediments from different limnetic ecosystems affect the P speciation. HCl-Pi was higher in wetland sediments than in riverine and lake sediments in Eastern China. Conversely, NaOH-Pi was lowest in wetland sediments. Total Po concentration was lower in riverine sediments than in other sediments, but Mono-P was higher, with an average concentration of 48 mg kg(-1). Diesters-P was highest in lake sediments. By revealing the regional distribution of TP, Pi and Po, this study will support eutrophication management in Eastern China.	[Zhang, Wenqiang; Jin, Xin; Zhu, Xiaolei; Shan, Baoqing] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing 100085, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Shan, BQ (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing 100085, Peoples R China.	bqshan@rcees.ac.cn			National Natural Science Foundation of China [21507146]; State Key Joint Laboratory of Environment Simulation and Pollution Control (Research Center for Eco-environmental Sciences, Chinese Academy of Sciences) [15Z01ESPCR]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Joint Laboratory of Environment Simulation and Pollution Control (Research Center for Eco-environmental Sciences, Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (Grant No. 21507146) and the special fund from the State Key Joint Laboratory of Environment Simulation and Pollution Control (Research Center for Eco-environmental Sciences, Chinese Academy of Sciences) (15Z01ESPCR).	Ahlgren J, 2005, ENVIRON SCI TECHNOL, V39, P867, DOI 10.1021/es049590h; Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; Cade-Menun BJ, 2005, TALANTA, V66, P359, DOI 10.1016/j.talanta.2004.12.024; Cade-Menun BJ, 1996, SOIL SCI, V161, P770, DOI 10.1097/00010694-199611000-00006; Cade-Menun BJ, 2005, MAR CHEM, V97, P293, DOI 10.1016/j.marchem.2005.05.005; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; Chen J, 2000, ACTA MINERALOGICA SI, V20, P112; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DETENBECK NE, 1991, ENVIRON SCI TECHNOL, V25, P403, DOI 10.1021/es00015a004; DIAZ OA, 1994, WATER RES, V28, P1755, DOI 10.1016/0043-1354(94)90248-8; Ding SM, 2013, J ENVIRON SCI, V25, P925, DOI 10.1016/S1001-0742(12)60137-5; Elser J, 2011, NATURE, V478, P29, DOI 10.1038/478029a; Gachter R, 1998, ENVIRON SCI TECHNOL, V32, P3659, DOI 10.1021/es980418l; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hupfer M, 2004, LIMNOL OCEANOGR, V49, P1, DOI 10.4319/lo.2004.49.1.0001; HUPFER M, 1995, LIMNOL OCEANOGR, V40, P610, DOI 10.4319/lo.1995.40.3.0610; [金相灿 Jin Xiangcan], 2004, [生态环境, Ecology and Environment], V13, P493; Kopacek J, 2005, ENVIRON SCI TECHNOL, V39, P8784, DOI 10.1021/es050916b; Kopacek J, 2000, LIMNOL OCEANOGR, V45, P212, DOI 10.4319/lo.2000.45.1.0212; Li C. H., 2006, THESIS; Li N., 2012, ENV SCI, V31, P2911; LIJKLEMA L, 1980, ENVIRON SCI TECHNOL, V14, P537, DOI 10.1021/es60165a013; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; Lu R, 1999, METHODS SOIL AGR CHE; McDowell RW, 2006, J ENVIRON QUAL, V35, P293, DOI 10.2134/jeq2005.0285; Meyers PA, 1997, ORG GEOCHEM, V27, P213, DOI 10.1016/S0146-6380(97)00049-1; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Meyers PA, 1999, J PALEOLIMNOL, V21, P345, DOI 10.1023/A:1008073732192; MORTIMER CH, 1971, LIMNOL OCEANOGR, V16, P387, DOI 10.4319/lo.1971.16.2.0387; Nielsen LP, 2010, NATURE, V463, P1071, DOI 10.1038/nature08790; Obersteiner M, 2013, NAT GEOSCI, V6, P897, DOI 10.1038/ngeo1990; Pan G, 2013, ENVIRON SCI TECHNOL, V47, P9685, DOI 10.1021/es4005619; Pernet-Coudrier B, 2012, ENVIRON SCI TECHNOL, V46, P5294, DOI 10.1021/es3004415; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Qu HJ, 2010, SCI TOTAL ENVIRON, V408, P2075, DOI 10.1016/j.scitotenv.2009.12.015; Qu JH, 2010, CRIT REV ENV SCI TEC, V40, P519, DOI 10.1080/10643380802451953; Reitzel K, 2006, WATER RES, V40, P647, DOI 10.1016/j.watres.2005.12.014; Reitzel K, 2007, BIOGEOCHEMISTRY, V82, P15, DOI 10.1007/s10533-006-9049-z; Ribeiro DC, 2014, ENVIRON SCI TECHNOL, V48, P9205, DOI 10.1021/es501037g; Ruban V, 2001, FRESEN J ANAL CHEM, V370, P224, DOI 10.1007/s002160100753; Ruban V, 2001, J ENVIRON MONITOR, V3, P121, DOI 10.1039/b005672n; Rydin E, 2000, LIMNOL OCEANOGR, V45, P226, DOI 10.4319/lo.2000.45.1.0226; Sattari SZ, 2012, P NATL ACAD SCI USA, V109, P6348, DOI 10.1073/pnas.1113675109; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Shinohara R, 2012, ENVIRON SCI TECHNOL, V46, P10572, DOI 10.1021/es301887z; Turner BL, 2005, TALANTA, V66, P294, DOI 10.1016/j.talanta.2004.11.012; Turner BL, 2003, SOIL SCI SOC AM J, V67, P1168, DOI 10.2136/sssaj2003.1168; Turner BL, 2003, ORG GEOCHEM, V34, P1199, DOI 10.1016/S0146-6380(03)00061-5; Wang LL, 2013, CHINESE GEOGR SCI, V23, P574, DOI 10.1007/s11769-013-0627-4; [王宇 Wang Yu], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2774; Xu D, 2013, J ENVIRON SCI-CHINA, V25, P637, DOI 10.1016/S1001-0742(12)60136-3; Xu D, 2012, J SOIL SEDIMENT, V12, P909, DOI 10.1007/s11368-012-0510-4; Zhang B, 2012, ECOL ENG, V40, P153, DOI 10.1016/j.ecoleng.2011.12.024; Zhang H, 2008, ENVIRON SCI TECHNOL, V42, P2328, DOI 10.1021/es0720208; Zhang RY, 2009, J ENVIRON QUAL, V38, P353, DOI 10.2134/jeq2007.0616; Zhang WQ, 2015, CLEAN-SOIL AIR WATER, V43, P544, DOI 10.1002/clen.201300254; Zhang WQ, 2014, ENVIRON SCI POLLUT R, V21, P3803, DOI 10.1007/s11356-013-2322-5; Zhang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076525; Zhou AM, 2005, WATER RES, V39, P1245, DOI 10.1016/j.watres.2005.01.026; Zhu MY, 2013, ENVIRON POLLUT, V173, P216, DOI 10.1016/j.envpol.2012.10.016	60	12	12	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156488	10.1371/journal.pone.0156488	http://dx.doi.org/10.1371/journal.pone.0156488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281191	Green Submitted, gold, Green Published			2022-12-27	WOS:000377563000031
J	Cai, JN; Jung, JE; Dang, MH; Kim, MA; Yi, HK; Jeon, JG				Cai, Jian-Na; Jung, Ji-Eun; Dang, Minh-Huy; Kim, Mi-Ah; Yi, Ho-Keun; Jeon, Jae-Gyu			Functional Relationship between Sucrose and a Cariogenic Biofilm Formation	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; IN-SITU; ENAMEL DEMINERALIZATION; DENTAL PLAQUE; CARIES INCIDENCE; EXPOSURE; FLUORIDE; GLUCOSYLTRANSFERASES	Sucrose is an important dietary factor in cariogenic biofilm formation and subsequent initiation of dental caries. This study investigated the functional relationships between sucrose concentration and Streptococcus mutans adherence and biofilm formation. Changes in morphological characteristics of the biofilms with increasing sucrose concentration were also evaluated. S. mutans biofilms were formed on saliva-coated hydroxyapatite discs in culture medium containing 0, 0.05, 0.1, 0.5, 1, 2, 5, 10, 20, or 40%(w/v) sucrose. The adherence (in 4-hour biofilms) and biofilm composition (in 46-hour biofilms) of the biofilms were analyzed using microbiological, biochemical, laser scanning confocal fluorescence microscopic, and scanning electron microscopic methods. To determine the relationships, 2nd order polynomial curve fitting was performed. In this study, the influence of sucrose on bacterial adhesion, biofilm composition (dry weight, bacterial counts, and water-insoluble extracellular polysaccharide (EPS) content), and acidogenicity followed a 2nd order polynomial curve with concentration dependence, and the maximum effective concentrations (MECs) of sucrose ranged from 0.45 to 2.4%. The bacterial and EPS bio-volume and thickness in the biofilms also gradually increased and then decreased as sucrose concentration increased. Furthermore, the size and shape of themicro-colonies of the biofilms depended on the sucrose concentration. Around the MECs, the micro-colonies were bigger and more homogeneous than those at 0 and 40%, and were surrounded by enough EPSs to support their structure. These results suggest that the relationship between sucrose concentration and cariogenic biofilm formation in the oral cavity could be described by a functional relationship.	[Cai, Jian-Na; Jung, Ji-Eun; Dang, Minh-Huy; Kim, Mi-Ah; Jeon, Jae-Gyu] Chonbuk Natl Univ, Sch Dent, Dept Prevent Dent, Inst Oral Biosci, Jeonju 561756, South Korea; [Yi, Ho-Keun] Chonbuk Natl Univ, Inst Oral Biosci, Sch Dent, Dept Oral Biochem, Jeonju 561756, South Korea	Jeonbuk National University; Jeonbuk National University	Jeon, JG (corresponding author), Chonbuk Natl Univ, Sch Dent, Dept Prevent Dent, Inst Oral Biosci, Jeonju 561756, South Korea.	dentjjk@jbnu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014R1A4A1005309]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2014R1A4A1005309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires CP, 2006, CARIES RES, V40, P28, DOI 10.1159/000088902; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; Ccahuana-Vasquez RA, 2007, CARIES RES, V41, P9, DOI 10.1159/000096100; Cury J A, 2001, Braz Dent J, V12, P101; Cury JA, 2000, CARIES RES, V34, P491, DOI 10.1159/000016629; Cury JA, 1997, CARIES RES, V31, P356, DOI 10.1159/000262418; de Sousa DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131941; dos Santos MN, 2002, CARIES RES, V36, P347, DOI 10.1159/000065959; HEFTI A, 1979, CARIES RES, V13, P298, DOI 10.1159/000260414; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Imfeld T N, 1983, Monogr Oral Sci, V11, P1; Jeon JG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-228; Kim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145844; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Leme AFP, 2004, J DENT RES, V83, P71, DOI 10.1177/154405910408300114; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; Meldrum RJ, 2003, FOOD MICROBIOL, V20, P97, DOI 10.1016/S0740-0020(02)00083-7; Mogen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133886; Chau NPT, 2014, J DENT, V42, P726, DOI 10.1016/j.jdent.2014.03.009; Pandit S, 2015, J APPL MICROBIOL, V119, P571, DOI 10.1111/jam.12851; Pandit S, 2011, ARCH ORAL BIOL, V56, P643, DOI 10.1016/j.archoralbio.2010.12.012; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; Sendamangalam V, 2011, BIOFOULING, V27, P13, DOI 10.1080/08927014.2010.535897; Takahashi N, 2010, J DENT RES, V89, P1383, DOI 10.1177/0022034510377792; Tenuta LMA, 2006, J DENT RES, V85, P834, DOI 10.1177/154405910608500911; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; Zero DT, 2004, CARIES RES, V38, P277, DOI 10.1159/000077767	34	18	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157184	10.1371/journal.pone.0157184	http://dx.doi.org/10.1371/journal.pone.0157184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275603	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700082
J	Stockl, D; Ruckert-Eheberg, IM; Heier, M; Peters, A; Schipf, S; Krabbe, C; Volzke, H; Tamayo, T; Rathmann, W; Meisinger, C				Stoeckl, Doris; Rueckert-Eheberg, Ina-Maria; Heier, Margit; Peters, Annette; Schipf, Sabine; Krabbe, Christine; Voelzke, Henry; Tamayo, Teresa; Rathmann, Wolfgang; Meisinger, Christa			Regional Variability of Lifestyle Factors and Hypertension with Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus: The Population-Based KORA-F4 and SHIP-TREND Studies in Germany	PLOS ONE			English	Article							SOUTHERN GERMANY; BLOOD-PRESSURE; PREVALENCE; HEALTH; RISK; INDIVIDUALS; DEPRIVATION	Objective Type 2 diabetes mellitus (T2D) shows regional differences in Germany. The purpose of the project was to compare the prevalence of prediabetes and undiagnosed T2D in two regions in Germany, the Northeast and the South, and to evaluate their associations with regional variations in lifestyle factors and hypertension. Methods Data from the KORA-F4 study (South Germany, 2006-2008) and the SHIP-TREND study (Northeast Germany, 2008-2012) were used. Participants aged 35-79 years without T2D with an overnight fasting of more than 8 hours and an oral glucose tolerance test were included: KORA-F4: n = 2,616 and SHIP-TREND: n = 1,968. Results The prevalence of prediabetes/newly diagnosed T2D was especially high in men (about 60%) and women (about 50%) in the Northeast, followed by men (about 50%) and women about 30%) in the South. Lifestyle factors associated with T2D varied between the regions: more participants in the Northeast were active smokers and the percentages of people with overweight or obesity were greater than in their southern counterparts. However, these differences could not explain the striking disparity in prediabetes/newly diagnosed T2D. The frequency of hypertension was also distinctly higher in the Northeast than in the South and clearly associated with prediabetes/newly diagnosed T2D. Especially in men living in the Northeast, screening individuals with blood pressure >= 140/90mmHg might reveal up to 70% of those with prediabetes/newly diagnosed T2D. Conclusions Knowledge about regional variability in T2D and related risk factors is important for the planning of diabetes prevention programs. In our analyses, common lifestyle factors did not nearly explain these variations between the northern SHIP-TREND and the southern KORA-F4 studies. Further examinations of regional socioeconomic, political, environmental and other aspects are needed. Meanwhile, targeted diabetes prevention strategies with a special focus on men living in the northern parts of Germany are reasonable.	[Stoeckl, Doris; Rueckert-Eheberg, Ina-Maria; Heier, Margit; Peters, Annette; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Stoeckl, Doris; Rueckert-Eheberg, Ina-Maria; Peters, Annette; Meisinger, Christa] German Ctr Diabet Res DZD eV, Partner Neuherberg, Neuherberg, Germany; [Stoeckl, Doris; Rueckert-Eheberg, Ina-Maria; Schipf, Sabine; Krabbe, Christine; Voelzke, Henry; Tamayo, Teresa; Rathmann, Wolfgang; Meisinger, Christa] Fed Minist Educ & Res, Competence Network Diabet Mellitus, Sites Dusseldorf Munich & Greifswald, Greifswald, Germany; [Stoeckl, Doris] Univ Munich, Klinikum Grosshadern, Dept Obstet & Gynaecol, D-80539 Munich, Germany; [Rueckert-Eheberg, Ina-Maria] Univ Munich, Klinikum Univ Munchen, Inst Allgemeinmed, Munich, Germany; [Schipf, Sabine; Krabbe, Christine; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Voelzke, Henry] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Greifswald Medical School; German Centre for Cardiovascular Research; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Stockl, D (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.; Stockl, D (corresponding author), German Ctr Diabet Res DZD eV, Partner Neuherberg, Neuherberg, Germany.; Stockl, D (corresponding author), Fed Minist Educ & Res, Competence Network Diabet Mellitus, Sites Dusseldorf Munich & Greifswald, Greifswald, Germany.; Stockl, D (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Obstet & Gynaecol, D-80539 Munich, Germany.	doris.stoeckl@helmholtz-muenchen.de	Heier, Margit/AAT-5280-2020; Peters, Annette/A-6117-2011; Meisinger, Christine/B-5358-2014	Peters, Annette/0000-0001-6645-0985; Meisinger, Christa/0000-0002-9026-6544	Competence Network Diabetes of the German Federal Ministry of Education and Research [01GI1110D]; Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research; Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; German Diabetes Center, Dusseldorf, Germany	Competence Network Diabetes of the German Federal Ministry of Education and Research; Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH) - German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania; German Diabetes Center, Dusseldorf, Germany	This work was supported by the Competence Network Diabetes of the German Federal Ministry of Education and Research (grant no. 01GI1110D). The Cooperative Research in the Region of Augsburg research platform (KORA) was initiated and financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The Study of Health in Pomerania (SHIP-TREND) is part of the Community Medicine Research net (CMR) at the University of Greifswald, Germany. The CMR encompasses several research projects that share data from the population-based SHIP project (http://ship.community-medicine.de). Funding was provided by grants from the German Federal Ministry of Education and Research, the Ministry for Education, Research and Cultural Affairs and the Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania. Oral glucose tolerance tests were funded by grants given to W.Rathmann (German Diabetes Center, Dusseldorf, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Balion CM, 2007, CLIN CHEM LAB MED, V45, P1180, DOI 10.1515/CCLM.2007.250; Greive Martin, 2014, WELT; Grundmann N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1264; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Krug S, 2013, BUNDESGESUNDHEITSBLA, V56, P765, DOI 10.1007/s00103-012-1661-6; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Maier W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089661; Meisinger C, 2010, DIABETIC MED, V27, P360, DOI 10.1111/j.1464-5491.2009.02905.x; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Meisinger C, 2008, J HYPERTENS, V26, P1809, DOI 10.1097/HJH.0b013e328307c3e9; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Mensink G B M, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1348, DOI 10.1007/s00103-005-1163-x; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Oba S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0017061; Psaltopoulou Theodora, 2010, Rev Diabet Stud, V7, P26, DOI 10.1900/RDS.2010.7.26; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Robert Koch Institut, 2014, GBE KOMP 25 JAHR NAC; Robert Koch-Institut. Beitrage zur Gesundheitsberichterstattung des Bundes, 2009, BEITR GES BUND 20 JA; Rueckert IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133493; Sachverstandigenrat zur Begutachtung der Entwicklung im Gesundheitswesen, 2014, GUT 2014 SACHV BEG E; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Schipf S, 2014, J EPIDEMIOL COMMUN H, V68, P1088, DOI 10.1136/jech-2014-203998; Sherman GD, 2012, P NATL ACAD SCI USA, V109, P17903, DOI 10.1073/pnas.1207042109; Statistisches Bundesamt, 2015, GES BUND; Stein JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098278; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; Tamayo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113154; Volzke H, 2015, DTSCH ARZTEBL INT, V112, P185, DOI 10.3238/arztebl.2015.0185; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	32	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156736	10.1371/journal.pone.0156736	http://dx.doi.org/10.1371/journal.pone.0156736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275745	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700034
J	Suzuki, T; Kazuki, Y; Oshimura, M; Hara, T				Suzuki, Teruhiko; Kazuki, Yasuhiro; Oshimura, Mitsuo; Hara, Takahiko			Highly Efficient Transfer of Chromosomes to a Broad Range of Target Cells Using Chinese Hamster Ovary Cells Expressing Murine Leukemia Virus-Derived Envelope Proteins	PLOS ONE			English	Article							HUMAN ARTIFICIAL CHROMOSOMES; FUSION	Microcell-mediated chromosome transfer (MMCT) is an essential step for introducing chromosomes from donor cells to recipient cells. MMCT allows not only for genetic/epigenetic analysis of specific chromosomes, but also for utilization of human and mouse artificial chromosomes (HACs/MACs) as gene delivery vectors. Although the scientific demand for genome scale analyses is increasing, the poor transfer efficiency of the current method has hampered the application of chromosome engineering technology. Here, we developed a highly efficient chromosome transfer method, called retro-MMCT, which is based on Chinese hamster ovary cells expressing envelope proteins derived from ecotropic or amphotropic murine leukemia viruses. Using this method, we transferred MACs to NIH3T3 cells with 26.5 times greater efficiency than that obtained using the conventional MMCT method. Retro-MMCT was applicable to a variety of recipient cells, including embryonic stem cells. Moreover, retro-MMCT enabled efficient transfer of MAC to recipient cells derived from humans, monkeys, mice, rats, and rabbits. These results demonstrate the utility of retro-MMCT for the efficient transfer of chromosomes to various types of target cell.	[Suzuki, Teruhiko; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Tokyo 113, Japan; [Kazuki, Yasuhiro] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori 680, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Tottori 680, Japan	Tokyo Metropolitan Institute of Medical Science; Tottori University; Tottori University	Suzuki, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Tokyo 113, Japan.	suzuki-tr@igakuken.or.jp			Japan Society for the Promotion of Science KAKENHI [24790696, 15K18392, 23390256]; Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [16H04728, 15K18392] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grant numbers 24790696, 15K18392 (T.S.) and 23390256 (T.H.) (http://www.jsps.go.jp/english/index.html); Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doherty AMO, 2003, MAMM GENOME, V14, P583, DOI 10.1007/s00335-003-4002-0; Hiratsuka M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0142-z; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Jensen N, 2013, J MOL NEUROSCI, V51, P994, DOI 10.1007/s12031-013-0085-6; Karavanas G, 1998, CRIT REV ONCOL HEMAT, V28, P7, DOI 10.1016/S1040-8428(98)00007-9; Katoh M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-37; Kazuki Y, 2013, HUM MOL GENET, V22, P578, DOI 10.1093/hmg/dds468; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kitajima K, 2013, STEM CELLS, V31, P2680, DOI 10.1002/stem.1500; Kouprina N, 2014, EXPERT OPIN DRUG DEL, V11, P517, DOI 10.1517/17425247.2014.882314; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Miller AD, 1996, J VIROL, V70, P1804, DOI 10.1128/JVI.70.3.1804-1809.1996; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oshimura M, 2015, CHROMOSOME RES, V23, P111, DOI 10.1007/s10577-014-9459-z; Paulis M, 2007, STEM CELLS, V25, P2543, DOI 10.1634/stemcells.2007-0052; Paulis M, 2011, METHODS MOL BIOL, V738, P57, DOI 10.1007/978-1-61779-099-7_4; Perkins CP, 1997, GENE DEV, V11, P914, DOI 10.1101/gad.11.7.914; RAGHEB JA, 1994, J VIROL, V68, P3220, DOI 10.1128/JVI.68.5.3220-3231.1994; Suzuki N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1168; Suzuki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110404; Takiguchi M, 2014, ACS SYNTH BIOL, V3, P903, DOI 10.1021/sb3000723; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Uno N, 2013, CYTOTECHNOLOGY, V65, P803, DOI 10.1007/s10616-013-9548-4; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yamaguchi Shigeyuki, 2006, Chromosome Science, V9, P65	27	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157187	10.1371/journal.pone.0157187	http://dx.doi.org/10.1371/journal.pone.0157187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271046	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000069
J	Nagai, K; Sairenchi, T; Irie, F; Watanabe, H; Ota, H; Yamagata, K				Nagai, Kei; Sairenchi, Toshimi; Irie, Fujiko; Watanabe, Hiroshi; Ota, Hitoshi; Yamagata, Kunihiro			Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; RENAL DYSFUNCTION; SERUM CREATININE; OUTCOMES; PROTEINURIA; ASSOCIATION; DECLINE	Background Patients with renal impairment are at risk of not only end-stage kidney disease but also cardiovascular disease (CVD). The current definition of CKD stage G3a is eGFR 45-59 ml/min/1.73 m(2) and of G3b is 30-44 ml/min/1.73 m(2), and subjects in the CKD 3a category are considered to be at lower risk of mortality than are those in CKD 3b. Methods We evaluated the outcome of 97,043 people (33,131 men and 63,912 women) living in Ibaraki Prefecture who underwent annual community-based health checkups beginning in 1993 at age 40-80 years and who were followed for a mean of 17.1 years. Results The number of all-causes deaths was 20,534 (10,375 men and 10,159 women), of which 5,995 (2,695men and 3,300 women) were deaths due to CVD. Multivariable-adjusted hazard ratio for CVD death in the eGFR 45-49 ml/min/1.73 m(2) category was significantly increased (1.82; 95% confidential interval, 1.23-2.69) in non-elderly men, whereas all-cause mortality and CVD mortality in elderly men with eGFR 45-49 ml/min/1.73 m(2) were non significant. In contrast, both in non-elderly women and in elderly women with eGFR 45-49 ml/min/1.73 m(2) showed small, but significant, increases in the risks of all-cause mortality and CVD. Conclusions We demonstrated proportionate increases in mortality with decreasing eGFR in a Japanese CKD population. Like patients in the CKD G3b subgroup, non-elderly men and women with an eGFR of 45-49 ml/min/1.73 m(2) (i.e. a part of CKD G3a) are at considerable risk of CVD mortality. Age dependent and eGFR dependent finer risk recognition were required for CVD prevention in clinical practice with regard to CKD patients.	[Nagai, Kei; Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Sairenchi, Toshimi; Watanabe, Hiroshi; Ota, Hitoshi] Ibaraki Hlth Serv Assoc, Ibaraki Hlth Plaza, Mito, Ibaraki, Japan; [Irie, Fujiko] Ibaraki Prefectural Off, Dept Hlth & Welf, Mito, Ibaraki, Japan	University of Tsukuba; Dokkyo Medical University	Yamagata, K (corresponding author), Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan.	k-yamaga@md.tsukuba.ac.jp		Sairenchi, Toshimi/0000-0001-8896-6501; Nagai, Kei/0000-0001-5050-5291	Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan [H17-Kenkou-007, H18-Junkankitou[Seishuu]-Ippan-012, H20-Junkankitou[Seishuu]-Ippan-013, H21-Nanchi-Ippan-059, H23-Junkankitou[Seishuu]-Ippan-005, H26-Junkankitou [Seisaku]-Ippan-001]	Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H18-Junkankitou[Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou[Seishuu]-Ippan-013; Intractable Diseases Conquest Research: H21-Nanchi-Ippan-059; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou[Seishuu]-Ippan-005; and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H26-Junkankitou [Seisaku]-Ippan-001). http://www.mhlw.go.jp/english/new-info/2012.html. This study was also part of Research on Advanced Chronic Kidney Disease (REACH-J), a Practical Research Project for Renal Diseases, from the Japan Agency for Medical Research and Development (AMED). http://www.amed.go.jp/program/list/01/05/017.html.; This work was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare, Health and Labor Sciences Research Grants, Japan (Research on Health Services: H17-Kenkou-007; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H18-Junkankitou[Seishuu]-Ippan-012; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H20-Junkankitou[Seishuu]-Ippan-013; Intractable Diseases Conquest Research: H21-Nanchi-Ippan-059; Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H23-Junkankitou[Seishuu]-Ippan-005; and Comprehensive Research on Cardiovascular and Life-Style Related Diseases: H26-Junkankitou [Seisaku]-Ippan-001). This study was also part of Research on Advanced Chronic Kidney Disease (REACH-J), a Practical Research Project for Renal Diseases, from the Japan Agency for Medical Research and Development (AMED).	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; [Anonymous], CLIN EXP NEPHROL, V13, P222; Chalmers J, 1999, J HYPERTENS, V17, P151; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Kasiske BL, 2013, KIDNEY INT SUPPL, V3, P2, DOI 10.1038/kisup.2012.74; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Menon V, 2007, ANN INTERN MED, V147, P19, DOI 10.7326/0003-4819-147-1-200707030-00004; Nagai K, 2015, CLIN EXP NEPHROL, V19, P152, DOI 10.1007/s10157-014-1034-6; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007	24	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156792	10.1371/journal.pone.0156792	http://dx.doi.org/10.1371/journal.pone.0156792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27272675	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200016
J	Bae, W; Park, KU; Song, EY; Kim, SJ; Lee, YJ; Park, JS; Cho, YJ; Yoon, HI; Yim, JJ; Lee, CT; Lee, JH				Bae, Won; Park, Kyoung Un; Song, Eun Young; Kim, Se Joong; Lee, Yeon Joo; Park, Jong Sun; Cho, Young-Jae; Yoon, Ho Il; Yim, Jae-Joon; Lee, Choon-Taek; Lee, Jae Ho			Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age	PLOS ONE			English	Article							INTERFERON-GAMMA RELEASE; LATENT TUBERCULOSIS INFECTION; RISK-FACTORS; TB-2G TEST; IMMUNOCOMPROMISED PATIENTS; ACTIVE TUBERCULOSIS; HIGH PREVALENCE; SKIN-TEST; ASSAYS; DIAGNOSIS	Currently, there are two types of interferon-gamma release assays (IGRAs) in use for the detection of tuberculosis (TB) infection, the QuantiFERON-TB Gold In-Tube test (GFT-GIT) and T-SPOT.TB. Owing to contradictory reports regarding whether the results of these IGRAs are affected by the age of the patient, we aimed to determine if these two tests have age-related differences in sensitivity. We retrospectively reviewed the medical records of diagnosed TB patients who were tested using either QFT-GIT or T-SPOT.TB from February 2008 to December 2013. The positivity of the two tests was analyzed and compared with true TB infection, which was defined as active TB based on either a positive Mycobacterium culture or a positive TB polymerase chain reaction. The QFT-GIT group included 192 TB patients, and the T-SPOT.TB group included 212 TB patients. Of the patients with pulmonary TB, 76 (39.6%) were in the QFT-GIT group and 143 (67.5%) in the T-SPOT.TB group. The overall sensitivity was 80.2% for QFT-GIT and 91.0% for T.SPOT.TB. The sensitivities of QFT-GIT and T-SPOT.TB according to age group were as follows: <29 years, 93.3% and 96.7%; 30-49 years, 86.5% and 94.7%; 50-69 years, 76.8% and 87.5%; and >70 years, 68.3% and 85.7%, respectively. The trend of age-related changes in sensitivity was significant for both QFT-GIT (p = 0.004) and T.SPOT.TB (p = 0.039). However, only QFT-GIT was significantly related to age in the multivariate analysis. QFT-GIT, but not T-SPOT.TB, was significantly affected by patient age.	[Bae, Won; Kim, Se Joong; Lee, Yeon Joo; Park, Jong Sun; Cho, Young-Jae; Yoon, Ho Il; Yim, Jae-Joon; Lee, Choon-Taek; Lee, Jae Ho] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Bae, Won; Kim, Se Joong; Lee, Yeon Joo; Park, Jong Sun; Cho, Young-Jae; Yoon, Ho Il; Lee, Choon-Taek; Lee, Jae Ho] Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea; [Park, Kyoung Un] Seoul Natl Univ, Dept Lab Med, Bundang Hosp, Seoul, South Korea; [Song, Eun Young] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Yim, Jae-Joon] Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.; Lee, JH (corresponding author), Seoul Natl Univ, Div Pulm & Crit Care Med, Dept Internal Med, Bundang Hosp, Songnam, Gyeonggi Do, South Korea.	jhlee7@snubh.org	Cho, Young-Jae/D-5528-2012; Park, Kyoung Un/J-5473-2012; Kim, Sejoong/J-5356-2015	Cho, Young-Jae/0000-0001-6943-4462; Park, Kyoung Un/0000-0002-2402-7633; Yim, Jae-Joon/0000-0002-9605-0074; Kim, Sejoong/0000-0002-7238-9962				Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556; Beffa P, 2008, EUR RESPIR J, V31, P842, DOI 10.1183/09031936.00117207; Bouwman JJM, 2012, J INFECTION, V64, P197, DOI 10.1016/j.jinf.2011.10.017; Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; Cho K, 2012, TUBERC RESPIR DIS, V72, P416, DOI 10.4046/trd.2012.72.5.416; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Elzi L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-319; Fan L, 2012, FEMS IMMUNOL MED MIC, V65, P456, DOI 10.1111/j.1574-695X.2012.00972.x; Faurholt-Jepsen D, 2014, SCAND J INFECT DIS, V46, P384, DOI 10.3109/00365548.2014.885657; Feng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032652; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jeong SJ, 2011, J INFECTION, V62, P347, DOI 10.1016/j.jinf.2011.03.004; Kamiya H, 2013, J INFECT CHEMOTHER, V19, P217, DOI 10.1007/s10156-012-0480-x; Kim EY, 2011, DIAGN MICR INFEC DIS, V70, P324, DOI 10.1016/j.diagmicrobio.2011.02.011; Kobashi Y, 2009, EUR RESPIR J, V33, P812, DOI 10.1183/09031936.00075008; Kobashi Y, 2008, CHEST, V133, P1196, DOI 10.1378/chest.07-1995; Kobashi Y, 2009, SCAND J INFECT DIS, V41, P841, DOI 10.3109/00365540903186215; Kwon YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129792; La Jeon Y, 2013, J INFECTION, V67, P288, DOI 10.1016/j.jinf.2013.06.005; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Lee SSJ, 2009, INFECTION, V37, P96, DOI 10.1007/s15010-008-8082-3; Lee YM, 2013, INFECTION, V41, P1089, DOI 10.1007/s15010-013-0478-z; Lee YM, 2014, INFECT CHEMOTHER, V46, P248, DOI 10.3947/ic.2014.46.4.248; Lee YM, 2013, INFECT CHEMOTHER, V45, P44, DOI 10.3947/ic.2013.45.1.44; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Louisiana Office of Public Health-Infectious Disease Epidemiology Section, 2010, TUB ANN REP; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pan LP, 2015, J INFECTION, V70, P367, DOI 10.1016/j.jinf.2014.12.018; Piana F, 2006, EUR RESPIR J, V28, P31, DOI 10.1183/09031936.06.00110205; Piana F, 2006, AM J RESP CRIT CARE, V173, P130, DOI 10.1164/ajrccm.173.1.130; Redelman-Sidi G, 2013, AM J RESP CRIT CARE, V188, P422, DOI 10.1164/rccm.201209-1621CI; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Wang SH, 2012, J CLIN MICROBIOL, V50, P2469, DOI 10.1128/JCM.00674-12; Wang SH, 2010, SCAND J INFECT DIS, V42, P845, DOI 10.3109/00365548.2010.498021; Whitworth HS, 2013, METHODS, V61, P52, DOI 10.1016/j.ymeth.2012.12.012; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhu CT, 2014, J THORAC DIS, V6, P713, DOI 10.3978/j.issn.2072-1439.2014.04.38	40	29	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156917	10.1371/journal.pone.0156917	http://dx.doi.org/10.1371/journal.pone.0156917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258377	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700153
J	Chao, WC; Wu, CL; Liu, PY; Shieh, CC				Chao, Wen-Cheng; Wu, Chieh-Liang; Liu, Po-Yu; Shieh, Chi-Chang			Regular Sputum Check-Up for Early Diagnosis of Tuberculosis after Exposure in Healthcare Facilities	PLOS ONE			English	Article							NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; COST-EFFECTIVENESS; TRANSMISSION; INFECTION; OUTBREAK	Background The early diagnosis of patients with TB disease is critical after an outbreak of tuberculosis (TB) infection in healthcare facilities. In this study, we report a catastrophic TB outbreak in a psychiatric healthcare facility and analyze the role of regular sputum check-ups and other diagnostic tools to facilitate an early diagnosis. Methods Every exposed participant received regular sputum check-ups and chest X-rays (CXR) as part of the outbreak management protocol. We retrospectively analyzed data from the contact participants to identify risk factors for eventual TB development and investigated the diagnostic efficacy of regular sputum check-ups. Results Among 133 contact participants, 16 (12.0%) developed TB during the 4-year follow-up period. Low body-mass-index (BMI) (<21) (adjusted hazard ratio (aHR) 3.16, 95% confidence interval (CI) 1.11-8.98) and long duration of contact (>3 months) (aHR 8.70, 95% CI, 1.14-63.34) independently predicted the development of TB. Even though regular sputum check-ups required significant resources, they did facilitate the early identification of new TB cases among the contact participants. Regular sputum check-ups for high-risk patients based on BMI, contact duration and CXR findings may be a practical approach when compared with universal sputum follow-up, with a slightly decreased sensitivity but high positive likelihood ratio (88%, [95% CI, 62-98%] and 5.12, [95% CI, 3.30-7.95], respectively). Conclusion While regular sputum check-ups for all contact participants facilitated the early identification of cases after the outbreak of TB in the healthcare facility, regular sputum check-ups for high-risk patients might be an effective alternative in resource-limited settings.	[Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chao, Wen-Cheng; Shieh, Chi-Chang] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Wu, Chieh-Liang; Liu, Po-Yu] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Wu, Chieh-Liang] Taichung Vet Gen Hosp, Ctr Qual Management, Taichung, Taiwan; [Shieh, Chi-Chang] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan	Taichung Veterans General Hospital; National Cheng Kung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Shieh, CC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan.; Shieh, CC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan.	cshieh@mail.ncku.edu.tw	LIU, PO-YU/AHB-4861-2022	Liu, Po-Yu/0000-0001-8006-4917				Alisjahbana B, 2005, INT J TUBERC LUNG D, V9, P814; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Bell DJ, 2009, INT J TUBERC LUNG D, V13, P99; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Biadglegne F, 2015, EPIDEMIOL INFECT, V143, P887, DOI 10.1017/S095026881400288X; Buregyeya E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-360; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P801; Chao WC, 2015, MICROBES INFECT, V17, P195, DOI 10.1016/j.micinf.2014.11.009; da Costa PA, 2009, J HOSP INFECT, V72, P57, DOI 10.1016/j.jhin.2009.01.016; de Vries G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-151; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; Djukanovic R, 2002, EUR RESPIR J, V20, p1S, DOI 10.1183/09031936.02.00000102; Gasner MR, 1999, NEW ENGL J MED, V340, P359, DOI 10.1056/NEJM199902043400506; Harris TG, 2013, AM J INFECT CONTROL, V41, P155, DOI 10.1016/j.ajic.2012.02.015; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Jou R, 2009, INT J TUBERC LUNG D, V13, P1142; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Neely F, 2010, J PUBLIC HEALTH-UK, V32, P44, DOI 10.1093/pubmed/fdp056; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Pachi Argiro, 2013, Tuberc Res Treat, V2013, P489865, DOI 10.1155/2013/489865; Pepper T, 2008, INT J TUBERC LUNG D, V12, P397; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Saito M, 2004, INT J TUBERC LUNG D, V8, P842; Schepisi MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121639; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; Warren JR, 2000, AM J RESP CRIT CARE, V161, P1559, DOI 10.1164/ajrccm.161.5.9908063; Yen CL, 2015, INT J OBESITY, V39, P270, DOI 10.1038/ijo.2014.93	35	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157054	10.1371/journal.pone.0157054	http://dx.doi.org/10.1371/journal.pone.0157054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258370	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700173
J	Geraldo, MT; Takeda, AAS; Braz, ASK; Lemke, N				Geraldo, Marcos Tadeu; Sekijima Takeda, Agnes Alessandra; Kimus Braz, Antonio Sergio; Lemke, Ney			Bending-Twisting Motions and Main Interactions in Nucleoplasmin Nuclear Import	PLOS ONE			English	Article							LOCALIZATION SEQUENCE-BINDING; LINEAR CONSTRAINT SOLVER; NORMAL-MODE ANALYSIS; STRUCTURAL BASIS; MOLECULAR-DYNAMICS; PROTEIN IMPORT; CRYSTALLOGRAPHIC ANALYSIS; ALPHA; RECOGNITION; SIGNALS	Alpha solenoid proteins play a key role in regulating the classical nuclear import pathway, recognizing a target protein and transporting it into the nucleus. Importin-alpha (Imp alpha) is the solenoid responsible for cargo protein recognition, and it has been extensively studied by X-ray crystallography to understand the binding specificity. To comprehend the main motions of Imp alpha and to extend the information about the critical interactions during carrier-cargo recognition, we surveyed different conformational states based on molecular dynamics (MD) and normal mode (NM) analyses. Our model of study was a crystallographic structure of Imp alpha complexed with the classical nuclear localization sequence (cNLS) from nucleoplasmin (Npl), which was submitted to multiple 100 ns of MD simulations. Representative conformations were selected for calculating the 87 lowest frequencies NMs of vibration, and a displacement approach was applied along each NM. Based on geometric criteria, using the radius of curvature and inter-repeat angles as the reference metrics, the main motions of Imp alpha were described. Moreover, we determined the salt bridges, hydrogen bonds and hydrophobic interactions in the Imp alpha-NplNLS interface. Our results show the bending and twisting motions participating in the recognition of nuclear proteins, allowing the accommodation and adjustment of a classical bipartite NLS sequence. The essential contacts for the nuclear import were also described and were mostly in agreement with previous studies, suggesting that the residues in the cNLS linker region establish important contacts with Imp alpha adjusting the cNLS backbone. The MD simulations combined with NM analysis can be applied to the Imp alpha-NLS system to help understand interactions between Imp alpha and cNLSs and the analysis of non-classic NLSs.	[Geraldo, Marcos Tadeu; Sekijima Takeda, Agnes Alessandra; Lemke, Ney] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Lab Bioinformat & Biofis Computac, BR-18618970 Botucatu, SP, Brazil; [Sekijima Takeda, Agnes Alessandra] UNESP Univ Estadual Paulista, Inst Biotecnol IBTEC, BR-18607440 Botucatu, SP, Brazil; [Kimus Braz, Antonio Sergio] UFABC Univ Fed ABC, Ctr Ciencias Nat & Humanas, Lab Biol Computac & Bioinformat, BR-09210170 Santo Andre, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Geraldo, MT (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Lab Bioinformat & Biofis Computac, BR-18618970 Botucatu, SP, Brazil.	mtgeraldo@gmail.com	Lemke, Ney/L-6761-2019; Geraldo, Marcos Tadeu/H-7187-2016; Lemke, Ney/A-8213-2008; Geraldo, Marcos Tadeu/S-4028-2019; Takeda, Agnes/AAH-3413-2020; Braz, Antonio Sergio/U-5377-2017	Lemke, Ney/0000-0001-7463-4303; Geraldo, Marcos Tadeu/0000-0001-8250-2159; Lemke, Ney/0000-0001-7463-4303; Geraldo, Marcos Tadeu/0000-0001-8250-2159; Takeda, Agnes/0000-0001-5000-6652; Braz, Antonio Sergio/0000-0003-2900-8703	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19447-2, 2014/21976-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [142110/2012-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant numbers 2012/19447-2; 2014/21976-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant number 142110/2012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bernardes NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128687; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christie M, 2015, JOURNAL OF MOLECULAR; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; de Barros AC, 2016, JOURNAL OF MOLECULAR; de Barros AC, 2012, ACTA CRYSTALLOGR D, V68, P743, DOI 10.1107/S0907444912010281; Dingwall C, 1990, Semin Cell Biol, V1, P11; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Doyle L, 2015, NATURE, V528, P585, DOI 10.1038/nature16191; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falces J, 2010, BIOCHEMISTRY-US, V49, P9756, DOI 10.1021/bi101179g; Floquet N, 2015, BIOPHYS J, V109, P1179, DOI 10.1016/j.bpj.2015.07.003; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Genheden S, 2012, PHYS CHEM CHEM PHYS, V14, P8662, DOI 10.1039/c2cp23961b; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Grossfield A, 2009, ANN REP COMP CHEM, V5, P23, DOI 10.1016/S1574-1400(09)00502-7; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Keskin O, 2002, BIOPHYS J, V83, P663, DOI 10.1016/S0006-3495(02)75199-0; Kirby TW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13405; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SJ, 2000, J MOL BIOL, V302, P251, DOI 10.1006/jmbi.2000.4055; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Moroianu J, 1996, P NATL ACAD SCI USA, V93, P7059, DOI 10.1073/pnas.93.14.7059; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pumroy RA, 2015, STRUCTURE, V23, P374, DOI 10.1016/j.str.2014.11.015; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schrodinger L, 2010, THE PYMOL MOLECULAR; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Settanni G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002864; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; Takeda AAS, 2013, PROTEIN PEPTIDE LETT, V20, P8; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	71	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157162	10.1371/journal.pone.0157162	http://dx.doi.org/10.1371/journal.pone.0157162			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258022	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700179
J	Grigoras, CA; Zervou, FN; Zacharioudakis, IM; Siettos, CI; Mylonakis, E				Grigoras, Christos A.; Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Siettos, Constantinos I.; Mylonakis, Eleftherios			Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data	PLOS ONE			English	Article							HEALTH-CARE SETTINGS; ASYMPTOMATIC CARRIERS; EPIDEMIOLOGIC MODEL; CONTACT PRECAUTIONS; HOSPITAL ADMISSION; UNITED-STATES; RISK-FACTORS; COLONIZATION; METAANALYSIS; PREVALENCE	Clostridium difficile infection is the most common hospital-acquired infection. Besides infected patients, carriers have emerged as a key player in C. difficile epidemiology. In this study, we evaluated the impact of identifying and isolating carriers upon hospital admission on the incidence of CDI incidence and hospital-acquired C. difficile colonization, as a single policy and as part of bundle approaches. We simulated C. difficile transmission using a stochastic mathematical approach, considering the contribution of carriers based on published literature. In the baseline scenario, CDI incidence was 6.18/1,000 admissions (95% CI, 5.72-6.65), simulating reported estimates from U.S. hospital discharges. The acquisition rate of C. difficile carriage was 9.72/1,000 admissions (95% CI, 9.15-10.31). Screening and isolation of colonized patients on admission to the hospital decreased CDI incidence to 4.99/1,000 admissions (95% CI, 4.59-5.42; relative reduction (RR) = 19.1%) and led to 36.2% reduction in the rate of hospital-acquired colonization. Simulating an antimicrobial stewardship program reduced CDI rate to 2.35/1,000 admissions (95% CI, 2.07-2.65). In sensitivity analysis, CDI incidence was less than 2.32/1,000 admissions (RR = 62.4%) in 95% of 1,000 simulations. The combined bundle, focusing on reducing C. difficile transmission from colonized patients and the individual risk of these patients to develop CDI, decreased significantly the incidence of both CDI and hospital-acquired colonization. Implementation of this bundle to current practice is expected to have an important impact in containing CDI.	[Grigoras, Christos A.; Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA; [Grigoras, Christos A.] Natl Tech Univ Athens, Sch Appl Math & Phys Sci, Athens, Greece	Brown University; National Technical University of Athens	Mylonakis, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA.	emylonakis@lifespan.org						Alasmari F, 2014, CLIN INFECT DIS, V59, P216, DOI 10.1093/cid/ciu258; Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; Austin M, 2014, AM J MED, V127, P479, DOI 10.1016/j.amjmed.2014.02.017; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cook PP, 2015, INT J ANTIMICROB AG, V45, P262, DOI 10.1016/j.ijantimicag.2014.11.006; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; Deshpande A, 2008, CURR MED RES OPIN, V24, P329, DOI 10.1185/030079908X253735; Deshpande A, 2013, J ANTIMICROB CHEMOTH, V68, P1951, DOI 10.1093/jac/dkt129; Deshpande A, 2012, CLIN GASTROENTEROL H, V10, P225, DOI 10.1016/j.cgh.2011.09.030; Deshpande A, 2011, CLIN INFECT DIS, V53, pE81, DOI 10.1093/cid/cir505; Dhar S, 2014, INFECT CONT HOSP EP, V35, P213, DOI 10.1086/675294; Donskey CJ, 2015, INFECT DIS CLIN N AM, V29, P13, DOI 10.1016/j.idc.2014.11.001; Dubberke ER, 2008, EMERG INFECT DIS, V14, P1031, DOI 10.3201/eid1407.070867; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Feazel LM, 2014, J ANTIMICROB CHEMOTH, V69, P1748, DOI 10.1093/jac/dku046; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Galdys AL, 2014, EXPERT REV ANTI-INFE, V12, P967, DOI 10.1586/14787210.2014.920252; Guerrero DM, 2013, J HOSP INFECT, V85, P155, DOI 10.1016/j.jhin.2013.07.002; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kundrapu S, 2012, CLIN INFECT DIS, V55, P1527, DOI 10.1093/cid/cis707; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Lanzas C, 2014, INFECT CONT HOSP EP, V35, P1043, DOI 10.1086/677162; Leekha S, 2013, AM J INFECT CONTROL, V41, P390, DOI 10.1016/j.ajic.2012.09.023; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Morgan DJ, 2013, INFECT CONT HOSP EP, V34, P69, DOI 10.1086/668775; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; O'Horo JC, 2012, MAYO CLIN PROC, V87, P643, DOI 10.1016/j.mayocp.2012.02.024; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rodriguez C, 2014, ANAEROBE, V30, P184, DOI 10.1016/j.anaerobe.2014.08.007; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Simor AE, 2013, INFECT CONT HOSP EP, V34, P687, DOI 10.1086/670998; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Yakob L, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.43; Yakob L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-376; Yanke E, 2015, AM J INFECT CONTROL, V43, P241, DOI 10.1016/j.ajic.2014.11.026; Yokoe DS, 2014, INFECT CONT HOSP EP, V35, P967, DOI 10.1086/677216; Zacharioudakis IM, 2015, AM J GASTROENTEROL, V110, P381, DOI 10.1038/ajg.2015.22	46	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156577	10.1371/journal.pone.0156577	http://dx.doi.org/10.1371/journal.pone.0156577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258068	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700081
J	Li, L; Liang, WQ; Ye, T; Chen, ZY; Zuo, XZ; Du, X; Qian, K; Zhang, CX; Hu, XR; Li, JH; Wang, L; Ma, ZF; Yao, Y				Li, Li; Liang, Wangqun; Ye, Ting; Chen, Zhenyan; Zuo, Xuezhi; Du, Xiang; Qian, Kun; Zhang, Chunxiu; Hu, Xiangrong; Li, Junhua; Wang, Le; Ma, Zufu; Yao, Ying			The Association between Nutritional Markers and Biochemical Parameters and Residual Renal Function in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; PROTEIN-INTAKE; CAPD PATIENTS; FLUID STATUS; ADEQUACY; PREVALENCE; MORBIDITY; MORTALITY; RISK	Residual renal function (RRF) is an important prognostic factor for peritoneal dialysis patients as it influences the quality of life and mortality. This study was conducted to explore the potential factors correlated with RRF. A cross-sectional study was conducted by recruiting 155 patients with residual GFR more than 1 mL/min per 1.73m(2) at the initiation of peritoneal dialysis. We collected the demographic characteristics, nutritional markers and biochemical parameters of all participants, and analyzed the correlation between these variables and residual GFR as well. The odds ratio of RRF loss associated with each of the nutritional markers and biochemical parameters were estimated by logistic regression model. The residual GFR was negatively correlated with serum phosphate (ORQ3 = 2.67, 95% CI: 1.03-6.92; ORQ4 = 3.45, 95% CI: 1.35-9.04), magnesium (ORQ4 = 3.77, 95% CI: 1.48-3.63), and creatinine (ORQ3 = 2.93, 95% CI: 1.09-7.88; ORQ4 = 8.64 95% CI: 2.792-6.78), while positively associated with normalized protein catabolic rate (ORQ3 = 0.24, 95% CI: 0.09-0.65; ORQ4 = 0.11, 95% CI: 0.03-0.35), 24 hours urine volume(ORQ1 = 22.87, 95% CI: 2.76-189.24; ORQ3 = 0.08, 95% CI: 0.02-0.28) and serum chlorine concentrations (ORQ1 = 5.34, 95% CI: 1.94-14.68; ORQ4 = 0.28, 95% CI: 0.09-0.85), respectively. Our study suggested that the nutritional markers and biochemical parameters, though not all, but at least in part were closely correlated with RRF in peritoneal dialysis patients.	[Li, Li; Ye, Ting; Chen, Zhenyan; Zuo, Xuezhi; Du, Xiang; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Nutr, Wuhan 430074, Peoples R China; [Liang, Wangqun; Qian, Kun; Zhang, Chunxiu; Hu, Xiangrong; Li, Junhua; Wang, Le; Ma, Zufu; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Nutr, Wuhan 430074, Peoples R China.; Ma, ZF; Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Peoples R China.	mazufu@sina.com; yaoyingkk@126.com	ye, ting/HGC-5924-2022		provincial Science Foundation of Hubei [WJ2015MB011]; National Science Foundation of China (NSF) [81300592]	provincial Science Foundation of Hubei; National Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC))	This work was supported by the provincial Science Foundation of Hubei (WJ2015MB011) and the National Science Foundation of China (NSF 81300592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI G, 1993, NEPHRON, V65, P469, DOI 10.1159/000187533; Aparicio M, 1999, NEPHROL DIAL TRANSPL, V14, P1679, DOI 10.1093/ndt/14.7.1679; Ates K, 2001, KIDNEY INT, V60, P767, DOI 10.1046/j.1523-1755.2001.060002767.x; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Chandna SM, 2005, NEPHROL DIAL TRANSPL, V20, P2130, DOI 10.1093/ndt/gfh940; Chang TI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001276; Chauveau P, 1996, NEPHROL DIAL TRANSPL, V11, P1568; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Kerkhof JV, 2004, NEPHROL DIAL TRANSPL, V19, P910, DOI 10.1093/ndt/gfh004; Diaz-Buxo Jose A, 2013, Adv Perit Dial, V29, P19; GEORGE SL, 1979, J PEDIATR-US, V94, P342, DOI 10.1016/S0022-3476(79)80870-7; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Ikizler TA, 1999, KIDNEY INT, V55, P1945, DOI 10.1046/j.1523-1755.1999.00410.x; IKIZLER TA, 1995, J AM SOC NEPHROL, V6, P1386; Konings CJAM, 2003, NEPHROL DIAL TRANSPL, V18, P797, DOI 10.1093/ndt/gfg147; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P477; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; LUTES R, 1993, ADV PERIT D, V9, P97; Maeda Yoshitaka, 2013, J Rural Med, V8, P171, DOI 10.2185/jrm.8.171; Maiorca R, 1995, NEPHROL DIAL TRANSPL, V10, P2295, DOI 10.1093/ndt/10.12.2295; MCCARTHY JT, 1994, J LAB CLIN MED, V123, P495; NOLPH KD, 1993, PERITON DIALYSIS INT, V13, P178; Noordzij M, 2006, NEPHROL DIAL TRANSPL, V21, P2513, DOI 10.1093/ndt/gfl257; Park HC, 2012, J KOREAN MED SCI, V27, P64, DOI 10.3346/jkms.2012.27.1.64; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Pollock CA, 1997, J AM SOC NEPHROL, V8, P777; Rocco M, 2000, KIDNEY INT, V58, P446, DOI 10.1046/j.1523-1755.2000.00184.x; Rroji M, 2014, INT UROL NEPHROL, V46, P175, DOI 10.1007/s11255-013-0438-7; Stengel B, 2014, NEPHROL DIAL TRANSPL, V29, P1500, DOI 10.1093/ndt/gft388; Szeto CC, 2000, KIDNEY INT, V58, P400, DOI 10.1046/j.1523-1755.2000.00179.x; Tattersall J, 1998, OXFORD TXB NEPHROLOG, P2074; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382; Wang AYM, 2004, AM J KIDNEY DIS, V43, P712, DOI 10.1053/j.ajkd.2003.12.032; Weisbord SD, 2006, CLIN CARDIOL, V29, P494, DOI 10.1002/clc.4960291105; Yamada S, 2014, THER APHER DIAL, V18, P383, DOI 10.1111/1744-9987.12170; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	37	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156423	10.1371/journal.pone.0156423	http://dx.doi.org/10.1371/journal.pone.0156423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258403	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700064
J	Medina, IR; Lubovac-Pilav, Z				Medina, Ignacio Riquelme; Lubovac-Pilav, Zelmina			Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD MONONUCLEAR-CELLS; VERSUS-HOST-DISEASE; NONALCOHOLIC STEATOHEPATITIS; SUSCEPTIBILITY GENES; CHILDREN; REGION; BETA; IDENTIFICATION; AUTOANTIGEN	Type 1 diabetes (T1D) is a complex disease, caused by the autoimmune destruction of the insulin producing pancreatic beta cells, resulting in the body's inability to produce insulin. While great efforts have been put into understanding the genetic and environmental factors that contribute to the etiology of the disease, the exact molecular mechanisms are still largely unknown. T1D is a heterogeneous disease, and previous research in this field is mainly focused on the analysis of single genes, or using traditional gene expression profiling, which generally does not reveal the functional context of a gene associated with a complex disorder. However, network-based analysis does take into account the interactions between the diabetes specific genes or proteins and contributes to new knowledge about disease modules, which in turn can be used for identification of potential new biomarkers for T1D. In this study, we analyzed public microarray data of T1D patients and healthy controls by applying a systems biology approach that combines network-based Weighted Gene Co-Expression Network Analysis (WGCNA) with functional enrichment analysis. Novel co-expression gene network modules associated with T1D were elucidated, which in turn provided a basis for the identification of potential pathways and biomarker genes that may be involved in development of T1D.	[Medina, Ignacio Riquelme; Lubovac-Pilav, Zelmina] Univ Skovde, Sch Biosci, Bioinformat Res Grp, Skovde, Sweden	University of Skovde	Lubovac-Pilav, Z (corresponding author), Univ Skovde, Sch Biosci, Bioinformat Res Grp, Skovde, Sweden.	zelmina.lubovac@his.se	Pilav, Zelmina Lubovac/E-9956-2016	Pilav, Zelmina Lubovac/0000-0001-6427-0315; Riquelme Medina, Ignacio/0000-0002-8631-7636				Aribi M, 2007, MED SCI MONITOR, V13, pCR372; Axelsson S, 2008, CRYOBIOLOGY, V57, P201, DOI 10.1016/j.cryobiol.2008.08.001; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BARKER RA, 1988, INT J NEUROSCI, V43, P1, DOI 10.3109/00207458808985773; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; BORCHJOHNSEN K, 1989, DAN MED BULL, V36, P336; Brorsson C, 2009, DIABETES OBES METAB, V11, P60, DOI 10.1111/j.1463-1326.2008.01004.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CDC, 2014, NAT DIAB STAT REP; Chen YG, 2014, DIABETES, V63, P3960, DOI 10.2337/db14-0214; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dakovic D, 2013, J CLIN PEDIATR DENT, V37, P377, DOI 10.17796/jcpd.37.4.l135531h4542gj66; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delunardo F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1940; Dinkins MB, 2015, J ALZHEIMERS DIS, V46, P55, DOI 10.3233/JAD-150088; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gao Shouguo, 2009, J Comput Sci Syst Biol, V2, P133; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Goldberg E, 2009, AUTOIMMUN REV, V8, P682, DOI 10.1016/j.autrev.2009.02.017; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gustafson EA, 2010, BIOCHEM BIOPH RES CO, V395, P1, DOI 10.1016/j.bbrc.2010.02.172; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hakonarson H, 2009, SEMIN IMMUNOL, V21, P355, DOI 10.1016/j.smim.2009.06.001; Holtan SG, 2014, BLOOD, V124, P363, DOI 10.1182/blood-2014-01-514786; Hu ZJ, 2013, NUCLEIC ACIDS RES, V41, pW225, DOI 10.1093/nar/gkt401; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jordan MA, 2011, DISSECTING GENETICS; Kaizer EC, 2007, J CLIN ENDOCR METAB, V92, P3705, DOI 10.1210/jc.2007-0979; Kallionpaa H, 2014, DIABETES, V63, P2402, DOI 10.2337/db13-1775; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Manton ND, 2000, MED J AUSTRALIA, V173, P476, DOI 10.5694/j.1326-5377.2000.tb139299.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Niewczas MA, 2009, CLIN J AM SOC NEPHRO, V4, P62, DOI 10.2215/CJN.03010608; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Qazi BS, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/908468; Rashid M, 2000, J PEDIATR GASTR NUTR, V30, P48, DOI 10.1097/00005176-200001000-00017; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Schwender H, 2012, MULTIPLE TESTING USI; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Xu SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099807; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao Yuxing, 2011, Inflammation & Allergy Drug Targets, V10, P208; Zipris D, 2010, ADV EXP MED BIOL, V654, P585, DOI 10.1007/978-90-481-3271-3_25; Zipris D, 2008, CURR OPIN ENDOCRINOL, V15, P326, DOI 10.1097/MED.0b013e3283073a46	66	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156006	10.1371/journal.pone.0156006	http://dx.doi.org/10.1371/journal.pone.0156006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257970	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700028
J	Niu, YH; Meng, QX; Li, SL; Ren, LP; Zhou, B; Schonewille, T; Zhou, ZM				Niu, Yuhong; Meng, Qingxiang; Li, Shengli; Ren, Liping; Zhou, Bo; Schonewille, Thomas; Zhou, Zhenming			Effects of Diets Supplemented with Ensiled Mulberry Leaves and Sun-Dried Mulberry Fruit Pomace on the Ruminal Bacterial and Archaeal Community Composition of Finishing Steers	PLOS ONE			English	Article							DAIRY-COWS; MICROBIAL-POPULATIONS; METHANE PRODUCTION; MORUS-ALBA; RUMEN; DIVERSITY; SHEEP; FERMENTATION; ABUNDANCE; METHANOGENESIS	This study investigated the effects of ensiled mulberry leaves (EML) and sun-dried mulberry fruit pomace (SMFP) on the ruminal bacterial and archaeal community composition of finishing steers. Corn grain- and cotton meal-based concentrate was partially replaced with EML or SMFP. The diets had similar crude protein (CP), neutral detergent fiber (NDF), and metabolizable energy. Following the feeding trial, the steers were slaughtered and ruminal liquid samples were collected to study the ruminal microbiome. Extraction of DNA, amplification of the V4 region of the 16S rRNA gene, and Illumina MiSeq pyrosequencing were performed for each sample. Following sequence de-noising, chimera checking, and quality trimming, an average of 209,610 sequences were generated per sample. Quantitative real-time PCR was performed to examine the selected bacterial species in the rumen. Our results showed that the predominant phyla were Bacteroidetes (43.90%), Firmicutes (39.06%), Proteobacteria (4.31%), and Tenericutes (2.04%), and the predominant genera included Prevotella (13.82%), Ruminococcus (2.51%), Butyrivibrio (2.38%), and Succiniclasticum (2.26%). Compared to the control group, EML and SMFP groups had a higher abundance of total bacteria (p < 0.001); however, the bacterial community composition was similar among the three groups. At the phylum level, there were no significant differences in Firmicutes (p = 0.7932), Bacteroidetes (p = 0.2330), Tenericutes (p = 0.2811), or Proteobacteria (p = 0.0680) levels among the three groups; however, Fibrobacteres decreased in EML (p = 0.0431). At the genus level, there were no differences in Prevotella (p = 0.4280), Ruminococcus (p = 0.2639), Butyrivibrio (p = 0.4433), or Succiniclasticum (p = 0.0431) levels among the groups. Additionally, the dietary treatments had no significant effects on the archaeal community composition in the rumen. Therefore, EML and SMFP supplementation had no significant effects on the ruminal bacterial or archaeal community composition of finishing steers.	[Niu, Yuhong; Meng, Qingxiang; Li, Shengli; Ren, Liping; Zhou, Bo; Zhou, Zhenming] State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Niu, Yuhong; Meng, Qingxiang; Li, Shengli; Ren, Liping; Zhou, Bo; Zhou, Zhenming] China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Niu, Yuhong] China Agr Univ, Coll Agron & Biotechnol, Beijing 100193, Peoples R China; [Schonewille, Thomas] Univ Utrecht, Dept Farm Anim Hlth, NL-3584 CL Utrecht, Netherlands	China Agricultural University; China Agricultural University; Utrecht University	Zhou, ZM (corresponding author), State Key Lab Anim Nutr, Beijing 100193, Peoples R China.; Zhou, ZM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	zhouzm@cau.edu.cn	Meng, Q./GSI-6185-2022		China Agricultural Research System [CARS-38]; National Natural Science Foundation of China [31372335]; Special Fund for Agro-scientific Research in the Public Interest [201503134]	China Agricultural Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by grants from the China Agricultural Research System (CARS-38), the National Natural Science Foundation of China (31372335), and Special Fund for Agro-scientific Research in the Public Interest (201503134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; Cheong SH, 2012, ANIM PROD SCI, V52, P240, DOI 10.1071/AN11087; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Ding GZ, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-24; Doran MP, 2007, ANIM FEED SCI TECH, V138, P239, DOI 10.1016/j.anifeedsci.2006.11.016; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hook SE, 2009, APPL ENVIRON MICROB, V75, P374, DOI 10.1128/AEM.01672-08; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Jewell KA, 2015, APPL ENVIRON MICROB, V81, P4697, DOI 10.1128/AEM.00720-15; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kobayashi Y, 2008, FOLIA MICROBIOL, V53, P195, DOI 10.1007/s12223-008-0024-z; Liu C, 2012, ARCH MICROBIOL, V194, P353, DOI 10.1007/s00203-011-0757-y; Liu JX, 2001, SMALL RUMINANT RES, V39, P131, DOI 10.1016/S0921-4488(00)00180-2; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; Mosoni P, 2011, J ANIM SCI, V89, P783, DOI 10.2527/jas.2010-2947; Patra AK, 2010, PHYTOCHEMISTRY, V71, P1198, DOI 10.1016/j.phytochem.2010.05.010; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Pitta DW, 2014, ANAEROBE, V30, P11, DOI 10.1016/j.anaerobe.2014.07.008; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Sahoo A, 2011, LIVEST SCI, V136, P175, DOI 10.1016/j.livsci.2010.08.019; Salinas-Chavira J, 2011, TROP ANIM HEALTH PRO, V43, P995, DOI 10.1007/s11250-011-9797-1; Sharma SK, 2010, RANGE MANAG AGROFOR, V31, P97; Shinkai T, 2010, ANIM SCI J, V81, P72, DOI 10.1111/j.1740-0929.2009.00698.x; Singh KM, 2015, MOL BIOL REP, V42, P95, DOI 10.1007/s11033-014-3746-9; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Todaro M, 2007, J ANIM VET ADV, V6, P509; Tymensen LD, 2012, APPL ENVIRON MICROB, V78, P4051, DOI 10.1128/AEM.07994-11; Vu CC, 2011, ASIAN AUSTRAL J ANIM, V24, P1233, DOI 10.5713/ajas.2011.90328; Weimer PJ, 2008, APPL MICROBIOL BIOT, V80, P135, DOI 10.1007/s00253-008-1528-9; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; Wetzels SU, 2015, J DAIRY SCI, V98, P5572, DOI 10.3168/jds.2014-9166; WOJCIECHOWICZ M, 1979, APPL ENVIRON MICROB, V37, P136, DOI 10.1128/AEM.37.1.136-142.1979; Wright ADG, 2008, MICROB ECOL, V56, P390, DOI 10.1007/s00248-007-9351-x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang RY, 2014, J SCI FOOD AGR, V94, P1886, DOI 10.1002/jsfa.6508; Zhou B, 2012, J ANIM FEED SCI, V21, P188, DOI 10.22358/jafs/66063/2012; Zhou M, 2011, J APPL MICROBIOL, V111, P1148, DOI 10.1111/j.1365-2672.2011.05126.x; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08; Zhou ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085406; Zhou ZM, 2012, BIORESOURCE TECHNOL, V103, P173, DOI 10.1016/j.biortech.2011.10.013; ZIOLECKI A, 1980, APPL ENVIRON MICROB, V39, P919	51	14	15	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156836	10.1371/journal.pone.0156836	http://dx.doi.org/10.1371/journal.pone.0156836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258373	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700143
J	Shahbazi, S; Sahrawat, TR; Ray, M; Dash, S; Kar, D; Singh, S				Shahbazi, Sajad; Sahrawat, Tammanna R.; Ray, Monalisa; Dash, Swagatika; Kar, Dattatreya; Singh, Shikha			Drug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug Studies	PLOS ONE			English	Article							IIB/IIIA RECEPTOR ANTAGONISTS; HERG K+ CHANNELS; INDUCIBLE CYCLOOXYGENASE; PREDICTION; DOCKING; SOLUBILITY; INHIBITORS; CURCUMIN; ANALOGS; GLIDE	Cyclooxygenase-2 (COX-2) plays an important role in memory consolidation and synaptic activity, the most fundamental functions of the brain. It converts arachidonic acid to prostaglandin endoperoxide H2. In contrast, if over-expressed, it causes inflammation in response to cytokine, pro-inflammatory molecule, and growth factor. Anti-inflammatory agents, by allosteric or competitive inhibition of COX-2, alleviate the symptoms of inflammation. Coxib family drugs, particularly celecoxib, are the most famous anti-inflammatory agents available in the market showing significant inhibitory effect on COX-2 activity. Due to high cardiovascular risk of this drug group, recent researches are focused on the investigation of new safer drugs for anti-inflammatory diseases. Natural compounds, particularly, phytochemicals are found to be good candidates for drug designing and discovery. In the present study, we performed in silico studies to quantitatively scrutinize the molecular interaction of curcumin and its structural analogs with COX-2, COX-1, FXa and integrin alpha IIB beta III to investigate their therapeutic potential as a cardiovascular-safe anti-inflammatory medicine (CVSAIM). The results of both ADMET and docking study indicated that out of all the 39 compounds studied, caffeic acid had remarkable interaction with proteins involved in inflammatory response. It was also found to inhibit the proteins that are involved in thrombosis, thereby, having the potential to be developed as therapeutic agent.	[Shahbazi, Sajad] Punjab Univ, Dept Biotechnol, Chandigarh 160014, India; [Sahrawat, Tammanna R.] Punjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh 160014, India; [Ray, Monalisa; Dash, Swagatika; Kar, Dattatreya; Singh, Shikha] Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar, Odisha, India	Panjab University; Panjab University; Siksha 'O' Anusandhan University	Singh, S (corresponding author), Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar, Odisha, India.	sajad642008@gmail.com	Shahbazi, Sajad/AAE-2750-2021; Kar, Dattatreya/ABB-8117-2020	Shahbazi, Sajad/0000-0002-6764-7963	Aravinda Biosolution Ltd.; Department of Pharmacology, Osmania University	Aravinda Biosolution Ltd.; Department of Pharmacology, Osmania University	The authors are grateful to Dr. Manoj Kumar Mahto of Aravinda Biosolution Ltd., Dr. Deepak Reddy, Department of Pharmacology, Osmania University, for providing financial support and encouraging throughout. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Manoj Kumar Mahto of Aravinda Biosolution Ltd., Dr. Deepak Reddy, Department of Pharmacology, Osmania University for providing financial support and encouraging throughout.	Abendschein DR, 2001, J PHARMACOL EXP THER, V296, P567; Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; [Anonymous], 2012, SUIT 2012 PRIM VERS; Aronov MM, 2005, DRUG DISCOV TODAY, V10, P149, DOI 10.1016/S1359-6446(04)03278-7; Awaad AS, 2013, J SAUDI CHEM SOC, V17, P101, DOI 10.1016/j.jscs.2012.03.002; Bertolini A, 2002, CURR MED CHEM, V9, P1033, DOI 10.2174/0929867024606650; Borer JS, 2005, ARTHRITIS RES THER, V7, pS14, DOI 10.1186/ar1794; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Chen IJ, 2013, BIOORGAN MED CHEM, V21, P7898, DOI 10.1016/j.bmc.2013.10.003; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Duffy EM, 2000, J AM CHEM SOC, V122, P2878, DOI 10.1021/ja993663t; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gupta S. K., 2010, J PHARM BIOMEDICAL S, V4, P1; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Kim HK, 2004, B KOREAN CHEM SOC, V25, P1769; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Meraj K, 2012, BIOINFORMATION, V8, P1139, DOI 10.6026/97320630081139; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nirmala JM, 2011, INT J APPL BIOL PHAR, V2, P200; Oviedo JA, 2001, BIODRUGS, V15, P563, DOI 10.2165/00063030-200115090-00001; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Press S., 2011, QIKPROP 3 4 USER MAN; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Ronner E, 1998, EUR HEART J, V19, P1608, DOI 10.1053/euhj.1998.1222; SEIBERT K, 1994, RECEPTOR, V4, P17; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Venkataramana CHS., 2011, J APPL PHARM SCI, V1, P159; Vorchheimer DA, 1999, JAMA-J AM MED ASSOC, V281, P1407, DOI 10.1001/jama.281.15.1407; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286	36	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156156	10.1371/journal.pone.0156156	http://dx.doi.org/10.1371/journal.pone.0156156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258084	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700041
J	Wilkins, J; Zheng, YM; Yu, JY; Liang, C; Liu, SL				Wilkins, Jordan; Zheng, Yi-Min; Yu, Jingyou; Liang, Chen; Liu, Shan-Lu			Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV	PLOS ONE			English	Article							ANCIENT ADAPTIVE EVOLUTION; WEST NILE VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; FAMILY PROTEINS; INTERFERON; INFECTION; RESTRICTION; GENE; RESISTANCE	Interferon-induced transmembrane (IFITM) proteins are potent antiviral factors shown to restrict the infection of many enveloped viruses, including HIV. Here we report cloning and characterization of a panel of nonhuman primate IFITMs. We show that, similar to human IFITM, nonhuman primate IFITM proteins inhibit HIV and other primate lentiviruses. While some nonhuman primate IFITM proteins are more potent than human counterparts to inhibit HIV-1, they are generally not effective against HIV-2 similar to that of human IFITMs. Notably, depending on SIV strains and also IFITM species tested, nonhuman primate IFITM proteins exhibit distinct activities against SIVs; no correlation was found to support the notion that IFITM proteins are most active in non-natural primate hosts. Consistent with our recent findings for human IFITMs, nonhuman primate IFITM proteins interact with HIV-1 Env and strongly act in viral producer cells to impair viral infectivity and block cell-to-cell transmission. Accordingly, knockdown of primate IFITM3 increases HIV-1 replication in nohuman primate cells. Interestingly, analysis of DNA sequences of human and nonhuman primate IFITMs suggest that IFITM proteins have been undergoing purifying selection, rather than positive selection typical for cellular restriction factors. Overall, our study reveals some new and unexpected features of IFITMs in restricting primate lentiviruses, which enhances our understanding of virus-host interaction and AIDS pathogenesis.	[Wilkins, Jordan; Zheng, Yi-Min; Yu, Jingyou; Liu, Shan-Lu] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Liang, Chen] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Liang, Chen] McGill Univ, Dept Med, Montreal, PQ, Canada; [Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	University of Missouri System; University of Missouri Columbia; Lady Davis Institute; McGill University; McGill University; McGill University	Liu, SL (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO USA.	liushan@missouri.edu	Liu, Shan-Lu/L-5923-2016	Liu, Shan-Lu/0000-0003-1620-3817	NIH [R01 AI112381]; Canadian Institutes of Health Research [MOP-133479]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112381] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from NIH to SLL (R01 AI112381) and a grant from Canadian Institutes of Health Research to CL (MOP-133479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982; Bailey CC, 2013, J BIOL CHEM, P203; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brem R, 2003, CELL MOL LIFE SCI, V60, P1235, DOI 10.1007/s00018-003-3016-9; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Daniel-Carmi V, 2009, INT J CANCER, V125, P2810, DOI 10.1002/ijc.24669; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Ding SL, 2014, VIROLOGY, V454, P11, DOI 10.1016/j.virol.2014.01.020; EVANS SS, 1993, J IMMUNOL, V150, P736; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jia R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118794; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; JUKES TH, 1969, SPACE LIFE SCI, V1, P469, DOI 10.1007/BF00924238; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Li K, 2015, J BIOL CHEM, V290, P4248, DOI 10.1074/jbc.M114.630780; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Qian J, 2015, VIROLOGY, V474, P10, DOI 10.1016/j.virol.2014.10.015; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharp Paul M, 2010, Philos Trans R Soc Lond B Biol Sci, V365, P2487, DOI 10.1098/rstb.2010.0031; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu Y, 2015, J BIOL CHEM, V290, P17935, DOI 10.1074/jbc.M115.665513; Xie MR, 2015, J VIROL, V89, P3049, DOI 10.1128/JVI.03416-14; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049265; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111	71	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156739	10.1371/journal.pone.0156739	http://dx.doi.org/10.1371/journal.pone.0156739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257969	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700118
J	Zheng, CF; Zhu, YJ; Wang, CY; Guo, TC				Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai			Wheat Grain Yield Increase in Response to Pre-Anthesis Foliar Application of 6-Benzylaminopurine Is Dependent on Floret Development	PLOS ONE			English	Article							STEM ELONGATION; DURUM-WHEAT; NITROGEN AVAILABILITY; WINTER-WHEAT; SPIKE GROWTH; SPRING WHEAT; CYTOKININ; NUMBER; BARLEY; PHOTOPERIOD	Wheat yield is largely determined during the period prior to flowering, when the final numbers of fertile florets and grains per spike are established. The aim of this study was to assess the dynamics of floret primordia development in winter wheat in response to pre-anthesis application of a synthetic cytokinin, 6-benzylaminopurine (6-BA). We conducted an experiment in which two foliar spray treatments were applied (water or 6-BA) to Chinese winter wheat at 25 days after jointing during two growing seasons (2012-2013 and 20132014). Both the final grain number per spike and grain yield at maturity exhibited remarkable increases in response to the 6-BA treatment. Application of 6-BA increased the number of fertile florets in basal spikelets and, to a greater extent, in central spikelets. The mechanism by which 6-BA application affected the final number of fertile florets primarily involved suppression of the floret abortion rates. Application of 6-BA considerably reduced the abortion rates of basal, central and apical spikelet florets (by as much as 77% compared with the control), as well as the degeneration rates of basal and central spikelet florets, albeit to a lesser degree. The effect of 6-BA application on the likelihood of proximal florets being set was limited to the distal florets in the whole spike, whereas obvious increases in the likelihood of grain set under 6-BA treatment were observed in distal florets, primarily in central spikelet positions. The results of this study provide important evidence that 6-BA application to florets (final fertile floret production) results in an increased grain yield.	[Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai] Henan Agr Univ, Coll Agron, Zhengzhou 450002, Peoples R China; [Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai] Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 450002, Peoples R China; [Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai] Henan Agr Univ, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Zhu, YJ (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou 450002, Peoples R China.; Zhu, YJ (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 450002, Peoples R China.; Zhu, YJ (corresponding author), Henan Agr Univ, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China.	zhuzheng2014@126.com			Special Fund for Agro-scientific Research in the Public Interest [201203031, 201203096]; National Natural Science Foundation of China [31571607]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financed by the Special Fund for Agro-scientific Research in the Public Interest (201203031, 201203096) and the National Natural Science Foundation of China (31571607). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreche MM, 2006, FIELD CROP RES, V98, P52, DOI 10.1016/j.fcr.2005.12.005; Arisnabarreta S, 2006, FIELD CROP RES, V96, P466, DOI 10.1016/j.fcr.2005.09.004; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Bingham IJ, 2007, FIELD CROP RES, V101, P212, DOI 10.1016/j.fcr.2006.11.004; Cheng X, 2013, CROP PROT, V43, P246, DOI 10.1016/j.cropro.2012.10.016; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Ferrante A, 2013, J EXP BOT, V64, P169, DOI 10.1093/jxb/ers320; Ferrante A, 2012, FIELD CROP RES, V136, P52, DOI 10.1016/j.fcr.2012.07.015; Ferrante A, 2010, J EXP BOT, V61, P4351, DOI 10.1093/jxb/erq236; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; Fischer RA, 2011, CROP PASTURE SCI, V62, P95, DOI 10.1071/CP10344; Gonzalez FG, 2011, J EXP BOT, V62, P4889, DOI 10.1093/jxb/err182; Gonzalez FG, 2003, FIELD CROP RES, V81, P17, DOI 10.1016/S0378-4290(02)00195-8; Gonzalez FG, 2003, FIELD CROP RES, V81, P29, DOI 10.1016/S0378-4290(02)00196-X; Leaden MI, 2007, WEED TECHNOL, V21, P406, DOI 10.1614/WT-06-102R1.1; Li CD, 2001, FIELD CROP RES, V71, P71, DOI 10.1016/S0378-4290(01)00144-7; Li CunDong, 1999, Scientia Agricultura Sinica, V32, P98; Miralles DJ, 2000, AUST J PLANT PHYSIOL, V27, P931, DOI 10.1071/PP00021; Miralles DJ, 1998, FIELD CROP RES, V59, P21, DOI 10.1016/S0378-4290(98)00103-8; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Murai N., 2014, AM J PLANT SCI, V05, P2178, DOI [10.4236/ajps.2014.514231, DOI 10.4236/AJPS.2014.514231]; Pedro A, 2012, FIELD CROP RES, V129, P59, DOI 10.1016/j.fcr.2012.01.016; PeltonenSainio P, 1997, FIELD CROP RES, V49, P169, DOI 10.1016/S0378-4290(96)01010-6; Prystupa P, 2004, FIELD CROP RES, V90, P245, DOI 10.1016/j.fcr.2004.03.001; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; Reynolds MP, 2005, ANN APPL BIOL, V146, P39, DOI 10.1111/j.1744-7348.2005.03100.x; Rijavec T, 2009, J INTEGR PLANT BIOL, V51, P840, DOI 10.1111/j.1744-7909.2009.00863.x; Serrago RA, 2008, EUR J AGRON, V28, P301, DOI 10.1016/j.eja.2007.08.004; [史瑞青 Shi Ruiqing], 2006, [河南农业大学学报, JOURNAL OF HENAN AGRICULTURAL UNIVERSITY], V40, P122; Slafer G. A., 2006, Handbook of seed science and technology, P95; Slafer GA, 2005, ANN APPL BIOL, V146, P61, DOI 10.1111/j.1744-7348.2005.04048.x; SLAFER GA, 1994, AUST J PLANT PHYSIOL, V21, P393, DOI 10.1071/PP9940393; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Slafer GA, 2001, EUPHYTICA, V119, P191, DOI 10.1023/A:1017535632171; WADDINGTON SR, 1983, ANN BOT-LONDON, V51, P119, DOI 10.1093/oxfordjournals.aob.a086434; Wang ZhaoLong, 2000, Journal of Nanjing Agricultural University, V23, P9; Wang ZL, 2001, PLANT GROWTH REGUL, V35, P225, DOI 10.1023/A:1014442006862; WILLIAMS RH, 1980, ANN BOT-LONDON, V46, P445, DOI 10.1093/oxfordjournals.aob.a085936; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; Zhang GP, 2001, PLANT GROWTH REGUL, V35, P239; Zhang JP, 2011, MOL BIOL REP, V38, P2337, DOI 10.1007/s11033-010-0367-9; Zheng CF, 2014, FIELD CROP RES, V169, P70, DOI 10.1016/j.fcr.2014.09.005	44	17	20	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156627	10.1371/journal.pone.0156627	http://dx.doi.org/10.1371/journal.pone.0156627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258059	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700091
J	Ormeno, F; Barrientos, C; Ramirez, S; Ponce, I; Valenzuela, L; Sepulveda, S; Bitar, M; Kemmerling, U; Machado, CR; Cabrera, G; Galanti, N				Ormeno, Fernando; Barrientos, Camila; Ramirez, Santiago; Ponce, Ivan; Valenzuela, Lucia; Sepulveda, Sofa; Bitar, Maina; Kemmerling, Ulrike; Machado, Carlos Renato; Cabrera, Gonzalo; Galanti, Norbel			Expression and the Peculiar Enzymatic Behavior of the Trypanosoma cruzi NTH1 DNA Glycosylase	PLOS ONE			English	Article							BASE EXCISION-REPAIR; COLI ENDONUCLEASE-III; ESCHERICHIA-COLI; THYMINE GLYCOL; SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION ELONGATION; FUNCTIONAL-ANALYSIS; OXIDATIVE STRESS; RNA-POLYMERASE; CHAGAS-DISEASE	Trypanosoma cruzi, the etiological agent of Chagas' disease, presents three cellular forms (trypomastigotes, epimastigotes and amastigotes), all of which are submitted to oxidative species in its hosts. However, T. cruzi is able to resist oxidative stress suggesting a high efficiency of its DNA repair machinery. The Base Excision Repair (BER) pathway is one of the main DNA repair mechanisms in other eukaryotes and in T. cruzi as well. DNA glycosylases are enzymes involved in the recognition of oxidative DNA damage and in the removal of oxidized bases, constituting the first step of the BER pathway. Here, we describe the presence and activity of TcNTH1, a nuclear T. cruzi DNA glycosylase. Surprisingly, purified recombinant TcNTH1 does not remove the thymine glycol base, but catalyzes the cleavage of a probe showing an AP site. The same activity was found in epimastigote and trypomastigote homogenates suggesting that the BER pathway is not involved in thymine glycol DNA repair. TcNTH1 DNA-binding properties assayed in silico are in agreement with the absence of a thymine glycol removing function of that parasite enzyme. Over expression of TcNTH1 decrease parasite viability when transfected epimastigotes are submitted to a sustained production of H2O2. Therefore, TcNTH1 is the only known NTH1 orthologous unable to eliminate thymine glycol derivatives but that recognizes and cuts an AP site, most probably by a beta-elimination mechanism. We cannot discard that TcNTH1 presents DNA glycosylase activity on other DNA base lesions. Accordingly, a different DNA repair mechanism should be expected leading to eliminate thymine glycol from oxidized parasite DNA. Furthermore, TcNTH1 may play a role in the AP site recognition and processing.	[Ormeno, Fernando; Barrientos, Camila; Ramirez, Santiago; Ponce, Ivan; Valenzuela, Lucia; Sepulveda, Sofa; Cabrera, Gonzalo; Galanti, Norbel] Univ Chile, Programa Biol Celular & Mol, Inst Ciencias Biomed, Fac Med, Santiago 7, Chile; [Bitar, Maina; Machado, Carlos Renato] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Kemmerling, Ulrike] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Anat & Biol Desarrollo, Santiago 7, Chile	Universidad de Chile; Universidade Federal de Minas Gerais; Universidad de Chile	Cabrera, G; Galanti, N (corresponding author), Univ Chile, Programa Biol Celular & Mol, Inst Ciencias Biomed, Fac Med, Santiago 7, Chile.	gcabrera@med.uchile.cl; ngalanti@med.uchile.cl	MACHADO, CARLOS/AAW-1492-2020; Kemmerling, Ulrike/H-8783-2013	Kemmerling, Ulrike/0000-0002-0201-1665; Valenzuela-Perez, Lucia/0000-0002-5145-303X; Ramirez arevalo, santiago/0000-0002-7335-3005	FONDECYT (Chile) [1130113, 1120230]; ERANET-LAC [ELAC2014/HID-0328]; CNPq (Brazil) [444334/2014-9]; FAPEMIG (Brazil) [APQ-00827-15, APQ-02308-13]	FONDECYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ERANET-LAC; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by FONDECYT (Chile) Grant No 1130113 (to NG); FONDECYT (Chile) Grant 1120230 (to UK); ERANET-LAC grant ELAC2014/HID-0328 (to NG and UK); CNPq (Brazil) Grant No 444334/2014-9 (to CRM); FAPEMIG (Brazil) Grant No APQ-00827-15 (to CRM); and FAPEMIG (Brazil) Grant No APQ-02308-13 (to CRM).; We thank Dr. Ulf Hellman and Dr. Ulla Engstrom, Ludwig Institute for Cancer Research, Box 595, SE - 751 24, Uppsala, Sweden, for the amino acid sequencing of the recombinant TcNTH1 protein expressed in E. coli. Financed by FONDECYT (Chile) Grant No 1130113 (to NG); FONDECYT (Chile) Grant 1120230 (to UK); ERANET-LAC grant ELAC2014/HID-0328 (to NG and UK); CNPq (Brazil) Grant No 444334/2014-9 (to CRM); and FAPEMIG (Brazil) Grant No APQ-00827-15 and APQ-02308-13 (to CRM).	Aguiar PHN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002279; Alanazi M, 2002, NUCLEIC ACIDS RES, V30, P4583, DOI 10.1093/nar/gkf588; Alseth I, 2004, NUCLEIC ACIDS RES, V32, P5119, DOI 10.1093/nar/gkh851; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amino R, 2002, J BIOL CHEM, V277, P6207, DOI 10.1074/jbc.M109874200; ASAHARA H, 1989, BIOCHEMISTRY-US, V28, P4444, DOI 10.1021/bi00436a048; Aspinwall R, 1997, P NATL ACAD SCI USA, V94, P109, DOI 10.1073/pnas.94.1.109; BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Bitar M, 2014, IEEE ACM T COMPUT BI, V11, P1052, DOI 10.1109/TCBB.2014.2325018; Cabrera G, 2011, J CELL BIOCHEM, V112, P2189, DOI 10.1002/jcb.23138; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Carvalho TMU, 1999, MEM I OSWALDO CRUZ, V94, P143, DOI 10.1590/S0074-02761999000700016; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; de Souza W, 2005, HISTOCHEM CELL BIOL, V123, P1, DOI 10.1007/s00418-004-0746-1; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; DECARVALHO TU, 1987, PARASITOL RES, V73, P213, DOI 10.1007/BF00578506; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dolinnaya NG, 2013, BIOCHIMIE, V95, P134, DOI 10.1016/j.biochi.2012.09.008; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Farez-Vidal ME, 2001, NUCLEIC ACIDS RES, V29, P1549, DOI 10.1093/nar/29.7.1549; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fromme JC, 2003, EMBO J, V22, P3461, DOI 10.1093/emboj/cdg311; Furtado C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042484; Galindo M, 2007, FEBS LETT, V581, P2022, DOI 10.1016/j.febslet.2007.03.093; Genois MM, 2014, MICROBIOL MOL BIOL R, V78, P40, DOI 10.1128/MMBR.00045-13; GIBSON WC, 1986, EMBO J, V5, P1299, DOI 10.1002/j.1460-2075.1986.tb04359.x; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gupta S, 2009, OXIDATIVE STRESS CHA; Gupta S, 2009, FREE RADICAL BIO MED, V47, P1414, DOI 10.1016/j.freeradbiomed.2009.08.008; Harlow E.D., 1988, LAB MANUAL, P579; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Henriksson J, 2002, PARASITOLOGY, V124, P277, DOI 10.1017/S0031182001001093; Hilbert TP, 1996, BIOCHEMISTRY-US, V35, P2505, DOI 10.1021/bi952516e; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Karahalil B, 2003, J BIOL CHEM, V278, P33701, DOI 10.1074/jbc.M301617200; KOW YW, 1987, BIOCHEMISTRY-US, V26, P8200, DOI 10.1021/bi00399a027; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokan HE, 1997, BIOCHEM J, V325, P1; Krzeminski J, 2013, CHEM RES TOXICOL, V26, P1746, DOI 10.1021/tx400296x; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee AJ, 2014, DNA REPAIR, V20, P23, DOI 10.1016/j.dnarep.2014.01.007; Lopes DD, 2008, DNA REPAIR, V7, P1882, DOI 10.1016/j.dnarep.2008.07.018; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; Martin-Plaza J, 2015, J BIOMOL SCREEN, V20, P3, DOI 10.1177/1087057114559907; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; MCCARTHYBURKE C, 1989, GENE, V82, P177, DOI 10.1016/0378-1119(89)90043-7; McCullough AK, 2001, BIOCHEMISTRY-US, V40, P561, DOI 10.1021/bi002404+; Mocquet V, 2007, EMBO J, V26, P2923, DOI 10.1038/sj.emboj.7601730; Morinaga H, 2009, DNA REPAIR, V8, P844, DOI 10.1016/j.dnarep.2009.04.020; Muelas-Serrano S, 2000, PARASITOL RES, V86, P999, DOI 10.1007/PL00008532; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; Oyama M, 2004, BIOCHEM BIOPH RES CO, V321, P183, DOI 10.1016/j.bbrc.2004.06.136; Passos-Silva DG, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/840768; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Perez J, 1999, NUCLEIC ACIDS RES, V27, P771, DOI 10.1093/nar/27.3.771; Piacenza L, 2013, ANTIOXID REDOX SIGN, V19, P723, DOI 10.1089/ars.2012.4618; Piacenza L, 2009, CURR OPIN MICROBIOL, V12, P415, DOI 10.1016/j.mib.2009.06.011; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Postel EH, 2003, P NATL ACAD SCI USA, V100, P13247, DOI 10.1073/pnas.2333230100; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; RADMAN M, 1976, J BIOL CHEM, V251, P1438; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Rinne ML, 2005, NUCLEIC ACIDS RES, V33, P2859, DOI 10.1093/nar/gki601; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Roldan-Arjona T, 2000, PLANT MOL BIOL, V44, P43, DOI 10.1023/A:1006429114451; RoldanArjona T, 1996, NUCLEIC ACIDS RES, V24, P3307, DOI 10.1093/nar/24.17.3307; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Sarker AH, 1998, J MOL BIOL, V282, P761, DOI 10.1006/jmbi.1998.2042; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Sepulveda S, 2014, J CELL BIOCHEM, V115, P397, DOI 10.1002/jcb.24675; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; SOLARI AJ, 1980, CHROMOSOMA, V78, P239, DOI 10.1007/BF00328395; Spadiliero B, 2002, J CELL BIOCHEM, V85, P798, DOI 10.1002/jcb.10183; Stierum RH, 1999, J BIOL CHEM, V274, P7128, DOI 10.1074/jbc.274.11.7128; Sugimoto T, 2005, DNA REPAIR, V4, P1270, DOI 10.1016/j.dnarep.2005.06.009; Tornaletti S, 2001, J BIOL CHEM, V276, P45367, DOI 10.1074/jbc.M105282200; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; van Dijk M, 2009, NUCLEIC ACIDS RES; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wallace SS, 2013, ENVIRON MOL MUTAGEN, V54, P691, DOI 10.1002/em.21820; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; World Health Organization, 2012, 2 WHO; World Health Organization, 2015, CHAG DIS AM TRYP; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yonekura S, 2007, J RADIAT RES, V48, P417, DOI 10.1269/jrr.07042; Yoshikawa Y, 2015, FREE RADICAL RES, V49, P1239, DOI 10.3109/10715762.2015.1061186; You HJ, 1999, BIOCHEMISTRY-US, V38, P11298, DOI 10.1021/bi991121i; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	98	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157270	10.1371/journal.pone.0157270	http://dx.doi.org/10.1371/journal.pone.0157270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284968	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000054
J	Kwiatkowska, M; Jarosiewicz, P; Michalowicz, J; Koter-Michalak, M; Huras, B; Bukowska, B				Kwiatkowska, Marta; Jarosiewicz, Pawel; Michalowicz, Jaromir; Koter-Michalak, Maria; Huras, Bogumila; Bukowska, Bozena			The Impact of Glyphosate, Its Metabolites and Impurities on Viability, ATP Level and Morphological changes in Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							AMINOMETHYLPHOSPHONIC ACID; OXIDATIVE STRESS; IN-VITRO; HERBICIDES; BROMFENVINPHOS; CYTOTOXICITY; FORMULATIONS; SPECTROMETRY; PRODUCT; DAMAGE	The toxicity of herbicides to animals and human is an issue of worldwide concern. The present study has been undertaken to assess toxic effect of widely used pesticide-glyphosate, its metabolites: aminomethylphosphonic acid (AMPA) and methylphosphonic acid and its impurities: N-(phosphonomethyl) iminodiacetic acid (PMIDA), N-methylglyphosate, hydroxymethylphosphonic acid and bis-(phosphonomethyl) amine on human peripheral blood mononuclear cells (PBMCs). We have evaluated the effect of those compounds on viability, ATP level, size (FSC-A parameter) and granulation (SSC-A parameter) of the cells studied. Human peripheral blood mononuclear cells were exposed to different concentrations of glyphosate, its metabolites and impurities (0.01-10 mM) for 4 and 24 h. It was found that investigated compounds caused statistically significant decrease in viability and ATP level of PBMCs. The strongest changes in cell viability and ATP level were observed after 24 h incubation of PBMCs with bis-(phosphonomethyl) amine, and particularly PMIDA. Moreover, all studied compounds changed cell granularity, while PMIDA and bis-(phosphonomethyl) amine altered PBMCs size. It may be concluded that bis-(phosphonomethyl) amine, and PMIDA caused a slightly stronger damage to PBMCs than did glyphosate. Changes in the parameters studied in PBMCs were observed only at high concentrations of the compounds examined, which clearly shows that they may occur in this cell type only as a result of acute poisoning of human organism with these substances.	[Kwiatkowska, Marta; Jarosiewicz, Pawel; Michalowicz, Jaromir; Koter-Michalak, Maria; Bukowska, Bozena] Univ Lodz, Dept Environm Pollut Biophys, PL-90131 Lodz, Poland; [Huras, Bogumila] Inst Ind Organ Chem, Warsaw, Poland	University of Lodz	Kwiatkowska, M (corresponding author), Univ Lodz, Dept Environm Pollut Biophys, PL-90131 Lodz, Poland.	m.n.kwiatkowska@wp.pl		Bukowska, Bozena/0000-0003-3044-2953; Michalowicz, Jaromir/0000-0002-7293-596X; Jarosiewicz, Pawel/0000-0002-9104-2593; Koter-Michalak, Maria/0000-0001-8660-4136	Polish National Science Centre [2013/11/N/NZ7/00371]	Polish National Science Centre	This work was supported by the Polish National Science Centre (Contract-2013/11/N/NZ7/00371).	Annett R, 2014, J APPL TOXICOL, V34, P458, DOI 10.1002/jat.2997; Aris A, 2011, REPROD TOXICOL, V31, P528, DOI 10.1016/j.reprotox.2011.02.004; Ayi AA, 2014, FRONTIERCHEM, V94, P1; Benachour N, 2009, CHEM RES TOXICOL, V22, P97, DOI 10.1021/tx800218n; Berge A, 2002, ENVIRON SCI POLLUT R, V19, P3798; Bukowska M, 2004, CELL BIOL INT, V28, P557, DOI 10.1016/j.cellbi.2004.04.013; Diaz-Rua R, 2015, J NUTR BIOCHEM, V26, P398, DOI 10.1016/j.jnutbio.2014.11.013; Duchnowicz P, 2002, PESTIC BIOCHEM PHYS, V74, P1, DOI 10.1016/S0048-3575(02)00139-6; Edwards V, 2015, INTEGRATIVE PHARM TO, V1, P71, DOI DOI 10.15761/IPTG.1000104; Gomes MP, 2014, J EXP BOT, V65, P4691, DOI 10.1093/jxb/eru269; Grube AH, 2011, PESTICIDES IND SALES; Guilherme S, 2014, ENVIRON SCI POLLUT R, V21, P8730, DOI 10.1007/s11356-014-2803-1; Martinez A, 2007, BIOMEDICA, V27, P594, DOI 10.7705/biomedica.v27i4.176; Mesnage R, 2015, FOOD CHEM TOXICOL, V84, P133, DOI 10.1016/j.fct.2015.08.012; Mesnage R, 2013, TOXICOLOGY, V313, P122, DOI 10.1016/j.tox.2012.09.006; Michalowicz J, 2015, TOXICOL IN VITRO, V29, P1464, DOI 10.1016/j.tiv.2015.05.012; Nicotera P, 1998, TOXICOL LETT, V103, P139; Niemann L, 2015, J VERBRAUCH LEBENSM, V10, P3, DOI 10.1007/s00003-014-0927-3; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Ribeiro DN, 2015, J AGR FOOD CHEM, V63, P1689, DOI 10.1021/jf5055722; Ribeiro DN, 2014, PLANTA, V239, P199, DOI 10.1007/s00425-013-1972-3; RILEY DP, 1991, INORG CHEM, V30, P4191, DOI 10.1021/ic00022a020; Saito T, 2012, FORENSIC TOXICOL, V30, P1, DOI 10.1007/s11419-011-0120-7; Schutt F, 2012, INVEST OPHTH VIS SCI, V53, P5354, DOI 10.1167/iovs.12-9845; Sedek L, 1995, ADV CELL BIOL, V35, P17; Shao XZ, 2015, FLUID PHASE EQUILIBR, V390, P7, DOI 10.1016/j.fluid.2015.01.009; She YX, 2012, FOOD CHEM, V132, P502, DOI 10.1016/j.foodchem.2011.09.131; Song HY, 2012, J KOREAN MED SCI, V27, P711, DOI 10.3346/jkms.2012.27.7.711; Sosnowska B, 2015, PESTIC BIOCHEM PHYS, V118, P43, DOI 10.1016/j.pestbp.2014.11.009; Sosnowska B, 2013, INT J BIOL MACROMOL, V57, P38, DOI 10.1016/j.ijbiomac.2013.02.011; Van Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI [10.1002/ps.1518, DOI 10.1002/PS.1518]; Yushchenko DY, 2013, J ANAL CHEM+, V68, P961, DOI 10.1134/S1061934813110166; Zouaoui K, 2013, FORENSIC SCI INT, V226, pE20, DOI 10.1016/j.forsciint.2012.12.010	33	24	24	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156946	10.1371/journal.pone.0156946	http://dx.doi.org/10.1371/journal.pone.0156946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280764	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000058
J	Eckart, N; Song, QF; Yang, R; Wang, RH; Zhu, H; McCallion, AS; Avramopoulos, D				Eckart, Nicole; Song, Qifeng; Yang, Rebecca; Wang, Ruihua; Zhu, Heng; McCallion, Andrew S.; Avramopoulos, Dimitrios			Functional Characterization of Schizophrenia-Associated Variation in CACNA1C	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; GATED CALCIUM-CHANNEL; BIPOLAR DISORDER; C-TERMINUS; METAANALYSIS; REVEALS; TUMORIGENICITY; PKNOX2; CELLS; GENE	Calcium channel subunits, including CACNA1C, have been associated with multiple psychiatric disorders. Specifically, genome wide association studies (GWAS) have repeatedly identified the single nucleotide polymorphism (SNP) rs1006737 in intron 3 of CACNA1C to be strongly associated with schizophrenia and bipolar disorder. Here, we show that rs1006737 marks a quantitative trait locus for CACNA1C transcript levels. We test 16 SNPs in high linkage disequilibrium with rs1007637 and find one, rs4765905, consistently showing allele-dependent regulatory function in reporter assays. We find allele-specific protein binding for 13 SNPs including rs4765905. Using protein microarrays, we identify several proteins binding >= 3 SNPs, but not control sequences, suggesting possible functional interactions and combinatorial haplotype effects. Finally, using circular chromatin conformation capture, we show interaction of the disease-associated region including the 16 SNPs with the CACNA1C promoter and other potential regulatory regions. Our results elucidate the pathogenic relevance of one of the best-supported risk loci for schizophrenia and bipolar disorder.	[Eckart, Nicole; Wang, Ruihua; McCallion, Andrew S.; Avramopoulos, Dimitrios] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Song, Qifeng; Zhu, Heng] Johns Hopkins Univ, Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Yang, Rebecca; Avramopoulos, Dimitrios] Johns Hopkins Med, Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Avramopoulos, D (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.; Avramopoulos, D (corresponding author), Johns Hopkins Med, Psychiat & Behav Sci, Baltimore, MD 21205 USA.	adimitr1@jhmi.edu			National Institute of Mental Health grant [MH092515, MH085018]; National Institute of Neurological Disorders and Stroke grant [NINDS NS062972]; NIH grants [MH092515, MH085018]; NINDS grant [R01 NS062972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085018, R01MH092515, R01MH106522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Mental Health grant numbers MH092515 and MH085018 to DA (https://www.nimh.nih.gov/index.shtml); and National Institute of Neurological Disorders and Stroke grant number NINDS NS062972 to ASM (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants MH092515 and MH085018 to D.A. and NINDS grant R01 NS062972 to A.S.M. We thank the Harvard Brain Tissue Resource Center and the University of Maryland National Institute of Child Health and Human Development Brain Bank for providing tissue samples, and to Megan Szymanski Pierce who previously extracted DNA and RNA from STG tissue samples.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Gershon ES, 2014, MOL PSYCHIATR, V19, P890, DOI 10.1038/mp.2013.107; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gomez-Ospina N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060526; GRAHAM FL, 1978, VIROLOGY, V86, P10, DOI 10.1016/0042-6822(78)90003-X; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Guo XB, 2013, GENET EPIDEMIOL, V37, P122, DOI 10.1002/gepi.21688; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Kasai K, 2003, AM J PSYCHIAT, V160, P156, DOI 10.1176/appi.ajp.160.1.156; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin RC, 2003, ANNU REV PSYCHOL, V54, P55, DOI 10.1146/annurev.psych.54.101601.145201; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Owen MJ, 2016, LANCET LOND ENG 0114; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Pers TH, 2016, HUM MOL GENET; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Skuse D, 2003, ANN NY ACAD SCI, V1008, P91, DOI 10.1196/annals.1301.010; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Szymanski M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.17; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wang KS, 2012, J MOL NEUROSCI, V48, P265, DOI 10.1007/s12031-012-9787-4; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Xie Z, 2010, BIOINFORMATICS, V26, P287, DOI 10.1093/bioinformatics/btp631; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P162, DOI 10.1038/mp.2014.143	46	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157086	10.1371/journal.pone.0157086	http://dx.doi.org/10.1371/journal.pone.0157086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276213	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700067
J	Inhestern, L; Haller, AC; Wlodarczyk, O; Bergelt, C				Inhestern, Laura; Haller, Anne-Catherine; Wlodarczyk, Olga; Bergelt, Corinna			Psychosocial Interventions for Families with Parental Cancer and Barriers and Facilitators to Implementation and Use - A Systematic Review	PLOS ONE			English	Review							ENHANCING CONNECTIONS PROGRAM; CHILD-CENTERED INTERVENTIONS; PREVENTIVE INTERVENTION; COUNSELING-SERVICE; BREAST-CANCER; IMPACT; EXPERIENCES; SUPPORT; MOTHERS; CARE	Background Parental cancer has a significant impact on minor children and families. Psychosocial interventions for affected families can provide support where necessary. This systematic review aims at providing an overview of existing interventions and support programs and focuses on the systematic investigation of barriers and facilitators for using psychosocial interventions for families affected by parental cancer (PROSPERO; registration number CRD42014013020). Methods A search of five electronic databases (EMBASE, MEDLINE, PsycInfo, Psyndex, CINAHL) was conducted in June 2014, and updated in September 2015. We included any kind of studies reporting psychosocial support services or interventions for families affected by parental cancer. Study quality was assessed using the Mixed Method Assessment Tool. Narrative synthesis and thematic analyses were undertaken to examine the included interventions and to identify barriers and facilitators for use and implementation. Results A total of 36 studies covering 19 interventions and support services were included in the systematic review. Interventions focused on children, parents or several family members and analyses revealed a broad picture of theoretical background and primary aims. Several studies focused on developmental or implementation phases or descriptions of interventions. Other included studies reported results of evaluations using qualitative and quantitative methods. Results suggest that interventions are helpful and that participants improved in various outcomes. The thematic analyses indicate that barriers for use of support services refer to aspects concerning the patients and families, such as practical difficulties, perceived need for support or fear of stigma. Cancer patients who understood the need and benefit of support services may have used them more often. Additionally, intervention characteristics such as a flexible structure and accessibility were important to reach families affected by parental cancer. Disease characteristics and complications in collaborations were identified as potential barriers. The provision of information about interventions by clinicians and understanding the support as part of routine care seem to be key issues for implementation and use of psychosocial support. Conclusion This review identified a broad number of intervention concepts for families with minor children affected by parental cancer. Findings provide a basis for existing or future psychosocial interventions to anticipate potential barriers and facilitators to implementation and use and can help to reach a wider range of families in need for support.	[Inhestern, Laura; Wlodarczyk, Olga; Bergelt, Corinna] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Haller, Anne-Catherine] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat & Psychotherapy, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Inhestern, L (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	l.inhestern@uke.de		Bergelt, Corinna/0000-0003-1413-1872	Foundation Science in Hamburg	Foundation Science in Hamburg	The systematic review is part of a dissertation project supported by the Foundation Science in Hamburg (Stiftung Wissenschaft in Hamburg im Stifterverband fur die Deutsche Wissenschaft). The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Bedway AJ, 1996, J PSYCHOSOC ONCOL, V14, P19; Brandt PA, 2004, ONCOL NURS FORUM, V31, P833, DOI 10.1188/04.ONF.833-837; Bugge KE, 2008, CANCER NURS, V31, P426, DOI 10.1097/01.NCC.0000339250.83571.b0; Bugge KE, 2009, J CLIN NURS, V18, P3480, DOI 10.1111/j.1365-2702.2009.02871.x; Buttstadt M., 2005, CANCER, V16, P27, DOI [10.1026/0933-6885.16.1.27, DOI 10.1026/0933-6885.16.1.27]; CALL D A, 1990, Journal of Psychosocial Oncology, V8, P97, DOI 10.1300/J077v08n01_07; CHRIST GH, 1991, AM J ORTHOPSYCHIAT, V61, P168, DOI 10.1037/h0079245; CHRIST GH, 1991, RECENT RES CANCER, V121, P426; Christ GH, 2005, J SOC WORK END-LIFE, V1, P57, DOI 10.1300/J457v01n03_05; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Davey MP, 2013, PSYCHO-ONCOLOGY, V22, P1572, DOI 10.1002/pon.3172; Davey MP, 2012, J CANCER EDUC, V27, P744, DOI 10.1007/s13187-012-0398-0; Diareme S., 2007, FAM SYST HEALTH, V25, P98, DOI [DOI 10.1037/1091-7527.25.1.98, 10.1037/1091-7527.25.1.98]; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Dorr P, 2012, PRAX KINDERPSYCHOL K, V61, P396; Ernst JC, 2012, GESUNDHEITSWESEN, V74, P742, DOI 10.1055/s-0032-1329953; Ernst JC, 2013, CANCER-AM CANCER SOC, V119, P2333, DOI 10.1002/cncr.28021; Ernst JC, 2011, PSYCHOTHER PSYCH MED, V61, P426, DOI 10.1055/s-0031-1286303; Faulkner RA, 2002, AM J FAM THER, V30, P63, DOI 10.1080/019261802753455651; Grabiak BR, 2007, PSYCHO-ONCOLOGY, V16, P127, DOI 10.1002/pon.1083; Greening Karen, 1992, Journal of Psychosocial Oncology, V10, P47, DOI 10.1300/J077v10n01_05; Hasson-Ohayon I, 2011, PALLIAT SUPPORT CARE, V9, P149, DOI 10.1017/S1478951511000174; Heiney S P, 1996, Cancer Pract, V4, P324; Helseth S, 2005, J ADV NURS, V52, P38, DOI 10.1111/j.1365-2648.2005.03562.x; Hoke LA, 1997, HARVARD REV PSYCHIAT, V5, P99, DOI 10.3109/10673229709034734; Huizinga GA, 2005, EUR J CANCER, V41, P288, DOI 10.1016/j.ejca.2004.10.005; Inhestern L, 2016, PSYCHO-ONCOLOGY, V25, P1092, DOI 10.1002/pon.4049; John K, 2013, PSYCHO-ONCOLOGY, V22, P2684, DOI 10.1002/pon.3329; John K, 2010, PRAX KINDERPSYCHOL K, V59, P333, DOI 10.13109/prkk.2010.59.5.333; Kirsch SED, 2003, CANCER NURS, V26, P47, DOI 10.1097/00002820-200302000-00007; Kissane D, 2007, OMEGA-J DEATH DYING, V56, P21, DOI 10.2190/OM.56.1.c; Kissane DW, 2006, AM J PSYCHIAT, V163, P1208, DOI 10.1176/appi.ajp.163.7.1208; Koch G, 2011, VERHALTENSTHERAPIE P, V43, P73; Komo-Lang M, 2010, PSYCHOTHERAPIE DIALO, V11, P179; Krattenmacher T, 2012, J PSYCHOSOM RES, V72, P344, DOI 10.1016/j.jpsychores.2012.01.011; Kuhne F, 2013, GEN HOSP PSYCHIAT, V35, P147, DOI 10.1016/j.genhosppsych.2012.10.005; Kuhne F, 2012, J PALLIAT MED, V15, P931, DOI 10.1089/jpm.2011.0380; Lewis FM, 2006, PSYCHO-ONCOLOGY, V15, P486, DOI 10.1002/pon.979; Lewis FM, 2015, J CONSULT CLIN PSYCH, V83, P12, DOI 10.1037/a0038219; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Moller B, 2014, CANCER-AM CANCER SOC, V120, P2361, DOI 10.1002/cncr.28644; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Muriel AC, 2012, CANCER-AM CANCER SOC, V118, P5671, DOI 10.1002/cncr.27572; Niemela M, 2012, J PSYCHOSOC ONCOL, V30, P316, DOI 10.1080/07347332.2012.664258; Niemela M, 2010, CANCER NURS, V33, pE18, DOI 10.1097/NCC.0b013e3181ddfcb5; Niemela M, 2010, PSYCHO-ONCOLOGY, V19, P451, DOI 10.1002/pon.1620; Osborn T, 2007, PSYCHO-ONCOLOGY, V16, P101, DOI 10.1002/pon.1113; Paschen B, 2007, PSYCHOTHERAPEUT, V52, P265, DOI 10.1007/s00278-006-0525-7; Pluye P, 2009, INT J NURS STUD, V46, P529, DOI 10.1016/j.ijnurstu.2009.01.009; Romer G, 2007, PSYCHO-ONCOLOGY, V16, P138, DOI 10.1002/pon.1105; Romer G, 2011, PSYCHOTHERAPEUT, V56, P400, DOI 10.1007/s00278-011-0849-9; Schmitt Florence, 2007, Clin Child Psychol Psychiatry, V12, P421, DOI 10.1177/1359104507078475; Semple CJ, 2013, EUR J CANCER CARE, V22, P219, DOI 10.1111/ecc.12018; Semple CJ, 2010, J ADV NURS, V66, P1280, DOI 10.1111/j.1365-2648.2010.05311.x; Semple CJ, 2010, CANCER NURS, V33, P110, DOI 10.1097/NCC.0b013e3181c024bb; SIEGEL K, 1990, AM J ORTHOPSYCHIAT, V60, P168, DOI 10.1037/h0079187; Taylor-Brown J., 1993, J PSYCHOSOC ONCOL, V11, P41; Thastum Mikael, 2006, Clin Child Psychol Psychiatry, V11, P529, DOI 10.1177/1359104506067875; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Tucker AR, 2013, J EXP EDUC, V36, P93, DOI 10.1177/1053825913487889	60	46	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156967	10.1371/journal.pone.0156967	http://dx.doi.org/10.1371/journal.pone.0156967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27276079	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700052
J	Ota, A; Kondo, N; Murayama, N; Tanabe, N; Shobugawa, Y; Kondo, K				Ota, Asami; Kondo, Naoki; Murayama, Nobuko; Tanabe, Naohito; Shobugawa, Yugo; Kondo, Katsunori		Japan Gerontological Evaluation St	Serum Albumin Levels and Economic Status in Japanese Older Adults	PLOS ONE			English	Article							SELF-RATED HEALTH; BODY-MASS INDEX; SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; COGNITIVE DECLINE; MORTALITY; ASSOCIATION; POPULATION; PEOPLE; PREDICTORS	Background Low serum albumin levels are associated with aging and medical conditions such as cancer, liver dysfunction, inflammation, and malnutrition and might be an independent predictor of long-term mortality in healthy older populations. We tested the hypothesis that economic status is associated with serum albumin levels and explained by nutritional and health status in Japanese older adults. Design We performed a cross-sectional analysis using data from the Japan Gerontological Evaluation study (JAGES). The study participants were 6528 functionally independent residents (3189 men and 3339 women) aged >= 65 years living in four municipalities in Aichi prefecture. We used household income as an indicator of economic status. Multiple linear regression was used to compare serum albumin levels in relation to household income, which was classified as low, middle, and high. Additionally, mediation by nutritional and health-related factors was analyzed in multivariable models. Results With the middle-income group as reference, participants with low incomes had a significantly lower serum albumin level, even after adjustment for sex, age, residential area, education, marital status, and household structure. The estimated mean difference was -0.17 g/L (95% confidence interval, -0.33 to -0.01 g/L). The relation between serum albumin level and low income became statistically insignificant when "body mass index", "consumption of meat or fish", "self-rated health", "presence of medical conditions", "hyperlipidemia", or "respiratory disease "was included in the model. Conclusion Serum albumin levels were lower in Japanese older adults with low economic status. The decrease in albumin levels appears to be mediated by nutrition and health-related factors with low household incomes. Future studies are needed to reveal the existence of other pathways.	[Ota, Asami; Murayama, Nobuko; Tanabe, Naohito] Univ Niigata Prefecture, Div Hlth & Nutr, Niigata, Japan; [Kondo, Naoki] Univ Tokyo, Dept Hlth & Social Behav, Dept Hlth Educ & Hlth Sociol, Sch Publ Hlth, Tokyo, Japan; [Shobugawa, Yugo] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth, Niigata, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Chita, Aichi, Japan; [Kondo, Katsunori] Natl Ctr Geriatr & Gerontol, Obu City, Aichi, Japan	University Niigata Prefecture; University of Tokyo; Niigata University; Chiba University; National Center for Geriatrics & Gerontology	Ota, A (corresponding author), Univ Niigata Prefecture, Div Hlth & Nutr, Niigata, Japan.	asammy@unii.ac.jp	Kondo, Naoki/K-3898-2012; Fujino, Yoshihisa/F-3054-2010; Aida, Jun/S-9371-2019; Kondo, Naoki/ABC-5865-2020; Kondo, Katsunori/AAI-6373-2020	Kondo, Naoki/0000-0002-6425-6844; Fujino, Yoshihisa/0000-0002-9126-206X; Aida, Jun/0000-0002-8405-9872; Kondo, Naoki/0000-0002-6425-6844; Misawa, Jimpei/0000-0003-3987-8251; Hanazato, Masamichi/0000-0002-0317-7616; Shobugawa, Yugo/0000-0003-2851-0101	Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), Center for Well-being and Society, Nihon Fukushi University; Japanese Ministry of Health, Labour and Welfare [H22-Choju-Shitei-008, H25-Choju-Ippan-003, H25-Kenki-Wakate-015, H26-Choju-Ippan-006, H27-Jyunkankito-ippan-002]; Japan Society for the Promotion of Science [22119506, 22330172, 22390400, 22592327, 23590786, 23700819, 25253052, 23243070, 26882010]; AXA Fixed Income Fund, AXA Life Insurance Co. LTD.	Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), Center for Well-being and Society, Nihon Fukushi University; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AXA Fixed Income Fund, AXA Life Insurance Co. LTD.	This study used data from the Japan Gerontological Evaluation Study (JAGES), a research project conducted by Nihon Fukushi University Center for Well-being and Society. This study was supported by a Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT), 2009-2013, for the Center for Well-being and Society, Nihon Fukushi University; a Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H22-Choju-Shitei-008, H25-Choju-Ippan-003, H25-Kenki-Wakate-015, H26-Choju-Ippan-006) and Comprehensive Research on Lifestyle Disease (H27-Jyunkankito-ippan-002) from the Japanese Ministry of Health, Labour and Welfare; and Grants-in-Aid for Scientific Research (22119506, 22330172, 22390400, 22592327, 23590786, 23700819, 25253052, 23243070, and 26882010) from the Japan Society for the Promotion of Science. NK was also supported by AXA Fixed Income Fund, AXA Life Insurance Co. LTD. He had no role in study design, data collection, analysis and decision to publish. He had helped on preparation of the manuscript. Other funders had no role in study design, decision to publish, or preparation of the manuscript. The authors are particularly grateful to the staff members from each study area and the central office for conducting the survey. The authors would like to thank everyone who participated in the surveys.	[Anonymous], 2013, OUTL VIT STAT 2013; [Anonymous], 2015, ANN REP HLTH LAB WEL; Cabrerizo S, 2015, MATURITAS, V81, P17, DOI 10.1016/j.maturitas.2015.02.009; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fujino Y, 2005, J OCCUP HEALTH, V47, P510, DOI 10.1539/joh.47.510; Fujino Y, 2005, PREV MED, V40, P444, DOI 10.1016/j.ypmed.2004.07.002; Fukuda Y, 2005, INT J EPIDEMIOL, V34, P100, DOI 10.1093/ije/dyh283; Fukuda Y, 2013, J EPIDEMIOL, V23, P21, DOI 10.2188/jea.JE20120021; Fukuda Y, 2012, BIOSCI TRENDS, V6, P176, DOI 10.5582/bst.2012.v6.4.176; Goldman N, 2011, SOC SCI MED, V72, P307, DOI 10.1016/j.socscimed.2010.11.004; Higashiguchi Mizuka, 2008, Nihon Koshu Eisei Zasshi, V55, P433; Hikichi H, 2015, J EPIDEMIOL COMMUN H, V69, P905, DOI 10.1136/jech-2014-205345; Hishida Akira SS, 2015, OV DIET REF INT JAP; Hong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117731; Ichida Y, 2013, SOC SCI MED, V94, P83, DOI 10.1016/j.socscimed.2013.05.006; Ichida Y, 2009, SOC SCI MED, V69, P489, DOI 10.1016/j.socscimed.2009.05.006; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Katsarou A, 2010, PUBLIC HEALTH NUTR, V13, P1614, DOI 10.1017/S1368980010000479; Kitamura Kaori, 2012, Environmental Health and Preventive Medicine, V17, P164, DOI 10.1007/s12199-011-0233-y; Kohler IV, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-4; Kondo N, 2009, J EPIDEMIOL COMMUN H, V63, P461, DOI 10.1136/jech.2008.078642; Kvamme JM, 2012, J EPIDEMIOL COMMUN H, V66, P611, DOI 10.1136/jech.2010.123232; Louie GH, 2011, AM J PUBLIC HEALTH, V101, P1322, DOI 10.2105/AJPH.2010.199455; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Murata C, 2008, HEALTH PLACE, V14, P406, DOI 10.1016/j.healthplace.2007.08.007; Ng TP, 2009, J AM GERIATR SOC, V57, P101, DOI 10.1111/j.1532-5415.2008.02086.x; Nishi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030179; Novakovic R, 2014, PUBLIC HEALTH NUTR, V17, P1031, DOI 10.1017/S1368980013001341; Ojima Toshiyuki, 2014, INDEX HLTH LIFE EXPE; Onem Y, 2010, ARCH GERONTOL GERIAT, V50, P56, DOI 10.1016/j.archger.2009.01.010; PHILLIPS A, 1989, LANCET, V2, P1434; Reuben DB, 1999, J AM GERIATR SOC, V47, P402, DOI 10.1111/j.1532-5415.1999.tb07230.x; Sahyoun NR, 1996, J CLIN EPIDEMIOL, V49, P981, DOI 10.1016/0895-4356(96)00135-7; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Schalk BWM, 2006, AM J EPIDEMIOL, V164, P969, DOI 10.1093/aje/kwj312; SHIBATA H, 1992, ARCH GERONTOL GERIAT, V14, P283, DOI 10.1016/0167-4943(92)90028-3; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; Takata Y, 2013, ARCH GERONTOL GERIAT, V57, P46, DOI 10.1016/j.archger.2013.02.006; Takata Y, 2012, ARCH GERONTOL GERIAT, V54, P39, DOI 10.1016/j.archger.2011.02.018; Taniguchi Y, 2014, J GERONTOL A-BIOL, V69, P1276, DOI 10.1093/gerona/glt286; Thalacker-Mercer AE, 2008, NUTR REV, V66, P91, DOI 10.1111/j.1753-4887.2007.00012.x; Ueda K, 2005, CANCER SCI, V96, P684, DOI 10.1111/j.1349-7006.2005.00104.x; Vanltallie TB, 2003, METABOLISM, V52, P22, DOI 10.1053/S0026-0495(03)00297-X; Watanabe M, 2010, J EPIDEMIOL, V20, pS531, DOI 10.2188/jea.JE20090221; World Health Organization, WORLD HLTH STAT 2014; Yamakita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141638	51	13	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155022	10.1371/journal.pone.0155022	http://dx.doi.org/10.1371/journal.pone.0155022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27276092	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700003
J	Ampah, KA; Pinho-Nascimento, CA; Kerber, S; Asare, P; De-Graft, D; Adu-Nti, F; Paixao, ICNP; Niel, C; Yeboah-Manu, D; Pluschke, G; Roltgen, K				Ampah, Kobina Assan; Pinho-Nascimento, Carlos Augusto; Kerber, Sarah; Asare, Prince; De-Graft, Daniel; Adu-Nti, Frank; Paixao, Izabel C. N. P.; Niel, Christian; Yeboah-Manu, Dorothy; Pluschke, Gerd; Roltgen, Katharina			Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana	PLOS ONE			English	Article							GENOTYPE-E; VIRAL-HEPATITIS; RISK-FACTORS; STRAINS; AFRICA; GENOME; SEROPREVALENCE; EPIDEMIOLOGY; DETERMINANTS; COINFECTION	Hepatitis B virus (HBV) infections account for approximately 780,000 deaths per year, most of which occur in the developing world. Co-infection with HBV and hepatitis delta virus (HDV) may lead to the most severe form of viral hepatitis. In Ghana, knowledge on the prevalence of HBV and HDV in the general population is scanty and the few genetic analyses of the prevailing HBV genotypes are dating back more than a decade. In the present study, 1,323 serum samples from individuals living in a rural area (Offin river valley) of Ghana were analyzed for the presence of the hepatitis B surface antigen (HBsAg). Positive sera were subsequently tested for the presence of anti-HDV antibodies. A total of 107 (8%) sera were HBsAg positive with an 8.4% prevalence of anti-HDV antibodies among the HBsAg positives. Phylogenetic analysis based on HBV pre-S/S sequences, attributed all 52 typable samples to genotype E. All belonged to serotype ayw4. While 19 sequences clustered with those from a number of African countries, the other 33 formed a separate cluster distinguished by an intergroup mean distance of 1.5% from the pan-African HBV/E cluster. Successful implementation of HBV vaccination in the region was reflected by the low HBsAg carrier rate of 1.8% among children <= 11 years.	[Ampah, Kobina Assan; Kerber, Sarah; Pluschke, Gerd; Roltgen, Katharina] Swiss Trop & Publ Hlth Inst, Mol Immunol, Basel, Switzerland; [Ampah, Kobina Assan; Kerber, Sarah; Pluschke, Gerd; Roltgen, Katharina] Univ Basel, Basel, Switzerland; [Ampah, Kobina Assan; Asare, Prince; De-Graft, Daniel; Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Pinho-Nascimento, Carlos Augusto] Univ Fed Fluminense, Inst Biol, Mol Virol Lab, Niteroi, RJ, Brazil; [Adu-Nti, Frank] Radford Univ Coll, Accra, Ghana; [Niel, Christian] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Ghana; Universidade Federal Fluminense; Fundacao Oswaldo Cruz	Roltgen, K (corresponding author), Swiss Trop & Publ Hlth Inst, Mol Immunol, Basel, Switzerland.; Roltgen, K (corresponding author), Univ Basel, Basel, Switzerland.	Katharina.roeltgen@unibas.ch	Paixão, Izabel/S-7490-2019; Paixão, Izabel/AAM-1668-2020; Yeboah-Manu, Dorothy/A-1933-2016	Pluschke, Gerd/0000-0003-1957-2925; Roltgen, Katharina/0000-0002-1582-1720; Yeboah-Manu, Dorothy/0000-0002-1663-6287; ADU-NTI, FRANK/0000-0002-7799-9380	Stop Buruli Initiative - UBS-Optimus Foundation	Stop Buruli Initiative - UBS-Optimus Foundation	This study was supported by the Stop Buruli Initiative funded by the UBS-Optimus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei A A, 2006, West Afr J Med, V25, P38; Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-33; Ampah KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004603; Ampah KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004387; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Asmah R H, 2014, West Afr J Med, V33, P32; Bahri O, 2006, J MED VIROL, V78, P353, DOI 10.1002/jmv.20554; Bell TG, 2015, VIRUSES-BASEL, V7, P781, DOI 10.3390/v7020781; Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0; Carrion AF, 2012, AM J GASTROENTEROL, V107, P691, DOI 10.1038/ajg.2012.7; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Damale NKR, 2005, INT J GYNECOL OBSTET, V90, P240, DOI 10.1016/j.ijgo.2005.05.014; Dongdem Julius Tieroyaare, 2012, BMC Res Notes, V5, P115, DOI 10.1186/1756-0500-5-115; Ezzikouri S, 2008, INFECT GENET EVOL, V8, P306, DOI 10.1016/j.meegid.2008.01.010; Forbi JC, 2013, J CLIN VIROL, V58, P59, DOI 10.1016/j.jcv.2013.06.028; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324; Huang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089753; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2006, J MED VIROL, V78, P178, DOI 10.1002/jmv.20525; Khelifa F, 2009, PATHOL BIOL, V57, P107, DOI 10.1016/j.patbio.2008.07.031; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kubio C, 2012, TRANSFUSION, V52, P2161, DOI 10.1111/j.1537-2995.2012.03709.x; Kwaansa-Ansah EE, 2010, B ENVIRON CONTAM TOX, V85, P476, DOI 10.1007/s00128-010-0141-7; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092223; Lemoine M, 2013, FUTURE VIROL, V8, P371, DOI 10.2217/FVL.13.11; Levicnik-Stezinar Snezna, 2004, Clin Lab, V50, P49; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Marcus EL, 1997, J AM GERIATR SOC, V45, P755, DOI 10.1111/j.1532-5415.1997.tb01484.x; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Mutocheluh Mohamed, 2014, BMC Res Notes, V7, P873, DOI 10.1186/1756-0500-7-873; NAUMANN H, 1993, J GEN VIROL, V74, P1627, DOI 10.1099/0022-1317-74-8-1627; Nkrumah Bernard, 2011, BMC Res Notes, V4, P529, DOI 10.1186/1756-0500-4-529; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Padmapriyadarsini C, 2006, J POSTGRAD MED, V52, P92; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Purdy MA, 2007, INTERVIROLOGY, V50, P45, DOI 10.1159/000096312; Purdy Michael A, 2007, Asian J Transfus Sci, V1, P62, DOI 10.4103/0973-6247.33445; Rizzetto M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021576; Rizzetto M, 2013, CLIN LIVER DIS, V17, P475, DOI 10.1016/j.cld.2013.05.007; Sagoe KWC, 2012, J MED VIROL, V84, P6, DOI 10.1002/jmv.22262; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sayiner AA, 2007, J CLIN VIROL, V38, P157, DOI 10.1016/j.jcv.2006.12.002; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Seremba E, 2010, J MED VIROL, V82, P1334, DOI 10.1002/jmv.21813; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Wong WM, 2000, HEPATOLOGY, V31, P201, DOI 10.1002/hep.510310129; World Health Organization, GUID PREV CAR TREATM; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156864	10.1371/journal.pone.0156864	http://dx.doi.org/10.1371/journal.pone.0156864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271290	gold, Green Published, Green Submitted			2022-12-27	WOS:000377560200023
J	Li, KJ; Wu, CH; Shen, CY; Kuo, YM; Yu, CL; Hsieh, SC				Li, Ko-Jen; Wu, Cheng-Han; Shen, Chieh-Yu; Kuo, Yu-Min; Yu, Chia-Li; Hsieh, Song-Chou			Membrane Transfer from Mononuclear Cells to Polymorphonuclear Neutrophils Transduces Cell Survival and Activation Signals in the Recipient Cells via Anti-Extrinsic Apoptotic and MAP Kinase Signaling Pathways	PLOS ONE			English	Article							SURFACE-EXPRESSED LACTOFERRIN; DELAYED-TYPE HYPERSENSITIVITY; INVIVO IMMUNE-RESPONSE; RED-BLOOD-CELLS; MHC CLASS-II; T-CELLS; SELECTIVE DEPLETION; MONOCLONAL-ANTIBODY; RP-3 TREATMENT; INTERCELLULAR TRANSFER	The biological significance of membrane transfer (trogocytosis) between polymorphonuclear neutrophils (PMNs) and mononuclear cells (MNCs) remains unclear. We investigated the biological/immunological effects and molecular basis of trogocytosis among various immune cells in healthy individuals and patients with active systemic lupus erythematosus (SLE). By flow cytometry, we determined that molecules in the immunological synapse, including HLA class-I and-II, CD11b and LFA-1, along with CXCR1, are exchanged among autologous PMNs, CD4(+) T cells, and U937 cells (monocytes) after cell-cell contact. Small interfering RNA knockdown of the integrin adhesion molecule CD11a in U937 unexpectedly enhanced the level of total membrane transfer from U937 to PMN cells. Functionally, phagocytosis and IL-8 production by PMNs were enhanced after co-culture with T cells. Total membrane transfer from CD4(+) T to PMNs delayed PMN apoptosis by suppressing the extrinsic apoptotic molecules, BAX, MYC and caspase 8. This enhancement of activities of PMNs by T cells was found to be mediated via p38- and P44/42-Akt-MAP kinase pathways and inhibited by the actin-polymerization inhibitor, latrunculin B, the clathrin inhibitor, Pit-stop-2, and human immunoglobulin G, but not by the caveolin inhibitor, methyl-beta-cyclodextrin. In addition, membrane transfer from PMNs enhanced IL-2 production by recipient anti-CD3/anti-CD28 activated MNCs, and this was suppressed by inhibitors of mitogen-activated protein kinase (PD98059) and protein kinase C (Rottlerin). Of clinical significance, decreased total membrane transfer from PMNs to MNCs in patients with active SLE suppressed mononuclear IL-2 production. In conclusion, membrane transfer from MNCs to PMNs, mainly at the immunological synapse, transduces survival and activation signals to enhance PMN functions and is dependent on actin polymerization, clathrin activation, and Fc gamma receptors, while membrane transfer from PMNs to MNCs depends on MAP kinase and PKC signaling. Defective membrane transfer from PMNs to MNCs in patients with active systemic lupus erythematous suppressed activated mononuclear IL-2 production.	[Li, Ko-Jen; Hsieh, Song-Chou] Natl Yang Ming Univ, Coll Med, Inst Clin Med, Taipei 112, Taiwan; [Wu, Cheng-Han; Shen, Chieh-Yu; Kuo, Yu-Min] Natl Taiwan Univ, Coll Med, Inst Clin Med, Taipei 10764, Taiwan; [Yu, Chia-Li] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Li, Ko-Jen; Wu, Cheng-Han; Shen, Chieh-Yu; Kuo, Yu-Min; Yu, Chia-Li; Hsieh, Song-Chou] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hsieh, SC (corresponding author), Natl Yang Ming Univ, Coll Med, Inst Clin Med, Taipei 112, Taiwan.; Hsieh, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	hsiehsc@ntu.edu.tw		LI, KO-JEN/0000-0002-4544-4620; Shen, Chieh-Yu/0000-0002-3218-0689	National Sciences Council [101-2314-B-002-142-MY3, 100-2314-B-002-144, 98-2314-B-002-068]	National Sciences Council	The paper was supported by grants from the National Sciences Council (101-2314-B-002-142-MY3, 100-2314-B-002-144, 98-2314-B-002-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2005, J INFECT DIS, V192, P399, DOI 10.1086/431680; Alvarado-Kristensson M, 2001, FASEB J, V15, P129, DOI 10.1096/fj.01-0817fje; Baba E, 2001, J IMMUNOL, V167, P875, DOI 10.4049/jimmunol.167.2.875; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Bourbie-Vaudaine S, 2006, J IMMUNOL, V177, P1460, DOI 10.4049/jimmunol.177.3.1460; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Choi KS, 2005, INFECT IMMUN, V73, P8209, DOI 10.1128/IAI.73.12.8209-8218.2005; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Davis DM, 2002, TRENDS IMMUNOL, V23, P356, DOI 10.1016/S1471-4906(02)02243-3; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; ELHAG A, 1987, J IMMUNOL, V139, P2406; Monsivais-Urenda AE, 2011, J CLIN IMMUNOL, V31, P369, DOI 10.1007/s10875-010-9496-0; Fanger NA, 1997, BLOOD, V89, P4128, DOI 10.1182/blood.V89.11.4128; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; HIROHATA S, 1995, CELL IMMUNOL, V160, P270, DOI 10.1016/0008-8749(95)80038-K; Hock BD, 2012, IMMUNOLOGY, V137, P249, DOI 10.1111/imm.12004; Honer H, 2007, J IMMUNOL, V179, P337; Hsieh SC, 2008, RHEUMATOLOGY, V47, P150, DOI 10.1093/rheumatology/kem320; Hsieh SC, 2003, CLIN EXP IMMUNOL, V131, P506, DOI 10.1046/j.1365-2249.2003.02084.x; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Iking-Konert C, 2001, KIDNEY INT, V60, P2247, DOI 10.1046/j.1523-1755.2001.00068.x; Iking-Konert C, 2005, ANN RHEUM DIS, V64, P1436, DOI 10.1136/ard.2004.034132; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; KUDO C, 1993, J IMMUNOL, V150, P3728; KUDO C, 1993, J IMMUNOL, V150, P3739; Li KJ, 2006, J LEUKOCYTE BIOL, V80, P350, DOI 10.1189/jlb.1105668; LLOYD AR, 1992, IMMUNOL TODAY, V13, P169, DOI 10.1016/0167-5699(92)90121-M; Masuda S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/345745; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Poupot M, 2003, J IMMUNOL, V171, P2517, DOI 10.4049/jimmunol.171.5.2517; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; Rossi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098315; Rossi EA, 2013, BLOOD, V122, P3020, DOI 10.1182/blood-2012-12-473744; Saba S, 2002, AM J RESP CELL MOL, V27, P561, DOI 10.1165/rcmb.2002-0019OC; SHALABY MR, 1985, J IMMUNOL, V135, P2069; Siao SC, 2011, MOLECULES, V16, P2119, DOI 10.3390/molecules16032119; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Tabiasco J, 2002, EUR J IMMUNOL, V32, P1502, DOI 10.1002/1521-4141(200205)32:5<1502::AID-IMMU1502>3.0.CO;2-Y; TAMURA M, 1994, J IMMUNOL, V153, P1301; TANAKA E, 1993, INT J CANCER, V54, P131, DOI 10.1002/ijc.2910540121; Thewissen M, 2011, MOL IMMUNOL, V48, P2094, DOI 10.1016/j.molimm.2011.07.006; Tomida T, 2015, J PHYSIOL SCI, V65, P37, DOI 10.1007/s12576-014-0332-9; Uddin M, 2010, THORAX, V65, P684, DOI 10.1136/thx.2009.120741; Wetzel SA, 2005, J IMMUNOL, V174, P80, DOI 10.4049/jimmunol.174.1.80; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yu CL, 1998, IMMUNOLOGY, V95, P480; Zhang HG, 2001, ARTHRITIS RHEUM-US, V44, P1555, DOI 10.1002/1529-0131(200107)44:7<1555::AID-ART279>3.0.CO;2-M	51	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156262	10.1371/journal.pone.0156262	http://dx.doi.org/10.1371/journal.pone.0156262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258015	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700049
J	Arruda, WD; Oldeland, J; Paranhos, AC; Pott, A; Cunha, NL; Ishii, IH; Damasceno, GA				Arruda, Wellinton de Sa; Oldeland, Jens; Paranhos Filho, Antonio Conceicao; Pott, Arnildo; Cunha, Nicolay L.; Ishii, Iria Hiromi; Damasceno-Junior, Geraldo Alves			Inundation and Fire Shape the Structure of Riparian Forests in the Pantanal, Brazil	PLOS ONE			English	Article							AMAZONIAN FLOODPLAIN; SEED DISPERSAL; TREE; TOLERANCE; WATER; PERSISTENCE; VEGETATION; DIVERSITY; WETLAND; GROWTH	Inundation and fire can affect the structure of riparian vegetation in wetlands. Our aim was to verify if there are differences in richness, abundance, basal area, composition and topographic preference of woody species in riparian forests related to the fire history, flooding duration, or the interaction between both. The study was conducted in the riparian forests of the Paraguay River some of which were burned three times between 2001 and 2011. We sampled trees with a girth of at least 5 cm at breast height in 150 5 x 10 m plots (79 burned and 71 unburned). We also measured height of the flood mark and estimated the flooding duration of each plot. We performed Generalized Linear Mixed Models to verify differences in richness, basal area, and abundance of individuals associated to interaction of fire and inundation. We used an analysis of similarity (ANOSIM) and indicator species analysis to identify differences in composition of species and the association with burned and unburned area according to different levels of inundation. Finally, we used a hierarchical set of Generalized Linear Models (GLM), the so-called HOF models, to analyse each species' specific response to inundation based on topography and to determine their preferred optimal topographic position for both burned as well as unburned areas. Richness was positively associated with elevation only in burned areas while abundance was negatively influenced by inundation only in burned areas. Basal area was negatively associated with time of inundation independent of fire history. There were 15 species which were significant indicators for at least one combination of the studied factors. We found nine species in burned areas and 15 in unburned areas, with response curves in HOF models along the inundation gradient. From these, five species shifted their optimal position along the inundation gradient in burned areas. The interaction of fire and inundation did not appear to affect the basal area, but it did affect the richness, number of individuals, success of some species, and seemed to shape the boundary of these forests as shown by the difference in the positioning of these species along the inundation gradient.	[Arruda, Wellinton de Sa; Pott, Arnildo; Damasceno-Junior, Geraldo Alves] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Lab Bot, Campo Grande, MS, Brazil; [Oldeland, Jens; Damasceno-Junior, Geraldo Alves] Univ Hamburg, Biodivers Evolut & Ecol Plants BEE Bioctr, Klein Flottbek & Bot Garden, Hamburg, Germany; [Paranhos Filho, Antonio Conceicao] Univ Fed Mato Grosso do Sul, Fac Engn Arquitetura & Urbanismo & Geog, Lab Geoproc Aplicacoes Ambientais, Campo Grande, MS, Brazil; [Cunha, Nicolay L.] Univ Fed Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Ishii, Iria Hiromi] Univ Fed Mato Grosso do Sul, Lab Bot, Campus Pantanal, Corumba, MS, Brazil	Universidade Federal de Mato Grosso do Sul; University of Hamburg; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Damasceno, GA (corresponding author), Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Lab Bot, Campo Grande, MS, Brazil.; Damasceno, GA (corresponding author), Univ Hamburg, Biodivers Evolut & Ecol Plants BEE Bioctr, Klein Flottbek & Bot Garden, Hamburg, Germany.	geraldodamasceno@gmail.com	Damasceno Junior, Geraldo/ABG-2834-2021; Cunha, Nicolay Leme da/D-3212-2012; Filho, Antonio Conceição Paranhos/C-7467-2018	Cunha, Nicolay Leme da/0000-0001-5509-6757; Filho, Antonio Conceição Paranhos/0000-0002-9838-5337; Pott, Arnildo/0000-0002-8599-9276; Oldeland, Jens/0000-0002-7833-4903; Alves Damasceno Junior, Geraldo/0000-0002-4554-9369	Instituto Nacional de Ciencia e Tecnologia em Areas Umidas/CNPq	Instituto Nacional de Ciencia e Tecnologia em Areas Umidas/CNPq	This study was supported by the Instituto Nacional de Ciencia e Tecnologia em Areas Umidas/CNPq, http://www.inau.org.br/homepage.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB'SABER AN, 1988, REV BRASILEIRA GEOGR, V50, P9; Agee JK, 2002, FOREST ECOL MANAG, V167, P57, DOI 10.1016/S0378-1127(01)00690-9; ARMSTRONG W, 1994, ACTA BOT NEERL, V43, P307; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barton K., 2015, MUMIN MULTIMODEL INF; Bates D., 2015, LME4 LINEAR MIXED EF; BELL DT, 1980, AUST J ECOL, V5, P9, DOI 10.1111/j.1442-9993.1980.tb01226.x; Bendix J, 2010, GEOMORPHOLOGY, V116, P297, DOI 10.1016/j.geomorph.2009.09.043; Bendix J, 2010, ECOSYSTEMS, V13, P99, DOI 10.1007/s10021-009-9303-z; Bertazzoni EC, 2011, ACTA BOT BRAS, V25, P476, DOI 10.1590/S0102-33062011000200023; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Breheny P, 2015, VISREG VISUALIZATION; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Crawford RMM, 1996, FOLIA GEOBOT PHYTOTX, V31, P7, DOI 10.1007/BF02803990; Cunha NL, 2012, BRAZ J BIOL, V72, P519, DOI 10.1590/S1519-69842012000300015; Da Silva JD, 1998, PESQUI AGROPECU BRAS, V33, P1703; Damasceno-Junior GA, 2005, FLORA, V200, P119, DOI 10.1016/j.flora.2004.09.002; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; de Oliveira MT, 2014, FOREST ECOL MANAG, V331, P256, DOI 10.1016/j.foreco.2014.08.011; Deng CN, 2012, J FOOD AGRIC ENVIRON, V10, P1329; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fernandes FA, 2007, 61 EMBR PANT, V61; Ferreira LV, 1999, OECOLOGIA, V120, P582, DOI 10.1007/s004420050893; Galdino S, 1997, 23 EMBR PANT, V23; Gelman A., 2007, DATA ANAL USING REGR; Gignoux J, 1997, OECOLOGIA, V110, P576, DOI 10.1007/s004420050198; Gignoux J, 2009, J ECOL, V97, P484, DOI 10.1111/j.1365-2745.2009.01493.x; Hamilton SK, 1996, ARCH HYDROBIOL, V137, P1; Heinl M, 2007, J ARID ENVIRON, V68, P77, DOI 10.1016/j.jaridenv.2005.10.023; Heinl M, 2008, AFR J ECOL, V46, P350, DOI 10.1111/j.1365-2028.2007.00847.x; Higgins SI, 2012, J ECOL, V100, P1400, DOI 10.1111/j.1365-2745.2012.02026.x; Hlavac M, 2015, STARGAZER LATEX HTML; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; HUISMAN J, 1993, J VEG SCI, V4, P37, DOI 10.2307/3235732; Instituto Brasileiro de Geografia e Estatistica-IBGE, 1992, MANUAL TECNICO DA VE; Jansen F, 2013, J VEG SCI, V24, P1108, DOI 10.1111/jvs.12050; JOLY CA, 1994, P ROY SOC EDINB B, V102, P343, DOI 10.1017/S0269727000014330; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Koponen P, 2004, PLANT ECOL, V173, P17, DOI 10.1023/B:VEGE.0000026328.98628.b8; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; KUBITZKI K, 1994, BIOTROPICA, V26, P30, DOI 10.2307/2389108; Lawes MJ, 2013, J ECOL, V101, P517, DOI 10.1111/1365-2745.12035; Lockwood JL, 2003, FRONT ECOL ENVIRON, V1, P462, DOI 10.1890/1540-9295(2003)001[0462:SOTWTI]2.0.CO;2; Lukac M, 2011, ECOL STUD-ANAL SYNTH, V212, P247, DOI 10.1007/978-90-481-9834-4_14; Macedo H.A., 2009, AN 2 S GEOT PANT COR, P452; Maurenza Daniel, 2009, Acta Amaz., V39, P519, DOI 10.1590/S0044-59672009000300005; MITSCH WJ, 1991, LANDSCAPE ECOL, V5, P75, DOI 10.1007/BF00124662; Myster RW, 2006, CAN J FOREST RES, V36, P1121, DOI 10.1139/X06-006; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Oksanen J, 2002, ECOL MODEL, V157, P119, DOI 10.1016/S0304-3800(02)00190-4; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Parolin P, 2002, ENVIRON EXP BOT, V48, P177, DOI 10.1016/S0098-8472(02)00036-9; Parolin P, 2009, ANN BOT-LONDON, V103, P359, DOI 10.1093/aob/mcn216; Parolin P, 2013, ECOTROPICA, V19, P15; Pettit NE, 2007, ECOSYSTEMS, V10, P673, DOI 10.1007/s10021-007-9048-5; Pettit NE, 2007, ECOLOGY, V88, P2094, DOI 10.1890/06-1270.1; Pott VJ., 1994, PLANTAS PANTANAL; Roberts DW, 2015, LABDSV ORDINATION MU; Rocha M, 2015, BRAZ J BIOL, V75, P114, DOI 10.1590/1519-6984.08613; Rodriguez-Gonzalez PM, 2010, FOREST ECOL MANAG, V259, P2015, DOI 10.1016/j.foreco.2010.02.012; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Silva LCR, 2013, PLANT SOIL, V373, P829, DOI 10.1007/s11104-013-1822-x; SORIANO BMA, 1997, B PESQUISA, V11; Stellmes Marion, 2013, Biodiversity Ecol, V5, P351, DOI 10.7809/b-e.00288; Strohbach Ben J., 2013, Biodiversity Ecol, V5, P321, DOI 10.7809/b-e.00286; Stromberg JC, 2009, RESTOR ECOL, V17, P327, DOI 10.1111/j.1526-100X.2007.00347.x; Ugurlu E, 2012, INT J BIOMETEOROL, V56, P85, DOI 10.1007/s00484-010-0399-9; Valio Ivany Ferraz Marques, 2001, Revista Brasileira de Botanica, V24, P79, DOI 10.1590/S0100-84042001000100009; Venables WN., 2002, MODERN APPL STAT S 4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wittmann F, 2006, J BIOGEOGR, V33, P1334, DOI 10.1111/j.1365-2699.2006.01495.x; Wittmann F, 2008, FOLIA GEOBOT, V43, P397, DOI 10.1007/s12224-008-9022-9; Zuur Alain F., 2009, P1	76	25	27	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156825	10.1371/journal.pone.0156825	http://dx.doi.org/10.1371/journal.pone.0156825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280879	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000049
J	Chen, C; Sung, KT; Shih, SC; Liu, CC; Kuo, JY; Hou, CJY; Hung, CL; Yeh, HI				Chen, Chi; Sung, Kuo-Tzu; Shih, Shou-Chuan; Liu, Chuan-Chuan; Kuo, Jen-Yuan; Hou, Charles Jia-Yin; Hung, Chung-Lieh; Yeh, Hung-I			Age, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population	PLOS ONE			English	Article							NORMAL EJECTION FRACTION; HEART-FAILURE; CLINICAL CHARACTERISTICS; CARDIOVASCULAR EVENTS; CARDIAC STRUCTURE; RISK-FACTORS; MASS; DISEASE; HYPERTROPHY; DYSFUNCTION	Background Advanced age is associated with left ventricle (LV) remodeling and impaired cardiac function that may increase the risk of heart failure. Even so, studies regarding age-related cardiac remodeling in a large, asymptomatic Asian population remain limited. Materials and Methods We studied 8,410 asymptomatic participants (49.7 +/- 11.7 y, 38.9% women) in a health evaluation cohort (2004-2012) at a tertiary center in Northern Taiwan. We analyzed age-related alterations for all echocardiography-derived cardiac structures/functions and the associations with circulating N-terminal prohormone of brain natriuretic peptide (NT-proBNP). We also explored sex-related differences in these measures. Results In our cohort of 8,410 participants, advanced age was associated with greater LV wall thickness, larger LV total mass (+ 5.08 g/decade), and greater LV mass index (4.41 g/m(2)/decade), as well as increased serum NT-proBNP level (+ 18.89 pg/mL/decade). An accompanying reduction of stress-corrected midwall fractional shortening (-0.1%/decade) with aging was apparent in women after multi-variate adjustment (-0.09%/decade, p = 0.001). Furthermore, women demonstrated greater overall increase in LV wall thickness, LV mass index, and NT-proBNP compared to men (p for interaction: < 0.001). All blood pressure components, including systolic, diastolic, and pulse pressures were independently associated with greater wall thickness and LV mass index after adjustment for confounders (all p < 0.001). The associations between age and cardiac remodeling or mid-wall functions were further confirmed in a subset of study subjects with repeated follow up by GEE model. Conclusions Significant associations of unfavorable LV remodeling and advanced age in our asymptomatic Asian population were observed, along with sex differences. These data may help explain the incidence of some diverse gender-related cardiovascular diseases, especially heart failure.	[Chen, Chi; Sung, Kuo-Tzu; Shih, Shou-Chuan; Kuo, Jen-Yuan; Hou, Charles Jia-Yin; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Sung, Kuo-Tzu; Hou, Charles Jia-Yin; Hung, Chung-Lieh; Yeh, Hung-I] Mackay Mem Hosp, Taipei Branch, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Shih, Shou-Chuan] Mackay Mem Hosp, Taipei Branch, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Liu, Chuan-Chuan] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University	Hung, CL (corresponding author), Mackay Med Coll, Dept Med, New Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Mem Hosp, Taipei Branch, Div Cardiol, Dept Internal Med, Taipei, Taiwan.	jotaro3791@gmail.com	Kuo, Jen-Yuan/AAX-5448-2021		National Science Council [NSC 103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3]; Mackay Memorial Hospital [10271, 10248, 10220, 10253, 10375, 10358, E-102003]	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This work was partly supported by grants of the National Science Council (NSC 103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3), and Mackay Memorial Hospital (10271, 10248, 10220, 10253, 10375, 10358, E-102003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov D, 2011, J CARD FAIL, V17, P547, DOI 10.1016/j.cardfail.2011.03.010; Aune E, 2015, JACC-CARDIOVASC IMAG, V8, P656, DOI 10.1016/j.jcmg.2015.02.014; AURIGEMMA GP, 1995, J AM COLL CARDIOL, V26, P195, DOI 10.1016/0735-1097(95)00153-Q; Bay M, 2003, HEART, V89, P150, DOI 10.1136/heart.89.2.150; Borlaug BA, 2014, NAT REV CARDIOL, V11, P507, DOI 10.1038/nrcardio.2014.83; Borlaug BA, 2009, J AM COLL CARDIOL, V54, P410, DOI 10.1016/j.jacc.2009.05.013; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Cain Peter A, 2009, BMC Med Imaging, V9, P2, DOI 10.1186/1471-2342-9-2; Chahal NS, 2012, JACC-CARDIOVASC IMAG, V5, P1191, DOI 10.1016/j.jcmg.2012.07.014; Chen CC, 2015, CHEMSUSCHEM, V8, P114, DOI 10.1002/cssc.201402886; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Choi EY, 2013, EUR HEART J, V34, P2354, DOI 10.1093/eurheartj/eht133; de Simone G, 2002, Eur J Echocardiogr, V3, P192, DOI 10.1053/euje.2002.0163; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gebhard C, 2013, ECHOCARDIOGR-J CARD, V30, P1143, DOI 10.1111/echo.12264; Gidding SS, 2013, CIRC-CARDIOVASC IMAG, V6, P769, DOI 10.1161/CIRCIMAGING.112.000450; Iwashima Y, 2006, HYPERTENSION, V47, P195, DOI 10.1161/01.HYP.0000200033.14574.14; Kallaras K, 2001, HERZ, V26, P129, DOI 10.1007/s00059-001-2259-1; Kaneko H, 2013, J CARDIOL, V62, P102, DOI 10.1016/j.jjcc.2013.03.013; Katz DH, 2013, AM J CARDIOL, V112, P1158, DOI 10.1016/j.amjcard.2013.05.061; Lai CL, 2011, INT J CARDIOL, V149, P347, DOI 10.1016/j.ijcard.2010.02.015; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LINDROOS M, 1994, AM J CARDIOL, V74, P385, DOI 10.1016/0002-9149(94)90408-1; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; Maurer MS, 2007, J AM COLL CARDIOL, V49, P972, DOI 10.1016/j.jacc.2006.10.061; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Park CM, 2013, HYPERTENSION, V61, P1014, DOI 10.1161/HYPERTENSIONAHA.111.00610; Persson H, 2007, J AM COLL CARDIOL, V49, P687, DOI 10.1016/j.jacc.2006.08.062; Redheuil A, 2011, J AM COLL CARDIOL, V58, P1262, DOI 10.1016/j.jacc.2011.06.012; Turley AJ, 2007, POSTGRAD MED J, V83, P206, DOI 10.1136/pgmj.2006.052886; Velagaleti RS, 2014, AM J CARDIOL, V113, P117, DOI 10.1016/j.amjcard.2013.09.028; Verdecchia P, 2003, AM J HYPERTENS, V16, P895, DOI 10.1016/S0895-7061(03)01018-5; Wong RCC, 2008, ECHOCARDIOGR-J CARD, V25, P805, DOI 10.1111/j.1540-8175.2008.00709.x; Yip GWK, 2009, HEART, V95, P980, DOI 10.1136/hrt.2008.153551; Zhang Y, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-86; Zhang YF, 2014, APPL THERM ENG, V65, P1, DOI 10.1016/j.applthermaleng.2013.12.069; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031	40	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156467	10.1371/journal.pone.0156467	http://dx.doi.org/10.1371/journal.pone.0156467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280886	gold, Green Submitted, Green Published			2022-12-27	WOS:000377563000029
J	Ingram, J; Hand, CJ; Maciejewski, G				Ingram, Joanne; Hand, Christopher J.; Maciejewski, Greg			Exploring the Measurement of Markedness and Its Relationship with Other Linguistic Variables	PLOS ONE			English	Article							EYE-MOVEMENTS; ADJECTIVES; WORDS	Antonym pair members can be differentiated by each word's markedness-that distinction attributable to the presence or absence of features at morphological or semantic levels. Morphologically marked words incorporate their unmarked counterpart with additional morphs (e.g., "unlucky" vs. "lucky"); properties used to determine semantically marked words (e.g., "short" vs. "long") are less clearly defined. Despite extensive theoretical scrutiny, the lexical properties of markedness have received scant empirical study. The current paper employs an antonym sequencing approach to measure markedness: establishing markedness probabilities for individual words and evaluating their relationship with other lexical properties (e.g., length, frequency, valence). Regression analyses reveal that markedness probability is, as predicted, related to affixation and also strongly related to valence. Our results support the suggestion that antonym sequence is reflected in discourse, and further analysis demonstrates that markedness probabilities, derived from the antonym sequencing task, reflect the ordering of antonyms within natural language. In line with the Pollyanna Hypothesis, we argue that markedness is closely related to valence; language users demonstrate a tendency to present words evaluated positively ahead of those evaluated negatively if given the choice. Future research should consider the relationship of markedness and valence, and the influence of contextual information in determining which member of an antonym pair is marked or unmarked within discourse.	[Ingram, Joanne; Hand, Christopher J.; Maciejewski, Greg] Univ Bedfordshire, Dept Psychol, Luton, Beds, England; [Ingram, Joanne; Hand, Christopher J.] Glasgow Caledonian Univ, Dept Psychol Social Work & Allied Hlth Sci, Glasgow G4 0BA, Lanark, Scotland; [Maciejewski, Greg] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England	University of Bedfordshire; Glasgow Caledonian University; University of Leeds	Ingram, J (corresponding author), Univ Bedfordshire, Dept Psychol, Luton, Beds, England.	joanne.ingram@gcu.ac.uk	Hand, Christopher/AAJ-1422-2020; Hand, Christopher/AAP-5209-2020; Hand, Christopher James/ABE-5912-2021; Ingram, Joanne/ABH-7643-2020	Hand, Christopher James/0000-0002-1536-4005; Ingram, Joanne/0000-0003-2419-8181; Maciejewski, Greg/0000-0002-5687-1302	University of Bedfordshire Research Centre for Applied Psychology	University of Bedfordshire Research Centre for Applied Psychology	This work was supported by funding from the University of Bedfordshire Research Centre for Applied Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battistella E.L., 1990, MARKEDNESS EVALUATIV; BOUCHER J, 1969, J VERB LEARN VERB BE, V8, P1, DOI 10.1016/S0022-5371(69)80002-2; Clark H. H., 1973, VISUAL INFORM PROCES, P311, DOI DOI 10.1016/B978-0-12-170150-5.50013-5; Clark H. H., 1977, PSYCHOL LANGUAGE INT; CLARK HH, 1969, PSYCHOL REV, V76, P387, DOI 10.1037/h0027578; Cooper W, 1975, 11 REG M CHIC LING S, P63; Cruse D., 1986, LEXICAL SEMANTICS; DiVesta FJ, 1961, CHILD DEV, V36, P186; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Fraenkel T, 2008, INTERCULT PRAGMAT, V5, P517, DOI 10.1515/IPRG.2008.025; Greenberg Joseph H., 1966, JANUA LINGUARUM SERI, V59; Hand CJ, 2010, J EXP PSYCHOL HUMAN, V36, P1294, DOI 10.1037/a0020363; Haspelmath M, 2006, J LINGUIST, V42, P25, DOI 10.1017/S0022226705003683; Hatzivassiloglou V, 1997, ACL, P174, DOI [10.3115/976909.979640, DOI 10.3115/976909.979640]; Horn L. R., 1989, NATURAL HIST NEGATIO; HUTTENLOCHER J, 1971, PSYCHOL REV, V78, P487, DOI 10.1037/h0031858; Jakobson R., 1962, SELECTED WRITINGS PH; Jones S, 2002, ANTONYMY CORPUS BASE; Kostic N, 2015, LANG SCI, V47, P18, DOI 10.1016/j.langsci.2014.07.013; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Leech G. N, 1983, PRINCIPLES PRAGMATIC; LEHRER A, 1985, J LINGUIST, V21, P397, DOI 10.1017/S002222670001032X; Levinson S. C., 1983, PRAGMATICS; Lyons, 1977, SEMANTICS 1 2; Medler D. A., 2005, MCWORD ON LINE ORTHO; Newmeyer Frederick., 2000, LANG SCI, V23, P187, DOI [10.1016/S0388-0001(00)00021-8, DOI 10.1016/S0388-0001(00)00021-8]; Osgood C.E., 1957, MEASUREMENT MEANING; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Schul Y., 2011, PERSPECTIVES FRAMING, P157, DOI 10.4324/9780203854167.; Scott GG, 2012, J EXP PSYCHOL LEARN, V38, P783, DOI 10.1037/a0027209; Trubetzkoy N, 1939, PHONOLOGICAL STUDIES; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157141	10.1371/journal.pone.0157141	http://dx.doi.org/10.1371/journal.pone.0157141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280450	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000377563000095
J	Manaf, MRA; Mustafa, M; Rahman, MRA; Yusof, KH; Abd Aziz, NA				Manaf, M. Rizal Abdul; Mustafa, Madihah; Rahman, Mohd Rizam Abdul; Yusof, Khairul Hazdi; Abd Aziz, Noor Azah			Factors Influencing the Prevalence of Mental Health Problems among Malay Elderly Residing in a Rural Community: A Cross-Sectional Study	PLOS ONE			English	Article							PEOPLE; LIFE	Background and Purpose Mental health problems are common in old age, but frequently remain undetected and untreated. Mental health problems in the elderly are the result of a complex interaction of social, psychological and biological factors. The aim of this study is to determine the prevalence of mental health problems (depression, anxiety, and emotional stress) and their associated factors among the Malay elderly in a rural community of Perak, Malaysia. Methods It was a cross-sectional study. The Malay elderly aged 60 years and above were selected through convenient sampling to give a total of 230 respondents. The Depression, Anxiety, and Stress Scale (DASS-21) was used to assess the symptoms of depression, anxiety, and stress. Bivariate analyses were performed using chi-square tests and multiple logistic regression analyses were conducted to determine the association between the factors and each of the mental health statuses assessed. Results The results showed that the prevalence of depression, anxiety, and stress among the elderly respondents was 27.8%, 22.6%, and 8.7%, respectively. The significant factors for depression were single elderly (Adjusted OR = 3.27, 95% CI 1.66, 6.44), living with family (Adjusted OR = 4.98, 95% CI 2.05, 12.10), and poor general health status (Adjusted OR = 2.28, 95% CI 1.20, 4.36). Living with family was the only significant factor for anxiety (Adjusted OR = 2.68, 95% CI 1.09, 6.57). There was no significant factor for stress. Conclusions Depression and anxiety among the Malay elderly in the rural community were very worrying. More equity in health should be created or strengthened in order to intensify the opportunity to identify, diagnose, and treat those with mental health problems. Living arrangement in the rural community was an important factor that had influenced depression and anxiety. Therefore, further research is recommended for more comprehensive information, as a result of which appropriate intervention can be made.	[Manaf, M. Rizal Abdul; Mustafa, Madihah; Rahman, Mohd Rizam Abdul; Yusof, Khairul Hazdi] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Community Hlth, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia; [Abd Aziz, Noor Azah] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Family Med, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Manaf, MRA (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Community Hlth, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia.	mrizal@ppukm.ukm.edu.my	Manaf, Rizal Abdul/C-3030-2017	Abdul Manaf, Mohd Rizal/0000-0002-0813-8376	Universiti Kebangsaan Malaysia [FF-2013-283]	Universiti Kebangsaan Malaysia	This work was supported by Universiti Kebangsaan Malaysia (FF-2013-283) (www.ukm.my/sppi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright Julia W, 2010, Curr Gerontol Geriatr Res, V2010, P614814, DOI 10.1155/2010/614814; Bernabei V, 2011, AGING MENT HEALTH, V15, P467, DOI 10.1080/13607863.2011.562483; Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411; Department of Statistic Malaysia, 2010, POP DISTR BAS SOC CH; Forlani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089859; Huang CQ, 2010, AGE AGEING, V39, P23, DOI 10.1093/ageing/afp187; Imran A, 2009, Med J Malaysia, V64, P134; Kirmizioglu Y, 2009, INT J GERIATR PSYCH, V24, P1026, DOI 10.1002/gps.2215; Kooshiar H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043125; Lim L.L., 2011, CURRENT GERONTOLOGY, V2011, DOI [10.1155/2011/673181, DOI 10.1155/2011/673181]; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Lucchetti G, 2011, J REHABIL MED, V43, P316, DOI 10.2340/16501977-0784; Majdi MR, 2011, IRAN J PSYCHIATRY BE, V5, P17; Michael YL, 2001, AM J EPIDEMIOL, V153, P123, DOI 10.1093/aje/153.2.123; Ministry of Health Malaysia, 2015, MAL HLTH FACTS; Ministry of Health Malaysia, 2009, MAL HLTH FACTS; Minkler M, 1999, AM J PUBLIC HEALTH, V89, P1384, DOI 10.2105/AJPH.89.9.1384; Mohamad Adam Bujang, 2012, Journal of Health Informatics in Developing Countries, V6, P521; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Nagaraj AKM, 2011, ONLINE J HLTH ALLIED, V10, P5; Osman, 2015, SCH J APP MED SCI, V3, P159; Rashid A, 2010, IRAN J CANC PREVENT, V1, P1; Sherina M., 2005, INT MED J, V4, P57; Sherina M.S., 2004, J MED SCI, V11, P52; Stone J, 2013, AGE AGEING, V42, P366, DOI 10.1093/ageing/aft006; Suwanmanee S., 2012, Journal of the Medical Association of Thailand, V95, P8; Taqui AM, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-57; UN, 2005, LIVING ARRANGEMENTS; World Health Organization, 2013, HLTH TOP ELD DEPR; World Health Organization, 2010, GLOBAL BURDEN DIS; World Health Organization, GLOB HLTH OBS GHO DA	31	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156937	10.1371/journal.pone.0156937	http://dx.doi.org/10.1371/journal.pone.0156937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280529	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000056
J	Ward, JL; Viner, RM				Ward, Joseph L.; Viner, Russell M.			Secondary Education and Health Outcomes in Young People from the Cape Area Panel Study (CAPS)	PLOS ONE			English	Article							SERIOUS MENTAL-ILLNESS; MATERNAL EDUCATION; GENERAL-POPULATION; CHILD SURVIVAL; COUNTRIES; DISTRESS; DISEASE; SCALE	Aim Education is one of the strongest social determinants of health, yet previous literature has focused on primary education. We examined whether there are additional benefits to completing upper secondary compared to lower secondary education in a middle-income country. Methods We performed a longitudinal analysis of the Cape Area Panel Study, a survey of adolescents living in South Africa. We undertook causal modeling using structural marginal models to examine the association between level of education and various health outcomes, using inverse probability weighting to control for sex, age, ethnicity, home language, income, whether employed in past year, region of birth, maternal educational status, marital status, whether currently pregnant and cognitive ability. Educational attainment was defined as primary (grades 1-7), lower secondary (grades 8-9) or upper secondary (grades 10-12). Results Of 3,432 participants, 165 (4.8%) had completed primary education, 646 (18.8%) lower secondary and 2,621 (76.3%) upper secondary. Compared to those completing lower secondary, males completing upper secondary education were less likely to have a health problem (OR 0.49; 95% CI 0.27-0.88; p = 0.02); describe their health as poor (0.52; 0.29-0.95; p = 0.03) or report that health interferes with daily life (0.54; 0.29-0.99; p = 0.047). Females were less likely to have been pregnant (0.45; 0.33-0.61; p<0.001) or pregnant under 18 (0.32; 0.22-0.46; p<0.001); and having had sex under 16 was also less likely (males 0.63; 0.44-0.91; p = 0.01; females 0.39; 0.26-0.58; p<0.001). Cigarette smoking was less likely (males 0.52; 0.38-0.70; p = <0.001; females 0.56; 0.41-0.76; p<0.001), as was taking illicit drugs in males (0.6; 0.38-0.96; p = 0.03). No associations were found between education and alcohol use, psychological distress, obesity, increased waist circumference or hypertension. Conclusion Completing upper secondary education was associated with improved health outcomes compared with lower secondary education. Expanding upper secondary education offers middle-income countries an effective way of improving adolescent health.	[Ward, Joseph L.; Viner, Russell M.] UCL, UCL Inst Child Hlth, London, England	University of London; University College London	Ward, JL (corresponding author), UCL, UCL Inst Child Hlth, London, England.	joseph.ward.14@ucl.ac.uk	Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247; Ward, Joseph/0000-0001-7263-8845				[Anonymous], 2015, FIX BROK PROM ED ALL; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2000, WHO TECHN REP SER; Silva GAE, 2009, REV SAUDE PUBL, V43, P48, DOI 10.1590/S0034-89102009000900007; BICEGO GT, 1993, SOC SCI MED, V36, P1207, DOI 10.1016/0277-9536(93)90241-U; Bongaarts J., 2010, VIENNA YB POPULATION, V2010, P31, DOI DOI 10.1553/POPULATIONYEARBOOK2010S31; Cleland J, 2002, COMPLETING FERTILITY, P187; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Cutler DM, 2012, ED HLTH INSIGHTS INT; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Desa U, 2016, TRANSF OUR WORLD 203; Fukuda-Parr S., 2003, HUMAN DEV REPORT 200; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Hosseinpoor AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020331; Institute of Health Metrics and Evaluation (IHME), 2015, HAND GLOB PROGR UN E; Kelly AB, 2015, ADDICTION, V110, P627, DOI 10.1111/add.12829; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Lam D, 2013, STUD FAM PLANN, V44; Lam D, 2011, CAPE AREA PANEL STUD; Mahy M., 2002, TRENDS DIFFERENTIALS; Mason A.D, 2001, ENGENDERING DEV GEND; Maughan-Brown B, 2014, AIDS BEHAV, V18, P958, DOI 10.1007/s10461-013-0636-4; Organization for Economic Cooperation and Development: Centre for Educational Research and Innovation, 2010, IMPR HLTH SOC COH ED; Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349; Sassi F, 2009, ED OBESITY 4 OECD CO; Shisana O, 2009, S AFRICAN NATL HIV P; Suhrcke M, 2011, IMPACT HLTH HLTH BEH; Townsend L, 2007, CLIN CHILD FAM PSYCH, V10, P295, DOI 10.1007/s10567-007-0023-7; UNESCO, 2006, INT STAND CLASS ED I; UNESCO Institute for Statistics (UIS), 2015, COUNTR PROF S AFR	35	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156883	10.1371/journal.pone.0156883	http://dx.doi.org/10.1371/journal.pone.0156883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280408	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000054
J	Auld, AF; Blain, M; Ekra, KA; Kouakou, JS; Ettiegne-Traore, V; Tuho, MZ; Mohamed, F; Shiraishi, RW; Sabatier, J; Essombo, J; Adjorlolo-Johnson, G; Marlink, R; Ellerbrock, TV				Auld, Andrew F.; Blain, Michela; Ekra, Kunomboa Alexandre; Kouakou, Joseph Sylvain; Ettiegne-Traore, Virginie; Tuho, Moise Zanga; Mohamed, Fayama; Shiraishi, Ray W.; Sabatier, Jennifer; Essombo, Joseph; Adjorlolo-Johnson, Georgette; Marlink, Richard; Ellerbrock, Tedd V.			Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Cote d'Ivoire	PLOS ONE			English	Article							RISK-FACTORS; ADULTS; INFECTION; BOTSWANA; VALUES	Background In Cote d'Ivoire, tuberculosis (TB) is a common cause of death among HIV-infected antiretroviral therapy (ART) enrollees. Ivorian guidelines recommend screening for TB and initiation of TB treatment before ART initiation. Compliance with these guidelines can help reduce TB-related mortality during ART and possibly nosocomial TB transmission. Methods and Findings In a retrospective cohort study among 3,682 randomly selected adults (>= 15 years old) starting ART during 2004-2007 at 34 randomly selected facilities, documentation of TB screening completion, prevalence of active TB at ART initiation, and incidence of TB during ART were evaluated. At ART initiation, median age was 36 years, 67% were female, and median CD4 count was 135 cells/mu L. Among all 3,682 enrollees, 73 (2%) were on TB treatment at the time of referral to the ART facility. Among the 3,609 not on TB treatment, 1,263 (36%) were documented to receive some TB screening before ART initiation; 21% were screened for cough, 21% for weight loss, 18% for fever, 18% for TB contacts, and 12% for night sweats. Among the 1,263 screened, 111 (11%) were diagnosed with TB and started TB treatment before ART. No associations between patient characteristics and probability of being screened were noted. However, documentation of TB screening completion before ART varied widely by ART facility from 0-100%. TB incidence during ART was 3.0 per 100 person-years but varied widely by ART facility from 0/100 person-year to 13.1/100 person-years. Conclusions Screening for TB before ART initiation was poorly documented. Facility-level variations in TB screening documentation suggest facility-level factors, such as investment in training programs, might determine documentation practices. Targeting under-performing ART facilities with improvement activities is needed. Variations among facilities in TB incidence warrant further research. These incidence variations could reflect differences between facilities in TB screening, diagnostic tests, documentation practices, or TB risk possibly related to infection control practices or local community TB incidence.	[Auld, Andrew F.; Blain, Michela; Shiraishi, Ray W.; Sabatier, Jennifer; Ellerbrock, Tedd V.] Ctr Dis Control & Prevent, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA USA; [Ekra, Kunomboa Alexandre] Ctr Dis Control & Prevent, Div Global HIV & TB, Ctr Global Hlth, Abidjan, Cote Ivoire; [Kouakou, Joseph Sylvain; Mohamed, Fayama; Essombo, Joseph] Elizabeth Glaser Pediat AIDS Fdn, Abidjan, Cote Ivoire; [Ettiegne-Traore, Virginie; Tuho, Moise Zanga] Minist Hlth, Natl Program Med Care Persons Living HIV AIDS, Abidjan, Cote Ivoire; [Mohamed, Fayama] Dept Econ & Finance, Directorate Gen Budget & Finance, Abidjan, Cote Ivoire; [Adjorlolo-Johnson, Georgette; Marlink, Richard] Elizabeth Glaser Pediat AIDS Fdn, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Auld, AF (corresponding author), Ctr Dis Control & Prevent, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA USA.	aauld@cdc.gov		Auld, Andrew/0000-0001-5089-9163; Shiraishi, Ray/0000-0001-7640-0666	U.S. Centers for Disease Control and Prevention (CDC)	U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the U.S. Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Auld AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098183; Auld AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054665; Chihota VN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138149; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Duncan K, 2015, J RADIOLOGY NURSING, V34, P43; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-253; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Momin SR, 2016, JAMA OTOLARYNGOL HEA; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Senbeto M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1222; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, UNAIDS GAP REP 2014; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO, GLOB TUB REP 2014; World Health Organization, SYST SCREEN ACT TUB; World Health Organization, CONS GUID US ANT DRU; World Health Organization (WHO), COT IV TUB PROF	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157059	10.1371/journal.pone.0157059	http://dx.doi.org/10.1371/journal.pone.0157059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275742	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700062
J	Gaillard, CA; Bock, AH; Carrera, F; Eckardt, KU; Van Wyck, DB; Bansal, SS; Cronin, M; Meier, Y; Larroque, S; Roger, SD; Macdougall, IC				Gaillard, Carlo A.; Bock, Andreas H.; Carrera, Fernando; Eckardt, Kai-Uwe; Van Wyck, David B.; Bansal, Sukhvinder S.; Cronin, Maureen; Meier, Yvonne; Larroque, Sylvain; Roger, Simon D.; Macdougall, Iain C.			Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS ASSOCIATIONS; ORAL IRON; SERUM HEPCIDIN; INTRAVENOUS IRON; ROUND-ROBIN; ERYTHROPOIETIN; BIOMARKER; FERRITIN; URINARY	Hepcidin is the key regulator of iron homeostasis but data are limited regarding its temporal response to iron therapy, and response to intravenous versus oral iron. In the 56-week, open-label, multicenter, prospective, randomized FIND-CKD study, 626 anemic patients with non-dialysis dependent chronic kidney disease (ND-CKD) and iron deficiency not receiving an erythropoiesis stimulating agent were randomized (1:1:2) to intravenous ferric carboxymaltose (FCM), targeting higher (400-600 mu g/L) or lower (100-200 mu g/L) ferritin, or to oral iron. Serum hepcidin levels were measured centrally in a subset of 61 patients. Mean (SD) baseline hepcidin level was 4.0(3.5), 7.3(6.4) and 6.5(5.6) ng/mL in the high ferritin FCM (n = 17), low ferritin FCM (n = 16) and oral iron group (n = 28). The mean (SD) endpoint value (i.e. the last post-baseline value) was 26.0(9.1), 15.7(7.7) and 16.3(11.0) ng/mL, respectively. The increase in hepcidin from baseline was significantly smaller with low ferritin FCM or oral iron vs high ferritin FCM at all time points up to week 52. Significant correlations were found between absolute hepcidin and ferritin values (r = 0.65, p< 0.001) and between final post-baseline increases in both parameters (r = 0.70, p< 0.001). The increase in hepcidin levels over the 12-month study generally mirrored the cumulative iron dose in each group. Hepcidin and transferrin saturation (TSAT) absolute values showed no correlation, although there was an association between final post-baseline increases (r = 0.42, p< 0.001). Absolute values (r = 0.36, p = 0.004) and final post-baseline increases of hepcidin and hemoglobin (p = 0.30, p = 0.030) correlated weakly. Baseline hepcidin levels were not predictive of a hematopoietic response to iron therapy. In conclusion, hepcidin levels rose in response to either intravenous or oral iron therapy, but the speed and extent of the rise was greatest with intravenous iron targeting a higher ferritin level. However neither the baseline level nor the change in hepcidin was able to predict response to therapy in this cohort.	[Gaillard, Carlo A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Bock, Andreas H.] Kantonsspital, Dept Nephrol, Aarau, Switzerland; [Carrera, Fernando] DaVita, Eurodial, Dept Dialysis, Leiria, Portugal; [Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Van Wyck, David B.] Davita Healthcare Partners, Clin Support Serv, Denver, CO USA; [Bansal, Sukhvinder S.] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Cronin, Maureen; Meier, Yvonne; Larroque, Sylvain] Vifor Pharma Ltd, Glattbrugg, Switzerland; [Roger, Simon D.] Renal Res, Gosford, NSW, Australia; [Macdougall, Iain C.] Kings Coll Hosp London, Dept Renal Med, London, England	University of Groningen; Kantonsspital Aarau AG (KSA); University of Erlangen Nuremberg; DaVita; University of London; King's College London; Vifor Pharma; King's College Hospital NHS Foundation Trust; King's College Hospital	Gaillard, CA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	c.a.j.m.gaillard@umcg.nl	Gaillard, Carlo/AAC-6729-2022; Cronin, Maureen/ABC-4218-2021	Gaillard, Carlo/0000-0002-8964-0236; 	Vifor Pharma, Glattbrugg, Switzerland; Vifor Pharma; Vifor Pharma Ltd; Davita Healthcare Partners	Vifor Pharma, Glattbrugg, Switzerland; Vifor Pharma; Vifor Pharma Ltd; Davita Healthcare Partners	The FIND-CKD study was funded by Vifor Pharma, Glattbrugg, Switzerland. Medical writing supported was provided by a freelance medical writer funded by Vifor Pharma (C Dunstall). MC, YM, and SL are employed by Vifor Pharma Ltd. Vifor Pharma Ltd provided support in the form of salaries for MC, YM, and SL, and contributed to the study design and data analysis, and these authors reviewed the manucript prior to publication. The specific roles of these authors are articulated in the 'author contributions' section. DBVW is employed by Davita Healthcare Partners. Davita Healthcare Partners provided support in the form of salary for author DBVW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Bansal SS, 2010, RAPID COMMUN MASS SP, V24, P1251, DOI 10.1002/rcm.4512; Bratescu LO, 2014, INT UROL NEPHROL, V46, P1005, DOI 10.1007/s11255-014-0696-z; Bregman DB, 2013, AM J HEMATOL, V88, P97, DOI 10.1002/ajh.23354; Camaschella C, 2008, HAEMATOL-HEMATOL J, V93, P1441, DOI 10.3324/haematol.13724; Chand S, 2015, J NEPHROL, V28, P81, DOI 10.1007/s40620-014-0083-y; Coyne DW, 2011, KIDNEY INT, V80, P240, DOI 10.1038/ki.2011.141; Eguchi A, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/239476; Ford BA, 2010, KIDNEY INT, V78, P769, DOI 10.1038/ki.2010.254; Fung E, 2013, HAEMATOLOGICA, V98, P1667, DOI 10.3324/haematol.2013.084624; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kroot JJC, 2012, AM J HEMATOL, V87, P977, DOI 10.1002/ajh.23289; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Macdougall IC, 2014, NEPHROL DIAL TRANSPL, V29, P2075, DOI 10.1093/ndt/gfu201; Macdougall IC, 2014, NEPHROL DIAL TRANSPL, V29, P843, DOI 10.1093/ndt/gft424; Macdougall IC, 2010, CLIN J AM SOC NEPHRO, V5, P1681, DOI 10.2215/CJN.05990809; Malyszko J, 2009, CLIN J AM SOC NEPHRO, V4, P1015, DOI 10.2215/CJN.02690409; Mercadel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099781; Moretti D, 2015, BLOOD, V126, P1981, DOI 10.1182/blood-2015-05-642223; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pechlaner R, 2016, CLIN CHEM LAB MED, V54, P151, DOI 10.1515/cclm-2015-0068; Peters HPE, 2010, NEPHROL DIAL TRANSPL, V25, P848, DOI 10.1093/ndt/gfp546; Takasawa K, 2015, NUTRIENTS, V7, P103, DOI 10.3390/nu7010103; Tessitore N, 2010, NEPHROL DIAL TRANSPL, V25, P3996, DOI 10.1093/ndt/gfq321; van der Putten K, 2010, EUR J HEART FAIL, V12, P943, DOI 10.1093/eurjhf/hfq099; van der Weerd NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039783; Weiss G, 2009, EUR J CLIN INVEST, V39, P883, DOI 10.1111/j.1365-2362.2009.02182.x; Xu Y, 2011, J INT MED RES, V39, P1961, DOI 10.1177/147323001103900542; Young B, 2009, CLIN J AM SOC NEPHRO, V4, P1384, DOI 10.2215/CJN.02190309; Zaritsky J, 2009, CLIN J AM SOC NEPHRO, V4, P1051, DOI 10.2215/CJN.05931108	35	26	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157063	10.1371/journal.pone.0157063	http://dx.doi.org/10.1371/journal.pone.0157063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276035	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700065
J	Kim, TK; Won, JY; Shin, JA; Park, YM; Yim, HW; Park, YH				Kim, Tai Kyong; Won, Jae Yon; Shin, Jeong Ah; Park, Yong-Moon; Yim, Hyeon Woo; Park, Young-Hoon			The Association of Metabolic Syndrome with Diabetic Retinopathy: The Korean National Health and Nutrition Examination Survey 2008-2012	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS; INSULIN-RESISTANCE; MACROVASCULAR COMPLICATIONS; INCREASED PREVALENCE; OBESITY; AUTOANTIBODIES; POPULATION; MORTALITY	Aims To explore gender differences and associations between metabolic syndrome (MetS) and its components, and diabetic retinopathy (DR) in Korean adults aged 40 years and older with diabetes. Methods We analyzed data from the Korean National Health and Nutrition Examination Surveys (2008-2012). In total, 2,576 type 2 diabetic participants, aged 40 and older, were evaluated. Seven standard retinal fundus photographs were obtained after pupil dilation in both eyes. DR was graded using the modified Airlie House classification system. Vision-threatening diabetic retinopathy (VTDR) included proliferative diabetic retinopathy and clinically significant macular edema. MetS was defined according to the Joint Interim Statement, proposed in 2009, by the International Diabetes Federation and the American Heart Association/ National Heart, Lung, and Blood Institute. Multivariate logistic regression analysis was used to assess the relationship between MetS and its individual components with DR and VTDR. Results After controlling for confounders, MetS was not associated with DR in men or women. Moreover, the risk for DR or VTDR did not increase with increasing MetS components. However, high waist circumference was significantly inversely associated with VTDR (adjusted odds ratio = 0.36; 95% confidence interval = 0.14-0.93) only in men. Conclusions MetS was not associated with DR or VTDR in a Korean diabetic population. However, among MetS components, it seems that abdominal obesity was inversely associated with VTDR in Korean diabetic men.	[Kim, Tai Kyong; Won, Jae Yon; Shin, Jeong Ah; Park, Young-Hoon] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Park, Yong-Moon; Yim, Hyeon Woo] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Park, YH (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	parkyh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2012. YHP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2006, ISR MED ASSOC J, V8, P378; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 1981, Invest Ophthalmol Vis Sci, V21, P1; [Anonymous], 1991, Ophthalmology, V98, P786; Bae YJ, 2010, BIOL TRACE ELEM RES, V135, P182, DOI 10.1007/s12011-009-8511-x; BALLARD DJ, 1986, DIABETES CARE, V9, P334, DOI 10.2337/diacare.9.4.334; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bonadonna RC, 2006, DIABETES CARE, V29, P2701, DOI 10.2337/dc06-0942; Bucholz EM, 2012, AM J MED, V125, P796, DOI 10.1016/j.amjmed.2012.01.018; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; Gavin JR, 2000, DIABETES CARE, V23, pS4; Hanley AJG, 2002, DIABETES, V51, P2642, DOI 10.2337/diabetes.51.8.2642; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; Henricsson M, 2003, DIABETES CARE, V26, P349, DOI 10.2337/diacare.26.2.349; Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Iwasaki T, 2008, DIABETES RES CLIN PR, V79, P427, DOI [10.1016/j.diabres.2007.10.035, 10.1016/j.diabres.2007.06.014]; Kilpatrick ES, 2007, DIABETES CARE, V30, P707, DOI 10.2337/dc06-1982; Kim DJ, 2001, METABOLISM, V50, P590, DOI 10.1053/meta.2001.22558; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; KINYOUN J, 1989, OPHTHALMOLOGY, V96, P746; KLEIN BEK, 1995, ARCH OPHTHALMOL-CHIC, V113, P601, DOI 10.1001/archopht.1995.01100050069033; KLEIN BEK, 1991, OPHTHALMOLOGY, V98, P1261; Klein R, 1997, ARCH INTERN MED, V157, P650, DOI 10.1001/archinte.157.6.650; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; Lohmann T, 2001, DIABETOLOGIA, V44, P1005, DOI 10.1007/s001250100602; Martidis A, 2002, OPHTHALMOLOGY, V109, P920, DOI 10.1016/S0161-6420(02)00975-2; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Min HK, 1996, DIABETIC MED, V13, pS13; Mohan V, 1997, DIABETES RES CLIN PR, V38, P101, DOI 10.1016/S0168-8227(97)00088-0; Pang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097928; Park JY, 1997, DIABETES RES CLIN PR, V35, P49, DOI 10.1016/S0168-8227(96)01363-0; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; Reaven GM, 1988, NUTRITION, V13, P66; REAVEN GM, 1988, NUTRITION, V13, P64; REAVEN GM, 1988, NUTRITION, V13, P65; Roh MO, 2013, ACTA DIABETOL, V50, P129, DOI 10.1007/s00592-010-0228-y; Saely CH, 2005, J CLIN ENDOCR METAB, V90, P5698, DOI 10.1210/jc.2005-0799; Shimajiri Y, 2008, DIABETES RES CLIN PR, V79, P310, DOI 10.1016/j.diabres.2007.08.026; Shin CS, 1997, DIABETES CARE, V20, P1842, DOI 10.2337/diacare.20.12.1842; Sone H, 2006, DIABETES CARE, V29, P145, DOI 10.2337/diacare.29.01.06.dc05-1341; Sone H, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12151-4; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tapp RJ, 2003, DIABETES CARE, V26, P1731, DOI 10.2337/diacare.26.6.1731; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Won KB, 2014, CATHETER CARDIO INTE, V83, P713, DOI 10.1002/ccd.25150; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu J, 2004, CLIN IMMUNOL, V113, P318, DOI 10.1016/j.clim.2004.08.009; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zheng YF, 2012, OPHTHALMOLOGY, V119, P2119, DOI 10.1016/j.ophtha.2012.04.027; ZIMMET PZ, 1995, DIABETES CARE, V18, P1050, DOI 10.2337/diacare.18.7.1050; Zinman B, 2004, DIABETES, V53, P3193, DOI 10.2337/diabetes.53.12.3193	59	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157006	10.1371/journal.pone.0157006	http://dx.doi.org/10.1371/journal.pone.0157006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275953	Green Submitted, gold, Green Published			2022-12-27	WOS:000377561700057
J	Terasaki, H; Yamashita, T; Yoshihara, N; Kii, Y; Tanaka, M; Nakao, K; Sakamoto, T				Terasaki, Hiroto; Yamashita, Takehiro; Yoshihara, Naoya; Kii, Yuya; Tanaka, Minoru; Nakao, Kumiko; Sakamoto, Taiji			Location of Tessellations in Ocular Fundus and Their Associations with Optic Disc Tilt, Optic Disc Area, and Axial Length in Young Healthy Eyes	PLOS ONE			English	Article							MYOPIA; POPULATION; BLINDNESS; PREVALENCE; TAJIMI	Tessellated fundus is found as common and early-phase characteristic of myopic eyes and their locations are varied among patients. However, the relationship between their locations and morphological parameters of the eyes is still unknown. The purpose is this study is to determine the locations of the tessellations in the ocular fundus of young healthy eyes, and to determine relationships between their locations and morphological parameters of the eyes. This is a prospective observational cross sectional study of 126 eyes of 126 healthy volunteers (mean age 26.0 +/- 4.1 years). The eyes were classified into eight groups based on the location of the tessellations; no tessellation, temporal, infra-temporal, inferior, nasal, peripapillary, whole retina, and unclassified tessellations. The degree of optic disc tilt was quantified using a sine curve fitting program on the optical coherence tomographic circle scan images. The correlations between each tessellation location and the axial length, area of the optic disc plus conus (AOC), and optic disc tilt were determined. Forty-four eyes were place in the no tessellation group, 12 eyes in the temporal, 21 eyes in the infra-temporal, 9 eyes in the inferior, 8 eyes in the nasal, 15 eyes in the peripapillary, 11 eyes in the whole, and 6 eyes in the unclassified groups. The differences in the axial lengths between the no tessellation group and the infra-temporal groups were significant. A significant difference was found in the AOC between the no tessellation and the inferior, infra-temporal, and peripapilalry groups. A significant difference was found in the optic disc tilt between the no tessellation and infra-temporal groups (P<0.05). The tessellations are located at specific sites in the fundus of young healthy eyes with the infra-temporal location most frequent. It was correlated with some parameters associated with myopia.	[Terasaki, Hiroto; Yamashita, Takehiro; Yoshihara, Naoya; Kii, Yuya; Tanaka, Minoru; Nakao, Kumiko; Sakamoto, Taiji] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kagoshima University	Sakamoto, T (corresponding author), Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			Ministry of Education, Science, and Culture of the Japanese Government, Tokyo, Japan	Ministry of Education, Science, and Culture of the Japanese Government, Tokyo, Japan	This study was sponsored by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; CHIHARA E, 1994, GRAEF ARCH CLIN EXP, V232, P265, DOI 10.1007/BF00194475; Curtin B J, 1977, Trans Am Ophthalmol Soc, V75, P67; GHAFOUR IM, 1983, BRIT J OPHTHALMOL, V67, P209, DOI 10.1136/bjo.67.4.209; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; How ACS, 2009, ARCH OPHTHALMOL-CHIC, V127, P894, DOI 10.1001/archophthalmol.2009.134; Hsiang HW, 2008, AM J OPHTHALMOL, V146, P102, DOI 10.1016/j.ajo.2008.03.010; Hyung S M, 1992, Korean J Ophthalmol, V6, P32; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P587, DOI 10.1007/BF02169209; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; McBrien NA, 1997, INVEST OPHTH VIS SCI, V38, P321; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Spaide RF, PATHOLOGIC MYOPIA; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yamashita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122191; Yoshihara N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103586	19	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156842	10.1371/journal.pone.0156842	http://dx.doi.org/10.1371/journal.pone.0156842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275584	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700040
J	Tian, DM; Wang, Y; Zhang, XH; Liu, KY; Huang, XJ; Chang, YJ				Tian, Deng-Mei; Wang, Yu; Zhang, Xiao-Hui; Liu, Kai-Yan; Huang, Xiao-Jun; Chang, Ying-Jun			Rapid Recovery of CD3(+)CD8(+) T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation	PLOS ONE			English	Article							IDENTICAL SIBLING TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; ABSOLUTE LYMPHOCYTE COUNT; ALLOGENEIC BONE-MARROW; IMMUNE RECONSTITUTION; HEMATOLOGICAL MALIGNANCIES; ANTITHYMOCYTE GLOBULIN; OUTCOMES; RELAPSE; DISEASE	Background Rapid immune reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is significantly associated with lower infection, relapse and possibly secondary malignancy rates. The aim of this study was to investigate the role of peripheral lymphocyte subsets, especially CD3(+)CD8(+) cytotoxic T cell recovery, in predicting transplant outcomes, including the overall survival (OS) and non-relapse mortality (NRM) rates after unmanipulated haploidentical blood and marrow transplantation (HBMT). Methods Peripheral blood samples were obtained from 214 HBMT recipients with hematological malignancies. The peripheral lymphocyte subsets (CD3(+) T cells, CD3(+)CD4(+) helper T cells, CD3(+)CD8(+) cytotoxic T cells, and CD19(+)B cells) were analyzed by flow cytometry at days 30, 60, 90, 180, 270 and 360 after HBMT. Results The CD3(+)CD8(+) cytotoxic T cell recovery at day 90 (CD3(+)CD8(+)-90) was correlated with bacterial infection (P = 0.001), NRM (P = 0.001), leukemia-free survival (LFS, P = 0.005), and OS (P = 0.001) at a cutoff value of 375 cells/mu L CD3(+)CD8(+) T cells. The incidence of bacterial infection in patients with the CD3(+)CD8(+)-90 at >= 375 cells/mu L was significantly lower than that of cases with the CD3(+)CD8(+)-90 at <375 cells/mu L after HBMT (14.6% versus 41.6%, P<0.001). Multivariate analysis showed the rapid recovery of CD3(+)CD8(+) T cells at day 90 after HBMT was strongly associated with a lower incidence of NRM (HR = 0.30; 95% CI: 0.15-0.60; P = 0.000) and superior LFS (HR = 0.51; 95% CI: 0.32-0.82; P = 0.005) and OS (HR = 0.38; 95% CI: 0.23-0.63; P = 0.000). Conclusion The results suggest that the rapid recovery of CD3(+)CD8(+) cytotoxic T cells at day 90 following HBMT could predict superior transplant outcomes.	[Tian, Deng-Mei; Wang, Yu; Zhang, Xiao-Hui; Liu, Kai-Yan; Huang, Xiao-Jun; Chang, Ying-Jun] Peking Univ, Peoples Hosp, 11 South St Xizhimen, Beijing 100871, Peoples R China; [Tian, Deng-Mei; Wang, Yu; Zhang, Xiao-Hui; Liu, Kai-Yan; Huang, Xiao-Jun; Chang, Ying-Jun] Peking Univ, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, 11 South St Xizhimen, Beijing 100871, Peoples R China; [Huang, Xiao-Jun] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Huang, Xiao-Jun; Chang, Ying-Jun] Peking Univ, Collabrat Innovat Ctr Hematol, Beijing 100871, Peoples R China; [Tian, Deng-Mei] Chinese Peoples Liberat Army, Hosp 309, Dept Hematol, Beijing, Peoples R China	Peking University; Peking University; Peking University	Chang, YJ (corresponding author), Peking Univ, Peoples Hosp, 11 South St Xizhimen, Beijing 100871, Peoples R China.; Chang, YJ (corresponding author), Peking Univ, Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, 11 South St Xizhimen, Beijing 100871, Peoples R China.; Chang, YJ (corresponding author), Peking Univ, Collabrat Innovat Ctr Hematol, Beijing 100871, Peoples R China.	rmcyj@bjmu.edu.cn	Huang, Xiao-Jun/HIK-3759-2022; Chang, Ying-Jun/AAA-1182-2020	Huang, Xiao-Jun/0000-0002-2145-6643; Chang, Ying-Jun/0000-0002-6124-6050	Beijing Committee of Science and technology [Z141107002514088]; National High Technology Research and Development Program of China (Program 863) [2013AA020104]; National Natural Science Foundation of China [81470342, 81400075]; Key Program of National Natural Science Foundation of China [81230013]	Beijing Committee of Science and technology; National High Technology Research and Development Program of China (Program 863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported (in part) by the Beijing Committee of Science and technology (NO. Z141107002514088), the National High Technology Research and Development Program of China (Program 863) (Grant No. 2013AA020104), the National Natural Science Foundation of China (Grant No. 81470342, 81400075) and the Key Program of National Natural Science Foundation of China (Grant No. 81230013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger M, 2008, BONE MARROW TRANSPL, V41, P55, DOI 10.1038/sj.bmt.1705870; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Carvalho A, 2012, BLOOD, V119, P967, DOI 10.1182/blood-2011-06-362582; Chang YJ, 2008, BIOL BLOOD MARROW TR, V14, P323, DOI 10.1016/j.bbmt.2007.12.497; Chang YJ, 2013, LEUKEMIA LYMPHOMA, V54, P2671, DOI 10.3109/10428194.2013.783912; Chang YJ, 2012, J CLIN IMMUNOL, V32, P268, DOI 10.1007/s10875-011-9630-7; Chang YJ, 2011, AM J HEMATOL, V86, P227, DOI 10.1002/ajh.21921; Chang YJ, 2009, MEDICINE, V88, P322, DOI 10.1097/MD.0b013e3181c167e2; Ding ZC, 2012, BLOOD, V120, P2229, DOI 10.1182/blood-2011-12-398321; Dong LJ, 2007, BIOL BLOOD MARROW TR, V13, P1515, DOI 10.1016/j.bbmt.2007.09.007; Fedele R, 2012, BLOOD TRANSFUS-ITALY, V10, P174, DOI 10.2450/2012.0034-11; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Huang XJ, 2006, BONE MARROW TRANSPL, V38, P291, DOI 10.1038/sj.bmt.1705445; Ishaqi MK, 2008, BONE MARROW TRANSPL, V41, P245, DOI 10.1038/sj.bmt.1705891; Kim DH, 2006, BONE MARROW TRANSPL, V37, P1119, DOI 10.1038/sj.bmt.1705381; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Kmieciak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082544; Koehl U, 2007, BONE MARROW TRANSPL, V39, P269, DOI 10.1038/sj.bmt.1705584; Le Blanc K, 2009, BIOL BLOOD MARROW TR, V15, P1108, DOI 10.1016/j.bbmt.2009.05.015; Lu DP, 2006, BLOOD, V107, P3065, DOI 10.1182/blood-2005-05-2146; Luo XH, 2010, BIOL BLOOD MARROW TR, V16, P994, DOI 10.1016/j.bbmt.2010.02.007; Merindol N, 2011, BLOOD, V118, P4480, DOI 10.1182/blood-2011-04-349241; Oghumu S, 2015, FASEB J, V29, P1019, DOI 10.1096/fj.14-264507; Oliver BG, 2010, J INFECT DIS, V202, P1728, DOI 10.1086/657082; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Parkman R, 2006, BIOL BLOOD MARROW TR, V12, P919, DOI 10.1016/j.bbmt.2006.05.008; Politikos I, 2014, BLOOD, V124, P3201, DOI 10.1182/blood-2014-07-589176; Savani BN, 2007, LEUKEMIA, V21, P2145, DOI 10.1038/sj.leu.2404892; Savani BN, 2007, BIOL BLOOD MARROW TR, V13, P1216, DOI 10.1016/j.bbmt.2007.07.005; Seggewiss R, 2010, BLOOD, V115, P3861, DOI 10.1182/blood-2009-12-234096; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Wang Y, 2013, CANCER-AM CANCER SOC, V119, P978, DOI 10.1002/cncr.27761; Yan CH, 2012, BLOOD, V119, P3256, DOI 10.1182/blood-2011-09-380386	35	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156777	10.1371/journal.pone.0156777	http://dx.doi.org/10.1371/journal.pone.0156777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276058	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700037
J	Tsujikawa, T; Kimura, H; Matsuda, T; Fujiwara, Y; Isozaki, M; Kikuta, K; Okazawa, H				Tsujikawa, Tetsuya; Kimura, Hirohiko; Matsuda, Tsuyoshi; Fujiwara, Yasuhiro; Isozaki, Makoto; Kikuta, Ken-ichiro; Okazawa, Hidehiko			Arterial Transit Time Mapping Obtained by Pulsed Continuous 3D ASL Imaging with Multiple Post-Label Delay Acquisitions: Comparative Study with PET-CBF in Patients with Chronic Occlusive Cerebrovascular Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PERFUSION MRI; WATER; INVERSION; MODEL; PERMEABILITY; EFFICIENCY; ACCURACY	Arterial transit time (ATT) is most crucial for measuring absolute cerebral blood flow (CBF) by arterial spin labeling (ASL), a noninvasive magnetic resonance (MR) perfusion assessment technique, in patients with chronic occlusive cerebrovascular disease. We validated ASL-CBF and ASL-ATT maps calculated by pulsed continuous ASL (pCASL) with multiple post-label delay acquisitions in patients with occlusive cerebrovascular disease. Fifteen patients underwent MR scans, including pCASL, and positron emission tomography (PET) scans with O-15-water to obtain PET-CBF. MR acquisitions with different post-label delays (1.0, 1.5, 2.0, 2.5 and 3.0 sec) were also obtained for ATT correction. The theoretical framework of 2-compartmental model (2CM) was also used for the delay compensation. ASL-CBF and ASL-ATT were calculated based on the proposed 2CM, and the effect on the CBF values and the ATT correction characteristics were discussed. Linear regression analyses were performed both on pixel-by-pixel and region-of-interest bases in the middle cerebral artery (MCA) territory. There were significant correlations between ASL-CBF and PET-CBF both for voxel values (r = 0.74 +/- 0.08, slope: 0.87 +/- 0.22, intercept: 6.1 +/- 4.9) and for the MCA territorial comparison in both affected (R-2 = 0.67, y = 0.83x + 6.3) and contralateral sides (R-2 = 0.66, y = 0.74x + 6.3). ASL-ATTs in the affected side were significantly longer than those in the contralateral side (1.51 +/- 0.41 sec and 1.12 +/- 0.30 sec, respectively, p < 0.0005). CBF measurement using pCASL with delay compensation was feasible and fairly accurate even in altered hemodynamic states.	[Kimura, Hirohiko; Fujiwara, Yasuhiro] Univ Fukui, Fac Med Sci, Dept Radiol, Fukui 910, Japan; [Tsujikawa, Tetsuya; Okazawa, Hidehiko] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan; [Matsuda, Tsuyoshi] GE Healthcare Japan, Hino, Tokyo, Japan; [Isozaki, Makoto] Univ Fukui, Dept Neurosurg, Fac Med Sci, Fukui 910, Japan; [Fujiwara, Yasuhiro] Kumamoto Univ, Dept Med Imaging, Fac Life Sci, Kumamoto, Japan	University of Fukui; University of Fukui; General Electric; University of Fukui; Kumamoto University	Kimura, H (corresponding author), Univ Fukui, Fac Med Sci, Dept Radiol, Fukui 910, Japan.	kimura@u-fukui.ac.jp	Okazawa, Hidehiko/I-2488-2019	Okazawa, Hidehiko/0000-0001-7046-3383	Japan Society for the Promotion of Science [23591757, 15K09916]; Eizai Co. Ltd.; GE Healthcare Japan; Grants-in-Aid for Scientific Research [15K21240, 15K15453] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Eizai Co. Ltd.; GE Healthcare Japan(General ElectricGE Healthcare); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by the grants-in-aid for scientific research from the Japan Society for the Promotion of Science (23591757, 15K09916) and a research grant about ASL perfusion from Eizai Co. Ltd. HK received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GE Healthcare Japan provided support in the form of salaries for authors [TM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Arakawa S, 2003, AM J NEURORADIOL, V24, P427; Bokkers RPH, 2010, J CEREBR BLOOD F MET, V30, P222, DOI 10.1038/jcbfm.2009.204; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Dai WY, 2013, MAGN RESON MED, V69, P1014, DOI 10.1002/mrm.24335; Dai WY, 2012, MAGN RESON MED, V67, P1252, DOI 10.1002/mrm.23103; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DEGRADO TR, 1994, J NUCL MED, V35, P1398; Detre JA, 1998, NEUROLOGY, V50, P633, DOI 10.1212/WNL.50.3.633; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; EDELMAN RR, 1994, RADIOLOGY, V192, P513, DOI 10.1148/radiology.192.2.8029425; Francis ST, 2008, MAGN RESON MED, V59, P316, DOI 10.1002/mrm.21442; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Gunther M, 2001, MAGNET RESON MED, V46, P974, DOI 10.1002/mrm.1284; HERSCOVITCH P, 1987, J CEREBR BLOOD F MET, V7, P527, DOI 10.1038/jcbfm.1987.102; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Isozaki M, 2011, EUR J NUCL MED MOL I, V38, P1075, DOI 10.1007/s00259-011-1734-z; Iwanaga T, 2014, MAGN RESON MED SCI, V13, P239, DOI 10.2463/mrms.2013-0117; Kamano H, 2013, ACTA RADIOL, V54, P99, DOI 10.1258/ar.2012.120450; Kimura H, 2004, INT CONGR SER, P238, DOI 10.1016/j.ics.2004.04.012; Kimura H, 2005, J MAGN RESON IMAGING, V22, P189, DOI 10.1002/jmri.20382; KWONG KK, 1995, MAGNET RESON MED, V34, P878, DOI 10.1002/mrm.1910340613; Okazawa H., 2002, BRAIN IMAGING USING, P15; Parkes LM, 2002, MAGN RESON MED, V48, P27, DOI 10.1002/mrm.10180; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Press William H., 2007, NUMERICAL RECIPES, P492; Qiu DQ, 2012, J MAGN RESON IMAGING, V36, P110, DOI 10.1002/jmri.23613; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Wang DJJ, 2013, NEUROIMAGE-CLIN, V3, P1, DOI 10.1016/j.nicl.2013.06.017; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang R, 2014, EUR RADIOL, V24, P1135, DOI 10.1007/s00330-014-3098-9; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; YAMAGUCHI T, 1986, STROKE, V17, P1220, DOI 10.1161/01.STR.17.6.1220; Zhao L, 2015, NEUROIMAGE, V121, P205, DOI 10.1016/j.neuroimage.2015.07.018	37	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156005	10.1371/journal.pone.0156005	http://dx.doi.org/10.1371/journal.pone.0156005			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275779	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700014
J	Pompa-Garcia, M; Venegas-Gonzalez, A				Pompa-Garcia, Marin; Venegas-Gonzalez, Alejandro			Temporal Variation of Wood Density and Carbon in Two Elevational Sites of Pinus cooperi in Relation to Climate Response in Northern Mexico	PLOS ONE			English	Article							TREE-RING WIDTH; RADIAL VARIATION; BIOMASS; TEMPERATURE; GROWTH; DROUGHT; RECONSTRUCTION; SENSITIVITY; SIGNALS; ACCUMULATION	Forest ecosystems play an important role in the global carbon cycle. Therefore, understanding the dynamics of carbon uptake in forest ecosystems is much needed. Pinus cooperi is a widely distributed species in the Sierra Madre Occidental in northern Mexico and future climatic variations could impact these ecosystems. Here, we analyze the variations of trunk carbon in two populations of P. cooperi situated at different elevational gradients, combining dendrochronological techniques and allometry. Carbon sequestration (50% biomass) was estimated from a specific allometric equation for this species based on: (i) variation of intraannual wood density and (ii) diameter reconstruction. The results show that the population at a higher elevation had greater wood density, basal area, and hence, carbon accumulation. This finding can be explained by an ecological response of trees to adverse weather conditions, which would cause a change in the cellular structure affecting the within-ring wood density profile. The influence of variations in climate on the maximum density of chronologies showed a positive correlation with precipitation and the Multivariate El Nino Southern Oscillation Index during the winter season, and a negative correlation with maximum temperature during the spring season. Monitoring previous conditions to growth is crucial due to the increased vulnerability to extreme climatic variations on higher elevational sites. We concluded that temporal variability of wood density contributes to a better understanding of environmental historical changes and forest carbon dynamics in Northern Mexico, representing a significant improvement over previous studies on carbon sequestration. Assuming a uniform density according to tree age is incorrect, so this method can be used for environmental mitigation strategies, such as for managing P. cooperi, a dominant species of great ecological amplitude and widely used in forest industries.	[Pompa-Garcia, Marin] Univ Juarez Estado Durango, Fac Ciencias Forest, Rio Papaloapan & Blvd Durango S-N, Durango 34120, Durango, Mexico; [Venegas-Gonzalez, Alejandro] Univ Sao Paulo, Wood Anat & Tree Ring Lab, Dept Forest Sci, BR-13418900 Piracicaba, SP, Brazil	Universidad Juarez del Estado de Durango; Universidade de Sao Paulo	Venegas-Gonzalez, A (corresponding author), Univ Sao Paulo, Wood Anat & Tree Ring Lab, Dept Forest Sci, BR-13418900 Piracicaba, SP, Brazil.	avenegasgon@gmail.com	Pompa-García, Marin/F-9544-2019; VENEGAS-GONZALEZ, ALEJANDRO/AAK-1882-2020	Pompa-García, Marin/0000-0001-7156-432X; VENEGAS-GONZALEZ, ALEJANDRO/0000-0003-4568-4533	Universidad Juarez del Estado de Durango; CONACYT [CB-2013/222522]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT); School of Forestry at Northern Arizona University	Universidad Juarez del Estado de Durango; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); School of Forestry at Northern Arizona University	The Universidad Juarez del Estado de Durango, and CONACYT provided funding through Project CB-2013/222522. Alejandro Venegas-Gonzalez was supported by scholarship from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT), during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the support given by the School of Forestry at Northern Arizona University. The Universidad Juarez del Estado de Durango, and CONACYT providing funding through Project CB-2013/222522. We acknowledge the help of Department of Forest Science of University of Sao Paulo, Dr. Mario Tomazello Filho for the x-ray densitometry analysis and Dr. Matheus Chagas Peres for the support in the preparation of samples. Jose Santiago Sanchez provides help with field data gathering. The authors are grateful to Editors and anonymous reviewers for their useful comments and suggestions. Alejandro Venegas-Gonzalezs was supported by scholarship from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT), during the writing of this paper	Adams HD, 2005, J BIOGEOGR, V32, P1629, DOI 10.1111/j.1365-2699.2005.01292.x; [Anonymous], 1996, TREE RINGS ENV DENDR; Auty D, 2014, MODELS PREDICTING WO; Babst F, 2014, OECOLOGIA, V176, P307, DOI 10.1007/s00442-014-3031-6; Babst F, 2014, DENDROCHRONOLOGIA, V32, P153, DOI 10.1016/j.dendro.2014.01.002; Babst F, 2014, NEW PHYTOL, V201, P1289, DOI 10.1111/nph.12589; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Bickford IN, 2011, WEST N AM NATURALIST, V71, P338, DOI 10.3398/064.071.0302; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Bouriaud O, 2005, TREE PHYSIOL, V25, P651, DOI 10.1093/treephys/25.6.651; Brauning A, 2004, GEOPHYS RES LETT, P31; Briffa KR, 2004, GLOBAL PLANET CHANGE, V40, P11, DOI 10.1016/S0921-8181(03)00095-X; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Campioli M, 2011, BIOGEOSCIENCES, V8, P2481, DOI 10.5194/bg-8-2481-2011; Linares JC, 2010, TREE PHYSIOL, V30, P795, DOI 10.1093/treephys/tpq052; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Clark DB, 2015, PLOS ONE, P10; Cleaveland MK, 2003, CLIMATIC CHANGE, V59, P369, DOI 10.1023/A:1024835630188; Cook E. R., 1985, TIME SERIES ANAL APP; Cruz-Cobos F, 2008, AGROCIENCIA-MEXICO, V42, P473; Decoux V, 2004, ANN FOREST SCI, V61, P251, DOI 10.1051/forest:2004018; Etzold S, 2011, ECOSYSTEMS, V14, P1289, DOI 10.1007/s10021-011-9481-3; Fan ZX, 2009, GLOBAL PLANET CHANGE, V65, P1, DOI 10.1016/j.gloplacha.2008.10.001; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; Franceschini T, 2013, TREES-STRUCT FUNCT, V27, P913, DOI 10.1007/s00468-013-0844-6; Frank DC, 2010, NATURE, V463, P527, DOI 10.1038/nature08769; FRITTS HC, 1989, ADV ECOL RES, V19, P111; Gindl W, 2000, TREES-STRUCT FUNCT, V14, P409, DOI 10.1007/s004680000057; Gonzalez-Elizondo M, 2005, FOREST ECOL MANAG, V213, P39, DOI 10.1016/j.foreco.2005.03.012; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; Hietz P, 2013, FUNCT ECOL, V27, P684, DOI 10.1111/1365-2435.12085; Huang JG, 2010, GLOBAL CHANGE BIOL, V16, P711, DOI 10.1111/j.1365-2486.2009.01990.x; Camarero JJ, 2010, NEW PHYTOL, V185, P471, DOI 10.1111/j.1469-8137.2009.03073.x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kerhoulas LP, 2013, FOREST ECOL MANAG, V289, P425, DOI 10.1016/j.foreco.2012.10.036; Kirdyanov AV, 2008, CHEM GEOL, V252, P31, DOI 10.1016/j.chemgeo.2008.01.023; Knapic S, 2007, ANN FOREST SCI, V64, P211, DOI 10.1051/forest:2006105; Lebourgeois F, 2012, TREES-STRUCT FUNCT, V26, P715, DOI 10.1007/s00468-011-0638-7; Luckman BH, 2005, CLIM DYNAM, V24, P131, DOI 10.1007/s00382-004-0511-0; Lupi C, 2011, TREE PHYSL; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Martin-Benito D, 2013, EUR J FOREST RES, V132, P33, DOI 10.1007/s10342-012-0652-3; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Nehrbass-Ahles C, 2014, GLOBAL CHANGE BIOL, V20, P2867, DOI 10.1111/gcb.12599; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parresol BR, 1999, FOREST SCI, V45, P573; Pasho E, 2012, TREES-STRUCT FUNCT, V26, P1875, DOI 10.1007/s00468-012-0756-x; Pederson Neil, 2004, Dendrochronologia, V22, P7, DOI 10.1016/j.dendro.2004.09.005; Pompa-Garcia M, 2014, THEOR APPL CLIMATOL, V117, P495, DOI 10.1007/s00704-013-1018-6; Pompa-Garcia M, 2013, DENDROCHRONOLOGIA, V31, P198, DOI 10.1016/j.dendro.2013.05.003; Raich JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100275; Rammig A., 2014, BIOGEOSCIENCES DISCU, V11, P2537, DOI [10.5194/bgd-11-2537-2014, DOI 10.5194/BGD-11-2537-2014]; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rozas V, 2012, INT J BIOMETEOROL, V56, P787, DOI 10.1007/s00484-011-0479-5; Seager R, 2009, ATMOSFERA, V22, P1; Stahle DW, 2012, CLIM DYNAM, V39, P1431, DOI 10.1007/s00382-011-1205-z; Taki S, 2014, J FOREST RES-JPN, V19, P226, DOI 10.1007/s10310-012-0382-x; Tomazello M, 2008, MADERAS-CIENC TECNOL, V10, P139, DOI 10.4067/S0718-221X2008000200006; van der Maaten E, 2012, ANN FOR RES, V55, P113; Vargas R, 2008, GLOBAL CHANGE BIOL, V14, P109, DOI 10.1111/j.1365-2486.2007.01462.x; Weber P, 2008, FOREST ECOL MANAG, V254, P96, DOI 10.1016/j.foreco.2007.07.031; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wutzler T, 2008, CAN J FOREST RES, V38, P1661, DOI 10.1139/X07-194; Zar J.H., 2010, BIOSTAT ANAL; Zscheischler J, 2014, GEOPHYS RES LETT, V41, P8853, DOI 10.1002/2014GL062409	70	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156782	10.1371/journal.pone.0156782	http://dx.doi.org/10.1371/journal.pone.0156782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272519	Green Submitted, gold, Green Published			2022-12-27	WOS:000377561000037
J	Sastre, E; Caracuel, L; Blanco-Rivero, J; Callejo, M; Xavier, FE; Balfagon, G				Sastre, Esther; Caracuel, Laura; Blanco-Rivero, Javier; Callejo, Maria; Xavier, Fabiano E.; Balfagon, Gloria			Biphasic Effect of Diabetes on Neuronal Nitric Oxide Release in Rat Mesenteric Arteries	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; OXIDATIVE STRESS; UP-REGULATION; L-ARGININE; SYNTHASE; DISEASE; ARGINASE; TETRAHYDROBIOPTERIN; DYSFUNCTION; INHIBITION	Introduction We analysed possible time-dependent changes in nitrergic perivascular innervation function from diabetic rats and mechanisms implicated. Materials and Methods In endothelium-denuded mesenteric arteries from control and four- (4W) and eight-week (8W) streptozotocin-induced diabetic rats the vasoconstriction to EFS (electrical field stimulation) was analysed before and after preincubation with L-NAME. Neuronal NO release was analysed in the absence and presence of L-arginine, tetrahydrobiopterine (BH4) and L-arginine plus BH4. Superoxide anion (O-2(-)), peroxynitrite (ONOO-) and superoxide dismutase (SOD) activity were measured. Expressions of Cu-Zn SOD, nNOS, p-nNOS Ser(1417), p-nNOS Ser(847), and Arginase (Arg) I and II were analysed. Results EFS response was enhanced at 4W, and to a lesser extent at 8W. L-NAME increased EFS response in control rats and at 8W, but not at 4W. NO release was decreased at 4W and restored at 8W. L-arginine or BH4 increased NO release at 4W, but not 8W. SOD activity and O-2(-) generation were increased at both 4W and 8W. ONOO- decreased at 4W while increased at 8W. Cu-Zn SOD, nNOS and p-NOS Ser(1417) expressions remained unmodified at 4W and 8W, whereas p-nNOS Ser(847) was increased at 4W. ArgI was overexpressed at 4W, remaining unmodified at 8W. ArgII expression was similar in all groups. Conclusions Our results show a time-dependent effect of diabetes on neuronal NO release. At 4W, diabetes induced increased O-2(-) generation, nNOS uncoupling and overexpression of ArgI and p-nNOS Ser(847), resulting in decreased NO release. At 8W, NO release was restored, involving normalisation of ArgI and p-nNOS Ser(847) expressions.	[Sastre, Esther; Caracuel, Laura; Blanco-Rivero, Javier; Callejo, Maria; Balfagon, Gloria] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Sastre, Esther; Caracuel, Laura; Blanco-Rivero, Javier; Balfagon, Gloria] Inst Invest La Paz IdIPAZ, Madrid, Spain; [Xavier, Fabiano E.] Univ Fed Pernambuco, Dept Fisiol & Farmacol, Recife, PE, Brazil	Autonomous University of Madrid; Universidade Federal de Pernambuco	Balfagon, G (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.; Balfagon, G (corresponding author), Inst Invest La Paz IdIPAZ, Madrid, Spain.	gloria.balfagon@uam.es	Xavier, Fabiano Elias/G-1253-2012; Xavier, Fabiano/G-1253-2012; Blanco Rivero, Javier/J-6118-2014	Xavier, Fabiano Elias/0000-0003-2028-2562; Balfagon Calvo, Gloria/0000-0001-9477-7950; Xavier, Fabiano/0000-0002-1387-8491; Blanco Rivero, Javier/0000-0001-7232-2314	Ministerio de Economia y Competitividad [SAF2012-38530]; FPI-UAM fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)	Ministerio de Economia y Competitividad(Spanish Government); FPI-UAM fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Ministerio de Economia y Competitividad (SAF2012-38530). ES received a FPI-UAM fellowship. FEX is recipient of research fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Al-Noah Z, 2014, AUTON NEUROSCI-BASIC, V183, P58, DOI 10.1016/j.autneu.2014.03.002; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Arrick DM, 2007, BRAIN RES, V1184, P365, DOI 10.1016/j.brainres.2007.10.004; Bagi Z, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00293; Bendall JK, 2014, ANTIOXID REDOX SIGN, V20, P3040, DOI 10.1089/ars.2013.5566; Blanco-Rivero J, 2011, CLIN SCI, V121, P331, DOI 10.1042/CS20110072; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Capellini VK, 2010, CURR VASC PHARMACOL, V8, P526; Cellek S, 2005, DIABETES, V54, P212, DOI 10.2337/diabetes.54.1.212; Cellek S, 2003, DIABETES, V52, P2353, DOI 10.2337/diabetes.52.9.2353; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; de las Heras N, 2013, NUTR METAB CARDIOVAS, V23, P1107, DOI 10.1016/j.numecd.2012.11.009; de Queiroz DB, 2015, BRIT J PHARMACOL, V172, P4699, DOI 10.1111/bph.13244; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Durlu NT, 2003, FUND CLIN PHARMACOL, V17, P609; Ferrer M, 1999, LIFE SCI, V66, P337; Ferrer M, 2003, J VASC RES, V40, P509, DOI 10.1159/000075183; Gangula PRR, 2010, AM J PHYSIOL-GASTR L, V298, pG692, DOI 10.1152/ajpgi.00450.2009; Heine CL, 2014, BIOCHEMISTRY-US, V53, P1284, DOI 10.1021/bi401307r; Hoang HH, 2013, CURR OPIN CLIN NUTR, V16, P76, DOI 10.1097/MCO.0b013e32835ad1ef; Jin L, 2007, J PHYSIOL PHARMACOL, V58, P191; Kasamatsu S, 2014, BIOCHEM J, V459, P251, DOI 10.1042/BJ20131262; Krentz AJ, 2007, DIABETES OBES METAB, V9, P781, DOI 10.1111/j.1463-1326.2007.00670.x; Leon BM, 2015, WORLD J DIABETES, V6, P1246, DOI 10.4239/wjd.v6.i13.1246; Marin J, 1998, BRIT J PHARMACOL, V124, P473, DOI 10.1038/sj.bjp.0701856; Melikian N, 2009, TRENDS CARDIOVAS MED, V19, P256, DOI 10.1016/j.tcm.2010.02.007; NIELSEN KC, 1971, BRAIN RES, V27, P33, DOI 10.1016/0006-8993(71)90370-2; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Pernow J, 2015, BRIT J PHARMACOL, V172, P4684, DOI 10.1111/bph.13242; Pernow J., 2015, CURR VASC PHARM; Pieper GM, 1997, J PHARMACOL EXP THER, V283, P684; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Ryoo S, 2006, CIRC RES, V99, P951, DOI 10.1161/01.RES.0000247034.24662.b4; Sanchez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036027; Sastre E, 2012, SHOCK, V38, P328, DOI 10.1097/SHK.0b013e31826240ba; Toque HA, 2013, J SEX MED, V10, P1502, DOI 10.1111/jsm.12134; Xavier FE, 2004, J HYPERTENS, V22, P949, DOI 10.1097/00004872-200405000-00017; Xavier FE, 2003, VASC PHARMACOL, V40, P67, DOI 10.1016/S1537-1891(02)00315-4	42	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156793	10.1371/journal.pone.0156793	http://dx.doi.org/10.1371/journal.pone.0156793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272874	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000038
J	Garcia, C				Garcia, Carlos			BoCluSt: Bootstrap Clustering Stability Algorithm for Community Detection	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; MODULARITY; EVOLUTION; MODULES; VALIDATION	The identification of modules or communities in sets of related variables is a key step in the analysis and modeling of biological systems. Procedures for this identification are usually designed to allow fast analyses of very large datasets and may produce suboptimal results when these sets are of a small to moderate size. This article introduces BoCluSt, a new, somewhat more computationally intensive, community detection procedure that is based on combining a clustering algorithm with a measure of stability under bootstrap resampling. Both computer simulation and analyses of experimental data showed that BoCluSt can outperform current procedures in the identification of multiple modules in data sets with a moderate number of variables. In addition, the procedure provides users with a null distribution of results to evaluate the support for the existence of community structure in the data. BoCluSt takes individual measures for a set of variables as input, and may be a valuable and robust exploratory tool of network analysis, as it provides 1) an estimation of the best partition of variables into modules, 2) a measure of the support for the existence of modular structures, and 3) an overall description of the whole structure, which may reveal hierarchical modular situations, in which modules are composed of smaller sub-modules.	[Garcia, Carlos] Univ Santiago, CIBUS, Campus Sur, Santiago De Compostela 15782, Galiza, Spain	Universidade de Santiago de Compostela	Garcia, C (corresponding author), Univ Santiago, CIBUS, Campus Sur, Santiago De Compostela 15782, Galiza, Spain.	carlos.garcia.suarez@usc.es			Ministerio de Economia and Competitividad [CGL2012-39861-C02-01]	Ministerio de Economia and Competitividad(Spanish Government)	This work was funded by Ministerio de Economia and Competitividad (URL: www.mineco.gob.es/; grant number: CGL2012-39861-C02-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bolker JA, 2000, AM ZOOL, V40, P770, DOI 10.1668/0003-1569(2000)040[0770:MIDAWI]2.0.CO;2; Borgelt C, 2007, INT J UNCERTAIN FUZZ, V15, P595, DOI 10.1142/S0218488507004893; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; BRECKENRIDGE JN, 1989, MULTIVAR BEHAV RES, V24, P147, DOI 10.1207/s15327906mbr2402_1; Callebaut W, 2005, MODULARITY UNDERSTAN; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carlson M., DROSOPHILA2 DB AFFYM; Csardi G., 2006, INT J COMPLEX SYST, V2006, P1695, DOI DOI 10.1093/NAR/; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Dupont YL, 2009, J ANIM ECOL, V78, P346, DOI 10.1111/j.1365-2656.2008.01501.x; Falasconi M, 2010, PATTERN RECOGN, V43, P1292, DOI 10.1016/j.patcog.2009.10.001; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fruciano C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069376; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Handcock MS, 2007, J ROY STAT SOC A STA, V170, P301, DOI 10.1111/j.1467-985X.2007.00471.x; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157; Jain AK., 1988, TECHNOMETRICS; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lange T, 2004, NEURAL COMPUT, V16, P1299, DOI 10.1162/089976604773717621; Levine E, 2001, NEURAL COMPUT, V13, P2573, DOI 10.1162/089976601753196030; Litvin O, 2009, P NATL ACAD SCI USA, V106, P6441, DOI 10.1073/pnas.0810208106; Maechler M., 2015, CLUSTER CLUSTER ANAL; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Pons P., COMPUTING COMMUNITIE; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; R Core Team, 2018, R LANG ENV STAT COMP; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Smith, 2010, ANNAFFY ANNOTATION T; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Zhou HJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.041908	55	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156576	10.1371/journal.pone.0156576	http://dx.doi.org/10.1371/journal.pone.0156576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258041	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700080
J	Junqueira, DM; de Medeiros, RM; Graf, T; Almeida, SED				Junqueira, Dennis Maletich; de Medeiros, Rubia Marilla; Graf, Tiago; de Matos Almeida, Sabrina Esteves			Short-Term Dynamic and Local Epidemiological Trends in the South American HIV-1B Epidemic	PLOS ONE			English	Article							RIO-DE-JANEIRO; SUBTYPE-B; TRANSMISSION NETWORKS; DRUG-RESISTANCE; PHYLOGENETIC ANALYSIS; POPULATION; TYPE-1; TOOL; PREVALENCE; CLUSTERS	The human displacement and sexual behavior are the main factors driving the HIV-1 pandemic to the current profile. The intrinsic structure of the HIV transmission among different individuals has valuable importance for the understanding of the epidemic and for the public health response. The aim of this study was to characterize the HIV-1 subtype B (HIV-1B) epidemic in South America through the identification of transmission links and infer trends about geographical patterns and median time of transmission between individuals. Sequences of the protease and reverse transcriptase coding regions from 4,810 individuals were selected from GenBank. Maximum likelihood phylogenies were inferred and submitted to ClusterPicker to identify transmission links. Bayesian analyses were applied only for clusters including >= 5 dated samples in order to estimate the median maximum inter-transmission interval. This study analyzed sequences sampled from 12 South American countries, from individuals of different exposure categories, under different antiretroviral profiles, and from a wide period of time (1989-2013). Continentally, Brazil, Argentina and Venezuela were revealed important sites for the spread of HIV-1B among countries inside South America. Of note, from all the clusters identified about 70% of the HIV-1B infections are primarily occurring among individuals living in the same geographic region. In addition, these transmissions seem to occur early after the infection of an individual, taking in average 2.39 years (95% CI 1.48-3.30) to succeed. Homosexual/Bisexual individuals transmit the virus as quickly as almost half time of that estimated for the general population sampled here. Public health services can be broadly benefitted from this kind of information whether to focus on specific programs of response to the epidemic whether as guiding of prevention campaigns to specific risk groups.	[Junqueira, Dennis Maletich] Ctr Univ Ritter Reis Uniritter, Dept Ciencias Saude, Porto Alegre, RS, Brazil; [Junqueira, Dennis Maletich; de Medeiros, Rubia Marilla; de Matos Almeida, Sabrina Esteves] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Junqueira, Dennis Maletich; de Medeiros, Rubia Marilla; Graf, Tiago; de Matos Almeida, Sabrina Esteves] FEPPS, CDCT, Porto Alegre, RS, Brazil; [Graf, Tiago] Univ Fed Santa Catarina, Programa Posgrad Biotecnol & Biociencias, Florianopolis, SC, Brazil; [de Matos Almeida, Sabrina Esteves] Univ FEEVALE, Inst Ciencias Saude, Novo Hamburgo, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Catarina (UFSC); Universidade Feevale	Junqueira, DM (corresponding author), Ctr Univ Ritter Reis Uniritter, Dept Ciencias Saude, Porto Alegre, RS, Brazil.; Junqueira, DM (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Junqueira, DM (corresponding author), FEPPS, CDCT, Porto Alegre, RS, Brazil.	dennismaletich@hotmail.com	Gräf, Tiago/S-8535-2019; de Medeiros, Rúbia M/L-2761-2015; Junqueira, Dennis/ABC-4378-2021	Gräf, Tiago/0000-0003-4921-7975; de Medeiros, Rúbia M/0000-0001-7403-5650; Esteves De Matos Almeida, Sabrina/0000-0003-3599-8520; Junqueira, Dennis/0000-0003-1576-484X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DMJ, TG, and RMM were funded by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SEM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-306; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Beyrer C, 2014, CURR OPIN HIV AIDS, V9, P95, DOI 10.1097/COH.0000000000000043; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Bezemer D, 2014, AIDS RES HUM RETROV, V30, P118, DOI [10.1089/aid.2013.0171, 10.1089/AID.2013.0171]; Biesinger Tasha, 2008, Virology (Auckl), V2008, P49; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2013, JAIDS-J ACQ IMM DEF, V63, pS248, DOI 10.1097/QAI.0b013e3182986f96; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ever-Silva WA, 2006, JAIDS-J ACQ IMM DEF, V41, P664, DOI 10.1097/01.qai.0000194736.66322.02; Eyer-Silva WA, 2007, MEM I OSWALDO CRUZ, V102, P809, DOI 10.1590/S0074-02762007005000112; Eyer-Silva WA, 2007, AIDS RES HUM RETROV, V23, P303, DOI 10.1089/aid.2006.0199; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Frost SDW, 2015, J INFECT DIS, V211, P856, DOI 10.1093/infdis/jiu563; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Hallett TB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001569; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jia Yujiang, 2014, Biomed Res Int, V2014, P497543, DOI 10.1155/2014/497543; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mehta SR, 2010, AIDS RES HUM RETROV, V26, P1273, DOI 10.1089/aid.2010.0021; Miller M.A., 2010, P GAT COMP ENV WORKS; Mir D, 2015, AIDS, V29, P1863, DOI 10.1097/QAD.0000000000000770; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pennings PS, 2014, J INFECT DIS, V209, P180, DOI 10.1093/infdis/jit525; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Poon AFY, 2015, J INFECT DIS, V211, P926, DOI 10.1093/infdis/jiu560; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Ragonnet-Cronin M, 2010, JAIDS-J ACQ IMM DEF, V55, P102, DOI 10.1097/QAI.0b013e3181e8c7b0; Rambaut A., 2007, TRACER V1 4; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Sinha S, 2012, CURR HIV RES, V10, P532, DOI 10.2174/157016212802429785; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UNAIDS, 2013, REP GLOB AIDS EP; van de Vijver DAMC, 2010, PANNONICA ADRIAT, V19, P3; Varella RB, 2008, BRAZ J INFECT DIS, V12, P380, DOI 10.1590/S1413-86702008000500007; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; World Health Organization (WHO), 2012, HIV DRUG RES REP; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	57	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156712	10.1371/journal.pone.0156712	http://dx.doi.org/10.1371/journal.pone.0156712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258369	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700111
J	Reynolds, LK; DuBois, K; Abbott, JM; Williams, SL; Stachowicz, JJ				Reynolds, Laura K.; DuBois, Katherine; Abbott, Jessica M.; Williams, Susan L.; Stachowicz, John J.			Response of a Habitat-Forming Marine Plant to a Simulated Warming Event Is Delayed, Genotype Specific, and Varies with Phenology	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CLIMATE-CHANGE; ENVIRONMENTAL VARIATION; PHENOTYPIC PLASTICITY; DIVERSITY; TEMPERATURE; SEAGRASSES; ECOSYSTEM; PHOTOSYNTHESIS; HERBIVORE	Growing evidence shows that increasing global temperature causes population declines and latitudinal shifts in geographical distribution for plants living near their thermal limits. Yet, even populations living well within established thermal limits of a species may suffer as the frequency and intensity of warming events increase with climate change. Adaptive response to this stress at the population level depends on the presence of genetic variation in thermal tolerance in the populations in question, yet few data exist to evaluate this. In this study, we examined the immediate effects of a moderate warming event of 4.5 degrees C lasting 5 weeks and the legacy effects after a 5 week recovery on different genotypes of the marine plant Zostera marina (eelgrass). We conducted the experiment in Bodega Bay, CA USA, where average summer water temperatures are 14-15 degrees C, but extended warming periods of 17-18 degrees C occur episodically. Experimental warming increased shoot production by 14% compared to controls held at ambient temperature. However, after returning temperature to ambient levels, we found strongly negative, delayed effects of warming on production: shoot production declined by 27% and total biomass decreased by 50% relative to individuals that had not been warmed. While all genotypes' production decreased in the recovery phase, genotypes that grew the most rapidly under benign thermal conditions (control) were the most susceptible to the detrimental effects of warming. This suggests a potential trade-off in relative performance at normal vs. elevated temperatures. Modest short-term increases in water temperature have potentially prolonged negative effects within the species' thermal envelope, but genetic variation within these populations may allow for population persistence and adaptation. Further, intraspecific variation in phenology can result in maintenance of population diversity and lead to enhanced production in diverse stands given sufficient frequency of warming or other stress events.	[Reynolds, Laura K.; DuBois, Katherine; Abbott, Jessica M.; Williams, Susan L.; Stachowicz, John J.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [DuBois, Katherine; Williams, Susan L.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA	University of California System; University of California Davis; University of California System; University of California Davis	Reynolds, LK (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA.	lkreynolds@ucdavis.edu		Reynolds, Laura K/0000-0002-4498-4641	National Science Foundation [OCE 12-1234345]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation (OCE 12-1234345 to JJS and SLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J, 2015, THESIS U CALIFORNIA; Abe M, 2008, FISHERIES SCI, V74, P1017, DOI 10.1111/j.1444-2906.2008.01619.x; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; [Anonymous], 1980, HDB SEAGRASS BIOL EC; AUCLAIR AND, 1993, WATER AIR SOIL POLL, V66, P207; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; Beer S, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P183, DOI 10.1016/B978-044450891-1/50010-4; Bergmann N, 2010, MOL ECOL, V19, P2870, DOI 10.1111/j.1365-294X.2010.04731.x; BIEBL R, 1971, MAR BIOL, V8, P48, DOI 10.1007/BF00349344; Bracken MES, 2013, ECOLOGY, V94, P1944, DOI 10.1890/12-2182.1; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; Cummings ME, 2003, AQUAT BOT, V75, P261, DOI 10.1016/S0304-3770(02)00180-8; Durako MJ, 2007, AQUAT BOT, V87, P83, DOI 10.1016/j.aquabot.2007.03.005; Durako MJ, 2002, AQUAT BOT, V73, P173, DOI 10.1016/S0304-3770(02)00020-7; EVANS AS, 1986, AQUAT BOT, V24, P185, DOI 10.1016/0304-3770(86)90095-1; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Franssen SU, 2011, P NATL ACAD SCI USA, V108, P19276, DOI 10.1073/pnas.1107680108; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Green E.P., 2003, WORLD ATLAS SEAGRASS; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HOPKINSON CS, 1984, ECOLOGY, V65, P961, DOI 10.2307/1938068; Hughes AR, 2011, J ECOL, V99, P445, DOI 10.1111/j.1365-2745.2010.01767.x; Hughes AR, 2009, ECOLOGY, V90, P1412, DOI 10.1890/07-2030.1; Hughes AR, 2009, OECOLOGIA, V159, P725, DOI 10.1007/s00442-008-1251-3; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johnson MTJ, 2008, J ECOL, V96, P947, DOI 10.1111/j.1365-2745.2008.01410.x; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kamel SJ, 2012, MAR ECOL PROG SER, V447, P127, DOI 10.3354/meps09447; Kelly MW, 2013, GLOBAL CHANGE BIOL, V19, P2536, DOI 10.1111/gcb.12251; Kelly MW, 2012, P ROY SOC B-BIOL SCI, V279, P349, DOI 10.1098/rspb.2011.0542; Kettenring KM, 2014, J APPL ECOL, V51, P339, DOI 10.1111/1365-2664.12202; Kramer K, 2000, INT J BIOMETEOROL, V44, P67, DOI 10.1007/s004840000066; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; MARSH JA, 1986, J EXP MAR BIOL ECOL, V101, P257, DOI 10.1016/0022-0981(86)90267-4; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Moore KA, 2012, MAR ECOL PROG SER, V448, P247, DOI 10.3354/meps09578; Moore KA, 2008, J COASTAL RES, P135, DOI 10.2112/SI55-014; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PENHALE PA, 1977, J EXP MAR BIOL ECOL, V26, P211, DOI 10.1016/0022-0981(77)90109-5; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; PLATT T, 1980, J MAR RES, V38, P687; QUIRING DT, 1994, ECOL ENTOMOL, V19, P230, DOI 10.1111/j.1365-2311.1994.tb00414.x; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ralph PJ, 1999, BOT MAR, V42, P11, DOI 10.1515/BOT.1999.003; Reed TE, 2011, CONSERV BIOL, V25, P56, DOI 10.1111/j.1523-1739.2010.01552.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Reusch TBH, 2014, EVOL APPL, V7, P104, DOI 10.1111/eva.12109; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Romero J, 2007, MAR POLLUT BULL, V55, P196, DOI 10.1016/j.marpolbul.2006.08.032; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Salo T, 2015, MAR ECOL PROG SER, V519, P129, DOI 10.3354/meps11083; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; SCHMITT J, 1986, EVOLUTION, V40, P830, DOI 10.1111/j.1558-5646.1986.tb00542.x; Sorte CJB, 2011, MAR ECOL PROG SER, V435, P63, DOI 10.3354/meps09234; Stiling P, 1996, ECOLOGY, V77, P2212, DOI 10.2307/2265714; Tani T, 2003, ECOL RES, V18, P15, DOI 10.1046/j.1440-1703.2003.00530.x; Taylor RB, 2003, OECOLOGIA, V136, P412, DOI 10.1007/s00442-003-1280-x; Terrados J, 1997, MAR ECOL PROG SER, V149, P267, DOI 10.3354/meps149267; Thomas RL, 2014, URBAN ECOSYST, V17, P911, DOI 10.1007/s11252-014-0360-5; TISSUE DT, 1991, PLANT CELL ENVIRON, V14, P407, DOI 10.1111/j.1365-3040.1991.tb00950.x; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Vermaat JE, 1996, AQUAT BOT, V52, P259, DOI 10.1016/0304-3770(95)00510-2; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Williams R, 2013, ICES J MAR SCI, V70, P1273, DOI 10.1093/icesjms/fst059; Winters G, 2011, MAR ECOL PROG SER, V435, P83, DOI 10.3354/meps09213	78	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154532	10.1371/journal.pone.0154532	http://dx.doi.org/10.1371/journal.pone.0154532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258011	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700009
J	Shiyanbola, OO; Smith, PD; Mansukhani, SG; Huang, YM				Shiyanbola, Olayinka O.; Smith, Paul D.; Mansukhani, Sonal Ghura; Huang, Yen-Ming			Refining Prescription Warning Labels Using Patient Feedback: A Qualitative Study	PLOS ONE			English	Article							DRUG LABEL; LOW-LITERACY; COMPREHENSION; INSTRUCTIONS	The complexity of written medication information hinders patients' understanding and leads to patient misuse of prescribedmedications. Incorporating patient feedback in designing prescription warning labels (PWLs) is crucial in enhancing patient comprehension of medication warning instructions. This qualitative study explored patient feedback on five newly designed PWLs. In-depth semi-structured face-to-face interviews were conducted with 21 patients, who were 18 years and older, spoke English, and took a prescription medication. These patients were shown different variations of the fivemost commonly used PWLs-Take with Food, Do not Drink Alcohol, Take with a Full glass of Water, Do not Chew or Break, and Protect from Sunlight. The 60-minute interviews explored feedback on patient comprehension of the PWL instructions and their suggestions for improving the clarity of the PWLs. At the end of the interview, patient self-reported socio-demographic information was collected with a 3-minute survey and a brief health literacy assessment was completed using the Newest Vital Sign. Twenty-one patients completed the interviews. Most patients were female (n = 15, 71.4%) with ages ranging from23 to 66 years old (mean: 47.6 +/- 13.3). The mean health literacy score was 2.4 on a scale of 0-6. Qualitative content analysis based on the text, pictures, and placement of the PWLs on the pill bottle showed preferences for including 'WARNING' on the PWL to create alertness, inclusion of a picture together with the text, yellow color highlighting behind the text, and placement of the PWL on the front of the pill bottle. Although patients had positive opinions of the redesigned PWLs, patients wanted further improvements to the content and design of the PWLs for enhanced clarity and understandability.	[Shiyanbola, Olayinka O.; Mansukhani, Sonal Ghura; Huang, Yen-Ming] Univ Wisconsin, Sch Pharm, Div Social & Adm Sci, Madison, WI 53705 USA; [Smith, Paul D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Family Med & Community Hlth, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shiyanbola, OO (corresponding author), Univ Wisconsin, Sch Pharm, Div Social & Adm Sci, Madison, WI 53705 USA.	Olayinka.Shiyanbola@wisc.edu	Huang, Yen-Ming/AAM-1672-2020; Huang, Yen-Ming/A-8175-2015	Huang, Yen-Ming/0000-0001-8673-2269; Huang, Yen-Ming/0000-0001-8673-2269	UW Graduate School/Wisconsin Alumni Research Foundation [MSN175988]; Clinical and Translational Science Award (CTSA) program, through the National Institute of Health (NIH) National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; UW Graduate School; Wisconsin Alumni Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	UW Graduate School/Wisconsin Alumni Research Foundation; Clinical and Translational Science Award (CTSA) program, through the National Institute of Health (NIH) National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); UW Graduate School; Wisconsin Alumni Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The UW Graduate School/Wisconsin Alumni Research Foundation funded this study. Grant number: MSN175988. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Wisconsin Research and Education Network for the coordination of all study activities and the recruitment of patients. We appreciate the advice and insights of Theo Raynor during the design of the project. The project described was supported by the Clinical and Translational Science Award (CTSA) program, through the National Institute of Health (NIH) National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank the UW Graduate School and the Wisconsin Alumni Research Foundation for the funding of this study.	Andre A., 1995, ERGONOM DESIGN Q HUM, V3, P10, DOI DOI 10.1177/106480469500300403; Bailey SC, 2015, ANN PHARMACOTHER, V49, P1222, DOI 10.1177/1060028015602272; Boudewyns V, 2015, PATIENT EDUC COUNS, V98, P1592, DOI 10.1016/j.pec.2015.07.003; Chan HK, 2014, INT J CLIN PHARM-NET, V36, P904, DOI 10.1007/s11096-014-0003-1; Davis TC, 2006, J GEN INTERN MED, V21, P847, DOI 10.1111/j.1525-1497.2006.00529.x; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; Davis TC, 2009, J GEN INTERN MED, V24, P57, DOI 10.1007/s11606-008-0833-4; Dieckmann P C M, 2015, J PATIENT SAF; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Institute of Medicine of the National Academies, PREVENTING MEDICATIO; Lee JY., 2013, INVESTIGATING THE EF; Locke MR, 2014, J AM PHARM ASSOC, V54, P267, DOI 10.1331/JAPhA.2014.13163; Mohan A, 2013, J HEALTH COMMUN, V18, P49, DOI 10.1080/10810730.2013.825664; MSWWJ VIGILANTE, 2003, ERGONOMICS, V46, P327; Shiyanbola Olayinka O., 2014, Pharmacy Pract (Granada), V12; Shrank WH, 2007, ARCH INTERN MED, V167, P1760, DOI 10.1001/archinte.167.16.1760; Sundar RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038819; Tong V, 2016, HEALTH EXPECT, V19, P948, DOI 10.1111/hex.12389; Webb J, 2008, PATIENT EDUC COUNS, V72, P443, DOI 10.1016/j.pec.2008.05.019; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; Williams K.C., 2012, RES BUSINESS EC J, V5, P1, DOI DOI 10.1007/978-94-017-2940-6_1; Wittich CM, 2014, MAYO CLIN PROC, V89, P1116, DOI 10.1016/j.mayocp.2014.05.007; Wolf M, 2011, AM J OBSTET GYNECOL, V204, pS312; Wolf MS, 2007, PATIENT EDUC COUNS, V67, P293, DOI 10.1016/j.pec.2007.03.024; Wolf MS, 2006, AM J HEALTH-SYST PH, V63, P1048, DOI 10.2146/ajhp050469; Wolf MS, 2011, MED CARE, V49, P96, DOI 10.1097/MLR.0b013e3181f38174; Wolf MS, 2010, ARCH INTERN MED, V170, P50, DOI 10.1001/archinternmed.2009.454; Zargarzadeh AH, 2011, INT J CLIN PHARM-NET, V33, P252, DOI 10.1007/s11096-011-9488-z	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156881	10.1371/journal.pone.0156881	http://dx.doi.org/10.1371/journal.pone.0156881			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258026	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700149
J	Sun, X; Qian, HN				Sun, Xin; Qian, Huinan			Chinese Herbal Medicine Image Recognition and Retrieval by Convolutional Neural Network	PLOS ONE			English	Article								Chinese herbal medicine image recognition and retrieval have great potential of practical applications. Several previous studies have focused on the recognition with hand-crafted image features, but there are two limitations in them. Firstly, most of these hand-crafted features are low-level image representation, which is easily affected by noise and background. Secondly, the medicine images are very clean without any backgrounds, which makes it difficult to use in practical applications. Therefore, designing high-level image representation for recognition and retrieval in real world medicine images is facing a great challenge. Inspired by the recent progress of deep learning in computer vision, we realize that deep learning methods may provide robust medicine image representation. In this paper, we propose to use the Convolutional Neural Network (CNN) for Chinese herbal medicine image recognition and retrieval. For the recognition problem, we use the softmax loss to optimize the recognition network; then for the retrieval problem, we fine-tune the recognition network by adding a triplet loss to search for the most similar medicine images. To evaluate our method, we construct a public database of herbal medicine images with cluttered back-grounds, which has in total 5523 images with 95 popular Chinese medicine categories. Experimental results show that our method can achieve the average recognition precision of 71% and the average retrieval precision of 53% over all the 95 medicine categories, which are quite promising given the fact that the real world images have multiple pieces of occluded herbal and cluttered backgrounds. Besides, our proposed method achieves the state-of-the-art performance by improving previous studies with a large margin.	[Sun, Xin; Qian, Huinan] Beijing Univ Chinese Med, Acad Basic Med Sci, Beijing, Peoples R China; [Sun, Xin; Qian, Huinan] 11 Beisanhuan East Rd, Beijing, Peoples R China	Beijing University of Chinese Medicine	Qian, HN (corresponding author), Beijing Univ Chinese Med, Acad Basic Med Sci, Beijing, Peoples R China.; Qian, HN (corresponding author), 11 Beisanhuan East Rd, Beijing, Peoples R China.	huinan.qian@gmail.com			Natural Science Foundation of China [30171188]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by the Natural Science Foundation of China (Grant No. 30171188). The funders provide the data and GPU computer servers.	Abdel-Hakim A. E., 2006, COMPUTER VISION PATT; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Chen X., 2013, INT C COMP VIS; Cinbis R. G., 2014, COMPUTER VISION PATT; Dalal N.B.T., 2005, COMPUTER VISION PATT; Girshick R., 2014, P IEEE C COMP VIS PA, P23; He K., 2014, ARXIV150201852; Huang J, 2015, ARXIV150507922; Huang Y., 2011, COMPUTER VISION PATT; Ke Y., 2004, COMPUTER VISION PATT; Krizhevsky A., 2012, NEURAL INFORM POCESS; Laiy H., 2014, ARXIV150403410; Le Cun Y., 1989, NEURIPS, V2, P396, DOI DOI 10.1111/DSU.12130; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; LeCun Y, 2010, IEEE INT SYMP CIRC S, P253, DOI 10.1109/ISCAS.2010.5537907; Lee H., 2007, NEURAL INFORM POCESS; Li Z. F., 2013, THESIS; Lin K., 2015, COMP VIS PATT REC WO; Lin Y., 2011, INT C COMP VIS; Liu L., 2011, INT C COMP VIS; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ma L., 2011, COMPUTER ENG APPL; Mikolajczyk K., 2003, COMPUTER VISION PATT; Morioka N., 2011, INT C COMP VIS; Ng J. Yue-Hei, 2015, COMPUTER VISION PATT; Shabou A., 2012, COMPUTER VISION PATT; Simonyan Karen, ICLR 2015; Szegedy C., 2015, P CVPR BOST MA US 7, P1, DOI DOI 10.1109/CVPR.2015.7298594; Tao O., 2011, WORLD SCI TECHNOLOGY; Tao O., 2014, WORLD SCI TECHNOLOGY; Wan J., 2015, INT C MULT; Wang C, 2014, LECT NOTES COMPUT SC, V8694, P431, DOI 10.1007/978-3-319-10599-4_28; Wang J., 2014, HASHING SIMILARITY S; Wang J., 2010, COMPUTER VISION PATT; Yang J.C., 2010, COMPUTER VISION PATT; Yang TT, 2014, THESIS; Yao F., 2011, GUIDE CHINESE MED; Yue- Hei J., 2015, COMP VIS PATT REC WO; Zhai G., 2011, J LANZHOU POLYTECHNI; Zhang J., 2011, COMPUTER VISION PATT; Zhao F., 2015, COMPUTER VISION PATT	42	9	9	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156327	10.1371/journal.pone.0156327	http://dx.doi.org/10.1371/journal.pone.0156327			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258404	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700054
J	Takaishi, M; Tarutani, M; Takeda, J; Sano, S				Takaishi, Mikiro; Tarutani, Masahito; Takeda, Junji; Sano, Shigetoshi			Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells	PLOS ONE			English	Article							REPRESSES E-CADHERIN; BREAST-CANCER; GASTROINTESTINAL CANCER; MOLECULAR-MECHANISMS; CARCINOMA METASTASIS; STEM-CELLS; PLURIPOTENCY; GENERATION; EXPRESSION; INVASION	Epithelial to mesenchymal transition (EMT) is a biological process of metastatic cancer. However, an effective anticancer therapy that directly targets the EMT program has not yet been discovered. Recent studies have indicated that mesenchymal to epithelial transition (MET), the reverse phenomenon of EMT, is observed in fibroblasts during the generation of induced pluripotent stem cells. In the present study, we investigated the effects of reprogramming factors (RFs) on squamous cell carcinoma (SCC) cells. RFs-introduced cancer cells (RICs) demonstrated the enhanced epithelial characteristics in morphology with altered expression of mRNA and microRNAs. The motility and invasive activities of RICs in vitro were significantly reduced. Furthermore, xenografts of RICs exhibited no lymph node metastasis, whereas metastasis was detected in parental SCC-inoculated mice. Thus, we concluded that RICs regained epithelial properties through MET and showed reduced cancer malignancy in vitro and in vivo. Therefore, the understanding of the MET process in cancer cells by introduction of RFs may lead to the designing of a novel anticancer strategy.	[Takaishi, Mikiro; Tarutani, Masahito; Sano, Shigetoshi] Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan; [Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan	Kochi University; Osaka University	Sano, S (corresponding author), Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan.	sano.derma@kochi-u.ac.jp			Japanese Ministry of Education, Science, Sports and Culture	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	M. Takaishi was supported by The Japanese Ministry of Education, Science, Sports and Culture (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Benaich N, 2014, CELL REP, V9, P104, DOI 10.1016/j.celrep.2014.08.062; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bruegger C, 2013, EXP DERMATOL, V22, P426, DOI 10.1111/exd.12153; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Diaz-Lopez A, 2014, CANCER MANAG RES, V6, P205, DOI 10.2147/CMAR.S38156; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Hayashi E, 1995, ORAL ONCOL, V31B, P323, DOI 10.1016/0964-1955(95)00038-0; Hezova R, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0280-6; Igawa K, 2014, STEM CELL TRANSL MED, V3, P992, DOI 10.5966/sctm.2013-0179; Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lamouille S, 2013, CURR OPIN CELL BIOL, V25, P200, DOI 10.1016/j.ceb.2013.01.008; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Maekawa K, 2002, CLIN EXP METASTAS, V19, P513, DOI 10.1023/A:1020329411957; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Muller M, 2016, STEM CELL RES, V16, P349, DOI 10.1016/j.scr.2016.02.005; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Orang AV, 2014, ASIAN PAC J CANCER P, V15, P577, DOI 10.7314/APJCP.2014.15.2.577; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Severino P, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0102-4; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; TADOKORO K, 1989, ONCOGENE, V4, P499; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249; Tian LL, 2014, TUMOR BIOL, V35, P5953, DOI 10.1007/s13277-014-1790-7; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang H, 2015, CANCER CELL, V27, P193, DOI 10.1016/j.ccell.2014.11.017; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang X, 2013, ONCOGENE, V32, P2249, DOI 10.1038/onc.2012.237; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128	47	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156904	10.1371/journal.pone.0156904	http://dx.doi.org/10.1371/journal.pone.0156904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258152	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700152
J	He, XQ; Song, YQ; Liu, R; Liu, Y; Zhang, F; Zhang, Z; Shen, YT; Xu, L; Chen, MH; Wang, YL; Xu, BH; Yang, XJ; Wang, HL				He, Xiao-Qin; Song, Yue-Qiang; Liu, Rui; Liu, Yu; Zhang, Fei; Zhang, Zhen; Shen, Yu-Ting; Xu, Lin; Chen, Ming-Huang; Wang, Ya-Long; Xu, Bai-Hui; Yang, Xiang-Jun; Wang, Hai-Long			Axin-1 Regulates Meiotic Spindle Organization in Mouse Oocytes	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MICROTUBULE NUCLEATION; CHROMOSOME ALIGNMENT; MITOTIC SPINDLE; GAMMA-TUBULIN; MEIOSIS-I; PROTEIN; CENTROSOME; MITOSIS; ACTIVATION	Axin-1, a negative regulator of Wnt signaling, is a versatile scaffold protein involved in centrosome separation and spindle assembly in mitosis, but its function in mammalian oogenesis remains unknown. Here we examined the localization and function of Axin-1 during meiotic maturation in mouse oocytes. Immunofluorescence analysis showed that Axin-1 was localized around the spindle. Knockdown of the Axin1 gene by microinjection of specific short interfering (si) RNA into the oocyte cytoplasm resulted in severely defective spindles, misaligned chromosomes, failure of first polar body (PB1) extrusion, and impaired pronuclear formation. However, supplementing the culture medium with the Wnt pathway activator LiCl improved spindle morphology and pronuclear formation. Downregulation of Axin1 gene expression also impaired the spindle pole localization of gamma-tubulin/Nek9 and resulted in retention of the spindle assembly checkpoint protein BubR1 at kinetochores after 8.5 h of culture. Our results suggest that Axin-1 is critical for spindle organization and cell cycle progression during meiotic maturation in mouse oocytes.	[He, Xiao-Qin; Liu, Yu; Wang, Ya-Long; Xu, Bai-Hui; Wang, Hai-Long] Xiamen Univ, Organ Transplantat Inst, Coll Med, Xiamen, Fujian Province, Peoples R China; [He, Xiao-Qin; Liu, Rui; Zhang, Fei; Chen, Ming-Huang; Yang, Xiang-Jun] Xiamen Univ, Zhongshan Hosp, Dept Obstet & Gynaecol, Xiamen, Fujian Province, Peoples R China; [Song, Yue-Qiang; Xu, Lin] New England Fertil Inst, Stamford, CT USA; [Zhang, Zhen] Xiamen Inst Food & Drug Qual Control, Xiamen, Fujian Province, Peoples R China; [Shen, Yu-Ting] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China; [He, Xiao-Qin] Fifth Hosp Wuhan, Wuhan, Hubei Province, Peoples R China	Xiamen University; Xiamen University; Tongji University	Wang, HL (corresponding author), Xiamen Univ, Organ Transplantat Inst, Coll Med, Xiamen, Fujian Province, Peoples R China.; Yang, XJ (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Obstet & Gynaecol, Xiamen, Fujian Province, Peoples R China.	xingyun207@126.com; hailongwang@xmu.edu.cn	Song, Yueqiang/AAX-3544-2020		Medical Innovation Foundation of Fujian Province of P. R. China [2009-cxb-66]; Natural Science Foundation of Fujian Province of China [2012J05068]; Fundamental Research Funds for the Central Universities [20720150055]; National Natural Science Foundation of P. R. China [31201695]; Natural Science Foundation of Fujian Province of P. R. China [2012J05068]	Medical Innovation Foundation of Fujian Province of P. R. China; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of P. R. China	This work was supported by the Medical Innovation Foundation of Fujian Province of P. R. China (No. 2009-cxb-66), the Natural Science Foundation of Fujian Province of China (No. 2012J05068), the Fundamental Research Funds for the Central Universities (No. 20720150055) and the National Natural Science Foundation of P. R. China (No. 31201695).; This work was supported by the Natural Science Foundation of Fujian Province of P. R. China (No. 2012J05068), the Medical Innovation Foundation of Fujian Province of P. R. China (No. 2009-cxb-66), the Fundamental Research Funds for the Central Universities (No. 20720150055) and the National Natural Science Foundation of P. R. China (No. 31201695).	Althoff F, 2012, MOL BIOL CELL, V23, P2275, DOI 10.1091/mbc.E12-02-0117; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Gunawardane RN, 2000, CURR TOP DEV BIOL, V49, P55; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Homer HA, 2006, HISTOL HISTOPATHOL, V21, P873, DOI 10.14670/HH-21.873; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Huang X, 2013, HISTOCHEM CELL BIOL, V139, P525, DOI 10.1007/s00418-012-1051-z; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kim SM, 2009, EXP CELL RES, V315, P943, DOI 10.1016/j.yexcr.2009.01.013; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077960; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; Niikura Y, 2010, AGING-US, V2, P999, DOI 10.18632/aging.100255; Niikura Y, 2009, AGING-US, V1, P971, DOI 10.18632/aging.100105; Ruan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049184; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Shan TF, 2015, CELL BIOL INT, V39, P35, DOI 10.1002/cbin.10340; Shen YT, 2013, REPROD FERTILITY DEV; Sonn S, 2011, ZYGOTE, V19, P15, DOI 10.1017/S0967199410000183; Sun SC, 2008, MOL REPROD DEV, V75, P1542, DOI 10.1002/mrd.20891; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Xiong B, 2008, BIOL REPROD, V79, P718, DOI 10.1095/biolreprod.108.069641; Yang SW, 2012, CELL CYCLE, V11, P4366, DOI 10.4161/cc.22690; Yang YJ, 2011, MOL BIOL REP, V38, P2043, DOI 10.1007/s11033-010-0328-3; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang CH, 2011, CELL CYCLE, V10, P1861, DOI 10.4161/cc.10.11.15797; Zhang Na, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P654; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhu XL, 2012, CELL CYCLE, V11, P818, DOI 10.4161/cc.11.4.19329	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157197	10.1371/journal.pone.0157197	http://dx.doi.org/10.1371/journal.pone.0157197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284927	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000044
J	Seleem, D; Benso, B; Noguti, J; Pardi, V; Murata, RM				Seleem, Dalia; Benso, Bruna; Noguti, Juliana; Pardi, Vanessa; Murata, Ramiro Mendonca			In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms	PLOS ONE			English	Article							MOUSE MODEL; EXPRESSION; INHIBITION; VIRULENCE; LICORICE; INVASION; ACID	Oral candidiasis (OC) is an opportunistic fungal infection with high prevalence among immunocompromised patients. Candida albicans is the most common fungal pathogen responsible for OC, often manifested in denture stomatitis and oral thrush. Virulence factors, such as biofilms formation and secretion of proteolytic enzymes, are key components in the pathogenicity of C. albicans. Given the limited number of available antifungal therapies and the increase in antifungal resistance, demand the search for new safe and effective antifungal treatments. Lichochalcone-A is a polyphenol natural compound, known for its broad protective activities, as an antimicrobial agent. In this study, we investigated the antifungal activity of lichochalcone-A against C. albicans biofilms both in vitro and in vivo. Lichochalcone-A (625 mu M; equivalent to 10x MIC) significantly reduced C. albicans (MYA 2876) biofilm growth compared to the vehicle control group (1% ethanol), as indicated by the reduction in the colony formation unit (CFU)/ml/g of biofilm dry weight. Furthermore, proteolytic enzymatic activities of proteinases and phospholipases, secreted by C. albicans were significantly decreased in the lichochalcone-A treated biofilms. In vivo model utilized longitudinal imaging of OC fungal load using a bioluminescent-engineered C. albicans (SKCa23-Act-gLUC) and coelenterazine substrate. Mice treated with lichochalcone-A topical treatments exhibited a significant reduction in total photon flux over 4 and 5 days post-infection. Similarly, ex vivo analysis of tongue samples, showed a significant decrease in CFU/ml/mg in tongue tissue sample of lichochalcone-A treated group, which suggest the potential of lichochalcone-A as a novel antifungal agent for future clinical use.	[Seleem, Dalia; Noguti, Juliana; Pardi, Vanessa; Murata, Ramiro Mendonca] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA USA; [Benso, Bruna] Univ Austral Chile, Fac Med, Sch Dent, Campus Isla Teja, Valdivia, Chile	University of Southern California; Universidad Austral de Chile	Murata, RM (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci Dent Hyg & Biomed Sc, Los Angeles, CA USA.	ramirofop@gmail.com	Pardi, Vanessa/AAV-3252-2021; Benso, Bruna/L-1010-2015; Murata, Ramiro M/P-9052-2014	Benso, Bruna/0000-0002-4425-5174; Murata, Ramiro M/0000-0002-8478-6981; Pardi, Vanessa/0000-0001-7120-4332	National Center for Complementary and Integrative Health of the National Institutes of Health (NIH) [R00AT006507]; Brazilian Federal Agency CAPES [2317/2014-01]; NIH/NIDCR Training grant [T90DE021982]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health (NIH); Brazilian Federal Agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH/NIDCR Training grant; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by: National Center for Complementary and Integrative Health of the National Institutes of Health (NIH) under award number R00AT006507, Brazilian Federal Agency CAPES under award number 2317/2014-01 (PhD fellowship to B.B.) and NIH/NIDCR Training grant under award number T90DE021982 (Postdoctoral fellowship to D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; Alnuaimi AD, 2013, FEMS YEAST RES, V13, P689, DOI 10.1111/1567-1364.12068; Badiee P, 2014, INDIAN J MED RES, V139, P195; Bilecova-Rabajdova M, 2013, CENT EUR J PUBL HEAL, V21, P213, DOI 10.21101/cejph.a3886; Borg-von Zepelin M, 1999, J INVEST DERMATOL, V113, P747, DOI 10.1046/j.1523-1747.1999.00747.x; Chen ZJ, 2014, CURR DRUG METAB, V15, P48, DOI 10.2174/138920021501140218125020; Chryssanthou E, 2002, J CLIN MICROBIOL, V40, P3841, DOI 10.1128/JCM.40.10.3841-3844.2002; Correia A, 2010, INFECT IMMUN, V78, P4839, DOI 10.1128/IAI.00248-10; Das I, 2011, INT J INFECT DIS, V15, pE759, DOI 10.1016/j.ijid.2011.06.006; Eggimann P, 2015, J HOSP INFECT, V89, P302, DOI 10.1016/j.jhin.2014.11.006; Gillies M, 2015, CAN MED ASSOC J, V187, pE21, DOI 10.1503/cmaj.140848; Goncalves LM, 2012, J DENT RES, V91, P985, DOI 10.1177/0022034512458689; Gresnigt MS, 2012, J IMMUNOL, V189, P4806, DOI 10.4049/jimmunol.1103551; Hao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067728; Inigo M, 2012, INT J ARTIF ORGANS, V35, P780, DOI 10.5301/ijao.5000170; Klepser ME, 1997, ANTIMICROB AGENTS CH, V41, P1392, DOI 10.1128/AAC.41.6.1392; Lalla Rajesh V, 2013, J Calif Dent Assoc, V41, P263; Lermann U, 2008, MICROBIOL-SGM, V154, P3281, DOI 10.1099/mic.0.2008/022525-0; Messier C, 2012, ORAL DIS, V18, P32, DOI 10.1111/j.1601-0825.2011.01842.x; Messier C, 2011, MYCOSES, V54, pE801, DOI 10.1111/j.1439-0507.2011.02028.x; Mosci P, 2013, VIRULENCE, V4, P250, DOI 10.4161/viru.23529; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Nanteza M, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-143; NCCLS, 2002, PLOS ONE; Neidrauer M, 2014, J MED MICROBIOL, V63, P203, DOI 10.1099/jmm.0.067322-0; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ohta K, 2010, FEMS IMMUNOL MED MIC, V60, P179, DOI 10.1111/j.1574-695X.2010.00734.x; Pande M, 2006, J AGR FOOD CHEM, V54, P10141, DOI 10.1021/jf062206a; Pasetto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115323; Prieto D, 2016, FUTURE MICROBIOL; Ryder N S, 1999, IDrugs, V2, P1253; Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x; Santana IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064645; Shahzad M, 2014, INT J ANTIMICROB AG, V44, P269, DOI 10.1016/j.ijantimicag.2014.05.017; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Sumathy V, 2014, MICROB PATHOGENESIS, V77, P7, DOI 10.1016/j.micpath.2014.10.004; Tang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099103; Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012; Thein ZM, 2007, ARCH ORAL BIOL, V52, P1200, DOI 10.1016/j.archoralbio.2007.06.007; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; Tsui C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw018; Vande Velde G, 2014, CELL MICROBIOL, V16, P115, DOI 10.1111/cmi.12184; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836; Yano J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046311	45	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157188	10.1371/journal.pone.0157188	http://dx.doi.org/10.1371/journal.pone.0157188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284694	gold, Green Submitted, Green Published			2022-12-27	WOS:000377564000043
J	Jiang, HX; Li, XL; Sun, YH; Hou, FJ; Zhang, YF; Li, F; Gu, ZM; Liu, XL				Jiang, Hongxia; Li, Xilian; Sun, Yuhang; Hou, Fujun; Zhang, Yufei; Li, Fei; Gu, Zhimin; Liu, Xiaolin			Insights into Sexual Precocity of Female Oriental River Prawn Macrobrachium nipponense through Transcriptome Analysis	PLOS ONE			English	Article							SHRIMP PENAEUS-MONODON; INSULIN-LIKE PEPTIDES; GENE-EXPRESSION DATA; RNA-SEQ DATA; GLUTATHIONE-PEROXIDASE; MOLECULAR CHARACTERIZATION; MARSUPENAEUS-JAPONICUS; LITOPENAEUS-VANNAMEI; SUPEROXIDE-DISMUTASE; SIGNAL-TRANSDUCTION	Background The oriental river prawn (Macrobrachium nipponense) is the most prevalent aquaculture species in China. The sexual precocity in this species has received considerable attention in recent years because more and more individuals matured at a small size, which devalues the commercial production. In this study, we developed deep-coverage transcriptomic sequencing data for the ovaries of sexually precocious and normal sexually mature M. nipponense using next-generation RNA sequencing technology and attempted to provide the first insight into the molecular regulatory mechanism of sexual precocity in this species. Results A total of 63,336 unigenes were produced from the ovarian cDNA libraries of sexually precocious and normal sexually mature M. nipponense using Illumina HiSeq 2500 platform. Through BLASTX searches against the NR, STRING, Pfam, Swissprot and KEGG databases, 15,134 unigenes were annotated, accounting for 23.89% of the total unigenes. 5,195 and 3,227 matched unigenes were categorized by GO and COG analysis respectively. 15,908 unigenes were consequently mapped into 332 KEGG pathways, and many reproduction-related pathways and genes were identified. Moreover, 26,008 SSRs were identified from 18,133 unigenes. 80,529 and 80,516 SNPs were yielded from ovarian libraries of sexually precocious and normal sexually mature prawn, respectively, and 29,851 potential SNPs between these two groups were also predicted. After comparing the ovarian libraries of sexually precocious and normal sexually mature prawn, 549 differentially expressed genes (DEGs) and 9 key DEGs that may be related to sexual precocity of M. nipponense were identified. 20 DEGs were selected for validation by quantitative real-time PCR (QPCR) and 19 DEGs show consistent expression between QPCR and RNAseq-based differential expression analysis datasets. Conclusion This is the first report on the large-scale RNA sequencing of ovaries of sexually precocious and normal sexually mature M. nipponense. The annotated transcriptome data will provide fundamental support for future research into the reproduction biology of M. nipponense. The large number of candidate SNPs and SSRs detected in this study could be used as genetic markers for population genetics and functional genomics in this species. More importantly, many DEGs, especially nine key DEGs between sexually precocious and normal sexually mature prawns were identified, which will dramatically improve understanding of molecular regulatory mechanism of sexual precocity of this species.	[Jiang, Hongxia; Sun, Yuhang; Hou, Fujun; Liu, Xiaolin] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Jiang, Hongxia; Li, Xilian; Zhang, Yufei; Li, Fei; Gu, Zhimin] Zhejiang Inst Freshwater Fisheries, Key Lab Hlth Freshwater Aquaculture, Key Lab Freshwater Aquat Anim Genet & Breeding Zh, Agr Minist, Huzhou, Zhejiang, Peoples R China; [Jiang, Hongxia] Henan Normal Univ, Coll Fisheries, Xinxiang, Henan, Peoples R China	Northwest A&F University - China; Henan Normal University	Liu, XL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.; Gu, ZM (corresponding author), Zhejiang Inst Freshwater Fisheries, Key Lab Hlth Freshwater Aquaculture, Key Lab Freshwater Aquat Anim Genet & Breeding Zh, Agr Minist, Huzhou, Zhejiang, Peoples R China.	guzhimin2006@163.com; liuxiaolin@nwsuaf.edu.cn	Zhang, yufei/HHC-7375-2022		Zhejiang Province Key S&T Special Projects of New Variety Breeding, China [2012C12907]; open project of Agriculture Ministry Key Laboratory of Healthy Freshwater Aquaculture [ZJK201506]	Zhejiang Province Key S&T Special Projects of New Variety Breeding, China; open project of Agriculture Ministry Key Laboratory of Healthy Freshwater Aquaculture	The work was financially supported by the Zhejiang Province Key S&T Special Projects of New Variety Breeding, China (No. 2012C12907), and the open project of Agriculture Ministry Key Laboratory of Healthy Freshwater Aquaculture (No. ZJK201506).	Arenas-Rios E, 2007, COMP BIOCHEM PHYS A, V148, P150, DOI 10.1016/j.cbpa.2007.04.003; Arukwe Augustine, 2003, Comp Hepatol, V2, P4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atli G, 2007, COMP BIOCHEM PHYS C, V145, P282, DOI 10.1016/j.cbpc.2006.12.012; Bai HK, 2015, GENE, V562, P22, DOI 10.1016/j.gene.2014.12.008; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Buaklin A, 2013, COMP BIOCHEM PHYS B, V164, P280, DOI 10.1016/j.cbpb.2013.02.004; Cai YX, 2002, HYDROBIOLOGIA, V487, P59, DOI 10.1023/A:1022991224381; Caruso JA, 1999, BIOCHEM PHARMACOL, V58, P1395, DOI 10.1016/S0006-2952(99)00225-7; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Chan SJ, 2000, AM ZOOL, V40, P213; Chandler JC, 2015, GEN COMP ENDOCR, V215, P76, DOI 10.1016/j.ygcen.2014.08.018; Chansela P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033154; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Christie AE, 2014, GEN COMP ENDOCR, V206, P235, DOI 10.1016/j.ygcen.2014.04.015; Chu SL, 2006, AQUACULTURE, V251, P537, DOI 10.1016/j.aquaculture.2005.05.040; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Du YX, 2015, AQUACULTURE, V442, P1, DOI 10.1016/j.aquaculture.2015.02.016; Duleba AJ, 1998, FERTIL STERIL, V69, P335, DOI 10.1016/S0015-0282(97)00473-1; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Fu HT, 2012, AQUAC RES, V43, P993, DOI 10.1111/j.1365-2109.2011.03085.x; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Glencross BD, 2001, AQUACULT NUTR, V7, P59, DOI 10.1046/j.1365-2095.2001.00168.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103; Hu KJ, 2004, COMP BIOCHEM PHYS B, V137, P21, DOI 10.1016/j.cbpc.2003.09.010; Ibarra AM, 2007, AQUACULTURE, V268, P23, DOI 10.1016/j.aquaculture.2007.04.028; Iwata H, 2003, ZYGOTE, V11, P1, DOI 10.1017/S0967199403001011; Jansen PAM, 2012, EXP DERMATOL, V21, P889, DOI 10.1111/exd.12022; Jin SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076840; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Le Moullac G, 2003, AQUACULTURE, V227, P89, DOI 10.1016/S0044-8486(03)00497-6; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li X, 2011, AQUACULT INT, V19, P251, DOI 10.1007/s10499-010-9400-1; Lin CM, 2012, CURR NEUROVASC RES, V9, P222; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Makkapan W, 2011, AQUACULTURE, V321, P101, DOI 10.1016/j.aquaculture.2011.08.016; Meunpol O, 2010, FISHERIES SCI, V76, P281, DOI 10.1007/s12562-009-0208-8; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Orn S, 2006, ARCH ENVIRON CON TOX, V51, P237, DOI 10.1007/s00244-005-0103-y; Qian Z, 2014, COMP BIOCHEM PHYS C, V159, P38, DOI 10.1016/j.cbpc.2013.09.009; Qiao H, 2012, COMP BIOCHEM PHYS D, V7, P268, DOI 10.1016/j.cbd.2012.04.003; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Racotta IS, 2003, AQUACULTURE, V227, P107, DOI 10.1016/S0044-8486(03)00498-8; Reddy PS, 2004, GEN COMP ENDOCR, V135, P35, DOI 10.1016/j.ygcen.2003.08.002; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; Sittikankaew K, 2010, AQUACULTURE, V308, pS91, DOI 10.1016/j.aquaculture.2010.06.039; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Soverchia L, 2005, TOXICOL APPL PHARM, V209, P236, DOI 10.1016/j.taap.2005.04.013; SPAZIANI EP, 1993, J COMP PHYSIOL B, V163, P541, DOI 10.1007/BF00302112; Surai PF, 1998, COMP BIOCHEM PHYS B, V120, P527, DOI 10.1016/S0305-0491(98)10039-1; Tahara D, 2004, COMP BIOCHEM PHYS A, V137, P631, DOI 10.1016/j.cbpb.2003.12.005; Talakhun W, 2012, COMP BIOCHEM PHYS D, V7, P180, DOI 10.1016/j.cbd.2012.02.003; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Thompson JL, 2006, COMP BIOCHEM PHYS B, V144, P86, DOI 10.1016/j.cbpb.2006.01.011; Tingaud-Sequeira A, 2007, GENE, V386, P98, DOI 10.1016/j.gene.2006.08.018; Wang S, 2014, FEBS J, V281, P877, DOI 10.1111/febs.12655; Warrier S, 2002, MOL REPROD DEV, V61, P536, DOI 10.1002/mrd.10106; Wimuttisuk W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076934; Wu LT, 2010, COMP BIOCHEM PHYS B, V155, P26, DOI 10.1016/j.cbpb.2009.09.005; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Xue SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076718; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zhang FY, 2010, COMP BIOCHEM PHYS B, V155, P288, DOI 10.1016/j.cbpb.2009.11.013; Zhang ZP, 2007, COMP BIOCHEM PHYS B, V147, P466, DOI 10.1016/j.cbpb.2007.02.013; Zhao W, 2013, GENET MOL RES, V12, P5215, DOI 10.4238/2013.October.30.6; Zhao WH, 2011, MOL BIOL REP, V38, P1399, DOI 10.1007/s11033-010-0243-7	90	17	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157173	10.1371/journal.pone.0157173	http://dx.doi.org/10.1371/journal.pone.0157173			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280288	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000103
J	Chiu, KW; Nakano, T; Chen, KD; Lin, CC; Hu, TH; Goto, S; Chen, CL				Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Lin, Chih-Che; Hu, Tsung-Hui; Goto, Shigeru; Chen, Chao-Long			Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation	PLOS ONE			English	Article							INTERLEUKIN-28B GENETIC-VARIANTS; CYP2C19 GENOTYPES; POLYMORPHISMS; GRAFT; RECIPIENTS; THERAPY	To investigate the effect of IL28B single nucleotide polymorphisms (SNPs) (rs8099917 and rs12979860) in the donors and recipients on the outcome of Hepatitis C virus-RNA clearance after living donor liver transplantation (LDLT). The rs8099917 and rs12979860 genotypes in 50 donor and recipients pairs were explored on the pre-operative day (POD) and post-operative day 30 (POD30). There was a significant difference in HCV-RNA clearance before (12%, 6/50) and after (48%, 24/50) liver transplantation (P < 0.001). The rs8099917 genotype TT was dominant in both the recipients (82%, 41/50) and donors (86%, 43/50), but had no significant effect on HCV-RNA clearance (87.5%, 21/24) and recurrence (76.9%, 20/26) after LDLT. One recipient was detected with genotype GG on POD, which changed to genotype GT on POD30. Prevalence of rs12979860 genotype CT was 98% (49/50 recipient) and 92% (46/50 donor) and prevalence of genotype CC was 2% (1/50 recipient) and 8% (4/50 donor) on POD and POD30, respectively. Of the 4 recipients with rs12979860 genotype CC on POD30, 3 recipients (12.5%, 3/24) exhibited HCV clearance and 1 experienced recurrence (3.9%, 1/26), however, this was not statistically significant. In conclusion, alterations in IL28B SNP genotype may occur after LDLT, leading to modifications in the host genome or donor proteome by HCV. This predicted mechanism will need to be investigated further.	[Chiu, King-Wah; Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Lin, Chih-Che; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Gen Surg, Kaohsiung, Taiwan; [Chiu, King-Wah; Nakano, Toshiaki; Chen, Kuang-Den; Lin, Chih-Che; Hu, Tsung-Hui; Goto, Shigeru; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan; [Chiu, King-Wah; Hu, Tsung-Hui] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chiu, KW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Chiu, KW (corresponding author), Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan.; Chiu, KW (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	kwchiu@adm.cgmh.org.tw		Chiu, King-Wah/0000-0003-2108-6539; Nakano, Toshiaki/0000-0003-3701-3449	Chang Gung Memorial Hospital of Taiwan [CMRPG8D1001]	Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital)	This work was supported by grant number CMRPG8D1001 from the Chang Gung Memorial Hospital of Taiwan.	Bewick MA, 2006, J CLIN ONCOL, V24, P5645, DOI 10.1200/JCO.2006.05.9923; Chang YC, 2016, ONCOL REP, V35, P2936, DOI 10.3892/or.2016.4662; Chiu KW, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0140-4; Chiu KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071314; Chiu KW, 2012, EUR J CLIN INVEST, V42, P352, DOI 10.1111/j.1365-2362.2011.02589.x; Chiu KW, 2010, ANN TRANSPL, V15, P38; Chiu KW, 2010, CLIN TRANSPLANT, V24, P830, DOI 10.1111/j.1399-0012.2010.01220.x; Chiu KW, 2005, HEPATO-GASTROENTEROL, V52, P1825; Chuang WL, 2013, J GASTROENTEROL, V48, P22, DOI 10.1007/s00535-012-0669-x; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Hung CH, 2013, HEPATOLOGY, V57, P2089, DOI 10.1002/hep.26002; Li SY, 2011, HEPAT MON, V11, P163; Lin CC, 2014, TRANSPLANTATION, V97, pS47, DOI 10.1097/01.tp.0000446277.36181.e7; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2011, HEPATOLOGY, V53, P1403, DOI 10.1002/hep.24117	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156846	10.1371/journal.pone.0156846	http://dx.doi.org/10.1371/journal.pone.0156846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275739	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700041
J	Hepworth, C; Turner, C; Landim, MG; Cameron, D; Gray, JE				Hepworth, Christopher; Turner, Carla; Landim, Marcela Guimaraes; Cameron, Duncan; Gray, Julie E.			Balancing Water Uptake and Loss through the Coordinated Regulation of Stomatal and Root Development	PLOS ONE			English	Article							GENETIC MANIPULATION; SECRETORY PEPTIDE; ABSCISIC-ACID; DENSITY; TOLERANCE; STOMAGEN; AUXIN; SIZE	Root development is influenced by nutrient and water availabilities. Plants are able to adjust many attributes of their root in response to environmental signals including the size and shape of the primary root, lateral roots and root hairs. Here we investigated the response of roots to changes in the levels of leaf transpiration associated with altered stomatal frequency. We found that plants with high stomatal density and conductance produce a larger rooting area and as a result have enhanced phosphate uptake capacity whereas plants with low stomatal conductance produce a smaller root. Manipulating the growth environment of plants indicated that enhanced root growth is most likely a result of an increased demand for water rather than phosphate. Plants manipulated to have an increase or reduction in root hair growth show a reduction or increase respectively, in stomatal conductance and density. Our results demonstrate that plants can balance their water uptake and loss through coordinated regulation of both stomatal and root development.	[Hepworth, Christopher; Cameron, Duncan] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Turner, Carla; Landim, Marcela Guimaraes; Gray, Julie E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Landim, Marcela Guimaraes] Univ Brasilia, Inst Biol, Brasilia, DF, Brazil	University of Sheffield; University of Sheffield; Universidade de Brasilia	Gray, JE (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	J.E.Gray@sheffield.ac.uk	Gray, Julie E/B-4271-2014	Gray, Julie E/0000-0001-9972-5156; Guimaraes Landim, Marcela/0000-0001-9519-5258; Cameron, Duncan/0000-0002-5439-6544; Hepworth, Christopher/0000-0002-7866-8567	Engineering and Physical Sciences Research Council [X/003926-12-45-4]; Biotechnology and Biological Research Council [X/004216-14-16]; Biotechnology and Biological Sciences Research Council [BB/I002154/1, BB/J001805/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1248095] Funding Source: researchfish; BBSRC [BB/I002154/1, BB/J001805/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CH received funding from the Engineering and Physical Sciences Research Council, Grant code: X/003926-12-45-4. CT received funding from the Biotechnology and Biological Research Council, Grant code: X/004216-14-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chater C, 2015, CURR BIOL, V25, P2709, DOI 10.1016/j.cub.2015.09.013; Cui HC, 2014, MOL PLANT, V7, P1727, DOI 10.1093/mp/ssu106; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Datta S, 2011, PLANT SOIL, V346, P1, DOI 10.1007/s11104-011-0845-4; Dodd IC, 2013, NEW PHYTOL, V197, P6, DOI 10.1111/nph.12052; Doheny-Adams T, 2012, PHILOS T R SOC B, V367, P547, DOI 10.1098/rstb.2011.0272; Dow GJ, 2014, NEW PHYTOL, V201, P1205, DOI 10.1111/nph.12586; Franks PJ, 2015, NEW PHYTOL, V207, P188, DOI 10.1111/nph.13347; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Harris Jeanne M., 2015, Plants-Basel, V4, P548, DOI 10.3390/plants4030548; Hepworth C, 2015, NEW PHYTOL, V208, P336, DOI 10.1111/nph.13598; Hewitt, 1966, SAND WATER CULTURE M; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Kwasniewski M, 2016, J EXP BOT, V67, P1079, DOI 10.1093/jxb/erv498; McAdam SAM, 2016, PLANT CELL ENVIRON, V39, P652, DOI 10.1111/pce.12669; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Muraro D, 2013, J THEOR BIOL, V317, P71, DOI 10.1016/j.jtbi.2012.08.032; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Tanaka Y, 2013, NEW PHYTOL, V198, P757, DOI 10.1111/nph.12186; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529; Zhang JY, 2014, P NATL ACAD SCI USA, V111, pE3015, DOI 10.1073/pnas.1400542111	25	19	19	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156930	10.1371/journal.pone.0156930	http://dx.doi.org/10.1371/journal.pone.0156930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275842	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700049
J	McDonald, JE; Larsen, N; Pennington, A; Connolly, J; Wallis, C; Rooks, DJ; Hall, N; McCarthy, AJ; Allison, HE				McDonald, James E.; Larsen, Niels; Pennington, Andrea; Connolly, John; Wallis, Corrin; Rooks, David J.; Hall, Neil; McCarthy, Alan J.; Allison, Heather E.			Characterising the Canine Oral Microbiome by Direct Sequencing of Reverse-Transcribed rRNA Molecules	PLOS ONE			English	Article							COMMUNITY COMPOSITION; PERIODONTAL-DISEASE; DIVERSITY; PCR; ARCHAEA; PROJECT; GENES; AMPLIFICATION; BACTERIA; TAXONOMY	PCR amplification and sequencing of phylogenetic markers, primarily Small Sub-Unit ribosomal RNA (SSU rRNA) genes, has been the paradigm for defining the taxonomic composition of microbiomes. However, `universal' SSU rRNA gene PCR primer sets are likely to miss much of the diversity therein. We sequenced a library comprising purified and reverse-transcribed SSU rRNA (RT-SSU rRNA) molecules from the canine oral microbiome and compared it to a general bacterial 16S rRNA gene PCR amplicon library generated from the same biological sample. In addition, we have developed BIONmeta, a novel, open-source, computer package for the processing and taxonomic classification of the randomly fragmented RT-SSU rRNA reads produced. Direct RT-SSU rRNA sequencing revealed that 16S rRNA molecules belonging to the bacterial phyla Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria and Spirochaetes, were most abundant in the canine oral microbiome (92.5% of total bacterial SSU rRNA). The direct rRNA sequencing approach detected greater taxonomic diversity (1 additional phylum, 2 classes, 1 order, 10 families and 61 genera) when compared with general bacterial 16S rRNA amplicons from the same sample, simultaneously provided SSU rRNA gene inventories of Bacteria, Archaea and Eukarya, and detected significant numbers of sequences not recognised by `universal' primer sets. Proteobacteria and Spirochaetes were found to be under-represented by PCR-based analysis of the microbiome, and this was due to primer mismatches and taxon-specific variations in amplification efficiency, validated by qPCR analysis of 16S rRNA amplicons from a mock community. This demonstrated the veracity of direct RT-SSU rRNA sequencing for molecular microbial ecology.	[McDonald, James E.] Bangor Univ, Sch Biol Sci, Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales; [Larsen, Niels] Danish Genome Inst, Skt Lucas Kirkeplads 8, DK-8000 Aarhus C, Denmark; [Pennington, Andrea; Connolly, John; Rooks, David J.; Hall, Neil; McCarthy, Alan J.; Allison, Heather E.] Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England; [Wallis, Corrin] WALTHAM Ctr Pet Nutr, Freeby Lane, Melton Mowbray LE14 4RT, Melton Mowbray, England	Bangor University; University of Liverpool; Mars; WALTHAM Petcare Science Institute	McDonald, JE (corresponding author), Bangor Univ, Sch Biol Sci, Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales.; Allison, HE (corresponding author), Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.	j.mcdonald@bangor.ac.uk; hallison@liv.ac.uk	Allison, Heather/AAE-8856-2021	Allison, Heather/0000-0003-0017-7992; Hall, Neil/0000-0003-2808-0009; McDonald, James/0000-0002-6328-3752	BBSRC [BB/G017980/1]; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AP was supported by a BBSRC industrial case PhD studentship (BB/G017980/1) awarded to HA.	Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHOI BK, 1994, INFECT IMMUN, V62, P1889, DOI 10.1128/IAI.62.5.1889-1895.1994; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Li XR, 2014, APPL MICROBIOL BIOT, V98, P3777, DOI 10.1007/s00253-014-5583-0; Loesche W J, 1988, Adv Dent Res, V2, P275; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wade WG, 2013, PHARMACOL RES, V69, P137, DOI 10.1016/j.phrs.2012.11.006; Wallis C, 2015, VET MICROBIOL, V181, P271, DOI 10.1016/j.vetmic.2015.09.003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	39	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157046	10.1371/journal.pone.0157046	http://dx.doi.org/10.1371/journal.pone.0157046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276347	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700060
J	Muris, AH; Smolders, J; Rolf, L; Klinkenberg, LJJ; van der Linden, N; Meex, S; Damoiseaux, J; Hupperts, R				Muris, Anne-Hilde; Smolders, Joost; Rolf, Linda; Klinkenberg, Lieke J. J.; van der Linden, Noreen; Meex, Steven; Damoiseaux, Jan; Hupperts, Raymond			Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; INTERFERON-BETA; RELAPSE RISK; DIAGNOSTIC-CRITERIA; DISEASE-ACTIVITY; SERUM; ONSET; ASSOCIATION; PREDICTION; EXPOSURE	Background and Objective The risk of developing multiple sclerosis (MS) as well as MS disease activity is associated with vitamin D (25(OH) D) status. The relationship between the main functional disability hallmark of MS, disability progression, and 25(OH) D status is less well established though, especially not in MS patients with progressive disease. Methods This retrospective follow-up study included 554 MS patients with a serum baseline 25(OH) D level and Expanded Disability Status Scale (EDSS) with a minimum follow-up of three years. Logistic regressions were performed to assess the effect of baseline 25(OH) D status on relapse rate. Repeated measures linear regression analyses were performed to assess the effect on disability and disability progression. Results Baseline deseasonalized 25(OH) D status was associated with subsequent relapse risk (yes/no), but only in the younger MS patients (<= 37.5 years; OR = 0.872, per 10 nmol/L 25 (OH) D, p = 0.041). Baseline 25(OH) D status was not significantly associated with either disability or disability progression, irrespective of MS phenotype. Conclusion Within the physiological range, 25(OH) D status is just significantly associated with the occurrence of relapses in younger MS patients, but is not associated with disability or disability progression over three years follow-up. Whether high dose supplementation to supra physiological 25(OH) D levels prevents disability progression in MS should become clear from long term follow-up of supplementation studies.	[Muris, Anne-Hilde; Rolf, Linda; Hupperts, Raymond] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands; [Muris, Anne-Hilde; Smolders, Joost; Rolf, Linda; Hupperts, Raymond] Zuyderland Med Ctr, Acad MS Ctr Limburg, Sittard, Netherlands; [Klinkenberg, Lieke J. J.; van der Linden, Noreen; Meex, Steven; Damoiseaux, Jan] Maastricht Univ, Med Ctr, Cent Diagnost Lab, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University	Muris, AH (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands.; Muris, AH (corresponding author), Zuyderland Med Ctr, Acad MS Ctr Limburg, Sittard, Netherlands.	a.muris@maastrichtuniversity.nl	Damoiseaux, Jan/B-8993-2009; Smolders, Joost/B-7658-2009	Damoiseaux, Jan/0000-0003-4007-6985; Smolders, Joost/0000-0001-9766-8661; Meex, Steven/0000-0001-8147-9006; Muris, Anne-Hilde/0000-0002-3749-5241	Nationaal MS Fonds "Vitamine D en progressie MS"	Nationaal MS Fonds "Vitamine D en progressie MS"	Funding for this study was provided by the Nationaal MS Fonds "Vitamine D en progressie MS" (http://www.nationaalmsfonds.nl/nationaal-ms-fonds/onderzoek). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Benth JS, 2012, NEUROEPIDEMIOLOGY, V39, P84, DOI 10.1159/000339360; Brown MG, 2007, NEUROLOGY, V69, P1498, DOI 10.1212/01.wnl.0000271884.11129.f3; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Central Commitee on Research Involving Human Subjects, NONWMO RES; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; D'hooghe MB, 2012, MULT SCLER J, V18, P451, DOI 10.1177/1352458511423778; Etemadifar M, 2006, ACTA NEUROL SCAND, V113, P283, DOI 10.1111/j.1600-0404.2006.00585.x; Ford C, 2010, MULT SCLER, V16, P342, DOI 10.1177/1352458509358088; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Hirst C, 2008, J NEUROL, V255, P280, DOI 10.1007/s00415-008-0743-8; Kimball SM, 2007, AM J CLIN NUTR, V86, P645, DOI 10.1093/ajcn/86.3.645; Knippenberg S, 2012, NEUROEPIDEMIOLOGY, V39, P94, DOI 10.1159/000339854; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lin R, 2015, ACTA NEUROL SCAND, V131, P231, DOI 10.1111/ane.12315; Loken-Amsrud KI, 2012, NEUROLOGY, V79, P267, DOI 10.1212/WNL.0b013e31825fdf01; Lublin FD, 2003, NEUROLOGY, V61, P1528, DOI 10.1212/01.WNL.0000096175.39831.21; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McDowell TY, 2011, NEUROEPIDEMIOLOGY, V36, P39, DOI 10.1159/000322512; Mowry EM, 2010, ANN NEUROL, V67, P618, DOI 10.1002/ana.21972; Munger KL, 2014, ANN CLIN TRANSL NEUR, V1, P605, DOI 10.1002/acn3.91; Nikfar S, 2010, CLIN THER, V32, P1871, DOI 10.1016/j.clinthera.2010.10.006; O'Connor P, 2014, NEUROLOGY, V83, P78, DOI 10.1212/WNL.0000000000000541; Panitch H, 2004, NEUROLOGY, V63, P1788; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rosjo E, 2015, J NEUROIMMUNOL, V280, P21, DOI 10.1016/j.jneuroim.2015.02.001; Runia TF, 2012, NEUROLOGY, V79, P261, DOI 10.1212/WNL.0b013e31825fdec7; Salzer J, 2014, EXPERT REV NEUROTHER, V14, P9, DOI 10.1586/14737175.2014.864952; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Shirani A, 2012, JAMA-J AM MED ASSOC, V308, P247, DOI 10.1001/jama.2012.7625; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Smolders J, 2013, J NEUROPATH EXP NEUR, V72, P91, DOI 10.1097/NEN.0b013e31827f4fcc; Smolders J, 2011, J NEUROL SCI, V311, P37, DOI 10.1016/j.jns.2011.07.033; Smolders J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015235; Soilu-Hanninen M, 2008, J NEUROL NEUROSUR PS, V79, P152, DOI 10.1136/jnnp.2006.105320; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Soilu-Hanninen M, 2012, J NEUROL NEUROSUR PS, V83, P566, DOI 10.1136/jnnp-2011-301876; Stewart N, 2012, NEUROLOGY, V79, P254, DOI 10.1212/WNL.0b013e31825fded9; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; Waschbisch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115488; Weinstock-Guttman B, 2011, J NEUROL NEUROSUR PS, V82, P189, DOI 10.1136/jnnp.2010.227942	50	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156122	10.1371/journal.pone.0156122	http://dx.doi.org/10.1371/journal.pone.0156122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276080	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700017
J	Naveen, V; Hsiao, CD				Naveen, Vankadari; Hsiao, Chwan-Deng			NrdR Transcription Regulation: Global Proteome Analysis and Its Role in Escherichia coli Viability and Virulence	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASES; GENE-EXPRESSION; GROWTH; IDENTIFICATION; PROTEINS; BINDING; ENVIRONMENT; COLLECTION; ABUNDANCE; STRATEGY	Bacterial ribonucleotide reductases (RNRs) play an important role in the synthesis of dNTPs and their expression is regulated by the transcription factors, NrdR and Fur. Recent transcriptomic studies using deletion mutants have indicated a role for NrdR in bacterial chemotaxis and in the maintenance of topoisomerase levels. However, NrdR deletion alone has no effect on bacterial growth or virulence in infected flies or in human blood cells. Furthermore, transcriptomic studies are limited to the deletion strain alone, and so are inadequate for drawing biological implications when the NrdR repressor is active or abundant. Therefore, further examination is warranted of changes in the cellular proteome in response to both NrdR overexpression, as well as deletion, to better understand its functional relevance as a bacterial transcription repressor. Here, we profile bacterial fate under conditions of overexpression and deletion of NrdR in E. coli. Biochemical assays show auxiliary zinc enhances the DNA binding activity of NrdR. We also demonstrate at the physiological level that increased nrdR expression causes a significant reduction in bacterial growth and fitness even at normal temperatures, and causes lethality at elevated temperatures. Corroborating these direct effects, global proteome analysis following NrdR overexpression showed a significant decrease in global protein expression. In parallel, studies on complementary expression of downregulated essential genes polA, eno and thiL showed partial rescue of the fitness defect caused by NrdR overexpression. Deletion of downregulated non-essential genes ygfK and trxA upon NrdR overexpression resulted in diminished bacterial growth and fitness suggesting an additional role for NrdR in regulating other genes. Moreover, in comparison with NrdR deletion, E. coli cells overexpressing NrdR showed significantly diminished adherence to human epithelial cells, reflecting decreased bacterial virulence. These results suggest that elevated expression of NrdR could be a suitable means to retard bacterial growth and virulence, as its elevated expression reduces bacterial fitness and impairs host cell adhesion.	[Naveen, Vankadari; Hsiao, Chwan-Deng] Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Mol Cell Biol, Taipei, Taiwan; [Naveen, Vankadari; Hsiao, Chwan-Deng] Acad Sinica, Taipei 115, Taiwan; [Naveen, Vankadari; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Hsiao, CD (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Mol Cell Biol, Taipei, Taiwan.; Hsiao, CD (corresponding author), Acad Sinica, Taipei 115, Taiwan.; Hsiao, CD (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	hsiao@gate.sinica.edu.tw	Vankadari, Naveen/AAE-7381-2020; Hsiao, Chwan-Deng/AAZ-8869-2021	Hsiao, Chwan-Deng/0000-0002-7012-1532; Vankadari, Naveen/0000-0001-9363-080X	Ministry of Science and Technology of Taiwan, Republic of China [MOST 104-2311-B-001-016-MY3]	Ministry of Science and Technology of Taiwan, Republic of China	This work was supported by grants from the Ministry of Science and Technology of Taiwan, Republic of China (MOST 104-2311-B-001-016-MY3 to CDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Ministry of Science and Technology of Taiwan, Republic of China (MOST 104-2311-B-001-016-MY3 to C.-D. H.). We thank Academia Sinica Common Mass Spectrometry Facilities located at the Institute of Biological Chemistry for LTQ-Orbitrap data processing and additional technical assistance. We thank Dr. Sue Lin Chao of IMB, and "NBRP-E. coli at NIG" for providing the deletion and over-expressing E. coli strains used in this study. We also thank the Image Core Facility for microscopy and the English Editing Core at the Institute of Molecular Biology, Academia Sinica.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; AUGUSTIN LB, 1994, J BACTERIOL, V176, P378, DOI 10.1128/JB.176.2.378-387.1994; Baba Tomoya, 2008, V416, P171, DOI 10.1007/978-1-59745-321-9_11; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Case ED, 2011, J BACTERIOL, V193, P4396, DOI 10.1128/JB.00294-11; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Crespo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123571; Crona M, 2013, J BIOL CHEM, V288, P8198, DOI 10.1074/jbc.M112.442434; Dassama LMK, 2012, J AM CHEM SOC, V134, P20498, DOI 10.1021/ja309468s; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Dreux N, 2015, INFECT IMMUN, V83, P1305, DOI 10.1128/IAI.02772-14; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Garcia-Ortiz MV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002152; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P773, DOI 10.1089/ars.2006.8.773; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; Grinberg I, 2009, J BACTERIOL, V191, P1169, DOI 10.1128/JB.01145-08; Harcum SW, 2006, J IND MICROBIOL BIOT, V33, P801, DOI 10.1007/s10295-006-0122-3; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Kim HC, 2008, APPL ENVIRON MICROB, V74, P4853, DOI 10.1128/AEM.02756-07; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Letourneau J, 2011, JOVE-J VIS EXP, DOI 10.3791/2783; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Marcos CM, 2012, FEMS YEAST RES, V12, P557, DOI 10.1111/j.1567-1364.2012.00806.x; Margulies C, 1998, NUCLEIC ACIDS RES, V26, P5170, DOI 10.1093/nar/26.22.5170; Maul RW, 2007, J BACTERIOL, V189, P4688, DOI 10.1128/JB.00476-07; McKethan BL, 2013, MOL MICROBIOL, V90, P278, DOI 10.1111/mmi.12364; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Panosa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011328; Persky NS, 2009, MOL MICROBIOL, V73, P253, DOI 10.1111/j.1365-2958.2009.06767.x; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Riess T, 2008, APPL ENVIRON MICROB, V74, P5224, DOI 10.1128/AEM.00621-08; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; Schyns G, 2005, J BACTERIOL, V187, P8127, DOI 10.1128/JB.187.23.8127-8136.2005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sieber M, 1998, BIOL CHEM, V379, P731; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wu CC, 2012, J BIOL CHEM, V287, P21461, DOI 10.1074/jbc.M112.344358; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134237; Zhang Y, 2015, APMIS, V123, P252, DOI 10.1111/apm.12340	60	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157165	10.1371/journal.pone.0157165	http://dx.doi.org/10.1371/journal.pone.0157165			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275780	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700077
J	Kwasniewska, M; Pikala, M; Bielecki, W; Dziankowska-Zaborszczyk, E; Rebowska, E; Kozakiewicz, K; Pajak, A; Piwonski, J; Tykarski, A; Zdrojewski, T; Drygas, W				Kwasniewska, Magdalena; Pikala, Malgorzata; Bielecki, Wojciech; Dziankowska-Zaborszczyk, Elzbieta; Rebowska, Ewa; Kozakiewicz, Krystyna; Pajak, Andrzej; Piwonski, Jerzy; Tykarski, Andrzej; Zdrojewski, Tomasz; Drygas, Wojciech			Ten-Year Changes in the Prevalence and Socio-Demographic Determinants of Physical Activity among Polish Adults Aged 20 to 74 Years. Results of the National Multicenter Health Surveys WOBASZ (2003-2005) and WOBASZ II (2013-2014)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TEMPORAL TRENDS; DOSE-RESPONSE; TIME TRENDS; MORTALITY; POLAND; POPULATION; DECLINE; BURDEN; RATES	Introduction The aim of the study was to estimate ten-year changes in physical activity (PA) patterns and sociodemographic determinants among adult residents of Poland. Methods The study comprised two independent samples of randomly selected adults aged 20-74 years participating in the National Multicentre Health Survey WOBASZ (2003-2005; n = 14572) and WOBASZ II (2013-2014; n = 5694). In both surveys the measurements were performed by six academic centers in all 16 voivodships of Poland (108 measurement points in each survey). Sociodemographic data were collected by an interviewer-administered questionnaire in both surveys. Physical activity was assessed in three domains: lei-sure-time, occupational and commuting physical activity. Results Leisure-time PA changed substantially between the surveys (p<0.001). The prevalence of subjects being active on most days of week fell in both genders in the years 2003-2014 (37.4% vs 27.3% in men); 32.7% vs 28.3% in women. None or occasional activity increased from 49.6% to 56.8% in men, while remained stable in women (55.2% vs 54.9%). In both WOBASZ surveys the likelihood of physical inactivity was higher in less educated individuals, smokers and those living in large agglomerations (p<0.01). No significant changes were observed in occupational activity in men between the surveys, while in women percentage of sedentary work increased from 43.4% to % 49.4% (p<0.01). Commuting PA decreased significantly in both genders (p<0.001). About 79.3% of men and 71.3% of women reported no active commuting in the WOBASZ II survey. Conclusions The observed unfavourable changes in PA emphasize the need for novel intervention concepts in order to reverse this direction. Further detailed monitoring of PA patterns in Poland is of particular importance.	[Kwasniewska, Magdalena; Rebowska, Ewa; Drygas, Wojciech] Med Univ Lodz, Dept Prevent Med, PL-90131 Lodz, Poland; [Pikala, Malgorzata; Dziankowska-Zaborszczyk, Elzbieta] Med Univ Lodz, Dept Epidemiol & Biostat, Lodz, Poland; [Bielecki, Wojciech] Med Univ Lodz, Dept Social Pathol, Lodz, Poland; [Kozakiewicz, Krystyna] Med Univ Silesia, Dept & Clin Cardiol, Katowice, Poland; [Pajak, Andrzej] Jagiellonian Univ, Inst Publ Hlth, Dept Epidemiol & Populat Studies, Krakow, Poland; [Piwonski, Jerzy; Drygas, Wojciech] Cardinal Stefan Wyszynski Univ, Inst Cardiol, Dept Epidemiol Cardiovasc Dis Prevent & Hlth Prom, Warsaw, Poland; [Tykarski, Andrzej] Poznan Univ Med Sci, Dept & Clin Hipertensiol Angiol & Internal Med, Poznan, Poland; [Zdrojewski, Tomasz] Med Univ Gdansk, Dept & Clin Hypertens & Diabetol, Gdansk, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz; Medical University Silesia; Jagiellonian University; Collegium Medicum Jagiellonian University; Cardinal Stefan Wyszynski University in Warsaw; Institute of Cardiology - Poland; Poznan University of Medical Sciences; Fahrenheit Universities; Medical University Gdansk	Kwasniewska, M (corresponding author), Med Univ Lodz, Dept Prevent Med, PL-90131 Lodz, Poland.	magdalena.kwasniewska@umed.lodz.pl	Zdrojewski, Tomasz/AAA-8875-2020; Kwaśniewska, Magdalena/S-6655-2016; Pikala, Malgorzata/S-9898-2016; Drygas, Wojciech/GLR-9863-2022	Zdrojewski, Tomasz/0000-0001-6015-8561; Pikala, Malgorzata/0000-0003-4426-4908; Rebowska, Ewa/0000-0002-3620-588X; Bielecki, Wojciech/0000-0002-1009-4536; Kwasniewska, Magdalena/0000-0003-4547-5627; Drygas, Wojciech/0000-0002-4351-6459; KOZAKIEWICZ, KRYSTYNA/0000-0001-9108-6636; Dziankowska-Zaborszczyk, Elzbieta/0000-0001-8423-9606	Minister of Health	Minister of Health	The WOBASZ II Project was financed from the resources at the disposal of the Minister of Health within the framework of the "National Program of Equalization and Accessibility to Cardiovascular Disease Prevention and Treatment for 2010-2012 POLKARD - goal: Analyses and epidemiology "Monitoring of the epidemiological situation in Poland in the field of cardiovascular diseases."	Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; [Anonymous], 1990, MONICA MAN; [Anonymous], 2011, EUR HLTH INT SURV EH; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Borodulin K, 2016, SCAND J MED SCI SPOR, V26, P93, DOI 10.1111/sms.12401; Broda Grazyna, 2005, Kardiol Pol, V63, pS601; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Drygas W, 2009, PUBLIC HEALTH, V123, P592, DOI 10.1016/j.puhe.2009.08.004; Drygas W, 2001, MED SPORT S2, V5, P119; Drygas W, 2005, KARDIOL POL S4, V63; Drygas W, 2016, KARDIOL POL, V74, P681, DOI 10.5603/KP.a2015.0235; Drygas W, 2013, INT J OCCUP MED ENV, V26, P846, DOI 10.2478/s13382-013-0160-9; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; Ekblom-Bak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126336; European Commission, 2014, SPEC EUR 412 SPORT P; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2014, J PHYS ACT HEALTH, V11, P1525, DOI 10.1123/jpah.2013-0031; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Hamrik Z, 2014, EUR J SPORT SCI, V14, P193, DOI 10.1080/17461391.2013.822565; Juneau CE, 2010, PREV MED, V51, P384, DOI 10.1016/j.ypmed.2010.09.002; Knuth AG, 2009, J PHYS ACT HEALTH, V6, P548, DOI 10.1123/jpah.6.5.548; Kwasniewska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085209; Kwasniewska M, 2010, PREV MED, V51, P482, DOI 10.1016/j.ypmed.2010.09.003; Lallukka T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006988; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Maniecka-Bryla I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1487-x; Maniecka-Bryla I, 2013, KARDIOL POL, V71, P1065, DOI 10.5603/KP.2013.0262; Mielke GI, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0101-4; Muller-Nordhorn J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-311; Nedo E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-60; Niewada M, 2014, POL ARCH MED WEWN, V124, P540, DOI 10.20452/pamw.2464; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Piatkowska M, 2012, BIOL SPORT, V29, P23, DOI 10.5604/20831862.979848; Rowinski R, 2015, ARCH GERONTOL GERIAT, V60, P486, DOI 10.1016/j.archger.2015.01.011; Ruszkowska-Majzel Joanna, 2005, Przegl Lek, V62 Suppl 3, P23; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Sigmundova D, 2011, INT J ENV RES PUB HE, V8, P341, DOI 10.3390/ijerph8020341; Stamatakis E, 2008, BRIT J SPORT MED, V42, P901, DOI 10.1136/bjsm.2008.048082; Tolonen H, 2015, SCAND J PUBLIC HEALT, V43, P212, DOI 10.1177/1403494814565692; WHO, 2011, GLOB STAT REP NONC D; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	44	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156766	10.1371/journal.pone.0156766	http://dx.doi.org/10.1371/journal.pone.0156766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272130	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000034
J	Pardos de la Gandara, M; Curry, M; Berger, J; Burstein, D; Della-Latta, P; Kopetz, V; Quale, J; Spitzer, E; Tan, RX; Urban, C; Wang, GQ; Whittier, S; de Lencastre, H; Tomasz, A				Pardos de la Gandara, Maria; Curry, Marie; Berger, Judith; Burstein, David; Della-Latta, Phyllis; Kopetz, Virgina; Quale, John; Spitzer, Eric; Tan, Rexie; Urban, Carl; Wang, Guiqing; Whittier, Susan; de Lencastre, Herminia; Tomasz, Alexander			MRSA Causing Infections in Hospitals in Greater Metropolitan New York: Major Shift in the Dominant Clonal Type between 1996 and 2014	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; MULTIPLEX PCR STRATEGY; METHICILLIN-RESISTANT; MEC ELEMENT; COMMUNITY; SEQUENCE; USA300; VIRULENCE; TRENDS	A surveillance study in 1996 identified the USA100 clone (ST5/SCCmecII)-also known as the "New York/Japan" clone-as the most prevalent MRSA causing infections in 12 New York City hospitals. Here we update the epidemiology of MRSA in seven of the same hospitals eighteen years later in 2013/14. Most of the current MRSA isolates (78 of 121) belonged to the MRSA clone USA300 (CC8/SCCmecIV) but the USA100 clone-dominant in the 1996 survey-still remained the second most frequent MRSA (25 of the 121 isolates) causing 32% of blood stream infections. The USA300 clone was most common in skin and soft tissue infections (SSTIs) and was associated with 84.5% of SSTIs compared to 5% caused by the USA100 clone. Our data indicate that by 2013/14, the USA300 clone replaced the New York/Japan clone as the most frequent cause of MRSA infections in hospitals in Metropolitan New York. In parallel with this shift in the clonal type of MRSA, there was also a striking change in the types of MRSA infections from 1996 to 2014.	[Pardos de la Gandara, Maria; Curry, Marie; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Berger, Judith] St Barnabas Hosp, Div Infect Dis, New York, NY USA; [Burstein, David; Kopetz, Virgina] Univ Richmond, Med Ctr, Dept Pathol, Staten Isl, NY USA; [Della-Latta, Phyllis] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York Presbyterian Hosp, New York, NY USA; [Quale, John] Suny Downstate Med Ctr, Div Infect Dis, Brooklyn, NY 11203 USA; [Quale, John] Kings Cty Hosp, Brooklyn, NY USA; [Spitzer, Eric] Stony Brook Hlth Serv Ctr, Dept Pathol, Stony Brook, NY USA; [Tan, Rexie] St Barnabas Hosp, Dept Microbiol, Bronx, NY USA; [Urban, Carl] New York Presbyterian Queens, Dr James J Rahal Jr Div Infect Dis, Flushing, NY USA; [Wang, Guiqing] Westchester Med Ctr, Dept Pathol, Valhalla, NY USA; [Wang, Guiqing] Westchester Med Ctr, Clin Labs, Valhalla, NY USA; [Wang, Guiqing] New York Med Coll, Valhalla, NY 10595 USA; [Whittier, Susan] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Clin Microbiol Serv, New York, NY USA; [de Lencastre, Herminia] Inst Tecnol Quim & Biol Antonio Xavier ITQB UNL, Mol Genet Lab, Oeiras, Portugal	Rockefeller University; Saint Barnabas Hospital; Columbia University; NewYork-Presbyterian Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Saint Barnabas Hospital; Westchester Medical Center; Westchester Medical Center; New York Medical College; Columbia University; NewYork-Presbyterian Hospital	Tomasz, A (corresponding author), Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	tomasz@rockefeller.edu	de la Gandara, Maria Pardos/G-9933-2017; Spitzer, Eric/T-7455-2019; de la Gandara, Maria Pardos/AAQ-1054-2020	de la Gandara, Maria Pardos/0000-0002-3273-6392; de la Gandara, Maria Pardos/0000-0002-3273-6392; Spitzer, Eric/0000-0002-8794-2441	US Public Health Service [2 RO1 AI457838-15]; RB Roberts Bacterial Antibiotic Resistance Group (BARG); National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); RB Roberts Bacterial Antibiotic Resistance Group (BARG); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Partial support for this study was provided by a US Public Health Service Award 2 RO1 AI457838-15 to AT and by funds from the RB Roberts Bacterial Antibiotic Resistance Group (BARG) to AT.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; [Anonymous], 2014, NEW YORK STAT HOSP A, P1; [Anonymous], 2012, ACIP RECOMMENDA 1206, P1; [Anonymous], 2009, NYS SEX OFF RES REST, P1; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chadha P, 2015, OPEN J MED MICROBIOL, P12; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; CLSI, 2013, PERFORMANCE STANDARD; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; David MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092760; David MZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018217; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P253, DOI 10.1089/mdr.2000.6.253; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Farr AM, 2012, INFECT CONT HOSP EP, V33, P725, DOI 10.1086/666329; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Ingram R., 2007, TRANSPORTING INFECT, P1; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2008, J ANTIMICROB CHEMOTH, V61, P959, DOI 10.1093/jac/dkn021; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Pardos de la Gandara M, 2015, J CLIN MICROBIOL, V53, P2648, DOI 10.1128/JCM.00591-15; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Roberts RB, 2000, MICROB DRUG RESIST, V6, P245, DOI 10.1089/mdr.2000.6.245; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Wilson J, 2011, J HOSP INFECT, V79, P211, DOI 10.1016/j.jhin.2011.05.013	43	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156924	10.1371/journal.pone.0156924	http://dx.doi.org/10.1371/journal.pone.0156924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272665	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000048
J	Walworth, AE; Chai, BL; Song, GQ				Walworth, Aaron E.; Chai, Benli; Song, Guo-qing			Transcript Profile of Flowering Regulatory Genes in VcFT-Overexpressing Blueberry Plants	PLOS ONE			English	Article							VACCINIUM-CORYMBOSUM L.; MADS-BOX GENE; MOLECULAR-BASIS; VERNALIZATION; FRUIT; ARABIDOPSIS; GENERATION; REPRESSOR; CEREALS; DOMAIN	In order to identify genetic components in flowering pathways of highbush blueberry (Vaccinium corymbosum L.), a transcriptome reference composed of 254,396 transcripts and 179,853 gene contigs was developed by assembly of 72.7 million reads using Trinity. Using this transcriptome reference and a query of flowering pathway genes of herbaceous plants, we identified potential flowering pathway genes/transcripts of blueberry. Transcriptome analysis of flowering pathway genes was then conducted on leaf tissue samples of transgenic blueberry cv. Aurora ('VcFT-Aurora'), which overexpresses a blueberry FLOWERING LOCUS T-like gene (VcFT). Sixty-one blueberry transcripts of 40 genes showed high similarities to 33 known flowering-related genes of herbaceous plants, of which 17 down-regulated and 16 up-regulated genes were identified in 'VcFT-Aurora'. All down-regulated genes encoded transcription factors/enzymes upstream in the signaling pathway containing VcFT. A blueberry CONSTANS-LIKE 5-like (VcCOL5) gene was down-regulated and associated with five other differentially expressed (DE) genes in the photoperiod-mediated flowering pathway. Three down-regulated genes, i.e., a MADS-AFFECTING FLOWERING 2-like gene (VcMAF2), a MADS-AFFECTING FLOWERING 5-like gene (VcMAF5), and a VERNALIZATION1-like gene (VcVRN1), may function as integrators in place of FLOWERING LOCUS C (FLC) in the vernalization pathway. Because no CONSTAN1-like or FLOWERING LOCUS C-like genes were found in blueberry, VcCOL5 and VcMAF2/VcMAF5 or VRN1 might be the major integrator(s) in the photoperiod-and vernalization-mediated flowering pathway, respectively. The major down-stream genes of VcFT, i.e., SUPPRESSOR of Overexpression of Constans 1-like (VcSOC1), LEAFY-like (VcLFY), APETALA1-like (VcAP1), CAULIFLOWER 1-like (VcCAL1), and FRUITFULL-like (VcFUL) genes were present and showed high similarity to their orthologues in herbaceous plants. Moreover, overexpression of VcFT promoted expression of all of these VcFT downstream genes. These results suggest that VcFT's down-stream genes appear conserved in blueberry.	[Walworth, Aaron E.; Song, Guo-qing] Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA; [Chai, Benli] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Song, GQ (corresponding author), Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA.	songg@msu.edu		Walworth, Aaron/0000-0001-7981-9657	Michigan State University, AgBioResearch Project GREEEN	Michigan State University, AgBioResearch Project GREEEN	This work was supported by Michigan State University, AgBioResearch Project GREEEN, URL: http://agbioresearch.msu.edu/project_greeen.	Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Bian Y, 2014, MOL BREEDING, V34, P675, DOI 10.1007/s11032-014-0066-7; Chavez DJ, 2009, HORTSCIENCE, V44, P1538; Die JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073354; Ehlenfeldt MK, 2001, J AGR FOOD CHEM, V49, P2222, DOI 10.1021/jf0013656; Fan ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09729; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Gupta V, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0046-9; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Song GQ, 2004, PLANT CELL REP, V23, P475, DOI 10.1007/s00299-004-0842-7; Song GQ, 2015, METHODS MOL BIOL, V1224, P121, DOI 10.1007/978-1-4939-1658-0_11; Song GQ, 2013, PLANT CELL REP, V32, P1819, DOI 10.1007/s00299-013-1495-1; Song GQ, 2013, PLANT CELL REP, V32, P1759, DOI 10.1007/s00299-013-1489-z; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Walworth AE, 2012, MOL BREEDING, V30, P1313, DOI 10.1007/s11032-012-9718-7; Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; Zamboni A, 2008, IFOREST, V1, P122, DOI 10.3832/ifor0465-0010122; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	30	26	26	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156993	10.1371/journal.pone.0156993	http://dx.doi.org/10.1371/journal.pone.0156993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271296	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000057
J	Vervoort, D; Vuillerme, N; Kosse, N; Hortobagyi, T; Lamoth, CJC				Vervoort, Danique; Vuillerme, Nicolas; Kosse, Nienke; Hortobagyi, Tibor; Lamoth, Claudine J. C.			Multivariate Analyses and Classification of Inertial Sensor Data to Identify Aging Effects on the Timed-Up-and-Go Test	PLOS ONE			English	Article							GAIT VARIABILITY; OLDER-ADULTS; FALL RISK; VALIDITY; RELIABILITY; BALANCE; ACCELEROMETER; IMPAIRMENT; FRAILTY	Many tests can crudely quantify age-related mobility decrease but instrumented versions of mobility tests could increase their specificity and sensitivity. The Timed-up-and-Go (TUG) test includes several elements that people use in daily life. The test has different transition phases: rise from a chair, walk, 180 degrees turn, walk back, turn, and sit-down on a chair. For this reason the TUG is an often used test to evaluate in a standardized way possible decline in balance and walking ability due to age and or pathology. Using inertial sensors, qualitative information about the performance of the sub-phases can provide more specific information about a decline in balance and walking ability. The first aim of our study was to identify variables extracted from the instrumented timed-up-and-go (iTUG) that most effectively distinguished performance differences across age (age 18-75). Second, we determined the discriminative ability of those identified variables to classify a younger (age 18-45) and older age group (age 46-75). From healthy adults (n = 59), trunk accelerations and angular velocities were recorded during iTUG performance. iTUG phases were detected with wavelet-analysis. Using a Partial Least Square (PLS) model, from the 72-iTUG variables calculated across phases, those that explained most of the covariance between variables and age were extracted. Subsequently, a PLS-discriminant analysis (DA) assessed classification power of the identified iTUG variables to discriminate the age groups. 27 variables, related to turning, walking and the stand-to-sit movement explained 71% of the variation in age. The PLS-DA with these 27 variables showed a sensitivity and specificity of 90% and 85%. Based on this model, the iTUG can accurately distinguish young and older adults. Such data can serve as a reference for pathological aging with respect to a widely used mobility test. Mobility tests like the TUG supplemented with smart technology could be used in clinical practice.	[Vervoort, Danique; Kosse, Nienke; Hortobagyi, Tibor; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Vuillerme, Nicolas; Kosse, Nienke] Univ Grenoble Alpes, AGEIS, La Tronche, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	University of Groningen; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France	Lamoth, CJC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	C.J.C.Lamoth@umcg.nl	Lamoth, Claudine JC/N-4325-2013; VUILLERME, Nicolas/U-5767-2019	Lamoth, Claudine JC/0000-0002-6495-2823; VUILLERME, Nicolas/0000-0003-3773-393X; Vervoort, Danique/0000-0002-0121-628X				Al-Jawad Ahmed, 2012, 2012 IEEE International Conference on Multisensor Fusion and Integration for Intelligent Systems (MFI 2012), P212, DOI 10.1109/MFI.2012.6343011; Ayachi FS, 2016, PHYSIOL MEAS, V37, P442, DOI 10.1088/0967-3334/37/3/442; Bidargaddi N, 2007, P ANN INT IEEE EMBS, P1884, DOI 10.1109/IEMBS.2007.4352683; Bonato P, 2010, IEEE ENG MED BIOL, V29, P25, DOI 10.1109/MEMB.2010.936554; Botolfsen P, 2008, PHYSIOTHER RES INT, V13, P94, DOI 10.1002/pri.394; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Danneskiold-Samsoe B, 2009, ACTA PHYSIOL, V197, P1, DOI 10.1111/j.1748-1716.2009.02022.x; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Eriksson L., 2006, MULTI MEGAVARIATE 1; Fernandez EA, 2008, ANN BIOMED ENG, V36, P1305, DOI 10.1007/s10439-008-9492-1; Galan-Mercant A, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-156; Galan-Mercant Alejandro, 2014, BMC Res Notes, V7, P100, DOI 10.1186/1756-0500-7-100; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Godfrey A, 2015, MATURITAS, V82, P116, DOI 10.1016/j.maturitas.2015.04.003; Godfrey A, 2015, PHYSIOL MEAS, V36, pN71, DOI 10.1088/0967-3334/36/5/N71; Greene BR, 2014, AGE AGEING, V43, P406, DOI 10.1093/ageing/aft176; Greene BR, 2010, IEEE T BIO-MED ENG, V57, P2918, DOI 10.1109/TBME.2010.2083659; Greve C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077760; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Herman T, 2014, EXP BRAIN RES, V232, P713, DOI 10.1007/s00221-013-3778-8; Jallon P, 2011, INT CONF ACOUST SPEE, P689; Konig N, 2014, GAIT POSTURE, V39, P615, DOI 10.1016/j.gaitpost.2013.06.014; Kosse NM, 2016, GAIT POSTURE, V46, P112, DOI 10.1016/j.gaitpost.2016.02.022; Kosse NM, 2015, ANN BIOMED ENG, V43, P1935, DOI 10.1007/s10439-014-1232-0; Lara J, 2013, MATURITAS, V76, P189, DOI 10.1016/j.maturitas.2013.07.007; Lockhart Thurmon E, 2013, Biomed Sci Instrum, V49, P224; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Mellone S, 2012, GAIT POSTURE, V36, P163, DOI 10.1016/j.gaitpost.2012.02.006; Mirelman A, 2014, J AM GERIATR SOC, V62, P673, DOI 10.1111/jgs.12734; Montero-Odasso M, 2011, J GERONTOL A-BIOL, V66, P568, DOI 10.1093/gerona/glr007; Moore AZ, 2014, J AM GERIATR SOC, V62, P230, DOI 10.1111/jgs.12653; Najafi B, 2003, IEEE T BIO-MED ENG, V50, P711, DOI 10.1109/TBME.2003.812189; Palmerini L, 2013, IEEE T NEUR SYS REH, V21, P664, DOI 10.1109/TNSRE.2012.2236577; Palmerini L, 2011, IEEE ENG MED BIO, P7179, DOI 10.1109/IEMBS.2011.6091814; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Rocchi L, 2014, IEEE T NEUR SYS REH, V22, P1064, DOI 10.1109/TNSRE.2013.2292496; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Sheehan KJ, 2014, GAIT POSTURE, V39, P1034, DOI 10.1016/j.gaitpost.2014.01.003; Soangra R, 1990, P HUM FACT ERG SOC A, V55; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Weiss A, 2011, PHYSIOL MEAS, V32, P2003, DOI 10.1088/0967-3334/32/12/009; Weiss A, 2013, PLOS ONE, V29; Zakaria NA, 2015, COMPUT METHOD BIOMEC, V18, P426, DOI 10.1080/10255842.2013.805211; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	49	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0155984	10.1371/journal.pone.0155984	http://dx.doi.org/10.1371/journal.pone.0155984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271994	Green Submitted, Green Published, gold			2022-12-27	WOS:000377560200004
J	Bili, M; Cortesero, AM; Mougel, C; Gauthier, JP; Ermel, G; Simon, JC; Outreman, Y; Terrat, S; Maheo, F; Poinsot, D				Bili, Mikael; Cortesero, Anne Marie; Mougel, Christophe; Gauthier, Jean Pierre; Ermel, Gwennola; Simon, Jean Christophe; Outreman, Yannick; Terrat, Sebastien; Maheo, Frederique; Poinsot, Denis			Bacterial Community Diversity Harboured by Interacting Species	PLOS ONE			English	Article							APHID ACYRTHOSIPHON-PISUM; GUT MICROBIOTA; SYMBIOTIC BACTERIA; WOLBACHIA; INSECT; COLEOPTERA; ENDOSYMBIONTS; BEETLE; MICROORGANISMS; TRANSMISSION	All animals are infected by microbial partners that can be passengers or residents and influence many biological traits of their hosts. Even if important factors that structure the composition and abundance of microbial communities within and among host individuals have been recently described, such as diet, developmental stage or phylogeny, few studies have conducted cross-taxonomic comparisons, especially on host species related by trophic relationships. Here, we describe and compare the microbial communities associated with the cabbage root fly Delia radicum and its three major parasitoids: the two staphylinid beetles Aleochara bilineata and A. bipustulata and the hymenopteran parasitoid Trybliographa rapae. For each species, two populations from Western France were sampled and microbial communities were described through culture independent methods (454 pyrosequencing). Each sample harbored at least 59 to 261 different bacterial phylotypes but was strongly dominated by one or two. Microbial communities differed markedly in terms of composition and abundance, being mainly influenced by phylogenetic proximity but also geography to a minor extent. Surprisingly, despite their strong trophic interaction, parasitoids shared a very low proportion of microbial partners with their insect host. Three vertically transmitted symbionts from the genus Wolbachia, Rickettsia, and Spiroplasma were found in this study. Among them, Wolbachia and Spiroplasma were found in both the cabbage fly and at least one of its parasitoids, which could result from horizontal transfers through trophic interactions. Phylogenetic analysis showed that this hypothesis may explain some but not all cases. More work is needed to understand the dynamics of symbiotic associations within trophic network and the effect of these bacterial communities on the fitness of their hosts.	[Bili, Mikael; Cortesero, Anne Marie; Poinsot, Denis] Univ Rennes 1, IGEPP UMR1349, F-35000 Rennes, France; [Outreman, Yannick] Agrocampus Ouest, IGEPP UMR1349, F-35000 Rennes, France; [Mougel, Christophe; Gauthier, Jean Pierre; Simon, Jean Christophe; Maheo, Frederique] INRA, IGEPP UMR1349, F-35000 Rennes, France; [Bili, Mikael; Cortesero, Anne Marie; Poinsot, Denis] Univ Europeenne Bretagne, Rennes, France; [Ermel, Gwennola] Univ Rennes, UMR CNRS Interact Cellulaires & Mol 6026, Rennes, France; [Terrat, Sebastien] Univ Bourgogne, UMR Agroecol 1347, Dijon, France	Universite de Rennes; Institut Agro; Agrocampus Ouest; INRAE; Universite de Bretagne Occidentale; Universite de Rennes; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Poinsot, D (corresponding author), Univ Rennes 1, IGEPP UMR1349, F-35000 Rennes, France.; Poinsot, D (corresponding author), Univ Europeenne Bretagne, Rennes, France.	denis.poinsot@univ-rennes1.fr	Terrat, Sebastien/T-3790-2017; Mougel, Christophe/D-5118-2017; Yannick, OUTREMAN/B-9309-2012	Terrat, Sebastien/0000-0001-5209-6196; Mougel, Christophe/0000-0001-8675-3115; Yannick, OUTREMAN/0000-0002-7337-3049	French Ministry of Research; University of Rennes 1	French Ministry of Research(Ministry of Research, FranceEuropean Commission); University of Rennes 1	This work was supported by the French Ministry of Research: PhD grant to MB and the University of Rennes 1: financed the sequencing costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Arias-Cordero E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051557; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Bennett DC, 2013, VET MICROBIOL, V166, P304, DOI 10.1016/j.vetmic.2013.05.018; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Brune A, 2001, BIOL TERMITES MODERN, P439; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLHOUN J, 1953, ANN APPL BIOL, V40, P639, DOI 10.1111/j.1744-7348.1953.tb01103.x; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Dedeine F, 2005, HEREDITY, V95, P394, DOI 10.1038/sj.hdy.6800739; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Fukatsu T, 2012, MOL ECOL, V21, P5908, DOI 10.1111/mec.12090; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gonella E, 2011, APPL ENVIRON MICROB, V77, P1423, DOI 10.1128/AEM.02121-10; Grunwald S, 2010, SYST APPL MICROBIOL, V33, P25, DOI 10.1016/j.syapm.2009.10.002; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hickman C. S., 2005, INFLUENCE COOPERATIV, P3; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hirsch J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S6; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Hosokawa T, 2005, FEMS MICROBIOL ECOL, V54, P471, DOI 10.1016/j.femsec.2005.06.002; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Humphreys NJ, 1997, APPL ENVIRON MICROB, V63, P3294, DOI 10.1128/AEM.63.8.3294-3296.1997; Hurst GDD, 2003, CONT T ENT, P177; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Husseneder Claudia, 2010, Open Microbiol J, V4, P53, DOI 10.2174/1874285801004010053; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kautz S, 2013, PSYCHE J ENTOMOLOGY; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369; Maus C, 1998, DEUT ENTOMOL Z, V45, P231, DOI 10.1002/mmnd.19980450209; Maus C, 2001, MOL PHYLOGENET EVOL, V18, P202, DOI 10.1006/mpev.2000.0874; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Neveu N., 1996, IOBC-WPRS Bulletin, V19, P173; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Moraes APR, 2014, REV BRAS PARASITOL V, V23, P194, DOI 10.1590/S1984-29612014037; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sasaki-Fukatsu K, 2006, APPL ENVIRON MICROB, V72, P7349, DOI 10.1128/AEM.01429-06; Shelomi Matan, 2013, BMC Research Notes, V6, P0001, DOI 10.1186/1756-0500-6-368; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TANG XR, 2012, PLOS GENET, V8, P47387, DOI DOI 10.1371/JOURNAL.PONE.0036978; Terrat S, 2015, MICROB BIOTECHNOL, V8, P131, DOI 10.1111/1751-7915.12162; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; VANKEYMEULEN M, 1981, ENTOMOL EXP APPL, V30, P231, DOI 10.1007/BF00347703; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WISHART G., 1956, CANADIAN ENT, V88, P634; WISHART G., 1957, CANADIAN ENT, V89, P510; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	99	24	27	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155392	10.1371/journal.pone.0155392	http://dx.doi.org/10.1371/journal.pone.0155392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258532	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700014
J	Chen, JF; Zavala, C; Ortega, N; Petroli, C; Franco, J; Burgueno, J; Costich, DE; Hearne, SJ				Chen, Jiafa; Zavala, Cristian; Ortega, Noemi; Petroli, Cesar; Franco, Jorge; Burgueno, Juan; Costich, Denise E.; Hearne, Sarah J.			The Development of Quality Control Genotyping Approaches: A Case Study Using Elite Maize Lines	PLOS ONE			English	Article							CONSTRUCTION; GERMPLASM; MARKERS; KASP; SSR; MAP	Quality control (QC) of germplasm identity and purity is a critical component of breeding and conservation activities. SNP genotyping technologies and increased availability of markers provide the opportunity to employ genotyping as a low-cost and robust component of this QC. In the public sector available low-cost SNP QC genotyping methods have been developed from a very limited panel of markers of 1,000 to 1,500 markers without broad selection of the most informative SNPs. Selection of optimal SNPs and definition of appropriate germplasm sampling in addition to platform section impact on logistical and resource-use considerations for breeding and conservation applications when mainstreaming QC. In order to address these issues, we evaluated the selection and use of SNPs for QC applications from large DArTSeq data sets generated from CIMMYT maize inbred lines (CMLs). Two QC genotyping strategies were developed, the first is a "rapid QC", employing a small number of SNPs to identify potential mislabeling of seed packages or plots, the second is a "broad QC", employing a larger number of SNP, used to identify each germplasm entry and to measure heterogeneity. The optimal marker selection strategies combined the selection of markers with high minor allele frequency, sampling of clustered SNP in proportion to marker cluster distance and selecting markers that maintain a uniform genomic distribution. The rapid and broad QC SNP panels selected using this approach were further validated using blind test assessments of related re-generation samples. The influence of sampling within each line was evaluated. Sampling 192 individuals would result in close to 100% possibility of detecting a 5% contamination in the entry, and approximately a 98% probability to detect a 2% contamination of the line. These results provide a framework for the establishment of QC genotyping. A comparison of financial and time costs for use of these approaches across different platforms is discussed providing a framework for institutions involved in maize conservation and breeding to assess the resource use effectiveness of QC genotyping. Application of these research findings, in combination with existing QC approaches, will ensure the regeneration, distribution and use in breeding of true to type inbred germplasm. These findings also provide an effective approach to optimize SNP selection for QC genotyping in other species.	[Chen, Jiafa; Zavala, Cristian; Ortega, Noemi; Petroli, Cesar; Franco, Jorge; Burgueno, Juan; Costich, Denise E.; Hearne, Sarah J.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco 56237, Edo De Mexico, Mexico; [Franco, Jorge] Univ Republ, Dept Biometria, Paysandu 60000, Uruguay	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Universidad de la Republica, Uruguay	Costich, DE; Hearne, SJ (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco 56237, Edo De Mexico, Mexico.	D.Costich@cgiar.org; S.Hearne@cgiar.org	Franco, Jorge/AAF-4161-2020	Franco, Jorge/0000-0001-8082-4007	Sustainable Modernization of Traditional Agriculture (MasAgro) Project by Ministry of Agriculture, Livestock, Rural Development, Fisheries and Nutrition (SAGARPA) of the Government of Mexico	Sustainable Modernization of Traditional Agriculture (MasAgro) Project by Ministry of Agriculture, Livestock, Rural Development, Fisheries and Nutrition (SAGARPA) of the Government of Mexico	The work was supported by Sustainable Modernization of Traditional Agriculture (MasAgro) Project (http://masagro.mx) awarded to CIMMYT by the Ministry of Agriculture, Livestock, Rural Development, Fisheries and Nutrition (SAGARPA) (http://www.sagarpa.gob.mx) of the Government of Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; [Anonymous], 2011, GLOBAL J SCI FRONTIE; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153428; Chen JF, 2012, MOL BREEDING, V30, P1649, DOI 10.1007/s11032-012-9748-1; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; CIMMYT International Maize and Wheat Improvement Center, 2005, LAB PROT CIMMYT APPL, VThird; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Ding JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141619; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ertiro BT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2180-2; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Gaafar R. M., 2006, World Journal of Agricultural Sciences, V2, P29; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Gelman A., 2021, BAYESIAN DATA ANAL; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; He CL, 2014, METHODS MOL BIOL, V1145, P75, DOI 10.1007/978-1-4939-0446-4_7; Islam MN, 2012, NOT BOT HORTI AGROBO, V40, P261; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kaga A, 2011, BREEDING SCI, V61, P566, DOI 10.1270/jsbbs.61.566; MacQueen J.B., 1967, P 5 BERKELEY S MATH, V1, P281; Nakamura T, 2005, J HUM GENET, V50, P53, DOI 10.1007/s10038-004-0220-x; R Core Team, 2013, R LANG ENV STAT COMP; Ren RS, 2015, MOL GENET GENOMICS, V290, P1457, DOI 10.1007/s00438-015-0997-7; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; *SAS I, 1999, SAS US GUID STAT; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; SCHMIDT RJ, 1987, SCIENCE, V238, P960, DOI 10.1126/science.2823388; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Semagn K, 2012, THEOR APPL GENET, V125, P1487, DOI 10.1007/s00122-012-1928-1; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Tan SY, 2005, PEST MANAG SCI, V61, P246, DOI 10.1002/ps.993; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Troggio M, 2008, VITIS, V47, P21; van de Wouw M, 2011, CROP SCI, V51, P736, DOI 10.2135/cropsci2010.09.0511; Warburton ML, 2010, CROP SCI, V50, P467, DOI 10.2135/cropsci2009.02.0089; Warburton ML, 2002, CROP SCI, V42, P1832, DOI 10.2135/cropsci2002.1832; Wen WW, 2012, MOL BREEDING, V29, P951, DOI 10.1007/s11032-011-9696-1; Wen WW, 2011, GENET RESOUR CROP EV, V58, P189, DOI 10.1007/s10722-010-9562-8; Wu M, 2010, MOL PLANT BREED, V4, P381; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yan XM, 2011, IFIP ADV INF COMM TE, V346, P620; Yonemaru J, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct188; Zheng HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066606	47	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157236	10.1371/journal.pone.0157236	http://dx.doi.org/10.1371/journal.pone.0157236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280295	Green Published, gold			2022-12-27	WOS:000377563000113
J	Liu, XD; Fang, QH; Kim, H				Liu, Xiangde; Fang, Qiuhong; Kim, Huijung			Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ELASTASE-INDUCED EMPHYSEMA; REGULATORY T-CELLS; STROMAL CELLS; BONE-MARROW; MOUSE MODEL; ADIPOSE-TISSUE; LUNG INJURY; AIRWAY INFLAMMATION; STEM/STROMAL CELLS; GROWTH-FACTOR	Background In the last two decades, mesenchymal stem cells (MSCs) have been pre-clinically utilized in the treatment of a variety of kinds of diseases including chronic obstructive pulmonary disease (COPD). The aim of the current study was to systematically review and conduct a meta-analysis on the published pre-clinical studies of MSC administration in the treatment of COPD in animal models. Methods and Results A systematic search of electronic databases was performed. Statistical analysis was performed using the Comprehensive Meta-Analysis software (Version 3). The pooled Hedges's g with 95% confidence intervals (95% CIs) was adopted to assess the effect size. Random effect model was used due to the heterogeneity between the studies. A total of 20 eligible studies were included in the current systematic review. The overall meta-analysis showed that MSC administration was significantly in favor of attenuating acute lung injury (Hedges's g = -2.325 +/- 0.145 with 95% CI: -2.609 similar to -2.040, P < 0.001 for mean linear intercept, MLI; Hedges's g = -3.488 +/- 0.504 with 95% CI: -4.476 similar to -2.501, P < 0.001 for TUNEL staining), stimulating lung tissue repair (Hedges's g = 3.249 +/- 0.586 with 95% CI: 2.103 similar to 4.394, P < 0.001) and improving lung function (Hedges's g = 2.053 +/- 0.408 with 95% CI: 1.253 similar to 2.854, P< 0.001). The mechanism of MSC therapy in COPD is through ameliorating airway inflammation (Hedges's g = -2.956 +/- 0.371 with 95% CI: -3.683 similar to -2.229, P< 0.001) and stimulating cytokine synthesis that involves lung tissue repair (Hedges's g = 3.103 +/- 0.734 with 95% CI: 1.664 similar to 4.541, P< 0.001). Conclusion This systematic review and meta-analysis suggest a promising role for MSCs in COPD treatment. Although the COPD models may not truly mimic COPD patients, these pre-clinical studies demonstrate that MSC hold promise in the treatment of chronic lung diseases including COPD. The mechanisms of MSCs role in preclinical COPD treatment may be associated with attenuating airway inflammation as well as stimulating lung tissue repair.	[Liu, Xiangde] Univ Nebraska Med Ctr, Dept Internal Med, Pulm Crit Care Sleep & Allergy Med, Omaha, NE USA; [Fang, Qiuhong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pulm & Crit Care, Beijing, Peoples R China; [Kim, Huijung] WonKwang Univ, Sanbon Med Ctr, Div Pulm & Crit Care, Seoul, South Korea	University of Nebraska System; University of Nebraska Medical Center; Capital Medical University; Wonkwang University	Kim, H (corresponding author), WonKwang Univ, Sanbon Med Ctr, Div Pulm & Crit Care, Seoul, South Korea.	hikim7337@gamil.com			WonKwang University Fund	WonKwang University Fund	This work was supported by WonKwang University Fund in the year 2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MA, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0118-x; Armstrong L, 2012, STEM CELLS, V30, P2, DOI 10.1002/stem.1007; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chen YB, 2015, CELL STRESS CHAPERON, V20, P979, DOI 10.1007/s12192-015-0627-7; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Duffy MM, 2011, EUR J IMMUNOL, V41, P2840, DOI 10.1002/eji.201141499; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Feizpour A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108974; Furuya N, 2012, REGEN MED, V7, P503, DOI [10.2217/RME.12.25, 10.2217/rme.12.25]; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Ghorbani A, 2014, DARU, V22, DOI 10.1186/2008-2231-22-26; Griffin MD, 2013, IMMUNOL CELL BIOL, V91, P40, DOI 10.1038/icb.2012.67; Gu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08733; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Gupta N, 2012, THORAX, V67, P533, DOI 10.1136/thoraxjnl-2011-201176; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Huh JW, 2011, AM J PHYSIOL-LUNG C, V301, pL255, DOI 10.1152/ajplung.00253.2010; Jasmin, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001971; Katsha AM, 2011, MOL THER, V19, P196, DOI 10.1038/mt.2010.192; Kavanagh H, 2011, ALLERGY, V66, P523, DOI 10.1111/j.1398-9995.2010.02509.x; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim YS, 2015, TUBERC RESPIR DIS, V78, P239, DOI 10.4046/trd.2015.78.3.239; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC; Li YQ, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0120-3; Minino AM, 2009, NCHS DATA BRIEF, V2011, P1; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Mulhall AM, 2015, EXPERT OPIN INV DRUG, V24, P1597, DOI 10.1517/13543784.2015.1094054; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Park BN, 2011, NUCL MED BIOL, V38, P1175, DOI 10.1016/j.nucmedbio.2011.05.009; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Rennard Stephen I, 2011, Proc Am Thorac Soc, V8, P368, DOI 10.1513/pats.201102-019RM; Ribeiro-Paes JT, 2011, INT J CHRONIC OBSTR, V6, P63, DOI 10.2147/COPD.S15292; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Peron JPS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136942; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Shigemura N, 2006, AM J TRANSPLANT, V6, P2592, DOI 10.1111/j.1600-6143.2006.01522.x; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tibboel J, 2014, COPD, V11, P310, DOI 10.3109/15412555.2013.854322; Tropea KA, 2012, AM J PHYSIOL-LUNG C, V302, pL829, DOI 10.1152/ajplung.00347.2011; von Bahr L, 2012, STEM CELLS, V30, P1575, DOI 10.1002/stem.1118; Weiss DJ, 2013, CHEST, V143, P1590, DOI 10.1378/chest.12-2094; Yuhgetsu H, 2006, EXP LUNG RES, V32, P413, DOI 10.1080/01902140601047633; Zhang WG, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-33; Zhao YM, 2014, INT J CLIN EXP MED, V7, P968; Zhen GH, 2008, FRONT BIOSCI, V13, P3415; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888	59	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157099	10.1371/journal.pone.0157099	http://dx.doi.org/10.1371/journal.pone.0157099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280283	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000083
J	Zhang, XH; Li, Y; Zhou, YD; Mao, F; Lin, Y; Guan, JH; Sun, Q				Zhang, Xiaohui; Li, Yan; Zhou, Yidong; Mao, Feng; Lin, Yan; Guan, Jinghong; Sun, Qiang			Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							BLUE-DYE; FLUORESCENCE NAVIGATION; SURGICAL NAVIGATION; PATENT BLUE; SURGERY; RESECTION; WOMEN; GFP	Background The diagnostic performance of indocyanine green (ICG) fluorescence-guided sentinel lymph node biopsy (SLNB) for the presence of metastases in breast cancer remains unclear. Objective We performed a meta-analysis to investigate the diagnostic performance of ICG-guided SLNB. Methods Eligible studies were identified from searches of the databases PubMed and EMBASE up to September 2015. Studies that reported the detection rate of ICG fluorescence-guided SLNB with full axillary lymph node dissection and histological or immunohistochemical examinations were included. A meta-analysis was performed to generate pooled detection rate, sensitivity, specificity, false negative rate, diagnostic odds ratio (DOR) and a summary receiver operator characteristic curve (SROC). Results Nineteen published studies were included to generate a pooled detection rate, comprising 2594 patients. The pooled detection rate was 0.98 (95% confidence interval [CI], 0.96-0.99). Six studies finally met the criteria for meta-analysis, which yielded a pooled sensitivity of 0.92 (95% CI, 0.85-0.96), specificity 1 (95% CI, 0.97-1), and DOR 311.47 (95% CI, 84.11-1153.39). The area under the SROC was 0.9758. No publication bias was found. Conclusion ICG fluorescence-guided SLNB is viable for detection of lymph node metastases in breast cancer. Large-scale randomized multi-center trials are necessary to confirm our results.	[Sun, Qiang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Sun, Q (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing 100730, Peoples R China.	sunqpumch@163.com	Mao, Feng/B-8280-2019					Abe H, 2011, SURG TODAY, V41, P197, DOI 10.1007/s00595-009-4254-8; Ahmed M, 2014, LANCET ONCOL, V15, pE351, DOI 10.1016/S1470-2045(13)70590-4; Aoyama K, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-157; Basso SM, 2015, SENTINEL NODE BIOPSY; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Chi CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083927; Freedman RA, 2013, BREAST, V22, pS176, DOI 10.1016/j.breast.2013.07.034; Goyal A, 2006, BREAST CANCER RES TR, V99, P203, DOI 10.1007/s10549-006-9192-1; Guo WB, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-290; Guo WB, 2014, TUMOR BIOL, V35, P3073, DOI 10.1007/s13277-013-1399-2; Hirano A, 2012, ANN SURG ONCOL, V19, P4112, DOI 10.1245/s10434-012-2478-0; Hirche C, 2012, J SURG ONCOL, V105, P162, DOI 10.1002/jso.22075; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Hojo T, 2010, BREAST, V19, P210, DOI 10.1016/j.breast.2010.01.014; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Mueller KF, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-60; Murawa D, 2009, BRIT J SURG, V96, P1289, DOI 10.1002/bjs.6721; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Polom K, 2012, EJSO-EUR J SURG ONC, V38, P137, DOI 10.1016/j.ejso.2011.11.004; Rutgers EJT, 2005, EJSO, V31, P568, DOI 10.1016/j.ejso.2005.02.008; Samorani D, 2015, EJSO-EUR J SURG ONC, V41, P64, DOI 10.1016/j.ejso.2014.10.047; Schaafsma BE, 2013, BRIT J SURG, V100, P1037, DOI 10.1002/bjs.9159; Stratmann SL, 1999, AM J SURG, V178, P454, DOI 10.1016/S0002-9610(99)00230-5; Sugie T, 2016, ANN SURG ONCOL, V23, P44, DOI 10.1245/s10434-015-4809-4; Sugie T, 2013, ANN SURG ONCOL, V20, P2213, DOI 10.1245/s10434-013-2890-0; Takeuchi M, 2012, BREAST J, V18, P535, DOI 10.1111/tbj.12004; Tong M, 2014, J BREAST CANCER, V17, P250, DOI 10.4048/jbc.2014.17.3.250; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van der Vorst JR, 2012, ANN SURG ONCOL, V19, P4104, DOI 10.1245/s10434-012-2466-4; Verbeek FPR, 2014, BREAST CANCER RES TR, V143, P333, DOI 10.1007/s10549-013-2802-9; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	35	37	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155597	10.1371/journal.pone.0155597	http://dx.doi.org/10.1371/journal.pone.0155597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280407	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000004
J	Hasegawa, Y; Hamada, S; Nishimura, T; Sasaki, T; Ebana, Y; Kawabata, M; Goya, M; Isobe, M; Koyama, T; Furukawa, T; Hirao, K; Sasano, T				Hasegawa, Yuki; Hamada, Satomi; Nishimura, Takuro; Sasaki, Takeshi; Ebana, Yusuke; Kawabata, Mihoko; Goya, Masahiko; Isobe, Mitsuaki; Koyama, Takatoshi; Furukawa, Tetsushi; Hirao, Kenzo; Sasano, Tetsuo			Novel Dielectric Coagulometer Identifies Hypercoagulability in Patients with a High CHADS(2) Score without Atrial Fibrillation	PLOS ONE			English	Article							RISK STRATIFICATION; DIABETES-MELLITUS; PREDICTING STROKE; HEART; TIME; COAGULATION; CHA(2)DS(2)-VASC; THROMBOEMBOLISM; HEMOSTASIS; EXPRESSION	Background Recent reports showed that the CHADS(2) score predicted the risk of strokes in patients without atrial fibrillation (AF). Although the hypercoagulability may contribute to the thrombogenesis, it has not been fully investigated due to a lack of a sensitive evaluation modality. Recently a novel dielectric blood coagulometry (DBCM) was invented for evaluating the coagulability by measuring the temporal change in whole blood dielectric permittivity. Objective We evaluated the utility of the DBCM for identifying the coagulability. Patients/Methods For fundamental experiments, 133 citrated blood samples were drawn from subjects with or without heparin administration. A DBCM analysis was performed to find the adequate coagulation index, and to delineate its measurement range by adding recombinant human tissue factor (TF) or heparin. Then the coagulability was assessed by DBCM and conventional coagulation assays in 84 subjects without AF, who were divided into 3 groups by their CHADS(2) score. Another 17 patients who received warfarin were also assessed by DBCM to evaluate the effect of anticoagulants. Results and Conclusions We calculated the derivative of the dielectric permittivity change after recalcification, and extracted the end of acceleration time (EAT) as a novel index. The EAT showed a dose-dependent shortening with the addition of serial dilutions of TF (x10(-2) to x10(-4)), and a dose-dependent prolongation with the addition of heparin (0.05 to 0.15 U/ml). The EAT was significantly shorter in the higher CHADS(2) score group (19.8 +/- 4.8, 18.6 +/- 3.1, and 16.3 +/- 2.7 min in the CHADS(2) = 0, 1, and >= 2 groups, respectively, p = 0.0065 by ANOVA). Patients receiving warfarin had a significantly more prolonged EAT than those without warfarin (18.6 +/- 4.2 vs. 25.8 +/- 7.3 min, p < 0.001). DBCM detected the whole blood coagulability with a high sensitivity. Subjects with higher CHADS(2) scores exhibited hypercoagulability without AF.	[Hasegawa, Yuki; Hamada, Satomi; Sasano, Tetsuo] Tokyo Med & Dent Univ, Dept Biofunct Informat, Tokyo, Japan; [Nishimura, Takuro; Sasaki, Takeshi; Kawabata, Mihoko; Goya, Masahiko; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan; [Koyama, Takatoshi] Tokyo Med & Dent Univ, Dept Lab Mol Genet Hematol, Tokyo, Japan; [Ebana, Yusuke; Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sasano, T (corresponding author), Tokyo Med & Dent Univ, Dept Biofunct Informat, Tokyo, Japan.	sasano.bi@tmd.ac.jp	Nishimura, Takuro/AAU-9352-2021; furukawa, tetsushi/ABD-3178-2020	Nishimura, Takuro/0000-0002-0234-390X; Ebana, Yusuke/0000-0002-5162-0838	 [25461045]; Grants-in-Aid for Scientific Research [15K15049] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Grant-in-Aid for Scientific Research (No. 25461045 to Tetsuo Sasano). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campello E, 2015, THROMB RES, V135, P548, DOI 10.1016/j.thromres.2015.01.003; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; Davies NA, 2015, THROMB RES, V135, P1075, DOI 10.1016/j.thromres.2015.03.021; Doherty TM, 2005, CATHETER CARDIO INTE, V65, P330, DOI 10.1002/ccd.20355; Franchini M, 2006, CRIT REV ONCOL HEMAT, V60, P144, DOI 10.1016/j.critrevonc.2006.06.004; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Goette A, 2000, PACE, V23, P1872; HATTERSLEY PG, 1966, J AMER MED ASSOC, V196, P436, DOI 10.1001/jama.196.5.436; Hayashi Y, 2008, PHYS MED BIOL, V53, P2553, DOI 10.1088/0031-9155/53/10/007; Hayashi Y, 2015, ANAL CHEM, V87, P10072, DOI 10.1021/acs.analchem.5b02723; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hron G, 2006, J THROMB HAEMOST, V4, P752, DOI 10.1111/j.1538-7836.2006.01868.x; JAFRI SM, 1993, EUR HEART J, V14, P205, DOI 10.1093/eurheartj/14.2.205; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Marcucci R, 2006, J THROMB HAEMOST, V4, P1017, DOI 10.1111/j.1538-7836.2006.01916.x; Mitchell LB, 2014, HEART, V100, P1524, DOI 10.1136/heartjnl-2013-305303; Ntaios G, 2013, NEUROLOGY, V80, P1009, DOI 10.1212/WNL.0b013e318287281b; Olesen JB, 2011, BMJ-BRIT MED J, P342, DOI [10.1136/bmj.2124, DOI 10.1136/BMJ.2124]; Reverter JL, 1997, AM J HEMATOL, V56, P93; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; Sagripanti A, 1998, EXP GERONTOL, V33, P891, DOI 10.1016/S0531-5565(98)00047-3; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; SBAROUNI E, 1994, AM HEART J, V127, P607, DOI 10.1016/0002-8703(94)90670-X; Sohara H, 1997, J AM COLL CARDIOL, V29, P106, DOI 10.1016/S0735-1097(96)00427-5; Tripodi A, 2004, BLOOD, V104, P3631, DOI 10.1182/blood-2004-03-1042; Tripodi A, 2011, J THROMB THROMBOLYS, V31, P165, DOI 10.1007/s11239-010-0506-0; Welles CC, 2011, AM HEART J, V162, P555, DOI 10.1016/j.ahj.2011.05.023; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156557	10.1371/journal.pone.0156557	http://dx.doi.org/10.1371/journal.pone.0156557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275926	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700029
J	Malhao, TA; Brito, AD; Pinheiro, RS; Cabral, CD; de Camargo, TMCR; Coeli, CM				Malhao, Thaina Alves; Brito, Alexandre dos Santos; Pinheiro, Rejane Sobrino; Cabral, Cristiane da Silva; Coeli Rochel de Camargo, Thais Medina; Coeli, Claudia Medina			Sex Differences in Diabetes Mellitus Mortality Trends in Brazil, 1980-2012	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; PREVALENCE; POPULATION; HEALTH; GENDER; WOMEN; MEN; EDUCATION; DISEASE	Aims To investigate the hypothesis that the change from the female predominance of diabetes mellitus to a standard of equality or even male preponderance can already be observed in Brazilian mortality statistics. Methods Data on deaths for which diabetes mellitus was listed as the underlying cause were obtained from the Brazilian Mortality Information System for the years 1980 to 2012. The mortality data were also analyzed according to the multiple causes of death approach from 2001 to 2012. The population data came from the Brazilian Institute of Geography and Statistics. The mortality rates were standardized to the world population. We used a log-linear joinpoint regression to evaluate trends in age-standardized mortality rates (ASMR). Results From 1980 to 2012, we found a marked increment in the diabetes ASMR among Brazilian men and a less sharp increase in the rate among women, with the latter period (2003-2012) showing a slight decrease among women, though it was not statistically significant. Conclusions The results of this study suggest that diabetes mellitus in Brazil has changed from a pattern of higher mortality among women compared to men to equality or even male predominance.	[Malhao, Thaina Alves; Brito, Alexandre dos Santos; Pinheiro, Rejane Sobrino; Coeli, Claudia Medina] Univ Fed Rio de Janeiro, Inst Studies Collect Hlth, Rio De Janeiro, RJ, Brazil; [Cabral, Cristiane da Silva] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, SP, Brazil; [Coeli Rochel de Camargo, Thais Medina] Univ Sao Paulo, Dept Polit Sci, Sao Paulo, SP, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo	Malhao, TA; Coeli, CM (corresponding author), Univ Fed Rio de Janeiro, Inst Studies Collect Hlth, Rio De Janeiro, RJ, Brazil.	thainaalvesmalhao@gmail.com; coelicm@gmail.com	Pinheiro, Rejane S/J-5129-2015; Coeli, Claudia M/P-4214-2016; CABRAL, CRISTIANE S/L-7472-2017; Malhão, Thainá/AFT-9923-2022	Pinheiro, Rejane S/0000-0002-3361-3626; Coeli, Claudia M/0000-0003-1757-3940; CABRAL, CRISTIANE S/0000-0003-3025-2404; 	National Council for Scientific and Technological Development [304101/2011-7, 309728/2012-6]; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro [E-26/102.771/2012, E-26/203.195/2015]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro	CMC was supported by research fellowship grants from the National Council for Scientific and Technological Development (http://cnpq.br/) (Grant number 304101/2011-7) and Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (http://www.faperj.br/) (Grant number E-26/102.771/2012 and E-26/203.195/2015). RSP was partially supported by research fellowship grants from the National Council for Scientific and Technological Development (http://cnpq.br/) (Grant number 309728/2012-6). TMCRC was supported by a PhD scholarship from the National Council for Scientific and Technological Development (http://cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Aschner P, 2014, DIABETES RES CLIN PR, V103, P238, DOI 10.1016/j.diabres.2013.11.010; Bajekal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059608; Beltrao KI, 2014, NOVO REGIME DEMOGRAF, P469; Bertoldi AD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-62; Brasil Ministerio da Saude, 2011, MANUAL RECOMENDACOES; Brasil Ministerio da Saude, 2014, VIG BRAS 2013 VIG FA; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, MORT GER; de Lima EEC, 2014, CAD SAUDE PUBLICA, V30, P1721, DOI 10.1590/0102-311X00131113; Chang HY, 2010, DIABETES RES CLIN PR, V90, P358, DOI 10.1016/j.diabres.2010.09.032; Charlton J, 2008, DIABETES CARE, V31, P1761, DOI 10.2337/dc08-0137; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Clegg LX, 2009, STAT MED, V28, P3670, DOI 10.1002/sim.3733; Coeli CM, 2009, DIABETES RES CLIN PR, V86, P134, DOI 10.1016/j.diabres.2009.08.003; Cunningham-Myrie C, 2013, TROP MED INT HEALTH, V18, P1365, DOI 10.1111/tmi.12190; de Almeida-Pititto B, 2015, DIABETES METAB SYNDR, V8, P17, DOI 10.2147/DMSO.S72542; Demakakos P, 2012, EUR J EPIDEMIOL, V27, P367, DOI 10.1007/s10654-012-9688-4; Devaux M., 2011, OECD J EC STUDIES, V1, P1, DOI [10.1787/eco_studies-2011-5kg5825v1k23, DOI 10.1787/ECO_STUDIES-2011-5KG5825V1K23]; Evans JMM, 2007, DIABETOLOGIA, V50, P729, DOI 10.1007/s00125-006-0585-9; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gary-Webb TL, 2013, CURR DIABETES REP, V13, P850, DOI 10.1007/s11892-013-0427-3; Grant JF, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-6; Guimaraes RM, 2012, CAD SAUDE COLET, V20, P121; Gulliford MC, 2009, AM J EPIDEMIOL, V169, P455, DOI 10.1093/aje/kwn342; Instituto Brasileiro de Geografia e Estatistica, 2014, PESQ NAC SAUD 2013 P; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Kautzky-Willer A, 2012, WIEN KLIN WOCHENSCHR, V124, P91, DOI 10.1007/s00508-012-0284-0; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; Li JH, 2015, SOC SCI MED, V127, P83, DOI 10.1016/j.socscimed.2014.07.021; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; Macinko J, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-33; MALERBI DA, 1992, DIABETES CARE, V15, P1509, DOI 10.2337/diacare.15.11.1509; Nucci LB, 2004, REV PANAM SALUD PUBL, V16, P320, DOI 10.1590/S1020-49892004001100005; Oliveira AF, 2009, CAD SAUDE PUBLICA, V25, P1234, DOI DOI 10.1590/S0102-311X2009000600006; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Redelings MD, 2006, EPIDEMIOLOGY, V17, P100, DOI 10.1097/01.ede.0000187177.96138.c6; de Freitas LRS, 2012, EPIDEMIOL SERV SAUDE, V21, P7, DOI 10.5123/S1679-49742012000100002; Sattar N, 2013, BEST PRACT RES CL EN, V27, P501, DOI 10.1016/j.beem.2013.05.006; Schmidt MI, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-123; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Smith PM, 2013, ANN EPIDEMIOL, V23, P143, DOI 10.1016/j.annepidem.2012.12.012; United States of America Department of Commerce. U.S. Census Bureau, 2012, INT DAT; Wandell PE, 2014, DIABETES RES CLIN PR, V106, pE90, DOI 10.1016/j.diabres.2014.09.013; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	51	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155996	10.1371/journal.pone.0155996	http://dx.doi.org/10.1371/journal.pone.0155996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275600	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700012
J	Srinivasan, P; Moss, JA; Gunawardana, M; Churchman, SA; Yang, F; Dinh, CT; Mitchell, JM; Zhang, JN; Fanter, R; Miller, CS; Butkyavichene, I; McNicholl, JM; Smith, TJ; Baum, MM; Smith, JM				Srinivasan, Priya; Moss, John A.; Gunawardana, Manjula; Churchman, Scott A.; Yang, Flora; Dinh, Chuong T.; Mitchell, James M.; Zhang, Jining; Fanter, Rob; Miller, Christine S.; Butkyavichene, Irina; McNicholl, Janet M.; Smith, Thomas J.; Baum, Marc M.; Smith, James M.			Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures	PLOS ONE			English	Article							PREVENT HIV-INFECTION; ANTIRETROVIRAL PREEXPOSURE PROPHYLAXIS; HUMAN-IMMUNODEFICIENCY-VIRUS; PIG-TAILED MACAQUES; SUSTAINED DELIVERY; TRICHOMONAS-VAGINALIS; CHLAMYDIA-TRACHOMATIS; SEXUAL TRANSMISSION; PIGTAIL MACAQUES; MENSTRUAL-CYCLE	Topical preexposure prophylaxis (PrEP) against HIV has been marginally successful in recent clinical trials with low adherence rates being a primary factor for failure. Controlled, sustained release of antiretroviral (ARV) drugs may help overcome these low adherence rates if the product is protective for extended periods of time. The oral combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is currently the only FDA-approved ARV drug for HIV PrEP. A novel pod-intravaginal ring (IVR) delivering TDF and FTC at independently controlled rates was evaluated for efficacy at preventing SHIV162p3 infection in a rigorous, repeat low-dose vaginal exposure model using normally cycling female pigtailed macaques. Six macaques received pod-IVRs containing TDF (65 mg) and FTC (68 mg) every two weeks, and weekly vaginal exposures to 50 TCID50 of SHIV162p3 began one week after the first pod-IVR insertion. All pod-IVR-treated macaques were fully protected throughout the study (P = 0.0002, Log-rank test), whereas all control animals became infected with a median of 4 exposures to infection. The topical, sustained release of TDF and FTC from the pod-IVR maintained protective drug levels in macaques over four months of virus exposures. This novel and versatile delivery system has the capacity to deliver and maintain protective levels of multiple drugs and the protection observed here warrants clinical evaluation of this pod-IVR design.	[Srinivasan, Priya; Mitchell, James M.; McNicholl, Janet M.; Smith, James M.] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Atlanta, GA USA; [Moss, John A.; Gunawardana, Manjula; Yang, Flora; Fanter, Rob; Miller, Christine S.; Smith, Thomas J.; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA USA; [Churchman, Scott A.; Butkyavichene, Irina; Smith, Thomas J.] Auritec Pharmaceut Inc, Pasadena, CA USA; [Dinh, Chuong T.; Zhang, Jining] Total Solut Inc, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Smith, JM (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Atlanta, GA USA.	ajo9@cdc.gov		Moss, John/0000-0001-8091-3245; Baum, Marc/0000-0003-1558-5649	National Institutes of Health [R43AI098743]; Centers for Disease Control and Prevention; Total Solutions, Inc.; Auritec	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Total Solutions, Inc.; Auritec	Auritec, National Institutes of Health under grant R43AI098743 (TJS, SAC, IB); Centers for Disease Control and Prevention, Intramural funding (PS, J.M. Mitchell, J.M. McNicholl, JMS); Total Solutions, Inc. (CTD, JZ). The funders provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Anderson PL, 2014, J ANTIMICROB CHEMOTH, V69, P2470, DOI 10.1093/jac/dku162; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; [Anonymous], 2015, LANCET HIV, V2, pe115, DOI [10.1016/S2352-3018(15)00046-6, DOI 10.1016/S2352-3018(15)00046-6]; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Buckheit RW, 2010, ANTIVIR RES, V85, P142, DOI 10.1016/j.antiviral.2009.10.013; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Dimitrov D, 2012, J AIDS CLIN RES S5; Dobard C, 2014, AIDS RES HUM RETROV, V30, pA13, DOI 10.1089/aid.2014.5013a.abstract; Dobard C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007701; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Elias CJ, 1996, AIDS, V10, pS43; Feng JY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-44; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Gao Y, 2015, DRUG DELIV TRANSL RE, V5, P279, DOI 10.1007/s13346-015-0227-1; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2012, CURR OPIN HIV AIDS, V7, P505, DOI 10.1097/COH.0b013e328358e484; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Gengiah TN, 2014, INT J CLIN PHARM-NET, V36, P70, DOI 10.1007/s11096-013-9861-1; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunawardana M, 2014, J PHARM SCI-US, V103, P3611, DOI 10.1002/jps.24154; Henning T, 2011, J MED PRIMATOL, V40, P214, DOI 10.1111/j.1600-0684.2011.00488.x; Henning TR, 2014, J INFECT DIS, V210, P1239, DOI 10.1093/infdis/jiu240; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kashuba ADM, 2015, JAIDS-J ACQ IMM DEF, V69, P264, DOI 10.1097/QAI.0000000000000607; Kersh EN, 2014, J MED PRIMATOL, V43, P310, DOI 10.1111/jmp.12124; Krakower DS, 2015, CURR HIV-AIDS REP, V12, P127, DOI 10.1007/s11904-014-0253-5; Krakower DS, 2015, DRUGS, V75, P243, DOI 10.1007/s40265-015-0355-4; Kulkarni R, 2014, ANTIMICROB AGENTS CH, V58, P6145, DOI 10.1128/AAC.03591-14; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, 2015, LANCET IN PRESS, DOI [10.1016/S0140-6736(15)00056-2, DOI 10.1016/S0140-6736(15)00056-2]; Meyers K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114700; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Moss JAB, 2014, MICROBICIDE VAGINAL, P221; Moss JA, 2014, ANTIMICROB AGENTS CH, V58, P5125, DOI 10.1128/AAC.02871-14; Moss JA, 2013, ANTIMICROB AGENTS CH, V57, P3994, DOI 10.1128/AAC.00547-13; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P5952, DOI 10.1128/AAC.01198-12; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P875, DOI 10.1128/AAC.05662-11; Nuttall J, 2010, DRUGS, V70, P1231, DOI 10.2165/10898650-000000000-00000; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Plosker GL, 2013, DRUGS, V73, P279, DOI 10.1007/s40265-013-0024-4; Promadej-Lanier N, 2009, J MED PRIMATOL, V38, P263, DOI 10.1111/j.1600-0684.2009.00354.x; Radzio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050632; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4879; Sluis-Cremer N, 2014, ANTIMICROB AGENTS CH, V58, P2430, DOI 10.1128/AAC.02114-13; Smith JM, 2015, JAIDS-J ACQ IMM DEF, V68, P1, DOI 10.1097/QAI.0000000000000402; Smith JM, 2013, P NATL ACAD SCI USA, V110, P16145, DOI 10.1073/pnas.1311355110; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; U.S. FDA, 1998, GUIDANCE IND BIOANAL; UNAIDS, 2013, GLOBAL REPORT UNAIDS; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Veazey RS, 2013, CURR OPIN HIV AIDS, V8, P295, DOI 10.1097/COH.0b013e328361d096; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778	61	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157061	10.1371/journal.pone.0157061	http://dx.doi.org/10.1371/journal.pone.0157061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275923	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700064
J	Zhao, J; Schnitzler, GR; Iyer, LK; Aronovitz, MJ; Baur, WE; Karas, RH				Zhao, Jin; Schnitzler, Gavin R.; Iyer, Lakshmanan K.; Aronovitz, Mark J.; Baur, Wendy E.; Karas, Richard H.			MicroRNA-Offset RNA Alters Gene Expression and Cell Proliferation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BIOGENESIS; ARGONAUTE2; DISCOVERY; CLEAVAGE; DISTINCT; PROTEIN; MIRNAS	MicroRNA-offset RNAs (moRs) were first identified in simple chordates and subsequently in mouse and human cells by deep sequencing of short RNAs. MoRs are derived from sequences located immediately adjacent to microRNAs (miRs) in the primary miR (pri-miR). Currently moRs are considered to be simply a by-product of miR biosynthesis that lack biological activity. Here we show for the first time that a moR is biologically active. We demonstrate that endogenous or over-expressed moR-21 significantly alters gene expression and inhibits the proliferation of vascular smooth muscle cells (VSMC). In addition, we find that miR-21 and moR-21 may regulate different genes in a given pathway and can oppose each other in regulating certain genes. We report that there is a "seed region" of moR-21 as well as a "seed match region" in the target gene 3'UTR that are indispensable for moR-21-mediated gene down-regulation. We further demonstrate that moR-21-mediated gene repression is Argonaute 2 (Ago2) dependent. Taken together, these findings provide the first evidence that microRNA offset RNA alters gene expression and is biologically active.	[Zhao, Jin; Schnitzler, Gavin R.; Iyer, Lakshmanan K.; Aronovitz, Mark J.; Baur, Wendy E.; Karas, Richard H.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Karas, RH (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.	rkaras@tuftsmedicalcenter.org			NINDS NIH HHS [P30 NS047243] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Bortoluzzi S, 2012, BLOOD, V119, pE120, DOI 10.1182/blood-2011-07-368001; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dueck A, 2014, BIOL CHEM, V395, P611, DOI 10.1515/hsz-2014-0116; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li J, 2014, CELL SIGNAL, V26, P724, DOI 10.1016/j.cellsig.2013.12.013; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Shi WY, 2009, NAT STRUCT MOL BIOL, V16, P183, DOI 10.1038/nsmb.1536; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SULLIVAN TR, 1995, J CLIN INVEST, V96, P2482, DOI 10.1172/JCI118307; Umbach JL, 2010, VIROLOGY, V405, P592, DOI 10.1016/j.virol.2010.06.036; Yao YX, 2012, J GEN VIROL, V93, P1530, DOI 10.1099/vir.0.040634-0; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247	27	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156772	10.1371/journal.pone.0156772	http://dx.doi.org/10.1371/journal.pone.0156772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276022	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700036
J	Chantraine, F; Filipetti, P; Schreiber, C; Remacle, A; Kolanowski, E; Moissenet, F				Chantraine, Frederic; Filipetti, Paul; Schreiber, Celine; Remacle, Angelique; Kolanowski, Elisabeth; Moissenet, Florent			Proposition of a Classification of Adult Patients with Hemiparesis in Chronic Phase	PLOS ONE			English	Article							STIFF-LEGGED GAIT; DISTURBED MOTOR CONTROL; STROKE PATIENTS; KNEE GAIT; SPASTIC PARESIS; MUSCLE-ACTIVITY; CEREBRAL-PALSY; RECTUS FEMORIS; HIP FLEXION; SWING PHASE	Background Patients who have developed hemiparesis as a result of a central nervous system lesion, often experience reduced walking capacity and worse gait quality. Although clinically, similar gait patterns have been observed, presently, no clinically driven classification has been validated to group these patients' gait abnormalities at the level of the hip, knee and ankle joints. This study has thus intended to put forward a new gait classification for adult patients with hemiparesis in chronic phase, and to validate its discriminatory capacity. Methods and Findings Twenty-six patients with hemiparesis were included in this observational study. Following a clinical examination, a clinical gait analysis, complemented by a video analysis, was performed whereby participants were requested to walk spontaneously on a 10m walkway. A patient's classification was established from clinical examination data and video analysis. This classification was made up of three groups, including two sub-groups, defined with key abnormalities observed whilst walking. Statistical analysis was achieved on the basis of 25 parameters resulting from the clinical gait analysis in order to assess the discriminatory characteristic of the classification as displayed by the walking speed and kinematic parameters. Results revealed that the parameters related to the discriminant criteria of the proposed classification were all significantly different between groups and subgroups. More generally, nearly two thirds of the 25 parameters showed significant differences (p<0.05) between the groups and sub-groups. However, prior to being fully validated, this classification must still be tested on a larger number of patients, and the repeatability of inter-operator measures must be assessed. Conclusions This classification enables patients to be grouped on the basis of key abnormalities observed whilst walking and has the advantage of being able to be used in clinical routines without necessitating complex apparatus. In the midterm, this classification may allow a decision-tree of therapies to be developed on the basis of the group in which the patient has been categorised.	[Chantraine, Frederic; Filipetti, Paul; Schreiber, Celine; Remacle, Angelique; Kolanowski, Elisabeth; Moissenet, Florent] CNRFR Rehazenter, Lab Anal Mouvement & Posture, Luxembourg, Luxembourg		Moissenet, F (corresponding author), CNRFR Rehazenter, Lab Anal Mouvement & Posture, Luxembourg, Luxembourg.	florent.moissenet@mailoo.org		Schreiber, Celine/0000-0001-9877-1863; Moissenet, Florent/0000-0001-6479-1911				Anderson FC, 2004, J BIOMECH, V37, P731, DOI 10.1016/j.jbiomech.2003.09.018; Appasamy M, 2015, PM&R, V7, P105, DOI 10.1016/j.pmrj.2014.10.015; Baker R, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-4; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Bleyenheuft C., 2010, Annals of Physical and Rehabilitation Medicine, V53, P189, DOI 10.1016/j.rehab.2010.01.001; BOHANNON RW, 1987, ARCH PHYS MED REHAB, V68, P777; Campanini I, 2013, GAIT POSTURE, V38, P165, DOI 10.1016/j.gaitpost.2013.05.003; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; DeQuervain IAK, 1996, J BONE JOINT SURG AM, V78A, P1506; Dobson F, 2007, GAIT POSTURE, V25, P140, DOI 10.1016/j.gaitpost.2006.01.003; Dumas R, 2007, J BIOMECH ENG-T ASME, V129, P786, DOI 10.1115/1.2768114; Everaert DG, 2010, NEUROREHAB NEURAL RE, V24, P168, DOI 10.1177/1545968309349939; Goldberg SR, 2006, J BIOMECH, V39, P689, DOI 10.1016/j.jbiomech.2005.01.015; Gregson JM, 2000, AGE AGEING, V29, P223, DOI 10.1093/ageing/29.3.223; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; Hyngstrom AS, 2014, MUSCLE NERVE, V49, P225, DOI 10.1002/mus.23886; JENSEN RH, 1975, J BIOMECH, V8, P103, DOI 10.1016/0021-9290(75)90090-1; KERRIGAN DC, 1991, AM J PHYS MED REHAB, V70, P294; Kinsella S, 2008, GAIT POSTURE, V27, P144, DOI 10.1016/j.gaitpost.2007.03.008; KNUTSSON E, 1979, BRAIN, V102, P405, DOI 10.1093/brain/102.2.405; Kottink AIR, 2012, J REHABIL MED, V44, P51, DOI 10.2340/16501977-0909; Kutch JJ, 2011, J BIOMECH, V44, P1264, DOI 10.1016/j.jbiomech.2011.02.014; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; Leardini A, 2007, GAIT POSTURE, V26, P560, DOI 10.1016/j.gaitpost.2006.12.018; LEHMANN JF, 1979, ARCH PHYS MED REHAB, V60, P200; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Perry D.J., 1992, GAIT ANAL NORMAL PAT; PERRY J, 1993, CLIN ORTHOP RELAT R, P10; Riley PO, 1998, J BIOMECH, V31, P835, DOI 10.1016/S0021-9290(98)00107-9; Roche N, 2015, CLIN BIOMECH, V30, P219, DOI 10.1016/j.clinbiomech.2015.02.001; Singh P, 2011, ANN INDIAN ACAD NEUR, V14, P23, DOI 10.4103/0972-2327.78045; Stoquart GG, 2008, ARCH PHYS MED REHAB, V89, P56, DOI 10.1016/j.apmr.2007.08.131; Sung DH, 2000, ARCH PHYS MED REHAB, V81, P910, DOI 10.1053/apmr.2000.5615; Tan AQ, 2014, J BIOMECH, V47, P949, DOI 10.1016/j.jbiomech.2014.01.025; Verdie C., 2004, Annales de Readaptation et de Medecine Physique, V47, P81, DOI 10.1016/j.annrmp.2003.10.005; Wang SJ, 2011, J NEUROSCI METH, V199, P98, DOI 10.1016/j.jneumeth.2011.04.031; Wang X, 2000, ERGONOMICS, V43, P1405, DOI 10.1080/001401300421833; WATERS RL, 1979, J BONE JOINT SURG AM, V61, P927, DOI 10.2106/00004623-197961060-00022	39	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156726	10.1371/journal.pone.0156726	http://dx.doi.org/10.1371/journal.pone.0156726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271533	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000033
J	Kopanska, KS; Alcheikh, Y; Staneva, R; Vignjevic, D; Betz, T				Kopanska, Katarzyna S.; Alcheikh, Yara; Staneva, Ralitza; Vignjevic, Danijela; Betz, Timo			Tensile Forces Originating from Cancer Spheroids Facilitate Tumor Invasion	PLOS ONE			English	Article							CELL INVASION; EXTRACELLULAR-MATRIX; RETROGRADE FLOW; COLLAGEN; GROWTH; MOTILITY; DEFORMATION; METASTASIS; MECHANICS; MIGRATION	The mechanical properties of tumors and the tumor environment provide important information for the progression and characterization of cancer. Tumors are surrounded by an extracellular matrix (ECM) dominated by collagen I. The geometrical and mechanical properties of the ECM play an important role for the initial step in the formation of metastasis, presented by the migration of malignant cells towards new settlements as well as the vascular and lymphatic system. The extent of this cell invasion into the ECM is a key medical marker for cancer prognosis. In vivo studies reveal an increased stiffness and different architecture of tumor tissue when compared to its healthy counterparts. The observed parallel collagen organization on the tumor border and radial arrangement at the invasion zone has raised the question about the mechanisms organizing these structures. Here we study the effect of contractile forces originated from model tumor spheroids embedded in a biomimetic collagen I matrix. We show that contractile forces act immediately after seeding and deform the ECM, thus leading to tensile radial forces within the matrix. Relaxation of this tension via cutting the collagen does reduce invasion, showing a mechanical relation between the tensile state of the ECM and invasion. In turn, these results suggest that tensile forces in the ECM facilitate invasion. Furthermore, simultaneous contraction of the ECM and tumor growth leads to the condensation and reorientation of the collagen at the spheroid's surface. We propose a tension-based model to explain the collagen organization and the onset of invasion by forces originating from the tumor.	[Kopanska, Katarzyna S.; Alcheikh, Yara; Betz, Timo] PSL Res Univ, CNRS, UMR 168, Inst Curie, F-75005 Paris, France; [Kopanska, Katarzyna S.; Alcheikh, Yara; Betz, Timo] Univ Paris 06, CNRS, UMR 168, Sorbonne Univ, F-75005 Paris, France; [Kopanska, Katarzyna S.; Alcheikh, Yara; Betz, Timo] CNRS, UMR168, 25 Rue Ulm, F-75248 Paris 05, France; [Kopanska, Katarzyna S.] Zurich Univ Appl Sci, Inst Chem & Biotechnol, Einsiedlerstr 31, CH-8820 Wadenswil, Switzerland; [Staneva, Ralitza; Vignjevic, Danijela] PSL Res Univ, CNRS, UMR 144, Inst Curie, F-75005 Paris, France; [Betz, Timo] Univ Munster, Inst Cell Biol, Ctr Mol Biol Inflammat, D-48149 Munster, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Zurich University of Applied Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Munster	Betz, T (corresponding author), PSL Res Univ, CNRS, UMR 168, Inst Curie, F-75005 Paris, France.; Betz, T (corresponding author), Univ Paris 06, CNRS, UMR 168, Sorbonne Univ, F-75005 Paris, France.; Betz, T (corresponding author), CNRS, UMR168, 25 Rue Ulm, F-75248 Paris 05, France.; Betz, T (corresponding author), Univ Munster, Inst Cell Biol, Ctr Mol Biol Inflammat, D-48149 Munster, Germany.	timo.betz@uni-muenster.de	Betz, Timo/ABF-9946-2021; vignjevic, Danijela Matic/R-5160-2019; Vignjevic, Danijela/L-9721-2017	vignjevic, Danijela Matic/0000-0003-4250-703X; Betz, Timo/0000-0002-1548-0655	program "Investissements d'Avenir" [ANR- JCJC SVSE 5 2011, Labex CelTisPhyBio ANR-10-LBX-0038 ANR-10-IDEX-0001-02 PSL]; Cells-in-Motion Cluster of Excellence, University of Munster, Germany [EXC 1003 - CiM]; Institut Thematique Multi-organismes Cancer - Plan Cancer; Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt; Fondation pour la Recherche Medicale (FRM) [DGE20111123020]; Cancerople-IdF [2012-2-EML-04-IC-1]; InCA (Cancer National Institute) [2011-1-LABEL-IC-4]; SiRIC@ CNRS-Institut Curie [INCa-DGOS- 4654]; PICT-IBiSA@ CNRS-Institut Curie [INCa-DGOS- 4654]; Nikon Imaging Center@ CNRS-Institut Curie [INCa-DGOS- 4654]	program "Investissements d'Avenir"(French National Research Agency (ANR)); Cells-in-Motion Cluster of Excellence, University of Munster, Germany; Institut Thematique Multi-organismes Cancer - Plan Cancer; Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Cancerople-IdF; InCA (Cancer National Institute); SiRIC@ CNRS-Institut Curie; PICT-IBiSA@ CNRS-Institut Curie; Nikon Imaging Center@ CNRS-Institut Curie	This work has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by ANR with the references ANR- JCJC SVSE 5 2011 (T.B.) and Labex CelTisPhyBio ANR-10-LBX-0038 ANR-10-IDEX-0001-02 PSL (T.B, K.K. and D.V.), Cells-in-Motion Cluster of Excellence (EXC 1003 - CiM), University of Munster, Germany (T.B.), Institut Thematique Multi-organismes Cancer - Plan Cancer 2014-2019 and Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt (R.S.). The intravital imaging was supported by the Fondation pour la Recherche Medicale (FRM No DGE20111123020), the Cancerople-IdF (no2012-2-EML-04-IC-1), InCA (Cancer National Institute, no2011-1-LABEL-IC-4), and SiRIC (INCa-DGOS- 4654), PICT-IBiSA and Nikon Imaging Center@ CNRS-Institut Curie.r This work has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by ANR with the references ANR-JCJC SVSE 5 2011 (T.B.) and Labex CelTisPhyBio ANR-10-LBX-0038 ANR-10-IDEX-0001-02 PSL (T.B, K.K. and D.V), Cells-in-Motion Cluster of Excellence (EXC 1003 -CiM), University of Munster, Germany (T.B.), Institut Thematique Multi-organismes Cancer-Plan Cancer 2014-2019 and Ecole Doctorale Frontieres du Vivant (FdV)-Programme Bettencourt (RS). The intravital imaging was supported by the Fondation pour la Recherche Medicale (FRM No GE20111123020), the Cancerople-IdF (no2012-2-EML-04-IC-1), InCA (Cancer National Institute, no2011-1-LABEL-IC-4), and SiRIC (INCa-DGOS- 4654), PICT-IBiSA and Nikon Imaging Center@ CNRS-Institut Curie. We would like to thank Sara Geraldo, Anthony Simon and Vasily Gurchenkov and Marie Irondelle for training and advice.	Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Betz T, 2009, BIOPHYS J, V96, P5130, DOI 10.1016/j.bpj.2009.03.045; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carey SP, 2013, CLIN EXP METASTAS, V30, P615, DOI 10.1007/s10585-013-9565-x; Carey SP, 2012, CRIT REV ONCOL HEMAT, V83, P170, DOI 10.1016/j.critrevonc.2011.11.005; Carey SP, 2012, BIOMATERIALS, V33, P4157, DOI 10.1016/j.biomaterials.2012.02.029; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chanrion M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6005; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Coulson-Thomas VJ, 2011, CELL TISSUE RES, V346, P223, DOI 10.1007/s00441-011-1254-y; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Geraldo S, 2013, JOVE-J VIS EXP, DOI 10.3791/50763; Geraldo S, 2012, EUR J CELL BIOL, V91, P930, DOI 10.1016/j.ejcb.2012.07.005; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Gordon VD, 2003, EXP CELL RES, V289, P58, DOI 10.1016/S0014-4827(03)00256-8; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Haeger A, 2014, BBA-GEN SUBJECTS, V1840, P2386, DOI 10.1016/j.bbagen.2014.03.020; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Iordan A, 2010, BIORHEOLOGY, V47, P277, DOI 10.3233/BIR-2010-0575; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Koch T, 2012, PLOS ONE, V7, DOI [10.1371/Citation, DOI 10.1371/CITATION]; Kopanska KS, 2015, METHOD CELL BIOL, V125, P353, DOI 10.1016/bs.mcb.2014.10.017; Kural MH, 2013, EXP CELL RES, V319, P2447, DOI 10.1016/j.yexcr.2013.06.019; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luchici A, 2013, MECH COUPLING CYTOSK, P1186; Mierke C, 2013, EUR J CELL BIOL; Mierke CT, 2011, CELL BIOCHEM BIOPHYS, V61, P217, DOI 10.1007/s12013-011-9193-5; Miron-Mendoza M, 2008, MOL BIOL CELL, V19, P2051, DOI 10.1091/mbc.E07-09-0930; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petroll WM, 2008, DEV DYNAM, V237, P2726, DOI 10.1002/dvdy.21629; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Sawhney RK, 2002, J CELL BIOL, V157, P1083, DOI 10.1083/jcb.200203069; Shi QM, 2014, P NATL ACAD SCI USA, V111, P658, DOI 10.1073/pnas.1311312110; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Torzilli PA, 2012, SEMIN CANCER BIOL, V22, P385, DOI 10.1016/j.semcancer.2012.05.002; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; WEISS P, 1959, REV MOD PHYS, V31, P11, DOI 10.1103/RevModPhys.31.11; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	57	46	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156442	10.1371/journal.pone.0156442	http://dx.doi.org/10.1371/journal.pone.0156442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271249	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000015
J	Yazawa, M; Kido, R; Ohira, S; Hasegawa, T; Hanafusa, N; Iseki, K; Tsubakihara, Y; Shibagaki, Y				Yazawa, Masahiko; Kido, Ryo; Ohira, Seiji; Hasegawa, Takeshi; Hanafusa, Norio; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Shibagaki, Yugo			Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry	PLOS ONE			English	Article							STARTING DIALYSIS; FRAILTY; INITIATION; OUTCOMES	Background Although dialysis is typically started in an effort to prolong survival, mortality is reportedly high in the first few months. However, it remains unclear whether this is true in Japanese patients who tend to have a better prognosis than other ethnicities, and if health conditions such as functional status (FS) at initiation of dialysis influence prognosis. Methods We investigated the epidemiology of early death and its association with FS using Japanese national registry data in 2007, which included 35,415 patients on incident dialysis and 7,664 with FS data. The main outcome was early death, defined as death within 3 months after initiation of hemodialysis (HD). The main predictor was FS at initiation of HD. Levels of functional disability were categorized as follows: severe (bedridden), moderate (overt difficulties in exerting basic activities of daily living), or mild/none (none or some functional disabilities). Results Early death remained relatively common, especially among elderly patients (overall: 7.1%; those aged >= 80 years: 15.8%). Severely and even only a moderately impaired FS were significantly associated with early death after starting dialysis (adjusted risk ratios: 3.93 and 2.38, respectively). The incidence of early death in those with impaired FS increased with age (36.5% in those with severely impaired FS and aged >= 80 years). Conclusions Early death after starting dialysis was relatively common, especially among the elderly, even in Japanese patients. Further, early death was significantly associated with impaired FS at initiation of HD.	[Yazawa, Masahiko; Shibagaki, Yugo] St Marianna Univ, Div Nephrol & Hypertens, Sch Med, Kawasaki, Kanagawa, Japan; [Kido, Ryo] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan; [Ohira, Seiji] Sapporo Kita Clin, Sapporo, Hokkaido, Japan; [Hasegawa, Takeshi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence, Fukushima, Japan; [Hanafusa, Norio] Tokyo Univ Hosp, Div Total Renal Care Med, Tokyo 113, Japan; [Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan; [Kido, Ryo] Inagi Municipal Hosp, Tokyo, Japan; [Hasegawa, Takeshi] Showa Univ, Fujigaoka Hosp, Dept Internal Med, Div Nephrol, Yokohama, Kanagawa 227, Japan	Saint Marianna University; Fukushima Medical University; University of Tokyo; Showa University	Yazawa, M (corresponding author), St Marianna Univ, Div Nephrol & Hypertens, Sch Med, Kawasaki, Kanagawa, Japan.	masahikoyazawa@gmail.com		Hasegawa, Takeshi/0000-0003-0420-5583	Committee of Renal Data Registry, Japanese Society for Dialysis Therapy; Grants-in-Aid for Scientific Research [16H05216] Funding Source: KAKEN	Committee of Renal Data Registry, Japanese Society for Dialysis Therapy; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Committee of Renal Data Registry, Japanese Society for Dialysis Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Committee of Renal Data Registry, Japanese Society for Dialysis Therapy.	[Anonymous], 2001, CANND ORG REPL REG A, P8; Bao YR, 2012, ARCH INTERN MED, V172, P1071, DOI 10.1001/archinternmed.2012.3020; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Cohen LM, 2010, CLIN J AM SOC NEPHRO, V5, P72, DOI 10.2215/CJN.03860609; Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; Dogan E, 2005, NEPHROLOGY, V10, P516, DOI 10.1111/j.1440-1797.2005.00433.x; Doi T, 2009, J JPN SOC DIAL THER, V42, P879; European Renal Association-European Dialysis and TransplantAssociation, ERA EDTA REG ANN REP; Hasegawa T, 2009, CLIN J AM SOC NEPHRO, V4, P595, DOI 10.2215/CJN.03540708; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Johansen KL, 2013, SEMIN DIALYSIS, V26, P690, DOI 10.1111/sdi.12126; Kawaguchi Y, 1999, Perit Dial Int, V19 Suppl 3, pS9; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Little R. J. A., 1987, STAT ANAL MISSING DA; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Moss AH, 2008, CLIN J AM SOC NEPHRO, V3, P1379, DOI 10.2215/CJN.00940208; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Noordzij M, 2014, KIDNEY INT, V85, P12, DOI 10.1038/ki.2013.316; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Rothman K, 2008, MODERN EPIDEMIOLOGY, P146; Soucie JM, 1996, J AM SOC NEPHROL, V7, P2169; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; U S Renal Data System. USRDS, 2012, ANN DAT REP ATL CHRO; Wagner M, 2011, AM J KIDNEY DIS, V57, P894, DOI 10.1053/j.ajkd.2010.12.023; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	27	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156951	10.1371/journal.pone.0156951	http://dx.doi.org/10.1371/journal.pone.0156951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270615	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000053
J	Al-Medhwahi, M; Hashim, F; Ali, BM; Sali, A				Al-Medhwahi, Mohammed; Hashim, Fazirulhisyam; Ali, Borhanuddin Mohd; Sali, Aduwati			Pliable Cognitive MAC for Heterogeneous Adaptive Cognitive Radio Sensor Networks	PLOS ONE			English	Article							PERFORMANCE ANALYSIS; ACCESS PROTOCOL	The rapid expansion of wireless monitoring and surveillance applications in several domains reinforces the trend of exploiting emerging technologies such as the cognitive radio. However, these technologies have to adjust their working concepts to consider the common characteristics of conventional wireless sensor networks (WSNs). The cognitive radio sensor network (CRSN), still an immature technology, has to deal with new networks that might have different types of data, traffic patterns, or quality of service (QoS) requirements. In this paper, we design and model a new cognitive radio-based medium access control (MAC) algorithm dealing with the heterogeneous nature of the developed networks in terms of either the traffic pattern or the required QoS for the node applications. The proposed algorithm decreases the consumed power on several fronts, provides satisfactory levels of latency and spectrum utilization with efficient scheduling, and manages the radio resources for various traffic conditions. An intensive performance evaluation is conducted to study the impact of key parameters such as the channel idle time length, node density, and the number of available channels. The performance evaluation of the proposed algorithm shows a better performance than the comparable protocols. Moreover, the results manifest that the proposed algorithm is suitable for real time monitoring applications.	[Al-Medhwahi, Mohammed] Univ Putra Malaysia, Dept Comp & Commun Syst Engn, Fac Engn, Seri Kembangan, Selangor, Malaysia; Univ Putra Malaysia, Res Ctr Excellence Wireless & Photon Networks WiP, Fac Engn, Seri Kembangan, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Al-Medhwahi, M (corresponding author), Univ Putra Malaysia, Dept Comp & Commun Syst Engn, Fac Engn, Seri Kembangan, Selangor, Malaysia.	med100013@yahoo.com	Al-Medhwahi, Mohammed/AAG-7040-2020	Al-Medhwahi, Mohammed/0000-0003-1595-378X; Sali, Aduwati/0000-0002-1692-6516				Abbasi AA, 2007, COMPUT COMMUN, V30, P2826, DOI 10.1016/j.comcom.2007.05.024; Akyildiz IF, 2006, COMPUT NETW, V50, P2127, DOI 10.1016/j.comnet.2006.05.001; Becker M., 2014, SERVICES WIRELESS SE; Bianchi G, 2000, IEEE J SEL AREA COMM, V18, P535, DOI 10.1109/49.840210; Collotta M, 2014, COMPUT IND, V65, P1181, DOI 10.1016/j.compind.2014.07.004; Deng RL, 2012, IEEE T VEH TECHNOL, V61, P716, DOI 10.1109/TVT.2011.2179323; Ergul O, 2013, IEEE S COMP COMM ISC, P465, DOI DOI 10.1109/ISCC.2013.6754990; Ergul O, 2014, IEEE WCNC, P2055, DOI 10.1109/WCNC.2014.6952606; Ghasemi A, 2008, IEEE COMMUN MAG, V46, P32, DOI 10.1109/MCOM.2008.4481338; Ghosh M, 2009, COGNITIVE RADIOS TEL, P187; Gulbahar B, 2012, IEEE T WIREL COMMUN, V11, P1788, DOI 10.1109/TWC.2012.030812.111166; Huang P, 2013, IEEE COMMUN SURV TUT, V15, P101, DOI 10.1109/SURV.2012.040412.00105; IEEE 802 Working Group, 2011, IEEE STANDARD LOCAL, DOI DOI 10.1109/IEEESTD.2011.6012487; IEEE. S. Association, 2011, COGN WIR RAN MED 22, V802; Kang D, 2014, COMPUT NETW, V64, P112, DOI 10.1016/j.comnet.2014.02.009; Kim KJ, 2013, J COMMUN NETW-S KOR, V15, P77, DOI 10.1109/JCN.2013.000013; Lee WY, 2011, IEEE T MOBILE COMPUT, V10, P161, DOI 10.1109/TMC.2010.147; Liang ZL, 2010, IEEE ICC; Ma LP, 2005, 2005 1ST IEEE INTERNATIONAL SYMPOSIUM ON NEW FRONTIERS IN DYNAMIC SPECTRUM ACCESS NETWORKS, CONFERENCE RECORD, P203; Mariani A, 2014, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-3-319-01402-9_1; Park JH, 2013, 2013 INTERNATIONAL CONFERENCE ON ICT CONVERGENCE (ICTC 2013): FUTURE CREATIVE CONVERGENCE TECHNOLOGIES FOR NEW ICT ECOSYSTEMS, P232, DOI 10.1109/ICTC.2013.6675346; Shah GA, 2015, IEEE T VEH TECHNOL, V64, P757, DOI 10.1109/TVT.2014.2324617; Shah GA, 2014, AD HOC NETW, V15, P4, DOI 10.1016/j.adhoc.2013.03.014; Suliman I, 2009, COGART: 2009 SECOND INTERNATIONAL WORKSHOP ON COGNITIVE RADIO AND ADVANCED SPECTRUM MANAGEMENT, P153, DOI 10.1109/COGART.2009.5167252; Wang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053434; Yang SH, 2014, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4471-5505-8; Zahmati AS, 2009, IEEE TIC-STH 09: 2009 IEEE TORONTO INTERNATIONAL CONFERENCE: SCIENCE AND TECHNOLOGY FOR HUMANITY, P593, DOI 10.1109/TIC-STH.2009.5444432; Zhao HT, 2009, COMPUT COMMUN, V32, P1050, DOI 10.1016/j.comcom.2008.12.031	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156880	10.1371/journal.pone.0156880	http://dx.doi.org/10.1371/journal.pone.0156880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257964	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700148
J	Jang, JY; Choi, YH; Shin, TS; Kim, TH; Shin, KS; Park, HW; Kim, YH; Kim, H; Choi, GJ; Jang, KS; Cha, B; Kim, IS; Myung, EJ; Kim, JC				Jang, Ja Yeong; Choi, Yong Ho; Shin, Teak Soo; Kim, Tae Hoon; Shin, Kee-Sun; Park, Hae Woong; Kim, Young Ho; Kim, Hun; Choi, Gyung Ja; Jang, Kyoung Soo; Cha, Byeongjin; Kim, In Seon; Myung, Eul Jae; Kim, Jin-Cheol			Biological Control of Meloidogyne incognita by Aspergillus niger F22 Producing Oxalic Acid	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; ROOT-KNOT NEMATODES; NEMATOCIDAL ACTIVITY; FORMULATION; STRAIN; BIOCONTROL; EXTRACTION; CULTIVARS; FRUIT; SPP.	Restricted usage of chemical nematicides has led to development of environmentally safe alternatives. A culture filtrate of Aspergillus niger F22 was highly active against Meloidogyne incognita with marked mortality of second-stage juveniles (J2s) and inhibition of egg hatching. The nematicidal component was identified as oxalic acid by organic acid analysis and gas chromatography-mass spectroscopy (GC-MS). Exposure to 2 mmol/L oxalic acid resulted in 100% juvenile mortality at 1 day after treatment and suppressed egg hatching by 95.6% at 7 days after treatment. Oxalic acid showed similar nematicidal activity against M. hapla, but was not highly toxic to Bursaphelenchus xylophilus. The fungus was incubated on solid medium and dried culture was used for preparation of a wettable powder-type (WP) formulation as an active ingredient. Two WP formulations, F22-WP10 (ai 10%) and oxalic acid-WP8 (ai 8%), were prepared using F22 solid culture and oxalic acid. In a field naturally infested with M. incognita, application of a mixture of F22-WP10 + oxalic acid-WP8 at 1,000-and 500-fold dilutions significantly reduced gall formation on the roots of watermelon plants by 58.8 and 70.7%, respectively, compared to the non-treated control. The disease control efficacy of the mixture of F22-WP10 + oxalic acid-WP8 was significantly higher than that of a chemical nematicide, Sunchungtan (ai 30% fosthiazate). These results suggest that A. niger F22 can be used as a microbial nematicide for the control of root-knot nematode disease.	[Jang, Ja Yeong; Kim, In Seon; Kim, Jin-Cheol] Chonnam Natl Univ, Coll Agr & Life Sci, Inst Environm Friendly Agr, Dept Agr Chem, Gwangju, South Korea; [Jang, Ja Yeong; Cha, Byeongjin] Chungbuk Natl Univ, Dept Plant Med, Cheongju, South Korea; [Choi, Yong Ho; Kim, Hun; Choi, Gyung Ja; Jang, Kyoung Soo] Korea Res Inst Chem Technol, Ctr Ecofriendly New Mat, Daejeon, South Korea; [Kim, Tae Hoon; Shin, Kee-Sun; Myung, Eul Jae] Dongbu Farm Hannong Co Ltd, Crop Protect Res Team, Dongbu Adv Res Inst, Nonsan Si, South Korea; [Shin, Kee-Sun] Korea Res Inst Biosci & Biotechnol, Biol Resources Ctr, Daejeon, South Korea; [Park, Hae Woong] World Inst Kimchi, Gwangju, South Korea; [Kim, Young Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Young Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Chonnam National University; Chungbuk National University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Kim, JC (corresponding author), Chonnam Natl Univ, Coll Agr & Life Sci, Inst Environm Friendly Agr, Dept Agr Chem, Gwangju, South Korea.	kjinc@jnu.ac.kr			Rural Development Administration, Republic of Korea; Dongbu Farm Hannong Company Ltd; Cooperative Research Program for Agricultural Science and Technology Development [PJ01020702]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Dongbu Farm Hannong Company Ltd; Cooperative Research Program for Agricultural Science and Technology Development	This study was performed with support from the Cooperative Research Program for Agricultural Science and Technology Development (Project PJ01020702), Rural Development Administration, Republic of Korea (http://www.rda.go.kr). The funder provided support in the form of salaries for authors JYJ, YHC, HK, GJC, KSJ, and JCK. Dongbu Farm Hannong Company Ltd provided support in the form of salaries for authors TSS, THK and EJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bansal R.K., 2003, Nematologia Mediterranea, V31, P135; Barker TR., 1985, ADV TREATISE MELOIDO, P19; Browning M, 2006, SOIL BIOL BIOCHEM, V38, P401, DOI 10.1016/j.soilbio.2005.05.020; Cabrefiga J, 2014, J APPL MICROBIOL, V117, P1122, DOI 10.1111/jam.12582; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Frisvad JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023496; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; Gasic S., 2013, Pesticidi i Fitomedicina, V28, P97; Glare T, 2012, TRENDS BIOTECHNOL, V30, P250, DOI 10.1016/j.tibtech.2012.01.003; Hu Y, 2013, J AGR FOOD CHEM, V61, P41, DOI 10.1021/jf304314g; Huang WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089717; Hwang SM, 2014, KOREAN J HORTIC SCI, V32, P217, DOI 10.7235/hort.2014.13129; Jain A, 2015, J BASIC MICROB, V55, P601, DOI 10.1002/jobm.201400156; Jayaraj J, 2010, J PLANT INTERACT, V5, P147, DOI 10.1080/17429140903291012; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Khan Z, 2008, BIORESOURCE TECHNOL, V99, P3016, DOI 10.1016/j.biortech.2007.06.031; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lamovsek Janja, 2013, Acta Agriculturae Slovenica, V101, P263, DOI 10.2478/acas-2013-0022; Liu Y, 2006, HELMINTHOLOGIA, V43, P51, DOI 10.2478/s11687-006-0010-4; MANKAU R, 1969, PHYTOPATHOLOGY, V59, P1170; Manzanilla-Lopez Rosa H., 2004, P637, DOI 10.1079/9780851996462.0637; Martinez-Espla A, 2014, J AGR FOOD CHEM, V62, P3432, DOI 10.1021/jf500224g; Mokbel A. A., 2009, Alexandria Journal of Agricultural Research, V54, P199; Nian XG, 2015, PEST MANAG SCI, V71, P1675, DOI 10.1002/ps.3977; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Nitao JK, 1999, J NEMATOL, V31, P172; OECD, 2001, BRID DIG DIV ISS POL; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park J, 2014, PLANT PATHOLOGY J, V30, P288, DOI 10.5423/PPJ.OA.02.2014.0013; Ruanpanun P, 2011, WORLD J MICROB BIOT, V27, P1373, DOI 10.1007/s11274-010-0588-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schisler DA, 2004, PHYTOPATHOLOGY, V94, P1267, DOI 10.1094/PHYTO.2004.94.11.1267; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Seo Y, 2014, PLANT PATHOLOGY J, V30, P450, DOI [10.5423/PPJ.NT.07.2014.0062, 10.5423/PPJ.NT.05.2014.0041]; Sikora Richard A., 2005, P319, DOI 10.1079/9780851997278.0319; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vu TT, 2013, PLANT DIS, V97, P1593, DOI 10.1094/PDIS-04-13-0350-RE; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; U.S. Department of Agriculture, 1984, AGR HDB; United States Environmental Protection Agency, 2015, EPA OK OX AC VARR MI, P12; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Wang Y, US Patent, Patent No. [12/152,788, 12152788]; Wilson MJ, 2013, BIOCONTROL, V58, P715, DOI 10.1007/s10526-013-9511-5; Yanez-Mendizabal V, 2012, J APPL MICROBIOL, V112, P954, DOI 10.1111/j.1365-2672.2012.05258.x; Yu ZT, 1999, CAN J MICROBIOL, V45, P269, DOI 10.1139/cjm-45-3-269; Zheng XL, 2012, FOOD CHEM, V132, P849, DOI 10.1016/j.foodchem.2011.11.049; ZUCKERMAN BM, 1994, J CHEM ECOL, V20, P33, DOI 10.1007/BF02065989	50	46	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156230	10.1371/journal.pone.0156230	http://dx.doi.org/10.1371/journal.pone.0156230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258452	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700044
J	Pruett, WA; Hester, RL				Pruett, W. Andrew; Hester, Robert L.			The Creation of Surrogate Models for Fast Estimation of Complex Model Outcomes	PLOS ONE			English	Article							BODY NEGATIVE-PRESSURE; HYPERTENSION; VARIABILITY; INTEGRATION; SIMULATION; PROJECT; DESIGN	A surrogate model is a black box model that reproduces the output of another more complex model at a single time point. This is to be distinguished from the method of surrogate data, used in time series. The purpose of a surrogate is to reduce the time necessary for a computation at the cost of rigor and generality. We describe a method of constructing surrogates in the form of support vector machine (SVM) regressions for the purpose of exploring the parameter space of physiological models. Our focus is on the methodology of surrogate creation and accuracy assessment in comparison to the original model. This is done in the context of a simulation of hemorrhage in one model, "Small", and renal denervation in another, HumMod. In both cases, the surrogate predicts the drop in mean arterial pressure following the intervention. We asked three questions concerning surrogate models: (1) how many training examples are necessary to obtain an accurate surrogate, (2) is surrogate accuracy homogeneous, and (3) how much can computation time be reduced when using a surrogate. We found the minimum training set size that would guarantee maximal accuracy was widely variable, but could be algorithmically generated. The average error for the pressure response to the protocols was -0.05 +/- 2.47 in Small, and -0.3+/-3.94 mmHg in HumMod. In the Small model, error grew with actual pressure drop, and in HumMod, larger pressure drops were overestimated by the surrogates. Surrogate use resulted in a 6 order of magnitude decrease in computation time. These results suggest surrogate modeling is a valuable tool for generating predictions of an integrative model's behavior on densely sampled subsets of its parameter space.	[Pruett, W. Andrew; Hester, Robert L.] Univ Mississippi, Dept Physiol & Biophys, Med Ctr, Ctr Computat Med, Jackson, MS 39215 USA	University of Mississippi; University of Mississippi Medical Center	Pruett, WA (corresponding author), Univ Mississippi, Dept Physiol & Biophys, Med Ctr, Ctr Computat Med, Jackson, MS 39215 USA.	wpruett@umc.edu		Hester, Robert/0000-0003-0227-557X	National Institute of Health [P01 HL 51971]; National Science Foundation (NSF) [EPS 0903787]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health, P01 HL 51971 and the National Science Foundation (NSF), EPS 0903787. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard DA, 2012, ANN BIOMED ENG, V40, P2365, DOI 10.1007/s10439-012-0611-7; Combs CD, 2016, DIGITAL PATIENT ADV; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; Hester RL, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00012; Hinojosa-Laborde C, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00085; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Jeong S, 2005, J AIRCRAFT, V42, P413, DOI 10.2514/1.6386; Kandzari DE, 2015, EUR HEART J, V36, P219, DOI 10.1093/eurheartj/ehu441; Pruett WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074329; Rikards R, 2004, COMPOS STRUCT, V63, P243, DOI 10.1016/S0263-8223(03)00171-5; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Schillaci G, 2014, NEW ENGL J MED, V371, P182, DOI 10.1056/NEJMc1405677; Scholkopf B., 1999, ADV KERNEL METHODS S; SKILLMAN JJ, 1967, ANN SURG, V166, P713, DOI 10.1097/00000658-196711000-00001; Topol EJ, 2012, CREATIVE DESTRUCTION; Viceconti M, 2010, PHILOS T R SOC A, V368, P2591, DOI 10.1098/rsta.2010.0096; Wan X., 2004, THESIS PURDUE U; Wijeysundera DN, 2001, CLIN SCI, V100, P303, DOI 10.1042/CS20000215	19	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156574	10.1371/journal.pone.0156574	http://dx.doi.org/10.1371/journal.pone.0156574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258010	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700079
J	Shen, QH; Kirschbaum, MUF; Hedley, MJ; Arbestain, MC				Shen, Qinhua; Kirschbaum, Miko U. F.; Hedley, Mike J.; Arbestain, Marta Camps			Testing an Alternative Method for Estimating the Length of Fungal Hyphae Using Photomicrography and Image Processing	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; MEMBRANE-FILTER TECHNIQUE; SOIL AGGREGATION; MYCELIUM; QUANTIFICATION; COMMUNITIES; PHOSPHORUS; BIOMASS	This study aimed to develop and test an unbiased and rapid methodology to estimate the length of external arbuscular mycorrhizal fungal (AMF) hyphae in soil. The traditional visual gridline intersection (VGI) method, which consists in a direct visual examination of the intersections of hyphae with gridlines on a microscope eyepiece after aqueous extraction, membrane-filtration, and staining (e.g., with trypan blue), was refined. For this, (i) images of the stained hyphae were taken by using a digital photomicrography technique to avoid the use of the microscope and the method was referred to as "digital gridline intersection" (DGI) method; and (ii), the images taken in (i) were processed and the hyphal length was measured by using ImageJ software, referred to as the "photomicrography-ImageJ processing" (PIP) method. The DGI and PIP methods were tested using known grade lengths of possum fur. Then they were applied to measure the hyphal lengths in soils with contrasting phosphorus (P) fertility status. Linear regressions were obtained between the known lengths (L-known) of possum fur and the values determined by using either the DGI (L-DGI) (L-DGI = 0.37 + 0.97 x L-known, r(2) = 0.86) or PIP (L-PIP) methods (L-PIP = 0.33 + 1.01 x L-known, r(2) = 0.98). There were no significant (P > 0.05) differences between the L-DGI and L-PIP values. While both methods provided accurate estimation (slope of regression being 1.0), the PIP method was more precise, as reflected by a higher value of r(2) and lower coefficients of variation. The average hyphal lengths (6.5-19.4 m g(-1)) obtained by the use of these methods were in the range of those typically reported in the literature (3-30 m g(-1)). Roots growing in P-deficient soil developed 2.5 times as many hyphae as roots growing in P-rich soil (17.4 vs 7.2 m g(-1)). These tests confirmed that the use of digital photomicrography in conjunction with either the grid-line intersection principle or image processing is a suitable method for the measurement of AMF hyphal lengths in soils for comparative investigations.	[Shen, Qinhua; Hedley, Mike J.; Arbestain, Marta Camps] Massey Univ, Inst Agr & Environm, New Zealand Biochar Res Ctr, Private Bag 11222, Palmerston North 4442, New Zealand; [Kirschbaum, Miko U. F.] Landcare Res, Private Bag 11-052, Palmerston North 4442, New Zealand	Massey University; Landcare Research - New Zealand	Shen, QH (corresponding author), Massey Univ, Inst Agr & Environm, New Zealand Biochar Res Ctr, Private Bag 11222, Palmerston North 4442, New Zealand.	Q.shen@massey.ac.nz		Hedley, Michael James/0000-0002-3739-2533; Camps Arbestain, Marta/0000-0002-5354-2087; Shen, Qinhua/0000-0001-8767-6852	New Zealand Biochar Research Centre	New Zealand Biochar Research Centre	The New Zealand Biochar Research Centre granted to QHS for this research project at Massey University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1984, NEW PHYTOL, V97, P437, DOI 10.1111/j.1469-8137.1984.tb03609.x; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BARDGETT RD, 1991, AGR ECOSYST ENVIRON, V34, P115, DOI 10.1016/0167-8809(91)90099-J; Boddington CL, 1999, SOIL BIOL BIOCHEM, V31, P479, DOI 10.1016/S0038-0717(98)00145-X; Brundrett M., 1994, PRACTICAL METH ODS M; Camenzind T, 2013, SOIL BIOL BIOCHEM, V64, P96, DOI 10.1016/j.soilbio.2013.04.011; Colla G, 2008, BIOL FERT SOILS, V44, P501, DOI 10.1007/s00374-007-0232-8; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; DODD JC, 1994, ADV LIF SCI, P147; ELMHOLT S, 1987, SOIL BIOL BIOCHEM, V19, P679, DOI 10.1016/0038-0717(87)90047-2; GREEN DC, 1994, MYCORRHIZA, V5, P105, DOI 10.1007/BF00202341; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hynes M. M., 2008, MICROSC MICROANAL, P139; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Leifheit EF, 2015, SOIL BIOL BIOCHEM, V81, P323, DOI 10.1016/j.soilbio.2014.12.003; Mallard F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064387; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; MORGAN P, 1991, SOIL BIOL BIOCHEM, V23, P609, DOI 10.1016/0038-0717(91)90072-R; PACOVSKY RS, 1982, PLANT SOIL, V68, P143, DOI 10.1007/BF02374736; R Core Team, 2013, R LANG ENV STAT COMP; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Sheffield J, 2008, MICROSC MICROANAL S2, V14, P898, DOI DOI 10.1017/S1431927608088752; Shen Q, 2016, J SOIL SCI IN PRESS; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; STAHL PD, 1995, SOIL BIOL BIOCHEM, V27, P1091, DOI 10.1016/0038-0717(94)00204-E; Sylvia DM, 1992, QUANTIFICATION EXTER, V53; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wu QS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05823; Zhang ZZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142371; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	31	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157017	10.1371/journal.pone.0157017	http://dx.doi.org/10.1371/journal.pone.0157017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284995	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000036
J	Link, D; de Lorenzo, MF				Link, Daniel; de Lorenzo, Michael F.			Seasonal Pacing - Match Importance Affects Activity in Professional Soccer	PLOS ONE			English	Article							PREMIER LEAGUE SOCCER; ELITE SOCCER; PERFORMANCE; FATIGUE; PLAYERS; TIME; PROFILES; FOOTBALL; FITNESS	This research explores the influence of match importance on player activity in professional soccer. Therefore, we used an observational approach and analyzed 1,211 matches of German Bundesliga and 2nd Bundesliga. The importance measurement employed is based on post season consequences of teams involved in a match. This means, if a match result could potentially influence the final rank, and this rank would lead to different consequences for a team, such as qualification for Champions League opposed to qualification for Europe League, then this match is classified as important; otherwise not. Activity was quantified by TOTAL DISTANCE COVERED, SPRINTS, FAST RUNS, DUELS, FOULS and ATTEMPTS. Running parameters were recorded using a semi-automatic optical tracking system, while technical variables were collected by professional data loggers. Based on our importance classification, low important matches occurred at the beginning of round 29. A two-way ANOVA indicates significantly increased FAST RUNS (+4%, d = 0.3), DUELS (+16%, d = 1.0) and FOULS (+36%, d = 1.2) in important matches compared to low important ones. For FAST RUNS and FOULS, this effect only exists in Bundesliga. A comparison of the two leagues show that TOTAL DISTANCE COVERED (+3%, d = 0.9), SPRINTS (+25%, d = 1.4) and FAST RUNS (+15%, d = 1.4) are higher compared to 2nd Bundesliga, whilst FOULS is less in Bundesliga (-7%, d = 0.3). No difference in player activity was found between matches at the beginning of a season (round 1-6) and at the end of a season (round 29-34). We conclude that match importance influences player activity in German professional soccer. The most reasonable explanation is a conscious or unconscious pacing strategy, motivated by preserving abilities or preventing injury. Since this tendency mainly exists in Bundesliga, this may suggest that more skilled players show a higher awareness for the need of pacing.	[Link, Daniel] Tech Univ Munich, Dept Exercise Sci & Sport Informat, D-80290 Munich, Germany; [de Lorenzo, Michael F.] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia	Technical University of Munich; Royal Melbourne Institute of Technology (RMIT)	Link, D (corresponding author), Tech Univ Munich, Dept Exercise Sci & Sport Informat, D-80290 Munich, Germany.	daniel.link@tum.de		Link, Daniel/0000-0003-3606-2986				Bedford A, 2006, J SPORT SCI MED, V5, P509; Bendiksen M, 2012, MED SCI SPORT EXER, V44, P1595, DOI 10.1249/MSS.0b013e31824cc23b; Bloomfield JR., 2005, J SPORT SCI, V23, P192, DOI DOI 10.1080/02640410512331334413; Bradley PS, 2013, J SPORT SCI, V31, P1627, DOI 10.1080/02640414.2013.796062; Bradley PS, 2013, HUM MOVEMENT SCI, V32, P808, DOI 10.1016/j.humov.2013.06.002; Bradley PS, 2011, J SPORT SCI, V29, P821, DOI 10.1080/02640414.2011.561868; Carling C, 2011, J SPORT SCI, V29, P63, DOI 10.1080/02640414.2010.521945; Carling C, 2010, J SCI MED SPORT, V13, P126, DOI 10.1016/j.jsams.2008.09.004; Castellano J, 2011, INT J SPORTS MED, V32, P415, DOI 10.1055/s-0031-1271771; DFL, 2014, DEF OFF SPIELD; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; Di Salvo V, 2013, INT J SPORTS MED, V34, P526, DOI 10.1055/s-0032-1327660; Drust B, 2007, SPORTS MED, V37, P783, DOI 10.2165/00007256-200737090-00003; Edwards AM, 2009, SPORTS MED, V39, P1, DOI 10.2165/00007256-200939010-00001; Ely MR, 2008, MED SCI SPORT EXER, V40, P1675, DOI 10.1249/MSS.0b013e3181788da9; Gabbett TJ, 2007, J SPORT SCI, V25, P1507, DOI 10.1080/02640410701215066; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Harper LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110995; Lago-Penas C, 2011, J SPORT SCI MED, V10, P465; Link D, 2015, J STRENGTH CONDITION; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Morris C., 1977, OPTIM STRATEG SPORTS, V5, P131; Mugglestone C, 2013, INT J SPORTS MED, V34, P514, DOI 10.1055/s-0032-1327647; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Paul DJ, 2015, IJSPP, P10; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Schilling M. F., 1994, MATH MAG, V67, P282; Siegle M, 2013, J SPORT SCI, V31, P166, DOI 10.1080/02640414.2012.723131; Silva JR, 2013, J STRENGTH COND RES, V27, P20, DOI 10.1519/JSC.0b013e31824e1946; Silva JR, 2011, J STRENGTH COND RES, V25, P2729, DOI 10.1519/JSC.0b013e31820da078; Varley MC, 2012, INT J SPORT PHYSIOL, V7, P183, DOI 10.1123/ijspp.7.2.183	31	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157127	10.1371/journal.pone.0157127	http://dx.doi.org/10.1371/journal.pone.0157127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281051	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000091
J	Reynard, O; Jacquot, F; Evanno, G; Mai, HL; Salama, A; Martinet, B; Duvaux, O; Bach, JM; Conchon, S; Judor, JP; Perota, A; Lagutina, I; Duchi, R; Lazzari, G; Le Berre, L; Perreault, H; Lheriteau, E; Raoul, H; Volchkov, V; Galli, C; Soulillou, JP				Reynard, Olivier; Jacquot, Frederic; Evanno, Gwenalle; Mai, Hoa Le; Salama, Apolline; Martinet, Bernard; Duvaux, Odile; Bach, Jean-Marie; Conchon, Sophie; Judor, Jean-Paul; Perota, Andrea; Lagutina, Irina; Duchi, Roberto; Lazzari, Giovanna; Le Berre, Ludmilla; Perreault, Helene; Lheriteau, Elsa; Raoul, Herve; Volchkov, Viktor; Galli, Cesare; Soulillou, Jean-Paul			Anti-EBOV GP IgGs Lacking alpha 1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs	PLOS ONE			English	Article							RABBIT ANTITHYMOCYTE GLOBULIN; HEMORRHAGIC-FEVER; VIRUS INFECTION; MOLECULAR CHARACTERIZATION; MONOCLONAL-ANTIBODY; NONHUMAN-PRIMATES; IMMUNOGLOBULIN-G; GLYCOPROTEIN; PROPHYLAXIS; DISEASE	Polyclonal xenogenic IgGs, although having been used in the prevention and cure of severe infectious diseases, are highly immunogenic, which may restrict their usage in new applications such as Ebola hemorrhagic fever. IgG glycans display powerful xenogeneic antigens in humans, for example alpha 1-3 Galactose and the glycolyl form of neuraminic acid Neu5Gc, and IgGs deprived of these key sugar epitopes may represent an advantage for passive immunotherapy. In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. For this purpose, a double knock-out pig lacking alpha 1-3 Galactose and Neu5Gc was immunized against virus-like particles displaying surface EBOV glycoprotein GP. Following purification from serum, hyperimmune polyclonal IgGs were obtained, exhibiting an anti-EBOV GP titer of 1:100,000 and a virus neutralizing titer of 1:100. Guinea pigs were injected intramuscularly with purified IgGs on day 0 and day 3 post-EBOV infection. Compared to control animals treated with IgGs from non-immunized double KO pigs, the anti-EBOV IgGs-treated animals exhibited a significantly prolonged survival and a decreased virus load in blood on day 3. The data obtained indicated that IgGs lacking alpha 1-3 Galactose and Neu5Gc, two highly immunogenic epitopes in humans, have a protective effect upon EBOV infection.	[Reynard, Olivier; Volchkov, Viktor] Univ Lyon 1, Ecole Normale Super Lyon, INSERM, CIRI,CNRS,UMR5308,U1111,Mol Basis Viral Pathogen, F-69365 Lyon, France; [Jacquot, Frederic; Raoul, Herve] INSERM, Jean Merieux Lab BSL4, US003, F-69008 Lyon, France; [Evanno, Gwenalle; Salama, Apolline; Duvaux, Odile; Bach, Jean-Marie; Lheriteau, Elsa; Soulillou, Jean-Paul] Xenothera, Nantes, France; [Mai, Hoa Le; Martinet, Bernard; Conchon, Sophie; Judor, Jean-Paul; Le Berre, Ludmilla] INSERM, UMR 1064, Nantes, France; [Mai, Hoa Le; Martinet, Bernard; Conchon, Sophie; Judor, Jean-Paul; Le Berre, Ludmilla] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Mai, Hoa Le; Martinet, Bernard; Conchon, Sophie; Judor, Jean-Paul; Le Berre, Ludmilla; Soulillou, Jean-Paul] Univ Nantes, Nantes, France; [Bach, Jean-Marie] Univ Nantes, IECM, EA4644, ONIRIS,USC1383,INRA, Nantes, France; [Perota, Andrea; Lagutina, Irina; Duchi, Roberto; Lazzari, Giovanna; Galli, Cesare] Avantea, Lab Reprod Technol, Cremona, Italy; [Lazzari, Giovanna; Galli, Cesare] Avantea Fdn, Cremona, Italy; [Perreault, Helene] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Galli, Cesare] Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; University of Manitoba; University of Bologna	Volchkov, V (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, INSERM, CIRI,CNRS,UMR5308,U1111,Mol Basis Viral Pathogen, F-69365 Lyon, France.; Raoul, H (corresponding author), INSERM, Jean Merieux Lab BSL4, US003, F-69008 Lyon, France.; Soulillou, JP (corresponding author), Xenothera, Nantes, France.; Soulillou, JP (corresponding author), Univ Nantes, Nantes, France.; Galli, C (corresponding author), Avantea, Lab Reprod Technol, Cremona, Italy.; Galli, C (corresponding author), Avantea Fdn, Cremona, Italy.; Galli, C (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Dell Emilia, Italy.	herve.raoul@inserm.fr; viktor.volchkov@inserm.fr; cesaregalli@avantea.it; jean-paul.soulillou@univ-nantes.fr	Bach, Jean-Marie/AAR-1086-2020; reynard, olivier AJ/M-8069-2014; Volchkov, Viktor/M-7846-2014	reynard, olivier AJ/0000-0001-7536-355X; Bach, Jean-Marie/0000-0002-5265-8854; Conchon, Sophie/0000-0003-2602-3385; Volchkov, Viktor/0000-0001-7896-8706	Institut national de la sante et de la recherche medicale (INSERM), Agence Nationale de la Recherche [ANR-14-EBOL-002-01]; European Union [278976]; Xenothera; Avantea	Institut national de la sante et de la recherche medicale (INSERM), Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission); Xenothera; Avantea	This work was supported by Institut national de la sante et de la recherche medicale (INSERM), Agence Nationale de la Recherche (ANR-14-EBOL-002-01) and the European Union FP7 project ANTIGONE (278976). The companies Xenothera and Avantea co-funded the study, and only provided financial support in the form of authors' salaries and/or research materials. The funders provided support in the form of salaries for authors AS, GE, AP, RD, and IL or consultance for JPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, XENOTRANSPLANTATION, V22, pS2, DOI [10.1111/xen.12204, DOI 10.1111/XEN.12204]; Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881; Bal C, 2015, LANCET INFECT DIS, V15, P285, DOI 10.1016/S1473-3099(14)71072-2; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Berry JD, 2011, NEW BIOTECHNOL, V28, P489, DOI 10.1016/j.nbt.2011.03.018; Bounds CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137786; Buelow R, 2007, ERNST SCHERING FOUND, V4, P83; CASADEVALL A, 1995, CLIN INFECT DIS, V21, P150, DOI 10.1093/clinids/21.1.150; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Conchon S, 2013, XENOTRANSPLANTATION, V20, P370; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Couvrat-Desvergnes G, 2015, J CLIN INVEST, V125, P4655, DOI 10.1172/JCI82267; Cross RW, 2015, J INFECT DIS, V212, pS305, DOI 10.1093/infdis/jiv237; de La Vega MA, 2015, J CLIN INVEST, V125, P4421, DOI 10.1172/JCI83162; Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219; Dolnik O, 2015, J INFECT DIS, V212, pS322, DOI 10.1093/infdis/jiv268; Dowall SD, 2016, J INFECT DIS, V213, P1124, DOI 10.1093/infdis/jiv565; DWEK RA, 1995, J ANAT, V187, P279; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Faye O, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001908; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Feng XM, 2014, HAEMATOLOGICA, V99, P1433, DOI 10.3324/haematol.2014.106542; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; Gitelman SE, 2013, LANCET DIABETES ENDO, V1, P306, DOI 10.1016/S2213-8587(13)70065-2; Jahrling PB, 1996, ARCH VIROL, P135; Jahrling PB, 2007, J INFECT DIS, V196, pS400, DOI 10.1086/520587; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lanini S, 2015, J CLIN INVEST, V125, P4692, DOI 10.1172/JCI83111; Lopez PG, 2016, GLYCOCONJUGATE J, V33, P79, DOI 10.1007/s10719-015-9637-z; Mateo M, 2011, J INFECT DIS, V204, pS1011, DOI 10.1093/infdis/jir338; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Nakayama E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00267; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Reynard O, 2015, J INFECT DIS, V212, pS372, DOI 10.1093/infdis/jiv303; Roux D, 2012, J ANTIMICROB CHEMOTH, V67, P2785, DOI 10.1093/jac/dks335; Sadek RF, 1999, J INFECT DIS, V179, pS24, DOI 10.1086/514311; Salama A, 2015, XENOTRANSPLANTATION, V22, P85, DOI 10.1111/xen.12142; Sano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078119; SOULILLOU JP, 1990, NEW ENGL J MED, V322, P1175, DOI 10.1056/NEJM199004263221702; Takada A, 2013, IMMUNOTHERAPY-UK, V5, P441, DOI [10.2217/IMT.13.29, 10.2217/imt.13.29]; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Volchkov VE, 2000, VIROLOGY, V277, P147, DOI 10.1006/viro.2000.0572; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472	53	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156775	10.1371/journal.pone.0156775	http://dx.doi.org/10.1371/journal.pone.0156775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280712	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000047
J	Sridhar, S; Steele-Mortimer, O				Sridhar, Sushmita; Steele-Mortimer, Olivia			Inherent Variability of Growth Media Impacts the Ability of Salmonella Typhimurium to Interact with Host Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ORGANIC-ACID PRODUCTION; PATHOGENICITY ISLAND 1; III SECRETION SYSTEMS; D-GLUCARIC ACID; IN-VITRO; GASTROINTESTINAL-TRACT; EPITHELIAL-CELLS; MAMMALIAN-CELLS; HELA-CELLS	Efficient invasion of non-phagocytic cells, such as intestinal epithelial cells, by Salmonella Typhimurium is dependent on the Salmonella Pathogenicity Island 1 (SPI-1)-encoded Type Three Secretion System. The environmental cues involved in SPI-1 induction are not well understood. In vitro, various conditions are used to induce SPI-1 and the invasive phenotype. Although lysogeny broth (LB) is widely used, multiple formulations exist, and variation can arise due to intrinsic differences in complex components. Minimal media are also susceptible to variation. Still, the impact of these inconsistencies on Salmonella virulence gene expression has not been well studied. The goal of this project is to identify growth conditions in LB and minimal mediumthat affect SPI-1 induction in vitro using both whole population and single cell analysis. Here we show, using a fluorescent reporter of the SPI-1 gene prgH, that growth of Salmonella in LB yields variable induction. Deliberate modification of media components can influence the invasive profile. Finally, we demonstrate that changes in SPI-1 inducing conditions can affect the ability of Salmonella to replicate intracellularly. These data indicate that the specific media growth conditions impact how the bacteria interact with host cells.	[Sridhar, Sushmita; Steele-Mortimer, Olivia] NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Steele-Mortimer, O (corresponding author), NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	omortimer@niaid.nih.gov			Intramural Research Program of the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001111, ZIAAI000909] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the Intramural Research Program of the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Intramural Research Program of the NIH, NIAID. We would like to thank Aaron Carmody for expert flow cytometry support, Anita Mora for figures, and members of the lab for helpful comments throughout the process.	Altier C, 2005, J MICROBIOL, V43, P85; ARGENZIO RA, 1975, AM J PHYSIOL, V228, P454, DOI 10.1152/ajplegacy.1975.228.2.454; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Blair JMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063912; BOHNHOFF M, 1964, J EXP MED, V120, P805, DOI 10.1084/jem.120.5.805; Bowden SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096266; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; ERNST RK, 1990, INFECT IMMUN, V58, P2014, DOI 10.1128/IAI.58.6.2014-2016.1990; Espinosa E, 2014, MOL MICROBIOL, V91, P1057, DOI 10.1111/mmi.12500; Ezraty B, 2014, FREE RADICAL BIO MED, V74, P245, DOI 10.1016/j.freeradbiomed.2014.07.010; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Jiang LY, 2015, CURR MICROBIOL, V70, P315, DOI 10.1007/s00284-014-0720-7; JONES GW, 1981, J GEN MICROBIOL, V127, P351; Kage H, 2008, J BACTERIOL, V190, P2470, DOI 10.1128/JB.01385-07; KHORAMIANFALSAFI T, 1990, MICROB PATHOGENESIS, V9, P47, DOI 10.1016/0882-4010(90)90039-S; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Lamichhane-Khadka R, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130146; Lamichhane-Khadka R, 2011, J BACTERIOL, V193, P5824, DOI 10.1128/JB.05456-11; Le Bouguenec C, 2011, INT J MED MICROBIOL, V301, P1, DOI 10.1016/j.ijmm.2010.04.021; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; MARSH CA, 1985, ANAL BIOCHEM, V145, P266, DOI 10.1016/0003-2697(85)90360-4; MATSUI M, 1972, CHEM PHARM BULL, V20, P845; Moon TS, 2010, METAB ENG, V12, P298, DOI 10.1016/j.ymben.2010.01.003; Saini S, 2010, PLOS PATHOG, V6, DOI [10.1371/annotation/df7e26bc-4c62-43b4-865f-a39274d98ab3, 10.1371/journal.ppat.1001025]; SCHIEMANN DA, 1991, INFECT IMMUN, V59, P437, DOI 10.1128/IAI.59.1.437-440.1991; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Singer HM, 2014, J BACTERIOL, V196, P1448, DOI 10.1128/JB.01438-13; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7; 2010, COLD SPRING HARBOR P	42	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157043	10.1371/journal.pone.0157043	http://dx.doi.org/10.1371/journal.pone.0157043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280414	gold, Green Submitted, Green Published			2022-12-27	WOS:000377563000074
J	Lou, BS; Lin, LX; Tan, JL; Yang, Y; Yuan, ZH; Lin, XF				Lou, Bingsheng; Lin, Lixia; Tan, Junlian; Yang, Yao; Yuan, Zhaohui; Lin, Xiaofeng			Survey of Intraocular Antibiotics Prophylaxis Practice after Open Globe Injury in China	PLOS ONE			English	Article							ONSET POSTOPERATIVE ENDOPHTHALMITIS; VANCOMYCIN-RESISTANT ENTEROCOCCI; POSTTRAUMATIC ENDOPHTHALMITIS; CATARACT-SURGERY; VISUAL OUTCOMES; BACTERIAL ENDOPHTHALMITIS; INTRACAMERAL CEFUROXIME; MOXIFLOXACIN; PENETRATION; INJECTION	Purpose To elucidate the Chinese practice of intraocular antibiotics administration for prophylaxis after open globe injury. Methods A cross-sectional questionnaire survey was performed online by scanning a Quickmark (QR) code with smartphones at the 20th Chinese National Conference of Ocular Trauma in November 2014. Results A total of 153 (30.6%) of all participators at the conference responded. Of the respondents, 20.9% were routinely administered with prophylactic intraocular injection of antibiotics at the conclusion of the primary eye repair, and 56.9% were used only in cases with high risk of endophthalmitis development. The intraocular route of delivery was mainly included with intracameral injection (47.9%) and intravitreal injection (42.0%). Cephalosporins (53.8%) and vancomycin (42.0%) were the main choices of antibiotic agents, followed by fluoroquinolones (24.3%), and aminoglycosides (13.4%). Only 21.9% preferred a combination of two or more two drugs routinely. In addition, significantly more respondents from the referral eye hospital (92.7%) replied using intraocular antibiotics injection for prophylaxis compared to those respondents from the primary hospital (69.4%) (p = 0.001, Fisher's exact test). Conclusions Intraocular antibiotics injection for post-traumatic endophthalmitis prophylaxis is widely used in China. However, the choice of antibiotic agents and the intraocular route of delivery vary. A well-designed clinical trial is needed to establish a standardized protocol of intraocular antibiotics administration for post-traumatic endophthalmitis prophylaxis.	[Lou, Bingsheng; Lin, Lixia; Tan, Junlian; Yang, Yao; Yuan, Zhaohui; Lin, Xiaofeng] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lin, XF (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	linxiaof@mail.sysu.edu.cn			Science and Technology Planning Project of Guangdong Province [2014A020212099]; Guangzhou Science and Technology Program key projects [15020088]	Science and Technology Planning Project of Guangdong Province; Guangzhou Science and Technology Program key projects	This study was supported by Science and Technology Planning Project of Guangdong Province (2014A020212099, http://pro.gdstc.gov.cn/egrantweb/) received by BSL and Guangzhou Science and Technology Program key projects (15020088, http://www.gzsi.gov.cn) received by XFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg TM, 1998, OPHTHALMOLOGY, V105, P1004, DOI 10.1016/S0161-6420(98)96000-6; AFFELDT JC, 1987, OPHTHALMOLOGY, V94, P407; Andreoli CM, 2009, AM J OPHTHALMOL, V147, P601, DOI 10.1016/j.ajo.2008.10.023; Arikan S, 2013, J PHARM PHARMACOL, V65, P659, DOI 10.1111/jphp.12029; ARIYASU RG, 1995, AM J OPHTHALMOL, V119, P181, DOI 10.1016/S0002-9394(14)73871-1; Azad R, 2003, GRAEF ARCH CLIN EXP, V241, P478, DOI 10.1007/s00417-003-0670-4; Barreau G, 2012, J CATARACT REFR SURG, V38, P1370, DOI 10.1016/j.jcrs.2012.03.024; Barry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032; Bhagat N, 2011, SURV OPHTHALMOL, V56, P214, DOI 10.1016/j.survophthal.2010.09.002; Bhala S, 2012, NEPAL J OPHTHALMOL, V4, P84, DOI 10.3126/nepjoph.v4i1.5857; BOHIGIAN GM, 1986, AM J OPHTHALMOL, V101, P332, DOI 10.1016/0002-9394(86)90829-9; BOLDT HC, 1989, OPHTHALMOLOGY, V96, P1722; CAMPOCHIARO PA, 1994, ARCH OPHTHALMOL-CHIC, V112, P48, DOI 10.1001/archopht.1994.01090130058017; Garcia-Saenz MC, 2010, J CATARACT REFR SURG, V36, P203, DOI 10.1016/j.jcrs.2009.08.023; Chhabra S, 2006, AM J OPHTHALMOL, V142, P852, DOI 10.1016/j.ajo.2006.05.024; Cornut PL, 2013, ACTA OPHTHALMOL, V91, P475, DOI 10.1111/j.1755-3768.2011.02349.x; Eifrig CWG, 2002, OPHTHALMIC SURG LAS, V33, P373; Esmaeli B, 2003, RETINA-J RET VIT DIS, V23, P118, DOI 10.1097/00006982-200302000-00024; Essex RW, 2004, OPHTHALMOLOGY, V111, P2015, DOI 10.1016/j.ophtha.2003.09.041; Galan F, 1997, Enferm Infecc Microbiol Clin, V15, P379; Gupta A, 2014, GRAEF ARCH CLIN EXP, V252, P1825, DOI 10.1007/s00417-014-2658-7; Gupta A, 2007, CLIN EXP OPHTHALMOL, V35, P432, DOI 10.1111/j.1442-9071.2007.01509.x; Kresloff MS, 1998, SURV OPHTHALMOL, V43, P193, DOI 10.1016/S0039-6257(98)00036-8; Lemley CA, 2007, RETINA-J RET VIT DIS, V27, P662, DOI 10.1097/IAE.0b013e3180323f96; Lieb DF, 2003, OPHTHALMOLOGY, V110, P1560, DOI 10.1016/S0161-6420(03)00497-4; Narang Subina, 2003, Indian J Ophthalmol, V51, P39; Norregaard JC, 1997, BRIT J OPHTHALMOL, V81, P102, DOI 10.1136/bjo.81.2.102; Reynolds D S, 1997, Curr Opin Ophthalmol, V8, P32, DOI 10.1097/00055735-199706000-00006; Sabaci G, 2002, AM J OPHTHALMOL, V133, P62, DOI 10.1016/S0002-9394(01)01320-4; Sakalar YB, 2011, J OCUL PHARMACOL TH, V27, P593, DOI 10.1089/jop.2011.0021; SEAL DV, 1992, EYE, V6, P465, DOI 10.1038/eye.1992.98; Soheilian M, 2005, OPHTHALMOLOGY, V112, P1845, DOI 10.1016/j.ophtha.2005.07.007; Soheilian M, 2007, ARCH OPHTHALMOL-CHIC, V125, P460, DOI 10.1001/archopht.125.4.460; Soheilian Masoud, 2001, International Ophthalmology, V24, P323, DOI 10.1023/B:INTE.0000006768.66170.c1; Somani S, 1997, CAN J OPHTHALMOL, V32, P303; Sun Shi-ying, 2012, Zhonghua Yi Xue Za Zhi, V92, P32; Tang CW, 2007, CAN J OPHTHALMOL, V42, P477, DOI 10.3129/i07-057; Uda T, 2014, J OCUL PHARMACOL TH, V30, P333, DOI 10.1089/jop.2013.0204	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156856	10.1371/journal.pone.0156856	http://dx.doi.org/10.1371/journal.pone.0156856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275777	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700042
J	Wang, TL; Hamann, A; Spittlehouse, D; Carroll, C				Wang, Tongli; Hamann, Andreas; Spittlehouse, Dave; Carroll, Carlos			Locally Downscaled and Spatially Customizable Climate Data for Historical and Future Periods for North America	PLOS ONE			English	Article							BRITISH-COLUMBIA; UNITED-STATES; CHANGING CLIMATE; WESTERN CANADA; MANAGEMENT; TEMPERATURE; ECOSYSTEM; SURFACES; MODEL; CMIP5	Large volumes of gridded climate data have become available in recent years including interpolated historical data from weather stations and future predictions from general circulation models. These datasets, however, are at various spatial resolutions that need to be converted to scales meaningful for applications such as climate change risk and impact assessments or sample-based ecological research. Extracting climate data for specific locations from large datasets is not a trivial task and typically requires advanced GIS and data management skills. In this study, we developed a software package, ClimateNA, that facilitates this task and provides a user-friendly interface suitable for resource managers and decision makers as well as scientists. The software locally downscales historical and future monthly climate data layers into scale-free point estimates of climate values for the entire North American continent. The software also calculates a large number of biologically relevant climate variables that are usually derived from daily weather data. ClimateNA covers 1) 104 years of historical data (1901-2014) in monthly, annual, decadal and 30-year time steps; 2) three paleoclimatic periods (Last Glacial Maximum, Mid Holocene and Last Millennium); 3) three future periods (2020s, 2050s and 2080s); and 4) annual time-series of model projections for 2011-2100. Multiple general circulation models (GCMs) were included for both paleo and future periods, and two representative concentration pathways (RCP4.5 and 8.5) were chosen for future climate data.	[Wang, Tongli] Univ British Columbia, Ctr Forest Conservat Genet, Dept Forest & Conservat Sci, 3041-2424 Main Mall, Vancouver, BC V6T 1Z4, Canada; [Hamann, Andreas] Univ Alberta, Dept Renewable Resources, 733 Gen Serv Bldg, Edmonton, AB T5H 4R1, Canada; [Spittlehouse, Dave] Minist Forests Lands & Nat Resources Operat Briti, Competitiveness & Innovat Branch, Victoria, BC V8W 9C2, Canada; [Carroll, Carlos] Klamath Ctr Conservat Res, 136 SW Washington Ave,Suite 202, Corvallis, OR 97333 USA	University of British Columbia; University of Alberta	Wang, TL (corresponding author), Univ British Columbia, Ctr Forest Conservat Genet, Dept Forest & Conservat Sci, 3041-2424 Main Mall, Vancouver, BC V6T 1Z4, Canada.	tongli.wang@ubc.ca	Wang, Tongli/AAC-8644-2020; Wang, Tongli/AAW-4427-2020	Wang, Tongli/0000-0002-9967-6769	Forest Genetic Council of British Columbia, Canada; Competitiveness and Innovation Branch of the Ministry of Forests, Lands and Natural Resources Operations of British Columbia, Canada	Forest Genetic Council of British Columbia, Canada; Competitiveness and Innovation Branch of the Ministry of Forests, Lands and Natural Resources Operations of British Columbia, Canada	Funding was received from the Forest Genetic Council of British Columbia, Canada, and from the Competitiveness and Innovation Branch of the Ministry of Forests, Lands and Natural Resources Operations of British Columbia, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Forest Genetic Council of British Columbia, Canada and Competitiveness and Innovation Branch, Ministry of Forests, Lands and Natural Resources Operations of British Columbia, Canada.	[Anonymous], 2014, SUMMARY POLICYMAKERS; Becker A, 2013, EARTH SYST SCI DATA, V5, P71, DOI 10.5194/essd-5-71-2013; Cortini F, 2012, FOREST ECOL MANAG, V277, P67, DOI 10.1016/j.foreco.2012.04.022; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; De La Torre AR, 2014, NEW PHYTOL, V201, P687, DOI 10.1111/nph.12540; EWRI ASCE, 2005, ASCE STANDARDIZED RE; Fitterer JL, 2013, ECOL APPL, V23, P888, DOI 10.1890/12-1225.1; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hamann A, 2015, GLOBAL CHANGE BIOL, V21, P997, DOI 10.1111/gcb.12736; Hargreaves GH, 2003, J IRRIG DRAIN ENG, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson MF, 1989, 895 CSIRO DIV WAT RE, V89, P95; Knutti R, 2013, GEOPHYS RES LETT, V40, P1194, DOI 10.1002/grl.50256; Liu Y, 2015, BIOGEOSCIENCES DISCU, V12, P14105; MacDonald RJ, 2014, CAN J FISH AQUAT SCI, V71, P189, DOI 10.1139/cjfas-2013-0221; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mosier TM, 2014, INT J CLIMATOL, V34, P2175, DOI 10.1002/joc.3829; Rehfeldt GE, 2001, CLIMATIC CHANGE, V50, P355, DOI 10.1023/A:1010614216256; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Shrestha RR, 2012, HYDROL PROCESS, V26, P1841, DOI 10.1002/hyp.9283; St Clair JB, 2013, EVOL APPL, V6, P933, DOI 10.1111/eva.12077; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wang TL, 2012, FOREST ECOL MANAG, V279, P128, DOI 10.1016/j.foreco.2012.05.034; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1	29	223	225	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156720	10.1371/journal.pone.0156720	http://dx.doi.org/10.1371/journal.pone.0156720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275583	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700033
J	Ameer, S; Gul, IH				Ameer, Shahid; Gul, Iftikhar Hussain			Influence of Reduced Graphene Oxide on Effective Absorption Bandwidth Shift of Hybrid Absorbers	PLOS ONE			English	Article							MICROWAVE-ABSORPTION; NANOPARTICLES; PERMEABILITY	The magnetic nanoparticle composite NiFe2O4 has traditionally been studied for high-frequency microwave absorption with marginal performance towards low-frequency radar bands (particularly L and S bands). Here, NiFe2O4 nanoparticles and nanohybrids using large-diameter graphene oxide (GO) sheets are prepared via solvothermal synthesis for low-frequency wide bandwidth shielding (L and S radar bands). The synthesized materials were characterized using XRD, SEM, FTIR and microwave magneto dielectric spectroscopy. The dimension of these solvothermally synthesized pristine particles and hybrids lies within 30-58 nm. Microwave magneto-dielectric spectroscopy was performed in the low-frequency region in the 1 MHz-3 GHz spectrum. The as-synthesized pristine nanoparticles and hybrids were found to be highly absorbing for microwaves throughout the L and S radar bands (<-10 dB from 1 MHz to 3 GHz). This excellent microwave absorbing property induced by graphene sheet coupling shows application of these materials with absorption bandwidth which is tailored such that these could be used for low frequency. Previously, these were used for high frequency absorptions (typically > 4 GHz) with limited selective bandwidth.	[Ameer, Shahid; Gul, Iftikhar Hussain] Natl Univ Sci & Technol, Sch Chem & Mat Engn, H-12, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Ameer, S (corresponding author), Natl Univ Sci & Technol, Sch Chem & Mat Engn, H-12, Islamabad, Pakistan.	shahidameer@scme.nust.edu.pk						Abbas SM, 2007, J MAGN MAGN MATER, V309, P20, DOI 10.1016/j.jmmm.2006.06.006; Bedre MD., 2012, AM J MAT SCI, V2, P39, DOI DOI 10.5923/J.MATERIALS.20120203.01; Chiou JW, 2012, J PHYS CHEM A; Fang JJ, 2013, J MATER SCI, V48, P8060, DOI 10.1007/s10853-013-7600-6; Fu YS, 2012, IND ENG CHEM RES, V51, P11700, DOI 10.1021/ie301347j; Fu YS, 2012, AICHE J, V58, P3298, DOI 10.1002/aic.13716; Gama AM, 2013, MATER RES-IBERO-AM J, V16, P997, DOI [10.1590/S1516-14392013000500006, 10.1590/S1516-14392013005000077]; Gu X, 2011, CHEM COMMUN, V47, P5337, DOI 10.1039/c0cc05800a; Huang NM, 2011, INT J NANOMED, V6, P3443, DOI 10.2147/IJN.S26812; Kaur R., 2014, INT J ENG RES TECHNO, V3, P160; Kavas H, 2009, CHEM PAP, V63, P450, DOI 10.2478/s11696-009-0034-6; Kooti M, 2013, J MATER SCI TECHNOL, V29, P34, DOI 10.1016/j.jmst.2012.11.016; Li XH, 2015, J MATER CHEM A, V3, P5535, DOI 10.1039/c4ta05718j; Liu PB, 2013, MATER LETT, V112, P117, DOI 10.1016/j.matlet.2013.08.126; Liu PJ, 2015, RSC ADV, V5, P93739, DOI 10.1039/c5ra18668d; MAGUIRE EA, 1976, J AM CERAM SOC, V59, P434, DOI 10.1111/j.1151-2916.1976.tb09512.x; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Micheli D, 2012, INT J MAT SCI, V2, P31; OLMEDO L, 1993, ADV MATER, V5, P373, DOI 10.1002/adma.19930050509; Pardavi-Horvath M, 2000, J MAGN MAGN MATER, V215, P171, DOI 10.1016/S0304-8853(00)00106-2; Petrov VM, 2001, INORG MATER, V37, P135; Qin F, 2012, J APPL PHYS, V111, DOI 10.1063/1.3688435; Qin F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3678192; Saville, 2005, REV RADAR ABSORBING; Sivakumar P, 2013, J ALLOY COMPD, V563, P6, DOI 10.1016/j.jallcom.2013.02.077; Soo YL, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3544059; Tyagi S, 2012, CERAM INT, V38, P4561, DOI 10.1016/j.ceramint.2012.02.034; Velmurugan K, 2010, MATER RES-IBERO-AM J, V13, P299, DOI 10.1590/S1516-14392010000300005; Vinoy K.J., 1996, RADAR ABSORBING MAT, DOI [10.1007/978-1-4613-0473-9, DOI 10.1007/978-1-4613-0473-9]; Wang C., 2012, APPL PHYS LETT, V100, DOI [DOI 10.1063/1/3678193, 10.1063/ 1.3678193, DOI 10.1063/1.3678193]; Wang ZZ, 2013, J MAGN MAGN MATER, V344, P101, DOI 10.1016/j.jmmm.2013.05.027; Xu HL, 2012, J APPL PHYS, V111, DOI 10.1063/1.3691527; Zhao HT, 2009, PHYSICA B, V404, P69, DOI 10.1016/j.physb.2008.10.006; Zivkovic I, 2012, MICROWAVE ABSORBING; Zong M, 2014, CERAM INT, V40, P6821, DOI 10.1016/j.ceramint.2013.11.145	35	18	18	5	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0153544	10.1371/journal.pone.0153544	http://dx.doi.org/10.1371/journal.pone.0153544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270944	Green Submitted, gold, Green Published			2022-12-27	WOS:000377561000001
J	Guido, N; Starostina, E; Leake, D; Saaem, I				Guido, Nicholas; Starostina, Elena; Leake, Devin; Saaem, Ishtiaq			Improved PCR Amplification of Broad Spectrum GC DNA Templates	PLOS ONE			English	Article							CHEMICAL-SYNTHESIS; GENE SYNTHESIS; HEMOPHILIA-A; BETAINE; ENHANCEMENT; REGIONS; MIXTURE; GENOME	Many applications in molecular biology can benefit from improved PCR amplification of DNA segments containing a wide range of GC content. Conventional PCR amplification of DNA sequences with regions of GC less than 30%, or higher than 70%, is complex due to secondary structures that block the DNA polymerase as well as mispriming and mis-annealing of the DNA. This complexity will often generate incomplete or nonspecific products that hamper downstream applications. In this study, we address multiplexed PCR amplification of DNA segments containing a wide range of GC content. In order to mitigate amplification complications due to high or low GC regions, we tested a combination of different PCR cycling conditions and chemical additives. To assess the fate of specific oligonucleotide ( oligo) species with varying GC content in a multiplexed PCR, we developed a novel method of sequence analysis. Here we show that subcycling during the amplification process significantly improved amplification of short template pools (similar to 200 bp), particularly when the template contained a low percent of GC. Furthermore, the combination of subcycling and 7-deaza-dGTP achieved efficient amplification of short templates ranging from 10-90% GC composition. Moreover, we found that 7-deaza-dGTP improved the amplification of longer products (similar to 1000 bp). These methods provide an updated approach for PCR amplification of DNA segments containing a broad range of GC content.	[Guido, Nicholas; Starostina, Elena; Leake, Devin; Saaem, Ishtiaq] Gen9 Inc, Res & Dev, Cambridge, MA USA		Saaem, I (corresponding author), Gen9 Inc, Res & Dev, Cambridge, MA USA.	isaaem@gen9bio.com			Gen9 Inc; DARPA grant [W911QX-13-C-0040]	Gen9 Inc; DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Gen9 employees' work was funded by Gen9 Inc and DARPA grant W911QX-13-C-0040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; Burbelo PD, 2010, AM J TRANSL RES, V2, P381; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chakrabarti R, 2001, NUCLEIC ACIDS RES, V29, P2377, DOI 10.1093/nar/29.11.2377; Chakrabarti R, 2001, GENE, V274, P293, DOI 10.1016/S0378-1119(01)00621-7; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; D'Souza GGM, 2007, PHARM RES-DORDR, V24, P228, DOI 10.1007/s11095-006-9150-y; Frackman S, 1998, BETAIN DMSO ENHANCIN, P27; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jacobson J, 2011, WIPO; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Kang J, 2005, J BIOCHEM BIOPH METH, V64, P147, DOI 10.1016/j.jbbm.2005.06.003; Kilian NL, 2006, THROMB HAEMOSTASIS, V95, P746, DOI 10.1160/TH05-09-0605; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Liu Q, 1998, BIOTECHNIQUES, V25, P1022, DOI 10.2144/98256rr01; Ma SY, 2012, TRENDS BIOTECHNOL, V30, P147, DOI 10.1016/j.tibtech.2011.10.002; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mantilla-Capacho JM, 2007, AM J HEMATOL, V82, P283, DOI 10.1002/ajh.20865; Musso M, 2006, J MOL DIAGN, V8, P544, DOI 10.2353/jmoldx.2006.060058; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Ragni MV, 2009, HAEMOPHILIA, V15, P1074, DOI 10.1111/j.1365-2516.2009.02058.x; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Saaem I, 2010, ACS APPL MATER INTER, V2, P491, DOI 10.1021/am900884b; Sahdev S, 2007, MOL CELL PROBE, V21, P303, DOI 10.1016/j.mcp.2007.03.004; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Stirling David, 2003, Methods Mol Biol, V226, P101; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266	34	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156478	10.1371/journal.pone.0156478	http://dx.doi.org/10.1371/journal.pone.0156478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271574	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000017
J	Ljungman, L; Boger, M; Ander, M; Ljotsson, B; Cernvall, M; von Essen, L; Hoven, E				Ljungman, Lisa; Boger, Marike; Ander, Malin; Ljotsson, Brjann; Cernvall, Martin; von Essen, Louise; Hoven, Emma			Impressions That Last: Particularly Negative and Positive Experiences Reported by Parents Five Years after the End of a Child's Successful Cancer Treatment or Death	PLOS ONE			English	Article							POSTTRAUMATIC STRESS SYMPTOMS; QUALITATIVE RESEARCH; SURVIVORS; GROWTH; CHALLENGES; SUPPORT; MOTHERS; IMPACT; GRIEF	Objective To describe the experience of parenting a child diagnosed with cancer by examining particularly negative and positive experiences reported by parents of childhood cancer survivors and parents of children lost to cancer. Methods 168 parents (88 mothers, 80 fathers) participated. Data were collected five years after the end of successful treatment or the child's death. The parents' experiences were identified by open-ended semi-structured questions about particularly negative and positive experiences of the child's cancer. An inductive approach was used in which the manifest verbal content of the answers was analysed using content analysis. Results The analysis revealed eight categories of negative experience (child late effects; distressing events; healthcare; impaired relationships; long-term psychological consequences; own reactions; surrounding institutions; the fact that the child got cancer) and seven categories of positive experience (healthcare; improved relationships; long-term consequences for the child; personal development; support systems; treatment outcome; unexpected joy). The categories were related to past events or to the present situation. The findings indicate variations in experiences between parents of survivors and bereaved parents, and between fathers and mothers, as some experiences were only reported by parents of survivors and some experiences were only reported by mothers. Conclusions The results highlight the importance of past and present events to parents, and accordingly the long-lasting impact of paediatric cancer on parents. The results also point to the wide range of negative as well as positive experiences involved in parenting a child diagnosed with cancer, and provide a comprehensive understanding of the overall experience for parents of children with cancer. Specifically, the findings give guidance to healthcare providers by illustrating the need to provide healthcare personnel with continuous training in communication skills, offering parents opportunities to meet other parents in the same situation and increasing the access to psychosocial supportive services and psychological care.	[Ljungman, Lisa; Boger, Marike; Ander, Malin; Cernvall, Martin; von Essen, Louise; Hoven, Emma] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden; [Ljotsson, Brjann] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Ljungman, L (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Psychol Healthcare, Uppsala, Sweden.	lisa.ljungman@pubcare.uu.se		Ljungman, Lisa/0000-0002-4512-8900; Hoven, Emma/0000-0001-9335-9714	Swedish Research Council [K2008-70X-20836-01- 3, K2011-70X-20836-04-4]; Swedish Cancer Society [2007/1015, 2010/726]; Swedish Childhood Cancer Foundation [PROJ08/010]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission)	Support was provided by The Swedish Research Council (grant numbers K2008-70X-20836-01- 3, K2011-70X-20836-04-4, LvE) [http://www.vr.se/ inenglish.4.12fff4451215cbd83e4800015152.html]; The Swedish Cancer Society (grant numbers 2007/1015, 2010/726, LvE) [https://www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society]; The Swedish Childhood Cancer Foundation (grant numbers PROJ08/010, LvE) [http://www. barncancerfonden.se/in-english/about-us/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by grants from the Swedish Research Council (grant numbers K2008-70X-20836-01-3, K2011-70X-20836-04-4, PI Louise von Essen), the Swedish Cancer Society (grant numbers 2007/1015, 2010/726, PI Louise von Essen) and the Swedish Childhood Cancer Foundation (grant numbers PROJ08/010, PI Louise von Essen). We gratefully acknowledge all the parents who participated in this study, the coordinating nurses at the paediatric oncology centres, research assistant Susanne Lorenz and Ulrika Poder, PhD, for their excellent work in terms of the collection and management of data.	Aho AL, 2009, AM J MENS HEALTH, V3, P93, DOI 10.1177/1557988307302094; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058; Bruce M, 2006, CLIN PSYCHOL REV, V26, P233, DOI 10.1016/j.cpr.2005.10.002; Bryant Rosalind, 2003, J Pediatr Nurs, V18, P113, DOI 10.1053/jpdn.2003.11; Chesler MA, 2001, QUAL HEALTH RES, V11, P363, DOI 10.1177/104973201129119163; Engelkemeyer SM, 2008, J TRAUMA STRESS, V21, P344, DOI 10.1002/jts.20338; Forinder U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126905; Forsey M, 2013, PSYCHO-ONCOLOGY, V22, P260, DOI 10.1002/pon.2084; Gibbins J, 2012, J PEDIATR ONCOL NURS, V29, P253, DOI 10.1177/1043454212452791; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gustafsson G., 2013, CHILDHOOD CANC INCID; Hungerbuehler I, 2011, J HEALTH PSYCHOL, V16, P1259, DOI 10.1177/1359105311405872; Kolb B., 2009, FUNDAMENTALS HUMAN N, V6th Edn; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Kreicbergs UC, 2007, J CLIN ONCOL, V25, P3307, DOI 10.1200/JCO.2006.10.0743; Ljungman L, 2015, PSYCHO-ONCOLOGY, V24, P1792, DOI 10.1002/pon.3856; Ljungman L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103340; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; McCarthy MC, 2012, J TRAUMA STRESS, V25, P558, DOI 10.1002/jts.21745; McCarthy MC, 2010, J PALLIAT MED, V13, P1321, DOI 10.1089/jpm.2010.0037; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meert KL, 2010, ARCH PEDIAT ADOL MED, V164, P1045, DOI 10.1001/archpediatrics.2010.187; Michel G, 2010, CHILD CARE HLTH DEV, V36, P123, DOI 10.1111/j.1365-2214.2009.01034.x; Norberg AL, 2008, ACTA ONCOL, V47, P267, DOI 10.1080/02841860701558773; Norris RE, 2012, NAT REV CANCER, V12, P776, DOI 10.1038/nrc3370; Patterson JM, 2004, PSYCHO-ONCOLOGY, V13, P390, DOI 10.1002/pon.761; Poder U, 2008, PSYCHO-ONCOLOGY, V17, P430, DOI 10.1002/pon.1263; Quin S, 2004, SOC WORK HEALTH CARE, V39, P129, DOI 10.1300/J010v39n01_09; Rosenberg AR, 2013, J PALLIAT MED, V16, P645, DOI 10.1089/jpm.2012.0494; Rosenberg AR, 2012, PEDIATR BLOOD CANCER, V58, P503, DOI 10.1002/pbc.23386; Steele AC, 2013, J PEDIAT HEMATOL ONC, V35, P253, DOI 10.1097/MPH.0b013e31828afe05; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vrijmoet-Wiersma CMJ, 2008, J PEDIATR PSYCHOL, V33, P694, DOI 10.1093/jpepsy/jsn007; Wakefield CE, 2011, PEDIATR BLOOD CANCER, V56, P524, DOI 10.1002/pbc.22725	37	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157076	10.1371/journal.pone.0157076	http://dx.doi.org/10.1371/journal.pone.0157076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272318	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000061
J	Muller, C; Schillert, A; Roethemeier, C; Tregouet, DA; Proust, C; Binder, H; Pfeiffer, N; Beutel, M; Lackner, KJ; Schnabel, RB; Tiret, L; Wild, PS; Blankenberg, S; Zeller, T; Ziegler, A				Mueller, Christian; Schillert, Arne; Roethemeier, Caroline; Tregouet, David-Alexandre; Proust, Carole; Binder, Harald; Pfeiffer, Norbert; Beutel, Manfred; Lackner, Karl J.; Schnabel, Renate B.; Tiret, Laurence; Wild, Philipp S.; Blankenberg, Stefan; Zeller, Tanja; Ziegler, Andreas			Removing Batch Effects from Longitudinal Gene Expression - Quantile Normalization Plus ComBat as Best Approach for Microarray Transcriptome Data	PLOS ONE			English	Article							UNWANTED VARIATION; AFFYMETRIX; REGRESSION; CORRECT; IMPACT	Technical variation plays an important role in microarray-based gene expression studies, and batch effects explain a large proportion of this noise. It is therefore mandatory to eliminate technical variation while maintaining biological variability. Several strategies have been proposed for the removal of batch effects, although they have not been evaluated in large-scale longitudinal gene expression data. In this study, we aimed at identifying a suitable method for batch effect removal in a large study of microarray-based longitudinal gene expression. Monocytic gene expression was measured in 1092 participants of the Gutenberg Health Study at baseline and 5-year follow up. Replicates of selected samples were measured at both time points to identify technical variability. Deming regression, Passing-Bablok regression, linear mixed models, non-linear models as well as ReplicateRUV and ComBat were applied to eliminate batch effects between replicates. In a second step, quantile normalization prior to batch effect correction was performed for each method. Technical variation between batches was evaluated by principal component analysis. Associations between body mass index and transcriptomes were calculated before and after batch removal. Results from association analyses were compared to evaluate maintenance of biological variability. Quantile normalization, separately performed in each batch, combined with ComBat successfully reduced batch effects and maintained biological variability. ReplicateRUV performed perfectly in the replicate data subset of the study, but failed when applied to all samples. All other methods did not substantially reduce batch effects in the replicate data subset. Quantile normalization plus ComBat appears to be a valuable approach for batch correction in longitudinal gene expression data.	[Mueller, Christian; Roethemeier, Caroline; Schnabel, Renate B.; Blankenberg, Stefan; Zeller, Tanja] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, D-20246 Hamburg, Germany; [Mueller, Christian; Schillert, Arne; Ziegler, Andreas] Univ Med Ctr Schleswig Holstein, Inst Med Biometry & Stat, Campus Luebeck, D-23562 Lubeck, Germany; [Mueller, Christian; Schillert, Arne; Schnabel, Renate B.; Blankenberg, Stefan; Zeller, Tanja; Ziegler, Andreas] German Ctr Cardiovasc Res DZHK eV, Partner Site Hamburg, D-20246 Kiel, Germany; [Tregouet, David-Alexandre; Proust, Carole; Tiret, Laurence] Univ Paris 06, INSERM, Unite Mixte Rech UMR enSante 1166, F-75013 Paris, France; [Tregouet, David-Alexandre; Proust, Carole; Tiret, Laurence] ICAN, F-75013 Paris, France; [Tregouet, David-Alexandre; Proust, Carole; Tiret, Laurence] Univ Paris 06, Sorbonne Univ, UMR S1166, Team Genom & Pathophysiol Cardiovasc Dis, F-75013 Paris, France; [Binder, Harald] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, D-55131 Mainz, Germany; [Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Expt Ophthalmol, Dept Ophthalmol, D-55131 Mainz, Germany; [Beutel, Manfred] Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, Univ Med Ctr, D-55122 Mainz, Germany; [Lackner, Karl J.] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr Mainz, Ctr Cardiol, Prevent Cardiol & Prevent Med, D-55131 Mainz, Germany; [Wild, Philipp S.] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, D-55131 Mainz, Germany; [Wild, Philipp S.] German Ctr Cardiovasc Res DZHK eV, Partner Site Rhine Main, D-55131 Mainz, Germany; [Ziegler, Andreas] Med Univ Lubeck, Ctr Clin Trials, D-23562 Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; University of Lubeck	Ziegler, A (corresponding author), Univ Med Ctr Schleswig Holstein, Inst Med Biometry & Stat, Campus Luebeck, D-23562 Lubeck, Germany.; Ziegler, A (corresponding author), German Ctr Cardiovasc Res DZHK eV, Partner Site Hamburg, D-20246 Kiel, Germany.; Ziegler, A (corresponding author), Med Univ Lubeck, Ctr Clin Trials, D-23562 Lubeck, Germany.	t.zeller@uke.de; ziegler@imbs.uni-luebeck.de	Trégouët, David-Alexandre/P-9210-2019; Schnabel, Renate B/ABE-6668-2021; Tregouet, David-Alexandre/E-3961-2016; Wild, Philipp S./M-2106-2019; Pfeiffer, Norbert/AAO-7586-2020; Binder, Harald/C-7413-2009; Ziegler, Andreas/G-4246-2012	Trégouët, David-Alexandre/0000-0001-9084-7800; Schnabel, Renate B/0000-0001-7170-9509; Binder, Harald/0000-0002-5666-8662; Muller, Christian/0000-0002-9449-6865; Zeller, Tanja/0000-0003-3379-2641; Wild, Philipp/0000-0003-4413-9752; Ziegler, Andreas/0000-0002-8386-5397	Gutenberg Health Study through the government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation") [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; BMBF (German federal ministry of education and research) [01ZX1408A]	Gutenberg Health Study through the government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation"); Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; BMBF (German federal ministry of education and research)(Federal Ministry of Education & Research (BMBF))	The Gutenberg Health Study is funded through the government of Rhineland-Palatinate ("Stiftung Rheinland-Pfalz fur Innovation", contract AZ 961-386261/733), the research programs "Wissenschafft Zukunft" and "Center for Translational Vascular Biology (CTVB)" of the Johannes Gutenberg-University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including an unrestricted grant for the Gutenberg Health Study. PSW, SB, TZ and AZ are PIs of the German Center for Cardiovascular Research (DZHK). The project was further supported by the BMBF (German federal ministry of education and research) grant no.01ZX1408A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chmielewski S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113318; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Jacob L, 2016, BIOSTATISTICS, V17, P16, DOI 10.1093/biostatistics/kxv026; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kitchen RR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-134; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; Martin RF, 2000, CLIN CHEM, V46, P100; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Ramasamy A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt069; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Sun ZF, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-84; Turnbull AK, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-35; Viljoen KS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-14; Walker WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-494; Workman C, 2002, GENOME BIOL, V3; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	28	58	59	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156594	10.1371/journal.pone.0156594	http://dx.doi.org/10.1371/journal.pone.0156594			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272489	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000021
J	Nazarbahjat, N; Kadir, FA; Ariffin, A; Abdulla, MA; Abdullah, Z; Yehye, WA				Nazarbahjat, Nafal; Kadir, Farkaad A.; Ariffin, Azhar; Abdulla, Mahmood A.; Abdullah, Zanariah; Yehye, Wageeh A.			Antioxidant Properties and Gastroprotective Effects of 2-(Ethylthio)Benzohydrazones on Ethanol-Induced Acute Gastric Mucosal Lesions in Rats	PLOS ONE			English	Article							LEAF EXTRACT; ULCER; INJURY; PATHOGENESIS; OMEPRAZOLE; STRESS; LANSOPRAZOLE; GASTROPATHY; INHIBITORS; INDUCTION	A series of new 2-(ethylthio)benzohydrazone derivatives (1-6) were prepared and characterised by IR, 1H NMR, and 13C NMR spectroscopy and mass spectrometry. The newly prepared compounds were screened for their in vitro antioxidant activities using free radical scavenging 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assays. Among them, most powerful antioxidant, compound 1 has been selected in order to illustrate anti-ulcer effect on ethanol-induced gastric mucosal lesions in rats. Four groups of Sprague Dawley rats were respectively treated with 10% Tween 20 as ulcer control group, 20 mg/kg omeprazole as reference group, 50 mg/kg and 100 mg/kg compound 1 as experimental animals. Macroscopically, ulcer control group showed extensive hemorrhagic lesions of gastric mucosa compared with omeprazole or compound 1. Rats pre-treated with compound 1 showed increased in gastric pH and gastric mucus. Histologically, ulcer control group showed severe damage to gastric mucosa with edema and leucocytes infiltration of submucosal layer. In immunohistochemical analysis, rats which were pre-treated with compound 1 showed up-regulation of HSP70 and down-regulation of Bax proteins. In conclusion, the gastroprotective effect of compound 1 may be due to its antioxidant activity, and/or due to up-regulation of HSP70 and down-regulation of Bax protein in stained tissue section.	[Nazarbahjat, Nafal; Ariffin, Azhar; Abdullah, Zanariah] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Kadir, Farkaad A.] Int Med Univ, Fac Med, Div Human Biol, Kuala Lumpur 57000, Malaysia; [Abdulla, Mahmood A.] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Yehye, Wageeh A.] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Block 3A,Inst Postgrad Studies Bldg, Kuala Lumpur, Malaysia	Universiti Malaya; International Medical University Malaysia; Universiti Malaya; Universiti Malaya	Ariffin, A (corresponding author), Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia.; Kadir, FA (corresponding author), Int Med Univ, Fac Med, Div Human Biol, Kuala Lumpur 57000, Malaysia.	faalhadi@yahoo.com; azhar70@um.edu.my	ARIFFIN, AZHAR/B-5353-2010; Musa, Ilina Syazwani/P-7977-2016; Yehye, Wageeh/I-9135-2012; Kashmola, Nafal/AAT-4411-2020	ARIFFIN, AZHAR/0000-0002-3626-8901; Musa, Ilina Syazwani/0000-0001-9095-4083; Abdulqader, Farqad/0000-0002-0574-7723; yehye, wageeh/0000-0003-1543-9887	University of Malaya Research Grant UMRG [RG149-11AFR, RPO43A-15HTM];  [PG033-2012B]	University of Malaya Research Grant UMRG; 	This work was supported by: 1. University of Malaya Research Grant UMRG (RG149-11AFR); 2. University of Malaya Research Grant UMRG (RPO43A-15HTM); 3. Postgraduate graduate research grant (PG033-2012B); http://umresearch.um.edu.my/mainpage.php?module=Maklumat&kategori=86&id=63&papar=1.	Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002; AlRashdi AS, 2012, EVIDENCE BASED COMPL, V2012; Alrdahe S.S., 2010, WORLD ACAD SCI ENG T, V43, P883; [Anonymous], 1996, GUIDE CARE USE LAB A; Bardi D. A. A., 2011, Scientific Research and Essays, V6, P3232; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Cheng HC, 2005, DIGEST DIS SCI, V50, P1194, DOI 10.1007/s10620-005-2759-6; Cheng LX, 2010, BIOORG MED CHEM LETT, V20, P2417, DOI 10.1016/j.bmcl.2010.03.039; de Heer MI, 1999, J ORG CHEM, V64, P6969, DOI 10.1021/jo9901485; Despaigne AAR, 2009, POLYHEDRON, V28, P3797, DOI 10.1016/j.poly.2009.07.059; Devaraj VC, 2011, SAUDI PHARM J, V19, P171, DOI 10.1016/j.jsps.2011.03.003; Dhuley J. N., 1999, Indian Journal of Pharmacology, V31, P128; El-Sayed NA, 2010, EUR J MED CHEM, V45, P3147, DOI 10.1016/j.ejmech.2010.04.005; Gerhauser C, 2003, MUTAT RES-FUND MOL M, V523, P163, DOI 10.1016/S0027-5107(02)00332-9; Ghosh R, 2007, INDIAN J PHARMACOL, V39, P214, DOI 10.4103/0253-7613.36544; Goel R. K., 2002, Indian Journal of Pharmacology, V34, P100; Gorinstein S, 2003, J NUTR BIOCHEM, V14, P154, DOI 10.1016/S0955-2863(02)00278-4; Hajrezaie M, 2012, ACUTE TOXICITY GASTR, DOI [10.1371/journal.pone.0051537, DOI 10.1371/JOURNAL.PONE.0051537]; Hajrezaie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121529; Ismail IF, 2012, EVIDENCE BASED COMPL, V2012; Jainu Mallika, 2006, Indian J Med Res, V123, P799; Karadag A, 2009, FOOD ANAL METHOD, V2, P41, DOI 10.1007/s12161-008-9067-7; Karthikeyan MS, 2006, BIOORGAN MED CHEM, V14, P7482, DOI 10.1016/j.bmc.2006.07.015; Ketuly KA, 2011, J MED PLANTS RES, V5, P514; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Konturek PC, 1999, J PHYSIOL PHARMACOL, V50, P211; Kwiecien S, 2012, J PHYSIOL PHARMACOL, V63, P143; Lapenna D, 1996, FEBS LETT, V382, P189, DOI 10.1016/0014-5793(96)00155-X; Lee W-L, 2013, OXIDATIVE MED CELLUL, V2013; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mahmood A. A., 2011, Scientific Research and Essays, V6, P2306; Maity P, 2003, MOL CELL BIOCHEM, V253, P329, DOI 10.1023/A:1026040723669; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Mikami KI, 2006, J GASTROEN HEPATOL, V21, P1669, DOI 10.1111/j.1440-1746.2006.04328.x; MOZSIK G, 1988, DIGEST DIS SCI, V33, P92, DOI 10.1007/BF01536637; Mughrabi FF, 2010, INT C SCI SOC RES CS; MURALIDHARAN P, 2009, J SCI RES, V1, P345, DOI DOI 10.3329/JSR.V1I2.1625; Nakamura T, 2014, EVIDENCE BASED COMPL, V2014; Nazarbahjat N, 2014, MOLECULES, V19, P11520, DOI 10.3390/molecules190811520; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; Sairam K., 2001, Indian Journal of Experimental Biology, V39, P137; Sathish D, 2011, CURR DRUG DELIV, V8, P494, DOI 10.2174/156720111796642273; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Sidahmed HMA, 2013, PHYTOMEDICINE, V20, P834, DOI 10.1016/j.phymed.2013.03.002; Sidahmed HMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121060; Sidahmed HMA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-183; Singh KD, 2015, ASIAN J PHARM CLIN R, V8; Susan G, 1999, INDIAN J PHARM, V31, P431; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Umamaheswari M, 2007, J ETHNOPHARMACOL, V110, P464, DOI 10.1016/j.jep.2006.10.017; Wasman SQ, 2010, J MED PLANTS RES, V4, P2658; Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u; Yehye WA, 2015, EUR J MED CHEM, V101, P295, DOI 10.1016/j.ejmech.2015.06.026; Zhang LY, 2011, BIOORG MED CHEM LETT, V21, P5722, DOI 10.1016/j.bmcl.2011.08.018	58	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156022	10.1371/journal.pone.0156022	http://dx.doi.org/10.1371/journal.pone.0156022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272221	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000006
J	Reinhart, JM; Motsinger-Reif, A; Dickey, A; Yale, S; Trepanier, LA				Reinhart, Jennifer M.; Motsinger-Reif, Alison; Dickey, Allison; Yale, Steven; Trepanier, Lauren A.			Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide Antimicrobials	PLOS ONE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; TOXIC EPIDERMAL NECROLYSIS; ADVERSE DRUG-REACTIONS; SULFAMETHOXAZOLE-INDUCED HYPERSENSITIVITY; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ENZYME GENE POLYMORPHISMS; STEVENS-JOHNSON-SYNDROME; HIV-INFECTED PATIENTS; INDUCED LIVER-INJURY; TRIMETHOPRIM-SULFAMETHOXAZOLE	Background Hypersensitivity (HS) reactions to sulfonamide antibiotics occur uncommonly, but with potentially severe clinical manifestations. A familial predisposition to sulfonamide HS is suspected, but robust predictive genetic risk factors have yet to be identified. Strongly linked genetic polymorphisms have been used clinically as screening tests for other HS reactions prior to administration of high-risk drugs. Objective The purpose of this study was to evaluate for genetic risk of sulfonamide HS in the immunocompetent population using genome-wide association. Methods Ninety-one patients with symptoms after trimethoprim-sulfamethoxazole (TMP-SMX) attributable to "probable" drug HS based on medical record review and the Naranjo Adverse Drug Reaction Probability Scale, and 184 age-and sex-matched patients who tolerated a therapeutic course of TMP-SMX, were included in a genome-wide association study using both common and rare variant techniques. Additionally, two subgroups of HS patients with a more refined clinical phenotype (fever and rash; or fever, rash and eosinophilia) were evaluated separately. Results For the full dataset, no single nucleotide polymorphisms were suggestive of or reached genome-wide significance in the common variant analysis, nor was any genetic locus significant in the rare variant analysis. A single, possible gene locus association (COL12A1) was identified in the rare variant analysis for patients with both fever and rash, but the sample size was very small in this subgroup (n = 16), and this may be a false positive finding. No other significant associations were found for the subgroups. Conclusions No convincing genetic risk factors for sulfonamide HS were identified in this population. These negative findings may be due to challenges in accurately confirming the phenotype in exanthematous drug eruptions, or to unidentified gene-environment interactions influencing sulfonamide HS.	[Reinhart, Jennifer M.; Trepanier, Lauren A.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Motsinger-Reif, Alison; Dickey, Allison] N Carolina State Univ, Dept Stat, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Yale, Steven] Marshfield Clin Res Fdn, Marshfield, WI USA; [Yale, Steven] North Florida Reg Med Ctr, Gainesville, FL USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; North Carolina State University	Trepanier, LA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.	lauren.trepanier@wisc.edu	Motsinger-Reif, Alison/I-4167-2018	Motsinger-Reif, Alison/0000-0003-1346-2493; Reinhart, Jennifer/0000-0002-3021-5075	NIH [R01 GM100784, T32 OD010423]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by NIH R01 GM100784 [http://www.nih.gov] and NIH T32 OD010423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfirevic A, 2009, PHARMACOGENOMICS, V10, P531, DOI 10.2217/PGS.09.6; [Anonymous], 2008, ZIAG; Ates NA, 2004, ARCH DERMATOL RES, V295, P429, DOI 10.1007/s00403-003-0446-z; Avgeri SG, 2009, INT J ANTIMICROB AG, V33, P394, DOI 10.1016/j.ijantimicag.2008.09.010; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Bousquet PJ, 2008, CURR PHARM DESIGN, V14, P2792, DOI 10.2174/138161208786369731; CARR A, 1993, J INFECT DIS, V167, P180, DOI 10.1093/infdis/167.1.180; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cribb AE, 1996, ADVERSE DRUG REACT T, V15, P9; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Del-Aguila JL, 2014, PHARMACOGENOMICS J, V14, P35, DOI 10.1038/tpj.2013.3; DELOMENIE C, 1994, BRIT J CLIN PHARMACO, V38, P581, DOI 10.1111/j.1365-2125.1994.tb04401.x; Drekonja DM, 2008, PRIMARY CARE, V35, P345, DOI 10.1016/j.pop.2008.01.001; Drekonja DM, 2009, DIAGN MICR INFEC DIS, V63, P201, DOI 10.1016/j.diagmicrobio.2008.10.001; Eliaszewicz M, 2002, J AM ACAD DERMATOL, V47, P40, DOI 10.1067/mjd.2002.120468; Gill HJ, 1999, PHARMACOGENETICS, V9, P43, DOI 10.1097/00008571-199902000-00007; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; GRUCHALLA RS, 1991, J ALLERGY CLIN IMMUN, V88, P784, DOI 10.1016/0091-6749(91)90186-R; Gupta D, 2008, JCR-J CLIN RHEUMATOL, V14, P267, DOI 10.1097/RHU.0b013e31817a7e30; HARLE DG, 1988, MOL IMMUNOL, V25, P1347, DOI 10.1016/0161-5890(88)90050-8; HENNESSY S, 1995, J GEN INTERN MED, V10, P380, DOI 10.1007/BF02599836; Hicks D, 2014, HUM MOL GENET, V23, P2353, DOI 10.1093/hmg/ddt637; Hubiche T, 2011, DERMATOLOGY, V222, P140, DOI 10.1159/000324506; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Kardaun SH, 2013, BRIT J DERMATOL, V169, P1071, DOI 10.1111/bjd.12501; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Korbila IP, 2009, CAN FAM PHYSICIAN, V55, P60; LANCASTER HO, 1961, AUST J STAT, V3, P20, DOI 10.1111/j.1467-842X.1961.tb00058.x; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lucena MI, 2011, GASTROENTEROLOGY, V141, P338, DOI 10.1053/j.gastro.2011.04.001; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; McCarty Gale A, 2005, AMIA Annu Symp Proc, P1049; MEDINA I, 1990, NEW ENGL J MED, V323, P776, DOI 10.1056/NEJM199009203231202; Mohanasundaram J, 1998, J Indian Med Assoc, V96, P21; Mooney MA, 2014, TRENDS GENET, V30, P390, DOI 10.1016/j.tig.2014.07.004; Morelli JG, 1999, J PEDIATR-US, V134, P365, DOI 10.1016/S0022-3476(99)70472-5; Morimoto T, 2006, INTERNAL MED, V45, P101, DOI 10.2169/internalmedicine.45.1352; Motsinger-Reif AA, 2013, PHARMACOGENET GENOM, V23, P383, DOI 10.1097/FPC.0b013e32833d7b45; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Nelson MR, 2009, PHARMACOGENOMICS J, V9, P23, DOI 10.1038/tpj.2008.4; Neuman MG, 2013, TRANSL RES, V161, P430, DOI 10.1016/j.trsl.2012.12.012; Neuman MG, 2000, CLIN BIOCHEM, V33, P517, DOI 10.1016/S0009-9120(00)00146-6; ORTIZ JE, 1982, ANN PLAS SURG, V9, P249, DOI 10.1097/00000637-198209000-00011; Ozkaya-Bayazit E, 2001, J AM ACAD DERMATOL, V45, P712, DOI 10.1067/mjd.2001.117854; Patel RM, 2008, INDIAN J DERMATOL VE, V74, DOI 10.4103/0378-6323.42883; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Pirmohamed M, 2000, PHARMACOGENETICS, V10, P705, DOI 10.1097/00008571-200011000-00005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Putnam PP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-369; Quiralte J, 1999, J ALLERGY CLIN IMMUN, V103, P685, DOI 10.1016/S0091-6749(99)70243-5; Rabaud C, 2001, SCAND J INFECT DIS, V33, P759, DOI 10.1080/003655401317074581; Reilly TP, 1998, BIOCHEM PHARMACOL, V55, P803, DOI 10.1016/S0006-2952(97)00547-9; RIEDER MJ, 1989, ANN INTERN MED, V110, P286, DOI 10.7326/0003-4819-110-4-286; Rizzo R, 2010, BREAST CANCER RES TR, V124, P593, DOI 10.1007/s10549-010-1034-5; Rodriguez M, 2004, CLIN INFECT DIS, V38, pE76, DOI 10.1086/383150; Ryan C, 1998, WMJ, V97, P23; Sacco JC, 2012, PHARMACOGENET GENOM, V22, P733, DOI 10.1097/FPC.0b013e328357a735; Saka B, 2010, Med Trop (Mars), V70, P255; Seger RA, 2008, BRIT J HAEMATOL, V140, P255, DOI 10.1111/j.1365-2141.2007.06880.x; SHEAR NH, 1986, ANN INTERN MED, V105, P179, DOI 10.7326/0003-4819-105-2-179; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Thomas M, 2009, SCAND J INFECT DIS, V41, P862, DOI 10.3109/00365540903214256; Walmsley SL, 1998, J ACQ IMMUN DEF SYND, V19, P498, DOI 10.1097/00042560-199812150-00009; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang D, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-32; Westphal GA, 2000, INT ARCH OCC ENV HEA, V73, P384, DOI 10.1007/s004200000159; Wolkenstein P, 2005, J INVEST DERMATOL, V125, P1080, DOI 10.1111/j.0022-202X.2005.23939.x; WOLKENSTEIN P, 1995, PHARMACOGENETICS, V5, P255, DOI 10.1097/00008571-199508000-00011; WOLKENSTEIN P, 1995, ARCH DERMATOL, V131, P544, DOI 10.1001/archderm.131.5.544; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xu J, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0331-3; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zielinska E, 1998, EUR J CLIN PHARMACOL, V54, P779, DOI 10.1007/s002280050551	79	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156000	10.1371/journal.pone.0156000	http://dx.doi.org/10.1371/journal.pone.0156000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272151	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000005
J	Cui, LL; Sheng, Y; Sun, M; Hu, JM; Qin, YY; Chen, ZJ				Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang			Chronic Pelvic Inflammation Diminished Ovarian Reserve as Indicated by Serum Anti Mulerrian Hormone	PLOS ONE			English	Article							MULLERIAN HORMONE; ANTRAL FOLLICLES; WOMEN; RESISTANCE; OBESITY	Objective To explore the potential damaging effect of chronic pelvic inflammation on ovarian reserve. Design Case-control study. Patients A total of 122 women with bilateral tubal occlusion, diagnosed by hysterosalipingography (HSG) and 217 women with normal fallopians were recruited. Measurements Serum anti-Mullerian hormone (AMH), basic follicle-stimulating hormone (FSH), luteining hormone (LH), estradiol (E-2), and testosterone (T) were measured; and antral follicle counts (AFCs) were recorded. Results Significantly lower level of AMH was observed in women with bilateral tubal occlusion compared to control group [2.62 (2.95) ng/ml vs. 3.37 (3.11) ng/ml, P = 0.03], and the difference remained after adjustment of BMI (P-adjust = 0.04). However, no statistical difference was found in the levels of FSH [7.00 (2.16) IU/L vs. 6.74 (2.30) IU/L], LH [4.18 (1.52) IU/L vs. 4.63 (2.52) IU/L], E-2 [35.95 (20.40) pg/ml vs. 34.90 (17.85) pg/ml], T [25.07 +/- 11.46 ng/dl vs. 24.84 +/- 12.75 ng/dl], and AFC [6.00 (4.00) vs. 7.00 (4.00)] between two groups (p>0.05). Conclusions Women with bilateral tubal occlusion showed decreased AMH level, suggesting that chronic pelvic inflammation may diminish ovarian reserve. More caution should be paid when evaluating the detriment of PID on female fertility.	[Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250001, Peoples R China; [Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan 250001, Peoples R China; [Cui, Linlin; Sheng, Yan; Sun, Mei; Hu, Jingmei; Qin, Yingying; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250001, Peoples R China; [Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200000, Peoples R China; [Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200000, Peoples R China	Shandong University; Shanghai Jiao Tong University	Qin, YY; Chen, ZJ (corresponding author), Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250001, Peoples R China.; Qin, YY; Chen, ZJ (corresponding author), Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China.; Qin, YY; Chen, ZJ (corresponding author), Shandong Prov Key Lab Reprod Med, Jinan 250001, Peoples R China.; Qin, YY; Chen, ZJ (corresponding author), Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250001, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200000, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200000, Peoples R China.	qyy106@yahoo.com; chenzijiang@hotmail.com	Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022; Li, Yuan/GXV-1310-2022	Chen, Zi-Jiang/0000-0001-6637-6631	National Natural Science Foundation of China [81501223]; Scientific Research Foundation of Shandong Province of Outstanding Young Scientist [BS2014YY013]; National Basic Research Program of China (973 Program) [2012CB944700]; State Key Program of National Natural Science Foundation of China [81430029]; Science research foundation item of no-earnings health vocation [201402004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Shandong Province of Outstanding Young Scientist; National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science research foundation item of no-earnings health vocation	This research was supported by National Natural Science Foundation of China (81501223), the Scientific Research Foundation of Shandong Province of Outstanding Young Scientist (BS2014YY013), National Basic Research Program of China (973 Program) (2012CB944700), the State Key Program of National Natural Science Foundation of China (81430029), and Science research foundation item of no-earnings health vocation (201402004).	Borodin Iu I., 1991, ARKH ANAT GISTOL EMB, V100, P37; Chen MJ, 2008, HUM REPROD, V23, P952, DOI 10.1093/humrep/den015; de Souza FHC, 2015, CLIN EXP RHEUMATOL, V33, P44; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Du BT, 2006, FERTIL STERIL, V85, P366, DOI 10.1016/j.fertnstert.2005.07.1316; El-Halawaty S, 2011, GYNECOL ENDOCRINOL, V27, P401, DOI 10.3109/09513590.2010.495433; Freeman EW, 2007, FERTIL STERIL, V87, P101, DOI 10.1016/j.fertnstert.2006.05.074; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Kiraly O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004901; Lin RH, 2015, ONCOTARGET, V6, P2856, DOI 10.18632/oncotarget.3091; Nteeba J, 2013, MOL REPROD DEV, V80, P948, DOI 10.1002/mrd.22231; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Roth Z, 2013, J DAIRY SCI, V96, P6499, DOI 10.3168/jds.2013-6903; Senates Ebubekir, 2013, J Crohns Colitis, V7, pe29, DOI 10.1016/j.crohns.2012.03.003; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Skalba P, 2011, EUR J OBSTET GYN R B, V158, P254, DOI 10.1016/j.ejogrb.2011.06.006; Zhao WH, 2014, GYNECOL OBSTET INVES, V77, P169, DOI 10.1159/000358393	19	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156130	10.1371/journal.pone.0156130	http://dx.doi.org/10.1371/journal.pone.0156130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27272680	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200006
J	Palko, JR; Morris, HJ; Pan, XL; Harman, CD; Koehl, KL; Gelatt, KN; Plummer, CE; Komaromy, AM; Liu, J				Palko, Joel R.; Morris, Hugh J.; Pan, Xueliang; Harman, Christine D.; Koehl, Kristin L.; Gelatt, Kirk N.; Plummer, Caryn E.; Komaromy, Andras M.; Liu, Jun			Influence of Age on Ocular Biomechanical Properties in a Canine Glaucoma Model with ADAMTS10 Mutation	PLOS ONE			English	Article							NERVE HEAD BIOMECHANICS; UVEOSCLERAL OUTFLOW; POSTERIOR SCLERA; VOLUME CHANGE; INTRAOCULAR-PRESSURE; INHERITED GLAUCOMA; MATRIX STIFFNESS; LAMINA-CRIBROSA; IOP ELEVATIONS; CROSS-LINKING	Soft tissue often displays marked age-associated stiffening. This study aims to investigate how age affects scleral biomechanical properties in a canine glaucoma model with ADAMTS10 mutation, whose extracellular matrix is concomitantly influenced by the mutation and an increased mechanical load from an early age. Biomechanical data was acquired from ADAMTS10-mutant dogs (n = 10, 21 to 131 months) and normal dogs (n = 5, 69 to 113 months). Infusion testing was first performed in the whole globes to measure ocular rigidity. After infusion experiments, the corneas were immediately trephined to prepare scleral shells that were mounted on a pressurization chamber to measure strains in the posterior sclera using an inflation testing protocol. Dynamic viscoelastic mechanical testing was then performed on dissected posterior scleral strips and the data were combined with those reported earlier by our group from the same animal model (Palko et al, IOVS 2013). The association between age and scleral biomechanical properties was evaluated using multi-variate linear regression. The relationships between scleral properties and the mean and last measured intraocular pressure (IOP) were also evaluated. Our results showed that age was positively associated with complex modulus (p<0.001) and negatively associated with loss tangent (p<0.001) in both the affected and the normal groups, suggesting an increased stiffness and decreased mechanical damping with age. The regression slopes were not different between the groups, although the complex modulus was significantly lower in the affected group (p = 0.041). The posterior circumferential tangential strain was negatively correlated with complex modulus (R = -0.744, p = 0.006) showing consistent mechanical evaluation between the testing methods. Normalized ocular rigidity was negatively correlated with the last IOP in the affected group (p = 0.003). Despite a mutation that affects the extracellular matrix and a chronic IOP elevation in the affected dogs, age-associated scleral stiffening and loss of mechanical damping were still prominent and had a similar rate of change as in the normal dogs.	[Palko, Joel R.; Morris, Hugh J.; Liu, Jun] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Palko, Joel R.] Washington Univ, Dept Ophthalmol, St Louis, MO USA; [Pan, Xueliang] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Harman, Christine D.; Koehl, Kristin L.; Komaromy, Andras M.] Michigan State Univ, Dept Small Anim Clin Sci, Lansing, MI USA; [Gelatt, Kirk N.; Plummer, Caryn E.; Komaromy, Andras M.] Univ Florida, Dept Small Anim Clin Sci, Gainesville, FL USA; [Komaromy, Andras M.] Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA; [Liu, Jun] Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Washington University (WUSTL); University System of Ohio; Ohio State University; Michigan State University; State University System of Florida; University of Florida; University of Pennsylvania; University System of Ohio; Ohio State University	Liu, J (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Komaromy, AM (corresponding author), Michigan State Univ, Dept Small Anim Clin Sci, Lansing, MI USA.; Komaromy, AM (corresponding author), Univ Florida, Dept Small Anim Clin Sci, Gainesville, FL USA.; Komaromy, AM (corresponding author), Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA.; Liu, J (corresponding author), Ohio State Univ, Dept Ophthalmol, Columbus, OH 43210 USA.	komaromy@cvm.msu.edu; liu.314@osu.edu		Liu, Jun/0000-0001-5984-4169; Pan, Xueliang/0000-0002-2342-3212	NIH [RO1EY020929]; University of Pennsylvania Research Foundation; Michigan State University Faculty Startup Funds; Edward Sheppard and Family; Gwathmey-Adams Laboratory for Vision Research; NATIONAL EYE INSTITUTE [R01EY020929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Research Foundation; Michigan State University Faculty Startup Funds; Edward Sheppard and Family; Gwathmey-Adams Laboratory for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded in part by NIH grant RO1EY020929, University of Pennsylvania Research Foundation, Michigan State University Faculty Startup Funds, Edward Sheppard and Family, and Gwathmey-Adams Laboratory for Vision Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, VISCOELASTIC PROPERT; Asrani S, 2000, J GLAUCOMA, V9, P134; BARRIE KP, 1985, AM J VET RES, V46, P84; BARRIE KP, 1985, AM J VET RES, V46, P89; Beaton L, 2015, BIOMED OPT EXPRESS, V6, P1694, DOI 10.1364/BOE.6.001694; BROOKS DE, 1989, AM J VET RES, V50, P936; BROOKS DE, 1995, EXP EYE RES, V60, P71, DOI 10.1016/S0014-4835(05)80085-5; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Downs JC, 2015, EXP EYE RES, V133, P19, DOI 10.1016/j.exer.2015.02.011; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Evans H.E., 2013, MILLERS ANATOMY DOG; FRIBERG TR, 1988, EXP EYE RES, V47, P429, DOI 10.1016/0014-4835(88)90053-X; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gelatt KN, 1998, J GLAUCOMA, V7, P187; GELATT KN, 1977, INVEST OPHTH VIS SCI, V16, P1135; GELATT KN, 1981, AM J VET RES, V42, P1691; Gelatt KN, 1976, T SECTION OPHTHALM 1, V81; Geraghty B, 2012, J MECH BEHAV BIOMED, V16, P181, DOI 10.1016/j.jmbbm.2012.10.011; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Gong HY, 2009, EXP EYE RES, V88, P729, DOI 10.1016/j.exer.2009.01.015; GREENE PR, 1985, AM J OPTOM PHYS OPT, V62, P870; Grytz R, 2014, INVEST OPHTH VIS SCI, V55, P8163, DOI 10.1167/iovs.14-14029; Gum G. G., 1983, ORTHOGRADE RAPID A 1, V5, P117; JANSSON F, 1961, ACTA OPHTHALMOL, V39, P899; Kallel F, 1997, ULTRASONIC IMAGING, V19, P195, DOI 10.1177/016173469701900303; Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kutz WE, J BIOL CHEM, V286, P17156; Liu J, 2009, INVEST OPHTH VIS SCI, V50, P2224, DOI 10.1167/iovs.08-2365; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Morris HJ, 2013, INVEST OPHTH VIS SCI, V54, P7215, DOI 10.1167/iovs.13-12441; Nagata N, 2011, J VET MED SCI, V73, P1585, DOI 10.1292/jvms.11-0251; Palko JR, 2013, INVEST OPHTH VIS SCI, V54, P2685, DOI 10.1167/iovs.12-10621; Palko JR, 2011, EXP EYE RES, V93, P825, DOI 10.1016/j.exer.2011.09.018; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; PEIFFER RL, 1980, AM J VET RES, V41, P1808; PERKINS ES, 1981, EXP EYE RES, V33, P141, DOI 10.1016/S0014-4835(81)80062-0; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rufer F, 2005, CORNEA, V24, P259; Sagara T, 1999, ARCH OPHTHALMOL-CHIC, V117, P794; SAMUELSON DA, 1983, GLAUCOMA, V5, P174; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Silverman RH, 2009, ULTRASOUND MED BIOL, V35, P839, DOI 10.1016/j.ultrasmedbio.2008.11.009; Slack JM, 2012, VET REC, V171, P373, DOI 10.1136/vr.100967; Somerville RPT, 2004, J BIOL CHEM, V279, P51208, DOI 10.1074/jbc.M409036200; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Tang JH, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007365; THIJSSEN JM, 1985, ULTRASOUND MED BIOL, V11, P157, DOI 10.1016/0301-5629(85)90018-3	53	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156466	10.1371/journal.pone.0156466	http://dx.doi.org/10.1371/journal.pone.0156466			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271467	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200009
J	Vogel, MW; Giorni, A; Vegh, V; Pellicer-Guridi, R; Reutens, DC				Vogel, Michael W.; Giorni, Andrea; Vegh, Viktor; Pellicer-Guridi, Ruben; Reutens, David C.			Rotatable Small Permanent Magnet Array for Ultra-Low Field Nuclear Magnetic Resonance Instrumentation: A Concept Study	PLOS ONE			English	Article							CONCOMITANT GRADIENTS; NMR; MRI	Object We studied the feasibility of generating the variable magnetic fields required for ultra-low field nuclear magnetic resonance relaxometry with dynamically adjustable permanent magnets. Our motivation was to substitute traditional electromagnets by distributed permanent magnets, increasing system portability. Materials and Methods The finite element method (COMSOL (R)) was employed for the numerical study of a small permanent magnet array to calculate achievable magnetic field strength, homogeneity, switching time and magnetic forces. A manually operated prototype was simulated and constructed to validate the numerical approach and to verify the generated magnetic field. Results A concentric small permanent magnet array can be used to generate strong sample pre-polarisation and variable measurement fields for ultra-low field relaxometry via simple prescribed magnet rotations. Using the array, it is possible to achieve a pre-polarisation field strength above 100 mT and variable measurement fields ranging from 20-50 mu T with 200 ppm absolute field homogeneity within a field-of-view of 5 x 5 x 5 cubic centimetres. Conclusions A dynamic small permanent magnet array can generate multiple highly homogeneous magnetic fields required in ultra-low field nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) instruments. This design can significantly reduce the volume and energy requirements of traditional systems based on electromagnets, improving portability considerably.	[Vogel, Michael W.; Giorni, Andrea; Vegh, Viktor; Pellicer-Guridi, Ruben; Reutens, David C.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	University of Queensland	Vogel, MW (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.	michael.vogel@cai.uq.edu.au	Reutens, David/C-7226-2018	Pellicer-Guridi, Ruben/0000-0001-9263-4921; Reutens, David/0000-0002-1652-9369; Vegh, Viktor/0000-0002-4310-1421	Australian Research Council [DE140100229]; Australian National Health and Medical Research Council [628952, 631352]; Bill & Melinda Gates Foundation [OPP1007237]	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	M. W. Vogel is financially supported by the Australian Research Council (http://www.arc.gov.au/) Discovery Early Career Research Award No. DE140100229. D. C. Reutens is supported by the Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) program grant No. 628952 and No. 631352. Parts of this project are supported by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/) (OPP1007237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Bjork R, 2010, J MAGN MAGN MATER, V322, P3664, DOI 10.1016/j.jmmm.2010.07.022; Burghoff M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2006981; Cooley CZ, 2015, MAGN RESON MED, V73, P872, DOI 10.1002/mrm.25147; Espy MA, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2365473; Espy M, 2013, J MAGN RESON, V228, P1, DOI 10.1016/j.jmr.2012.11.030; Espy M, 2009, IEEE T APPL SUPERCON, V19, P835, DOI 10.1109/TASC.2009.2018517; Haake E. M., 1999, MAGNETIC RESONANCE I; Hennig J, 2008, MAGN RESON MATER PHY, V21, P5, DOI 10.1007/s10334-008-0105-7; Keeler J., 2013, UNDERSTANDING NMR SP; Kraus R., 2014, ULTRALOW FIELD NUCL; Ledbetter MP, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.107601; Lee SK, 2005, MAGN RESON MED, V53, P9, DOI 10.1002/mrm.20316; MACOVSKI A, 1993, MAGNET RESON MED, V30, P221, DOI 10.1002/mrm.1910300211; Matlachov AN, 2004, J MAGN RESON, V170, P1, DOI 10.1016/j.jmr.2004.05.015; McDermott R, 2004, J LOW TEMP PHYS, V135, P793, DOI 10.1023/B:JOLT.0000029519.09286.c5; McDermott R, 2002, SCIENCE, V295, P2247, DOI 10.1126/science.1069280; Moresi G, 2003, CONCEPT MAGN RESON B, V19B, P35, DOI 10.1002/cmr.b.10082; Nieminen JO, 2010, J MAGN RESON, V207, P213, DOI 10.1016/j.jmr.2010.09.001; Raich H, 2004, CONCEPT MAGN RESON B, V23B, P16, DOI 10.1002/cmr.b.20018; Sarracanie M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15177; Soltner H, 2010, CONCEPT MAGN RESON A, V36A, P211, DOI 10.1002/cmr.a.20165; Sun N, 2011, IEEE J SOLID-ST CIRC, V46, P342, DOI 10.1109/JSSC.2010.2074630; Trahrns L, 2010, MAGN RESON IMAGING, V28, P1244, DOI 10.1016/j.mri.2010.02.004; Vesanen PT, 2013, MAGN RESON MED, V69, P1795, DOI 10.1002/mrm.24413; Vogel MW, 2013, MED PHYS, V40, DOI 10.1118/1.4800491; Volegov P, 2010, IFMBE PROC, V28, P82; Volegov PL, 2005, J MAGN RESON, V175, P103, DOI 10.1016/j.jmr.2005.03.015; Zalesskiy SS, 2014, CHEM REV, V114, P5641, DOI 10.1021/cr400063g; Zhu ZQ, 2001, IEE P-ELECT POW APPL, V148, P299, DOI 10.1049/ip-epa:20010479; Zotev VS, 2007, SUPERCOND SCI TECH, V20, pS367, DOI 10.1088/0953-2048/20/11/S13	31	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157040	10.1371/journal.pone.0157040	http://dx.doi.org/10.1371/journal.pone.0157040			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271886	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200030
J	Abramson, DH; Marr, BP; Francis, JH; Dunkel, IJ; Fabius, AWM; Brodie, SE; Mondesire-Crump, I; Gobin, YP				Abramson, David H.; Marr, Brian P.; Francis, Jasmine H.; Dunkel, Ira J.; Fabius, Armida W. M.; Brodie, Scott E.; Mondesire-Crump, Ijah; Gobin, Y. Pierre			Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)	PLOS ONE			English	Article							INTRAOCULAR RETINOBLASTOMA; INTRAARTERIAL CHEMOTHERAPY; SUBCONJUNCTIVAL CARBOPLATIN; RETINAL FUNCTION; PHASE-I/II; MELPHALAN; TOPOTECAN; MANAGEMENT; DELIVERY	Objective Report on the 7-year experience with bilateral ophthalmic artery chemosurgery (OAC-Tandem therapy) for bilateral retinoblastoma. Design Retrospective, single institution study. Subjects 120 eyes of 60 children with bilateral retinoblastoma treated since March 2008. Methods Retrospective review of all children treated at Memorial Sloan Kettering with bilateral ophthalmic artery chemosurgery (Melphalan, Carboplatin, Topotecan, Methotrexate) delivered in the same initial session to both naive and previously treated eyes. Main Outcome Measures Ocular survival, metastatic disease, patient survival from metastases, second cancers, systemic adverse effects, need for transfusion of blood products, electroretinogram before and after treatment. Results 116 eyes were salvaged (4 eyes were enucleated: 3 because of progressive disease, 1 family choice). Kaplan Meier ocular survival was 99.2% at one year, 96.9% at 2 and 3 years and 94.9% for years 4 through 7. There were no cases of metastatic disease or metastatic deaths with a mean follow-up of 3.01 years. Two children developed second cancers (both pineoblastoma) and one of them died. Transfusion of blood products was required in 3 cases (4 transfusions), 1.9%. Two children developed fever/neutropenia requiring hospitalization (0.95%). ERGs were improved in 21.6% and unchanged after treatment in 52.5% of cases (increase or decrease of less than 25 mu V). Conclusions Bilateral ophthalmic artery chemosurgery is a safe and effective technique for managing bilateral retinoblastoma-even when eyes are advanced bilaterally, and if both eyes have progressed after systemic chemotherapy. Ocular survival was excellent (94.9% at 8 years), there were no cases of of metastatic disease and no deaths from metastatic disease, but children remain at risk for second cancers. In 21.6% of cases ERG function improved. Despite using chemotherapy in both eyes in the same session, systemic toxicity was low.	[Abramson, David H.; Marr, Brian P.; Francis, Jasmine H.; Fabius, Armida W. M.; Brodie, Scott E.; Mondesire-Crump, Ijah; Gobin, Y. Pierre] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Abramson, David H.; Marr, Brian P.; Francis, Jasmine H.] New York Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Dunkel, Ira J.] New York Presbyterian Hosp, Dept Pediat, Weill Cornell Med Coll, New York, NY USA; [Fabius, Armida W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Brodie, Scott E.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Dept Radiol, Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Vrije Universiteit Amsterdam; Icahn School of Medicine at Mount Sinai; Cornell University; NewYork-Presbyterian Hospital	Abramson, DH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.; Abramson, DH (corresponding author), New York Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, New York, NY USA.	abramsod@mskcc.org		Brodie, Scott/0000-0002-3303-4552; Francis, Jasmine/0000-0002-7637-3108	Fund for Ophthalmic Knowledge, Inc, New York; NIH/NCI Cancer Center Support Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, Inc, New York; NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Fund for Ophthalmic Knowledge, Inc, New York (No grant number; philanthropic fund) and funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2015, JAMA OPHTHALMOL, V133, P1341, DOI 10.1001/jamaophthalmol.2015.3108; Abramson David H, 2012, Retin Cases Brief Rep, V6, P209, DOI 10.1097/ICB.0b013e318234ccf4; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Abramson DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034120; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 2010, BRIT J OPHTHALMOL, V94, P396, DOI 10.1136/bjo.2009.174268; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Abramson DH, 2005, INVEST OPHTH VIS SCI, V46, P2684, DOI 10.1167/iovs.04-1462; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1316, DOI 10.1001/archopht.122.9.1316; ABRAMSON DH, 1976, T AM ACAD OPHTHALMOL, V81, pP454; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1761; ABRAMSON DH, 1982, ARCH OPHTHALMOL-CHIC, V100, P1249; Allen S, 2010, PEDIATR BLOOD CANCER, V55, P47, DOI 10.1002/pbc.22467; Brodie SE, 2012, BRIT J OPHTHALMOL, V96, P877, DOI 10.1136/bjophthalmol-2011-301248; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Carcaboso AM, 2010, INVEST OPHTH VIS SCI, V51, P2126, DOI 10.1167/iovs.09-4050; Chantada GL, 2009, INVEST OPHTH VIS SCI, V50, P1492, DOI 10.1167/iovs.08-2737; De Jong MC, 2015, AM J OPHTHALMOL, V160, P1116, DOI 10.1016/j.ajo.2015.09.009; Dunkel IJ, 2007, PEDIATR BLOOD CANCER, V49, P643, DOI 10.1002/pbc.21163; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Francis JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072441; Francis JH, 2013, DOC OPHTHALMOL, V127, P113, DOI 10.1007/s10633-013-9391-0; Gallie B, 2009, CAN J OPHTHALMOL, V44, P639, DOI [10.3129/i09-229, 10.1139/i09-229]; Grigorovski N, 2014, INT J OPHTHALMOL-CHI, V7, P726, DOI 10.3980/j.issn.2222-3959.2014.04.26; INOMATA M, 1987, JPN J CANCER RES, V78, P858; Liu CY, 2014, DOC OPHTHALMOL, V128, P13, DOI 10.1007/s10633-013-9416-8; Marr BP, 2012, BRIT J OPHTHALMOL, V96, P1300, DOI 10.1136/bjophthalmol-2012-301925; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Murphree AL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1348, DOI 10.1001/archopht.1996.01100140548005; REESE AB, 1958, ARCH OPHTHALMOL-CHIC, V60, P897; Schaiquevich P, 2014, RETINA-J RET VIT DIS, V34, P1719, DOI 10.1097/IAE.0000000000000253; Schaiquevich P, 2013, PEDIATR BLOOD CANCER, V60, P766, DOI 10.1002/pbc.24356; Schefler AC, 2008, CURR OPIN OPHTHALMOL; Shields CL, 2013, EYE, V27, P253, DOI 10.1038/eye.2012.175; Shields CL, 2014, OPHTHALMOLOGY, V121, P1453, DOI 10.1016/j.ophtha.2014.01.026; Shields CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1330, DOI 10.1001/archopht.1996.01100140530002; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Taich P, 2014, OPHTHALMOLOGY, V121, P889, DOI 10.1016/j.ophtha.2013.10.045; Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060	41	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156806	10.1371/journal.pone.0156806	http://dx.doi.org/10.1371/journal.pone.0156806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258771	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700134
J	Cieszanowski, A; Lisowska, A; Dabrowska, M; Korczynski, P; Zukowska, M; Grudzinski, IP; Pacho, R; Rowinski, O; Krenke, R				Cieszanowski, Andrzej; Lisowska, Antonina; Dabrowska, Marta; Korczynski, Piotr; Zukowska, Malgorzata; Grudzinski, Ireneusz P.; Pacho, Ryszard; Rowinski, Olgierd; Krenke, Rafal			MR Imaging of Pulmonary Nodules: Detection Rate and Accuracy of Size Estimation in Comparison to Computed Tomography	PLOS ONE			English	Article							LUNG-CANCER; CT SCANS; POPULATION; SEQUENCE; RISKS	Objective The aims of this study were to assess the sensitivity of various magnetic resonance imaging (MRI) sequences for the diagnosis of pulmonary nodules and to estimate the accuracy of MRI for the measurement of lesion size, as compared to computed tomography (CT). Methods Fifty patients with 113 pulmonary nodules diagnosed by CT underwent lung MRI and CT. MRI studies were performed on 1.5T scanner using the following sequences: T2-TSE, T2-SPIR, T2-STIR, T2-HASTE, T1-VIBE, and T1-out-of-phase. CT and MRI data were analyzed independently by two radiologists. Results The overall sensitivity of MRI for the detection of pulmonary nodules was 80.5% and according to nodule size: 57.1% for nodules <= 4mm, 75% for nodules >4-6mm, 87.5% for nodules >6-8mm and 100% for nodules >8mm. MRI sequences yielded following sensitivities: 69% (T1-VIBE), 54.9% (T2-SPIR), 48.7% (T2-TSE), 48.7% (T1-out-of-phase), 45.1% (T2-STIR), 25.7% (T2-HASTE), respectively. There was very strong agreement between the maximum diameter of pulmonary nodules measured by CT and MRI (mean difference -0.02 mm; 95% CI -1.6-1.57 mm; Bland-Altman analysis). Conclusions MRI yielded high sensitivity for the detection of pulmonary nodules and enabled accurate assessment of their diameter. Therefore it may be considered an alternative to CT for follow-up of some lung lesions. However, due to significant number of false positive diagnoses, it is not ready to replace CT as a tool for lung nodule detection.	[Cieszanowski, Andrzej; Lisowska, Antonina; Zukowska, Malgorzata; Pacho, Ryszard; Rowinski, Olgierd] Med Univ Warsaw, Cent Clin Hosp, Dept Clin Radiol 2, Warsaw, Poland; [Cieszanowski, Andrzej] Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Warsaw, Poland; [Dabrowska, Marta; Korczynski, Piotr; Krenke, Rafal] Med Univ Warsaw, Dept Internal Med Pneumonol & Allergol, Warsaw, Poland; [Grudzinski, Ireneusz P.] Med Univ Warsaw, Dept Toxicol, Fac Pharm, Warsaw, Poland	Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Medical University of Warsaw	Cieszanowski, A (corresponding author), Med Univ Warsaw, Cent Clin Hosp, Dept Clin Radiol 2, Warsaw, Poland.; Cieszanowski, A (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Warsaw, Poland.	andrzej.cieszanowski@wum.edu.pl		Grudzinski, Ireneusz/0000-0002-6113-1771; Grudzinski, Ireneusz/0000-0002-1485-7529; Dabrowska, Marta/0000-0003-1872-7737				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Albert RH, 2009, AM FAM PHYSICIAN, V80, P827; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Baumann T, 2008, INVEST RADIOL, V43, P359, DOI 10.1097/RLI.0b013e31816901fa; Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8; Biederer J, 2003, RADIOLOGY, V227, P475, DOI 10.1148/radiol.2272020635; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; Biederer J, 2008, CANCER IMAGING, V8, P125, DOI 10.1102/1470-7330.2008.0018; Both M, 2005, EUR J RADIOL, V53, P478, DOI 10.1016/j.ejrad.2004.05.007; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Bruegel M, 2007, J MAGN RESON IMAGING, V25, P73, DOI 10.1002/jmri.20824; Choromanska A, 2012, POL J RADIOL, V77, P22, DOI 10.12659/PJR.882967; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Heye T, 2012, ACTA RADIOL, V53, P153, DOI 10.1258/ar.2011.110445; Kersjes W, 1997, EUR RADIOL, V7, P1190, DOI 10.1007/s003300050272; Khan Ali Nawaz, 2011, Avicenna J Med, V1, P39, DOI 10.4103/2231-0770.90915; Luboldt W, 2006, EUR J MED RES, V11, P336; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; McWilliams Annette, 2008, Proc Am Thorac Soc, V5, P900, DOI 10.1513/pats.200809-111QC; McWilliams AM, 2006, J THORAC ONCOL, V1, P61, DOI 10.1097/01243894-200601000-00012; Regier M, 2011, J MED IMAG RADIAT ON, V55, P266, DOI 10.1111/j.1754-9485.2011.02263.x; Rubin GD, 2005, RADIOLOGY, V234, P274, DOI 10.1148/radiol.2341040589; Schroeder T, 2005, AM J ROENTGENOL, V185, P979, DOI 10.2214/AJR.04.0814; Sieren JC, 2010, J MAGN RESON IMAGING, V32, P1353, DOI 10.1002/jmri.22383; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012; Stolzmann P, 2013, INVEST RADIOL, V48, P241, DOI 10.1097/RLI.0b013e31826f2de9; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Vogt FM, 2004, AM J ROENTGENOL, V183, P71, DOI 10.2214/ajr.183.1.1830071; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Wu NY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-242; Yi CA, 2007, AM J ROENTGENOL, V189, P386, DOI 10.2214/AJR.07.2082	33	43	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156272	10.1371/journal.pone.0156272	http://dx.doi.org/10.1371/journal.pone.0156272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258047	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700050
J	Khanal, P; Johnsen, L; Axel, AMD; Hansen, PW; Kongsted, AH; Lyckegaard, NB; Nielsen, MO				Khanal, Prabhat; Johnsen, Laerke; Axel, Anne Marie Dixen; Hansen, Pernille Willert; Kongsted, Anna Hauntoft; Lyckegaard, Nette Brinch; Nielsen, Mette Olaf			Long-Term Impacts of Foetal Malnutrition Followed by Early Postnatal Obesity on Fat Distribution Pattern and Metabolic Adaptability in Adult Sheep	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; ADIPOSE-TISSUE; LATE-GESTATION; PRENATAL UNDERNUTRITION; HYPERCALORIC NUTRITION; DIFFERENTIAL IMPACTS; INSULIN ADAPTATIONS; VISCERAL ADIPOSITY; RENAL DYSFUNCTION; OBESOGENIC DIET	We aimed to investigate whether over- versus undernutrition in late foetal life combined with obesity development in early postnatal life have differential implications for fat distribution and metabolic adaptability in adulthood. Twin-pregnant ewes were fed NORM (100% of daily energy and protein requirements), LOW (50% of NORM) or HIGH (150%/110% of energy/protein requirements) diets during the last trimester. Postnatally, twin-lambs received obesogenic (HCHF) or moderate (CONV) diets until 6 months of age, and a moderate (obesity correcting) diet thereafter. At 2(1)/(2) years of age (adulthood), plasma metabolite profiles during fasting, glucose, insulin and propionate (in fed and fasted states) tolerance tests were examined. Organ weights were determined at autopsy. Early obesity development was associated with lack of expansion of perirenal, but not other adipose tissues from adolescence to adulthood, resulting in 10% unit increased proportion of mesenteric of intra-abdominal fat. Prenatal undernutrition had a similar but much less pronounced effect. Across tolerance tests, LOW-HCHF sheep had highest plasma levels of cholesterol, urea-nitrogen, creatinine, and lactate. Sex specific differences were observed, particularly with respect to fat deposition, but direction of responses to early nutrition impacts were similar. However, prenatal undernutrition induced greater metabolic alterations in adult females than males. Foetal undernutrition, but not overnutrition, predisposed for adult hypercholesterolaemia, hyperureaemia, hypercreatinaemia and hyperlactataemia, which became manifested only in combination with early obesity development. Perirenal expandability may play a special role in this context. Differential nutrition recommendations may be advisable for individuals with low versus high birth weights.	[Khanal, Prabhat; Johnsen, Laerke; Axel, Anne Marie Dixen; Hansen, Pernille Willert; Kongsted, Anna Hauntoft; Lyckegaard, Nette Brinch; Nielsen, Mette Olaf] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark	University of Copenhagen	Nielsen, MO (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark.	mette.olaf.nielsen@sund.ku.dk	Khanal, Prabhat/AAZ-4444-2021	Khanal, Prabhat/0000-0001-6774-0503; Kongsted, Anna/0000-0003-1959-8308	Danish Council for Strategic Research [09-067124]; Lundbeck Foundation [R167-2013-16124] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden)	The study was conducted as part of the research program of the Centre for Fetal Programming (CFP), Denmark. The CFP was supported by the Danish Council for Strategic Research (grant 09-067124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, INT J OBES, V35, P325; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Battista MC, 2002, AM J PHYSIOL-ENDOC M, V283, pE124, DOI 10.1152/ajpendo.00004.2001; Bauer R, 2002, ACTA PHYSIOL SCAND, V176, P83, DOI 10.1046/j.1365-201X.2002.01027.x; Bayol SA, BR J NUTR, V98, P843; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Cho CE, 2013, INT J OBESITY, V37, P1177, DOI 10.1038/ijo.2012.210; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Dotsch J, 2009, J MOL MED, V87, P841, DOI 10.1007/s00109-009-0507-7; FINCO DR, 1976, J AM VET MED ASSOC, V168, P593; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gowda S, 2010, N AM J MED SCI, V2, P170; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hou L, 2014, ACTA PHYSIOL, V210, P317, DOI 10.1111/apha.12211; Hou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065452; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Johnsen L, 2013, J ENDOCRINOL, V216, P389, DOI 10.1530/JOE-12-0389; Khanal P, 2015, ACTA PHYSIOL, V213, P519, DOI 10.1111/apha.12391; Khanal P, 2014, ACTA PHYSIOL, V210, P110, DOI 10.1111/apha.12129; Kongsted AH, 2014, ACTA PHYSIOL, V210, P84, DOI 10.1111/apha.12080; Kongsted AH, 2013, J ENDOCRINOL, V219, P159, DOI 10.1530/JOE-13-0099; Lackland DT, 2000, ARCH INTERN MED, V160, P1472, DOI 10.1001/archinte.160.10.1472; Li ZL, 2011, AM J PHYSIOL-RENAL, V301, pF1078, DOI 10.1152/ajprenal.00333.2011; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; MARIN P, 1992, METABOLISM, V41, P1242, DOI 10.1016/0026-0495(92)90016-4; Nielsen MO, 2013, BRIT J NUTR, V109, P2098, DOI 10.1017/S0007114512004199; Nwagwu MO, 2000, BRIT J NUTR, V83, P79, DOI 10.1017/S0007114500000118; Rea DJ, 2006, KIDNEY INT, V70, P1636, DOI 10.1038/sj.ki.5001799; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; TURLEY SD, 1995, J LIPID RES, V36, P67; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Yates Z, 2009, BRIT J NUTR, V101, P1185, DOI 10.1017/S0007114508066786; Zuo YG, 2008, ANAL SCI, V24, P1589, DOI 10.2116/analsci.24.1589	42	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156700	10.1371/journal.pone.0156700	http://dx.doi.org/10.1371/journal.pone.0156700			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257993	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700109
J	Ng, TLM; Karim, R; Tan, YS; Teh, HF; Danial, AD; Ho, LS; Khalid, N; Appleton, DR; Harikrishna, JA				Ng, Theresa Lee Mei; Karim, Rezaul; Tan, Yew Seong; Teh, Huey Fang; Danial, Asma Dazni; Ho, Li Sim; Khalid, Norzulaani; Appleton, David Ross; Harikrishna, Jennifer Ann			Amino Acid and Secondary Metabolite Production in Embryogenic and Non-Embryogenic Callus of Fingerroot Ginger (Boesenbergia rotunda)	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; L. MANSF.; CULTURES; DIFFERENTIATION; LOCALIZATION; REGENERATION; FLAVONOIDS; TRYPTOPHAN; GLUTAMINE; TISSUES	Interest in the medicinal properties of secondary metabolites of Boesenbergia rotunda (fingerroot ginger) has led to investigations into tissue culture of this plant. In this study, we profiled its primary and secondary metabolites, as well as hormones of embryogenic and non-embryogenic (dry and watery) callus and shoot base, Ultra Performance Liquid Chromatography-Mass Spectrometry together with histological characterization. Metabolite profiling showed relatively higher levels of glutamine, arginine and lysine in embryogenic callus than in dry and watery calli, while shoot base tissue showed an intermediate level of primary metabolites. For the five secondary metabolites analyzed (ie. panduratin, pinocembrin, pinostrobin, cardamonin and alpinetin), shoot base had the highest concentrations, followed by watery, dry and embryogenic calli. Furthermore, intracellular auxin levels were found to decrease from dry to watery calli, followed by shoot base and finally embryogenic calli. Our morphological observations showed the presence of fibrils on the cell surface of embryogenic callus while diphenylboric acid 2-aminoethylester staining indicated the presence of flavonoids in both dry and embryogenic calli. Periodic acid-Schiff staining showed that shoot base and dry and embryogenic calli contained starch reserves while none were found in watery callus. This study identified several primary metabolites that could be used as markers of embryogenic cells in B. rotunda, while secondary metabolite analysis indicated that biosynthesis pathways of these important metabolites may not be active in callus and embryogenic tissue.	[Ng, Theresa Lee Mei; Karim, Rezaul; Tan, Yew Seong; Khalid, Norzulaani; Harikrishna, Jennifer Ann] Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur 50603, Malaysia; [Ng, Theresa Lee Mei; Karim, Rezaul; Tan, Yew Seong; Khalid, Norzulaani; Harikrishna, Jennifer Ann] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Ng, Theresa Lee Mei; Teh, Huey Fang; Danial, Asma Dazni; Ho, Li Sim; Appleton, David Ross] Univ Putra Malaysia, UPM MTDC Technol Ctr 3, Sime Darby Technol Ctr, 1st Floor Block B, Serdang 43400, Selangor, Malaysia; [Karim, Rezaul] Rajshahi Univ, Fac Life & Earth Sci, Dept Bot, Rajshahi 6205, Bangladesh	Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia; University of Rajshahi	Harikrishna, JA (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur 50603, Malaysia.; Harikrishna, JA (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.	jennihari@um.edu.my	Harikrishna, Jennifer Ann/B-2778-2010; KHALID, NORZULAANI/B-9405-2010	Harikrishna, Jennifer Ann/0000-0002-4687-709X; 	High Impact Research Chancellory Grant from the University of Malaya [UM.C/625/1/HIR/MOHE/SCI/19]; Bright Spark Programme of the University of Malaya	High Impact Research Chancellory Grant from the University of Malaya; Bright Spark Programme of the University of Malaya	This work was supported by High Impact Research Chancellory Grant UM.C/625/1/HIR/MOHE/SCI/19 from the University of Malaya. Also, the authors would like to acknowledge Bright Spark Programme of the University of Malaya for supporting Rezaul Karim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by High Impact Research Chancellory Grant UM.C/625/1/HIR/MOHE/SCI/19 from the University of Malaya. We acknowledge colleagues at the Centre for Research in Biotechnology for Agriculture (CEBAR), University of Malaya and at Sime Darby Technology Centre (SDTC) for their kind support and guidance during this research. We thank Ms. Alena Lee Sanusi for editorial assistance and Dr. Melina Ong Abdullah from Malaysian Palm Oil Board (MPOB) for assisting in histology sectioning. A special thank you to Professor Pat Heslop-Harrison, Leicester University, United Kingdom for his considerable input and advice during the study and manuscript preparation. Finally, we would like to acknowledge Bright Spark Programme of the University of Malaya for supporting Rezaul Karim.	Abdelwahab SI, 2011, J ETHNOPHARMACOL, V137, P963, DOI 10.1016/j.jep.2011.07.010; [Anonymous], 2003, J SCI TECHNOL; [Anonymous], MATH PROBL ENG, DOI DOI 10.7873/DATE.2014.232; Bhamarapravati S, 2006, SONGKLANAKARIN J SCI, V28, P157; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Businge E, 2012, TREE PHYSIOL; Chapman A, 2000, CAN J BOT, V78, P816, DOI 10.1139/cjb-78-6-816; Chaudhury R.R., 2001, TRADITIONAL MED ASIA; CHOWDHRY CN, 1993, PLANT CELL TISS ORG, V32, P357, DOI 10.1007/BF00042300; Dubravina GA, 2005, RUSS J PLANT PHYSL+, V52, P672, DOI 10.1007/s11183-005-0100-z; Feirer RP, 1995, SOMATIC EMBRYOGENESI; Gerdakaneh M, 2011, ACTA PHYSIOL PLANT, V33, P1847, DOI 10.1007/s11738-011-0725-9; Guiderdoni E, 1995, BIOTECHNOLOGY AGR FO, V31, P92; Jeyaseelan M., 2005, Indian Journal of Experimental Biology, V43, P555; Jimenez VM, 2001, PLANT CELL TISS ORG, V67, P37, DOI 10.1023/A:1011671310451; Jimenez VM, 2001, PLANT SCI, V160, P247, DOI 10.1016/S0168-9452(00)00382-4; Jing LJ, 2010, J MED PLANTS RES, V4, P27; KAMADA H, 1984, PLANT CELL PHYSIOL, V25, P27; Kirana C, 2007, J NAT MED-TOKYO, V61, P131, DOI 10.1007/s11418-006-0100-0; Thuc LV, 2011, MOL BIOTECHNOL, V48, P156, DOI 10.1007/s12033-010-9356-4; Li QF, 2015, PHYSIOL PLANTARUM, V154, P95, DOI 10.1111/ppl.12276; MALdL Ventosa, 2010, DIFFERENTIAL PROTEOM; MICHALCZUK L, 1992, PLANT PHYSIOL, V100, P1346, DOI 10.1104/pp.100.3.1346; MICHALCZUK L, 1992, PHYTOCHEMISTRY, V31, P1097, DOI 10.1016/0031-9422(92)80241-6; Minocha R, 2004, IN VITRO CELL DEV-PL, V40, P572, DOI 10.1079/IVP2004569; Morikawa T, 2008, CHEM PHARM BULL, V56, P956, DOI 10.1248/cpb.56.956; Muller M, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-37; Naz S, 2008, PAK J BOT, V40, P2525; Neoh BK, 2013, J AGR FOOD CHEM, V61, P1920, DOI 10.1021/jf304561f; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; Nor Azma Yusuf, 2013, Australian Journal of Crop Science, V7, P730; Ogita S, 2001, IN VITRO CELL DEV-PL, V37, P268, DOI 10.1007/s11627-001-0048-4; Palama TL, 2010, BMC PLANT BIOL, V10, P1, DOI 10.1186/1471-2229-10-82; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Policegoudra RS, 2008, FOOD HYDROCOLLOID, V22, P513, DOI 10.1016/j.foodhyd.2007.01.008; Pongtongkam P., 2004, Kasetsart Journal, Natural Sciences, V38, P190; Popielarska M, 2006, ACTA BIOL CRACOV BOT, V48, P97; Poustka F, 2007, PLANT PHYSIOL, V145, P1323, DOI 10.1104/pp.107.105064; RODRIGUEZ R, 1982, HORTSCIENCE, V17, P195; Rodriguez S, 1996, TISSUE CELL, V28, P149, DOI 10.1016/S0040-8166(96)80003-6; Sarath G, 2014, PLANT SCI, V217, P140, DOI 10.1016/j.plantsci.2013.12.012; SUNG ZR, 1979, PLANTA, V145, P339, DOI 10.1007/BF00388358; Takacs EM, 2012, PLANT CELL, V24, P3219, DOI 10.1105/tpc.112.099614; Tan BC, 2015, EVIDENCE BASED COMPL, V2015; Tan E, 2012, EVIDENCE BASED COMPL; Tan SK, 2005, IN VITRO CELL DEV-PL, V41, P757, DOI 10.1079/IVP2005695; Wong SM, 2013, IN VITRO CELL DEV-PL, V49, P665, DOI 10.1007/s11627-013-9570-4; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022992; Yusuf NA, 2012, ACTA PHYSIOL PLANT, P1; Yusuf NA, 2011, J MED PLANTS RES, V5, P2629; ZARATE R, 1994, NEW PHYTOL, V126, P295, DOI 10.1111/j.1469-8137.1994.tb03948.x; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411; Zouine J, 2005, PLANT CELL TISS ORG, V82, P83, DOI 10.1007/s11240-004-6914-0	54	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156714	10.1371/journal.pone.0156714	http://dx.doi.org/10.1371/journal.pone.0156714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258536	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700112
J	Suzuki, K; Tsunoda, H; Omiya, R; Matoba, K; Baba, T; Suzuki, S; Segawa, H; Kumanogoh, A; Iwasaki, K; Hattori, K; Takagi, J				Suzuki, Kei; Tsunoda, Hiroyuki; Omiya, Ryusuke; Matoba, Kyoko; Baba, Takeshi; Suzuki, Sachiyo; Segawa, Hiroaki; Kumanogoh, Atsushi; Iwasaki, Kenji; Hattori, Kunihiro; Takagi, Junichi			Structure of the Plexin Ectodomain Bound by Semaphorin-Mimicking Antibodies	PLOS ONE			English	Article							SECRETED SEMAPHORINS; SYSTEM; CELLS; GENERATION; RECEPTORS; 3A	Semaphorin family proteins act on cells to mediate both repulsive and attractive guidance via binding to plexin family receptors, thereby playing fundamental roles in the morphogenesis and homeostasis of various tissues. Although semaphorin-plexin signaling is implicated in various diseases and is thus a target of intensive research, our mechanistic understanding of how semaphorins activate plexins on the cell surface is limited. Here, we describe unique anti-plexin-A1 antibodies that can induce a collapsed morphology in mouse dendritic cells as efficiently as the semaphorin 3A (Sema3A) ligand. Precise epitope analysis indicates that these "semaphorin-mimicking" antibodies dimerize cell-surface plexin-A1 by binding to the N-terminal sema domain of the plexin at sites away from the interface used by the Sema3A ligand. Structural analysis of plexin-A1 fragments using negative stain electron microscopy further revealed that this agonistic capacity is closely linked to the location and orientation of antibody binding. In addition, the full-length plexin-A1 ectodomain exhibited a highly curved "C" shape, reinforcing the very unusual dimeric receptor conformation of this protein at the cell surface when engaged with Sema3A or agonistic antibodies.	[Suzuki, Kei; Matoba, Kyoko; Iwasaki, Kenji; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 565, Japan; [Tsunoda, Hiroyuki; Omiya, Ryusuke; Baba, Takeshi; Suzuki, Sachiyo; Segawa, Hiroaki; Hattori, Kunihiro] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan	Osaka University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Osaka University	Takagi, J (corresponding author), Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 565, Japan.; Hattori, K (corresponding author), Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan.	hattoriknh@chugai-pharm.co.jp; takagi@protein.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); "Platform for Drug Discovery, Informatics, and Structural Life Science" grant from the MEXT; Chugai Pharmaceutical Co.Ltd.	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Platform for Drug Discovery, Informatics, and Structural Life Science" grant from the MEXT; Chugai Pharmaceutical Co.Ltd.	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (Analysis and Synthesis of Multidimensional Immune Organ Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to JT, and by the "Platform for Drug Discovery, Informatics, and Structural Life Science" grant from the MEXT to JT. The Chugai Pharmaceutical Co.Ltd. provided support in the form of salaries for authors HT, RO, TB, SS, HS, and KH, HT, TB and KH has stocks of Chugai Pharmaceutical Co., Ltd. AK received research grants from Chugai Pharmaceutical Co., Ltd. All funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Catalano A, 2006, BLOOD, V107, P3321, DOI 10.1182/blood-2005-06-2445; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Montolio M, 2009, CHEM BIOL, V16, P691, DOI 10.1016/j.chembiol.2009.05.006; Nogi T, 2006, EMBO J, V25, P3675, DOI 10.1038/sj.emboj.7601240; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Sangawa T, 2008, HYBRIDOMA, V27, P331, DOI 10.1089/hyb.2008.0027; Scheer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051817; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; Siebold C, 2013, SEMIN CELL DEV BIOL, V24, P139, DOI 10.1016/j.semcdb.2012.11.003; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Yamamoto M, 2008, INT IMMUNOL, V20, P413, DOI 10.1093/intimm/dxn006; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang L., 2015, PLOS ONE, V10	34	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156719	10.1371/journal.pone.0156719	http://dx.doi.org/10.1371/journal.pone.0156719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258772	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700114
J	Xu, M; Cheung, CCM; Chow, C; Lun, SWM; Cheung, ST; Lo, KW				Xu, Meng; Cheung, Chartia Ching-Mei; Chow, Chit; Lun, Samantha Wei-Man; Cheung, Siu-Tim; Lo, Kwok-Wai			Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; TUMOR-SUPPRESSOR; BREAST-CANCER; CELL-DEATH; ESTABLISHMENT; DEGRADATION; EXPRESSION; PHOSPHORYLATION; INHIBITION; ACTIVATION	Background Nasopharyngeal carcinoma (NPC) is a peculiar Epstein Barr virus (EBV)-associated malignancy that is prevalent in South-East Asia. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) isomerizes specific phosphorylated amino acid residues, which makes it an important regulator in cell survival and apoptosis. In this study, we investigated the contribution made by PIN1 in NPC tumorigenesis and PIN1's potential role as a therapeutic target. Methods The expression of PIN1 was examined in a panel of NPC cell lines, xenografts and primary tumors. The functional roles of PIN1 in NPC cells were elucidated by the knockdown and overexpression of PIN1 in in vitro and in vivo nude mice models by siRNA and lenti-viral transfection, respectively. The antitumor effects of the PIN1 inhibitor Juglone in NPC cells were also evaluated. Results We revealed the consistent overexpression of PIN1 in almost all EBV-associated NPC cell lines, xenografts and primary tumors. PIN1 suppression was capable of inhibiting cyclin D1 expression and activating caspase-3 in NPC cells. It positively regulated NPC cell proliferation, colony formation and anchorage-independent growth. The inhibition of PIN1 suppressed tumor growth in vitro and in vivo. Conclusions This study demonstrates the oncogenic role of PIN1 in NPC tumorigenesis, and shows that its overexpression can enhance tumor cell growth via the upregulation of cyclinD1. Our findings inform the development of novel treatments targeting PIN1 for NPC patients.	[Xu, Meng] Sun Yat Sen Univ, Dept Oral Pathol, Guangdong Prov Key Lab Stomatol, Hosp Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Meng; Cheung, Chartia Ching-Mei; Chow, Chit; Lun, Samantha Wei-Man; Lo, Kwok-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China; [Cheung, Siu-Tim] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China; [Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong	Lo, KW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China.; Lo, KW (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.	kwlo@cuhk.edu.hk	Cheung, Siu-Tim/C-4238-2009	Cheung, Siu-Tim/0000-0003-2147-315X; Lo, Kwok Wai/0000-0002-3488-6124	Chinese University of Hong Kong; Hong Kong Research Grants Council - GRF [470413, 470312, 471211]; Hong Kong Research Grants Council - CRF [CUHK8/CRF/11R]; Hong Kong Research Grants Council - AoE NPC [AoE/M06/08]; Hong Kong Research Grants Council - Theme-Based Research Scheme [T12-403/11, T12-401/13-R]	Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Research Grants Council - GRF(Hong Kong Research Grants Council); Hong Kong Research Grants Council - CRF(Hong Kong Research Grants Council); Hong Kong Research Grants Council - AoE NPC(Hong Kong Research Grants Council); Hong Kong Research Grants Council - Theme-Based Research Scheme(Hong Kong Research Grants Council)	This study was supported by grant from the Chinese University of Hong Kong (Focus Investigation Scheme-A), and the Hong Kong Research Grants Council - GRF (470413, 470312, 471211), CRF (CUHK8/CRF/11R), AoE NPC (AoE/M06/08), Theme-Based Research Scheme (T12-403/11 and T12-401/13-R).	Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Basu A, 2002, NEOPLASIA, V4, P218, DOI 10.1038/sj.neo.7900233; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Guito J, 2014, J VIROL, V88, P547, DOI 10.1128/JVI.02877-13; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; HUANG DP, 1989, INT J CANCER, V43, P936, DOI 10.1002/ijc.2910430535; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Jin HW, 2011, ONCOL LETT, V2, P1191, DOI 10.3892/ol.2011.392; Kamei H, 1998, CANCER BIOTHER RADIO, V13, P185, DOI 10.1089/cbr.1998.13.185; Khanal P, 2012, ONCOGENE, V31, P3845, DOI 10.1038/onc.2011.548; Kim CJ, 2005, WORLD J GASTROENTERO, V11, P5006, DOI 10.3748/wjg.v11.i32.5006; Kuramochi J, 2006, J SURG ONCOL, V94, P155, DOI 10.1002/jso.20510; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Lim YS, 2011, J VIROL, V85, P8777, DOI 10.1128/JVI.02533-10; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu Y, 2013, MOL BIOL REP, V40, P3777, DOI 10.1007/s11033-012-2454-6; Man CH, 2012, J PATHOL, V226, P471, DOI 10.1002/path.2997; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Misumi S, 2010, J BIOL CHEM, V285, P25185, DOI 10.1074/jbc.M110.114256; Narita Y, 2013, J VIROL, V87, P2120, DOI 10.1128/JVI.02634-12; Pak MW, 2002, HEAD NECK-J SCI SPEC, V24, P989, DOI 10.1002/hed.10161; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; Paulsen MT, 2005, TOXICOL APPL PHARM, V209, P1, DOI 10.1016/j.taap.2005.03.005; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Spence T, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.03.09; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang YHN, 2013, ONCOGENE, V32, P1488, DOI 10.1038/onc.2012.178; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443; Zhou CX, 2006, ONCOL REP, V16, P505	48	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156833	10.1371/journal.pone.0156833	http://dx.doi.org/10.1371/journal.pone.0156833			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258148	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700142
J	Alba, S; Bakker, MI; Hatta, M; Scheelbeek, PFD; Dwiyanti, R; Usman, R; Sultan, AR; Sabir, M; Tandirogang, N; Amir, M; Yasir, Y; Pastoor, R; van Beers, S; Smits, HL				Alba, Sandra; Bakker, Mirjam I.; Hatta, Mochammad; Scheelbeek, Pauline F. D.; Dwiyanti, Ressy; Usman, Romi; Sultan, Andi R.; Sabir, Muhammad; Tandirogang, Nataniel; Amir, Masyhudi; Yasir, Yadi; Pastoor, Rob; van Beers, Stella; Smits, Henk L.			Risk Factors of Typhoid Infection in the Indonesian Archipelago	PLOS ONE			English	Article							FEVER; BURDEN; SANITATION; DIARRHEA; HYGIENE; JAKARTA; WATER	Background Knowledge of risk factors and their relative importance in different settings is essential to develop effective health education material for the prevention of typhoid. In this study, we examine the effect of household level and individual behavioural risk factors on the risk of typhoid in three Indonesian islands (Sulawesi, Kalimantan and Papua) in the Eastern Indonesian archipelago encompassing rural, peri-urban and urban areas. Methods We enrolled 933 patients above 10 years of age in a health facility-based case-control study between June 2010 and June 2011. Individuals suspected of typhoid were tested using the typhoid IgM lateral flow assay for the serodiagnosis of typhoid fever followed by blood culture testing. Cases and controls were defined post-recruitment: cases were individuals with a culture or serology positive result (n = 449); controls were individuals negative to both serology and culture, with or without a diagnosis other than typhoid (n = 484). Logistic regression was used to examine the effect of household level and individual level behavioural risk factors and we calculated the population attributable fraction (PAF) of removing each risk significant independent behavioural risk factor. Results Washing hands at critical moments of the day and washing hands with soap were strong independent protective factors for typhoid (OR = 0.38 95% CI 0.25 to 0.58 for each unit increase in hand washing frequency score with values between 0 = Never and 3 = Always; OR = 3.16 95% CI = 2.09 to 4.79 comparing washing hands with soap sometimes/never vs. often). These effects were independent of levels of access to water and sanitation. Up to two thirds of cases could be prevented by compliance to these practices (hand washing PAF = 66.8 95% CI 61.4 to 71.5; use of soap PAF = 61.9 95% CI 56.7 to 66.5). Eating food out in food stalls or restaurant was an important risk factor (OR = 6.9 95% CI 4.41 to 10.8 for every unit increase in frequency score). Conclusions Major gains could potentially be achieved in reducing the incidence of typhoid by ensuring adherence to adequate hand-washing practices alone. This confirms that there is a pivotal role for 'software' related interventions to encourage behavior change and create demand for goods and services, alongside development of water and sanitation infrastructure.	[Alba, Sandra; Bakker, Mirjam I.; Scheelbeek, Pauline F. D.; Pastoor, Rob; van Beers, Stella; Smits, Henk L.] Royal Trop Inst KIT, KIT Biomed Res, Amsterdam, Netherlands; [Hatta, Mochammad; Dwiyanti, Ressy; Usman, Romi; Sultan, Andi R.; Sabir, Muhammad] Hasanuddin Univ, Fac Med, Mol Biol & Immunol Lab, Dept Med Microbiol, Makassar, South Sulawesi, Indonesia; [Tandirogang, Nataniel; Amir, Masyhudi; Yasir, Yadi] Mulawarman Univ, Fac Med, Dept Microbiol, Samarinda, East Kalimantan, Indonesia	Universitas Hasanuddin; Universitas Mulawarman	Alba, S (corresponding author), Royal Trop Inst KIT, KIT Biomed Res, Amsterdam, Netherlands.	s.alba@kit.nl	Alba, Sandra/AAQ-7009-2021; HATTA, MOCHAMMAD/D-3742-2019; Tandirogang, Nataniel/AAB-6070-2021; , Yadi/A-7428-2015	HATTA, MOCHAMMAD/0000-0002-8456-4203; Tandirogang, Nataniel/0000-0001-6814-7357; , Yadi/0000-0002-4740-6222; Mallongi, Anwar/0000-0001-6438-1154; Dwiyanti, Ressy/0000-0003-2377-3965	UBS Optimus Foundation	UBS Optimus Foundation	This study was funded by the UBS Optimus Foundation with a grant awarded on 5 October 2009 (https://www.ubs.com/global/en/wealth_management/optimusfoundation.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agtini MD, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-89; Andy Peal, 2010, HYGIENE SANITATION S; Anwar E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub3; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; DeRoeck D, 2008, EXPERT REV VACCINES, V7, P547, DOI 10.1586/14760584.7.5.547; Ejemot RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub2; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS COUNTR; LaFond AK., 1995, REV SANITATION PROGR; Moore CE, 2014, AM J TROP MED HYG, V90, P114, DOI 10.4269/ajtmh.13-0384; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Ochiai RL, 2007, CLIN INFECT DIS, V45, pS34, DOI 10.1086/518144; Pastoor R, 2008, DIAGN MICR INFEC DIS, V61, P129, DOI 10.1016/j.diagmicrobio.2007.12.014; Statistics Indonesia National Population and Family Planning Board Ministry of Health of the Republic of Indonesia and ICF International, 2013, IND DEM HLTH SURV 20; Sutiono Agung Budi, 2010, BMC Res Notes, V3, P106, DOI 10.1186/1756-0500-3-106; Varley RCG, 1998, B WORLD HEALTH ORGAN, V76, P617; Velema JP, 1997, TROP MED INT HEALTH, V2, P1088, DOI 10.1046/j.1365-3156.1997.d01-179.x; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607	23	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155286	10.1371/journal.pone.0155286	http://dx.doi.org/10.1371/journal.pone.0155286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281311	Green Submitted, gold, Green Published			2022-12-27	WOS:000377563000002
J	Meng, YM; Chen, X; Peng, Z; Liu, XX; Sun, YF; Dai, SM				Meng, Yuming; Chen, Xiang; Peng, Zheng; Liu, Xuexiang; Sun, Yifan; Dai, Shengming			Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CARDIOVASCULAR RISK-FACTORS; NONOBESE WOMEN; PLASMA HOMOCYSTEINE; INSULIN-RESISTANCE; OXIDATIVE STRESS; ASYMMETRIC DIMETHYLARGININE; SYNDROME PCOS; YOUNG-WOMEN; METFORMIN; MARKERS	Background Elevated homocysteine levels have been observed in previous studies of PCOS; however, the nature of the associations between high homocysteine levels and the biochemical characteristics of polycystic ovarian syndrome (PCOS)-such as obesity, insulin resistance (IR), and androgen levels-is still uncertain. Methods A systematic search was conducted electronically up to December 28, 2015 using specific eligibility criteria. Standardized mean difference (SMD) and the corresponding 95% confidence intervals (95% CIs) were used as a measure of effect size. Results A total of 34 studies (with 1,718 cases and 1,399 controls) of homocysteine levels in PCOS were pooled in this meta-analysis. Significantly lower homocysteine levels were found in controls than in PCOS patients (SMD = 0.895, 95% CI = 0.643-1.146, P<0.001; I-2 = 90.4% and P<0.001 for heterogeneity), regardless of the degree of obesity, IR, or androgen levels. Homocysteine levels in non-IR PCOS patients were significantly lower than those of PCOS patients with IR (SMD = 0.69, 95% CI = 0.37-1.01, P<0.01; I-2 = 0% and P = 0.50 for heterogeneity). However, metformin treatment did not appear to cause any significant change in the homocysteine levels of PCOS patients (SMD = -0.17, 95% CI = -1.10-0.75, P = 0.71; I-2 = 92% and P<0.01 for heterogeneity). Conclusions High homocysteine levels in women with PCOS are not related to degree of obesity, IR, or androgen levels. Metformin treatment cannot decrease the homocysteine levels in PCOS patients.	[Meng, Yuming; Chen, Xiang; Peng, Zheng; Liu, Xuexiang; Dai, Shengming] Guangxi Med Univ, Affiliated Hosp 4, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China; [Sun, Yifan] Liuzhou Hosp Tradit Chinese Med, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China	Guangxi Medical University	Dai, SM (corresponding author), Guangxi Med Univ, Affiliated Hosp 4, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China.	daishm@sina.com	Peng, Zheng/ABH-3205-2021	Peng, Zheng/0000-0001-9117-840X				Arikan S, 2010, GYNECOL ENDOCRINOL, V26, P161, DOI 10.3109/09513590903247816; Atamer A, 2008, J INT MED RES, V36, P96, DOI 10.1177/147323000803600113; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Battaglia C, 2008, OBSTET GYNECOL, V111, P385, DOI 10.1097/01.AOG.0000296657.41236.10; Bayrak T, 2012, GYNECOL ENDOCRINOL, V28, P874, DOI 10.3109/09513590.2012.683068; Bayraktar F, 2004, ENDOCR J, V51, P601, DOI 10.1507/endocrj.51.601; Bickerton AST, 2005, J CLIN PATHOL, V58, P151, DOI 10.1136/jcp.2003.015271; Caglar GS, 2011, FERTIL STERIL, V95, P310, DOI 10.1016/j.fertnstert.2010.06.092; Cetinkalp S, 2009, J ASSIST REPROD GEN, V26, P1, DOI 10.1007/s10815-008-9280-8; Curro M, 2014, NEUROCHEM RES, V39, P1485, DOI 10.1007/s11064-014-1338-7; Daniilidis A, 2009, HIPPOKRATIA, V13, P90; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Deveer R, 2012, GYNECOL ENDOCRINOL, V28, P602, DOI 10.3109/09513590.2011.650758; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ESHRE TR, 2004, FERTIL STERIL, V81, P19; Faeh D, 2006, SWISS MED WKLY, V136, P745; Fulghesu A, 2010, J ADOLESCENT HEALTH, V46, P474, DOI 10.1016/j.jadohealth.2009.10.008; Grodnitskaya EE, 2012, GYNECOL ENDOCRINOL, V28, P186, DOI 10.3109/09513590.2011.589927; Guzelmeric K, 2007, GYNECOL ENDOCRINOL, V23, P505, DOI 10.1080/09513590701554306; Harmanci A, 2013, CLIN ENDOCRINOL, V78, P120, DOI 10.1111/j.1365-2265.2012.04466.x; Haydardedeoglu B, 2009, INT J GYNECOL OBSTET, V105, P32, DOI 10.1016/j.ijgo.2008.11.039; Hemati T, 2011, IRAN J REPROD MED, V9, P223; Heutling D, 2008, J CLIN ENDOCRINOLOGY; Karadeniz M, 2010, ENDOCRINE, V38, P127, DOI 10.1007/s12020-010-9370-0; Karaer A, 2010, J OBSTET GYNAECOL, V30, P387, DOI 10.3109/01443611003763408; Kaya C, 2010, FERTIL STERIL, V94, P230, DOI 10.1016/j.fertnstert.2009.02.076; Kaya C, 2009, REPROD BIOMED ONLINE, V19, P721, DOI 10.1016/j.rbmo.2009.06.005; Kilic-Okman T, 2004, ENDOCR J, V51, P505, DOI 10.1507/endocrj.51.505; Kilicdag EB, 2005, HUM REPROD, V20, P1521, DOI 10.1093/humrep/deh825; Kirchengast S, 2001, MATURITAS, V39, P133, DOI 10.1016/S0378-5122(01)00205-5; Lin YH, 2013, EUR J OBSTET GYN R B, V171, P314, DOI 10.1016/j.ejogrb.2013.09.041; Maleedhu P, 2014, J CLIN DIAGN RES, V8, P31, DOI 10.7860/JCDR/2014/7070.3999; Miranda-Furtado CL, 2015, REPROD SCI; Mohamadin AM, 2010, ANN SAUDI MED, V30, P278, DOI 10.4103/0256-4947.65255; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moti M, 2015, INT J REPROD BIOMED, V13, P373; Murri M, 2013, HUM REPROD UPDATE, V19, P268, DOI 10.1093/humupd/dms059; Nafiye Y, 2010, FERTIL STERIL, V93, P1864, DOI 10.1016/j.fertnstert.2008.12.024; NAURATH HJ, 1995, LANCET, V346, P85, DOI 10.1016/S0140-6736(95)92113-3; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Oktem M, 2009, FERTIL STERIL, V91, P2545, DOI 10.1016/j.fertnstert.2008.03.039; Orio F, 2003, J CLIN ENDOCR METAB, V88, P673, DOI 10.1210/jc.2002-021142; Palep-Singh M, 2007, Hum Fertil (Camb), V10, P33, DOI 10.1080/14647270600950157; Rajagopal G, 2012, METAB SYNDR RELAT D, V10, P273, DOI 10.1089/met.2011.0127; Sahin Y, 2007, CLIN ENDOCRINOL, V67, P904, DOI 10.1111/j.1365-2265.2007.02985.x; Salehpour S, 2011, INT J FERTIL STERIL, V4, P168; Schachter M, 2007, FERTIL STERIL, V88, P227, DOI 10.1016/j.fertnstert.2006.11.071; Schneede J, 2000, SEMIN THROMB HEMOST, V26, P263, DOI 10.1055/s-2000-8471; Sen TA, 2011, J PEDIATR ADOL GYNEC, V24, P211, DOI 10.1016/j.jpag.2011.02.007; Soares GM, 2009, CLIN ENDOCRINOL, V71, P406, DOI 10.1111/j.1365-2265.2008.03506.x; Temel I, 2010, TURK J MED SCI, V40, P221, DOI 10.3906/sag-0904-56; Topcu S, 2006, HUM REPROD, V21, P930, DOI 10.1093/humrep/dei431; Toulis KA, 2011, HUM REPROD UPDATE, V17, P741, DOI 10.1093/humupd/dmr025; Vrbikova J, 2002, EXP CLIN ENDOCR DIAB, V110, P74, DOI 10.1055/s-2002-23489; Wells G, 2000, NEWCASTLE OTTAWA SCA; Yarali H, 2001, FERTIL STERIL, V76, P511, DOI 10.1016/S0015-0282(01)01937-9; Yilmaz M, 2005, HUM REPROD, V20, P3333, DOI 10.1093/humrep/dei258; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	59	18	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157389	10.1371/journal.pone.0157389	http://dx.doi.org/10.1371/journal.pone.0157389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281026	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000120
J	Rogge, J; Kittel, B				Rogge, Jana; Kittel, Bernhard			Who Shall Not Be Treated: Public Attitudes on Setting Health Care Priorities by Person-Based Criteria in 28 Nations	PLOS ONE			English	Article							PREFERENCES; WELFARE; VIEWS; REDISTRIBUTION; RESPONSIBILITY; DELIBERATION; RESOURCES; RELEVANCE; CITIZENS; FAIRNESS	The principle of distributing health care according to medical need is being challenged by increasing costs. As a result, many countries have initiated a debate on the introduction of explicit priority regulations based on medical, economic and person-based criteria, or have already established such regulations. Previous research on individual attitudes towards setting health care priorities based on medical and economic criteria has revealed consistent results, whereas studies on the use of person-based criteria have generated controversial findings. This paper examines citizens' attitudes towards three person-based priority criteria, patients' smoking habits, age and being the parent of a young child. Using data from the ISSP Health Module (2011) in 28 countries, logistic regression analysis demonstrates that self-interest as well as socio-demographic predictors significantly influence respondents' attitudes towards the use of person-based criteria for health care prioritization. This study contributes to resolving the controversial findings on person-based criteria by using a larger country sample and by controlling for country-level differences with fixed effects models.	[Rogge, Jana] Carl von Ossietzky Univ Oldenburg, Dept Special Educ & Rehabil, D-26111 Oldenburg, Germany; [Kittel, Bernhard] Univ Vienna, Dept Econ Sociol, Vienna, Austria	Carl von Ossietzky Universitat Oldenburg; University of Vienna	Rogge, J (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Special Educ & Rehabil, D-26111 Oldenburg, Germany.	jana.rogge@uni-oldenburg.de		Kittel, Bernhard/0000-0001-9799-8310				Allison PD, 2009, FIXED EFFECT REGRESS; Anand P, 2001, J ECON PSYCHOL, V22, P247, DOI 10.1016/S0167-4870(01)00031-9; Andress HJ, 2001, EUR SOCIOL REV, V17, P337, DOI 10.1093/esr/17.4.337; [Anonymous], 2011, THESIS; Arts W, 2001, ACTA SOCIOL, V44, P283, DOI 10.1177/000169930104400401; Beske F, 2010, BEDARFSGERECHTE GESU; Bies R.J., 1993, EMPL RESPONSIB RIGHT, V6, P227, DOI [10.1007/BF01419446, DOI 10.1007/BF01419446]; Bobbert M, 2003, G G WISSENSCHAFT, V3, P7; BOWIE C, 1995, BMJ-BRIT MED J, V311, P1155, DOI 10.1136/bmj.311.7013.1155; Bowling A, 1996, BRIT MED J, V312, P670; Busse R, 2010, BUNDESGESUNDHEITSBLA, V53, P882, DOI 10.1007/s00103-010-1115-y; Cappelen AW, 2006, HEALTH POLICY, V76, P312, DOI 10.1016/j.healthpol.2005.06.013; Cappelen AW, 2005, J MED ETHICS, V31, P476, DOI 10.1136/jme.2004.010421; CHARNY MC, 1989, SOC SCI MED, V28, P1331, DOI 10.1016/0277-9536(89)90352-3; Chinitz D, 1997, HEALTH AFFAIR, V16, P205, DOI 10.1377/hlthaff.16.5.205; CROPPER ML, 1994, J RISK UNCERTAINTY, V8, P243, DOI 10.1007/BF01064044; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Diederich A, 2012, 655 FOR, P35; Diederich A, 2010, 655 FOR, P27; Dolan P, 1999, BRIT MED J, V318, P916, DOI 10.1136/bmj.318.7188.916; Dolan P, 2005, HEALTH ECON, V14, P197, DOI 10.1002/hec.924; Dolan Paul, 2003, Health Expect, V6, P53, DOI 10.1046/j.1369-6513.2003.00210.x; Esser H., 1999, SOZIOLOGIE SPEZIELLE, V1; Evans JG, 1997, BRIT MED J, V314, P822, DOI 10.1136/bmj.314.7083.822; Farrant A, 2009, J MED ETHICS, V35, P53, DOI 10.1136/jme.2007.023762; Fuchs C, 2011, DTSCH ARZTEBLATT, V108, P1356; Gallego G, 2007, HEALTH EXPECT, V10, P224, DOI 10.1111/j.1369-7625.2007.00439.x; Gendall P., 2011, STUDY MONITORING 201; Green C, 2009, HEALTH ECON, V18, P951, DOI 10.1002/hec.1414; Hanmer MJ, 2013, AM J POLIT SCI, V57, P263, DOI 10.1111/j.1540-5907.2012.00602.x; Johannesson M, 1996, HEALTH POLICY, V37, P153, DOI 10.1016/S0168-8510(96)90022-6; Kahneman D., 1986, J BUS, V59, P285, DOI DOI 10.1086/296367; Klugel J, 1986, BELIEFS INEQUALITY A; Lees Ann, 2002, Health Expect, V5, P47, DOI 10.1046/j.1369-6513.2002.00157.x; Lenaghan J, 1999, HEALTH POLICY, V49, P45, DOI 10.1016/S0168-8510(99)00042-1; Liebig S., 2009, AUS POLITIK ZEITGESC, V47, P3; Liedtke A, 2009, PRIORISIERUNG GESUND; Linos K, 2003, EUR SOCIOL REV, V19, P393, DOI 10.1093/esr/19.4.393; Marckmann G, 2010, Z WIRTSCHAFTS UNTERN, V10, P8; Mossialos E, 1999, HEALTH POLICY, V49, P75, DOI 10.1016/S0168-8510(99)00044-5; Myllykangas M, 2003, J HEALTH ORGAN MANAG, V17, P228; NORD E, 1995, SOC SCI MED, V41, P1429, DOI 10.1016/0277-9536(95)00121-M; OECD, 2015, HLTH STAT 2015 FOC H; Olsen JA, 2003, SOC SCI MED, V57, P1163, DOI 10.1016/S0277-9536(02)00492-6; Post S., 1994, HLTH CARE AGING POPU, P35; Richardson A, 1997, J Manag Med, V11, P222, DOI 10.1108/02689239710177332; Ryynanen OP, 1999, SOC SCI MED, V49, P1529, DOI 10.1016/S0277-9536(99)00222-1; Sabik LM, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-4; Schwappach DLB, 2003, HEALTH ECON, V12, P255, DOI 10.1002/hec.713; Shani S, 2000, HEALTH POLICY, V54, P169, DOI 10.1016/S0168-8510(00)00109-3; Shmueli A, 2000, ISR MED ASSOC J, V2, P746; Staber J, 2010, GESELLSCHAFT GESUNDH, V10, P16; Starke P, 2010, J HEALTH POLIT POLIC, V35, P487, DOI 10.1215/03616878-2010-014; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Svallfors S, 1997, EUR SOCIOL REV, V13, P283, DOI 10.1093/oxfordjournals.esr.a018219; Tinghog G, 2016, ETHICAL PSYCHOL CHAL; Tragake E, 1998, KEY ISSUES RATIONING; van Exel J, 2015, SOC SCI MED, V126, P128, DOI 10.1016/j.socscimed.2014.12.023; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Werntoft E, 2007, HEALTH EXPECT, V10, P117, DOI 10.1111/j.1369-7625.2006.00426.x; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B; Wilmot Stephen, 2002, Health Expect, V5, P199, DOI 10.1046/j.1369-6513.2002.00176.x; Winkelhage J, 2012, INT J ENV RES PUB HE, V9, P223, DOI 10.3390/ijerph9010223; World Bank, 2011, PPP CONV FACT PRIV C; ZWEIBEL NR, 1993, GERONTOLOGIST, V33, P74, DOI 10.1093/geront/33.1.74	65	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157018	10.1371/journal.pone.0157018	http://dx.doi.org/10.1371/journal.pone.0157018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280775	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000377563000068
J	Abram, NK; MacMillan, DC; Xofis, P; Ancrenaz, M; Tzanopoulos, J; Ong, R; Goossens, B; Koh, LP; Del Valle, C; Peter, L; Morel, AC; Lackman, I; Chung, R; Kler, H; Ambu, L; Baya, W; Knight, AT				Abram, Nicola K.; MacMillan, Douglas C.; Xofis, Panteleimon; Ancrenaz, Marc; Tzanopoulos, Joseph; Ong, Robert; Goossens, Benoit; Koh, Lian Pin; Del Valle, Christian; Peter, Lucy; Morel, Alexandra C.; Lackman, Isabelle; Chung, Robin; Kler, Harjinder; Ambu, Laurentius; Baya, William; Knight, Andrew T.			Identifying Where REDD plus Financially Out-Competes Oil Palm in Floodplain Landscapes Using a Fine-Scale Approach	PLOS ONE			English	Article							ECOSYSTEM SERVICES; FOREST DEGRADATION; CARBON STOCKS; CONSERVATION; DEFORESTATION; EMISSIONS; PAYMENTS; BIODIVERSITY; WILLINGNESS; MANAGEMENT	Reducing Emissions from Deforestation and forest Degradation (REDD+) aims to avoid forest conversion to alternative land-uses through financial incentives. Oil-palm has high opportunity costs, which according to current literature questions the financial competitiveness of REDD+ in tropical lowlands. To understand this more, we undertook regional fine-scale and coarse-scale analyses (through carbon mapping and economic modelling) to assess the financial viability of REDD+ in safeguarding unprotected forest (30,173 ha) in the Lower Kinabatangan floodplain in Malaysian Borneo. Results estimate 4.7 million metric tons of carbon (MgC) in unprotected forest, with 64% allocated for oil-palm cultivations. Through fine-scale mapping and carbon accounting, we demonstrated that REDD+ can outcompete oil-palm in regions with low suitability, with low carbon prices and low carbon stock. In areas with medium oil-palm suitability, REDD+ could outcompete oil palm in areas with: very high carbon and lower carbon price; medium carbon price and average carbon stock; or, low carbon stock and high carbon price. Areas with high oil palm suitability, REDD+ could only outcompete with higher carbon price and higher carbon stock. In the coarse-scale model, oil-palm outcompeted REDD+ in all cases. For the fine-scale models at the landscape level, low carbon offset prices (US $3 MgCO(2)e) would enable REDD+ to outcompete oil-palm in 55% of the unprotected forests requiring US $27 million to secure these areas for 25 years. Higher carbon offset price (US $30 MgCO(2)e) would increase the competitiveness of REDD+ within the landscape but would still only capture between 69%-74% of the unprotected forest, requiring US $380-416 million in carbon financing. REDD+ has been identified as a strategy to mitigate climate change by many countries (including Malaysia). Although REDD+ in certain scenarios cannot outcompete oil palm, this research contributes to the global REDD+ debate by: highlighting REDD+ competitiveness in tropical floodplain landscapes; and, providing a robust approach for identifying and targeting limited REDD+ funds.	[Abram, Nicola K.] Living Landscape Alliance, 110 Maui Court,Jalan Aru, Kota Kinabalu 88100, Sabah, Malaysia; [Abram, Nicola K.; Knight, Andrew T.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Abram, Nicola K.; Ancrenaz, Marc; Lackman, Isabelle; Kler, Harjinder] HUTAN Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu 88874, Sabah, Malaysia; [Abram, Nicola K.; MacMillan, Douglas C.; Tzanopoulos, Joseph] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Marlowe Bldg, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc] Borneo Futures Initiat, Jakarta 15412, Indonesia; [Xofis, Panteleimon] Technol Educ Inst Kavala, Dept Forestry & Management Nat Environm, GR-61100 Drama, Greece; [Ancrenaz, Marc] North England Zool Soc, Chester, Cheshire, England; [Ancrenaz, Marc; Goossens, Benoit; Baya, William] Sabah Wildlife Dept, Kota Kinabalu 88100, Sabah, Malaysia; [Ong, Robert] Sabah Forestry Dept, Forest Res Ctr, POB 1407, Sandakan 90715, Sabah, Malaysia; [Goossens, Benoit; Peter, Lucy] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu 88100, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales; [Koh, Lian Pin] Univ Adelaide Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Del Valle, Christian] Ecosphere Capital Ltd, Althelia Ecosphere, 1 Lumley St, London W1K 6TT, England; [Morel, Alexandra C.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Chung, Robin] CH Williams Talhar & Wong Sabah Sdn Bhd, Sandakan 90715, Sabah, Malaysia; [Ambu, Laurentius] Borneo Conservat Trust, 5th Floor,Block B, Kota Kinabalu 88100, Sabah, Malaysia; [Knight, Andrew T.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England; [Knight, Andrew T.] Nelson Mandela Metropolitan Univ, Dept Bot, POB 77000, ZA-6031 Port Elizabeth, Eastern Cape, South Africa	University of Queensland; University of Kent; Pusat Penyelidikan Hutan; Cardiff University; University of Adelaide; University of Oxford; Imperial College London; Nelson Mandela University	Abram, NK (corresponding author), Living Landscape Alliance, 110 Maui Court,Jalan Aru, Kota Kinabalu 88100, Sabah, Malaysia.; Abram, NK (corresponding author), Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia.; Abram, NK (corresponding author), HUTAN Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu 88874, Sabah, Malaysia.; Abram, NK (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Marlowe Bldg, Canterbury, Kent, England.; Abram, NK (corresponding author), Borneo Futures Initiat, Jakarta 15412, Indonesia.	nicola_abram@hotmail.com	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Xofis, Panteleimon/AAG-9513-2019; Morel, Alexandra/J-4071-2019; Koh, Lian Pin/A-5794-2010; Knight, Andrew Thomas/C-8394-2009; Abram, Nicola/K-2060-2014	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Xofis, Panteleimon/0000-0003-0528-3073; Morel, Alexandra/0000-0002-0905-8079; Koh, Lian Pin/0000-0001-8152-3871; Knight, Andrew Thomas/0000-0002-6563-0500; Abram, Nicola/0000-0003-1886-7297	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London (UK); ARC Centre of Excellence in Environmental Decisions; University of Queensland (Australia); HUTAN/Kinabatangan Orangutan Conservation Programme; Althelia ecosphere; C H Williams, Talhar and Wong; Sabah Biodiversity Centre (SaBC); Economic Planning Unit (EPU); Ecosphere Capital Limited	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London (UK); ARC Centre of Excellence in Environmental Decisions(Australian Research Council); University of Queensland (Australia)(University of Queensland); HUTAN/Kinabatangan Orangutan Conservation Programme; Althelia ecosphere; C H Williams, Talhar and Wong; Sabah Biodiversity Centre (SaBC); Economic Planning Unit (EPU); Ecosphere Capital Limited	NKA would like to thank RICS Research Trust, U.S. Fish and Wildlife Service's Great Ape Fund and The Arcus Foundation (part of a larger study for the Borneo Futures initiative) for financial support; Planet Action and Trimble for providing satellite imagery and the Definiens eCognition Licence. These funders provided support either financial or in-kind support in the form of a PhD stipend, and/or project costs for lead author NKA, or software licenses/satellite imagery for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ATK acknowledges support from the Department of Life Sciences at Imperial College London (UK), and ARC Centre of Excellence in Environmental Decisions, University of Queensland (Australia) for salary contribution. The specific roles of authors are articulated in the 'author contributions' section. HUTAN/Kinabatangan Orangutan Conservation Programme [MA, HK, IL], Althelia ecosphere, Ecosphere Capital Limited [CDV] and C H Williams, Talhar and Wong [RC] provided support in the form of salaries for authors, but did not have any additional role in the study design, da collection and analysis, decision to publish, or preparation of the manuscript. These affiliations did not fund this study. CDV and RC provided guidance on this research outside of their commercial affiliation and provisioned some data. The specific roles of these authors are articulated in the 'author contributions' section.; Thanks to Sabah Biodiversity Centre (SaBC) and the Economic Planning Unit (EPU) for supporting this project. Thank you to HUTAN/KOCP staff especially Abdul Rajak Bin Saharon for his botanical expertise.	Abram NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095388; Abram NK, 2014, ECOSYST SERV, V7, P116, DOI 10.1016/j.ecoser.2013.11.004; Abram NK, 2013, UNDERSTANDING INVEST; Abram NK, 2013, SPATIAL PLANNING CON; Ancrenaz M, 2015, ORYX, V49, P465, DOI 10.1017/S0030605313001270; Angelsen A, 2008, VINNV PROGR REN MOV; [Anonymous], 2009, JAKARTA POST; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Borrego A, 2014, ECOL ECON, V101, P1, DOI 10.1016/j.ecolecon.2014.02.005; Bottrill MC, 2009, TRENDS ECOL EVOL, V24, P183, DOI 10.1016/j.tree.2008.11.007; Broch SW, 2013, ECOL ECON, V92, P78, DOI 10.1016/j.ecolecon.2011.12.017; Brown S., 1997, FAO Forestry Paper; Burnett C, 2003, ECOL MODEL, V168, P233, DOI 10.1016/S0304-3800(03)00139-X; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; Butler RA, 2009, CONSERV LETT, V2, P67, DOI 10.1111/j.1755-263X.2009.00047.x; Cacho OJ, 2014, ECOL ECON, V107, P321, DOI 10.1016/j.ecolecon.2014.09.012; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Caro-Borrero A, 2015, LAND USE POLICY, V43, P138, DOI 10.1016/j.landusepol.2014.11.008; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; CRIST EP, 1984, PHOTOGRAMM ENG REM S, V50, P343; de Koning GHJ, 2007, LANDSCAPE URBAN PLAN, V83, P255, DOI 10.1016/j.landurbplan.2007.04.010; Delacote P, 2014, RESOUR ENERGY ECON, V36, P508, DOI 10.1016/j.reseneeco.2013.07.002; den Besten JW, 2014, ENVIRON SCI POLICY, V35, P40, DOI 10.1016/j.envsci.2013.03.009; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Ebeling J, 2008, GENERATING CARBON FI, P1917; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601; Estrada M., 2010, TRADING CARBON MAGAZ, V4, ps6; Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2; Fisher B, 2011, FRONT ECOL ENVIRON, V9, P329, DOI 10.1890/100079; Fosci M, 2013, ECOL ECON, V89, P196, DOI 10.1016/j.ecolecon.2012.11.022; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Giam X, 2011, BIOL CONSERV, V144, P3149, DOI 10.1016/j.biocon.2011.10.001; Grainger A, 2011, ENVIRON SCI POLICY, V14, P127, DOI 10.1016/j.envsci.2010.10.006; Hernandez-Morcillo M, 2013, ECOL INDIC, V29, P434, DOI 10.1016/j.ecolind.2013.01.013; Heumann BW, 2011, REMOTE SENS-BASEL, V3, P2440, DOI 10.3390/rs3112440; IPCC, 2007, CLIMATE CHANGE 2007; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Larson AM, 2013, GLOBAL ENVIRON CHANG, V23, P678, DOI 10.1016/j.gloenvcha.2013.02.014; Lee JSH, 2014, AGRON SUSTAIN DEV, V34, P501, DOI 10.1007/s13593-013-0159-4; Leventon J, 2014, FOREST POLICY ECON, V44, P10, DOI 10.1016/j.forpol.2014.03.005; Levin J., 2012, ANAL INCREMENTAL FIN; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Matsuda I, 2009, INT J PRIMATOL, V30, P313, DOI 10.1007/s10764-009-9344-3; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; McMorrow J, 2001, GLOBAL ENVIRON CHANG, V11, P217, DOI 10.1016/S0959-3780(00)00059-5; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Hoang MH, 2013, LAND USE POLICY, V31, P48, DOI 10.1016/j.landusepol.2011.09.013; Molenaar JW, 2010, ANAL AGRONOMIC I CON; Monserud RA, 1990, METHOD COMP GLOBAL V, P90; Morel AC, 2011, FOREST ECOL MANAG, V262, P1786, DOI 10.1016/j.foreco.2011.07.008; MPOB, 2010, PALM OIL COST PRODUC; NRE UNDP, 2013, MAL REDD READ PROJ N; Pagiola S, 2009, ESIMATING COSTS REED; Parolin P, 2004, FOLIA GEOBOT, V39, P371, DOI 10.1007/BF02803209; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Permandu, 2010, EC TRANSF PROGR ROAD; Peters-Stanley M., 2013, MANEUVERING MOSAIC S; Peters-Stanley M, 2013, COVERING NEW GROUNDS; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Vo QT, 2012, ECOL INDIC, V23, P431, DOI 10.1016/j.ecolind.2012.04.022; Reinhardt ED, 2008, FOREST ECOL MANAG, V256, P1997, DOI 10.1016/j.foreco.2008.09.016; Rowling M, 2013, PALM OIL EXPASION TH; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sabah Forestry Department, 2007, VEGETATION ASSESSMEN; Saner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029642; Schalatek Liane, 2010, WHERES MONEY STATUS; Skutsch M, 2011, ENVIRON SCI POLICY, V14, P140, DOI 10.1016/j.envsci.2010.12.005; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Somorin OA, 2014, ENVIRON SCI POLICY, V35, P87, DOI 10.1016/j.envsci.2013.02.004; Stark D. J., 2012, Endangered Species Research, V16, P31, DOI 10.3354/esr00385; Tauli-Corpuz V., 2009, GUIDE CLIMATE CHANGE; Teoh CH, 2000, LAND USE OIL PALM IN; Tockner K., 2011, Ecohydrology and Hydrobiology, V11, P167; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; UNDP-GEF, 2013, PROJ INC WORKSH JUL; UNFCCC, 2005, RED EM DEF DEV COUNT; UNFCCC, 2009, COP ACC; Vancutsem C, 2009, INT J APPL EARTH OBS, V11, P62, DOI 10.1016/j.jag.2008.08.001; Veloo R, 2015, NJAS-WAGEN J LIFE SC, V72-73, P33, DOI 10.1016/j.njas.2014.11.001; Venter O, 2012, ANN NY ACAD SCI, V1249, P137, DOI 10.1111/j.1749-6632.2011.06306.x; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wells JA, 2013, FOREST FLOODS PEOPLE; Wertz-Kanounnikoff S., 2009, 46 CIFOR; Wich SA, 2014, CURR BIOL, V24, P1659, DOI 10.1016/j.cub.2014.05.077; Yuen JQ, 2013, FOREST ECOL MANAG, V310, P915, DOI 10.1016/j.foreco.2013.09.042; Ziegler AD, 2012, GLOBAL CHANGE BIOL, V18, P3087, DOI 10.1111/j.1365-2486.2012.02747.x	91	18	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156481	10.1371/journal.pone.0156481	http://dx.doi.org/10.1371/journal.pone.0156481			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276218	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000377561700025
J	Levitsky, J; Miller, J; Huang, XM; Gallon, L; Leventhal, JR; Mathew, JM				Levitsky, Josh; Miller, Joshua; Huang, Xuemei; Gallon, Lorenzo; Leventhal, Joseph R.; Mathew, James M.			Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses	PLOS ONE			English	Article							REGULATORY T-CELLS; LIVER-TRANSPLANT RECIPIENTS; RENAL-FUNCTION; MAMMALIAN TARGET; CYCLOSPORINE-A; RAPAMYCIN; CALCINEURIN; TACROLIMUS; INHIBITION; GENERATION	Everolimus (EVL) is a novel mTOR-inhibitor similar to sirolimus (SRL) that is used in organ transplant recipients, often in combination with tacrolimus (TAC) or mycophenolate (MPA). The current study aims to determine its effects on regulatory T cells. Increasing concentrations of EVL, MPA and TAC alone or in combination were added to MLRs of healthy volunteers. Lymphoproliferation by H-3-TdR incorporation and the percentage of newly generated CD4(+)CD127(-)CD25(+)FOXP3(+) (total Treg) and CD4(+)CD127(-)CD25(High)FOXP3(+) (natural Treg) in CFSE labeled responder cells were assessed by flow cytometry. In comparison to medium controls, EVL and other agents dose-dependently inhibited H-3-TdR incorporation in HLA-2DR-matched and HLA-mismatched MLRs (n = 3-10). However, EVL significantly amplified newly generated total and natural Tregs in CFSE labeled responder cells (p<0.05) at all concentrations, while MPA and SRL did this only at sub-therapeutic concentrations and inhibited at therapeutic levels. In contrast, TAC inhibited newly generated Tregs at all concentrations. When tested in combination with TAC, EVL failed to reverse TAC inhibition of Treg generation. Combinations of EVL and low concentrations of MPA inhibited proliferation and amplified Treg generation in an additive manner when compared to medium controls or each drug tested alone (p<0.05). The relative tolerogenic effect from high to low was EVL > SRL > MPA > TAC. If the results from these in vitro studies are extrapolated to clinical transplantation, it would suggest EVL plus low concentrations of MPA may be the most tolerogenic combination.	[Levitsky, Josh] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA; [Levitsky, Josh; Miller, Joshua; Huang, Xuemei; Gallon, Lorenzo; Leventhal, Joseph R.; Mathew, James M.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA; [Gallon, Lorenzo] Northwestern Univ, Dept Med, Div Nephrol, Feinberg Sch Med, Chicago, IL 60611 USA; [Mathew, James M.] Northwestern Univ, Dept Immunol Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Mathew, JM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Comprehens Transplant Ctr, Chicago, IL 60611 USA.; Mathew, JM (corresponding author), Northwestern Univ, Dept Immunol Microbiol, Feinberg Sch Med, Chicago, IL 60611 USA.	James-mathew@northwestern.edu	Levitsky, Josh/AAF-8662-2019	Levitsky, Josh/0000-0001-7527-6093	Novartis [CRAD001AUSNC10T]; National Institutes of Health [2R01DK25243-25A2]	Novartis(Novartis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Novartis (CRAD001AUSNC10T; https://www.novartis.com/;JL; JM & JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the funders approved the publication of the results. This work was supported by the National Institutes of Health (2R01DK25243-25A2; http://www.niddk.nih.gov; JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrani SK, 2014, AM J TRANSPLANT, V14, P356, DOI 10.1111/ajt.12543; Baan CC, 2005, TRANSPLANTATION, V80, P110, DOI 10.1097/01.TP.0000164142.98167.4B; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Benitez C, 2013, HEPATOLOGY, V58, P1824, DOI 10.1002/hep.26426; Bohne F, 2012, J CLIN INVEST, V122, P368, DOI 10.1172/JCI59411; Daniel C, 2010, P NATL ACAD SCI USA, V107, P16246, DOI 10.1073/pnas.1007422107; De Simone P, 2012, AM J TRANSPLANT, V12, P3008, DOI 10.1111/j.1600-6143.2012.04212.x; Demirkiran A, 2008, TRANSPLANTATION, V85, P783, DOI 10.1097/TP.0b013e318166910b; Fourtounas C, 2010, AM J NEPHROL, V32, P1, DOI 10.1159/000313940; Gallon L, 2015, TRANSPLANTATION, V99, P1774, DOI 10.1097/TP.0000000000000717; Game DS, 2005, AM J TRANSPLANT, V5, P454, DOI 10.1111/j.1600-6143.2005.00758.x; Gao W, 2007, AM J TRANSPLANT, V7, P1722, DOI 10.1111/j.1600-6143.2007.01842.x; Jin YP, 2014, AM J TRANSPLANT, V14, P806, DOI 10.1111/ajt.12669; Levitsky J, 2013, TRANSPLANTATION, V96, P689, DOI 10.1097/TP.0b013e31829f1607; Levitsky J, 2013, HEPATOLOGY, V57, P239, DOI 10.1002/hep.25579; Levitsky J, 2012, HUM IMMUNOL, V73, P141, DOI 10.1016/j.humimm.2011.11.008; Levitsky J, 2011, LIVER TRANSPLANT, V17, pS60, DOI 10.1002/lt.22385; Levitsky J, 2011, TRANSPLANTATION, V91, P199, DOI 10.1097/TP.0b013e318200e97; Levitsky J, 2009, TRANSPLANTATION, V88, P1303, DOI 10.1097/TP.0b013e3181bbee98; Levitsky J, 2009, HUM IMMUNOL, V70, P146, DOI 10.1016/j.humimm.2008.12.008; Merino D, 2016, IMMUNOLOGY, V148, P206, DOI 10.1111/imm.12603; Mittal SK, 2009, TRANSPLANTATION, V88, P435, DOI 10.1097/TP.0b013e3181af20fd; Mjornstedt L, 2012, AM J TRANSPLANT, V12, P2744, DOI 10.1111/j.1600-6143.2012.04162.x; Roat E, 2012, CYTOM PART A, V81A, P303, DOI 10.1002/cyto.a.22019; Sabbatini M, 2015, CLIN EXP IMMUNOL, V182, P230, DOI 10.1111/cei.12669; Saliba F, 2013, AM J TRANSPLANT, V13, P1734, DOI 10.1111/ajt.12280; Saliba F, 2011, LIVER TRANSPLANT, V17, P905, DOI 10.1002/lt.22292; San Segundo D, 2010, TRANSPL P, V42, P2871, DOI 10.1016/j.transproceed.2010.07.045; Szabo G, 2001, J INVEST MED, V49, P442, DOI 10.2310/6650.2001.33789; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Yamashita K, 2014, AM J TRANSPLANT, V14, P6; Yu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022450; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156535	10.1371/journal.pone.0156535	http://dx.doi.org/10.1371/journal.pone.0156535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275747	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700027
J	Patel, YM; Park, SL; Carmella, SG; Paiano, V; Olvera, N; Stram, DO; Haiman, CA; Le Marchand, L; Hecht, SS				Patel, Yesha M.; Park, Sungshim L.; Carmella, Steven G.; Paiano, Viviana; Olvera, Natalie; Stram, Daniel O.; Haiman, Christopher A.; Le Marchand, Loic; Hecht, Stephen S.			Metabolites of the Polycyclic Aromatic Hydrocarbon Phenanthrene in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer	PLOS ONE			English	Article							PREFERENTIAL GLUTATHIONE CONJUGATION; REGION DIOL EPOXIDE; MUTATIONAL HOTSPOTS; MASS-SPECTROMETRY; TOBACCO; CARCINOGENS; NICOTINE; GLUCURONIDATION; EXPOSURE; ADDUCTS	Results from the Multiethnic Cohort Study demonstrated significant differences in lung cancer risk among cigarette smokers from five different ethnic/racial groups. For the same number of cigarettes smoked, and particularly among light smokers, African Americans and Native Hawaiians had the highest risk for lung cancer, Whites had intermediate risk, while Latinos and Japanese Americans had the lowest risk. We analyzed urine samples from 331-709 participants from each ethnic group in this study for metabolites of phenanthrene, a surrogate for carcinogenic polycyclic aromatic hydrocarbon exposure. Consistent with their lung cancer risk and our previous studies of several other carcinogens and toxicants of cigarette smoke, African Americans had significantly (p<0.0001) higher median levels of the two phenanthrene metabolites 3-hydroxyphenanthrene (3-PheOH, 0.931 pmol/ml) and phenanthrene tetraol (PheT, 1.13 pmol/ml) than Whites (3-PheOH, 0.697 pmol/ml; PheT, 0.853 pmol/ml) while Japanese-Americans had significantly (p = 0.002) lower levels of 3-PheOH (0.621 pmol/ml) than Whites. PheT levels (0.838 pmol/ml) in Japanese-Americans were not different from those of Whites. These results are mainly consistent with the lung cancer risk of these three groups, but the results for Native Hawaiians and Latinos were more complex. We also carried out a genome wide association study in search of factors that could influence PheT and 3-PheOH levels. Deletion of GSTT1 explained 2.2% of the variability in PheT, while the strongest association, rs5751777 (p = 1.8x10-62) in the GSTT2 gene, explained 7.7% of the variability in PheT. These GWAS results suggested a possible protective effect of lower GSTT1 copy number variants on the diol epoxide pathway, which was an unexpected result. Collectively, the results of this study provide further evidence that different patterns of cigarette smoking are responsible for the higher lung cancer risk of African Americans than of Whites and the lower lung cancer risk of Japanese Americans, while other factors appear to be involved in the differing risks of Native Hawaiians and Latinos.	[Patel, Yesha M.; Park, Sungshim L.; Stram, Daniel O.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90032 USA; [Carmella, Steven G.; Paiano, Viviana; Olvera, Natalie; Hecht, Stephen S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96813 USA	University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research Center of Hawaii; University of Hawaii System	Hecht, SS (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	hecht002@umn.edu			U.S. National Cancer Institute [CA-138338]; National Cancer Institute Cancer Center [CA-77598]; NATIONAL CANCER INSTITUTE [P30CA077598, P01CA138338] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grant no. CA-138338 from the U.S. National Cancer Institute (http://www.cancer.gov). Mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, supported in part by National Cancer Institute Cancer Center Support grant no. CA-77598.	Branstetter SA, 2015, NICOTINE TOB RES, V17, P819, DOI 10.1093/ntr/ntu236; Camella SG, 2013, CHEM RES TOXICOL, V26, P1209, DOI 10.1021/tx400121n; Carmella SG, 2004, CANCER EPIDEM BIOMAR, V13, P2167; CHU I, 1992, J ENVIRON SCI HEAL B, V27, P729, DOI 10.1080/03601239209372809; CONNEY AH, 1982, CANCER RES, V42, P4875; COOPER CS, 1983, PROG DRUG METAB, V7, P295; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dipple A., 1984, ACS MONOGR SER, V182, P41, DOI DOI 10.1074/JBC.M409155200; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Fields WR, 1998, MOL PHARMACOL, V54, P298, DOI 10.1124/mol.54.2.298; Garter S, 2007, INT J CANCER, V120, P2499, DOI 10.1002/ijc.22477; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Haiman CA, 2015, PLOS ONE; Hecht SS, 2002, CARCINOGENESIS, V23, P907, DOI 10.1093/carcin/23.6.907; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2003, CANCER EPIDEM BIOMAR, V12, P1501; Hecht SS, 2011, CURR CANCER RES, P53, DOI 10.1007/978-1-61737-995-6_3; Hecht SS, 2009, CHEM RES TOXICOL, V22, P426, DOI 10.1021/tx800315m; Hochalter JB, 2011, CHEM RES TOXICOL, V24, P262, DOI 10.1021/tx100391z; Hoffmann D., 1978, POLYCYCLIC HYDROCARB, P85; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Murphy Sharon E, 2014, Carcinogenesis, V35, P2526, DOI 10.1093/carcin/bgu191; Park S-L, 2016, CARCINOGENE IN PRESS; Park SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124841; Park SL, 2015, CANCER EPIDEM BIOMAR, V24, P561, DOI 10.1158/1055-9965.EPI-14-1054; Patel YM, 2015, CANCER EPIDEM BIOMAR, V24, P119, DOI 10.1158/1055-9965.EPI-14-0815; Rodgman A., 2008, CHEM COMPONENTS TOBA; Rojas M, 2000, CARCINOGENESIS, V21, P35, DOI 10.1093/carcin/21.1.35; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Stewart BW, 2014, WORLD CANC REPORT 20, P16, DOI DOI 10.1136/oemed-2019-106012; Sundberg K, 2002, CHEM RES TOXICOL, V15, P170, DOI 10.1021/tx015546t; Suwan-Ampai P, 2009, CANCER EPIDEM BIOMAR, V18, P884, DOI 10.1158/1055-9965.EPI-08-0939; Tretyakova N, 2002, BIOCHEMISTRY-US, V41, P9535, DOI 10.1021/bi025540i; Upadhyaya P, 2010, DRUG METAB DISPOS, V38, P1397, DOI 10.1124/dmd.110.034181	40	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156203	10.1371/journal.pone.0156203	http://dx.doi.org/10.1371/journal.pone.0156203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275760	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700020
J	Ferreira, RB; Beard, KH; Crump, ML				Ferreira, Rodrigo B.; Beard, Karen H.; Crump, Martha L.			Breeding Guild Determines Frog Distributions in Response to Edge Effects and Habitat Conversion in the Brazil's Atlantic Forest	PLOS ONE			English	Article							FRAGMENTATION; ABUNDANCE; SOUTHEASTERN; AMPHIBIANS; DIVERSITY; MATRIX; SPLIT; ISLAND; LIFE; MAP	Understanding the response of species with differing life-history traits to habitat edges and habitat conversion helps predict their likelihood of persistence across changing landscape. In Brazil's Atlantic Forest, we evaluated frog richness and abundance by breeding guild at four distances from the edge of a reserve: i) 200 m inside the forest, ii) 50 m inside the forest, iii) at the forest edge, and iv) 50 m inside three different converted habitats (coffee plantation, non-native Eucalyptus plantation, and abandoned pastures, hereafter matrix types). By sampling a dry and a wet season, we recorded 622 individual frogs representing 29 species, of which three were undescribed. Breeding guild (i.e. bromeliad, leaf-litter, and water-body breeders) was the most important variable explaining frog distributions in relation to edge effects and matrix types. Leaf-litter and bromeliad breeders decreased in richness and abundance from the forest interior toward the matrix habitats. Water-body breeders increased in richness toward the matrix and remained relatively stable in abundance across distances. Number of large trees (i.e. DBH > 15 cm) and bromeliads best explained frog richness and abundance across distances. Twenty species found in the interior of the forest were not found in any matrix habitat. Richness and abundance across breeding guilds were higher in the rainy season but frog distributions were similar across the four distances in the two seasons. Across matrix types, leaf-litter species primarily used Eucalyptus plantations, whereas water-body species primarily used coffee plantations. Bromeliad breeders were not found inside any matrix habitat. Our study highlights the importance of primary forest for bromeliad and leaf-litter breeders. We propose that water-body breeders use edge and matrix habitats to reach breeding habitats along the valleys. Including life-history characteristics, such as breeding guild, can improve predictions of frog distributions in response to edge effect and matrix types, and can guide more effective management and conservation actions.	[Ferreira, Rodrigo B.; Beard, Karen H.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Ferreira, Rodrigo B.; Beard, Karen H.; Crump, Martha L.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Ferreira, Rodrigo B.] Univ Vila Velha, Lab Ecol Populacoes & Conservacao, Vila Velha, ES, Brazil; [Crump, Martha L.] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Centro Universitario Vila Velha; Utah System of Higher Education; Utah State University	Ferreira, RB (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.; Ferreira, RB (corresponding author), Utah State Univ, Ctr Ecol, Logan, UT 84322 USA.; Ferreira, RB (corresponding author), Univ Vila Velha, Lab Ecol Populacoes & Conservacao, Vila Velha, ES, Brazil.	rodrigoecologia@yahoo.com.br	Beard, Karen/B-7177-2011	Beard, Karen/0000-0003-4997-2495; Ferreira, Rodrigo/0000-0001-6099-5116	Herpetologists' League; Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [231020/2013-9]; Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES); Utah Agricultural Experiment Station, Utah State University	Herpetologists' League; Ecology Center at Utah State University; Dr. Dinesh and Kalpana Patel Fellowship; IdeaWild; Jack Berryman Institute; Rufford Foundation; Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES); Utah Agricultural Experiment Station, Utah State University	RBF received funding from The Herpetologists' League, Ecology Center at Utah State University, Dr. Dinesh and Kalpana Patel Fellowship, IdeaWild, Jack Berryman Institute, the Rufford Foundation, Centro Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 231020/2013-9), Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo (FAPES). This research was supported by the Utah Agricultural Experiment Station, Utah State University, and approved as journal paper number 8876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Antonio de Padua, 2011, Check List, V7, P542; Almeida-Gomes M, 2015, BIOTROPICA, V47, P113, DOI 10.1111/btp.12168; American Veterinary Medical Association, 2013, GUID EUTH AN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Becker CG, 2010, CONSERV BIOL, V24, P287, DOI 10.1111/j.1523-1739.2009.01324.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Both C, 2008, J NAT HIST, V42, P205, DOI 10.1080/00222930701847923; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CEBEA/CFMV CdEBeB-EA, 2013, GUIA BRAS BOAS PRAT; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Dixo M, 2008, J TROP ECOL, V24, P551, DOI 10.1017/S0266467408005282; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058093; Ferreira RB, 2012, IHERINGIA SER ZOOL, V102, P163, DOI 10.1590/S0073-47212012000200008; Fletcher RJ, 2005, J ANIM ECOL, V74, P342, DOI 10.1111/j.1365-2656.2005.00930.x; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Fundacao SOS Mata Atlantica & Instituto Nacional de Pesquisas Espaciais, 2013, ATL REM FLOR MAT ATL; Gardner TA, 2007, CONSERV BIOL, V21, P775, DOI 10.1111/j.1523-1739.2007.00659.x; Giaretta AA, 1999, BIOTROPICA, V31, P669, DOI 10.1111/j.1744-7429.1999.tb00416.x; Haddad CFB, 2013, GUIA ANTIBIOS MATA A; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Kurz DJ, 2014, BIOL CONSERV, V170, P246, DOI 10.1016/j.biocon.2013.12.027; Laurance WF, 2008, BIOL CONSERV, V141, P1731, DOI 10.1016/j.biocon.2008.05.011; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lion MB, 2014, DIVERS DISTRIB, V20, P1245, DOI 10.1111/ddi.12228; Marsh DM, 1997, CONSERV BIOL, V11, P1323, DOI 10.1046/j.1523-1739.1997.95519.x; Mendes Sergio L., 2000, Boletim do Museu de Biologia Mello Leitao, V11-12, P7; Mendiburu F, 2014, AGRICOLAE STAT PROCE; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Roedder Dennis, 2007, Salamandra, V43, P91; Santos-Pereire M, 2011, ZOOLOGIA-CURITIBA, V28, P755, DOI 10.1590/S1984-46702011000600008; Thomaz L. D., 1997, B MUSEU BIOL MELLO L, V7, P3; Tocher M., 2002, LESSONS AMAZONIA ECO, P235; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X; Venables WN., 2002, MODERN APPL STAT S, V4; Watanabe S, 2005, J TROP ECOL, V21, P85, DOI 10.1017/S0266467404002068; Wright K, 2014, CORRGRAM PLOT CORREL; Zimmerman BL, 1996, J BIOGEOGR, V23, P27, DOI 10.1046/j.1365-2699.1996.d01-218.x; Zuur Alain F., 2009, P1	50	25	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156781	10.1371/journal.pone.0156781	http://dx.doi.org/10.1371/journal.pone.0156781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272328	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000036
J	Schon, C; Paquet-Durand, F; Michalakis, S				Schoen, Christian; Paquet-Durand, Francois; Michalakis, Stylianos			Ca(v)1.4 L-Type Calcium Channels Contribute to Calpain Activation in Degenerating Photoreceptors of rd1 Mice	PLOS ONE			English	Article							D-CIS-DILTIAZEM; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; RIBBON SYNAPSES; CNG CHANNELS; MOUSE; RESCUE; BLOCKER; INHIBITORS; SUBUNIT	Retinitis pigmentosa is an inherited blinding disorder characterized by progressive degeneration and loss of photoreceptors. The exact mechanism of degeneration and cell death of photoreceptors is not known, but is thought to involve disturbed Ca2+-signaling. Ca2+ can enter the photoreceptor cell via outer segment cyclic nucleotide-gated (CNG) channels or synaptic Ca(v)1.4 L-type voltage-gated calcium channels (VGCC). Previously, we have shown that genetic ablation of the Cngb1 gene encoding the B subunit of the rod CNG channel delays the fast progressing degeneration in the rd1 mutant mouse model of retinitis pigmentosa. In this study, we crossbred rd1 mice with the Cacna1f-deficient mouse lacking the Ca(v)1.4 alpha 1 subunit of the L-type VGCC. Longitudinal in vivo examinations of photoreceptor layer thickness by optical coherence tomography revealed a significant, but not sustained delay of retinal degeneration in Cacna1f x rd1 double mutant mice compared to rd1 mice. This was accompanied by a reduction of TUNEL positive cells in the early phase of rod degeneration. Remarkably, Cacna1f x rd1 double mutant mice displayed a strong decrease in the activation of the Ca2+-dependent protease calpain during photoreceptor loss. Our results show that genetic deletion of the synaptic Ca-v 1.4 L-type VGCCs impairs calpain activation and leads to a short-term preservation of photoreceptors in the rd1 mouse.	[Schoen, Christian; Michalakis, Stylianos] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Dept Pharm, Ctr Drug Res, Munich, Germany; [Paquet-Durand, Francois] Univ Tubingen, Ctr Ophthalmol, Div Ocular Neurodegenerat, Inst Ophthalm Res, Schleichstr 4-3, D-72076 Tubingen, Germany	University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Michalakis, S (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Dept Pharm, Ctr Drug Res, Munich, Germany.; Paquet-Durand, F (corresponding author), Univ Tubingen, Ctr Ophthalmol, Div Ocular Neurodegenerat, Inst Ophthalm Res, Schleichstr 4-3, D-72076 Tubingen, Germany.	francois.paquet-durand@klinikum.uni-tuebingen.de; stylianos.michalakis@cup.lmu.de	Michalakis, Stylianos/M-4677-2019; Michalakis, Stylianos/W-2094-2018; Paquet-Durand, Francois/G-6709-2015	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Paquet-Durand, Francois/0000-0001-7355-5742	Deutsche Forschungsgemeinschaft (DFG) [EXC114]; Tistou and Charlotte Kerstan Foundation (RD-CURE)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tistou and Charlotte Kerstan Foundation (RD-CURE)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, EXC114, http://www.dfg.de/) and the Tistou and Charlotte Kerstan Foundation (RD-CURE, http://www.kerstanstiftung.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barabas P, 2010, ADV EXP MED BIOL, V664, P491, DOI 10.1007/978-1-4419-1399-9_56; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Biel M, 2007, MOL NEUROBIOL, V35, P266, DOI 10.1007/s12035-007-0025-y; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Bush RA, 2000, INVEST OPHTH VIS SCI, V41, P2697; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; Frasson M, 1999, NAT MED, V5, P1183, DOI 10.1038/13508; Katiyar R, 2015, INVEST OPHTH VIS SCI, V56, P2312, DOI 10.1167/iovs.15-16654; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Liu XN, 2013, CHANNELS, V7, P514, DOI 10.4161/chan.26376; Mercer AJ, 2011, VISUAL NEUROSCI, V28, P453, DOI 10.1017/S0952523811000356; Michalakis S, 2014, HUM MOL GENET, V23, P1538, DOI 10.1093/hmg/ddt541; Nakazawa M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/585729; Nakazawa M, 2011, OPHTHALMOLOGICA, V225, P120, DOI 10.1159/000320500; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Pawlyk BS, 2002, INVEST OPHTH VIS SCI, V43, P1912; Pearce-Kelling SE, 2001, MOL VIS, V7, P42; Read DS, 2002, EXP EYE RES, V75, P415, DOI 10.1006/exer.2002.2034; Regus-Leidig H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086769; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Schon C, 2016, HUM MOL GENET, V25, P1165, DOI 10.1093/hmg/ddv639; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Striessnig Jorg, 2014, Wiley Interdiscip Rev Membr Transp Signal, V3, P15; Zabouri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063853	30	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156974	10.1371/journal.pone.0156974	http://dx.doi.org/10.1371/journal.pone.0156974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270916	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561000054
J	Turgeon, K; Kramer, DL				Turgeon, Katrine; Kramer, Donald L.			Immigration Rates during Population Density Reduction in a Coral Reef Fish	PLOS ONE			English	Article							TERRITORIAL DAMSELFISH; CONSPECIFIC-ATTRACTION; DEPENDENT DISPERSAL; BEHAVIORAL ECOLOGY; LARVAL SETTLEMENT; MODEL SELECTION; MARINE RESERVE; LOCAL DYNAMICS; RECRUITMENT; PATTERNS	Although the importance of density-dependent dispersal has been recognized in theory, few empirical studies have examined how immigration changes over a wide range of densities. In a replicated experiment using a novel approach allowing within-site comparison, we examined changes in immigration rate following the gradual removal of territorial damselfish from a limited area within a much larger patch of continuous habitat. In all sites, immigration occurred at intermediate densities but did not occur before the start of removals and only rarely as density approached zero. In the combined data and in 5 of 7 sites, the number of immigrants was a hump-shaped function of density. This is the first experimental evidence for hump-shaped, density-dependent immigration. This pattern may be more widespread than previously recognized because studies over more limited density ranges have identified positive density dependence at low densities and negative density dependence at high densities. Positive density dependence at low density can arise from limits to the number of potential immigrants and from behavioral preferences for settling near conspecifics. Negative density dependence at high density can arise from competition for resources, especially high quality territories. The potential for non-linear effects of local density on immigration needs to be recognized for robust predictions of conservation reserve function, harvest impacts, pest control, and the dynamics of fragmented populations.	[Turgeon, Katrine; Kramer, Donald L.] McGill Univ, Dept Biol, 1205 Docteur Penfield Ave, Montreal, PQ H3A 1B1, Canada	McGill University	Turgeon, K (corresponding author), McGill Univ, Dept Biol, 1205 Docteur Penfield Ave, Montreal, PQ H3A 1B1, Canada.	katrine.turgeon@mail.mcgill.ca	Kramer, Donald L/E-9058-2011; Turgeon, Katrine/K-9980-2019	Turgeon, Katrine/0000-0002-2528-130X	Natural Sciences and Engineering Research Council (NSERC); Fonds Quebec de Recherche sur la Nature et les Technologies (FQRNT) [97423]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebec de Recherche sur la Nature et les Technologies (FQRNT)	Funded by Natural Sciences and Engineering Research Council (NSERC) Discovery grants to DLK (http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=285204, http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=388214). Natural Sciences and Engineering Research Council (NSERC) Strategic Grant to DLK (P.I.; Michael Jenkin, York University) (http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=364899), Natural Sciences and Engineering Research Council (NSERC) postgraduate scholarship to KT (http://www.nserc-crsng.gc.ca/aseoro/Details-Detailles_eng.asp?id=370685), and Fonds Quebec de Recherche sur la Nature et les Technologies (FQRNT) (http://www.frqnt.gouv.qc.ca/en/bourses-et-subventions/consulter-lesprogrammes- remplir-une-demande/bourse/programs-of-scholarships-of-2supndsup-and-3suprdsup-cycles-o7unxnhm1432651694011 Number: 97423, concours B2, comite 02A, 2004-2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Ahlering MA, 2010, CONDOR, V112, P252, DOI 10.1525/cond.2010.090239; Anderson TW, 2007, MAR ECOL PROG SER, V350, P109, DOI 10.3354/meps07135; Baird TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041819; BARTELS PJ, 1984, BEHAVIOUR, V91, P312, DOI 10.1163/156853984X00137; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; BOOTH DJ, 1992, J EXP MAR BIOL ECOL, V155, P85, DOI 10.1016/0022-0981(92)90029-A; BOUTIN S, 1985, CAN J ZOOL, V63, P106, DOI 10.1139/z85-019; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Bullock JM, 2002, DISPERSAL ECOLOGY, pxv; BURKE RD, 1986, B MAR SCI, V39, P323; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CHABOT R, 1988, MAR BIOL, V97, P45, DOI 10.1007/BF00391244; Cheney KL, 2003, J EXP MAR BIOL ECOL, V287, P1, DOI 10.1016/S0022-0981(02)00500-2; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Clobert J, 2001, DISPERSAL; Danchin Etienne, 2001, P243; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; Detto T, 2010, AM NAT, V175, pE119, DOI 10.1086/651588; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Donahue MJ, 2006, OECOLOGIA, V149, P33, DOI 10.1007/s00442-006-0419-y; Efford M, 2000, WILDLIFE RES, V27, P117, DOI 10.1071/WR99005; Eggleston DB, 2008, MAR ECOL PROG SER, V371, P213, DOI 10.3354/meps07699; FORRESTER GE, 1995, OECOLOGIA, V103, P275, DOI 10.1007/BF00328615; FOSTER SA, 1987, OIKOS, V50, P153, DOI 10.2307/3565995; FOSTER SA, 1985, ANIM BEHAV, V33, P782, DOI 10.1016/S0003-3472(85)80011-7; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; GRANT JWA, 1990, CAN J FISH AQUAT SCI, V47, P1724, DOI 10.1139/f90-197; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heg D, 2000, BEHAVIOUR, V137, P473, DOI 10.1163/156853900502187; Herrando-Perez S, 2012, OECOLOGIA, V170, P585, DOI 10.1007/s00442-012-2347-3; HESTBECK JB, 1982, OIKOS, V39, P157, DOI 10.2307/3544480; Hixon Mark A., 2002, P303, DOI 10.1016/B978-012615185-5/50018-9; ITZKOWITZ M, 1978, BEHAVIOUR, V65, P125, DOI 10.1163/156853978X00233; JONES GP, 1987, J EXP MAR BIOL ECOL, V114, P169; KARINO K, 1993, J ETHOL, V11, P99, DOI 10.1007/BF02350043; Komdeur J, 2001, BEHAV ECOL, V12, P706, DOI 10.1093/beheco/12.6.706; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; KREBS J R, 1971, Ecology (Washington D C), V52, P2, DOI 10.2307/1934734; Kritzer Jacob P., 2006, P31, DOI 10.1016/B978-012088781-1/50005-4; Lambin X, 2001, DISPERSAL, P111; LARSEN KW, 1995, CAN J ZOOL, V73, P1115, DOI 10.1139/z95-133; Lloyd-Smith JO, 2010, J THEOR BIOL, V265, P160, DOI 10.1016/j.jtbi.2010.03.032; Loe LE, 2009, P ROY SOC B-BIOL SCI, V276, P2581, DOI 10.1098/rspb.2009.0224; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; McDougall PT, 2007, BEHAV ECOL, V18, P53, DOI 10.1093/beheco/arl055; Meadows DW, 2001, BEHAVIOUR, V138, P1085, DOI 10.1163/156853901753287154; Mihoub JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027453; NEWTON I, 1992, BIOL REV, V67, P129, DOI 10.1111/j.1469-185X.1992.tb01017.x; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; ROBERTSON DR, 1986, ECOLOGY, V67, P1372, DOI 10.2307/1938693; ROBERTSON DR, 1995, OECOLOGIA, V103, P180, DOI 10.1007/BF00329078; ROBERTSON DR, 1979, ENVIRON BIOL FISH, V4, P125, DOI 10.1007/BF00005448; ROBERTSON DR, 1976, ECOLOGY, V57, P1208, DOI 10.2307/1935045; ROBERTSON DR, 1993, MAR ECOL PROG SER, V94, P105, DOI 10.3354/meps094105; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Saether BE, 1999, P ROY SOC B-BIOL SCI, V266, P113, DOI 10.1098/rspb.1999.0610; SALE PF, 1979, OECOLOGIA, V42, P159, DOI 10.1007/BF00344855; Schaub M, 2013, ECOLOGY, V94, P1828, DOI 10.1890/12-1395.1; Schmitt RJ, 1996, MAR FRESHWATER RES, V47, P449, DOI 10.1071/MF9960449; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; Stamps Judy A., 2001, P230; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; STIMSON JS, 1990, ENVIRON BIOL FISH, V29, P1, DOI 10.1007/BF00000563; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Turgeon K, 2012, J ANIM ECOL, V81, P1161, DOI 10.1111/j.1365-2656.2012.01990.x; Turgeon K, 2010, ECOLOGY, V91, P3332, DOI 10.1890/09-2015.1; Tuyttens FAM, 2000, J ANIM ECOL, V69, P567, DOI 10.1046/j.1365-2656.2000.00419.x; Waser PM, 2006, MOL ECOL, V15, P1929, DOI 10.1111/j.1365-294X.2006.02893.x; WELLINGTON GM, 1988, AM NAT, V131, P588, DOI 10.1086/284808; Wilson AG, 2008, J AVIAN BIOL, V39, P341, DOI 10.1111/j.0908-8857.2008.04239.x; Wilson J, 2002, OECOLOGIA, V130, P205, DOI 10.1007/s004420100784; Wood S., MIXED GAM COMPUTATIO; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Wormald CL, 2013, ECOL APPL, V23, P365, DOI 10.1890/12-0790.1	89	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156417	10.1371/journal.pone.0156417	http://dx.doi.org/10.1371/journal.pone.0156417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271081	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000014
J	Arai, M; Nakamura, C				Arai, Manabu; Nakamura, Chie			It's Harder to Break a Relationship When you Commit Long	PLOS ONE			English	Article							EYE-MOVEMENTS; SENTENCE; PLAUSIBILITY; EXPECTATION; CONSTRAINTS; INFORMATION; ATTACHMENT; RECOVERY	Past research has produced evidence that parsing commitments strengthen over the processing of additional linguistic elements that are consistent with the commitments and undoing strong commitments takes more time than undoing weak commitments. It remains unclear, however, whether this so-called digging-in effect is exclusively due to the length of an ambiguous region or at least partly to the extra cost of processing these additional phrases. The current study addressed this issue by testing Japanese relative clause structure, where lexical content and sentence meaning were controlled for. The results showed evidence for a digging-in effect reflecting the strengthened commitment to an incorrect analysis caused by the processing of additional adjuncts. Our study provides strong support for the dynamical, self-organizing models of sentence processing but poses a problem for other models including serial two-stage models as well as frequency-based probabilistic models such as the surprisal theory.	[Arai, Manabu] Seijo Univ, Dept Econ, Tokyo, Japan; [Nakamura, Chie] MIT, Dept Linguist & Philosophy, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nakamura, Chie] Univ Tokyo, Dept Language & Informat Sci, Tokyo, Japan; [Nakamura, Chie] Japan Soc Promot Sci, Tokyo, Japan	Massachusetts Institute of Technology (MIT); University of Tokyo; Japan Society for the Promotion of Science	Arai, M (corresponding author), Seijo Univ, Dept Econ, Tokyo, Japan.	manabu-arai@seijo.ac.jp	Nakamura, Chie/AAX-8788-2021	Nakamura, Chie/0000-0003-4534-7385	Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [26770134]	Japan Society for the Promotion of Science (JSPS KAKENHI Grant)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers 26770134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Farmer TA, 2014, P 36 ANN M COGN SCI, V1, P2181; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FERREIRA F, 1991, J MEM LANG, V30, P725, DOI 10.1016/0749-596X(91)90034-H; FERREIRA F, 1993, CAN J EXP PSYCHOL, V47, P247, DOI 10.1037/h0078819; Frazier L, 1997, J PSYCHOLINGUIST RES, V26, P277, DOI 10.1023/A:1025024524133; Frazier L., 1996, CONSTRUAL; Frazier Lyn, 1998, REANALYSIS SENTENCE, P143, DOI DOI 10.1007/978-94-015-9070-9_5; Garnsey SM, 1997, J MEM LANG, V37, P58, DOI 10.1006/jmla.1997.2512; Hale J, 2001, 2ND MEETING OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P159; Kamide Y, 1999, LANG COGNITIVE PROC, V14, P631, DOI 10.1080/016909699386211; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Koizumi M, 1993, JAPANESE KOREAN LING, P409; Koizumi M, 2006, NINTI KAGAKU, V13, P392; Konieczny Lars., JOINT INT C COGN SCI, P13; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Levy RP, 2013, J MEM LANG, V68, P199, DOI 10.1016/j.jml.2012.02.005; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; Miyamoto ET, 2002, J PSYCHOLINGUIST RES, V31, P307, DOI 10.1023/A:1019540324040; Nakamura C, 2016, COGNITIVE SCI, V40, P909, DOI 10.1111/cogs.12266; Namba E, P 6 CORP JAP SCI WOR, P165; OSAKA N, 1992, J OPT SOC AM A, V9, P5, DOI 10.1364/JOSAA.9.000005; Pickering MJ, 1998, J EXP PSYCHOL LEARN, V24, P940, DOI 10.1037/0278-7393.24.4.940; PRITCHETT BL, 1991, J PSYCHOLINGUIST RES, V20, P251, DOI 10.1007/BF01067218; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K., 1994, HDB PSYCHOLINGUISTIC, P57; Sturt P, 1999, J MEM LANG, V40, P136, DOI 10.1006/jmla.1998.2606; Tabor W, 2004, J EXP PSYCHOL LEARN, V30, P431, DOI 10.1037/0278-7393.30.2.431; Tabor W, 1997, LANG COGNITIVE PROC, V12, P211, DOI 10.1080/016909697386853; Traxler MJ, 1998, J MEM LANG, V39, P558, DOI 10.1006/jmla.1998.2600; Van Gompel RPG, 2001, J MEM LANG, V45, P283; WARNER J, 1987, J MEM LANG, V26, P714, DOI 10.1016/0749-596X(87)90111-2; Yamashita H, 1997, J PSYCHOLINGUIST RES, V26, P163, DOI 10.1023/A:1025009615473	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156482	10.1371/journal.pone.0156482	http://dx.doi.org/10.1371/journal.pone.0156482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1SU	27271881	Green Submitted, gold, Green Published			2022-12-27	WOS:000377560200011
J	Abubakar, A; Kalu, RB; Katana, K; Kabunda, B; Hassan, AS; Newton, CR; Van de Vijver, F				Abubakar, Amina; Kalu, Raphael Birya; Katana, Khamis; Kabunda, Beatrice; Hassan, Amin S.; Newton, Charles R.; Van de Vijver, Fons			Adaptation and Latent Structure of the Swahili Version of Beck Depression Inventory-II in a Low Literacy Population in the Context of HIV	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; LOW-INCOME; VALIDATION; SYMPTOM; PREVALENCE; COMMUNITY; AFRICA; PEOPLE; HEALTH	Objective We set out to adapt the Beck Depression Inventory (BDI)-II in Kenya and examine its factorial structure. Methods In the first phase we carried out in-depth interviews involving 29 adult members of the community to elicit their understanding of depression and identify aspects of the BDI-II that required adaptation. In the second phase, a modified version of BDI-II was administered to 221 adults randomly selected from the community to allow for the evaluation of its psychometric properties. In the third phase of the study we evaluated the discriminative validity of BDI-11 by comparing a randomly chosen community sample (n = 29) with caregivers of adolescents affected by HIV (n = 77). Results A considerable overlap between the BDI symptoms and those generated in the interviews was observed. Relevant idioms and symptoms such as 'thinking too much' and 'Kuchoka moyo (having a tired heart)' were identified. The administration of the BDI had to be modified to make it suitable for the low literacy levels of our participants. Fit indices for several models (one factorial, two-factor model and a three factor model) were all within acceptable range. Evidence indicated that while multidimensional models could be fitted, the strong correlations between the factors implied that a single factor model may be the best suited solution (alpha [0.89], and a significant correlation with locally identified items [r = 0.51]) confirmed the good psychometric properties of the adapted BDI-II. No evidence was found to support the hypothesis that somatization was more prevalent. Lastly, caregivers of HIV affected adolescents had significantly higher scores compared to adults randomly selected from the community F(1, 121) = 23.31, p < .001 indicating the discriminative validity of the adapted BDI = II. Conclusions With an adapted administration procedure, the BDI-II provides an adequate measure of depressive symptoms which can be used alongside other measures for proper diagnosis in a low literacy population.	[Abubakar, Amina; Kalu, Raphael Birya; Katana, Khamis; Kabunda, Beatrice; Hassan, Amin S.; Newton, Charles R.] KEMRI Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Abubakar, Amina; Van de Vijver, Fons] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Abubakar, Amina] Univ Utrecht, Utrecht, Netherlands; [Newton, Charles R.] UCL, Inst Child Hlth, Neurosci Unit, London, England; [Newton, Charles R.] London Sch Hyg & Trop Med, London WC1, England; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England; [Newton, Charles R.] Inst Child Hlth, Ctr Int Hlth & Dev, London, England; [Van de Vijver, Fons] North West Univ, Potchefstroom, South Africa; [Van de Vijver, Fons] Univ Queensland, Brisbane, Qld, Australia	Tilburg University; Utrecht University; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of London; University College London; North West University - South Africa; University of Queensland	Abubakar, A (corresponding author), KEMRI Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya.; Abubakar, A (corresponding author), Tilburg Univ, NL-5000 LE Tilburg, Netherlands.; Abubakar, A (corresponding author), Univ Utrecht, Utrecht, Netherlands.	A.AbubakarAli@uvt.nl	van de Vijver, Fons/A-4317-2012; Newton, Charles RJC/B-7578-2014; Abubakar, Amina/F-1479-2017	van de Vijver, Fons/0000-0003-0220-2485; Newton, Charles RJC/0000-0002-6999-5507; Abubakar, Amina/0000-0002-3686-7904; Hassan, Amin S./0000-0001-5296-4264	Netherlands Organisation for Scientific Research (NWO); IUPsyS and ICP Change Fellowship Award; Jacobs Foundation/NRC/International Congress of Psychology;  [400-08-198-MaGW]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); IUPsyS and ICP Change Fellowship Award; Jacobs Foundation/NRC/International Congress of Psychology; 	The study was funded by an open competition grant to Fons van de Vijver (400-08-198-MaGW) which is financed by the Netherlands Organisation for Scientific Research (NWO) and IUPsyS and ICP2012 Change Fellowship Award to Amina Abubakar; fellowship awards were funds by Jacobs Foundation/NRC/International Congress of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article is published with permission of the Director of Kemri. The study was funded by an open competition grant to Fons van de Vijver (400-08-198-MaGW) which is financed by the Netherlands Organisation for Scientific Research (NWO) and IUPsyS and ICP2012 Change Fellowship Award to Amina Abubakar; fellowship awards were funds by Jacobs Foundation/NRC/International Congress of Psychology. We would like to thank Rachel Odhiambo for data entry and management. We would also like to thank the late Dr. Victor Mung'ala-Odera, Mr. Joseph Gona and Mr. Tuva for their input and advice during the adaptation process.	Abas MA, 1997, PSYCHOL MED, V27, P59, DOI 10.1017/S0033291796004163; Abubakar A, 2008, ANN TROP PAEDIATR, V28, P217, DOI 10.1179/146532808X335679; Alcock KJ, 2008, J CROSS CULT PSYCHOL, V39, P529, DOI 10.1177/0022022108321176; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Corbiere M, 2011, CLIN J PAIN, V27, P62, DOI 10.1097/AJP.0b013e3181eef903; Cox JL, 1987, BR J PSYCHIAT, V150; Grothe KB, 2005, PSYCHOL ASSESSMENT, V17, P110, DOI 10.1037/1040-3590.17.1.110; Holding P, 2008, A SYSTEMATIC APPROAC; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kagotho N, 2012, AIDS CARE, V24, P1226, DOI 10.1080/09540121.2012.658754; Langhaug LF, 2009, J AFFECT DISORDERS, V118, P220, DOI 10.1016/j.jad.2009.02.003; Malda M., 2008, PSYCHOL SCI Q, V50, P451, DOI DOI 10.1177/0022022109349172; Nyirenda M, 2013, J AFFECT DISORDERS, V151, P31, DOI 10.1016/j.jad.2013.05.005; Osman A, 1997, J PSYCHOPATHOL BEHAV, V19, P359, DOI 10.1007/BF02229026; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 2007, BRIT MED BULL, V81-82, P81, DOI 10.1093/bmb/ldm010; Quilty LC, 2010, PSYCHOL ASSESSMENT, V22, P603, DOI 10.1037/a0019698; Rahman A, 2005, J PAK PSYCHIAT SOC, V2, P69; Skeen S, 2014, AIDS CARE, V26, pS11, DOI 10.1080/09540121.2014.906559; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; Tomlinson M, 2007, J AFFECT DISORDERS, V102, P191, DOI 10.1016/j.jad.2006.09.029; van de Vijver F, 1997, EUR REV APPL PSYCHOL, V47, P263; van de Vijver FJR, 2002, APPL PSYCHOL-INT REV, V51, P545, DOI 10.1111/1464-0597.00107; Van Hemert D.A., 2002, J HAPPINESS STUD, V3, P257, DOI DOI 10.1023/A:1020601806080; Wang YP, 2005, BRAZ J MED BIOL RES, V38, P399, DOI 10.1590/S0100-879X2005000300011; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048	30	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0151030	10.1371/journal.pone.0151030	http://dx.doi.org/10.1371/journal.pone.0151030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258530	Green Published, gold			2022-12-27	WOS:000377369700004
J	Aouar, B; Kovarova, D; Letard, S; Font-Haro, A; Florentin, J; Weber, J; Durantel, D; Chaperot, L; Plumas, J; Trejbalova, K; Hejnar, J; Nunes, JA; Olive, D; Dubreuil, P; Hirsch, I; Stranska, R				Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Font-Haro, Albert; Florentin, Jonathan; Weber, Jan; Durantel, David; Chaperot, Laurence; Plumas, Joel; Trejbalova, Katerina; Hejnar, Jiri; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena			Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; B-VIRUS; ALPHA; INTERFERON; SECRETION; RESPONSES	Crosslinking of regulatory immunoreceptors (RR), such as BDCA-2 (CD303) or ILT7 (CD85g), of plasmacytoid dendritic cells (pDCs) efficiently suppresses production of type-I interferon (IFN)-alpha/beta and other cytokines in response to Toll-like receptor (TLR) 7/9 ligands. This cytokine-inhibitory pathway is mediated by spleen tyrosine kinase (Syk) associated with the ITAM-containing adapter of RR. Here we demonstrate by pharmacological targeting of Syk that in addition to the negative regulation of TLR7/9 signaling via RR, Syk also positively regulates the TLR7/9 pathway in human pDCs. Novel highly specific Syk inhibitor AB8779 suppressed IFN-alpha, TNF-alpha and IL-6 production induced by TLR7/9 agonists in primary pDCs and in the pDC cell line GEN2.2. Triggering of TLR9 or RR signaling induced a differential kinetics of phosphorylation at Y352 and Y525/526 of Syk and a differential sensitivity to AB8779. Consistent with the different roles of Syk in TLR7/9 and RR signaling, a concentration of AB8779 insufficient to block TLR7/9 signaling still released the block of IFN-alpha production triggered via the RR pathway, including that induced by hepatitis B and C viruses. Thus, pharmacological targeting of Syk partially restored the main pDC function-IFN-alpha production. Opposing roles of Syk in TLR7/9 and RR pathways may regulate the innate immune response to weaken inflammation reaction.	[Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] Ctr Rech Cancerol Marseille, Inserm U1068, Marseille, France; [Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] CNRS, UMR7258, Marseille, France; [Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] Aix Marseille Univ, UM105, Marseille, France; [Kovarova, Denisa; Font-Haro, Albert; Trejbalova, Katerina; Hejnar, Jiri; Hirsch, Ivan] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; [Kovarova, Denisa; Font-Haro, Albert; Hirsch, Ivan] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Letard, Sebastien] AB Sci, Paris, France; [Font-Haro, Albert; Weber, Jan; Hirsch, Ivan] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic; [Durantel, David] Ctr Rech Cancerol Lyon, Inserm U1052, CNRS UMR5286, Lyon, France; [Chaperot, Laurence; Plumas, Joel] Univ Grenoble Alpes, UJF, INSERM U823, EFS Rhone Alpes, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Hirsch, I; Stranska, R (corresponding author), Ctr Rech Cancerol Marseille, Inserm U1068, Marseille, France.; Hirsch, I; Stranska, R (corresponding author), CNRS, UMR7258, Marseille, France.; Hirsch, I; Stranska, R (corresponding author), Inst J Paoli I Calmettes, F-13009 Marseille, France.; Hirsch, I; Stranska, R (corresponding author), Aix Marseille Univ, UM105, Marseille, France.; Hirsch, I (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.; Hirsch, I (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.; Hirsch, I (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic.	ivan.hirsch@inserm.fr; ruzena.stranska@kuleuven.be	Dubreuil, Patrice/V-4816-2019; Durantel, David/I-4639-2018; chaperot, laurence/N-2927-2013; Weber, Jan/B-5405-2013; Hirsch, Ivan/J-7726-2015; Font Haro, Albert/N-9267-2017; NUNES, Jacques A/F-4952-2013; dubreuil, patrice/F-5346-2011; Trejbalova, Katerina/G-4394-2014	Dubreuil, Patrice/0000-0003-1155-1150; Durantel, David/0000-0002-9226-3419; chaperot, laurence/0000-0002-1479-9410; Weber, Jan/0000-0002-2799-7352; Hirsch, Ivan/0000-0003-1701-1438; Font Haro, Albert/0000-0002-2568-3309; NUNES, Jacques A/0000-0003-4865-0400; dubreuil, patrice/0000-0003-1155-1150; LETARD, Sebastien/0000-0002-6508-7376	Grantova agentura Ceske republiky (Czech Science Foundation) [14-32547S]; Fondation ARC pour la Recherche sur le Cancer [PJA 20131200304]; Fondation pour la Recherche Medicale [SPF20121226309]; BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Ligue contre le cancer; Algerian Ministry of Higher Education and Research; Franco-Algerian Cooperation; AB Science	Grantova agentura Ceske republiky (Czech Science Foundation); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund; Ligue contre le cancer(Ligue nationale contre le cancer); Algerian Ministry of Higher Education and Research; Franco-Algerian Cooperation; AB Science	Grantova agentura Ceske republiky (Czech Science Foundation) 14-32547S (http://gacr.cz/) DK AFH KT JH IH. Fondation ARC pour la Recherche sur le Cancer, PJA 20131200304, (http://www.fondation-arc.org/) BA JAN DO IH RS. Fondation pour la Recherche Medicale, SPF20121226309, (http://www.frm.org/) RS. BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund (http://www.biocev.eu/) IH. Ligue contre le cancer (http://www.ligue-cancer.net/) BA. Algerian Ministry of Higher Education and Research, and Franco-Algerian Cooperation BA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SL is an employee of AB Science. AB Science provided support in the form of salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Carsetti L, 2009, CELL SIGNAL, V21, P1187, DOI 10.1016/j.cellsig.2009.03.007; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Dental C, 2012, J VIROL, V86, P1090, DOI 10.1128/JVI.05444-11; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Firaguay G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286pl3; Florentin J, 2012, BLOOD, V120, P4544, DOI 10.1182/blood-2012-02-413286; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glitzner E, 2014, SPECIFIC ROLES DENDR, DOI 10.15252/emmm.201404114; Gondois-Rey F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004319; Hirsch I, 2010, TRENDS IMMUNOL, V31, P391, DOI 10.1016/j.it.2010.07.004; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Luangsay S, 2015, J HEPATOL, V63, P1314, DOI 10.1016/j.jhep.2015.07.014; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Rao S, 2013, J BIOL CHEM, V288, P12448, DOI 10.1074/jbc.M113.454405; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Vincent IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026315; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	27	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156063	10.1371/journal.pone.0156063	http://dx.doi.org/10.1371/journal.pone.0156063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258042	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700030
J	Bwire, G; Mwesawina, M; Baluku, Y; Kanyanda, SSE; Orach, CG				Bwire, Godfrey; Mwesawina, Maurice; Baluku, Yosia; Kanyanda, Setiala S. E.; Orach, Christopher Garimoi			Cross-Border Cholera Outbreaks in Sub-Saharan Africa, the Mystery behind the Silent Illness: What Needs to Be Done?	PLOS ONE			English	Article							EPIDEMIC	Introduction Cross-border cholera outbreaks are a major public health problem in Sub-Saharan Africa contributing to the high annual reported cholera cases and deaths. These outbreaks affect all categories of people and are challenging to prevent and control. This article describes lessons learnt during the cross-border cholera outbreak control in Eastern and Southern Africa sub-regions using the case of Uganda-DRC and Malawi-Mozambique borders and makes recommendations for future outbreak prevention and control. Materials and Methods We reviewed weekly surveillance data, outbreak response reports and documented experiences on the management of the most recent cross-border cholera outbreaks in Eastern and Southern Africa sub-regions, namely in Uganda and Malawi respectively. Uganda-Democratic Republic of Congo and Malawi-Mozambique borders were selected because the countries sharing these borders reported high cholera disease burden to WHO. Results A total of 603 cross-border cholera cases with 5 deaths were recorded in Malawi and Uganda in 2015. Uganda recorded 118 cases with 2 deaths and CFR of 1.7%. The under-fives and school going children were the most affected age groups contributing 24.2% and 36.4% of all patients seen along Malawi-Mozambique and Uganda-DRC borders, respectively. These outbreaks lasted for over 3 months and spread to new areas leading to 60 cases with 3 deaths, CRF of 5%, and 102 cases 0 deaths in Malawi and Uganda, respectively. Factors contributing to these outbreaks were: poor sanitation and hygiene, use of contaminated water, floods and rampant cross- border movements. The outbreak control efforts mainly involved unilateral measures implemented by only one of the affected countries. Conclusions Cross-border cholera outbreaks contribute to the high annual reported cholera burden in Sub-Saharan Africa yet they remain silent, marginalized and poorly identified by cholera actors (governments and international agencies). The under-fives and the school going children were the most affected age groups. To successfully prevent and control these outbreaks, guidelines and strategies should be reviewed to assign clear roles and responsibilities to cholera actors on collaboration, prevention, detection, monitoring and control of these epidemics.	[Bwire, Godfrey] Minist Hlth Uganda, Control Diarrheal Dis Unit, Kampala, Uganda; [Mwesawina, Maurice; Kanyanda, Setiala S. E.] Minist Hlth Malawi, Lilongwe, Malawi; [Baluku, Yosia] Bwera Hosp, Minist Hlth Uganda, Kasese, Uganda; [Orach, Christopher Garimoi] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Makerere University	Bwire, G (corresponding author), Minist Hlth Uganda, Control Diarrheal Dis Unit, Kampala, Uganda.	cddmoh@yahoo.com	Bwire, Godfrey/J-7715-2019	Bwire, Godfrey/0000-0002-8376-2857	Ministry of Health of Malawi; Ministry of Health of Uganda	Ministry of Health of Malawi; Ministry of Health of Uganda	Data collection for this study was supported by the ministries of Health of Malawi and Uganda as part of the routine outbreak surveillance and response activities.	Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bhattacharya S, 2009, SCIENCE, V324, P885, DOI 10.1126/science.1173890; Bradley M, 1996, T ROY SOC TROP MED H, V90, P378, DOI 10.1016/S0035-9203(96)90512-X; Coalition for Cholera Prevention and Control, 2013, COMPR INT STRAT PREV; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; GLASS RI, 1991, LANCET, V338, P791, DOI 10.1016/0140-6736(91)90673-D; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Kasolo F, 2013, BIOSECUR BIOTERROR, V11, P163, DOI 10.1089/bsp.2013.0032; Mengel MA, 2014, T ROY SOC TROP MED H, V108, P391, DOI 10.1093/trstmh/tru077; Mengel MA, 2014, CURR TOP MICROBIOL, V379, P117, DOI 10.1007/82_2014_369; Msyamboza KP, 2014, J INFECT DEV COUNTR, V8, P720, DOI 10.3855/jidc.3506; Naidoo A, 2002, J R SOC PROMO HEALTH, V122, P89, DOI 10.1177/146642400212200209; Okeke IN, 2012, EMERG INFECT DIS, P362; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2010, WHO POS PAP; WHO, 2013, IHR NEWS        1220; WHO, 2013, CHOL SIT WHO AFR REG; WHO, 2013, OR CHOL VACC STOCKP; WHO, 2011, CHOL MECH CONTR PREV, V7, P13; World Health Organization, 2012, OB OV, P1; World Health Organization (WHO), 2016, INT HLTH REG 2005	24	30	31	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156674	10.1371/journal.pone.0156674	http://dx.doi.org/10.1371/journal.pone.0156674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258124	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700101
J	Murray, DL; Morris, D; Lavoie, C; Leavitt, PR; MacIsaac, H; Masson, MEJ; Villard, MA				Murray, Dennis L.; Morris, Douglas; lavoie, Claude; Leavitt, Peter R.; MacIsaac, Hugh; Masson, Michael E. J.; Villard, Marc-Andre			Bias in Research Grant Evaluation Has Dire Consequences for Small Universities	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH; MENTORING PROGRAMS; SCIENTIFIC IMPACT; SUCCESS; METRICS; SCIENCE; NATIONS; SELECT; BLIND	Federal funding for basic scientific research is the cornerstone of societal progress, economy, health and well-being. There is a direct relationship between financial investment in science and a nation's scientific discoveries, making it a priority for governments to distribute public funding appropriately in support of the best science. However, research grant proposal success rate and funding level can be skewed toward certain groups of applicants, and such skew may be driven by systemic bias arising during grant proposal evaluation and scoring. Policies to best redress this problem are not well established. Here, we show that funding success and grant amounts for applications to Canada's Natural Sciences and Engineering Research Council (NSERC) Discovery Grant program (2011-2014) are consistently lower for applicants from small institutions. This pattern persists across applicant experience levels, is consistent among three criteria used to score grant proposals, and therefore is interpreted as representing systemic bias targeting applicants from small institutions. When current funding success rates are projected forward, forecasts reveal that future science funding at small schools in Canada will decline precipitously in the next decade, if skews are left uncorrected. We show that a recently-adopted pilot program to bolster success by lowering standards for select applicants from small institutions will not erase funding skew, nor will several other post-evaluation corrective measures. Rather, to support objective and robust review of grant applications, it is necessary for research councils to address evaluation skew directly, by adopting procedures such as blind review of research proposals and bibliometric assessment of performance. Such measures will be important in restoring confidence in the objectivity and fairness of science funding decisions. Likewise, small institutions can improve their research success by more strongly supporting productive researchers and developing competitive graduate programming opportunities.	[Murray, Dennis L.] Trent Univ, Inst Integrat Conservat Biol, Peterborough, ON K9J 7B8, Canada; [Morris, Douglas] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [lavoie, Claude] Univ Laval, Ecole Super Amenagement Terr & Dev Reg, Quebec City, PQ G1V 0A6, Canada; [Leavitt, Peter R.] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [MacIsaac, Hugh] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Masson, Michael E. J.] Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8W 2Y2, Canada; [Villard, Marc-Andre] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada	Trent University; Lakehead University; Laval University; University of Regina; University of Windsor; University of Victoria; University of Moncton	Murray, DL (corresponding author), Trent Univ, Inst Integrat Conservat Biol, Peterborough, ON K9J 7B8, Canada.	dennismurray@trentu.ca	lafreniere, judy/R-9281-2016; Bah, Idiatou/R-9375-2016; GAO, Jianan/R-6090-2016; Bojanowski, Angelique/R-8243-2016; Leavitt, Peter R/A-1048-2013; macisaac, hugh/AAE-3742-2020; DANSOU, dossa Hyppolite/R-9367-2016; Lavoie, Claude/A-1601-2011	Leavitt, Peter R/0000-0001-9805-9307; Masson, Michael/0000-0002-5430-6078; Lavoie, Claude/0000-0001-6510-5178	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We are grateful to NSERC for providing access to the Discovery Grant funding dataset. The conclusions emerging from this work are exclusively those of the authors and do not necessarily reflect the opinions of NSERC.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Belanger CH, 1989, CAN J HIGHER ED, V19, P13; Bornmann L, 2004, BIF FUTURA, V19, P7; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Bornmann Mungra P, 2011, EUR SCI EDIT, V37, P41; Budden AE, 2008, TRENDS ECOL EVOL, V23, P4, DOI 10.1016/j.tree.2007.07.008; Campbell D, 2010, AM J EVAL, V31, P66, DOI 10.1177/1098214009354774; Carr JP, 2013, BIOSCIENCE, V63, P922, DOI 10.1525/bio.2013.63.12.3; CHUBIN DE, 1994, EVALUATION REV, V18, P20, DOI 10.1177/0193841X9401800103; Cimini G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113470; Day TE, 2015, RES POLICY, DOI org/10.1016/j.respol.2015.01.006; Demicheli V, 2007, COCHRANE DB SYST REV, V2007; Ferreira C, 2016, BIOL REV, V91, P597, DOI 10.1111/brv.12185; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; Fullerton AS, 2009, SOCIOL METHOD RES, V38, P306, DOI 10.1177/0049124109346162; Furrow D, 1996, RES 2 SMALL CANADIAN, V26, P57; Geuna A, 2003, MINERVA, V41, P277, DOI 10.1023/B:MINE.0000005155.70870.bd; Heinze T, 2009, RES POLICY, V38, P610, DOI 10.1016/j.respol.2009.01.014; Hemmings B, 2010, J HIGH EDUC POLICY M, V32, P185, DOI 10.1080/13600800903575520; Hosmer D. W., 2013, APPL LOGISTIC REGRES; International Review Committee, 2009, REP INT REV COMM DIS; International Review Panel, 2014, EV NSERCS DISC PROGR; Kaatz A, 2014, TRENDS PHARMACOL SCI, V35, P371, DOI 10.1016/j.tips.2014.06.005; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Laudel G, 2008, HIGH EDUC, V55, P387, DOI 10.1007/s10734-007-9063-7; Lee CJ, 2013, J AM SOC INF SCI TEC, V64, P2, DOI 10.1002/asi.22784; Lee M, 2000, SCIENTOMETRICS, V48, P99, DOI 10.1023/A:1005636503358; Li D, 2015, SCIENCE, V348, P434, DOI 10.1126/science.aaa0185; Ma A, 2015, P NATL ACAD SCI USA, V112, P14760, DOI 10.1073/pnas.1513651112; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Marsh HW, 2009, REV EDUC RES, V79, P1290, DOI 10.3102/0034654309334143; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; Morris W. F., 2002, QUANTITATIVE CONSERV; Murray D. L., 2006, WILDLIFE MONOGRAPHS, V166; Neufeld J, 2013, RES EVALUAT, V22, P237, DOI 10.1093/reseval/rvt014; Owen M, 1992, CANADIAN J HIGHER ED, V22, P1; Scheiner SM, FRONT ECOL ENV, V11, P406; Stallings J, 2013, P NATL ACAD SCI USA, V110, P9680, DOI 10.1073/pnas.1220184110; TRAVIS GDL, 1991, SCI TECHNOL HUM VAL, V16, P322, DOI 10.1177/016224399101600303; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; von Bartheld CS, 2015, PEERJ, V3, DOI 10.7717/peerj.1262; Wasserstein AG, 2007, J GEN INTERN MED, V22, P210, DOI 10.1007/s11606-006-0051-x; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1; Zellers DF, 2008, REV EDUC RES, V78, P552, DOI 10.3102/0034654308320966	44	25	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155876	10.1371/journal.pone.0155876	http://dx.doi.org/10.1371/journal.pone.0155876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258385	Green Published, gold			2022-12-27	WOS:000377369700024
J	Lee, KS; Yu, J; Shim, D; Choi, H; Jang, MY; Kim, KR; Choi, JH; Cho, SH				Lee, Kyung Suk; Yu, Jinho; Shim, Dahee; Choi, Hana; Jang, Man-Young; Kim, Kyung Rae; Choi, Jae-Hoon; Cho, Seok Hyun			Local Immune Responses in Children and Adults with Allergic and Nonallergic Rhinitis	PLOS ONE			English	Article							IDIOPATHIC RHINITIS; IGE ANTIBODIES; REGULATORY-T; B-CELLS; PREVALENCE; ABSENCE; ASTHMA; SKIN; INFLAMMATION; DIVERSITY	Background Allergic rhinitis (AR) is the most common allergic disease but little is known about the difference of local immune responses in children and adults with AR. Objective To compare local immune responses between children and adults with AR and nonallergic rhinitis (NAR), and to investigate whether the association of local and systemic immune responses is different between the two age groups. Methods Fifty-one patients with chronic rhinitis were enrolled and grouped into children (N = 27, mean age 7.2 years) and adults (N = 24, mean age 29.9 years). Diagnosis of AR was based on symptoms, skin prick tests and serum specific IgEs. Nasal lavage (NAL) fluids were collected from all subjects and used to measure the levels of total IgE, specific IgEs to house dust mites (Dp and Df), and cytokines (TNF-alpha, IL-4, IL-10, IL-17A and IFN-gamma). Flow cytometry was used to measure inflammatory cell types in NAL fluids. Results AR had significantly increased local levels of total IgE and specific IgEs to Dp and Df compared with NAR in both age groups (P < 0.05). Nasal eosinophils %(P = 0.01) was significantly increased only in children with AR. Local-systemic correlations of total IgE (r = 0.662, P = 0.000) and eosinophil %(r = 0.461, P = 0.015) between the peripheral blood and NAL fluids were found only in children. Moreover, children had correlations between total IgE and eosinophil % in the peripheral blood (r = 0.629, P = 0.001) and in NAL fluids (r = 0.373, P = 0.061). Conclusion Elevated local IgE is a common feature of AR in children and adults. Local measures in NAR showed naive state of immune response which disagree with the hypothesis of local allergic rhinitis. Children showed intense local inflammation and close local-systemic interactions compared to adults supporting pediatric AR as a distinct feature.	[Lee, Kyung Suk] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Pediat, Songnam, Gyeonggi Do, South Korea; [Yu, Jinho] Univ Ulsan, Coll Med, Childhood Asthma Atopy Ctr, Dept Pediat,Asan Med Ctr, Seoul, South Korea; [Shim, Dahee; Jang, Man-Young; Choi, Jae-Hoon] Seoul Natl Univ, Coll Nat Sci, Res Inst Nat Sci, Dept Life Sci, Seoul 151742, South Korea; [Choi, Hana; Kim, Kyung Rae; Cho, Seok Hyun] Hanyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 133791, South Korea	Pochon Cha University; University of Ulsan; Seoul National University (SNU); Hanyang University	Choi, JH (corresponding author), Seoul Natl Univ, Coll Nat Sci, Res Inst Nat Sci, Dept Life Sci, Seoul 151742, South Korea.; Cho, SH (corresponding author), Hanyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 133791, South Korea.	jchoi75@hanyang.ac.kr; shcho@hanyang.ac.kr	Cho, Seok Hyun/F-6753-2017	Cho, Seok Hyun/0000-0001-8218-5894	Hanyang University [HY-2013, HY-2012-N]; National Research Foundation of Korea [NRF-2013S1A2A2035348]	Hanyang University; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the research fund of Hanyang University (HY-2013 to SHC, HY-2012-N to JHC), and a National Research Foundation of Korea grant (NRF-2013S1A2A2035348).	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bellanti JA, 2000, ALLERGY ASTHMA PROC, V21, P367, DOI 10.2500/108854100778249088; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, ALLERGY, V67, P18, DOI 10.1111/j.1398-9995.2011.02728.x; Carney AS, 2002, CLIN EXP ALLERGY, V32, P1436, DOI 10.1046/j.1365-2745.2002.01465.x; Cho SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035114; Choi CH, 2014, AM J RHINOL ALLERGY, V28, P281, DOI 10.2500/ajra.2014.28.4050; Choi EB, 2014, ALLERGY, V69, P517, DOI 10.1111/all.12374; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Eckl-Dorna J, 2012, CLIN EXP ALLERGY, V42, P1347, DOI 10.1111/j.1365-2222.2012.04030.x; Expert W.H.O., 1980, WHO TECHNICAL REPORT, V530; Fokkens WJ, 2007, ALLERGY, V62, P1078, DOI 10.1111/j.1398-9995.2007.01522.x; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; Grabenhenrich LB, 2015, J ALLERGY CLIN IMMUN, V136, P932, DOI 10.1016/j.jaci.2015.03.040; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Hirano M, 2012, MICROBIOL IMMUNOL, V56, P392, DOI 10.1111/j.1348-0421.2012.00449.x; Hong Soyoung, 2012, Environ Health Toxicol, V27, pe2012006, DOI 10.5620/eht.2012.27.e2012006; HUGGINS KG, 1975, LANCET, V2, P148; Johansson S, 2005, ALLERGY, V60, P638, DOI 10.1111/j.1398-9995.2005.00775.x; Katelaris CH, 2012, CLIN EXP ALLERGY, V42, P186, DOI 10.1111/j.1365-2222.2011.03891.x; Kerkhof M, 1996, ALLERGY, V51, P770, DOI 10.1111/j.1398-9995.1996.tb04465.x; Kirmaz C, 2011, EUR CYTOKINE NETW, V22, P15, DOI 10.1684/ecn.2011.0277; Korea Centers for Disease Control and Prevention, 2012, 5 KOR NAT HLTH NUTR; Liu JN, 2014, ALLERGY ASTHMA IMMUN, V6, P263, DOI 10.4168/aair.2014.6.3.263; Mathur SK, 2008, CHEST, V133, P412, DOI 10.1378/chest.07-2114; Osman Mustafa, 2007, Prim Care Respir J, V16, P28, DOI 10.3132/pcrj.2007.00006; PLATTSMILLS TAE, 1979, J IMMUNOL, V122, P2218; Powe DG, 2003, CLIN EXP ALLERGY, V33, P1374, DOI 10.1046/j.1365-2222.2003.01737.x; Rondon C, 2008, ALLERGY, V63, P1352, DOI 10.1111/j.1398-9995.2008.01695.x; Rondon C, 2012, ALLERGY, V67, P1282, DOI 10.1111/all.12002; Rondon C, 2012, J ALLERGY CLIN IMMUN, V129, P1460, DOI 10.1016/j.jaci.2012.02.032; SEAGROATT V, 1981, J BIOL STAND, V9, P431, DOI 10.1016/S0092-1157(81)80034-0; Segundo GRS, 2009, BIOL-TARGETS THER, V3, P469; Settipane RA, 2011, IMMUNOL ALLERGY CLIN, V31, P457, DOI 10.1016/j.iac.2011.05.011; Simola M, 1999, ANN ALLERG ASTHMA IM, V82, P152, DOI 10.1016/S1081-1206(10)62589-6; Sogut A, 2012, INT ARCH ALLERGY IMM, V157, P349, DOI 10.1159/000329159; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Wang M, 2013, CLIN EXP ALLERGY, V43, P956, DOI 10.1111/cea.12123; Wang SB, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-9	41	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156979	10.1371/journal.pone.0156979	http://dx.doi.org/10.1371/journal.pone.0156979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281182	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000061
J	Lester, J; Paige, S; Chapman, CA; Gibson, M; Jones, JH; Switzer, WM; Ting, N; Goldberg, TL; Frost, SDW				Lester, James; Paige, Sarah; Chapman, Colin A.; Gibson, Mhairi; Jones, James Holland; Switzer, William M.; Ting, Nelson; Goldberg, Tony L.; Frost, Simon D. W.			Assessing Commitment and Reporting Fidelity to a Text Message-Based Participatory Surveillance in Rural Western Uganda	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; DISEASE; HEALTH	Syndromic surveillance, the collection of symptom data from individuals prior to or in the absence of diagnosis, is used throughout the developed world to provide rapid indications of outbreaks and unusual patterns of disease. However, the low cost of syndromic surveillance also makes it highly attractive for the developing world. We present a case study of electronic participatory syndromic surveillance, using participant-mobile phones in a rural region of Western Uganda, which has a high infectious disease burden, and frequent local and regional outbreaks. Our platform uses text messages to encode a suite of symptoms, their associated durations, and household disease burden, and we explore the ability of participants to correctly encode their symptoms, with an average of 75.2% of symptom reports correctly formatted between the second and 11th reporting timeslots. Concomitantly we identify divisions between participants able to rapidly adjust to this unusually participatory style of data collection, and those few for whom the study proved more challenging. We then perform analyses of the resulting syndromic time series, examining the clustering of symptoms by time and household to identify patterns such as a tendency towards the within-household sharing of respiratory illness.	[Lester, James; Frost, Simon D. W.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Paige, Sarah; Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Paige, Sarah; Goldberg, Tony L.] Univ Wisconsin, Global Hlth Inst, Madison, WI USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA; [Gibson, Mhairi] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Jones, James Holland] Stanford Univ, Woods Inst Environm, Dept Anthropol, Stanford, CA 94305 USA; [Switzer, William M.] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA; [Ting, Nelson] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA	University of Cambridge; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; McGill University; McGill University; Wildlife Conservation Society; University of Bristol; Stanford University; Centers for Disease Control & Prevention - USA; University of Oregon	Frost, SDW (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	sdf22@cam.ac.uk	Gibson, Mhairi A/D-4726-2009; Chapman, Colin/S-1911-2019; Frost, Simon/F-3648-2010	Gibson, Mhairi A/0000-0001-7963-4759; Chapman, Colin/0000-0002-8827-8140; Frost, Simon/0000-0002-5207-9879; Jones, James/0000-0003-1680-6757; Lester, James/0000-0002-4102-8662	National Institute of Health [TW009237]; UK Economic and Social Research Council [ES/J011266/1]; NIH as part of the joint NIH-NSF Ecology of Infectious Disease program [TW009237]; Economic and Social Research Council [ES/J011266/1, 1227381] Funding Source: researchfish; ESRC [ES/J011266/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R01TW009237] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NIH as part of the joint NIH-NSF Ecology of Infectious Disease program; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institute of Health grant TW009237 (http://www.nih.gov/, TG), and UK Economic and Social Research Council grant ES/J011266/1 (http://www.esrc.ac.uk/, MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by NIH grant TW009237 as part of the joint NIH-NSF Ecology of Infectious Disease program and the UK Economic and Social Research Council (grant ES/J011266/1). We thank Annet Abwooki Nyamwija, Bashil Araali Musabe, and James Amooti Tuhaise for their field work, and Geoffrey Weny for his logistical assistance. We also thank two anonymous reviewers for their valuable comments. Use of trade names is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services, the Public Health Service, or the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention, or any of the authors' affiliated institutions.	Cayce R, 2014, INT J INTEGR PEDIAT, V1, P27, DOI DOI 10.6000/IJIPEM/2014/4; Centers for Disease Control and Prevention, 2013, PHIN MESS GUID SYNDR; Central Intelligence Agency, 2014, WORLD FACTB MAJ INF; Chretien JP, 2008, PLOS MED, V5, P367, DOI 10.1371/journal.pmed.0050072; Ciha M., GAMMU PROJECT; Cox J, 2007, EMERG INFECT DIS, V13, P779, DOI 10.3201/eid1305.061410; Drumright LN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0789-z; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goldberg T., KIBALE ECOHEALTH PRO; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; International Telecommunication Union, 2013, MEASURING INFORM SOC; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Lamunu M, 2004, INT J INFECT DIS, P1; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Mutebi JP, 2012, J MED ENTOMOL, V49, P1289, DOI 10.1603/ME12111; Organization WH, 2014, UG STAT SUMM 2002 PR; Paige SB, 2014, ECOHEALTH, V11, P534, DOI 10.1007/s10393-014-0942-y; Paterson BJ, 2012, GLOB PUBLIC HEALTH, V7, P682, DOI 10.1080/17441692.2012.699713; Rosewell A, 2013, EMERG INFECT DIS, V19, P1811, DOI 10.3201/eid1911.121843; Sawford K, 2012, J BIOTERRORISM BIODE, V01, P1; Shoemaker T, 2012, EMERG INFECT DIS, V18, P1480, DOI 10.3201/eid1809.111536; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; Tuarob S, 2014, J BIOMED INFORM, V49, P255, DOI 10.1016/j.jbi.2014.03.005; Uganda Bureau of Statistics (UBOS) ICF Macro, 2010, TECHNICAL REPORT; Uganda Communications Commission, 2013, TECHNICAL REPORT; Velardi P, 2014, ARTIF INTELL MED, V61, P153, DOI 10.1016/j.artmed.2014.01.002; Wamala JF, 2010, EMERG INFECT DIS, V16, P1087, DOI 10.3201/eid1607.091525; Wojcik OP, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-7; Yan WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062749	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155971	10.1371/journal.pone.0155971	http://dx.doi.org/10.1371/journal.pone.0155971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281020	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000010
J	Narayanan, S; Nieh, AH; Kenwood, BM; Davis, CA; Tosello-Trampont, AC; Elich, TD; Breazeale, SD; Ward, E; Anderson, RJ; Caldwell, SH; Hoehn, KL; Hahn, YS				Narayanan, Sowmya; Nieh, Albert H.; Kenwood, Brandon M.; Davis, Christine A.; Tosello-Trampont, Annie-Carole; Elich, Tedd D.; Breazeale, Steven D.; Ward, Eric; Anderson, Richard J.; Caldwell, Stephen H.; Hoehn, Kyle L.; Hahn, Young S.			Distinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; FATTY-ACID SYNTHASE; CORE PROTEIN; HIGH-CARBOHYDRATE; RNA REPLICATION; PALMITOYLATION; HCV; TRIGLYCERIDE; METABOLISM; SOFOSBUVIR	Hepatitis C is a chronic liver disease that contributes to progressive metabolic dysfunction. Infection of hepatocytes by hepatitis C virus (HCV) results in reprogramming of hepatic and serum lipids. However, the specific contribution of these distinct pools of lipids to HCV infection remains ill defined. In this study, we investigated the role of hepatic lipogenesis in HCV infection by targeting the rate-limiting step in this pathway, which is catalyzed by the acetylCoA carboxylase (ACC) enzymes. Using two structurally unrelated ACC inhibitors, we determined that blockade of lipogenesis resulted in reduced viral replication, assembly, and release. Supplementing exogenous lipids to cells treated with ACC inhibitors rescued HCV assembly with no effect on viral replication and release. Intriguingly, loss of viral RNA was not recapitulated at the protein level and addition of 2-bromopalmitate, a competitive inhibitor of protein palmitoylation, mirrored the effects of ACC inhibitors on reduced viral RNA without a concurrent loss in protein expression. These correlative results suggest that newly synthesized lipids may have a role in protein palmitoylation during HCV infection.	[Narayanan, Sowmya; Nieh, Albert H.; Tosello-Trampont, Annie-Carole; Hahn, Young S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA USA; [Narayanan, Sowmya; Hahn, Young S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Kenwood, Brandon M.; Hoehn, Kyle L.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Davis, Christine A.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Elich, Tedd D.; Breazeale, Steven D.; Ward, Eric; Anderson, Richard J.] Cropsolution Inc, Morrisville, NY USA; [Caldwell, Stephen H.] Univ Virginia, Div Gastroenterol & Hepatol, Charlottesville, VA USA; [Kenwood, Brandon M.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Hoehn, Kyle L.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Virginia; University of Virginia; University of Virginia; University of Richmond; University of Virginia; University System of Georgia; Georgia Institute of Technology; University of New South Wales Sydney	Hahn, YS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA USA.; Hahn, YS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA.	ysh5e@virginia.edu		NARAYANAN, SOWMYA/0000-0002-0725-9731; Hoehn, Kyle/0000-0002-0214-3238	Cropsolution, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098126, T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK104562, R01DK101803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM007055] Funding Source: NIH RePORTER	Cropsolution, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Cropsolution, Inc. provided support in the form of the salaries for authors TDE, SDB, EW, and RJA, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anania VG, 2011, J VIROL, V85, P2288, DOI 10.1128/JVI.01961-10; Anderson R, 2012, MODULATORS ACETYLCOE; Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Castera L, 2005, AM J GASTROENTEROL, V100, P711, DOI 10.1111/j.1572-0241.2005.40898.x; Castera L, 2004, GUT, V53, P420, DOI 10.1136/gut.2002.009936; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; Chen SL, 2013, ELECTROPHORESIS, V34, P2848, DOI 10.1002/elps.201200629; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; DIENES HP, 1982, HEPATOLOGY, V2, P562; Diraison F, 1998, AM J PHYSIOL-ENDOC M, V274, pE321, DOI 10.1152/ajpendo.1998.274.2.E321; Elkrief L, 2014, HEPATOLOGY, V60, P823, DOI 10.1002/hep.27228; Etienne L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137182; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; Fukasawa M, 2006, BIOL PHARM BULL, V29, P1958, DOI 10.1248/bpb.29.1958; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; HELLERSTEIN MK, 1991, J CLIN INVEST, V87, P1841, DOI 10.1172/JCI115206; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Lambert JE, 2013, HEPATOLOGY, V57, P1697, DOI 10.1002/hep.25990; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Liefhebber JMP, 2014, J BIOL CHEM, V289, P21276, DOI 10.1074/jbc.M114.582999; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Majeau N, 2009, J BIOL CHEM, V284, P33915, DOI 10.1074/jbc.M109.018549; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; MOENCH SJ, 1994, BIOCHEMISTRY-US, V33, P5783, DOI 10.1021/bi00185a016; Muir AJ, 2015, CLIN GASTROENTEROL H, V13, P2166, DOI 10.1016/j.cgh.2015.07.015; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Ng CG, 2008, P NATL ACAD SCI USA, V105, P16326, DOI 10.1073/pnas.0808720105; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Paul D, 2015, J GEN VIROL, V96, P1696, DOI 10.1099/vir.0.000111; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Singaravelu R, 2015, ACS INFECT DIS, V1, P130, DOI 10.1021/acsinfecdis.5b00019; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Taddeo EP, 2014, MOL METAB, V3, P124, DOI 10.1016/j.molmet.2013.11.003; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; VAHLENSIECK HF, 1994, CURR GENET, V25, P95, DOI 10.1007/BF00309532; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Visser BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-442; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang XF, 2011, J VIROL, V85, P5494, DOI 10.1128/JVI.02031-10; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011; Wei XC, 2011, J BIOL CHEM, V286, P2933, DOI 10.1074/jbc.M110.193037; Wu LY, 2014, METABOLISM, V63, P1469, DOI 10.1016/j.metabol.2014.08.010; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Yu GY, 2006, J VIROL, V80, P6013, DOI 10.1128/JVI.00053-06; Zhu YZ, 2012, VIROLOGY, V429, P112, DOI 10.1016/j.virol.2012.03.002	79	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156996	10.1371/journal.pone.0156996	http://dx.doi.org/10.1371/journal.pone.0156996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280294	gold, Green Submitted, Green Published			2022-12-27	WOS:000377563000063
J	Erickson, DL; Lew, CS; Kartchner, B; Porter, NT; McDaniel, SW; Jones, NM; Mason, S; Wu, E; Wilson, E				Erickson, David L.; Lew, Cynthia S.; Kartchner, Brittany; Porter, Nathan T.; McDaniel, S. Wade; Jones, Nathan M.; Mason, Sara; Wu, Erin; Wilson, Eric			Lipopolysaccharide Biosynthesis Genes of Yersinia pseudotuberculosis Promote Resistance to Antimicrobial Chemokines	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; SIGNATURE-TAGGED MUTAGENESIS; O-ANTIGEN; FUNCTIONAL-CHARACTERIZATION; TRANSPOSON MUTAGENESIS; CELL ACCUMULATION; MUCOSAL TISSUES; MAMMARY-GLAND; PESTIS; INFECTION	Antimicrobial chemokines (AMCs) are a recently described family of host defense peptides that play an important role in protecting a wide variety of organisms from bacterial infection. Very little is known about the bacterial targets of AMCs or factors that influence bacterial susceptibility to AMCs. In an effort to understand how bacterial pathogens resist killing by AMCs, we screened Yersinia pseudotuberculosis transposon mutants for those with increased binding to the AMCs CCL28 and CCL25. Mutants exhibiting increased binding to AMCs were subjected to AMC killing assays, which revealed their increased sensitivity to chemokine-mediated cell death. The majority of the mutants exhibiting increased binding to AMCs contained transposon insertions in genes related to lipopolysaccharide biosynthesis. A particularly strong effect on susceptibility to AMC mediated killing was observed by disruption of the hldD/waaF/waaC operon, necessary for ADP-L-glycero-D-manno-heptose synthesis and a complete lipopolysaccharide core oligosaccharide. Periodate oxidation of surface carbohydrates also enhanced AMC binding, whereas enzymatic removal of surface proteins significantly reduced binding. These results suggest that the structure of Y. pseudotuberculosis LPS greatly affects the antimicrobial activity of AMCs by shielding a protein ligand on the bacterial cell surface.	[Erickson, David L.; Lew, Cynthia S.; Kartchner, Brittany; Porter, Nathan T.; McDaniel, S. Wade; Jones, Nathan M.; Mason, Sara; Wu, Erin; Wilson, Eric] Brigham Young Univ, Dept Microbiol & Mol Biol, 4007 LSB, Provo, UT 84602 USA; [Porter, Nathan T.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Brigham Young University; University of Michigan System; University of Michigan	Erickson, DL (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, 4007 LSB, Provo, UT 84602 USA.	david_erickson@byu.edu	Porter, Nathan/AAV-9098-2020	Porter, Nathan/0000-0001-8523-6909; Erickson, David/0000-0001-6149-273X; Mason, Sara/0000-0002-0684-2714	NIH grant [R0102057]	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R0102057 to DLE and E. Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi KL, 2015, MICROBIOL-SGM, V161, P628, DOI 10.1099/mic.0.000018; Berri M, 2008, MOL IMMUNOL, V45, P271, DOI 10.1016/j.molimm.2007.04.026; Berri M, 2014, DEV COMP IMMUNOL, V44, P286, DOI 10.1016/j.dci.2014.01.005; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; Dai C, 2015, J IMMUNOL, V194, P5980, DOI 10.4049/jimmunol.1402634; Dentovskaya SV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P808, DOI 10.1134/S0006297911070121; Distelhorst K, 2010, VET IMMUNOL IMMUNOP, V138, P134, DOI 10.1016/j.vetimm.2010.07.008; Durand EA, 2010, CELL MICROBIOL, V12, P1064, DOI 10.1111/j.1462-5822.2010.01451.x; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Felek S, 2010, INFECT IMMUN, V78, P1163, DOI 10.1128/IAI.00997-09; Feng NG, 2006, J IMMUNOL, V176, P5749, DOI 10.4049/jimmunol.176.10.5749; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Guo JT, 2011, MICROB PATHOGENESIS, V51, P121, DOI 10.1016/j.micpath.2011.04.010; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Ho N, 2008, MOL MICROBIOL, V68, P424, DOI 10.1111/j.1365-2958.2008.06163.x; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Karlyshev AV, 2001, INFECT IMMUN, V69, P7810, DOI 10.1128/IAI.69.12.7810-7819.2001; Kiljunen S, 2011, J BACTERIOL, V193, P4963, DOI 10.1128/JB.00339-11; Klein KA, 2012, J BACTERIOL, V194, P653, DOI 10.1128/JB.06237-11; Knirel YA, 2008, ADV SCI LETT, V1, P192, DOI 10.1166/asl.2008.020; Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; Langereis JD, 2014, MBIO, V5, DOI 10.1128/mBio.01478-14; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Liu B, 2010, EUR J IMMUNOL, V40, P186, DOI 10.1002/eji.200939819; Logsdon LK, 2006, INFECT IMMUN, V74, P1516, DOI 10.1128/IAI.74.3.1516-1527.2006; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2157, DOI 10.1007/s00018-011-0709-3; Marceau M, 2004, MICROBIOL-SGM, V150, P3947, DOI 10.1099/mic.0.27426-0; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; Morteau O, 2008, J IMMUNOL, V181, P6309, DOI 10.4049/jimmunol.181.9.6309; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Otvos L, 2005, J PEPT SCI, V11, P697, DOI 10.1002/psc.698; Pallister KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138084; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Prior JL, 2001, FEMS MICROBIOL LETT, V197, P229, DOI 10.1111/j.1574-6968.2001.tb10608.x; QADRI F, 1988, J CLIN MICROBIOL, V26, P1343, DOI 10.1128/JCM.26.7.1343-1348.1988; Rebeil R, 2006, J BACTERIOL, V188, P1381, DOI 10.1128/JB.188.4.1381-1388.2006; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Reid-Yu SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004648; Reines M, 2012, J BACTERIOL, V194, P3173, DOI 10.1128/JB.00308-12; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	54	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157092	10.1371/journal.pone.0157092	http://dx.doi.org/10.1371/journal.pone.0157092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275606	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700068
J	Le Bonniec, A; Haesebaert, J; Derex, L; Porthault, S; Preau, M; Schott, AM				Le Bonniec, Alice; Haesebaert, Julie; Derex, Laurent; Porthault, Sylvie; Preau, Marie; Schott, Anne-Marie			Why Patients Delay Their First Contact with Health Services After Stroke? A Qualitative Focus Group-Based Study	PLOS ONE			English	Article							THROMBOLYSIS; ALTEPLASE	Background Despite national and local French information campaigns, when acute stroke occurs, waiting times before calling mobile emergency medical services (EMS) to receive appropriate treatment (i.e. thrombolysis) and decrease the risk of physical disability, remain long. We aimed to identify the representations of stroke in the general population and to determine barriers to and facilitators for rapidly contacting EMS. Method We conducted a qualitative study among the general population with 10 focus groups, 5 comprising employed people (N = 29) and 5 comprising retirees (N = 32). The themes discussed were general knowledge about stroke and its risk factors, symptoms, appropriate management and the awareness that stroke is an emergency issue. Results In addition to a lack of knowledge about stroke, other barriers to rapidly contacting the EMS were difficulties in recognizing symptoms and understanding that these symptoms constitute an emergency. Furthermore, when faced with stroke, a feeling of inevitability and fatalism about the consequences of a stroke was highlighted. Participants were unaware of the existence of an effective treatment and they mistrusted medical competences. Finally, we found a strong presence and participant appreciation of common knowledge, resulting in the sharing of experiences of stroke. This could partly compensate for the lack of specific knowledge about symptom recognition and appropriate action. Conclusion Information campaigns should not only inform the public about stroke symptoms in order to ensure people act appropriately, but should also focus on increasing public awareness about the fact that an effective treatment exists.	[Le Bonniec, Alice; Haesebaert, Julie; Schott, Anne-Marie] Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Lyon, France; [Le Bonniec, Alice] Univ Montpellier 3, Lab Epsylon EA4556, F-34032 Montpellier, France; [Le Bonniec, Alice; Preau, Marie] Univ Lyon 2, Grp Rech Psychol Sociale GRePS EA4163, F-69365 Lyon 07, France; [Derex, Laurent] Hop Pierre Wertheimer, Hosp Civils Lyon, Unite Neurol Vasc, Lyon, France; [Porthault, Sylvie] Hosp Civils Lyon, SAMU Rhone, F-69000 Lyon, France; [Preau, Marie] INSERM, SESSTIM U912, F-13258 Marseille, France; [Haesebaert, Julie; Derex, Laurent; Schott, Anne-Marie] Univ Lyon, Equipe Accueil HESPER 7425, F-69003 Lyon, France	CHU Lyon; Universite de Montpellier; Universite Paul-Valery; Universite Lyon 2; CHU Lyon; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Haesebaert, J (corresponding author), Hosp Civils Lyon, Pole Informat Med Evaluat Rech, Lyon, France.; Haesebaert, J (corresponding author), Univ Lyon, Equipe Accueil HESPER 7425, F-69003 Lyon, France.	julie.haesebaert@chu-lyon.fr	Carmen, Team3/Y-7384-2019; Derex, Laurent/AAQ-1034-2020; Haesebaert, Julie/AAN-1702-2020; Derex, Laurent/AAK-5890-2020; Schott, Anne-Marie/V-7580-2018; HAESEBAERT, JULIE/E-7141-2017	Carmen, Team3/0000-0002-3614-0924; Derex, Laurent/0000-0002-0909-8900; Haesebaert, Julie/0000-0001-9109-5604; Schott, Anne-Marie/0000-0003-3337-4474; HAESEBAERT, JULIE/0000-0001-9109-5604; Lab, Carmen/0000-0002-5935-3236; Le Bonniec, Alice/0000-0001-9916-8038				BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bardin L, 1991, ANAL DE CONTENU; Derex L, 2002, STROKE, V33, P153, DOI 10.1161/hs0102.100533; Dombrowski SU, 2015, STROKE, V46, P3220, DOI 10.1161/STROKEAHA.115.009997; Dombrowski SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039852; Evenson KR, 2009, INT J STROKE, V4, P187, DOI 10.1111/j.1747-4949.2009.00276.x; Flynn D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104289; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jodelet D, 2007, PLACE EXPERIENCE VEC; Jones SP, 2010, AGE AGEING, V39, P11, DOI 10.1093/ageing/afp196; Kitzinger J., 2004, B PSYCHOL, V57, P237; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Mackintosh JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046124; Mellon L, 2013, EMERG MED J EMJ 0726; Porthault-Chatard S, 2012, INT J STROKE, V7, pE13, DOI 10.1111/j.1747-4949.2012.00887.x; Redfern J, 2006, STROKE, V37, P2410, DOI 10.1161/01.STR.0000237097.00342.a9; Sarradon-Eck A, 2007, PREVOIR PREDIRE MALA, P153; Skolarus LE, 2013, CIRC-CARDIOVASC QUAL, V6, P278, DOI 10.1161/CIRCOUTCOMES.111.000017; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Yoon SS, 2002, BMJ-BRIT MED J, V324, P1065, DOI 10.1136/bmj.324.7345.1065	21	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156933	10.1371/journal.pone.0156933	http://dx.doi.org/10.1371/journal.pone.0156933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275948	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700050
J	Modur, V; Joshi, P; Nie, DT; Robbins, KT; Khan, AU; Rao, K				Modur, Vishnu; Joshi, Pooja; Nie, Daotai; Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna			CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; PROGNOSTIC MARKER; POOR-PROGNOSIS; OVARIAN-CANCER; IDENTIFICATION	Platinum-based therapy is most often used to treat advanced cases of head and neck cancers, but only a small fraction of the patient population responds to cisplatin, with a median survival time of less than a year. Although gene signatures and molecular etiology of head and neck cancers have been previously described, none of them are predictive indicators of cisplatin treatment response in particular. Therefore, currently, there is a lack of clinically employable predictive indicators of the disease beyond HPV status to specifically predict patients' response to platinum-based therapy. It beckons a substantial effort to look for predictive indicators of cisplatin treatment response. In this regard, CD24 expression level appears to be a significant molecular phenotype of cisplatin-resistant residual cells in laryngeal carcinoma lines. CD24 expression level directly affects cisplatin sensitivity and affects the expression of critical apoptotic, stem and drug resistance genes. A relatively small retrospective patient tumor analysis suggests that CD24 high tumors go on to show an unfavorable response to cisplatin treatment. Overall, based on the strength of further analysis, CD24 presents a strong rationale to be utilized as a predictive indicator to stratify head and neck cancer patients for platinum-based therapy. It also provides a rationale for using CD24 as a therapeutic adjuvant target along with standard cisplatin therapy.	[Modur, Vishnu; Joshi, Pooja; Nie, Daotai; Rao, Krishna] SIU, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA; [Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna] SIU, Div Hematol & Oncol, Dept Internal Med, Springfield, IL 62794 USA; [Robbins, K. Thomas; Khan, Aziz U.] SIU, Dept ENT Otolaryngol, Springfield, IL 62794 USA; [Nie, Daotai; Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna] So Illinois Univ, Sch Med, Springfield, IL USA; [Nie, Daotai; Robbins, K. Thomas; Khan, Aziz U.; Rao, Krishna] SIU, Simmons Canc Inst, POB 19678, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Rao, K (corresponding author), SIU, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62794 USA.; Rao, K (corresponding author), SIU, Div Hematol & Oncol, Dept Internal Med, Springfield, IL 62794 USA.; Rao, K (corresponding author), So Illinois Univ, Sch Med, Springfield, IL USA.; Rao, K (corresponding author), SIU, Simmons Canc Inst, POB 19678, Springfield, IL 62794 USA.	krao@siumed.edu			SCI Chair in Oncology Fund	SCI Chair in Oncology Fund	Funding was received from the SCI Chair in Oncology Fund.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Brockstein BE, 2011, DRUGS, V71, P1551, DOI 10.2165/11592540-000000000-00000; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gourin CG, 2006, LARYNGOSCOPE, V116, P1093, DOI 10.1097/01.mlg.0000224939.61503.83; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Johnsson A, 2000, BRIT J CANCER, V83, P1047, DOI 10.1054/bjoc.2000.1420; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kristiansen G, 2004, PROSTATE, V58, P183, DOI 10.1002/pros.10324; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Lee HJ, 2010, J THORAC ONCOL, V5, P649, DOI 10.1097/JTO.0b013e3181d5e554; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; PIRRUCCELLO SJ, 1986, J IMMUNOL, V136, P3779; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Shi Y, 2012, ORL-J OTO-RHIN-LARYN, V74, P78, DOI 10.1159/000335584; Surowiak P, 2006, ANTICANCER RES, V26, P629; Wang M, 2011, INT J CANCER, V128, P72, DOI 10.1002/ijc.25317; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156651	10.1371/journal.pone.0156651	http://dx.doi.org/10.1371/journal.pone.0156651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276062	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700031
J	Sagar, KA; Dahlgren, MK; Racine, MT; Dreman, MW; Olson, DP; Gruber, SA				Sagar, Kelly A.; Dahlgren, M. Kathryn; Racine, Megan T.; Dreman, Meredith W.; Olson, David P.; Gruber, Staci A.			Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; AGE-OF-ONSET; CANNABIS USE; MOMENTARY ASSESSMENT; CLINICAL-RESEARCH; I DISORDER; MANIA; ABUSE; METAANALYSIS; DEFICITS	Marijuana is the most widely used illicit substance in those diagnosed with bipolar I disorder. However, there is conflicting evidence as to whether marijuana may alleviate or exacerbate mood symptomatology. As bipolar disorder and marijuana use are individually associated with cognitive impairment, it also remains unclear whether there is an additive effect on cognition when bipolar patients use marijuana. The current study aimed to determine the impact of marijuana on mood in bipolar patients and to examine whether marijuana confers an additional negative impact on cognitive function. Twelve patients with bipolar disorder who smoke marijuana (MJBP), 18 bipolar patients who do not smoke (BP), 23 marijuana smokers without other Axis 1 pathology (MJ), and 21 healthy controls (HC) completed a neuropsychological battery. Further, using ecological momentary assessment, participants rated their mood three times daily as well as after each instance of marijuana use over a four-week period. Results revealed that although the MJ, BP, and MJBP groups each exhibited some degree of cognitive impairment relative to HCs, no significant differences between the BP and MJBP groups were apparent, providing no evidence of an additive negative impact of BPD and MJ use on cognition. Additionally, ecological momentary assessment analyses indicated alleviation of mood symptoms in the MJBP group after marijuana use; MJBP participants experienced a substantial decrease in a composite measure of mood symptoms. Findings suggest that for some bipolar patients, marijuana may result in partial alleviation of clinical symptoms. Moreover, this improvement is not at the expense of additional cognitive impairment.	[Sagar, Kelly A.; Dahlgren, M. Kathryn; Racine, Megan T.; Dreman, Meredith W.; Olson, David P.; Gruber, Staci A.] McLean Hosp, McLean Imaging Ctr, Cognit & Clin Neuroimaging Core, 115 Mill St, Belmont, MA 02178 USA; [Sagar, Kelly A.; Olson, David P.; Gruber, Staci A.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Dahlgren, M. Kathryn] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Tufts University	Gruber, SA (corresponding author), McLean Hosp, McLean Imaging Ctr, Cognit & Clin Neuroimaging Core, 115 Mill St, Belmont, MA 02178 USA.; Gruber, SA (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	gruber@mclean.harvard.edu	Sagar, Kelly/AAA-1432-2021; Dahlgren, Mary/GWC-8602-2022	Sagar, Kelly/0000-0002-4131-9259; Dahlgren, Mary/0000-0003-0706-531X; Gruber, Staci/0000-0002-6921-677X	National Institute of Drug Abuse [R21 DA21241-2, 1R01-DA032646]; Jim and Pat Poitras Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032646] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Jim and Pat Poitras Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for this project was provided by the National Institute of Drug Abuse (https://www.drugabuse.gov/) R21 DA21241-2 and 1R01-DA032646 awarded to SG and by generous funds donated by the Jim and Pat Poitras Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, PSYCHIAT RES, V185, P459, DOI 10.1016/j.psychres.2010.07.007; Ashton CH, 2005, J PSYCHOPHARMACOL, V19, P293, DOI 10.1177/0269881105051541; Baethge C, 2008, BIPOLAR DISORD, V10, P738, DOI 10.1111/j.1399-5618.2007.00575.x; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bizzarri JV, 2007, BIPOLAR DISORD, V9, P213, DOI 10.1111/j.1399-5618.2007.00383.x; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Braga RJ, 2012, PSYCHIAT RES, V200, P242, DOI 10.1016/j.psychres.2012.05.025; Bryan J, 2000, J CLIN EXP NEUROPSYC, V22, P40, DOI 10.1076/1380-3395(200002)22:1;1-8;FT040; Cahill Catherine M, 2006, Expert Rev Neurother, V6, P591, DOI 10.1586/14737175.6.4.591; Cerullo MA, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-29; Crane NA, 2013, NEUROPSYCHOL REV, V23, P117, DOI 10.1007/s11065-012-9222-1; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Schier ARD, 2012, REV BRAS PSIQUIATR, V34, pS104; Delis DC., 2000, CALIFORNIA VERBAL LE; Ehrenreich H, 1999, PSYCHOPHARMACOLOGY, V142, P295, DOI 10.1007/s002130050892; Filbey FM, 2014, P NATL ACAD SCI USA, V111, P16913, DOI 10.1073/pnas.1415297111; Fontes MA, 2011, BRIT J PSYCHIAT, V198, P442, DOI 10.1192/bjp.bp.110.077479; Gibbs M, 2015, J AFFECT DISORDERS, V171, P39, DOI 10.1016/j.jad.2014.09.016; Goldberg JF, 1999, J CLIN PSYCHIAT, V60, P733, DOI 10.4088/JCP.v60n1103; Grinspoon L, 1998, J PSYCHOACTIVE DRUGS, V30, P171; Gruber A J, 1996, Depression, V4, P77, DOI 10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.3.CO;2-T; Gruber SA, 2014, PSYCHOPHARMACOLOGY, V231, P1455, DOI 10.1007/s00213-013-3326-z; Gruber SA, 2012, PSYCHOL ADDICT BEHAV, V26, P496, DOI 10.1037/a0026269; Gruber SA, 2012, NEUROSCI LETT, V511, P89, DOI 10.1016/j.neulet.2012.01.039; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Healey C, 2009, J AFFECT DISORDERS, V113, P118, DOI 10.1016/j.jad.2008.05.010; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Henquet C, 2006, J AFFECT DISORDERS, V95, P103, DOI 10.1016/j.jad.2006.05.002; Hooper H.E., 1958, HOOPER VISUAL ORG TE; Hurd YL, 2014, NEUROPHARMACOLOGY, V76, P416, DOI 10.1016/j.neuropharm.2013.07.028; Johnston L. D., 2014, MONITORING FUTURE NA; Kvitland LR, 2016, EARLY INTERV PSYCHIA, V10, P36, DOI 10.1111/eip.12138; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lisdahl Krista M, 2014, Curr Addict Rep, V1, P144; Lyon G.R., 1994, FRAMES REFERENCE ASS, P117; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Mechoulam R, 2002, J CLIN PHARMACOL, V42, p11S, DOI 10.1002/j.1552-4604.2002.tb05998.x; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Merikangas KR, 2008, ARCH GEN PSYCHIAT, V65, P47, DOI 10.1001/archgenpsychiatry.2007.18; Montgomery SA, 1979, THE BRITISH JOURNAL, V134, P561; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Nestor L, 2008, NEUROIMAGE, V40, P1328, DOI 10.1016/j.neuroimage.2007.12.059; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Power BD, 2015, SCHIZOPHR RES, V168, P245, DOI 10.1016/j.schres.2015.06.026; Ringen PA, 2010, PSYCHOL MED, V40, P1337, DOI 10.1017/S0033291709991620; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Rosenberg EC, 2015, NEUROTHERAPEUTICS, V12, P747, DOI 10.1007/s13311-015-0375-5; Sato H, 2011, ANXIETY STRESS COPIN, V24, P359, DOI 10.1080/10615806.2010.543132; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Simon NM, 2004, AM J PSYCHIAT, V161, P2222, DOI 10.1176/appi.ajp.161.12.2222; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; Solowij N, 2012, PSYCHOPHARMACOLOGY, V219, P575, DOI 10.1007/s00213-011-2486-y; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Strakowski SM, 1998, J CLIN PSYCHIAT, V59, P465, DOI 10.4088/JCP.v59n0905; Strakowski SM, 2007, ARCH GEN PSYCHIAT, V64, P57, DOI 10.1001/archpsyc.64.1.57; Substance Abuse and Mental Health Services Administration, 2013, NSDUH SER H, VH-46; Tijssen MJA, 2010, ACTA PSYCHIAT SCAND, V122, P255, DOI 10.1111/j.1600-0447.2010.01539.x; Tohen M, 1998, HARVARD REV PSYCHIAT, V6, P133, DOI 10.3109/10673229809000321; Trull TJ, 2009, PSYCHOL ASSESSMENT, V21, P457, DOI 10.1037/a0017653; Tyler E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123953; van Laar M, 2007, ADDICTION, V102, P1251, DOI 10.1111/j.1360-0443.2007.01875.x; van Rossum I, 2009, J NERV MENT DIS, V197, P35, DOI 10.1097/NMD.0b013e31819292a6; Wagner D, 2010, PROG NEURO-PSYCHOPH, V34, P871, DOI 10.1016/j.pnpbp.2010.04.004; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Weiss RD, 2004, J AFFECT DISORDERS, V79, P279, DOI 10.1016/S0165-0327(02)00454-8; Woods SW, 2000, J CLIN PSYCHIAT, V61, P38; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694; Zuardi AW, 2012, CURR PHARM DESIGN, V18, P5131, DOI 10.2174/138161212802884681	74	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157060	10.1371/journal.pone.0157060	http://dx.doi.org/10.1371/journal.pone.0157060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275781	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700063
J	Salim, T; Sershen, CL; May, EE				Salim, Taha; Sershen, Cheryl L.; May, Elebeoba E.			Investigating the Role of TNF-alpha and IFN-gamma Activation on the Dynamics of iNOS Gene Expression in LPS Stimulated Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; HIGH-AFFINITY RECEPTOR; INTERFERON-GAMMA; KAPPA-B; CYTOKINE PRODUCTION; T-CELLS; PERITONEAL-MACROPHAGES; TRANSCRIPTION FACTORS; PRIMED MACROPHAGES	Macrophage produced inducible nitric oxide synthase (iNOS) is known to play a critical role in the proinflammatory response against intracellular pathogens by promoting the generation of bactericidal reactive nitrogen species. Robust and timely production of nitric oxide (NO) by iNOS and analogous production of reactive oxygen species are critical components of an effective immune response. In addition to pathogen associated lipopolysaccharides (LPS), iNOS gene expression is dependent on numerous proinflammatory cytokines in the cellular microenvironment of the macrophage, two of which include interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha). To understand the synergistic effect of IFN-gamma and TNF-alpha activation, and LPS stimulation on iNOS expression dynamics and NO production, we developed a systems biology based mathematical model. Using our model, we investigated the impact of pre-infection cytokine exposure, or priming, on the system. We explored the essentiality of IFN-gamma priming to the robustness of initial proinflammatory response with respect to the ability of macrophages to produce reactive species needed for pathogen clearance. Results from our theoretical studies indicated that IFN-gamma and subsequent activation of IRF1 are essential in consequential production of iNOS upon LPS stimulation. We showed that IFN-gamma priming at low concentrations greatly increases the effector response of macrophages against intracellular pathogens. Ultimately the model demonstrated that although TNF-alpha contributed towards a more rapid response time, measured as time to reach maximum iNOS production, IFN-gamma stimulation was significantly more significant in terms of the maximum expression of iNOS and the concentration of NO produced.	[Salim, Taha; Sershen, Cheryl L.; May, Elebeoba E.] Univ Houston, Dept Biomed Engn, Houston, TX USA	University of Houston System; University of Houston	May, EE (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX USA.	eemay@central.uh.edu			Defense Threat Reduction Agency grant [FA8650-10-2-6062, 2381]; Sandia National Laboratories' Laboratory Directed Research and Development grant [151348]	Defense Threat Reduction Agency grant(United States Department of DefenseDefense Threat Reduction Agency); Sandia National Laboratories' Laboratory Directed Research and Development grant	Research supported in part by Defense Threat Reduction Agency grant# FA8650-10-2-6062 subaward #2381 to EEM and Sandia National Laboratories' Laboratory Directed Research and Development grant #151348 to EEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2014, MULTILEVEL PARALLEL; Afford SC, 1998, J PATHOL, V186, P82, DOI 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D; Ahlers JD, 2001, INT IMMUNOL, V13, P897, DOI 10.1093/intimm/13.7.897; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Aksan I, 2003, J RECEPT SIG TRANSD, V23, P197, DOI 10.1081/RRS-120025203; Arroyo-Espliguero R, 2004, HEART, V90, P983, DOI 10.1136/hrt.2002.001297; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Bartee E, 2013, CYTOKINE, V63, P237, DOI 10.1016/j.cyto.2013.04.036; Bedoui Sammy, 2005, J Inflamm (Lond), V2, P2, DOI 10.1186/1476-9255-2-2; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bocek P, 2004, J EXP MED, V199, P1619, DOI 10.1084/jem.20032014; Bokhari SM, 2008, INFECT IMMUN, V76, P1379, DOI 10.1128/IAI.00745-07; Butchar JP, 2008, FEBS LETT, V582, P1044, DOI 10.1016/j.febslet.2008.02.058; Casals-Casas C, 2009, EUR J IMMUNOL, V39, P1902, DOI 10.1002/eji.200839037; Chang A, 2015, NUCLEIC ACIDS RES, V43, pD439, DOI 10.1093/nar/gku1068; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Conradi C, 2012, J MATH BIOL, V65, P107, DOI 10.1007/s00285-011-0453-1; DAMAS P, 1989, CRIT CARE MED, V17, P975, DOI 10.1097/00003246-198910000-00001; De Lean A, KINETICS COOPERATIVE; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Frigo DE, 2004, CARCINOGENESIS, V25, P249, DOI 10.1093/carcin/bgh009; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Gouwy M, 2005, CYTOKINE GROWTH F R, V16, P561, DOI 10.1016/j.cytogfr.2005.03.005; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Guo H, 2008, J BIOL CHEM, V283, P25209, DOI 10.1074/jbc.M804062200; Gutierrez J, 2010, THEORETICAL BIOL MED; Gutierrez J, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-7; Haldorsen Helge H., 1990, STOCHASTIC MODELING, V42; HAN JH, 1994, J BIOL CHEM, V269, P8172; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; HAYES MP, 1995, CYTOKINE, V7, P427, DOI 10.1006/cyto.1995.0058; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Herman Friedman, 2012, MICROBIAL INFECT ROL; Hirata N, 2008, MOL IMMUNOL, V45, P2734, DOI 10.1016/j.molimm.2008.02.010; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu XY, 2005, J IMMUNOL, V175, P3637, DOI 10.4049/jimmunol.175.6.3637; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Jablonska E, 2002, MELANOMA RES, V12, P123; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Klipp E, 2009, SYSTEMS BIOL; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kwon H, 2001, EUR J BIOCHEM, V268, P565, DOI 10.1046/j.1432-1327.2001.01897.x; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Bedran TBL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106766; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Mustafa SB, 1998, J BIOL CHEM, V273, P5073, DOI 10.1074/jbc.273.9.5073; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; Nelson G, 2002, J CELL SCI, V115, P1137; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Procyk KJ, 2000, BLOOD, V96, P2592; Quaiser T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-30; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; REIN T, 1994, NUCLEIC ACIDS RES, V22, P3033, DOI 10.1093/nar/22.15.3033; RENIER G, 1994, J LIPID RES, V35, P1413; Robert-Gangneux F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033413; Ryser S, 2004, BIOCHEM J, V378, P473, DOI 10.1042/BJ20031022; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schoffelen T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00093; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seguin R, 1997, INFECT IMMUN, V65, P2522; Sharp GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070180; Shin HJ, 2007, MOL CELLS, V24, P119; SODHI A, 1992, CLIN EXP IMMUNOL, V88, P350; Tan RST, 2013, IMMUNOL CELL BIOL, V91, P377, DOI 10.1038/icb.2013.13; Taniguchi S, 1997, EXP HEMATOL, V25, P193; ten Hagen TL, 1998, LIVER, V18, P299; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; UTSUMI T, 1992, ARCH BIOCHEM BIOPHYS, V294, P271, DOI 10.1016/0003-9861(92)90168-V; VANLOON APGM, 1991, J LEUKOCYTE BIOL, V49, P462, DOI 10.1002/jlb.49.5.462; Vila-del Sol V, 2008, J IMMUNOL, V181, P4461, DOI 10.4049/jimmunol.181.7.4461; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; WILLIAMS JG, 1992, J LEUKOCYTE BIOL, V52, P579, DOI 10.1002/jlb.52.6.579; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5; Yoon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004560; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511	94	93	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0153289	10.1371/journal.pone.0153289	http://dx.doi.org/10.1371/journal.pone.0153289			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276061	gold, Green Published			2022-12-27	WOS:000377561700002
J	Wei, HM; Lin, LC; Wang, CF; Lee, YJ; Chen, YT; Liao, YD				Wei, Hung-Mu; Lin, Li-Chih; Wang, Chiu-Feng; Lee, Yi-Jang; Chen, Yuan-Tsong; Liao, You-Di			Antimicrobial Properties of an Immunomodulator-15 kDa Human Granulysin	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; MEMBRANE-PERMEABILITY; PROTEINS; EXPRESSION; MECHANISM; MOLECULE; CELLS; TRANSPLANTATION; HYDROPHOBICITY; DIVERSITY	Granulysin, a cationic protein expressed by human natural killer cells and cytotoxic T lymphocytes, is a mediator for drug-induced Stevens-Johnson syndrome and graft-versus-host disease. Some 15 kDa granulysin are processed into 9 kDa forms and sequestered in cytolytic granules, while others are constitutively secreted into body fluids. Both 9 and 15 kDa granulysin have been shown to be a serum marker for cell-mediated immunity. Furthermore, 15 kDa is able to activate monocyte differentiation. However, its antimicrobial properties have not been clearly addressed. Here, we report a novel method to prepare both the soluble 9 and 15 kDa granulysin and show that the 15 kDa form is more effective than the 9 kDa form in exerting specific antimicrobial activity against Pseudomonas aeruginosa within a range of few micromolars. We also show that the 15 kDa granulysin is able to hyperpolarize the membrane potential and increase membrane permeability of treated bacteria. Interestingly, the bactericidal activity and membrane permeability of the granulysins were markedly reduced at lower pH (pH 5.4) as a result of probable increase in hydrophobicity of the granulysins. Additionally, we've also shown the granulysin to inhibit biofilm formation by P. aeruginosa. These results suggest that the 15 kDa granulysin exhibits a novel mechanism in bacteria killing in a way that's different from most antimicrobial peptides. Our novel granulysin preparation methodology will be useful for further study of action mechanisms of other antimicrobial, cytotoxic and immunomodulating properties in granulysin-mediated diseases.	[Wei, Hung-Mu; Lee, Yi-Jang] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lin, Li-Chih; Wang, Chiu-Feng; Liao, You-Di] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Wei, Hung-Mu; Liao, You-Di] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Wei, Hung-Mu; Liao, You-Di] Acad Sinica, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Liao, YD (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.; Liao, YD (corresponding author), Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan.; Liao, YD (corresponding author), Acad Sinica, Taipei, Taiwan.	ydliao@ibms.sinica.edu.tw	Liao, You-Di/S-7018-2018	Liao, You-Di/0000-0001-5527-4736	Academia Sinica Thematic Research Program [AS-102-TP-B04]; Ministry of Science and Technology, Taiwan [104-0210-01-09-02]; Academia Sinica, Taiwan	Academia Sinica Thematic Research Program(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by a grant from the Academia Sinica Thematic Research Program (AS-102-TP-B04), and funds from Academia Sinica and Ministry of Science and Technology (104-0210-01-09-02), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; [Anonymous], 2011, TXB MED PHYSL; Ashokkumar C, 2011, AM J PATHOL, V179, P1929, DOI 10.1016/j.ajpath.2011.06.040; Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chang TW, 2015, ANTIMICROB AGENTS CH, V59, P6210, DOI 10.1128/AAC.01406-15; Chang TW, 2012, J BIOL CHEM, V287, P418, DOI 10.1074/jbc.M111.290361; Chen HL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003425; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Clayberger C, 2012, J IMMUNOL, V188, P6119, DOI 10.4049/jimmunol.1200570; Deng AM, 2005, J IMMUNOL, V174, P5243, DOI 10.4049/jimmunol.174.9.5243; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Finn MW, 2011, PROTEIN EXPRES PURIF, V75, P70, DOI 10.1016/j.pep.2010.07.009; Gammon K, 2014, NATURE, V509, pS10, DOI 10.1038/509S10a; Guo YG, 2013, APPL MICROBIOL BIOT, V97, P7669, DOI 10.1007/s00253-012-4602-2; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Kaspar AA, 2001, J IMMUNOL, V167, P350, DOI 10.4049/jimmunol.167.1.350; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Krensky AM, 2005, AM J TRANSPLANT, V5, P1789, DOI 10.1111/j.1600-6143.2005.00970.x; Nagasawa M, 2006, AM J HEMATOL, V81, P340, DOI 10.1002/ajh.20570; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Okada S, 2003, J IMMUNOL, V171, P2556, DOI 10.4049/jimmunol.171.5.2556; Pardo J, 2001, J IMMUNOL, V167, P1222, DOI 10.4049/jimmunol.167.3.1222; Pena S V, 1997, Semin Immunol, V9, P117, DOI 10.1006/smim.1997.0061; Pena SV, 1997, J IMMUNOL, V158, P2680; Rasamiravaka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132791; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Saini RV, 2011, J IMMUNOL, V186, P3497, DOI 10.4049/jimmunol.1003409; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Sarwal MM, 2001, HUM IMMUNOL, V62, P21, DOI 10.1016/S0198-8859(00)00228-7; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Spindler EC, 2011, ANTIMICROB AGENTS CH, V55, P1706, DOI 10.1128/AAC.01053-10; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Vanhauteghem D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060328; Wang Z, 2000, J IMMUNOL, V165, P1486, DOI 10.4049/jimmunol.165.3.1486; Waugh A, 2010, ROSS WILSON ANATOMY; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502; Zhu X, 2015, ANTIMICROB AGENTS CH, V59, P3008, DOI 10.1128/AAC.04830-14	50	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156321	10.1371/journal.pone.0156321	http://dx.doi.org/10.1371/journal.pone.0156321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276051	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700023
J	Kang, HS; Takeda, Y; Jeon, K; Jetten, AM				Kang, Hong Soon; Takeda, Yukimasa; Jeon, Kilsoo; Jetten, Anton M.			The Spatiotemporal Pattern of Glis3 Expression Indicates a Regulatory Function in Bipotent and Endocrine Progenitors during Early Pancreatic Development and in Beta, PP and Ductal Cells	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; NEONATAL DIABETES-MELLITUS; ZINC-FINGER PROTEINS; PHYSIOLOGICAL FUNCTIONS; LINEAGE DETERMINANTS; ADULT PANCREAS; NEUROGENIN 3; TRANSCRIPTION; GENE; LOCI	The transcription factor Glis-similar 3 (Glis3) has been implicated in the development of neonatal, type 1 and type 2 diabetes. In this study, we examined the spatiotemporal expression of Glis3 protein during embryonic and neonatal pancreas development as well as its function in PP cells. To obtain greater insights into the functions of Glis3 in pancreas development, we examined the spatiotemporal expression of Glis3 protein in a knockin mouse strain expressing a Glis3-EGFP fusion protein. Immunohistochemistry showed that Glis3-EGFP was not detectable during early pancreatic development (E11.5 and E12.5) and at E13.5 and 15.5 was not expressed in Ptf1a(+) cells in the tip domains indicating that Glis3 is not expressed in multipotent pancreatic progenitors. Glis3 was first detectable at E13.5 in the nucleus of bipotent progenitors in the trunk domains, where it co-localized with Sox9, Hnf6, and Pdx1. It remained expressed in preductal and Ngn3(+) endocrine progenitors and at later stages becomes restricted to the nucleus of pancreatic beta and PP cells as well as ductal cells. Glis3-deficiency greatly reduced, whereas exogenous Glis3, induced Ppy expression, as reported for insulin. Collectively, our study demonstrates that Glis3 protein exhibits a temporal and cell type-specific pattern of expression during embryonic and neonatal pancreas development that is consistent with a regulatory role for Glis3 in promoting endocrine progenitor generation, regulating insulin and Ppy expression in beta and PP cells, respectively, and duct morphogenesis.	[Kang, Hong Soon; Takeda, Yukimasa; Jeon, Kilsoo; Jetten, Anton M.] NIEHS, Cell Biol Grp, Immun Inflammat & Dis Lab, Div Intramural Res,NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), NIEHS, Cell Biol Grp, Immun Inflammat & Dis Lab, Div Intramural Res,NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445	National Institute of Environmental Health Sciences, National Institutes of Health [Z01-ES-100485]; Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100485, Z01ES100485] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by National Institute of Environmental Health Sciences, National Institutes of Health Z01-ES-100485.; This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485]. The authors thank Laura Miller DeGraff for her excellent assistance with managing the mouse colonies.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ames L., 2012, PLOS ONE, V7, DOI [10.13713ournal.pone.0052026, DOI 10.1371/JOURNAL.PONE.0052026]; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Benitez C. M., 2012, COLD SPRING HARBOR P, V4; Boesgaard TW, 2010, DIABETOLOGIA, V53, P1647, DOI 10.1007/s00125-010-1753-5; Carolan PJ, 2013, CURR OPIN ENDOCRINOL, V20, P1, DOI 10.1097/MED.0b013e32835bc380; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Happe H, 2011, BBA-MOL BASIS DIS, V1812, P1249, DOI 10.1016/j.bbadis.2011.05.005; Hashimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006299; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015542; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kim YS, 2012, MOL CELLS, V34, P193, DOI 10.1007/s10059-012-0109-z; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Lichti-Kaiser K, 2012, VITAM HORM, V88, P141, DOI 10.1016/B978-0-12-394622-5.00007-9; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Puri S, 2015, CELL STEM CELL, V16, P18, DOI 10.1016/j.stem.2014.11.001; Rieck S, 2012, SEMIN CELL DEV BIOL, V23, P673, DOI 10.1016/j.semcdb.2012.06.005; Sakai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076317; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Takeda Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004331; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Yang Y, 2011, DIABETOLOGIA, V54, P2595, DOI 10.1007/s00125-011-2255-9; Yang YS, 2013, EMBO MOL MED, V5, P92, DOI 10.1002/emmm.201201398; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	46	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157138	10.1371/journal.pone.0157138	http://dx.doi.org/10.1371/journal.pone.0157138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270601	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561000067
J	Kumar, KLS; Tangadpalliwar, SR; Desai, A; Singh, VK; Jere, A				Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.; Desai, Aarti; Singh, Vivek K.; Jere, Abhay			Integrated Computational Solution for Predicting Skin Sensitization Potential of Molecules	PLOS ONE			English	Article							ADVERSE OUTCOME PATHWAY; ALLERGIC CONTACT-DERMATITIS; LYMPH-NODE DATA; IN-VITRO; FORCE FIELD; READ-ACROSS; QSAR MODELS; MECHANISMS; SYSTEMS; CLASSIFICATION	Introduction Skin sensitization forms a major toxicological endpoint for dermatology and cosmetic products. Recent ban on animal testing for cosmetics demands for alternative methods. We developed an integrated computational solution (SkinSense) that offers a robust solution and addresses the limitations of existing computational tools i.e. high false positive rate and/or limited coverage. Results The key components of our solution include: QSAR models selected from a combinatorial set, similarity information and literature-derived sub-structure patterns of known skin protein reactive groups. Its prediction performance on a challenge set of molecules showed accuracy = 75.32%, CCR = 74.36%, sensitivity = 70.00% and specificity = 78.72%, which is better than several existing tools including VEGA (accuracy = 45.00% and CCR = 54.17% with 'High' reliability scoring), DEREK (accuracy = 72.73% and CCR = 71.44%) and TOPKAT (accuracy = 60.00% and CCR = 61.67%). Although, TIMES-SS showed higher predictive power (accuracy = 90.00% and CCR = 92.86%), the coverage was very low (only 10 out of 77 molecules were predicted reliably). Conclusions Owing to improved prediction performance and coverage, our solution can serve as a useful expert system towards Integrated Approaches to Testing and Assessment for skin sensitization. It would be invaluable to cosmetic/dermatology industry for pre-screening their molecules, and reducing time, cost and animal testing.	[Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.; Desai, Aarti; Singh, Vivek K.; Jere, Abhay] Persistent Syst Ltd, LABS, Pune, Maharashtra, India; [Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Vaishali, Bihar, India	National Institute of Pharmaceutical Education & Research (NIPER)	Jere, A (corresponding author), Persistent Syst Ltd, LABS, Pune, Maharashtra, India.	abhay_jere@persistent.com		Konda, Leela Sarath Kumar/0000-0001-9877-5039				Alves VM, 2015, TOXICOL APPL PHARM, V284, P262, DOI [10.1016/j.taap.2014.12.013, 10.1016/j.taap.2014.12.014]; Anderson Stacey E, 2011, J Allergy (Cairo), V2011, P424203, DOI 10.1155/2011/424203; [Anonymous], 2010, VLIFEMDS MOLECULAR D; [Anonymous], 2012, TEST NO 109 DENS LIQ, DOI DOI 10.1787/9789264123298-EN; Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Blum LC, 2011, J COMPUT AID MOL DES, V25, P637, DOI 10.1007/s10822-011-9436-y; Bruce CL, 2007, J CHEM INF MODEL, V47, P219, DOI 10.1021/ci600332j; Chaudhry Q, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S5; Chipinda I., 2011, J ALLERGY, V2011, DOI DOI 10.1155/2011/839682; Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901; Divkovic M, 2005, CONTACT DERMATITIS, V53, P189, DOI 10.1111/j.0105-1873.2005.00683.x; Dudek AZ, 2006, COMB CHEM HIGH T SCR, V9, P213, DOI 10.2174/138620706776055539; Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985; Enoch SJ, 2009, QSAR COMB SCI, V28, P696, DOI 10.1002/qsar.200960011; Enslein K, 1997, FOOD CHEM TOXICOL, V35, P1091, DOI 10.1016/S0278-6915(97)87277-8; EU. REGULATION (EC), 2006, OFFICIAL JOURNAL OF; Garg P, 2015, MOL DIVERS, V19, P163, DOI 10.1007/s11030-014-9562-2; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Greene N, 2002, ADV DRUG DELIVER REV, V54, P417, DOI 10.1016/S0169-409X(02)00012-1; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heller S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-7; Hewitt M, 2010, REPROD TOXICOL, V30, P147, DOI 10.1016/j.reprotox.2009.12.003; Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399; Johnson M. A., 1990, CONCEPTS APPL MOL SI; Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239; Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038; Kimber I, 2001, TOXICOL SCI, V59, P198, DOI 10.1093/toxsci/59.2.198; Li SQ, 2005, J CHEM INF MODEL, V45, P952, DOI 10.1021/ci050049u; Low Y, 2011, CHEM RES TOXICOL, V24, P1251, DOI 10.1021/tx200148a; MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473; Magee PS, 2000, QUANT STRUCT-ACT REL, V19, P356, DOI 10.1002/1521-3838(200010)19:4<356::AID-QSAR356>3.0.CO;2-I; Nantasenamat C, 2014, CHEM PAP, V68, P697, DOI 10.2478/s11696-013-0498-2; Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868; Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; Patlewicz G, 2007, SAR QSAR ENVIRON RES, V18, P515, DOI 10.1080/10629360701427872; Patlewicz G, 2008, JRC SCI TECH REP EUR, P23225; Patlewicz G, 2008, QSAR COMB SCI, V27, P60, DOI 10.1002/qsar.200710067; Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001; Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ren YY, 2006, ANAL CHIM ACTA, V572, P272, DOI 10.1016/j.aca.2006.05.027; Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w; Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y; Rodford R, 2003, ENVIRON TOXICOL CHEM, V22, P1855, DOI 10.1897/01-438; Ruet Rossignol Martine, 2005, Altern Lab Anim, V33 Suppl 1, P19; Ryan D, 2011, WAO WHITE BOOK ALLER, P5; Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257; Schlede E, 2003, TOXICOLOGY, V193, P219, DOI 10.1016/S0300-483X(03)00266-X; Singla Deepak, 2011, BMC Pharmacology, V11, P5, DOI 10.1186/1471-2210-11-5; Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007; Tou J., 1977, PATTERN RECOGNITION; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; van der Veen JW, 2014, CRIT REV TOXICOL, V44, P590, DOI 10.3109/10408444.2014.925425; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Yao XJ, 2004, J CHEM INF COMP SCI, V44, P1257, DOI 10.1021/ci049965i; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0155419	10.1371/journal.pone.0155419	http://dx.doi.org/10.1371/journal.pone.0155419			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271321	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000003
J	Minlikeeva, AN; Browne, RW; Ochs-Balcom, HM; Marian, C; Shields, PG; Trevisan, M; Krishnan, S; Modali, R; Seddon, M; Lehman, T; Freudenheim, JL				Minlikeeva, Albina N.; Browne, Richard W.; Ochs-Balcom, Heather M.; Marian, Catalin; Shields, Peter G.; Trevisan, Maurizio; Krishnan, Shiva; Modali, Ramakrishna; Seddon, Michael; Lehman, Teresa; Freudenheim, Jo L.			Single-Nucleotide Polymorphisms and Markers of Oxidative Stress in Healthy Women	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; BREAST-CANCER RISK; ANTIOXIDANT STATUS; LIPID-PEROXIDATION; GENERAL-POPULATION; DAMAGE; ASSOCIATION; BIOMARKERS; CATALASE; LUNG	Purpose There is accumulating evidence that oxidative stress is an important contributor to carcinogenesis. We hypothesized that genetic variation in genes involved in maintaining antioxidant/oxidant balance would be associated with overall oxidative stress. Methods We examined associations between single nucleotide polymorphisms (SNPs) in MnSOD, GSTP1, GSTM1, GPX1, GPX3, and CAT genes and thiobarbituric acid-reactive substances (TBARS), a blood biomarker of oxidative damage, in healthy white women randomly selected from Western New York (n = 1402). We used general linear models to calculate age-adjusted geometric means of TBARS across the variants. We also examined the associations within strata of menopausal status. Results For MnSOD, being heterozygous was associated with lower geometric means of TBARS (less oxidative stress), 1.28 mg/dL, compared to homozygous T-allele or homozygous Callele, 1.35 mg/dL, and 1.31 mg/dL correspondingly (p for trend = 0.01). This difference remained among postmenopausal women, 1.40 mg/dL for TT, 1.32 mg/dL for TC, and 1.34mg/dL for CC (p for trend 0.015); it was attenuated among premenopausal women. SNPs in the other genes examined (GSTP1, GSTM1, GPX1, GPX3, and CAT) were not associated with TBARS. Conclusions Our findings suggest that genetic variation in MnSOD gene may be associated with oxidative status, particularly among postmenopausal women.	[Minlikeeva, Albina N.; Ochs-Balcom, Heather M.; Freudenheim, Jo L.] Univ Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Browne, Richard W.] Univ Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY USA; [Marian, Catalin; Shields, Peter G.; Krishnan, Shiva] Ohio State Univ, Ctr Comprehens Canc, Div Canc Prevent & Control, Columbus, OH 43210 USA; [Marian, Catalin] Victor Babes Univ Med & Pharm, Timisoara, Romania; [Trevisan, Maurizio] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Modali, Ramakrishna; Seddon, Michael; Lehman, Teresa] BioServe Biotechnol Ltd, Beltsville, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Victor Babes University of Medicine & Pharmacy, Timisoara; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Minlikeeva, AN (corresponding author), Univ Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY USA.	albinami@buffalo.edu; jfreuden@buffalo.edu	Marian, Catalin/P-2885-2019; Ochs-Balcom, Heather M/F-3500-2012	Marian, Catalin/0000-0002-7749-1384; Freudenheim, Jo/0000-0002-9301-0499	U.S. Army Medical Research [DAMD170010417, DAMD179616202]; National Institute on Alcohol Abuse and Alcoholism [P50-AA09802]; BioServe Biotechnologies Ltd.; NATIONAL CANCER INSTITUTE [R25CA113951] Funding Source: NIH RePORTER	U.S. Army Medical Research(United States Department of DefenseUS Army Research Laboratory (ARL)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BioServe Biotechnologies Ltd.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The following grants provided funding for the study: U.S. Army Medical Research (http://mrmc.amedd.army.mil/) Grant DAMD170010417 (to JF); U.S. Army Medical Research (http://mrmc.amedd.army.mil/) Grant DAMD179616202 (to PS, CM, SK, and JF); National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/) Grant P50-AA09802 (to RB, HOB, MT, and JF). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, BioServe Biotechnologies Ltd., synthesized primers that were used for genotyping of the SNPs and provided support in the form of salaries for authors RM, MS, and TL for the laboratory analyses. BioServe did not have any additional role in the study design, data collection and analysis, decision to publish. The co-authors were involved in review and approval of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambrosone CB, 2000, ANTIOXID REDOX SIGN, V2, P903, DOI 10.1089/ars.2000.2.4-903; Andersen HR, 1997, CLIN CHEM, V43, P562; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Bastaki M, 2006, PHARMACOGENET GENOM, V16, P279, DOI 10.1097/01.fpc.0000199498.08725.9c; Battisti V, 2011, BIOMED PHARMACOTHER, V65, P516, DOI 10.1016/j.biopha.2011.06.003; Bonner MR, 2005, CANCER EPIDEM BIOMAR, V14, P53; Cai QY, 2004, BREAST CANCER RES, V6, pR647, DOI 10.1186/bcr929; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Forsberg L, 2001, FREE RADICAL BIO MED, V30, P500, DOI 10.1016/S0891-5849(00)00487-1; Gonenc A, 2001, J CLIN PHARM THER, V26, P141, DOI 10.1046/j.1365-2710.2001.00334.x; Halliwell B., 2007, FREE RADICALS BIOL M; Hamanishi T, 2004, DIABETES, V53, P2455, DOI 10.2337/diabetes.53.9.2455; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hiroi S, 1999, BIOCHEM BIOPH RES CO, V261, P332, DOI 10.1006/bbrc.1999.1036; Hong YC, 2002, TOXICOL LETT, V129, P255, DOI 10.1016/S0378-4274(02)00014-0; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Kalkan G, 2014, ARCH DERMATOL RES, V306, P253, DOI 10.1007/s00403-013-1427-5; Kang D, 2007, CANCER EPIDEM BIOMAR, V16, P1581, DOI 10.1158/1055-9965.EPI-07-0160; Kariz S, 2012, DIABETES RES CLIN PR, V98, P144, DOI 10.1016/j.diabres.2012.07.003; Khanzode SS, 2004, FREE RADICAL RES, V38, P81, DOI 10.1080/01411590310001637066; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Lee KH, 2010, CANCER EPIDEM BIOMAR, V19, P877, DOI 10.1158/1055-9965.EPI-09-1098; Li YL, 2013, ENVIRON RES, V121, P31, DOI 10.1016/j.envres.2012.10.003; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827; Moore LE, 2005, CANCER EPIDEM BIOMAR, V14, P1823, DOI 10.1158/1055-9965.EPI-05-0037; Ochs-Balcom HM, 2005, AM J EPIDEMIOL, V162, P1137, DOI 10.1093/aje/kwi339; Pansini F, 2005, CURR PHARM DESIGN, V11, P2063, DOI 10.2174/1381612054065819; Platek ME, 2010, BREAST CANCER RES TR, V121, P453, DOI 10.1007/s10549-009-0587-7; Quick SK, 2008, CANCER EPIDEM BIOMAR, V17, P1082, DOI 10.1158/1055-9965.EPI-07-2755; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Samir M, 1999, CLIN OTOLARYNGOL, V24, P232, DOI 10.1046/j.1365-2273.1999.00249.x; Sanchez-Rodriguez MA, 2012, MENOPAUSE, V19, P361, DOI 10.1097/gme.0b013e318229977d; Sener DE, 2007, CELL BIOCHEM FUNCT, V25, P377, DOI 10.1027/cbf.1308; Slanger TE, 2006, CANCER CAUSE CONTROL, V17, P1025, DOI 10.1007/s10552-006-0043-5; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Trevisan M, 2001, AM J EPIDEMIOL, V154, P348, DOI 10.1093/aje/154.4.348; Wang SM, 2009, EUR J CANCER, V45, P2874, DOI 10.1016/j.ejca.2009.04.024; Wei BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046982; Wu K, 2013, MOL BIOL REP, V40, P687, DOI 10.1007/s11033-012-2109-7; ZIMNIAK P, 1994, EUR J BIOCHEM, V224, P893, DOI 10.1111/j.1432-1033.1994.00893.x	42	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156450	10.1371/journal.pone.0156450	http://dx.doi.org/10.1371/journal.pone.0156450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271305	Green Published, gold			2022-12-27	WOS:000377561000016
J	Ogbunugafor, CB; Robinson, SP				Ogbunugafor, C. Brandon; Robinson, Sean P.			OFFl Models: Novel Schema for Dynamical Modeling of Biological Systems	PLOS ONE			English	Article							SYMMETRY; PHYSICS	Flow diagrams are a common tool used to help build and interpret models of dynamical systems, often in biological contexts such as consumer-resource models and similar compartmental models. Typically, their usage is intuitive and informal. Here, we present a formalized version of flow diagrams as a kind of weighted directed graph which follow a strict grammar, which translate into a system of ordinary differential equations (ODEs) by a single unambiguous rule, and which have an equivalent representation as a relational database. (We abbreviate this schema of "ODEs and formalized flow diagrams" as OFFL.) Drawing a diagram within this strict grammar encourages a mental discipline on the part of the modeler in which all dynamical processes of a system are thought of as interactions between dynamical species that draw parcels from one or more source species and deposit them into target species according to a set of transformation rules. From these rules, the net rate of change for each species can be derived. The modeling schema can therefore be understood as both an epistemic and practical heuristic for modeling, serving both as an organizational framework for the model building process and as a mechanism for deriving ODEs. All steps of the schema beyond the initial scientific (intuitive, creative) abstraction of natural observations into model variables are algorithmic and easily carried out by a computer, thus enabling the future development of a dedicated software implementation. Such tools would empower the modeler to consider significantly more complex models than practical limitations might have otherwise proscribed, since the modeling framework itself manages that complexity on the modeler's behalf. In this report, we describe the chief motivations for OFFL, carefully outline its implementation, and utilize a range of classic examples from ecology and epidemiology to showcase its features.	[Ogbunugafor, C. Brandon] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Robinson, Sean P.] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Robinson, SP (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	spatrick@mit.edu		Robinson, Sean/0000-0002-5057-2715	Ford Foundation Postdoctoral Fellowship	Ford Foundation Postdoctoral Fellowship	CBO was funded by the Ford Foundation Postdoctoral Fellowship (http://sites.nationalacademies.org/pga/fordfellowships/index.htm). SPR received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Medical Colleges Howard Hughes Medical Institute, 2009, SCI FDN FUT PHYS REP; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Caruso W, 2016, OFFLMAKER OPEN SOURC; Chitnis N, 2012, P NATL ACAD SCI USA, V109, pE3055, DOI 10.1073/pnas.1213115109; Fawcett TW, 2012, P NATL ACAD SCI USA, V109, P11735, DOI 10.1073/pnas.1205259109; Feinberg M., 1979, LECT CHEM REACTION N; Funahashi A, 2003, CELLDESIGNER; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jenness S. M., 2016, EPIMODEL MATH MODELI; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kirchhoff G., 1845, ANN PHYS-NEW YORK, V140, P497, DOI [10.1002/andp.18451400402, DOI 10.1002/ANDP.18451400402]; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lotka AJ, 1920, P NATL ACAD SCI USA, V6, P410, DOI 10.1073/pnas.6.7.410; MACEY R, 1993, BERKELEY MADONNA; Meadows D., 2004, LIMITS GROWTH 30 YEA; Moodie S., 2011, NATURE PRECEDINGS; Noether E, 1918, MATHEMATISCH PHYSIKA, P235, DOI DOI 10.1080/00411457108231446; Otto SP, 2007, BIOL GUIDE MATH MODE; Pachter L, 2014, BITS OF DNA; PARK D, 1968, AM J PHYS, V36, P577, DOI 10.1119/1.1975017; Richmond Berry, 1985, STELLA; ROSEN J, 1981, AM J PHYS, V49, P304, DOI 10.1119/1.12504; Schaff J, 1997, VCELL; Volterra V, 1926, VARIAZIONI FLUTTUAZI, P2; Volterra V, 1926, NATURE, V118, DOI 10.1038/118558a0; Watts D.J, 2004, 6 DEGREES SCI CONNEC	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156844	10.1371/journal.pone.0156844	http://dx.doi.org/10.1371/journal.pone.0156844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270918	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000041
J	Rose, JA; Wanner, N; Cheong, HI; Queisser, K; Barrett, P; Park, M; Hite, C; Prasad, SVN; Erzurum, S; Asosingh, K				Rose, Jonathan A.; Wanner, Nicholas; Cheong, Hoi I.; Queisser, Kimberly; Barrett, Patrick; Park, Margaret; Hite, Corrine; Prasad, Sathyamangla V. Naga; Erzurum, Serpil; Asosingh, Kewal			Flow Cytometric Quantification of Peripheral Blood Cell beta-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							FAILING HUMAN HEART; CIRCULATING MICROPARTICLES; EXTRACELLULAR VESICLES; LYMPHOCYTES; MARKER; KINASE	Pulmonary arterial hypertension (PAH) is a heterogeneous disease characterized by severe angiogenic remodeling of the pulmonary artery wall and right ventricular hypertrophy. Thus, there is an increasing need for novel biomarkers to dissect disease heterogeneity, and predict treatment response. Although beta-adrenergic receptor (beta AR) dysfunction is well documented in left heart disease while endothelial cell-derived microparticles (Ec-MPs) are established biomarkers of angiogenic remodeling, methods for easy large clinical cohort analysis of these biomarkers are currently absent. Here we describe flow cytometric methods for quantification of beta AR density on circulating white blood cells (WBC) and Ec-MPs in urine samples that can be used as potential biomarkers of right heart failure in PAH. Biotinylated beta-blocker alprenolol was synthesized and validated as a beta AR specific probe that was combined with immunophenotyping to quantify beta AR density in circulating WBC subsets. Ec-MPs obtained from urine samples were stained for annexin-V and CD144, and analyzed by a micro flow cytometer. Flow cytometric detection of alprenolol showed that beta AR density was decreased in most WBC subsets in PAH samples compared to healthy controls. EcMPs in urine was increased in PAH compared to controls. Furthermore, there was a direct correlation between Ec-MPs and Tricuspid annular plane systolic excursion (TAPSE) in PAH patients. Therefore, flow cytometric quantification of peripheral blood cell beta AR density and urinary Ec-MPs may be useful as potential biomarkers of right ventricular function in PAH.	[Rose, Jonathan A.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Wanner, Nicholas; Cheong, Hoi I.; Queisser, Kimberly; Park, Margaret; Hite, Corrine; Erzurum, Serpil; Asosingh, Kewal] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Barrett, Patrick] Cleveland Clin, Lerner Res Inst, Flow Cytometry Core, Cleveland, OH 44106 USA; [Prasad, Sathyamangla V. Naga] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Erzurum, Serpil] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Asosingh, K (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.	asosink@ccf.org			National Institutes of Health [HL081064, HL60917, HL115008, M01 RR018390]; American Thoracic Society/Pulmonary Association Research grant [PH-07-003]; Cleveland Clinic Research Program Committee Pilot Grant (RPC) [2014-1045]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018390] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, P01HL081064, R01HL115008, R37HL060917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society/Pulmonary Association Research grant; Cleveland Clinic Research Program Committee Pilot Grant (RPC); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL081064 (SE), HL60917 (SE), HL115008 (SE) and M01 RR018390 (SE) from the National Institutes of Health, American Thoracic Society/Pulmonary Association Research grant (PH-07-003 (KA)), and Cleveland Clinic Research Program Committee Pilot Grant (RPC# 2014-1045 (JR)).; We sincerely appreciate Marybeth Boyle, Laura Peterson, Dr. Suzy Comhair and Michelle Koo's assistance in collecting patients samples and clinical data. Kewal Asosingh is a Scholar of the International Society for Advancement of Cytometry (ISAC). This work was supported by grants HL081064, HL60917, HL115008 and M01 RR018390 from the National Institutes of Health, American Thoracic Society/Pulmonary Association Research grant (PH-07-003), and Cleveland Clinic Research Program Committee Pilot Grant (RPC# 2014-1045).	Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC; Asosingh K, 2012, BLOOD, V120, P1218, DOI 10.1182/blood-2012-03-419275; Barteneva NS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-23; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Bretelle F, 2003, THROMB HAEMOSTASIS, V89, P486, DOI 10.1055/s-0037-1613378; BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; BRODDE OE, 1986, SCIENCE, V231, P1584, DOI 10.1126/science.3006250; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Bull TM, 2003, THROMB HAEMOSTASIS, V90, P698, DOI 10.1160/TH03-04-0251; Chow S, 2005, CYTOM PART A, V67A, P4, DOI 10.1002/cyto.a.20167; Chow Sue, 2008, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0927s46; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; COLUCCI WS, 1981, NEW ENGL J MED, V305, P185, DOI 10.1056/NEJM198107233050402; Curtis AM, 2013, VASC MED, V18, P204, DOI 10.1177/1358863X13499773; Erdbrugger U, 2016, CYTOM PART A, V89A, P123, DOI 10.1002/cyto.a.22795; Fan XL, 2009, PROG NAT SCI-MATER, V19, P17, DOI 10.1016/j.pnsc.2008.10.001; Farha S, 2011, BLOOD, V117, P3485, DOI 10.1182/blood-2010-09-306357; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Haeck MLA, 2015, HEART, V101, P311, DOI 10.1136/heartjnl-2011-301386; Hargett LA, 2013, PULM CIRC, V3, P329, DOI 10.4103/2045-8932.114760; Hata JA, 2006, J CARD FAIL, V12, P360, DOI 10.1016/j.cardfail.2006.02.011; Inglis HC, 2015, CYTOM PART A, V87A, P1052, DOI 10.1002/cyto.a.22649; Jimenez JJ, 2003, BRIT J HAEMATOL, V123, P896, DOI 10.1046/j.1365-2141.2003.04716.x; KURIYAMA H, 1982, AM J PHYSIOL, V243, pH641, DOI 10.1152/ajpheart.1982.243.5.H641; Lanzola E, 2013, PULM CIRC, V3, P781, DOI 10.1086/674769; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; MEIER KE, 1983, BIOCHIM BIOPHYS ACTA, V761, P257, DOI 10.1016/0304-4165(83)90074-0; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Naga Prasad S V, 2001, Trends Genet, V17, pS44, DOI 10.1016/S0168-9525(01)02487-8; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Smadja DM, 2010, EUR RESPIR J, V36, P1284, DOI 10.1183/09031936.00130809; Tonelli AR, 2013, AM J RESP CRIT CARE, V188, P365, DOI 10.1164/rccm.201209-1640OC; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; van der Pol E, 2014, NANO LETT, V14, P6195, DOI 10.1021/nl503371p; WILLIAMS LT, 1976, J CLIN INVEST, V57, P149, DOI 10.1172/JCI108254; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yan LH, 2011, DEV GROWTH DIFFER, V53, P772, DOI 10.1111/j.1440-169X.2011.01284.x; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	44	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156940	10.1371/journal.pone.0156940	http://dx.doi.org/10.1371/journal.pone.0156940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270458	Green Submitted, gold, Green Published			2022-12-27	WOS:000377561000052
J	Kanzi, AM; Wingfield, BD; Steenkamp, ET; Naidoo, S; van der Merwe, NA				Kanzi, Aquillah Mumo; Wingfield, Brenda Diana; Steenkamp, Emma Theodora; Naidoo, Sanushka; van der Merwe, Nicolaas Albertus			Intron Derived Size Polymorphism in the Mitochondrial Genomes of Closely Related Chrysoporthe Species	PLOS ONE			English	Article							HOMING ENDONUCLEASE GENES; OPHIOSTOMA-NOVO-ULMI; ELM DISEASE FUNGUS; OPEN READING FRAME; GROUP-II INTRONS; CRYPHONECTRIA-CUBENSIS; FUSARIUM-OXYSPORUM; EVOLUTION; SEQUENCES; EUCALYPTUS	In this study, the complete mitochondrial (mt) genomes of Chrysoporthe austroafricana (190,834 bp), C. cubensis (89,084 bp) and C. deuterocubensis (124,412 bp) were determined. Additionally, the mitochondrial genome of another member of the Cryphonectriaceae, namely Cryphonectria parasitica (158,902 bp), was retrieved and annotated for comparative purposes. These genomes showed high levels of synteny, especially in regions including genes involved in oxidative phosphorylation and electron transfer, unique open reading frames (uORFs), ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs), as well as intron positions. Comparative analyses revealed signatures of duplication events, intron number and length variation, and varying intronic ORFs which highlighted the genetic diversity of mt genomes among the Cryphonectriaceae. These mt genomes showed remarkable size polymorphism. The size polymorphism in the mt genomes of these closely related Chrysoporthe species was attributed to the varying number and length of introns, coding sequences and to a lesser extent, intergenic sequences. Compared to publicly available fungal mt genomes, the C. austroafricana mt genome is the second largest in the Ascomycetes thus far.	[Kanzi, Aquillah Mumo; Wingfield, Brenda Diana; Naidoo, Sanushka; van der Merwe, Nicolaas Albertus] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag x20, ZA-0028 Pretoria, South Africa; [Steenkamp, Emma Theodora] Univ Pretoria, Dept Microbiol & Plant Pathol, Forestry & Agr Biotechnol Inst, Private Bag x20, ZA-0028 Pretoria, South Africa	University of Pretoria; University of Pretoria	van der Merwe, NA (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag x20, ZA-0028 Pretoria, South Africa.	albe.vdmerwe@up.ac.za	Van der Merwe, Nicolaas A/A-9096-2008; Naidoo, Sanushka/B-2844-2010; Wingfield, Brenda D./B-1376-2008; Steenkamp, Emma T/B-7958-2009	Wingfield, Brenda D./0000-0002-6189-1519; Steenkamp, Emma T/0000-0003-0217-8219; van der Merwe, Albe/0000-0003-3185-348X; Kanzi, Aquillah/0000-0001-6081-9438	Genomics Research Institute (GRI) University of Pretoria; University of Pretoria Research Development Programme; DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria); National Research Foundation (NRF) [87332]	Genomics Research Institute (GRI) University of Pretoria; University of Pretoria Research Development Programme; DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria); National Research Foundation (NRF)	This work was co-funded by the Genomics Research Institute (GRI) University of Pretoria, the University of Pretoria Research Development Programme, the DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria), and the National Research Foundation (NRF) (grant number 87332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was co-funded by the Genomics Research Institute (GRI) University of Pretoria, the University of Pretoria Research Development Programme, the DST/NRF Centre of Excellence in Tree Health Biotechnology (FABI, University of Pretoria), and the National Research Foundation (NRF) (Grant number 87332).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Al-Reedy RM, 2012, FUNGAL GENET BIOL, V49, P2, DOI 10.1016/j.fgb.2011.11.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2015, IMA FUNGUS, V6, P493, DOI 10.5598/imafungus.2015.06.02.13; [Anonymous], WROTE PAPER AMK BDW; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Beaudet D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060768; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bullerwell CE, 2004, CURR OPIN MICROBIOL, V7, P528, DOI 10.1016/j.mib.2004.08.008; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Capella- Gutierrez S., 2009, BIOINFORMATICS, V25; Chungu D, 2010, MYCOL PROG, V9, P379, DOI 10.1007/s11557-009-0646-9; Cole TE, 2000, VIROLOGY, V268, P239, DOI 10.1006/viro.1999.0097; Cunnington JH, 2009, SYDOWIA, V61, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ferandon C, 2013, FUNGAL GENET BIOL, V55, P85, DOI 10.1016/j.fgb.2013.01.009; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Fourie G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-605; Gilmore SR, 2009, MOL ECOL RESOUR, V9, P90, DOI 10.1111/j.1755-0998.2009.02636.x; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gryzenhout M, 2006, MYCOLOGIA, V98, P239, DOI 10.3852/mycologia.98.2.239; Gryzenhout M, 2005, FUNGAL DIVERS, V20, P39; Gryzenhout M, 2004, STUD MYCOL, P119; Gryzenhout M, 2006, MYCOL RES, V110, P833, DOI 10.1016/j.mycres.2006.02.010; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Hausner G, 2003, APPLIED MYCOLOGY AND BIOTECHNOLOGY, VOL 3, P101; Hausner G, 1999, CURR GENET, V35, P109, DOI 10.1007/s002940050439; Hausner G, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P329, DOI 10.1007/978-3-642-22380-8_13; Himmelstrand K, 2014, CURR GENET, V60, P303, DOI 10.1007/s00294-014-0436-z; HODGES C S, 1976, Fitopatologia Brasileira, V1, P129; HODGES CS, 1979, PLANT DIS REP, V63, P216; Hong YG, 1999, VIROLOGY, V258, P118, DOI 10.1006/viro.1999.9691; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kouvelis VN, 2008, MYCOL RES, V112, P829, DOI 10.1016/j.mycres.2008.01.016; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lin RM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0341-8; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; Mardanov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107536; Monteiro-Vitorello CB, 2009, FUNGAL GENET BIOL, V46, P837, DOI 10.1016/j.fgb.2009.07.005; Myburg H, 2002, CAN J BOT, V80, P590, DOI [10.1139/b02-039, 10.1139/B02-039]; Pantou MP, 2008, GENE, V419, P7, DOI 10.1016/j.gene.2008.04.009; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Pramateftaki PV, 2006, PLOS ONE; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Salavirta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097141; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Shimko N, 2001, NUCLEIC ACIDS RES, V29, P128, DOI 10.1093/nar/29.1.128; Stamatakis A, 2014, BIOINFORMATICS; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stone CL, 2010, MYCOLOGIA, V102, P887, DOI 10.3852/09-198; Torriani SFF, 2014, FUNGAL GENET BIOL, V62, P34, DOI 10.1016/j.fgb.2013.11.001; Tuller T, 2011, NUCL ACIDS RES; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; Van der Merwe NA, 2010, FUNGAL BIOL-UK, V114, P966, DOI 10.1016/j.funbio.2010.09.007; Wingfield BD, 2015, IMA FUNGUS, V6, P233, DOI 10.5598/imafungus.2015.06.01.15; WINGFIELD M J, 1989, Phytophylactica, V21, P311; Wu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-238; Yin LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049096; Youssar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074792	71	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156104	10.1371/journal.pone.0156104	http://dx.doi.org/10.1371/journal.pone.0156104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27272523	Green Submitted, Green Published, gold			2022-12-27	WOS:000377560200005
J	Kim, JK; Lee, SH; Lee, SY; Kim, EK; Kwon, JE; Seo, HB; Lee, HH; Lee, BI; Park, SH; Cho, ML				Kim, Jae-kyung; Lee, Seung Hoon; Lee, Seon-Young; Kim, Eun-Kyung; Kwon, Jeong-Eun; Seo, Hyeon-Beom; Lee, Han Hee; Lee, Bo-In; Park, Sung-Hwan; Cho, Mi-La			Grim19 Attenuates DSS Induced Colitis in an Animal Model	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; STAT3; GRIM-19; MICE; INHIBITION; ENTEROCOLITIS; MACROPHAGES; ARTHRITIS; PATHWAY	DSS induced colitis is a chronic inflammatory disease characterized by inflammation in the gastrointestinal tract, which destabilizes the gut and induces an uncontrolled immune response. Although DSS induced colitis is generally thought to develop as a result of an abnormally active intestinal immune system, its pathogenesis remains unclear. Gene associated with retinoid interferon induced mortality (Grim) 19 is an endogenous specific inhibitor of STAT3, which regulates the expression of proinflammatory cytokines. In this study, we investigated the influence of GRIM19 in a DSS induced colitis mouse model. We hypothesized that Grim19 would ameliorate DSS induced colitis by altering STAT3 activity and intestinal inflammation. Grim19 ameliorated DSS induced colitis severity and protected intestinal tissue. The expression of STAT3 and proinflammatory cytokines such as IL-1 beta and TNF-alpha in colon and lymph nodes was decreased significantly by Grim19. Moreover, DSS induced colitis progression in a Grim19 transgenic mouse line was inhibited in association with a reduction in STAT3 and IL-17 expression. These results suggest that Grim19 attenuates DSS induced colitis by suppressing the excessive inflammatory response mediated by STAT3 activation.	[Kim, Jae-kyung; Lee, Seung Hoon; Lee, Seon-Young; Kim, Eun-Kyung; Kwon, Jeong-Eun; Seo, Hyeon-Beom; Park, Sung-Hwan; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, 222 Banpo Daero, Seoul 137701, South Korea; [Kim, Jae-kyung; Lee, Seung Hoon; Lee, Seon-Young; Kim, Eun-Kyung; Kwon, Jeong-Eun; Seo, Hyeon-Beom; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Lab Immune Network, 222 Banpo Daero, Seoul 137701, South Korea; [Lee, Han Hee; Lee, Bo-In] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterl, Seoul, South Korea; [Park, Sung-Hwan] Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Seoul 137040, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, 222 Banpo Daero, Seoul 137701, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Lab Immune Network, 222 Banpo Daero, Seoul 137701, South Korea.	iammila@catholic.ac.kr	Lee, Han Hee/AAB-7987-2022		Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1062]; Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C3417, HI13C0016]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (https://www.khidi.or.kr/) (HI15C1062). This study was also supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417); and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0016).	Alonzi T, 2004, CYTOKINE, V26, P45, DOI 10.1016/j.cyto.2003.12.002; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Cenit MC, 2010, GENES IMMUN, V11, P264, DOI 10.1038/gene.2010.10; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Ekchariyawat P, 2013, INNATE IMMUN-LONDON, V19, P655, DOI 10.1177/1753425913479149; Fitzpatrick LR, 2013, INT REV IMMUNOL, V32, P544, DOI 10.3109/08830185.2013.821118; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Kalakonda S, 2013, P NATL ACAD SCI USA, V110, pE4213, DOI 10.1073/pnas.1303760110; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mitsuyama K, 2007, ANTICANCER RES, V27, P3749; Moon YM, 2014, ARTHRITIS RHEUMATOL, V66, P569, DOI 10.1002/art.38267; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rogler G, 2010, BEST PRACT RES CL GA, V24, P157, DOI 10.1016/j.bpg.2009.10.011; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sugimoto K, 2008, WORLD J GASTROENTERO, V14, P5110, DOI 10.3748/wjg.14.5110; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Vuitton L, 2013, CURR DRUG TARGETS, V14, P1385, DOI 10.2174/13894501113149990160; Yan JW, 2014, EXPERT OPIN THER TAR, V18, P29, DOI 10.1517/14728222.2013.843669; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109625	29	11	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155853	10.1371/journal.pone.0155853	http://dx.doi.org/10.1371/journal.pone.0155853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258062	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700021
J	Mech, LD; Barber-Meyer, SM; Erb, J				Mech, L. David; Barber-Meyer, Shannon M.; Erb, John			Wolf (Canis lupus) Generation Time and Proportion of Current Breeding Females by Age	PLOS ONE			English	Article							REPRODUCTIVE ACTIVITY; GRAY WOLVES; WILD; GUIDELINES; ECOLOGY; SIZE; PACK	Information is sparse about aspects of female wolf (Canis lupus) breeding in the wild, including age of first reproduction, mean age of primiparity, generation time, and proportion of each age that breeds in any given year. We studied these subjects in 86 wolves (113 captures) in the Superior National Forest (SNF), Minnesota (MN), during 1972-2013 where wolves were legally protected for most of the period, and in 159 harvested wolves from throughout MN wolf range during 2012-2014. Breeding status of SNF wolves were assessed via nipple measurements, and wolves from throughout MN wolf range, by placental scars. In the SNF, proportions of currently breeding females (those breeding in the year sampled) ranged from 19% at age 2 to 80% at age 5, and from throughout wolf range, from 33% at age 2 to 100% at age 7. Excluding pups and yearlings, only 33% to 36% of SNF females and 58% of females from throughout MN wolf range bred in any given year. Generation time for SNF wolves was 4.3 years and for MN wolf range, 4.7 years. These findings will be useful in modeling wolf population dynamics and in wolf genetic and dog-domestication studies.	[Mech, L. David; Barber-Meyer, Shannon M.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA; [Erb, John] Minnesota Dept Nat Resources, Grand Rapids, MI USA; [Mech, L. David] Raptor Ctr, 1920 Fitch Ave, St Paul, MN USA; [Barber-Meyer, Shannon M.] US Geol Survey, 1393 Highway 169, Ely, MN USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Mech, LD (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA.; Mech, LD (corresponding author), Raptor Ctr, 1920 Fitch Ave, St Paul, MN USA.	mechx002@umn.edu		Barber-Meyer, Shannon/0000-0002-3048-2616	US Geological Survey; Minnesota Dept. of Natural Resources	US Geological Survey(United States Geological Survey); Minnesota Dept. of Natural Resources	This work was funded by US Geological Survey to LDM SMB; Minnesota Dept. of Natural Resources to JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber-Meyer SM, 2015, NORTHEAST NAT, V22, P652, DOI 10.1656/045.022.0402; BOERTJE RD, 1992, CAN J ZOOL, V70, P2441, DOI 10.1139/z92-328; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cook R.D., 1999, RESPONSE TRANSFORMAT, DOI DOI 10.1002/9780470316948; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Erb J, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P49, DOI 10.1007/978-0-387-85952-1_4; FRENZEL L D, 1974, Naturaliste Canadien (Quebec), V101, P467; Fritts SH, 1992, USFWS RESOURCE PUBL, P1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GASAWAY WC, 1983, WILDLIFE MONOGR, P1; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Gude JA, 2012, J WILDLIFE MANAGE, V76, P108, DOI 10.1002/jwmg.201; Hedrick PW, 2014, CONSERV GENET, V15, P1111, DOI 10.1007/s10592-014-0604-1; Hillis TL, 1996, CAN J ZOOL, V74, P2211, DOI 10.1139/z96-251; Hillis TL, 1990, THESIS LAURENTIAN U; Jochle W, 1997, REPROD DOMEST ANIM, V32, P183, DOI 10.1111/j.1439-0531.1997.tb01280.x; Kreeger Terry J., 2003, P192; Landon DB, 1998, J WILDLIFE MANAGE, V62, P674, DOI 10.2307/3802343; McNay ME, 2006, J MAMMAL, V87, P85, DOI 10.1644/05-MAMM-A-057R1.1; Mech LD, 2006, J WILDLIFE MANAGE, V70, P1481, DOI 10.2193/0022-541X(2006)70[1481:EASOWI]2.0.CO;2; Mech L.D, 1974, P 11 INT C GAM BIOL, P315; Mech LD, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P15, DOI 10.1007/978-0-387-85952-1_2; Mech LD, 2006, J MAMMAL, V87, P80, DOI 10.1644/05-MAMM-F-212R1.1; MECH LD, 1993, AM MIDL NAT, V129, P266, DOI 10.2307/2426507; MECH LD, 1987, J MAMMAL, V68, P871, DOI 10.2307/1381570; Mech LD., 1998, WOLVES DENALI; MEDJO DC, 1976, J MAMMAL, V57, P406, DOI 10.2307/1379708; Mlot C, 2013, SCIENCE, V340, P919, DOI 10.1126/science.340.6135.919; Olson SF, 1938, ECOLOGY, V19, P168, DOI 10.2307/1930384; PACKARD JM, 1992, CAN J ZOOL, V70, P1269, DOI 10.1139/z92-177; PETERSON RO, 1984, J WILDLIFE MANAGE, P1; Pimlott DH, 1969, 87 ONT DEP LANDS FOR, P1; RAUSCH RA, 1967, AM ZOOL, V7, P253; SEAL US, 1979, BIOL REPROD, V21, P1057, DOI 10.1095/biolreprod21.5.1057; Sikes RS, 2012, BIOSCIENCE, V62, P830, DOI 10.1525/bio.2012.62.9.9; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Stahler DR, 2013, J ANIM ECOL, V82, P222, DOI 10.1111/j.1365-2656.2012.02039.x; STENLUND MILTON H., 1955, TECH BULL MINNESOTA DEPT CONSERV, V4, P1; van Ballenberghe V., 1975, Wildlife Monogr, VNo. 43, P1; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; ZIMEN E, 1976, Z TIERPSYCHOL, V40, P300	43	25	25	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156682	10.1371/journal.pone.0156682	http://dx.doi.org/10.1371/journal.pone.0156682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258193	Green Published, gold			2022-12-27	WOS:000377369700102
J	Zhu, HM; Liu, J; Cui, CC; Song, YJ; Ge, HT; Hu, LY; Li, Q; Jin, YP; Zhang, Y				Zhu, Hongmei; Liu, Jun; Cui, Chenchen; Song, Yujie; Ge, Hengtao; Hu, Linyong; Li, Qian; Jin, Yaping; Zhang, Yong			Targeting Human alpha-Lactalbumin Gene Insertion into the Goat beta-Lactoglobulin Locus by TALEN-Mediated Homologous Recombination	PLOS ONE			English	Article							HUMAN-MILK; PROTEINS; DESIGN	Special value of goat milk in human nutrition and well being is associated with medical problems of food allergies which are caused by milk proteins such as beta-lactoglobulin (BLG). Here, we employed transcription activator-like effector nuclease (TALEN)-assisted homologous recombination in goat fibroblasts to introduce human alpha-lactalbumin (hLA) genes into goat BLG locus. TALEN-mediated targeting enabled isolation of colonies with mono-and bi-allelic transgene integration in up to 10.1% and 1.1%, respectively, after selection. Specifically, BLG mRNA levels were gradually decreasing in both mo- and bi-allelic goat mammary epithelial cells (GMECs) while hLA demonstrated expression in GMECs in vitro. Gene-targeted fibroblast cells were efficiently used in somatic cell nuclear transfer, resulting in production of hLA knock-in goats directing down-regulated BLG expression and abundant hLA secretion in animal milk. Our findings provide valuable background for animal milk optimization and expedited development for agriculture and biomedicine.	[Zhu, Hongmei; Liu, Jun; Cui, Chenchen; Song, Yujie; Ge, Hengtao; Hu, Linyong; Li, Qian; Jin, Yaping; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhu, Hongmei; Liu, Jun; Cui, Chenchen; Song, Yujie; Ge, Hengtao; Hu, Linyong; Li, Qian; Jin, Yaping; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Jin, YP; Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.; Jin, YP; Zhang, Y (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China.	yapingjin@163.com; zhangyong1956@nwsuaf.edu.cn	Cui, Chenchen/AAJ-1061-2020		China National Program for Transgenic Animal [2014ZX08008-004]; National High Technology Research and Development Program of China [2011AA100303]	China National Program for Transgenic Animal; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is financially supported by the China National Program for Transgenic Animal (2014ZX08008-004) and the National High Technology Research and Development Program of China (2011AA100303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Leung S, 2006, ALLERGY, V61, P1358, DOI 10.1111/j.1398-9995.2006.01193.x; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Brew K, 2013, ADV DAIRY CHEM, V4th, P261, DOI [DOI 10.1007/978-1-4614-4714-6_8, 10.1007/978-1-4614-4714-6_8]; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chatterton DEW, 2006, INT DAIRY J, V16, P1229, DOI 10.1016/j.idairyj.2006.06.001; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; del Val G, 1999, J ALLERGY CLIN IMMUN, V103, P690, DOI 10.1016/S0091-6749(99)70244-7; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Feng XJ, 2015, TRANSGENIC RES, V24, P73, DOI 10.1007/s11248-014-9818-8; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao Q, 2007, STEM CELLS, V25, P3085, DOI 10.1634/stemcells.2007-0478; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Hursel R, 2010, BRIT J NUTR, V103, P775, DOI 10.1017/S0007114509992352; Kasparek P, 2014, FEBS LETT, V588, P3982, DOI 10.1016/j.febslet.2014.09.014; Kehoe JJ, 2014, FOOD HYDROCOLLOID, V34, P217, DOI 10.1016/j.foodhyd.2012.09.009; Lantinga-van Leeuwen IS, 2006, GENESIS, V44, P225, DOI 10.1002/dvg.20207; Liu J, 2013, ANTIBACTERIAL ACTIVI; Liu X, 2013, NATURE COMMUNICATION, V4; Lonnerdal B, 2014, AM J CLIN NUTR, V99, p712S, DOI 10.3945/ajcn.113.071993; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Moghaddassi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089631; Papapetrou EP, 2016, MOL THERAPY; Park Y, 2012, 1 AS DAIR GOAT C; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Sharma S, 2001, J CHROMATOGR B, V756, P183, DOI 10.1016/S0378-4347(01)00107-4; Spencer WJ, 2010, PEDIATR RES, V68, P490, DOI 10.1203/PDR.0b013e3181f70f21; STACEY A, 1995, P NATL ACAD SCI USA, V92, P2835, DOI 10.1073/pnas.92.7.2835; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Wheeler MB, 2003, J ANIM SCI, V81, P32; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Zhu Lihua Julie, 2015, [Frontiers in Biology, 生物学前沿], V10, P289	41	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156636	10.1371/journal.pone.0156636	http://dx.doi.org/10.1371/journal.pone.0156636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258157	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700093
J	Hao, Y; Yu, FF; Lv, RT; Ma, CX; Zhang, ZT; Rui, YK; Liu, LM; Cao, WD; Xing, BS				Hao, Yi; Yu, Feifan; Lv, Ruitao; Ma, Chuanxin; Zhang, Zetian; Rui, Yukui; Liu, Liming; Cao, Weidong; Xing, Baoshan			Carbon Nanotubes Filled with Different Ferromagnetic Alloys Affect the Growth and Development of Rice Seedlings by Changing the C:N Ratio and Plant Hormones Concentrations	PLOS ONE			English	Article							SILVER NANOPARTICLES EXPOSURE; OXIDE NANOPARTICLES; ABSCISIC-ACID; CERIA NANOPARTICLES; SEED-GERMINATION; HIGH-TEMPERATURE; SALICYLIC-ACID; WHEAT; ARABIDOPSIS; TOXICITY	The aim of this study was to investigate the phytotoxicity of thin-walled carbon nanotubes (CNTs) to rice (Oryza sativa L.) seedlings. Three different CNTs, including hollow multi-walled carbon nanotubes (MWCNTs), Fe-filled carbon nanotubes (Fe-CNTs), and Fe-Cofilled carbon nanotubes (FeCo-CNTs), were evaluated. The CNTs significantly inhibited rice growth by decreasing the concentrations of endogenous plant hormones. The carbon to nitrogen ratio (C:N ratio) significantly increased in rice roots after treatments with CNTs, and all three types of CNTs had the same effects on the C:N ratio. Interestingly, the increase in the C:N ratio in roots was largely because of decreased N content, indicating that the CNTs significantly decreased N assimilation. Analyses of the Fe and Co contents in plant tissues, transmission electron microscope (TEM) observations and energy dispersive X-ray spectroscopy (EDS) analysis proved that the CNTs could penetrate the cell wall and the cell membrane, and then enter the root cells. According to the author's knowledge, this is the first time to study the relationship between carbon nanotubes and carbon nitrogen ratio and plant hormones.	[Hao, Yi; Zhang, Zetian; Rui, Yukui; Liu, Liming] China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China; [Yu, Feifan; Lv, Ruitao] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Ma, Chuanxin; Rui, Yukui; Xing, Baoshan] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Cao, Weidong] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Crop Nutr & Fertilizat, Beijing 100081, Peoples R China	China Agricultural University; Tsinghua University; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Rui, YK (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100093, Peoples R China.; Rui, YK (corresponding author), Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA.	ruiyukui@163.com	Ma, Chuanxin/AFO-5267-2022; Xing, Baoshan/AAE-7826-2019; Lv, Ruitao/P-2557-2014	Ma, Chuanxin/0000-0001-5125-7322; Lv, Ruitao/0000-0001-9967-263X	Key National Natural Science Foundation of China [41130526]; National Natural Science Foundation of China [41371471, 51372131]; NSFC-Guangdong Joint Fund [U1401234]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Joint Fund	This work was supported by the Key National Natural Science Foundation of China (No. 41130526), National Natural Science Foundation of China (No. 41371471), NSFC-Guangdong Joint Fund (U1401234), and National Natural Science Foundation of China (No. 51372131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by the Key National Natural Science Foundation of China (No. 41130526), the National Natural Science Foundation of China (No. 41371471) and the NSFC-Guangdong Joint Fund (U1401234). The authors gratefully acknowledge Ouyang Li for technical assistance with ICP-MS. We also acknowledged the support from the National Natural Science Foundation of China (No. 51372131).	Agami RA, 2013, ECOTOX ENVIRON SAFE, V94, P164, DOI 10.1016/j.ecoenv.2013.04.013; Anjum SA, 2011, J AGRON CROP SCI, V197, P177, DOI 10.1111/j.1439-037X.2010.00459.x; Clarke SM, 2009, NEW PHYTOL, V182, P175, DOI 10.1111/j.1469-8137.2008.02735.x; Cools N, 2014, FOREST ECOL MANAG, V311, P3, DOI 10.1016/j.foreco.2013.06.047; Corral-Diaz B, 2014, PLANT PHYSIOL BIOCH, V84, P277, DOI 10.1016/j.plaphy.2014.09.018; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dong W, 2013, PLANT PHYSIOL, V161, P1217, DOI 10.1104/pp.112.211854; Erb M, 2009, THE UNDERESTIMATED R, P653; Garcia-Sanchez S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1530-4; Gawronska H, 2003, PLANT PHYSIOL BIOCH, V41, P605, DOI 10.1016/S0981-9428(03)00059-7; Ghosh M, 2015, MUTAT RES-FUND MOL M, V774, P49, DOI 10.1016/j.mrfmmm.2015.03.004; Gomez LM, 2009, NANO LETT, V9, P3592, DOI 10.1021/nl901802m; Gui X, 2015, RSC ADV, V5, P4554, DOI 10.1039/c4ra13915a; Herrero-Latorre C, 2015, ANAL CHIM ACTA, V853, P77, DOI 10.1016/j.aca.2014.10.008; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Hu YJ, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-42; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Jackson P, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-154; Jain A, 2014, PLANT PHYSIOL BIOCH, V84, P189, DOI 10.1016/j.plaphy.2014.09.013; Ji J, 2011, CHEM ENG J, V170, P525, DOI 10.1016/j.cej.2010.11.026; Khodakovskaya MV, 2013, SMALL, V9, P115, DOI 10.1002/smll.201201225; Khodakovskaya MV, 2012, ACS NANO, V6, P2128, DOI 10.1021/nn204643g; Kim J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00020; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lahiani MH, 2013, ACS APPL MATER INTER, V5, P7965, DOI 10.1021/am402052x; Lam SK, 2012, GLOBAL CHANGE BIOL, V18, P2853, DOI 10.1111/j.1365-2486.2012.02758.x; Lanone S, 2013, ADV DRUG DELIVER REV, V65, P2063, DOI 10.1016/j.addr.2013.07.019; Larue C, 2012, J HAZARD MATER, V227, P155, DOI 10.1016/j.jhazmat.2012.05.033; Nhan LV, 2015, SCI REP-UK, V5, DOI 10.1038/srep11618; Li BQ, 2012, AMINO ACIDS, V43, P2469, DOI 10.1007/s00726-012-1327-6; Li XG, 2014, J HAZARD MATER, V274, P173, DOI 10.1016/j.jhazmat.2014.04.025; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Liu SJ, 2015, PHYSIOL PLANTARUM, V154, P142, DOI 10.1111/ppl.12292; Liu Z, 2015, RICE, V8, DOI 10.1186/s12284-015-0042-9; Lv RT, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3042099; Ma YH, 2015, NANOTOXICOLOGY, V9, P262, DOI 10.3109/17435390.2014.921344; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Mansouri H, 2009, J INTEGR PLANT BIOL, V51, P553, DOI 10.1111/j.1744-7909.2009.00833.x; Miralles P, 2012, J R SOC INTERFACE, V9, P3514, DOI 10.1098/rsif.2012.0535; Mittal G, 2015, J IND ENG CHEM, V21, P11, DOI 10.1016/j.jiec.2014.03.022; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Mondal A, 2011, J NANOPART RES, V13, P4519, DOI 10.1007/s11051-011-0406-z; Mukherjee A, 2014, CHEM ENG J, V258, P394, DOI 10.1016/j.cej.2014.06.112; Nair PMG, 2014, CHEMOSPHERE, V112, P105, DOI 10.1016/j.chemosphere.2014.03.056; PATEL V, 2011, NANOTECH INSIGHTS, V2, P31; Peralta-Videa JR, 2014, PLANT PHYSIOL BIOCH, V80, P128, DOI 10.1016/j.plaphy.2014.03.028; Poborilova Z, 2013, ENVIRON EXP BOT, V91, P1, DOI 10.1016/j.envexpbot.2013.03.002; Royer M, 2013, PHYTOCHEMISTRY, V88, P25, DOI 10.1016/j.phytochem.2012.12.003; Rui YK, 2015, ENVIRON POLLUT, V198, P8, DOI 10.1016/j.envpol.2014.12.017; Savchenko T, 2014, PLANT PHYSIOL, V164, P1151, DOI 10.1104/pp.113.234310; Serag MF, 2011, ACS NANO, V5, P493, DOI 10.1021/nn102344t; Shaw AK, 2014, ENVIRON EXP BOT, V102, P37, DOI 10.1016/j.envexpbot.2014.02.016; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Shu HM, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1823-x; Shukla D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00652; Singh S, 2015, PLANT GROWTH REGUL, V77, P87, DOI 10.1007/s10725-015-0039-9; Song J, 2014, BIOTECHNOL LETT, V36, P1043, DOI 10.1007/s10529-013-1436-7; Srivastava V, 2015, IND ENG CHEM RES, V54, P6209, DOI 10.1021/acs.iecr.5b01610; Syu YY, 2014, PLANT PHYSIOL BIOCH, V83, P57, DOI 10.1016/j.plaphy.2014.07.010; Thuesombat P, 2014, ECOTOX ENVIRON SAFE, V104, P302, DOI 10.1016/j.ecoenv.2014.03.022; Tripathi S, 2011, NANOSCALE, V3, P1176, DOI 10.1039/c0nr00722f; Le VN, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0050-8; Vannini C, 2014, J PLANT PHYSIOL, V171, P1142, DOI 10.1016/j.jplph.2014.05.002; Wang WX, 2007, CARBON, V45, P1127, DOI 10.1016/j.carbon.2006.12.029; Wang XP, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0841-5; Wang Y, 2002, CHEM PHYS LETT, V364, P568, DOI 10.1016/S0009-2614(02)01384-2; Yan SH, 2013, J HAZARD MATER, V246, P110, DOI 10.1016/j.jhazmat.2012.12.013; Yang Y, 2011, PLANT SOIL, V346, P215, DOI 10.1007/s11104-011-0811-1; Zhai GS, 2015, ENVIRON SCI TECHNOL, V49, P7380, DOI 10.1021/acs.est.5b01145; Zhang P, 2015, NANOTOXICOLOGY, V9, P1, DOI 10.3109/17435390.2013.855829; Zhang Q, 2013, SMALL, V9, P1237, DOI 10.1002/smll.201203252; Zhang Q, 2011, CHEMSUSCHEM, V4, P864, DOI 10.1002/cssc.201100177; Zhang X, 2014, J INTEGR AGR, V13, P82, DOI 10.1016/S2095-3119(13)60348-2; Zhao XC, 2012, ENVIRON INT, V40, P244, DOI 10.1016/j.envint.2011.12.003; Zhu Y, 2015, PLANT CELL PHYSIOL, V56, P1442, DOI 10.1093/pcp/pcv061	75	40	42	9	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157264	10.1371/journal.pone.0157264	http://dx.doi.org/10.1371/journal.pone.0157264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284692	Green Submitted, Green Published, gold			2022-12-27	WOS:000377564000052
J	Saikkonen, K; Phillips, TD; Faeth, SH; McCulley, RL; Saloniemi, I; Helander, M				Saikkonen, Kari; Phillips, Timothy D.; Faeth, Stanley H.; McCulley, Rebecca L.; Saloniemi, Irma; Helander, Marjo			Performance of Endophyte Infected Tall Fescue in Europe and North America	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; PLANT INVASIONS; DIVERSITY; GRASS; ALKALOIDS; RANGE; RESISTANCE; EVOLUTION; SYMBIOSIS; ECOLOGY	Human assisted plant invasions from Europe to North America have been more common than the reverse. We tested endophyte-mediated performance of tall fescue in parallel three year experiments in Europe and the USA using endophyte infected and uninfected wild and cultivated plants. Experimental plants were subjected to nutrient and water treatments. Whereas endophyte infection increased tall fescue performance in general, the effects of endophytes on plant growth and reproduction varied among plant origins under different environmental conditions. Naturally endophyte-free Finnish cultivar 'Retu' performed equally well as 'Kentucky-31' in both geographic locations. All Eurasian origin plants performed well in the US. In Finland, plants established well and both cultivars survived over the first winter. However, winter mortality of 'Kentucky-31' plants was higher, particularly in fertilized soils in the subsequent winters. Our results suggest that tall fescue ecotype 'Kentucky-31' that flourishes in North America is poorly adapted to Northern European conditions.	[Saikkonen, Kari; Helander, Marjo] Nat Resources Inst Finland Luke, Turku, Finland; [Phillips, Timothy D.; McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Faeth, Stanley H.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Saloniemi, Irma; Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland	Natural Resources Institute Finland (Luke); University of Kentucky; University of North Carolina; University of North Carolina Greensboro; University of Turku	Saikkonen, K (corresponding author), Nat Resources Inst Finland Luke, Turku, Finland.	kari.saikkonen@luke.fi	Saloniemi, Irma/C-8893-2011	Helander, Marjo/0000-0002-9759-4321				Afkhami ME, 2014, ECOL LETT, V17, P1265, DOI 10.1111/ele.12332; ARECHAVALETA M, 1992, APPL ENVIRON MICROB, V58, P857, DOI 10.1128/AEM.58.3.857-861.1992; BACON CW, 1977, APPL ENVIRON MICROB, V34, P576, DOI 10.1128/AEM.34.5.576-581.1977; BALL DM, 1993, AM SCI, V81, P370; Belesky DP, 1997, ANN BOT-LONDON, V79, P259, DOI 10.1006/anbo.1996.0342; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bhamidimarri S, 2012, CROP SCI, V52, P413, DOI 10.2135/cropsci2010.11.0660; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Clay K, 2005, P NATL ACAD SCI USA, V102, P12465, DOI 10.1073/pnas.0503059102; Clay K, 2009, MYCOL SER, V27, P9; DARWIN C, 1872, ORIGIN SPECIES, V1; Elton C. S., 1958, ECOLOGY INVASIONS AN; Firn J, 2011, ECOL LETT, V14, P274, DOI 10.1111/j.1461-0248.2010.01584.x; Hand ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-303; HOVELAND CS, 1993, AGR ECOSYST ENVIRON, V44, P3, DOI 10.1016/0167-8809(93)90036-O; Lehtonen P, 2005, ECOL LETT, V8, P1256, DOI 10.1111/j.1461-0248.2005.00834.x; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Mack R. N., 1989, BIOL INVASIONS GLOBA, P155; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Malinowski DP, 2008, AUST J AGR RES, V59, P1092, DOI 10.1071/AR08084; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; MARX DH, 1977, CAN J MICROBIOL, V23, P217, DOI 10.1139/m77-033; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Murray J. J., 1979, Agronomy, P293; Niemela P, 1996, BIOSCIENCE, V46, P741, DOI 10.2307/1312850; Pringle A, 2009, MOL ECOL, V18, P817, DOI 10.1111/j.1365-294X.2008.04030.x; R Core Team, 2012, R LANG ENV STAT COMP; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Saari S, 2010, MICROB ECOL, V60, P928, DOI 10.1007/s00248-010-9749-8; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2000, SCIENCE, V287, P1887; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Saikkonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011395; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saxena P, 2014, CROP SCI, V54, P1205, DOI 10.2135/cropsci2013.08.0565; Seastedt TR, 2011, ANNU REV ECOL EVOL S, V42, P133, DOI 10.1146/annurev-ecolsys-102710-145057; STEVENS GC, 1991, ANNU REV ECOL SYST, V22, P177, DOI 10.1146/annurev.es.22.110191.001141; Takach JE, 2012, APPL ENVIRON MICROB, V78, P5501, DOI 10.1128/AEM.01084-12; VANSANTEN E, 1991, PLANT BREEDING, V107, P210, DOI 10.1111/j.1439-0523.1991.tb01208.x; Winter M, 2010, GLOBAL ECOL BIOGEOGR, V19, P332, DOI 10.1111/j.1466-8238.2010.00520.x; Young CA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00095	50	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157382	10.1371/journal.pone.0157382	http://dx.doi.org/10.1371/journal.pone.0157382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284909	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000062
J	Chereau, E; Uzan, C; Boutmy-Deslandes, E; Zohar, S; Bezu, C; Mazouni, C; Garbay, JR; Darai, E; Rouzier, R				Chereau, Elisabeth; Uzan, Catherine; Boutmy-Deslandes, Emmanuelle; Zohar, Sarah; Bezu, Corinne; Mazouni, Chafika; Garbay, Jean-Remi; Darai, Emile; Rouzier, Roman			Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study	PLOS ONE			English	Article							CLOSED SUCTION DRAINAGE; SEROMA FORMATION; CONTROLLED-TRIAL; CLINICAL-TRIALS; LYMPHORRHEA; SOMATOSTATIN; OCTREOTIDE; LYMPHADENECTOMY; MASTECTOMY; SURGERY	Objective The aim of this study was to assess the efficacy (response rate centered on 80%) of a somatostatin analog with high affinity for 4 somatostatin receptors in reducing the postoperative incidence of symptomatic lymphocele formation following total mastectomy with axillary lymph node dissection. Setting This prospective, double-blind, randomised, placebo-controlled, phase 2 trial was conducted in two secondary care centres. Participants All female patients for whom mastectomy and axillary lymph node dissection were indicated were eligible for the study, including patients who had received neo-adjuvant chemotherapy. Main exclusion criteria were related to diabetes, cardiac insufficiency, disorder of cardiac conduction or hepatic failure. Interventions Patients were randomised to receive one injection of either prolonged-release pasireotide 60 mg or placebo (physiological serum), which were administered intramuscularly 7 to 10 days before the scheduled surgery. The study was conducted in a double-blind manner. Primary and Secondary Outcome Measures The primary outcome measure was the percentage of patients who did not develop postoperative axillary symptomatic lymphoceles during the 2 postoperative months. Secondary endpoints were the total quantity of lymph drained, duration and daily volume of drainage and aspirated volumes of lymph. Results Ninety-one patients were randomised. Ninety patients were evaluable: 42 patients received pasireotide, and 48 patients received placebo. The mean estimated response rate were 62.4% (95% Credibility Interval [CrI]: 48.6%-75.3%) in the treatment group and 50.2%(95% CrI: 37.6%-62.8%) in the placebo group. Overall safety was comparable across groups, and one serious adverse event occurred. In the treatment group, one patient with known insulin-depe* ndent diabetes required hospitalization for hyperglycaemia. Conclusions With this phase 2 preliminary study, even if our results indicate a trend towards a reduction in symptomatic lymphocele, pre-operative injection of pasireotide failed to achieve a response rate centered on 80%. Pharmacokinetics analysis suggests that effect of pasireotide could be optimised.	[Chereau, Elisabeth; Bezu, Corinne; Darai, Emile; Rouzier, Roman] Hop Tenon, Dept Gynecol, F-75970 Paris, France; [Chereau, Elisabeth; Darai, Emile] ED 394 Ecole Doctorale Physiol Physiopathol, Paris, France; [Chereau, Elisabeth] EA 3499 Transporteurs ABC & Epitheliums Normaux &, Paris, France; [Uzan, Catherine; Mazouni, Chafika; Garbay, Jean-Remi] Gustave Roussy, Dept Surg, Paris, France; [Boutmy-Deslandes, Emmanuelle] Hop St Louis, Dept Biostat, Paris, France; [Zohar, Sarah] Univ Paris 06, Univ Paris 05, INSERM, U1138,Team 22, Paris, France; [Rouzier, Roman] Inst Curie, Dept Surg, St Cloud, France; [Rouzier, Roman] Versailles St Quentin En Yvelines Univ, EA Risques Clin & Secur Sante Femmes & Sante Peri, Montigny Le Bretonneux, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay	Rouzier, R (corresponding author), Hop Tenon, Dept Gynecol, F-75970 Paris, France.; Rouzier, R (corresponding author), Inst Curie, Dept Surg, St Cloud, France.; Rouzier, R (corresponding author), Versailles St Quentin En Yvelines Univ, EA Risques Clin & Secur Sante Femmes & Sante Peri, Montigny Le Bretonneux, France.	roman.rouzier@curie.fr	Zohar, Sarah/ACE-9228-2022; Zohar, Sarah/A-5026-2016; Rouzier, Roman/G-2953-2018	Zohar, Sarah/0000-0002-8429-2340; Boutmy, Emmanuelle/0000-0001-9657-9376; Rouzier, Roman/0000-0002-8167-6808	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	Financial support for this trial was provided by Novartis Pharmaceuticals. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruns C, 2002, EUR J ENDOCRINOL, V146, P707, DOI 10.1530/eje.0.1460707; Capocasale E, 2006, TRANSPL P, V38, P1047, DOI 10.1016/j.transproceed.2006.03.040; Carcoforo P, 2003, J AM COLL SURGEONS, V196, P365, DOI 10.1016/S1072-7515(02)01757-X; Classe JM, 2006, BRIT J SURG, V93, P820, DOI 10.1002/bjs.5433; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Daimon T, 2008, CONTEMP CLIN TRIALS, V29, P507, DOI 10.1016/j.cct.2007.12.001; Farthing MJ, 1994, GUT, V35, P5; Frati A, 2011, ANN BIOL CLIN-PARIS, V69, P385, DOI 10.1684/abc.2011.0588; Gauthier T, 2012, EJSO-EUR J SURG ONC, V38, P902, DOI 10.1016/j.ejso.2012.05.009; HARRIS AG, 1990, METABOLISM, V39, P180, DOI 10.1016/0026-0495(90)90241-4; Kuroi K, 2006, JPN J CLIN ONCOL, V36, P197, DOI 10.1093/jjco/hyl019; Mahmoud SA, 2007, BREAST J, V13, P108, DOI 10.1111/j.1524-4741.2006.00380.x; Mandrekar SJ, 2010, J THORAC ONCOL, V5, P932, DOI 10.1097/JTO.0b013e3181e2eadf; O'Hea BJ, 1999, AM J SURG, V177, P450, DOI 10.1016/S0002-9610(99)00089-6; Porter KA, 1998, AM J SURG, V176, P8, DOI 10.1016/S0002-9610(98)00093-2; Schmid Herbert A, 2004, Neuroendocrinology, V80 Suppl 1, P47, DOI 10.1159/000080741; Shamley DR, 2005, BREAST CANCER RES TR, V90, P263, DOI 10.1007/s10549-004-4727-9; SOMERS RG, 1992, ANN SURG, V215, P146, DOI 10.1097/00000658-199202000-00009; Taflampas P, 2009, AM J SURG, V198, P55, DOI 10.1016/j.amjsurg.2008.06.043; ULIBARRI JI, 1990, LANCET, V336, P258, DOI 10.1016/0140-6736(90)91793-A; van Bemmel AJM, 2011, EJSO-EUR J SURG ONC, V37, P829, DOI 10.1016/j.ejso.2011.04.012; Wolin EM, 2013, CANCER CHEMOTH PHARM, V72, P387, DOI 10.1007/s00280-013-2202-1; Zohar S, 2008, CONTEMP CLIN TRIALS, V29, P608, DOI 10.1016/j.cct.2007.11.005	23	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156096	10.1371/journal.pone.0156096	http://dx.doi.org/10.1371/journal.pone.0156096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280398	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000014
J	Wu, XC; Zhao, LL; Chen, Z; Ji, X; Qiao, XF; Jin, YP; Liu, W				Wu, Xiaochun; Zhao, Lingling; Chen, Zhi; Ji, Xin; Qiao, Xianfeng; Jin, Yaping; Liu, Wei			FLCN Maintains the Leucine Level in Lysosome to Stimulate mTORC1	PLOS ONE			English	Article							BIRT-HOGG-DUBE; AMINO-ACID TRANSPORTERS; TUMOR-SUPPRESSOR; RAG GTPASES; CELL-LINE; BHD GENE; COMPLEX; FOLLICULIN; ACTIVATION; INTERACTS	The intracellular amino acid pool within lysosome is a signal that stimulates the nutrient-sensing mTORC1 signalling pathway. The signal transduction cascade has garnered much attention, but little is known about the sequestration of the signalling molecules within the lysosome. Using human HEK293 cells as a model, we found that suppression of the BHD syndrome gene FLCN reduced the leucine level in lysosome, which correlated with decreased mTORC1 activity. Both consequences could be reversed by supplementation with high levels of leucine, but not other tested amino acids. Conversely, overexpressed FLCN could sequester lysosomal leucine and stimulate mTORC1 in an amino acid limitation environment. These results identify a novel function of FLCN: it controls mTORC1 by modulating the leucine signal in lysosome. Furthermore, we provided evidence that FLCN exerted this role by inhibiting the accumulation of the amino acid transporter PAT1 on the lysosome surface, thereby maintaining the signal level within the organelle.	[Wu, Xiaochun; Zhao, Lingling; Chen, Zhi; Ji, Xin; Qiao, Xianfeng; Jin, Yaping; Liu, Wei] Northwest Agr & Forest Univ, Minist Agr, Coll Vet Med, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Jin, YP; Liu, W (corresponding author), Northwest Agr & Forest Univ, Minist Agr, Coll Vet Med, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	yapingjin@163.com; wliucn150@yahoo.com			NWAF [Z111021005]; National Natural Science Foundation of China [31372256]	NWAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in whole or part by a NWAF grant [http://www.nwsuaf.edu.cn/ (Z111021005) and a National Natural Science Foundation of China [http://www.nsfc.gov.cn/] (31372256) to WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Berra E, 2006, ANN LIMNOL-INT J LIM, V42, P79, DOI 10.1051/limn/2006012; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cash TP, 2011, ONCOGENE, V30, P2534, DOI 10.1038/onc.2010.628; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Dunlop EA, 2014, AUTOPHAGY, V10, P1749, DOI 10.4161/auto.29640; Fiandra L, 2010, J INSECT PHYSIOL, V56, P165, DOI 10.1016/j.jinsphys.2009.09.015; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Goncharova EA, 2014, CELL REP, V7, P412, DOI 10.1016/j.celrep.2014.03.025; Hasumi H, 2012, JNCI-J NATL CANCER I, V104, P1750, DOI 10.1093/jnci/djs418; Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Khabibullin D, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12107; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Liu B, 2012, SCIENCE, V337, P351, DOI 10.1126/science.1220281; Liu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065869; Luijten MNH, 2013, HUM MOL GENET, V22, P4383, DOI 10.1093/hmg/ddt288; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Neufeld TP, 2003, CURR TOP MICROBIOL, V279, P139; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Nookala RK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120071; Ogmundsdottir MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036616; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Possik E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004273; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Roberg KJ, 1997, GENETICS, V147, P1569; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt LS, 2013, FAM CANCER, V12, P357, DOI 10.1007/s10689-012-9574-y; Schmidt LS, 2001, AM J HUM GENET, V69, P876, DOI 10.1086/323744; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Tee AR, 2013, FAM CANCER, V12, P367, DOI 10.1007/s10689-012-9576-9; Thwaites DT, 2011, BRIT J PHARMACOL, V164, P1802, DOI 10.1111/j.1476-5381.2011.01438.x; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; van Slegtenhorst M, 2007, J BIOL CHEM, V282, P24583, DOI 10.1074/jbc.M700857200; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wreden CC, 2003, J NEUROSCI, V23, P1265, DOI 10.1523/JNEUROSCI.23-04-01265.2003; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	49	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157100	10.1371/journal.pone.0157100	http://dx.doi.org/10.1371/journal.pone.0157100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280402	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000084
J	Nguyen, DT; Gomez-Zurita, J				Nguyen, Dinh T.; Gomez-Zurita, Jesus			Subtle Ecological Gradient in the Tropics Triggers High Species-Turnover in a Local Geographical Scale	PLOS ONE			English	Article							GEOMETRID MOTHS LEPIDOPTERA; BETA-DIVERSITY PATTERNS; COMMUNITY COMPOSITION; ELEVATIONAL PATTERNS; DIVERGENCE TIMES; SPATIAL SCALE; R PACKAGE; RICHNESS; CHRYSOMELIDAE; ASSEMBLAGES	Our perception of diversity, including both alpha- and beta-diversity components, depends on spatial scale. Studies of spatial variation of the latter are just starting, with a paucity of research on beta-diversity patterns at smaller scales. Understanding these patterns and the processes shaping the distribution of diversity is critical to describe this diversity, but it is paramount in conservation too. Here, we investigate the diversity and structure of a tropical community of herbivorous beetles at a reduced local scale of some 10 km(2), evaluating the effect of a small, gradual ecological change on this structure. We sampled leaf beetles in the Nui Chua National Park (S Vietnam), studying changes in alpha-and beta-diversity across an elevation gradient up to 500 m, encompassing the ecotone between critically endangered lowland dry deciduous forest and mixed evergreen forest at higher elevations. Leaf beetle diversity was assessed using several molecular tree-based species delimitation approaches (with mtDNA cox1 data), species richness using rarefaction and incidence-based diversity indexes, and beta-diversity was investigated decomposing the contribution of species turnover and nestedness. We documented 155 species in the area explored and species-richness estimates 1.5-2.0x higher. Species diversity was similar in both forest types and changes in alpha-diversity along the elevation gradient showed an expected local increase of diversity in the ecotone. Beta-diversity was high among forest paths (average Sorensen's dissimilarity = 0.694) and, tentatively fixing at 300 m the boundary between otherwise continuous biomes, demonstrated similarly high beta-diversity (Sorensen's dissimilarity = 0.581), with samples clustering according to biome/elevation. Highly relevant considering the local scale of the study, beta-diversity had a high contribution of species replacement among locales (54.8%) and between biomes (79.6%), suggesting environmental heterogeneity as the dominant force shaping diversity at such small scale, directly and indirectly on the plant communities. Protection actions in the Park, especially these addressed at the imperative conservation of dry forest, must ponder the small scale at which processes shape species diversity and community structure for inconspicuous, yet extraordinarily diverse organisms such as the leaf beetles.	[Nguyen, Dinh T.; Gomez-Zurita, Jesus] CSIC Univ Pompeu Fabra, Inst Evolutionary Biol, Anim Biodivers & Evolut, Barcelona, Spain; [Nguyen, Dinh T.] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, 18 Hoang Quoc Viet, Hanoi, Vietnam	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Vietnam Academy of Science & Technology (VAST)	Gomez-Zurita, J (corresponding author), CSIC Univ Pompeu Fabra, Inst Evolutionary Biol, Anim Biodivers & Evolut, Barcelona, Spain.	j.gomez-zurita@csic.es	Gomez-Zurita, Jesus/C-4248-2008; Nguyen, Dinh/AAU-2573-2021	Gomez-Zurita, Jesus/0000-0001-7337-6541; Nguyen, Dinh/0000-0002-2706-8166	Grup de Recerca Consolidad en Biologia Animal i Evolucio [2014SGR1532]; Spanish Ministry of Economy and Competitiveness	Grup de Recerca Consolidad en Biologia Animal i Evolucio; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work results from the activity in the "Grup de Recerca Consolidad en Biologia Animal i Evolucio" (project 2014SGR1532) and was possible thanks to funds from the Spanish Ministry of Economy and Competitiveness to promote a Scientific Cooperation Agreement between the Spanish High Research Council (CSIC) and the Vietnamese Academy of Sciences and Technology (VAST). These funds allowed a three-year predoctoral training period for NTD in the lab of the senior author.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2021, SPLITS SPECIES LIMIT; Gomez-Anaya JA, 2011, REV BIOL TROP, V59, P1559; Axmacher JC, 2004, DIVERS DISTRIB, V10, P293, DOI 10.1111/j.1366-9516.2004.00101.x; Aynekulu E, 2012, BIODIVERS CONSERV, V21, P2691, DOI 10.1007/s10531-012-0328-9; Bach K, 2007, DIVERS DISTRIB, V13, P863, DOI 10.1111/j.1472-4642.2007.00357.x; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Benedick S, 2006, J APPL ECOL, V43, P967, DOI 10.1111/j.1365-2664.2006.01209.x; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Brehm G, 2004, J TROP ECOL, V20, P165, DOI 10.1017/S0266467403001184; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Charles E, 2005, J TROP ECOL, V21, P329, DOI 10.1017/S0266467405002300; Colwell RK, 2013, ESTIMATES STAT ESTIM; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dossa GGO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067720; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunn RR, 2007, GLOBAL ECOL BIOGEOGR, V16, P305, DOI 10.1111/j.1466-8238.2006.00284.x; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; Escobar F, 2006, J BIOGEOGR, V33, P1793, DOI 10.1111/j.1365-2699.2006.01528.x; Flowers R. Wills, 2003, International Congress of Entomology Proceedings, V21, P25; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Lopez A, 2013, J BIOGEOGR, V40, P2134, DOI 10.1111/jbi.12148; Garcia-Lopez A, 2012, DIVERS DISTRIB, V18, P543, DOI 10.1111/j.1472-4642.2011.00846.x; Gomez-Hernandez M, 2012, BIODIVERS CONSERV, V21, P2247, DOI 10.1007/s10531-011-0180-3; Gomez-Zurita J, 2012, ZOOL SCR, V41, P47, DOI 10.1111/j.1463-6409.2011.00500.x; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Jamoneau A, 2012, ECOGRAPHY, V35, P124, DOI 10.1111/j.1600-0587.2011.06900.x; Jankowski JE, 2009, J ANIM ECOL, V78, P315, DOI 10.1111/j.1365-2656.2008.01487.x; Sanchez-Reyes UJ, 2014, ZOOKEYS, P103, DOI 10.3897/zookeys.417.7551; Keil P, 2012, J BIOGEOGR, V39, P1473, DOI 10.1111/j.1365-2699.2012.02701.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; KIMOTO S, 1989, Esakia, P1; KIMOTO S, 1981, PAC INSECTS, V23, P286; Kimoto S, 1982, ESAKIA, V18, P1; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Lloyd H, 2012, AUSTRAL ECOL, V37, P470, DOI 10.1111/j.1442-9993.2011.02308.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Mohamedsaid MS, 2004, CATALOGUE MALAYSIAN; Molina-Martinez A, 2013, J INSECT CONSERV, V17, P1169, DOI 10.1007/s10841-013-9598-0; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Novotny V, 2005, ANN ZOOL FENN, V42, P463; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Ochoa-Ochoa LM, 2014, REV MEX BIODIVERS, V85, P918, DOI 10.7550/rmb.38737; Odegaard F., 2006, BIODIVERS CONSERV, V15, P69; Olivier PI, 2014, J BIOGEOGR, V41, P1428, DOI 10.1111/jbi.12303; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; R Development Core Team, 2014, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rambaut A., 2014, TRACER V1 6; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Tello JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121458; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sorensen T., 1948, BIOL SKAR, V5, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Szava-Kovats RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110485; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Thormann B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148268; Voda R, 2015, ECOGRAPHY, V38, P405, DOI 10.1111/ecog.00762; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; Wang SP, 2014, ECOL LETT, V17, P891, DOI 10.1111/ele.12292; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	82	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156840	10.1371/journal.pone.0156840	http://dx.doi.org/10.1371/journal.pone.0156840			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276228	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700039
J	Yue, YJ; Guo, TT; Yuan, C; Liu, JB; Guo, J; Feng, RL; Niu, CN; Sun, XP; Yang, BH				Yue, Yaojing; Guo, Tingting; Yuan, Chao; Liu, Jianbin; Guo, Jian; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui			Integrated Analysis of the Roles of Long Noncoding RNA and Coding RNA Expression in Sheep (Ovis aries) Skin during Initiation of Secondary Hair Follicle	PLOS ONE			English	Article							COLLAGEN-VI CHAINS; DIFFERENTIAL EXPRESSION; MORPHOGENESIS; BIOLOGY; IDENTIFICATION; REVEALS; TRANSCRIPTOMES; ANNOTATION; MECHANISMS; GENOMICS	Initiation of hair follicle (HF) is the first and most important stage of HF morphogenesis. However the precise molecular mechanism of initiation of hair follicle remains elusive. Meanwhile, in previous study, the more attentions had been paid to the function of genes, while the roles of non-coding RNAs (such as long noncoding RNA and microRNA) had not been described. Therefore, the roles of long noncoding RNA(LncRNA) and coding RNA in sheep skin during the initiation of sheep secondary HF were integrated and analyzed, by using strand-specific RNA sequencing (ssRNA-seq). A total of 192 significant differentially expressed genes were detected, including 67 up-regulated genes and 125 down-regulated genes between stage 0 and stage 1 of HF morphogenesis during HF initiation. Only Wnt2, FGF20 were just significant differentially expressed among Wnt, Shh, Notch and BMP signaling pathways. Further expression profile analysis of lncRNAs showed that 884 novel lncRNAs were discovered in sheep skin expression profiles. A total of 15 lncRNAs with significant differential expression were detected, 6 up-regulated and 9 down-regulated. Among of differentially expressed genes and LncRNA, XLOC002437 lncRNA and potential target gene COL6A6 were all significantly down-regulated in stage 1. Furthermore, by using RNA-hybrid, XLOC005698 may be as a competing endogenous RNA "sponges" oar-miR-39555p activity. Gene Ontology and KEGG pathway analyses indicated that the significantly enriched pathway was peroxisome proliferator-activated receptors (PPARs) pathway (corrected P-value < 0.05), indicating that PPAR pathway is likely to play significant roles during the initiation of secondary HF. Results suggest that the key differentially expressed genes and LncRNAs may be considered as potential candidate genes for further study on the molecular mechanisms of HF initiation, as well as supplying some potential values for understanding human hair disorders.	[Yue, Yaojing; Guo, Tingting; Yuan, Chao; Liu, Jianbin; Guo, Jian; Feng, Ruilin; Niu, Chune; Sun, Xiaoping; Yang, Bohui] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Yang, BH (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China.	lzyangbohui@163.com			Central Level, Scientific Research Institutes for Basic R & D Special Fund Business [1610322015014]; Earmarked Fund for Modern China Wool & Cashmere Technology Research System [nycytx-40-3]; National Natural Science Foundation for Young Scholars of China [31402057]	Central Level, Scientific Research Institutes for Basic R & D Special Fund Business; Earmarked Fund for Modern China Wool & Cashmere Technology Research System; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This study was supported by the Central Level, Scientific Research Institutes for Basic R & D Special Fund Business (Grant No. 1610322015014), the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (Grant No. nycytx-40-3), and the National Natural Science Foundation for Young Scholars of China (Grant No. 31402057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Central Level, Scientific Research Institutes for Basic R & D Special Fund Business (Grant No. 1610322015014), the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (Grant No. nycytx-40-3), and the National Natural Science Foundation for Young Scholars of China (Grant No. 31402057).	Al-Nuaimi Y, 2010, EXP DERMATOL, V19, P707, DOI 10.1111/j.1600-0625.2010.01114.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Botchkarev VA, 2006, J INVEST DERMATOL, V126, P1719, DOI 10.1038/sj.jid.5700270; Botchkareva NV, 2006, J INVEST DERMATOL, V126, P258, DOI 10.1038/sj.jid.5700007; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Bushby KMD, 2014, ADV EXP MED BIOL, V802, P185, DOI 10.1007/978-94-007-7893-1_12; Cadau S, 2013, EUR J DERMATOL, V23, P4, DOI 10.1684/ejd.2013.1972; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Folgueras AR, 2013, CELL STEM CELL, V13, P314, DOI 10.1016/j.stem.2013.06.018; Fu J, 2013, J INVEST DERMATOL, V133, P890, DOI 10.1038/jid.2012.407; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Hanley K, 1999, J INVEST DERMATOL, V113, P788, DOI 10.1046/j.1523-1747.1999.00743.x; HARDY MARGARET H., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P423; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Huh SH, 2013, GENE DEV, V27, P450, DOI 10.1101/gad.198945.112; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kamberov YG, 2015, P NATL ACAD SCI USA, V112, P9932, DOI 10.1073/pnas.1511680112; Khorkova O, 2014, HUM MOL GENET, V23, pR54, DOI 10.1093/hmg/ddu207; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Liang WC, 2015, ONCOTARGET; Lim X, 2013, COLD SPRING HARBOR P, V5, DOI DOI 10.1101/CSHPERSPECTA008029; Lin CM, 2014, BIOCHEM BIOPH RES CO, V453, P508, DOI 10.1016/j.bbrc.2014.09.119; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Nishizawa M, 2015, FRONT BIOSCI-LANDMRK, V20, P1, DOI 10.2741/4297; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rippa A, 2015, HISTOCHEM CELL BIOL, V143, P481, DOI 10.1007/s00418-014-1291-1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers GE, 2006, EXP DERMATOL, V15, P931, DOI 10.1111/j.1600-0625.2006.00512.x; Sabatelli P, 2011, J INVEST DERMATOL, V131, P99, DOI 10.1038/jid.2010.284; Sen R, 2014, SCI WORLD J, DOI 10.1155/2014/896206; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tagliavini F, 2014, BBA-MOL BASIS DIS, V1842, P1604, DOI 10.1016/j.bbadis.2014.05.033; Thiboutot D, 2004, J INVEST DERMATOL, V123, P1, DOI 10.1111/j.1523-1747.2004.t01-2-.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wan DC, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015404; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; [吴瑜瑜 Wu Yuyu], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1923; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yue Y, 2015, PLOS ONE, V10, DOI [10.1371/tournal.pone.0129249, DOI 10.1371/TOURNAL.PONE.0129249]; Zhao LX, 2011, MOL BIOL REP, V38, P3495, DOI 10.1007/s11033-010-0460-0	73	31	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156890	10.1371/journal.pone.0156890	http://dx.doi.org/10.1371/journal.pone.0156890			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276011	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700044
J	Demares, FJ; Crous, KL; Pirk, CWW; Nicolson, SW; Human, H				Demares, Fabien J.; Crous, Kendall L.; Pirk, Christian W. W.; Nicolson, Susan W.; Human, Hannelie			Sucrose Sensitivity of Honey Bees Is Differently Affected by Dietary Protein and a Neonicotinoid Pesticide	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; APIS-MELLIFERA; RESPONSE THRESHOLDS; FORAGING BEHAVIOR; COLONY LOSSES; NUTRITION; EXPOSURE; SURVIVAL; HISTOCHEMISTRY; CURRENTS	Over a decade, declines in honey bee colonies have raised worldwide concerns. Several potentially contributing factors have been investigated, e.g. parasites, diseases, and pesticides. Neonicotinoid pesticides have received much attention due to their intensive use in crop protection, and their adverse effects on many levels of honey bee physiology led the European Union to ban these compounds. Due to their neuronal target, a receptor expressed throughout the insect nervous system, studies have focused mainly on neuroscience and behaviour. Through the Geometric Framework of nutrition, we investigated effects of the neonicotinoid thiamethoxam on survival, food consumption and sucrose sensitivity of honey bees (Apis mellifera). Thiamethoxam did not affect protein and carbohydrate intake, but decreased responses to high concentrations of sucrose. Interestingly, when bees ate fixed unbalanced diets, dietary protein facilitated better sucrose detection. Both thiamethoxam and dietary protein influenced survival. These findings suggest that, in the presence of a pesticide and unbalanced food, honey bee health may be severely challenged. Consequences for foraging efficiency and colony activity, cornerstones of honey bee health, are also discussed.	[Demares, Fabien J.; Crous, Kendall L.; Pirk, Christian W. W.; Nicolson, Susan W.; Human, Hannelie] Univ Pretoria, Dept Zool & Entomol, Social Res Insect Grp, Private Bag X20, ZA-0028 Pretoria, South Africa	University of Pretoria	Demares, FJ (corresponding author), Univ Pretoria, Dept Zool & Entomol, Social Res Insect Grp, Private Bag X20, ZA-0028 Pretoria, South Africa.	fabien.demares@zoology.up.ca.za	Pirk, Christian/E-4180-2010; Demares, Fabien/I-6679-2016	Pirk, Christian/0000-0001-6821-7044; Demares, Fabien/0000-0002-2638-4247; Human, Hannelie/0000-0002-3887-1202; Nicolson, Susan/0000-0001-6024-9383	University of Pretoria	University of Pretoria	FJD is supported by a postdoctoral fellowship from the University of Pretoria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Altaye SZ, 2010, J EXP BIOL, V213, P3311, DOI 10.1242/jeb.046953; Archer CR, 2014, FUNCT ECOL, V28, P913, DOI 10.1111/1365-2435.12226; Arganda S, 2014, J INSECT PHYSIOL, V69, P19, DOI 10.1016/j.jinsphys.2014.04.002; Armengaud C, 2000, BRAIN RES, V859, P390, DOI 10.1016/S0006-8993(00)02016-3; Barbara GS, 2005, J COMP PHYSIOL A, V191, P823, DOI 10.1007/s00359-005-0007-3; Bazazi S, 2011, P ROY SOC B-BIOL SCI, V278, P356, DOI 10.1098/rspb.2010.1447; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Cutler GC, 2015, PEST MANAG SCI, V71, P1368, DOI 10.1002/ps.4042; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Demares F, 2014, PHARMACOL BIOCHEM BE, V124, P137, DOI 10.1016/j.pbb.2014.05.025; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Dupuis JP, 2011, J NEUROPHYSIOL, V106, P1604, DOI 10.1152/jn.00126.2011; Dussutour A, 2012, P ROY SOC B-BIOL SCI, V279, P2402, DOI 10.1098/rspb.2012.0051; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Fewell J, 1992, BEHAV ECOL SOCIOBIOL, V30; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Henry M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2110; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Human H, 2014, J INSECT PHYSIOL, V69, P74, DOI 10.1016/j.jinsphys.2014.03.012; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Kohler A, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.03; Kohler A, 2012, J INSECT PHYSIOL, V58, P918, DOI 10.1016/j.jinsphys.2012.04.007; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lihoreau M, 2014, J INSECT PHYSIOL, V69, P2, DOI 10.1016/j.jinsphys.2014.03.004; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Nicodemo D, 2014, ENVIRON TOXICOL CHEM, V33, P2070, DOI 10.1002/etc.2655; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P387, DOI 10.1007/BF00177334; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pirk CWW, 2016, APIDOLOGIE, V47, P276, DOI 10.1007/s13592-015-0406-6; Pirk CWW, 2014, J APICULT RES, V53, P35, DOI 10.3896/IBRA.1.53.1.03; Ponton F, 2013, J INSECT PHYSIOL, V59, P130, DOI 10.1016/j.jinsphys.2012.10.011; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Simpson SJ, 2012, NATURE NUTR UNIFYING; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; SMIRLE MJ, 1993, PHYSIOL ENTOMOL, V18, P420, DOI 10.1111/j.1365-3032.1993.tb00616.x; Stabler D, 2015, J EXP BIOL, V218, P793, DOI 10.1242/jeb.114249; Stanley DA, 2015, NATURE, V528, P548, DOI 10.1038/nature16167; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wolschin F, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-10	69	26	28	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156584	10.1371/journal.pone.0156584	http://dx.doi.org/10.1371/journal.pone.0156584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272274	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000020
J	Eslami-Mossallam, B; Schram, RD; Tompitak, M; van Noort, J; Schiessel, H				Eslami-Mossallam, Behrouz; Schram, Raoul D.; Tompitak, Marco; van Noort, John; Schiessel, Helmut			Multiplexing Genetic and Nucleosome Positioning Codes: A Computational Approach	PLOS ONE			English	Article							IN-VITRO; MOLECULAR-DYNAMICS; CORE PARTICLE; DNA; ORGANIZATION; CHROMATIN; BINDING; MAP	Eukaryotic DNA is strongly bent inside fundamental packaging units: the nucleosomes. It is known that their positions are strongly influenced by the mechanical properties of the underlying DNA sequence. Here we discuss the possibility that these mechanical properties and the concomitant nucleosome positions are not just a side product of the given DNA sequence, e.g. that of the genes, but that a mechanical evolution of DNA molecules might have taken place. We first demonstrate the possibility of multiplexing classical and mechanical genetic information using a computational nucleosome model. In a second step we give evidence for genome-wide multiplexing in Saccharomyces cerevisiae and Schizosacharomyces pombe. This suggests that the exact positions of nucleosomes play crucial roles in chromatin function.	[Eslami-Mossallam, Behrouz; Schram, Raoul D.; Tompitak, Marco; Schiessel, Helmut] Leiden Univ, Inst Lorentz Theoret Phys, Niels Bohrweg 2, Leiden, Netherlands; [Eslami-Mossallam, Behrouz; van Noort, John] Leiden Univ, Huygens Kamerlingh Onnes Lab, Biol & Soft Matter Phys, Niels Bohrweg 2, NL-2333 CA Leiden, Netherlands; [Eslami-Mossallam, Behrouz] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Delft University of Technology	Schiessel, H (corresponding author), Leiden Univ, Inst Lorentz Theoret Phys, Niels Bohrweg 2, Leiden, Netherlands.	schiessel@lorentz.leidenuniv.nl	van Noort, John/B-1242-2008	van Noort, John/0000-0002-9094-5598; Tompitak, Marco/0000-0003-4275-2262	NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) - Dutch Ministry of Education, Culture and Science (OCW); research programme of the Foundation for Fundamental Research on Matter (FOM) - NWO; NWO-VICI program; National Science Foundation [NSF PHY11-25915]	NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) - Dutch Ministry of Education, Culture and Science (OCW); research programme of the Foundation for Fundamental Research on Matter (FOM) - NWO; NWO-VICI program; National Science Foundation(National Science Foundation (NSF))	This research is supported by the NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) that is funded by the Dutch Ministry of Education, Culture and Science (OCW) and by the research programme of the Foundation for Fundamental Research on Matter (FOM), which is financially supported by NWO; and by the NWO-VICI program (JN). HS thanks the KITP at Santa Barbara for hospitality where part of this work has been performed and the National Science Foundation under Grant No. NSF PHY11-25915 for support.; This study has been inspired by the work of the late Jonathan Widom. We would like to acknowledge Arman Fathizadeh for fruitful discussions. This research is supported by the NanoFront consortium, a program of the Netherlands Organisation for Scientific Research (NWO) that is funded by the Dutch Ministry of Education, Culture and Science (OCW); by the research programme of the Foundation for Fundamental Research on Matter (FOM), which is financially supported by NWO; and by the NWO-VICI program. HS thanks the KITP at Santa Barbara for hospitality where part of this work has been performed and the National Science Foundation under Grant No. NSF PHY11-25915 for support.	Becker NB, 2006, NUCLEIC ACIDS RES, V34, P5638, DOI 10.1093/nar/gkl683; Becker NB, 2009, STRUCTURE, V17, P579, DOI 10.1016/j.str.2009.01.013; Bettecken T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-273; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; CALLADINE CR, 1984, J MOL BIOL, V178, P773, DOI 10.1016/0022-2836(84)90251-1; Coleman BD, 2003, J CHEM PHYS, V118, P7127, DOI 10.1063/1.1559690; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Diament A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6876; Fathizadeh A, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13021-4; Freeman GS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.168101; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Jin H, 2016, NUCLEIC ACIDS RES, V44, P2047, DOI 10.1093/nar/gkw101; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kodgire P, 2012, MOL CELL BIOL, V32, P2030, DOI 10.1128/MCB.06722-11; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Liu H, 2014, BRIEF BIOINFORM, V15, P1014, DOI 10.1093/bib/bbt062; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; Moyle-Heyrman G, 2013, P NATL ACAD SCI USA, V110, P20158, DOI 10.1073/pnas.1315809110; Nalabothula N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-391; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Rosanio G, 2015, BIOPOLYMERS, V103, P303, DOI 10.1002/bip.22608; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Teif VB, 2016, BRIEF BIOINFORM, V17, P745, DOI 10.1093/bib/bbv086; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; TRIFONOV EN, 1989, B MATH BIOL, V51, P417, DOI 10.1007/BF02460081; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Vaillant C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.218103; van Loenhout MTJ, 2012, SCIENCE, V338, P94, DOI 10.1126/science.1225810; Widom J, 2011, KITP C SOFT MATT PHY; Yazdi PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136574; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018	37	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156905	10.1371/journal.pone.0156905	http://dx.doi.org/10.1371/journal.pone.0156905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272176	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000045
J	Kostereva, NV; Wang, Y; Fletcher, DR; Unadkat, JV; Schnider, JT; Komatsu, C; Yang, Y; Stolz, DB; Davis, MR; Plock, JA; Gorantla, VS				Kostereva, Nataliya V.; Wang, Yong; Fletcher, Derek R.; Unadkat, Jignesh V.; Schnider, Jonas T.; Komatsu, Chiaki; Yang, Yang; Stolz, Donna B.; Davis, Michael R.; Plock, Jan A.; Gorantla, Vijay S.			IGF-1 and Chondroitinase ABC Augment Nerve Regeneration after Vascularized Composite Limb Allotransplantation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MUSCLE REINNERVATION; AXONAL REGENERATION; PROTEOGLYCANS; EXPRESSION; SYSTEM; GLYCOSAMINOGLYCANS; CELLS; FK506	Impaired nerve regeneration and inadequate recovery of motor and sensory function following peripheral nerve repair remain the most significant hurdles to optimal functional and quality of life outcomes in vascularized tissue allotransplantation (VCA). Neurotherapeutics such as Insulin-like Growth Factor-1 (IGF-1) and chondroitinase ABC (CH) have shown promise in augmenting or accelerating nerve regeneration in experimental models and may have potential in VCA. The aim of this study was to evaluate the efficacy of low dose IGF-1, CH or their combination (IGF-1+CH) on nerve regeneration following VCA. We used an allogeneic rat hind limb VCA model maintained on low-dose FK506 (tacrolimus) therapy to prevent rejection. Experimental animals received neurotherapeutics administered intraoperatively as multiple intraneural injections. The IGF-1 and IGF-1+CH groups received daily IGF-1 (intramuscular and intraneural injections). Histomorphometry and immunohistochemistry were used to evaluate outcomes at five weeks. Overall, compared to controls, all experimental groups showed improvements in nerve and muscle (gastrocnemius) histomorphometry. The IGF-1 group demonstrated superior distal regeneration as confirmed by Schwann cell (SC) immunohistochemistry as well as some degree of extrafascicular regeneration. IGF-1 and CH effectively promote nerve regeneration after VCA as confirmed by histomorphometric and immunohistochemical outcomes.	[Kostereva, Nataliya V.; Wang, Yong; Fletcher, Derek R.; Unadkat, Jignesh V.; Schnider, Jonas T.; Komatsu, Chiaki; Yang, Yang; Plock, Jan A.; Gorantla, Vijay S.] Univ Pittsburgh, Dept Plast Surg, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA; [Kostereva, Nataliya V.; Plock, Jan A.; Gorantla, Vijay S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Wang, Yong] East Hosp Shanghai, Dept Trauma Surg, Shanghai, Peoples R China; [Stolz, Donna B.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA; [Davis, Michael R.] US Army, Inst Surg Res, San Antonio Mil Med Ctr, 3698 Chambers Rd, San Antonio, TX USA; [Fletcher, Derek R.] Univ Penn, Div Plast Surg, Philadelphia, PA 19104 USA; [Schnider, Jonas T.] Univ Hosp Bern, Inselspital, Dept Plast & Hand Surg, CH-3010 Bern, Switzerland; [Yang, Yang] Fourth Mil Med Univ, Xijing Hosp, Dept Plast & Reconstruct Surg, Xian 710032, Xincheng, Peoples R China; [Plock, Jan A.] Univ Zurich Hosp, Div Plast & Hand Surg, CH-8091 Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; San Antonio Military Medical Center; University of Pennsylvania; University of Bern; University Hospital of Bern; Air Force Military Medical University; University of Zurich; University Zurich Hospital	Gorantla, VS (corresponding author), Univ Pittsburgh, Dept Plast Surg, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA.; Gorantla, VS (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.	gorantlavs@upmc.edu	Plock, Jan/ABE-9876-2020; Plock, Jan A./I-2451-2017	Plock, Jan A./0000-0002-9495-6198; Unadkat, Jashvant/0000-0002-4820-8455	Department of Defense (Congressionally Directed Medical Research Programs) [W81XWH-11-2-0215]	Department of Defense (Congressionally Directed Medical Research Programs)(United States Department of Defense)	The study was supported by a generous grant by the Department of Defense (Congressionally Directed Medical Research Programs)- Grant # W81XWH-11-2-0215, PI: Vijay Gorantla (URL: http://cdmrp.army.mil). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahori Y, 1997, NEUROREPORT, V8, P2265, DOI 10.1097/00001756-199707070-00034; AMIR R, 1993, BRAIN RES, V630, P283, DOI 10.1016/0006-8993(93)90667-C; Apel PJ, 2010, MUSCLE NERVE, V41, P335, DOI 10.1002/mus.21485; Brenner MJ, 2008, MICROSURG, V28, P265, DOI 10.1002/micr.20483; Brenner MJ, 2005, RESTOR NEUROL NEUROS, V23, P237; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; CURTIS R, 1992, J CELL BIOL, V116, P1455, DOI 10.1083/jcb.116.6.1455; Fansa H, 2002, MUSCLE NERVE, V26, P87, DOI 10.1002/mus.10165; GILLERY P, 1992, J CELL PHYSIOL, V152, P389, DOI 10.1002/jcp.1041520221; Gorantla VS, 2011, HAND CLIN, V27, P511, DOI 10.1016/j.hcl.2011.08.008; Gorio A, 1998, NEUROSCIENCE, V82, P1029; Graham JB, 2007, EXP NEUROL, V203, P185, DOI 10.1016/j.expneurol.2006.08.004; Hansen M, 2012, SCAND J MED SCI SPOR, P1; Hattori T, 2008, J CLIN NEUROSCI, V15, P185, DOI 10.1016/j.jocn.2006.12.009; HENDERSON N, 1988, CR ACAD SCI III-VIE, V307, P403; Ishii DN, 1993, PHARMACOL THERAPEUT, V62, P125; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Nachemson AK, 1990, GROWTH FACTORS, V3, P309, DOI 10.3109/08977199009003673; NOTTERPEK LM, 1994, NEURON, V13, P473, DOI 10.1016/0896-6273(94)90361-1; Ono A, 1998, J SPINAL DISORD, V11, P253; Park SE, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-12; Puglianiello A, 2000, J ENDOCRINOL, V165, P123, DOI 10.1677/joe.0.1650123; Rabinovsky ED, 2004, NEUROL RES, V26, P204, DOI 10.1179/016164104225013851; Soleman S, 2012, BRAIN, V135, P1210, DOI 10.1093/brain/aws027; Tester NJ, 2007, J NEUROSCI RES, V85, P1110, DOI 10.1002/jnr.21199; Thiebot B, 1997, BBA-MOL CELL RES, V1358, P127, DOI 10.1016/S0167-4889(97)00070-0; Tuffaha S, 2011, J HAND SURG-AM, V36A, P1447, DOI 10.1016/j.jhsa.2011.06.007; TYLER JA, 1989, BIOCHEM J, V260, P543, DOI 10.1042/bj2600543; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Vergani L, 1998, J NEUROSCI RES, V54, P840, DOI 10.1002/(SICI)1097-4547(19981215)54:6<840::AID-JNR12>3.3.CO;2-C; Yang RK, 2003, PLAST RECONSTR SURG, V112, P1832, DOI 10.1097/01.PRS.0000091167.27303.18	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156149	10.1371/journal.pone.0156149	http://dx.doi.org/10.1371/journal.pone.0156149			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272754	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000008
J	Covarrubias-Pazaran, G				Covarrubias-Pazaran, Giovanny			Genome-Assisted Prediction of Quantitative Traits Using the R Package sommer	PLOS ONE			English	Article							AVERAGE INFORMATION REML; LINEAR MIXED MODELS; RIDGE-REGRESSION; SELECTION; ASSOCIATION; VARIANCE; PERFORMANCE; PEDIGREE; HYBRIDS; NUMBER	Most traits of agronomic importance are quantitative in nature, and genetic markers have been used for decades to dissect such traits. Recently, genomic selection has earned attention as next generation sequencing technologies became feasible for major and minor crops. Mixed models have become a key tool for fitting genomic selection models, but most current genomic selection software can only include a single variance component other than the error, making hybrid prediction using additive, dominance and epistatic effects unfeasible for species displaying heterotic effects. Moreover, Likelihood-based software for fitting mixed models with multiple random effects that allows the user to specify the variance-covariance structure of random effects has not been fully exploited. A new open-source R package called sommer is presented to facilitate the use of mixed models for genomic selection and hybrid prediction purposes using more than one variance component and allowing specification of covariance structures. The use of sommer for genomic prediction is demonstrated through several examples using maize and wheat genotypic and phenotypic data. At its core, the program contains three algorithms for estimating variance components: Average information (AI), Expectation-Maximization (EM) and Efficient Mixed Model Association (EMMA). Kernels for calculating the additive, dominance and epistatic relationship matrices are included, along with other useful functions for genomic analysis. Results from sommer were comparable to other software, but the analysis was faster than Bayesian counterparts in the magnitude of hours to days. In addition, ability to deal with missing data, combined with greater flexibility and speed than other REML-based software was achieved by putting together some of the most efficient algorithms to fit models in a gentle environment such as R.	[Covarrubias-Pazaran, Giovanny] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Covarrubias-Pazaran, G (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	covarrubiasp@wisc.edu		COVARRUBIAS-PAZARAN, GIOVANNY/0000-0002-7194-3837	CONACYT (Mexico)	CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT (Mexico) funded PhD studies of GCP, but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir D, 2015, EMMREML FITTING MIXE; [Anonymous], 2021, LANG ENV STAT COMP; BERNARDO R, 1994, CROP SCI, V34, P20, DOI 10.2135/cropsci1994.0011183X003400010003x; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Bernardo R, 2006, CROP SCI, V46, P1972, DOI 10.2135/cropsci2006.01-0057; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; David Clifford PM, 2006, R NEWS, P6; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Gianola D, 2015, ANNU REV ANIM BIOSCI, V3, P19, DOI 10.1146/annurev-animal-022114-110733; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Henderson C.R., 1963, STAT GENETICS PLANT, V982, P141, DOI DOI 10.17226/20264; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Lee SH, 2016, BIOINFORMATICS, V32, P1420, DOI 10.1093/bioinformatics/btw012; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meuwissen THE, 2001, GENETICS, V157, P1819; Munoz PR, 2014, GENETICS, V198, P1759, DOI 10.1534/genetics.114.171322; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Rosyara UR, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0073; Sax K, 1923, GENETICS, V8, P301; Searle S. R., 2006, VARIANCE COMPONENTS; Searle SR, PAPER INVITED FOR TH; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Technow F, 2014, GENETICS, V197, P1343, DOI 10.1534/genetics.114.165860; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao YS, 2015, PLANT BREEDING, V134, P1, DOI 10.1111/pbr.12231; Zhong SQ, 2007, GENETICS, V177, P567, DOI 10.1534/genetics.107.075358; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	36	210	217	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156744	10.1371/journal.pone.0156744	http://dx.doi.org/10.1371/journal.pone.0156744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271781	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200014
J	Gupta, GK; Agrawal, T; Rai, V; Del Core, MG; Hunter, WJ; Agrawal, DK				Gupta, Gaurav K.; Agrawal, Tanupriya; Rai, Vikrant; Del Core, Michael G.; Hunter, William J., III; Agrawal, Devendra K.			Vitamin D Supplementation Reduces Intimal Hyperplasia and Restenosis following Coronary Intervention in Atherosclerotic Swine	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; SIROLIMUS-ELUTING STENT; SMOOTH-MUSCLE-CELLS; ARTERY-DISEASE; D DEFICIENCY; BALLOON ANGIOPLASTY; CARDIOVASCULAR-DISEASE; DENDRITIC CELLS; 1,25-DIHYDROXYVITAMIN D-3; HEART-DISEASE	Vitamin D is a fat-soluble steroid hormone that activates vitamin D receptor to regulate multiple downstream signaling pathways and transcription of various target genes. There is an association between vitamin D deficiency and increased risk for cardiovascular disease. However, most of the studies are observational and associative in nature with limited data on clinical application. Thus, there is a need for more prospective randomized controlled studies to determine whether or not vitamin D supplementation provides cardiovascular protection. In this study, we examined the effects of the deficiency and supplementation of vitamin D on coronary restenosis following coronary intervention in atherosclerotic Yucatan microswine. Twelve Yucatan microswine were fed vitamin D-deficient (n = 4) or -sufficient (n = 8) high cholesterol diet for 6-months followed by coronary intervention. Post-intervention, swine in the vitamin D-sufficient high cholesterol diet group received daily oral supplementation of either 1,000 IU (n = 4) or 3,000 IU (n = 4) vitamin D3. Six months later, optical coherence tomography (OCT) was performed to monitor the development of intimal hyperplasia and restenosis. Animals were euthanized to isolate arteries for histomorphometric and immunohistochemical studies. Animals had graded levels of serum 25(OH)D; vitamin D-deficient (15.33 +/- 1.45 ng/ml), vitamin D-sufficient + 1,000 IU oral vitamin D post-intervention (32.27 +/- 1.20 ng/ml), and vitamin D-sufficient + 3,000 IU oral vitamin D post-intervention (51.00 +/- 3.47 ng/ml). Findings from the OCT and histomorphometric studies showed a decrease in intimal hyperplasia and restenosis in vitamin D-supplemented compared to vitamin D-deficient swine. Vitamin D supplementation significantly decreased serum levels of TNF-alpha and IFN-gamma, upregulated serum levels of IL-10, and had no effect on serum IL-6 levels. These findings suggest that vitamin D supplementation limits neointimal formation following coronary intervention in atherosclerotic swine and provide the support for vitamin D supplementation to protect against the development of coronary restenosis.	[Gupta, Gaurav K.; Agrawal, Tanupriya; Rai, Vikrant; Del Core, Michael G.; Hunter, William J., III; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA	Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA.	dkagr@creighton.edu	Rai, Vikrant/J-3680-2019; Agrawal, Devendra/GLR-3925-2022	Rai, Vikrant/0000-0001-6286-2341; Agrawal, Devendra/0000-0001-5445-0013; Agrawal, Tanupriya/0000-0002-7649-2828	National Institutes of Health from the Office of the Dietary Supplements [R01HL112597, R01HL116042]; National Institutes of Health; National Heart, Lung and Blood Institute (NHLBI)	National Institutes of Health from the Office of the Dietary Supplements; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by research grants from the National Institutes of Health award numbers R01HL112597 and R01HL116042 from the Office of the Dietary Supplements and the Director, National Institutes of Health (OD) and the National Heart, Lung and Blood Institute (NHLBI) to DKA. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bagchi AK, 2013, CYTOKINE, V61, P304, DOI 10.1016/j.cyto.2012.10.013; Battes LC, 2014, ATHEROSCLEROSIS, V236, P18, DOI 10.1016/j.atherosclerosis.2014.06.010; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; Canning MO, 2001, EUR J ENDOCRINOL, V145, P351, DOI 10.1530/eje.0.1450351; Carrelli AL, 2011, STROKE, V42, P2240, DOI 10.1161/STROKEAHA.110.608539; Chen WR, 2014, HEART LUNG CIRC, V23, P314, DOI 10.1016/j.hlc.2013.08.012; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Guagliumi G, 2003, CIRCULATION, V107, P1340, DOI 10.1161/01.CIR.0000062700.42060.6F; Gupta GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042789; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Jordan NJ, 1997, BRIT J PHARMACOL, V122, P749, DOI 10.1038/sj.bjp.0701433; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Kranzhofer R, 1996, CIRC RES, V79, P286, DOI 10.1161/01.RES.79.2.286; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michos ED, 2008, CURR OPIN CLIN NUTR, V11, P7, DOI 10.1097/MCO.0b013e3282f2f4dd; MITSUMATA M, 1993, AM J PHYSIOL, V265, pH3, DOI 10.1152/ajpheart.1993.265.1.H3; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Profumo E, 2007, ATHEROSCLEROSIS, V191, P340, DOI 10.1016/j.atherosclerosis.2006.03.030; Rao VH, 2016, ATHEROSCLEROSIS, V248, P160, DOI 10.1016/j.atherosclerosis.2016.03.021; REITMAN JS, 1982, ATHEROSCLEROSIS, V43, P119, DOI 10.1016/0021-9150(82)90104-6; RUPPRECHT HJ, 1990, CATHETER CARDIO DIAG, V19, P151, DOI 10.1002/ccd.1810190302; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5; Seker T, 2014, J CLIN LAB ANAL, V28, P52, DOI 10.1002/jcla.21643; SERRUYS PW, 1993, AM HEART J, V126, P1243, DOI 10.1016/0002-8703(93)90689-7; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; STEELE PM, 1985, CIRC RES, V57, P105, DOI 10.1161/01.RES.57.1.105; Thorand B, 2011, DIABETES CARE, V34, P2320, DOI 10.2337/dc11-0775; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Verdoia M, 2014, EUR J CLIN INVEST, V44, P634, DOI 10.1111/eci.12281; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544; Zittermann A, 1998, EUR J CLIN NUTR, V52, P501, DOI 10.1038/sj.ejcn.1600591	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156857	10.1371/journal.pone.0156857	http://dx.doi.org/10.1371/journal.pone.0156857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271180	gold, Green Submitted, Green Published			2022-12-27	WOS:000377560200022
J	Jackson, JW; Singh, MV; Singh, VB; Jones, LD; Davidson, GA; Ture, S; Morrell, CN; Schifitto, G; Maggirwar, SB				Jackson, Joseph W.; Singh, Meera V.; Singh, Vir B.; Jones, Letitia D.; Davidson, Gregory A.; Ture, Sara; Morrell, Craig N.; Schifitto, Giovanni; Maggirwar, Sanjay B.			Novel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; P38 MAP KINASE; PLATELET-DERIVED CD40L; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; RANDOMIZED-TRIAL; HIV-INFECTION; UP-REGULATION; MOUSE MODEL; IN-VIVO	Platelets play an essential role in hemostasis and wound healing by facilitating thrombus formation at sites of injury. Platelets also mediate inflammation and contain several pro-inflammatory molecules including cytokines and chemokines that mediate leukocyte recruitment and activation. Not surprisingly, platelet dysfunction is known to contribute to several inflammatory disorders. Antiplatelet therapies, such as aspirin, adenosine diphosphate (ADP) antagonists, glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors, and anticoagulants such as warfarin, dampen platelet activity at the risk of unwarranted bleeding. Thus, the development of drugs that reduce platelet-mediated inflammation without interfering with thrombus formation is of importance to combat platelet-associated disorders. We have shown here for the first time that the tetracycline antibiotic, minocycline, administered to HIV-infected individuals reduces plasma levels of soluble CD40L and platelet factor 4 levels, host molecules predominately released by platelets. Minocycline reduced the activation of isolated platelets in the presence of the potent platelet activator, thrombin, as measured by ELISA and flow cytometry. Platelet degranulation was reduced upon exposure to minocycline as shown by mepacrine retention and flow cytometry. However, minocycline had no effect on spreading, aggregation, GPIIb/IIIa activation, or in vivo thrombus formation. Lastly, immunoblot analysis suggests that the antiplatelet activity of minocycline is likely mediated by inhibition of mixed lineage kinase 3 (MLK3)-p38 MAPK signaling axis and loss of p38 activity. Our findings provide a better understanding of platelet biology and a novel repurposing of an established antibiotic, minocycline, to specifically reduce platelet granule release without affecting thrombosis, which may yield insights in generating novel, specific antiplatelet therapies.	[Jackson, Joseph W.; Singh, Meera V.; Singh, Vir B.; Jones, Letitia D.; Davidson, Gregory A.; Maggirwar, Sanjay B.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Ture, Sara; Morrell, Craig N.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Schifitto, Giovanni] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Maggirwar, SB (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Sanjay_Maggirwar@URMC.Rochester.edu		Jackson, Joseph/0000-0002-3826-2749; Jones, Letitia/0000-0002-1889-5629	National Institutes of Health, USA [R01 NS066801, R01 HL128155, T32AI049815, R01 NS054578-08S1]; University of Rochester Center for AIDS Research (CFAR) through an NIH grant [P30 AI078498]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for AIDS Research (CFAR) through an NIH grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health, USA: R01 NS066801 and R01 HL128155 (to SBM) and T32AI049815 and R01 NS054578-08S1 (to JWJ). This publication was also made possible through core services and support from the University of Rochester Center for AIDS Research (CFAR) through an NIH grant: P30 AI078498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 2008, J THROMB HAEMOST, V6, P2007, DOI 10.1111/j.1538-7836.2008.03169.x; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; Begonja AJ, 2007, BLOOD, V109, P616, DOI 10.1182/blood-2006-07-038158; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Canault M, 2010, BLOOD, V115, P1835, DOI 10.1182/blood-2009-03-211706; Capodanno D, 2013, J THROMB HAEMOST, V11, P316, DOI 10.1111/jth.12219; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; Cuello AC, 2010, NEURODEGENER DIS, V7, P96, DOI 10.1159/000285514; Davidson DC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-144; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; DiCenzo R, 2008, ANTIMICROB AGENTS CH, V52, P3035, DOI 10.1128/AAC.00194-08; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Follstaedt SC, 2008, J NEUROVIROL, V14, P376, DOI 10.1080/13550280802199898; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Goubran HA, 2014, SEMIN ONCOL, V41, P359, DOI 10.1053/j.seminoncol.2014.04.006; Gowert NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090523; Gresele P, 2012, ANTIPLATELET AGENTS, Vxii; Harrington RA, 2003, CIRCULATION, V108, pE45, DOI 10.1161/01.CIR.0000083142.13956.D6; Haynes BF, 2006, NAT MED, V12, P1351, DOI 10.1038/nm1206-1351; Hottz ED, 2014, J IMMUNOL, V193, P1864, DOI 10.4049/jimmunol.1400091; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Jackson SP, 2003, NAT REV DRUG DISCOV, V2, P775, DOI 10.1038/nrd1198; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Manolis Antonis S., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P203, DOI 10.2174/1568016054368188; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; Metz LM, 2009, MULT SCLER, V15, P1183, DOI 10.1177/1352458509106779; Michelson AD, 2007, PLATELETS, Vxlii; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; Nakasujja N, 2013, NEUROLOGY, V80, P196, DOI 10.1212/WNL.0b013e31827b9121; Neidecker M, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-14; O'Brien JJ, 2008, BLOOD, V112, P4051, DOI 10.1182/blood-2008-05-158535; O'Brien M, 2013, JAIDS-J ACQ IMM DEF, V63, P280, DOI 10.1097/QAI.0b013e31828a292c; Ombrello C, 2010, J CARDIOVASC TRANSL, V3, P538, DOI 10.1007/s12265-010-9213-7; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Robinson M, 2000, BRIT J HAEMATOL, V108, P859, DOI 10.1046/j.1365-2141.2000.01939.x; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Singh M, 2014, IMMUNOLOGY, V142, P562, DOI 10.1111/imm.12246; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Steele RW, 2012, OCHSNER J, V12, P202; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui Z, 2006, J IMMUNOL, V177, P702, DOI 10.4049/jimmunol.177.1.702; Thushara RM, 2014, BIOL PLATELET APOPTO; von Hundelshausen P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00294; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wang CX, 2003, BRAIN RES, V963, P327, DOI 10.1016/S0006-8993(02)04045-3; Yeung J, 2012, J BLOOD MED, V3, P33, DOI 10.2147/JBM.S25421; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zabad RK, 2007, MULT SCLER, V13, P517, DOI 10.1177/1352458506070319; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	61	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157115	10.1371/journal.pone.0157115	http://dx.doi.org/10.1371/journal.pone.0157115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270236	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200032
J	Bucher, EH; Stein, AF				Bucher, Enrique H.; Stein, Ariel F.			Large Salt Dust Storms Follow a 30-Year Rainfall Cycle in the Mar Chiquita Lake (Cordoba, Argentina)	PLOS ONE			English	Article							SEA; CALIFORNIA	Starting in 2006, a new source of intense salt dust storms developed in Mar Chiquita (Cordoba, Argentina), the largest saline lake in South America. Storms originate from vastmudflats left by a 30-year expansion-retreat cycle of the lake due to changes in the regional rainfall regime. The annual frequency of salt dust storms correlated with the size of the salt mudflats. Events were restricted to the coldest months, and reached up to 800 km from the source. Occurrence of dust storms was associated with specific surface colors and textures easily identifiable in satellite images. High-emission surfaces were characterized by the presence of sodium sulfate hydrous/anhydrous crystals (mirabilite and thenardite), and a superficial and variable water table, which may result in the periodic development of a characteristic "fluffy" surface derived from salt precipitation-dissolution processes. HYSPLIT model simulation estimates a deposition maximum near the sources (of about 2.5 kg/ha/yr), and a decreasing trend from the emission area outwards, except for the relative secondary maximum modeled over the mountain ranges in southern Bolivia and northern Argentina due to an orographic effect. The 2009 total deposition of salt dust generated in Mar Chiquita was estimated at 6.5 million tons.	[Bucher, Enrique H.] Univ Nacl Cordoba, CONICET, Inst Diversidad & Ecol Anim, Rondeau 798, RA-5000 Cordoba, Argentina; [Bucher, Enrique H.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Zool Aplicada, Rondeau 798, RA-5000 Cordoba, Argentina; [Stein, Ariel F.] NOAA, Air Resources Lab, R ARL, NCWCP, Room 4205,5830 Univ Res Court, College Pk, MD 20740 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National Oceanic Atmospheric Admin (NOAA) - USA	Bucher, EH (corresponding author), Univ Nacl Cordoba, CONICET, Inst Diversidad & Ecol Anim, Rondeau 798, RA-5000 Cordoba, Argentina.; Bucher, EH (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Zool Aplicada, Rondeau 798, RA-5000 Cordoba, Argentina.	buchereh@gmail.com	Stein, Ariel/ABE-7423-2021; Stein, Ariel F/L-9724-2014	Stein, Ariel/0000-0002-9560-9198; Stein, Ariel F/0000-0002-9560-9198; Bucher, Enrique H./0000-0001-8152-1104	NASA/HQ	NASA/HQ	We acknowledge the use of Rapid Response imagery from the Land, Atmosphere Near realtime Capability for EOS (LANCE) system operated by the NASA/GSFC/Earth Science Data and Information System (ESDIS) with funding provided by NASA/HQ. We are also grateful to the Municipality of Miramar, Cordoba, Argentina for providing research infrastructure in Mar Chiquita, and also thank Fantine Ngan for help with the HYSPLIT graphics.	Abuduwaili J, 2010, J ARID LAND, V2, P144, DOI 10.3724/SP.J.1227.2010.00144; Bucher E., 2006, BANADOS RIO DULCE LA, P79; Bucher EH., 2006, BANADOS RIO DULCE LA; Buck BJ, 2011, SOIL SCI SOC AM J, V75, P1971, DOI 10.2136/sssaj2011.0049; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Draxler RR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013167; Escudero M, 2011, ATMOS RES, V99, P518, DOI 10.1016/j.atmosres.2010.12.002; Escudero M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006395; Frank H., 1912, B DEP GEN CULTURA GA, V6, P87; GAIERO D, 2013, J GEOPHYS RES-ATMOS, V118, P1, DOI DOI 10.1002/JGRD.50036; Gasso S, 2010, ATMOS CHEM PHYS, V10, P8287, DOI 10.5194/acp-10-8287-2010; Ginoux P, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000388; Kanamitsu M, 1989, WEA FORECASTING, p[4, 335], DOI [10.1175/1520-0434(1989)004&LT;0335:DOTNGD&GT;2.0.CO;2, DOI 10.1175/1520-0434(1989)004<0335:D0TNGD>2.0.C0;2, 10.1175/1520-0434(1989)0042.0.CO;2]; King J, 2011, AEOLIAN RES, V3, P67, DOI 10.1016/j.aeolia.2011.03.005; Krohling DM, 1999, QUATERN INT, V57-8, P149, DOI 10.1016/S1040-6182(98)00056-1; Micklin P, 2007, ANNU REV EARTH PL SC, V35, P47, DOI 10.1146/annurev.earth.35.031306.140120; NASA Observatory, 2008, DUST STORM AR SEA; Piovano E.L., 2006, BANADOS RIO DULCE LA, P37; Reynolds R., 2009, NATURAL RESOURCES EN, V15, P18; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stein AF, 2011, WEATHER FORECAST, V26, P236, DOI 10.1175/WAF-D-10-05044.1; Troin M, 2010, J HYDROL, V393, P233, DOI 10.1016/j.jhydrol.2010.08.019; Wang YQ, 2011, ATMOS ENVIRON, V45, P6368, DOI 10.1016/j.atmosenv.2011.08.035	23	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156672	10.1371/journal.pone.0156672	http://dx.doi.org/10.1371/journal.pone.0156672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258088	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700100
J	Huang, BN; Gomez-Rodriguez, J; Preite, S; Garrett, LJ; Harper, UL; Schwartzberg, PL				Huang, Bonnie; Gomez-Rodriguez, Julio; Preite, Silvia; Garrett, Lisa J.; Harper, Ursula L.; Schwartzberg, Pamela L.			CRISPR-Mediated Triple Knockout of SLAMF1, SLAMF5 and SLAMF6 Supports Positive Signaling Roles in NKT Cell Development	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; CONTROLS T-CELL; HUMORAL IMMUNITY; NEGATIVE REGULATION; FAMILY RECEPTORS; GENE-PRODUCT; ADAPTER SAP; B-CELLS; MICE; DIFFERENTIATION	The SLAM family receptors contribute to diverse aspects of lymphocyte biology and signal via the small adaptor molecule SAP. Mutations affecting SAP lead to X-linked lymphoproliferative syndrome Type 1, a severe immunodysregulation characterized by fulminant mononucleosis, dysgammaglobulinemia, and lymphoproliferation/lymphomas. Patients and mice having mutations affecting SAP also lack germinal centers due to a defect in T:B cell interactions and are devoid of invariant NKT (iNKT) cells. However, which and how SLAM family members contribute to these phenotypes remains uncertain. Three SLAM family members: SLAMF1, SLAMF5 and SLAMF6, are highly expressed on T follicular helper cells and germinal center B cells. SLAMF1 and SLAMF6 are also implicated in iNKT development. Although individual receptor knockout mice have limited iNKT and germinal center phenotypes compared to SAP knockout mice, the generation of multi-receptor knockout mice has been challenging, due to the genomic linkage of the genes encoding SLAM family members. Here, we used Cas9/CRISPR-based mutagenesis to generate mutations simultaneously in Slamf1, Slamf5 and Slamf6. Genetic disruption of all three receptors in triple-knockout mice (TKO) did not grossly affect conventional T or B cell development and led to mild defects in germinal center formation post-immunization. However, the TKO worsened defects in iNKT cells development seen in SLAMF6 single gene-targeted mice, supporting data on positive signaling and potential redundancy between these receptors.	[Huang, Bonnie; Gomez-Rodriguez, Julio; Preite, Silvia; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Garrett, Lisa J.] NHGRI, Embryon Stem Cell & Transgen Mouse Core, Bethesda, MD 20892 USA; [Harper, Ursula L.] NHGRI, Genom Core, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schwartzberg, PL (corresponding author), NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA.	pams@mail.nih.gov			National Human Genome Research Institute [HG000123, HG200349]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200346, ZIAHG000123, ZICHG200349] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by intramural funding from the National Human Genome Research Institute (HG000123 and HG200349).	Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Behringer R, 2014, MANIPULATING MOUSE E, P814; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chan AY, 2006, CURR OPIN IMMUNOL, V18, P656, DOI 10.1016/j.coi.2006.09.010; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; De Calisto J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00186; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dutta M, 2013, J IMMUNOL, V190, P2121, DOI 10.4049/jimmunol.1202145; Dutta M, 2012, J IMMUNOL, V188, P3031, DOI 10.4049/jimmunol.1103226; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Gomez-Rodriguez J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10857; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Hislop AD, 2010, BLOOD, V116, P3249, DOI 10.1182/blood-2009-09-238832; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Preite S, 2015, EUR J IMMUNOL, V45, P3010, DOI 10.1002/eji.201545920; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Snow AL, 2009, J CLIN INVEST, V119, P2976, DOI 10.1172/JCI39518; Sood R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057239; Tangye SG, 2014, J CLIN IMMUNOL, V34, P772, DOI 10.1007/s10875-014-0083-7; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wang N, 2006, AM J RESP CELL MOL, V35, P206, DOI 10.1165/rcmb.2005-0294OC; Wang NH, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00158; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Wu N, 2016, CURR OPIN IMMUNOL, V38, P45, DOI 10.1016/j.coi.2015.11.003; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	52	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156072	10.1371/journal.pone.0156072	http://dx.doi.org/10.1371/journal.pone.0156072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258160	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700033
J	Katz, JS				Katz, J. Sylvan			What Is a Complex Innovation System?	PLOS ONE			English	Article							POWER LAWS; CUMULATIVE ADVANTAGE; COMMUNITY STRUCTURE; SELF-ORGANIZATION; NATIONAL SYSTEMS; GROWTH DYNAMICS; SCALING RULES; SCIENCE; EMERGENCE; NETWORKS	Innovation systems are sometimes referred to as complex systems, something that is intuitively understood but poorly defined. A complex system dynamically evolves in non-linear ways giving it unique properties that distinguish it from other systems. In particular, a common signature of complex systems is scale-invariant emergent properties. A scale-invariant property can be identified because it is solely described by a power law function, f(x) = kx(alpha), where the exponent, a, is a measure of scale-invariance. The focus of this paper is to describe and illustrate that innovation systems have properties of a complex adaptive system. In particular scale-invariant emergent properties indicative of their complex nature that can be quantified and used to inform public policy. The global research system is an example of an innovation system. Peer-reviewed publications containing knowledge are a characteristic output. Citations or references to these articles are an indirect measure of the impact the knowledge has on the research community. Peer-reviewed papers indexed in Scopus and in the Web of Science were used as data sources to produce measures of sizes and impact. These measures are used to illustrate how scale-invariant properties can be identified and quantified. It is demonstrated that the distribution of impact has a reasonable likelihood of being scale-invariant with scaling exponents that tended toward a value of less than 3.0 with the passage of time and decreasing group sizes. Scale-invariant correlations are shown between the evolution of impact and size with time and between field impact and sizes at points in time. The recursive or self-similar nature of scale-invariance suggests that any smaller innovation system within the global research system is likely to be complex with scale-invariant properties too.	[Katz, J. Sylvan] Univ Sussex, SPRU, Brighton, E Sussex, England; [Katz, J. Sylvan] Univ Saskatchewan, Johnson Shoyama Grad Sch Publ Policy, Saskatoon, SK, Canada; [Katz, J. Sylvan] Sci Metrix, Montreal, PQ, Canada	University of Sussex; University of Saskatchewan	Katz, JS (corresponding author), Univ Sussex, SPRU, Brighton, E Sussex, England.; Katz, JS (corresponding author), Univ Saskatchewan, Johnson Shoyama Grad Sch Publ Policy, Saskatoon, SK, Canada.; Katz, JS (corresponding author), Sci Metrix, Montreal, PQ, Canada.	j.s.katz@sussex.ac.uk			Science Metrix	Science Metrix	The author received no funding for this work. As an affiliation for author J. Sylvan Katz, Science Metrix did not have any role in the study design and analysis, decision to publish, or preparation of the manuscript. Science Metrix provided access to data through a research fellowship. The specific role of author J. Sylvan Katz is articulated in the 'author contributions' section.	Abbott A, 2010, NATURE, V465, P860, DOI 10.1038/465860a; AHRWEILER P., 2010, INNOVATION COMPLEX S; Albarran P, 2011, SCIENTOMETRICS, V88, P385, DOI 10.1007/s11192-011-0407-9; [Anonymous], 1991, FRACTALS CHAOS POWER; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Archambault E, 2011, PRO INT CONF SCI INF, P78; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baranger M., 2001, CHAOS COMPLEXITY ENT; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Biggiero L, 2015, TECHNOL FORECAST SOC, V94, P21, DOI 10.1016/j.techfore.2014.04.009; Borner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039464; Bound J., 1984, RD PATENTS PRODUCTIV; Brantle TF, 2007, PORTL INT CONF MANAG, P540, DOI 10.1109/PICMET.2007.4349367; Brzezinski M, 2015, SCIENTOMETRICS, P1; Buchanan M, 2008, NAT PHYS, V4, P339, DOI 10.1038/nphys946; Carlsson B, 2016, IND INNOV, V23, P1, DOI 10.1080/13662716.2015.1120658; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen IR, 2007, J R SOC INTERFACE, V4, P175, DOI 10.1098/rsif.2006.0173; Cohen R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.058701; Collevecchio A, 2013, PREFERENTIAL ATTACHM, P1219; Cooksey RW, 2011, J AGRIC EDUC EXT, V17, P283, DOI 10.1080/1389224X.2011.559083; Corominas-Murtra B, 2015, P NATL ACAD SCI USA, V112, P5348, DOI 10.1073/pnas.1420946112; Crespo JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049156; Davies PCW, 2013, BIOSYSTEMS, V111, P1, DOI 10.1016/j.biosystems.2012.10.005; Dosi G, 1988, TECHNICAL CHANGE EC, P222; Dougherty D, 2011, ORGAN SCI, V22, P1214, DOI 10.1287/orsc.1100.0605; Egghe L, 2009, LOTKAIAN INFORM APPL, P689; Filippetti A, 2011, RES POLICY, V40, P179, DOI 10.1016/j.respol.2010.09.001; Foster J, 2012, J ECON BEHAV ORGAN, V82, P420, DOI 10.1016/j.jebo.2011.09.008; FREEMAN C, 1995, CAMBRIDGE J ECON, V19, P5; Gao X, 2010, J INFORMETR, V4, P618, DOI 10.1016/j.joi.2010.07.001; Gao X, 2009, J INFORMETR, V3, P321, DOI 10.1016/j.joi.2009.04.004; Gibrat R., 1931, INEGALITES EC; Gillespie C. S., 2014, ARXIV PREPRINT ARXIV; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Harper DA, 2012, J ECON BEHAV ORGAN, V82, P352, DOI 10.1016/j.jebo.2011.03.013; Hebert-Dufresne L, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032304; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Husbands F, 2011, SCI SCI POLICY A HDB; Ivanova IA, 2014, TECHNOL FORECAST SOC, V86, P143, DOI 10.1016/j.techfore.2013.08.022; Katz J. S, 2012, 17 INT C SCI TECHN I; Katz J.S., 2012, P 17 INT C SCI TECHN, P1; Katz JS, 2006, RES EVALUAT, V15, P85, DOI 10.3152/147154406781775922; Katz JS, 2005, MEAS-INTERDISCIP RES, V3, P24, DOI 10.1207/s15366359mea0301_3; Katz JS, 2006, RES POLICY, V35, P893, DOI 10.1016/j.respol.2006.03.007; Katz JS, 1999, RES POLICY, V28, P501, DOI 10.1016/S0048-7333(99)00010-4; Katz JS., 2000, SCI PUBL POLICY, V27, P23, DOI [DOI 10.3152/147154300781782156, 10.3152/147154300781782156]; Katz S, 2012, SCALE INDEPENDENT ME; Kazuko Y, 2006, PHYS REV E, V74; KUHLMANN S, 1999, IMPROVING DISTRIBUTE; Kwapien J, 2012, PHYS REP, V515, P115, DOI 10.1016/j.physrep.2012.01.007; Lane J, 2009, BRIDGES, V22; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Lemay MA, 2012, EVID POLICY, V8, P473, DOI 10.1332/174426412X660133; Leydesdorff L., 1996, SCI PUBL POL, V23, P279, DOI [10.1093/spp/23.5.279, DOI 10.1093/SPP/23.5.279]; Lundvall BA, 2002, RES POLICY, V31, P213, DOI 10.1016/S0048-7333(01)00137-8; Madhushani K, 2012, P TECHN SESS, V28, P59; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Markovic D, 2014, PHYS REP, V536, P41, DOI 10.1016/j.physrep.2013.11.002; Matia K, 2005, J AM SOC INF SCI TEC, V56, P893, DOI 10.1002/asi.20183; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Morel B, 1999, ORGAN SCI, V10, P278, DOI 10.1287/orsc.10.3.278; NARANAN S, 1970, NATURE, V227, P631, DOI 10.1038/227631a0; Newman M. E. J., 2011, SIGMETRICS POSTING; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Nomaler O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110805; O'Neale DRJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049501; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Paradisi P, 2015, CHAOS SOLITON FRACT, V81, P407, DOI 10.1016/j.chaos.2015.09.017; Pavitt K., 2003, PROCESS INNOVATION; Pennock DM, 2002, P NATL ACAD SCI USA, V99, P5207, DOI 10.1073/pnas.032085699; Peterson GJ, 2010, P NATL ACAD SCI USA, V107, P16023, DOI 10.1073/pnas.1010757107; Piantadosi ST, 2014, PSYCHON B REV, V21, P1112, DOI 10.3758/s13423-014-0585-6; Plerou V, 1999, NATURE, V400, P433, DOI 10.1038/22719; Plerou V, 1999, PHYS REV E, V60, P6519, DOI 10.1103/PhysRevE.60.6519; POLI ROBERTO, 2013, CADUM, V2, P142; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Redner S, 1998, EUROPEAN PHYS J B, V4, P1434; Reed W.J., 2003, SCI MATH JAPONICAE, V58, P473; Ronda-Pupo GA, 2015, JASIST; Ronda-Pupo GA, 2016, JASIST IN PRESS; Rose-Anderssen C, 2005, TECHNOVATION, V25, P1093, DOI 10.1016/j.technovation.2004.03.006; Rousseau B., 2000, Cybermetrics, V4; Rus C. O., 2008, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Horticulture, V65, P603; Stephens C, 2012, ENCUENTROS CON COMPL; Thelwall M, 2014, J INFORMETR, V8, P824, DOI 10.1016/j.joi.2014.08.001; van Raan AFJ, 2008, J AM SOC INF SCI TEC, V59, P565, DOI 10.1002/asi.20765; van Raan AFJ, 2008, J AM SOC INF SCI TEC, V59, P461, DOI 10.1002/asi.20761; van Raan AFJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059384; VANRAAN AFJ, 1990, NATURE, V347, P626, DOI 10.1038/347626a0; Vicsek T, 2002, NATURE, V418, P131, DOI 10.1038/418131a; Waltman L, 2011, J INFORMETR, V5, P37, DOI 10.1016/j.joi.2010.08.001; WEAVER W, 1948, Am Sci, V36, P536; Whitfield J, 2005, NATURE, V436, P905, DOI 10.1038/436905a; Yilmaz L., 2008, AAAI SPRING S, P142	101	21	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156150	10.1371/journal.pone.0156150	http://dx.doi.org/10.1371/journal.pone.0156150			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258040	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000377369700040
J	Kot, W; Kilstrup, M; Vogensen, FK; Hammer, K				Kot, Witold; Kilstrup, Mogens; Vogensen, Finn K.; Hammer, Karin			Clear Plaque Mutants of Lactococcal Phage TP901-1	PLOS ONE			English	Article							BACTERIOPHAGE TP901-1; ESCHERICHIA-COLI; TEMPERATE BACTERIOPHAGE; GENETIC SWITCH; CI REPRESSOR; LACTIS; DNA; PROTEIN; MUTATIONS; PHI-LC3	We report a method for obtaining turbid plaques of the lactococcal bacteriophage TP901-1 and its derivative TP901-BC1034. We have further used the method to isolate clear plaque mutants of this phage. Analysis of 8 such mutants that were unable to lysogenize the host included whole genome resequencing. Four of the mutants had different mutations in structural genes with no relation to the genetic switch. However all 8 mutants had a mutation in the cl repressor gene region. Three of these were located in the promoter and Shine-Dalgarno sequences and five in the N-terminal part of the encoded Cl protein involved in the DNA binding. The conclusion is that cl is the only gene involved in clear plaque formation i.e. the Cl protein is the determining factor for the lysogenic pathway and its maintenance in the lactococcal phage TP901-1.	[Kot, Witold] Aarhus Univ, Dept Environm Sci, Frederiksborgvej 399, DK-4000 Roskilde, Denmark; [Kilstrup, Mogens; Hammer, Karin] Tech Univ Denmark, Dept Syst Biol, Matemat Torvet Bldg 301, DK-2800 Lyngby, Denmark; [Vogensen, Finn K.] Univ Copenhagen, Dept Food Sci, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark	Aarhus University; Technical University of Denmark; University of Copenhagen	Kot, W (corresponding author), Aarhus Univ, Dept Environm Sci, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.; Hammer, K (corresponding author), Tech Univ Denmark, Dept Syst Biol, Matemat Torvet Bldg 301, DK-2800 Lyngby, Denmark.	wk@envs.au.dk; kha@bio.dtu.dk	Kot, Witold/N-3747-2017; Kot, Witold/M-2170-2014; Kilstrup, Mogens/AAV-2030-2021	Kot, Witold/0000-0002-0188-4587; Kot, Witold/0000-0002-0188-4587; Kilstrup, Mogens/0000-0002-3900-723X	Danish Council for Independent Research [4093-00198, 0602-02271B, 4002-00107, DFF-4002-00107]; University of Copenhagen; Danish Council for Independent Research grant (PHAGEMID) [4093-00198]; Danish Council for Independent Research grant (MetaPhageLAB) [0602-02271B]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); University of Copenhagen; Danish Council for Independent Research grant (PHAGEMID); Danish Council for Independent Research grant (MetaPhageLAB)	This work was supported by the Danish Council for Independent Research (http://ufm.dk/en/research-andinnovation/councils-and-commissions/the-danish-council-for-independent-research) grant 4093-00198 (received by WK), used to cover cost of data generation and analysis; and the Danish Council for Independent Research (http://ufm.dk/en/researchandinnovation/councils-and-commissions/the-danishcouncil-for-independent-research) grant 0602-02271B (received by FKV), used to cover cost of data generation and analysis. Grant 4002-00107 from Danish Council for Independent Research received by Dr. Leila Lo Leggio, at the Chemical Department, University of Copenhagen is acknowledged for sponsoring materials for cloning and enzyme activity assays. Dr. Leila Lo Leggio had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Danish Council for Independent Research grants 4093-00198 (PHAGEMID), 0602-02271B (MetaPhageLAB) and DFF-4002-00107. We thank Lars H. Hansen from the Department of Environmental Science, Aarhus University for providing sequencing facilities. We thank Bashir Aideh from Department of Food Science, University of Copenhagen for his technical support. Marzanna Pulka-Amin and Lise Sorensen from Department of Systems Biology, The Technical University of Denmark, are also thanked for their technical support.	Blatny JM, 2001, MOL GENET GENOMICS, V265, P189, DOI 10.1007/s004380000407; BRAUN V, 1989, J GEN MICROBIOL, V135, P2551; Brondsted L, 2001, VIROLOGY, V283, P93, DOI 10.1006/viro.2001.0871; Brondsted L, 1999, APPL ENVIRON MICROB, V65, P752; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Frandsen KH, 2013, BIOCHEMISTRY-US, V52, P6892, DOI 10.1021/bi400439y; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; KAISER AD, 1957, VIROLOGY, V3, P42, DOI 10.1016/0042-6822(57)90022-3; Koch B, 1997, APPL ENVIRON MICROB, V63, P2439, DOI 10.1128/AEM.63.6.2439-2441.1997; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; Lildballe DL, 2008, J MOL BIOL, V384, P9, DOI 10.1016/j.jmb.2008.09.014; LILLEHAUG D, 1991, APPL ENVIRON MICROB, V57, P3206, DOI 10.1128/AEM.57.11.3206-3211.1991; Madsen PL, 1999, J BACTERIOL, V181, P7430, DOI 10.1128/JB.181.24.7430-7438.1999; Nanda AM, 2015, J BACTERIOL, V197, P410, DOI 10.1128/JB.02230-14; Pedersen M, 2008, J MOL BIOL, V376, P983, DOI 10.1016/j.jmb.2007.12.022; Pedersen M, 2010, J BACTERIOL, V192, P2102, DOI 10.1128/JB.01387-09; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Russell DW, 1989, MOL CLONING LAB MANU, V1; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Vegge CS, 2006, APPL ENVIRON MICROB, V72, P6815, DOI 10.1128/AEM.01033-06; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155233	10.1371/journal.pone.0155233	http://dx.doi.org/10.1371/journal.pone.0155233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258092	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700011
J	Kunogi, H; Yamaguchi, N; Terao, Y; Sasai, K				Kunogi, Hiroaki; Yamaguchi, Nanae; Terao, Yasuhisa; Sasai, Keisuke			Kidney-Sparing Methods for Extended-Field Intensity-Modulated Radiotherapy (EF-IMRT) in Cervical Carcinoma Treatment	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; RADIATION-THERAPY; LYMPH-NODES; CONCURRENT CISPLATIN; CANCER; CHEMOTHERAPY; WOMEN	Coplanar extended-field intensity-modulated radiation therapy (EF-IMRT) targeting the whole-pelvic and para-aortic lymph nodes in patients with advanced cervical cancer results in impaired creatinine clearance. An improvement in renal function cannot be expected unless low-dose (approximately 10 Gy) kidney exposure is reduced. The dosimetric method should be considered during EF-IMRT planning to further reduce low-dose exposure to the kidneys. To assess the usefulness of non-coplanar EF-IMRT with kidney-avoiding beams to spare the kidneys during cervical carcinoma treatment in dosimetric analysis between non-coplanar and coplanar EF-IMRT, we compared the doses of the target organ and organs at risk, including the kidney, in 10 consecutive patients. To estimate the influence of EFRT on renal dysfunction, creatinine clearance values after treatment were also examined in 18 consecutive patients. Of these 18 patients, 10 patients who were included in the dosimetric analysis underwent extended field radiation therapy (EFRT) with concurrent chemotherapy, and eight patients underwent whole-pelvis radiation therapy with concurrent chemotherapy to treat cervical carcinoma between April 2012 and March 2015 at our institution. In the dosimetric analysis, non-coplanar EF-IMRT was effective at reducing low-dose (approximately 10 Gy) exposure to the kidneys, thus maintaining target coverage and sparing other organs at risk, such as the small bowel, rectum, and bladder, compared with coplanar EF-IMRT. Renal function in all 10 patients who underwent EFRT, including coplanar EF-IMRT (with kidney irradiation), was low after treatment, and differed significantly from that of the eight patients who underwent WPRT (no kidney irradiation) 6 months after the first day of treatment (P = 0.005). In conclusion, non-coplanar EF-IMRT should be considered in patients with advanced cervical cancer, particularly in patients with a long life expectancy or with pre-existing renal dysfunction.	[Kunogi, Hiroaki; Yamaguchi, Nanae; Sasai, Keisuke] Juntendo Univ, Dept Radiat Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Terao, Yasuhisa] Juntendo Univ, Dept Gynecol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Kunogi, H (corresponding author), Juntendo Univ, Dept Radiat Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hkunogi@juntendo.ac.jp	TERAO, YASUHISA/AAH-6307-2019					Beriwal S, 2007, INT J RADIAT ONCOL, V68, P166, DOI 10.1016/j.ijrobp.2006.12.023; Beriwal S, 2006, GYNECOL ONCOL, V102, P195, DOI 10.1016/j.ygyno.2006.01.062; BERMAN ML, 1984, GYNECOL ONCOL, V19, P8, DOI 10.1016/0090-8258(84)90151-3; Dunlop A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120141; Egeler R M, 1999, Semin Urol Oncol, V17, P55; Gay HA, 2012, INT J RADIAT ONCOL, V83, pE353, DOI 10.1016/j.ijrobp.2012.01.023; Gerszten K, 2006, GYNECOL ONCOL, V102, P182, DOI 10.1016/j.ygyno.2005.12.044; Jabbour SK, 2014, PRACT RADIAT ONCOL, V4, P82, DOI 10.1016/j.prro.2013.06.004; Jung J, 2014, ANTICANCER RES, V34, P4361; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; Mundt AJ, 2003, INT J RADIAT ONCOL, V56, P1354, DOI 10.1016/S0360-3016(03)00325-0; Mundt AJ, 2001, GYNECOL ONCOL, V82, P456, DOI 10.1006/gyno.2001.6250; Murakami N, 2014, ANTICANCER RES, V34, P5091; Orlandi E, 2014, RADIOTHER ONCOL, V113, P260, DOI 10.1016/j.radonc.2014.11.024; ROTMAN M, 1995, JAMA-J AM MED ASSOC, V274, P387, DOI 10.1001/jama.274.5.387; Toita T, 2010, JPN J CLIN ONCOL, V40, P456, DOI 10.1093/jjco/hyp191; Varia MA, 1998, INT J RADIAT ONCOL, V42, P1015, DOI 10.1016/S0360-3016(98)00267-3; Varlotto JM, 2006, AM J CLIN ONCOL-CANC, V29, P281, DOI 10.1097/01.coc.0000217828.95729.b5; Wersall PJ, 2005, RADIOTHER ONCOL, V77, P88, DOI 10.1016/j.radonc.2005.03.022; Zhang GY, 2014, J GYNECOL ONCOL, V25, P14, DOI 10.3802/jgo.2014.25.1.14	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156623	10.1371/journal.pone.0156623	http://dx.doi.org/10.1371/journal.pone.0156623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258030	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700090
J	Xing, FX; Prince, JL; Landman, BA				Xing, Fangxu; Prince, Jerry L.; Landman, Bennett A.			Investigation of Bias in Continuous Medical Image Label Fusion	PLOS ONE			English	Article							SEGMENTATION; VALIDATION; ALGORITHMS	Image labeling is essential for analyzing morphometric features in medical imaging data. Labels can be obtained by either human interaction or automated segmentation algorithms, both of which suffer from errors. The Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm for both discrete-valued and continuous-valued labels has been proposed to find the consensus fusion while simultaneously estimating rater performance. In this paper, we first show that the previously reported continuous STAPLE in which bias and variance are used to represent rater performance yields a maximum likelihood solution in which bias is indeterminate. We then analyze the major cause of the deficiency and evaluate two classes of auxiliary bias estimation processes, one that estimates the bias as part of the algorithm initialization and the other that uses a maximum a posteriori criterion with a priori probabilities on the rater bias. We compare the efficacy of six methods, three variants from each class, in simulations and through empirical human rater experiments. We comment on their properties, identify deficient methods, and propose effective methods as solution.	[Xing, Fangxu] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Prince, Jerry L.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Prince, Jerry L.; Landman, Bennett A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Landman, Bennett A.] Vanderbilt Univ, Dept Elect Engn, Nashville, TN 37235 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Vanderbilt University	Xing, FX (corresponding author), Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	fxing1@mgh.harvard.edu	Landman, Bennett A/A-2343-2009	Landman, Bennett A/0000-0001-5733-2127; Xing, Fangxu/0000-0002-0517-0952	National Institute of Neurological Disorders and Stroke [1R01NS056307, 1R21NS064534]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institute of Neurological Disorders and Stroke grants 1R01NS056307 and 1R21NS064534 (http://www.ninds.nih.gov/). The author who received the funding is BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asman AJ, 2011, IEEE T MED IMAGING, V30, P1779, DOI 10.1109/TMI.2011.2147795; Bilmes J., 1997, ICSITR9702 UC BERK; BREU H, 1995, IEEE T PATTERN ANAL, V17, P529, DOI 10.1109/34.391389; Cerqueira MD, 2002, J AM SOC ECHOCARDIOG, V15, P463, DOI 10.1067/mje.2002.123374; Commowick O, 2009, IEEE T MED IMAGING, V28, P838, DOI 10.1109/TMI.2008.2010438; Gauvain JL, 1994, IEEE T SPEECH AUDI P, V2, P291, DOI 10.1109/89.279278; Graca J. V., 2007, ADV NEURAL INFORM PR; Lampert TA, 2013, ARXIV13070426; Landman BA, 2012, IEEE T MED IMAGING, V31, P512, DOI 10.1109/TMI.2011.2172215; McLachlan GJ, 1997, EM ALGORITHM EXTENSI; Rohlfing T, 2003, LECT NOTES COMPUT SC, V2732, P210; Rohlfing T, 2007, IEEE T IMAGE PROCESS, V16, P153, DOI 10.1109/TIP.2006.884936; Sabuncu MR, 2010, IEEE T MED IMAGING, V29, P1714, DOI 10.1109/TMI.2010.2050897; Snyder Donald Lee, 1991, RANDOM POINT PROCESS, DOI DOI 10.1007/978-1-4612-3166-0; Suinesiaputra A, 2014, MED IMAGE ANAL, V18, P50, DOI 10.1016/j.media.2013.09.001; Udupa JK, 2006, COMPUT MED IMAG GRAP, V30, P75, DOI 10.1016/j.compmedimag.2005.12.001; Wang HZ, 2011, PROC CVPR IEEE, P1113, DOI 10.1109/CVPR.2011.5995382; Wang HZ, 2011, NEUROIMAGE, V55, P968, DOI 10.1016/j.neuroimage.2011.01.006; Warfield SK, 2008, PHILOS T R SOC A, V366, P2361, DOI 10.1098/rsta.2008.0040; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; WU CFJ, 1983, ANN STAT, V11, P95, DOI 10.1214/aos/1176346060; Xing FX, 2012, PROC SPIE, V8314, DOI 10.1117/12.911524; Xing FX, 2011, PROC SPIE, V7962, DOI 10.1117/12.877884	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155862	10.1371/journal.pone.0155862	http://dx.doi.org/10.1371/journal.pone.0155862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258158	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700023
J	Hey, F; Giblett, S; Forrest, S; Herbert, C; Pritchard, C				Hey, Fiona; Giblett, Susan; Forrest, Stephanie; Herbert, Chelsea; Pritchard, Catrin			Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3 alpha/beta Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine	PLOS ONE			English	Article							EPITHELIAL STEM-CELL; POLYPOSIS-COLI APC; BETA-CATENIN; PROTEIN-KINASE; CYCLIN D1; EXPRESSION; GSK3; PATHWAY; INSULIN; TARGET	The WNT signalling pathway controls many developmental processes and plays a key role in maintenance of intestine renewal and homeostasis. Glycogen Synthase Kinase 3 (GSK3) is an important component of the WNT pathway and is involved in regulating beta-catenin stability and expression of WNT target genes. The mechanisms underpinning GSK3 regulation in this context are not completely understood, with some evidence suggesting this occurs through inhibitory N-terminal serine phosphorylation in a similar way to GSK3 inactivation in insulin signaling. To investigate this in a physiologically relevant context, we have analysed the intestinal phenotype of GSK3 knockin mice in which N-terminal serines 21/9 of GSK3 alpha/beta have been mutated to non-phosphorylatable alanine residues. We show that these knockin mutations have very little effect on overall intestinal integrity, cell lineage commitment, beta-catenin localization or WNT target gene expression although a small increase in apoptosis at villi tips is observed. Our results provide in vivo evidence that GSK3 is regulated through mechanisms independent of N-terminal serine phosphorylation in order for beta-catenin to be stabilised.	[Hey, Fiona; Giblett, Susan; Forrest, Stephanie; Herbert, Chelsea; Pritchard, Catrin] Univ Leicester, Dept Mol Cell Biol, Henry Wellcome Bldg, Leicester, Leics, England; [Pritchard, Catrin] Univ Leicester, Dept Canc Studies, Robert Kilpatrick Clin Sci Bldg, Leicester, Leics, England	University of Leicester; University of Leicester	Pritchard, C (corresponding author), Univ Leicester, Dept Mol Cell Biol, Henry Wellcome Bldg, Leicester, Leics, England.; Pritchard, C (corresponding author), Univ Leicester, Dept Canc Studies, Robert Kilpatrick Clin Sci Bldg, Leicester, Leics, England.	cap8@le.ac.uk		Pritchard, Catrin/0000-0003-1859-4487	Cancer Research UK Programme grant [A13083]; Royal Society-Wolfson Research Merit Award; Cancer Research UK [13083] Funding Source: researchfish	Cancer Research UK Programme grant(Cancer Research UK); Royal Society-Wolfson Research Merit Award(Royal Society of London); Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK Programme grant (Ref A13083), and CP was the recipient of a Royal Society-Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Cancer Research UK Programme grant (Ref A13083) and CP was the recipient of a Royal Society-Wolfson Research Merit Award. We are extremely grateful to Dario Alessi for providing the GSK3 mutant mice. We are also indebted to the Department of Biomedical Services for their invaluable help throughout this project and the Genomic Services within Core Biotechnology Services at Leicester for help with qRT-PCR. Furthermore we acknowledge Mr David Brown for all mouse genotyping carried out for this project.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Beurel E., 2014, PHARM THER; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gao XJ, 2014, BIOCHEM CELL BIOL, V92, P349, DOI 10.1139/bcb-2014-0065; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; HALL PA, 1994, J CELL SCI, V107, P3569; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419	51	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156877	10.1371/journal.pone.0156877	http://dx.doi.org/10.1371/journal.pone.0156877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284979	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000027
J	Christesen, HT; Pedersen, BT; Pournara, E; Petit, IO; Juliusson, PB				Christesen, Henrik Thybo; Pedersen, Birgitte Tonnes; Pournara, Effie; Petit, Isabelle Oliver; Juliusson, Petur Benedikt			Short Stature: Comparison of WHO and National Growth Standards/References for Height	PLOS ONE			English	Article							BODY-MASS INDEX; WORLD-HEALTH-ORGANIZATION; HORMONE DEFICIENCY; CHILDREN; WEIGHT; REFERENCES; BIRTH; ADOLESCENTS; INFANTS; CHARTS	The use of appropriate growth standards/references is of significant clinical importance in assessing the height of children with short stature as it may determine eligibility for appropriate therapy. The aim of this study was to determine the impact of using World Health Organization (WHO) instead of national growth standards/references on height assessment in short children. Data were collected from routine clinical practice (1998-2014) from nine European countries that have available national growth references and were enrolled in NordiNet (R) International Outcome Study (IOS) (NCT00960128), a large-scale, non-interventional, multinational study. The patient cohort consisted of 5996 short pediatric patients diagnosed with growth hormone deficiency (GHD), Turner syndrome (TS) or born small for gestational age (SGA). The proportions of children with baseline height standard deviation score (SDS) below clinical cut-off values (-2 SDS for GHD and TS; -2.5 SDS for SGA) based on national growth references and WHO growth standards/references were compared for children aged < 5 years and children aged >= 5 years. In seven of the countries evaluated, significantly fewer children aged >= 5 years with GHD (22%; P<0.0001), TS (21%; P<0.0001) or born SGA (32%; P<0.0001) had height below clinical cut-off values using WHO growth references vs. national references. Likewise, among children aged < 5 years in the pooled analysis of the same seven countries, a significantly lower proportion of children with GHD (8%; P<0.0001), TS (12%; P = 0.0003) or born SGA (12%; P<0.0001) had height below clinical cut-off values using WHO growth standards vs. national references. In conclusion, in NordiNet (R) IOS the number of patients misclassified using WHO growth standards/references was significantly higher than with national references. This study highlights that, although no growth reference has 100% sensitivity for identifying growth disorders, the most recent national or regional growth charts may offer the most appropriate tool for monitoring childhood growth in Europe.	[Christesen, Henrik Thybo] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, DK-5000 Odense, Denmark; [Pedersen, Birgitte Tonnes] Novo Nordisk AS, Epidemiol, Soborg, Denmark; [Pournara, Effie] Novo Nordisk Hlth Care AG, Zurich, Switzerland; [Petit, Isabelle Oliver] Hop Enfants, Dept Paediat Endocrinol, Toulouse, France; [Juliusson, Petur Benedikt] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Juliusson, Petur Benedikt] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway	University of Southern Denmark; Odense University Hospital; Novo Nordisk; Novo Nordisk; CHU de Toulouse; University of Bergen; University of Bergen; Haukeland University Hospital	Christesen, HT (corresponding author), Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, DK-5000 Odense, Denmark.	henrik.christesen@rsyd.dk	Christesen, Henrik/AAR-9023-2021	Christesen, Henrik/0000-0001-5330-6853	Novo Nordisk Healthcare AG, Zurich, Switzerland	Novo Nordisk Healthcare AG, Zurich, Switzerland	NordiNet (R) IOS is funded by Novo Nordisk Healthcare AG, Zurich, Switzerland. Novo Nordisk is responsible for conducting the study and performing the data analysis. The decision to publish, results' interpretation and manuscript development is the outcome of Novo Nordisk collaboration with the members of the International Study Committee (ISC) who are co-authoring this manuscript. The NordiNet (R) IOS ISC acts as the custodian of the database and provides governance with respect to the data analyses and the publication plan of the study. Writing and editorial assistance from Watermeadow Medical was funded by Novo Nordisk Healthcare AG, Zurich, Switzerland.	Bonthuis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042506; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; deOnis M, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.5.e8; Foote JM, 2014, J PEDIATR HEALTH CAR, V28, P413, DOI 10.1016/j.pedhc.2014.01.001; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Gokcay G, 2008, CHILD CARE HLTH DEV, V34, P454, DOI 10.1111/j.1365-2214.2008.00813.x; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Haas JD, 2006, FOOD NUTR BULL, V27, pS212, DOI 10.1177/15648265060274S505; Hall DMB, 2000, ARCH DIS CHILD, V82, P10, DOI 10.1136/adc.82.1.10; Haymond M, 2013, ACTA PAEDIATR, V102, P787, DOI 10.1111/apa.12266; Hof MHP, 2011, ANN HUM BIOL, V38, P544, DOI 10.3109/03014460.2011.576701; Hoybye Charlotte, 2013, Clin Epidemiol, V5, P119, DOI 10.2147/CLEP.S42602; Hughes I, 2014, J PAEDIATR CHILD H, V50, P895, DOI 10.1111/jpc.12672; Hughes IP, 2012, CLIN ENDOCRINOL, V77, P62, DOI 10.1111/j.1365-2265.2011.04230.x; Hughes IP, 2010, CLIN ENDOCRINOL, V73, P760, DOI 10.1111/j.1365-2265.2010.03874.x; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-166; Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; Saari A, 2013, JAMA PEDIATR, V167, P194, DOI 10.1001/jamapediatrics.2013.436; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; Scherdel P, 2014, ARCH PEDIAT S1, V21, P50; Scherdel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120806; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Sempe M., 1979, AUXOLOGIE METHODE SE; Staub K, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13238; Thomas M, 2004, EUR J ENDOCRINOL, V151, P67, DOI 10.1530/eje.0.1510067; Tinggaard J, 2014, ACTA PAEDIATR, V103, P214, DOI 10.1111/apa.12468; van Buuren S, 2008, ARCH DIS CHILD, V93, P549, DOI 10.1136/adc.2007.136010; WHO, 2006, WHO CHILD GROWTH STA; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; Willows ND, 2011, AM J HUM BIOL, V23, P126, DOI 10.1002/ajhb.21115	38	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157277	10.1371/journal.pone.0157277	http://dx.doi.org/10.1371/journal.pone.0157277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280591	gold, Green Submitted, Green Published			2022-12-27	WOS:000377563000116
J	Colombatti, R; Lucchetta, M; Montanaro, M; Rampazzo, P; Ermani, M; Talenti, G; Baracchini, C; Favaro, A; Basso, G; Manara, R; Sainati, L				Colombatti, Raffaella; Lucchetta, Marta; Montanaro, Maria; Rampazzo, Patrizia; Ermani, Mario; Talenti, Giacomo; Baracchini, Claudio; Favaro, Angela; Basso, Giuseppe; Manara, Renzo; Sainati, Laura			Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study	PLOS ONE			English	Article							SILENT CEREBRAL INFARCTS; INTELLECTUAL FUNCTION; RISK-FACTORS; ANEMIA; BRAIN; CONNECTIVITY; SCHIZOPHRENIA; HEMOGLOBIN; STROKE; CORTEX	Cerebrovascular complications are frequent events in children with sickle cell disease, yet routinely used techniques such as Transcranial Doppler (TCD), Magnetic Resonance (MRI) and Angiography (MRA), insufficiently explain the cause of poor cognitive performances. Forty children with SS-S beta degrees (mean age 8 years) underwent neurocognitive evaluation and comprehensive brain imaging assessment with TCD, MRI, MRA, Resting State (RS) Functional MRI with evaluation of the Default Mode Network (DMN). Sixteen healthy age-matched controls underwent MRI, MRA and RS functional MRI. Children with SCD display increased brain connectivity in the DMN even in the absence of alterations in standard imaging techniques. Patients with low neurocognitive scores presented higher brain connectivity compared to children without cognitive impairment or controls, suggesting an initial compensatory mechanism to maintain performances. In our cohort steady state haemoglobin level was not related to increased brain connectivity, but SatO2<97% was. Our findings provide novel evidence that SCD is characterized by a selective disruption of connectivity among relevant regions of the brain, potentially leading to reduced cognition and altered functional brain dynamics. RS functional MRI could be used as a useful tool to evaluate cognition and cerebral damage in SCD in longitudinal trials.	[Colombatti, Raffaella; Montanaro, Maria; Basso, Giuseppe; Sainati, Laura] Azienda Osped Univ Padova, Dept Maternal & Child Hlth, Clin Pediat Hematol Oncol, Padua, Italy; [Lucchetta, Marta; Rampazzo, Patrizia; Ermani, Mario; Talenti, Giacomo; Baracchini, Claudio; Favaro, Angela] Azienda Osped Univ Padova, Dept Neurosci, Padua, Italy; [Manara, Renzo] Univ Salerno, Neuroradiol Unit, Dept Neurosci, I-84100 Salerno, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Salerno	Colombatti, R (corresponding author), Azienda Osped Univ Padova, Dept Maternal & Child Hlth, Clin Pediat Hematol Oncol, Padua, Italy.	rcolombatti@gmail.com	Colombatti, Raffaella/D-2910-2017	Colombatti, Raffaella/0000-0001-9797-0457; BASSO, GIUSEPPE/0000-0002-2634-9302	Fondazione Citta della Speranza [07/04, 11/04, 14/02]	Fondazione Citta della Speranza	The research was performed with funding from Fondazione Citta della Speranza Grants 07/04, 11/04, 14/02. www.cittadellasperanza.org.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Bernaudin F, 2000, J CHILD NEUROL, V15, P333, DOI 10.1177/088307380001500510; Bernaudin F, 2015, BLOOD, V125, P1653, DOI 10.1182/blood-2014-09-599852; Bernaudin F, 2011, BLOOD, V117, P1130, DOI 10.1182/blood-2010-06-293514; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bohlken MM, 2016, JAMA PSYCHIAT, V73, P11, DOI 10.1001/jamapsychiatry.2015.1925; Brousse V, 2015, BRIT J HAEMATOL, V170, P615, DOI 10.1111/bjh.13477; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Colombatti R, 2015, BRIT J HAEMATOL, V169, P597, DOI 10.1111/bjh.13232; Colombatti R, 2012, PEDIATR BLOOD CANCER, V59, P1275, DOI 10.1002/pbc.24110; CONNES P, 2000, BRIT J HAEMATOL, V161, P484; Darbari DS, 2015, J PAIN, V16, P1077, DOI 10.1016/j.jpain.2015.07.005; Debaun M.R., 2016, BLOOD; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Droby A, 2015, BRAIN IMAGING BEHAV; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldin PR, 2013, JAMA PSYCHIAT, V70, P1048, DOI 10.1001/jamapsychiatry.2013.234; Gorges M, 2015, NEUROBIOL AGING, V36, P1727, DOI 10.1016/j.neurobiolaging.2014.12.026; Hijmans CT, 2011, PEDIATR BLOOD CANCER, V57, P297, DOI 10.1002/pbc.22892; Hogan AM, 2006, DEVELOPMENTAL SCI, V9, P379, DOI 10.1111/j.1467-7687.2006.00503.x; Hollocks MJ, 2012, J INT NEUROPSYCH SOC, V18, P168, DOI 10.1017/S1355617711001469; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; Kawadler JM, 2015, STROKE, V46, P1793, DOI 10.1161/STROKEAHA.115.008721; Kawadler JM, 2013, BRIT J HAEMATOL, V163, P373, DOI 10.1111/bjh.12496; Kim DS, 2014, J LIPID RES, V55, P1173, DOI 10.1194/jlr.P049247; King AA, 2014, AM J HEMATOL, V89, pE188, DOI 10.1002/ajh.23805; King AA, 2014, AM J HEMATOL, V89, P162, DOI 10.1002/ajh.23604; Kirk GR, 2009, CEREB CORTEX, V19, P1549, DOI 10.1093/cercor/bhn193; Kloppel S, 2015, EBIOMEDICINE, V2, P1420, DOI 10.1016/j.ebiom.2015.08.002; Kwiatkowski JL, 2009, BRIT J HAEMATOL, V146, P300, DOI 10.1111/j.1365-2141.2009.07753.x; Lanzkron S, 2015, HEMATOL-AM SOC HEMAT, P420, DOI 10.1182/asheducation-2015.1.420; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Marshall MJ, 2009, HAEMATOL-HEMATOL J, V94, P1006, DOI 10.3324/haematol.2008.005215; Montanaro M, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-36; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Ohene-Frempong K, 1998, BLOOD, V91, P288; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Orsini A, 1996, WPPSI R CONTRIBUTO T; Orsini A., 2006, WISC 3 CONTRIBUTO TA; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Schatz J, 2002, J CHILD NEUROL, V17, P891, DOI 10.1177/08830738020170122401; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Steen RG, 2003, AM J NEURORADIOL, V24, P382; van der Land V, 2015, CEREBROVASC DIS, V39, P181, DOI 10.1159/000373917; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	50	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157090	10.1371/journal.pone.0157090	http://dx.doi.org/10.1371/journal.pone.0157090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281287	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000081
J	Hayat, T; Hussain, Z; Alsaedi, A; Farooq, M				Hayat, T.; Hussain, Zakir; Alsaedi, A.; Farooq, M.			Magnetohydrodynamic Flow by a Stretching Cylinder with Newtonian Heating and Homogeneous-Heterogeneous Reactions	PLOS ONE			English	Article							STAGNATION POINT FLOW; BOUNDARY-LAYER-FLOW; EYRING-POWELL FLUID; MELTING HEAT; NANOFLUID; MHD; SURFACE; MODEL	This article examines the effects of homogeneous-heterogeneous reactions and Newtonian heating in magnetohydrodynamic (MHD) flow of Powell-Eyring fluid by a stretching cylinder. The nonlinear partial differential equations of momentum, energy and concentration are reduced to the nonlinear ordinary differential equations. Convergent solutions of momentum, energy and reaction equations are developed by using homotopy analysis method (HAM). This method is very efficient for development of series solutions of highly nonlinear differential equations. It does not depend on any small or large parameter like the other methods i. e., perturbation method, delta-perturbation expansion method etc. We get more accurate result as we increase the order of approximations. Effects of different parameters on the velocity, temperature and concentration distributions are sketched and discussed. Comparison of present study with the previous published work is also made in the limiting sense. Numerical values of skin friction coefficient and Nusselt number are also computed and analyzed. It is noticed that the flow accelerates for large values of Powell-Eyring fluid parameter. Further temperature profile decreases and concentration profile increases when Powell-Eyring fluid parameter enhances. Concentration distribution is decreasing function of homogeneous reaction parameter while opposite influence of heterogeneous reaction parameter appears.	[Hayat, T.; Hussain, Zakir] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, POB 80257, Jeddah 21589, Saudi Arabia; [Farooq, M.] Riphah Int Univ, Dept Math, Islamabad 44000, Pakistan	Quaid I Azam University; King Abdulaziz University	Hussain, Z (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	zakir.qamar@yahoo.com	Alsaedi, Ahmed/A-2094-2013; Farooq, Muhammad/AAX-3841-2020; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; Farooq, Muhammad/0000-0002-5481-6393; 				Ara A, 2014, AIN SHAMS ENG J, V5, P1337, DOI 10.1016/j.asej.2014.06.002; Ellahi R, 2015, COMMUN THEOR PHYS, V63, P353, DOI 10.1088/0253-6102/63/3/353; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2012, INT J NUMER METHOD H, V22, P24, DOI 10.1108/09615531211188775; Fang TG, 2009, COMMUN NONLINEAR SCI, V14, P3731, DOI 10.1016/j.cnsns.2009.02.012; Farooq M, 2015, APPL MATH MECH-ENGL, V36, P1319, DOI 10.1007/s10483-015-1981-9; Fathizadeh M., 2013, J KING SAUD UNIV SCI, V25, P107, DOI [10.1016/j.jksus.2011.08.003, DOI 10.1016/j.jksus.2011.08.003]; Hayat T, 2016, J MOL LIQ, V220, P49, DOI 10.1016/j.molliq.2016.04.032; Hayat T, 2016, J MOL LIQ, V220, P200, DOI 10.1016/j.molliq.2016.04.012; Hayat T, 2016, J MOL LIQ, V215, P749, DOI 10.1016/j.molliq.2015.12.109; Hayat T, 2015, J MAGN MAGN MATER, V385, P222, DOI 10.1016/j.jmmm.2015.02.046; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4908602; Hayat T, 2015, APPL MATH MECH-ENGL, V36, P61, DOI 10.1007/s10483-015-1895-9; Hayat T, 2014, INT J NONLIN SCI NUM, V15, P77, DOI 10.1515/ijnsns-2013-0069; Hayat T, 2013, J THERMOPHYS HEAT TR, V27, P761, DOI 10.2514/1.T4059; Hayat T, 2012, INT J HEAT MASS TRAN, V55, P1817, DOI 10.1016/j.ijheatmasstransfer.2011.10.046; Hayat T., 2013, J EGYPTIAN MATH SOC, V21, P379, DOI [10.1016/j.joems.2013.02.009, DOI 10.1016/J.JOEMS.2013.02.009]; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148662; Javed T, 2013, CHEM ENG COMMUN, V200, P327, DOI 10.1080/00986445.2012.703151; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Kumar JP, 2012, J APPL FLUID MECH, V5, P13; Liao S., 2012, HOMOTOPY ANAL METHOD; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Rashidi S, 2015, J MAGN MAGN MATER, V378, P128, DOI 10.1016/j.jmmm.2014.11.020; Salleh MZ, 2012, MECCANICA, V47, P1261, DOI 10.1007/s11012-011-9510-5; Salleh MZ, 2010, ACTA APPL MATH, V112, P263, DOI 10.1007/s10440-010-9567-5; Shaw S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-77; Waqas M, 2016, J MOL LIQ, V220, P642, DOI 10.1016/j.molliq.2016.04.086; Zeeshan A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14261-5; Zeeshan A, 2013, APPL MATH INFORM SCI, V7, P257, DOI 10.12785/amis/070132	31	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156955	10.1371/journal.pone.0156955	http://dx.doi.org/10.1371/journal.pone.0156955			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280883	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000059
J	Jiang, WD; Qu, B; Feng, L; Jiang, J; Kuang, SY; Wu, P; Tang, L; Tang, WN; Zhang, YA; Zhou, XQ; Liu, Y				Jiang, Wei-Dan; Qu, Biao; Feng, Lin; Jiang, Jun; Kuang, Sheng-Yao; Wu, Pei; Tang, Ling; Tang, Wu-Neng; Zhang, Yong-An; Zhou, Xiao-Qiu; Liu, Yang			Histidine Prevents Cu-Induced Oxidative Stress and the Associated Decreases in mRNA from Encoding Tight Junction Proteins in the Intestine of Grass Carp (Ctenopharyngodon idella)	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ANTIOXIDANT GENE-EXPRESSION; TROUT ONCORHYNCHUS-MYKISS; DIETARY COPPER EXPOSURE; MUCOSAL IMMUNE-SYSTEM; SALMON SALMO-SALAR; FRESH-WATER FISH; RAINBOW-TROUT; OREOCHROMIS-NILOTICUS; ENZYME-ACTIVITIES	Copper (Cu) is a common heavy metal pollutant in aquatic environments that originates from natural as well as anthropogenic sources. The present study investigated whether Cu causes oxidative damage and induces changes in the expression of genes that encode tight junction (TJ) proteins, cytokines and antioxidant-related genes in the intestine of the grass carp (Ctenopharyngodon idella). We demonstrated that Cu decreases the survival rate of fish and increases oxidative damage as measured by increases in malondialdehyde and protein carbonyl contents. Cu exposure significantly decreased the expression of genes that encode the tight junction proteins, namely, claudin (CLDN)-c, -3 and -15 as well as occludin and zonula occludens-1, in the intestine of fish. In addition, Cu exposure increases the mRNA levels of the pro-inflammatory cytokines, specifically, IL-8, TNF-alpha and its related signalling factor (nuclear factor kappa B, NF-kappa B), which was partly correlated to the decreased mRNA levels of NF-kappa B inhibitor protein (I kappa B). These changes were associated with Cu-induced oxidative stress detected by corresponding decreases in glutathione (GSH) content, as well as decreases in the copper, zinc-superoxide dismutase (SOD1) and glutathione peroxidase (GPx) activities and mRNA levels, which were associated with the down-regulated antioxidant signalling factor NF-E2-related factor-2 (Nrf2) mRNA levels, and the Kelch-like-ECH-associated protein1 (Keap1) mRNA levels in the intestine of fish. Histidine supplementation in diets (3.7 up to 12.2 g/kg) blocked Cu-induced changes. These results indicated that Cu-induced decreases in intestinal TJ proteins and cytokine mRNA levels might be partially mediated by oxidative stress and are prevented by histidine supplementation in fish diet.	[Jiang, Wei-Dan; Qu, Biao; Feng, Lin; Jiang, Jun; Wu, Pei; Zhou, Xiao-Qiu; Liu, Yang] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China; [Jiang, Wei-Dan; Feng, Lin; Wu, Pei; Zhou, Xiao-Qiu; Liu, Yang] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China; [Jiang, Wei-Dan; Feng, Lin; Wu, Pei; Zhou, Xiao-Qiu; Liu, Yang] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu 611130, Sichuan, Peoples R China; [Kuang, Sheng-Yao; Tang, Ling; Tang, Wu-Neng] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu 610066, Peoples R China; [Zhang, Yong-An] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhou, XQ; Liu, Y (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Sichuan, Peoples R China.; Zhou, XQ; Liu, Y (corresponding author), Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China.; Zhou, XQ; Liu, Y (corresponding author), Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Chengdu 611130, Sichuan, Peoples R China.	xqzhouqq@tom.com; kyckgk@hotmail.com	jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022; liu, yang/HHY-8583-2022		National Basic Research Program of China (973 Program) [2014CB138600]; Science and Technology Support Program of Sichuan Province of China [2014NZ0003]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007, 2013NC0045]; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2015CC0011]; Natural Science Foundation for Young Scientists of Sichuan Province [2014JQ0007]; Sichuan Province Research Foundation for Basic Research [2013JY0082]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Support Program of Sichuan Province of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Natural Science Foundation for Young Scientists of Sichuan Province; Sichuan Province Research Foundation for Basic Research	This research was financially supported by the National Basic Research Program of China (973 Program) (2014CB138600), Science and Technology Support Program of Sichuan Province of China (2014NZ0003), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007, 2013NC0045), the Demonstration of Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2015CC0011), Natural Science Foundation for Young Scientists of Sichuan Province (2014JQ0007), and Sichuan Province Research Foundation for Basic Research (2013JY0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2005, AQUACULT NUTR, V11, P359, DOI 10.1111/j.1365-2095.2005.00358.x; Al-Bairuty GA, 2013, AQUAT TOXICOL, V126, P104, DOI 10.1016/j.aquatox.2012.10.005; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; Bakke S, 2010, COMP BIOCHEM PHYS B, V156, P48, DOI 10.1016/j.cbpb.2010.02.002; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bopp SK, 2008, AQUAT TOXICOL, V86, P197, DOI 10.1016/j.aquatox.2007.10.014; Castro-Gonzalez MI, 2008, ENVIRON TOXICOL PHAR, V26, P263, DOI 10.1016/j.etap.2008.06.001; Cereijido M, 2004, PHYSIOL REV, V84, P1229, DOI 10.1152/physrev.00001.2004; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; Cifarelli V, 2008, ATHEROSCLEROSIS, V201, P248, DOI 10.1016/j.atherosclerosis.2007.12.060; Corridoni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042067; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Dreger H, 2009, CARDIOVASC RES, P107; Fatima RA, 2005, SCI TOTAL ENVIRON, V346, P256, DOI 10.1016/j.scitotenv.2004.12.004; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Garcia-Hernandez V, 2015, J CELL PHYSIOL, V230, P105, DOI 10.1002/jcp.24687; Glover CN, 2008, J MEMBRANE BIOL, V221, P87, DOI 10.1007/s00232-007-9088-y; Glover CN, 2008, J COMP PHYSIOL B, V178, P101, DOI 10.1007/s00360-007-0203-2; Gonzalez-Mariscal L, 1999, EXP CELL RES, V248, P97, DOI 10.1006/excr.1999.4392; Grosell M, 2004, AQUAT TOXICOL, V68, P249, DOI 10.1016/j.aquatox.2004.03.006; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hoyle I, 2007, AQUAT TOXICOL, V83, P62, DOI 10.1016/j.aquatox.2007.03.014; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jacquillet G, 2006, AM J PHYSIOL-RENAL, V290, pF127, DOI 10.1152/ajprenal.00366.2004; Jiang WD, 2014, AQUAT TOXICOL, V155, P301, DOI 10.1016/j.aquatox.2014.07.003; Jiang WD, 2013, AQUAT TOXICOL, V132, P100, DOI 10.1016/j.aquatox.2013.02.005; Jiang WD, 2011, AQUAT TOXICOL, V105, P543, DOI 10.1016/j.aquatox.2011.08.012; Jing G, 2006, COMP BIOCHEM PHYS C, V144, P184, DOI 10.1016/j.cbpc.2006.08.005; KADIISKA MB, 1993, MOL PHARMACOL, V44, P222; Kamunde C, 2002, AM J PHYSIOL-REG I, V283, pR69, DOI 10.1152/ajpregu.00016.2002; Khan MA, 2004, AQUAC RES, V35, P1277, DOI 10.1111/j.1365-2109.2004.01150.x; Larsson T, 2014, AQUACULTURE, V426, P288, DOI 10.1016/j.aquaculture.2014.01.034; Lee MH, 2002, FISH SHELLFISH IMMUN, V13, P259, DOI 10.1006/fsim.2001.0401; Li HT, 2013, AQUAT TOXICOL, V126, P169, DOI 10.1016/j.aquatox.2012.11.005; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Lin YH, 2008, AQUACULTURE, V284, P207, DOI 10.1016/j.aquaculture.2008.07.049; Liu DS, 2013, FOOD CHEM, V140, P105, DOI 10.1016/j.foodchem.2013.02.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVINGSTONE DR, 1990, FUNCT ECOL, V4, P415, DOI 10.2307/2389604; LLAMES CR, 1994, J AOAC INT, V77, P1362; Lu Z, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24978; Luo JB, 2014, FISH SHELLFISH IMMUN, V40, P197, DOI 10.1016/j.fsi.2014.07.003; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; McCarthy MP, 2013, AQUAT TOXICOL, V138, P123, DOI 10.1016/j.aquatox.2013.04.015; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Nadella SR, 2006, J COMP PHYSIOL B, V176, P793, DOI 10.1007/s00360-006-0101-z; Niklasson L, 2011, FISH SHELLFISH IMMUN, V31, P1072, DOI 10.1016/j.fsi.2011.09.011; Ning L, 2010, EUR J PHARM SCI, V40, P1, DOI 10.1016/j.ejps.2010.02.001; OECD, 1994, OECD GUIDELINES TEST; Oner M, 2008, ENVIRON TOXICOL CHEM, V27, P360, DOI 10.1897/07-281R.1; Pandey S, 2008, CHEM-BIOL INTERACT, V174, P183, DOI 10.1016/j.cbi.2008.05.014; Piche T, 2009, GUT, V58, P196, DOI 10.1136/gut.2007.140806; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rau MA, 2004, COMP BIOCHEM PHYS C, V137, P335, DOI 10.1016/j.cca.2004.03.001; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Rincon-Heredia R, 2014, EXP CELL RES, V320, P108, DOI 10.1016/j.yexcr.2013.10.008; ROBBINS KR, 1979, J NUTR, V109, P1710, DOI 10.1093/jn/109.10.1710; Sampaio FG, 2008, COMP BIOCHEM PHYS C, V147, P43, DOI 10.1016/j.cbpc.2007.07.009; Sandrini JZ, 2009, AQUAT TOXICOL, V95, P285, DOI 10.1016/j.aquatox.2009.02.016; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Sevgili H, 2012, AQUACULTURE, V344, P126, DOI 10.1016/j.aquaculture.2012.03.030; Shaw BJ, 2006, AQUAT TOXICOL, V76, P111, DOI 10.1016/j.aquatox.2005.10.002; Shiau SY, 2003, ANIM SCI, V77, P287, DOI 10.1017/S1357729800059026; Shiau SY, 2002, AQUACULTURE, V210, P335, DOI 10.1016/S0044-8486(01)00853-5; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Subudhi U, 2012, MOL BIOL REP, V39, P9849, DOI 10.1007/s11033-012-1851-1; Syakuri H, 2013, FISH SHELLFISH IMMUN, V34, P305, DOI 10.1016/j.fsi.2012.11.010; Tan BP, 2001, AQUACULTURE, V192, P67, DOI 10.1016/S0044-8486(00)00435-X; Tang QQ, 2013, BIOL TRACE ELEM RES, V155, P370, DOI 10.1007/s12011-013-9785-6; Tantikitti C, 2001, AQUAC RES, V32, P135, DOI 10.1046/j.1355-557x.2001.00011.x; Wachtel M, 2001, J NEUROCHEM, V78, P155, DOI 10.1046/j.1471-4159.2001.00399.x; Wade AM, 1998, J NUTR BIOCHEM, V9, P308, DOI 10.1016/S0955-2863(98)00022-9; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wu CL, 2010, COMP BIOCHEM PHYS C, V152, P121, DOI 10.1016/j.cbpc.2010.03.007; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; Ye P, 2012, AUST DENT J, V57, P11, DOI 10.1111/j.1834-7819.2011.01651.x; Yruela Inmaculada, 2005, Braz. J. Plant Physiol., V17, P145, DOI 10.1590/S1677-04202005000100012; Yu HC, 2013, INT J BIOL SCI, V9, P966, DOI 10.7150/ijbs.6996; Zhao J, 2012, AQUACULTURE, V368, P117, DOI 10.1016/j.aquaculture.2012.09.019; Zhen-Yu D, 2006, CTENOPHARYNGODON IDE, P247	85	57	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157001	10.1371/journal.pone.0157001	http://dx.doi.org/10.1371/journal.pone.0157001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280406	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000064
J	Jouffroy-Bapicot, I; Vanniere, B; Iglesias, V; Debret, M; Delarras, JF				Jouffroy-Bapicot, Isabelle; Vanniere, Boris; Iglesias, Virginia; Debret, Maxime; Delarras, Jean-Francois			2000 Years of Grazing History and the Making of the Cretan Mountain Landscape, Greece	PLOS ONE			English	Article							EASTERN MEDITERRANEAN REGION; CLIMATE-CHANGE; FIRE HISTORY; PALYNOLOGICAL RICHNESS; CENTRAL TURKEY; POLLEN DATA; HOLOCENE; VEGETATION; SEDIMENTS; LAKE	Understanding the processes that led to the recent evolution of Mediterranean landscapes is a challenging question that can be addressed with paleoecological data. Located in the White Mountains of Crete, Asi Gonia peat bog constitutes an exceptional 2000-years-long sedimentary archive of environmental change. In this study, we document the making of the White Mountains landscape and assess human impact on ecosystem trajectories. The paleoenvironmental reconstruction is based on high-resolution analyses of sediment, pollen, dung fungal spores and charcoal obtained from a 6-m core collected from the bog. Multiproxy analyses and a robust chronological control have shed light on anthropogenic and natural processes that have driven ecological changes, giving rise to the present-day Mediterranean ecosystem. Our results suggest that sediment accumulation began during the transition from the Hellenistic to the Roman period, likely due to watershed management. The evolution of the peat bog as well as vegetation dynamics in the surrounding area were linked to past climate changes but were driven by human activities, among which breeding was of great importance. Charcoal analysis reveals that fire was largely used for the construction and maintenance of sylvo-agropastoral areas. Pollen data allow the identification of three main vegetation assemblages: 1) evergreen oak forest (before ca. 850 AD), 2) heather maquis (ca. 850 to 1870 AD), 3) phrygana/steppe landscape. Rapid changes between phases in vegetation development are associated with tipping-points in ecosystem dynamics resulting from anthropogenic impact. The modern ecosystem did not get established until the 20th century, and it is characterized by biodiversity loss along with a dramatic drying of the peat bog.	[Jouffroy-Bapicot, Isabelle; Vanniere, Boris; Iglesias, Virginia; Delarras, Jean-Francois] Univ Bourgogne Franche Comte, Lab Chronoenvironm, UMR 6249, CNRS, F-25000 Besancon, France; [Jouffroy-Bapicot, Isabelle; Vanniere, Boris; Iglesias, Virginia] Univ Bourgogne Franche Comte, Maison Sci Homme & Environm, USR 3124, CNRS, F-25000 Besancon, France; [Debret, Maxime] Univ Rouen, Morphodynam Continentale & Cotiere, UMR 6143, CNRS, F-76821 Mont St Aignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rouen Normandie	Jouffroy-Bapicot, I (corresponding author), Univ Bourgogne Franche Comte, Lab Chronoenvironm, UMR 6249, CNRS, F-25000 Besancon, France.; Jouffroy-Bapicot, I (corresponding author), Univ Bourgogne Franche Comte, Maison Sci Homme & Environm, USR 3124, CNRS, F-25000 Besancon, France.	isabelle.jouffroy@univ-fcomte.fr	Vannière, Boris C/E-4002-2010; Debret, Maxime/L-4236-2017	Vannière, Boris C/0000-0002-6779-6053; Debret, Maxime/0000-0002-8852-0152; Jouffroy-Bapicot, Isabelle/0000-0001-5920-7565; Iglesias, Virginia/0000-0001-5732-3714	PALEOMEX/ARCHEOMED-MISTRALS project (CNRS, France)	PALEOMEX/ARCHEOMED-MISTRALS project (CNRS, France)	The research leading to these results was funded by the PALEOMEX/ARCHEOMED-MISTRALS project (CNRS, France) and conducted in the framework of the Pole 2 "Environnement: ressources et paysages" of the MSHE Ledoux, through the laboratory facilities of the UMR Chrono-environnement (Besancon, France). The Greek Institute of Geology and Mineral Exploration (I.G.M.E.) authorized fieldwork and core analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez-Saez JA, 2014, QUATERN INT, V353, P98, DOI 10.1016/j.quaint.2013.06.034; Atherden MA, 1999, HOLOCENE, V9, P183, DOI 10.1191/095968399673523574; Atherden MA, 2000, LANDSCAPE LAND USE P; Baker AG, 2013, QUATERNARY SCI REV, V62, P21, DOI 10.1016/j.quascirev.2012.11.018; Bakker J, 2013, CLIM PAST, V9, P57, DOI 10.5194/cp-9-57-2013; Balsam W.L, 1997, OCEAN DRILLING PRO S, V155s, P193, DOI DOI 10.2973/0DP.PR0C.SR.155.210.1997; Beug H.J, 2004, LEITFADEN POLLENBEST; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Blondel J, 2010, MEDITERRANEAN REGION; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Bottema S, 2003, HOLOCENE, V13, P733, DOI 10.1191/0959683603hl659rp; Carrion Y, 2010, HOLOCENE, V20, P53, DOI 10.1177/0959683609348849; Chaniotis A., 1999, MINOAN FARMERS ROMAN, P181; Charman D.J., 2002, J CHEM ENG; Chester PI, 2012, GRANA, V46, P299; CLARK J.S., 1997, SEDIMENT RECORDS BIO, P23, DOI DOI 10.1007/978-3-642-59171-6_3; Clark JS, 1996, ECOLOGY, V77, P2148, DOI 10.2307/2265709; Clark RL, 1988, HOLOCENE, V8, P113; CRUISE GM, 1990, REV PALAEOBOT PALYNO, V63, P173, DOI 10.1016/0034-6667(90)90097-3; Cugny C, 2010, VEG HIST ARCHAEOBOT, V19, P391, DOI 10.1007/s00334-010-0242-6; Dean JR, 2015, QUATERNARY SCI REV, V124, P162, DOI 10.1016/j.quascirev.2015.07.023; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dearing JA, 2015, ANTHROPOCENE REV; Debret M, 2011, EARTH-SCI REV, V109, P1, DOI 10.1016/j.earscirev.2011.07.002; Eastwood WJ, 2007, J QUATERNARY SCI, V22, P327, DOI 10.1002/jqs.1062; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Enache MD, 2007, J PALEOLIMNOL, V38, P347, DOI 10.1007/s10933-006-9084-8; England A, 2008, HOLOCENE, V18, P1229, DOI 10.1177/0959683608096598; Etienne D, 2014, VEG HIST ARCHAEOBOT, V23, P743, DOI 10.1007/s00334-014-0439-1; Fielding J., 2005, FLOWERS OF CRETE; Finne M, 2011, J ARCHAEOL SCI, V38, P3153, DOI 10.1016/j.jas.2011.05.007; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Giesecke T, 2014, VEG HIST ARCHAEOBOT, V23, P217, DOI 10.1007/s00334-014-0435-5; Grimm E.C., 1991, TILIA TILIA GRAPH; Harris VV.V., 1999, MINOAN FARMERS ROMAN, P353; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; ISPIKOUDIS I, 1993, LANDSCAPE URBAN PLAN, V24, P259, DOI 10.1016/0169-2046(93)90105-M; Iversen J, 1989, J BIOGEOGR; Kaniewski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102090; Kouli K, 2012, VEG HIST ARCHAEOBOT, V21, P267, DOI 10.1007/s00334-011-0336-9; Kouli K, 2009, GEOBIOS-LYON, V42, P43, DOI 10.1016/j.geobios.2008.07.004; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Macklin MG, 2010, GLOBAL PLANET CHANGE, V70, P35, DOI 10.1016/j.gloplacha.2009.11.006; Magny M, 2013, HOLOCENE CHANGES ENV; Marlon J, 2006, HOLOCENE, V16, P1059, DOI 10.1177/0959683606069396; Mercuri AM, 2013, QUATERN INT, V303, P24, DOI 10.1016/j.quaint.2013.01.005; Mix A. C., 1992, P ODP INIT REP, V138, P67, DOI DOI 10.2973/0DP.PR0C.IR.138.104.1992; Nixon L., 2009, MEDIEVAL POSTMEDIEVA, P395; Odgaard B, 2001, DIVERSITY DISTRIBUTI, V7, P197; Rackham O., 1996, MAKING CRETAN LANDSC; Reille M., 1992, POLLEN SPORES EUROPE; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rhodes AN, 1998, HOLOCENE, V8, P113, DOI 10.1191/095968398671104653; Roberts N, 2001, HOLOCENE, V11, P721, DOI 10.1191/09596830195744; ROBERTS N, 1990, MANS ROLE IN THE SHAPING OF THE EASTERN MEDITERRANEAN LANDSCAPE, P53; Roberts N, 2012, GLOBAL PLANET CHANGE, V84-85, P23, DOI 10.1016/j.gloplacha.2011.11.002; RULL V, 1987, Pollen et Spores, V29, P471; Sadori L, 2016, QUATERNARY SCI REV, V136, P173, DOI 10.1016/j.quascirev.2015.09.020; Stallsmith AB, 2007, VENICE ISTANBUL COLO, P151; Stockmarr J, 1971, POLLEN SPORES, V13, P614; Van Geel B., 2001, TRACKING ENV CHANGE, V3, P99, DOI DOI 10.1007/0-306-47668-1_6; VANGEEL B, 1983, REV PALAEOBOT PALYNO, V38, P269, DOI 10.1016/0034-6667(83)90026-X; VANGEEL B, 1989, REV PALAEOBOT PALYNO, V60, P25, DOI 10.1016/0034-6667(89)90072-9; VANGEEL B, 1981, REV PALAEOBOT PALYNO, V31, P367; Vanniere B, 2008, QUATERNARY SCI REV, V27, P1181, DOI 10.1016/j.quascirev.2008.02.011; Vanniere B, 2016, QUATERNARY SCI REV, V132, P206, DOI 10.1016/j.quascirev.2015.11.012; Vanniere B, 2011, HOLOCENE, V21, P53, DOI 10.1177/0959683610384164; Walsh K., 2014, HUMAN ENV INTERACTIO; Weng CY, 2006, DIVERS DISTRIB, V12, P310, DOI 10.1111/j.1366-9516.2006.00230.x; Whitlock C, 1996, HOLOCENE, V6, P7, DOI 10.1177/095968369600600102; Whitlock C, 2001, TRACKING ENV CHANGE, P75, DOI DOI 10.1007/0-306-47668-1_5; Wolfe AP, 2006, J PALEOLIMNOL, V36, P91, DOI 10.1007/s10933-006-0006-6; Zanchetta G, 2013, QUATERN INT, V303, P1, DOI 10.1016/j.quaint.2013.05.009	75	22	22	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156875	10.1371/journal.pone.0156875	http://dx.doi.org/10.1371/journal.pone.0156875			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280287	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000053
J	Koduvayur, SP; Su, Y; Kay, BK; Lavie, A				Koduvayur, Sujatha P.; Su, Ying; Kay, Brian K.; Lavie, Arnon			Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine	PLOS ONE			English	Article							CANCER-THERAPY; PICOMOLAR AFFINITY; AFFIBODY MOLECULES; TRASTUZUMAB; ANTICANCER; MECHANISM; PROTEINS; 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE; PHARMACOKINETICS; PHOSPHORYLATION	Cytotoxic drugs, such as nucleoside analogs and toxins, commonly suffer from off-target effects. One approach to mitigate this problem is to deliver the cytotoxic drug selectively to the intended site. While for toxins this can be achieved by conjugating the cell-killing moiety to a targeting moiety, it is not an option for nucleoside analogs, which rely on intracellular enzymes to convert them to their active triphosphorylated form. To overcome this limitation, and achieve site-targeted activation of nucleoside analogs, we fused the coding region of a prodrug-activating enzyme, deoxycytidine kinase (dCK), to affinity reagents that bind to the Her2 cell surface protein. We evaluated dCK fusions to an anti-Her2 affibody and Designed Ankyrin Repeat Protein (DARPin) for their ability to kill cancer cells by promoting the activation of the nucleoside analog fludarabine. Cell staining and flow cytometry experiments with three Her2 positive cancer cell lines (BT-474-JB, JIMT-1 and SK-OV-3) indicate dCK fusions binding and cellular internalization. In contrast, these reagents bind only weakly to the Her2 negative cell line, MCF-7. Cell proliferation assays indicate that SK-OV-3 and BT-474-JB cell lines exhibit significantly reduced proliferation rates when treated with targeting-module fused dCK and fludarabine, compared to fludarabine alone. These findings demonstrate that we have succeeded in delivering active dCK into the Her2-positive cells, thereby increasing the activation of fludarabine, which ultimately reduces the dose of nucleoside analog needed for cell killing. This strategy may help establish the therapeutic index required to differentiate between healthy tissues and cancer cells.	[Koduvayur, Sujatha P.; Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Su, Ying; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Lavie, Arnon] Jesse Brown VA Med Ctr, Chicago, IL USA; [Koduvayur, Sujatha P.] Stevens Inst Technol, Dept Elect & Comp Engn, Hoboken, NJ 07030 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Stevens Institute of Technology	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.; Lavie, A (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL USA.	Lavie@uic.edu		Lavie, Arnon/0000-0001-5591-8722	National Institutes of Health [R21 CA155424]; NATIONAL CANCER INSTITUTE [R21CA155424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R21 CA155424 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; AVRAMIS VI, 1982, CANCER RES, V42, P2587; BARRUECO JR, 1987, CANCER RES, V47, P700; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Burris HA, 2013, AM SOC CLIN ONCOL ED; Campbell DO, 2012, J BIOL CHEM, V287, P446, DOI 10.1074/jbc.M111.314666; Canonici A, 2013, ONCOTARGET, V4, P1592, DOI 10.18632/oncotarget.1148; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Friedman M, 2007, PROTEIN ENG DES SEL, V20, P189, DOI 10.1093/protein/gzm011; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Koduvayur SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087964; Koshkaryev A, 2013, ADV DRUG DELIVER REV, V65, P24, DOI 10.1016/j.addr.2012.08.009; Lambert JM, 2005, CURR OPIN PHARMACOL, V5, P543, DOI 10.1016/j.coph.2005.04.017; Lambert JM, 2013, BRIT J CLIN PHARMACO, V76, P248, DOI 10.1111/bcp.12044; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Leal M, 2014, ANN NY ACAD SCI, V1321, P41, DOI 10.1111/nyas.12499; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; McDonagh CF, 2006, PROTEIN ENG DES SEL, V19, P299, DOI 10.1093/protein/gzl013; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; PLUNKETT W, 1993, SEMIN ONCOL, V20, P2; Ricci Francesca, 2009, Ther Clin Risk Manag, V5, P187; ROSS SR, 1993, DRUGS, V45, P737, DOI 10.2165/00003495-199345050-00009; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Singh Y, 2008, CURR MED CHEM, V15, P1802, DOI 10.2174/092986708785132997; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Steiner M, 2011, CLIN CANCER RES, V17, P6406, DOI 10.1158/1078-0432.CCR-11-0483; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tanner M, 2004, MOL CANCER THER, V3, P1585; Vlashi E, 2009, MOL PHARMACEUT, V6, P1868, DOI 10.1021/mp900158d; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	42	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157114	10.1371/journal.pone.0157114	http://dx.doi.org/10.1371/journal.pone.0157114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280468	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000086
J	Maddock, ST; Briscoe, AG; Wilkinson, M; Waeschenbach, A; San Mauro, D; Day, JJ; Littlewood, DTJ; Foster, PG; Nussbaum, RA; Gower, DJ				Maddock, Simon T.; Briscoe, Andrew G.; Wilkinson, Mark; Waeschenbach, Andrea; San Mauro, Diego; Day, Julia J.; Littlewood, D. Tim J.; Foster, Peter G.; Nussbaum, Ronald A.; Gower, David J.			Next-Generation Mitogenomics: A Comparison of Approaches Applied to Caecilian Amphibian Phylogeny	PLOS ONE			English	Article							MITOCHONDRIAL GENOMES; EXPERIMENTAL-DESIGN; EVOLUTIONARY TREES; SOFTWARE PACKAGE; GYMNOPHIONA; MODEL; SYSTEMATICS; SELECTION; ALIGNMENT; HISTORY	Mitochondrial genome (mitogenome) sequences are being generated with increasing speed due to the advances of next-generation sequencing (NGS) technology and associated analytical tools. However, detailed comparisons to explore the utility of alternative NGS approaches applied to the same taxa have not been undertaken. We compared a 'traditional' Sanger sequencing method with two NGS approaches (shotgun sequencing and non-indexed, multiplex amplicon sequencing) on four different sequencing platforms (Illumina's HiSeq and MiSeq, Roche's 454 GS FLX, and Life Technologies' Ion Torrent) to produce seven (near-) complete mitogenomes from six species that form a small radiation of caecilian amphibians from the Seychelles. The fastest, most accurate method of obtaining mitogenome sequences that we tested was direct sequencing of genomic DNA (shotgun sequencing) using the MiSeq platform. Bayesian inference and maximum likelihood analyses using seven different partitioning strategies were unable to resolve compellingly all phylogenetic relationships among the Seychelles caecilian species, indicating the need for additional data in this case.	[Maddock, Simon T.; Briscoe, Andrew G.; Wilkinson, Mark; Waeschenbach, Andrea; Littlewood, D. Tim J.; Foster, Peter G.; Gower, David J.] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [Maddock, Simon T.; Day, Julia J.] UCL, Dept Genet Evolut & Environm, Mortimer St, London WC1E 6BT, England; [Maddock, Simon T.] Reaseheath Coll, Dept Anim Management, Nantwich CW5 6DF, England; [San Mauro, Diego] Univ Complutense Madrid, Dept Zool & Phys Anthropol, E-28040 Madrid, Spain; [Nussbaum, Ronald A.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; [Nussbaum, Ronald A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Natural History Museum London; University of London; University College London; Complutense University of Madrid; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Maddock, ST (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.; Maddock, ST (corresponding author), UCL, Dept Genet Evolut & Environm, Mortimer St, London WC1E 6BT, England.; Maddock, ST (corresponding author), Reaseheath Coll, Dept Anim Management, Nantwich CW5 6DF, England.	s.t.maddock@gmail.com	Littlewood, Tim/B-5230-2008; San Mauro, Diego/E-7996-2012; Maddock, Simon/AAK-5713-2021	Littlewood, Tim/0000-0002-2718-4001; San Mauro, Diego/0000-0002-2214-1125; Day, Julia/0000-0002-6765-7782; Maddock, Simon/0000-0002-5455-6990; Foster, Peter/0000-0003-0194-9237; Briscoe, Andrew/0000-0002-9422-6056; Waeschenbach, Andrea/0000-0001-8571-9345	Biotechnology and Biological Sciences Research Council/Natural Environment Research Council; SynTax grant; Natural History Museum/University College London (NHM/UCL) Impact Scholarship; Darwin Initiative grant [19-002]; Ministry of Economy and Competitiveness of Spain [CGL2012-40082, RYC-2011-09321]	Biotechnology and Biological Sciences Research Council/Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Biotechnology and Biological Sciences Research Council (BBSRC)); SynTax grant; Natural History Museum/University College London (NHM/UCL) Impact Scholarship; Darwin Initiative grant; Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was funded by Biotechnology and Biological Sciences Research Council/Natural Environment Research Council (http://www.bbsrc.ac.uk/ and http://www.nerc.ac.uk/), SynTax grant (MW, JJD); Natural History Museum/University College London (NHM/UCL) Impact Scholarship (http://www.nhm.ac.uk/ and http://www.ucl.ac.uk/), PhD studentship (JJD, DJG); Darwin Initiative grant (19-002) (https://www.gov.uk/government/groups/the-darwin-initiative) (DJG, MW, JJD); and Ministry of Economy and Competitiveness of Spain (grants ERDF co-funded CGL2012-40082 and RYC-2011-09321) (http://www.mineco.gob.es/portal/site/mineco?lang_choosen=en-DSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Gan HM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-19; Gillett CPDT, 2014, MOL BIOL EVOL, V31, P2223, DOI 10.1093/molbev/msu154; Gower DJ, 2011, MOL PHYLOGENET EVOL, V59, P698, DOI 10.1016/j.ympev.2011.03.002; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hedges S. Blair, 1993, Herpetological Monographs, V7, P64, DOI 10.2307/1466952; Kamei RG, 2012, P ROY SOC B-BIOL SCI, V279, P2396, DOI 10.1098/rspb.2012.0150; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lewis CJ, 2014, CONSERV GENET RESOUR, V6, P289, DOI 10.1007/s12686-013-0127-y; Liu Lin, 2012, J Biomed Biotechnol, V2012, P251364, DOI 10.1155/2012/251364; Lloyd RE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-496; Loader SP, 2007, BIOL LETTERS, V3, P505, DOI 10.1098/rsbl.2007.0266; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Lupi R, 2010, MITOCHONDRION, V10, P192, DOI 10.1016/j.mito.2010.01.004; Miller M.A., 2010, P GAT COMP ENV WORKS; Nowak C, 2014, CONSERV GENET RESOUR, V6, P159, DOI 10.1007/s12686-013-0033-3; Nussbaum R, 1984, BIOGEOGRAPHY ECOLOGY, P378; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; San Mauro D, 2006, MOL BIOL EVOL, V23, P227, DOI 10.1093/molbev/msj025; San Mauro D, 2004, MOL PHYLOGENET EVOL, V33, P413, DOI 10.1016/j.ympev.2004.05.014; San Mauro D, 2014, MOL PHYLOGENET EVOL, V73, P177, DOI 10.1016/j.ympev.2014.01.009; San Mauro D, 2012, SYST BIOL, V61, P661, DOI 10.1093/sysbio/sys028; San Mauro D, 2009, SYST BIOL, V58, P425, DOI 10.1093/sysbio/syp043; Schwartz RS, 2013, 13053665 ARXIV; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Wilkinson M, 2002, MOL PHYLOGENET EVOL, V23, P401, DOI 10.1016/S1055-7903(02)00031-3; Wilkinson Mark, 2003, African Journal of Herpetology, V52, P83; Wilkinson M, 2011, ZOOTAXA, P41; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Zardoya R, 2000, GENETICS, V155, P765; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P479, DOI 10.1016/j.ympev.2009.06.018	52	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156757	10.1371/journal.pone.0156757	http://dx.doi.org/10.1371/journal.pone.0156757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280454	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000377563000045
J	Sinnott, SJ; Brick, A; Layte, R; Cunningham, N; Turner, MJ				Sinnott, Sarah-Jo; Brick, Aoife; Layte, Richard; Cunningham, Nathan; Turner, Michael J.			National Variation in Caesarean Section Rates: A Cross Sectional Study in Ireland	PLOS ONE			English	Article							DELIVERY RATES; MATERNAL MORTALITY; RISK; BIRTH; MORBIDITY; QUALITY	Objective Internationally, caesarean section (CS) rates are rising. However, mean rates of CS across providers obscure extremes of CS provision. We aimed to quantify variation between all maternity units in Ireland. Methods Two national databases, the National Perinatal Reporting System and the Hospital Inpatient Enquiry Scheme, were used to analyse data for all women delivering singleton births weighing >= 500g. We used multilevel models to examine variation between hospitals in Ireland for elective and emergency CS, adjusted for individual level sociodemographic, clinical and organisational variables. Analyses were subsequently stratified for nullipara and multipara with and without prior CS. Results The national CS rate was 25.6% (range 18.2% - 35.1%). This was highest in multipara with prior CS at 86.1%(range 6.9% - 100%). The proportion of variation in CS that was attributable to the hospital of birth was 11.1% (95% CI, 6.0 - 19.4) for elective CS and 2.9% (95% CI, 1.4 - 5.6) for emergency CS, after adjustment. Stratifying across parity group, variation between hospitals was greatest for multipara with prior CS. Both types of CS were predicted by increasing age, prior history of miscarriage or stillbirth, prior CS, antenatal complications and private model of care. Conclusion The proportion of variation attributable to the hospital was higher for elective CS than emergency CS suggesting that variation is more likely influenced by antenatal decision making than intrapartum decision making. Multipara with prior CS were particularly subject to variability, highlighting a need for consensus on appropriate care in this group.	[Sinnott, Sarah-Jo; Brick, Aoife; Layte, Richard; Cunningham, Nathan] Econ & Social Res Inst, Whitaker Sq, Dublin 2, Ireland; [Brick, Aoife] Trinity Coll Dublin, Dublin, Ireland; [Layte, Richard] Univ Dublin Trinity Coll, Dept Sociol, Dublin 2, Ireland; [Turner, Michael J.] Coombe Women & Infants Univ Hosp, UCD Ctr Human Reprod, Dublin 8, Ireland	Economic & Social Research Institute (ESRI); Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Sinnott, SJ (corresponding author), Econ & Social Res Inst, Whitaker Sq, Dublin 2, Ireland.	sarah-jo.sinnott@esri.ie		Turner, Michael/0000-0003-0064-5098; Brick, Aoife/0000-0002-5046-8336	Health Research Board in Ireland [HRA_HSR/2012/8]	Health Research Board in Ireland	This work was supported by the Health Research Board in Ireland under grant no. HRA_HSR/2012/8. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baicker K, 2006, HEALTH AFFAIR, V25, pW355, DOI 10.1377/hlthaff.25.w355; Bragg F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5065; Bramley Michelle, 2005, Health Inf Manag, V34, P40, DOI 10.1177/183335830503400205; Caceres IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057817; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Chaillet N, 2015, NEW ENGL J MED, V372, P1710, DOI 10.1056/NEJMoa1407120; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Edmonds JK, 2014, BIRTH-ISS PERINAT C, V41, P290, DOI 10.1111/birt.12108; Fitzmaurice G, 2000, NUTRITION, V16, P313, DOI 10.1016/S0899-9007(99)00293-2; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; Healthcare Pricing Office, 2014, ACT AC PUBL HOSP IR; Healthcare Pricing Office, 2013, NAT PER STAT REP 201; Higgins JR, 2013, ESTABLISHMENT HOSP G, V2013; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Kozhimannil KB, 2013, HEALTH AFFAIR, V32, P527, DOI 10.1377/hlthaff.2012.1030; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Lobel M, 2007, SOC SCI MED, V64, P2272, DOI 10.1016/j.socscimed.2007.02.028; Macfarlane A, 2015, BJOG INT J OBSTET GY; Mohammed MA, 2016, STAT METHODS MED RES, V25, P706, DOI 10.1177/0962280212465165; Murphy DJ, BRIT MED J OPEN; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; O'Neill SM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001670; Organisation for Economic Co-operation and Development, 2015, OECD HLTH STAT 2015; Paranjothy S, 2005, BJOG-INT J OBSTET GY, V112, P658, DOI 10.1111/j.1471-0528.2005.00501.x; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Potter JE, 2001, UNWANTED CAESAREAN S; Scott JR, 2011, OBSTET GYNECOL, V118, P342, DOI 10.1097/AOG.0b013e3182245b39; Sebastiao YV, 2015, AM J OBSTET GYNECOLO; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Turner MJ, 2011, INT J GYNECOL OBSTET, V113, P175, DOI 10.1016/j.ijgo.2011.01.012; WHO, 2010, WOR HEALT REP, P1; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zich K., 2012, KAISERSCHNITTGEBURTE	34	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156172	10.1371/journal.pone.0156172	http://dx.doi.org/10.1371/journal.pone.0156172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280848	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000377563000019
J	Thangaraj, SV; Shyamsundar, V; Krishnamurthy, A; Ramani, P; Ganesan, K; Muthuswami, M; Ramshankar, V				Thangaraj, Soundara Viveka; Shyamsundar, Vidyarani; Krishnamurthy, Arvind; Ramani, Pratibha; Ganesan, Kumaresan; Muthuswami, Muthulakshmi; Ramshankar, Vijayalakshmi			Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; LAMININ GAMMA-2 CHAIN; WEB-BASED TOOL; POOR-PROGNOSIS; E-CADHERIN; CLINICOPATHOLOGICAL SIGNIFICANCE; MATRIX METALLOPROTEINASE-2; CLINICAL-RELEVANCE; TUMOR INVASION	Oral Tongue Squamous cell carcinoma (OTSCC), the most frequently affected oral cancer sub-site, is associated with a poor therapeutic outcome and survival despite aggressive multi-modality management. Till date, there are no established biomarkers to indicate prognosis and outcome in patients presenting with tongue cancer. There is an urgent need for reliable molecular prognostic factors to enable identification of patients with high risk of recurrence and treatment failure in OTSCC management. In the current study, we present the meta-analysis of OTSCC microarray based gene expression profiles, deriving a comprehensive molecular portrait of tongue cancer biology, showing the relevant genes and pathways which can be pursued further to derive novel, tailored therapeutics as well as for prognostication. We have studied 5 gene expression profiling data sets available on exclusively oral tongue subsite comprising of sample size; n = 190, consisting of 111 tumors and 79 normals. The meta-analysis results showed 2405 genes differentially regulated comparing OTSCC tumor and normal. The top up regulated genes were found to be involved in Extracellular matrix degradation (ECM) and Epithelial to mesenchymal transition (EMT) pathways. The top down regulated genes were found to be involved in detoxication pathways. We validated the results in clinical samples (n = 206), comprising of histologically normals (n = 10), prospective (n = 29) and retrospective (n = 167) OTSCC by evaluating MMP9 and E-cadherin gene expression by qPCR and immunohistochemistry. Consistent with meta-analysis results, MMP9 mRNA expression was significantly up regulated in OTSCC primary tumors compared to normals. MMP9 protein over expression was found to be a significant predictor of poor prognosis, disease recurrence and poor Disease Free Survival (DFS) in OTSCC patients. Analysis by univariate and multivariate Cox proportional hazard model showed patients with loss of E-cadherin expression in OTSCC tumors having a poorer DFS (HR = 1.566; P value = 0.045) and poorer Overall Survival (OS) (HR = 1.224; P value = 0.003) respectively. Combined over-expression of MMP9 and loss of E-cadherin membrane positivity in the invasive tumor front (ITF) of OTSCC had a significant association with poorer DFS (Log Rank = 16.040; P value = 0.001). These results suggest that along with known clinical indicators of prognosis like occult node positivity, assessment of MMP9 and E-cadherin expression at ITF can be useful to identify patients at high risk and requiring a more intensive treatment strategy for OTSCC. Meta-analysis study of gene expression profiles indicates that OTSCC is a disease of ECM degradation leading to activated EMT processes implying the aggressive nature of the disease. The triggers for these processes should be studied further. Newer clinical application with agents that can inhibit the mediators of ECM degradation may be a key to achieving clinical control of invasion and metastasis of OTSCC.	[Thangaraj, Soundara Viveka; Ramshankar, Vijayalakshmi] Canc Inst WIA, Dept Prevent Oncol Res, Chennai, Tamil Nadu, India; [Shyamsundar, Vidyarani] Sree Balaji Dent Coll & Hosp, Ctr Oral Canc Prevent Awareness & Res, Chennai, Tamil Nadu, India; [Krishnamurthy, Arvind] Canc Inst WIA, Dept Surg Oncol, Chennai, Tamil Nadu, India; [Ramani, Pratibha] Saveetha Univ, Dept Oral & Maxillofacial Pathol, Saveetha Dent Coll, Chennai, Tamil Nadu, India; [Ganesan, Kumaresan; Muthuswami, Muthulakshmi] Madurai Kamaraj Univ, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India	Bharath Institute of Higher Education & Research; Sree Balaji Dental College & Hospital; Saveetha Institute of Medical & Technical Science; Saveetha Dental College & Hospital; Madurai Kamaraj University	Ramshankar, V (corresponding author), Canc Inst WIA, Dept Prevent Oncol Res, Chennai, Tamil Nadu, India.	vijiciwia@gmail.com	Ramani, Pratibha/AAM-2777-2021; Krishnamurthy, Arvind/D-7592-2017	Krishnamurthy, Arvind/0000-0002-5604-0955; Ramshankar, Vijayalakshmi/0000-0003-2464-0806; Shyamsundar, Vidyarani/0000-0001-9550-7741; Ramshankar, Vijayalakshmi/0000-0001-6890-4231; Ganesan, Kumaresan/0000-0003-0533-3181; Thangaraj, Soundara Viveka/0000-0003-4902-468X	University Research Council, Tamilnadu DR MGR Medical University [SW(3)/44699/2012]	University Research Council, Tamilnadu DR MGR Medical University	This study was supported by the University Research Council, Tamilnadu DR MGR Medical University, SW(3)/44699/2012.	Awakura Y, 2008, INT J ONCOL, V33, P893, DOI 10.3892/ijo_00000078; Bankfalvi A, 2002, J PATHOL, V198, P343, DOI 10.1002/path.1204; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; BRYNE M, 1992, J PATHOL, V166, P375, DOI 10.1002/path.1711660409; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chang YC, 2010, HISTOPATHOLOGY, V57, P295, DOI 10.1111/j.1365-2559.2010.03616.x; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Dass CR, 2008, CANCER BIOL THER, V7, P1262, DOI 10.4161/cbt.7.8.6265; De Cecco L, 2015, ONCOTARGET, V6, P9627, DOI 10.18632/oncotarget.3301; Dogan E, 2014, J LARYNGOL OTOL, V128, P268, DOI 10.1017/S0022215114000267; Elango J Kalavathy, 2006, Asian Pac J Cancer Prev, V7, P108; Estilo CL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-11; Fan HX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-90; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hlubek F, 2001, CANCER RES, V61, P8089; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Horikawa T, 2000, CANCER-AM CANCER SOC, V89, P715, DOI 10.1002/1097-0142(20000815)89:4<715::AID-CNCR1>3.0.CO;2-9; Kagesato Y, 2001, JPN J CANCER RES, V92, P184, DOI 10.1111/j.1349-7006.2001.tb01081.x; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Karatzanis AD, 2012, EUR ARCH OTO-RHINO-L, V269, P731, DOI 10.1007/s00405-011-1809-2; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Koshikawa N, 1999, CANCER RES, V59, P5596; Krishnamurthy A, 2013, ASIAN PAC J CANCER P, V14, P5061, DOI 10.7314/APJCP.2013.14.9.5061; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu Q, 2009, ONCOL REP, V22, P1069, DOI 10.3892/or_00000538; Liu W, 2014, J SURG RES, V186, P150, DOI 10.1016/j.jss.2013.09.008; Mishra A, 2014, ASIAN PAC J CANCER P, V15, P537, DOI 10.7314/APJCP.2014.15.2.537; Moon YW, 2015, CELL DEATH DIFFER, V22, P1341, DOI 10.1038/cdd.2014.228; Moore SR, 2000, ORAL DIS, V6, P65; ODELL EW, 1994, CANCER, V74, P789, DOI 10.1002/1097-0142(19940801)74:3<789::AID-CNCR2820740302>3.0.CO;2-A; Ohmura G, 2015, MOL CANCER RES, V13, P721, DOI 10.1158/1541-7786.MCR-14-0410; Ono Y, 1999, CANCER, V85, P2315, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2315::AID-CNCR3>3.0.CO;2-Y; Pastuszak-Lewandoska D, 2015, ADV EXP MED BIOL, V852, P39, DOI 10.1007/5584_2014_109; PYKE C, 1995, CANCER RES, V55, P4132; Pyo SW, 2007, J CRANIO MAXILL SURG, V35, P1, DOI 10.1016/j.jcms.2006.11.004; Ramshankar V, 2014, ASIAN PAC J CANCER P, V15, P8351, DOI 10.7314/APJCP.2014.15.19.8351; Ranogajec I, 2012, MED ONCOL, V29, P561, DOI 10.1007/s12032-011-9984-y; Rao SVK, 2013, ASIAN PAC J CANCER P, V14, P5567, DOI 10.7314/APJCP.2013.14.10.5567; Reis PP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-437; Rentoft M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035276; Scanlon CS, 2013, J DENT RES, V92, P114, DOI 10.1177/0022034512467352; Sgaramella N, 2015, BRIT J CANCER, V113, P321, DOI 10.1038/bjc.2015.207; Simon R, 2007, CANCER INFORM, V3, P11; Skyldberg B, 1999, J NATL CANCER I, V91, P1882, DOI 10.1093/jnci/91.21.1882; Sobral LM, 2011, ORAL ONCOL, V47, P840, DOI 10.1016/j.oraloncology.2011.06.011; Soini Y, 1996, J PATHOL, V180, P290, DOI 10.1002/(SICI)1096-9896(199611)180:3<290::AID-PATH661>3.0.CO;2-6; Sordat I, 1998, J PATHOL, V185, P44, DOI 10.1002/(SICI)1096-9896(199805)185:1<44::AID-PATH46>3.0.CO;2-A; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stoltzfus P, 2004, ANTICANCER RES, V24, P3109; Sugiura T, 2009, INT J ONCOL, V34, P673, DOI 10.3892/ijo_00000193; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takahashi S, 2002, CANCER, V94, P1894, DOI 10.1002/cncr.10395; Tan WJ, 2012, ORL J OTO-RHINO-LARY, V74, P264, DOI 10.1159/000343796; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Udali S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0077-1; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Volker HU, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-25; Wang C, 2011, J ORAL PATHOL MED, V40, P545, DOI 10.1111/j.1600-0714.2011.01041.x; Wang X, 2015, MOL MED REP, V12, P3439, DOI 10.3892/mmr.2015.3790; Wang XH, 2009, ORAL SURG ORAL MED O, V107, P547, DOI 10.1016/j.tripleo.2008.11.021; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wong TS, 2004, EJSO-EUR J SURG ONC, V30, P560, DOI 10.1016/j.ejso.2004.02.007; Xia JG, 2013, NUCLEIC ACIDS RES, V41, pW63, DOI 10.1093/nar/gkt338; Yamamoto H, 2001, CLIN CANCER RES, V7, P896; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang ZA, 2011, J ORAL PATHOL MED, V40, P127, DOI 10.1111/j.1600-0714.2010.00953.x; Zhong S, 2003, NUCLEIC ACIDS RES, V31, P3483, DOI 10.1093/nar/gkg598; Zhou CX, 2010, AUST DENT J, V55, P385, DOI 10.1111/j.1834-7819.2010.01258.x	74	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156582	10.1371/journal.pone.0156582	http://dx.doi.org/10.1371/journal.pone.0156582			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280700	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000037
J	Wu, SQ; Wang, YJ; Tang, XY; Wang, Y; Wu, JC; Ji, GY; Zhang, MM; Chen, G; Liu, QQ; Sandford, AJ; He, JQ				Wu, Shouquan; Wang, You-Juan; Tang, Xiaoyan; Wang, Yu; Wu, Jingcan; Ji, Guiyi; Zhang, Miaomiao; Chen, Guo; Liu, Qianqian; Sandford, Andrew J.; He, Jian-Qing			Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity	PLOS ONE			English	Article							INDUCED LIVER-INJURY; HEPATOCELLULAR-CARCINOMA; CAUSALITY ASSESSMENT; ADVERSE REACTIONS; CANCER PATIENTS; BREAST-CANCER; SURVIVAL; RISK; TUBERCULOSIS; METAANALYSIS	Background Anti-tuberculosis drug-induced hepatotoxicity (ATDH) is one of the most common adverse effects associated with tuberculosis (TB) therapy. Animal studies have demonstrated important roles of glutathione S-transferases in the prevention of chemical-induced hepatotoxicity. The aim of this study was to investigate the relationship between single nucleotide polymorphisms (SNPs) of glutathione S-transferase P1 (GSTP1) and ATDH in TB patients. Methods We used two independent samples for this genetic association study. In the initial prospective study, 322 newly diagnosed TB patients were followed up for three months after initiating anti-TB therapy. In an independent retrospective study, 115 ATDH patients and 116 patients without ATDH were selected to verify the results of the prospective study. TagSNPs of GSTP1 were genotyped either with the MassARRAY platform or the improved multiple ligase detection reaction (iMLDR) method. The associations between SNPs and ATDH were analyzed by logistic regression analysis adjusting for confounding factors. Results Of the 322 patients recruited in the prospective cohort, 35 were excluded during the 3 months of follow-up, and 30 were diagnosed with ATDH and were considered as the ATDH group. The remaining 257 subjects without ATDH were considered as the non-ATDH group. After correction for potential confounding factors, significant differences were found for rs1695 (A>G) under an allelic model (OR = 3.876, 95% CI: 1.258011.905; P = 0.018). In the retrospective study, rs1695 allele A also had a higher risk of ATDH (OR = 2.10, 95% CI: 1.17-3.76; P = 0.012). We only found rs4147581AA genotype under a dominant model was related to ATDH in the prospective study (OR = 2.578, 95% CI: 1.076-6.173; P = 0.034). Conclusions This is the first study to suggest that GSTP1 genotyping can be an important tool for identifying patients who are susceptible to ATDH. This result should be verified in independent large sample studies and also in other ethnic populations.	[Wu, Shouquan; Tang, Xiaoyan; Wang, Yu; Wu, Jingcan; Ji, Guiyi; Zhang, Miaomiao; He, Jian-Qing] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu 610064, Sichuan, Peoples R China; [Wang, You-Juan] Sichuan Univ, West China Hosp, Phys Examinat Ctr, Chengdu 610064, Sichuan, Peoples R China; [Chen, Guo] Sichuan Prov Peoples Hosp, Div Geriatr, Chengdu, Sichuan, Peoples R China; [Liu, Qianqian] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan, Peoples R China; [Sandford, Andrew J.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Sandford, Andrew J.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada	Sichuan University; Sichuan University; Sichuan Provincial People's Hospital; Sichuan University; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	He, JQ (corresponding author), Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu 610064, Sichuan, Peoples R China.	jianqhe@gmail.com	liu, qian/HDM-2936-2022; He, Jian-Qing/AAA-6269-2021	He, Jian-Qing/0000-0002-0966-1302	National Natural Science Foundation of China [81170042, 81370121]; National Scientific and Technological Major Project of China [2012ZX10004-901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific and Technological Major Project of China	This work was supported by the National Natural Science Foundation of China (Grant No. 81170042 and Grant No. 81370121), and the National Scientific and Technological Major Project of China (Grant No. 2012ZX10004-901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajith TA, 2007, FOOD CHEM TOXICOL, V45, P2267, DOI 10.1016/j.fct.2007.06.001; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Azuma J, 2013, EUR J CLIN PHARMACOL, V69, P1091, DOI 10.1007/s00228-012-1429-9; BENICHOU C, 1993, J CLIN EPIDEMIOL, V46, P1331, DOI 10.1016/0895-4356(93)90102-7; Bewick MA, 2008, BREAST CANCER RES TR, V111, P93, DOI 10.1007/s10549-007-9764-8; Cai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047769; Chen R, 2015, ARCH TOXICOL, V89, P883, DOI 10.1007/s00204-015-1473-1; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Devoto Flavio Marcelo, 1997, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V47, P197; Dossing M, 1996, TUBERCLE LUNG DIS, V77, P335, DOI 10.1016/S0962-8479(96)90098-2; He L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119481; Henderson CJ, 2005, METHOD ENZYMOL, V401, P116, DOI 10.1016/S0076-6879(05)01007-4; Henrion-Caude A, 2002, HEPATOLOGY, V36, P913, DOI 10.1053/jhep.2002.35534; Hu X, 1998, CANCER RES, V58, P5340; Il Gum S, 2007, J ETHNOPHARMACOL, V112, P568, DOI 10.1016/j.jep.2007.05.014; Lee JM, 2005, CLIN CANCER RES, V11, P4749, DOI 10.1158/1078-0432.CCR-04-2333; Li C, 2013, EUR J CLIN MICROBIOL, V32, P859, DOI 10.1007/s10096-013-1831-y; Li CG, 2012, ASIAN PAC J CANCER P, V13, P3247, DOI 10.7314/APJCP.2012.13.7.3247; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liang F, 2009, SWISS MED WKLY, V139, P724, DOI smw-12754; Liu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115410; Liu YP, 2013, MOL MED REP, V7, P1904, DOI 10.3892/mmr.2013.1435; Nagle CM, 2007, EUR J CANCER, V43, P283, DOI 10.1016/j.ejca.2006.09.011; Qu K, 2015, WORLD J GASTROENTERO, V21, P4310, DOI 10.3748/wjg.v21.i14.4310; Ramappa V, 2013, J CLIN EXP HEPATOL, V3, P37, DOI 10.1016/j.jceh.2012.12.001; Reszka E, 2011, CLIN BIOCHEM, V44, P1153, DOI 10.1016/j.clinbiochem.2011.05.024; Saxena A, 2012, EXP THER MED, V4, P1097, DOI 10.3892/etm.2012.710; Sun F, 2008, INT J TUBERC LUNG D, V12, P994; Sun N, 2010, CANCER CHEMOTH PHARM, V65, P437, DOI 10.1007/s00280-009-1046-1; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2014, GLOB TUB REP 2014; Wong WM, 2000, HEPATOLOGY, V31, P201, DOI 10.1002/hep.510310129; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x; ZIMNIAK P, 1994, EUR J BIOCHEM, V224, P893, DOI 10.1111/j.1432-1033.1994.00893.x	36	14	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157478	10.1371/journal.pone.0157478	http://dx.doi.org/10.1371/journal.pone.0157478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281183	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000121
J	Maekawa, N; Konnai, S; Okagawa, T; Nishimori, A; Ikebuchi, R; Izumi, Y; Takagi, S; Kagawa, Y; Nakajima, C; Suzuki, Y; Kato, Y; Murata, S; Ohashi, K				Maekawa, Naoya; Konnai, Satoru; Okagawa, Tomohiro; Nishimori, Asami; Ikebuchi, Ryoyo; Izumi, Yusuke; Takagi, Satoshi; Kagawa, Yumiko; Nakajima, Chie; Suzuki, Yasuhiko; Kato, Yukinari; Murata, Shiro; Ohashi, Kazuhiko			Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; MAST-CELL TUMORS; BREAST-CANCER; B7-H1 PD-L1; DOGS; OSTEOSARCOMA; PROGNOSIS; HEMANGIOSARCOMA; CARCINOMA; BLOCKADE	Spontaneous cancers are common diseases in dogs. Among these, some malignant cancers such as oral melanoma, osteosarcoma, hemangiosarcoma, and mast cell tumor are often recognized as clinical problems because, despite their high frequencies, current treatments for these cancers may not always achieve satisfying outcomes. The absence of effective systemic therapies against these cancers leads researchers to investigate novel therapeutic modalities, including immunotherapy. Programmed death 1 (PD-1) is a costimulatory receptor with immunosuppressive function. When it binds its ligands, PD-ligand 1 (PD-L1) or PD-L2, PD-1 on T cells negatively regulates activating signals from the T cell receptor, resulting in the inhibition of the effector function of cytotoxic T lymphocytes. Aberrant PD-L1 expression has been reported in many human cancers and is considered an immune escape mechanism for cancers. In clinical trials, anti-PD-1 or anti-PD-L1 antibodies induced tumor regression for several malignancies, including advanced melanoma, non-small cell lung carcinoma, and renal cell carcinoma. In this study, to assess the potential of the PD-1/PD-L1 axis as a novel therapeutic target for canine cancer immunotherapy, immunohistochemical analysis of PD-L1 expression in various malignant cancers of dogs was performed. Here, we show that dog oral melanoma, osteosarcoma, hemangiosarcoma, mast cell tumor, mammary adenocarcinoma, and prostate adenocarcinoma expressed PD-L1, whereas some other types of cancer did not. In addition, PD-1 was highly expressed on tumor-infiltrating lymphocytes obtained from oral melanoma, showing that lymphocytes in this cancer type might have been functionally exhausted. These results strongly encourage the clinical application of PD-1/PD-L1 inhibitors as novel therapeutic agents against these cancers in dogs.	[Maekawa, Naoya; Konnai, Satoru; Okagawa, Tomohiro; Nishimori, Asami; Ikebuchi, Ryoyo; Murata, Shiro; Ohashi, Kazuhiko] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Izumi, Yusuke; Takagi, Satoshi] Hokkaido Univ, Vet Teaching Hosp, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kagawa, Yumiko] North Lab, Sapporo, Hokkaido, Japan; [Kagawa, Yumiko] Hokkaido Univ, Dept Diagnost Pathol, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Nakajima, Chie; Suzuki, Yasuhiko] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Kato, Yukinari] Tohoku Univ, Dept Reg Innovat, Grad Sch Med, Sendai, Miyagi 980, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Tohoku University	Ohashi, K (corresponding author), Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	okazu@vetmed.hokudai.ac.jp	Ikebuchi, Ryoyo/AAG-1138-2019; Suzuki, Yasuhiko/F-6890-2012; Nakajima, Chie/A-5020-2012; Okagawa, Tomohiro/AAX-1284-2021	Ikebuchi, Ryoyo/0000-0003-0231-7733; TAKAGI, Satoshi/0000-0001-6653-5890; Kato, Yukinari/0000-0001-5385-8201; Satoru, Konnai/0000-0002-3230-7109	Japan Society for the Promotion of Science (JSPS) [16K15042, 15J01989]; Platform for Drug Discovery, Informatics, and Structural Life Science from Japan Agency for Medical Research and Development (AMED) [2157]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-in-Aid for Scientific Research (Grant Number 16K15042) and Grant-in-aid for JSPS Fellows (Grant Number 15J01989) from Japan Society for the Promotion of Science (JSPS). This research is (partially) supported by the Platform for Drug Discovery, Informatics, and Structural Life Science (Proposal No. 2157) from Japan Agency for Medical Research and Development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; BOSTOCK DE, 1989, BRIT J CANCER, V59, P915, DOI 10.1038/bjc.1989.193; Brahmer JR, 2012, NEW ENGL J MED, P1; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; D'Angelo SP, 2015, HUM PATHOL, V46, P357, DOI 10.1016/j.humpath.2014.11.001; Dickerson EB, 2005, VET PATHOL, V42, P618, DOI 10.1354/vp.42-5-618; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eppihimer MJ, 2002, MICROCIRCULATION, V9, P133, DOI 10.1038/sj/mn/7800123; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Ikebuchi R, 2014, IMMUNOLOGY, V142, P551, DOI 10.1111/imm.12243; Kanae Y, 2006, AM J VET RES, V67, P127, DOI 10.2460/ajvr.67.1.127; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082870; Koenig A, 2002, VET PATHOL, V39, P458, DOI 10.1354/vp.39-4-458; Levine RA, 2002, VET PATHOL, V39, P372, DOI 10.1354/vp.39-3-372; Lussier DM, 2015, J IMMUNOTHER, V38, P96, DOI 10.1097/CJI.0000000000000065; MACEWEN EG, 1986, CANCER INVEST, V4, P397, DOI 10.3109/07357908609017520; MACVEAN DW, 1978, VET PATHOL, V15, P700, DOI 10.1177/030098587801500602; Maekawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098415; Massari F, 2015, TARGET ONCOL; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Mittendorf EA, 2014, CANCER IMMUNOL RES, V2, P361, DOI 10.1158/2326-6066.CIR-13-0127; Murphy S, 2005, Vet Comp Oncol, V3, P222, DOI 10.1111/j.1476-5810.2005.00082.x; Ogilvie GK, 1996, J VET INTERN MED, V10, P379, DOI 10.1111/j.1939-1676.1996.tb02085.x; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; PATNAIK AK, 1984, VET PATHOL, V21, P469, DOI 10.1177/030098588402100503; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Smith SH, 2002, VET PATHOL, V39, P651, DOI 10.1354/vp.39-6-651; Sorenmo K U, 2004, Vet Comp Oncol, V2, P13, DOI 10.1111/j.1476-5810.2004.00035.x; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; Szewczyk M, 2015, VET RES COMMUN, V39, P61, DOI 10.1007/s11259-014-9623-0; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Topalian SL, 2012, NEW ENGL J MED, V366, P1, DOI DOI 10.1056/NEJM0A1200690; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Wong RM, 2007, INT IMMUNOL, V19, P1223, DOI 10.1093/intimm/dxm091; Wood CA, 1998, J AM ANIM HOSP ASSOC, V34, P417, DOI 10.5326/15473317-34-5-417; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003	44	58	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157176	10.1371/journal.pone.0157176	http://dx.doi.org/10.1371/journal.pone.0157176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276060	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700080
J	Petrescu, DC; Hollands, GJ; Couturier, DL; Ng, YL; Marteau, TM				Petrescu, Dragos C.; Hollands, Gareth J.; Couturier, Dominique-Laurent; Ng, Yin-Lam; Marteau, Theresa M.			Public Acceptability in the UK and USA of Nudging to Reduce Obesity: The Example of Reducing Sugar-Sweetened Beverages Consumption	PLOS ONE			English	Article							HEALTH BEHAVIOR; SUPPORT; INTERVENTIONS; STRATEGIES; INFERENCE; ATTITUDES	Background "Nudging"-modifying environments to change people's behavior, often without their conscious awareness-can improve health, but public acceptability of nudging is largely unknown. Methods We compared acceptability, in the United Kingdom (UK) and the United States of America (USA), of government interventions to reduce consumption of sugar-sweetened beverages. Three nudge interventions were assessed: i. reducing portion Size, ii. changing the Shape of the drink containers, iii. changing their shelf Location; alongside two traditional interventions: iv. Taxation and v. Education. We also tested the hypothesis that describing interventions as working through non-conscious processes decreases their acceptability. Predictors of acceptability, including perceived intervention effectiveness, were also assessed. Participants (n = 1093 UK and n = 1082 USA) received a description of each of the five interventions which varied, by randomisation, in how the interventions were said to affect behaviour: (a) via conscious processes; (b) via non-conscious processes; or (c) no process stated. Acceptability was derived from responses to three items. Results Levels of acceptability for four of the five interventions did not differ significantly between the UK and US samples; reducing portion size was less accepted by the US sample. Within each country, Education was rated as most acceptable and Taxation the least, with the three nudge-type interventions rated between these. There was no evidence to support the study hypothesis: i.e. stating that interventions worked via non-conscious processes did not decrease their acceptability in either the UK or US samples. Perceived effectiveness was the strongest predictor of acceptability for all interventions across the two samples. Conclusion In conclusion, nudge interventions to reduce consumption of sugar-sweetened beverages seem similarly acceptable in the UK and USA, being more acceptable than taxation, but less acceptable than education. Contrary to prediction, we found no evidence that highlighting the non-conscious processes by which nudge interventions may work decreases their acceptability. However, highlighting the effectiveness of all interventions has the potential to increase their acceptability.	[Petrescu, Dragos C.; Hollands, Gareth J.; Couturier, Dominique-Laurent; Ng, Yin-Lam; Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England	University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England.	tm388@cam.ac.uk		Marteau, Theresa/0000-0003-3025-1129; Hollands, Gareth/0000-0002-0492-3924; Couturier, Dominique-Laurent/0000-0001-5774-5036	UK Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health) [PR-UN-0409-10109]; Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health) [PR-UN-0409-10109]	UK Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health); Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health)	The study was funded by the UK Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health [PR-UN-0409-10109]). The Department of Health had no role in the study design, data collection, analysis, or interpretation. The research was conducted independently of the funders, and the views expressed in this paper are those of the authors and not necessarily those of the Department of Health in England. The final version of the report and ultimate decision to submit for publication was determined by the authors.; This report is independent research commissioned and funded by the Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health (PR-UN-0409-10109)). The views expressed in this publication are those of the authors and not necessarily those of the Department of Health.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2012, NY TIMES; Beeken RJ, 2013, PUBLIC HEALTH NUTR, V16, P2132, DOI 10.1017/S1368980013001821; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Blumenthal-Barby JS, 2012, AM J BIOETHICS, V12, P1, DOI 10.1080/15265161.2011.634481; Bos C, 2015, NUTRIENTS, V7, P7842, DOI 10.3390/nu7095370; Branson C, 2012, ACCEPTABLE BEHAV PUB; Bretz F, 2011, BIOMETRICAL J, V53, P894, DOI 10.1002/bimj.201000239; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Buykx P, 2015, INT J DRUG POLICY, V26, P371, DOI 10.1016/j.drugpo.2014.08.006; Cantoni E, 2001, J AM STAT ASSOC, V96, P1022, DOI 10.1198/016214501753209004; Canty AJ, 1999, J ROY STAT SOC D-STA, V48, P379, DOI 10.1111/1467-9884.00196; Davison AC, 1997, BOOTSTRAP METHODS TH; Deming WE, 1940, ANN MATH STAT, V11, P427, DOI 10.1214/aoms/1177731829; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Dunn PK., 1996, J COMPUTATIONAL GRAP, V5, P236, DOI DOI 10.2307/1390802; Evans WD, 2005, AM J PREV MED, V28, P26, DOI 10.1016/j.amepre.2004.09.008; Felsen G, 2013, JUDGM DECIS MAK, V8, P202; Gabbatt A, 2014, GUARDIAN; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Graubard BI, 2002, STAT SCI, V17, P73, DOI 10.1214/ss/1023798999; Grynbaum MM, 2012, NY TIMES; Hauser DJ, 2015, SOC COGNITION, V33, P120, DOI 10.1521/soco.2015.33.2.120; Hollands GJ, 2016, HEALTH PSYCHOL REV, V10, P381, DOI 10.1080/17437199.2015.1138093; Hollands GJ, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009164.pub2, 10.1002/14651858.CD011045.pub2]; Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Lykke M, 2016, PREV MED, V83, P5, DOI 10.1016/j.ypmed.2015.11.016; Marteau TM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5863; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Mazzocchi M, 2015, HEALTH ECON POLICY L, V10, P267, DOI 10.1017/S1744133114000346; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609; Oliver JE, 2005, J HEALTH POLIT POLIC, V30, P923, DOI 10.1215/03616878-30-5-923; Pechey R, 2014, SOC SCI MED, V113, P104, DOI 10.1016/j.socscimed.2014.05.010; Pomeranz JL, 2014, NEW ENGL J MED, V371, P1956, DOI 10.1056/NEJMp1410076; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Ross L., 2011, PERSON SITUATION PER; Sikorski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039325; Subramanian C., 2013, TIME; Sunstein, 2015, CHOOSING NOT CHOOSE; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Tannenbaum D., 2015, MISPLACED POLITICS B; Tedstone A., 2015, SUGAR REDUCTION EVID; Thaler R.H., 2021, NUDGE FINAL EDITION; Waldron J., 2014, ITS ALL YOUR OWN GOO; White MD, 2013, MANIPULATION OF CHOICE: ETHICS AND LIBERTARIAN PATERNALISM, P1, DOI 10.1057/9781137313577	48	72	72	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155995	10.1371/journal.pone.0155995	http://dx.doi.org/10.1371/journal.pone.0155995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27276222	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700011
J	Potenza, N; Castiello, F; Panella, M; Colonna, G; Ciliberto, G; Russo, A; Costantini, S				Potenza, Nicoletta; Castiello, Filomena; Panella, Marta; Colonna, Giovanni; Ciliberto, Gennaro; Russo, Aniello; Costantini, Susan			Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; REGULATES EXPRESSION; LIVER-CANCER; IN-VITRO; SELENOPROTEINS; MICRORNAS; PROMOTES; ETIOLOGY; TARGETS	Hepatocellular carcinoma (HCC) is a multi-factorial cancer with a very poor prognosis; therefore, there are several investigations aimed at the comprehension of the molecular mechanisms leading to development and progression of HCC and at the definition of new therapeutic strategies. We have recently evaluated the expression of selenoproteins in HCC cell lines in comparison with normal hepatocytes. Recent results have shown that some of them are down- and others up-regulated, including the selenoprotein K (SELK), whose expression was also induced by sodium selenite treatment on cells. However, so far very few studies have been dedicated to a possible effect of microRNAs on the expression of selenoproteins and their implication in HCC. In this study, the analysis of SELK 3'UTR by bioinformatics tools led to the identification of eight sites potentially targeted by human microRNAs. They were then subjected to a validation test based on luciferase reporter constructs transfected in HCC cell lines. In this functional screening, miR-544a was able to interact with SELK 3'UTR suppressing the reporter activity. Transfection of a miR-544a mimic or inhibitor was then shown to decrease or increase, respectively, the translation of the endogenous SELK mRNA. Intriguingly, miR-544a expression was found to be modulated by selenium treatment, suggesting a possible role in SELK induction by selenium.	[Potenza, Nicoletta; Castiello, Filomena; Panella, Marta; Russo, Aniello] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy; [Colonna, Giovanni] Univ Naples 2, Azienda Osped Univ, Serv Informat Med, Naples, Italy; [Ciliberto, Gennaro] Ist Nazl Tumori Fdn G Pascale IRCCS, Direttore Sci, Naples, Italy; [Costantini, Susan] Ist Nazl Tumori Fdn G Pascale IRCCS, CROM, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Potenza, N (corresponding author), Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy.; Costantini, S (corresponding author), Ist Nazl Tumori Fdn G Pascale IRCCS, CROM, Naples, Italy.	nicoletta.potenza@unina2.it; s.costantini@istitutotumori.na.it	Colonna, Giovanni/AAY-3568-2021; Ciliberto, Gennaro/J-4131-2017; Costantini, Susan/J-9914-2018	Ciliberto, Gennaro/0000-0003-2851-8605; Colonna, Giovanni/0000-0002-0473-1455; Potenza, Nicoletta/0000-0002-9736-792X; Costantini, Susan/0000-0002-7538-4657				Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Bronte F, 2016, CRIT REV ONCOL HEMAT, V97, P312, DOI 10.1016/j.critrevonc.2015.09.007; Capone F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134594; DAEMER RJ, 1980, INFECT IMMUN, V30, P607; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Diamond AM, 2015, NUTRIENTS, V7, P3938, DOI 10.3390/nu7053938; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Guariniello S, 2015, ANAL CELL PATHOL AMS, V2015; Haga CL, 2015, ACS CHEM BIOL, V10, P2267, DOI 10.1021/acschembio.5b00265; He XX, 2016, TUMOR BIOL, V37, P807, DOI 10.1007/s13277-015-3857-5; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee JH, 2015, J BIOL CHEM, V290, P29941, DOI 10.1074/jbc.M115.680215; Liu J, 2014, FEBS LETT, V588, P3311, DOI 10.1016/j.febslet.2014.07.037; Maciel-Dominguez A, 2013, MOL NUTR FOOD RES, V57, P2195, DOI 10.1002/mnfr.201300168; Mao LY, 2015, AM J CANCER RES, V5, P1939; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meplan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048709; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mo XM, 2014, ONCOL LETT, V8, P1731, DOI 10.3892/ol.2014.2387; Mo XM, 2014, ONCOTARGETS THER, V7, P895, DOI 10.2147/OTT.S61695; Morishita A, 2015, HEPATOL RES, V45, P128, DOI 10.1111/hepr.12386; Mosca N, 2014, BIOCHEM BIOPH RES CO, V449, P141, DOI 10.1016/j.bbrc.2014.05.009; Mukhopadhyay B, 2015, HEPATOLOGY, V61, P1615, DOI 10.1002/hep.27686; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Rusolo F, 2013, MOLECULES, V18, P2549, DOI 10.3390/molecules18032549; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Stiuso P, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.8; Sun J, 2013, SCI WORLD J, V2013, P14; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106; Yang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149227; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	40	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156908	10.1371/journal.pone.0156908	http://dx.doi.org/10.1371/journal.pone.0156908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275761	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700048
J	Bird, MF; Cerlesi, MC; Brown, M; Malfacini, D; Vezzi, V; Molinari, P; Micheli, L; Mannelli, LD; Ghelardini, C; Guerrini, R; Calo, G; Lambert, DG				Bird, Mark F.; Cerlesi, Maria Camilla; Brown, Mark; Malfacini, Davide; Vezzi, Vanessa; Molinari, Paola; Micheli, Laura; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla; Guerrini, Remo; Calo, Girolamo; Lambert, David G.			Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)	PLOS ONE			English	Article							NOCICEPTIN/ORPHANIN FQ PEPTIDE; DELTA-OPIOID RECEPTORS; SOLID-PHASE SYNTHESIS; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; PARTIAL AGONIST; ORPHANIN-FQ; MORPHINE; MICE; TOLERANCE	Introduction Opioid receptors are currently classified as Mu (mu), Delta (delta), Kappa (kappa) plus the opioid related nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP). Despite compelling evidence for interactions and benefits of targeting more than one receptor type in producing analgesia, clinical ligands are Mu agonists. In this study we have designed a Mu-NOP agonist named DeNo. The Mu agonist component is provided by dermorphin, a peptide isolated from the skin of Phyllomedusa frogs and the NOP component by the endogenous agonist N/OFQ. Methods We have assessed receptor binding profile of DeNo and compared with dermorphin and N/OFQ. In a series of functional screens we have assessed the ability to (i) increase Ca2+ in cells coexpressing recombinant receptors and a the chimeric protein G alpha(qi5), (ii) stimulate the binding of GTP gamma[S-35], (iii) inhibit cAMP formation, (iv) activate MAPKinase, (v) stimulate receptor-G protein and arrestin interaction using BRET, (vi) electrically stimulated guinea pig ileum (gpI) assay and (vii) ability to produce analgesia via the intrathecal route in rats. Results DeNo bound to Mu (pK(i); 9.55) and NOP (pK(i); 10.22) and with reasonable selectivity. This translated to increased Ca2+ in G alpha(qi5) expressing cells (pEC(50) Mu 7.17; NOP 9.69), increased binding of GTP gamma[S-35] (pEC(50) Mu 7.70; NOP 9.50) and receptor-G protein interaction in BRET (pEC(50) Mu 8.01; NOP 9.02). cAMP formation was inhibited and arrestin was activated (pEC(50) Mu 6.36; NOP 8.19). For MAPK DeNo activated p38 and ERK1/2 at Mu but only ERK1/2 at NOP. In the gpI DeNO inhibited electrically-evoked contractions (pEC(50) 8.63) that was sensitive to both Mu and NOP antagonists. DeNo was antinociceptive in rats. Conclusion Collectively these data validate the strategy used to create a novel bivalent Mu-NOP peptide agonist by combining dermorphin (Mu) and N/OFQ (NOP). This molecule behaves essentially as the parent compounds in vitro. In the antonocicoeptive assays employed in this study DeNo displays only weak antinociceptive properties.	[Bird, Mark F.; Brown, Mark; Lambert, David G.] Univ Leicester, Div Anaesthesia Crit Care & Pain Management, Leicester Royal Infirm, Dept Cardiovascular Sci, Leicester LE2 7LX, Leics, England; [Cerlesi, Maria Camilla; Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Pharmacol Sect, Dept Med Sci, I-44100 Ferrara, Italy; [Cerlesi, Maria Camilla; Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Natl Inst Neurosci, I-44100 Ferrara, Italy; [Vezzi, Vanessa; Molinari, Paola] Ist Super Sanita, Dept Pharmacol, Viale Regina Elena 299, I-00161 Rome, Italy; [Micheli, Laura; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla] Univ Florence, Pharmacol & Toxicol Sect, Dept Neurosci Psychol Drug Res & Child Health Neu, Florence, Italy; [Guerrini, Remo] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44100 Ferrara, Italy; [Guerrini, Remo] Univ Ferrara, LTTA, I-44100 Ferrara, Italy	University of Leicester; University of Ferrara; University of Ferrara; Istituto Superiore di Sanita (ISS); University of Florence; University of Ferrara; University of Ferrara	Lambert, DG (corresponding author), Univ Leicester, Div Anaesthesia Crit Care & Pain Management, Leicester Royal Infirm, Dept Cardiovascular Sci, Leicester LE2 7LX, Leics, England.	dgl3@le.ac.uk	Vezzi, Vanessa/H-7084-2018; Di Cesare Mannelli, Lorenzo/A-1641-2015	Vezzi, Vanessa/0000-0002-7649-345X; Lambert, David/0000-0003-4769-8090; molinari, paola/0000-0002-8454-0121; Micheli, Laura/0000-0001-8834-5801; Di Cesare Mannelli, Lorenzo/0000-0001-8374-4432; Malfacini, Davide/0000-0003-4562-9550; GHELARDINI, CARLA/0000-0001-9856-8144	British Journal of Anaesthesia; Italian Ministry of University and Research (FIRB grant) [RBFR109SBM]; University of Ferrara (FAR grant)	British Journal of Anaesthesia; Italian Ministry of University and Research (FIRB grant)(Ministry of Education, Universities and Research (MIUR)); University of Ferrara (FAR grant)	The British Journal of Anaesthesia funded a PhD studentship to MFB. Other UK based Departmental miscellaneous funds were used for consumable items. Research in Ferrara and Florence was funded by the Italian Ministry of University and Research (RBFR109SBM FIRB grant) and the University of Ferrara (FAR grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAMID EE, 1991, J PHARMACOL EXP THER, V258, P299; Aceto MD, 2012, INT J MED CHEM, V2012, DOI 10.1155/2012/327257; [Anonymous], 2008, HDB LAB ANIMAL MANAG; Bigoni R, 1999, N-S ARCH PHARMACOL, V359, P160, DOI 10.1007/PL00005338; Bird MF, 2015, BRIT J ANAESTH, V114, P646, DOI 10.1093/bja/aeu454; Bobeck EN, 2016, BEHAV BRAIN RES, V298, P17, DOI 10.1016/j.bbr.2015.10.032; Brighton PJ, 2011, BRIT J PHARMACOL, V162, P1603, DOI 10.1111/j.1476-5381.2010.01173.x; BYCROFT BW, 1993, J CHEM SOC CHEM COMM, P778, DOI 10.1039/c39930000778; Camarda Valeria, 2013, Methods Mol Biol, V937, P293; Camarda V, 2009, N-S ARCH PHARMACOL, V379, P599, DOI 10.1007/s00210-009-0396-x; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Ciccarelli A, 2013, NEUROPHARMACOLOGY, V70, P168, DOI 10.1016/j.neuropharm.2012.12.010; Courteix C, 2004, PAIN, V110, P236, DOI 10.1016/j.pain.2004.03.037; Cremeans CM, 2012, J PHARMACOL EXP THER, V343, P72, DOI 10.1124/jpet.112.194308; Daniels DJ, 2005, P NATL ACAD SCI USA, V102, P19208, DOI 10.1073/pnas.0506627102; Evans RM, 2010, J BIOL CHEM, V285, P1032, DOI 10.1074/jbc.M109.040634; Goeldner C, 2008, J NEUROSCI, V28, P2190, DOI 10.1523/JNEUROSCI.3711-07.2008; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Guerrini R, 2005, J MED CHEM, V48, P1421, DOI 10.1021/jm040106v; Guerrini R, 2014, BIOORGAN MED CHEM, V22, P3703, DOI 10.1016/j.bmc.2014.05.005; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hu E, 2010, PAIN, V148, P107, DOI 10.1016/j.pain.2009.10.026; Ibba M, 2008, N-S ARCH PHARMACOL, V378, P553, DOI 10.1007/s00210-008-0350-3; Khroyan TV, 2007, J PHARMACOL EXP THER, V320, P934, DOI 10.1124/jpet.106.111997; Khroyan TV, 2011, J PHARMACOL EXP THER, V336, P952, DOI 10.1124/jpet.110.175620; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kitayama M, 2007, N-S ARCH PHARMACOL, V375, P369, DOI 10.1007/s00210-007-0170-x; Ko MC, 2009, J PAIN, V10, P509, DOI 10.1016/j.jpain.2008.11.006; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; LEIGHTON GE, 1988, BRIT J PHARMACOL, V93, P553, DOI 10.1111/j.1476-5381.1988.tb10310.x; Linz K, 2014, J PHARMACOL EXP THER, V349, P535, DOI 10.1124/jpet.114.213694; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malfacini D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132865; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Micheli L, 2015, EUR J PHARMACOL, V754, P79, DOI 10.1016/j.ejphar.2015.02.020; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Molinari S, 2013, BRIT J PHARMACOL, V168, P151, DOI 10.1111/j.1476-5381.2012.02115.x; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; Nitsche JF, 2002, J NEUROSCI, V22, P10906; Pan YX, 2002, BIOCHEM BIOPH RES CO, V297, P659, DOI 10.1016/S0006-291X(02)02258-1; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Reiss D, 2008, EUR J PHARMACOL, V579, P141, DOI 10.1016/j.ejphar.2007.10.031; Rizzi A, 2014, BRIT J PHARMACOL, V171, P4138, DOI 10.1111/bph.12799; Schroder W, 2014, BRIT J PHARMACOL, V171, P3777, DOI 10.1111/bph.12744; Schunk S, 2014, ACS MED CHEM LETT, V5, P857, DOI 10.1021/ml500117c; SOLE NA, 1992, J ORG CHEM, V57, P5399, DOI 10.1021/jo00046a022; Sukhtankar DD, 2013, J PHARMACOL EXP THER, V346, P11, DOI 10.1124/jpet.113.203984; Tian JH, 1997, BRIT J PHARMACOL, V120, P676, DOI 10.1038/sj.bjp.0700942; VACHON L, 1987, BIOCHEM PHARMACOL, V36, P2889, DOI 10.1016/0006-2952(87)90199-7; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang HL, 2005, J NEUROCHEM, V92, P1285, DOI 10.1111/j.1471-4159.2004.02921.x; Wu Y L, 1997, Cell Res, V7, P69; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9	55	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156897	10.1371/journal.pone.0156897	http://dx.doi.org/10.1371/journal.pone.0156897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272042	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000044
J	Le Moing, AG; Seferian, AM; Moraux, A; Annoussamy, M; Dorveaux, E; Gasnier, E; Hogrel, JY; Voit, T; Vissiere, D; Servais, L				Le Moing, Anne-Gaelle; Seferian, Andreea Mihaela; Moraux, Amelie; Annoussamy, Melanie; Dorveaux, Eric; Gasnier, Erwan; Hogrel, Jean-Yves; Voit, Thomas; Vissiere, David; Servais, Laurent			A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment	PLOS ONE			English	Article							DAILY PHYSICAL-ACTIVITY; NEUROMUSCULAR DISEASE; CALIBRATION METHODOLOGY; ATTITUDE ESTIMATION; PARKINSONS-DISEASE; ACCELEROMETRY DATA; EPILEPSY PATIENTS; MOTOR FUNCTION; UPPER LIMBS; CHILDREN	Measurement of muscle strength and activity of upper limbs of non-ambulant patients with neuromuscular diseases is a major challenge. ActiMyo (R) is an innovative device that uses magneto-inertial sensors to record angular velocities and linear accelerations that can be used over long periods of time in the home environment. The device was designed to insure long-term stability and good signal to noise ratio, even for very weak movements. In order to determine relevant and pertinent clinical variables with potential for use as outcome measures in clinical trials or to guide therapy decisions, we performed a pilot study in non-ambulant neuromuscular patients. We report here data from seven Duchenne Muscular Dystrophy (DMD) patients (mean age 18.5 +/- 5.5 years) collected in a clinical setting. Patients were assessed while wearing the device during performance of validated tasks (MoviPlate, Box and Block test and Minnesota test) and tasks mimicking daily living. The ActiMyo (R) sensors were placed on the wrists during all the tests. Software designed for use with the device computed several variables to qualify and quantify muscular activity in the non-ambulant subjects. Four variables representative of upper limb activity were studied: the rotation rate, the ratio of the vertical component in the overall acceleration, the hand elevation rate, and an estimate of the power of the upper limb. The correlations between clinical data and physical activity and the ActiMyo (R) movement parameters were analyzed. The mean of the rotation rate and mean of the elevation rate appeared promising since these variables had the best reliability scores and correlations with task scores. Parameters could be computed even in a patient with a Brooke functional score of 6. The variables chosen are good candidates as potential outcome measures in non-ambulant patients with Duchenne Muscular Dystrophy and use of the ActiMyo (R) is currently being explored in home environment.	[Le Moing, Anne-Gaelle; Seferian, Andreea Mihaela; Moraux, Amelie; Annoussamy, Melanie; Gasnier, Erwan; Hogrel, Jean-Yves; Voit, Thomas; Servais, Laurent] Grp Hosp La Pitie Salpetriere, Inst Myol, Paris, France; [Le Moing, Anne-Gaelle] Ctr Hosp Univ Amiens Picardie, Grp Rech Anal Multimodale Fonct Cerebrale, Serv Neurol Pediat, Amiens, France; [Dorveaux, Eric; Vissiere, David] SYSNAV, Vernon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Servais, L (corresponding author), Grp Hosp La Pitie Salpetriere, Inst Myol, Paris, France.	l.servais@institut-myologie.org	Servais, Laurent/AAL-7384-2020; Dorveaux, Eric/ABE-9144-2021	Dorveaux, Eric/0000-0003-1606-6461; Hogrel, Jean-Yves/0000-0003-0045-7505; Servais, Laurent/0000-0001-9270-4061	Institute of Myology	Institute of Myology	The PreActi study was entirely funded by Institute of Myology, AIM. Eric Dorveaux and David Vissiere are employed by the commercial company SYSNAV. SYSNAV provided support in the form of salaries for authors ED and DV and provided the prototype used for the study and the operating system on a collaboration agreement, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; [Anonymous], PLOS CURR; Bartels B, 2011, J REHABIL MED, V43, P770, DOI 10.2340/16501977-0841; Becq G, 2011, COMPUT BIOL MED, V41, P46, DOI 10.1016/j.compbiomed.2010.11.005; Berard C, 2006, REV NEUROL-FRANCE, V162, P485; BROOKE MH, 1981, MUSCLE NERVE, V4, P186, DOI 10.1002/mus.880040304; Carpinella I, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-67; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Clanchy KM, 2011, EUR J APPL PHYSIOL, V111, P2951, DOI 10.1007/s00421-011-1915-2; Connolly AM, 2015, MUSCLE NERVE, V51, P522, DOI 10.1002/mus.24346; Crassidis JL, 2007, J GUID CONTROL DYNAM, V30, P12, DOI 10.2514/1.22452; Dash D, 2012, EPILEPTIC DISORD, V14, P290, DOI 10.1684/epd.2012.0529; Dencker M, 2008, CLIN PHYSIOL FUNCT I, V28, P133, DOI 10.1111/j.1475-097X.2008.00788.x; Dorveaux E, 2009, IEEE DECIS CONTR P, P8296, DOI 10.1109/CDC.2009.5399503; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; El-Zayat BF, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-72; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Escolar DM, 2001, MUSCLE NERVE, V24, P787, DOI 10.1002/mus.1070; Foster CC, 2008, IEEE T AERO ELEC SYS, V44, P1070, DOI 10.1109/TAES.2008.4655364; Ganea R, 2012, J CHILD NEUROL, V27, P30, DOI 10.1177/0883073811413581; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; GLOSS DS, 1982, PERCEPT MOTOR SKILL, V55, P527, DOI 10.2466/pms.1982.55.2.527; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Gorter JW, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/329284; Grimpampi E, 2013, GAIT POSTURE, V38, P523, DOI 10.1016/j.gaitpost.2013.01.031; Grootenhuis MA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-31; Hamel T, 2006, IEEE INT CONF ROBOT, P2170; HILLER LB, 1992, ARCH PHYS MED REHAB, V73, P527; Hogrel JY, 2016, NEUROLOGY, V86, P1022, DOI 10.1212/WNL.0000000000002464; Jeannet PY, 2011, EUR J PAEDIATR NEURO, V15, P40, DOI 10.1016/j.ejpn.2010.07.002; Kurillo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045341; Lan KC, 2013, SENSORS-BASEL, V13, P4781, DOI 10.3390/s130404781; LORD JP, 1987, ARCH PHYS MED REHAB, V68, P8; Lowes LP, 2015, MUSCLE NERVE, V52, P356, DOI 10.1002/mus.24557; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Mattar FL, 2008, NEUROMUSCULAR DISORD, V18, P193, DOI 10.1016/j.nmd.2007.11.004; Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mazzone ES, 2012, DEV MED CHILD NEUROL, V54, P879, DOI 10.1111/j.1469-8749.2012.04345.x; McDonald CM, 2005, ARCH PHYS MED REHAB, V86, P793, DOI 10.1016/j.apmr.2004.10.011; McDonald CM, 2002, AM J PHYS MED REHAB, V81, pS108, DOI 10.1097/00002060-200211001-00012; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nijsen TME, 2007, IEEE T BIO-MED ENG, V54, P2073, DOI 10.1109/TBME.2007.895114; Nijsen TME, 2010, IEEE T INF TECHNOL B, V14, P1197, DOI 10.1109/TITB.2010.2058123; Paulis WD, 2011, GAIT POSTURE, V33, P185, DOI 10.1016/j.gaitpost.2010.10.094; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; Prahm KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114273; Ricci L, 2014, SENSORS-BASEL, V14, P1057, DOI 10.3390/s140101057; Santoso F, 2015, PHYSIOL MEAS, V36, DOI 10.1088/0967-3334/36/10/R53; Schoeppe S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2053-2; Schulc E, 2011, EPILEPSY RES, V95, P173, DOI 10.1016/j.eplepsyres.2011.02.010; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121799; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; Sosnoff JJ, 2010, MULT SCLER J, V16, P868, DOI 10.1177/1352458510373111; Taffoni F, 2014, IEEE ENG MED BIO, P3638, DOI 10.1109/EMBC.2014.6944411; Van de Vel A, 2013, EPILEPSY BEHAV, V26, P118, DOI 10.1016/j.yebeh.2012.10.006; Vincent KA, 2007, NEUROLOGY, V68, P1051, DOI 10.1212/01.wnl.0000257819.47628.41; Vissiere D, 2007, CONTR C ECC 2007 EUR, P2853; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Zampieri C, 2011, PARKINSONISM RELAT D, V17, P277, DOI 10.1016/j.parkreldis.2010.08.001; Zimetbaum P, 2010, CIRCULATION, V122, P1629, DOI 10.1161/CIRCULATIONAHA.109.925610	68	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156696	10.1371/journal.pone.0156696	http://dx.doi.org/10.1371/journal.pone.0156696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271157	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000032
J	Zuiderveen, GH; Padder, BA; Kamfwa, K; Song, QJ; Kelly, JD				Zuiderveen, Grady H.; Padder, Bilal A.; Kamfwa, Kelvin; Song, Qijian; Kelly, James D.			Genome-Wide Association Study of Anthracnose Resistance in Andean Beans (Phaseolus vulgaris)	PLOS ONE			English	Article							COLLETOTRICHUM-LINDEMUTHIANUM; DISEASE-RESISTANCE; CONDITIONING RESISTANCE; MOLECULAR MARKERS; COMMON; GENES; LOCUS; RACES; IDENTIFICATION; INHERITANCE	Anthracnose is a seed-borne disease of common bean (Phaseolus vulgaris L.) caused by the fungus Colletotrichum lindemuthianum, and the pathogen is cosmopolitan in distribution. The objectives of this study were to identify new sources of anthracnose resistance in a diverse panel of 230 Andean beans comprised of multiple seed types and market classes from the Americas, Africa, and Europe, and explore the genetic basis of this resistance using genome-wide association mapping analysis (GWAS). Twenty-eight of the 230 lines tested were resistant to six out of the eight races screened, but only one cultivar Uyole98 was resistant to all eight races (7, 39, 55, 65, 73, 109, 2047, and 3481) included in the study. Outputs from the GWAS indicated major quantitative trait loci (QTL) for resistance on chromosomes, Pv01, Pv02, and Pv04 and two minor QTL on Pv10 and Pv11. Candidate genes associated with the significant SNPs were detected on all five chromosomes. An independent QTL study was conducted to confirm the physical location of the Co-1 locus identified on Pv01 in an F-4:6 recombinant inbred line (RIL) population. Resistance was determined to be conditioned by the single dominant gene Co-1 that mapped between 50.16 and 50.30 Mb on Pv01, and an InDel marker (NDSU_IND_1_50.2219) tightly linked to the gene was developed. The information reported will provide breeders with new and diverse sources of resistance and genomic regions to target in the development of anthrac-nose resistance in Andean beans.	[Zuiderveen, Grady H.; Padder, Bilal A.; Kamfwa, Kelvin; Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA; [Song, Qijian] USDA ARS, Soybean Genom & Improvement Lab, BARC, 10300 Baltimore Ave, Beltsville, MD 20705 USA; [Zuiderveen, Grady H.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Padder, Bilal A.] Sher E Kashmir Univ Agr Sci & Technol Kashmir, Srinagar 191121, Jammu & Kashmir, India; [Kamfwa, Kelvin] Univ Zambia, Dept Plant Sci, Sch Agr Sci, POB 32379,Great East Rd, Lusaka, Zambia	Michigan State University; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); University of Zambia	Kelly, JD (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA.	kellyj@msu.edu		Padder, Bilal A/0000-0001-8842-2432	Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005-00]	Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID))	Research was supported by the Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Cooperative Agreement No. EDH-A-00-07-00005-00. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; Balardin RS, 1998, J AM SOC HORTIC SCI, V123, P1038, DOI 10.21273/JASHS.123.6.1038; Bello MH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-903; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Burt AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139450; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Cichy KA, 2015, CROP SCI, V55, P2149, DOI 10.2135/cropsci2014.09.0653; Coelho RT., 2013, ANN REP BEAN IMPROV, V56, P43; Coimbra GK, 2014 CON C BRAZ; Collazo C., 2006, BIOTECNOL APL, V23, P1; Creusot F, 1999, GENOME, V42, P254, DOI 10.1139/gen-42-2-254; Delledonne M, P NAT ACAD SCI, V20-98, P13454; Doyle J. J., 1987, PHYTOCHEM B, P11; DRIJFHOUT E, 1989, PLANT PATHOL, V38, P391, DOI 10.1111/j.1365-3059.1989.tb02158.x; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; Fivawo NC, 2011, TANZANIA J NAT APPL, V2, P337; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 2000, MOL PLANT MICROBE IN, V13, P287, DOI 10.1094/MPMI.2000.13.3.287; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Gepts Paul, 2008, V1, P113; Gon?alves AMO., 2010, ANN REP BEAN IMPROV, V53, P220; Goncalves-Vidigal MC, 2013, THEOR APPL GENET, V126, P2245, DOI 10.1007/s00122-013-2131-8; Goncalves-Vidigal MC, 2009, CROP SCI, V49, P133, DOI 10.2135/cropsci2008.01.0004; Goncalves-Vidigal MC, 2008, PLANT BREEDING, V127, P592, DOI 10.1111/j.1439-0523.2008.01530.x; Goncalves-Vidigal MC, 2006, EUPHYTICA, V151, P411, DOI 10.1007/s10681-006-9164-x; Goncalves-Vidigal MC, 2012, PLANT BREEDING, V131, P423, DOI 10.1111/j.1439-0523.2011.01939.x; Goncalves-Vidigal MC, 2011, THEOR APPL GENET, V122, P893, DOI 10.1007/s00122-010-1496-1; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; GUZMAN P, 1979, TURRIALBA, V29, P65; Kamfwa K, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0059; KELLY JD, 1994, PLANT DIS, V78, P892, DOI 10.1094/PD-78-0892; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kelly JD, 1998, CROP SCI, V38, P280; Kelly JD, 2001, CROP SCI, V41, P1647, DOI 10.2135/cropsci2001.4151647x; Lacanallo G. F., 2015, Australian Journal of Crop Science, V9, P394; Lopez CE, 2003, PHYTOPATHOLOGY, V93, P88, DOI 10.1094/PHYTO.2003.93.1.88; Melotto M, 2000, EUPHYTICA, V116, P143, DOI 10.1023/A:1004005001049; Melotto M, 2004, THEOR APPL GENET, V109, P690, DOI 10.1007/s00122-004-1697-6; Melotto M, 2000, COLLETOTRICHUM, P346; Mendoza A, 2001, PLANT DIS, V85, P252, DOI 10.1094/PDIS.2001.85.3.252; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; Moghaddam SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00185; Oblessuc PR, 2015, THEOR APPL GENET, V128, P1193, DOI 10.1007/s00122-015-2500-6; Oblessuc PR, 2014, MOL BREEDING, V34, P1313, DOI 10.1007/s11032-014-0118-z; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Sousa L. L., 2014, Australian Journal of Crop Science, V8, P317; Sousa LL, 2015, CROP SCI, V55, P1900, DOI 10.2135/cropsci2014.09.0604; Trabanco N, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.10.0079; Valentini G, 2015, ANN REP BEAN IMPROV, V58, P21; Vallejo VA, 2003, ANN REP BEAN IMPROV, V44, P121; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Vazin MA, 2014, ANN REPT BEAN IMPROV, V57, P161; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., WINDOWS QTL CARTOGRA; Young RA, 1996, ANN REP BEAN IMPROV, V39, P296; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	65	75	76	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156391	10.1371/journal.pone.0156391	http://dx.doi.org/10.1371/journal.pone.0156391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270627	gold, Green Published, Green Submitted			2022-12-27	WOS:000377560200008
J	Barnett, I; Khanna, T; Onnela, JP				Barnett, Ian; Khanna, Tarun; Onnela, Jukka-Pekka			Social and Spatial Clustering of People at Humanity's Largest Gathering	PLOS ONE			English	Article							HUMAN MOBILITY; NETWORKS; COMMUNICATION; SEGREGATION	Macroscopic behavior of scientific and societal systems results from the aggregation of microscopic behaviors of their constituent elements, but connecting the macroscopic with the microscopic in human behavior has traditionally been difficult. Manifestations of homophily, the notion that individuals tend to interact with others who resemble them, have been observed in many small and intermediate size settings. However, whether this behavior translates to truly macroscopic levels, and what its consequences may be, remains unknown. Here, we use call detail records (CDRs) to examine the population dynamics and manifestations of social and spatial homophily at a macroscopic level among the residents of 23 states of India at the Kumbh Mela, a 3-month-long Hindu festival. We estimate that the festival was attended by 61 million people, making it the largest gathering in the history of humanity. While we find strong overall evidence for both types of homophily for residents of different states, participants from low-representation states show considerably stronger propensity for both social and spatial homophily than those from high-representation states. These manifestations of homophily are amplified on crowded days, such as the peak day of the festival, which we estimate was attended by 25 million people. Our findings confirm that homophily, which here likely arises from social influence, permeates all scales of human behavior.	[Barnett, Ian; Onnela, Jukka-Pekka] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Khanna, Tarun] Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University; Harvard University	Onnela, JP (corresponding author), Harvard Univ, Dept Biostat, Boston, MA 02115 USA.	onnela@hsph.harvard.edu			Harvard T.H. Chan School of Public Health Career Incubator Award; HBS Division of Research	Harvard T.H. Chan School of Public Health Career Incubator Award; HBS Division of Research	IB and JPO are supported by Harvard T.H. Chan School of Public Health Career Incubator Award to JPO. TK is supported by the HBS Division of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; IB and JPO are supported by Harvard T. H. Chan School of Public Health Career Incubator Award to JPO. TK is supported by the HBS Division of Research. The authors declare no conflict of interests. The authors would like to thank Gautam Ahuja, Clare Evans, Gokul Madhavan, Daniel Malter, and Peter Sloot for contributing their helpful comments, suggestions, critiques and discussion, and would like to thank the operator for providing access to their data. A special thanks to the operator for both providing us access to their data as well as accomodating us on their campus grounds as we worked on the analysis. In particular, we wish to express our thanks to employees Rohit Dev and Vikas Singhal for their assistance.	Aleissa F, 2014, KDD WORKSH LEARN EM; [Anonymous], 2013, TRA INDIA ANN REPORT; Blondel VD, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0046-0; Blumer H., 1946, NEW OUTLINE PRINCIPL, P170; COLEMAN JS, 1958, HUM ORGAN, V17, P28, DOI 10.17730/humo.17.4.q5604m676260q8n7; Currarini S, 2009, ECONOMETRICA, V77, P1003, DOI 10.3982/ECTA7528; Gonzalez MC, 2007, PHYSICA A, V379, P307, DOI 10.1016/j.physa.2007.01.002; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Greenough PG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3254; Hallinan MT, 1985, SOC PSYCHOL Q, P3, DOI [10.2307/3033777, DOI 10.2307/3033777]; Hatna E, 2014, ARXIV14065215; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Ingram P, 2007, ADMIN SCI QUART, V52, P558, DOI 10.2189/asqu.52.4.558; Le Bon G., 1897, CROWD STUDY POPULAR; Maclean KK., 2003, POWER PILGRIMAGE KUM; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Ngai KM, 2009, DISASTER MED PUBLIC, V3, P191, DOI 10.1097/DMP.0b013e3181c5b494; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Park R. E., 1972, CROWD PUBLIC; Schelling T.C, 2006, MICROMOTIVES MACROBE; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Simmel G., 1950, SOCIOLOGY G SIMMEL; Simmel G., 1964, SOCIOLOGY G SIMMEL, P409; Strandburg-Peshkin A, 2015, SCIENCE, V348, P1358, DOI 10.1126/science.aaa5099; Sugden J., 2013, WALL STREET J; Vera F., 2015, KUMBH MELA MAPPING E; Vermeij L, 2009, SOC NETWORKS, V31, P230, DOI 10.1016/j.socnet.2009.06.002; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156794	10.1371/journal.pone.0156794	http://dx.doi.org/10.1371/journal.pone.0156794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258037	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700130
J	Genolini, C; Ecochard, R; Benghezal, M; Driss, T; Andrieu, S; Subtil, F				Genolini, Christophe; Ecochard, Rene; Benghezal, Mamoun; Driss, Tarak; Andrieu, Sandrine; Subtil, Fabien			kmlShape: An Efficient Method to Cluster Longitudinal Data (Time-Series) According to Their Shapes	PLOS ONE			English	Article							ALGORITHM; MODEL; CLASSIFICATION; REGISTRATION; TRAJECTORIES; ALIGNMENT; EUROPE; KML3D; CYCLE	Background Longitudinal data are data in which each variable is measured repeatedly over time. One possibility for the analysis of such data is to cluster them. The majority of clustering methods group together individual that have close trajectories at given time points. These methods group trajectories that are locally close but not necessarily those that have similar shapes. However, in several circumstances, the progress of a phenomenon may be more important than the moment at which it occurs. One would thus like to achieve a partitioning where each group gathers individuals whose trajectories have similar shapes whatever the time lag between them. Method In this article, we present a longitudinal data partitioning algorithm based on the shapes of the trajectories rather than on classical distances. Because this algorithm is time consuming, we propose as well two data simplification procedures that make it applicable to high dimensional datasets. Results In an application to Alzheimer disease, this algorithm revealed a "rapid decline" patient group that was not found by the classical methods. In another application to the feminine menstrual cycle, the algorithm showed, contrarily to the current literature, that the luteinizing hormone presents two peaks in an important proportion of women (22%).	[Genolini, Christophe; Benghezal, Mamoun; Andrieu, Sandrine] Univ Toulouse 3, Inserm UMR 1027, F-31062 Toulouse, France; [Genolini, Christophe; Driss, Tarak] Univ Paris Ouest Nanterre La Def, UFR STAPS, CeRSM EA 2931, Nanterre, France; [Ecochard, Rene; Subtil, Fabien] Univ Lyon 1, Serv Biostat, F-69622 Villeurbanne, France; [Ecochard, Rene; Subtil, Fabien] CNRS, UMR5558, Equipe Biotatist Sante, Lab Biometrie & Biol Evolut, Villeurbanne, France; [Andrieu, Sandrine] CHU Toulouse, Dept Epidemiol & Publ Hlth, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Paris Nanterre; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; CHU de Toulouse	Genolini, C (corresponding author), Univ Toulouse 3, Inserm UMR 1027, F-31062 Toulouse, France.; Genolini, C (corresponding author), Univ Paris Ouest Nanterre La Def, UFR STAPS, CeRSM EA 2931, Nanterre, France.	christophe.genolini@u-paris10.fr	DRISS, Tarak/AAR-2823-2020; ANDRIEU, Sandrine/G-1343-2018	DRISS, Tarak/0000-0001-6109-7393; ANDRIEU, Sandrine/0000-0002-1142-770X	Agence National de la Recherche grant [IDoL: ANR-12-BSV1-0036]	Agence National de la Recherche grant(French National Research Agency (ANR))	This research was funded by the Agence National de la Recherche grant IDoL: ANR-12-BSV1-0036 (CG received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was founded by the ANR grant IDoL: ANR-12-BSV1-0036.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Naymat G., 2009, AUSTRALASIAN DATA MI, V101, P117, DOI DOI 10.1007/s10115-004-0154-9; Alliende ME, 2002, FERTIL STERIL, V78, P90, DOI 10.1016/S0015-0282(02)03167-9; ALT H, 1995, INT J COMPUT GEOM AP, V5, P75, DOI 10.1142/S0218195995000064; [Anonymous], 1973, PATTERN CLASSIFICATI; Berndt D.J., 1994, P 3 INT C KNOWL DAT, P359; Bolstad WM., 2007, INTRO BAYESIAN STAT, DOI [10.1002/9780470181188, DOI 10.1002/9780470181188]; Buchin K, 2011, COMP GEOM-THEOR APPL, V44, P465, DOI 10.1016/j.comgeo.2011.05.004; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Cao H, 2006, VLDB J, V15, P211, DOI 10.1007/s00778-005-0163-7; CELEUX G, 1992, COMPUT STAT DATA AN, V14, P315, DOI 10.1016/0167-9473(92)90042-E; Chen L., 2005, P 2005 ACM SIGMOD IN, P491, DOI DOI 10.1145/1066157.1066213; Chen Y, 2015, THE UCR TIME SERIES; Chiou JM, 2007, J ROY STAT SOC B, V69, P679, DOI 10.1111/j.1467-9868.2007.00605.x; Chudova D., 2003, P 9 ACM SIGKDD INT C, P79, DOI DOI 10.1145/956755.956763; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dimeglio C, 2014, COMPUT STAT DATA AN, V70, P373, DOI 10.1016/j.csda.2013.09.030; Direito A, 2013, FERTIL STERIL, V99, P279, DOI 10.1016/j.fertnstert.2012.08.047; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Ecochard R, 2006, STAT METHODS MED RES, V15, P141, DOI 10.1191/0962280206sm436oa; Ecochard R, 2001, BRIT J OBSTET GYNAEC, V108, P822, DOI 10.1111/j.1471-0528.2001.00194.x; Ecochard R, 2000, HUM REPROD, V15, P752, DOI 10.1093/humrep/15.4.752; Elsensohn MH, 2013, STAT METHODS MED RES; Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7; Everitt B. S., 2001, CLUSTER ANAL; Frechet M., 1906, REND CIRC MATEM PALE, V22, P1, DOI [DOI 10.1007/BF03018603, 10.1007/BF03018603]; Gaffney S. J., 2004, NIPS, P473; Garcia-Escudero LA, 2005, J CLASSIF, V22, P185, DOI 10.1007/s00357-005-0013-8; Genolini C, 2013, COMPUT METH PROG BIO, V109, P104, DOI 10.1016/j.cmpb.2012.08.016; Genolini C, 2013, OPEN J STAT, V3, P26, DOI [DOI 10.4236/OJS.2013.34A004, 10.4236/ojs.2013.34A004]; Genolini C, 2015, COMPUTER ME IN PRESS, P1; Genolini C, 2015, J STAT SOFTW, V65, P1, DOI 10.18637/jss.v065.i04; Genolini C, 2010, COMPUTATION STAT, V25, P317, DOI 10.1007/s00180-009-0178-4; Gudmundsson J, 2009, COMP GEOM-THEOR APPL, V42, P825, DOI 10.1016/j.comgeo.2009.02.002; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; James GM, 2007, ANN APPL STAT, V1, P480, DOI 10.1214/07-AOAS127; James GM, 2003, J AM STAT ASSOC, V98, P397, DOI 10.1198/016214503000189; Kadous MW, 1999, MACHINE LEARNING, PROCEEDINGS, P454; Kaziska D, 2007, J AM STAT ASSOC, V102, P1114, DOI 10.1198/016214507000000464; Keogh E, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P289, DOI 10.1109/ICDM.2001.989531; Keogh E, 2005, KNOWL INF SYST, V7, P358, DOI 10.1007/s10115-004-0154-9; Khan SS, 2004, PATTERN RECOGN LETT, V25, P1293, DOI 10.1016/j.patrec.2004.04.007; Lee J.-G., 2007, P 2007 ACM SIGMOD IN, P593, DOI DOI 10.1145/1247480.1247546; Liu XL, 2009, COMPUT STAT DATA AN, V53, P1361, DOI 10.1016/j.csda.2008.11.019; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; Lucero JC, 1997, J SPEECH LANG HEAR R, V40, P1111, DOI 10.1044/jslhr.4005.1111; Mackelprang RD, 2012, J INFECT DIS, V206, P1299, DOI 10.1093/infdis/jis480; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Magidson J., 2002, CAN J MARKET RES, V20, P37, DOI DOI 10.1017/CBO9780511499531.004; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Panagiotakis C, 2012, IEEE T KNOWL DATA EN, V24, P1328, DOI 10.1109/TKDE.2011.39; Patriarca M, 2013, FDAKMA CLUSTERING AL; Pena JM, 1999, PATTERN RECOGN LETT, V20, P1027, DOI 10.1016/S0167-8655(99)00069-0; Pingault JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062594; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; Ramer U., 1972, COMPUT GRAPH-UK, V1, P244, DOI [DOI 10.1016/S0146-664X(72)80017-0, 10.1016/S0146-664X(72)80017-0]; Ramsay J, 1998, SPRINGER SERIES STAT; Ramsay JO, 1998, J ROY STAT SOC B, V60, P351, DOI 10.1111/1467-9868.00129; Ranciere F, 2013, ALLERGY, V68, P1158, DOI 10.1111/all.12208; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ray S., 1999, P 4 INT C ADV PATTER, P137; Redmond SJ, 2007, PATTERN RECOGN LETT, V28, P965, DOI 10.1016/j.patrec.2007.01.001; Reynish E, 2007, NEUROEPIDEMIOLOGY, V29, P29, DOI 10.1159/000108915; Roverso D., 2000, 3 ANS INT TOP M NUCL, V20, P1; Sangalli LM, 2010, COMPUT STAT DATA AN, V54, P1219, DOI 10.1016/j.csda.2009.12.008; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shim Y, 2006, INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE FOR MODELLING, CONTROL & AUTOMATION JOINTLY WITH INTERNATIONAL CONFERENCE ON INTELLIGENT AGENTS, WEB TECHNOLOGIES & INTERNET COMMERCE, VOL 1, PROCEEDINGS, P199; Steinley D, 2007, J CLASSIF, V24, P99, DOI 10.1007/s00357-007-0003-0; Tarpey T, 2003, J CLASSIF, V20, P93, DOI 10.1007/s00357-003-0007-3; Tarpey T, 2007, COMPUTATION STAT, V22, P71, DOI 10.1007/s00180-007-0022-7; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; Vellas B, 2012, CURR ALZHEIMER RES, V9, P902, DOI 10.2174/156720512803251066; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784	78	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0150738	10.1371/journal.pone.0150738	http://dx.doi.org/10.1371/journal.pone.0150738			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258355	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700003
J	Matsuo, R; Ago, T; Hata, J; Wakisaka, Y; Kuroda, J; Kuwashiro, T; Kitazono, T; Kamouchi, M				Matsuo, Ryu; Ago, Tetsuro; Hata, Jun; Wakisaka, Yoshinobu; Kuroda, Junya; Kuwashiro, Takahiro; Kitazono, Takanari; Kamouchi, Masahiro		Fukuoka Stroke Registry Investigat	Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); RISK; INFLAMMATION; DISEASE; INCREASES; PROGNOSIS; MORTALITY; PREDICT; EVENTS	Background and Purpose Although plasma C-reactive protein (CRP) is elevated in response to inflammation caused by brain infarction, the association of CRP with clinical outcomes after acute ischemic stroke remains uncertain. This study examined whether plasma high-sensitivity CRP (hsCRP) levels at onset were associated with clinical outcomes after acute ischemic stroke independent of conventional risk factors and acute infections after stroke. Methods We prospectively included 3653 patients with first-ever ischemic stroke who had been functionally independent and were hospitalized within 24 h of onset. Plasma hsCRP levels were measured on admission and categorized into quartiles. The association between hsCRP levels and clinical outcomes, including neurological improvement, neurological deterioration, and poor functional outcome (modified Rankin scale >= 3 at 3 months), were investigated using a logistic regression analysis. Results Higher hsCRP levels were significantly associated with unfavorable outcomes after adjusting for age, sex, baseline National Institutes of Health Stroke Scale score, stroke subtype, conventional risk factors, intravenous thrombolysis and endovascular therapy, and acute infections during hospitalization (multivariate-adjusted odds ratios [95% confidence interval] in the highest quartile versus the lowest quartile as a reference: 0.80 [0.65-0.97] for neurological improvement, 1.72 [1.26-2.34] for neurological deterioration, and 2.03 [1.55-2.67] for a poor functional outcome). These associations were unchanged after excluding patients with infectious diseases occurring during hospitalization, or those with stroke recurrence or death. These trends were similar irrespective of stroke subtypes or baseline stroke severity, but more marked in patients aged <70 years (P-heterogeneity = 0.001). Conclusions High plasma hsCRP is independently associated with unfavorable clinical outcomes after acute ischemic stroke.	[Matsuo, Ryu; Ago, Tetsuro; Wakisaka, Yoshinobu; Kuroda, Junya; Kuwashiro, Takahiro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Matsuo, Ryu; Kamouchi, Masahiro] Kyushu Univ, Dept Hlth Care Adm & Management, Grad Sch Med Sci, Fukuoka 812, Japan; [Hata, Jun; Wakisaka, Yoshinobu; Kitazono, Takanari; Kamouchi, Masahiro] Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, Fukuoka 812, Japan; [Kuwashiro, Takahiro] Kyushu Med Ctr, Natl Hosp Org, Dept Cerebrovasc Med & Neurol, Cerebrovasc Ctr, Fukuoka, Japan; [Kuwashiro, Takahiro] Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Kamouchi, M (corresponding author), Kyushu Univ, Dept Hlth Care Adm & Management, Grad Sch Med Sci, Fukuoka 812, Japan.; Kamouchi, M (corresponding author), Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, Fukuoka 812, Japan.	kamouchi@hcam.med.kyushu-u.ac.jp		Ago, Tetsuro/0000-0003-4560-6594	Japan Society for the Promotion of Science (JSPS) KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology [26293158, 15K08849]; Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [15K08849] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 26293158 to MK and 15K08849 to RM from the Japanese Ministry of Education, Culture, Sports, Science and Technology and the Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus to MK from Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Arenillas JF, 2003, STROKE, V34, P2463, DOI 10.1161/01.STR.0000089920.93927.A7; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Christensen H, 2004, CEREBROVASC DIS, V18, P214, DOI 10.1159/000079944; Cucchiara BL, 2009, STROKE, V40, P2332, DOI 10.1161/STROKEAHA.109.553545; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; Di Napoli M, 2002, STROKE, V33, P1763, DOI 10.1161/01.STR.0000019124.54361.08; Di Napoli M, 2001, STROKE, V32, P133, DOI 10.1161/01.STR.32.1.133; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Di Napoli M, 2011, EXPERT REV CARDIOVAS, V9, P1565, DOI [10.1586/erc.11.159, 10.1586/ERC.11.159]; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Lane T, 2014, CIRC RES, V114, P672, DOI 10.1161/CIRCRESAHA.114.302770; Luna JM, 2014, STROKE, V45, P979, DOI 10.1161/STROKEAHA.113.002289; Makita S, 2009, ATHEROSCLEROSIS, V204, P234, DOI 10.1016/j.atherosclerosis.2008.07.040; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Montaner J, 2006, STROKE, V37, P1205, DOI 10.1161/01.STR.0000217744.89208.4e; Muir KW, 1999, STROKE, V30, P981, DOI 10.1161/01.STR.30.5.981; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shinohara Y, 2008, INT J STROKE, V3, P55, DOI 10.1111/j.1747-4949.2008.00178.x; Song IU, 2010, EUR NEUROL, V64, P304, DOI 10.1159/000321415; Song IU, 2009, CEREBROVASC DIS, V28, P545, DOI 10.1159/000247597; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Toyoda K, 2009, STROKE, V40, P2585, DOI 10.1161/STROKEAHA.108.543587; Verma S, 2003, AM J PHYSIOL-REG I, V285, pR1253, DOI 10.1152/ajpregu.00170.2003; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wakugawa Y, 2006, STROKE, V37, P27, DOI 10.1161/01.STR.0000194958.88216.87; Welsh P, 2009, CEREBROVASC DIS, V27, P247, DOI 10.1159/000196823; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Yong M, 2008, STROKE, V39, P2749, DOI 10.1161/STROKEAHA.108.514307	37	39	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156790	10.1371/journal.pone.0156790	http://dx.doi.org/10.1371/journal.pone.0156790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258004	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700129
J	Robinson, NJ; Majewska, R; Lazo-Wasem, EA; Nel, R; Paladino, FV; Rojas, L; Zardus, JD; Pinou, T				Robinson, Nathan J.; Majewska, Roksana; Lazo-Wasem, Eric A.; Nel, Ronel; Paladino, Frank V.; Rojas, Lourdes; Zardus, John D.; Pinou, Theodora			Epibiotic Diatoms Are Universally Present on All Sea Turtle Species	PLOS ONE			English	Article							CHELONIA-MYDAS; CARETTA-CARETTA; MARINE TURTLES; BACILLARIOPHYTA; SKIN; GENERA	The macro-epibiotic communities of sea turtles have been subject to growing interest in recent years, yet their micro-epibiotic counterparts are almost entirely unknown. Here, we provide the first evidence that diatoms are epibionts for all seven extant species of sea turtle. Using Scanning Electron Microscopy, we inspected superficial carapace or skin samples from a single representative of each turtle species. We distinguished 18 diatom taxa from these seven individuals, with each sea turtle species hosting at least two diatom taxa. We recommend that future research is undertaken to confirm whether diatom communities vary between sea turtle species and whether these diatom taxa are facultative or obligate commensals.	[Robinson, Nathan J.; Paladino, Frank V.] Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Guanacaste, Costa Rica; [Robinson, Nathan J.; Paladino, Frank V.] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA; [Majewska, Roksana] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, BioNEM Lab, Catanzaro, Italy; [Lazo-Wasem, Eric A.; Rojas, Lourdes] Yale Univ, Peabody Museum Nat Hist, Div Invertebrate Zool, New Haven, CT USA; [Nel, Ronel] Nelson Mandela Metropolitan Univ, Inst Coastal & Marine Res, Port Elizabeth, South Africa; [Zardus, John D.] The Citadel, Dept Biol, 171 Moultrie St, Charleston, SC 29407 USA; [Pinou, Theodora] Western Connecticut State Univ, Dept Biol & Environm Sci, Danbury, CT USA	Purdue University System; Indiana University Purdue University Fort Wayne; Magna Graecia University of Catanzaro; Yale University; Nelson Mandela University; Connecticut State University System; Western Connecticut State University	Robinson, NJ (corresponding author), Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Guanacaste, Costa Rica.; Robinson, NJ (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA.	nathan@leatherback.org	Zardus, John/V-4470-2019; Robinson, Nathan/AAE-4717-2019; Majewska, Roksana/P-1280-2015	Robinson, Nathan/0000-0001-7384-3576; Majewska, Roksana/0000-0003-2681-4304; Paladino, Frank V./0000-0002-6452-0086	WCSU-AAUP [241290]	WCSU-AAUP	This study was funded by a WCSU-AAUP grant (#241290) to Theodora Pinou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunkley-Williams L, 2008, COMP PARASITOL, V75, P263, DOI 10.1654/4252.1; Denys Luc, 1997, Diatom Research, V12, P1; Frankovich TA, 2015, PHYTOTAXA, V234, P227, DOI 10.11646/phytotaxa.234.3.3; Frankovich TA, 2015, PHYTOTAXA, V204, P33, DOI 10.11646/phytotaxa.204.1.3; Frenguelli J., 1958, I ANTARTICO ARGENTIN, V5; Frick MG, 2013, CRC MAR BIOL SER, P399; Frick Michael G., 1998, Herpetological Review, V29, P211; GIFFEN MH, 1970, BOT MAR, V13, P87; Greenblatt RJ, 2004, VIROLOGY, V321, P101, DOI 10.1016/j.virol.2003.12.026; Grunow A., 1860, VERHANDLUNGEN KAISER, V10, P503; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014; Holmes R.W., 1989, OTSUCHI MARINE RES C, V15, P15; Holmes Robert W., 1993, Bulletin of the National Science Museum Series B (Botany), V19, P1; HOLMES RW, 1985, BRIT PHYCOL J, V20, P43, DOI 10.1080/00071618500650061; Hustedt F., 1958, DSCH ANTARKT EXPED 1, P103; Lazo-Wasem EA, 2011, B PEABODY MUS NAT HI, V52, P221, DOI 10.3374/014.052.0203; Majewska R, 2015, PHYTOTAXA, V233, P236, DOI 10.11646/phytotaxa.233.3.2; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; Pfaller JB, 2014, MAR BIOL, V161, P2167, DOI 10.1007/s00227-014-2498-3; Reich KJ, 2010, MAR BIOL, V157, P113, DOI 10.1007/s00227-009-1300-4; Robinson NJ, J MAR BIOL ASSOC UK, DOI [10.1017/S0025315416000734, DOI 10.1017/S0025315416000734]; Round F. E., 1990, DIATOMS BIOL MORPHOL; Senties A, 1999, B MAR SCI, V64, P185; Wahl M, 1999, MAR ECOL PROG SER, V187, P59, DOI 10.3354/meps187059; Wetzel CE, 2012, DIATOM RES, V27, P1, DOI 10.1080/0269249X.2011.642498; Witkowski A., 2000, ICONOGRAPHIA DIATOMO, V7, P1	27	35	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157011	10.1371/journal.pone.0157011	http://dx.doi.org/10.1371/journal.pone.0157011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257972	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700168
J	Sarker, PK; Kapuscinski, AR; Lanois, AJ; Livesey, ED; Bernhard, KP; Coley, ML				Sarker, Pallab K.; Kapuscinski, Anne R.; Lanois, Alison J.; Livesey, Erin D.; Bernhard, Katie P.; Coley, Mariah L.			Towards Sustainable Aquafeeds: Complete Substitution of Fish Oil with Marine Microalga Schizochytrium sp Improves Growth and Fatty Acid Deposition in Juvenile Nile Tilapia (Oreochromis niloticus)	PLOS ONE			English	Article							X-O-AUREUS; DOCOSAHEXAENOIC ACID; IMMUNE FUNCTION; DIETARY LIPIDS; HYBRID TILAPIA; REPLACEMENT; PROTEIN; QUALITY; MEAL; METABOLISM	We conducted a 84-day nutritional feeding experiment with dried whole cells of DHA-rich marine microalga Schizochytrium sp. (Sc) to determine the optimum level of fish-oil substitution (partial or complete) for maximum growth of Nile tilapia. When we fully replaced fish oil with Schizochytrium (Sc100 diet), we found significantly higher weight gain and protein efficiency ratio (PER), and lower (improved) feed conversion ratio (FCR) and feed intake compared to a control diet containing fish oil (Sc0); and no significant change in SGR and survival rate among all diets. The Sc100 diet had the highest contents of 22:6n3 DHA, led to the highest DHA content in fillets, and consequently led to the highest DHA: EPA ratios in tilapia fillets. Schizochytrium sp. is a high quality candidate for complete substitution of fish oil in juvenile Nile tilapia feeds, providing an innovative means to formulate and optimize the composition of tilapia juvenile feed while simultaneously raising feed efficiency of tilapia aquaculture and to further develop environmentally and socially sustainable aquafeeds. Results show that replacing fish oil with DHA-rich marine Sc improves the deposition of n3 LC PUFA levels in tilapia fillet. These results support further studies to lower Schizochytrium production costs and to combine different marine microalgae to replace fish oil and fishmeal into aquafeeds.	[Sarker, Pallab K.; Kapuscinski, Anne R.; Lanois, Alison J.; Livesey, Erin D.; Bernhard, Katie P.; Coley, Mariah L.] Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; [Coley, Mariah L.] Univ Calif Davis, Sustainable Agr Res & Educ Program, One Shields Ave, Davis, CA 95616 USA	Dartmouth College; University of California System; University of California Davis	Sarker, PK (corresponding author), Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA.	Pallab.K.Sarker@dartmouth.edu		Bernhard, Katie P./0000-0002-4121-7850	Sherman Fairchild Distinguished Professorship in Sustainability Science; Dean of the Faculty of Arts and Sciences, Dartmouth College	Sherman Fairchild Distinguished Professorship in Sustainability Science; Dean of the Faculty of Arts and Sciences, Dartmouth College	This research was supported by the Sherman Fairchild Distinguished Professorship in Sustainability Science (to ARK) and the Dean of the Faculty of Arts and Sciences, Dartmouth College.	Association of Official Analytical Chemists, 1995, OFFICIAL METHODS ANA, V1; Barrows F, 2010, FUTURE AQUAFEEDS, P15; Brasky TM, 2011, AM J EPIDEMIOL, V173, P1429, DOI 10.1093/aje/kwr027; Bureau DP, 2008, J WORLD AQUACULT SOC, V39, P1, DOI 10.1111/j.1749-7345.2007.00146.x; Chauton MS, 2015, AQUACULTURE, V436, P95, DOI 10.1016/j.aquaculture.2014.10.038; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; FAO (Food and Agriculture Organization of the United Nations), 2012, STAT WORLD FISH AQ S; Glencross B, 2011, AQUACULT NUTR, V17, pE536, DOI 10.1111/j.1365-2095.2010.00795.x; Glencross BD, 2001, AQUACULT NUTR, V7, P101, DOI 10.1046/j.1365-2095.2001.00158.x; Gross M, 2015, APPL MICROBIOL BIOT, V99, P5781, DOI 10.1007/s00253-015-6736-5; Hall SJ., 2011, BLUE FRONTIERS MANAG; Hemaiswarya S, 2011, WORLD J MICROB BIOT, V27, P1737, DOI 10.1007/s11274-010-0632-z; Huang CH, 1998, COMP BIOCHEM PHYS B, V120, P331, DOI 10.1016/S0305-0491(98)10022-6; Hussein E. E., 2012, AQUAC RES, V44, P937; Karapanagiotidis IT, 2007, LIPIDS, V42, P547, DOI 10.1007/s11745-007-3057-1; Kousoulaki K, 2016, AQUACULTURE, V451, P47, DOI 10.1016/j.aquaculture.2015.08.027; Menoyo D, 2005, J ANIM SCI, V83, P2853; Menoyo D, 2004, BRIT J NUTR, V92, P41, DOI 10.1079/BJN20041165; Mourente G, 2007, BRIT J NUTR, V98, P770, DOI 10.1017/S000711450773461X; Nauroth JM, 2010, LIPIDS, V45, P375, DOI 10.1007/s11745-010-3406-3; Ng W.K., 2005, GLOB AQUACULT AD OCT, P60; Ng WK, 2009, FOOD CHEM, V113, P1041, DOI 10.1016/j.foodchem.2008.08.060; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; Raghukumar S, 2008, MAR BIOTECHNOL, V10, P631, DOI 10.1007/s10126-008-9135-4; Ryckebosch E., 2012, Lipid Technology, V24, P128, DOI 10.1002/lite.201200197; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sarker PK, 2016, AQUACULT NUTR, V22, P109, DOI 10.1111/anu.12230; Sarker PK, 2013, REV AQUACULT, V5, P199, DOI 10.1111/raq.12013; SHIAU SY, 1990, AQUACULTURE, V86, P401, DOI 10.1016/0044-8486(90)90328-K; Suloma A., 2008, 8 INT S TIL AQ CAIR, P921; Tacon AGJ., 2011, DEMAND SUPPLY FEED I; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; TAKEUCHI T, 1983, B JPN SOC SCI FISH, V49, P1127; Thompson KR, 2012, N AM J AQUACULT, V74, P365, DOI 10.1080/15222055.2012.675999; Trushenski JT, 2009, N AM J AQUACULT, V71, P242, DOI 10.1577/A08-051.1; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Vechklang K, 2011, AQUACULT NUTR, V17, P685, DOI 10.1111/j.1365-2095.2011.00870.x; Walker DA, 2009, J APPL PHYCOL, V21, P509, DOI 10.1007/s10811-009-9446-5; Weaver KL, 2008, J AM DIET ASSOC, V108, P1178, DOI 10.1016/j.jada.2008.04.023; White R.L., 2015, IND BIOTECHNOL, V11, P213, DOI [DOI 10.1089/IND.2015.0006, 10.1089/ind.2015.0006]; Yokoyama Rinka, 2007, Mycoscience, V48, P199, DOI 10.1007/s10267-006-0362-0; YONES AM, 2013, MERIT RES J FOOD SCI, V1, P9	43	110	116	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156684	10.1371/journal.pone.0156684	http://dx.doi.org/10.1371/journal.pone.0156684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258552	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700104
J	Kelly, C; Gaskell, KM; Richardson, M; Klein, N; Garner, P; MacPherson, P				Kelly, Christine; Gaskell, Katherine M.; Richardson, Marty; Klein, Nigel; Garner, Paul; MacPherson, Peter			Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes	PLOS ONE			English	Review							T-CELL-ACTIVATION; POOR IMMUNOLOGICAL RESPONDERS; INFECTED PATIENTS; MICROBIAL TRANSLOCATION; VIROLOGICAL RESPONSES; POSITIVE INDIVIDUALS; INCREASED MORTALITY; LYMPHOID-TISSUE; RECOVERY; RECONSTITUTION	Background A discordant immune response (DIR) is a failure to satisfactorily increase CD4 counts on ART despite successful virological control. Literature on the clinical effects of DIR has not been systematically evaluated. We aimed to summarise the risk of mortality, AIDS and serious non-AIDS events associated with DIR with a systematic review. Methods The protocol is registered with the Centre for Review Dissemination, University of York (registration number CRD42014010821). Included studies investigated the effect of DIR on mortality, AIDS, or serious non-AIDS events in cohort studies or cohorts contained in arms of randomised controlled trials for adults aged 16 years or older. DIR was classified as a suboptimal CD4 count (as defined by the study) despite virological suppression following at least 6 months of ART. We systematically searched PubMed, Embase, and the Cochrane Library to December 2015. Risk of bias was assessed using the Cochrane tool for assessing risk of bias in cohort studies. Two authors applied inclusion criteria and one author extracted data. Risk ratios were calculated for each clinical outcome reported. Results Of 20 studies that met the inclusion criteria, 14 different definitions of DIR were used. Risk ratios for mortality in patients with and without DIR ranged between 1.00 (95% CI 0.26 to 3.92) and 4.29 (95% CI 1.96 to 9.38) with the majority of studies reporting a 2 to 3 fold increase in risk. Conclusions DIR is associated with a marked increase in mortality in most studies but definitions vary widely. We propose a standardised definition to aid the development of management options for DIR.	[Kelly, Christine] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Kelly, Christine; Gaskell, Katherine M.] Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Gaskell, Katherine M.] London Sch Hyg & Trop Med, London WC1, England; [Richardson, Marty; Garner, Paul] Univ Liverpool, Liverpool Sch Trop Med, Ctr Evidence Synth, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Klein, Nigel] UCL, Inst Child Hlth, London, England; [MacPherson, Peter] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [MacPherson, Peter] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [MacPherson, Peter] North West Publ Hlth England Ctr, Liverpool, Merseyside, England	University of Liverpool; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; University of London; University College London; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Kelly, C (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.; Kelly, C (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi.	christine.kelly@liverpool.ac.uk	MacPherson, Peter/AHD-2477-2022; Garner, Paul/Y-8385-2019; Garner, Paul/HII-5856-2022	MacPherson, Peter/0000-0002-0329-9613; Garner, Paul/0000-0002-0607-6941; Richardson, Marty/0000-0002-7097-8704; Gaskell, Katherine M/0000-0003-4691-6359; Klein, Nigel/0000-0003-3925-9258; Kelly, Christine/0000-0002-3239-7714	Wellcome Trust Training Fellowship [099934/Z/12/A]; Wellcome Trust [WT089673]; Effective Health Care Research Consortium; UK Government [5242]; EPSRC [EP/I019405/1] Funding Source: UKRI; National Institute for Health Research [ACF-2014-20-001] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26304008, 23592747, 23659643, 26461240] Funding Source: KAKEN	Wellcome Trust Training Fellowship(Wellcome Trust); Wellcome Trust(Wellcome Trust); Effective Health Care Research Consortium; UK Government; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	CK was supported by a Wellcome Trust Training Fellowship, grant number: 099934/Z/12/A. PM was supported by the Wellcome Trust (grant number: WT089673). PG is supported by the Effective Health Care Research Consortium. This Consortium is funded by UK aid from the UK Government for the benefit of developing countries (Grant: 5242). The views expressed in this publication do not necessarily reflect UK government policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Barrett L, 2014, AIDS, V28, P2045, DOI 10.1097/QAD.0000000000000405; Batista G, 2015, MED MALADIES INFECT, V45, P199, DOI 10.1016/j.medmal.2015.03.009; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BenMarzouk-Hidalgo OJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000781; Beq S, 2004, EUR CYTOKINE NETW, V15, P279; Berenguer J, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES.2015.20.47.30070; Castro P, 2013, AIDS RES HUM RETROV, V29, P68, DOI [10.1089/aid.2012.0145, 10.1089/AID.2012.0145]; Cenderello G, 2016, EXPERT REV ANTI-INFE, V14, P29, DOI 10.1586/14787210.2016.1106937; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Delobel P, 2006, J VIROL, V80, P10229, DOI 10.1128/JVI.00965-06; Diaz A, 2010, AIDS, V24, P2029, DOI 10.1097/QAD.0b013e32833c3268; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Falster K, 2009, JAIDS-J ACQ IMM DEF, V50, P307, DOI 10.1097/QAI.0b013e3181945ed4; Funderburg NT, 2014, CURR OPIN HIV AIDS, V9, P80, DOI 10.1097/COH.0000000000000019; Funderburg NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083514; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Ganesan A, 2011, J INFECT DIS, V203, P756, DOI 10.1093/infdis/jiq115; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hermans SM, 2012, TROP MED INT HEALTH, V17, P1527, DOI 10.1111/tmi.12001; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Imamichi H, 2011, AIDS, V25, P159, DOI 10.1097/QAD.0b013e328340a270; Jacobson JM, 2014, JAIDS-J ACQ IMM DEF, V66, P399, DOI 10.1097/QAI.0000000000000195; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Li TS, 2011, CLIN INFECT DIS, V53, P944, DOI 10.1093/cid/cir552; Lichtfuss GF, 2012, J IMMUNOL, V189, P1491, DOI 10.4049/jimmunol.1200458; Loutfy MR, 2010, JAIDS-J ACQ IMM DEF, V55, P451, DOI 10.1097/QAI.0b013e3181ec28ff; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mavigner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007658; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Nakanjako D, 2015, TROP MED INT HEALTH, V20, P380, DOI 10.1111/tmi.12442; Nakanjako Damalie, 2008, AIDS Res Ther, V5, P23, DOI 10.1186/1742-6405-5-23; Negredo E, 2013, J ANTIMICROB CHEMOTH, V68, P2358, DOI 10.1093/jac/dkt183; Nicastri E, 2005, J MED VIROL, V76, P153, DOI 10.1002/jmv.20352; Okulicz JF, 2015, JAMA INTERN MED, V175, P88, DOI 10.1001/jamainternmed.2014.4010; Pacheco YM, 2009, CURR HIV RES, V7, P612, DOI 10.2174/157016209789973673; Pakker NG, 1999, AIDS, V13, P203, DOI 10.1097/00002030-199902040-00008; Pallikkuth S, 2013, J INFECT DIS, V208, P1613, DOI 10.1093/infdis/jit387; Plana M, 2011, IMMUNOLOGY, V133, P318, DOI 10.1111/j.1365-2567.2011.03442.x; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Savarino A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0178-0; Schechter M, 2006, J ANTIMICROB CHEMOTH, V58, P506, DOI 10.1093/jac/dkl263; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Shive CL, 2014, J INFECT DIS, V210, P619, DOI 10.1093/infdis/jiu125; Smith CJ, 2003, AIDS, V17, P963, DOI 10.1097/00002030-200305020-00004; Somsouk M, 2015, AIDS, V29, P43, DOI 10.1097/QAD.0000000000000511; Stiksrud B, 2015, JAIDS-J ACQ IMM DEF, V70, P329, DOI 10.1097/QAI.0000000000000784; Taiwo BO, 2009, HIV MED, V10, P657, DOI 10.1111/j.1468-1293.2009.00739.x; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Tan R, 1999, J ACQ IMMUN DEF SYND, V47, P553, DOI [10.1097/QAI.0b013e31816856c5, DOI 10.1097/QAI.OBO13E31816856C5]; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; Vogler MA, 1999, J ACQ IMMUN DEF SYND, V36, P576; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Wilson EMP, 2013, IMMUNOL REV, V254, P343, DOI 10.1111/imr.12064; Yi TJ, 2013, CLIN INFECT DIS, V57, P1331, DOI 10.1093/cid/cit539; Zanussi S, 1999, CLIN EXP IMMUNOL, V116, P486; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055	81	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156099	10.1371/journal.pone.0156099	http://dx.doi.org/10.1371/journal.pone.0156099			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284683	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000377564000007
J	Liew, TS; Schilthuizen, M				Liew, Thor-Seng; Schilthuizen, Menno			A Method for Quantifying, Visualising, and Analysing Gastropod Shell Form	PLOS ONE			English	Article							GEOMETRIC ANALYSIS; SECTORIAL-EXPANSION; MOLLUSCAN SHELL; COILED-SHELL; GROWTH; SHAPE; MORPHOGENESIS; 3D; REPRESENTATION; PLECTOSTOMA	Quantitative analysis of organismal form is an important component for almost every branch of biology. Although generally considered an easily-measurable structure, the quantification of gastropod shell form is still a challenge because many shells lack homologous structures and have a spiral form that is difficult to capture with linear measurements. In view of this, we adopt the idea of theoretical modelling of shell form, in which the shell form is the product of aperture ontogeny profiles in terms of aperture growth trajectory that is quantified as curvature and torsion, and of aperture form that is represented by size and shape. We develop a workflow for the analysis of shell forms based on the aperture ontogeny profile, starting from the procedure of data preparation (retopologising the shell model), via data acquisition (calculation of aperture growth trajectory, aperture form and ontogeny axis), and data presentation (qualitative comparison between shell forms) and ending with data analysis (quantitative comparison between shell forms). We evaluate our methods on representative shells of the genera Opisthostoma and Plectostoma, which exhibit great variability in shell form. The outcome suggests that our method is a robust, reproducible, and versatile approach for the analysis of shell form. Finally, we propose several potential applications of our methods in functional morphology, theoretical modelling, taxonomy, and evolutionary biology.	[Liew, Thor-Seng; Schilthuizen, Menno] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia; [Liew, Thor-Seng; Schilthuizen, Menno] Leiden Univ, Inst Biol Leiden, POB 9516, NL-2300 RA Leiden, Netherlands; [Liew, Thor-Seng; Schilthuizen, Menno] Nat Biodivers Ctr, POB 9517, NL-2300 RA Leiden, Netherlands	Universiti Malaysia Sabah; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center	Liew, TS (corresponding author), Univ Malaysia Sabah, Inst Trop Biol & Conservat, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.; Liew, TS (corresponding author), Leiden Univ, Inst Biol Leiden, POB 9516, NL-2300 RA Leiden, Netherlands.; Liew, TS (corresponding author), Nat Biodivers Ctr, POB 9517, NL-2300 RA Leiden, Netherlands.	thorsengliew@gmail.com	Liew, Thor-Seng/AHC-0363-2022	Liew, Thor-Seng/0000-0002-9437-5924	Research Council for Earth and Life Sciences (ALW-NWO) [819.01.012]	Research Council for Earth and Life Sciences (ALW-NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by project 819.01.012 of Research Council for Earth and Life Sciences (ALW-NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2012, PALAEONTOL ELECTRON, V15, P1, DOI DOI 10.26879/284; ACKERLY S C, 1989, Palaios, V4, P374, DOI 10.2307/3514561; ACKERLY SC, 1989, PALEOBIOLOGY, V15, P147, DOI 10.1017/S0094837300009337; Andrei RM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S16; Atwood JW, 2012, J PALEONTOL, V86, P813, DOI 10.1666/12-003.1; Bayer U., 1978, ABHANDLUNGEN, V156, P226; Boettiger A, 2009, P NATL ACAD SCI USA, V106, P6837, DOI 10.1073/pnas.0810311106; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1980, AM ZOOL, V20, P627; BOOKSTEIN FL, 1977, MATH BIOSCI, V34, P177, DOI 10.1016/0025-5564(77)90101-8; Brandmaier AM, 2015, J STAT SOFTWARE, V65, DOI 10.18637/jss.v067.i05; Brandmaier AM, 2012, PERMUTATION DISTRIBU; CAIN AJ, 1977, PHILOS T ROY SOC B, V277, P377, DOI 10.1098/rstb.1977.0026; CAMERON RAD, 1981, BIOL J LINN SOC, V16, P157, DOI 10.1111/j.1095-8312.1981.tb01648.x; Cardini A, 2013, HYSTRIX, V24, P1, DOI 10.4404/hystrix-24.1-8749; Cassola VF, 2010, PHYS MED BIOL, V55, P133, DOI 10.1088/0031-9155/55/1/009; Chacon R, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412300054; Chaplin TA, 2013, J COMP NEUROL, V521, P1001, DOI 10.1002/cne.23215; CHECA A, 1992, PALAEONTOLOGY, V35, P913; CHECA A, 1991, LETHAIA, V24, P97, DOI 10.1111/j.1502-3931.1991.tb01183.x; Cignoni P., 2008, ERCIM NEWS, V73, P45, DOI DOI 10.2312/L0CALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPC0NF2008/129-136; Clarke RK, 1999, J ZOOL, V247, P145, DOI 10.1111/j.1469-7998.1999.tb00978.x; Claude J, 2008, MORPHOMETRICS R; CORTIE MB, 1993, COMPUT GRAPH, V17, P79, DOI 10.1016/0097-8493(93)90054-D; CORTIE MB, 1989, S AFR J SCI, V85, P454; Costa C, 2008, J ZOOL, V276, P71, DOI 10.1111/j.1469-7998.2008.00469.x; Davoli E, 1974, B SOC PALEONTOLOGICA, V13, P108; Dera G, 2008, PALEOBIOLOGY, V34, P301, DOI 10.1666/07070.1; EKARATNE SUK, 1983, J MAR BIOL ASSOC UK, V63, P777, DOI 10.1017/S0025315400071216; EMBERTON KC, 1994, BIOL J LINN SOC, V52, P241, DOI 10.1111/j.1095-8312.1994.tb00989.x; Evans AR, 2013, HYSTRIX ITALIAN J MA, V24, P8; FOOTE M, 1988, EVOLUTION, V42, P396, DOI 10.1111/j.1558-5646.1988.tb04143.x; FOWLER DR, 1992, COMP GRAPH, V26, P379, DOI 10.1145/142920.134096; Galbraith C, 2002, VISUAL COMPUT, V18, P70, DOI 10.1007/s003710100136; Godefroy JE, 2012, CR BIOL, V335, P205, DOI 10.1016/j.crvi.2011.12.004; GOODFRIED G A, 1983, Malacological Review, V16, P79; GRAUS RR, 1974, LETHAIA, V7, P303, DOI 10.1111/j.1502-3931.1974.tb00906.x; Harary G, 2011, COMPUT GRAPH FORUM, V30, P237, DOI 10.1111/j.1467-8659.2011.01855.x; Hardy OJ, 2012, EVOLUTION, V66, P2614, DOI 10.1111/j.1558-5646.2012.01623.x; Haug C., 2012, PALAEONTOL ELECTRON, V15, P2; Haug JT, 2010, ARTHROPOD STRUCT DEV, V39, P154, DOI 10.1016/j.asd.2010.01.005; Haug JT, 2009, PALAEONTOGR ABT A, V289, P1; HUTCHINSON JMC, 1999, TRENDS ECOL EVOL, V14, P414; ILLERT C, 1983, MATH BIOSCI, V63, P21, DOI 10.1016/0025-5564(83)90049-4; ILLERT C, 1992, IEEE COMPUT GRAPH, V12, P18, DOI 10.1109/38.135910; Im CH, 2012, PHYS MED BIOL, V57, P2137, DOI 10.1088/0031-9155/57/8/2137; JOHNSTON MR, 1991, PALEOBIOLOGY, V17, P19, DOI 10.1017/S0094837300010320; KAESLER RL, 1972, GEOL SOC AM BULL, V83, P1169, DOI 10.1130/0016-7606(1972)83[1169:FAOTOM]2.0.CO;2; Kawaguchi K., 1982, Computer Graphics, V16, P223, DOI 10.1145/965145.801284; Klingenberg CP, 2013, HYSTRIX ITALIAN J MA, V24, P10; KOHN AJ, 1975, SYST ZOOL, V24, P346, DOI 10.2307/2412720; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Lewiner T, 2005, COMPUT GRAPH-UK, V29, P641, DOI 10.1016/j.cag.2005.08.004; Liew TS, 2014, PEERJ, V2, DOI 10.7717/peerj.383; Liew TS, 2014, PEERJ, V2, DOI 10.7717/peerj.329; Liew TS, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.393.6717; LOVTRUP S, 1974, B MATH BIOL, V36, P567, DOI 10.1016/S0092-8240(74)80051-0; Lv ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057990; Mayer G, 2012, Z ANZEIGER A J COMP, V252, P536; MCGHEE GR, 1978, LETHAIA, V11, P315, DOI 10.1111/j.1502-3931.1978.tb01889.x; McGhee GR., 2007, GEOMETRY EVOLUTION A; McGhee GR, 1999, PERS PALEOB; Meinhardt H., 2009, ALGORITHMIC BEAUTY S; Monnet C, 2009, PALAEONTOL ELECTRON, V12; Moseley H., 1838, PHILOS T ROY SOC LON, V128, P351; Moulton DE, 2012, J THEOR BIOL, V311, P69, DOI 10.1016/j.jtbi.2012.07.009; Moulton DE, 2012, J MATH BIOL, P1; NEWKIRK GF, 1975, MAR BIOL, V30, P227, DOI 10.1007/BF00390745; Noshita K, 2016, J THEOR BIOL, V389, P11, DOI 10.1016/j.jtbi.2015.10.011; Noshita K, 2014, J THEOR BIOL, V363, P93, DOI 10.1016/j.jtbi.2014.08.010; Noshita Koji, 2010, Geoscience Reports of Shizuoka University, V37, P57; Okajima R, 2013, EVOLUTION, V67, P429, DOI 10.1111/j.1558-5646.2012.01772.x; Okajima R, 2011, AM NAT, V178, P801, DOI 10.1086/662674; OKAMOTO T, 1988, PALAEONTOLOGY, V31, P35; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pappas JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077551; PICADO J., 2009, MAA MATH SCI DIGITAL, P1; Pyka M, 2010, NEUROINFORMATICS, V8, P21, DOI 10.1007/s12021-009-9060-3; R Core Team, 2021, R LANGUAGE ENV STAT; Raup D. M., 1967, Journal of Paleontology, V41, P43; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; RAUP DM, 1961, P NATL ACAD SCI USA, V47, P602, DOI 10.1073/pnas.47.4.602; Raup DM, 1972, MATH GEOL, V4, P307; Rice SH, 1998, PALEOBIOLOGY, V24, P133, DOI 10.1017/S0094837300020017; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; RStudio, 2012, RSTUDIO INT DEV ENV; Samadi S, 2000, EVOLUTION, V54, P492, DOI 10.1111/j.0014-3820.2000.tb00052.x; Sarkar D, 2008, USE R, P1; SAUNDERS WB, 1986, PALEOBIOLOGY, V12, P64, DOI 10.1017/S0094837300002980; SAVAZZI E, 1992, PALAEOGEOGR PALAEOCL, V99, P349, DOI 10.1016/0031-0182(92)90022-W; SAVAZZI E, 1990, LETHAIA, V23, P195, DOI 10.1111/j.1502-3931.1990.tb01360.x; SAVAZZI E, 1993, COMPUT GEOSCI, V19, P931, DOI 10.1016/0098-3004(93)90003-N; SAVAZZI E, 1985, COMPUT GEOSCI, V11, P521, DOI 10.1016/0098-3004(85)90083-4; Savazzi E, 1995, ABHANDLUNGEN, V195, P229; Schindel D.E., 1990, P270; Shojaei MF, 2012, J MECH BEHAV BIOMED, V16, P38, DOI 10.1016/j.jmbbm.2012.08.006; Stepien C, 2009, COMPUT GRAPH-UK, V33, P576, DOI 10.1016/j.cag.2009.02.003; Stone JR, 1997, LETHAIA, V30, P213; Thompson D.W, 1917, GROWTH FORM; TISSOT BN, 1988, EVOLUTION, V42, P103, DOI 10.1111/j.1558-5646.1988.tb04111.x; Ubukata Takao, 2001, Historical Biology, V15, P303, DOI 10.1080/0891296021000024475; Urdy S, 2010, J EXP ZOOL PART B, V314B, P280, DOI 10.1002/jez.b.21337; Van Bocxlaer B, 2010, PALEOBIOLOGY, V36, P497, DOI 10.1666/08068.1; Verduin A., 1982, Basteria, V45, P127; VERMEIJ GJ, 1971, J ZOOL, V163, P15; Vermeulen JJ, 1994, BASTERIA, V58, P73; WARBURTON K, 1979, J NAT HIST, V13, P385, DOI 10.1080/00222937900770301	108	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157069	10.1371/journal.pone.0157069	http://dx.doi.org/10.1371/journal.pone.0157069			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280463	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000075
J	Sheaffer, AK; Lee, MS; Qi, HL; Chaniewski, S; Zheng, XF; Farr, GA; Esposito, K; Harden, D; Lei, M; Schweizer, L; Friborg, J; Agler, M; McPhee, F; Gentles, R; Beno, BR; Chupak, L; Mason, S				Sheaffer, Amy K.; Lee, Min S.; Qi, Huilin; Chaniewski, Susan; Zheng, Xiaofan; Farr, Glen A.; Esposito, Kim; Harden, David; Lei, Ming; Schweizer, Liang; Friborg, Jacques; Agler, Michele; McPhee, Fiona; Gentles, Robert; Beno, Brett R.; Chupak, Lou; Mason, Stephen			A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS-16 E6 PROTEIN; CERVICAL-CARCINOMA CELLS; FASL-MEDIATED APOPTOSIS; CANCER-CELLS; E7 PROTEIN; CASPASE 8; TYPE-16; GENE; DNA; KERATINOCYTES	A phenotypic high-throughput cell culture screen was performed to identify compounds that prevented proliferation of the human Papilloma virus type 16 (HPV-16) transformed cell line Ca Ski. A series of quinoxaline compounds exemplified by Compound 1 was identified. Testing against a panel of cell lines demonstrated that Compound 1 selectively inhibited replication of all HPV-16, HPV-18, and HPV-31 transformed cell lines tested with 50% Inhibitory Concentration (IC50) values of 2 to 8 mu M relative to IC50 values of 28 to 73 mu M in HPV-negative cell lines. Treatment with Compound 1 resulted in a cascade of multiple apoptotic events, including selective activation of effector caspases 3 and 7, fragmentation of cellular DNA, and PARP (poly(ADP-ribose) polymerase) cleavage in HPV-positive cells relative to HPV-negative cells. Unregulated proliferation of HPV transformed cells is dependent on the viral oncogenes, E6 and E7. Treatment with Compound 1 resulted in a decrease in HPV E7 protein in Ca Ski cells. However, the timing of this reduction relative to other effects of compound treatment suggests that this was a consequence, rather than a cause, of the apoptotic cascade. Likewise, compound treatment resulted in no obvious effects on the E6- and E7-mediated down regulation of p53 and Rb, or their downstream effectors, p21 or PCNA. Further investigation of apoptotic signals induced by Compound 1 revealed cleavage of Caspase-8 in HPV-positive cells as early as 2 hours post-treatment, suggesting the compound initiates apoptosis through the extrinsic, death receptor-mediated, pathway of cell death. These studies provide proof of concept that cells transformed by oncogenic Papillo-maviruses can be selectively induced to undergo apoptosis by compound treatment.	[Sheaffer, Amy K.; Lee, Min S.; Qi, Huilin; Chaniewski, Susan; Zheng, Xiaofan; Farr, Glen A.; Esposito, Kim; Harden, David; Lei, Ming; Schweizer, Liang; Friborg, Jacques; Agler, Michele; McPhee, Fiona; Gentles, Robert; Beno, Brett R.; Chupak, Lou; Mason, Stephen] Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA; [Farr, Glen A.] Regeneron, Tarrytown, NY USA; [Agler, Michele] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA; [Lei, Ming] Bristol Myers Squibb Co, Res & Dev, Hopewell, NJ USA; [Schweizer, Liang] Sanofi Oncol, Shanghai, Peoples R China; [Friborg, Jacques] Merck Res Labs, N Wales, PA USA; [Mason, Stephen] SWM Consulting, Wallingford, CT USA	Bristol-Myers Squibb; Regeneron; Boehringer Ingelheim; Bristol-Myers Squibb; Merck & Company	Sheaffer, AK (corresponding author), Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA.	amy.sheaffer@bms.com		Sheaffer, Amy/0000-0002-4776-4679; Mason, Stephen/0000-0002-6662-9624; Farr, Glen/0000-0002-5651-7995	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	Bristol-Myers Squibb Company provided support in the form of salaries for all the authors at the time this work was carried out, and the authors designed, collected and analyzed data, and prepared the manuscript as employees of Bristol-Myers Squibb. Bristol-Myers Squibb Company approved the decision to disclose this work. The specific roles of the authors are articulated in the 'author contributions' section.	BOSCH FX, 1992, INT J CANCER, V52, P750, DOI 10.1002/ijc.2910520514; Boyer SN, 1996, CANCER RES, V56, P4620; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Darus CJ, 2013, CLIN OBSTET GYNECOL, V56, P10, DOI 10.1097/GRF.0b013e31827af770; DELVECCHIO AM, 1992, J VIROL, V66, P5949, DOI 10.1128/JVI.66.10.5949-5958.1992; DiMaio D, 2013, VIROLOGY, V445, P99, DOI 10.1016/j.virol.2013.05.006; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fehrmann Frauke, 2005, Methods Mol Biol, V292, P317; Filippova M, 2005, CELL DEATH DIFFER, V12, P1622, DOI 10.1038/sj.cdd.4401678; Filippova M, 2004, J BIOL CHEM, V279, P25729, DOI 10.1074/jbc.M401172200; Filippova M, 2002, J BIOL CHEM, V277, P21730, DOI 10.1074/jbc.M200113200; Filippova M, 2007, J VIROL, V81, P4116, DOI 10.1128/JVI.01924-06; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Garnett TO, 2006, ARCH VIROL, V151, P2321, DOI 10.1007/s00705-006-0821-0; Garnett TO, 2006, CELL DEATH DIFFER, V13, P1915, DOI 10.1038/sj.cdd.4401886; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hu Z, 2015, J CLIN INVEST, V125, P425, DOI 10.1172/JCI78206; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kabsch K, 2004, INTERVIROLOGY, V47, P48, DOI 10.1159/000076642; Kabsch K, 2002, J VIROL, V76, P12162, DOI 10.1128/JVI.76.23.12162-12172.2002; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Li CY, 2013, CELL CYCLE, V12, P923, DOI 10.4161/cc.23882; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Magaldi TG, 2012, VIROLOGY, V422, P114, DOI 10.1016/j.virol.2011.10.012; Manzo-Merino J, 2014, VIROLOGY, V450, P146, DOI 10.1016/j.virol.2013.12.013; Massad LS, 2013, J LOW GENIT TRACT DI, V17, pS1, DOI 10.1097/LGT.0b013e318287d329; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Morozov A, 1997, J VIROL, V71, P3451, DOI 10.1128/JVI.71.5.3451-3457.1997; MUNGER K, 1989, J VIROL, V63, P4417; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; POMMIER Y, 1995, MUTAT RES-DNA REPAIR, V337, P135, DOI 10.1016/0921-8777(95)00019-G; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Reesink-Peters N, 2005, GYNECOL ONCOL, V96, P705, DOI 10.1016/j.ygyno.2004.10.046; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Samson SLA, 2005, OBSTET GYNECOL, V105, P325, DOI 10.1097/01.AOG.0000151991.09124.bb; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SEDMAN SA, 1991, J VIROL, V65, P4860, DOI 10.1128/JVI.65.9.4860-4866.1991; Stoppler MC, 1996, VIROLOGY, V223, P251, DOI 10.1006/viro.1996.0475; Wang Y, 2004, J BIOL CHEM, V279, P6976, DOI 10.1074/jbc.M311376200; White PW, 2005, ANTIMICROB AGENTS CH, V49, P4834, DOI 10.1128/AAC.49.12.4834-4842.2005; Yuan CH, 2012, BIOORG MED CHEM LETT, V22, P2125, DOI 10.1016/j.bmcl.2011.12.145; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014	49	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155909	10.1371/journal.pone.0155909	http://dx.doi.org/10.1371/journal.pone.0155909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280728	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000008
J	Wenzel, M; Zahn, D; Rowland, Z; Kubiak, T				Wenzel, Mario; Zahn, Daniela; Rowland, Zarah; Kubiak, Thomas			The Benefits of Self-Set Goals: Is Ego Depletion Really a Result of Self-Control Failure?	PLOS ONE			English	Article							POSITIVE AFFECT; MODEL; RESOURCE; TASK	Research on ego depletion aims at explaining self-control failures in daily life. Both resource models and motivational accounts have been proposed for explanation. The aim of the present research was to test the different assumptions in two dual-task experiments where we operationalized ego depletion as a performance deviation from a self-set goal. In two experiments, we found evidence for this deviation contradicting motivational accounts of ego depletion: Participants experiencing ego depletion set themselves a stricter instead of a more lenient goal than controls, in that they chose to eat less cookies or wanted to perform better. Moreover, only participants without an initial self-control task could adhere to their self-set goal, whereas participants in the ego depletion condition in both experiments could not follow through with their more ambitious intentions. Taken together, our findings demonstrate the importance of goals in ego depletion research.	[Wenzel, Mario; Zahn, Daniela; Rowland, Zarah; Kubiak, Thomas] Johannes Gutenberg Univ Mainz, Inst Psychol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Wenzel, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Psychol, D-55122 Mainz, Germany.	wenzelma@uni-mainz.de	Kubiak, Thomas/D-4655-2009	Kubiak, Thomas/0000-0003-0095-9265; Zahn, Daniela/0000-0002-0477-1369; Wenzel, Mario/0000-0003-2839-9482	Internal University Research Funding	Internal University Research Funding	The study was funded by the Internal University Research Funding (https://www.uni-mainz.de/forschung/140_ENG_HTML.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Baumeister RF, 2002, SELF IDENTITY, V1, P129, DOI 10.1080/152988602317319302; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Carter EC, 2015, J EXP PSYCHOL GEN, V144, P796, DOI 10.1037/xge0000083; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Carter EC, 2013, BEHAV BRAIN SCI, V36, P683, DOI 10.1017/S0140525X13000952; Converse PD, 2009, J APPL PSYCHOL, V94, P1318, DOI 10.1037/a0014604; Dewitte S, 2009, J CONSUM RES, V36, P394, DOI 10.1086/598615; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Fishbach A, 2010, J EXP SOC PSYCHOL, V46, P29, DOI 10.1016/j.jesp.2009.09.008; Hagger M. S., 2016, PERSPECTIVE IN PRESS; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hofmann W, 2009, PERSPECT PSYCHOL SCI, V4, P162, DOI 10.1111/j.1745-6924.2009.01116.x; Huberts JCD, 2014, PERS SOC PSYCHOL REV, V18, P119, DOI 10.1177/1088868313507533; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Moller AC, 2006, PERS SOC PSYCHOL B, V32, P1024, DOI 10.1177/0146167206288008; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Schmeichel BJ, 2010, J PERS SOC PSYCHOL, V99, P162, DOI 10.1037/a0019797; Shamosh NA, 2007, COGNITION EMOTION, V21, P1833, DOI 10.1080/02699930701273658; Wenzel M, 2014, COGNITION EMOTION, V28, P747, DOI 10.1080/02699931.2013.851069; Wenzel M, 2013, EUR J SOC PSYCHOL, V43, P175, DOI 10.1002/ejsp.1936	25	4	4	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157009	10.1371/journal.pone.0157009	http://dx.doi.org/10.1371/journal.pone.0157009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280531	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000066
J	Bakshi, MV; Azimzadeh, O; Merl-Pham, J; Verreet, T; Hauck, SM; Benotmane, MA; Atkinson, MJ; Tapio, S				Bakshi, Mayur V.; Azimzadeh, Omid; Merl-Pham, Juliane; Verreet, Tine; Hauck, Stefanie M.; Benotmane, Mohammed A.; Atkinson, Michael J.; Tapio, Soile			In-Utero Low-Dose Irradiation Leads to Persistent Alterations in the Mouse Heart Proteome	PLOS ONE			English	Article							IONIZING-RADIATION; SHOCK-PROTEIN; DILATED CARDIOMYOPATHY; MICE; EXPOSURE; CELLS; ATHEROSCLEROSIS; IDENTIFICATION; CYTOSKELETAL; SURVIVORS	Prenatal exposure to stress such as increased level of reactive oxygen species or antiviral therapy are known factors leading to adult heart defects. The risks following a radiation exposure during fetal period are unknown, as are the mechanisms of any potential cardiac damage. The aim of this study was to gather evidence for possible damage by investigating long-term changes in the mouse heart proteome after prenatal exposure to low and moderate radiation doses. Pregnant C57Bl/6J mice received on embryonic day 11 (E11) a single total body dose of ionizing radiation that ranged from 0.02 Gy to 1.0 Gy. The offspring were sacrificed at the age of 6 months or 2 years. Quantitative proteomic analysis of heart tissue was performed using Isotope Coded Protein Label technology and tandem mass spectrometry. The proteomics data were analyzed by bioinformatics and key changes were validated by immunoblotting. Persistent changes were observed in the expression of proteins representing mitochondrial respiratory complexes, redox and heat shock response, and the cytoskeleton, even at the low dose of 0.1 Gy. The level of total and active form of the kinase MAP4K4 that is essential for the embryonic development of mouse heart was persistently decreased at the radiation dose of 1.0 Gy. This study provides the first insight into the molecular mechanisms of cardiac impairment induced by ionizing radiation exposure during the prenatal period.	[Bakshi, Mayur V.; Azimzadeh, Omid; Atkinson, Michael J.; Tapio, Soile] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Radiat Biol, D-85764 Neuherberg, Germany; [Merl-Pham, Juliane; Hauck, Stefanie M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Prot Sci, D-80939 Munich, Germany; [Atkinson, Michael J.] Tech Univ Munich, Chair Radiat Biol, D-80333 Munich, Germany; [Verreet, Tine; Benotmane, Mohammed A.] CEN SCK, Belgian Nucl Res Ctr, Radiobiol Unit, B-2400 Mol, Belgium; [Verreet, Tine] Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol Sect, Lab Neural Circuit Dev & Regenerat, B-3000 Leuven, Belgium	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Belgian Nuclear Research Centre (SCK-CEN); KU Leuven	Tapio, S (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Radiat Biol, D-85764 Neuherberg, Germany.	soile.tapio@helmholtz-muenchen.de	Tapio, Soile/CAJ-5871-2022; Atkinson, Michael/AAU-5127-2020; Atkinson, Michael J/E-5537-2011; Tapio, Soile/M-7358-2014; Merl-Pham, Juliane/N-7258-2014; Hauck, Stefanie/B-3300-2013	Atkinson, Michael/0000-0003-3358-2089; Atkinson, Michael J/0000-0003-3358-2089; Tapio, Soile/0000-0001-9860-3683; Merl-Pham, Juliane/0000-0002-3422-4083; Hauck, Stefanie/0000-0002-1630-6827; Benotmane, Rafi/0000-0002-8985-1578; Verreet, Tine/0000-0001-7810-6102; Azimzadeh, Omid/0000-0001-8984-0388	European Community's Seventh Framework Program (EURATOM) [295823];  [295552]	European Community's Seventh Framework Program (EURATOM); 	The research leading to these results is supported by a grant from the European Community's Seventh Framework Program (EURATOM), Contract No. 295823 (PROCARDIO) and Contract No. 295552 (CEREBRAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, OBSTET GYNECOL, V104, P647; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Bakshi MV, 2015, J PROTEOME RES, V14, P366, DOI 10.1021/pr500890n; Bakshi MV, 2013, RADIAT ENVIRON BIOPH, V52, P451, DOI 10.1007/s00411-013-0483-8; Banmeyer I, 2005, FEBS LETT, V579, P2327, DOI 10.1016/j.febslet.2005.03.027; Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Beqqali A, 2010, J CELL SCI, V123, P1141, DOI 10.1242/jcs.063859; Beutner G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113330; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chapple SJ, 2015, FREE RADIC BIOL MED; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; Fattibene P, 1999, ACTA PAEDIATR, V88, P693; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Fuller SJ, 2015, CARDIOVASC RES, V108, P87, DOI 10.1093/cvr/cvv210; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Kempf SJ, 2015, J PROTEOME RES; Kempf SJ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-57; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2009, J BIOL CHEM, V284, P23602, DOI 10.1074/jbc.M109.024323; Li ZH, 2010, CIRC-ARRHYTHMIA ELEC, V3, P646, DOI 10.1161/CIRCEP.109.929240; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; OTAKE M, 1991, J RADIAT RES, V32, P249, DOI 10.1269/jrr.32.SUPPLEMENT_249; Protection IICoR. ICRP, 2000, ICRP PUBL, V30; Qian J, 2011, CIRC RES, V108, P1429, DOI 10.1161/CIRCRESAHA.110.237644; Raddatz E., 2006, Annales de Cardiologie et d'Angeiologie, V55, P79, DOI 10.1016/j.ancard.2006.02.007; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sarioglu H, 2006, PROTEOMICS, V6, P2407, DOI 10.1002/pmic.200500680; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Talmud PJ, 2003, ARTERIOSCL THROM VAS, V23, P644, DOI 10.1161/01.ATV.0000065196.61663.8D; Tatsukawa Y, 2008, RADIAT RES, V170, P269, DOI 10.1667/RR1434.1; van Eldik W, 2011, INT J DEV BIOL, V55, P649, DOI 10.1387/ijdb.103207wv; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Wang DM, 2011, EXP LUNG RES, V37, P291, DOI 10.3109/01902148.2011.554599; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Williams PM, 2010, AM FAM PHYSICIAN, V82, P488; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200; Zhou Y, 2000, BIOCHEM BIOPH RES CO, V268, P921, DOI 10.1006/bbrc.2000.2231	52	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156952	10.1371/journal.pone.0156952	http://dx.doi.org/10.1371/journal.pone.0156952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276052	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700051
J	Kopp, M; Morisset, R; Koehler, P; Rychlik, M				Kopp, Markus; Morisset, Rosalie; Koehler, Peter; Rychlik, Michael			Stable Isotope Dilution Assays for Clinical Analyses of Folates and Other One-Carbon Metabolites: Application to Folate-Deficiency Studies	PLOS ONE			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; TANDEM MASS-SPECTROMETRY; SMALL-VESSEL DISEASE; NEURAL-TUBE DEFECTS; FOLIC-ACID; LC-MS/MS; TISSUE DISTRIBUTION; TOTAL HOMOCYSTEINE; ADENOSYLMETHIONINE; PLASMA	Folate deficiency is generally accepted as a potential direct or indirect risk factor for diseases including spina bifida, coronary heart diseases, malfunctions of the central nervous system, and cancer. The direct inclusion of folates in the methylation cycle, including the remethylation of homocysteine and regeneration of S-adenosylmethionine, underlines the importance of these vitamins and other components of one-carbon metabolism. Therefore, the aim of the present study was to develop a multiple stable isotope dilution assay (SIDA) for the respective analytes in plasma and tissue samples to allow for a closer look at the interaction between a severe folate deficiency and local folate status, as well as further interactions with circulating S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine. The analytical methods were based on SIDAs coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis using the deuterated folates [H-2(4)]-5-methyltetrahydrofolic acid, [H-2(4)]-5-formyltetrahydrofolic acid, [H-2(4)]-tetrahydrofolic acid, [H-2(4)]-10-formylfolic acid, and [H-2(4)]-folic acid and the deuterated one-carbon metabolites [H-2(4)]-homocysteine, [H-2(4)]-S-adenosylhomocysteine, and [H-2(3)]-S-adenosylmethionine as internal standards. Three analytical methods have been developed for the analysis of homocysteine, S-adenosylmethionine, S-adenosylhomocysteine, and six folate vitamers. Validation data for the analysis of C-1-metabolites in plasma and tissue samples or folate analysis in tissue samples revealed excellent sensitivity, precision, and recovery for all analytes studied. The miniaturized methods using sample volumes as low as 50 mu L and weighed portions of 5-25 mg will allow the assessment of the status of folates and additional biomarkers of impaired one-carbon metabolism during folate deficiency.	[Kopp, Markus; Rychlik, Michael] Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany; [Kopp, Markus; Morisset, Rosalie] Tech Univ Munich, Inst Food & Hlth ZIEL, Weihenstephaner Berg 1, D-85354 Freising Weihenstephan, Germany; [Morisset, Rosalie] Tech Univ Munich, Chair Nutr Physiol, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany; [Koehler, Peter] Deutsch Forschungsanstalt Lebensmittelchem, Leibniz Inst, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Leibniz-Institute for Food Systems Biology at the Technical University of Munich	Rychlik, M (corresponding author), Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany.	michael.rychlik@tum.de	Rychlik, Michael/G-6064-2015	Rychlik, Michael/0000-0002-5826-6288; Kopp, Markus/0000-0003-2166-3164	TUM; DFG; TUM Open Access Publishing Fund; TUM Graduate School	TUM; DFG(German Research Foundation (DFG)); TUM Open Access Publishing Fund; TUM Graduate School	This work was funded by TUM, DFG (https://www.ub.tum.de/en/publishing-fund), TUM Open Access Publishing Fund, and TUM Graduate School (https://www.gs.tum.de/en/about-tum-gs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcot J, 2005, TRENDS FOOD SCI TECH, V16, P253, DOI 10.1016/j.tifs.2005.03.013; Baggott JE, 2000, BIOCHEMISTRY-US, V39, P14647, DOI 10.1021/bi001362m; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; BENESCH R, 1982, BIOCHEM BIOPH RES CO, V106, P1359, DOI 10.1016/0006-291X(82)91263-3; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; Bottiglieri T, 2002, AM J CLIN NUTR, V76, p1151S, DOI 10.1093/ajcn/76.5.1151S; Caudill M, 2004, J FOOD SCI, V69, pS55, DOI 10.1111/j.1365-2621.2004.tb17887.x; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; CLIFFORD AJ, 1990, J NUTR, V120, P1633, DOI 10.1093/jn/120.12.1633; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dahlhoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057387; EISENGA BH, 1992, J NUTR, V122, P977, DOI 10.1093/jn/122.4.977; ELORANTA TO, 1976, BIOCHEM J, V160, P287, DOI 10.1042/bj1600287; ELORANTA TO, 1977, BIOCHEM J, V166, P521, DOI 10.1042/bj1660521; Finkelstein JD, 2007, CLIN CHEM LAB MED, V45, P1694, DOI 10.1515/CCLM.2007.341; Freisleben A, 2002, J AGR FOOD CHEM, V50, P4760, DOI 10.1021/jf025571k; Fu WY, 2000, BIOCHEM BIOPH RES CO, V271, P47, DOI 10.1006/bbrc.2000.2587; Gardner LA, 2013, ELECTROPHORESIS, V34, P1710, DOI 10.1002/elps.201200536; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; HELLAND S, 1983, CANCER RES, V43, P1847; HELLAND S, 1983, CANCER RES, V43, P4142; Hinterberger M, 2013, J NEURAL TRANSM, V120, P211, DOI 10.1007/s00702-012-0822-y; HOPPNER K, 1980, AM J CLIN NUTR, V33, P862, DOI 10.1093/ajcn/33.4.862; Inoue-Choi M, 2012, INT J MOL EPIDEMIOL, V3, P160; Jakubowski H., 2013, HOMOCYSTEINE PROTEIN; Jeon SB, 2014, NEUROLOGY, V83, P695, DOI 10.1212/WNL.0000000000000720; Kirsch SH, 2009, J CHROMATOGR B, V877, P3865, DOI 10.1016/j.jchromb.2009.09.039; Kloppenborg RP, 2014, NEUROLOGY, V82, P777, DOI 10.1212/WNL.0000000000000168; Kopp M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143639; Korinek M, 2013, BIOMED CHROMATOGR, V27, P111, DOI 10.1002/bmc.2755; Krijt J, 2009, J CHROMATOGR B, V877, P2061, DOI 10.1016/j.jchromb.2009.05.039; LADJIMI H, 1992, ARCH INT PHYSIOL BIO, V100, P67, DOI 10.3109/13813459209035261; Li SJ, 2008, J CHROMATOGR B, V870, P63, DOI 10.1016/j.jchromb.2008.06.003; Luippold G, 1999, J CHROMATOGR B, V724, P231, DOI 10.1016/S0378-4347(98)00580-5; Mari M, 2004, J CLIN INVEST, V113, P895, DOI 10.1172/JCI200419852; McNeil CJ, 2012, MOL NUTR FOOD RES, V56, P1122, DOI 10.1002/mnfr.201100694; Monch S, 2015, FOOD FUNCT, V6, P242, DOI 10.1039/c4fo00658e; Monch S, 2010, ANAL BIOCHEM, V398, P150, DOI 10.1016/j.ab.2009.11.007; Nakata R, 2000, J NUTR SCI VITAMINOL, V46, P215, DOI 10.3177/jnsv.46.215; Neha Rastogi, 2012, PRACTICAL PEDIAT HEM, P41; Nelson BC, 2005, ANAL CHEM, V77, P3586, DOI 10.1021/ac050235z; Nelson BC, 2003, ANAL CHEM, V75, P775, DOI 10.1021/ac0204799; Obeid R, 2015, REPROD TOXICOL, V56, P30, DOI DOI 10.1016/J.REPR0T0X.2015.07.073; Persichilli S, 2010, J SEP SCI, V33, P3119, DOI 10.1002/jssc.201000399; REED LS, 1980, J AGR FOOD CHEM, V28, P801, DOI 10.1021/jf60230a044; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Ringling C, 2013, EUR FOOD RES TECHNOL, V236, P17, DOI 10.1007/s00217-012-1849-x; Robinson K, 2000, HEART, V83, P127, DOI 10.1136/heart.83.2.127; Rychlik M, 2003, J CHROMATOGR B, V792, P167, DOI 10.1016/S1570-0232(03)00254-X; Satterfield MB, 2006, ANAL BIOANAL CHEM, V385, P612, DOI 10.1007/s00216-006-0434-1; Shane B., 2010, FOLATE HLTH DIS, V2nd, P1; Shane B, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013367; Snowdon DA, 2000, AM J CLIN NUTR, V71, P993; Souci SW, 2009, KLEINE SOUCI FACHMAN; Thomas AH, 2000, J PHOTOCH PHOTOBIO A, V135, P147, DOI 10.1016/S1010-6030(00)00304-X; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234; Wang ZG, 2010, J LIPID RES, V51, P3158, DOI 10.1194/jlr.M007948; Wilcken DEL, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P1; Wild CP, 2001, BRIT J NUTR, V86, pS37, DOI 10.1079/BJN2001338; Zhang HY, 2008, EXP NEUROL, V212, P515, DOI 10.1016/j.expneurol.2008.04.044; 2014, EFSA J, V12	63	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156610	10.1371/journal.pone.0156610	http://dx.doi.org/10.1371/journal.pone.0156610			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276031	gold, Green Published			2022-12-27	WOS:000377561700030
J	Lundgren, S; Warfvinge, CF; Elebro, J; Heby, M; Nodin, B; Krzyzanowska, A; Bjartell, A; Leandersson, K; Eberhard, J; Jirstrom, K				Lundgren, Sebastian; Warfvinge, Carl Fredrik; Elebro, Jacob; Heby, Margareta; Nodin, Bjorn; Krzyzanowska, Agnieszka; Bjartell, Anders; Leandersson, Karin; Eberhard, Jakob; Jirstrom, Karin			The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PREDICTIVE SIGNIFICANCE; CHEMOTHERAPY; CANCER; LYMPHOCYTES; EXPRESSION; CARCINOMA; IMPROVES	Background Natural killer (NK) cells and NK T cells (NKT) are vital parts of tumour immunosurveillance. However, their impact on prognosis and chemotherapy response in periampullary adenocarcinoma, including pancreatic cancer, has not yet been described. Methods Immune cell-specific expression of CD56, CD3, CD68 and CD1a was analysed by immunohistochemistry on tissue microarrays with tumours from 175 consecutive cases of periampullary adenocarcinoma, 110 of pancreatobiliary type (PB-type) and 65 of intestinal type (I-type) morphology. Kaplan-Meier and Cox regression analysis were applied to determine the impact of CD56+ NK/NKT cells on 5-year overall survival (OS). Results High density of CD56+ NK/NKT cells correlated with low N-stage and lack of perineural, lymphatic vessel and peripancreatic fat invasion. High density of CD56+ NK/NKT cells was associated with prolonged OS in Kaplan-Meier analysis (p = 0.003), and in adjusted Cox regression analysis (HR = 0.49; 95% CI 0.29-0.86). The prognostic effect of high CD56+ NK/NKT cell infiltration was only evident in cases not receiving adjuvant chemotherapy in PB-type tumours (p for interaction = 0.014). Conclusion This study demonstrates that abundant infiltration of CD56+ NK/NKT cells is associated with a prolonged survival in periampullary adenocarcinoma. However, the negative interaction with adjuvant treatment is noteworthy. NK cell enhancing strategies may prove to be successful in the management of these cancers.	[Lundgren, Sebastian; Warfvinge, Carl Fredrik; Elebro, Jacob; Heby, Margareta; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin] Lund Univ, Dept Clin Sci Lund Oncol & Pathol, S-22185 Lund, Sweden; [Krzyzanowska, Agnieszka; Bjartell, Anders; Leandersson, Karin] Lund Univ, Dept Translat Med, Ctr Mol Pathol, Lund, Sweden	Lund University; Lund University	Lundgren, S (corresponding author), Lund Univ, Dept Clin Sci Lund Oncol & Pathol, S-22185 Lund, Sweden.	sebastian.lundgren@med.lu.se			Swedish Cancer Society [2014/540]; Swedish Research Council; Swedish Government Grant for Clinical Research; Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Lund University Faculty of Medicine; University Hospital Research Grants	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Grant for Clinical Research; Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Lund University Faculty of Medicine; University Hospital Research Grants	This work was supported by grants from the Swedish Cancer Society [grant number 2014/540 to KJ] (https://www.cancerfonden.se); the Swedish Research Council (http://www.vr.se); the Swedish Government Grant for Clinical Research, the Gunnar Nilsson Cancer Foundation (http://www.cancerstiftelsen.com); the Mrs Berta Kamprad Foundation, Lund University Faculty of Medicine and University Hospital Research Grants (http://www.lu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Swedish Cancer Society [grant number 2014/540 to KJ]; the Swedish Research Council; the Swedish Government Grant for Clinical Research, the Gunnar Nilsson Cancer Foundation; the Mrs Berta Kamprad Foundation, Lund University Faculty of Medicine and University Hospital Research Grants.	Al-Shibli K, 2009, HISTOPATHOLOGY, V55, P301, DOI 10.1111/j.1365-2559.2009.03379.x; Aloysius MM, 2010, BRIT J SURG, V97, P1269, DOI 10.1002/bjs.7107; BRENNER BG, 1991, CANCER-AM CANCER SOC, V68, P482, DOI 10.1002/1097-0142(19910801)68:3<482::AID-CNCR2820680306>3.0.CO;2-9; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cui JW, 2015, CYTOTHERAPY, V17, P979, DOI 10.1016/j.jcyt.2015.03.605; Elebro J, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0289-8; Elebro J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-80; Gall TM, 2015, POSTGRAD MED J, DOI [10.1136/postgradmed62014-133222, DOI 10.1136/POSTGRADMED62014-133222]; Gulubova M, 2009, APMIS, V117, P870, DOI 10.1111/j.1600-0463.2009.02547.x; Halama N, 2011, CLIN CANCER RES, V17, P678, DOI 10.1158/1078-0432.CCR-10-2173; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Izawa S, 2011, CANCER IMMUNOL IMMUN, V60, P1801, DOI 10.1007/s00262-011-1082-7; Langers I, 2012, BIOL-TARGETS THER, V6, P73, DOI 10.2147/BTT.S23976; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Mozaffari F, 2007, BRIT J CANCER, V97, P105, DOI 10.1038/sj.bjc.6603840; Navarro AG, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00202; Pahl J, 2017, IMMUNOBIOLOGY, V222, P11, DOI 10.1016/j.imbio.2015.07.012; Pan QZ, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1038017; Roothans D, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23037; Sconocchia G, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.952197; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stojanovic A, 2011, J INNATE IMMUN, V3, P355, DOI 10.1159/000325465; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Yu HS, 2015, PROTEIN CELL, V6, P297, DOI 10.1007/s13238-015-0140-x; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	28	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156497	10.1371/journal.pone.0156497	http://dx.doi.org/10.1371/journal.pone.0156497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275582	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700026
J	Bilgic, HB; Karagenc, T; Bakirci, S; Shiels, B; Tait, A; Kinnaird, J; Eren, H; Weir, W				Bilgic, Huseyin Bilgin; Karagenc, Tulin; Bakirci, Serkan; Shiels, Brian; Tait, Andrew; Kinnaird, Jane; Eren, Hasan; Weir, William			Identification and Analysis of Immunodominant Antigens for ELISA-Based Detection of Theileria annulata	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PIROPLASM SURFACE-ANTIGEN; TROPICAL THEILERIOSIS; MULTIPLEX PCR; INFECTION; DIAGNOSIS; DIVERSITY; PROTEIN; CATTLE; IMMUNITY	Tropical or Mediterranean theileriosis, caused by the protozoan parasite Theileria annulata, remains an economically important bovine disease in North Africa, Southern Europe, India, the Middle East and Asia. The disease affects mainly exotic cattle and imposes serious constraints upon livestock production and breed improvement programmes. While microscopic and molecular methods exist which are capable of detecting T. annulata during acute infection, the identification of animals in the carrier state is more challenging. Serological tests, which detect antibodies that react against parasite-encoded antigens, should ideally have the potential to identify carrier animals with very high levels of sensitivity and specificity. However, assays developed to date have suffered from a lack of sensitivity and/or specificity and it is, therefore, necessary to identify novel parasite antigens, which can be developed for this purpose. In the present study, genes encoding predicted antigens were bioinformatically identified in the T. annulata genome. These proteins, together with a panel of previously described antigens, were assessed by western blot analysis for immunoreactivity, and this revealed that four novel candidates and five previously described antigens were recognised by immune bovine serum. Using a combination of immunoprecipitation and mass spectrophotometric analysis, an immunodominant protein (encoded by TA15705) was identified as Ta9, a previously defined T cell antigen. Western blotting revealed another of the five proteins in the Ta9 family, TA15710, also to be an immunodominant protein. However, validation by Enzyme-Linked Immunosorbent Assay indicated that due to either allelic polymorphism or differential immune responses of individual hosts, none of the novel candidates can be considered ideal for routine detection of T. annulata-infected/carrier animals.	[Bilgic, Huseyin Bilgin; Karagenc, Tulin; Bakirci, Serkan; Eren, Hasan] Adnan Menderes Univ, Dept Parasitol, Fac Vet Med, TR-09016 Isikli Mevki, Aydin, Turkey; [Shiels, Brian; Tait, Andrew; Kinnaird, Jane; Weir, William] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland	Adnan Menderes University; University of Glasgow	Bilgic, HB (corresponding author), Adnan Menderes Univ, Dept Parasitol, Fac Vet Med, TR-09016 Isikli Mevki, Aydin, Turkey.	huseyin_bilgic@yahoo.com	Bilgic, Huseyin Bilgin/AAH-4568-2019; BAKIRCI, Serkan/ABD-1433-2020	BAKIRCI, Serkan/0000-0002-6033-2205; Weir, William/0000-0001-8648-666X; Shiels, Brian/0000-0001-7595-2514	Wellcome Trust Foundation [075820/A/04/Z]; University of Adnan Menderes, Scientific Research Programs [VFT-06006]	Wellcome Trust Foundation(Wellcome Trust); University of Adnan Menderes, Scientific Research Programs(Adnan Menderes University)	This work was supported by the Wellcome Trust Foundation (www.wellcome.ac.uk/funding/) (Ref: 075820/A/04/Z, AT BS TK) and the University of Adnan Menderes, Scientific Research Programs (http://idari.adu.edu.tr/bap/) (Project no. VFT-06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED JS, 1988, ZBL BAKT-INT J MED M, V267, P425; Al-Hosary Amira A.T., 2015, Journal of Parasitology Research, P787812, DOI 10.1155/2015/787812; Ali AM, 2008, ANN NY ACAD SCI, V1149, P218, DOI 10.1196/annals.1428.025; Bakheit M. A., 2007, Parassitologia (Rome), V49, P53; Bakheit MA, 2004, PARASITOL RES, V92, P299, DOI 10.1007/s00436-003-1055-7; Beniwal RK, 1997, TROP ANIM HEALTH PRO, V29, p109S, DOI 10.1007/BF02632947; BENMILED L, 1994, PARASITOLOGY, V108, P51, DOI 10.1017/S0031182000078513; Betton JM, 2004, BIOCHIMIE, V86, P601, DOI 10.1016/j.biochi.2004.07.004; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; Bilgic HB, 2013, EXP PARASITOL, V133, P222, DOI 10.1016/j.exppara.2012.11.005; Bilgic HB, 2010, VET PARASITOL, V174, P341, DOI 10.1016/j.vetpar.2010.08.025; Boulter N, 2000, ADV PARASIT, V44, P41; BREWER S, 1990, J MOL BIOL, V216, P883, DOI 10.1016/S0022-2836(99)80008-4; Brown C.G.D., 1987, P230; Chen JH, 2014, J PROTEOMICS, V98, P289, DOI 10.1016/j.jprot.2014.01.010; DEKOK JB, 1993, EXP APPL ACAROL, V17, P839, DOI 10.1007/BF00225857; DICKSON J, 1993, MOL BIOCHEM PARASIT, V57, P55, DOI 10.1016/0166-6851(93)90243-Q; dOliveira C, 1997, VACCINE, V15, P1796, DOI 10.1016/S0264-410X(97)00197-7; DOLIVEIRA C, 1995, J CLIN MICROBIOL, V33, P2665, DOI 10.1128/JCM.33.10.2665-2669.1995; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Gharbi M, 2006, VET PARASITOL, V137, P231, DOI 10.1016/j.vetpar.2006.01.015; Ghoneim AM, 2014, ACTA PARASITOL, V59, P85, DOI 10.2478/s11686-014-0211-9; GLASCODINE J, 1990, MOL BIOCHEM PARASIT, V40, P105, DOI 10.1016/0166-6851(90)90084-Y; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Gray MA, 1981, IN VITRO NEUTRALIZAT, P127; GREINER M, 1995, J IMMUNOL METHODS, V185, P145, DOI 10.1016/0022-1759(95)00078-O; Gubbels JM, 1999, J CLIN MICROBIOL, V37, P1782, DOI 10.1128/JCM.37.6.1782-1789.1999; Gubbels MJ, 2000, CLIN DIAGN LAB IMMUN, V7, P404, DOI 10.1128/CDLI.7.3.404-411.2000; Gubbels MJ, 2000, MOL BIOCHEM PARASIT, V110, P23, DOI 10.1016/S0166-6851(00)00253-X; Ilhan T, 1999, THESIS U EDINBURGH; Irvin A. D., 1987, Immune responses in parasitic infections: immunology, immunopathology, and immunoprophylaxis. Volume III: Protozoa, P223; Jongejan F., 1994, EUR UN 3 COORD M TRO, P59; KACHANI M, 1992, VET IMMUNOL IMMUNOP, V34, P221, DOI 10.1016/0165-2427(92)90166-N; Katzer F, 1998, ANN NY ACAD SCI, V849, P96, DOI 10.1111/j.1749-6632.1998.tb11039.x; KILTZ HH, 1986, RES VET SCI, V40, P197, DOI 10.1016/S0034-5288(18)30512-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leemans I, 1999, VET PARASITOL, V82, P193, DOI 10.1016/S0304-4017(99)00014-X; Limenitakis J, 2011, FEBS LETT, V585, P1579, DOI 10.1016/j.febslet.2011.05.002; Machugh ND, 2008, PARASITE IMMUNOL, V30, P385, DOI 10.1111/j.1365-3024.2008.01038.x; MacHugh ND, 2011, INFECT IMMUN, V79, P2059, DOI 10.1128/IAI.01285-10; Martin-Sanchez J, 1999, PARASITOL RES, V85, P243, DOI 10.1007/s004360050541; Matita G, 1994, STAGE SPECIFIC DIAGN; MINAMI T, 1983, RES VET SCI, V35, P334, DOI 10.1016/S0034-5288(18)32029-0; Miranda JPG, 2006, ANN NY ACAD SCI, V1081, P468, DOI 10.1196/annals.1373.067; Mohamed AM, 2012, VET PARASITOL, V186, P486, DOI 10.1016/j.vetpar.2011.11.028; NEITZ W. O., 1957, ONDERSTEPOORT JOUR VET RES, V27, P275; Oura CAL, 2004, PARASITOLOGY, V129, P27, DOI 10.1017/S003118200400513X; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pieszko MWW, 2015, PLOS NEGL TROP DIS, V14; PRESTON PM, 1985, PARASITE IMMUNOL, V7, P301, DOI 10.1111/j.1365-3024.1985.tb00078.x; Rajendran C., 2014, Journal of Parasitic Diseases, V38, P41, DOI 10.1007/s12639-012-0183-3; Renneker S, 2008, TRANSBOUND EMERG DIS, V55, P249, DOI 10.1111/j.1865-1682.2008.01036.x; ROBINSON PM, 1982, TROP ANIM HEALTH PRO, V14, P3, DOI 10.1007/BF02281092; Salih DA, 2008, TRANSBOUND EMERG DIS, V55, P238, DOI 10.1111/j.1865-1682.2008.01033.x; Salih DEA, 2005, PARASITOL RES, V97, P302, DOI 10.1007/s00436-005-1431-6; Santos M, 2013, TICKS TICK-BORNE DIS, V4, P72, DOI 10.1016/j.ttbdis.2012.07.006; Schnittger L, 2002, MOL BIOCHEM PARASIT, V120, P247, DOI 10.1016/S0166-6851(02)00013-0; Schnittger L, 2000, PARASITOL RES, V86, P444, DOI 10.1007/s004360050692; Seitzer U, 2008, TRANSBOUND EMERG DIS, V55, P244, DOI 10.1111/j.1865-1682.2008.01030.x; Seitzer U, 2008, VACCINE, V26, pG24, DOI 10.1016/j.vaccine.2008.10.039; Seitzer U, 2007, PARASITOL RES, V101, pS217, DOI 10.1007/s00436-007-0685-6; Shayan P, 1998, ANN NY ACAD SCI, V849, P88, DOI 10.1111/j.1749-6632.1998.tb11038.x; SHIELS B, 1989, MOL BIOCHEM PARASIT, V34, P209, DOI 10.1016/0166-6851(89)90049-2; SHIELS BR, 1995, MOL BIOCHEM PARASIT, V72, P149, DOI 10.1016/0166-6851(95)00074-B; SHIELS BR, 1986, PARASITE IMMUNOL, V8, P69, DOI 10.1111/j.1365-3024.1986.tb00834.x; Shiels Brian R., 1994, Molecular and Cellular Differentiation, V2, P101; Towbin H., 1990, P NATL ACAD SCI USA, P4350; UILENBERG G, 1995, VET PARASITOL, V57, P19, DOI 10.1016/0304-4017(94)03107-8; Van Regenmortel MHV, 2006, J MOL RECOGNIT, V19, P183, DOI 10.1002/jmr.768; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Weir W, 2006, GENOMIC POPULATION G; Weir W, 2007, MOL BIOCHEM PARASIT, V154, P170, DOI 10.1016/j.molbiopara.2007.04.015; Weir W, 2011, INT J PARASITOL, V41, P193, DOI 10.1016/j.ijpara.2010.08.004; WILLIAMSON S, 1989, P NATL ACAD SCI USA, V86, P4639, DOI 10.1073/pnas.86.12.4639; Williamson S, 1994, 3 EUR UN COORD M TRO; Williamson SM, 1988, THEILERIA ANNULATA S	78	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156645	10.1371/journal.pone.0156645	http://dx.doi.org/10.1371/journal.pone.0156645			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270235	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000377561000026
J	Crabtree-Ramirez, B; Caro-Vega, Y; Shepherd, BE; Grinsztejn, B; Wolff, M; Cortes, CP; Padgett, D; Carriquiry, G; Fink, V; Jayathilake, K; Person, AK; McGowan, C; Sierra-Madero, J				Crabtree-Ramirez, Brenda; Caro-Vega, Yanink; Shepherd, Bryan E.; Grinsztejn, Beatriz; Wolff, Marcelo; Cortes, Claudia P.; Padgett, Denis; Carriquiry, Gabriela; Fink, Valeria; Jayathilake, Karu; Person, Anna K.; McGowan, Catherine; Sierra-Madero, Juan		Int Epidemiol Databases Evaluate	Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CRYPTOCOCCAL MENINGITIS; HIV; TUBERCULOSIS; INDIVIDUALS; COHORT; MORTALITY; ENGLAND; ADULTS; WALES	Background Since 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an opportunistic infection (OI) has been recommended based on lower risks of death and AIDS-related progression found in clinical trials. Delay in HAART initiation after OIs may be an important barrier for successful outcomes in patients with advanced disease. Timing of HAART initiation after an OI in "real life" settings in Latin America has not been evaluated. Methods Patients in the Caribbean, Central and South America network for HIV Epidemiology (CCA-SAnet) >= 18 years of age at enrolment, from 2001-2012 who had an OI before HAART initiation were included. Patients were divided in an early HAART (EH) group (those initiating within 4 weeks of an OI) and a delayed HAART (DH) group (those initiating more than 4 weeks after an OI). All patients with an AIDS-defining OI were included. In patients with more than one OI the first event reported was considered. Calendar trends in the proportion of patients in the EH group (before and after 2009) were estimated by site and for the whole cohort. Factors associated with EH were estimated using multivariable logistic regression models. Results A total of 1457 patients had an OI before HAART initiation and were included in the analysis: 213 from Argentina, 686 from Brazil, 283 from Chile, 119 from Honduras and 156 from Mexico. Most prevalent OI were Tuberculosis (31%), followed by Pneumocystis pneumonia (24%), Invasive Candidiasis (16%) and Toxoplasmosis (9%). Median time from OI to HAART initiation decreased significantly from 5.7 (interquartile range [IQR] 2.8-12.1) weeks before 2009 to 4.3 (IQR 2.0-7.1) after 2009 (p<0.01). Factors associated with starting HAART within 4 weeks of OI diagnosis were lower CD4 count at enrolment (p-<0.001), having a non-tuberculosis OI (p<0.001), study site (p<0.001), and more recent years of OI diagnosis (p<0.001). Discussion The time from diagnosis of an OI to HAART initiation has decreased in Latin America coinciding with the publication of evidence of its benefit. We found important heterogeneity between sites which may reflect differences in clinical practices, local guidelines, and access to HAART. The impact of the timing of HAART initiation after OI on patient survival in this "real life" context needs further evaluation.	[Crabtree-Ramirez, Brenda; Caro-Vega, Yanink; Sierra-Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Shepherd, Bryan E.] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Grinsztejn, Beatriz] Inst Nacl Infectol Evandro Chagas Fiocruz, Rio De Janeiro, Brazil; [Wolff, Marcelo; Cortes, Claudia P.] Univ Chile, Fdn Arriaran, Santiago, Chile; [Padgett, Denis] Inst Hondureno Seguro Social, Tegucigalpa, Honduras; [Padgett, Denis] Hosp Escuela Univ, Tegucigalpa, Honduras; [Carriquiry, Gabriela] Inst Med Trop Alexander von Humboldt, Lima, Peru; [Fink, Valeria] Fdn Huesped, Invest Clin, Buenos Aires, DF, Argentina; [Jayathilake, Karu; Person, Anna K.; McGowan, Catherine] Vanderbilt Univ, Dept Med, Nashville, TN USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Vanderbilt University; Fundacao Oswaldo Cruz; Universidad de Chile; Universidad Peruana Cayetano Heredia; Vanderbilt University	Crabtree-Ramirez, B (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico.	brendcrabtree@hotmail.com	Sierra Madero, Juan/AAW-8825-2021; Cortes, Claudia P/AAF-7326-2020	Cortes, Claudia P/0000-0001-9101-9783; Crabtree-Ramirez, Brenda/0000-0002-2587-1123; Wolff, Marcelo/0000-0002-9956-8872	National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as part of the International epidemiologic Databases to Evaluate AIDS (IeDEA) [U01 AI069923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069476, U01AI069923] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as part of the International epidemiologic Databases to Evaluate AIDS (IeDEA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as part of the International epidemiologic Databases to Evaluate AIDS (IeDEA): U01 AI069923.	Bisson GP, 2013, CLIN INFECT DIS, V56, P1165, DOI 10.1093/cid/cit019; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Centers for Disease Control and Prevention, 1993, JAMA-J AM MED ASSOC, V269, P460; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; Cingolani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089861; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hocking JS, 2000, INT J STD AIDS, V11, P503, DOI 10.1258/0956462001916407; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manzardo C, 2013, CLIN MICROBIOL INFEC, V19, P646, DOI 10.1111/j.1469-0691.2012.03991.x; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Sax PE, 2010, HIV CLIN TRIALS, V11, P248, DOI 10.1310/hct1105-248; Vijayan T, 2013, CLIN INFECT DIS, V57, P1766, DOI 10.1093/cid/cit654; WHO, 2010, ANT THER HIV INF AD; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	22	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0153921	10.1371/journal.pone.0153921	http://dx.doi.org/10.1371/journal.pone.0153921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271083	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000002
J	Kurokawa, K; Makita, S; Yasuno, Y				Kurokawa, Kazuhiro; Makita, Shuichi; Yasuno, Yoshiaki			Investigation of Thermal Effects of Photocoagulation on Retinal Tissue Using Fine-Motion-Sensitive Dynamic Optical Coherence Tomography	PLOS ONE			English	Article							MICRO-DISPLACEMENT MEASUREMENT; LASER PHOTOCOAGULATION; SUBTHRESHOLD LASER; VEIN OCCLUSION; OCT; ELASTOGRAPHY; COEFFICIENTS; MANAGEMENT; STRAIN; LESION	To enable an objective evaluation of photocoagulation, we characterize thermal tissue changes induced by laser irradiation with different laser parameters using optical coherence tomography (OCT). Spectral-domain OCT with a newly developed image processing method was used to monitor the thermal changes of ex vivo porcine retina. A sequence of OCT B-scans was obtained at the same retinal position simultaneously with the photocoagulation. Cross-sectional tissue displacement maps with respect to an OCT image taken before laser irradiation were computed for images taken before, during, and after laser irradiation, by using a correlation-based custom algorithm. Cross-sectional correlation maps (OCT correlation maps) were also computed from an OCT image taken before laser irradiation as a base-line to visualize alterations of tissue microstructure induced by laser irradiation. By systematically controlling laser power and exposure times, tissue displacements and structural changes of 200 retinal regions of 10 porcine eyes were characterized. Thermal tissue changes were characterized by B-scan images, OCT correlation maps, and tissue displacement maps. Larger tissue deformation was induced with higher laser power and shorter exposure time, while the same total laser energy (10 mJ) was applied. The measured tissue displacements revealed the complicated dynamics of tissue displacements. Three types of dynamics were observed; lateral expansion, lateral constriction, and a type showing more complicated dynamics. The results demonstrated the ability of this OCT-based method to evaluate retinal changes induced by laser irradiation. This evaluation could lead to further understanding of thermal effects, and increasing reproducibility of photocoagulation therapy.	[Kurokawa, Kazuhiro; Makita, Shuichi; Yasuno, Yoshiaki] Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan; [Kurokawa, Kazuhiro; Makita, Shuichi; Yasuno, Yoshiaki] Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki, Japan	University of Tsukuba	Yasuno, Y (corresponding author), Univ Tsukuba, Computat Opt Grp, Tsukuba, Ibaraki, Japan.; Yasuno, Y (corresponding author), Computat Opt & Ophthalmol Grp, Tsukuba, Ibaraki, Japan.	yasuno@optlab2.bk.tsukuba.ac.jp	Yasuno, Yoshiaki/F-2586-2011; Makita, Shuichi/G-3806-2011	Yasuno, Yoshiaki/0000-0003-1645-7948; Makita, Shuichi/0000-0002-6614-3640	Japan Society for Promotion of Science (JSPS); Nidek Inc.	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nidek Inc.	This research is supported by Japan Society for Promotion of Science (JSPS) and Nidek Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2009, OPT EXPRESS, V17, P8125, DOI 10.1364/OE.17.008125; Al-Hussainy S, 2008, EYE, V22, P96, DOI 10.1038/sj.eye.6703026; Chen K, 2010, J BIOMECH, V43, P1417, DOI 10.1016/j.jbiomech.2009.09.056; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; Deak GG, 2012, INVEST OPHTH VIS SCI, V53, P7019, DOI 10.1167/iovs.12-10196; Duck FA., PHYS PROPERTIES TISS; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; FERRIS FL, 1987, OPHTHALMOLOGY, V94, P761; Franze K, 2011, SOFT MATTER, V7, P3147, DOI 10.1039/c0sm01017k; Gemert MJ, 2011, OPTICAL THERMAL RESP; Jain A, 2008, ARCH OPHTHALMOL-CHIC, V126, P78, DOI 10.1001/archophthalmol.2007.29; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Kennedy BF, 2011, OPT EXPRESS, V19, P6623, DOI 10.1364/OE.19.006623; Koinzer S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/492679; Koinzer S, 2013, LASER SURG MED, V45, P427, DOI 10.1002/lsm.22163; Kurokawa K, 2015, INVEST OPHTH VIS SCI, V56; Kurokawa K, 2015, OPT LETT, V40, P2153, DOI 10.1364/OL.40.002153; Kurokawa K, 2015, BIOMED OPT EXPRESS, V6, P170, DOI 10.1364/BOE.6.000170; Lanzetta P, 2008, OPHTHALMOLOGY, V115, P216, DOI 10.1016/j.ophtha.2007.08.007; Lavinsky D, 2014, RETINA-J RET VIT DIS, V34, P87, DOI 10.1097/IAE.0b013e3182993edc; Liu X, 2012, OPT EXPRESS, V20, P16567, DOI 10.1364/OE.20.016567; Mainster M A, 1999, Semin Ophthalmol, V14, P200; Mojana F, 2011, RETINA-J RET VIT DIS, V31, P235, DOI 10.1097/IAE.0b013e3181ec80ad; Muller HH, 2012, BIOMED OPT EXPRESS, V3, P1025, DOI 10.1364/BOE.3.001025; Muqit MMK, 2010, BRIT J OPHTHALMOL, V94, P1493, DOI 10.1136/bjo.2009.176677; Muqit MMK, 2011, INVEST OPHTH VIS SCI, V52, P994, DOI 10.1167/iovs.10-6309; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; ROSENBERG N, 1986, ARCH OPHTHALMOL-CHIC, V104, P34; Schmitt JM, 1998, OPT EXPRESS, V3, P199, DOI 10.1364/OE.3.000199; Shah AM, 2011, AM J OPHTHALMOL, V152, P332, DOI 10.1016/j.ajo.2011.04.015; Sramek C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130282; Steiner P, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2374594; Sun CR, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121515; Vakoc BJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714027; Vermeer KA, 2014, BIOMED OPT EXPRESS, V5, P322, DOI 10.1364/BOE.5.000322; Wang RKK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357854	36	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156761	10.1371/journal.pone.0156761	http://dx.doi.org/10.1371/journal.pone.0156761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271952	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200015
J	Jehi, SE; Nanavaty, V; Li, BB				Jehi, Sanaa E.; Nanavaty, Vishal; Li, Bibo			Trypanosoma brucei TIF2 and TRF Suppress VSG Switching Using Overlapping and Independent Mechanisms	PLOS ONE			English	Article							GENE-EXPRESSION SITES; ANTIGENIC VARIATION; HOMOLOGOUS RECOMBINATION; TELOMERE LENGTH; END; REPLICATION; ROLES; IDENTIFICATION; DEGRADATION; POLYMERASE	Trypanosoma brucei causes debilitating human African trypanosomiasis and evades the host's immune response by regularly switching its major surface antigen, VSG, which is expressed exclusively from subtelomeric loci. We previously showed that two interacting telomere proteins, TbTRF and TbTIF2, are essential for cell proliferation and suppress VSG switching by inhibiting DNA recombination events involving the whole active VSG expression site. We now find that TbTIF2 stabilizes TbTRF protein levels by inhibiting their degradation by the 26S proteasome, indicating that decreased TbTRF protein levels in TbTIF2-depleted cells contribute to more frequent VSG switching and eventual cell growth arrest. Surprisingly, although TbTIF2 depletion leads to more subtelomeric DNA double strand breaks (DSBs) that are both potent VSG switching inducers and detrimental to cell viability, TbTRF depletion does not increase the amount of DSBs inside subtelomeric VSG expression sites. Furthermore, expressing an ectopic allele of F2H-TbTRF in TbTIF2 RNAi cells allowed cells to maintain normal TbTRF protein levels for a longer frame of time. This resulted in a mildly better cell growth and partially suppressed the phenotype of increased VSG switching frequency but did not suppress the phenotype of more subtelomeric DSBs in TbTIF2-depleted cells. Therefore, TbTIF2 depletion has two parallel effects: decreased TbTRF protein levels and increased subtelomeric DSBs, both resulting in an acute increased VSG switching frequency and eventual cell growth arrest.	[Jehi, Sanaa E.; Nanavaty, Vishal; Li, Bibo] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Li, Bibo] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Li, Bibo] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Li, Bibo] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Jehi, Sanaa E.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University System of Ohio; Cleveland State University; Rockefeller University; Cleveland Clinic Foundation; Case Western Reserve University; Scripps Research Institute	Li, BB (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.; Li, BB (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.; Li, BB (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA.; Li, BB (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	b.li37@csuohio.edu		Nanavaty, Vishal/0000-0001-7946-8076	National Institute of Allergy and Infectious Diseases [AI066095]; Cleveland State University Faculty Research and Development; Center for Gene Regulation in Health and Disease at Cleveland State University research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066095] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cleveland State University Faculty Research and Development; Center for Gene Regulation in Health and Disease at Cleveland State University research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases, R01 grant (AI066095), https://www.niaid.nih.gov/Pages/default.aspx, PI: Li; Cleveland State University 2010 Faculty Research and Development, http://www.csuohio.edu/, PI: Li; The Center for Gene Regulation in Health and Disease at Cleveland State University research fund, https://www.csuohio.edu/grhd/grhd, PI: Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2001, MOL BIOCHEM PARASIT, V113, P79, DOI 10.1016/S0166-6851(00)00388-1; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Benmerzouga I, 2013, MOL MICROBIOL, V87, P196, DOI 10.1111/mmi.12093; BERNARDS A, 1983, NATURE, V303, P592, DOI 10.1038/303592a0; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Burton P, 2007, EUKARYOT CELL, V6, P1773, DOI 10.1128/EC.00212-07; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Dreesen O, 2006, EUKARYOT CELL, V5, P2114, DOI 10.1128/EC.00059-06; Glover L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003260; Glover L, 2012, MOL BIOCHEM PARASIT, V183, P78, DOI 10.1016/j.molbiopara.2012.01.008; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hartley CL, 2008, MOL MICROBIOL, V68, P1237, DOI 10.1111/j.1365-2958.2008.06230.x; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; Hovel-Miner GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002900; Huang L, 1999, MOL BIOCHEM PARASIT, V102, P211, DOI 10.1016/S0166-6851(99)00096-1; Jehi SE, 2014, NUCLEIC ACIDS RES, V42, P12899, DOI 10.1093/nar/gku942; Jehi SE, 2014, CELL RES, V24, P870, DOI 10.1038/cr.2014.60; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim H.T., 2010, INT C 2 COMP ENG TEC, V6, pV6, DOI DOI 10.1371/J0URNAL.PPAT.1000992; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li BB, 2015, EUKARYOT CELL, V14, P196, DOI 10.1128/EC.00207-14; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; McCulloch R, 1999, GENE DEV, V13, P2875, DOI 10.1101/gad.13.21.2875; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; Murnane JP, 2006, DNA REPAIR, V5, P1082, DOI 10.1016/j.dnarep.2006.05.030; MYLER PJ, 1984, CELL, V39, P203, DOI 10.1016/0092-8674(84)90206-X; Pandya UM, 2013, NUCLEIC ACIDS RES, V41, P7673, DOI 10.1093/nar/gkt562; Proudfoot C, 2005, NUCLEIC ACIDS RES, V33, P6906, DOI 10.1093/nar/gki996; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; Rudenko G, 1996, MOL BIOCHEM PARASIT, V80, P65, DOI 10.1016/0166-6851(96)02669-2; RUDENKO G, 1989, EMBO J, V8, P2633, DOI 10.1002/j.1460-2075.1989.tb08403.x; Sandhu R, 2013, CELL RES, V23, P537, DOI 10.1038/cr.2013.35; Sandhu R, 2011, JOVE-J VIS EXP, DOI 10.3791/1959; Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003; SCHOLLER JK, 1989, MOL BIOCHEM PARASIT, V35, P11, DOI 10.1016/0166-6851(89)90137-0; Neto JLS, 2007, BIOCHEM BIOPH RES CO, V358, P417, DOI 10.1016/j.bbrc.2007.04.144; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Valdes J, 1996, NUCLEIC ACIDS RES, V24, P1809, DOI 10.1093/nar/24.10.1809; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wei Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073869; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032	64	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156746	10.1371/journal.pone.0156746	http://dx.doi.org/10.1371/journal.pone.0156746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258069	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700120
J	Ride, J; Lancsar, E				Ride, Jemimah; Lancsar, Emily			Women's Preferences for Treatment of Perinatal Depression and Anxiety: A Discrete Choice Experiment	PLOS ONE			English	Article							POSTNATAL DEPRESSION; MENTAL-HEALTH; POSTPARTUM DEPRESSION; PERCEIVED BARRIERS; LOW-INCOME; PREGNANCY; CARE; SERVICES; OUTCOMES; ACCESS	Perinatal depression and anxiety (PNDA) are an international healthcare priority, associated with significant short-and long-term problems for women, their children and families. Effective treatment is available but uptake is suboptimal: some women go untreated whilst others choose treatments without strong evidence of efficacy. Better understanding of women's preferences for treatment is needed to facilitate uptake of effective treatment. To address this issue, a discrete choice experiment (DCE) was administered to 217 pregnant or postnatal women in Australia, who were recruited through an online research company and had similar sociodemographic characteristics to Australian data for perinatal women. The DCE investigated preferences regarding cost, treatment type, availability of childcare, modality and efficacy. Data were analysed using logit-based models accounting for preference and scale heterogeneity. Predicted probability analysis was used to explore relative attribute importance and policy change scenarios, including how these differed by women's sociodemographic characteristics. Cost and treatment type had the greatest impact on choice, such that a policy of subsidising effective treatments was predicted to double their uptake compared with the base case. There were differences in predicted uptake associated with certain sociodemographic characteristics: for example, women with higher educational attainment were more likely to choose effective treatment. The findings suggest policy directions for decision makers whose goal is to reduce the burden of PNDA on women, their children and families.	[Ride, Jemimah; Lancsar, Emily] Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia	Monash University	Ride, J (corresponding author), Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia.	jemimah.ride@monash.edu		Lancsar, Emily/0000-0003-2404-6735; Ride, Jemimah/0000-0002-1820-5499				AIHW, 2012, PER DEPR DAT 2010 AU; Almond P, 2011, J ADV NURS, V67, P2350, DOI 10.1111/j.1365-2648.2011.05669.x; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; Alvidrez J, 1999, GEN HOSP PSYCHIAT, V21, P340, DOI 10.1016/S0163-8343(99)00038-9; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2012, SIGN PUBL; Austin MPV, 2010, ARCH WOMEN MENT HLTH, V13, P395, DOI 10.1007/s00737-010-0153-7; Banti S, 2011, COMPR PSYCHIAT, V52, P343, DOI 10.1016/j.comppsych.2010.08.003; Bech M, 2011, HEALTH ECON, V20, P273, DOI 10.1002/hec.1587; beyondblue, 2011, CLIN PRACT GUID DEPR; Boath E, 2004, J PSYCHOSOM OBST GYN, V25, P221, DOI 10.1080/01674820400017889; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Buist Anne, 2005, Aust Fam Physician, V34, P787; Byatt N, 2012, J PSYCHOSOM OBST GYN, V33, P143, DOI 10.3109/0167482X.2012.728649; Chaudron LH, 2014, J PSYCHOSOM RES, V76, P489, DOI 10.1016/j.jpsychores.2014.03.011; Chew-Graham CA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-7; Clarke K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001541; COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; Dagher RK, 2012, J OCCUP ENVIRON MED, V54, P210, DOI 10.1097/JOM.0b013e31823fdf85; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; C-L D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006116.pub2; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Dennis CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006795.pub3; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Fiebig DG, 2010, MARKET SCI, V29, P393, DOI 10.1287/mksc.1090.0508; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gelhorn Heather L, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.11r01161; Gerard K, 2008, ECON NON-MARK GOOD, V11, P117; Goodman JH, 2009, BIRTH-ISS PERINAT C, V36, P60, DOI 10.1111/j.1523-536X.2008.00296.x; Hancock-Howard RL, 2012, BIRTH DEFECTS RES A, V94, P532, DOI 10.1002/bdra.23042; Hay DF, 2010, CHILD DEV, V81, P149, DOI 10.1111/j.1467-8624.2009.01386.x; Herbild L, 2009, VALUE HEALTH, V12, P560, DOI 10.1111/j.1524-4733.2008.00465.x; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hess S, 2012, TRANSPORTATION, V39, P1225, DOI 10.1007/s11116-012-9394-9; Horowitz June Andrews, 2004, Res Theory Nurs Pract, V18, P149; Johnson FR, 2012, CONSTRUCTING EXPT DE; Keane M, 2013, J APPL ECONOMET, V28, P1018, DOI 10.1002/jae.2304; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Knox SA, 2013, SOC SCI MED, V83, P70, DOI 10.1016/j.socscimed.2012.12.025; Korhonen M, 2012, J AFFECT DISORDERS, V136, P680, DOI 10.1016/j.jad.2011.10.007; KUMAR R, 1994, SOC PSYCH PSYCH EPID, V29, P250, DOI 10.1007/BF00802048; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2007, SOC SCI MED, V64, P1738, DOI 10.1016/j.socscimed.2006.12.007; Lancsar E, 2014, PHARMACOECONOMICS, V32, P951, DOI 10.1007/s40273-014-0181-7; Lau MA, 2012, MINDFULNESS, V3, P318, DOI 10.1007/s12671-012-0108-3; Lin P, 2005, ANN BEHAV MED, V30, P164, DOI 10.1207/s15324796abm3002_9; Lloyd A, 2011, INT J TECHNOL ASSESS, V27, P215, DOI 10.1017/S0266462311000249; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Mooney G, 1998, HEALTH CARE ANAL, V6, P99, DOI 10.1002/(SICI)1099-1042(199806)6:2<99::AID-HCA250>3.0.CO;2-U; Nadeem E, 2008, ARCH WOMEN MENT HLTH, V11, P93, DOI 10.1007/s00737-008-0002-0; O'Mahen HA, 2013, J AFFECT DISORDERS, V150, P814, DOI 10.1016/j.jad.2013.03.005; O'Mahen HA, 2008, J WOMENS HEALTH, V17, P1301, DOI 10.1089/jwh.2007.0631; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Orme B., 2009, P SAET SOFTW C; Paczkowski MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046788; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Petrou S, 2002, BRIT J PSYCHIAT, V181, P505, DOI 10.1192/bjp.181.6.505; Poobalan AS, 2007, BRIT J PSYCHIAT, V191, P378, DOI 10.1192/bjp.bp.106.032789; Proctor EK, 2009, ADM POLICY MENT HLTH, V36, P24, DOI 10.1007/s10488-008-0197-4; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Reay R, 2011, J AFFECT DISORDERS, V129, P94, DOI 10.1016/j.jad.2010.07.035; Salkeld G, 2000, HEALTH ECON, V9, P267, DOI 10.1002/(SICI)1099-1050(200004)9:3<267::AID-HEC511>3.0.CO;2-H; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Scott A, 2003, SOC SCI MED, V56, P803, DOI 10.1016/S0277-9536(02)00079-5; Sleath B, 2005, J PSYCHOSOM OBST GYN, V26, P135, DOI 10.1080/01443610400023130A; Thombs BD, 2014, J PSYCHOSOM RES, V76, P433, DOI 10.1016/j.jpsychores.2014.01.006; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Waschbusch DA, 2011, J CLIN CHILD ADOLESC, V40, P546, DOI 10.1080/15374416.2011.581617; Webster J, 2001, J Qual Clin Pract, V21, P144, DOI 10.1046/j.1440-1762.2001.00432.x; Weier KM, 2004, J MIDWIFERY WOM HEAL, V49, P96, DOI 10.1016/j.jmwh.2003.12.013; Woolhouse H, 2009, ARCH WOMEN MENT HLTH, V12, P75, DOI 10.1007/s00737-009-0049-6	72	14	14	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156629	10.1371/journal.pone.0156629	http://dx.doi.org/10.1371/journal.pone.0156629			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258096	Green Published, Green Accepted, gold			2022-12-27	WOS:000377369700092
J	Sun, XH; Zhang, JY				Sun, Xiaohan; Zhang, Junying			Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma	PLOS ONE			English	Article							CANCER; KIDNEY; GENES; EXPRESSION; PROGNOSIS	Past research on pathogenesis of a complex disease suggests that differentially expressed message RNAs (mRNAs) can be noted as biomarkers of a disease. However, significant miRNA-mediated regulation change might also be more deep underlying cause of a disease. In this study, a miRNA-mediated regulation module is defined based on GO terms (Gene Ontology terms) from which dysfunctional modules are identified as the suspected cause of a disease. A miRNA-mediated regulation module contains mRNAs annotated to a GO term and MicroRNAs (miRNAs) which regulate the mRNAs. Based on the miRNA-mediated regulation coefficients estimated from the expression profiles of the mRNA and the miRNAs, a SW (single regulation-weight) value is then designed to evaluate the miRNA-mediated regulation change of an mRNA, and the modules with significantly differential SW values are thus identified as dysfunctional modules. The approach is applied to Chromophobe renal cell carcinoma and it identifies 70 dysfunctional miRNA-mediated regulation modules from initial 4381 modules. The identified dysfunctional modules are detected to be comprehensive reflection of chromophobe renal cell carcinoma. The proposed approach suggests that accumulated alteration in miRNA-mediated regulation might cause functional alterations, which further cause a disease. Moreover, this approach can also be used to identify diffentially miRNA-mediated regulated mRNAs showing more comprehensive underlying association with a disease than differentially expressed mRNAs.	[Sun, Xiaohan; Zhang, Junying] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Sun, Xiaohan] Weinan Normal Univ, Coll Math & Informat Sci, Weinan, Shaanxi, Peoples R China	Xidian University; Weinan Normal University	Zhang, JY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	jyzhang@mail.xidian.edu.cn		Sun, Xiaohan/0000-0003-0336-3053	Natural Science Foundation of China [61571341, 61201312, 91530113]; Research Fund for the Doctoral Program of Higher Education of China [20130203110017]; Fundamental Research Funds for the Central Universities of China [BDY171416, JB140306]; Scientific research plan projects of Shaanxi Education Department [14JK1249]; Subject Fund for Shaanxi Province of China [14SXZD014]; research plan projects of Weinan Normal University [16YKP002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Scientific research plan projects of Shaanxi Education Department; Subject Fund for Shaanxi Province of China; research plan projects of Weinan Normal University	This work was supported by the Natural Science Foundation of China under Grants [61571341, 61201312, 91530113], Research Fund for the Doctoral Program of Higher Education of China [20130203110017], the Fundamental Research Funds for the Central Universities of China [BDY171416, JB140306], Scientific research plan projects of Shaanxi Education Department [14JK1249], the Subject Fund for Shaanxi Province of China [14SXZD014] and the research plan projects of Weinan Normal University [16YKP002].	Barrera-Vilarmau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021413; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Chang I, 2013, MOL CANCER THER, V12, P1049, DOI 10.1158/1535-7163.MCT-12-1187; Ge YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10328; Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; Hirata H, 2007, CLIN CANCER RES, V13, P4123, DOI 10.1158/1078-0432.CCR-07-0609; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043441; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kennedy JC, 2016, SEMIN CELL DEV BIOL, V52, P47, DOI 10.1016/j.semcdb.2016.02.014; Kleftogiannis D, 2013, J BIOMED INFORM, V46, P563, DOI 10.1016/j.jbi.2013.02.002; Linehan WM, 2009, CANCER-AM CANCER SOC, V115, P2252, DOI 10.1002/cncr.24230; Liou Louis S, 2004, BMC Urol, V4, P9, DOI 10.1186/1471-2490-4-9; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; More Vijay R, 2012, Comp Hepatol, V11, P1, DOI 10.1186/1476-5926-11-1; Nair N, 2013, MOL CELL BIOCHEM, V376, P33, DOI 10.1007/s11010-012-1546-x; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Oparina NY, 2013, RUSS J GENET+, V49, P707, DOI 10.1134/S1022795413050104; Peiris-John R, 2006, EXPOSURE ACETYLCHOLI; SAWILOWSKY SS, 1992, PSYCHOL BULL, V111, P352, DOI 10.1037/0033-2909.111.2.352; Saxena M, 1998, J BIOL CHEM, V273, P15340, DOI 10.1074/jbc.273.25.15340; Srikanth MS, 2005, OBES SURG, V15, P1165, DOI 10.1381/0960892055002185; Tabatabaeifar M, 2009, PEDIATR NEPHROL, V24, P2361, DOI 10.1007/s00467-009-1287-6; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Xiao Y, 2013, NEURO-ONCOLOGY, V15, P818, DOI 10.1093/neuonc/not018; Yamazaki K, 2003, ONCOGENE, V22, P847, DOI 10.1038/sj.onc.1206153; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zheng H, 2013, INT J MOL SCI, V14, P8179, DOI 10.3390/ijms14048179	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156324	10.1371/journal.pone.0156324	http://dx.doi.org/10.1371/journal.pone.0156324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258182	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700053
J	Thomas, RC; Cowley, PM; Singh, A; Myagmar, BE; Swigart, PM; Baker, AJ; Simpson, PC				Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Swigart, Philip M.; Baker, Anthony J.; Simpson, Paul C.			The Alpha-1A Adrenergic Receptor in the Rabbit Heart	PLOS ONE			English	Article							RIGHT-VENTRICULAR MYOCARDIUM; ALPHA-1-ADRENERGIC RECEPTORS; SELECTIVE ANTAGONIST; CARDIAC MYOCYTES; IN-VIVO; SUBTYPE; FAILURE; ALPHA(1D)-ADRENOCEPTORS; STIMULATION; ALPHA(1B)	The alpha-1A-adrenergic receptor (AR) subtype is associated with cardioprotective signaling in the mouse and human heart. The rabbit is useful for cardiac disease modeling, but data on the alpha-1A in the rabbit heart are limited. Our objective was to test for expression and function of the alpha-1A in rabbit heart. By quantitative real-time reverse transcription PCR (qPCR) on mRNA from ventricular myocardium of adult male New Zealand White rabbits, the alpha-1B was 99% of total alpha-1-AR mRNA, with <1% alpha-1A and alpha-1D, whereas alpha-1A mRNA was over 50% of total in brain and liver. Saturation radioligand binding identified similar to 4 fmol total alpha-1-ARs per mg myocardial protein, with 17% alpha-1A by competition with the selective antagonist 5-methylurapidil. The alpha-1D was not detected by competition with BMY-7378, indicating that 83% of alpha-1-ARs were alpha-1B. In isolated left ventricle and right ventricle, the selective alpha-1A agonist A61603 stimulated a negative inotropic effect, versus a positive inotropic effect with the nonselective alpha-1-agonist phenylephrine and the beta-agonist isoproterenol. Blood pressure assay in conscious rabbits using an indwelling aortic telemeter showed that A61603 by bolus intravenous dosing increased mean arterial pressure by 20 mm Hg at 0.14 mu g/kg, 10-fold lower than norepinephrine, and chronic A61603 infusion by iPRECIO programmable micro Infusion pump did not increase BP at 22 mu g/kg/d. A myocardial slice model useful in human myocardium and an anthracycline cardiotoxicity model useful in mouse were both problematic in rabbit. We conclude that alpha-1A mRNA is very low in rabbit heart, but the receptor is present by binding and mediates a negative inotropic response. Expression and function of the alpha-1A in rabbit heart differ from mouse and human, but the vasopressor response is similar to mouse.	[Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Swigart, Philip M.; Baker, Anthony J.; Simpson, Paul C.] VA Med Ctr, Dept Med, Div Cardiol, San Francisco, CA USA; [Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Swigart, Philip M.; Baker, Anthony J.; Simpson, Paul C.] VA Med Ctr, Res Serv, San Francisco, CA USA; [Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Baker, Anthony J.; Simpson, Paul C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Baker, Anthony J.; Simpson, Paul C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Singh, Abhishek] Temple Univ, Philadelphia, PA 19122 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Simpson, PC (corresponding author), VA Med Ctr, Dept Med, Div Cardiol, San Francisco, CA USA.; Simpson, PC (corresponding author), VA Med Ctr, Res Serv, San Francisco, CA USA.; Simpson, PC (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.; Simpson, PC (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA.	paul.simpson@ucsf.edu			Department of Veterans Affairs [BX001970]; National Institutes of Health [HL31113, 5T32HL007731]; Western States Affiliate of the American Heart Association; Veterans Affairs [I01BX000740] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Western States Affiliate of the American Heart Association(American Heart Association); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by: Department of Veterans Affairs (PCS, BX001970, AJB); National Institutes of Health (PCS, HL31113; AS, 5T32HL007731); and Western States Affiliate of the American Heart Association (AJB, B-EM, RCT, PMC).	Cowley PM, 2015, AM J PHYSIOL-HEART C, V309, pH888, DOI 10.1152/ajpheart.00042.2015; Dash R, 2011, MAGN RESON MED, V66, P1152, DOI 10.1002/mrm.22876; ENDOH M, 1992, N-S ARCH PHARMACOL, V345, P578; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Jensen BC, 2014, J CARDIOVASC PHARM, V63, P291, DOI 10.1097/FJC.0000000000000032; Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014; Jensen BC, 2009, CIRC-HEART FAIL, V2, P654, DOI 10.1161/CIRCHEARTFAILURE.108.846212; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Klimtova I, 2002, HUM EXP TOXICOL, V21, P649, DOI 10.1191/0960327102ht311oa; KNEPPER SM, 1995, J PHARMACOL EXP THER, V274, P97; KOHI M, 1993, EUR J PHARMACOL, V250, P95, DOI 10.1016/0014-2999(93)90625-R; Methven L, 2009, BRIT J PHARMACOL, V158, P1663, DOI 10.1111/j.1476-5381.2009.00462.x; Miyamoto S, 1997, LIFE SCI, V60, P2069, DOI 10.1016/S0024-3205(97)00194-X; Nagashima M, 1996, AM J PHYSIOL-HEART C, V271, pH1423, DOI 10.1152/ajpheart.1996.271.4.H1423; O'Connell TD, 2014, PHARMACOL REV, V66, P308, DOI 10.1124/pr.112.007203; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piao H, 2000, EUR J PHARMACOL, V396, P9, DOI 10.1016/S0014-2999(00)00171-0; Pogwizd Steven M, 2008, Drug Discov Today Dis Models, V5, P185, DOI 10.1016/j.ddmod.2009.02.001; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Rokosh DG, 1996, J BIOL CHEM, V271, P5839, DOI 10.1074/jbc.271.10.5839; Simunek T, 2004, EUR J HEART FAIL, V6, P377, DOI 10.1016/j.ejheart.2003.05.003; Sterba M, 2011, J MOL CELL CARDIOL, V50, P849, DOI 10.1016/j.yjmcc.2011.01.018; Tanoue A, 2002, HYPERTENSION, V40, P101, DOI 10.1161/01.HYP.0000022062.70639.1C; Thomas R Croft, 2016, JACC Basic Transl Sci, V1, P155; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GY, 2006, AM J PHYSIOL-HEART C, V291, pH2013, DOI 10.1152/ajpheart.00167.2006; Yang HT, 1996, EUR J PHARMACOL, V312, P281, DOI 10.1016/0014-2999(96)00442-6	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155238	10.1371/journal.pone.0155238	http://dx.doi.org/10.1371/journal.pone.0155238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258143	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700012
J	Thomsson, O; Sjunnesson, Y; Magnusson, U; Eliasson-Selling, L; Wallenbeck, A; Bergqvist, AS				Thomsson, Ola; Sjunnesson, Ylva; Magnusson, Ulf; Eliasson-Selling, Lena; Wallenbeck, Anna; Bergqvist, Ann-Sofi			Consequences for Piglet Performance of Group Housing Lactating Sows at One, Two, or Three Weeks Post-Farrowing	PLOS ONE			English	Article							MATERNAL-BEHAVIOR; NURSING BEHAVIOR; SURVIVAL; PIGS; MORTALITY; QUALITY; WEIGHTS	Housing lactating sows with piglets in a multi-suckling pen from around 14 days post-farrowing is common practice in Swedish organic piglet production. However, nursing-suckling interaction is less frequent in multi-suckling pens than in individual farrowing pens, thus affecting piglet performance, e.g., piglet growth. Moreover, piglet mortality is higher in systems using multi-suckling pens. Three management routines whereby lactating sows with piglets were moved from individual farrowing pens to multi-suckling pens at one, two, or three weeks post-farrowing were compared in terms of nursing-suckling interaction and piglet performance. Correlations between nursing-suckling interaction, piglet performance, and piglet mortality were also examined. In total, 43 Yorkshire sows with piglets were included in the study. Nursing-suckling interaction and all piglet performance parameters except piglet mortality did not differ between management routines. Piglet mortality in the individual farrowing pens did not differ between management routines, but piglet mortality in the multi-suckling pen was lower (P<0.05) when piglets were group housed at three weeks compared with one week post-farrowing. Overall piglet mortality was positively correlated with mortality in the multi-suckling pen for piglets group housed at one week (r = 0.61: P<0.05) and at two weeks post-farrowing (r = 0.62: P<0.05) but not for piglets group housed at three weeks post-farrowing. In conclusion, overall piglet mortality could be reduced if sows and piglets are group housed at three weeks post-farrowing and piglet survival the first week post-farrowing is improved.	[Thomsson, Ola; Sjunnesson, Ylva; Magnusson, Ulf; Bergqvist, Ann-Sofi] Swedish Univ Agr Sci, SLU, Dept Clin Sci, Div Reprod, Uppsala, Sweden; [Eliasson-Selling, Lena] Farm & Anim Hlth, Uppsala, Sweden; [Wallenbeck, Anna] Swedish Univ Agr Sci, SLU, Dept Anim Breeding & Genet, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Bergqvist, AS (corresponding author), Swedish Univ Agr Sci, SLU, Dept Clin Sci, Div Reprod, Uppsala, Sweden.	ann-sofi.bergqvist@slu.se	Eliasson-Selling, Lena/AAX-9805-2021; Sjunnesson, Ylva/AAN-6152-2020	Sjunnesson, Ylva/0000-0003-4500-5123; Thomsson, Ola/0000-0002-6065-7923; Magnusson, Ulf/0000-0002-7087-6820; Wallenbeck, Anna/0000-0001-8012-2849	Swedish Research Council; Swedish University of Agricultural Sciences; Farm and Animal Health, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish University of Agricultural Sciences; Farm and Animal Health, Sweden	Funding for this study was provided by the Swedish Research Council for environment, agricultural sciences and spatial planning (UM) (http://proj.formas.se/detail.asp?arendeid=24161&sprak=2&x=230&y=0 Reg.no 2010-1895). The Swedish University of Agricultural Sciences provided funding in the form of salary for Ylva Sjunnesson (YS), Ulf Magnusson (UM), Anna Wallenbeck (AW) and Ann-Sofi Bergqvist (ASB). The Farm and Animal Health, Sweden provided funding in the form of salary for Lena Eliasson-Selling (LES). The funders had no role in study design, data collection, and -analysis, decision to publish or preparation of the manuscript but decided that if the data was published it had to be with Open Access.	ALGERS B, 1990, APPL ANIM BEHAV SCI, V26, P143, DOI 10.1016/0168-1591(90)90094-T; Alonso-Spilsbury M, 2007, J ANIM VET ADV, V6, P76; Andersen IL, 2005, APPL ANIM BEHAV SCI, V93, P229, DOI 10.1016/j.applanim.2004.11.015; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; BOE K, 1993, APPL ANIM BEHAV SCI, V35, P327, DOI 10.1016/0168-1591(93)90084-3; Dybjaer L, 2001, ACTA AGR SCAND A-AN, V51, P134, DOI 10.1080/090647001750193477; EDWARDS SA, 1994, VET REC, V135, P324, DOI 10.1136/vr.135.14.324; Edwards SA, 2002, LIVEST PROD SCI, V78, P3, DOI 10.1016/S0301-6226(02)00180-X; EEC CR, 2007, OFFICIAL J EUROPEAN, P1; Hessel EF, 2006, J ANIM SCI, V84, P2847, DOI 10.2527/jas.2005-606; Hulten F, 1997, ACTA VET SCAND, V38, P119; Lindgren Y, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-33; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Oostindjer M, 2011, APPL ANIM BEHAV SCI, V134, P31, DOI 10.1016/j.applanim.2011.06.011; Pajor EA, 2002, APPL ANIM BEHAV SCI, V76, P267, DOI 10.1016/S0168-1591(02)00010-2; Pedersen ML, 2011, LIVEST SCI, V140, P253, DOI 10.1016/j.livsci.2011.04.001; Silerova J, 2006, APPL ANIM BEHAV SCI, V101, P167, DOI 10.1016/j.applanim.2006.01.002; Su G, 2007, J ANIM SCI, V85, P1385, DOI 10.2527/jas.2006-631; THOMPSON BK, 1986, CAN J ANIM SCI, V66, P361, DOI 10.4141/cjas86-037; Thomsson O, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0101-7; Valros AE, 2002, APPL ANIM BEHAV SCI, V76, P93, DOI 10.1016/S0168-1591(02)00006-0; Vasdal G, 2012, LIVEST SCI, V146, P91, DOI 10.1016/j.livsci.2012.02.005; Wallenbeck A, 2008, LIVEST SCI, V116, P216, DOI 10.1016/j.livsci.2007.10.008; Wallenbeck A, 2009, ACTA AGR SCAND A-AN, V59, P181, DOI 10.1080/09064700903307824; Weary DM, 2002, APPL ANIM BEHAV SCI, V76, P279, DOI 10.1016/S0168-1591(02)00011-4; Wulbers-Mindermann M, 2002, LIVEST PROD SCI, V73, P285, DOI 10.1016/S0301-6226(01)00257-3	26	8	9	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156581	10.1371/journal.pone.0156581	http://dx.doi.org/10.1371/journal.pone.0156581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258149	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700083
J	Yang, SS; Jin, LH; Park, SH; Kim, MS; Kim, YJ; Choi, BH; Lee, CT; Park, SR; Min, BH				Yang, Soon Sim; Jin, Long Hao; Park, Sang-Hyug; Kim, Moon Suk; Kim, Young Jick; Choi, Byung Hyune; Lee, Chun Tek; Park, So Ra; Min, Byoung-Hyun			Extracellular Matrix (ECM) Multilayer Membrane as a Sustained Releasing Growth Factor Delivery System for rhTGF-beta(3) in Articular Cartilage Repair	PLOS ONE			English	Article							BONE-MARROW STIMULATION; MESENCHYMAL STEM-CELLS; FACTOR-BETA; IN-VIVO; POLYELECTROLYTE MULTILAYERS; SEQUENTIAL RELEASE; THICKNESS DEFECTS; TGF-BETA; IGF-I; SCAFFOLDS	Recombinant human transforming growth factor beta-3 (rhTGF-beta(3)) is a key regulator of chondrogenesis in stem cells and cartilage formation. We have developed a novel drug delivery system that continuously releases rhTGF-beta(3) using a multilayered extracellular matrix (ECM) membrane. We hypothesize that the sustained release of rhTGF-beta(3) could activate stem cells and result in enhanced repair of cartilage defects. The properties and efficacy of the ECM multilayer-based delivery system (EMLDS) are investigated using rhTGF-beta(3) as a candidate drug. The bioactivity of the released rhTGF-beta(3) was evaluated through chondrogenic differentiation of mesenchymal stem cells (MSCs) using western blot and circular dichroism (CD) analyses in vitro. The cartilage reparability was evaluated through implanting EMLDS with endogenous and exogenous MSC in both in vivo and ex vivo models, respectively. In the results, the sustained release of rhTGF-beta(3) was clearly observed over a prolonged period of time in vitro and the released rhTGF-beta(3) maintained its structural stability and biological activity. Successful cartilage repair was also demonstrated when rabbit MSCs were treated with rhTGF-beta(3)-loaded EMLDS ((+) rhTGF-beta(3) EMLDS) in an in vivo model and when rabbit chondrocytes and MSCs were treated in ex vivo models. Therefore, the multilayer ECM membrane could be a useful drug delivery system for cartilage repair.	[Yang, Soon Sim; Kim, Moon Suk; Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Jin, Long Hao; Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Orthoped Surg, Suwon 441749, South Korea; [Park, Sang-Hyug] Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea; [Kim, Young Jick; Min, Byoung-Hyun] Ajou Univ, Med Ctr, Cell Therapy Ctr, Suwon 441749, South Korea; [Choi, Byung Hyune] Inha Univ, Coll Med, Div Biomed & Bioengn Sci, Inchon, South Korea; [Lee, Chun Tek] Lee Chun Tek Orthoped Specialty Hosp, Suwon, South Korea; [Park, So Ra] Inha Univ, Coll Med, Dept Physiol, Inchon, South Korea	Ajou University; Ajou University; Pukyong National University; Ajou University; Inha University; Inha University	Min, BH (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.; Min, BH (corresponding author), Ajou Univ, Sch Med, Dept Orthoped Surg, Suwon 441749, South Korea.; Min, BH (corresponding author), Ajou Univ, Med Ctr, Cell Therapy Ctr, Suwon 441749, South Korea.	bhmin@ajou.ac.kr			Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2013R1A1A1011040]	Ministry of Science, ICT & Future Planning, Republic of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by a grant from the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A1011040), Republic of Korea. There is no other potential conflict of interest relevant to this article.	Abarrategi A, 2008, BIOMACROMOLECULES, V9, P711, DOI 10.1021/bm701049g; Anraku Y, 2009, J BONE MINER METAB, V27, P272, DOI 10.1007/s00774-009-0038-x; BH M, 2013, J ORTHOPAEDIC RES; Cai DZ, 2007, CHINESE MED J-PEKING, V120, P197, DOI 10.1097/00029330-200702010-00005; Catelas I, 2008, TISSUE ENG PART C-ME; Cui JH, 2007, TISSUE ENG, V13, P351, DOI 10.1089/ten.2006.0080; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271; Gillogly SD, 2005, ORTHOP CLIN N AM, V36, P433, DOI 10.1016/j.ocl.2005.06.005; Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004; Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184; Jin CZ, 2011, TISSUE ENG PT A, V17, P3057, DOI [10.1089/ten.tea.2010.0605, 10.1089/ten.TEA.2010.0605]; Jin LH, 2011, OSTEOARTHR CARTILAGE, V19, P1440, DOI 10.1016/j.joca.2011.07.012; Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034; Karlsson AJ, 2010, BIOMACROMOLECULES, V11, P2321, DOI 10.1021/bm100424s; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kim JM, 2012, TISSUE ENG REGEN MED, V9, P175, DOI 10.1007/s13770-012-0175-5; Kittitheeranun P, 2010, LANGMUIR, V26, P6869, DOI 10.1021/la1003676; Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004; LaPorta TF, 2012, ORTHOP CLIN N AM, V43, P245, DOI 10.1016/j.ocl.2012.02.002; Li TZ, 2012, ADV FUNCT MATER, V22, P4292, DOI 10.1002/adfm.201102695; Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b; Mierisch CM, 2002, ARTHROSCOPY, V18, P892, DOI 10.1053/jars.2002.36117; Miura Y, 2002, J BONE JOINT SURG AM, V84A, P793, DOI 10.2106/00004623-200205000-00015; Mueller-Rath R, 2007, BIO-MED MATER ENG, V17, P357; Park JS, 2008, TRANSPLANTATION, V85, P589, DOI 10.1097/TP.0b013e3181639b3a; Pavlukhina S, 2011, ADV DRUG DELIVER REV, V63, P822, DOI 10.1016/j.addr.2011.03.017; Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802; Shah NJ, 2011, BIOMATERIALS; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Sohier J, 2007, INT J PHARMACEUT, V332, P80, DOI 10.1016/j.ijpharm.2006.09.037; Solheim E, 2010, KNEE SURG SPORT TR A, V18, P504, DOI 10.1007/s00167-009-0974-y; Steinbrech DS, 2000, PLAST RECONSTR SURG, V105, P2028, DOI 10.1097/00006534-200005000-00018; Strobel C, 2011, J CONTROL RELEASE, V156, P37, DOI 10.1016/j.jconrel.2011.07.006; Vinardell T, 2009, ANN BIOMED ENG, V37, P2556, DOI 10.1007/s10439-009-9791-1; Wang L, 2009, LANGMUIR, V25, P7990, DOI 10.1021/la9004664; Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813; Wells RG, 1997, J BIOL CHEM, V272, P11444; Yang HS, 2011, TISSUE ENG PT A, V17, P1809, DOI 10.1089/ten.tea.2010.0540	43	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156292	10.1371/journal.pone.0156292	http://dx.doi.org/10.1371/journal.pone.0156292			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258120	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700052
J	Carver, LM; Perlaky, P; Cressler, A; Zigler, KS				Carver, Linnea M.; Perlaky, Patricia; Cressler, Alan; Zigler, Kirk S.			Reproductive Seasonality in Nesticus (Araneae: Nesticidae) Cave Spiders	PLOS ONE			English	Article							LIFE-HISTORY; META-MENARDI; TETRAGNATHIDAE; CRAYFISH; ECOLOGY; FAUNA	Spiders of the family Nesticidae are members of cave communities around the world with cave-obligate (troglobiotic) species known from North America, Europe, Asia and the Indo-Pacific. A radiation of Nesticus (Araneae: Nesticidae) in the southern Appalachians includes ten troglobiotic species. Many of these species are of conservation interest due to their small ranges, with four species being single-cave endemics. Despite conservation concerns and their important role as predators in cave communities, we know little about reproduction and feeding in this group. We addressed this knowledge gap by examining populations of two species on a monthly basis for one year. We made further observations on several other species and populations, totaling 671 individual spider observations. This more than doubled the reported observations of reproduction and feeding in troglobiotic Nesticus. Female Nesticus carry egg sacs, facilitating the determination of the timing and frequency of reproduction. We found that Nesticus exhibit reproductive seasonality. Females carried egg sacs from May through October, with a peak in frequency in June. These spiders were rarely observed with prey; only 3.3% (22/671) of individuals were observed with prey items. The frequency at which prey items were observed did not vary by season. Common prey items were flies, beetles and millipedes. Troglobiotic species constituted approximately half of all prey items observed. This result represents a greater proportion of troglobiotic prey than has been reported for various troglophilic spiders. Although our findings shed light on the life history of troglobiotic Nesticus and on their role in cave ecosystems, further work is necessary to support effective conservation planning for many of these rare species.	[Carver, Linnea M.; Zigler, Kirk S.] Sewanee Univ South, Dept Biol, Sewanee, TN 37375 USA; [Perlaky, Patricia] Raccoon Mt Caverns, Chattanooga, TN USA	Sewanee: University of the South	Zigler, KS (corresponding author), Sewanee Univ South, Dept Biol, Sewanee, TN 37375 USA.	kzigler@sewanee.edu	Zigler, Kirk S./GZM-2049-2022		Cave Conservancy Foundation; Sewanee: The University of the South; Raccoon Mountain Caverns	Cave Conservancy Foundation; Sewanee: The University of the South; Raccoon Mountain Caverns	LMC received a Fellowship in Karst Studies from the Cave Conservancy Foundation (http://www.caveconservancyfoundation.org/). The Cave Conservancy Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KSZ received research support from Sewanee: The University of the South (http://www.sewanee.edu/). The University of the South had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Raccoon Mountain Caverns provided support in the form of salary for one author [PP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR T C JR, 1971, Annales de Speleologie, V26, P47; BARR TC, 1967, AM NAT, V101, P475, DOI 10.1086/282512; Benjamin SP., REV SUISSE ZOOLOGIE, V111, P303; Buhlmann Kurt A., 2001, Journal of Cave and Karst Studies, V63, P91; Cokendolpher James, 2001, Texas Memorial Museum Speleological Monograph, V5, P25; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; GERTSCH WJ, 1984, TEX MEM MUS B, V31, P1; Harvey MS, 2011, INVERTEBR SYST, V25, P1, DOI 10.1071/IS11011; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Hedin M, 2005, ZOOTAXA, P1; Hedin MC, 1997, EVOLUTION, V51, P1929, DOI 10.1111/j.1558-5646.1997.tb05115.x; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; IVES J. D., 1935, JOUR ELISHA MITCHELL SCI SOC, V51, P297; Ives JD, 1947, BREEDING HABITS CAVE, V63, P215; JEGLA TC, 1966, BIOL BULL, V130, P345, DOI 10.2307/1539741; JEGLA TC, 1970, COMP BIOCHEM PHYSIOL, V33, P347, DOI 10.1016/0010-406X(70)90355-5; Kane T.C., 1975, International J Speleol, V7, P45; Lopez-Pancorbo A, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.89.921; Mammola S, 2014, INT J SPELEOL, V43, P343, DOI 10.5038/1827-806X.43.3.11; Mays JD, 2002, THESIS; Nakamura H., 1973, B AKIYOSHI DAI MUSEU, V9, P29; Niemiller ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064177; Niemiller ML, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P169, DOI 10.1201/EBK1578086702-c7; Novak T, 2010, ACTA OECOL, V36, P522, DOI 10.1016/j.actao.2010.07.005; PECK SB, 1986, EVOLUTION, V40, P1021, DOI 10.1111/j.1558-5646.1986.tb00569.x; Reddell JR, 2012, ENCY CAVES, P787; Reeves Will, 1999, Insecta Mundi, V13, P93; Ribera C, 2014, ZOOKEYS, P87, DOI 10.3897/zookeys.419.5739; Slay Michael E., 2009, Speleobiology Notes, V1, P3; Smithers P, 2005, J ARACHNOL, V33, P243, DOI 10.1636/CT-05-2.1; Snowman CV, 2010, J ARACHNOL, V38, P49, DOI 10.1636/A09-057.1; Weary DJ, 20141156 US GEOL SUR, P1; Zhang YY, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-183; Zigler Kirk S., 2011, Speleobiology Notes, V3, P1	36	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156751	10.1371/journal.pone.0156751	http://dx.doi.org/10.1371/journal.pone.0156751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280416	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000044
J	Gayek, AS; Ohi, R				Gayek, A. Sophia; Ohi, Ryoma			CDK-1 Inhibition in G2 Stabilizes Kinetochore-Microtubules in the following Mitosis	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; SPINDLE ASSEMBLY CHECKPOINT; MITOTIC KINESIN EG5; REGULATED PROTEIN; CELLS; HURP; ACTIVATION; DYNAMICS; PHASE; PROGRESSION	Cell proliferation is driven by cyclical activation of cyclin-dependent kinases (CDKs), which produce distinct biochemical cell cycle phases. Mitosis (M phase) is orchestrated by CDK-1, complexed with mitotic cyclins. During M phase, chromosomes are segregated by a bipolar array of microtubules called the mitotic spindle. The essential bipolarity of the mitotic spindle is established by the kinesin-5 Eg5, but factors influencing the maintenance of spindle bipolarity are not fully understood. Here, we describe an unexpected link between inhibiting CDK-1 before mitosis and bipolar spindle maintenance. Spindles in human RPE-1 cells normally collapse to monopolar structures when Eg5 is inhibited at metaphase. However, we found that inhibition of CDK-1 in the G2 phase of the cell cycle improved the ability of RPE-1 cells to maintain spindle bipolarity without Eg5 activity in the mitosis immediately after release from CDK-1 inhibition. This improved bipolarity maintenance correlated with an increase in the stability of kinetochore-microtubules, the subset of microtubules that link chromosomes to the spindle. The improvement in bipolarity maintenance after CDK-1 inhibition in G2 required both the kinesin-12 Kif15 and increased stability of kinetochore-microtubules. Consistent with increased kinetochore-microtubule stability, we find that inhibition of CDK-1 in G2 impairs mitotic fidelity by increasing the incidence of lagging chromosomes in anaphase. These results suggest that inhibition of CDK-1 in G2 causes unpredicted effects in mitosis, even after CDK-1 inhibition is relieved.	[Gayek, A. Sophia; Ohi, Ryoma] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA	Vanderbilt University	Ohi, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA.	ryoma.ohi@vanderbilt.edu			National Institutes of Health [R01 GM086610]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health R01 GM086610 (https://www.nigms.nih.gov/Pages/default.aspx) to RO, and the Leukemia and Lymphoma Society (http://www.lls.org/) Scholar Career Development Award to RO.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; El-Nassan HB, 2013, EUR J MED CHEM, V62, P614, DOI 10.1016/j.ejmech.2013.01.031; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gayek AS, 2014, MOL BIOL CELL, V25, P2051, DOI 10.1091/mbc.E14-03-0785; Hardwick LJA, 2014, TRENDS GENET, V30, P254, DOI 10.1016/j.tig.2014.04.001; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Ly T, 2015, ELIFE, V4, DOI 10.7554/eLife.04534; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Peco E, 2012, DEVELOPMENT, V139, P1095, DOI 10.1242/dev.068569; Pines J, 2011, PHILOS T R SOC B, V366, P3625, DOI 10.1098/rstb.2011.0080; Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3; Sacristan C, 2015, TRENDS CELL BIOL, V25, P21, DOI 10.1016/j.tcb.2014.08.006; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; SHERWOOD SW, 1994, EXP CELL RES, V211, P275, DOI 10.1006/excr.1994.1087; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sturgill EG, 2013, CURR BIOL, V23, P1280, DOI 10.1016/j.cub.2013.05.043; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; van Heesbeen RGHP, 2014, CELL REP, V8, P948, DOI 10.1016/j.celrep.2014.07.015; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yasutis KM, 2013, CELL CYCLE, V12, P1501, DOI 10.4161/cc.24637; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	57	6	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157491	10.1371/journal.pone.0157491	http://dx.doi.org/10.1371/journal.pone.0157491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281342	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000122
J	Liu, YF; Ren, J; Wang, XR; Fan, ZQ				Liu, Yafeng; Ren, Jing; Wang, Xiangrong; Fan, Zhengqiu			Mechanism and Reaction Pathways for Microcystin-LR Degradation through UV/H2O2 Treatment	PLOS ONE			English	Article							ULTRASONICALLY INDUCED DEGRADATION; DRINKING-WATER; PHOTOCATALYTIC OXIDATION; HYDROXYL RADICALS; AQUEOUS-SOLUTION; UV; CYANOBACTERIA; PHOTODEGRADATION; DETOXIFICATION; DECOMPOSITION	Microcystin-LR (MCLR) is the most common cyanotoxin in contaminated aquatic systems. MCLR inhibits protein phosphatases 1 and 2A, leading to liver damage and tumor formation. MCLR is relatively stable owing to its cyclic structures. The combined UV/H2O2 technology can degrade MCLR efficiently. The second-order rate constant of the reaction between MCLR and hydroxyl radical (center dot OH) is 2.79(+/- 0.23)x10(10) M-1 s(-1) based on the competition kinetics model using nitrobenzene as reference compound. The probable degradation pathway was analyzed through liquid chromatography mass spectrometry. Results suggested that the major destruction pathways of MCLR were initiated by center dot OH attack on the benzene ring and diene of the Adda side chain. The corresponding aldehyde or ketone peptide residues were formed through further oxidation. Another minor destruction pathway involved center dot OH attack on the methoxy group of the Adda side chain, followed by complete removal of the methoxy group. The combined UV/H2O2 system is a promising technology for MCLR removal in contaminated aquatic systems.	[Liu, Yafeng; Ren, Jing; Wang, Xiangrong; Fan, Zhengqiu] Fudan Univ, Dept Environm Engn Sci, Shanghai 200433, Peoples R China	Fudan University	Fan, ZQ (corresponding author), Fudan Univ, Dept Environm Engn Sci, Shanghai 200433, Peoples R China.	zhqfan@fudan.edu.cn	Fan, zhengqiu/AAF-8705-2021		Key Laboratory Open Fund of Fishery Ecology Environment, Ministry of Agriculture, China	Key Laboratory Open Fund of Fishery Ecology Environment, Ministry of Agriculture, China	This work was supported by a grant from the Key Laboratory Open Fund of Fishery Ecology Environment, Ministry of Agriculture, China.	AN JS, 1994, TOXICON, V32, P1495, DOI 10.1016/0041-0101(94)90308-5; Antoniou MG, 2008, TOXICON, V51, P1103, DOI 10.1016/j.toxicon.2008.01.018; Antoniou MG, 2008, ENVIRON SCI TECHNOL, V42, P8877, DOI 10.1021/es801637z; Antoniou MG, 2005, J ENVIRON ENG, V131, P1239, DOI 10.1061/(ASCE)0733-9372(2005)131:9(1239); Bandala ER, 2004, TOXICON, V43, P829, DOI 10.1016/j.toxicon.2004.03.013; BARFORD D, 1994, J MOL BIOL, V235, P763, DOI 10.1006/jmbi.1994.1027; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; CARMICHAEL WW, 1994, SCI AM, V270, P78, DOI 10.1038/scientificamerican0194-78; FALCONER IR, 1989, J AM WATER WORKS ASS, V81, P102; Feitz AJ, 2003, ENVIRON SCI TECHNOL, V37, P561, DOI 10.1021/es0256010; Gajdek P, 2001, TOXICON, V39, P1575, DOI 10.1016/S0041-0101(01)00139-8; Gao NY, 2009, J HAZARD MATER, V164, P640, DOI 10.1016/j.jhazmat.2008.08.038; Kaya K, 1998, CHEM RES TOXICOL, V11, P159, DOI 10.1021/tx970132e; Keijola AM, 1988, TOXICOL ASSESS, V81, P102; Lawton LA, 1999, ENVIRON SCI TECHNOL, V33, P771, DOI 10.1021/es9806682; Lee J, 2006, ENVIRON SCI TECHNOL, V40, P7336, DOI 10.1021/es060352r; Lei L, 2009, J ZHEJIANG UNIBERS A, V11, P1666; Linda IL, 2003, ENVIRON SCI TECHNOL, V37, P3214; Liu I, 2002, J PHOTOCH PHOTOBIO A, V148, P349, DOI 10.1016/S1010-6030(02)00062-X; McMurray J., 1995, ORGANIC CHEM, P1243; Onstad GD, 2007, ENVIRON SCI TECHNOL, V41, P4397, DOI 10.1021/es0625327; Qiao RP, 2005, TOXICON, V45, P745, DOI 10.1016/j.toxicon.2005.01.012; Rafael OR, 2010, TOXICON, V56, P1342, DOI [10.1016/j.toxicon.2010.07.020, DOI 10.1016/J.TOXICON.2010.07.020]; RINEHART KL, 1994, J APPL PHYCOL, V6, P159, DOI 10.1007/BF02186070; Rosenfeldt EJ, 2004, ENVIRON SCI TECHNOL, V38, P5476, DOI 10.1021/es035413p; Schwarzenbach RP, 1993, ENV ORGANIC CHEM, P134; Song W, 2006, ENVIRON SCI TECHNOL, V40, P3941, DOI 10.1021/es0521730; Song WH, 2009, ENVIRON SCI TECHNOL, V43, P1487, DOI 10.1021/es802282n; Song WH, 2005, ENVIRON SCI TECHNOL, V39, P6300, DOI 10.1021/es048350z; Tsuji K, 1995, TOXICON, V33, P1619, DOI 10.1016/0041-0101(95)00101-8; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; Vogna D, 2004, CHEMOSPHERE, V54, P497, DOI 10.1016/S0045-6535(03)00757-4; Wu CL, 2007, J AGR FOOD CHEM, V55, P4059, DOI 10.1021/jf0635762; Wu CL, 2008, WATER RES, V42, P4780, DOI 10.1016/j.watres.2008.08.023; YOSHIZAWA S, 1990, J CANCER RES CLIN, V116, P609, DOI 10.1007/BF01637082	35	7	8	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156236	10.1371/journal.pone.0156236	http://dx.doi.org/10.1371/journal.pone.0156236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281173	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000021
J	Tourino, LFPG; Correa-Faria, P; Ferreira, RC; Bendo, CB; Zarzar, PM; Vale, MP				Padua Goncalves Tourino, Luciana Fonseca; Correa-Faria, Patricia; Ferreira, Raquel Conceciao; Bendo, Cristiane Baccin; Zarzar, Patricia Maria; Vale, Miriam Pimenta			Association between Molar Incisor Hypomineralization in Schoolchildren and Both Prenatal and Postnatal Factors: A Population-Based Study	PLOS ONE			English	Article							ETIOLOGIC FACTORS; DEMARCATED OPACITIES; ENAMEL DEFECTS; PREVALENCE; CHILDREN	Background Although studies throughout the world have investigated potential factors involved in the occurrence of molar incisor hypomineralization (MIH), the findings are varied and inconclusive. Objective The aim of the present study was to evaluate the prevalence of MIH and identify associated prenatal, perinatal and postnatal factors among Brazilian schoolchildren aged 8 and 9 years. Methods A cross-sectional study was conducted with a randomly selected population-based sample of 1181 schoolchildren. Information on demographic and socioeconomic characteristics as well as prenatal, perinatal and postnatal aspects was obtained through questionnaires. The clinical examination included the investigation of MIH based on the criteria of the European Academy of Paediatric Dentistry. Dental caries in the permanent dentition and developmental defects of enamel (DDE) on the primary second molars were also recorded. Data analysis involved descriptive statistics, bivariate tests and Poisson regression with robust variance. Results The prevalence of MIH was 20.4%. MIH was more frequent among children with dental caries in the permanent dentition (PR: 2.67; 95% CI: 1.98-3.61), those with DDE on the primary second molars (PR: 2.54; 95% CI: 1.87-3.45) and those who experienced asthma/bronchitis in the first four years of life (PR: 1.93; 95% CI: 1.45-2.56). Conclusions The prevalence of MIH was high and was associated with dental caries, the presence of DDE on primary second molars and the experience of asthma/bronchitis in early life. These findings could be useful in the identification of children in need of shorter recall intervals to prevent the consequences of MIH, such as enamel breakdown dental caries.	[Padua Goncalves Tourino, Luciana Fonseca] Ctr Univ Lavras, Dept Pediat Dent, Lavras, MG, Brazil; [Correa-Faria, Patricia; Bendo, Cristiane Baccin; Zarzar, Patricia Maria; Vale, Miriam Pimenta] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Ferreira, Raquel Conceciao] Univ Fed Minas Gerais, Sch Dent, Dept Publ Oral Hlth, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Tourino, LFPG (corresponding author), Ctr Univ Lavras, Dept Pediat Dent, Lavras, MG, Brazil.	lucianapaduatourino@yahoo.com	de Faria, Patricia Corrêa/N-9428-2013; Bendo, Cristiane Baccin/H-5835-2012; de Araújo Zarzar, Patricia Maria Pereira/H-9534-2012; de araujo zarzar, patricia maria pereira/F-4237-2018; Ferreira, Raquel Conceição/J-5236-2015	de Faria, Patricia Corrêa/0000-0002-0528-1425; Bendo, Cristiane Baccin/0000-0003-4849-8779; de Araújo Zarzar, Patricia Maria Pereira/0000-0002-6952-5767; Ferreira, Raquel Conceição/0000-0001-8897-9345; Tourino, Luciana/0000-0002-3640-036X				Alaluusua S, 2010, EUR ARCH PAEDIATR DE, V11, P53, DOI 10.1007/BF03262713; [Anonymous], 1992, Int Dent J, V42, P411; Arrow P, 2009, COMMUNITY DENT ORAL, V37, P405, DOI 10.1111/j.1600-0528.2009.00480.x; Beentjes V E, 2002, Eur J Paediatr Dent, V3, P9; Brogardh-Roth S, 2011, EUR J ORAL SCI, V119, P33, DOI 10.1111/j.1600-0722.2011.00792.x; Casanova-Rosado AJ, 2011, EUR J PAEDIATR DENT, V12, P155; Cho SY, 2008, INT J PAEDIATR DENT, V18, P348, DOI 10.1111/j.1365-263X.2008.00927.x; Crombie F, 2009, INT J PAEDIATR DENT, V19, P73, DOI 10.1111/j.1365-263X.2008.00966.x; da Costa-Silva CM, 2010, INT J PAEDIATR DENT, V20, P426, DOI 10.1111/j.1365-263X.2010.01097.x; Fagrell TG, 2008, INT J PAEDIATR DENT, V18, P333, DOI 10.1111/j.1365-263X.2007.00908.x; Garcia-Margarit M, 2014, INT J PAEDIATR DENT, V24, P14, DOI 10.1111/ipd.12020; Ghanim A, 2013, INT J PAEDIATR DENT, V23, P197, DOI 10.1111/j.1365-263X.2012.01244.x; Ghanim A, 2013, INT J PAEDIATR DENT, V23, P48, DOI 10.1111/j.1365-263X.2012.01223.x; Guergolette RP, 2009, J BRAS PNEUMOL, V35, P295, DOI 10.1590/S1806-37132009000400002; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Harju M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1357-6; Jalevik B, 2010, EUR ARCH PAEDIATR DE, V11, P59; Jalevik B, 2001, EUR J ORAL SCI, V109, P230, DOI 10.1034/j.1600-0722.2001.00047.x; Jeremias F, 2013, ACTA ODONTOL SCAND, V71, P870, DOI 10.3109/00016357.2012.734412; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Petrou MA, 2014, INT J PAEDIATR DENT, V24, P434, DOI 10.1111/ipd.12089; Pitiphat W, 2014, EUR J ORAL SCI, V122, P265, DOI 10.1111/eos.12136; Souza JF, 2012, EUR ARCH PAEDIATR DE, V13, P164, DOI 10.1007/BF03262865; Soviero V, 2009, ACTA ODONTOL SCAND, V67, P170, DOI 10.1080/00016350902758607; Suga S, 1989, Adv Dent Res, V3, P188; Tung K, 2006, ARCH ORAL BIOL, V51, P464, DOI 10.1016/j.archoralbio.2005.12.001; VANAMERONGEN WE, 1995, J DENT CHILD, V62, P266; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Weerheijm K L, 2004, Dent Update, V31, P9; Weerheijm K L, 2003, Eur J Paediatr Dent, V4, P110; Weerheijm K L, 2003, Int J Paediatr Dent, V13, P411, DOI 10.1046/j.1365-263X.2003.00498.x; Whatling R, 2008, INT J PAEDIATR DENT, V18, P155, DOI 10.1111/j.1365-263X.2007.00901.x; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	33	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156332	10.1371/journal.pone.0156332	http://dx.doi.org/10.1371/journal.pone.0156332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280451	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000025
J	Rosso, MC; Badino, P; Ferrero, G; Costa, R; Cordero, F; Steidler, S				Rosso, Marilena Caterina; Badino, Paola; Ferrero, Giulio; Costa, Roberto; Cordero, Francesca; Steidler, Stephanie			Biologic Data of Cynomolgus Monkeys Maintained under Laboratory Conditions	PLOS ONE			English	Article							MACAQUES MACACA-FASCICULARIS; CLINICAL-CHEMISTRY; NONHUMAN-PRIMATES; BASE-LINE; STRESS; HEMATOLOGY; PARAMETERS; VALUES; CORTISOL; BLOOD	The cynomolgus monkey (Macaca fascicularis) is a well-known non-human primate species commonly used in non-clinical research. It is important to know basal clinical pathology parameters in order to have a reference for evaluating any potential treatment-induced effects, maintaining health status among animals and, if needed, evaluating correct substantiative therapies. In this study, data from 238 untreated cynomolgus monkeys (119 males and 119 females of juvenile age, 2.5 to 3.5 years) kept under laboratory conditions were used to build up a reference database of clinical pathology parameters. Twenty-two hematology markers, 24 clinical chemistry markers and two blood coagulation parameters were analyzed. Gender-related differences were evaluated using statistical analyses. To assess the possible effects of stress induced by housing or handling involved in treatment procedures, 78 animals (35 males and 35 females out of 238 juvenile monkeys and four adult males and four adult females) were used to evaluate cortisol, corticosterone and behavioral assessment over time. Data were analyzed using a non-parametric statistical test and machine learning approaches. Reference clinical pathology data obtained from untreated animals may be extremely useful for investigators employing cynomolgus monkeys as a test system for non-clinical safety studies.	[Rosso, Marilena Caterina; Badino, Paola] Univ Turin, Dept Vet Sci, Grugliasco, TO, Italy; [Rosso, Marilena Caterina; Costa, Roberto; Steidler, Stephanie] RBM SpA Merck Serono, Ivrea, Italy; [Ferrero, Giulio; Cordero, Francesca] Univ Turin, Dept Comp Sci, Turin, Italy; [Ferrero, Giulio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Ferrero, Giulio; Cordero, Francesca] Univ Turin, Ctr Mol Syst Biol, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Cordero, F (corresponding author), Univ Turin, Dept Comp Sci, Turin, Italy.; Cordero, F (corresponding author), Univ Turin, Ctr Mol Syst Biol, Turin, Italy.	fcordero@di.unito.it	Cordero, Francesca/AAB-3655-2019; Badino, Paola/AAC-5779-2019; Ferrero, Giulio/K-9508-2019; Steidler, Stephanie/AAE-8099-2022; Steidler, Stephanie/AAC-6369-2022	Cordero, Francesca/0000-0002-3143-3330; Ferrero, Giulio/0000-0002-4580-0680; Steidler, Stephanie/0000-0002-4441-7962; BADINO, Paola/0000-0002-2716-8853	Merck KGaA-Merck Serono [489]	Merck KGaA-Merck Serono	This research was supported and granted by Merck KGaA-Merck 489 Serono. The funder provided support in the form of salaries for authors MCR, RC and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson KSP, 2005, IN VIVO, V19, P815; Andrade MCR, 2004, MEM I OSWALDO CRUZ, V99, P581, DOI 10.1590/S0074-02762004000600009; [Anonymous], 1990, Lab Anim, V24, P97; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Bailey Jarrod, 2005, Biogenic Amines, V19, P235, DOI 10.1163/156939105774647385; Bonfanti U, 2009, J MED PRIMATOL, V38, P228, DOI 10.1111/j.1600-0684.2009.00345.x; Bourges-Abella N, 2014, J MED PRIMATOL, V43, P1, DOI 10.1111/jmp.12077; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Field AE, 2015, J AM ASSOC LAB ANIM, V54, P59; Gauvin David V., 2008, Journal of Pharmacological and Toxicological Methods, V58, P88, DOI 10.1016/j.vascn.2008.05.002; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall Robert L., 2003, Toxicologic Pathology, V31, P6, DOI 10.1080/01926230309765; Herodin F, 2005, EUR CYTOKINE NETW, V16, P104; *I LAB AN RES, 2000, ILAR J, V41, P59; Joshi Girish P, 2005, Anesthesiol Clin North Am, V23, P21, DOI 10.1016/j.atc.2004.11.013; Kim CY, 2005, J MED PRIMATOL, V34, P188, DOI 10.1111/j.1600-0684.2005.00116.x; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Lee JI, 2013, J MED PRIMATOL, V42, P10, DOI 10.1111/jmp.12023; Liu YW, 2008, EXP ANIM TOKYO, V57, P139, DOI 10.1538/expanim.57.139; Malisch JL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P146, DOI 10.1086/508828; Maninger N, 2010, PSYCHONEUROENDOCRINO, V35, P1055, DOI 10.1016/j.psyneuen.2010.01.006; MATSUZAWA T, 1994, COMP HAEMATOL INT, V4, P43, DOI 10.1007/BF00368266; McCarthy C.R., 1999, ILAR J, V40, P1, DOI [10.1093/ilar.40.1.1, DOI 10.1093/ILAR.40.1.1]; Novak MA, 2013, APPL ANIM BEHAV SCI, V143, P135, DOI 10.1016/j.applanim.2012.10.012; Ogawa LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-748; PERRETTA G, 1991, J MED PRIMATOL, V20, P345; Perry P, 2007, ILAR J, V48, P42, DOI 10.1093/ilar.48.1.42; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Ruys JD, 2004, PHYSIOL BEHAV, V82, P205, DOI 10.1016/j.physbeh.2004.02.031; Schuurman HJ, 2005, XENOTRANSPLANTATION, V12, P72, DOI 10.1111/j.1399-3089.2004.00186.x; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; Stockman SL, 2002, FUNDAMENTALS VET CLI, P443; SUGIMOTO Y, 1986, EXP ANIM TOKYO, V35, P443, DOI 10.1538/expanim1978.35.4_443; Suzuki J, 2002, J MED PRIMATOL, V31, P340, DOI 10.1034/j.1600-0684.2002.01011.x; Wang H, 2012, VET MED-CZECH, V57, P233, DOI 10.17221/5953-VETMED; Weatherall D., 2006, USE NONHUMAN PRIMATE; Westlund K, 2012, LAB ANIM-UK, V46, P51, DOI 10.1258/la.2011.011040; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892; Zhou Q, 2014, TRENDS GENET, V30, P476, DOI 10.1016/j.tig.2014.09.005	39	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157003	10.1371/journal.pone.0157003	http://dx.doi.org/10.1371/journal.pone.0157003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280447	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000065
J	Umehara, H; Numata, S; Tajima, A; Nishi, A; Nakataki, M; Imoto, I; Sumitani, S; Ohmori, T				Umehara, Hidehiro; Numata, Shusuke; Tajima, Atsushi; Nishi, Akira; Nakataki, Masahito; Imoto, Issei; Sumitani, Satsuki; Ohmori, Tetsuro			Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; WEB SERVER; GENE; AUGMENTATION; IDENTIFICATION; SCHIZOPHRENIA; POLYMORPHISM; I-GSEA4GWAS; POPULATION; EXPRESSION	Background Selective serotonin reuptake inhibitors (SSRI) are established first-line pharmacological treatments for obsessive-compulsive disorder (OCD), while antipsychotics are used as an augmentation strategy for SSRI in OCD patients who have either no response or a partial response to SSRI treatment. The goal of the present study was to identify genetic variants and pathways that are associated with the long-term clinical response of OCD patients to SSRI or SSRI with antipsychotics. Methods We first performed a genome-wide association study of 96 OCD patients to examine genetic variants contributing to the response to SSRI or SSRI with antipsychotics. Subsequently, we conducted pathway-based analyses by using Improved Gene Set Enrichment Analysis for Genome-wide Association Study (i-GSEA4GWAS) to examine the combined effects of genetic variants on the clinical response in OCD. Results While we failed to detect specific genetic variants associated with clinical responses to SSRI or to SSRI with an atypical antipsychotic at genome-wide levels of significance, we identified 8 enriched pathways for the SSRI treatment response and 5 enriched pathways for the treatment response to SSRI with an antipsychotic medication. Notably, the calcium signaling pathway was identified in both treatment responses. Conclusions Our results provide novel insight into the molecular mechanisms underlying the variability in clinical response to SSRI and SSRI with antipsychotics in OCD patients.	[Umehara, Hidehiro; Numata, Shusuke; Nishi, Akira; Nakataki, Masahito; Sumitani, Satsuki; Ohmori, Tetsuro] Univ Tokushima, Inst Biomed Sci, Dept Psychiat, Grad Sch, Tokushima 770, Japan; [Tajima, Atsushi] Kanazawa Univ, Grad Sch Adv Prevent Med Sci, Dept Bioinformat & Genom, Kanazawa, Ishikawa 9201192, Japan; [Tajima, Atsushi; Imoto, Issei] Univ Tokushima, Dept Human Genet, Inst Biomed Sci, Grad Sch, Tokushima 770, Japan; [Sumitani, Satsuki] Univ Tokushima, Dept Support Students Special Needs, Inst Biomed Sci, Grad Sch, Tokushima 770, Japan	Tokushima University; Kanazawa University; Tokushima University; Tokushima University	Numata, S (corresponding author), Univ Tokushima, Inst Biomed Sci, Dept Psychiat, Grad Sch, Tokushima 770, Japan.	shu-numata@umin.ac.jp	Imoto, Issei/AAD-5799-2020; Tajima, Atsushi/C-1053-2008	Tajima, Atsushi/0000-0001-6808-5491	Japan Science and Technology Agency, CREST; Japan Agency for Medical Research and development, AMED;  [90346594];  [15k19734]; Grants-in-Aid for Scientific Research [15H02898] Funding Source: KAKEN	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Science and Technology Agency, CREST (TO)(http://www.jst.go.jp/), Japan Agency for Medical Research and development, AMED (TO)(http://www.amed.go.jp/), Grant-in-Aid for Scientific Research (C) (No. 90346594) (SS)(https://www.jsps.go.jp/english/egrants/), and Grant-in-Aid for Young Scientists (B) (No. 15k19734) (HU) (https://www.jsps.go.jp/english/e-grants/).	Arumugham SS, 2013, EXPERT REV NEUROTHER, V13, P187, DOI [10.1586/ERN.12.160, 10.1586/ern.12.160]; Ben-David E, 2013, MOL PSYCHIATR, V18, P1054, DOI 10.1038/mp.2012.148; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Bocchio-Chiavetto L, 2013, EUR NEUROPSYCHOPHARM, V23, P602, DOI 10.1016/j.euroneuro.2012.06.013; Chertkow Y, 2007, PROG NEURO-PSYCHOPH, V31, P1356, DOI 10.1016/j.pnpbp.2007.04.016; de Bartolomeis A, 2013, EUR J PHARMACOL, V718, P502, DOI 10.1016/j.ejphar.2013.06.034; Du T, 2014, CELL CALCIUM, V55, P166, DOI 10.1016/j.ceca.2014.01.002; Edwards AC, 2015, ADDICTION, V110, P461, DOI 10.1111/add.12822; Fineberg NA, 2015, PSYCHIAT RES, V227, P114, DOI 10.1016/j.psychres.2014.12.003; Gobin V, 2015, CELL CALCIUM, V58, P254, DOI 10.1016/j.ceca.2015.06.003; Gobin V, 2014, INT IMMUNOPHARMACOL, V20, P148, DOI 10.1016/j.intimp.2014.02.030; Gray SM, 2012, CURR PSYCHIAT REP, V14, P220, DOI 10.1007/s11920-012-0272-0; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hashimoto R, 2005, SCHIZOPHR RES, V73, P383, DOI 10.1016/j.schres.2004.01.017; Kanazawa T, 2013, AM J MED GENET B, V162, P679, DOI 10.1002/ajmg.b.32164; Kim HN, 2015, GENES BRAIN BEHAV, V14, P345, DOI 10.1111/gbb.12212; Kinnersley B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9559; Malli T, 2014, AM J MED GENET A, V164, P3126, DOI 10.1002/ajmg.a.36738; McPherson R, 2016, CIRC RES, V118, P564, DOI 10.1161/CIRCRESAHA.115.306566; Mizoguchi Y, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00370, 10.3389/fncel.2014.00370]; Qin H, 2016, MOL PSYCHIATR, V21, P270, DOI 10.1038/mp.2015.32; Rao NP, 2015, PSYCHIAT RES, V229, P949, DOI 10.1016/j.psychres.2015.07.009; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Schipke CG, 2011, J PSYCHIATR RES, V45, P242, DOI 10.1016/j.jpsychires.2010.06.005; Shimada-Sugimoto M, 2015, BRAIN BEHAV IMMUN, V46, P96, DOI 10.1016/j.bbi.2015.01.002; Sim JCH, 2015, INTRACTABLE RARE DIS, V4, P17, DOI 10.5582/irdr.2014.01021; Soomro GM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001765.pub3; Umehara H, 2015, HUM PSYCHOPHARM CLIN, V30, P372, DOI 10.1002/hup.2485; Veale D, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0317-5; YUAN SX, 1995, CANCER RES, V55, P3456; Zai G, 2014, PHARMACOGENOMICS, V15, P1147, DOI [10.2217/pgs.14.83, 10.2217/PGS.14.83]; Zeng P, 2015, J BIOMED RES, V29, P285, DOI 10.7555/JBR.29.20140007; Zhang KL, 2015, PROTEIN CELL, V6, P221, DOI 10.1007/s13238-014-0114-4; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	35	7	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157232	10.1371/journal.pone.0157232	http://dx.doi.org/10.1371/journal.pone.0157232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281126	Green Published, gold			2022-12-27	WOS:000377563000111
J	Armengot, L; Caldarella, E; Marques-Bueno, MM; Martinez, MC				Armengot, Laia; Caldarella, Eleonora; Mar Marques-Bueno, Maria; Carmen Martinez, M.			The Protein Kinase CK2 Mediates Cross-Talk between Auxin- and Salicylic Acid-Signaling Pathways in the Regulation of PINOID Transcription	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; TRANSPORT; POLARITY; NPR1; PHOSPHORYLATION; EXPRESSION; INSIGHTS; SURVIVAL; MOTIFS	The protein kinase CK2 is a ubiquitous and highly conserved enzyme, the activity of which is vital for eukaryotic cells. We recently demonstrated that CK2 modulates salicylic acid (SA) homeostasis in Arabidopsis thaliana, and that functional interplay between CK2 and SA sustains transcriptional expression of PIN-FORMED (PIN) genes. In this work, we show that CK2 also plays a key role in the transcriptional regulation of PINOID (PID), an AGC protein kinase that modulates the apical/basal localization of auxin-efflux transporters. We show that PID transcription is up-regulated by auxin and by SA and that CK2 is involved in both pathways. On the one hand, CK2 activity is required for proteosome-dependent degradation of AXR3, a member of the AUX/IAA family of auxin transcriptional repressors that must be degraded to activate auxin-responsive gene expression. On the other hand, the role of CK2 in SA homeostasis and, indirectly, in SA-driven PID transcription, was confirmed by using Arabidopsis NahG transgenic plants, which cannot accumulate SA. In conclusion, our results evidence a role for CK2 as a functional link in the negative cross-talk between auxin- and SA-signaling.	[Armengot, Laia; Caldarella, Eleonora; Mar Marques-Bueno, Maria; Carmen Martinez, M.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Barcelona, Spain; [Armengot, Laia] Univ Lyon, Lab Reprod & Dev Plantes, UCB Lyon 1, ENS Lyon,CNRS,INRA, F-69342 Lyon, France	Autonomous University of Barcelona; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Martinez, MC (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Barcelona, Spain.	carmen.martinez@uab.es	Marques-Bueno, Mar/Q-7111-2018; Armengot, Laia/AAI-7650-2021; Armengot, Laia/AAI-6684-2021	Armengot, Laia/0000-0002-3790-9838; Martinez, M. Carmen/0000-0002-7472-4349	Ministerio de Educacion, Cultura y Deporte; Fondos FEDER [BFU2010-15090, BFU2013-42695-P]; Ministerio de Economia y Competitividad; Departament d'Universitats, Recerca i Societat de la Informacio [2009SGR-795]	Ministerio de Educacion, Cultura y Deporte(Spanish Government); Fondos FEDER(European Commission); Ministerio de Economia y Competitividad(Spanish Government); Departament d'Universitats, Recerca i Societat de la Informacio	This work was supported by: Ministerio de Educacion, Cultura y Deporte (www.mecd.gob.es/) and Fondos FEDER, Grant nr: BFU2010-15090 (MCM); Ministerio de Economia y Competitividad (www.mineco.gob.es/) and fondos FEDER, Grant nr: BFU2013-42695-P (MCM); Departament d'Universitats, Recerca i Societat de la Informacio (www.gencat.es/dursi), Grant nr. 2009SGR-795 (MCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Armengot L, 2014, PLANT J, V78, P411, DOI 10.1111/tpj.12481; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Blakeslee JJ, 2004, PLANT PHYSIOL, V134, P28, DOI 10.1104/pp.103.031690; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Chen ZY, 2007, P NATL ACAD SCI USA, V104, P20131, DOI 10.1073/pnas.0704901104; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Davies P.J., 2004, PLANT HORMONES BIOSY; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; Espunya MC, 1999, PLANT J, V19, P655, DOI 10.1046/j.1365-313x.1999.00563.x; Feraru E, 2008, PLANT PHYSIOL, V147, P1553, DOI 10.1104/pp.108.121756; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; Hosek P, 2012, J EXP BOT, V63, P3815, DOI 10.1093/jxb/ers074; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Leyser O, 2005, CELL, V121, P819, DOI 10.1016/j.cell.2005.06.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marques-Bueno MM, 2011, PLANT J, V67, P169, DOI 10.1111/j.1365-313X.2011.04585.x; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Moreno-Romero J, 2012, PLANT J, V71, P627, DOI 10.1111/j.1365-313X.2012.05019.x; Moreno-Romero J, 2011, MOL CELL BIOCHEM, V356, P233, DOI 10.1007/s11010-011-0970-7; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SHUGAR D, 1994, CELL MOL BIOL RES, V40, P411; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; Stomp A-M., 1992, GUS PROTOCOLS GUS PR, DOI [10.1016/B978-0-12-274010-7.50013-6, DOI 10.1016/13978-0-12-274010-7.500133-6]; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Willemsen V, 2003, PLANT CELL, V15, P612, DOI 10.1105/tpc.008433; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; Zegzouti H, 2006, J BIOL CHEM, V281, P35520, DOI 10.1074/jbc.M605167200; Zhang J, 2010, P NATL ACAD SCI USA, V107, P918, DOI 10.1073/pnas.0909460107; Zheng ZY, 2013, NAT CHEM BIOL, V9, P244, DOI [10.1038/nchembio.1178, 10.1038/NCHEMBIO.1178]; Zourelidou M, 2014, ELIFE, V3, DOI 10.7554/eLife.02860	53	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157168	10.1371/journal.pone.0157168	http://dx.doi.org/10.1371/journal.pone.0157168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275924	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700078
J	Baba, W; Kalaji, HM; Kompala-Baba, A; Goltsev, V				Baba, Wojciech; Kalaji, Hazem M.; Kompala-Baba, Agnieszka; Goltsev, Vasilij			Acclimatization of Photosynthetic Apparatus of Tor Grass (Brachypodium pinnatum) during Expansion	PLOS ONE			English	Article							A FLUORESCENCE INDUCTION; TRITICUM-AESTIVUM L; CHLOROPHYLL-A; GENETIC DIVERSITY; PHOTOSYSTEM-II; CHALK GRASSLAND; IN-VIVO; ELECTRON-TRANSPORT; PSII CENTERS; LIGHT	The aim of this study was to understand the acclimatization mechanisms of photosynthetic apparatus in Brachypodium pinnatum (L.) P. Beauv grass during its expansion. Twelve populations differentiated by age: young (30-50 years old), intermediate age (ca. 100 y) and old (> 300 y) were studied. It was confirmed that the decrease of the number of genotypes as a result of environmental stress and competition were reflected in changes in chlorophyll fluorescence (ChlF) parameters. The old stands were dominated by a few genotypes which seem to be the best acclimatized to the self-shading/competition by lowering their photosynthetic performance during light-phase of photosynthesis. On the other hand, the 'high-speed' photosynthetic rate observed in the young populations can be seen as acclimatization to very adverse conditions. Our results clearly confirm that ChlF is a powerful method of inferring physiological mechanisms of the expansion of tor grass. The Principal Component and Redundancy Analyses, followed with k-means classification, allowed to find the differentiation of groups of distinct ChlF parameters and enabled us to relate them to changes in genotypic diversity of populations. We conclude that the plastic morphological and physiological response to changeable habitat light conditions with its optimum in half-shade refers to its forest-steppe origin.	[Baba, Wojciech] Jagiellonian Univ, Inst Bot, Dept Plant Ecol, Lubicz 46, PL-31512 Krakow, Poland; [Kalaji, Hazem M.] Warsaw Univ Life Sci SGGW, Dept Plant Physiol, Nowoursynowska 159, PL-02776 Warsaw, Poland; [Kompala-Baba, Agnieszka] Silesian Univ, Dept Bot & Nat Protect, Jagiellonska 28, PL-40032 Katowice, Poland; [Goltsev, Vasilij] St Kliment Ohridski Univ Sofia, Fac Biol, Dept Biophys & Radiobiol, 8 Dr Tzankov Blvd, Sofia 1164, Bulgaria	Jagiellonian University; Warsaw University of Life Sciences; University of Silesia in Katowice; Bulgarian Academy of Sciences; Medical University Sofia; University of Sofia	Baba, W (corresponding author), Jagiellonian Univ, Inst Bot, Dept Plant Ecol, Lubicz 46, PL-31512 Krakow, Poland.	wojciech.baba12@gmail.com	Kalaji, Mohamed Hazem/E-8086-2012; Goltsev, Vasilij N/H-7423-2012; Bąba, Wojciech/AFX-4233-2022	Kalaji, Mohamed Hazem/0000-0002-3833-4917; Goltsev, Vasilij N/0000-0003-4338-6671; Baba, Wojciech/0000-0001-7428-0429; Kompala-Baba, Agnieszka/0000-0002-4736-4704				Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Baba W, 2004, BIOLOGIA, V59, P447; Baba W, 2003, ACTA SOC BOT POL, V72, P61, DOI 10.5586/asbp.2003.008; Baba W, 2012, FLORA, V207, P346, DOI 10.1016/j.flora.2012.01.011; Baba W, 2012, POL J ECOL, V60, P31; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; BOBBINK R, 1987, BIOL CONSERV, V40, P301, DOI 10.1016/0006-3207(87)90122-4; Bobbink R, 1998, NEW PHYTOL, V139, P161, DOI 10.1046/j.1469-8137.1998.00175.x; BOBBINK R, 1991, BIOL CONSERV, V56, P1, DOI 10.1016/0006-3207(91)90085-N; Brestic M, 2012, PLANT PHYSIOL BIOCH, V57, P93, DOI 10.1016/j.plaphy.2012.05.012; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; DEKROON H, 1990, OIKOS, V59, P39, DOI 10.2307/3545120; Doorduin LJ, 2010, BASIC APPL ECOL, V11, P244, DOI 10.1016/j.baae.2009.12.007; Dujardin G, 2011, FLORA, V206, P1030, DOI 10.1016/j.flora.2011.05.012; Falbel TG, 1996, PLANT PHYSIOL, V112, P821, DOI 10.1104/pp.112.2.821; Falinska K, 2010, POL J ECOL, V58, P27; Farmer A.M., 1998, J PRACT ECOL CONSERV, V2, P9; Force L, 2003, PHOTOSYNTH RES, V78, P17, DOI 10.1023/A:1026012116709; Forsman A, 2014, P NATL ACAD SCI USA, V111, P302, DOI 10.1073/pnas.1317745111; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Fuzy A, 2014, J PLANT PHYSIOL, V171, P1, DOI 10.1016/j.jplph.2013.11.002; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Holderegger R, 2006, LANDSCAPE ECOL, V21, P797, DOI 10.1007/s10980-005-5245-9; Hurst A, 1999, BIOL CONSERV, V89, P261, DOI 10.1016/S0006-3207(99)00005-1; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Jacquemyn H, 2010, CONSERV GENET, V11, P1979, DOI 10.1007/s10592-010-0089-5; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; JOLIOT P, 2005, DISCOVERIES PHOTOSYN, P187; Kahlert BR, 2005, J VEG SCI, V16, P433, DOI 10.1111/j.1654-1103.2005.tb02383.x; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Kalaji HM, 2014, PLANT PHYSIOL BIOCH, V81, P16, DOI 10.1016/j.plaphy.2014.03.029; Kalaji HM, 2012, J PHOTOCH PHOTOBIO B, V112, P1, DOI 10.1016/j.jphotobiol.2012.03.009; Kalaji HM, 2014, EMERGING TECHNOLOGIE, P347, DOI DOI 10.1016/B978-0-12-800875-1.00015-6; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Khan MA, 1999, NORD J BOT, V19, P257, DOI 10.1111/j.1756-1051.1999.tb01108.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Mathis P, 1995, PHOTOSYNTHESIS FROM, DOI [10.1007/978-94-009-0173-5, DOI 10.1007/978-94-009-0173-5]; Mojzes A, 2003, FLORA, V198, P304, DOI 10.1078/0367-2530-00102; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Murchie EH, 1997, PLANT CELL ENVIRON, V20, P438, DOI 10.1046/j.1365-3040.1997.d01-95.x; Nishiyama Y, 2014, APPL MICROBIOL BIOT, V98, P8777, DOI 10.1007/s00253-014-6020-0; Oukarroum A, 2007, ENVIRON EXP BOT, V60, P438, DOI 10.1016/j.envexpbot.2007.01.002; Papageorgiou GC, 2007, PHOTOSYNTH RES, V94, P275, DOI 10.1007/s11120-007-9193-x; Pattanayak GK, 2005, BIOCHEM BIOPH RES CO, V326, P466, DOI 10.1016/j.bbrc.2004.11.049; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pogan M, 1991, ACTA BIOL CRACOV BOT, V32, P1; R Core Team, 2008, LANG ENV STAT COMP; Rapacz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134820; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Sapek A, 1997, METODY ANALIZY CHEM; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Schansker G, 2006, BBA-BIOENERGETICS, V1757, P787, DOI 10.1016/j.bbabio.2006.04.019; Schansker G, 2011, BBA-BIOENERGETICS, V1807, P1032, DOI 10.1016/j.bbabio.2011.05.022; Schlapfer F, 1998, ECOGRAPHY, V21, P351, DOI 10.1111/j.1600-0587.1998.tb00400.x; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Stirbet A, 2013, PHOTOSYNTH RES, V116, P189, DOI 10.1007/s11120-013-9863-9; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser RJ, 2004, ACTA PHYSIOL PLANT, V26, P94; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; Strasser RJ, 2001, MATH COMPUT SIMULAT, V56, P451, DOI 10.1016/S0378-4754(01)00314-7; Stroch M, 2004, PHOTOSYNTHETICA, V42, P323, DOI 10.1023/B:PHOT.0000046149.97220.18; Sutkowska A, 2015, SURTSEY RES, V13, P17; Tanaka R., 2000, PORPHYRINS, V9, P240; Tikkanen M, 2011, TRENDS PLANT SCI, V16, P126, DOI 10.1016/j.tplants.2010.11.006; Tsimilli-Michael M, 2004, ACTA PHYSIOL PLANT, V26, P176; Way DA, 2012, TREE PHYSIOL, V32, P1066, DOI 10.1093/treephys/tps064; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Zivcak M, 2008, PLANT SOIL ENVIRON, V54, P133, DOI 10.17221/392-PSE; Zivcak M, 2014, PHOTOSYNTH RES, V119, P339, DOI 10.1007/s11120-014-9969-8; Zurek G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091475	80	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156201	10.1371/journal.pone.0156201	http://dx.doi.org/10.1371/journal.pone.0156201			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275605	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700019
J	Rayl, M; Truitt, M; Held, A; Sargeant, J; Thorsen, K; Hay, JC				Rayl, Mariah; Truitt, Mishana; Held, Aaron; Sargeant, John; Thorsen, Kevin; Hay, Jesse C.			Penta-EF-Hand Protein Peflin Is a Negative Regulator of ER-To-Golgi Transport	PLOS ONE			English	Article							RETICULUM EXIT SITES; COPII VESICLE FUSION; ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; (ER)-TO-GOLGI TRANSPORT; CA2+-DEPENDENT MANNER; SECRETORY PATHWAY; MAMMALIAN-CELLS; CALCIUM; ALG-2	Luminal calcium regulates vesicle transport early in the secretory pathway. In ER-to-Golgi transport, depletion of luminal calcium leads to significantly reduced transport and a buildup of budding and newly budded COPII vesicles and vesicle proteins. Effects of luminal calcium on transport may be mediated by cytoplasmic calcium sensors near ER exits sites (ERES). The penta-EF-hand (PEF) protein apoptosis-linked gene 2 (ALG-2) stabilizes sec31A at ER exit sites (ERES) and promotes the assembly of inner and outer shell COPII components. However, in vitro and intact cell approaches have not determined whether ALG-2 is a negative or positive regulator, or a regulator at all, under basal physiological conditions. ALG-2 interacts with another PEF protein, peflin, to form cytosolic heterodimers that dissociate in response to calcium. However, a biological function for peflin has not been demonstrated and whether peflin and the ALG-2/peflin interaction modulates transport has not been investigated. Using an intact, single cell, morphological assay for ER-to-Golgi transport in normal rat kidney (NRK) cells, we found that depletion of peflin using siRNA resulted in significantly faster transport of the membrane cargo VSV-G. Double depletion of peflin and ALG-2 blocked the increased transport resulting from peflin depletion, demonstrating a role for ALG-2 in the increased transport. Furthermore, peflin depletion caused increased targeting of ALG-2 to ERES and increased ALG-2/sec31A interactions, suggesting that peflin may normally inhibit transport by preventing ALG-2/sec31A interactions. This work identifies for the first time a clear steady state role for a PEF protein in ER-to-Golgi transport-peflin is a negative regulator of transport.	[Hay, Jesse C.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Thorsen, Kevin] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY USA	University of Montana System; University of Montana; University of Montana System; University of Montana; Cornell University	Hay, JC (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	jesse.hay@umontana.edu			National Institutes of Health [GM106323]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a grant from the National Institutes of Health (GM106323) to JCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Cao Q, 2015, J CELL BIOL, V209, P879, DOI 10.1083/jcb.201409071; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Kitaura Y, 2002, ARCH BIOCHEM BIOPHYS, V399, P12, DOI 10.1006/abbi.2001.2736; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Micaroni M, 2010, TRAFFIC COPENHAGEN D; Micaroni M, 2012, ADV EXP MED BIOL, V740, P439, DOI 10.1007/978-94-007-2888-2_18; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Parkinson K, 2014, NAT CELL BIOL, V16, P87, DOI 10.1038/ncb2887; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Tabata K, 2009, EMBO J; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; von Blume J, 2012, J CELL BIOL, V199, P1057, DOI 10.1083/jcb.201207180; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yoshibori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040765; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	40	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157227	10.1371/journal.pone.0157227	http://dx.doi.org/10.1371/journal.pone.0157227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276012	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700085
J	Denomme, MM; McCallie, BR; Parks, JC; Schoolcraft, WB; Katz-Jaffe, MG				Denomme, Michelle M.; McCallie, Blair R.; Parks, Jason C.; Schoolcraft, William B.; Katz-Jaffe, Mandy G.			Epigenetic Dysregulation Observed in Monosomy Blastocysts Further Compromises Developmental Potential	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BECKWITH-WIEDEMANN-SYNDROME; IN-SITU HYBRIDIZATION; UNIPARENTAL DISOMY; DNA METHYLATION; HUMAN EMBRYOS; PRADER-WILLI; ANEUPLOIDY; MOSAICISM; GENE	Epigenetic mechanisms such as DNA methylation regulate genomic imprinting and account for the distinct non-equivalence of the parental genomes in the embryo. Chromosomal aneuploidy, a major cause of infertility, distorts this highly regulated disparity by the presence or absence of chromosomes. The implantation potential of monosomy embryos is negligible compared to their trisomy counterparts, yet the cause for this is unknown. This study investigated the impact of chromosomal aneuploidy on strict epigenetically regulated domains, specifically imprinting control regions present on aneuploid chromosomes. Donated cryopreserved human IVF blastocysts of transferable quality, including trisomy 15, trisomy 11, monosomy 15, monosomy 11, and donor oocyte control blastocysts were examined individually for DNA methylation profiles by bisulfite mutagenesis and sequencing analysis of two maternally methylated imprinting control regions (ICRs), SNRPN (15q11.2) and KCNQ1OT1 (11p15.5), and one paternally methylated imprinting control region, H19 (11p15.5). Imprinted genes within the regions were also evaluated for transcript abundance by RT-qPCR. Overall, statistically significant hypermethylated and hypomethylated ICRs were found in both the trisomy and monosomy blastocysts compared to controls, restricted only to the chromosome affected by the aneuploidy. Increased expression was observed for maternally-expressed imprinted genes in trisomy blastocysts, while a decreased expression was observed for both maternally-and paternally-expressed imprinted genes in monosomy blastocysts. This epigenetic dysregulation and altered monoallelic expression observed at imprinting control regions in aneuploid IVF embryos supports euploid embryo transfer during infertility treatments, and may specifically highlight an explanation for the compromised implantation potential in monosomy embryos.	[Denomme, Michelle M.; McCallie, Blair R.; Parks, Jason C.; Katz-Jaffe, Mandy G.] Fertil Labs Colorado, Lone Tree, CO USA; [Schoolcraft, William B.; Katz-Jaffe, Mandy G.] Colorado Ctr Reprod Med, Lone Tree, CO USA		Katz-Jaffe, MG (corresponding author), Fertil Labs Colorado, Lone Tree, CO USA.; Katz-Jaffe, MG (corresponding author), Colorado Ctr Reprod Med, Lone Tree, CO USA.	MKatz-Jaffe@ColoCRM.com						Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Chen SL, 2010, FERTIL STERIL, V94, P2356, DOI 10.1016/j.fertnstert.2010.01.120; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Davidsson J, 2014, EPIGENOMICS-UK, V6, P45, DOI 10.2217/epi.13.78; Davidsson J, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-18; DELHANTY JDA, 1993, HUM MOL GENET, V2, P1183, DOI 10.1093/hmg/2.8.1183; Denomme MM, 2012, JOVE-J VIS EXP, DOI 10.3791/4046; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Fragouli E, 2006, HUM REPROD, V21, P2319, DOI 10.1093/humrep/del157; Fragouli E, 2009, REPROD BIOMED ONLINE, V19, P228, DOI 10.1016/S1472-6483(10)60078-8; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Geuns E, 2003, HUM MOL GENET, V12, P2873, DOI 10.1093/hmg/ddg315; Geuns E, 2007, EUR J HUM GENET, V15, P352, DOI 10.1038/sj.ejhg.5201759; Gueye NA, 2014, FERTIL STERIL, V101, P232, DOI 10.1016/j.fertnstert.2013.08.051; Haas O. A., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P239; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Herrera LA, 2008, CURR GENOMICS, V9, P43, DOI 10.2174/138920208783884883; Horsthemke B, 1997, J CELL PHYSIOL, V173, P237, DOI 10.1002/(SICI)1097-4652(199711)173:2<237::AID-JCP28>3.0.CO;2-B; Horsthemke B, 2014, J PATHOL, V232, P485, DOI 10.1002/path.4326; Ibala-Romdhane S, 2011, EUR J HUM GENET, V19, P1138, DOI 10.1038/ejhg.2011.99; Iwarsson E, 1999, HUM GENET, V104, P376, DOI 10.1007/s004390050971; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KAMIGUCHI Y, 1993, HUM GENET, V90, P533; Khoueiry R, 2013, ZYGOTE, V21, P129, DOI 10.1017/S0967199411000694; Lim JH, 2015, PLACENTA, V36, P322, DOI 10.1016/j.placenta.2014.12.020; McCallie BR, 2014, J ASSIST REPROD GEN, V31, P913, DOI 10.1007/s10815-014-0235-y; McCallie BR PJ, 2014, 70 AM SOC REPR MED A; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; MUNNE S, 1993, HUM REPROD, V8, P2185, DOI 10.1093/oxfordjournals.humrep.a138001; Munne S, 2016, FERTIL STERIL, V105, P1146, DOI 10.1016/j.fertnstert.2016.01.016; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Parks JC, 2011, FERTIL STERIL, V95, P1367, DOI 10.1016/j.fertnstert.2010.08.009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Rabinowitz M, 2012, FERTIL STERIL, V97, P395, DOI 10.1016/j.fertnstert.2011.11.034; Robinson WP, 2000, BIOESSAYS, V22, P452; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Rodriguez-Purata J, 2015, FERTIL STERIL, V104, P1460, DOI 10.1016/j.fertnstert.2015.08.007; Sailani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135555; Schoolcraft WB, 2010, FERTIL STERIL, V94, P1700, DOI [10.1016/itertnstert2009.10.015, DOI 10.1016/ITERTNSTERT.2009.10.015]; Shi XY, 2014, REPROD SCI, V21, P978, DOI 10.1177/1933719113519173; Shuman C, 1993, BECKWITH WIEDEMANN S; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Viana J, 2014, EPIGENETICS-US, V9, P587, DOI 10.4161/epi.27806; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; White CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17311; Wilton L, 2003, FERTIL STERIL, V80, P860, DOI 10.1016/S0015-0282(03)01162-2; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156980	10.1371/journal.pone.0156980	http://dx.doi.org/10.1371/journal.pone.0156980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271036	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000055
J	Kang, MJ; Kang, JW				Kang, Min-Joo; Kang, Je-Won			Intrusion Detection System Using Deep Neural Network for In-Vehicle Network Security	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; MEMORY	A novel intrusion detection system (IDS) using a deep neural network (DNN) is proposed to enhance the security of in-vehicular network. The parameters building the DNN structure are trained with probability-based feature vectors that are extracted from the in-vehicular network packets. For a given packet, the DNN provides the probability of each class discriminating normal and attack packets, and, thus the sensor can identify any malicious attack to the vehicle. As compared to the traditional artificial neural network applied to the IDS, the proposed technique adopts recent advances in deep learning studies such as initializing the parameters through the unsupervised pre-training of deep belief networks (DBN), therefore improving the detection accuracy. It is demonstrated with experimental results that the proposed technique can provide a real-time response to the attack with a significantly improved detection ratio in controller area network (CAN) bus.	[Kang, Min-Joo; Kang, Je-Won] Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea	Ewha Womans University	Kang, JW (corresponding author), Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea.	jewonk@ewha.ac.kr	Kang, Jewon/AAU-9722-2020	Kang, Jewon/0000-0002-1637-9479	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2056587]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2014R1A1A2056587).	BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bengio Y., 2009, FDN TRENDS MACH LEAR; Bengio Y, 2012, ADV NEURAL INFORM PR, V25; Biswas S, 2006, IEEE SIGNAL PROCESSI, V44, P82; Borazjani P, 2014, P EMB SEC CARS C 201; Charlie M, 2013, ADVENTURES AUTOMOTIV; Checkoway S., 2011, P USENIX SEC 2011; Chen WH, 2005, COMPUTERS OPERATIONS; Dan C, 2012, NEURAL NETWORKS; Deepa AJ, 2012, PROCEDIA ENGINEER, V38, P2063, DOI 10.1016/j.proeng.2012.06.248; Deng L, 2011, APSIPA; Erhan D., 2010, J MACHINE LEARNING R; Fan Y, 2008, VEH POW PROP C 2008; Farsi M, 1999, COMPUTING CONTROL EN, V10; Geiger A, 2012, IEEE T INTELL TRANSP, V13, P1018; Golovko V, 2005, INTRUSION RECOGNITIO; Hinton G, 2012, COMMUNICATIONS MAGAZ; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hoppe T, 2008, P 27 INT C SAFECOMP; Hu W, 2003, INT C MACH LEARN; Jin WL, 2006, TRANSP RES B, P3; Johansson K. H., 2005, HDB NETWORKED EMBEDD; Kemmerer D, 2002, COMPUTER, P27, DOI 10.1109/MC.2002.1012428; Kesting A, 2010, IEEE T INTELL TRANSP, V11, P172, DOI 10.1109/TITS.2009.2037924; Kleberger P, 2011, INT VEH S IV 2011; Koscher K, 2010, P IEEE S SECUR PRIV, P447, DOI 10.1109/SP.2010.34; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Larson E, 2008, IEEE INT VEH S GOLD; Lenz H, 1999, EUR PHYS J B, V7, P331, DOI 10.1007/s100510050618; Lidstrom K, 2012, IEEE T INTELL TRANSP, V13, P1050, DOI 10.1109/TITS.2012.2204877; Lv Y., 2015, IEEE T INTELLIGENT T; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Muter M, 2010, 6 INT C INF ASS SEC; Park TJ, 2005, MECHATRONICS, V15, P899, DOI 10.1016/j.mechatronics.2005.05.002; Patsakis C, 2014, COMPUT SECUR, V40, P60, DOI 10.1016/j.cose.2013.11.003; Sun XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139513; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2014, NONLINEAR DYNAM, V76, P2017, DOI 10.1007/s11071-014-1265-9; Tsai CF, 2009, EXPERT SYST APPL, V36, P11994, DOI 10.1016/j.eswa.2009.05.029; Tsugawa S., 2002, IEEE INT VEH S 2002; Tuohy S, 2015, IEEE T INTELL TRANSP, V16, P534, DOI 10.1109/TITS.2014.2320605; Tyagi P, 2014, ADV COMPUTING COMMUN; van Nunen E, 2012, IEEE T INTELL TRANSP, V13, P1018, DOI 10.1109/TITS.2012.2200475; Woo S, 2015, IEEE T INTELLIGENT T; Wu JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120976; Yu SW, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215500848; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Yu SW, 2014, PHYSICA A, V407, P152, DOI 10.1016/j.physa.2014.03.081; Zhang JP, 2011, IEEE T INTELL TRANSP, V12, P1624, DOI 10.1109/TITS.2011.2158001; Zhang Z, 2001, IEEE WORKSH INF ASS; Zhou SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107122	52	293	302	16	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0155781	10.1371/journal.pone.0155781	http://dx.doi.org/10.1371/journal.pone.0155781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271802	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000004
J	Reepalu, A; Balcha, TT; Skogmar, S; Guner, N; Sturegard, E; Bjorkman, P				Reepalu, Anton; Balcha, Taye Tolera; Skogmar, Sten; Guner, Nuray; Sturegard, Erik; Bjorkman, Per			Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; INFECTED ADULTS; DEATH; INDIVIDUALS; INITIATION; PROGRAMS; SEX	Introduction Despite increasing access to antiretroviral treatment (ART) in low-income countries, HIV-related mortality is high, especially in the first months following ART initiation. We aimed to evaluate the impact of TB coinfection on early mortality and to assess gender-specific predictors of mortality in a cohort of Ethiopian adults subjected to intensified casefinding for active TB before starting ART. Material and Methods Prospectively recruited ART-eligible adults (n = 812, 58.6% female) at five Ethiopian health centers were followed for 6 months. At inclusion sputum culture, Xpert MTB/RIF, and smear microscopy were performed (158/812 [19.5%] had TB). Primary outcome was all-cause mortality. We used multivariate Cox models to identify predictors of mortality. Results In total, 37/812 (4.6%) participants died, 12 (32.4%) of whom had TB. Karnofsky performance score (KPS) and mid-upper arm circumference (MUAC) were associated with mortality in the whole population. However, the associations were different in men and women. In men, only MUAC remained associated with mortality (adjusted hazard ratio [aHR] 0.71 [95% CI 0.57-0.88]). In women, KPS <80% was associated with mortality (aHR 10.95 [95% CI 2.33-51.49]), as well as presence of cough (aHR 3.98 [95% CI 1.10-14.36]). Cough was also associated with mortality for TB cases (aHR 8.30 [95% CI 1.06-65.14]), but not for non-TB cases. Conclusions In HIV-positive Ethiopian adults managed at health centers, mortality was associated with reduced performance score and malnutrition, with different distribution with regard to gender and TB coinfection. These robust variables could be used at clinic registration to identify persons at increased risk of early mortality.	[Reepalu, Anton; Balcha, Taye Tolera; Skogmar, Sten; Bjorkman, Per] Lund Univ, Dept Clin Sci, Fac Med, Infect Dis Res Unit, Malmo, Sweden; [Balcha, Taye Tolera] Minist Hlth, Addis Ababa, Ethiopia; [Guner, Nuray] Skane Univ Hosp, Reg Skane Competence Ctr, Lund, Sweden; [Sturegard, Erik] Malmo Lund Univ, Dept Lab Med, Med Microbiol, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University	Reepalu, A (corresponding author), Lund Univ, Dept Clin Sci, Fac Med, Infect Dis Res Unit, Malmo, Sweden.	anton.reepalu@med.lu.se	MIZEKA, PANU/A-3952-2017	Reepalu, Anton/0000-0003-1690-8921	Swedish Civil Contingency Agency; Swedish International Development Cooperation Agency; Swedish Medical Society; Crafoord Foundation	Swedish Civil Contingency Agency; Swedish International Development Cooperation Agency; Swedish Medical Society; Crafoord Foundation	This work was supported by the Swedish Civil Contingency Agency (www.msb.se), the Swedish International Development Cooperation Agency (www.sida.se), the Swedish Medical Society (www.sls.se), and the Crafoord Foundation (www.crafoord.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOB UPD HLTH SECT R; Balcha TT, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu095; Balcha TT, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27048; Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Bates M, 2015, LANCET INFECT DIS, V15, P544, DOI 10.1016/S1473-3099(15)70058-7; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Burkey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P41, DOI 10.1097/QAI.0000000000000094; Byass P, 2015, J GLOB HEALTH, V5, P65, DOI 10.7189/jogh.05.010402; Cornell M, 2014, J ACQ IMMUN DEF SYND, P67; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Cox JA, 2010, AIDS REV, V12, P183; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Federal Ministry of Health, 2012, GUID CLIN PROGR MAN; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gustafson P, 2007, INFECTION, V35, P69, DOI 10.1007/s15010-007-6090-3; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hosseinipour MC, 2015, 8 INT AIDS SOC C HIV; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Ministry of Health of Ethiopia, 2008, GUID MAN OPP INF ANT; Reepalu A, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu039; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Van Rie A, 2014, INT J TUBERC LUNG D, V18, P1340, DOI 10.5588/ijtld.14.0153; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, GUIDELINE ON WHEN TO; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197	35	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156602	10.1371/journal.pone.0156602	http://dx.doi.org/10.1371/journal.pone.0156602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272622	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000022
J	Li, C; Zou, XH; Zhang, CY; Shao, QH; Liu, J; Liu, B; Li, HY; Zhao, T				Li, Cong; Zou, Xiaohua; Zhang, Chunyu; Shao, Qinghao; Liu, Jun; Liu, Bin; Li, Hongyu; Zhao, Tao			OsLBD3-7 Overexpression Induced Adaxially Rolled Leaves in Rice	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; BULLIFORM CELLS; GENE FAMILY; LEAF; BOUNDARIES; ARABIDOPSIS; PROTEIN; EXPRESSION; DEFINES; FATE	Appropriate leaf rolling enhances erect-leaf habits and photosynthetic efficiency, which consequently improves grain yield. Here, we reported the novel lateral organ boundaries domain (LBD) gene OsLBD3-7, which is involved in the regulation of leaf rolling. OsLBD3-7 works as a transcription activator and its protein is located on the plasma membrane and in the nucleus. Overexpression of OsLBD3-7 leads to narrow and adaxially rolled leaves. Microscopy of flag leaf cross-sections indicated that overexpression of OsLBD3-7 led to a decrease in both bulliform cell size and number. Transcriptional analysis showed that key genes that had been reported to be negative regulators of bulliform cell development were up-regulated in transgenic plants. These results indicated that OsLBD3-7 might acts as an upstream regulatory gene of bulliform cell development to regulate leaf rolling, which will give more insights on the leaf rolling regulation mechanism.	[Li, Cong; Zhang, Chunyu; Liu, Jun; Liu, Bin; Li, Hongyu; Zhao, Tao] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Zou, Xiaohua] Shanghai Acad Agr Sci, Forestry & Fruit Tree Res Inst, Shanghai Key Lab Protected Hort Technol, Shanghai 201403, Peoples R China; [Shao, Qinghao] Jinan Licheng 2 High Sch, Jinan 250104, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanghai Academy of Agricultural Sciences	Li, HY; Zhao, T (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China.	lihongyu@caas.cn; zhaotao02@caas.cn	Zhang, Chun-yu/HDP-5776-2022	Zhao, Tao/0000-0002-5641-8161	National Natural Science Foundation of China [31571758]; CAAS Innovation Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAAS Innovation Program	This work is supported by the National Natural Science Foundation of China (31571758 to TZ) and the CAAS Innovation Program.	Alvarez JM, 2008, BRAZ ARCH BIOL TECHN, V51, P113, DOI 10.1590/S1516-89132008000100014; Becraft PW, 2002, DEVELOPMENT, V129, P5217; Chen XF, 2013, J EXP BOT, V64, P4895, DOI 10.1093/jxb/ert278; Coudert Y, 2013, MOL BIOL EVOL, V30, P569, DOI 10.1093/molbev/mss250; Fang LK, 2012, PLANT BIOTECHNOL J, V10, P524, DOI 10.1111/j.1467-7652.2012.00679.x; Govaerts YM, 1996, APPL OPTICS, V35, P6585, DOI 10.1364/AO.35.006585; Hibara K, 2009, DEV BIOL, V334, P345, DOI 10.1016/j.ydbio.2009.07.042; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Li L, 2010, MOL PLANT, V3, P807, DOI 10.1093/mp/ssq022; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Ma Y, 2009, J PLANT BIOL, V52, P374, DOI 10.1007/s12374-009-9048-4; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Matsumura Y, 2009, PLANT J, V58, P525, DOI 10.1111/j.1365-313X.2009.03797.x; Meng YY, 2013, PLANT CELL, V25, P4405, DOI 10.1105/tpc.113.116590; Ohashi M, 2015, PLANT CELL PHYSIOL, V56, P769, DOI 10.1093/pcp/pcv005; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Steffen A, 1994, PLANT J, V5, P421; Xiang JJ, 2012, PLANT PHYSIOL, V159, P1488, DOI 10.1104/pp.112.199968; Yan S, 2008, PLANT MOL BIOL, V68, P239, DOI 10.1007/s11103-008-9365-x; Yang CH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-158; Yang Y, 2006, MOL PHYLOGENET EVOL, V39, P248, DOI 10.1016/j.ympev.2005.09.016; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhao T, 2015, SCI CHINA LIFE SCI, V58, P1160, DOI 10.1007/s11427-015-4937-x; Zou LP, 2011, PLANT PHYSIOL, V156, P1589, DOI 10.1104/pp.111.176016	27	15	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156413	10.1371/journal.pone.0156413	http://dx.doi.org/10.1371/journal.pone.0156413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258066	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700061
J	Lee, HW; Park, SY; Kim, SU; Jang, JY; Park, H; Kim, JK; Lee, CK; Chon, YE; Han, KH				Lee, Hye Won; Park, Soo Young; Kim, Seung Up; Jang, Jae Young; Park, Hana; Kim, Ja Kyung; Lee, Chun Kyon; Chon, Young Eun; Han, Kwang-Hyub			Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; HEPATIC STEATOSIS; NONINVASIVE ASSESSMENT; SAMPLING VARIABILITY; SCORING SYSTEM; FIBROSIS SCORE; BIOPSY; NAFLD; VALIDATION; PREDICTORS	Background/aims The accuracy of noninvasive markers to discriminate nonalcoholic steatohepatitis (NASH) is unsatisfactory. We investigated whether transient elastography (TE) could discriminate patients with NASH from those with nonalcoholic fatty liver disease (NAFLD). Methods The patients suspected of NAFLD who underwent liver biopsy and concomitant TE were recruited from five tertiary centers between November 2011 and December 2013. Results The study population (n = 183) exhibited a mean age of 40.6 years and male predominance (n = 111, 60.7%). Of the study participants, 89 (48.6%) had non-NASH and 94 (51.4%) had NASH. The controlled attenuation parameter (CAP) and liver stiffness (LS) were significantly correlated with the degrees of steatosis (r = 0.656, P<0.001) and fibrosis (r = 0.714, P<0.001), respectively. The optimal cut-off values for steatosis were 247 dB/m for S1, 280 dB/m for S2, and 300 dB/m for S3. Based on the independent predictors derived from multivariate analysis [P = 0.044, odds ratio (OR) 4.133, 95% confidence interval (CI) 1.037-16.470 for CAP>250 dB/m; P = 0.013, OR 3.399, 95% CI 1.295-8.291 for LS>7.0 kPa; and P<0.001, OR 7.557, 95% CI 2.997-19.059 for Alanine aminotransferase>60 vertical bar U/L], we developed a novel CLA model for discriminating patients with NASH. The CLA model showed good discriminatory capability, with an area under the receiver operating characteristic curve (AUROC) of 0.812 (95% CI 0.724-0.880). To assess discriminatory power, the AUROCs, as determined by the bootstrap method, remained largely unchanged between iterations, with an average value of 0.833 (95% CI 0.740-0.893). Conclusion This novel TE-based CLA model showed acceptable accuracy in discriminating NASH from simple steatosis. However, further studies are required for external validation.	[Lee, Hye Won; Kim, Seung Up; Kim, Ja Kyung; Chon, Young Eun; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea; [Park, Soo Young] Kyungpook Natl Univ, Coll Med, Kyungpook Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Jang, Jae Young] Soonchunhyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Hana] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Bundang, South Korea; [Lee, Chun Kyon] Ilsan Hosp, Natl Hlth Insurance Cooperat, Ilsan, South Korea	Yonsei University; Yonsei University Health System; Kyungpook National University; Kyungpook National University Hospital; Soonchunhyang University; Pochon Cha University; NHIS Ilsan Hospital	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea.; Jang, JY (corresponding author), Soonchunhyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	ksukorea@yuhs.ac; jyjaung@schmc.ac.kr		Han, Kwang-Hyub/0000-0003-3960-6539; KIM, JA KYUNG/0000-0001-5025-6846; Kim, Seung Up/0000-0002-9658-8050	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R&D project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Liver Cirrhosis Clinical Research Center; Korea Healthcare Technology R&D project, Ministry of Health and Welfare, Republic of Korea	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare Technology R&D project, the Ministry of Health and Welfare, Republic of Korea (no. HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2015, CLIN GASTROENTEROL H, V13, P772, DOI 10.1016/j.cgh.2014.12.014; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Aykut UE, 2014, SCAND J GASTROENTERO, V49, P1343, DOI 10.3109/00365521.2014.958099; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cholongitas E, 2006, AM J CLIN PATHOL, V125, P710, DOI 10.1309/W3XCNT4HKFBN2G0B; Chon YE, 2015, DIGEST DIS SCI, V60, P234, DOI 10.1007/s10620-014-3293-1; Chon YE, 2014, LIVER INT, V34, P102, DOI 10.1111/liv.12282; Cordeiro A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/839253; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hyysalo J, 2014, J HEPATOL, V60, P839, DOI 10.1016/j.jhep.2013.12.009; Jia JD, 2015, J GASTROEN HEPATOL, V30, P756, DOI 10.1111/jgh.12840; Jung KS, 2012, CLIN MOL HEPATOL, V18, P163, DOI 10.3350/cmh.2012.18.2.163; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Kwok R, 2016, GUT, V65, P1359, DOI 10.1136/gutjnl-2015-309265; Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007; Lupsor-Platon M, 2015, J GASTROINTEST LIVER, V24, P35, DOI 10.15403/jgld.2014.1121.mlp; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Marcos A, 2000, TRANSPLANTATION, V69, P2410, DOI 10.1097/00007890-200006150-00034; Masaki K, 2013, HEPATOL RES, V43, P1182, DOI 10.1111/hepr.12094; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Ong JP, 2005, OBES SURG, V15, P310, DOI 10.1381/0960892053576820; Pathik P, 2015, ANN GASTROENTEROL, V28, P281; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ratziu V, 2009, BIOMARK MED, V3, P353, DOI 10.2217/BMM.09.36; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Seo YS, 2015, LIVER INT, V35, P2246, DOI 10.1111/liv.12808; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sharma P, 2014, INDIAN J GASTROENTER, V33, P445, DOI 10.1007/s12664-014-0491-x; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vuppalanchi R, 2009, CLIN GASTROENTEROL H, V7, P481, DOI 10.1016/j.cgh.2008.12.015; Yamazaki H, 2015, DIABETES CARE, V38, P1673, DOI 10.2337/dc15-0140	45	45	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157358	10.1371/journal.pone.0157358	http://dx.doi.org/10.1371/journal.pone.0157358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284700	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000061
J	Wang, D; Lin, HD; Xia, MF; Aleteng, QQG; Li, XM; Ma, H; Pan, BS; Gao, J; Gao, X				Wang, Dan; Lin, Huandong; Xia, Mingfeng; Aleteng, Qiqige; Li, Xiaoming; Ma, Hui; Pan, Baishen; Gao, Jian; Gao, Xin			Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study	PLOS ONE			English	Article							METABOLIC SYNDROME; 25-HYDROXYVITAMIN D; INSULIN-RESISTANCE; D DEFICIENCY; ULTRASOUND; STEATOSIS; INCREASES; DIAGNOSIS; HISTOLOGY; RECEPTOR	Background/Objectives Vitamin D exerts metabolic activities. We investigated whether the 25-hydroxy vitamin D [25(OH)D] is associated with liver fat content (LFC) and non-alcoholic fatty liver disease (NAFLD) in a middle-aged, elderly Chinese population. Subject/Methods A total of 2,960 participants (954 men and 2,006 women) aged over 45 years old were enrolled. Each participant underwent a standard interview, anthropometric measurements and laboratory examinations. Vitamin D deficiency and insufficiency was diagnosed when serum 25(OH)D level was < 50 and 50-75nmol/L. An ultrasound quantitative method was used to assess the LFC. Results Among the 2,960 participants, 1,982 (67.0%) subjects had vitamin D deficiency, 769 (26.0%) had vitamin D insufficiency, and 209 (7%) had normal vitamin D. Male subjects with vitamin D deficiency and insufficiency had significantly higher LFC than those with normal 25(OH)D (P = 0.034), while the LFC values showed no significant difference among the female subjects with vitamin D sufficiency, insufficiency and deficiency (P = 0.396). Univariate correlation analysis showed that 25(OH)D had a significantly negative association with LFC in men (r = -0.085, P = 0.009), but not in women. After adjusting for age, cigarette smoking, examination season, serum calcium, PTH and all possible confounders that displayed significant associations with LFC in univariate correlation analysis, serum 25(OH)D remained associated with LFC in middle-aged and elderly Chinese men. Conclusion Serum 25(OH)D level was inversely associated with LFC in middle-aged and elderly Chinese men.	[Wang, Dan; Lin, Huandong; Xia, Mingfeng; Aleteng, Qiqige; Li, Xiaoming; Ma, Hui; Gao, Xin] Fudan Univ, Dept Endocrinol & Metab, Shanghai Zhongshan Hosp, Inst Chron Metab Dis, Shanghai 200032, Peoples R China; [Pan, Baishen] Fudan Univ, Zhongshan Hosp, Dept Lab Med, Shanghai 200032, Peoples R China; [Gao, Jian] Fudan Univ, Zhongshan Hosp, Dept Clin Nutr, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Gao, X (corresponding author), Fudan Univ, Dept Endocrinol & Metab, Shanghai Zhongshan Hosp, Inst Chron Metab Dis, Shanghai 200032, Peoples R China.	zhongshan_endo@126.com	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gao, Xin/0000-0003-1864-7796	National Key Basic Research Program of China [2012CB524906]; Shanghai Municipal Health Project Grant [2013ZYJB0802]; Shanghai Health and Family Planning Commission Foundation [12GWZX0103, 2013SY005]; Shanghai Hospital Development Center Foundation [SHDC12012201]	National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Health Project Grant; Shanghai Health and Family Planning Commission Foundation; Shanghai Hospital Development Center Foundation	This work was supported by grants from the National Key Basic Research Program of China (grant no. 2012CB524906 to X. Gao), URL www.973.gov.cn/Default_3.aspx; the Shanghai Municipal Health Project Grant (grant no. 2013ZYJB0802 to X. Gao); the Shanghai Health and Family Planning Commission Foundation (Grant Nos. 12GWZX0103 and 2013SY005 to X. Gao); the Shanghai Hospital Development Center Foundation (SHDC12012201 to X. Gao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Barchetta I, 2012, HEPATOLOGY, V56, P2180, DOI 10.1002/hep.25930; Bhatt SP, 2013, ATHEROSCLEROSIS, V230, P157, DOI 10.1016/j.atherosclerosis.2013.07.006; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Eliades M, 2013, ALIMENT PHARM THER, V38, P246, DOI 10.1111/apt.12377; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Feldman D, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Gao X, 2010, EUR J EPIDEMIOL, V25, P885, DOI 10.1007/s10654-010-9525-6; Jafari T, 2016, CLIN NUTR; Kayaniyil S, 2011, J CLIN ENDOCR METAB, V96, P168, DOI 10.1210/jc.2010-1439; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Kim MK, 2010, CLIN ENDOCRINOL, V73, P330, DOI 10.1111/j.1365-2265.2010.03798.x; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065210; Li XM, 2012, ATHEROSCLEROSIS, V224, P480, DOI 10.1016/j.atherosclerosis.2012.07.002; Lin SC, 2015, CLIN GASTROENTEROL H, V13, P1337, DOI 10.1016/j.cgh.2014.11.027; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Musso G, 2013, TRENDS MOL MED, V19, P522, DOI 10.1016/j.molmed.2013.05.006; Nelson JE, 2016, AM J GASTROENTEROL, V111, P852, DOI 10.1038/ajg.2016.51; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Pilz S, 2016, NAT REV CARDIOL, V13, P404, DOI 10.1038/nrcardio.2016.73; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Sundstrom J, 2008, HEART, V94, P874, DOI 10.1136/hrt.2007.121020; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Verdoia M, 2015, NUTR METAB CARDIOVAS, V25, P464, DOI 10.1016/j.numecd.2015.01.009; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xia MF, 2016, ALIMENT PHARM THER, V43, P631, DOI 10.1111/apt.13521; Xia MF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0766-3; Xia MF, 2015, OBESITY, V23, P1929, DOI 10.1002/oby.21182; Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhai H. L., 2016, BR J NUTR, V115, P1; Zhou QG, 2008, DIABETES-METAB RES, V24, P459, DOI 10.1002/dmrr.873	41	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157515	10.1371/journal.pone.0157515	http://dx.doi.org/10.1371/journal.pone.0157515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284686	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000070
J	Junqueira, VS; Peixoto, LD; Laviola, BG; Bhering, LL; Mendonca, S; Costa, TDA; Antoniassi, R				Junqueira, Vinicius Silva; Peixoto, Leonardo de Azevedo; Laviola, Bruno Galveas; Bhering, Leonardo Lopes; Mendonca, Simone; Agostini Costa, Tania da Silveira; Antoniassi, Rosemar			Bayesian Multi-Trait Analysis Reveals a Useful Tool to Increase Oil Concentration and to Decrease Toxicity in Jatropha curcas L.	PLOS ONE			English	Article							GENETIC-PARAMETERS; MOLECULAR MARKERS; SELECTION; VARIABILITY; BIOFUEL; COLLECTION; MODELS; VALUES; PLANT; SEEDS	The biggest challenge for jatropha breeding is to identify superior genotypes that present high seed yield and seed oil content with reduced toxicity levels. Therefore, the objective of this study was to estimate genetic parameters for three important traits (weight of 100 seed, oil seed content, and phorbol ester concentration), and to select superior genotypes to be used as progenitors in jatropha breeding. Additionally, the genotypic values and the genetic parameters estimated under the Bayesian multi-trait approach were used to evaluate different selection indices scenarios of 179 half-sib families. Three different scenarios and economic weights were considered. It was possible to simultaneously reduce toxicity and increase seed oil content and weight of 100 seed by using index selection based on genotypic value estimated by the Bayesian multi-trait approach. Indeed, we identified two families that present these characteristics by evaluating genetic diversity using the Ward clustering method, which suggested nine homogenous clusters. Future researches must integrate the Bayesian multi- trait methods with realized relationship matrix, aiming to build accurate selection indices models.	[Junqueira, Vinicius Silva] Univ Fed Vicosa, Dept Anim Sci, BR-36570000 Vicosa, MG, Brazil; [Peixoto, Leonardo de Azevedo; Bhering, Leonardo Lopes] Univ Fed Vicosa, Dept Biol, BR-36570000 Vicosa, MG, Brazil; [Laviola, Bruno Galveas; Mendonca, Simone] Embrapa Agroenergia, Empresa Brasileira Pesquisa Agr, Parque Estacao Biol PqEB S-N, BR-70770901 Brasilia, DF, Brazil; [Agostini Costa, Tania da Silveira] Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Recursos Genet & Biotecnol, Final PqEB, PqEB, Parque Estacao Biol,W5 Norte, BR-70770917 Brasilia, DF, Brazil; [Antoniassi, Rosemar] Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Tecnol Agroind Alimentos, Ave Amer 29501 Guaratiba, BR-23020470 Rio De Janeiro, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Peixoto, LD (corresponding author), Univ Fed Vicosa, Dept Biol, BR-36570000 Vicosa, MG, Brazil.	leoazevedop@gmail.com	Laviola, Bruno Galvêas/AAK-8551-2020; Bhering, Leonardo/AAK-9548-2020; Laviola, Bruno G/F-5855-2010	Laviola, Bruno/0000-0002-6360-1204; Bhering, Leonardo/0000-0002-6072-0996; Antoniassi, Rosemar/0000-0002-0795-9877	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Cnpq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Cnpq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior http://www.capes.gov.br/ and Cnpq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico http://cnpq.br/.	ADOLF W, 1984, PHYTOCHEMISTRY, V23, P129, DOI 10.1016/0031-9422(84)83091-5; Akintayo ET, 2004, BIORESOURCE TECHNOL, V92, P307, DOI 10.1016/S0960-8524(03)00197-4; Alves AA, 2015, BIOTECHNOL J, V10, P505, DOI 10.1002/biot.201400201; [Anonymous], 1991, EVALUATING ACCURACY; Bahadur B., 2012, JATROPHA CHALLENGES; Bailis R, 2011, GCB BIOENERGY, V3, P449, DOI 10.1111/j.1757-1707.2011.01100.x; Basha SD, 2007, EUPHYTICA, V156, P375, DOI 10.1007/s10681-007-9387-5; Bhering LL, 2015, IND CROP PROD, V74, P898, DOI 10.1016/j.indcrop.2015.06.004; Bhering LL, 2013, IND CROP PROD, V41, P260, DOI 10.1016/j.indcrop.2012.04.026; Bhering LL, 2012, PESQUI AGROPECU BRAS, V47, P402, DOI 10.1590/S0100-204X2012000300012; Carels N, 2013, JATROPHA CHALLENGES; DIAS L. A. S., 2007, CULTIVO PINHAOMANSO; Franco J, 2001, THEOR APPL GENET, V103, P944, DOI 10.1007/s001220100641; Gomes RA, 2014, IND CROP PROD, V52, P512, DOI 10.1016/j.indcrop.2013.10.036; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Gupta P, 2012, MOL BREEDING, V30, P1325, DOI 10.1007/s11032-012-9719-6; Hayashi T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-34; Hazel LN, 1943, GENETICS, V28, P476; Laviola BG, 2012, CIENC RURAL, V42, P429, DOI 10.1590/S0103-84782012000300008; Laviola BG, 2010, PESQUI AGROPECU BRAS, V45, P1117, DOI 10.1590/S0100-204X2010001000010; LIBERALINO AAA, 1988, ARQ BIOL TECNOL, V31, P539; Makkar HPS, 1998, FOOD CHEM, V62, P207, DOI 10.1016/S0308-8146(97)00183-0; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MISZTAL I., 2002, WORLD C GEN APPL LIV, V7; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; Nithiyanantham S, 2012, J AM OIL CHEM SOC, V89, P961, DOI 10.1007/s11746-012-2012-3; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Peixoto LD, 2016, IND CROP PROD, V80, P70, DOI 10.1016/j.indcrop.2015.10.034; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Resende JCF, 2013, PINHAO MANSO; Rolf MM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0106-8; Rosado TB, 2010, CROP SCI, V50, P2372, DOI 10.2135/cropsci2010.02.0112; Singh P, 2010, GENES GENOMES GENOMI, V4, P1, DOI DOI 10.1007/S11033-009-9712-2; Smith BJ, 2007, J STAT SOFTW, V21, P1; Spinelli VM, 2015, IND CROP PROD, V69, P355, DOI 10.1016/j.indcrop.2015.02.024; Team RC, 2012, R LANG ENV STAT COMP; Ventura HT, 2015, LIVEST SCI, V176, P47, DOI 10.1016/j.livsci.2015.03.030	38	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157038	10.1371/journal.pone.0157038	http://dx.doi.org/10.1371/journal.pone.0157038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281340	Green Published, gold			2022-12-27	WOS:000377563000072
J	McLachlan, S; Giambartolomei, C; White, J; Charoen, P; Wong, A; Finan, C; Engmann, J; Shah, T; Hersch, M; Podmore, C; Cavadino, A; Jefferis, BJ; Dale, CE; Hypponen, E; Morris, RW; Casas, JP; Kumari, M; Ben-Shlomo, Y; Gaunt, TR; Drenos, F; Langenberg, C; Kuh, D; Kivimaki, M; Rueedi, R; Waeber, G; Hingorani, AD; Price, JF; Walker, AP				McLachlan, Stela; Giambartolomei, Claudia; White, Jon; Charoen, Pimphen; Wong, Andrew; Finan, Chris; Engmann, Jorgen; Shah, Tina; Hersch, Micha; Podmore, Clara; Cavadino, Alana; Jefferis, Barbara J.; Dale, Caroline E.; Hypponen, Elina; Morris, Richard W.; Casas, Juan P.; Kumari, Meena; Ben-Shlomo, Yoav; Gaunt, Tom R.; Drenos, Fotios; Langenberg, Claudia; Kuh, Diana; Kivimaki, Mika; Rueedi, Rico; Waeber, Gerard; Hingorani, Aroon D.; Price, Jacqueline F.; Walker, Ann P.		UCLEB Consortium	Replication and Characterization of Association between ABO SNPs and Red Blood Cell Traits by Meta-Analysis in Europeans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VON-WILLEBRAND-FACTOR; DENSITY-LIPOPROTEIN CHOLESTEROL; HFE C282Y HOMOZYGOTES; GENETIC-VARIANTS; HEMATOLOGICAL TRAITS; AFRICAN-AMERICANS; IRON HOMEOSTASIS; PLASMA-LEVELS; RISK-FACTORS	Red blood cell (RBC) traits are routinely measured in clinical practice as important markers of health. Deviations from the physiological ranges are usually a sign of disease, although variation between healthy individuals also occurs, at least partly due to genetic factors. Recent large scale genetic studies identified loci associated with one or more of these traits; further characterization of known loci and identification of new loci is necessary to better understand their role in health and disease and to identify potential molecular mechanisms. We performed meta-analysis of Metabochip association results for six RBC traits-hemoglobin concentration (Hb), hematocrit (Hct), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV) and red blood cell count (RCC)-in 11 093 Europeans from seven studies of the UCL-LSHTM-Edinburgh-Bristol (UCLEB) Consortium. We identified 394 non-overlapping SNPs in five loci at genome-wide significance: 6p22.1-6p21.33 (with HFE among others), 6q23.2 (with HBS1L among others), 6q23.3 (contains no genes), 9q34.3 (only ABO gene) and 22q13.1 (with TMPRSS6 among others), replicating previous findings of association with RBC traits at these loci and extending them by imputation to 1000 Genomes. We further characterized associations between ABO SNPs and three traits: hemoglobin, hematocrit and red blood cell count, replicating them in an independent cohort. Conditional analyses indicated the independent association of each of these traits with ABO SNPs and a role for blood group O in mediating the association. The 15 most significant RBC-associated ABO SNPs were also associated with five cardiometabolic traits, with discordance in the direction of effect between groups of traits, suggesting that ABO may act through more than one mechanism to influence cardiometabolic risk.	[McLachlan, Stela; Price, Jacqueline F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Giambartolomei, Claudia] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Psychiat, Leon & Norma Hess Ctr Sci & Med, New York, NY 10029 USA; [White, Jon] UCL, Dept Genet Environm & Evolut, Genet Inst, London, England; [Charoen, Pimphen] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Charoen, Pimphen] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Wong, Andrew; Kuh, Diana] UCL, MRC Unit Lifelong Hlth & Ageing, London, England; [Finan, Chris; Hingorani, Aroon D.] UCL, Inst Cardiovasc Sci, London, England; [Engmann, Jorgen; Shah, Tina] UCL, Inst Cardiovasc Sci, Genet Epidemiol Grp, London, England; [Engmann, Jorgen; Dale, Caroline E.; Hingorani, Aroon D.] UCL, Farr Inst Hlth Informat Res, Dept Epidemiol & Publ Hlth, London, England; [Hersch, Micha; Rueedi, Rico] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Hersch, Micha; Rueedi, Rico] Swiss Inst Bioinformat, Lausanne, Switzerland; [Podmore, Clara; Langenberg, Claudia] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England; [Cavadino, Alana] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London, England; [Cavadino, Alana; Hypponen, Elina] UCL, UCL Inst Child Hlth, Populat Policy & Practice, London, England; [Jefferis, Barbara J.; Morris, Richard W.] UCL, UCL Inst Epidemiol & Hlth Care, Dept Primary Care & Populat Hlth, London, England; [Hypponen, Elina] Univ S Australia, Ctr Populat Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Hypponen, Elina] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Morris, Richard W.; Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Casas, Juan P.; Langenberg, Claudia] UCL, Inst Hlth Informat, London, England; [Kumari, Meena] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England; [Kumari, Meena; Kivimaki, Mika] UCL, UCL Inst Epidemiol & Hlth Care, Dept Epidemiol & Publ Hlth, London, England; [Gaunt, Tom R.; Drenos, Fotios] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Drenos, Fotios; Walker, Ann P.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Waeber, Gerard] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Waeber, Gerard] Univ Lausanne, Lausanne, Switzerland	University of Edinburgh; Icahn School of Medicine at Mount Sinai; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Mahidol University; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Lausanne; Swiss Institute of Bioinformatics; University of Cambridge; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Bristol; University of London; University College London; University of Essex; University of London; University College London; University of Bristol; University of London; University College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	McLachlan, S (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	stela.mclachlan@ed.ac.uk	Whittaker, John C/B-8609-2012; Walker, Ann P/C-1628-2008; Kivimaki, Mika/B-3607-2012; Kuh, Diana/L-6019-2014; Wong, Andrew/AAE-6995-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Langenberg, Claudia/ABG-9067-2021; Gaunt, Tom R/O-3918-2014; Hypponen, Elina/B-2596-2014; Cavadino, Alana/CAG-8915-2022; Jefferis, Barbara/AAE-5186-2020; Wong, Andrew/M-8899-2016	Whittaker, John C/0000-0002-3529-2379; Kivimaki, Mika/0000-0002-4699-5627; Kuh, Diana/0000-0001-7386-2857; Wong, Andrew/0000-0003-2079-4779; Ben-Shlomo, Yoav/0000-0001-6648-3007; Langenberg, Claudia/0000-0002-5017-7344; Gaunt, Tom R/0000-0003-0924-3247; Hypponen, Elina/0000-0003-3670-9399; Cavadino, Alana/0000-0002-5709-367X; Jefferis, Barbara/0000-0002-0850-3177; Wong, Andrew/0000-0003-2079-4779; Engmann, Jorgen/0000-0001-7015-7773; Hingorani, Aroon/0000-0001-8365-0081; Waeber, Gerard/0000-0003-4193-788X; Kumari, Meena/0000-0001-9716-1035; Morris, Richard/0000-0001-7240-4563; Finan, Chris/0000-0002-3319-1937; Drenos, Fotios/0000-0003-2469-5516; Podmore, Clara/0000-0002-2452-8067; Price, Jackie/0000-0003-3251-3970	British Heart Foundation [RG/10/12/28456, RG/08/013/25942, RG/13/16/30528, RG/98002, RG/07/008/23674]; UK Medical Research Council [G0000934, MC_UU_12019/1]; Wellcome Trust [068545/Z/02, 097451/Z/11/Z]; European Commission Framework Programme 6 [018996]; French Ministry of Research; Department of Health Policy Research Programme (England); Medical Research Council of the United Kingdom; Chief Scientist Office of Scotland [CZB/4/672, CZQ/1/38]; National Institute on Ageing (NIA) [AG1764406S1]; Medical Research Council [G0500877, K013351]; Pfizer plc; Diabetes UK [10/0003985]; Stroke Association; National Heart Lung and Blood Institute [5RO1 HL036310]; National Institute on Aging [5RO1AG13196]; Agency for Health Care Policy Research [HS06516]; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Swiss National Science Foundation [33CSCO-122661]; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; ESRC [ES/K005774/1] Funding Source: UKRI; MRC [MC_UU_12019/1, MC_UU_12013/5, MR/N01104X/1, MC_UU_12015/1, MR/K013351/1, G1001799, G0500877, G0000934] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098, PG/13/66/30442] Funding Source: researchfish; Economic and Social Research Council [ES/K005774/1] Funding Source: researchfish; Medical Research Council [MR/K006584/1, MC_UU_12015/1, MC_UU_12019/1, MR/K013351/1, G0000934, MC_UU_12013/5, MR/N01104X/1, G1001799] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10091, CL-2011-18-004] Funding Source: researchfish; Chief Scientist Office [CZB/4/672] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Commission Framework Programme 6(European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Department of Health Policy Research Programme (England); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of Scotland; National Institute on Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer plc(Pfizer); Diabetes UK(Diabetes UK); Stroke Association; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	UCLEB: This work was supported by a British Heart Foundation Programme Grant (RG/10/12/28456). Individual studies were supported as follows. 1958BC: DNA collection of the 1958 birth cohort was funded by the UK Medical Research Council (G0000934); and the Wellcome Trust (Grant 068545/Z/02). Genotyping was supported by a contract from the European Commission Framework Programme 6 (018996); and grants from the French Ministry of Research. BRHS: The authors acknowledge the British Regional Heart Study team for data collection. The British Regional Heart study is supported by a British Heart Foundation grants (RG/08/013/25942, RG/13/16/30528). The British Heart Foundation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. BWHHS: The British Women's Heart and Health Study is supported by funding from the British Heart Foundation; and the Department of Health Policy Research Programme (England). CaPS: The Caerphilly Prospective study was conducted by the former MRC Epidemiology Unit (South Wales) and funded by the Medical Research Council of the United Kingdom. The Department of Social and Community Medicine, University of Bristol now maintains the archive. EAS: The Edinburgh Artery Study is funded by the British Heart Foundation (Programme Grant RG/98002), with Metabochip genotyping funded by a project grant from the Chief Scientist Office of Scotland (Project Grant CZB/4/672). ELSA: Samples from the English Longitudinal Study of Ageing DNA Repository (EDNAR), received support under a grant (AG1764406S1) awarded by the National Institute on Ageing (NIA). ELSA was developed by a team of researchers based at the National Centre for Social Research, University College London and the Institute of Fiscal Studies. The data were collected by the National Centre for Social Research. ET2DS: The Edinburgh Type 2 Diabetes Study is funded by the Medical Research Council (Project Grant G0500877); the Chief Scientist Office of Scotland (Programme Support Grant CZQ/1/38); Pfizer plc (Unrestricted Investigator Led Grant); and Diabetes UK (Clinical Research Fellowship 10/0003985). Research clinics were held at the Wellcome Trust Clinical Research Facility and Princess Alexandra Eye Pavilion in Edinburgh. MRC NSHD: The MRC National Survey of Health and Development 1946 is funded by the UK Medical Research Council (MC_UU_12019/1). WHII: The Whitehall II study is supported by grants from the Medical Research Council (K013351); British Heart Foundation (RG/07/008/23674); Stroke Association; National Heart Lung and Blood Institute (5RO1 HL036310); National Institute on Aging (5RO1AG13196); Agency for Health Care Policy Research (HS06516); and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. CoLaus: The Cohorte Lausannoise study was supported by research grants from the Swiss National Science Foundation (33CSCO-122661); from GlaxoSmithKline; and the Faculty of Biology and Medicine of Lausanne, Switzerland. The authors also express their gratitude to the participants in the Lausanne CoLaus study and to the investigators who have contributed to the recruitment, in particular the research nurses of CoLaus: Yolande Barreau, Anne-Lise Bastian, Binasa Ramic, Martine Moranville, Martine Baumer, Marcy Sagette, Jeanne Ecoffey, Sylvie Mermoud. CP is funded by the Wellcome Trust (grant 097451/Z/11/Z).; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 2009, CIRC-CARDIOVASC GENE, V2, P34, DOI 10.1161/CIRCGENETICS.108.813089; Andrews NC, 2009, NAT GENET, V41, P1161, DOI 10.1038/ng1109-1161; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Barton JC, 2010, INT J LAB HEMATOL, V32, P282, DOI 10.1111/j.1751-553X.2009.01182.x; Benyamin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5926; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Cardoso CS, 2002, IMMUNOGENETICS, V53, P1002, DOI 10.1007/s00251-001-0414-8; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Chami N, 2014, GENES-BASEL, V5, P51, DOI 10.3390/genes5010051; Chen Z, 2013, HUM MOL GENET, V22, P2529, DOI 10.1093/hmg/ddt087; Choi JW, 2001, ANN CLIN LAB SCI, V31, P151; De Falco L, 2013, HAEMATOLOGICA, V98, P845, DOI 10.3324/haematol.2012.075515; Ding KY, 2013, G3-GENES GENOM GENET, V3, P1061, DOI 10.1534/g3.113.006452; Eastlund T, 1998, TRANSFUSION, V38, P975, DOI 10.1046/j.1537-2995.1998.381098440863.x; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Fagherazzi G, 2015, DIABETOLOGIA, V58, P519, DOI 10.1007/s00125-014-3472-9; Ferreira MAR, 2009, AM J HUM GENET, V85, P745, DOI 10.1016/j.ajhg.2009.10.005; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Franchini M, 2016, SEMIN THROMB HEMOST, V42, P75, DOI 10.1055/s-0035-1564843; Franchini M, 2015, CLIN CHIM ACTA, V444, P66, DOI 10.1016/j.cca.2015.02.016; Franchini M, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0250-y; Galesloot TE, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0246-4; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Garner C, 2000, BLOOD, V95, P342; Gupta PK, 2014, DYNAMIC TRAIT MAPPIN; Hong KW, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-78; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Johansson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142518; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Li J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-684; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; McLaren CE, 2007, AM J HEMATOL, V82, P898, DOI 10.1002/ajh.20937; Namjou B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138677; Nwafia W C, 2006, Niger J Physiol Sci, V21, P9; Okada Y, 2012, J HUM GENET, V57, P161, DOI 10.1038/jhg.2012.2; Ozdemir A, 2007, AM J MED SCI, V334, P331, DOI 10.1097/MAJ.0b013e318145b107; Pacho Arantza, 2004, BMC Med Genet, V5, P25, DOI 10.1186/1471-2350-5-25; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Pankow JS, 2008, TRANSL RES, V152, P3, DOI 10.1016/j.trsl.2008.05.005; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pistis G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069206; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rochette J, 1999, AM J HUM GENET, V64, P1056, DOI 10.1086/302318; Shah T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071345; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sullivan JL, 2007, EXP BIOL MED, V232, P1014, DOI 10.3181/0703-MR-54; Takagi H, 2015, AM J CARDIOL, V116, P699, DOI 10.1016/j.amjcard.2015.05.043; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zabaneh D, 2011, ANN HUM GENET, V75, P456, DOI 10.1111/j.1469-1809.2011.00654.x; Zhang HR, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/641917; Zhong M, 2015, ARTERIOSCL THROM VAS, V35, P1570, DOI 10.1161/ATVBAHA.115.305337	64	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156914	10.1371/journal.pone.0156914	http://dx.doi.org/10.1371/journal.pone.0156914			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280446	Green Published, Green Accepted, gold			2022-12-27	WOS:000377563000055
J	Yang, CC; Chen, FL; Lo, YC				Yang, Ching-Ching; Chen, Fong-Lin; Lo, Yeh-Chi			Improving Image Quality of On-Board Cone-Beam CT in Radiation Therapy Using Image Information Provided by Planning Multi-Detector CT: A Phantom Study	PLOS ONE			English	Article							X-RAY SCATTER; RADIOTHERAPY; NECK; HEAD	Purpose The aim of this study was to improve the image quality of cone-beam computed tomography (CBCT) mounted on the gantry of a linear accelerator used in radiation therapy based on the image information provided by planning multi-detector CT (MDCT). Methods MDCT-based shading correction for CBCT and virtual monochromatic CT (VMCT) synthesized using the dual-energy method were performed. In VMCT, the high-energy data were obtained from CBCT, while the low-energy data were obtained from MDCT. An electron density phantom was used to investigate the efficacy of shading correction and VMCT on improving the target detectability, Hounsfield unit (HU) accuracy and variation, which were quantified by calculating the contrast-to-noise ratio (CNR), the percent difference (%Diff) and the standard deviation of the CT numbers for tissue equivalent background material, respectively. Treatment plan studies for a chest phantom were conducted to investigate the effects of image quality improvement on dose planning. Results For the electron density phantom, the mean value of CNR was 17.84, 26.78 and 34.31 in CBCT, shading-corrected CBCT and VMCT, respectively. The mean value of %Diff was 152.67%, 11.93% and 7.66% in CBCT, shading-corrected CBCT and VMCT, respectively. The standard deviation within a uniform background of CBCT, shading-corrected CBCT and VMCT was 85, 23 and 15 HU, respectively. With regards to the chest phantom, the monitor unit (MU) difference between the treatment plan calculated using MDCT and those based on CBCT, shading corrected CBCT and VMCT was 6.32%, 1.05% and 0.94%, respectively. Conclusions Enhancement of image quality in on-board CBCT can contribute to daily patient setup and adaptive dose delivery, thus enabling higher confidence in patient treatment accuracy in radiation therapy. Based on our results, VMCT has the highest image quality, followed by the shading corrected CBCT and the original CBCT. The research results presented in this study should be able to provide a route to reach a high level of image quality for CBCT imaging in radiation oncology.	[Yang, Ching-Ching] Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan; [Chen, Fong-Lin] Koo Fdn Sun Yat Sen Canc Ctr, Dept Med Phys, Taipei, Taiwan; [Lo, Yeh-Chi] Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY USA	Tzu Chi University of Science & Technology; Icahn School of Medicine at Mount Sinai	Yang, CC (corresponding author), Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan.	cyang@tcust.edu.tw		Yang, Ching-Ching/0000-0002-9420-3102				Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Boda-Heggemann J, 2011, STRAHLENTHER ONKOL, V187, P284, DOI 10.1007/s00066-011-2236-4; Chen GTY, 2009, RADIOL PHYS TECHNOL, V2, P1, DOI 10.1007/s12194-008-0045-y; Chuanyong B, 2003, NUCL SCI IEEE T, V50, P1510, DOI [10.1109/tns.2003.817281, DOI 10.1109/TNS.2003.817281]; Elstrom UV, 2011, ACTA ONCOL, V50, P908, DOI 10.3109/0284186X.2011.590525; Endo M, 2001, MED PHYS, V28, P469, DOI 10.1118/1.1357457; Glide-Hurst C, 2013, MED PHYS, V40, DOI 10.1118/1.4805102; Goldman LW, 2007, J NUCL MED TECHNOL, V35, DOI 10.2967/jnmt.106.037846; Guckenberger M, 2007, STRAHLENTHER ONKOL, V183, P307, DOI 10.1007/s00066-007-1695-0; Hsieh J, 2000, MED PHYS, V27, P23, DOI 10.1118/1.598853; Li H, 2012, MED PHYS, V39, P6056, DOI 10.1118/1.4752212; Marchant TE, 2008, PHYS MED BIOL, V53, P5719, DOI 10.1088/0031-9155/53/20/010; Miracle AC, 2009, AM J NEURORADIOL, V30, P1088, DOI 10.3174/ajnr.A1653; Oldham M, 2005, RADIOTHER ONCOL, V75, P271, DOI 10.1016/j.radonc.2005.03.026; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Siewerdsen JH, 2006, MED PHYS, V33, P187, DOI 10.1118/1.2148916; Siewerdsen JH, 2001, MED PHYS, V28, P220, DOI 10.1118/1.1339879; Srinivasan K, 2014, POL J RADIOL, V79, P181, DOI 10.12659/PJR.890745; Steinke MF, 2008, AUSTRALAS PHYS ENG S, V31, P167, DOI 10.1007/BF03179341; van Zijtvetd M, 2007, RADIOTHER ONCOL, V85, P195, DOI 10.1016/j.radonc.2007.08.010; Wagenaar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127932; Yang Y, 2007, PHYS MED BIOL, V52, P685, DOI 10.1088/0031-9155/52/3/011; Yoo S, 2006, INT J RADIAT ONCOL, V66, P1553, DOI 10.1016/j.ijrobp.2006.08.031; Yu HY, 2007, ACAD RADIOL, V14, P495, DOI 10.1016/j.acra.2006.12.015	24	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157072	10.1371/journal.pone.0157072	http://dx.doi.org/10.1371/journal.pone.0157072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280593	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000076
J	Yang, ZW; Jiang, YH; Ma, C; Silvestri, G; Bosinger, SE; Li, BL; Jong, A; Zhou, YH; Huang, SH				Yang, Zhao-Wan; Jiang, Yan-Hua; Ma, Chuang; Silvestri, Guido; Bosinger, Steven E.; Li, Bai-Lian; Jong, Ambrose; Zhou, Yan-Hong; Huang, Sheng-He			Coexpression Network Analysis of Benign and Malignant Phenotypes of SIV-Infected Sooty Mangabey and Rhesus Macaque	PLOS ONE			English	Article							HIV-INFECTION; NEUROCOGNITIVE DISORDERS; IMMUNE ACTIVATION; NATURAL HOSTS; IN-VITRO; GENE; IMMUNODEFICIENCY; CELLS; EXPRESSION; APOPTOSIS	To explore the differences between the extreme SIV infection phenotypes, nonprogression (BEN: benign) to AIDS in sooty mangabeys (SMs) and progression to AIDS (MAL: malignant) in rhesus macaques (RMs), we performed an integrated dual positive-negative connectivity (DPNC) analysis of gene coexpression networks (GCN) based on publicly available big data sets in the GEO database of NCBI. The microarray-based gene expression data sets were generated, respectively, from the peripheral blood of SMs and RMs at several time points of SIV infection. Significant differences of GCN changes in DPNC values were observed in SIV-infected SMs and RMs. There are three groups of enriched genes or pathways (EGPs) that are associated with three SIV infection phenotypes (BEN+, MAL(+) and mixed BEN+/MAL(+)). The MAL(+) phenotype in SIV-infected RMs is specifically associated with eight EGPs, including the protein ubiquitin proteasome system, p53, granzyme A, gramzyme B, polo-like kinase, Glucocorticoid receptor, oxidative phosyphorylation and mitochondrial signaling. Mitochondrial (endosymbiotic) dysfunction is solely present in RMs. Specific BEN+ pattern changes in four EGPs are identified in SIV-infected SMs, including the pathways contributing to interferon signaling, BRCA1/DNA damage response, PKR/INF induction and LGALS8. There are three enriched pathways (PRR-activated IRF signaling, RIG1-like receptor and PRR pathway) contributing to the mixed (BEN+/MAL(+)) phenotypes of SIV infections in RMs and SMs, suggesting that these pathways play a dual role in the host defense against viral infections. Further analysis of Hub genes in these GCNs revealed that the genes LGALS8 and IL-17RA, which positively regulate the barrier function of the gut mucosa and the immune homeostasis with the gut microbiota (exosym-biosis), were significantly differentially expressed in RMs and SMs. Our data suggest that there exists an exo-(dysbiosis of the gut microbiota) and endo- (mitochondrial dysfunction) symbiotic imbalance (EESI) in HIV/SIV infections. Dissecting the mechanisms of the exo-endo symbiotic balance (EESB) that maintains immune homeostasis and the EESI problems in HIV/SIV infections may lead to a better understanding of the pathogenesis of AIDS and the development of novel interventions for the rational control of this disease.	[Yang, Zhao-Wan; Jiang, Yan-Hua; Zhou, Yan-Hong; Huang, Sheng-He] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China; [Ma, Chuang; Jong, Ambrose; Huang, Sheng-He] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA; [Silvestri, Guido; Bosinger, Steven E.] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Dept Pathol & Lab Med, Atlanta, GA USA; [Li, Bai-Lian] Univ Calif Riverside, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA	Huazhong University of Science & Technology; Children's Hospital Los Angeles; University of Southern California; Emory University; University of California System; University of California Riverside	Zhou, YH; Huang, SH (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China.; Huang, SH (corresponding author), Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA.	yhzhou@hust.edu.cn; shhuang@usc.edu			Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative; NIH [R37-AI66998/P30-AI-504, RR000165/OD011132]; National Natural Science Foundation of China [30971642]; Natural Science Foundation of Hubei Province of China [2009CDA161]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066998] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the Bill & Melinda Gates Foundation through the Grant Challenges Explorations Initiative (S.H.H.), NIH (R37-AI66998/P30-AI-504 to G.S., and RR000165/OD011132 to the Yerkes National Primate Research Center and the Emory Center for AIDS Research), National Natural Science Foundation of China (30971642)(Y.H.Z.) and Natural Science Foundation of Hubei Province of China (2009CDA161)(Y.H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Bakkebo M, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-57; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Bostik P, 2004, J VIROL, V78, P1464, DOI 10.1128/JVI.78.3.1464-1472.2004; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Buenz EJ, 2004, MITOCHONDRION, V4, P235, DOI 10.1016/j.mito.2004.05.017; Byrareddy SN, 2015, J IMMUNOL, V194, P5968, DOI 10.4049/jimmunol.1402866; Campello S, 2014, BBA-BIOENERGETICS, V1837, P451, DOI 10.1016/j.bbabio.2013.11.010; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116; Dimitrova DI, 2005, J INTERF CYTOK RES, V25, P345, DOI 10.1089/jir.2005.25.345; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Eckhardt I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.498; Elliott ST, 2015, J VIROL; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Fields JA, 2015, CURR HIV RES, V13, P43, DOI 10.2174/1570162X13666150311164201; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Fukata M, 2009, CURR OPIN PHARMACOL, V9, P680, DOI 10.1016/j.coph.2009.09.006; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Gustin MP, 2008, PHYSIOL GENOMICS, V34, P34, DOI 10.1152/physiolgenomics.00008.2008; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SH, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/856314; Huang Sheng-He, 2013, Anti-Infective Agents, V11, P93; Huang SH, 2010, BIOACTIVE FOODS IN PROMOTING HEALTH: PROBIOTICS AND PREBIOTICS, P267, DOI 10.1016/B978-0-12-374938-3.00018-9; Ingenuity Systems, QIAGENS ING PATHW AN; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Klase Z, 2015, MUCOSAL IMMUNOL, V8, P1009, DOI 10.1038/mi.2014.128; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Li HY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004551; Li XF, 2015, CLIN SCI, V129, P395, DOI 10.1042/CS20140511; Ma C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/926407; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mir KD, 2011, MICROBES INFECT, V13, P14, DOI 10.1016/j.micinf.2010.09.011; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Palmisano L, 2011, ANN I SUPER SANITA, V47, P44, DOI 10.4415/ANN_11_01_10; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Pereira LE, 2008, CELL IMMUNOL, V254, P10, DOI 10.1016/j.cellimm.2008.06.006; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rai P, 2013, AM J PHYSIOL-RENAL, V305, pF343, DOI 10.1152/ajprenal.00135.2013; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Rotger M, 2011, J CLIN INVEST, V121, P2391, DOI 10.1172/JCI45235; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Salgado M, 2011, CLIN IMMUNOL, V139, P110, DOI 10.1016/j.clim.2011.02.008; Sassano A, 2015, MOL CELL BIOL, V35, P2684, DOI 10.1128/MCB.00019-15; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shedlock DJ, 2008, APOPTOSIS, V13, P1088, DOI 10.1007/s10495-008-0239-0; Shityakov S, 2015, HIV AIDS-RES PALLIAT, V7, P265, DOI 10.2147/HIV.S88438; Silvestri G, 2005, J VIROL, V79, P4043, DOI 10.1128/JVI.79.7.4043-4054.2005; Silvestri G, 2009, J INTERN MED, V265, P97, DOI 10.1111/j.1365-2796.2008.02049.x; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Sivro A, 2013, AIDS RES HUM RETROV, V29, P1428, DOI [10.1089/aid.2013.0098, 10.1089/AID.2013.0098]; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Sun GH, 2011, TRENDS PHARMACOL SCI, V32, P675, DOI 10.1016/j.tips.2011.07.003; Teoh H, 2013, GENE THER, V20, P51, DOI 10.1038/gt.2011.214; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tomasicchio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062895; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Villinger F, 2010, EUR CYTOKINE NETW, V21, P215, DOI 10.1684/ecn.2010.0206; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Vyboh K, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/614127; Walley AJ, 2012, INT J OBESITY, V36, P137, DOI 10.1038/ijo.2011.22; Wang MQ, 2015, GENET MOL RES, V14, P13799, DOI 10.4238/2015.October.28.42	71	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156170	10.1371/journal.pone.0156170	http://dx.doi.org/10.1371/journal.pone.0156170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280726	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000018
J	Kirchgesner, J; Beaugerie, L; Carrat, F; Sokol, H; Cosnes, J; Schwarzinger, M				Kirchgesner, Julien; Beaugerie, Laurent; Carrat, Fabrice; Sokol, Harry; Cosnes, Jacques; Schwarzinger, Michael		BERENICE Study Grp	Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; POPULATION-BASED COHORT; TERM NET SURVIVAL; COLORECTAL NEOPLASIA; NATURAL-HISTORY; CO-TREATMENT; INFLIXIMAB; ADALIMUMAB; AZATHIOPRINE; IMMUNOMODULATORS	Objective Long-term treatment with thiopurines is associated with a decreased risk of Crohn's disease (CD) flare but an increased risk of various cancers depending on gender, age, and presence of extensive colitis. We evaluated risks and benefits of withdrawing thiopurines in patients with CD in prolonged remission. Methods We developed a Markov model assessing risks and benefits of withdrawing thiopurines compared to continuing thiopurines in a lifetime horizon. The model was stratified by age (35 and 65 years old at thiopurine withdrawal), gender and presence of extensive colitis. Parameter estimates were taken from French cohorts and hospital databases, cancer and death national registries and published literature. Life expectancy, rates of relapse, serious adverse events, and causes-of-death were evaluated. Results In patients without extensive colitis, continuing thiopurines increased life expectancy up to 0.03 years for 35 year-old men and women but decreased life expectancy down to 0.07 years for 65 year-old men and women. Withdrawal strategy became the preferred strategy at 40.6 years for men, and 45.7 years for women without extensive colitis. In patients with extensive colitis, continuation strategy was the preferred strategy regardless of age. Risk-benefit analysis was not modified by duration of CD activity. Conclusions Factors determining life expectancy associated with withdrawal or continuation of thiopurines in patients with CD and in sustained clinical remission vary substantially according to gender, age and presence of extensive colitis. Individual decisions to continue or withdraw thiopurines in patients with CD in sustained remission should take into account these parameters.	[Kirchgesner, Julien; Beaugerie, Laurent; Sokol, Harry; Cosnes, Jacques] Hop St Antoine, Dept Gastroenterol, AP HP, F-75571 Paris, France; [Kirchgesner, Julien; Carrat, Fabrice] INSERM, UMR S 1136, Paris, France; [Kirchgesner, Julien; Carrat, Fabrice] Univ Paris 06, Paris, France; [Beaugerie, Laurent] Univ Paris 06, INSERM, ERL 1057, UMRS 7203, Paris, France; [Beaugerie, Laurent] Univ Paris 06, GRC UPMC 03, Paris, France; [Carrat, Fabrice] Hop St Antoine, Dept Publ Hlth, AP HP, F-75571 Paris, France; [Schwarzinger, Michael] Translat Hlth Econ Network, Paris, France; [Schwarzinger, Michael] INSERM, UMR 1137, Infect, Antimicrobials,Modelizat,Evolut IAME, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Kirchgesner, J (corresponding author), Hop St Antoine, Dept Gastroenterol, AP HP, F-75571 Paris, France.; Kirchgesner, J (corresponding author), INSERM, UMR S 1136, Paris, France.; Kirchgesner, J (corresponding author), Univ Paris 06, Paris, France.	julien.kirchgesner@gmx.com	sokol, harry/ABA-8991-2020; Carrat, Fabrice/AAU-8480-2020; Kirchgesner, Julien/ABA-1398-2021; Sokol, Harry/E-2290-2019; Schwarzinger, Michael/F-7367-2011	sokol, harry/0000-0002-2914-1822; Carrat, Fabrice/0000-0002-8672-7918; Sokol, Harry/0000-0002-2914-1822; Schwarzinger, Michael/0000-0002-0573-6856; Kirchgesner, Julien/0000-0002-2314-9284	French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament (ANSM))	French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament (ANSM))	The BERENICE project is supported by grants from the French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament (ANSM)).	Ariyaratnam J, 2014, AM J GASTROENTEROL, V109, P163, DOI 10.1038/ajg.2013.451; ATIH. Agence technique de l'information sur l'hospitalisation, 2015, PROGR MED SYST INF P; Beaugerie L, 2013, GASTROENTEROLOGY, V145, P166, DOI 10.1053/j.gastro.2013.03.044; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Benchimol EI, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006792.pub2; Bewtra M, 2015, AM J GASTROENTEROL, V110, P1675, DOI 10.1038/ajg.2015.321; Binder-Foucard F., 2013, TUMEURS SOLIDES 1, V122; Bourrier A, 2016, ALIMENT PHARM THER, V43, P252, DOI 10.1111/apt.13466; Buisson A, 2012, ALIMENT PHARM THER, V35, P625, DOI 10.1111/j.1365-2036.2012.05002.x; Burmester GR, 2013, ANN RHEUM DIS, V72, P517, DOI 10.1136/annrheumdis-2011-201244; CepiDc INSERM, 2015, CTR EP CAUS MED DEC; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Eshuis EJ, 2013, INFLAMM BOWEL DIS, V19, P1622, DOI 10.1097/MIB.0b013e318281f4c4; Fidder H, 2009, GUT, V58, P501, DOI 10.1136/gut.2008.163642; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Gordillo J, 2015, J CROHNS COLITIS, V9, P1063, DOI 10.1093/ecco-jcc/jjv145; Gordon M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010233.pub2; Horne R, 2009, INFLAMM BOWEL DIS, V15, P837, DOI 10.1002/ibd.20846; Jess T, 2014, CLIN GASTROENTEROL H, V12, P1793, DOI 10.1016/j.cgh.2014.05.019; Jooste V, 2013, INT J CANCER, V132, P2370, DOI 10.1002/ijc.27857; Katz L, 2012, INFLAMM BOWEL DIS, V18, P2026, DOI 10.1002/ibd.22902; Kotlyar DS, 2015, CLIN GASTROENTEROL H, V13, P847, DOI 10.1016/j.cgh.2014.05.015; Lemann M, 2005, GASTROENTEROLOGY, V128, P1812, DOI 10.1053/j.gastro.2005.03.031; Lewis JD, 2008, AM J GASTROENTEROL, V103, P1428, DOI 10.1111/j.1572-0241.2008.01836.x; Lopez A, 2014, CLIN GASTROENTEROL H, V12, P1324, DOI 10.1016/j.cgh.2014.02.026; Monnereau A, 2013, ST MAURICE FRA I VEI, P88; Monnereau A, 2013, INT J CANCER, V132, P2378, DOI 10.1002/ijc.27889; Peters CP, 2014, J CROHNS COLITIS, V8, P866, DOI 10.1016/j.crohns.2014.01.012; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1693, DOI 10.1038/ajg.2012.298; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Rahier JF, 2009, J CROHNS COLITIS, V3, P47, DOI 10.1016/j.crohns.2009.02.010; Reenaers C, 2012, ALIMENT PHARM THER, V36, P1040, DOI 10.1111/apt.12076; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; Sandborn WJ, 2011, INFLAMM BOWEL DIS, V17, P141, DOI 10.1002/ibd.21328; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Savarino E, 2013, AM J GASTROENTEROL, V108, P1731, DOI 10.1038/ajg.2013.287; Singh S, 2014, CLIN GASTROENTEROL H, V12, P210, DOI 10.1016/j.cgh.2013.04.033; Sokol H, 2010, GUT, V59, P1363, DOI 10.1136/gut.2010.212712; Tang DH, 2013, INFLAMM BOWEL DIS, V19, P2673, DOI 10.1097/MIB.0b013e3182916046; Targownik LE, 2013, AM J GASTROENTEROL, V108, P1835, DOI 10.1038/ajg.2013.294; Torres J, 2015, GASTROENTEROLOGY, V149, P1, DOI 10.1053/j.gastro.2015.08.055; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Treton X, 2009, CLIN GASTROENTEROL H, V7, P80, DOI 10.1016/j.cgh.2008.08.028; Vilien M, 2004, ALIMENT PHARM THER, V19, P1147, DOI 10.1111/j.1365-2036.2004.01944.x; Wolters FL, 2006, GUT, V55, P510, DOI 10.1136/gut.2005.072793	46	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157191	10.1371/journal.pone.0157191	http://dx.doi.org/10.1371/journal.pone.0157191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271176	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200034
J	Ahmed, T; Vafaei, A; Auais, M; Guralnik, J; Zunzunegui, MV				Ahmed, Tamer; Vafaei, Afshin; Auais, Mohammad; Guralnik, Jack; Zunzunegui, Maria Victoria			Gender Roles and Physical Function in Older Adults: Cross-Sectional Analysis of the International Mobility in Aging Study (IMIAS)	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; ACUTE CORONARY SYNDROME; PSYCHOLOGICAL ANDROGYNY; SUBSEQUENT DISABILITY; PERFORMANCE-MEASURES; GENERAL-POPULATION; ROLE ATTITUDES; AGE; HEALTH; LIFE	Objectives To examine the relationships between physical function and gender-stereotyped traits and whether these relationships are modified by sex or social context. Methods A total of 1995 community-dwelling older adults from the International Mobility in Aging Study (IMIAS) aged 65 to 74 years were recruited in Natal (Brazil), Manizales (Colombia), Tirana (Albania), Kingston (Ontario, Canada), and Saint-Hyacinthe (Quebec, Canada). We performed a cross-sectional analysis. Study outcomes were mobility disability, defined as having difficulty in walking 400 meters without assistance or climbing a flight of stairs without resting, and low physical performance, defined as a score < 8 on the Short Physical Performance Battery. The 12-item Bem Sex Role Inventory (BSRI) was used to classify participants into four gender roles (Masculine, Feminine, Androgynous, and Undifferentiated) using site-specific medians of femininity and masculinity as cut-off points. Poisson regression models were used to estimate prevalence rate ratios (PRR) of mobility disability and poor physical performance according to gender roles. Results In models adjusted for sex, marital status, education, income, and research site, when comparing to the androgynous role, we found higher prevalence of mobility disability and poor physical performance among participants endorsing the feminine role (PRR = 1.20, 95% confidence interval (CI) 1.03-1.39 and PRR = 1.37, CI 1.01-1.88, respectively) or the undifferentiated role (PRR = 1.23, 95% CI 1.07-1.42 and PRR = 1.58, CI 1.18-2.12, respectively). Participants classified as masculine did not differ from androgynous participants in prevalence rates of mobility disability or low physical performance. None of the multiplicative interactions by sex and research site were significant. Conclusion Feminine and undifferentiated gender roles are independent risk factors for mobility disability and low physical performance in older adults. Longitudinal research is needed to assess the mediation pathways through which gender-stereotyped traits influence functional limitations and to investigate the longitudinal nature of these relationships.	[Ahmed, Tamer; Zunzunegui, Maria Victoria] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Vafaei, Afshin; Auais, Mohammad] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Guralnik, Jack] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Gerontol, Baltimore, MD 21201 USA	Universite de Montreal; Queens University - Canada; University System of Maryland; University of Maryland Baltimore	Ahmed, T (corresponding author), Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada.	tis.ahmed@umontreal.ca		Ahmed, Tamer/0000-0002-5708-0270; Zunzunegui, Maria-Victoria/0000-0003-0827-2804	Canadian Institutes of Health [AAM 108751]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by The Canadian Institutes of Health, grant number AAM 108751. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahacic K, 2000, AGING-CLIN EXP RES, V12, P190, DOI 10.1007/BF03339836; Ahmed T, 2016, CANADIAN J IN PRESS; Alabas OA, 2012, EUR J PAIN, V16, P1211, DOI 10.1002/j.1532-2149.2012.00121.x; Alvarado BE, 2007, J AGING HEALTH, V19, P1004, DOI 10.1177/0898264307308618; Bannerman E, 2002, PUBLIC HEALTH NUTR, V5, P655, DOI 10.1079/PHN2002336; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beland F, 1999, AGE AGEING, V28, P153, DOI 10.1093/ageing/28.2.153; Bem S. L., 1981, J PERS SOC PSYCHOL; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; BEM SL, 1977, J CONSULT CLIN PSYCH, V45, P196, DOI 10.1037//0022-006X.45.2.196; Bentley JP, 2013, QUAL LIFE RES, V22, P1621, DOI 10.1007/s11136-012-0315-3; Bolzendahl CI, 2004, SOC FORCES, V83, P759, DOI 10.1353/sof.2005.0005; Campbell C., 2005, J PAIN, V6, pS60; Carver LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076356; Chant Sylvia H., 2003, GENDER LATIN AM; CIHR, 2010, GEND SEX HLTH RES GU; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Crompton R, 2005, BRIT J SOCIOL, V56, P601, DOI 10.1111/j.1468-4446.2005.00085.x; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Doulougou B, 2016, J HUM HYPERTENS, V30, P112, DOI 10.1038/jhh.2015.30; Gomez JF, 2013, COLOMB MEDICA, V44, P165; Forlani C, 2014, AM J GERIAT PSYCHIAT, V22, P370, DOI 10.1016/j.jagp.2012.08.015; Freire AN, 2012, J AGING HEALTH, V24, P863, DOI 10.1177/0898264312438551; Gale-Ross R, 2009, CAN J AGING, V28, P135, DOI 10.1017/S0714980809090187; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gomez F, 2009, J AM GERIATR SOC, V57, P1692, DOI 10.1111/j.1532-5415.2009.02341.x; Guallar-Castillon P, 2007, OBESITY, V15, P233, DOI 10.1038/oby.2007.532; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Health Canada, 2000, HLTH CAN GEND BAS AN; Helliwell B, 2001, INT PSYCHOGERIATR, V13, P49, DOI 10.1017/S1041610202007986; Ho SC, 1997, J GERONTOL A-BIOL, V52, pM356, DOI 10.1093/gerona/52A.6.M356; Hunt K, 2007, INT J EPIDEMIOL, V36, P612, DOI 10.1093/ije/dym022; Hunt K, 2006, SOC PSYCH PSYCH EPID, V41, P641, DOI 10.1007/s00127-006-0074-y; IBGE FIBDGEE, 1987, SER EST RETR; Juster RP, 2012, GENDER MED, V9, P511, DOI 10.1016/j.genm.2012.10.008; Kada Olivia, 2010, REV PSYCHOL, V17, P97; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; LACKEY PN, 1989, SEX ROLES, V20, P271, DOI 10.1007/BF00287724; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Leveille SG, 2000, AGING-CLIN EXP RES, V12, P106, DOI 10.1007/BF03339897; Leveille SG, 2002, J GEN INTERN MED, V17, P766, DOI 10.1046/j.1525-1497.2002.20229.x; Marks JL, 2009, SEX ROLES, V61, P221, DOI 10.1007/s11199-009-9619-3; Mateo M., 1991, INVESTIGACIONES PSIC, V9, P95; Mechakra-Tahiri SD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-598; Melzer D, 2004, J GERONTOL A-BIOL, V59, P1295, DOI 10.1093/gerona/59.12.1295; Merrill SS, 1997, J GERONTOL A-BIOL, V52, pM19, DOI 10.1093/gerona/52A.1.M19; Miluka J, 2009, ED MIGRATION LABOR M; Miszkurka M, 2012, GLOB PUBLIC HEALTH, V7, P495, DOI 10.1080/17441692.2011.630676; Mori M, 2002, Arch Womens Ment Health, V5, P161, DOI 10.1007/s00737-002-0148-0; NAGI SZAN, 1976, THE MILBANK MEMORIAL, V54, P439; Newman AB, 2001, EPIDEMIOL REV, V23, P343, DOI 10.1093/oxfordjournals.epirev.a000810; Onadja Y, 2013, ARCH GERONTOL GERIAT, V57, P311, DOI 10.1016/j.archger.2013.06.007; Pelletier R, 2016, J AM COLL CARDIOL, V67, P127, DOI 10.1016/j.jacc.2015.10.067; Pelletier R, 2015, PSYCHOSOM MED, V77, P517, DOI 10.1097/PSY.0000000000000186; Pirkle CM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-293; Price EC, 2018, AM J MENS HEALTH, V12, P19, DOI 10.1177/1557988315619676; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Sarnhult V., 2014, GENDER POWER IMAGES; Schwartz S, 1999, AM J PUBLIC HEALTH, V89, P1175, DOI 10.2105/AJPH.89.8.1175; Seidel D, 2011, AGE AGEING, V40, P463, DOI 10.1093/ageing/afr054; Shimonaka Y, 1996, INT J AGING HUM DEV, V42, P173, DOI 10.2190/UMWD-64W7-3M2K-2MKJ; Shumway-Cook A, 2005, J AM GERIATR SOC, V53, P1217, DOI 10.1111/j.1532-5415.2005.53372.x; Silova I, 2004, COMP EDUC REV, V48, P417, DOI 10.1086/423358; Sinnott JD, 1986, SEX ROLES AGING THEO; Siren A, 2009, TOP GERIATR REHABIL, V25, P3; Stecklov G, 2010, DEMOGRAPHY, V47, P935, DOI 10.1007/BF03213734; Tilvis RS, 1997, ARCH GERONTOL GERIAT, V25, P311, DOI 10.1016/S0167-4943(97)00024-1; Urwin M, 1998, ANN RHEUM DIS, V57, P649, DOI 10.1136/ard.57.11.649; Vafaei A, 2014, ARCH GERONTOLOGY GER; Vafaei A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146867; Webber SC, 2010, GERONTOLOGIST, V50, P443, DOI 10.1093/geront/gnq013; Wilkie R, 2007, ARTHRIT RHEUM-ARTHR, V57, P1381, DOI 10.1002/art.23083; Wong R, 2006, J AGING HEALTH, V18, P157, DOI 10.1177/0898264305285655; Zunzunegui MV, 2015, ARCH GERONTOL GERIAT, V61, P140, DOI 10.1016/j.archger.2015.06.005	78	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156828	10.1371/journal.pone.0156828	http://dx.doi.org/10.1371/journal.pone.0156828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258050	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700140
J	Canioni, D; Michot, JM; Rabiega, P; Molina, TJ; Charlotte, F; Lazure, T; Davi, F; Settegrana, C; Berger, F; Alric, L; Cacoub, P; Terrier, B; Suarez, F; Sibon, D; Dupuis, J; Feray, C; Tilly, H; Pol, S; Fischer, BD; Roulland, S; Thieblemont, C; Leblond, V; Carrat, F; Hermine, O; Besson, C				Canioni, Danielle; Michot, Jean-Marie; Rabiega, Pascaline; Molina, Thierry J.; Charlotte, Frederic; Lazure, Thierry; Davi, Frederic; Settegrana, Catherine; Berger, Francoise; Alric, Laurent; Cacoub, Patrice; Terrier, Benjamin; Suarez, Felipe; Sibon, David; Dupuis, Jehan; Feray, Cyrille; Tilly, Herve; Pol, Stanislas; Fischer, Benedicte Deau; Roulland, Sandrine; Thieblemont, Catherine; Leblond, Veronique; Carrat, Fabrice; Hermine, Olivier; Besson, Caroline		Natl ANRS HC13 LymphoC Study	In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas	PLOS ONE			English	Article							VIRUS-INFECTION; MONOCYTES	Hepatitis C Virus (HCV) infection is associated with the B-cell non-Hodgkin lymphomas (NHL), preferentially marginal zone lymphomas (MZL) and diffuse large B-cell lymphomas (DLBCL). While chronic antigenic stimulation is a main determinant of lymphomagenesis in marginal zone lymphomas (MZL), a putative role of HCV infection of B-cells is supported by in vitro studies. We performed a pathological study within the "ANRS HC-13 LymphoC" observational study focusing on in situ expression of the oncogenic HCV non structural 3 (NS3) protein. Lympho-C study enrolled 116 HCV-positive patients with B-NHL of which 86 histological samples were collected for centralized review. Main histological subtypes were DLBCL (36%) and MZL (34%). Almost half of DLBCL (12/26) were transformed from underlying small B-cell lymphomas. NS3 immunostaining was found positive in 17 of 37 tested samples (46%). There was a striking association between NS3 detection and presence of high grade lymphoma features: 12 out of 14 DLBCL were NS3+ compared to only 4 out of 14 MZL (p = 0.006). Moreover, 2 among the 4 NS3+ MZL were enriched in large cells. Remarkably, this study supports a new mechanism of transformation with a direct oncogenic role of HCV proteins in the occurrence of high-grade B lymphomas.	[Canioni, Danielle; Molina, Thierry J.] Paris Descartes Univ, Hop Necker, AP HP, Dept Pathol,Sorbonne Paris Cite, Paris, France; [Michot, Jean-Marie] Inst Gustave Roussy, Dept Hematol & Drug Dev, F-94805 Villejuif, France; [Rabiega, Pascaline; Carrat, Fabrice] Univ Paris 06, INSERM, UMR S1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Charlotte, Frederic] Univ Paris 06, Hop Pitie Salpetriere, Dept Pathol, Paris, France; [Lazure, Thierry] Univ Paris 11, Dept Pathol, Hop Bicetre, AP HP, Le Kremlin Bicetre, France; [Davi, Frederic; Settegrana, Catherine] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Dept Biol Hematol, Paris, France; [Berger, Francoise] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Hop Lyon Sud, Dept Pathol, Lyon, France; [Alric, Laurent] Univ Toulouse 3, Dept Internal Med & Digest Dis, UMR 152, IRD,Hop Purpan, F-31062 Toulouse, France; [Cacoub, Patrice; Terrier, Benjamin] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Dept Internal Med,INSERM,UMR S 959,CNRS,UMR 7211, Paris, France; [Suarez, Felipe; Sibon, David; Hermine, Olivier] Univ Paris 05, Hop Necker, AP HP, Dept Adult Hematol, Paris, France; [Suarez, Felipe; Sibon, David; Hermine, Olivier] Univ Sorbonne Paris Cite, Imagine Inst, INSERM, U1163,CNRS,ERL 8254, Paris, France; [Dupuis, Jehan] Paris 12 Est Creteil Univ, Dept Lymphoid Malignancies & Clin Hematol, Hop Henri Mondor, AP HP, Creteil, France; [Feray, Cyrille] Univ Nantes, Hop Nantes, Dept Hepatol, Nantes, France; [Tilly, Herve] Univ Rouen, Ctr Henri Becquerel, Dept Hematol, Rouen, France; [Pol, Stanislas] Univ Paris 05, Hop Cochin, AP HP, Dept Hepatol,INSERM,U1016, Paris, France; [Fischer, Benedicte Deau] Paris Descartes Univ, Hop Cochin, AP HP, Dept Hematol, Paris, France; [Roulland, Sandrine] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, U1104,CNRS,UMR7280, Marseille, France; [Thieblemont, Catherine] Univ Paris 07, Hop St Louis, AP HP, Dept Hematooncol,INSERM,U728, Paris, France; [Leblond, Veronique] Univ Paris 06, Dept Clin Hematol, Paris, France; [Besson, Caroline] Univ Paris 11, Dept Internal Med & Clin Immunol Biol Immunol & H, Hop Bicetre, AP HP,INSERM,U1184, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU de Toulouse; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Nantes Universite; CHU de Nantes; UNICANCER; Centre Henri Becquerel; Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Canioni, D (corresponding author), Paris Descartes Univ, Hop Necker, AP HP, Dept Pathol,Sorbonne Paris Cite, Paris, France.; Hermine, O (corresponding author), Univ Paris 05, Hop Necker, AP HP, Dept Adult Hematol, Paris, France.; Hermine, O (corresponding author), Univ Sorbonne Paris Cite, Imagine Inst, INSERM, U1163,CNRS,ERL 8254, Paris, France.; Besson, C (corresponding author), Univ Paris 11, Dept Internal Med & Clin Immunol Biol Immunol & H, Hop Bicetre, AP HP,INSERM,U1184, Le Kremlin Bicetre, France.	danielle.canioni@aphp.fr; ohermine@gmail.com; caroline.besson@bct.aphp.fr	Besson, Caroline/H-4648-2018; Hermine, Olivier/Q-7072-2018; Michot, Jean-Marie/AAC-3028-2022; Molina, Thierry/ABA-5214-2020; Sibon, David/AAX-5243-2020; roulland, sandrine/H-9843-2014; Thieblemont, Catherine/AAZ-8423-2020; Carrat, Fabrice/AAU-8480-2020; Feray, Cyrille/S-2559-2018	Besson, Caroline/0000-0003-4364-7173; Michot, Jean-Marie/0000-0003-3482-3331; Molina, Thierry/0000-0002-3929-9754; Sibon, David/0000-0002-9205-625X; roulland, sandrine/0000-0003-2187-1959; Thieblemont, Catherine/0000-0002-9941-2448; Carrat, Fabrice/0000-0002-8672-7918; Hermine, Olivier/0000-0003-2574-3874; Cacoub, Patrice/0000-0002-6727-4992; Charlotte, Frederic/0000-0003-2803-6606; DEAU FISCHER, Benedicte/0000-0002-7468-5466	Inserm-ANRS (Institut national de la sante et de la recherche medicale - France Recherche Nord&Sud SIDA-HIV Hepatites) Paris, France	Inserm-ANRS (Institut national de la sante et de la recherche medicale - France Recherche Nord&Sud SIDA-HIV Hepatites) Paris, France	This research has been funded by Inserm-ANRS (Institut national de la sante et de la recherche medicale - France Recherche Nord&Sud SIDA-HIV Hepatites) 101, rue de Tolbiac, 75013 Paris, France. Grant LymphoC-HC13. http://www.anrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaini L, 2004, CANCER, V100, P107, DOI 10.1002/cncr.11893; Dai B, 2016, ONCOGENE, V35, P2979, DOI 10.1038/onc.2015.364; Ducoulombier D, 2004, HEPATOLOGY, V39, P817, DOI 10.1002/hep.20087; Engels EA, 2004, INT J CANCER, V111, P76, DOI 10.1002/ijc.20021; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; Michot JM, 2015, AM J HEMATOL, V90, P197, DOI 10.1002/ajh.23889; Nieters A, 2006, GASTROENTEROLOGY, V131, P1879, DOI 10.1053/j.gastro.2006.09.019; Peveling-Oberhag J, 2013, J HEPATOL, V59, P169, DOI 10.1016/j.jhep.2013.03.018; Swerdlow SH, 2008, WHO CLASSIFICATION T; Takeshita M, 2006, HISTOPATHOLOGY, V48, P189, DOI 10.1111/j.1365-2559.2005.02311.x; Takeshita M, 2005, HUM PATHOL, V36, P878, DOI 10.1016/j.humpath.2005.06.005; Tsutsumi Yutaka, 2011, Adv Hematol, V2011, P717951, DOI 10.1155/2011/717951	14	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156384	10.1371/journal.pone.0156384	http://dx.doi.org/10.1371/journal.pone.0156384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257992	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700058
J	Manzanera, OM; Elting, JW; van der Hoeven, JH; Maurits, NM				Manzanera, Octavio Martinez; Elting, Jan Willem; van der Hoeven, Johannes H.; Maurits, Natasha M.			Tremor Detection Using Parametric and Non-Parametric Spectral Estimation Methods: A Comparison with Clinical Assessment	PLOS ONE			English	Article							PSYCHOGENIC TREMOR; PARKINSONS-DISEASE; QUANTIFICATION	In the clinic, tremor is diagnosed during a time-limited process in which patients are observed and the characteristics of tremor are visually assessed. For some tremor disorders, a more detailed analysis of these characteristics is needed. Accelerometry and electromyography can be used to obtain a better insight into tremor. Typically, routine clinical assessment of accelerometry and electromyography data involves visual inspection by clinicians and occasionally computational analysis to obtain objective characteristics of tremor. However, for some tremor disorders these characteristics may be different during daily activity. This variability in presentation between the clinic and daily life makes a differential diagnosis more difficult. A long-term recording of tremor by accelerometry and/or electromyography in the home environment could help to give a better insight into the tremor disorder. However, an evaluation of such recordings using routine clinical standards would take too much time. We evaluated a range of techniques that automatically detect tremor segments in accelerometer data, as accelerometer data is more easily obtained in the home environment than electromyography data. Time can be saved if clinicians only have to evaluate the tremor characteristics of segments that have been automatically detected in longer daily activity recordings. We tested four non-parametric methods and five parametric methods on clinical accelerometer data from 14 patients with different tremor disorders. The consensus between two clinicians regarding the presence or absence of tremor on 3943 segments of accelerometer data was employed as reference. The nine methods were tested against this reference to identify their optimal parameters. Non-parametric methods generally performed better than parametric methods on our dataset when optimal parameters were used. However, one parametric method, employing the high frequency content of the tremor bandwidth under consideration (High Freq) performed similarly to nonparametric methods, but had the highest recall values, suggesting that this method could be employed for automatic tremor detection.	[Manzanera, Octavio Martinez; Elting, Jan Willem; van der Hoeven, Johannes H.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen	Manzanera, OM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	o.e.martinez.manzanera@umcg.nl		Maurits, Natasha/0000-0001-6231-7044	Mexican National Council for Science and Technology (CONACYT)	Mexican National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by the Mexican National Council for Science and Technology (CONACYT).	Akaike H, 1974, AUTOM CONTROL IEEE T; Burg JP, 1968, MOD SPECTR ANAL; Collomb C, 2010, BURGS METHOD ALGORIT, P1; Davis J., 2006, P 23 INT C MACH LEAR, V23, P233, DOI DOI 10.1145/1143844.1143874; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Houston B, 2015, IEEE ENG MED BIO, P3427, DOI 10.1109/EMBC.2015.7319129; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Jankovic J, 2006, CNS SPECTRUMS, V11, P501, DOI 10.1017/S1092852900013535; Mansur Paulo Henrique G., 2007, Critical Reviews in Biomedical Engineering, V35, P343, DOI 10.1615/CritRevBiomedEng.v35.i5.10; Maurits N, 2012, NEUROLOGY METHODOLOG, V37, P37; O'Suilleabhain PE, 1998, BRAIN, V121, P2127, DOI 10.1093/brain/121.11.2127; Orfanidis S., 2007, OPTIMUM SIGNAL PROCE; Parees I, 2012, BRAIN, V135, P117, DOI 10.1093/brain/awr292; Pedrosa DJ, 2012, EXP NEUROL, V237, P435, DOI 10.1016/j.expneurol.2012.07.002; Peleg N, 2009, LINEAR PREDICTIVE CO, P1; Roper Louise S, 2013, Pract Neurol, V13, P396, DOI 10.1136/practneurol-2013-000549; Salarian A, 2007, IEEE T BIO-MED ENG, V54, P313, DOI 10.1109/TBME.2006.886670; Spyers-Ashby JM, 1998, J NEUROSCI METH, V83, P35, DOI 10.1016/S0165-0270(98)00064-8; Takalo Reijo, 2005, J Clin Monit Comput, V19, P401, DOI 10.1007/s10877-005-7089-x; Vaseghi S, 2007, MULTIMEDIA SIGNAL PR; Welch P, 1967, AUDIO ELECTROACOUST; Zhao MJ, 2013, J MACH LEARN RES, V14, P1033	22	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156822	10.1371/journal.pone.0156822	http://dx.doi.org/10.1371/journal.pone.0156822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258018	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700139
J	Banerjee, M; Okun, MS; Vaillancourt, DE; Vemuri, BC				Banerjee, Monami; Okun, Michael S.; Vaillancourt, David E.; Vemuri, Baba C.			A Method for Automated Classification of Parkinson's Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI	PLOS ONE			English	Article							ATLAS CONSTRUCTION; SUBSTANTIA-NIGRA; FREE-WATER; TENSOR; RESOLUTION; REGISTRATION	Parkinson's disease (PD) is a common and debilitating neurodegenerative disorder that affects patients in all countries and of all nationalities. Magnetic resonance imaging (MRI) is currently one of the most widely used diagnostic imaging techniques utilized for detection of neurologic diseases. Changes in structural biomarkers will likely play an important future role in assessing progression of many neurological diseases inclusive of PD. In this paper, we derived structural biomarkers from diffusion MRI (dMRI), a structural modality that allows for non-invasive inference of neuronal fiber connectivity patterns. The structural biomarker we use is the ensemble average propagator (EAP), a probability density function fully characterizing the diffusion locally at a voxel level. To assess changes with respect to a normal anatomy, we construct an unbiased template brain map from the EAP fields of a control population. Use of an EAP captures both orientation and shape information of the diffusion process at each voxel in the dMRI data, and this feature can be a powerful representation to achieve enhanced PD brain mapping. This template brain map construction method is applicable to small animal models as well as to human brains. The differences between the control template brain map and novel patient data can then be assessed via a nonrigid warping algorithm that transforms the novel data into correspondence with the template brain map, thereby capturing the amount of elastic deformation needed to achieve this correspondence. We present the use of a manifold-valued feature called the Cauchy deformation tensor (CDT), which facilitates morphometric analysis and automated classification of a PD versus a control population. Finally, we present preliminary results of automated discrimination between a group of 22 controls and 46 PD patients using CDT. This method may be possibly applied to larger population sizes and other parkinsonian syndromes in the near future.	[Banerjee, Monami; Vemuri, Baba C.] Univ Florida, Dept CISE, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Okun, Michael S.; Vaillancourt, David E.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Vaillancourt, David E.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vemuri, BC (corresponding author), Univ Florida, Dept CISE, Gainesville, FL USA.	vermuri@cise.ufl.edu			NIH [R01 NS066340, R01 NS075012, R01 NS052318]; NSF [IIS-1525431]; Bachmann-Strauss and Tyler's Hope Foundation; Div Of Information & Intelligent Systems [1525431] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052318, R01NS066340, R01NS075012] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Bachmann-Strauss and Tyler's Hope Foundation; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was in part supported by NIH grants R01 NS066340, NSF grant IIS-1525431 to BCV, and NIH grants R01 NS075012, R01 NS052318 to DEV. Additionally, DEV reports grants from Bachmann-Strauss and Tyler's Hope Foundation during the conduct of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was in part supported by the NIH grants R01 NS066340, and the NSF grant IIS-1525431 to Vemuri and the NIH grants R01 NS075012, R01 NS052318 to Vaillancourt.	Axelrad JE, 2008, ARCH NEUROL-CHICAGO, V65, P101, DOI 10.1001/archneurol.2007.8; Barmpoutis A, 2007, LECT NOTES COMPUT SC, V4791, P908; Barmpoutis A, 2009, LECT NOTES COMPUT SC, V5761, P640, DOI 10.1007/978-3-642-04268-3_79; Barmpoutis A, 2009, NEUROIMAGE, V45, pS153, DOI 10.1016/j.neuroimage.2008.10.056; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bouix S., 2010, MICCAI WORKSH COMP D, P84; Callaghan, 1993, PRINCIPLES NUCL MAGN; Cao Yan, 2006, Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit, V2006, P67; Cheng G, 2011, I S BIOMED IMAGING, P549, DOI [10.1109/KAM.2011.147, 10.1109/ISBI.2011.5872466]; Cheng G, 2009, LECT NOTES COMPUT SC, V5761, P190, DOI 10.1007/978-3-642-04268-3_24; Chiang MC, 2008, IEEE T MED IMAGING, V27, P442, DOI 10.1109/TMI.2007.907326; Descoteaux M, 2006, I S BIOMED IMAGING, P81; Descoteaux M, 2011, MED IMAGE ANAL, V15, P603, DOI 10.1016/j.media.2010.07.001; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Du GW, 2012, MOVEMENT DISORD, V27, P1636, DOI 10.1002/mds.25182; Du J, 2012, IEEE T MED IMAGING, V31, P1021, DOI 10.1109/TMI.2011.2178253; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Geng XJ, 2009, LECT NOTES COMPUT SC, V5636, P626, DOI 10.1007/978-3-642-02498-6_52; Gerber S, 2009, LECT NOTES COMPUT SC, V5761, P305, DOI 10.1007/978-3-642-04268-3_38; Ghosh SS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00004; Hosseinbor AP, 2011, LECT NOTES COMPUT SC, V6892, P217, DOI 10.1007/978-3-642-23629-7_27; Jia Du, 2013, Geometric Science of Information. First International Conference, GSI 2013. Proceedings. LNCS 8085, P149, DOI 10.1007/978-3-642-40020-9_15; Jian B, 2007, IEEE T MED IMAGING, V26, P1464, DOI 10.1109/TMI.2007.907552; Jian B, 2007, NEUROIMAGE, V37, P164, DOI 10.1016/j.neuroimage.2007.03.074; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Liu ZX, 2009, I S BIOMED IMAGING, P807, DOI 10.1109/ISBI.2009.5193172; Ma J, 2008, NEUROIMAGE, V42, P252, DOI 10.1016/j.neuroimage.2008.03.056; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Ofori E, 2015, BRAIN, V138, P2322, DOI 10.1093/brain/awv136; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Ozarslan E, 2006, NEUROIMAGE, V31, P1086, DOI 10.1016/j.neuroimage.2006.01.024; Park H, 2005, LECT NOTES COMPUT SC, V3750, P419, DOI 10.1007/11566489_52; Pennec X, 2006, J MATH IMAGING VIS, V25, P127, DOI 10.1007/s10851-006-6228-4; Planetta PJ, 2016, BRAIN, V139, P495, DOI 10.1093/brain/awv361; Prodoehl J, 2013, MOVEMENT DISORD, V28, P1816, DOI 10.1002/mds.25491; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tan LCS, 2004, NEUROLOGY, V62, P1999, DOI 10.1212/01.WNL.0000128090.79756.10; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Xie YC, 2010, LECT NOTES COMPUT SC, V6361, P682; Xie YC, 2010, PROC CVPR IEEE, P2933, DOI 10.1109/CVPR.2010.5540035; Yang JZ, 2008, LECT NOTES COMPUT SC, V5242, P905, DOI 10.1007/978-3-540-85990-1_109; Yanovsky I, 2007, IEEE C COMP VIS PATT, P1; Yeo BTT, 2009, IEEE T MED IMAGING, V28, P1914, DOI 10.1109/TMI.2009.2025654; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang P, 2014, MED IMAGE ANAL, V18, P1290, DOI 10.1016/j.media.2014.06.012	49	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155764	10.1371/journal.pone.0155764	http://dx.doi.org/10.1371/journal.pone.0155764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280486	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000006
J	Campanelli, R; Fois, G; Catarsi, P; Poletto, V; Villani, L; Erba, BG; Maddaluno, L; Jemos, B; Salmoiraghi, S; Guglielmelli, P; Abbonante, V; Di Buduo, CA; Balduini, A; Iurlo, A; Barosi, G; Rosti, V; Massa, M				Campanelli, Rita; Fois, Gabriela; Catarsi, Paolo; Poletto, Valentina; Villani, Laura; Erba, Benedetta Gaia; Maddaluno, Luigi; Jemos, Basilio; Salmoiraghi, Silvia; Guglielmelli, Paola; Abbonante, Vittorio; Di Buduo, Christian Andrea; Balduini, Alessandra; Iurlo, Alessandra; Barosi, Giovanni; Rosti, Vittorio; Massa, Margherita		AGIMM Investigators	Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis	PLOS ONE			English	Article							MYELOID METAPLASIA; TIE2-EXPRESSING MONOCYTES; CD14(++)CD16(+) MONOCYTES; CIRCULATING CD34(+); PERIPHERAL-BLOOD; GROWTH-FACTOR; ANGIOGENESIS; CANCER; CELLS; MACROPHAGES	Primary myelofibrosis (PMF) is a Philadelphia-negative (Ph-) myeloproliferative disorder, showing abnormal CD34(+) progenitor cell trafficking, splenomegaly, marrow fibrosis leading to extensive extramedullary haematopoiesis, and abnormal neoangiogenesis in either the bone marrow or the spleen. Monocytes expressing the angiopoietin-2 receptor (Tie2) have been shown to support abnormal angiogenic processes in solid tumors through a paracrine action that takes place in proximity to the vessels. In this study we investigated the frequency of Tie2 expressing monocytes in the spleen tissue samples of patients with PMF, and healthy subjects (CTRLs), and evaluated their possible role in favouring spleen angiogenesis. We show by confocal microscopy that in the spleen tissue of patients with PMF, but not of CTRLs, the most of the CD14(+) cells are Tie2(+) and are close to vessels; by flow cytometry, we found that Tie2 expressing monocytes were Tie2(+)CD14(low)CD16(bright)CDL62(-)CCR2(-) (TEMs) and their frequency was higher (p = 0.008) in spleen tissue-derived mononuclear cells (MNCs) of patients with PMF than in spleen tissue-derived MNCs from CTRLs undergoing splenectomy for abdominal trauma. By in vitro angiogenesis assay we evidenced that conditioned medium of immunomagnetically selected spleen tissue derived CD14(+) cells of patients with PMF induced a denser tube like net than that of CTRLs; in addition, CD14(+)Tie2(+) cells sorted from spleen tissue derived single cell suspension of patients with PMF show a higher expression of genes involved in angiogenesis than that found in CTRLs. Our results document the enrichment of Tie2(+) monocytes expressing angiogenic genes in the spleen of patients with PMF, suggesting a role for these cells in starting/maintaining the pathological angiogenesis in this organ.	[Campanelli, Rita; Fois, Gabriela; Catarsi, Paolo; Poletto, Valentina; Villani, Laura; Barosi, Giovanni; Rosti, Vittorio] IRCCS Policlin S Matteo Fdn, Biotechnol Res Area, Ctr Study Myelofibrosis, Pavia, Italy; [Erba, Benedetta Gaia; Maddaluno, Luigi] FIRC Inst Mol Oncol, Vasc Biol Grp, IFOM, Milan, Italy; [Jemos, Basilio] IRCCS Policlin San Matteo Fdn, Unit Hepatopancreat Surg, Pavia, Italy; [Salmoiraghi, Silvia] Azienda Osped Papa Giovanni XXIII, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy; [Guglielmelli, Paola] Univ Florence, AOU Careggi, Ctr Res & Innovat Myeloproliferat Neoplasms CRIMM, Florence, Italy; [Guglielmelli, Paola] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Abbonante, Vittorio; Di Buduo, Christian Andrea; Balduini, Alessandra; Massa, Margherita] IRCCS Policlin S Matteo Fdn, Biotechnol Res Area, Pavia, Italy; [Abbonante, Vittorio; Di Buduo, Christian Andrea; Balduini, Alessandra] Univ Pavia, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy; [Iurlo, Alessandra] Univ Milan, Oncohematol Div, IRCCS Ca Granda Maggiore Policlin Hosp Fdn, Milan, Italy	IRCCS Fondazione San Matteo; IFOM - FIRC Institute of Molecular Oncology; IRCCS Fondazione San Matteo; ASST Papa Giovanni XXIII; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Massa, M (corresponding author), IRCCS Policlin S Matteo Fdn, Biotechnol Res Area, Pavia, Italy.	m.massa@smatteo.pv.it	Guglielmelli, Paola/K-7509-2016; Villani, Laura/K-1794-2018; Catarsi, Paolo/J-4463-2016; Barosi, Giovanni/AAI-1714-2019; Di Buduo, Christian A/G-4771-2018; Balduini, Alessandra/K-6802-2016; Malcovati, Luca/CAJ-1695-2022; Abbonante, Vittorio/K-4028-2016; Fois, Gabrila/K-4718-2016; Abbonante, Vittorio/AAA-9303-2020; BALDUINI, ALESSANDRA/AAC-3363-2022; Massa, Margherita/K-4682-2016; Rosti, Vittorio/K-1743-2018; Campanelli, Rita/K-4686-2016; Tagliafico, Enrico/C-9079-2009; Catricala, Silvia/AAV-2964-2021; Bianchi, Elisa/F-2242-2015	Guglielmelli, Paola/0000-0003-1809-284X; Villani, Laura/0000-0003-4199-5633; Catarsi, Paolo/0000-0002-1862-8168; Di Buduo, Christian A/0000-0002-6472-2008; Balduini, Alessandra/0000-0003-3145-1245; Malcovati, Luca/0000-0002-1460-1611; Abbonante, Vittorio/0000-0001-8066-9895; Fois, Gabrila/0000-0002-6506-9135; Abbonante, Vittorio/0000-0001-8066-9895; BALDUINI, ALESSANDRA/0000-0003-3145-1245; Massa, Margherita/0000-0001-8037-0439; Rosti, Vittorio/0000-0003-4195-2289; Campanelli, Rita/0000-0003-4923-2761; Bartalucci, Niccolo/0000-0002-9328-3948; Galli, Andrea/0000-0001-5416-6290; Tagliafico, Enrico/0000-0003-0981-2542; Catricala, Silvia/0000-0001-8294-1768; Bianchi, Elisa/0000-0002-6110-5944; PANCRAZZI, ALESSANDRO/0000-0002-6943-6924; milanesi, chiara/0000-0003-0391-4126; ELENA, CHIARA/0000-0002-0058-7142; BOSI, ALBERTO/0000-0002-5486-4838; Rossi, Marianna/0000-0003-1661-1511	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) [1005]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	The study was funded by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5x1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative), project number #1005. A detailed description of the AGIMM project is available at http://www.progettoagimm.it and AIRC Investigator grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barosi G, 1999, J CLIN ONCOL, V17, P2954, DOI 10.1200/JCO.1999.17.9.2954; Barosi G, 2004, BRIT J HAEMATOL, V124, P618, DOI 10.1111/j.1365-2141.2004.04829.x; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Belgi G, 2002, CLIN EXP DERMATOL, V27, P546, DOI 10.1046/j.1365-2230.2002.01146.x; Bronckaers A, 2009, MED RES REV, V29, P903, DOI 10.1002/med.20159; Campanelli R, 2014, EXP HEMATOL, V42, P244, DOI 10.1016/j.exphem.2013.12.002; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Dupriez B, 1996, BLOOD, V88, P1013; Giovanni B, 2002, LEUKEMIA LYMPHOMA, V43, P2301, DOI 10.1080/1042819021000040008; Goede V, 2012, CANCER INVEST, V30, P225, DOI 10.3109/07357907.2011.636114; Goulis J, 1999, GUT, V44, P754, DOI 10.1136/gut.44.5.754; Irino T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022148; Jagielska J, 2012, ARTERIOSCL THROM VAS, V32, P1280, DOI 10.1161/ATVBAHA.111.243477; Liu BY, 2015, J IMMUNOL, V194, P5150, DOI 10.4049/jimmunol.1402409; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Massa M, 2005, J CLIN ONCOL, V23, P5688, DOI 10.1200/JCO.2005.09.021; Matsubara T, 2013, HEPATOLOGY, V57, P1416, DOI 10.1002/hep.25965; Mesa RA, 2000, BLOOD, V96, P3374; Mesa RA, 2003, BLOOD, V101, P2534, DOI 10.1182/blood-2002-09-2928; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Patel AS, 2013, EMBO MOL MED, V5, P858, DOI 10.1002/emmm.201302752; Piccaluga PP, 2002, LEUKEMIA, V16, P1609, DOI 10.1038/sj.leu.2402596; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Rojiani MV, 2015, J NEUROPATH EXP NEUR, V74, P293, DOI 10.1097/NEN.0000000000000175; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; Shantsila E, 2013, THROMB HAEMOSTASIS, V109, P255, DOI 10.1160/TH12-06-0395; Tefferi A, 2014, LEUKEMIA, V28, P1472, DOI 10.1038/leu.2014.3; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Toi M, 2005, LANCET ONCOL, V6, P158, DOI 10.1016/S1470-2045(05)01766-3; Toyoda Y, 2014, ARTHRITIS RHEUMATOL, V66, P560, DOI 10.1002/art.38263; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827	37	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156990	10.1371/journal.pone.0156990	http://dx.doi.org/10.1371/journal.pone.0156990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281335	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000062
J	Meyer, M; Dhamne, SC; LaCoursiere, CM; Tambunan, D; Poduri, A; Rotenberg, A				Meyer, Michaela; Dhamne, Sameer C.; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna; Rotenberg, Alexander			Microarray Noninvasive Neuronal Seizure Recordings from Intact Larval Zebrafish	PLOS ONE			English	Article							EPILEPTIC SEIZURES; IDENTIFY; COMPLEX; SCREEN; MODEL	Zebrafish epilepsy models are emerging tools in experimental epilepsy. Zebrafish larvae, in particular, are advantageous because they can be easily genetically altered and used for developmental and drug studies since agents applied to the bath penetrate the organism easily. Methods for electrophysiological recordings in zebrafish are new and evolving. We present a novel multi-electrode array method to non-invasively record electrical activity from up to 61 locations of an intact larval zebrafish head. This method enables transcranial non-invasive recording of extracellular field potentials (which include multi-unit activity and EEG) to identify epileptic seizures. To record from the brains of zebrafish larvae, the dorsum of the head of an intact larva was secured onto a multi-electrode array. We recorded from individual electrodes for at least three hours and quantified neuronal firing frequency, spike patterns (continuous or bursting), and synchrony of neuronal firing. Following 15 mM potassium chloride-or pentylenetetrazole-infusion into the bath, spike and burst rate increased significantly. Additionally, synchrony of neuronal firing across channels, a hallmark of epileptic seizures, also increased. Notably, the fish survived the experiment. This non-invasive method complements present invasive zebrafish neurophysiological techniques: it affords the advantages of high spatial and temporal resolution, a capacity to measure multiregional activity and neuronal synchrony in seizures, and fish survival for future experiments, such as studies of epileptogenesis and development.	[Meyer, Michaela; Dhamne, Sameer C.; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna; Rotenberg, Alexander] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Epilepsy & Clin Neurophysiol,Dept Neurol, Boston, MA 02163 USA; [Meyer, Michaela; Dhamne, Sameer C.; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna; Rotenberg, Alexander] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02163 USA; [Meyer, Michaela; LaCoursiere, Christopher M.; Tambunan, Dimira; Poduri, Annapurna] Harvard Univ, Sch Med, Boston Childrens Hosp, Epilepsy Genet Program,Neurogenet Program,Dept Ne, Boston, MA 02163 USA; [Meyer, Michaela; Dhamne, Sameer C.; Rotenberg, Alexander] Harvard Univ, Sch Med, Boston Childrens Hosp, Neuromodulat Program,Dept Neurol, Boston, MA 02163 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Epilepsy & Clin Neurophysiol,Dept Neurol, Boston, MA 02163 USA.; Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02163 USA.; Rotenberg, A (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Neuromodulat Program,Dept Neurol, Boston, MA 02163 USA.	Alexander.Rotenberg@childrens.harvard.edu			Richard A. and Susan F. Smith President's Innovation Award; Boston Children's Hospital Translational Research Program; NIH NINDS [R01NS088583]; NIMH [R01100186]; Sage Therapeutics; Massachusetts Life Sciences Foundation; Autism Speaks; Assimon Family Fund; National Institute of Neurological Disorders and Stroke [NINDS K23NS069784]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS069784, R01NS088583] Funding Source: NIH RePORTER	Richard A. and Susan F. Smith President's Innovation Award; Boston Children's Hospital Translational Research Program; NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sage Therapeutics; Massachusetts Life Sciences Foundation; Autism Speaks; Assimon Family Fund; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Richard A. and Susan F. Smith President's Innovation Award, and the Boston Children's Hospital Translational Research Program (AP, AR). Related research in Dr. Rotenberg's laboratory includes support from the NIH NINDS R01NS088583 and NIMH R01100186, Sage Therapeutics, Massachusetts Life Sciences Foundation, Autism Speaks and the Assimon Family Fund. A.P. was supported by the National Institute of Neurological Disorders and Stroke (NINDS K23NS069784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Baraban SC, 2007, CURR OPIN NEUROL, V20, P164, DOI 10.1097/WCO.0b013e328042bae0; Baraban SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50104; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hortopan GA, 2010, DIS MODEL MECH, V3, P144, DOI 10.1242/dmm.002139; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Moorman S J, 2001, ILAR J, V42, P292; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; RAMANJANEYULU R, 1984, EUR J PHARMACOL, V98, P337, DOI 10.1016/0014-2999(84)90282-6; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Zdebik AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079765; Zhang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125898	25	18	18	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156498	10.1371/journal.pone.0156498	http://dx.doi.org/10.1371/journal.pone.0156498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281339	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000032
J	Varet, H; Brillet-Gueguen, L; Coppee, JY; Dillies, MA				Varet, Hugo; Brillet-Gueguen, Loraine; Coppee, Jean-Yves; Dillies, Marie-Agnes			SARTools: A DESeq2-and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data	PLOS ONE			English	Article								Background Several R packages exist for the detection of differentially expressed genes from RNA-Seq data. The analysis process includes three main steps, namely normalization, dispersion estimation and test for differential expression. Quality control steps along this process are recommended but not mandatory, and failing to check the characteristics of the dataset may lead to spurious results. In addition, normalization methods and statistical models are not exchangeable across the packages without adequate transformations the users are often not aware of. Thus, dedicated analysis pipelines are needed to include systematic quality control steps and prevent errors from misusing the proposed methods. Results SARTools is an R pipeline for differential analysis of RNA-Seq count data. It can handle designs involving two or more conditions of a single biological factor with or without a blocking factor (such as a batch effect or a sample pairing). It is based on DESeq2 and edgeR and is composed of an R package and two R script templates (for DESeq2 and edgeR respectively). Tuning a small number of parameters and executing one of the R scripts, users have access to the full results of the analysis, including lists of differentially expressed genes and a HTML report that (i) displays diagnostic plots for quality control and model hypotheses checking and (ii) keeps track of the whole analysis process, parameter values and versions of the R packages used. Conclusions SARTools provides systematic quality controls of the dataset as well as diagnostic plots that help to tune the model parameters. It gives access to the main parameters of DESeq2 and edgeR and prevents untrained users from misusing some functionalities of both packages. By keeping track of all the parameters of the analysis process it fits the requirements of reproducible research.	[Varet, Hugo; Coppee, Jean-Yves; Dillies, Marie-Agnes] Inst Pasteur, Ctr Innovat & Rech Technol Citech, Plate Forme Transcriptome & Epigenome, Paris, France; [Varet, Hugo; Dillies, Marie-Agnes] Inst Pasteur, Hub Bioinformat & Biostat, Ctr Bioinformat Biostat & Biol Integrat C3BI, USR 3756,IP,CNRS, Paris, France; [Brillet-Gueguen, Loraine] UPMC, CNRS, FR2424, ABiMS,Stn Biol, Roscoff, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Dillies, MA (corresponding author), Inst Pasteur, Ctr Innovat & Rech Technol Citech, Plate Forme Transcriptome & Epigenome, Paris, France.; Dillies, MA (corresponding author), Inst Pasteur, Hub Bioinformat & Biostat, Ctr Bioinformat Biostat & Biol Integrat C3BI, USR 3756,IP,CNRS, Paris, France.	marie-agnes.dillies@pasteur.fr			France Genomique National infrastructure as part of the "Investissements d'Avenir" [ANR-10-INBS-09]	France Genomique National infrastructure as part of the "Investissements d'Avenir"(French National Research Agency (ANR))	This work was supported by the France Genomique National infrastructure, funded as part of the "Investissements d'Avenir" program managed by the Agence Nationale pour la Recherche (contract ANR-10-INBS-09).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Girke T., 2014, SYSTEMPIPER NGS WORK; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Patro R, 2015, BIORXIV PREPRINT; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russo F, 2014, BIOINFORMATICS, V30, P2514, DOI 10.1093/bioinformatics/btu308; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Soneson C, 2016, F1000RESEARCH, DOI 10.12688/f1000research.7563.2; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Zhou X, 2013, RNA	20	392	397	12	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157022	10.1371/journal.pone.0157022	http://dx.doi.org/10.1371/journal.pone.0157022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280887	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000069
J	Bakhshi, B; Fard, EM; Nikpay, N; Ebrahimi, MA; Bihamta, MR; Mardi, M; Salekdeh, GH				Bakhshi, Behnam; Fard, Ehsan Mohseni; Nikpay, Nava; Ebrahimi, Mohammad Ali; Bihamta, Mohammad Reza; Mardi, Mohsen; Salekdeh, Ghasem Hosseini			MicroRNA Signatures of Drought Signaling in Rice Root	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; CLASS IIIHD-ZIP; ARABIDOPSIS-THALIANA; PLANT MICRORNA; RESPONSIVE MICRORNAS; EXPRESSION PROFILES; POPULUS-TRICHOCARPA; WIDE IDENTIFICATION; SEED-GERMINATION; ABSCISIC-ACID	Background Drought stress is one of the most important abiotic stresses and the main constraint to rice agriculture. MicroRNA-mediated post-transcriptional gene regulation is one of the ways to establish drought stress tolerance in plants. MiRNAs are 20-24-nt regulatory RNAs that play an important role in regulating plant gene expression upon exposure to biotic and abiotic stresses. Methodology/Principal Findings In this study, we applied a partial root drying system as well as a complete root drying system to identify miRNAs involved in conditions of drought stress, drought signaling and wet signaling using high-throughput sequencing. To this end, we produced four small RNA libraries: (1) fully-watered (WW), (2) fully-droughted (WD), and split-root systems where (3) one-half was well watered (SpWW) and (4) the other half was water-deprived (SpWD). Our analysis revealed 10,671 and 783 unique known and novel miRNA reads in all libraries, respectively. We identified, 65 (52 known + 13 novel), 72 (61 known + 11 novel) and 51 (38 known + 13 novel) miRNAs that showed differential expression under conditions of drought stress, drought signaling and wet signaling, respectively. The results of quantitative real-time PCR showed expression patterns similar to the high-throughput sequencing results. Furthermore, our target prediction led to the identification of 244, 341 and 239 unique target genes for drought-stress-, drought-signaling-and wet-signaling-responsivemiRNAs, respectively. Conclusions/Significance Our results suggest that miRNAs that are responsive under different conditions could play different roles in the regulation of abscisic acid signaling, calcium signaling, detoxification and lateral root formation.	[Bakhshi, Behnam; Nikpay, Nava; Mardi, Mohsen; Salekdeh, Ghasem Hosseini] Agr Res Educ & Extens Org, Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran; [Bakhshi, Behnam] Islamic Azad Univ, Sci & Res Branch, Dept Plant Breeding, Tehran, Iran; [Fard, Ehsan Mohseni] Univ Zanjan, Fac Agr, Dept Agron & Plant Breeding, Zanjan, Iran; [Ebrahimi, Mohammad Ali] Payame Noor Univ, Dept Biotechnol, Tehran, Iran; [Bihamta, Mohammad Reza] Univ Tehran, Fac Agr Sci & Engn, Dept Agron & Plant Breeding, Coll Agr & Nat Resources, Karaj, Iran; [Salekdeh, Ghasem Hosseini] Royan Inst Stem Cell Biol & Technol, Dept Mol Syst Biol, Cell Sci Res Ctr, ACECR, Tehran, Iran	Islamic Azad University; University Zanjan; Payame Noor University; University of Tehran; Academic Center for Education, Culture & Research (ACECR)	Salekdeh, GH (corresponding author), Agr Res Educ & Extens Org, Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran.; Salekdeh, GH (corresponding author), Royan Inst Stem Cell Biol & Technol, Dept Mol Syst Biol, Cell Sci Res Ctr, ACECR, Tehran, Iran.	h_salekdeh@abrii.ac.ir	Bakhshi, Behnam/N-2159-2016; Mardi, Mohsen/M-5829-2017; Salekdeh, Ghasem Hosseini/E-4198-2012; Ebrahimi, Mohammad Ali/AFL-4657-2022	Bakhshi, Behnam/0000-0001-6099-6565; Mardi, Mohsen/0000-0002-4718-7701; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Ebrahimi, Mohammad Ali/0000-0002-2610-9018	Agricultural Biotechnology Research Institute of Iran; Iran National Science Foundation	Agricultural Biotechnology Research Institute of Iran; Iran National Science Foundation(Iran National Science Foundation (INSF))	This project was partially funded by grants from the Agricultural Biotechnology Research Institute of Iran and Iran National Science Foundation to GHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bhardwaj AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092456; Bologna NG, 2013, BRIEF FUNCT GENOMICS, V12, P37, DOI 10.1093/bfgp/els050; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Boudsocq M, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P75, DOI 10.1007/978-90-481-3112-9_4; Budak H, 2011, OMICS, V15, P791, DOI 10.1089/omi.2011.0073; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castaings L, 2011, J EXP BOT, V62, P1391, DOI 10.1093/jxb/erq375; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Close TJ, 1993, PLANT RESPONSES CELL; Covarrubias AA, 2010, PLANT CELL ENVIRON, V33, P481, DOI 10.1111/j.1365-3040.2009.02048.x; Ding YF, 2013, J EXP BOT, V64, P3077, DOI 10.1093/jxb/ert164; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Ehya F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066372; Gleeson M, 2014, J PLANT BIOCHEM BIOT, P1; GOLLAN T, 1986, FUNCT PLANT BIOL, V13, P459; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Jian XY, 2010, GENOMICS, V95, P47, DOI 10.1016/j.ygeno.2009.08.017; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Khan GA, 2011, PLANT MOL BIOL, V77, P47, DOI 10.1007/s11103-011-9793-x; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-264; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liang MX, 2006, PLANTA, V224, P1185, DOI 10.1007/s00425-006-0300-6; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu Q, 2009, BIOCHEM BIOPH RES CO, V384, P1, DOI 10.1016/j.bbrc.2009.04.028; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Mirzaei M, 2014, J PROTEOME RES, V13, P517, DOI 10.1021/pr400696u; Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779; Pandey S., 2008, DROUGHT FRONTIERS RI, P3, DOI DOI 10.1142/9789814280013_0001; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Qibin L., 2008, MIREAP MICRORNA DISC; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shinozaki K, 1999, MOL RESPONSES DROUGH; Shuai P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-233; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wei LY, 2009, INT J PLANT SCI, V170, P979, DOI 10.1086/605122; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	82	35	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156814	10.1371/journal.pone.0156814	http://dx.doi.org/10.1371/journal.pone.0156814			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276090	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700038
J	Chowdhury, G; Koya, K; Philipson, P				Chowdhury, Gobinda; Koya, Kushwanth; Philipson, Pete			Measuring the Impact of Research: Lessons from the UK's Research Excellence Framework 2014	PLOS ONE			English	Article							BETA REGRESSION; RANKINGS	Impactful academic research plays a stellar role in society, pressing to ask the question of how one measures the impact created by different areas of academic research. Measuring the societal, cultural, economic and scientific impact of research is currently the priority of the National Science Foundation, European Commission and several research funding agencies. The recently concluded United Kingdom's national research quality exercise, the Research Excellence Framework (REF) 2014, which piloted impact assessment as part of the overall evaluation offers a lens to view how impact of research in different disciplines can be measured. Overall research quality was assessed through quality of outputs, `impact' and research environment. We performed two studies using the REF 2014 as a case study. The first study on 363 Impact Case Studies (ICSs) submitted in 5 research areas (UoAs) reveals that, in general, the impact scores were constructed upon a combination of factors i.e. quantity of quartile-one (Q1) publications, quantity and value of grants/income, number of researchers stated in the ICSs, spin-offs created, discoveries/patents and presentation of esteem data, informing researchers/ academics of the factors to consider in order to achieve a better impact score in research impact assessments. However, there were differences among disciplines in terms of the role played by the factors in achieving their overall scores for the ICSs. The outcome of this study is thus a set of impact indicators, and their relationship with the overall score of impact of research in different disciplines as determined in REF2014, which would in the first instance provide some answers to impact measures that would be useful for researchers in different disciplines. The second study extracts the general themes of impact reported by universities by performing a word frequency analysis in all the ICSs submitted in the five chosen research areas, which were substantially varied owing to their fields.	[Chowdhury, Gobinda; Koya, Kushwanth; Philipson, Pete] Northumbria Univ, Fac Engn & Environm, Dept Math & Informat Sci, Pandon Bldg,Camden St,Newcastle City Campus, Newcastle Upon Tyne NE2 1XE, Tyne & Wear, England	Northumbria University	Koya, K (corresponding author), Northumbria Univ, Fac Engn & Environm, Dept Math & Informat Sci, Pandon Bldg,Camden St,Newcastle City Campus, Newcastle Upon Tyne NE2 1XE, Tyne & Wear, England.	k.koya@northumbria.ac.uk	chowdhury, gobinda/K-3518-2019	chowdhury, gobinda/0000-0002-2122-9547; Koya, Kushwanth/0000-0002-7718-1116; Philipson, Pete/0000-0001-7846-0208				[Anonymous], 2016, METHODOLOGY BUILDING; [Anonymous], 2014, REF 2014; [Anonymous], 2015, J CITATION REPORTS; Bornmann L, 2012, EMBO REPORTS, V13, P373; Bornmann L, 2013, J AM SOC INF SCI TEC, V64, P217, DOI 10.1002/asi.22803; Butler L, 2003, RES POLICY, V32, P143, DOI 10.1016/S0048-7333(02)00007-0; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Economic and Social Research Council, 2009, MEAS IMP ESRC FUND; Engineering and Physical Sciences Research Council, 2012, RES PERF EC IMP REP; European Commission, 2015, HOR 2020 IND ASS RES; Felipe Fernandez-Armesto, 2009, TIMES HIGHER ED; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Hefce, 2015, ANN FUND ALL; Hicks Diana, 2015, Nature, V520, P429, DOI 10.1038/520429a; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jump P., 2015, TIMES HIGHER ED; Jump P., 2013, TIMES HIGHER ED; Kousha K, 2014, BEYOND BIBLIOMETRICS: HARNESSING MULTIDIMENSIONAL INDICATORS OF SCHOLARLY IMPACT, P289; Manville C., 2015, ASSESSING IMPACT SUB; Olson S, 2011, MEASURING IMPACT FED; Oswald A., 2011, INDEPENDENT; Pepe A., 2012, PLOS ONE, V7; Priem J, 2014, BEYOND BIBLIOMETRICS: HARNESSING MULTIDIMENSIONAL INDICATORS OF SCHOLARLY IMPACT, P263; R Core Team, 2021, R LANGUAGE ENV STAT; Rafols I, 2012, RES POLICY, V41, P1262, DOI 10.1016/j.respol.2012.03.015; Reeves M., 2002, MEASURING EC SOCIAL; Saisana M, 2011, RES POLICY, V40, P165, DOI 10.1016/j.respol.2010.09.003; Shepherd J., 2009, GUARDIAN; Simas AB, 2010, COMPUT STAT DATA AN, V54, P348, DOI 10.1016/j.csda.2009.08.017; Smith S, 2011, RES POLICY, V40, P1369, DOI 10.1016/j.respol.2011.05.026; Sutherland WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027537; Swain H., 2013, GUARDIAN; Taylor M., 2013, RES TRENDS; Times Higher Education, 2015, TIMES HIGHER ED; Van Raan AFJ, 2005, SCIENTOMETRICS, V62, P133, DOI 10.1007/s11192-005-0008-6; Wilsdon J., 2015, METRIC TIDE LIT REV; Wolff J., 2013, GUARDIAN	37	36	36	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156978	10.1371/journal.pone.0156978	http://dx.doi.org/10.1371/journal.pone.0156978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27276219	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000377561700053
J	Stommel, C; Hofer, H; East, ML				Stommel, Claudia; Hofer, Heribert; East, Marion L.			The Effect of Reduced Water Availability in the Great Ruaha River on the Vulnerable Common Hippopotamus in the Ruaha National Park, Tanzania	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD ANALYSIS; GENERALIZED LINEAR-MODELS; RAINFALL; ECOLOGY; AFRICA	In semi-arid environments, 'permanent' rivers are essential sources of surface water for wildlife during 'dry' seasons when rainfall is limited or absent, particularly for species whose resilience to water scarcity is low. The hippopotamus (Hippopotamus amphibius) requires submersion in water to aid thermoregulation and prevent skin damage by solar radiation; the largest threat to its viability are human alterations of aquatic habitats. In the Ruaha National Park (NP), Tanzania, the Great Ruaha River (GRR) is the main source of surface water for wildlife during the dry season. Recent, large-scale water extraction from the GRR by people upstream of Ruaha NP is thought to be responsible for a profound decrease in dry season water-flow and the absence of surface water along large sections of the river inside the NP. We investigated the impact of decreased water flow on daytime hippo distribution using regular censuses at monitoring locations, transects and camera trap records along a 104km section of the GRR within the Ruaha NP during two dry seasons. The minimum number of hippos per monitoring location increased with the expanse of surface water as the dry seasons progressed, and was not affected by water quality. Hippo distribution significantly changed throughout the dry season, leading to the accumulation of large numbers in very few locations. If surface water loss from the GRR continues to increase in future years, this will have serious implications for the hippo population and other water dependent species in Ruaha NP.	[Stommel, Claudia; Hofer, Heribert; East, Marion L.] Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung	Stommel, C (corresponding author), Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany.	stommel@izw-berlin.de	Hofer, Heribert/AAF-7854-2021	Hofer, Heribert/0000-0002-2813-7442	Leibniz Institute for Zoo and Wildlife Research IZW institutional budget; German Academic Exchange Service (DAAD) [D/11/44168]; Leibniz Association	Leibniz Institute for Zoo and Wildlife Research IZW institutional budget; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Leibniz Association	Funding for this study came from the Leibniz Institute for Zoo and Wildlife Research IZW institutional budget and the German Academic Exchange Service (DAAD), https://www.daad.de, grant number: D/11/44168, to CS. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2013, CATEGORICAL DATA ANA; Aitkin M, 1999, BIOMETRICS, V55, P117, DOI 10.1111/j.0006-341X.1999.00117.x; Aitkin M, 1996, STAT COMPUT, V6, P251, DOI 10.1007/BF00140869; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; BARNES RFW, 1983, AFR J ECOL, V21, P185, DOI 10.1111/j.1365-2028.1983.tb01180.x; Bates D., PACKAGE LME4; Bobbink R, 2006, ECOL STUD-ANAL SYNTH, V191, P1; Cerioli A, 1997, BIOMETRICS, V53, P619, DOI 10.2307/2533962; Cerling TE, 2008, J ZOOL, V276, P204, DOI 10.1111/j.1469-7998.2008.00450.x; Chen CJ, 2015, INT J CLIMATOL, V35, P2698, DOI 10.1002/joc.4165; Dudley JP, 2016, MAMMAL REV, V46, P191, DOI 10.1111/mam.12056; East ML, 2015, BEHAV ECOL SOCIOBIOL, V69, P805, DOI 10.1007/s00265-015-1897-x; Eltringham S. K., 1999, HIPPOS NATURAL HIST; Eltringham SK, 1993, PIGS PECCARIES HIPPO, P161; FESTABIANCHET M, 1989, J ANIM ECOL, V58, P785, DOI 10.2307/5124; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Harrison ME, 2008, AFR J ECOL, V46, P507, DOI 10.1111/j.1365-2028.2007.00887.x; Hijmans R., 2005, DIVA GIS VERSION 7 5; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Hofer H, 2012, NEW DIRECTIONS CONSE, P82; Hosmer D. W., 2013, APPL LOGISTIC REGRES; JACOBSEN NHG, 1993, WATER SA, V19, P301; KARSTAD EL, 1986, MAMMALIA, V50, P153, DOI 10.1515/mamm.1986.50.2.153; Klingel H., 2013, MAMMALS OF AFRICA, P68; KLINGEL H, 1991, AFRICAN WILDLIFE RES, P73; LEIVESTAD H, 1973, RESP PHYSIOL, V19, P19, DOI 10.1016/0034-5687(73)90086-8; Lewison R, 1998, ETHOL ECOL EVOL, V10, P277, DOI 10.1080/08927014.1998.9522857; Lewison R, 2015, IUCN RED LIST THREAT; Lewison R, 2007, AFR J ECOL, V45, P407, DOI 10.1111/j.1365-2028.2006.00747.x; LOCK JM, 1972, J ECOL, V60, P445, DOI 10.2307/2258356; Lyon B, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050337; Mtahiko M. G. G., 2006, Wetlands Ecology and Management, V14, P489, DOI 10.1007/s11273-006-9002-x; OLIVIER R C D, 1974, East African Wildlife Journal, V12, P249; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Rowell DP, 2015, J CLIMATE, V28, P9768, DOI 10.1175/JCLI-D-15-0140.1; Saikawa Y, 2004, NATURE, V429, P363, DOI 10.1038/429363a; SMUTS G.L., 1981, KOEDOE, V24, P169, DOI DOI 10.4102/koedoe.v24i1.626; Stommel C, 2016, MAMM BIOL, V81, P21, DOI 10.1016/j.mambio.2015.08.005; Tanzania Wildlife Research Institute, 2006, TECHNICAL REPORT; Tanzania Wildlife Research Institute, 2009, TECHNICAL REPORT; Team R core, 2015, R LANG ENV STAT COMP; Timbuka CD, 2012, THESIS U E ANGLIA; Venables WN., 2002, MODERN APPL STAT S 4; Viljoen P. C., 1995, Koedoe, V38, P115; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wafula MM, 2008, AFR J ECOL, V46, P24, DOI 10.1111/j.1365-2028.2007.00796.x	48	16	16	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157145	10.1371/journal.pone.0157145	http://dx.doi.org/10.1371/journal.pone.0157145			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276362	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700074
J	Bai, KJ; Lee, JJ; Chien, ST; Suk, CW; Chiang, CY				Bai, Kuan-Jen; Lee, Jen-Jyh; Chien, Shun-Tien; Suk, Chi-Won; Chiang, Chen-Yuan			The Influence of Smoking on Pulmonary Tuberculosis in Diabetic and Non-Diabetic Patients	PLOS ONE			English	Article							CESSATION; MELLITUS; IMPACT	Background Both smoking and diabetes can increase the risk and influence the manifestations and outcomes of tuberculosis (TB). It is not clear whether the influence of smoking on pulmonary TB differs between non-diabetic and diabetic patients. Herein, we assessed the manifestations and outcomes of TB in relation to smoking in both diabetic and non-diabetic TB patients. Methodology/Principal Findings All diabetic culture-positive pulmonary TB patients notified from 2005-2010 at three teaching hospitals in Taiwan were enrolled. A culture-positive pulmonary TB patient without DM who was notified to the health authority immediately prior to each diabetic TB patient was selected for comparison. The 972 patients in this study cohort included 365 (37.6%) nondiabetic non-smokers, 149 (15.3%) non-diabetic smokers, 284 (29.2%) diabetic non-smokers, and 174 (17.9%) diabetic smokers. The adjusted relative risk of a pretreatment positive smear for a smoker compared with a non-smoker was 2.19 (95% CI 1.38-3.47) in non-diabetic patients and 2.23 (95% CI 1.29-3.87) in diabetic culture-positive pulmonary TB patients. The adjusted relative risk for a positive smear among diabetic smokers was 5.61 (95% CI 3.35-9.41) compared with non-diabetic non-smokers. Smoking was significantly associated with an increased frequency of bilateral lung parenchyma involvement (AdjOR 1.84, 95% CI 1.16-2.93), far-advanced pulmonary TB (AdjOR 1.91, 95% CI 1.04-3.50), cavitary lesions (AdjOR 2.03, 95% CI 1.29-3.20), and unfavorable outcomes of TB (AdjOR 2.35, 95% CI 1.02-5.41) in non-diabetic patients. However, smoking was not associated with cavitary lung parenchyma lesions regarding the location, number or size of the cavity in diabetic TB patients. Conclusions/Significance Smoking and diabetes have joint effects on a pretreatment positive smear. Diabetic smokers had more than a 5-fold increased risk of a pretreatment positive smear than did non-diabetic non-smokers, indicating remarkable joint effects of diabetes and smoking on the risk of TB transmission.	[Bai, Kuan-Jen; Suk, Chi-Won; Chiang, Chen-Yuan] Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Bai, Kuan-Jen] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei, Taiwan; [Lee, Jen-Jyh] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Lee, Jen-Jyh] Tzu Chi Univ, Hualien, Taiwan; [Chien, Shun-Tien] Chest Hosp, Dept Hlth & Welf, Tainan, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Int Union TB & Lung Dis, Paris, France	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Medical University	Chiang, CY (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan.; Chiang, CY (corresponding author), Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan.; Chiang, CY (corresponding author), Int Union TB & Lung Dis, Paris, France.	cychiang@theunion.org			Taiwan Centers for Disease Control [DOH101-DC-1103]	Taiwan Centers for Disease Control	This study was funded by a research grant DOH101-DC-1103 of Taiwan Centers for Disease Control. http://www.cdc.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bam TS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1972-2; Basu S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5506; Bissel K, 2010, SMOKING CESSATION SM, P1; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Chiang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121698; Chiang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093397; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Huang CC, 2014, INT J TUBERC LUNG D, V18, P1285, DOI 10.5588/ijtld.14.0309; International Union Against Tuberculosis and Lung Disease World Health Organization, 2011, WHO DOCUMENT, V15, P1; Jafta N, 2015, INT J TUBERC LUNG D, V19, P596, DOI 10.5588/ijtld.14.0686; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kaur Jagdish, 2013, WHO South East Asia J Public Health, V2, P28, DOI 10.4103/2224-3151.115833; Leung CC, 2003, INT J TUBERC LUNG D, V7, P980; Leung CC, 2015, EUR RESPIR J, V45, P583; Levy D T, 2013, B WORLD HEALTH ORGAN, V91, P501; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin Y, 2015, PUBLIC HEALTH ACTION, V5, P183, DOI 10.5588/pha.15.0025; Batista JDL, 2008, INT J EPIDEMIOL, V37, P841, DOI 10.1093/ije/dyn113; Magee MJ, 2015, INT J TUBERC LUNG D, V19, P685, DOI 10.5588/ijtld.14.0811; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Siddiquea BN, 2013, PUBLIC HEALTH ACTION, V3, P243, DOI 10.5588/pha.13.0051; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; van Zyl-Smit RN, 2014, THORAX, V69, P363, DOI 10.1136/thoraxjnl-2013-204229; Wampande EM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-484; Wang CS, 2009, EPIDEMIOL INFECT, V137, P203, DOI 10.1017/S0950268808000782; Wang JY, 2007, INT J TUBERC LUNG D, V11, P143	32	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156677	10.1371/journal.pone.0156677	http://dx.doi.org/10.1371/journal.pone.0156677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270725	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000029
J	Kadipasaoglu, CM; Conner, CR; Whaley, ML; Baboyan, VG; Tandon, N				Kadipasaoglu, Cihan Mehmet; Conner, Christopher Richard; Whaley, Meagan Lee; Baboyan, Vatche George; Tandon, Nitin			Category-Selectivity in Human Visual Cortex Follows Cortical Topology: A Grouped icEEG Study	PLOS ONE			English	Article							HUMAN FACE PERCEPTION; WORD FORM AREA; VENTRAL TEMPORAL CORTEX; HUMAN BRAIN; INFEROTEMPORAL CORTEX; OCCIPITOTEMPORAL CORTEX; FUNCTIONAL ARCHITECTURE; ELECTRICAL-STIMULATION; OBJECT RECOGNITION; GAMMA-OSCILLATIONS	Neuroimaging studies suggest that category-selective regions in higher-order visual cortex are topologically organized around specific anatomical landmarks: the mid-fusiform sulcus (MFS) in the ventral temporal cortex (VTC) and lateral occipital sulcus (LOS) in the lateral occipital cortex (LOC). To derive precise structure-function maps from direct neural signals, we collected intracranial EEG (icEEG) recordings in a large human cohort (n = 26) undergoing implantation of subdural electrodes. A surface-based approach to grouped icEEG analysis was used to overcome challenges from sparse electrode coverage within subjects and variable cortical anatomy across subjects. The topology of category-selectivity in bilateral VTC and LOC was assessed for five classes of visual stimuli-faces, animate non-face (animals/ body-parts), places, tools, and words-using correlational and linear mixed effects analyses. In the LOC, selectivity for living (faces and animate non-face) and non-living (places and tools) classes was arranged in a ventral-to-dorsal axis along the LOS. In the VTC, selectivity for living and non-living stimuli was arranged in a latero-medial axis along the MFS. Written word-selectivity was reliably localized to the intersection of the left MFS and the occipito-temporal sulcus. These findings provide direct electrophysiological evidence for topological information structuring of functional representations within higher-order visual cortex.	[Kadipasaoglu, Cihan Mehmet; Conner, Christopher Richard; Whaley, Meagan Lee; Baboyan, Vatche George; Tandon, Nitin] Univ Texas Houston, Sch Med, Vivian Smith Dept Neurosurg, Houston, TX USA; [Tandon, Nitin] Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Tandon, N (corresponding author), Univ Texas Houston, Sch Med, Vivian Smith Dept Neurosurg, Houston, TX USA.; Tandon, N (corresponding author), Texas Med Ctr, Mem Hermann Hosp, Houston, TX USA.	Nitin.tandon@uth.tmc.edu	; Kadipasaoglu, Cihan/G-6077-2016	Baboyan, Vatche/0000-0001-9025-591X; Kadipasaoglu, Cihan/0000-0001-5390-372X	National Center for Advancing Translational Sciences of the National Institutes of Health [5TL1TR000369-08]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB006350]; National Institute for Deafness and communication disorders [NIDCD - R01DC014589]; National Science Foundation [NSF-FO 1533664]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014589] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute for Deafness and communication disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (5TL1TR000369-08 to CMK), the National Institute of Biomedical Imaging and Bioengineering (NIBIB; T32EB006350 to CRC), National Institute for Deafness and communication disorders (NIDCD - R01DC014589 to NT) and partially by the National Science Foundation (NSF-FO 1533664 to NT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Andrews TJ, 2010, NEUROIMAGE, V49, P703, DOI 10.1016/j.neuroimage.2009.08.046; Anticevic A, 2008, NEUROIMAGE, V41, P835, DOI 10.1016/j.neuroimage.2008.02.052; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baldassi C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003167; Barton Jason J S, 2014, Continuum (Minneap Minn), V20, P922, DOI 10.1212/01.CON.0000453311.29519.67; Bastin J, 2013, J NEUROSCI, V33, P10123, DOI 10.1523/JNEUROSCI.4646-12.2013; Bates D., 2015, LME4 LINEAR MIXED EF; Bates D, 2015, J STAT SOFTWARE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Brants M, 2011, NEUROIMAGE, V56, P1372, DOI 10.1016/j.neuroimage.2011.02.079; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; Caspers J, 2015, BRAIN STRUCT FUNCT, V220, P205, DOI 10.1007/s00429-013-0646-z; Caspers J, 2013, BRAIN STRUCT FUNCT, V218, P511, DOI 10.1007/s00429-012-0411-8; Chan AM, 2011, J NEUROSCI, V31, P18119, DOI 10.1523/JNEUROSCI.3122-11.2011; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Conner CR, 2014, CEREB CORTEX, V24, P2741, DOI 10.1093/cercor/bht130; Conner CR, 2011, J NEUROSCI, V31, P12855, DOI 10.1523/JNEUROSCI.1457-11.2011; Connolly AC, 2012, J NEUROSCI, V32, P2608, DOI 10.1523/JNEUROSCI.5547-11.2012; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Davidenko N, 2012, HUM BRAIN MAPP, V33, P2334, DOI 10.1002/hbm.21367; Davidesco I, 2014, CEREB CORTEX, V24, P1879, DOI 10.1093/cercor/bht038; Davidesco I, 2013, J NEUROSCI, V33, P1228, DOI 10.1523/JNEUROSCI.3181-12.2013; Dehaene S., 2009, READING BRAIN NEW SC; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Dilks DD, 2013, J NEUROSCI, V33, P1331, DOI 10.1523/JNEUROSCI.4081-12.2013; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Drane DL, 2008, NEUROPSYCHOLOGIA, V46, P1242, DOI 10.1016/j.neuropsychologia.2007.11.034; Dubois J, 2015, J NEUROSCI, V35, P2791, DOI 10.1523/JNEUROSCI.4037-14.2015; Dykstra AR, 2012, NEUROIMAGE, V59, P3563, DOI 10.1016/j.neuroimage.2011.11.046; Ellmore TM, 2009, J NEUROSURG, V111, P755, DOI 10.3171/2009.3.JNS081427; Engell AD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00642; Engell AD, 2012, NEUROIMAGE, V59, P2600, DOI 10.1016/j.neuroimage.2011.08.079; Engell AD, 2011, CEREB CORTEX, V21, P1213, DOI 10.1093/cercor/bhq206; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Esposito F, 2013, NEUROIMAGE, V66, P457, DOI 10.1016/j.neuroimage.2012.10.080; Falk EB, 2015, P NATL ACAD SCI USA, V112, P1977, DOI 10.1073/pnas.1500247112; Fisch L, 2009, NEURON, V64, P562, DOI 10.1016/j.neuron.2009.11.001; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Ghuman AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6672; Gomez J, 2015, NEURON, V85, P216, DOI 10.1016/j.neuron.2014.12.027; Green DM, 1966, SIGNAL DETECTION THE; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Haxby JV, 2012, NEUROIMAGE, V62, P852, DOI 10.1016/j.neuroimage.2012.03.016; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hermes D, 2015, CEREB CORTEX, V25, P2951, DOI 10.1093/cercor/bhu091; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Jacques C, 2016, NEUROPSYCHOLOGIA, V83, P14, DOI 10.1016/j.neuropsychologia.2015.07.024; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Jonas J, 2012, NEUROSCIENCE, V222, P281, DOI 10.1016/j.neuroscience.2012.07.021; Kadipasaoglu CM, 2014, NEUROIMAGE, V101, P215, DOI 10.1016/j.neuroimage.2014.07.006; Kadipasaoglu CM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01008; Kaiser D, 2016, J NEUROPHYSIOL, V115, P2246, DOI 10.1152/jn.01074.2015; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Kojima K, 2013, CLIN NEUROPHYSIOL, V124, P2368, DOI 10.1016/j.clinph.2013.05.030; Konkle T, 2013, J NEUROSCI, V33, P10235, DOI 10.1523/JNEUROSCI.0983-13.2013; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kujovic M, 2013, BRAIN STRUCT FUNCT, V218, P157, DOI 10.1007/s00429-012-0390-9; Kuznetsova A., 2015, R PACKAGE VERSION, V2, P734; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lehky SR, 2016, CURR OPIN NEUROBIOL, V37, P23, DOI 10.1016/j.conb.2015.12.001; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lingnau A, 2015, TRENDS COGN SCI, V19, P268, DOI 10.1016/j.tics.2015.03.006; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Lorenz S, 2017, CEREB CORTEX, V27, P373, DOI 10.1093/cercor/bhv225; Mahon BZ, 2009, NEURON, V63, P397, DOI 10.1016/j.neuron.2009.07.012; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Majaj NJ, 2015, J NEUROSCI, V35, P13402, DOI 10.1523/JNEUROSCI.5181-14.2015; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Marr D., 1982, VISION; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Matsuo T, 2013, CEREB CORTEX, DOI [10.1093/cercor/bht319, DOI 10.1093/CERC0R/BHT319]; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Mendola JD, 1999, J NEUROSCI, V19, P8560; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Miller KJ, 2014, NEUROIMAGE, V85, P711, DOI 10.1016/j.neuroimage.2013.08.070; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mukamel R, 2012, ANNU REV PSYCHOL, V63, P511, DOI 10.1146/annurev-psych-120709-145401; Nasr S, 2011, J NEUROSCI, V31, P13771, DOI 10.1523/JNEUROSCI.2792-11.2011; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Oosterhof NN, 2011, NEUROIMAGE, V56, P593, DOI 10.1016/j.neuroimage.2010.04.270; Op de Beeck HP, 2008, NAT REV NEUROSCI, V9, P123, DOI 10.1038/nrn2314; Orlov T, 2010, NEURON, V68, P586, DOI 10.1016/j.neuron.2010.09.032; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pieters TA, 2013, J NEUROSURG, V118, P1086, DOI 10.3171/2013.2.JNS121450; Pourtois G, 2007, NEUROPSYCHOLOGIA, V45, P2621, DOI 10.1016/j.neuropsychologia.2007.04.005; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Privman E, 2007, J NEUROSCI, V27, P6234, DOI 10.1523/JNEUROSCI.4627-06.2007; Privman E, 2011, CEREB CORTEX, V21, P616, DOI 10.1093/cercor/bhq128; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Pyles JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061611; R Core Team, 2012, R LANG ENV STAT COMP; Rice GE, 2014, J NEUROSCI, V34, P8837, DOI 10.1523/JNEUROSCI.5265-13.2014; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Rossion Bruno, 2014, Front Biosci (Elite Ed), V6, P258; Rouse AG, 2013, J NEUROSCI, V33, P1326, DOI 10.1523/JNEUROSCI.0271-12.2013; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sha L, 2015, J COGNITIVE NEUROSCI, V27, P665, DOI 10.1162/jocn_a_00733; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tandon N, 2008, TXB EPILEPSY SURG, P1001, DOI DOI 10.3109/9780203091708-129; Tang HL, 2014, NEURON, V83, P736, DOI 10.1016/j.neuron.2014.06.017; Vidal JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00195; Vinberg J, 2008, J NEUROPHYSIOL, V99, P1380, DOI 10.1152/jn.01223.2007; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108; Wandell BA, 2012, ANNU REV PSYCHOL, V63, P31, DOI 10.1146/annurev-psych-120710-100434; Weiner KS, 2014, NEUROIMAGE, V84, P453, DOI 10.1016/j.neuroimage.2013.08.068; Weiner KS, 2013, PSYCHOL RES-PSYCH FO, V77, P74, DOI 10.1007/s00426-011-0392-x; Weiner KS, 2011, NEUROIMAGE, V56, P2183, DOI 10.1016/j.neuroimage.2011.03.041; Weiner KS, 2010, NEUROIMAGE, V52, P1559, DOI 10.1016/j.neuroimage.2010.04.262; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winawer J, 2013, CURR BIOL, V23, P1145, DOI 10.1016/j.cub.2013.05.001; Yamins DLK, 2016, CURR OPIN NEUROBIOL, V37, P114, DOI 10.1016/j.conb.2016.02.001; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yeatman JD, 2014, P NATL ACAD SCI USA, V111, pE5214, DOI 10.1073/pnas.1418503111; Yeatman JD, 2013, BRAIN LANG, V125, P146, DOI 10.1016/j.bandl.2012.04.010; Yoshor D, 2007, CEREB CORTEX, V17, P2293, DOI 10.1093/cercor/bhl138	164	25	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157109	10.1371/journal.pone.0157109	http://dx.doi.org/10.1371/journal.pone.0157109			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272936	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000065
J	Wright, CJ; Zeeman, H; Biezaitis, V				Wright, Courtney J.; Zeeman, Heidi; Biezaitis, Valda			Holistic Practice in Traumatic Brain Injury Rehabilitation: Perspectives of Health Practitioners	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE REHABILITATION; CARE PERSPECTIVES; SELF-AWARENESS; DISABILITY; TRANSITION; OUTCOMES; ADULTS; MODEL; PROFESSIONALS	Given that the literature suggests there are various (and often contradictory) interpretations of holistic practice in brain injury rehabilitation and multiple complexities in its implementation (including complex setting, discipline, and client-base factors), this study aimed to examine the experiences of practitioners in their conceptualization and delivery of holistic practice in their respective settings. Nineteen health practitioners purposively sampled from an extensive Brain Injury Network in Queensland, Australia participated in individual interviews. A systematic text analysis process using Leximancer qualitative analysis program was undertaken, followed by manual thematic analysis to develop overarching themes. The findings from this study have identified several items for future inter-professional development that will not only benefit the practitioners working in brain injury rehabilitation settings, but the patients and their families as well.	[Wright, Courtney J.; Zeeman, Heidi] Griffith Univ, Menzies Hlth Inst Queensland, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia; [Wright, Courtney J.; Zeeman, Heidi] Griffith Univ, RECOVER Injury Res Ctr, Meadowbrook, Qld 4131, Australia; [Biezaitis, Valda] Mater Childrens Hosp, ROBIN Team, South Brisbane, Qld, Australia; [Biezaitis, Valda] Mater Res, Improving Treatment Dis, South Brisbane, Qld, Australia	Griffith University; Griffith University; Mater Research	Wright, CJ (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia.; Wright, CJ (corresponding author), Griffith Univ, RECOVER Injury Res Ctr, Meadowbrook, Qld 4131, Australia.	Courtney.wright@griffith.edu.au		Wright, Courtney/0000-0003-4735-4378	Mater Children's Hospital	Mater Children's Hospital	The authors are grateful to the Mater Children's Hospital and the Brain Injury Network team led by Dr. Ron Hazelton, who supported this study throughout. Many thanks in particular, to the participants of the study who gave so generously of their time. Special thanks are also extended to Dr. Valda Biezaitis for her willingness and enthusiasm to engage in research as a practicing clinician.	Allan Chris M, 2006, J Interprof Care, V20, P235, DOI 10.1080/13561820600718139; Australian Institute of Health and Welfare, 2008, AUSTR HLTH 2008; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Ben-Yishay Y, 2011, HDB HOLISTIC NEUROPS; Ben-Yishay Y., 1990, COGNITIVE REMEDIATIO; Bolderston A, 2012, J MED IMAGING RADIAT, V43, P66, DOI 10.1016/j.jmir.2011.12.002; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Breen LJ, 2011, DISABIL REHABIL, V33, P862, DOI 10.3109/09638288.2010.520799; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Charleswell C, 2015, J EPIDEMIOL COMMUN H, V69, P290, DOI 10.1136/jech-2014-204239; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Dion GR, 2014, J VOICE, V28, P88, DOI 10.1016/j.jvoice.2013.08.005; Engel George L, 2012, Psychodyn Psychiatry, V40, P377, DOI 10.1037/h0089260; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Flick U., 2019, INTRO QUALITATIVE RE, V6th; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gibbins S, 2015, QUAL HEALTH RES, V25, P763, DOI 10.1177/1049732315580105; Goldstein K., 1939, ORG HOLISTIC APPROAC; Guion L.A., 2011, TRIANGULATION ESTABL, V2011, P3; Gzil F, 2007, DISABIL REHABIL, V29, P1616, DOI 10.1080/09638280701618620; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Hall Pippa, 2005, J Interprof Care, V19 Suppl 1, P188; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Heinemann AW, 2005, REHABIL PSYCHOL, V50, P6, DOI 10.1037/0090-5550.50.1.6; Helps Y. L., 2008, INJURY RES STAT SERI, V45; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Huber JG, 2010, DISABIL REHABIL, V32, P1955, DOI 10.3109/09638281003797414; Jenesick V, 2000, HDB QUALITATIVE RES; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Kuipers P, 2014, J INTERPROF CARE, V28, P246, DOI 10.3109/13561820.2013.821601; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Leonardi M, 2009, DISABIL REHABIL, V31, pS83, DOI 10.3109/09638280903317948; Leplege A, 2007, DISABIL REHABIL, V29, P1555, DOI 10.1080/09638280701618661; Lexell J, 2007, J HEAD TRAUMA REHAB, V22, P229, DOI 10.1097/01.HTR.0000281838.00344.03; Lyons AC., 2006, HLTH PSYCHOL CRITICA; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; McEvoy Liz, 2008, Nurse Educ Pract, V8, P412, DOI 10.1016/j.nepr.2008.02.002; McHugh J C, 2007, Ir Med J, V100, P518; McMillan SS, 2013, MED CARE RES REV, V70, P567, DOI 10.1177/1077558713496318; Merriam S. B., 2009, QUALITATIVE RES GUID; Moos R, 1979, HLTH PSYCHOL HDB; Nicassio PM., 1995, MANAGING CHRONIC ILL; PETRIE HG, 1976, J AESTHET EDUC, V10, P29, DOI 10.2307/3332007; Ponsford J., 2013, TRAUMATIC BRAIN INJU, V2nd ed; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1997, J INT NEUROPSYCH SOC, V3, P497, DOI 10.1017/S1355617797004979; Prigatano GP, 1999, REHABILITATION ADULT; Rahman B, 2013, NEUROPSYCHOL REHABIL, V23, P501, DOI 10.1080/09602011.2013.787938; RAND Corporation, 2012, LAB FORC REENTR ISS; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rowe H, 1996, J Nurs Manag, V4, P93, DOI 10.1046/j.1365-2834.1996.01946.x; SCHWARTZ MA, 1985, PERSPECT BIOL MED, V28, P331; Silberg T, 2015, BRAIN INJURY, V29, P481, DOI 10.3109/02699052.2014.984758; Smith AE, 2006, BEHAV RES METHODS, V38, P262, DOI 10.3758/BF03192778; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Tate DG, 2003, AM PSYCHOL, V58, P289, DOI 10.1037/0003-066X.58.4.289; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; WHO, 2001, WHO INT CLASS FUNCT; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wilkinson-Meyers L, 2010, SOC SCI MED, V71, P1882, DOI 10.1016/j.socscimed.2010.08.019; Williams J, 2011, DISABIL REHABIL, V33, P423, DOI 10.3109/09638288.2010.498555; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Wilmot S, 2007, HEALTH CARE ANAL, V15, P59, DOI 10.1007/s10728-006-0032-6; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; Young NL, 2009, PHYS OCCUP THER PEDI, V29, P345, DOI 10.3109/01942630903245994; Young NL, 2005, DISABIL REHABIL, V27, P1455, DOI 10.1080/00222930500218946	89	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156826	10.1371/journal.pone.0156826	http://dx.doi.org/10.1371/journal.pone.0156826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1SU	27270604	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200019
J	Bogaard, G; Meijer, EH; Vrij, A; Merckelbach, H				Bogaard, Glynis; Meijer, Ewout H.; Vrij, Aldert; Merckelbach, Harald			Strong, but Wrong: Lay People's and Police Officers' Beliefs about Verbal and Nonverbal Cues to Deception	PLOS ONE			English	Article							CONFIRMATION BIAS; LIE DETECTION; ACCURACY; TRUTH; CBCA; SUSPECTS; ABILITY; CREDIBILITY; PREVALENCE; STATEMENTS	The present study investigated the beliefs of students and police officers about cues to deception. A total of 95 police officers and 104 undergraduate students filled out a questionnaire addressing beliefs about cues to deception. Twenty-eight verbal cues were included in the questionnaire, all extracted from verbal credibility assessment tools (i.e., CBCA, RM, and SCAN). We investigated to what extent beliefs about nonverbal and verbal cues of deception differed between lay people (students) and police officers, and whether these beliefs were in agreement with objective cues known from research. Both students and police officers believed the usual stereotypical, but non-diagnostic (nonverbal) cues such as gaze aversion and increased movement to be indicative of deception. Yet, participants were less inclined to overestimate the relationship between verbal cues and deception and their beliefs fitted better with what we know from research. The implications of these findings for practice are discussed.	[Bogaard, Glynis; Meijer, Ewout H.; Merckelbach, Harald] Maastricht Univ, Dept Clin Psychol Sci, Sect Forens Psychol, NL-6200 MD Maastricht, Netherlands; [Vrij, Aldert] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	Maastricht University; University of Portsmouth	Bogaard, G (corresponding author), Maastricht Univ, Dept Clin Psychol Sci, Sect Forens Psychol, NL-6200 MD Maastricht, Netherlands.	Glynis.bogaard@maastrichtuniversity.nl	Bogaard, Glynis/I-7159-2019	Bogaard, Glynis/0000-0001-6795-9433; Vrij, Aldert/0000-0001-8647-7763	Ministry of the Interior and Kingdom Relations of the Netherlands	Ministry of the Interior and Kingdom Relations of the Netherlands	This research was funded by a grant from the Ministry of the Interior and Kingdom Relations of the Netherlands.	Aamodt M. G., 2006, FORENSIC EXAMINER, V15, P6, DOI DOI 10.1177/0146167207311282; Aavik T, 2006, J CROSS CULT PSYCHOL, V37, P60, DOI 10.1177/0022022105282295; Akehurst L, 1996, APPL COGNITIVE PSYCH, V10, P461, DOI 10.1002/(SICI)1099-0720(199612)10:6<461::AID-ACP413>3.0.CO;2-2; Akehurst L., 2001, LEGAL CRIMINOL PSYCH, V6, P65, DOI DOI 10.1348/135532501168208; Amado BG, 2015, EUR J PSYCHOL APPL L, V7, P3, DOI 10.1016/j.ejpal.2014.11.002; Bockstaele M, 2008, TIJDSCHRIFT POLITIE, V70, P8; Bogaard G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00243; Bogaard G, 2014, J INVEST PSYCHOL OFF, V11, P151, DOI 10.1002/jip.1409; Bogaard G, 2014, PSYCHOL CRIME LAW, V20, P430, DOI 10.1080/1068316X.2013.793338; Bogaard G, 2014, APPL COGNITIVE PSYCH, V28, P79, DOI 10.1002/acp.2959; Bond CF, 2008, PSYCHOL BULL, V134, P477, DOI 10.1037/0033-2909.134.4.477; Bond CF, 2006, PERS SOC PSYCHOL REV, V10, P214, DOI 10.1207/s15327957pspr1003_2; Burgoon JK, 2008, HUMAN COMMUNICATION, V34, P552; Curtis DA, 2015, INT J ADV COUNS, V37, P279, DOI 10.1007/s10447-015-9243-6; Curtis DA, 2015, NURS EDUC, V40, P254, DOI 10.1097/NNE.0000000000000157; Davis M, 2006, J NONVERBAL BEHAV, V30, P181, DOI 10.1007/s10919-006-0016-0; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Driskell JE, 2012, PSYCHOL CRIME LAW, V18, P713, DOI 10.1080/1068316X.2010.535820; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Granhag PA, 2004, LEGAL CRIMINOL PSYCH, V9, P103, DOI 10.1348/135532504322776889; Halevy R, 2014, HUM COMMUN RES, V40, P54, DOI 10.1111/hcre.12019; Hart C., 2006, INDIV DIFFER RES, V4, P176; Hartwig M, 2014, APPL COGNITIVE PSYCH, V28, P661, DOI 10.1002/acp.3052; Hartwig M, 2011, PSYCHOL BULL, V137, P643, DOI 10.1037/a0023589; Hauch V, 2014, COMMUN RES, P1, DOI DOI 10.1177/00993650214534974; Hill C, 2008, LEGAL CRIMINOL PSYCH, V13, P357, DOI 10.1348/135532507X238682; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; Jones M, 2001, THEOR DECIS, V50, P59, DOI 10.1023/A:1005296023424; Kassin SM, 2010, LEGAL CRIMINOL PSYCH, V15, P39, DOI 10.1348/135532509X449361; Kassin SM, 2010, LAW HUMAN BEHAV, V34, P3, DOI 10.1007/s10979-009-9188-6; Kassin SM, 2003, LAW HUMAN BEHAV, V27, P187, DOI 10.1023/A:1022599230598; Lamb ME, 1997, CHILD ABUSE NEGLECT, V21, P255, DOI 10.1016/S0145-2134(96)00170-6; Levine TR, 2013, COMMUN RES REP, V30, P211, DOI 10.1080/08824096.2013.806254; Levine TR, 2014, J LANG SOC PSYCHOL, V33, P431, DOI 10.1177/0261927X14536397; MAIER NRF, 1968, PERS PSYCHOL, V21, P23, DOI 10.1111/j.1744-6570.1968.tb02283.x; Mann S, 2004, J APPL PSYCHOL, V89, P137, DOI 10.1037/0021-9010.89.1.137; Mann S, 2002, LAW HUMAN BEHAV, V26, P365, DOI 10.1023/A:1015332606792; Mann SA, 2008, APPL COGNITIVE PSYCH, V22, P1062, DOI 10.1002/acp.1406; Masip J, 2005, J APPL SOC PSYCHOL, V35, P1046, DOI 10.1111/j.1559-1816.2005.tb02159.x; Masip J, 2005, PSYCHOL CRIME LAW, V11, P99, DOI 10.1080/10683160410001726356; Masip J, 2015, J COMMUN, V65, P125, DOI 10.1111/jcom.12135; Nahari G, 2012, LAW HUMAN BEHAV, V36, P68, DOI 10.1037/h0093965; Newman ML, 2003, PERS SOC PSYCHOL B, V29, P665, DOI 10.1177/0146167203029005010; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Ofshe RJ, 1997, DENVER U LAW REV, V74, P979; Porter S, 2000, LAW HUMAN BEHAV, V24, P643, DOI 10.1023/A:1005500219657; RASKIN DC, 1991, BEHAV ASSESS, V13, P265; Roma P, 2011, CHILD ABUSE NEGLECT, V35, P613, DOI 10.1016/j.chiabu.2011.04.004; Sapir A., 2005, LSI COURSE SCI CONTE; Serota KB, 2010, HUM COMMUN RES, V36, P2, DOI 10.1111/j.1468-2958.2009.01366.x; Smets L, 2008, ANAL GELOOFWAARDIGHE, P105; Smith N, 2001, POLICE RES SERIES PA, V135, P1; Snook B, 2008, CRIM JUSTICE BEHAV, V35, P1257, DOI 10.1177/0093854808321528; Sporer S.L., 2004, DETECTION DECEPTION, P64, DOI DOI 10.1017/CBO9780511490071.004; Sporer SL, 2007, PSYCHOL PUBLIC POL L, V13, P1, DOI 10.1037/1076-8971.13.1.1; Sporer SL, 1997, APPL COGNITIVE PSYCH, V11, P373; Steller M., 1989, PSYCHOL METHODS CRIM, P217; Stromwall L, 2004, DETECTION DECEPTION; Stromwall LA, 2003, PSYCHOL CRIME LAW, V9, P19, DOI 10.1080/10683160308138; Taylor R, 2007, LEGAL CRIMINOL PSYCH, V12, P321, DOI 10.1348/135532506X116101; Undeutsch U., 1967, HDB PSYCHOL; van Amelsvoort A., 2015, HANDLEIDING VERHOOR; Vanden Bossche Marc, 2015, 2015 IEEE MTT-S International Microwave Symposium (IMS2015), P1, DOI 10.1109/MWSYM.2015.7167125; Vrij A, 1996, J NONVERBAL BEHAV, V20, P65, DOI 10.1007/BF02248715; Vrij A, 2005, PSYCHOL PUBLIC POL L, V11, P3, DOI 10.1037/1076-8971.11.1.3; Vrij A, 2004, CAN J BEHAV SCI, V36, P113, DOI 10.1037/h0087222; Vrij A, 2004, HUM COMMUN RES, V30, P8, DOI 10.1111/j.1468-2958.2004.tb00723.x; Vrij A, 2002, LAW HUMAN BEHAV, V26, P261, DOI 10.1023/A:1015313120905; Vrij A, 2001, PSYCHOL CRIME LAW, V7, P119, DOI 10.1080/10683160108401791; Vrij A., 2008, DETECTING LIES DECEI; Vrij A., 2008, DETECTING LIES DECEI, P261; Vrij A, 2008, CRIM JUSTICE BEHAV, V35, P1323, DOI 10.1177/0093854808321530; Vrij A, 2006, LEGAL CRIMINOL PSYCH, V11, P297, DOI 10.1348/135532505X60816; Vrij Aldert, 2010, Psychol Sci Public Interest, V11, P89, DOI 10.1177/1529100610390861; Vrij Aldert., 2008, DETECTING LIES DECEI, P115	76	48	49	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156615	10.1371/journal.pone.0156615	http://dx.doi.org/10.1371/journal.pone.0156615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258014	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700089
J	Eriksen, AHM; Andersen, RF; Nielsen, BS; Sorensen, FB; Appelt, AL; Jakobsen, A; Hansen, TF				Eriksen, Anne Haahr Mellergaard; Andersen, Rikke Fredslund; Nielsen, Boye Schnack; Sorensen, Flemming Brandt; Appelt, Ane Lindegaard; Jakobsen, Anders; Hansen, Torben Frostrup			Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMORADIATION; RELATIVE QUANTIFICATION; REFERENCE GENES; COLON; CHEMORADIOTHERAPY; IDENTIFICATION; BIOMARKERS	Introduction An increasing number of studies have investigated microRNAs (miRNAs) as potential markers of diagnosis, treatment and prognosis. So far, agreement between studies has been minimal, which may in part be explained by intratumoral heterogeneity of miRNA expression. The aim of the present study was to assess the heterogeneity of a panel of selected miRNAs in rectal cancer, using two different technical approaches. Materials and Methods The expression of the investigated miRNAs was analysed by real- time quantitative polymerase chain reaction (RT-qPCR) and in situ hybridization (ISH) in tumour specimens from 27 patients with T3-4 rectal cancer. From each tumour, tissue from three different luminal localisations was examined. Inter- and intra-patient variability was assessed by calculating intra-class correlation coefficients (ICCs). Correlations between RT-qPCR and ISH were evaluated using Spearman's correlation. Results ICCsingle (one sample from each patient) was higher than 50% for miRNA-21 and miRNA-31. For miRNA-125b, miRNA-145, and miRNA-630, ICCsingle was lower than 50%. The ICCmean (mean of three samples from each patient) was higher than 50% for miRNA-21(RT-qPCR and ISH), miRNA-125b (RT-qPCR and ISH), miRNA-145 (ISH), miRNA-630 (RT-qPCR), and miRNA-31 (RT-qPCR). For miRNA-145 (RT-qPCR) and miRNA-630 (ISH), ICCmean was lower than 50%. Spearman correlation coefficients, comparing results obtained by RT-qPCR and ISH, respectively, ranged from 0.084 to 0.325 for the mean value from each patient, and from -0.085 to 0.515 in the section including the deepest part of the tumour. Conclusion Intratumoral heterogeneity may influence the measurement of miRNA expression and consequently the number of samples needed for representative estimates. Our findings with two different methods suggest that one sample is sufficient for adequate assessment of miRNA-21 and miRNA-31, whereas more samples would improve the assessment of miRNA-125b, miRNA-145, and miRNA-630. Interestingly, we found a poor correlation between the expression estimates obtained by RT-qPCR and ISH, respectively.	[Eriksen, Anne Haahr Mellergaard; Andersen, Rikke Fredslund; Sorensen, Flemming Brandt; Appelt, Ane Lindegaard; Jakobsen, Anders; Hansen, Torben Frostrup] Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark; [Eriksen, Anne Haahr Mellergaard; Andersen, Rikke Fredslund; Sorensen, Flemming Brandt; Jakobsen, Anders; Hansen, Torben Frostrup] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Nielsen, Boye Schnack] Bioneer AS, Horsholm, Denmark; [Appelt, Ane Lindegaard] Univ Copenhagen, Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark	University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Bioneer A/S; Rigshospitalet; University of Copenhagen	Eriksen, AHM (corresponding author), Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark.; Eriksen, AHM (corresponding author), Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark.	anne.haahr.mellergaard@rsyd.dk	Andersen, Rikke/GRS-3064-2022; Hansen, Torben Frøstrup/K-5583-2019	Hansen, Torben Frøstrup/0000-0001-7476-671X; Jakobsen, Anders/0000-0003-2110-2615; Appelt, Ane L/0000-0003-2792-9218; Eriksen, Anne Haahr Mellergaard/0000-0003-0134-3374; Andersen, Rikke Fredslund/0000-0002-5894-7745; Sorensen, Flemming Brandt/0000-0002-5446-1035	Agency of Research and Innovation	Agency of Research and Innovation	The project expenses regarding research materials were covered by Vejle Hospital Research Council. The funder did not provide support in the form of salaries for authors. The Agency of Research and Innovation provided funding for BSN (Bioneer A/S). The funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2010, CLIN CHIM ACTA, V411, P1181, DOI 10.1016/j.cca.2010.05.002; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Drebber U, 2011, INT J ONCOL, V39, P409, DOI 10.3892/ijo.2011.1036; Eriksen AHM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150593; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEPPNER GH, 1984, CANCER RES, V44, P2259; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kheirelseid EAH, 2013, INT J COLORECTAL DIS, V28, P247, DOI 10.1007/s00384-012-1549-9; Knudsen KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140503; Kuremsky JG, 2009, INT J RADIAT ONCOL, V74, P673, DOI 10.1016/j.ijrobp.2009.03.003; Laurila EM, 2013, GENES CHROMOSOMES CA; Li T, 2013, WORLD J GASTROENTERO, V19, P5615, DOI 10.3748/wjg.v19.i34.5615; Lim SH, 2015, CRIT REV ONCOL HEMAT, V96, P67, DOI 10.1016/j.critrevonc.2015.05.003; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peveling-Oberhag J, 2014, TRANSL ONCOL, V7, P672, DOI 10.1016/j.tranon.2014.09.003; Raychaudhuri M, 2012, J MOL DIAGN, V14, P376, DOI 10.1016/j.jmoldx.2012.01.016; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Svoboda M, 2008, INT J ONCOL, V33, P541, DOI 10.3892/ijo_00000038; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009	27	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156919	10.1371/journal.pone.0156919	http://dx.doi.org/10.1371/journal.pone.0156919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258547	gold, Green Published			2022-12-27	WOS:000377369700154
J	Yasuoka, T; Kuwahara, M; Yamada, T; Maruyama, S; Suzuki, J; Taniguchi, M; Yasukawa, M; Yamashita, M				Yasuoka, Toshiaki; Kuwahara, Makoto; Yamada, Takeshi; Maruyama, Saho; Suzuki, Junpei; Taniguchi, Masaru; Yasukawa, Masaki; Yamashita, Masakatsu			The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1-and NKT2-Type iNKT Cells	PLOS ONE			English	Article							V-ALPHA-14I NKT CELLS; KILLER T-CELLS; LYMPHOCYTE DEVELOPMENT; TERMINAL MATURATION; EFFECTOR FUNCTIONS; ROR-GAMMA; TGF-BETA; DIFFERENTIATION; HOMEOSTASIS; EXPRESSION	Gfi1 plays an important role in the development and maintenance of many hematopoietic linage cells. However, the impact of Gfi1-deficiency on the iNKT cell differentiation remains unclear. We herein demonstrate a critical role of Gfi1 in regulating the development of iNKT cell subsets. In the thymus of T cell-specific Gfi1-deficient mice, iNKT cells normally developed up to stage 2, while the number of stage 3 NK1.1(pos) iNKT cells was significantly reduced. Furthermore, CD4(pos) iNKT cells were selectively reduced in the peripheral organs of T cell-specific Gfi1-deficient mice. The alpha-GalCer-dependent production of IFN-gamma and Th2 cytokines, but not IL-17A, was severely reduced in T cell-specific Gfi1-deficient mice. In addition, a reduction of the alpha-GalCer-induced anti-tumor activity was observed in Gfi1-deficient mice. These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.	[Yasuoka, Toshiaki] Ehime Univ, Grad Sch Med, Dept Obstet & Gynecol, Toon, Ehime, Japan; [Yasuoka, Toshiaki; Kuwahara, Makoto; Maruyama, Saho; Yamashita, Masakatsu] Ehime Univ, Grad Sch Med, Dept Immunol, Toon, Ehime, Japan; [Kuwahara, Makoto; Suzuki, Junpei; Yamashita, Masakatsu] Ehime Univ Hosp, Translat Res Ctr, Toon, Ehime, Japan; [Kuwahara, Makoto; Yamashita, Masakatsu] Ehime Univ, Div Immune Regulat, Dept Proteoinovat, Proteosci Ctr, Toon, Ehime, Japan; [Yamada, Takeshi] Ehime Univ, Dept Infect & Host Def, Grad Sch Med, Toon, Ehime, Japan; [Suzuki, Junpei; Yasukawa, Masaki] Ehime Univ, Dept Hematol Clin Immunol & Infect Dis, Grad Sch Med, Toon, Ehime, Japan; [Taniguchi, Masaru] RIKEN, Ctr Integrat Med Sci, Lab Immune Regulat, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan	Ehime University; Ehime University; Ehime University; Ehime University; Ehime University; Ehime University; RIKEN	Yamashita, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Immunol, Toon, Ehime, Japan.; Yamashita, M (corresponding author), Ehime Univ Hosp, Translat Res Ctr, Toon, Ehime, Japan.; Yamashita, M (corresponding author), Ehime Univ, Div Immune Regulat, Dept Proteoinovat, Proteosci Ctr, Toon, Ehime, Japan.	yamamasa@m.ehime-u.ac.jp			Japan Society for Promotion of Science KAKENHI [15K20149, 15K19133, 25860376, 23390075]; Naito Foundation Natural Science Scholarship	Japan Society for Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation Natural Science Scholarship	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Numbers 15K20149, 15K19133, 25860376, 23390075, and the Naito Foundation Natural Science Scholarship.	Anderson BL, 2013, MOLECULES, V18, P15662, DOI 10.3390/molecules181215662; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Chang CL, 2011, J IMMUNOL, V187, P1235, DOI 10.4049/jimmunol.1100270; Chowdhury AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053666; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Gordy LE, 2011, J IMMUNOL, V187, P6335, DOI 10.4049/jimmunol.1003965; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Ichiyama K, 2009, INT IMMUNOL, V21, P881, DOI 10.1093/intimm/dxp054; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Khandanpour C, 2013, CANCER CELL, V23, P200, DOI 10.1016/j.ccr.2013.01.011; Khandanpour C, 2011, STEM CELLS, V29, P376, DOI 10.1002/stem.575; Kim EY, 2015, SEMIN IMMUNOL, V27, P26, DOI 10.1016/j.smim.2015.02.005; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Miller SA, 2010, IMMUNOL REV, V238, P233, DOI 10.1111/j.1600-065X.2010.00952.x; Miyake Sachiko, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P315, DOI 10.2174/1568008054863772; Monteiro M, 2014, CRIT REV IMMUNOL, V34, P81, DOI 10.1615/CritRevImmunol.2014010088; Montoya-Durango DE, 2008, J BIOL CHEM, V283, P32056, DOI 10.1074/jbc.M802320200; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shinnakasu R, 2008, J BIOL CHEM, V283, P28216, DOI 10.1074/jbc.M804174200; Suzuki J, 2016, IMMUNOLOGY, V147, P476, DOI 10.1111/imm.12580; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Webster KE, 2014, MUCOSAL IMMUNOL, V7, P1058, DOI 10.1038/mi.2013.122; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zajonc DM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00400; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666; Zornig M, 1996, ONCOGENE, V12, P1789	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157395	10.1371/journal.pone.0157395	http://dx.doi.org/10.1371/journal.pone.0157395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284976	Green Published, gold, Green Submitted			2022-12-27	WOS:000377564000063
J	Balaguera-Reina, SA; Venegas-Anaya, M; Sanchez, A; Arbelaez, I; Lessios, HA; Densmore, LD				Balaguera-Reina, Sergio A.; Venegas-Anaya, Miryam; Sanchez, Andres; Arbelaez, Italo; Lessios, Harilaos A.; Densmore, Llewellyn D., III			Spatial Ecology of the American Crocodile in a Tropical Pacific Island in Central America	PLOS ONE			English	Article							CROCODYLUS-POROSUS; HOME RANGES; GROWTH-RATES; ARNHEM-LAND; MOVEMENTS; ACUTUS; RIVER; DISPERSAL; PATTERNS	Conservation of large predators has long been a challenge for biologists due to the limited information we have about their ecology, generally low numbers in the wild, large home ranges and the continuous expansion of human settlements. The American crocodile (Crocodylus acutus) is a typical apex predator, that has suffered from all of these characteristic problems, especially the latter one. Humans have had a major impact on the recovery of this species throughout its range, even though most of the countries it inhabits have banned hunting. The last decade has made it clear that in order to implement sound conservation and management programs, we must increase our understanding of crocodile spatial ecology. However, in only two countries where American crocodiles have telemetry studies even been published. Herein we have characterized the spatial ecology of C. acutus on Coiba Island, Panama, by radio-tracking (VHF transmitters) 24 individuals between 2010 and 2013, to determine movement patterns, home range, and habitat use. We have then compared our findings with those of previous studies to develop the most comprehensive assessment of American crocodile spatial ecology to date. Females showed a higher average movement distance (AMD) than males; similarly, adults showed a higher AMD than sub-adults and juveniles. However, males exhibited larger home ranges than females, and concomitantly sub-adults had larger home ranges than juveniles, hatchlings, and adults. There was an obvious relationship between seasonal precipitation and AMD, with increased AMD in the dry and "low-wet" seasons, and reduced AMD during the "true" wet season. We found disaggregate distributions according to age groups throughout the 9 habitat types in the study area; adults and hatchlings inhabited fewer habitat types than juveniles and sub-adults. These sex-and age-group discrepancies in movement and habitat choice are likely due to the influences of reproductive biology and Coiba's precipitation cycle. Juveniles also showed distinct movement patterns and home ranges; however, with sexual maturation and development, these behaviors became more characteristic of adults and sub-adults. Ours is one of a very small number of studies that will allow future management and conservation planning to be based on the comprehensive integration of the spatial ecology of a Neotropical crocodylian apex predator.	[Balaguera-Reina, Sergio A.; Densmore, Llewellyn D., III] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Venegas-Anaya, Miryam; Lessios, Harilaos A.] Smithsonian Trop Res Inst, Apartado Postal 0843-03092, Balboa, Ancon, Panama; [Sanchez, Andres] Univ Quindio, Fac Biol, Armenia, Colombia; [Arbelaez, Italo] Univ Bogota Jorge Tadeo Lozano, Fac Biol Marina, Bogota, Colombia	Texas Tech University System; Texas Tech University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad del Quindio; Universidad de Bogota Jorge Tadeo Lozano	Balaguera-Reina, SA (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	sergio.balaguera-reina@ttu.edu	Balaguera-Reina, Sergio A./I-9102-2019	Balaguera-Reina, Sergio A./0000-0002-5153-0031; Lessios, Harilaos/0000-0003-4726-1382; Venegas-Anaya, Miryam/0000-0003-4287-0162	Panamanian Environmental Agency (ANAM); Panamanian National Secretariat of Science, Technology, and Innovation (SENACYT) [APB11-004, PNCOIBA08]; Texas Tech University [10086-01]	Panamanian Environmental Agency (ANAM); Panamanian National Secretariat of Science, Technology, and Innovation (SENACYT); Texas Tech University	This research project was approved and supported by the Panamanian Environmental Agency (ANAM), the Panamanian National Secretariat of Science, Technology, and Innovation (SENACYT; project number ID APB11-004, permit number PNCOIBA08), and the Texas Tech University (animal care ACUC permit 10086-01) to capture, mark, and tag American crocodiles inside the CNP. All procedures followed ethical practices for animals approved by the Panamanian Environmental Agency and the Smithsonian Tropical Research Institute (STRI).	Alroy J, 2015, P NATL ACAD SCI USA, V112, P13003, DOI 10.1073/pnas.1508681112; Anam, 2009, PLAN MAN PARQ NAC CO; [Anonymous], 1970, P ANN C SE ASS GAM F; Balaguera-Reina S. A., 2008, HERPETOTROPICOS, V4, P59; Balaguera-Reina Sergio A., 2015, Mesoamerican Herpetology, V2, P566; Balaguera-Reina SA, 2015, J HERPETOL, V49, P200, DOI 10.1670/13-065; Balaguera-Reina SA, 2015, S AM J HERPETOL, V10, P10, DOI 10.2994/SAJH-D-14-00024.1; Bonke R, 2014, SALAMANDRA, V50, P40; Brien ML, 2008, WILDLIFE RES, V35, P140, DOI 10.1071/WR06116; Britton ARC, 2012, CROCODILIAN BIOL DAT; Campos Z, 2004, B PESQUISA DESENVOLV, V57, P1; Campos Z, 2006, HERPETOL J, V16, P123; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chabreck Robert H., 1966, P 20 ANN C SE ASS GA, P105; CMNUDS (Cumbre Mundial de las Naciones Unidas para el Desarrollo Sostenible), 2002, CORR MAR CONS DESS S; CSG (Crocodile Specialist Group), 1996, IUCN RED LIST THREAT; Di Rienzo, 2014, INFOSTAT; Ding Y., 2004, CROC P 17 WORK M CRO, P109; Espinal M, 2011, SOUTHWEST NAT, V56, P212, DOI 10.1894/F10-PAS-13.1; ESRI (Environmental Systems Research Institute), 2014, ARC GISVERS 10 2 2; ETESA, 2015, HIDROMETEOROLOGIA; Fergusson R.A., 1992, P98; GABY R, 1985, J HERPETOL, V19, P189, DOI 10.2307/1564172; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; GOODWIN TM, 1979, J HERPETOL, V13, P157, DOI 10.2307/1563922; Green TW, 2014, WETLANDS, V34, pS213, DOI 10.1007/s13157-012-0370-0; Gross B, 2014, TECHNICAL REPORT; Hagan JMI, 1982, THESIS; Hernandez-Hurtado H, 2011, REV MEX BIODIVERS, V82, P887; HUTTON J, 1989, AM ZOOL, V29, P1033; Hutton JM., 1982, CROCODILES, P100; Kay Winston R., 2004, Herpetological Review, V35, P354; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; KUSHLAN JA, 1989, J HERPETOL, V23, P7, DOI 10.2307/1564310; MAGNUSSON WE, 1991, J HERPETOL, V25, P41, DOI 10.2307/1564793; Martin AR, 1998, MAR TECHNOL SOC J, V32, P82; Mazzotti FJ, 1983, THESIS; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; Medem F., 1981, CROCODYLIA AM CROCOD; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morea CR, 1999, THESIS; MUNGER JC, 1984, ECOLOGY, V65, P1077, DOI 10.2307/1938315; Munoz M., 1997, CIENCIA CONSERVACION, P161; Munoz MD, 2000, J HERPETOL, V34, P397; Platt SG, 2000, BIOL CONSERV, V96, P13, DOI 10.1016/S0006-3207(00)00038-0; Ponce-Campos P., 2012, IUCN RED LIST THREAT; R Development Core Team, 2012, R LANG ENV STAT COMP; Read M, 2004, CROC P 17 WORK M IUC, P386; RODDA GH, 1984, HERPETOLOGICA, V40, P444; ROOTES WL, 1993, J HERPETOL, V27, P121, DOI 10.2307/1564926; SAMUEL MD, 1992, J WILDLIFE MANAGE, V56, P725, DOI 10.2307/3809466; Seijas A. E, 1988, THESIS; Signer J, 2015, WILDLIFE SOC B; SPRINGER JT, 1979, J WILDLIFE MANAGE, V43, P926, DOI 10.2307/3808276; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; Swihart Robert K., 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P48, DOI 10.2307/1400640; Targarona RR, 1996, IUCN RED LIST THREAT; Thorbjarnarson J., 2010, CHINESE ALLIGATOR EC; Thorbjarnarson J.B., 2010, CROCODILES STATUS SU, P46; Tucker AD, 1997, WILDLIFE RES, V24, P379, DOI 10.1071/WR95073; Venegas-Anaya M, 2013, CSG NEWSLETTER, V32, P10; Venegas-Anaya M, 2015, J HERPETOL, V49, P349, DOI 10.1670/13-193; Wall J., 2014, MOVEMENT ECOLOGY TOO; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P263, DOI 10.1071/WR9780263; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured]	70	11	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157152	10.1371/journal.pone.0157152	http://dx.doi.org/10.1371/journal.pone.0157152			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280554	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000096
J	Enomoto, K; Aoki, S; Toma, R; Fujiwara, K; Sakamaki, K; Hirahara, F				Enomoto, Kimiko; Aoki, Shigeru; Toma, Rie; Fujiwara, Kana; Sakamaki, Kentaro; Hirahara, Fumiki			Pregnancy Outcomes Based on Pre-Pregnancy Body Mass Index in Japanese Women	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; SPONTANEOUS PRETERM BIRTH; WEIGHT-GAIN; FETAL-GROWTH	Objective To verify whether body mass index (BMI) classification proposed by the Institute of Medicine (IOM) is valid in Japanese women. Method A study was conducted in 97,157 women with singleton pregnancies registered in the Japan Society of Obstetrics and Gynecology (JSOG) Successive Pregnancy Birth Registry System between January 2013 and December 2013, to examine pregnancy outcomes in four groups stratified by pre-pregnancy BMI category according to the 2009 criteria recommended by the Institute of Medicine (IOM). The groups comprised 17,724 underweight women with BMI <18.5, 69,126 normal weight women with BMI 18.5-24.9, 7,502 overweight women with BMI 25-29.9, and 2,805 obese women with BMI >= 30. The pregnancy outcomes were also compared among subgroups stratified by a gestational weight gain below, within, and above the optimal weight gain. Results The higher the pre-pregnancy BMI, the higher the incidences of pregnancy-induced hypertension, gestational diabetes mellitus, macrosomia, cesarean delivery, postpartum hemorrhage, and post-term birth, but the lower the incidence of small for gestational age (SGA). In all pre-pregnancy BMI category groups, excess gestational weight gain was associated with a higher frequency of large for gestational age and macrosomia; poor weight gain correlated with a higher frequency of SGA, preterm birth, preterm premature rupture of membranes, and spontaneous preterm birth; and optimal weight gain within the recommended range was associated with a better outcome. Conclusion The BMI classification by the IOM was demonstrated to be valid in Japanese women.	[Enomoto, Kimiko; Aoki, Shigeru; Toma, Rie; Fujiwara, Kana] Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonate, Yokohama, Kanagawa 232, Japan; [Sakamaki, Kentaro] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Sakamaki, Kentaro] Univ Med Ctr, Yokohama, Kanagawa, Japan; [Hirahara, Fumiki] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Aoki, S (corresponding author), Yokohama City Univ, Med Ctr, Perinatal Ctr Matern & Neonate, Yokohama, Kanagawa 232, Japan.	smyyaoki@yahoo.co.jp						[Anonymous], 2015, PROM COUNC HLTH PAR, V21; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Challis JRG, 2004, AM J OBSTET GYNECOL, V191, P1059, DOI 10.1016/j.ajog.2004.06.071; de la Torre L, 2011, AM J PERINAT, V28, P285, DOI 10.1055/s-0030-1271211; Fujiwara K, 2014, J OBSTET GYNAECOL RE, V40, P988, DOI 10.1111/jog.12283; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; JOHNSON JWC, 1992, AM J OBSTET GYNECOL, V167, P353, DOI 10.1016/S0002-9378(11)91414-8; Li CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136850; Masho SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-120; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Poston L, 2015, LANCET DIABETES ENDO, V3, P767, DOI 10.1016/S2213-8587(15)00227-2; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Stotland N, 2006, OBSTET GYNECOL, V108; Takimoto H, 2011, J OBSTET GYNAECOL RE, V37, P553, DOI 10.1111/j.1447-0756.2010.01396.x; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070	17	91	95	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157081	10.1371/journal.pone.0157081	http://dx.doi.org/10.1371/journal.pone.0157081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280958	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000079
J	Meca, O; Cruz, MJ; Sanchez-Ortiz, M; Gonzalez-Barcala, FJ; Ojanguren, I; Munoz, X				Meca, Olga; Cruz, Maria-Jesus; Sanchez-Ortiz, Monica; Gonzalez-Barcala, Francisco-Javier; Ojanguren, Inigo; Munoz, Xavier			Do Low Molecular Weight Agents Cause More Severe Asthma than High Molecular Weight Agents?	PLOS ONE			English	Article							DIAGNOSING OCCUPATIONAL ASTHMA; EXPOSURE; CHALLENGE; POPULATION; MECHANISMS; MANAGEMENT; CESSATION; HISTORY	Introduction The aim of this study was to analyse whether patients with occupational asthma (OA) caused by low molecular weight (LMW) agents differed from patients with OA caused by high molecular weight (HMW) with regard to risk factors, asthma presentation and severity, and response to various diagnostic tests. Methods Seventy-eight patients with OA diagnosed by positive specific inhalation challenge (SIC) were included. Anthropometric characteristics, atopic status, occupation, latency periods, asthma severity according to the Global Initiative for Asthma (GINA) control classification, lung function tests and SIC results were analysed. Results OA was induced by an HMW agent in 23 patients (29%) and by an LMW agent in 55 (71%). A logistic regression analysis confirmed that patients with OA caused by LMW agents had a significantly higher risk of severity according to the GINA classification after adjusting for potential confounders (OR = 3.579, 95% CI 1.136-11.280; p = 0.029). During the SIC, most patients with OA caused by HMW agents presented an early reaction (82%), while in patients with OA caused by LMW agents the response was mainly late (73%) (p = 0.0001). Similarly, patients with OA caused by LMW agents experienced a greater degree of bronchial hyperresponsiveness, measured as the difference in the methacholine dose-response ratio (DRR) before and after SIC (1.77, range 0-16), compared with patients with OA caused by HMW agents (0.87, range 0-72), (p = 0.024). Conclusions OA caused by LMW agents may be more severe than that caused by HMW agents. The severity of the condition may be determined by the different mechanisms of action of these agents.	[Meca, Olga] Hosp Gen Univ Morales Messeguer, Serv Neumol, Murcia, Spain; [Cruz, Maria-Jesus; Sanchez-Ortiz, Monica; Ojanguren, Inigo; Munoz, Xavier] Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Catalonia, Spain; [Cruz, Maria-Jesus; Sanchez-Ortiz, Monica; Ojanguren, Inigo; Munoz, Xavier] ISCIII, Ctr Invest Red Enfermedades Resp CIBERES, Barcelona, Spain; [Gonzalez-Barcala, Francisco-Javier] Clin Univ Hosp, Resp Dept, Santiago De Compostela, Spain; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Catalonia, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Autonomous University of Barcelona	Cruz, MJ (corresponding author), Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Catalonia, Spain.; Cruz, MJ (corresponding author), ISCIII, Ctr Invest Red Enfermedades Resp CIBERES, Barcelona, Spain.	mj.cruz@vhir.org	Meca Birlanga, Olga/ABE-4440-2021; Cruz, Maria Jesus/I-9073-2014	Ojanguren, Inigo/0000-0003-1270-5772; Munoz, Xavier/0000-0002-8693-022X; Cruz, Maria Jesus/0000-0001-9759-5466; Gonzalez-Barcala, Francisco-Javier/0000-0001-5847-4784	Miguel Servet programme from Instituto de Salud Carlos III [CP12/03101]	Miguel Servet programme from Instituto de Salud Carlos III(Instituto de Salud Carlos III)	MJC is a researcher supported by the Miguel Servet programme from Instituto de Salud Carlos III (CP12/03101). The funders had no role in the study design, the data collection or analysis, the decision to publish, or the preparation of the manuscript. Competing	Baur X, 2012, EUR RESPIR J, V39, P529, DOI 10.1183/09031936.00096111; Baur X, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-15; Bernstein DI, 2013, TOXICOL SCI, V131, P242, DOI 10.1093/toxsci/kfs272; Bernstein IL, 2013, ASTHMA WORKPLACE, P1; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; CHANYEUNG M, 1982, J ALLERGY CLIN IMMUN, V70, P32, DOI 10.1016/0091-6749(82)90198-1; Chester DA, 2005, AM J IND MED, V48, P78, DOI 10.1002/ajim.20183; COTE J, 1990, AM REV RESPIR DIS, V141, P373, DOI 10.1164/ajrccm/141.2.373; Cruz MJ, 2012, CURR OPIN ALLERGY CL, V12, P119, DOI 10.1097/ACI.0b013e328351137c; Descatha A, 2007, ALLERGY, V62, P795, DOI 10.1111/j.1398-9995.2007.01424.x; Dufour MH, 2009, EUR RESPIR J, V33, P734, DOI 10.1183/09031936.00120407; Girard F, 2004, AM J RESP CRIT CARE, V170, P845, DOI 10.1164/rccm.200403-380OC; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Hox V, 2013, AM J RESP CRIT CARE, V187, P486, DOI 10.1164/rccm.201208-1358OC; Hur GY, 2009, J CLIN IMMUNOL, V29, P786, DOI 10.1007/s10875-009-9314-8; Jones MG, 2004, CLIN EXP ALLERGY, V34, P812, DOI 10.1111/j.1365-2222.2004.1956.x; Le Moual N, 2005, AM J RESP CRIT CARE, V172, P440, DOI 10.1164/rccm.200501-111OC; Le Moual N, 2014, EUR RESPIR J, V43, P374, DOI 10.1183/09031936.00034913; Lemiere C, 2013, J ALLERGY CLIN IMMUN, V131, P704, DOI 10.1016/j.jaci.2012.08.024; Maestrelli P, 2013, ASTHMA WORKPLACE, P40; Maestrelli P, 2009, J ALLERGY CLIN IMMUN, V123, P531, DOI 10.1016/j.jaci.2009.01.057; Malo JL, 2005, AM J RESP CRIT CARE, V172, P406, DOI 10.1164/rccm.2506006; Malo JL, 1997, EUR RESPIR J, V10, P1513, DOI 10.1183/09031936.97.10071513; MALO JL, 1991, AM REV RESPIR DIS, V143, P528, DOI 10.1164/ajrccm/143.3.528; MALO JL, 1992, J ALLERGY CLIN IMMUN, V90, P937, DOI 10.1016/0091-6749(92)90466-F; Mapp CE, 2005, AM J RESP CRIT CARE, V172, P280, DOI 10.1164/rccm.200311-1575SO; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ortega HG, 2002, AM J IND MED, V42, P50, DOI 10.1002/ajim.10088; PAGGIARO PL, 1984, CLIN ALLERGY, V14, P463, DOI 10.1111/j.1365-2222.1984.tb02230.x; Tordera MP, 2013, ARCH BRONCONEUMOL, V49, P432, DOI 10.1016/j.arbres.2013.05.001; Rachiotis G, 2007, THORAX, V62, P147, DOI 10.1136/thx.2006.061952; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Tarlo SM, 2008, CHEST, V134, p1S, DOI 10.1378/chest.08-0201; Vandenplas O, 1997, EUR RESPIR J, V10, P2612, DOI 10.1183/09031936.97.10112612; Vandenplas O, 2011, EUR RESPIR J, V38, P804, DOI 10.1183/09031936.00177510; Vandenplas O, 2014, EUR RESPIR J, V43, P1573, DOI 10.1183/09031936.00180313; Vandenplas O, 2013, CHEST, V143, P1261, DOI 10.1378/chest.12-1983; Vandenplas O, 2011, ALLERGY ASTHMA IMMUN, V3, P157, DOI 10.4168/aair.2011.3.3.157; Wisnewski AV, 2008, CLIN EXP ALLERGY, V38, P957, DOI 10.1111/j.1365-2222.2008.02982.x	39	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156141	10.1371/journal.pone.0156141	http://dx.doi.org/10.1371/journal.pone.0156141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280473	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000016
J	Thakoor, JPD; Dong, HX; Zhang, XJ; Wang, G; Huang, H; Xiang, YT; Hao, W				Thakoor, Jaya Prishni Devi; Dong, Huixi; Zhang, Xiaojie; Wang, Gang; Huang, Hui; Xiang, Yutao; Hao, Wei			Duration of Untreated Psychosis in Chinese and Mauritian: Impact of Clinical Characteristics and Patients' and Families' Perspectives on Psychosis	PLOS ONE			English	Article							MENTAL-HEALTH; HELP-SEEKING; 1ST-EPISODE SCHIZOPHRENIA; INTERNALIZED STIGMA; BIPOLAR DISORDER; ILLNESS; PATHWAYS; CARE; METAANALYSIS; SERVICES	Background Duration of untreated psychosis (DUP) is a potentially modifiable prognostic factor of course and prognosis of psychiatric disorders. Few studies have demonstrated that different cultural backgrounds or perspectives on psychosis may be important factors to the DUP. This study attempted to explore whether the DUP was different in Chinese and Mauritians and to clarify potential influencing factors to a long DUP (>3 months). Methods 200 patients from China and 100 patients from Mauritius were enrolled in the study. Their respective family members were also recruited. Demographic and clinical characteristics were collected, and the Internalized Stigma of Mental Illness (ISMI) scale was adapted to measure the stigma in all subjects. Binary logistic regression analysis was used to find the potential influencing factors to the long DUP. Results 35.3% of the enrolled patients had a long DUP. No significant difference was found in frequency of long DUP between the two countries. Chinese patients had relatively less perceptions of stigma. Furthermore, Chinese patients with a long DUP had more perception of breakup due to mental illness (OR = 2.22, p = 0.04) and more families' perception of the patient being disinherited due to mental illness (OR = 6.47, p = 0.01). Mauritian patients with a long DUP were less likely to have high monthly income (OR = 0.12, p<0.01), while they had less patients' awareness of mental illness (OR = 0.31, p<0.05) and less families' awareness of mental illness (OR = 0.14, p<0.01). Conclusion The results of this study underlined the importance of DUP in economic conditions, racial and sociocultural factors, and public awareness on psychosis in developing countries.	[Thakoor, Jaya Prishni Devi] Sir Seewoosagur Ramgoolam Natl Hosp, Pamplemousses, Mauritius; [Dong, Huixi; Zhang, Xiaojie; Wang, Gang; Huang, Hui; Hao, Wei] Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhang, Xiaojie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Xiang, Yutao] Univ Macau, Fac Hlth Sci, Unit Psychiat, Taipa, Macao Sar, Peoples R China	Central South University; University of British Columbia; University of Macau	Hao, W (corresponding author), Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	weihao57@gmail.com			National Natural Science of China [81130020]; National 973 Program [2015CB553500]; Fundamental Research Funds for the Central Universities of Central South University	National Natural Science of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of Central South University	This work was supported by the Key Program of the National Natural Science of China (81130020) and National 973 Program (2015CB553500) to WH and the Fundamental Research Funds for the Central Universities of Central South University to HXD.	Altamura AC, 2010, EUR ARCH PSY CLIN N, V260, P385, DOI 10.1007/s00406-009-0085-2; [Anonymous], 2011, IND HLTH WORKF PSYCH; [Anonymous], 2014, MEAS PROGR UN HLTH C; Appiah-Poku J, 2004, SOC PSYCH PSYCH EPID, V39, P208, DOI 10.1007/s00127-004-0725-9; Bergner E, 2008, COMPR PSYCHIAT, V49, P530, DOI 10.1016/j.comppsych.2008.02.010; Bhikha AG, 2012, INT REV PSYCHIATR, V24, P450, DOI 10.3109/09540261.2012.711746; Birchwood M, 2013, BRIT J PSYCHIAT, V203, P58, DOI 10.1192/bjp.bp.112.125500; Boyd CP, 2011, RURAL REMOTE HEALTH, V11; Boyd JE, 2014, COMPR PSYCHIAT, V55, P221, DOI 10.1016/j.comppsych.2013.06.005; Brent BK, 2011, SCHIZOPHR RES, V127, P100, DOI 10.1016/j.schres.2010.12.024; Buoli M, 2014, EUR NEUROPSYCHOPHARM, V24, pS416, DOI 10.1016/S0924-977X(14)70665-0; Compton MT, 2004, SCHIZOPHR RES, V68, P373, DOI 10.1016/j.schres.2003.09.001; Dai Y., 2006, SHANGHAI ARCHPSYCHIA, V18, P1, DOI DOI 10.3969/J.ISSN.1002-0829.2006.01.001; de Diego-Adelino J, 2010, J AFFECT DISORDERS, V120, P221, DOI 10.1016/j.jad.2009.03.012; Drancourt N, 2013, ACTA PSYCHIAT SCAND, V127, P136, DOI 10.1111/j.1600-0447.2012.01917.x; Ehmann TS, 2014, EARLY INTERV PSYCHIA, V8, P240, DOI 10.1111/eip.12051; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Girma E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-138; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Hanlon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088437; Harris MG, 2005, SCHIZOPHR RES, V79, P85, DOI 10.1016/j.schres.2005.05.024; Hill M, 2012, SCHIZOPHR RES, V141, P215, DOI 10.1016/j.schres.2012.08.013; Jeppesen P, 2008, PSYCHOL MED, V38, P1157, DOI 10.1017/S0033291708003449; Lahariya Chandrakant, 2010, Indian J Psychiatry, V52, P333, DOI 10.4103/0019-5545.74308; Meltzer H, 2003, INT REV PSYCHIATR, V15, P123, DOI 10.1080/0954026021000046038; Murru A, 2015, J AFFECT DISORDERS, V188, P319, DOI 10.1016/j.jad.2015.09.009; Naqvi HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007409; Norman RMG, 2001, PSYCHOL MED, V31, P381, DOI 10.1017/S0033291701003488; O'Callaghan E, 2010, SOC PSYCH PSYCH EPID, V45, P381, DOI 10.1007/s00127-009-0081-x; OECD, 2011, HLTH AT A GLANC; Penttila M, 2014, BRIT J PSYCHIAT, V205, P88, DOI 10.1192/bjp.bp.113.127753; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Qin Hongyun, 2014, Shanghai Arch Psychiatry, V26, P42, DOI 10.3969/j.issn.1002-0829.2014.01.006; Qin LH, 2012, EARLY INTERV PSYCHIA, V6, P239, DOI 10.1111/j.1751-7893.2011.00325.x; Razali SM, 2000, INT J SOC PSYCHIATR, V46, P281, DOI 10.1177/002076400004600405; Renwick L, 2015, SCHIZOPHR RES, V168, P30, DOI 10.1016/j.schres.2015.07.001; Ritsher JB, 2003, PSYCHIAT RES, V121, P31, DOI 10.1016/j.physchres.2003.08.008; Schimmelmann BG, 2008, J PSYCHIATR RES, V42, P982, DOI 10.1016/j.jpsychires.2007.12.001; Tang YL, 2007, ADM POLICY MENT HLTH, V34, P101, DOI 10.1007/s10488-006-0084-9; WHO, 2006, REP ASS MENT HLTH SY	42	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157083	10.1371/journal.pone.0157083	http://dx.doi.org/10.1371/journal.pone.0157083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281125	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000080
J	van Mansfeld, R; de Vrankrijker, A; Brimicombe, R; Heijerman, H; van Berkhout, FT; Spitoni, C; Grave, S; van der Ent, C; Wolfs, T; Willems, R; Bonten, M				van Mansfeld, Rosa; de Vrankrijker, Angelica; Brimicombe, Roland; Heijerman, Harry; van Berkhout, Ferdinand Teding; Spitoni, Cristian; Grave, Sanne; van der Ent, Cornelis; Wolfs, Tom; Willems, Rob; Bonten, Marc			The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients	PLOS ONE			English	Article							EPIDEMIC STRAIN; TRANSMISSIBLE STRAINS; PARANASAL SINUSES; CROSS-INFECTION; SPREAD; CHILDREN; ADULTS	Introduction Segregation of patients with cystic fibrosis (CF) was implemented to prevent chronic infection with epidemic Pseudomonas aeruginosa strains with presumed detrimental clinical effects, but its effectiveness has not been carefully evaluated. Methods The effect of strict segregation on the incidence of P. aeruginosa infection in CF patients was investigated through longitudinal protocolized follow-up of respiratory tract infection before and after segregation. In two nested cross-sectional studies in 2007 and 2011 the P. aeruginosa population structure was investigated and clinical parameters were determined in patients with and without infection with the Dutch epidemic P. aeruginosa clone (ST406). Results Of 784 included patients 315 and 382 were at risk for acquiring chronic P. aeruginosa infection before and after segregation. Acquisition rates were, respectively, 0.14 and 0.05 per 1,000 days at risk (HR: 0.66, 95% CI [0.2548-1.541]; p = 0.28). An exploratory subgroup analysis indicated lower acquisition after segregation in children < 15 years of age (HR: 0.43, 95% CI[0.21-0.95]; p = 0.04). P. aeruginosa population structure did not change after segregation and ST406 was not associated with lung function decline, death or lung transplantation. Conclusions Strict segregation was not associated with a statistically significant lower acquisition of chronic P. aeruginosa infection and ST406 was not associated with adverse clinical outcome. After segregation there were no new acquisitions of ST406. In an unplanned exploratory analysis chronic acquisition of P. aeruginosa was lower after implementation of segregation in patients under 15 years of age.	[van Mansfeld, Rosa; Grave, Sanne; Willems, Rob; Bonten, Marc] UMCU, Dept Med Microbiol, Utrecht, Netherlands; [de Vrankrijker, Angelica; van der Ent, Cornelis] UMCU, Dept Pediat Pulm Dis, Utrecht, Netherlands; [Brimicombe, Roland] Haga Teaching Hosp, Dept Med Microbiol, The Hague, Netherlands; [Heijerman, Harry] Haga Teaching Hosp, Dept Pulmonol, The Hague, Netherlands; [van Berkhout, Ferdinand Teding] UMCU, Dept Pulmonol, Utrecht, Netherlands; [Spitoni, Cristian] Univ Utrecht, Dept Math, Utrecht, Netherlands; [Wolfs, Tom] UMCU, Dept Pediat Infect Dis, Utrecht, Netherlands; [Bonten, Marc] Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Unilever; Utrecht University; Utrecht University Medical Center; Unilever; Utrecht University; Utrecht University Medical Center; Haga Hospital; Haga Hospital; Unilever; Utrecht University; Utrecht University Medical Center; Utrecht University; Unilever; Utrecht University; Utrecht University Medical Center	van Mansfeld, R (corresponding author), UMCU, Dept Med Microbiol, Utrecht, Netherlands.	r.vanmansfeld@vumc.nl	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; Van der Ent, Cornelis/0000-0002-2501-4121	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO))	This research was partly funded by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanaes K, 2013, RHINOLOGY, V51, P222, DOI [10.4193/Rhino12.207, 10.4193/Rhin12.207]; Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Ashish Abdul, 2013, JRSM Short Rep, V4, P1, DOI 10.1258/shorts.2012.012018; Ashish A, 2012, J CYST FIBROS, V11, P173, DOI 10.1016/j.jcf.2011.11.004; Brimicombe RW, 2008, J CYST FIBROS, V7, P30, DOI 10.1016/j.jcf.2007.04.002; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; de Vrankrijker AMM, 2011, CLIN MICROBIOL INFEC, V17, P382, DOI 10.1111/j.1469-0691.2010.03295.x; Dutch Institute for Healthcare Improvement, 2007, CBO GUID DIAGN TREAT; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Frederiksen B, 1999, PEDIATR PULM, V28, P159, DOI 10.1002/(SICI)1099-0496(199909)28:3<159::AID-PPUL1>3.0.CO;2-1; Green DM, 2012, J PEDIATR-US, V161, P290, DOI 10.1016/j.jpeds.2012.01.042; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Griffiths AL, 2012, J CYST FIBROS, V11, P49, DOI 10.1016/j.jcf.2011.08.005; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Johansen HK, 2012, J CYST FIBROS, V11, P525, DOI 10.1016/j.jcf.2012.04.011; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jones AM, 2005, AM J RESP CRIT CARE, V171, P257, DOI 10.1164/rccm.200404-513OC; Jones AM, 2002, THORAX, V57, P924, DOI 10.1136/thorax.57.11.924; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Liu GH, 1997, BIOMETRICS, V53, P937, DOI 10.2307/2533554; McCallum SJ, 2001, LANCET, V358, P558, DOI 10.1016/S0140-6736(01)05715-4; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Taccetti G, 2012, THORAX, V67, P853, DOI 10.1136/thoraxjnl-2011-200832; Tingpej P, 2010, RESPIROLOGY, V15, P923, DOI 10.1111/j.1440-1843.2010.01792.x; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Wiehlmann L, 2012, INT J MED MICROBIOL, V302, P69, DOI 10.1016/j.ijmm.2011.11.001	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157189	10.1371/journal.pone.0157189	http://dx.doi.org/10.1371/journal.pone.0157189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280467	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000106
J	Zhang, YY; Guallar, E; Blasco-Colmenares, E; Harms, AC; Vreeken, RJ; Hankemeier, T; Tomaselli, GF; Cheng, A				Zhang, Yiyi; Guallar, Eliseo; Blasco-Colmenares, Elena; Harms, Amy C.; Vreeken, Rob J.; Hankemeier, Thomas; Tomaselli, Gordon F.; Cheng, Alan			Serum-Based Oxylipins Are Associated with Outcomes in Primary Prevention Implantable Cardioverter Defibrillator Patients	PLOS ONE			English	Article							17,18-EPOXYEICOSATETRAENOIC ACID TARGETS; N-3 FATTY-ACIDS; VENTRICULAR-ARRHYTHMIAS; HEART-FAILURE; RISK; PROTEIN; PLASMA; DEATH; METABOLITE; BIOMARKERS	Introduction Individuals with systolic heart failure are at risk of ventricular arrhythmias and all-cause mortality. Little is known regarding the mechanisms underlying these events. We sought to better understand if oxylipins, a diverse class of lipid metabolites derived from the oxidation of polyunsaturated fatty acids, were associated with these outcomes in recipients of primary prevention implantable cardioverter defibrillators (ICDs). Methods Among 479 individuals from the PROSE-ICD study, baseline serum were analyzed and quantitatively profiled for 35 known biologically relevant oxylipin metabolites. Associations with ICD shocks for ventricular arrhythmias and all-cause mortality were evaluated using Cox proportional hazards models. Results Six oxylipins, 17,18-DiHETE (HR = 0.83, 95% CI 0.70 to 0.99 per SD change in oxylipin level), 19,20-DiHDPA (HR = 0.79, 95% CI 0.63 to 0.98), 5,6-DiHETrE (HR = 0.73, 95% CI 0.58 to 0.91), 8,9-DiHETrE (HR = 0.76, 95% CI 0.62 to 0.95), 9,10-DiHOME (HR = 0.81, 95% CI 0.65 to 1.00), and PGF(1 alpha) (HR = 1.33, 95% CI 1.04 to 1.71) were associated with the risk of appropriate ICD shock after multivariate adjustment for clinical factors. Additionally, 4 oxylipin-to-precursor ratios, 15S-HEPE / FA (20: 5-omega 3), 17,18-DiHETE / FA (20: 5-omega 3), 19,20-DiHDPA / FA (20: 5-omega 3), and 5S-HEPE / FA (20: 5-omega 3) were positively associated with the risk of all-cause mortality. Conclusion In a prospective cohort of patients with primary prevention ICDs, we identified several novel oxylipin markers that were associated with appropriate shock and mortality using metabolic profiling techniques. These findings may provide new insight into the potential biologic pathways leading to adverse events in this patient population.	[Zhang, Yiyi; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Blasco-Colmenares, Elena; Tomaselli, Gordon F.; Cheng, Alan] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Harms, Amy C.; Vreeken, Rob J.; Hankemeier, Thomas] Leiden Univ, Leiden Acad Ctr Drug Res, Netherlands Metabol Ctr, Leiden, Netherlands; [Vreeken, Rob J.; Hankemeier, Thomas] Leiden Univ, Leiden Acad Ctr Drug Res, Analyt Biosci, Leiden, Netherlands; [Vreeken, Rob J.] Janssen R&D, Discovery Sci, Beerse, Belgium	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Cheng, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	alcheng@jhmi.edu	Hankemeier, Thomas/V-5407-2019; Vreeken, Rob/AAA-4563-2021	Hankemeier, Thomas/0000-0001-7871-2073; Vreeken, Rob/0000-0003-3568-1371; Harms, Amy/0000-0002-2931-4295	Donald W. Reynolds Foundation; National Institutes of Health [R01 HL103946, R01 HL091062]	Donald W. Reynolds Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Donald W. Reynolds Foundation and the National Institutes of Health [R01 HL103946 to AC and R01 HL091062 to GFT]. RJV is currently employed by Janssen R&D. His work in this project predated his employment with Janssen. Janssen R&D did not support nor had any input in this work.	Albert CM, 2002, CIRCULATION, V105, P2595, DOI 10.1161/01.CIR.0000017493.03108.1C; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248; Cheng A, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1084, DOI 10.1161/CIRCEP.113.001705; Cheng A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000083; Cheng ML, 2015, J AM COLL CARDIOL, V65, P1509, DOI 10.1016/j.jacc.2015.02.018; Christensen JH, 2005, EUROPACE, V7, P338, DOI 10.1016/j.eupc.2005.02.118; Cuthbert MF, 1973, PROSTAGLANDINS PHARM, Vxi; Cygankiewicz I, 2009, HEART RHYTHM, V6, P468, DOI 10.1016/j.hrthm.2008.12.023; Falck JR, 2011, J MED CHEM, V54, P4109, DOI 10.1021/jm200132q; Finzi AA, 2011, AM HEART J, V161, P338, DOI 10.1016/j.ahj.2010.10.032; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Gleim S, 2012, CELL MOL LIFE SCI, V69, P3361, DOI 10.1007/s00018-012-0982-9; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Hercule HC, 2007, EXP PHYSIOL, V92, P1067, DOI 10.1113/expphysiol.2007.038166; Hercule HC, 2009, ARTERIOSCL THROM VAS, V29, P54, DOI 10.1161/ATVBAHA.108.171298; Jouven X, 2001, CIRCULATION, V104, P756, DOI 10.1161/hc3201.094151; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; LAVERY HA, 1970, BRIT J PHARMACOL, V39, P511, DOI 10.1111/j.1476-5381.1970.tb10359.x; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; MILLER CC, 1990, J NUTR, V120, P36, DOI 10.1093/jn/120.1.36; Morin C, 2011, AM J PHYSIOL-HEART C, V301, pH1311, DOI 10.1152/ajpheart.00380.2011; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Saudubray JM, 1999, J INHERIT METAB DIS, V22, P488; Schuchardt JP, 2013, PROSTAG LEUKOTR ESS, V89, P19, DOI 10.1016/j.plefa.2013.04.001; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Singh JP, 2005, J AM COLL CARDIOL, V46, P1712, DOI 10.1016/j.jacc.2005.05.088; Smith SC, 2008, HEART RHYTHM, V5, P934, DOI 10.1016/j.hrthm.2008.04.015; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; STRONG CG, 1967, AM J PHYSIOL, V213, P725, DOI 10.1152/ajplegacy.1967.213.3.725; Tourdot BE, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00176; van Erk MJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-5; Wang J, 2013, MOL BIOSYST, V9, P2618, DOI 10.1039/c3mb70227h; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; WILLEBRANDS AF, 1968, AM J PHYSIOL, V215, P1089, DOI 10.1152/ajplegacy.1968.215.5.1089; Yang KC, 2015, CIRC RES, V116, P1937, DOI 10.1161/CIRCRESAHA.116.304691; Zhang Y, 2015, EUROPACE, DOI [10.1093/europace/euv342, DOI 10.1093/EUR0PACE/EUV342]	42	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157035	10.1371/journal.pone.0157035	http://dx.doi.org/10.1371/journal.pone.0157035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281224	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000071
J	Zhou, H; Zhang, L; Ye, F; Wang, HJ; Huntington, D; Huang, YJ; Wang, AQ; Liu, SQ; Wang, Y				Zhou, Hong; Zhang, Long; Ye, Fang; Wang, Hai-jun; Huntington, Dale; Huang, Yanjie; Wang, Anqi; Liu, Shuiqing; Wang, Yan			The Effect of Maternal Death on the Health of the Husband and Children in a Rural Area of China: A Prospective Cohort Study	PLOS ONE			English	Article							SHORT SCREENING SCALE; FEEDING PATTERNS; MORTALITY; IMPACTS; INFANT; MALNUTRITION; SURVIVAL; FAMILIES; BUTAJIRA; COUNTIES	Objective To examine the effects of maternal death on the health of the index child, the health and educational attainment of the older children, and the mental health and quality of life of the surviving husband. Methods A cohort study including 183 households that experienced a maternal death matched to 346 households that experienced childbirth but not a maternal death was conducted prospectively between June 2009 and October 2011 in rural China. Data on household sociodemographic characteristics, physical and mental health were collected using a quantitative questionnaire and medical examination at baseline and follow-up surveys. Multivariate linear regression, logistic regression models and difference-in-difference (DID) were used to compare differences of outcomes between two groups. Findings The index children who experienced the loss of a mother had a significantly higher likelihood of dying, abandonment and malnutrition compared to children whose mothers survived at the follow-up survey. The risk of not attending school on time and dropping out of school among older children in the affected group was higher than those in the control group during the follow-up. Husbands whose wife died had significantly lower EQ-5D index and EQ-VAS both at baseline and at follow-up surveys compared to those without experiencing a wife's death, suggesting an immediate and sustained poorer mental health quality of life among the surviving husbands. Also the prevalence of posttraumatic stress disorder (PTSD) was 72.6% at baseline and 56.2% at follow-up among husbands whose wife died. Conclusions Maternal death has multifaceted and spillover effects on the physical and mental health of family members that are sustained over time. Programmes that reduce maternal mortality will mitigate repercussions on surviving family members are critical and needed.	[Zhou, Hong; Wang, Anqi; Liu, Shuiqing; Wang, Yan] Peking Univ, Div Maternal & Child Hlth, Sch Publ Hlth, 38 Xueyuan Rd Haidian Dist, Beijing 100871, Peoples R China; [Zhang, Long] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ye, Fang] China Japan Friendship Hosp, Dept Prevent Hlth Care, 38 Xueyuan Rd Haidian Dist, Beijing, Peoples R China; [Wang, Hai-jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, 38 Xueyuan Rd Haidian Dist, Beijing 100871, Peoples R China; [Huntington, Dale] World Hlth Org Western Pacific Reg Off, Asia Pacific Observ Hlth Syst & Policies, Manila, Philippines; [Huang, Yanjie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; China-Japan Friendship Hospital; Peking University; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, Y (corresponding author), Peking Univ, Div Maternal & Child Hlth, Sch Publ Hlth, 38 Xueyuan Rd Haidian Dist, Beijing 100871, Peoples R China.	wangyan@bjmu.edu.cn	huang, yan/GWM-4747-2022; Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland [A65403]; Chinese Ministry of Health and Provincial Health Offices	UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland; Chinese Ministry of Health and Provincial Health Offices	This study was supported by a grant from the UNDP/UNFPA/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland (http://www.who.int/reproductivehealth/en/). The grant number is A65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank research teams from Hebei, Henan, and Yunnan provinces for their hard work in orchestrating the field work and the support from the Chinese Ministry of Health and Provincial Health Offices in assistance with identifying study population through the registration system. We also want to thank all of family members who participated in this study and expressed our condolences to those who experienced the loss of their loved one. We are grateful for endeavors from each member in Economic Impact of Maternal Deaths study, including Yan Wang (principal investigator), Hai-Jun Wang, Fang Ye, Hong Zhou, Chu-Yun Kang, Shan-Shan Hou, Du Wang, Deng Ao, Yao Feng, Yi-Chong Xu (Division of Maternal and Child Health, School of Public Health, Peking University), Jin-Hua Li, Hai-Ying Ma (Hebei Women and Children Health Center) in Hebei; Mei-Lin Yao, Feng-Zhi You, Wei-jie Zhang, Hui-Min Qu, Xiao-Hui Xu, Rui Wang, Jian Liu, Wen-Bin Jia, De-Qi Du, Jie Deng (Women's healthcare section, Zheng-zhou University 3rd Affiliated Hospital) in Henan; Yan Li, Wen-Long Cui, Ying Huang, Jing Long, Hai-Mei Hu, Shi-Hong Xu, Jun-Ying Wang, Hai-Xia Yang, Ying Tan, Gui-Cun Chen, Xi-Ying Luo (School of Public Health, Kunming Medical College); Ya-Ping Zhu, Hong Zhou, Tao Zhao, Wei Li, Guang-Ping Guo (Maternal and Child Health Hospital of Yunnan) in Yunnan. We acknowledge Robert Black for providing intellectual suggestions on the revision of manuscript.	Ang M, 2013, OPTOMETRY VISION SCI, V90, P861, DOI 10.1097/OPX.0000000000000004; Bazile J, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S1; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Case A, 2006, DEMOGRAPHY, V43, P401, DOI 10.1353/dem.2006.0022; China . NHaFPCo, 2016, CHIN HLTH STAT YB; Dalen N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-321; de Souza Orivaldo Florencio, 2012, Rev Bras Epidemiol, V15, P211, DOI 10.1590/S1415-790X2012000100019; Ferdous F, 2013, AM J TROP MED HYG, V89, P223, DOI 10.4269/ajtmh.12-0743; Finlay JE, 2015, MATERN CHILD HLTH J, V19, P2393, DOI 10.1007/s10995-015-1758-2; Fujikawa Ai, 2011, Environmental Health and Preventive Medicine, V16, P25, DOI 10.1007/s12199-010-0162-1; Hauksdottir A, 2013, PSYCHO-ONCOLOGY, V22, P352, DOI 10.1002/pon.2096; Houle B, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S7; Karakartal D., 2012, INT ONLINE J PRIMARY, V1, P37; Kimerling R, 2006, J GEN INTERN MED, V21, P65, DOI 10.1111/j.1525-1497.2005.00292.x; Knight L, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S5; Mihrshahi S, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-28; Molla M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S6; Moucheraud C, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S4; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Ratti ML, 2011, I HAVE GO EFFECT MOT; RISMAN BJ, 1986, FAM RELAT, V35, P95, DOI 10.2307/584288; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; Tessema M, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.75.1630; Tremblay GC, 1998, CLIN PSYCHOL-SCI PR, V5, P424, DOI 10.1111/j.1468-2850.1998.tb00165.x; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Unicef, 2014, TRENDS MAT MORT 1990; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076624; Wang YP, 2016, LANCET, V387, P273, DOI 10.1016/S0140-6736(15)00554-1; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Ye F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134756; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038467; Zhou H, 2012, ASIA PAC J CLIN NUTR, V21, P234	33	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157122	10.1371/journal.pone.0157122	http://dx.doi.org/10.1371/journal.pone.0157122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280717	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000088
J	Nahvijou, A; Daroudi, R; Tahmasebi, M; Hashemi, FA; Hemami, MR; Sari, AA; Marenani, AB; Zendehdel, K				Nahvijou, Azin; Daroudi, Rajabali; Tahmasebi, Mamak; Hashemi, Farnaz Amouzegar; Hemami, Mohsen Rezaei; Sari, Ali Akbari; Marenani, Ahmad Barati; Zendehdel, Kazem			Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; NATURAL-HISTORY; HPV; CYTOLOGY; INFECTION; WOMEN; ABNORMALITIES; PREVENTION; MANAGEMENT; FREQUENCY	Objective Invasive cervical cancer (ICC) is the fourth most common cancer among women worldwide. Cervical screening programs have reduced the incidence and mortality rates of ICC. We studied the cost-effectiveness of different cervical screening strategies in the Islamic Republic of Iran, a Muslim country with a low incidence rate of ICC. Methods We constructed an 11-state Markov model, in which the parameters included regression and progression probabilities, test characteristics, costs, and utilities; these were extracted from primary data and the literature. Our strategies included Pap smear screening and human papillomavirus (HPV) DNA testing plus Pap smear triaging with different starting ages and screening intervals. Model outcomes included lifetime costs, life years gained, quality-adjusted life years (QALY), and incremental cost-effectiveness ratios (ICERs). One-way sensitivity analysis was performed to examine the stability of the results. Results We found that the prevented mortalities for the 11 strategies compared with no screening varied from 26% to 64%. The most cost-effective strategy was HPV screening, starting at age 35 years and repeated every 10 years. The ICER of this strategy was $ 8,875 per QALY compared with no screening. We found that screening at 5-year intervals was also costeffective based on GDP per capita in Iran. Conclusion We recommend organized cervical screening with HPV DNA testing for women in Iran, beginning at age 35 and repeated every 10 or 5 years. The results of this study could be generalized to other countries with low incidence rates of cervical cancer.	[Nahvijou, Azin; Tahmasebi, Mamak; Hashemi, Farnaz Amouzegar] Univ Tehran Med Sci, Canc Inst Iran, Canc Res Ctr, Tehran, Iran; [Daroudi, Rajabali; Sari, Ali Akbari] Univ Tehran Med Sci, Dept Hlth Management & Econ, Sch Publ Hlth, Tehran, Iran; [Hemami, Mohsen Rezaei] Univ Glasgow, Inst Hlth & Wellbeing Hlth Econ & Hlth Technol As, Glasgow G12 8QQ, Lanark, Scotland; [Marenani, Ahmad Barati] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Dept Hlth Serv Management, Tehran, Iran; [Zendehdel, Kazem] Univ Tehran Med Sci, Canc Inst Iran, Canc Model Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Glasgow; Iran University of Medical Sciences; Tehran University of Medical Sciences	Zendehdel, K (corresponding author), Univ Tehran Med Sci, Canc Inst Iran, Canc Model Res Ctr, Tehran, Iran.	kzendeh@tums.ac.ir	Nahvijou, Azin/O-5612-2017; Nahvijou, Azin/AAL-4117-2020	Nahvijou, Azin/0000-0003-1973-7638; Nahvijou, Azin/0000-0003-1973-7638; Daroudi, Rajabali/0000-0002-0487-4114; Zendehdel, Kazem/0000-0002-0269-4945	Iran University of Medical Sciences [IUMS/SHMIS-1391/128]	Iran University of Medical Sciences	This work was part of a PhD dissertation supported by Iran University of Medical Sciences (Grant No.: IUMS/SHMIS-1391/128).	Andres-Gamboa O, 2008, SALUD PUBLICA MEXICO, V50, P276, DOI 10.1590/s0036-36342008000400005; [Anonymous], 2016, NETW ICS ORG CERV CA; [Anonymous], 2014, FDA OKS HPV DNA TEST; Anttila A, 2004, BRIT J CANCER, V91, P935, DOI 10.1038/sj.bjc.6602069; Anttila A, 2009, EUR J CANCER, V45, P2649, DOI 10.1016/j.ejca.2009.07.020; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Behtash N., 2008, Research Journal of Biological Sciences, V3, P627; Bergeron C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju423; Berkhof J, 2010, INT J CANCER, V127, P2147, DOI 10.1002/ijc.25211; BOFFETTA P, 1994, CA-CANCER J CLIN, V44, P81, DOI 10.3322/canjclin.44.2.81; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Burger E, 2012, BRIT J CANC; Center for Disease Control & prevention Noncomunicable Diseases Unit Cancer Office, 2012, IR ANN NAT CANC REG; Chow IHI, 2010, BRIT J CANCER, V103, P1773, DOI 10.1038/sj.bjc.6605974; Cox JT, 2009, J CLIN VIROL, V45, pS3, DOI 10.1016/S1386-6532(09)70002-2; Cuzick J, 2000, BRIT J CANCER, V83, P561, DOI 10.1054/bjoc.2000.1375; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Daroudi A, 2014, REV METHODS ESTIMATI; Denny L, 2015, INT J GYNECOLOGY OBS; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Garber AM, 2010, HEALTH AFFAIR, V29, P1805, DOI 10.1377/hlthaff.2010.0647; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hadji M, 2015, BASIC CLIN CANC RES, V7, P9; Huh WK, 2015, GYNECOLOGIC ONCOLOGY; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Khaksar N KF, 2014, SURVIVAL AN IN PRESS; Khodakarami N, 2012, INT J CANCER, V131, pE156, DOI 10.1002/ijc.26488; Khorasanizadeh F, 2013, GYNECOL ONCOL, V128, P277, DOI 10.1016/j.ygyno.2012.11.032; Kim JJ, 2005, JNCI-J NATL CANCER I, V97, P888, DOI 10.1093/jnci/dji162; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; Kulasingam SL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-69; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; LAARA E, 1987, LANCET, V1, P1247; Levin CE, 2010, INT J CANCER, V127, P1404, DOI 10.1002/ijc.25150; Macroeconomics W, 2001, HLTH INV HLTH EC DEV; Majidi A, 2015, INT J HLTH POLICY MA; Malloy C., 2000, HPV DNA TESTING TECH; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Melnikow J, 1998, OBSTET GYNECOL, V92, P727, DOI 10.1016/S0029-7844(98)00245-2; Melnikow J, 2010, OBSTET GYNECOL, V116, P1158, DOI 10.1097/AOG.0b013e3181f88e72; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nahar K N, 2011, Mymensingh Med J, V20, P528; Nahvijou A, 2014, ASIAN PAC J CANCER P, V15, P8209, DOI 10.7314/APJCP.2014.15.19.8209; Nahvijou A, 2014, ASIAN PAC J CANCER P, V15, P8229, DOI 10.7314/APJCP.2014.15.19.8229; Nessa A, 2013, ASIAN PAC J CANCER P, V14, P7607, DOI 10.7314/APJCP.2013.14.12.7607; Organization W.H, 2013, GLOB HLTH OBS DAT RE; Park Y, 2012, J CLIN MICROBIOL, V50, P2359, DOI 10.1128/JCM.00337-12; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Ronco G, 2007, EUR J CANCER, V43, P476, DOI 10.1016/j.ejca.2006.11.013; Sankaranarayanan R, 2012, CERVICAL CANC SCREEN, P3; Sawaya GF, 2007, NEW ENGL J MED, V356, P1991, DOI 10.1056/NEJMe078060; Sawaya GF, 2000, OBSTET GYNECOL, V96, P219, DOI 10.1016/S0029-7844(00)00882-6; Sroczynski G, 2011, EUR J CANCER, V47, P1633, DOI 10.1016/j.ejca.2011.03.006; Sroczynski G., 2010, GMS HLTH TECHNOL ASS, V6, P05; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Szende A, 2007, EQ 5D VALUE SETS INV; Tanprasertkul C, 2010, THAMMASAT MED J, V9, P15; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; Vijayaraghavan A, 2009, GYNECOL ONCOL, V112, P377, DOI 10.1016/j.ygyno.2008.08.030; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Zarchi MK, 2010, ASIAN PAC J CANCER P, V11, P1289	67	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156705	10.1371/journal.pone.0156705	http://dx.doi.org/10.1371/journal.pone.0156705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276093	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000377561700032
J	Cheng, J; Yang, W; Huang, MY; Huang, W; Jiang, J; Zhou, YJ; Yang, R; Zhao, J; Feng, YQ; Feng, QJ; Chen, WF				Cheng, Jun; Yang, Wei; Huang, Meiyan; Huang, Wei; Jiang, Jun; Zhou, Yujia; Yang, Ru; Zhao, Jie; Feng, Yanqiu; Feng, Qianjin; Chen, Wufan			Retrieval of Brain Tumors by Adaptive Spatial Pooling and Fisher Vector Representation	PLOS ONE			English	Article							IMAGE RETRIEVAL	Content-based image retrieval (CBIR) techniques have currently gained increasing popularity in the medical field because they can use numerous and valuable archived images to support clinical decisions. In this paper, we concentrate on developing a CBIR system for retrieving brain tumors in T1-weighted contrast-enhanced MRI images. Specifically, when the user roughly outlines the tumor region of a query image, brain tumor images in the database of the same pathological type are expected to be returned. We propose a novel feature extraction framework to improve the retrieval performance. The proposed framework consists of three steps. First, we augment the tumor region and use the augmented tumor region as the region of interest to incorporate informative contextual information. Second, the augmented tumor region is split into subregions by an adaptive spatial division method based on intensity orders; within each subregion, we extract raw image patches as local features. Third, we apply the Fisher kernel framework to aggregate the local features of each subregion into a respective single vector representation and concatenate these per-subregion vector representations to obtain an image-level signature. After feature extraction, a closed-form metric learning algorithm is applied to measure the similarity between the query image and database images. Extensive experiments are conducted on a large dataset of 3604 images with three types of brain tumors, namely, meningiomas, gliomas, and pituitary tumors. The mean average precision can reach 94.68%. Experimental results demonstrate the power of the proposed algorithm against some related state-of-the-art methods on the same dataset.	[Cheng, Jun; Yang, Wei; Huang, Meiyan; Huang, Wei; Jiang, Jun; Zhou, Yujia; Yang, Ru; Zhao, Jie; Feng, Yanqiu; Feng, Qianjin; Chen, Wufan] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Zhao, Jie] Guangdong Pharmaceut Univ, Sch Med Informat Engn, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Pharmaceutical University	Feng, QJ (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.	qianjinfeng08@gmail.com	feng, qianjin/GNM-7856-2022; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; 	National Natural Science Foundation of China [61471187, 31371009]; Pearl River Young Talents of Science and Technology in Guangzhou [2013J2200065]; Science and Technology Planning Project of Guangdong Province, China [2015B010106008]; Medical Science and Technology Research Fund of Guangdong [B2014241]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pearl River Young Talents of Science and Technology in Guangzhou; Science and Technology Planning Project of Guangdong Province, China; Medical Science and Technology Research Fund of Guangdong	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grant no. 61471187 and no. 31371009; Program of Pearl River Young Talents of Science and Technology in Guangzhou (http://www.gzsi.gov.cn/) under grant no. 2013J2200065; Science and Technology Planning Project of Guangdong Province, China, no. 2015B010106008; and Medical Science and Technology Research Fund of Guangdong under grant no. B2014241. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanahi B., 2008, PROC 23 NAT C ARTIF, P598; Boiman O, 2008, PROC CVPR IEEE, P1992, DOI 10.1109/CVPR.2008.4587598; Fan B, 2011, PROC CVPR IEEE, DOI 10.1109/CVPR.2011.5995385; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Greenspan H, 2007, IEEE T INF TECHNOL B, V11, P190, DOI 10.1109/TITB.2006.874191; Guan HY, 2009, I S BIOMED IMAGING, P354, DOI 10.1109/ISBI.2009.5193057; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Huang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102754; Huang MY, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/280538; Iakovidis DK, 2009, IEEE T INF TECHNOL B, V13, P442, DOI 10.1109/TITB.2008.923144; Jaakkola TS, 1999, ADV NEUR IN, V11, P487; Jegou H, 2012, IEEE T PATTERN ANAL, V34, P1704, DOI 10.1109/TPAMI.2011.235; Jiang J, 2013, COMPUT MED IMAG GRAP, V37, P512, DOI 10.1016/j.compmedimag.2013.05.007; Jiang ML, 2015, IEEE T BIO-MED ENG, V62, P783, DOI 10.1109/TBME.2014.2365494; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Lu GJ, 2002, IEEE T MULTIMEDIA, V4, P372, DOI 10.1109/TMM.2002.802831; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Perronnin F., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383266; Perronnin F, 2010, PROC CVPR IEEE, P3384, DOI 10.1109/CVPR.2010.5540009; Perronnin F, 2010, LECT NOTES COMPUT SC, V6314, P143, DOI 10.1007/978-3-642-15561-1_11; Quellec G, 2010, MED IMAGE ANAL, V14, P227, DOI 10.1016/j.media.2009.11.004; Rahman MM, 2008, COMPUT MED IMAG GRAP, V32, P95, DOI 10.1016/j.compmedimag.2007.10.001; Rogowitz B., 2001, P IEEE INT C IM PROC, P1, DOI [10.1109/ICIP.2001.958942, DOI 10.1109/ICIP.2001.958942]; Simonyan K, 2014, IEEE T PATTERN ANAL, V36, P1573, DOI 10.1109/TPAMI.2014.2301163; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Weinberger K., 2006, ADV NEURAL INFORM PR, V18, P1473, DOI DOI 10.1007/978-3-319-13168-9_; Wu PC, 2016, IEEE T KNOWL DATA EN, V28, P454, DOI 10.1109/TKDE.2015.2477296; Xing E. P., 2003, ADV NEURAL INF PROCE, P521; Yang M, 2014, INT J COMPUT VISION, V109, P209, DOI 10.1007/s11263-014-0722-8; Yang W, 2012, J DIGIT IMAGING, V25, P708, DOI 10.1007/s10278-012-9495-1; Yang W, 2012, MED PHYS, V39, P6929, DOI 10.1118/1.4754305; Zheng L, 2003, IEEE T INF TECHNOL B, V7, P249, DOI 10.1109/TITB.2003.822952	35	50	50	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157112	10.1371/journal.pone.0157112	http://dx.doi.org/10.1371/journal.pone.0157112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27273091	Green Submitted, gold, Green Published			2022-12-27	WOS:000377560200031
J	Al-Mahtab, M; Bazinet, M; Vaillant, A				Al-Mahtab, Mamun; Bazinet, Michel; Vaillant, Andrew			Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg plus Chronic Hepatitis B Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; VIRUS INFECTION; ANTISENSE OLIGONUCLEOTIDE; ADEFOVIR DIPIVOXIL; NATURAL-HISTORY; IMMUNE GLOBULIN; LAMIVUDINE; ENTECAVIR; ESTABLISHMENT; COMBINATION	Previous in vivo studies have suggested that nucleic acid polymers (NAPs) may reduce circulating levels of HBsAg in the blood by blocking its release from infected hepatocytes and that this effect may have clinical benefit. NAP treatment, was evaluated in two clinical studies in patients with HBeAg positive chronic HBV infection. The REP 101 study examined REP 2055 monotherapy in 8 patients and the REP 102 study examined REP 2139-Ca, in monotherapy in 12 patients, 9 of which transitioned to short term combined treatment with pegylated interferon alpha 2a or thymosin alpha 1. In both studies NAP monotherapy was accompanied by 2-7 log reductions of serum HBsAg, 3-9 log reductions in serum HBV DNA and the appearance of serum anti-HBsAg antibodies (10-1712 mIU/ml). Eight of the 9 patients transitioning to combined treatment with immunotherapy (pegylated interferon or thymosin alpha 1) in the REP 102 study experienced HBsAg loss and all 9 patients experienced substantial increases in serum anti-HBsAg antibody titers before withdrawal of therapy. For 52 weeks after removal of REP 2055 therapy, rebound of serum viremia (HBV DNA > 1000 copies / ml, HBsAg > 1IU / ml) was not observed in 3 / 8 patients. Suppression of serum virema was further maintained for 290 and 231 weeks in 2 of these patients. After withdrawal of all therapy in the 9 patients that transitioned to combination therapy in the REP 102 study, 8 patients achieved HBV DNA < 116 copies / ml after treatment withdrawal. Viral rebound occurred over a period of 12 to 123 weeks in 7 patients but was still absent in two patients at 135 and 137 weeks of follow-up. Administration tolerability issues observed with REP 2055 were rare with REP 2139-Ca but REP 2139-Ca therapy was accompanied by hair loss, dysphagia and dysgeusia which were considered related to heavy metal exposure endemic at the trial site. These preliminary studies suggest that NAP can elicit important antiviral responses during treatment which may improve the effect of immunotherapy. NAPs may be a potentially useful component of future combination therapies for the treatment of chronic hepatitis B.	[Al-Mahtab, Mamun] Bangabandhu Sheikh Mujib Med Univ, Shahbagh Rd, Dhaka 1000, Bangladesh; [Bazinet, Michel; Vaillant, Andrew] Replicor Inc, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada	Bangabandhu Sheikh Mujib Medical University (BSMMU)	Vaillant, A (corresponding author), Replicor Inc, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	availlant@replicor.com		VAILLANT, Andrew/0000-0002-1433-0700	Replicor Inc.	Replicor Inc.	This work was supported by Replicor Inc. The funder provided support in the form of salaries for authors [AV, MB] and funds required to conduct all clinical activities, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahtab M, 2015, J CLIN VIROL, V69, P228, DOI 10.1016/j.jcv.2015.06.021; Burda MR, 2001, ANTIVIR RES, V52, P125, DOI 10.1016/S0166-3542(01)00177-2; Cardin RD, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-214; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Cheng JD, 2005, J HEPATOL, V43, P465, DOI 10.1016/j.jhep.2005.02.033; Chi KN, 2005, J NATL CANCER I, V97, P1287, DOI 10.1093/jnci/dji252; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Franke C, 2007, VIROLOGY, V359, P126, DOI 10.1016/j.virol.2006.09.006; Frenette CT, 2009, AM J GASTROENTEROL, V104, P1948, DOI 10.1038/ajg.2009.204; Fung J, 2011, AM J GASTROENTEROL, V106, P1766, DOI 10.1038/ajg.2011.253; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Hsu CW, 2011, HEPATOLOGY, V54, P101, DOI 10.1002/hep.24363; Islam M. S., 2014, International Food Research Journal, V21, P2121; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Mata JE, 2000, J TOXICOL-CLIN TOXIC, V38, P383, DOI 10.1081/CLT-100100947; Monia BP, 1996, J BIOL CHEM, V271, P14533, DOI 10.1074/jbc.271.24.14533; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Noordeen F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140909; Noordeen F, 2013, ANTIMICROB AGENTS CH, V57, P5299, DOI 10.1128/AAC.01005-13; Noordeen F, 2013, ANTIMICROB AGENTS CH, V57, P5291, DOI 10.1128/AAC.01003-13; Protzer-Knolle U, 1998, HEPATOLOGY, V27, P254, DOI 10.1002/hep.510270138; Rakib MA., 2014, INT RES J ENV SCI, V3, P1; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shi BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044900; Tolcher AW, 2004, CLIN CANCER RES, V10, P5048, DOI 10.1158/1078-0432.CCR-03-0701; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Vanlandschoot P, 2002, J GEN VIROL, V83, P1281, DOI 10.1099/0022-1317-83-6-1281; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2013, CLIN GASTROENTEROL H, V11, P1004, DOI 10.1016/j.cgh.2013.01.026; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Zoutendijk R, 2011, J INFECT DIS, V204, P415, DOI 10.1093/infdis/jir282	39	118	125	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156667	10.1371/journal.pone.0156667	http://dx.doi.org/10.1371/journal.pone.0156667			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257978	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700098
J	Colella, S; Falcini, F; Rinaldi, E; Sammartino, M; Santoleri, R				Colella, Simone; Falcini, Federico; Rinaldi, Eleonora; Sammartino, Michela; Santoleri, Rosalia			Mediterranean Ocean Colour Chlorophyll Trends	PLOS ONE			English	Article							A CONCENTRATION; COASTAL WATERS; TIME-SERIES; VARIABILITY; EUTROPHICATION; SEA; PRODUCTIVITY; EGYPT; NORTH; SEASONALITY	In being at the base of the marine food web, phytoplankton is particularly important for marine ecosystem functioning (e.g., biodiversity). Strong anthropization, over-exploitation of natural resources, and climate change affect the natural amount of phytoplankton and, therefore, represent a continuous threat to the biodiversity in marine waters. In particular, a concerning risks for coastal waters is the increase in nutrient inputs of terrestrial/anthropogenic origin that can lead to undesirable modifications of phytoplankton concentration (i.e., eutrophication). Monitoring chlorophyll (Chl) concentration, which is a proxy of phytoplankton biomass, is an efficient tool for recording and understanding the response of the marine ecosystem to human pressures and thus for detecting eutrophication. Here, we compute Chl trends over the Mediterranean Sea by using satellite data, also highlighting the fact that remote sensing may represent an efficient and reliable solution to synoptically control the "good environmental status" (i.e., the Marine Directive to achieve Good Environmental Status of EU marine waters by 2020) and to assess the application of international regulations and environmental directives. Our methodology includes the use of an ad hoc regional (i.e., Mediterranean) algorithm for Chl concentration retrieval, also accounting for the difference between offshore (i.e., Case I) and coastal (i.e., Case II) waters. We apply the Mann-Kendall test and the Sens's method for trend estimation to the Chl concentration de-seasonalized monthly time series, as obtained from the X-11 technique. We also provide a preliminary analysis of some particular trends by evaluating their associated inter-annual variability. The high spatial resolution of our approach allows a clear identification of intense trends in those coastal waters that are affected by river outflows. We do not attempt to attribute the observed trends to specific anthropogenic events. However, the trends that we document are consistent with the findings of several previous studies.	[Colella, Simone; Falcini, Federico; Rinaldi, Eleonora; Sammartino, Michela; Santoleri, Rosalia] CNR ISAC, Via Fosso del Cavaliere 100, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR)	Santoleri, R (corresponding author), CNR ISAC, Via Fosso del Cavaliere 100, I-00133 Rome, Italy.	r.santoleri@isac.cnr.it		Falcini, Federico/0000-0001-8105-2491; COLELLA, SIMONE/0000-0002-7727-7353	RITMARE - Italian Research Ministry (MIUR) Projects; EU Project EMODNET MedSea checkpoint [MARE/2012/1]; EU Project MyOceanFO - Pre-Operational Marine Service Continuity in Transition towards Copernicus [210129802]	RITMARE - Italian Research Ministry (MIUR) Projects; EU Project EMODNET MedSea checkpoint; EU Project MyOceanFO - Pre-Operational Marine Service Continuity in Transition towards Copernicus	This work was supported by the RITMARE - Italian Research Ministry (MIUR) Projects, and the EU Projects EMODNET MedSea checkpoint (#MARE/2012/1; www.emodnet-mediterranean.eu) and MyOceanFO - Pre-Operational Marine Service Continuity in Transition towards Copernicus (#210129802; marine.copernicus.eu). All authors have no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz OIA, 2006, J HYDROL, V319, P282, DOI 10.1016/j.jhydrol.2005.06.039; Barale V, 2008, REMOTE SENS ENVIRON, V112, P3300, DOI 10.1016/j.rse.2007.10.014; Beaulieu C, 2013, BIOGEOSCIENCES, V10, P2711, DOI 10.5194/bg-10-2711-2013; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Berthon J-F, 2002, SEAWIFS POSTLAUNCH T, V20, P1; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Brown CW, 2014, DEEP-SEA RES PT I, V90, P166, DOI 10.1016/j.dsr.2014.05.009; Bulut H, 2008, INT J NATURAL ENG SC, V1, P115; Coppini G., 2013, INT J GEOSCI, V4, P927, DOI [DOI 10.4236/IJG.2013.46087, 10.4236/ijg.2013.46087]; Cozzi S, 2011, CONT SHELF RES, V31, P1881, DOI 10.1016/j.csr.2011.08.010; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2833, DOI 10.1109/TGRS.2003.818020; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2861, DOI 10.1109/TGRS.2003.817682; Dagum E. B., 1980, 12564E STAT CAN; Deyab Mohamed Ali Ibraheem, 2015, Journal of Coastal Life Medicine, V3, P113, DOI 10.12980/JCLM.3.2015JCLM-2014-0097; Djakovac T, 2012, ESTUAR COAST SHELF S, V115, P25, DOI 10.1016/j.ecss.2012.03.029; Dorgham MM, 2004, OCEANOLOGIA, V46, P25; *EEA, 2005, 7 EEA; *EEA, 2005, 1 EEA; Ferreira JG, 2011, ESTUAR COAST SHELF S, V93, P117, DOI 10.1016/j.ecss.2011.03.014; Findley DF, 1998, J BUS ECON STAT, V16, P127, DOI 10.2307/1392565; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Gohin F, 2008, REMOTE SENS ENVIRON, V112, P3329, DOI 10.1016/j.rse.2008.02.014; Gregg WW, 2014, J GEOPHYS RES-OCEANS, V119, P5921, DOI 10.1002/2014JC010158; Gregg WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021808; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; Karageorgis AP, 2005, REG ENVIRON CHANGE, V5, P138, DOI 10.1007/s10113-004-0078-7; Kendall M., 1938, NATURE, V142, P402, DOI [10.2307/2280246, DOI 10.2307/2280246]; Khairy HM, 2014, REV BIOL MAR OCEANOG, V49, P267, DOI 10.4067/S0718-19572014000200007; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Lavender S, 2013, REMOTE SENSING APPL, P12; Loisel H, 2014, REMOTE SENS ENVIRON, V150, P218, DOI 10.1016/j.rse.2014.05.006; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Markovic M, 2001, UN ENV PROGRAMME DIV; Marsaleix P, 1998, J MARINE SYST, V14, P99, DOI 10.1016/S0924-7963(97)00011-0; Melin F, 2011, PROG OCEANOGR, V91, P229, DOI 10.1016/j.pocean.2010.12.001; Melin F, 2000, INTEGRATED TOOL SEAW; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Nikolaidis NP, 2009, ECOL MODEL, V220, P383, DOI 10.1016/j.ecolmodel.2008.10.003; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Pezzulli S, 2005, J CLIMATE, V18, P71, DOI 10.1175/JCLI-3256.1; Rinaldi E, 2012, THESIS U BOLOGNA ITA; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Rudnick DL, 2003, DEEP-SEA RES PT I, V50, P691, DOI 10.1016/S0967-0637(03)00053-0; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shiskin J., 1978, SEASONAL ANAL EC TIM, P97; Smith SV, 2003, BIOSCIENCE, V53, P235, DOI 10.1641/0006-3568(2003)053[0235:HHATDO]2.0.CO;2; Solidoro C, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004838; Tsiaras KP, 2014, J SEA RES, V86, P97, DOI 10.1016/j.seares.2013.11.007; *UNEP MAP PAP, 2001, WHIT PAP COAST ZON M; Vantrepotte V, 2011, DEEP-SEA RES PT I, V58, P429, DOI 10.1016/j.dsr.2011.02.003; Vantrepotte V, 2009, ICES J MAR SCI, V66, P1547, DOI 10.1093/icesjms/fsp107; Volpe G, 2007, REMOTE SENS ENVIRON, V107, P625, DOI 10.1016/j.rse.2006.10.017; Volpe G, 2012, OCEAN SCI, V8, P869, DOI 10.5194/os-8-869-2012; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Zanchettin D, 2008, CLIMATIC CHANGE, V89, P411, DOI 10.1007/s10584-008-9395-z	61	73	75	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155756	10.1371/journal.pone.0155756	http://dx.doi.org/10.1371/journal.pone.0155756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258025	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700020
J	Jaber, AAS; Khan, AH; Sulaiman, SAS; Ahmad, N; Anaam, MS				Jaber, Ammar Ali Saleh; Khan, Amer Hayat; Sulaiman, Syed Azhar Syed; Ahmad, Nafees; Anaam, Mohamed Saif			Evaluation of Health-Related Quality of Life among Tuberculosis Patients in Two Cities in Yemen	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SF-36; DIAGNOSIS; MANAGEMENT; GENDER; SCORES; IMPACT	Background The health-related quality of life (HRQoL) of Tuberculosis (TB) patients is important because it directly influences the outcome of TB patients in several aspects. The current study aims to evaluate and to find the factors influencing the HRQoL of TB patients in two major TB-prevalent cities (Taiz and Alhodidah) in Yemen. Methods A prospective study was conducted, and all TB patients meeting the HRQoL criteria were asked to complete the HRQoL SF-36 survey. The records of TB patients were examined for disease confirmation, and a follow-up was consequently performed for patients during treatment between March 2013 and February 2014 in Taiz and Alhodidah Cities. HRQol scores were calculated by using QM scoring software version 4.5, in which the physical component score (PCS) and mental component score (MCS) were obtained. The scores obtained between 47-53 normal based score (NBS) were considered equivalent to the US normal score. Low scores indicate the poor health situation of TB patients Results A total of 243 TB patients enrolled in the study at the beginning of the treatment. A total of 235 and 197 TB patients completed the questionnaire at the end of the intensive phase (I. P.) and continuation phase (C.P.), respectively. The final dropout rate was 16.2%. The mean PCS and MCS scores at the beginning of treatment were low, thus showing the poor health situation of TB patients. The mean PCS scores at the beginning of treatment, end of I.P., and end of treatment were (36.1), (44.9), and (48), respectively. Moreover, the mean MCS score at the beginning of treatment, end of I.P., and end of treatment were (35.1), (42.2), and (44.3), respectively. The result shows that significant increases are observed at the end of I. P. for PCS and MCS because of the treatment and slight changes at the end of C.P. Despite this finding, the MCS score remains below the normal range (47), thus indicating a significant risk of depression among TB patients. Furthermore, general linear repeated measure ANOVA was performed for selected variables, to examine the changes of PCS and MCS over time. It was found that Alhodiah city, chewing khat habit, stigmatization, and duration of treatment more than six months were greatly associated with low mean MCS score of TB patient, indicating great risk of depression which may result in poor treatment outcome. Conclusion TB patients in Yemen were found to have poor QoL, with a significant likelihood of depression. Highly risk depression was found among TB patients in Alhodiah city, khat chewers, stigmatization and having a duration of treatment more than 6 months. Therefore, additional efforts should be made to improve their QoL because it may affect the final clinical outcome of patients.	[Jaber, Ammar Ali Saleh; Khan, Amer Hayat; Sulaiman, Syed Azhar Syed; Ahmad, Nafees; Anaam, Mohamed Saif] USM, Sch Pharmaceut Sci, Dept Clin Pharm, George Town, Malaysia	Universiti Sains Malaysia	Jaber, AAS (corresponding author), USM, Sch Pharmaceut Sci, Dept Clin Pharm, George Town, Malaysia.	amarali2014015@gmail.com	Khan, Amer Hayat/O-5310-2018	Khan, Amer Hayat/0000-0003-4802-6181; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X; Khan, Amer Hayat/0000-0001-6079-0567; Jaber, Ammar/0000-0003-0411-1923				Aggarwal AN, 2013, INT J TUBERC LUNG D, V17, P947, DOI 10.5588/ijtld.12.0299; Al-Akhali A, 2007, INT J TUBERC LUNG D, V11, P1328; Al-Hebshi NN, 2005, ADDICT BIOL, V10, P299, DOI 10.1080/13556210500353020; Al-Qahtani MF, 2014, J TAIBAH UNIV MED SC, V9, P311, DOI 10.1016/j.jtumed.2014.04.005; Al-Sharafi BA, 2015, CLIN MED INSIGHTS-EN, V8, P47, DOI 10.4137/CMED.S26045; Ali AA, 2006, J ORAL PATHOL MED, V35, P81, DOI 10.1111/j.1600-0714.2006.00362.x; Anaam MS, 2013, J PHARM HEALTH SERV, V4, P115, DOI 10.1111/jphs.12012; Atif M, 2015, PUBLIC HEALTH, V129, P777, DOI 10.1016/j.puhe.2015.04.010; Atif M, 2014, VALUE HEALTH, V17, pA778, DOI 10.1016/j.jval.2014.08.361; Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19; Atif M, 2013, QUAL LIFE RES, V22, P1955, DOI 10.1007/s11136-012-0337-x; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x; Bauer M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0250-4; Brown J, 2015, INT J INFECT DIS, V32, P68, DOI 10.1016/j.ijid.2014.12.045; Budweiser S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-92; Chamla D, 2004, INT J TUBERC LUNG D, V8, P1100; Chan-Yeung M., 2003, Hong Kong Medical Journal, V9, P263; Chang B, 2004, QUAL LIFE RES, V13, P1633, DOI 10.1007/s11136-004-0374-1; Coates A, 1997, EUR J CANCER, V33, P1025, DOI 10.1016/S0959-8049(97)00049-X; Cronberg T, 2015, JAMA NEUROL, V72, P634, DOI 10.1001/jamaneurol.2015.0169; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Daiffallah Ali A., 2015, AM J HLTH RES, V3, P91; Demiral Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-247; Dhuria M., 2009, ASIA PACIFIC J PUBLI; Dion MJ, 2004, QUAL LIFE RES, V13, P653, DOI 10.1023/B:QURE.0000021320.89524.64; Dujaili JA, 2015, INT J INFECT DIS, V31, P4, DOI 10.1016/j.ijid.2014.12.004; Duyan V, 2005, INT J TUBERC LUNG D, V9, P1361; Granich R, 2005, INT J TUBERC LUNG D, V9, P590; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Hart PD., 2015, WORLD J PREV MED, V3, P17, DOI DOI 10.12691/JPM-3-2-1; Hassan NA, 2002, SAUDI MED J, V23, P850; Hemingway H, 1997, AM J PUBLIC HEALTH, V87, P1484, DOI 10.2105/AJPH.87.9.1484; Julie P, 2002, SPSS SURVIVAL MANUAL; Kakhki AD, 2015, TUBERC RESPIR DIS, V78, P309, DOI 10.4046/trd.2015.78.4.309; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Knight SJ, 2007, CANCER, V109, P1769, DOI 10.1002/cncr.22597; Kruijshaar ME, 2010, INT J TUBERC LUNG D, V14, P296; Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; Loosman WL, 2015, NEPHROL DIAL TRANSPL, V30, P1170, DOI 10.1093/ndt/gfv066; Mamani Mojgan, 2014, Oman Med J, V29, P102, DOI 10.5001/omj.2014.25; Marra CA, 2004, HEALTH QUAL LIFE OUT, V2, P1, DOI DOI 10.1186/1477-7525-2-58; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Mitlin Diana, 2004, UNDERSTANDING URBAN; Montazeri A, 2005, QUAL LIFE RES, V14, P875, DOI 10.1007/s11136-004-1014-5; Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P887; Organization WH, 2013, YEM WHO STAT PROF; Organization WH, 20132013 WHO; Othman GQ, 2011, AFR J PHARM PHARMACO, V5, P547; Pappa E, 2005, QUAL LIFE RES, V14, P1433, DOI 10.1007/s11136-004-6014-y; Peck M, 2013, BURNS, V39, P1054, DOI 10.1016/j.burns.2013.04.010; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Ritu K, 2015, INT J HLTH SCI RES I, V5, P357; Sajid MS, 2008, INT J HEALTH CARE Q, V21, P365, DOI 10.1108/09526860810880162; Shalaeva O, 2003, PROBLEMY TUBERKULEZA, P7; Tadesse S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152900; Unalan Demet, 2008, Indian J Tuberc, V55, P127; Vinaccia S, 2007, AN PSICOL-SPAIN, V23, P245; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Ware JE, 2008, USERS MANUAL SF 36V2	62	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156258	10.1371/journal.pone.0156258	http://dx.doi.org/10.1371/journal.pone.0156258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257990	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700048
J	Kanaya, M; Shibuya, K; Hirochika, R; Kanemoto, M; Ohashi, K; Okada, M; Wagatsuma, Y; Cho, Y; Kojima, H; Teshima, T; Imamura, M; Sakamaki, H; Shibuya, A				Kanaya, Minoru; Shibuya, Kazuko; Hirochika, Rei; Kanemoto, Miyoko; Ohashi, Kazuteru; Okada, Masafumi; Wagatsuma, Yukiko; Cho, Yukiko; Kojima, Hiroshi; Teshima, Takanori; Imamura, Masahiro; Sakamaki, Hisashi; Shibuya, Akira			Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease	PLOS ONE			English	Article							PVR CD155; LIGANDS; CELLS; DIFFERENTIATION; INJURY	Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Because diagnosis of aGVHD is exclusively based on clinical symptoms and pathological findings, reliable and noninvasive laboratory tests for accurate diagnosis are required. An activating immunoreceptor, DNAM-1 (CD226), is expressed on T cells and natural killer cells and is involved in the development of aGVHD. Here, we identified a soluble form of DNAM-1 (sDNAM-1) in human sera. In retrospective univariate and multivariate analyses of allo-HSCT patients (n = 71) at a single center, cumulative incidences of all grade (grade I-IV) and sgrade II-IV aGVHD in patients with high maximal serum levels of sDNAM-1 (>= 30 pM) in the 7 days before allo-HSCT were significantly higher than those in patients with low maximal serum levels of sDNAM-1 (<30 pM) in the same period. However, sDNAM-1 was not associated with other known allo-HSCT complications. Our data suggest that sDNAM-1 is potentially a unique candidate as a predictive biomarker for the development of aGVHD.	[Kanaya, Minoru; Shibuya, Kazuko; Hirochika, Rei; Cho, Yukiko; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Ibaraki, Japan; [Kanaya, Minoru; Teshima, Takanori; Imamura, Masahiro] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Kanemoto, Miyoko; Ohashi, Kazuteru; Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Okada, Masafumi; Wagatsuma, Yukiko] Univ Tsukuba, Dept Clin Trial & Clin Epidemiol, Ibaraki, Japan; [Cho, Yukiko; Kojima, Hiroshi] Ibaraki Cent Hosp, Dept Clin Oncol, Ibaraki, Japan; [Kojima, Hiroshi] Univ Tsukuba Hosp, Ibaraki Clin Educ & Training Ctr, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, TARA, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, CREST, Japan Sci & Technol Agcy, Ibaraki, Japan; [Okada, Masafumi] Univ Tokyo, Univ Hosp Med Informat Network Ctr, Tokyo, Japan; [Imamura, Masahiro] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan	University of Tsukuba; Hokkaido University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tokyo	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Ibaraki, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, Life Sci Ctr, TARA, Ibaraki, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, CREST, Japan Sci & Technol Agcy, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp	Wagatsuma, Yukiko/AAE-5881-2020; Kanaya, Minoru/AAE-7446-2020	Wagatsuma, Yukiko/0000-0002-8056-9998; teshima, takanori/0000-0002-0941-271X; Kanaya, Minoru/0000-0002-0035-8657	Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan	This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan.; We thank the members of the Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital for serum sampling, the members of CREIL Center, University of Tsukuba for data management, Satoko Mitsuishi and Yuka Nomura (University of Tsukuba) for secretarial assistance, and Mizuha Kosugi-Kanaya (Hokkaido University, Sapporo) for helpful discussions. This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan.	Ando M, 2010, BONE MARROW TRANSPL, V45, P1427, DOI 10.1038/bmt.2009.377; Ayano M, 2015, J IMMUNOL, V195, P892, DOI 10.4049/jimmunol.1403046; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Harris AC, 2013, BRIT J HAEMATOL, V160, P288, DOI 10.1111/bjh.12142; Harris AC, 2012, BLOOD, V119, P2960, DOI 10.1182/blood-2011-10-387357; Hattori K, 1997, BLOOD, V90, P542, DOI 10.1182/blood.V90.2.542.542_542_548; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Koyama M, 2013, BLOOD, V121, P3511, DOI 10.1182/blood-2012-07-444026; Luft T, 2011, BLOOD, V118, P1685, DOI 10.1182/blood-2011-02-334821; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Martinez C, 2011, HAEMATOL-HEMATOL J, V96, P1249, DOI 10.3324/haematol.2011.050534; McDonald GB, 2015, BLOOD, V126, P113, DOI 10.1182/blood-2015-03-636753; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Nakai K, 2005, LEUKEMIA, V19, P396, DOI 10.1038/sj.leu.2403640; Paczesny S, 2013, BLOOD, V121, P585, DOI 10.1182/blood-2012-08-355990; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sato M, 2013, BONE MARROW TRANSPL, V48, P698, DOI 10.1038/bmt.2012.193; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586	32	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154173	10.1371/journal.pone.0154173	http://dx.doi.org/10.1371/journal.pone.0154173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257974	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700008
J	Lee, H; Um, SJ; Kim, YS; Kim, DK; Jang, AS; Choi, HS; Kim, YH; Kim, TE; Yoo, KH; Jung, KS				Lee, Heock; Um, Soo-Jung; Kim, Yun Seong; Kim, Deog Kyeom; Jang, An Soo; Choi, Hye Sook; Kim, Yee Hyung; Kim, Tae Eun; Yoo, Kwang Ha; Jung, Ki-Suck			Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							INFLAMMATORY BIOMARKERS; COPD; VALIDATION	Background The ratio of neutrophils to lymphocytes (NLR) is a widely available marker of inflammation. Several types of inflammatory cells and mediators have been found to be involved in the progression of chronic obstructive pulmonary disease (COPD). We sought to evaluate the association of the NLR with severity of airflow limitation and disease exacerbations in a COPD population. Methods We analyzed 885 patients from the Korean COPD Subtype Study cohort that recruited subjects with COPD from 44 referral hospitals. We determined the relationship of NLR levels to severity of lung function using a linear regression model. In addition, we analyzed the experiences of COPD exacerbation according to the NLR quartiles. Results NLR levels were inversely associated with severity of airflow limitation as measured by FEV1% predicted and absolute values after adjustments for age, gender, body mass index, pack-years of smoking, and the use of inhaled corticosteroid (P<0.001, respectively). In the multivariate binary regression model, the NLR 4th quartile (vs. 1st quartile) was found to be a significant predictor of exacerbations during 1-year follow-up (OR = 2.05, 95% CI = 1.03 to 4.06, P = 0.041). Adding an NLR to FEV1 significantly improved prediction for exacerbations during 1-year follow-up as measured by the net reclassification improvement (NRI = 7.8%, P = 0.032) and the integrated discrimination improvement (IDI = 0.014, P = 0.021). Conclusions The NLR showed a significant inverse relationship to airflow limitation and was a prognostic marker for future exacerbations in patients with COPD.	[Lee, Heock; Um, Soo-Jung] Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Yun Seong] Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Deog Kyeom] Seoul Natl Univ, Coll Med, Dept Internal Med, SMG SNU Boramae Med Ctr, Seoul 151, South Korea; [Jang, An Soo] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Bucheon, South Korea; [Choi, Hye Sook] Dongguk Univ, Gyeongju Hosp, Dept Internal Med, Gyeongju, South Korea; [Kim, Yee Hyung] Kyung Hee Univ, Gangdong Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Tae Eun] Konkuk Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yoo, Kwang Ha] Konkuk Univ, Coll Med, Dept Clin Pharmacol, Seoul, South Korea; [Jung, Ki-Suck] Hallym Univ, Coll Med, Dept Internal Med, Anyang, South Korea	Dong A University; Pusan National University; Seoul National University (SNU); Seoul National University Hospital; Soonchunhyang University; Dongguk University; Kyung Hee University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Hallym University	Um, SJ (corresponding author), Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea.	sjum@dau.ac.kr	Jung, Ki-Suck/AAN-2473-2021		Dong-A University	Dong-A University	This study was supported by research funds from Dong-A University.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Furutate R, 2016, INTERNAL MED, V55, P223, DOI 10.2169/internalmedicine.55.5772; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOB STRAT DIAGN MAN; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Gunay E, 2014, INFLAMMATION, V37, P374, DOI 10.1007/s10753-013-9749-1; Han YC, 2013, KOREAN CIRC J, V43, P93, DOI 10.4070/kcj.2013.43.2.93; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Milara J, 2012, RESPIRATION, V83, P147, DOI 10.1159/000332834; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Sorensen AK, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0064-5; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Taylan M, 2017, CLIN RESPIR J, V11, P311, DOI 10.1111/crj.12336; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Walter RE, 2008, CHEST, V133, P19, DOI 10.1378/chest.07-0058; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105	28	45	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156511	10.1371/journal.pone.0156511	http://dx.doi.org/10.1371/journal.pone.0156511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258044	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700070
J	Lombardi, F; Belmonti, S; Fabbiani, M; Morandi, M; Rossetti, B; Tordini, G; Cauda, R; De Luca, A; Di Giambenedetto, S; Montagnani, F				Lombardi, Francesca; Belmonti, Simone; Fabbiani, Massimiliano; Morandi, Matteo; Rossetti, Barbara; Tordini, Giacinta; Cauda, Roberto; De Luca, Andrea; Di Giambenedetto, Simona; Montagnani, Francesca			Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; SEROLOGICAL RESPONSE; ANTIBODY-RESPONSES; RANDOMIZED-TRIAL; DISEASE; CHILDREN; ERA; INDIVIDUALS; ADOLESCENTS	Objectives Definition of the optimal pneumococcal vaccine strategy in HIV-infected adults is still under evaluation. We aimed to compare immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) versus the 23-valent polysaccharide vaccine (PPSV23) in HIV-infected adults. Methods We performed a pilot, prospective controlled study enrolling HIV-infected pneumococcal vaccine-naive outpatients, aged 18-65 years with CD4 counts >= 200 cells/mu L. Eligible subjects were recruited into two parallel groups: group 1 (n = 50) received two doses of PCV13 eight weeks apart, and group 2 (n = 50) received one dose of PPSV23, as part of their standard of care. Anti-pneumococcal capsular polysaccharide immunoglobulin G concentrations were quantified by ELISA at baseline, 8, 24 and 48 weeks. Clinical and viroimmunological follow-up was performed at the same time points. Unvaccinated, age-atched HIV-negative adults (n = 100) were also enrolled as baseline controls. Results Pre-vaccination specific IgG titers for each pneumococcal antigen did not differ between study groups but they were constantly lower than those from the HIV-negative controls. After immunization, significant increases in IgG titers were observed in both study groups at each time point compared to baseline, but response to serotype 3 was blunted in group 1. Antibody titers for each antigen did not differ between study groups at week 48. Overall, the proportion of subjects achieving seroprotection and seroconversion to all serotypes was comparable between groups. A marked decrease in IgG levels over time was observed with both vaccines. No relevant adverse reactions were reported in either group. Conclusions In this population with favorable immune profile, no relevant differences were observed in immunogenicity between PCV13 and PPSV23. Both vaccines were safe and well tolerated.	[Lombardi, Francesca; Belmonti, Simone; Fabbiani, Massimiliano; Cauda, Roberto; Di Giambenedetto, Simona] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Largo Agostino Gemelli 8, I-00168 Rome, Italy; [Morandi, Matteo; Tordini, Giacinta; De Luca, Andrea; Montagnani, Francesca] Univ Siena, Dept Med Biotechnol, Viale Bracci 16, Siena, Italy; [Rossetti, Barbara; De Luca, Andrea; Montagnani, Francesca] Hosp Dept Specialized & Internal Med, Univ Div Infect Dis, Viale Bracci 16, Siena, Italy; [Fabbiani, Massimiliano] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy	Catholic University of the Sacred Heart; University of Siena; San Gerardo Hospital; University of Milano-Bicocca	Montagnani, F (corresponding author), Univ Siena, Dept Med Biotechnol, Viale Bracci 16, Siena, Italy.; Montagnani, F (corresponding author), Hosp Dept Specialized & Internal Med, Univ Div Infect Dis, Viale Bracci 16, Siena, Italy.	francesca.montagnani@unisi.it	Rossetti, Barbara/AAA-5989-2019; Montagnani, Francesca/R-3334-2016; Fabbiani, Massimiliano/K-8842-2016; digiambenedetto, simona/AAL-4429-2020; Belmonti, Simone/N-7746-2018; De Luca, Andrea/G-8810-2011; Lombardi, Francesca/ABC-7379-2020	Montagnani, Francesca/0000-0002-2267-1337; Fabbiani, Massimiliano/0000-0002-1343-812X; De Luca, Andrea/0000-0002-9561-9193; Lombardi, Francesca/0000-0001-5757-8346; CAUDA, Roberto/0000-0002-1498-4229	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR) [2011-004518-40]	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	The study was funded by the Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR) through a PRIN 2009 project to FM (EudraCT number 2011-004518-40). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abzug MJ, 2006, PEDIATR INFECT DIS J, V25, P920, DOI 10.1097/01.inf.0000237830.33228.c3; Ahmed F, 1996, J INFECT DIS, V173, P83, DOI 10.1093/infdis/173.1.83; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2014, CADTH RAPID RESPONSE; Bamford A, 2014, AIDS, V28, P2033, DOI 10.1097/QAD.0000000000000385; Belmonti Simone, 2016, J Immunoassay Immunochem, V37, P189, DOI 10.1080/15321819.2015.1106949; Bhorat AE, 2015, AIDS, V29, P1345, DOI 10.1097/QAD.0000000000000689; *CDC, 1989, MMWR-MORBID MORTAL W, V38, P73; *CDC, 1989, MMWR-MORBID MORTAL W, V38, P64; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; European Medicine Agency ( EMA), REVENAR13 SUMM PROD; Falco V, 2006, VACCINE, V24, P2567, DOI 10.1016/j.vaccine.2005.12.021; Feikin DR, 2001, VACCINE, V20, P545, DOI 10.1016/S0264-410X(01)00347-4; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gebo KA, 1996, J INFECT DIS, V173, P857, DOI 10.1093/infdis/173.4.857; Girden E. R., 1992, SAGE U PAPER SERIES, V07-084; Glesby MJ, 2015, J INFECT DIS, V212, P18, DOI 10.1093/infdis/jiu631; Goldblatt D, 2011, CLIN VACCINE IMMUNOL, V18, P1728, DOI 10.1128/CVI.05252-11; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Ho YL, 2013, VACCINE, V31, P4047, DOI 10.1016/j.vaccine.2013.04.065; Hung CC, 2010, HIV MED, V11, P54, DOI 10.1111/j.1468-1293.2009.00744.x; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Kourtis AP, 2010, JAIDS-J ACQ IMM DEF, V55, P128, DOI 10.1097/QAI.0b013e3181e8ed15; Lu CL, 2014, VACCINE, V32, P1031, DOI 10.1016/j.vaccine.2014.01.009; MASCARTLEMONE F, 1995, J INFECT DIS, V172, P1253, DOI 10.1093/infdis/172.5.1253; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Munoz-Almagro C, 2013, CURR INFECT DIS REP, V15, P184, DOI 10.1007/s11908-013-0326-4; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI [10.1093/cid/cit816, 10.1093/cid/cit684]; Thanee C, 2011, VACCINE, V29, P5886, DOI 10.1016/j.vaccine.2011.06.072; Vila-Corcoles A, 2013, DRUG AGING, V30, P263, DOI 10.1007/s40266-013-0060-5; WHO, 2005, WHO TECHN REP SER, V927; WHO Pneumococcal Serology Reference Laboratories, MMWR MORB MORTAL WKL	38	16	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156523	10.1371/journal.pone.0156523	http://dx.doi.org/10.1371/journal.pone.0156523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258647	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700074
J	Meng, LH; Wang, RH; Zhu, BZ; Zhu, HL; Luo, YB; Fu, DQ				Meng, Lan-Huan; Wang, Rui-Heng; Zhu, Ben-Zhong; Zhu, Hong-Liang; Luo, Yun-Bo; Fu, Da-Qi			Efficient Virus-Induced Gene Silencing in Solanum rostratum	PLOS ONE			English	Article							TOBACCO RATTLE VIRUS; BIOSYNTHESIS; TOMATO	Solanum rostratum is a "super weed" that grows fast, is widespread, and produces the toxin solanine, which is harmful to both humans and other animals. To our knowledge, no study has focused on its molecular biology owing to the lack of available transgenic methods and sequence information for S. rostratum. Virus-induced gene silencing (VIGS) is a powerful tool for the study of gene function in plants; therefore, in the present study, we aimed to establish tobacco rattle virus (TRV)-derived VIGS in S. rostratum. The genes for phytoene desaturase (PDS) and Chlorophyll H subunit (ChlH) of magnesium protoporphyrin chelatase were cloned from S. rostratum and used as reporters of gene silencing. It was shown that high-efficiency VIGS can be achieved in the leaves, flowers, and fruit of S. rostratum. Moreover, based on our comparison of three different types of infection methods, true leaf infection was found to be more efficient than cotyledon and sprout infiltration in long-term VIGS in multiple plant organs. In conclusion, the VIGS technology and tomato genomic sequences can be used in the future to study gene function in S. rostratum.	[Meng, Lan-Huan; Wang, Rui-Heng; Zhu, Ben-Zhong; Zhu, Hong-Liang; Luo, Yun-Bo; Fu, Da-Qi] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, 17 Qinghua Donglu Rd, Beijing 100083, Peoples R China	China Agricultural University	Fu, DQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, 17 Qinghua Donglu Rd, Beijing 100083, Peoples R China.	daqifu@cau.edu.cn			National Natural Science Foundation of China [31000925, 31571898]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31000925, 31571898).; We would like to thank Dr. S.P. Dinesh-Kumar (University of California, Davis) for providing the pTRV1 and pTRV2 vectors. This work was supported by grants from the National Natural Science Foundation of China (31571898). We also would like to thank Editage [http://www.editage.cn/english-editing/] for English language editing.	Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chung E, 2004, MOL CELLS, V17, P377; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Hao Li-Juan, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2034; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Hiriart JB, 2002, PLANT MOL BIOL, V50, P213, DOI 10.1023/A:1016000627231; Kaloshian Isgouhi, 2007, Methods Mol Biol, V354, P173; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Liu HP, 2012, J INTEGR PLANT BIOL, V54, P422, DOI 10.1111/j.1744-7909.2012.01102.x; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Spitzer B, 2007, PLANT PHYSIOL, V145, P1241, DOI 10.1104/pp.107.105916; Vallejo-Marin M, 2013, PLANT BIOLOGY, V15, P948, DOI 10.1111/j.1438-8677.2012.00715.x; Walker CJ, 1997, BIOCHEM J, V327, P321; Yan HX, 2012, PLANT CELL REP, V31, P1713, DOI 10.1007/s00299-012-1285-1; Zhang CQ, 2006, VIROLOGY, V344, P401, DOI 10.1016/j.virol.2005.08.046; Zhao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079807	22	5	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156228	10.1371/journal.pone.0156228	http://dx.doi.org/10.1371/journal.pone.0156228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258320	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700043
J	Menon, VK; George, S; Sarkar, R; Giri, S; Samuel, P; Vivek, R; Saravanabavan, A; Liakath, FB; Ramani, S; Iturriza-Gomara, M; Gray, JJ; Brown, DW; Estes, MK; Kang, G				Menon, Vipin Kumar; George, Santosh; Sarkar, Rajiv; Giri, Sidhartha; Samuel, Prasanna; Vivek, Rosario; Saravanabavan, Anuradha; Liakath, Farzana Begum; Ramani, Sasirekha; Iturriza-Gomara, Miren; Gray, James J.; Brown, David W.; Estes, Mary K.; Kang, Gagandeep			Norovirus Gastroenteritis in a Birth Cohort in Southern India	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; NORWALK VIRUS; GENETIC DIVERSITY; ACUTE DIARRHEA; MOLECULAR CHARACTERIZATION; HUMAN CALICIVIRUSES; NONSENSE MUTATION; CHILDREN; ROTAVIRUS; INFECTIONS	Background Noroviruses are an important cause of gastroenteritis but little is known about disease and re-infection rates in community settings in Asia. Methods Disease, re-infection rates, strain prevalence and genetic susceptibility to noroviruses were investigated in a birth cohort of 373 Indian children followed up for three years. Stool samples from 1856 diarrheal episodes and 147 vomiting only episodes were screened for norovirus by RT-PCR. Norovirus positivity was correlated with clinical data, secretor status and ABO blood group. Results Of 1856 diarrheal episodes, 207 (11.2%) were associated with norovirus, of which 49(2.6%) were norovirus GI, 150(8.1%) norovirus GII, and 8 (0.4%) were mixed infections with both norovirus GI and GII. Of the 147 vomiting only episodes, 30 (20.4%) were positive for norovirus in stool, of which 7 (4.8%) were norovirus GI and 23 (15.6%) GII. At least a third of the children developed norovirus associated diarrhea, with the first episode at a median age of 5 and 8 months for norovirus GI and GII, respectively. Norovirus GI. 3 and GII. 4 were the predominant genotypes (40.3% and 53.0%) with strain diversity and change in the predominant sub-cluster over time observed among GII viruses. A second episode of norovirus gastroenteritis was documented in 44/174 (25.3%) ever-infected children. Children with the G428A homozygous mutation for inactivation of the FUT2 enzyme (se(428)se(428)) were at a significantly lower risk (48/190) of infection with norovirus (p = 0.01). Conclusions This is the first report of norovirus documenting disease, re-infection and genetic susceptibility in an Asian birth cohort. The high incidence and apparent lack of genogroupII specific immunity indicate the need for careful studies on further characterization of strains, asymptomatic infection and shedding and immune response to further our understanding of norovirus infection and disease.	[Menon, Vipin Kumar; George, Santosh; Sarkar, Rajiv; Giri, Sidhartha; Vivek, Rosario; Saravanabavan, Anuradha; Liakath, Farzana Begum; Ramani, Sasirekha; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Samuel, Prasanna] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Iturriza-Gomara, Miren; Gray, James J.; Brown, David W.] Hlth Protect Agcy, Ctr Infect, Virus Reference Dept, London, England; [Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Menon, Vipin Kumar] Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Ramani, Sasirekha] Baylor Coll Med, Houston, TX 77030 USA; [Iturriza-Gomara, Miren] Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Gray, James J.] Norwich Med Sch, Norwich, Norfolk, England	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Health Protection Agency; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Liverpool; University of East Anglia	Kang, G (corresponding author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India.	gkang@cmcvellore.ac.in	Sarkar, Rajiv/AAU-7203-2021; George, Santosh/AAX-4797-2021; Gomara, Miren Iturriza/B-4351-2013; Giri, Sidhartha/Y-9516-2018; Menon, Vipin Kumar/J-7451-2019; George, Santosh/F-2054-2018	Sarkar, Rajiv/0000-0003-0616-3129; Gomara, Miren Iturriza/0000-0001-5816-6423; Giri, Sidhartha/0000-0003-3927-7392; George, Santosh/0000-0003-0886-9766; Menon, Vipin/0000-0001-7404-678X	Indian Council of Medical Research (ICMR) [18/11/23/2006-ECD-I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057788] Funding Source: NIH RePORTER	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Indian Council of Medical Research (ICMR), award number: 18/11/23/2006-ECD-I, grant recipient: Gagandeep Kang (http://icmr.nic.in/projects/projectsanc07-09.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; Al-Mashhadani MN, 2008, J MED VIROL, V80, P506, DOI 10.1002/jmv.21099; Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589; Arness MK, 2000, EMERG INFECT DIS, V6, P204; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Banerjee I, 2007, J MED VIROL, V79, P1768, DOI 10.1002/jmv.20988; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brick T, 2004, INT J HYG ENVIR HEAL, V207, P473, DOI 10.1078/1438-4639-00318; Brookhart MA, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-67; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Carlsson B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005593; Cheng WX, 2010, ARCH VIROL, V155, P553, DOI 10.1007/s00705-010-0592-5; Chhabra P, 2008, J CLIN VIROL, V42, P429, DOI 10.1016/j.jcv.2008.03.014; Chhabra P, 2010, VIRUS RES, V147, P242, DOI 10.1016/j.virusres.2009.11.007; Chhabra P, 2009, J MED VIROL, V81, P922, DOI 10.1002/jmv.21458; Chung JY, 2010, J MED VIROL, V82, P146, DOI 10.1002/jmv.21650; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Estevez A, 2013, J MED VIROL, V85, P1293, DOI 10.1002/jmv.23578; Gladstone BP, 2008, ARCH DIS CHILD, V93, P479, DOI 10.1136/adc.2006.114546; Gladstone BP, 2010, J TROP PEDIATRICS, V56, P221, DOI 10.1093/tropej/fmp116; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Barreira DMPG, 2010, J CLIN VIROL, V47, P60, DOI 10.1016/j.jcv.2009.11.012; GREEN J, 1995, J MED VIROL, V47, P392, DOI 10.1002/jmv.1890470416; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Hassine-Zaafrane M, 2013, J MED VIROL, V85, P1100, DOI 10.1002/jmv.23552; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Knipe DM, 2007, FIELDS VIROLOGY; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lukkarinen H, 2009, PEDIATR INFECT DIS J, V28, P847, DOI 10.1097/INF.0b013e31819d1cd9; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Murata T, 2007, PEDIATR INFECT DIS J, V26, P46, DOI 10.1097/01.inf.0000247102.04997.e0; Nakagomi T, 2008, ARCH VIROL, V153, P957, DOI 10.1007/s00705-008-0060-7; Nataraju SM, 2010, EPIDEMIOL INFECT, V19, P1; Nguyen TA, 2007, J MED VIROL, V79, P582, DOI 10.1002/jmv.20857; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; O'Ryan ML, 2010, PEDIATR INFECT DIS J, V29, P855, DOI 10.1097/INF.0b013e3181e8b346; O'Ryan ML, 2009, PEDIATR INFECT DIS J, V28, P879, DOI 10.1097/INF.0b013e3181a4bb60; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Parashar UD, 2004, J INFECT DIS, V190, P1088, DOI 10.1086/423324; Rachakonda G, 2008, J CLIN VIROL, V43, P42, DOI 10.1016/j.jcv.2008.05.006; Ramani S, 2009, CURR OPIN INFECT DIS, V22, P477, DOI 10.1097/QCO.0b013e328330662f; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Ribeiro LR, 2008, MEM I OSWALDO CRUZ, V103, P201, DOI 10.1590/S0074-02762008000200013; Rockx BHG, 2005, J INFECT DIS, V191, P749, DOI 10.1086/427779; Saito M, 2013, CLIN INFECT DIS; Shioda K, 2015, VACCINE, V33, P4065, DOI 10.1016/j.vaccine.2015.05.051; Shirato H, 2011, JPN J INFECT DIS, V64, P95; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; Trainor E, 2013, J MED VIROL, V85, P1299, DOI 10.1002/jmv.23589; Yori PP, 2009, PEDIATR INFECT DIS J, V28, P844, DOI 10.1097/INF.0b013e3181a24730	62	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157007	10.1371/journal.pone.0157007	http://dx.doi.org/10.1371/journal.pone.0157007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284939	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000035
J	Kuan, CS; Ismail, R; Kwan, Z; Yew, SM; Yeo, SK; Chan, CL; Toh, YF; Na, SL; Lee, KW; Hoh, CC; Yee, WY; Ng, KP				Kuan, Chee Sian; Ismail, Rokiah; Kwan, Zhenli; Yew, Su Mei; Yeo, Siok Koon; Chan, Chai Ling; Toh, Yue Fen; Na, Shiang Ling; Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan; Ng, Kee Peng			Isolation and Characterization of an Atypical Metschnikowia sp Strain from the Skin Scraping of a Dermatitis Patient	PLOS ONE			English	Article							SP-NOV.; ASCOMYCETOUS YEASTS; PULCHERRIMA; FRUIT; IDENTIFICATION; BIOCONTROL; PHYLOGENY; SEQUENCES; BACTERIAL; FUNGAL	A yeast-like organism was isolated from the skin scraping sample of a stasis dermatitis patient in the Mycology Unit Department of Medical Microbiology, University Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia. The isolate produced no pigment and was not identifiable using chromogenic agar and API 20C AUX. The fungus was identified as Metschnikowia sp. strain UM 1034, which is close to that of Metschnikowia drosophilae based on ITS-and D1/D2 domain-based phylogenetic analysis. However, the physiology of the strain was not associated to M. drosophilae. This pathogen exhibited low sensitivity to all tested azoles, echinocandins, 5-flucytosine and amphotericin B. This study provided insight into Metschnikowia sp. strain UM 1034 phenotype profiles using a Biolog phenotypic microarray (PM). The isolate utilized 373 nutrients of 760 nutrient sources and could adapt to a broad range of osmotic and pH environments. To our knowledge, this is the first report of the isolation of Metschnikowia non-pulcherrima sp. from skin scraping, revealing this rare yeast species as a potential human pathogen that may be misidentified as Candida sp. using conventional methods. Metschnikowia sp. strain UM 1034 can survive in flexible and diverse environments with a generalist lifestyle.	[Kuan, Chee Sian; Yew, Su Mei; Chan, Chai Ling; Toh, Yue Fen; Na, Shiang Ling; Ng, Kee Peng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Ismail, Rokiah; Kwan, Zhenli] Univ Malaya, Div Dermatol, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Yeo, Siok Koon] Taylors Univ, Sch Biosci, Lakeside Campus, Selangor Darul Ehsan, Malaysia; [Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan] Codon Genom SB, Selangor Darul Ehsan, Malaysia	Universiti Malaya; Universiti Malaya; Taylor's University	Ng, KP (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	kpng@ummc.edu.my	Kwan, Zhenli/ABG-8880-2021; Kwan, Zhenli/GRO-6219-2022	Kwan, Zhenli/0000-0001-9772-0087; 	High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/MED/31, H-20001-00-E000070]; Codon Genomics SB	High Impact Research MoE Grant from the Ministry of Education Malaysia; Codon Genomics SB	This study was supported by High Impact Research MoE Grant, UM.C/625/1/HIR/MOHE/MED/31 (Account no. H-20001-00-E000070) from the Ministry of Education Malaysia. Codon Genomics SB provided support in the form of salaries for authors KWL, CCH and WYY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	de Vega C, 2012, INT J SYST EVOL MICR, V62, P2538, DOI 10.1099/ijs.0.040790-0; Dorko E, 2000, FOLIA MICROBIOL, V45, P364, DOI 10.1007/BF02817563; Graser Y, 2008, MYCOPATHOLOGIA, V166, P239, DOI 10.1007/s11046-008-9099-y; Hong SG, 2001, INT J SYST EVOL MICR, V51, P1927, DOI 10.1099/00207713-51-5-1927; Jautova J, 2001, FOLIA MICROBIOL, V46, P333, DOI 10.1007/BF02815623; KENNEDY WPU, 1972, THORAX, V27, P604, DOI 10.1136/thx.27.5.604; KLUYVER AJ, 1953, P NATL ACAD SCI USA, V39, P583, DOI 10.1073/pnas.39.7.583; Kozak M, 2003, Bratisl Lek Listy, V104, P211; Kuan CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145932; Kuan CS, 2015, DNA RES, V22, P219, DOI 10.1093/dnares/dsv007; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 2001, SYST APPL MICROBIOL, V24, P395, DOI 10.1078/0723-2020-00045; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2001, CAN J MICROBIOL, V47, P103, DOI 10.1139/cjm-47-2-103; Leverentz B, 2006, APPL ENVIRON MICROB, V72, P1135, DOI 10.1128/AEM.72.2.1135-1140.2006; Marine M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004982; MENDONCAHAGLER LC, 1993, INT J SYST BACTERIOL, V43, P368, DOI 10.1099/00207713-43-2-368; Mohl W, 1998, MYCOSES, V41, P425, DOI 10.1111/j.1439-0507.1998.tb00365.x; Ng KP, 2015, TROP MED INT HEALTH, V20, P1447, DOI 10.1111/tmi.12577; Oro L, 2014, J APPL MICROBIOL, V116, P1209, DOI 10.1111/jam.12446; POSPISIL L, 1989, MYCOSES, V32, P581, DOI 10.1111/j.1439-0507.1989.tb02186.x; Savini V, 2013, MED MYCOL, V51, P438, DOI 10.3109/13693786.2012.733429; Sipiczki M, 2006, APPL ENVIRON MICROB, V72, P6716, DOI 10.1128/AEM.01275-06; Sipiczki M, 2014, INT J SYST EVOL MICR, V64, P1847, DOI 10.1099/ijs.0.061796-0; Sisti M, 2014, FOLIA MICROBIOL, V59, P263, DOI 10.1007/s12223-013-0290-2; Suh SO, 2004, INT J SYST EVOL MICR, V54, P1883, DOI 10.1099/ijs.0.63152-0; Tullio V, 2010, FUNGAL BIOL-UK, V114, P345, DOI 10.1016/j.funbio.2010.02.003; Turkel Sezai, 2014, Biotechnol Res Int, V2014, P397167, DOI 10.1155/2014/397167; Turkel S, 2009, Z NATURFORSCH C, V64, P405; Xue ML, 2006, INT J SYST EVOL MICR, V56, P2245, DOI 10.1099/ijs.0.64391-0; Yew SM, 2013, GENOME ANNOUNC, V1; Yew SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104352	33	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156119	10.1371/journal.pone.0156119	http://dx.doi.org/10.1371/journal.pone.0156119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280438	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000015
J	Liu, D; Xu, M; Niu, DX; Wang, SK; Liang, S				Liu, Da; Xu, Ming; Niu, Dongxiao; Wang, Shoukai; Liang, Sai			Forecast Modelling via Variations in Binary Image-Encoded Information Exploited by Deep Learning Neural Networks	PLOS ONE			English	Article								Traditional forecasting models fit a function approximation from dependent invariables to independent variables. However, they usually get into trouble when date are presented in various formats, such as text, voice and image. This study proposes a novel image-encoded forecasting method that input and output binary digital two-dimensional (2D) images are transformed from decimal data. Omitting any data analysis or cleansing steps for simplicity, all raw variables were selected and converted to binary digital images as the input of a deep learning model, convolutional neural network (CNN). Using shared weights, pooling and multiple-layer back-propagation techniques, the CNN was adopted to locate the nexus among variations in local binary digital images. Due to the computing capability that was originally developed for binary digital bitmap manipulation, this model has significant potential for forecasting with vast volume of data. The model was validated by a power loads predicting dataset from the Global Energy Forecasting Competition 2012.	[Liu, Da; Niu, Dongxiao; Wang, Shoukai] North China Elect Power Univ, Sch Econ & Management, Beijing, Peoples R China; [Xu, Ming; Liang, Sai] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	North China Electric Power University; University of Michigan System; University of Michigan	Liu, D (corresponding author), North China Elect Power Univ, Sch Econ & Management, Beijing, Peoples R China.	liuda315@163.com	Xu, Ming/F-3653-2010; Liu, Da/G-9784-2014	Xu, Ming/0000-0002-7106-8390; Liu, Da/0000-0003-0816-1901; Liang, Sai/0000-0002-6306-5800	National Natural Science Foundation of China (NSFC) [70901025]; Social Science Funding Project of Beijing [13JDJGC055]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Social Science Funding Project of Beijing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (NSFC) (70901025), the Social Science Funding Project of Beijing (13JDJGC055) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Baldi P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5308; Ben Taieb S, 2014, INT J FORECASTING, V30, P382, DOI 10.1016/j.ijforecast.2013.07.005; Charlton N, 2014, INT J FORECASTING, V30, P364, DOI 10.1016/j.ijforecast.2013.07.003; Chouard T, 2015, NATURE, V521, P435, DOI 10.1038/521435a; Ciresan D.C., 2011, PROC 22 INT JOINT C, P1237; Gandomi A, 2015, INT J INFORM MANAGE, V35, P137, DOI 10.1016/j.ijinfomgt.2014.10.007; Hahn H, 2009, EUR J OPER RES, V199, P902, DOI 10.1016/j.ejor.2009.01.062; Hippert HS, 2001, IEEE T POWER SYST, V16, P44, DOI 10.1109/59.910780; Hong T, 2014, INT J FORECASTING, V30, P357, DOI 10.1016/j.ijforecast.2013.07.001; Jones N, 2014, NATURE, V505, P146, DOI 10.1038/505146a; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Kang HW, 2015, ADV SOC SCI EDUC HUM, V41, P638; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lloyd JR, 2014, INT J FORECASTING, V30, P369, DOI 10.1016/j.ijforecast.2013.07.002; Meade N, 1986, J OPER RES SOC, V5; Niu DX, 2010, APPL SOFT COMPUT, V10, P868, DOI 10.1016/j.asoc.2009.10.004; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Silva L, 2014, INT J FORECASTING, V30, P395, DOI 10.1016/j.ijforecast.2013.07.007; Taylor JW, 2007, IEEE T POWER SYST, V22, P2213, DOI 10.1109/TPWRS.2007.907583; Tufekci P, 2014, INT J ELEC POWER, V60, P126, DOI 10.1016/j.ijepes.2014.02.027; Yann LeCun, 2015, Nature, V521, P436, DOI 10.1038/nature14539	25	1	1	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157028	10.1371/journal.pone.0157028	http://dx.doi.org/10.1371/journal.pone.0157028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281032	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000070
J	Mosquera, T; Alvarez, MF; Jimenez-Gomez, JM; Muktar, MS; Paulo, MJ; Steinemann, S; Li, JQ; Draffehn, A; Hofmann, A; Lubeck, J; Strahwald, J; Tacke, E; Hofferbert, HR; Walkemeier, B; Gebhardt, C				Mosquera, Teresa; Fernanda Alvarez, Maria; Jimenez-Gomez, Jose M.; Muktar, Meki Shehabu; Paulo, Maria Joao; Steinemann, Sebastian; Li, Jinquan; Draffehn, Astrid; Hofmann, Andrea; Luebeck, Jens; Strahwald, Josef; Tacke, Eckhard; Hofferbert, Hans-Reinhardt; Walkemeier, Birgit; Gebhardt, Christiane			Targeted and Untargeted Approaches Unravel Novel Candidate Genes and Diagnostic SNPs for Quantitative Resistance of the Potato (Solanum tuberosum L.) to Phytophthora infestans Causing the Late Blight Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BROAD-SPECTRUM RESISTANCE; A REDUCTASE GENES; ARABIDOPSIS-THALIANA; FIELD-RESISTANCE; TRAIT LOCI; R-GENE; PATHOGEN RESISTANCE; CULTIVATED POTATO; TETRAPLOID POTATO	The oomycete Phytophthora infestans causes late blight of potato, which can completely destroy the crop. Therefore, for the past 160 years, late blight has been the most important potato disease worldwide. The identification of cultivars with high and durable field resistance to P. infestans is an objective of most potato breeding programs. This type of resistance is polygenic and therefore quantitative. Its evaluation requires multi-year and location trials. Furthermore, quantitative resistance to late blight correlates with late plant maturity, a negative agricultural trait. Knowledge of the molecular genetic basis of quantitative resistance to late blight not compromised by late maturity is very limited. It is however essential for developing diagnostic DNA markers that facilitate the efficient combination of superior resistance alleles in improved cultivars. We used association genetics in a population of 184 tetraploid potato cultivars in order to identify single nucleotide polymorphisms (SNPs) that are associated with maturity corrected resistance (MCR) to late blight. The population was genotyped for almost 9000 SNPs from three different sources. The first source was candidate genes specifically selected for their function in the jasmonate pathway. The second source was novel candidate genes selected based on comparative transcript profiling (RNA-Seq) of groups of genotypes with contrasting levels of quantitative resistance to P. infestans. The third source was the first generation 8.3k SolCAP SNP genotyping array available in potato for genome wide association studies (GWAS). Twenty seven SNPs from all three sources showed robust association with MCR. Some of those were located in genes that are strong candidates for directly controlling quantitative resistance, based on functional annotation. Most important were: a lipoxygenase (jasmonate pathway), a 3-hydroxy- 3-methylglutaryl coenzyme A reductase (mevalonate pathway), a P450 protein (terpene biosynthesis), a transcription factor and a homolog of a major gene for resistance to P. infestans from the wild potato species Solanum venturii. The candidate gene approach and GWAS complemented each other as they identified different genes. The results of this study provide new insight in the molecular genetic basis of quantitative resistance in potato and a toolbox of diagnostic SNP markers for breeding applications.	[Mosquera, Teresa; Fernanda Alvarez, Maria; Jimenez-Gomez, Jose M.; Muktar, Meki Shehabu; Steinemann, Sebastian; Li, Jinquan; Draffehn, Astrid; Walkemeier, Birgit; Gebhardt, Christiane] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Mosquera, Teresa; Fernanda Alvarez, Maria] Univ Nacl Colombia, Fac Agr Sci, Bogota, Colombia; [Paulo, Maria Joao] Wageningen Univ, Biometris, NL-6700 AP Wageningen, Netherlands; [Hofmann, Andrea] Univ Bonn, Inst Human Genet, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Luebeck, Jens; Strahwald, Josef] SaKa Pflanzenzucht GmbH & Co KG, D-24340 Windeby, Germany; [Tacke, Eckhard] Bioplant GmbH, Ebstorf, Germany; [Hofferbert, Hans-Reinhardt] Bohm Nordkartoffel Agrarprod GbR, Ebstorf, Germany; [Jimenez-Gomez, Jose M.] Univ Paris Saclay, AgroParis Tech, CNRS, Inst Jean Pierre Bourgin,INRA, Versailles, France	Max Planck Society; Universidad Nacional de Colombia; Wageningen University & Research; University of Bonn; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gebhardt, C (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany.	gebhardt@mpipz.mpg.de	Gebhardt, Chris/HGD-6090-2022; Muktar, Meki/AAJ-1732-2020; Alvarez, Maria/GZH-1345-2022	Muktar, Meki/0000-0003-4750-8031; Mosquera, Teresa/0000-0003-4854-1079; Caldas Paulo, Maria Joao/0000-0002-4180-0763; Jimenez-Gomez, Jose M/0000-0002-5033-7192	German Federal Ministry of Education and Research [0315065]; International Development Research Centre (IDRC); Department of Foreign Affairs, Trade and Development (DFATD) from Canada through the Canadian International Food Security Research Fund; Max-Planck Society	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); International Development Research Centre (IDRC); Department of Foreign Affairs, Trade and Development (DFATD) from Canada through the Canadian International Food Security Research Fund; Max-Planck Society(Max Planck Society)	This work was funded by the German Federal Ministry of Education and Research under the GABI (_g_enome_a_nalysis in the_bi_ological system plant) program (grant No. 0315065, PAPATOMICS), by the International Development Research Centre (IDRC) and Department of Foreign Affairs, Trade and Development (DFATD) from Canada through the Canadian International Food Security Research Fund, and the Max-Planck Society. The breeding companies SaKa-Pflanzenzucht GmbH & Co. KG, Windeby, Germany, Bohm-Nordkartoffel Agrarproduktion GbR, Ebstorf, Germany, and Bioplant GmbH, Ebstorf, Germany, were partners in a collaborative research project that was funded by a public institution (The German Federal Ministry for Education and Research). The role of the companies in the project was the provision of plant material and phenotypic data from field experiments. The companies contributions were in part funded by the public institution (The German Federal Ministry for Education and Research) and in part by themselves, but not including salaries of JS, JL, H-RH and ET. The funders provided support in the form of salaries for authors MFA and AD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Ballvora A, 2001, MOL PLANT MICROBE IN, V14, P629, DOI 10.1094/MPMI.2001.14.5.629; Basso B, 1996, PLANT PHYSIOL, V110, P714; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Beketova MP, 2006, RUSS J PLANT PHYSL+, V53, P384, DOI 10.1134/S1021443706030149; Bogdanova EA, 2008, MOL BIOSYST, V4, P205, DOI 10.1039/b715110c; Bormann CA, 2004, MOL PLANT MICROBE IN, V17, P1126, DOI 10.1094/MPMI.2004.17.10.1126; Boutanaev AM, 2015, P NATL ACAD SCI USA, V112, pE81, DOI 10.1073/pnas.1419547112; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradshaw JE, 2004, GENETICS, V168, P983, DOI 10.1534/genetics.104.030056; Bradshaw JE, 2006, THEOR APPL GENET, V113, P943, DOI 10.1007/s00122-006-0353-8; Brenner ED, 1998, PLANT PHYSIOL, V118, P237, DOI 10.1104/pp.118.1.237; Brouwer DJ, 2004, GENOME, V47, P475, DOI 10.1139/G04-001; Brouwer DJ, 2004, THEOR APPL GENET, V108, P628, DOI 10.1007/s00122-003-1469-8; Chen KM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-43; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; CHOI D, 1992, PLANT CELL, V4, P1333, DOI 10.1105/tpc.4.10.1333; Collins A, 1999, MOL BREEDING, V5, P387, DOI 10.1023/A:1009601427062; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; COLON LT, 1995, EUR J PLANT PATHOL, V101, P387, DOI 10.1007/BF01874852; CORNELISSEN BJC, 1986, NATURE, V321, P531, DOI 10.1038/321531a0; Mondego JMC, 2011, PLANTA, V233, P123, DOI 10.1007/s00425-010-1284-9; Costanzo S, 2005, THEOR APPL GENET, V111, P609, DOI 10.1007/s00122-005-2053-1; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; Danan S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-16; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dhaubhadel S, 2005, J EXP BOT, V56, P2335, DOI 10.1093/jxb/eri226; Diaz M, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue1-fulltext-3; Douches D, 2014, POTATO RES, V57, P215, DOI 10.1007/s11540-014-9267-z; Draffehn AM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00423; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ECKES P, 1986, MOL GEN GENET, V205, P14, DOI 10.1007/BF02428027; El-Kasmi F, 2011, PLANT J, V66, P268, DOI 10.1111/j.1365-313X.2011.04487.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing EE, 2000, MOL BREEDING, V6, P25, DOI 10.1023/A:1009648408198; Farmaki T, 2007, J EXP BOT, V58, P555, DOI 10.1093/jxb/erl230; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Fidantsef AL, 1998, PHYSIOL PLANTARUM, V102, P257, DOI 10.1034/j.1399-3054.1998.1020214.x; Fischer M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-113; Foster SJ, 2009, MOL PLANT MICROBE IN, V22, P589, DOI 10.1094/MPMI-22-5-0589; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; FRY WE, 1978, PHYTOPATHOLOGY, V68, P1650, DOI 10.1094/Phyto-68-1650; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; Ghislain M, 2001, THEOR APPL GENET, V103, P433, DOI 10.1007/s00122-001-0545-1; Glaczinski H, 2002, POTATO RES, V45, P163, DOI 10.1007/BF02736112; Gunnewich N, 2013, PHYTOCHEMISTRY, V91, P93, DOI 10.1016/j.phytochem.2012.07.019; Gyetvai G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031526; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HERMANS J, 1988, PLANT MOL BIOL, V10, P323, DOI 10.1007/BF00029882; Hrmova M, 2001, PLANT MOL BIOL, V47, P73, DOI 10.1023/A:1010619128894; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Jo KR, 2015, THEOR APPL GENET, V128, P931, DOI 10.1007/s00122-015-2480-6; Jo KR, 2011, THEOR APPL GENET, V123, P1331, DOI 10.1007/s00122-011-1670-0; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Kollas AK, 2002, FEBS LETT, V532, P432, DOI 10.1016/S0014-5793(02)03725-0; Kolomiets MV, 2000, PLANT PHYSIOL, V124, P1121, DOI 10.1104/pp.124.3.1121; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Kushalappa AC, 2013, TRENDS PLANT SCI, V18, P522, DOI 10.1016/j.tplants.2013.05.002; Lascombe MB, 2008, PROTEIN SCI, V17, P1522, DOI 10.1110/ps.035972.108; LEONARDSSCHIPPERS C, 1994, GENETICS, V137, P67; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li JC, 2012, THEOR APPL GENET, V124, P1339, DOI 10.1007/s00122-012-1791-0; Li L, 2005, GENETICS, V170, P813, DOI 10.1534/genetics.104.040006; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2008, THEOR APPL GENET, V116, P1167, DOI 10.1007/s00122-008-0746-y; Lindqvist-Kreuze H, 2014, PHYTOPATHOLOGY, V104, P624, DOI 10.1094/PHYTO-10-13-0270-R; Lokossou AA, 2009, MOL PLANT MICROBE IN, V22, P630, DOI 10.1094/MPMI-22-6-0630; Lu W, 2012, GENE, V503, P65, DOI 10.1016/j.gene.2012.04.042; Madsen DK, 2006, AM J POTATO RES, V83, P349, DOI 10.1007/BF02871596; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Marcos R, 2015, PLANT PHYSIOL, V169, P2324, DOI 10.1104/pp.15.00992; MASON HS, 1988, PLANT MOL BIOL, V11, P845, DOI 10.1007/BF00019524; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Miernyk JA, 2001, CELL STRESS CHAPERON, V6, P209, DOI 10.1379/1466-1268(2001)006<0209:TJDPOA>2.0.CO;2; Muktar MS, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00294; MUSGROVE JE, 1986, PHILOS T ROY SOC B, V313, P419, DOI 10.1098/rstb.1986.0048; Oberhagemann P, 1999, MOL BREEDING, V5, P399, DOI 10.1023/A:1009623212180; Odeny DA, 2010, PLANT CELL ENVIRON, V33, P2149, DOI 10.1111/j.1365-3040.2010.02213.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pajerowska KM, 2005, MOL PLANT MICROBE IN, V18, P1107, DOI 10.1094/MPMI-18-1107; Pajerowska-Mukhtar K, 2009, GENETICS, V181, P1115, DOI 10.1534/genetics.108.094268; Pajerowska-Mukhtar KM, 2008, PLANTA, V228, P293, DOI 10.1007/s00425-008-0737-x; Park TH, 2005, MOL PLANT MICROBE IN, V18, P722, DOI 10.1094/MPMI-18-0722; Pel MA, 2009, MOL PLANT MICROBE IN, V22, P601, DOI 10.1094/MPMI-22-5-0601; Pritchard JK, 2000, GENETICS, V155, P945; Qiao Y, 2009, MOL PLANT MICROBE IN, V22, P1523, DOI 10.1094/MPMI-22-12-1523; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Rapala-Kozik M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-2; Rauscher G, 2010, THEOR APPL GENET, V121, P1553, DOI 10.1007/s00122-010-1410-x; Revenkova E, 1999, INVOLVEMENT ARABIDOP, P490; Rickert AM, 2003, PLANT BIOTECHNOL J, V1, P399, DOI 10.1046/j.1467-7652.2003.00036.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Royo J, 1996, J BIOL CHEM, V271, P21012, DOI 10.1074/jbc.271.35.21012; Sade D, 2015, METABOLOMICS, V11, P81, DOI 10.1007/s11306-014-0670-x; Sandbrink JM, 2000, MOL BREEDING, V6, P215, DOI 10.1023/A:1009697318518; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; SCHWARTZ E, 1991, PLANT MOL BIOL, V17, P923, DOI 10.1007/BF00037074; Sharma R, 2014, SCI HORTIC-AMSTERDAM, V179, P204, DOI 10.1016/j.scienta.2014.09.018; Sharma SK, 2013, G3-GENES GENOM GENET, V3, P2031, DOI 10.1534/g3.113.007153; Simko I, 2006, PLANT BREEDING, V125, P385, DOI 10.1111/j.1439-0523.2006.01232.x; Singh B, 2013, GENE, V532, P177, DOI 10.1016/j.gene.2013.09.078; Sliwka J, 2007, THEOR APPL GENET, V115, P101, DOI 10.1007/s00122-007-0546-9; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Sorensen KK, 2006, PLANT BREEDING, V125, P268, DOI 10.1111/j.1439-0523.2006.01219.x; Stich B, 2013, PLANT BREEDING, V132, P718, DOI 10.1111/pbr.12102; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tamburrini M, 2005, PROTEIN J, V24, P423, DOI 10.1007/s10930-005-7638-7; Tchorzewski M, 2000, BBA-MOL CELL RES, V1499, P63, DOI 10.1016/S0167-4889(00)00108-7; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Urbany C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-7; Vadassery J, 2009, PLANT SIGNAL BEHAV, V4, P1024, DOI 10.4161/psb.4.11.9800; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; Van Lijsebettens M, 2014, TRENDS PLANT SCI, V19, P717, DOI 10.1016/j.tplants.2014.07.002; Vazquez-Flota FA, 1998, PLANT PHYSIOL, V117, P1351, DOI 10.1104/pp.117.4.1351; Villamon FG, 2005, THEOR APPL GENET, V111, P1201, DOI 10.1007/s00122-005-0053-9; Visker MHPW, 2005, EUPHYTICA, V143, P189, DOI 10.1007/s10681-005-3444-8; Visker MHPW, 2003, THEOR APPL GENET, V106, P317, DOI 10.1007/s00122-002-1021-2; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; VSN INTERNATIONAL, 2014, GENSTAT WINDOWS; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; Wastie R., 1991, ADV PLANT PATHOL, V7, P193; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; YANG ZB, 1991, PLANT CELL, V3, P397, DOI 10.1105/tpc.3.4.397; Yin Y, 2010, GLYCOSYLTRANSFERASES, P167; Yogendra KN, 2015, J EXP BOT, V66, P7377, DOI 10.1093/jxb/erv434; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhang CZ, 2014, THEOR APPL GENET, V127, P1353, DOI 10.1007/s00122-014-2303-1; Zhang ZW, 2009, BRIEF BIOINFORM, V10, P664, DOI 10.1093/bib/bbp050; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	145	36	40	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156254	10.1371/journal.pone.0156254	http://dx.doi.org/10.1371/journal.pone.0156254			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281327	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000022
J	Davido, B; Saleh-Mghir, A; Laurent, F; Danel, C; Couzon, F; Gatin, L; Vandenesch, F; Rasigade, JP; Cremieux, AC				Davido, Benjamin; Saleh-Mghir, Azzam; Laurent, Frederic; Danel, Claire; Couzon, Florence; Gatin, Laure; Vandenesch, Francois; Rasigade, Jean-Philippe; Cremieux, Anne-Claude			Phenol-Soluble Modulins Contribute to Early Sepsis Dissemination Not Late Local USA300-Osteomyelitis Severity in Rabbits	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; VIRULENCE DETERMINANTS; JOINT INFECTIONS; OSTEOMYELITIS; MODEL; BONE; CHILDREN; SURVIVAL	Introduction In bone and joint infections (BJIs), bacterial toxins are major virulence factors: Panton-Valentine leukocidin (PVL) expression leads to severe local damage, including bone distortion and abscesses, while alpha-hemolysin (Hla) production is associated with severe sepsis-related mortality. Recently, other toxins, namely phenol-soluble modulins (PSMs) expressed by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strain USA300 (LAC WT) were shown to have ex vivo intracellular cytotoxic activity after S. aureus invasion of osteoblasts, but their in vivo contribution in a relatively PVL-sensitive osteomyelitis model remains poorly elucidated. Materials and Methods We compared the outcomes of experimental rabbit osteomyelitises induced with pvl(+)hla(+-) psms(+) LAC WT and its isogenic Delta psm derivatives (LAC Delta psm alpha and LAC Delta psm alpha beta hld) using an inoculum of 3 x 10(8) CFUs. Mortality, hematogenous spread (blood culture, spleen and kidney), lung and bone involvements were assessed in two groups (non-survivors of severe sepsis and survivors sacrificed on day (D) 14). Results Severe sepsis-related mortality tended to be lower for Delta psm derivatives (Kaplan-Meier curves, P =.06). Non-survivors' bone LAC-Delta psm alpha (6.9 log(10) CFUs/g of bone, P =.04) or -Delta psm alpha beta hld (6.86 log(10) CFUs/g of bone, P =.014) densities were significantly higher than LAC WT (6.43 log(10) CFUs/g of bone). Conversely, lung Delta psm alpha beta hld CFUs were significantly lower than LAC WT (P =.04). LAC Delta psm alpha, Delta psm alpha beta hld and WT induced similar bone damage in D14 survivors, with comparable bacterial densities (respectively: 5.89, 5.91, and 6.15 log(10) CFUs/g of bone). Meanwhile, pulmonary histological scores of inflammation were significantly higher for LAC Delta psm alpha- and Delta psm alpha beta hld-infected rabbits compared to LAC WT (P =.04 and .01, respectively) but with comparable lung bacterial densities. Conclusion Our experimental results showed that deactivating PSM peptides significantly limited bacterial dissemination from bone during the early phase of infection, but did not affect local severity of USA300 rabbit osteomyelitis.	[Davido, Benjamin; Saleh-Mghir, Azzam; Gatin, Laure; Cremieux, Anne-Claude] Hop Raymond Poincare, AP HP, Dept Med Aigue Specialisee, Garches, France; [Davido, Benjamin; Saleh-Mghir, Azzam; Gatin, Laure; Cremieux, Anne-Claude] Univ Versailles St Quentin, Fac Med Paris Ile de France Ouest, EA 3647, Versailles, France; [Laurent, Frederic; Couzon, Florence; Vandenesch, Francois; Rasigade, Jean-Philippe] Univ Lyon 1, Int Ctr Infectiol Res, Inserm U1111, ENS Lyon,CNRS UMR5308,Hosp Civils Lyon,CIRI, F-69365 Lyon, France; [Danel, Claire] UFR Med Paris 7, Dept Pathol, Site Bichat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Davido, B (corresponding author), Hop Raymond Poincare, AP HP, Dept Med Aigue Specialisee, Garches, France.; Davido, B (corresponding author), Univ Versailles St Quentin, Fac Med Paris Ile de France Ouest, EA 3647, Versailles, France.	benjamin.davido@aphp.fr	Crémieux, A/AAP-9147-2020; LAURENT, Frederic/AGM-0706-2022; Rasigade, Jean-Philippe/AAE-1667-2021; Vandenesch, Francois/C-7209-2014; Rasigade, Jean-Philippe/L-9320-2014	Vandenesch, Francois/0000-0001-9412-7106; Rasigade, Jean-Philippe/0000-0002-8264-0452; laurent, frederic/0000-0003-0609-9091	Raymond Poincare University Hospital; Raymond Poincare University Hospital and Infectious Diseases	Raymond Poincare University Hospital; Raymond Poincare University Hospital and Infectious Diseases	The authors thank the Raymond Poincare University Hospital and Infectious Diseases Colleagues: Aurore Lagrange and Aurelien Dinh for their support and Janet Jacobson for editorial assistance.	Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; Cassat JE, 2013, CELL HOST MICROBE, V13, P759, DOI 10.1016/j.chom.2013.05.003; Chen Y, 2015, J INFECT DIS, V211, P472, DOI 10.1093/infdis/jiu462; Cremieux AC, 2014, J INFECT DIS, V209, P1773, DOI 10.1093/infdis/jit840; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Deplanche M, 2015, FASEB J, V29, P1950, DOI 10.1096/fj.14-260513; Dohin B, 2007, PEDIATR INFECT DIS J, V26, P1042, DOI 10.1097/INF.0b013e318133a85e; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Horewicz VV, 2015, EUR J PHARMACOL, V746, P267, DOI 10.1016/j.ejphar.2014.11.026; Hua L, 2015, ANTIMICROB AGENTS CH, V59, P4526, DOI 10.1128/AAC.00510-15; Iwamoto M, 2013, PEDIATRICS, V132, pE817, DOI 10.1542/peds.2013-1112; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Martinez-Aguilar G, 2004, PEDIATR INFECT DIS J, V23, P701, DOI 10.1097/01.inf.0000133044.79130.2a; NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Periasamy Saravanan, 2012, Commun Integr Biol, V5, P275, DOI 10.4161/cib.19420; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Rasigade JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063176; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Spaulding AR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00018; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; Valentino MD, 2014, MBIO, V5, DOI 10.1128/mBio.01729-14; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Vardakas KZ, 2013, EUR J CLIN MICROBIOL, V32, P711, DOI 10.1007/s10096-012-1807-3; Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wilde AD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005341	35	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157133	10.1371/journal.pone.0157133	http://dx.doi.org/10.1371/journal.pone.0157133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275944	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700071
J	Eimori, K; Endo, N; Uchiyama, S; Takahashi, Y; Kawashima, H; Watanabe, K				Eimori, Keiko; Endo, Naoto; Uchiyama, Seiji; Takahashi, Yoshinori; Kawashima, Hiroyuki; Watanabe, Kei			Disrupted Bone Metabolism in Long-Term Bedridden Patients	PLOS ONE			English	Article							CEREBRAL-PALSY; MINERAL DENSITY; CHILDREN; ADULTS; OSTEOPOROSIS; ADOLESCENTS	Background Bedridden patients are at risk of osteoporosis and fractures, although the long-term bone metabolic processes in these patients are poorly understood. Therefore, we aimed to determine how long-term bed confinement affects bone metabolism. Methods This study included 36 patients who had been bedridden from birth due to severe immobility. Bone mineral density and bone metabolism markers were compared to the bedridden period in all study patients. Changes in the bone metabolism markers during a follow-up of 12 years were studied in 17 patients aged <30 years at baseline. Results The bone mineral density was reduced (0.58 +/- 0.19g/cm(3)), and the osteocalcin (13.9 +/- 12.4 ng/mL) and urine N-terminal telopeptide (NTX) levels (146.9 +/- 134.0 mM BCE/mM creatinine) were greater than the cutoff value for predicting fracture. Among the bone metabolism markers studied, osteocalcin and NTX were negatively associated with the bedridden period. During the follow-up, osteocalcin and parathyroid hormone were decreased, and the 25(OH) vitamin D was increased. NTX at baseline was negatively associated with bone mineral density after 12 years. Conclusions Unique bone metabolic abnormalities were found in patients who had been bedridden for long periods, and these metabolic abnormalities were altered by further bed confinement. Appropriate treatment based on the unique bone metabolic changes may be important in long-term bedridden patients.	[Eimori, Keiko] Nishi Niigata Chuo Natl Hosp, Div Pediat Orthoped Surg, Niigata, Japan; [Eimori, Keiko; Endo, Naoto; Kawashima, Hiroyuki; Watanabe, Kei] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Dept Regenerat & Transplant Med, Niigata, Japan; [Uchiyama, Seiji; Takahashi, Yoshinori] Nishi Niigata Chuo Natl Hosp, Div Orthoped Surg, Niigata, Japan	Niigata University	Eimori, K (corresponding author), Nishi Niigata Chuo Natl Hosp, Div Pediat Orthoped Surg, Niigata, Japan.; Eimori, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Dept Regenerat & Transplant Med, Niigata, Japan.	keimori@masa.go.jp		Eimori, Keiko/0000-0003-3484-9195				Apkon SD, 2008, J PEDIATR REHAB MED, V1, P115; Bikle Daniel D, 2003, Gravit Space Biol Bull, V16, P45; Bikle DD, 1999, J BONE MINER METAB, V17, P233, DOI 10.1007/s007740050090; Coppola G, 2009, EPILEPSIA, V50, P2140, DOI 10.1111/j.1528-1167.2009.02082.x; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Finbraten AK, 2015, OSTEOPOROSIS INT, V26, P141, DOI 10.1007/s00198-014-2840-0; HENDERSON RC, 1995, J BONE JOINT SURG AM, V77A, P1671, DOI 10.2106/00004623-199511000-00005; Henderson RC, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e5; Houlihan CM, 2014, J PEDIATR REHAB MED, V7, P143, DOI 10.3233/PRM-140283; Houlihan CM, 2009, PHYS MED REH CLIN N, V20, P493, DOI 10.1016/j.pmr.2009.04.004; Iwasaki T, 2008, PEDIATR INT, V50, P269, DOI 10.1111/j.1442-200X.2008.02571.x; King W, 2003, DEV MED CHILD NEUROL, V45, P12, DOI 10.1017/S0012162203000033; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Mughal MZ, 2014, CURR OSTEOPOROS REP, V12, P313, DOI 10.1007/s11914-014-0224-1; NISHIYAMA S, 1986, EUR J PEDIATR, V144, P457, DOI 10.1007/BF00441738; Sheridan KJ, 2009, DEV MED CHILD NEUROL, V51, P38, DOI 10.1111/j.1469-8749.2009.03432.x; Tasdemir HA, 2001, PEDIATR INT, V43, P157, DOI 10.1046/j.1442-200x.2001.01352.x; Thomas R, 2010, NEUROREHABILITATION, V27, P201, DOI 10.3233/NRE-2010-0597; Unay B, 2003, TURKISH J PEDIATR, V45, P11; Ward K. A., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P154; Wimalasundera Neil, 2016, Pract Neurol, V16, P184, DOI 10.1136/practneurol-2015-001184	21	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156991	10.1371/journal.pone.0156991	http://dx.doi.org/10.1371/journal.pone.0156991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275738	Green Submitted, gold, Green Published			2022-12-27	WOS:000377561700055
J	Jakob, RP; Schmidpeter, PAM; Koch, JR; Schmid, FX; Maier, T				Jakob, Roman P.; Schmidpeter, Philipp A. M.; Koch, Johanna R.; Schmid, Franz X.; Maier, Timm			Structural and Functional Characterization of a Novel Family of Cyclophilins, the AquaCyps	PLOS ONE			English	Article							PEPTIDYL-PROLYL ISOMERASE; CIS-TRANS ISOMERASES; ACTIVE-SITE MUTANTS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CIS/TRANS ISOMERASES; BINDING-PROTEIN; CHAPERONE; SEQUENCE; VIRULENCE	Cyclophilins are ubiquitous cis-trans-prolyl isomerases (PPIases) found in all kingdoms of life. Here, we identify a novel family of cyclophilins, termed AquaCyps, which specifically occurs in marine Alphaproteobacteria, but not in related terrestric species. In addition to a canonical PPIase domain, AquaCyps contain large extensions and insertions. The crystal structures of two representatives from Hirschia baltica, AquaCyp293 and AquaCyp300, reveal the formation of a compact domain, the NIC domain, by the N- and C-terminal extensions together with a central insertion. The NIC domain adopts a novel mixed alpha-helical, beta-sheet fold that is linked to the cyclophilin domain via a conserved disulfide bond. In its overall fold, AquaCyp293 resembles AquaCyp300, but the two proteins utilize distinct sets of active site residues, consistent with differences in their PPIase catalytic properties. While AquaCyp293 is a highly active general PPIase, AquaCyp300 is specific for hydrophobic substrate peptides and exhibits lower overall activity.	[Jakob, Roman P.; Maier, Timm] Univ Basel, Dept Biozentrum, CH-4056 Basel, Switzerland; [Schmidpeter, Philipp A. M.; Koch, Johanna R.; Schmid, Franz X.] Univ Bayreuth, Biochem Lab, POB 101251, D-95440 Bayreuth, Germany; [Schmidpeter, Philipp A. M.; Koch, Johanna R.; Schmid, Franz X.] Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, POB 101251, D-95440 Bayreuth, Germany	University of Basel; University of Bayreuth; University of Bayreuth	Jakob, RP; Maier, T (corresponding author), Univ Basel, Dept Biozentrum, CH-4056 Basel, Switzerland.	roman.jakob@unibas.ch; timm.maier@unibas.ch	Schmidpeter, Philipp/Q-5540-2019	Schmidpeter, Philipp/0000-0003-2871-9706; Jakob, Roman/0000-0002-6451-8656	Swiss National Science Foundation [R'EQUIP 145023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (R'EQUIP 145023).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andreeva L, 1999, INT J EXP PATHOL, V80, P305, DOI 10.1046/j.1365-2613.1999.00128.x; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Budiman C, 2011, PROTEIN SCI, V20, P1755, DOI 10.1002/pro.714; Chakraborty A, 2002, J BIOL CHEM, V277, P47451, DOI 10.1074/jbc.M204827200; Chen MM, 2011, MOL PLANT PATHOL, V12, P239, DOI 10.1111/j.1364-3703.2010.00665.x; Chertkov O, 2011, STAND GENOMIC SCI, V5, P287, DOI 10.4056/sigs.2205004; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; COMPTON LA, 1992, EUR J BIOCHEM, V206, P927, DOI 10.1111/j.1432-1033.1992.tb17002.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Edwards KJ, 1997, J MOL BIOL, V271, P258, DOI 10.1006/jmbi.1997.1151; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; HACKER J, 1993, MOL MICROBIOL, V10, P445, DOI 10.1111/j.1365-2958.1993.tb00917.x; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; Hoffmann H, 2014, BIOL CHEM, V395, P721, DOI 10.1515/hsz-2014-0125; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ivery MTG, 2000, MED RES REV, V20, P452, DOI 10.1002/1098-1128(200011)20:6<452::AID-MED2>3.0.CO;2-6; Jackson SE, 2013, TOP CURR CHEM, V328, P35, DOI 10.1007/128_2011_151; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jakob RP, 2015, J BIOL CHEM, V290, P3278, DOI 10.1074/jbc.M114.622910; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kale A, 2011, J BIOL CHEM, V286, P21254, DOI 10.1074/jbc.M111.220442; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KE HM, 1991, P NATL ACAD SCI USA, V88, P9483, DOI 10.1073/pnas.88.21.9483; KE HM, 1992, J MOL BIOL, V228, P539, DOI 10.1016/0022-2836(92)90841-7; Kim IS, 2010, J MICROBIOL BIOTECHN, V20, P974, DOI 10.4014/jmb.0911.11005; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Marin-Menendez A, 2011, PROTEIN EXPRES PURIF, V78, P225, DOI 10.1016/j.pep.2011.04.012; Mayr LM, 1996, BIOCHEMISTRY-US, V35, P5550, DOI 10.1021/bi953035y; MAYR LM, 1993, J MOL BIOL, V231, P897, DOI 10.1006/jmbi.1993.1336; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mok D, 2006, FEBS LETT, V580, P2761, DOI 10.1016/j.febslet.2006.04.039; Moparthi SB, 2009, PROTEIN SCI, V18, P475, DOI 10.1002/pro.28; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Phadke ND, 2001, PROTEOMICS, V1, P705, DOI 10.1002/1615-9861(200104)1:5<705::AID-PROT705>3.3.CO;2-E; RAHFELD JU, 1994, FEBS LETT, V352, P180, DOI 10.1016/0014-5793(94)00932-5; Reffuveille F, 2012, INFECT IMMUN, V80, P1728, DOI 10.1128/IAI.06251-11; Riboldi-Tunnicliffe A, 2001, NAT STRUCT BIOL, V8, P779, DOI 10.1038/nsb0901-779; Saphire ACS, 2000, IMMUNOL RES, V21, P211, DOI 10.1385/IR:21:2-3:211; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schiene-Fischer C, 2015, BBA-GEN SUBJECTS, V1850, P2005, DOI 10.1016/j.bbagen.2014.11.012; SCHLESNER H, 1990, INT J SYST BACTERIOL, V40, P443, DOI 10.1099/00207713-40-4-443; Schmid FX, 1996, BIOL CHEM, V377, P417; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Scholz C, 2006, BIOCHEMISTRY-US, V45, P20, DOI 10.1021/bi051922n; Scholz C, 1997, FEBS LETT, V414, P69, DOI 10.1016/S0014-5793(97)00979-4; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P1634, DOI 10.1128/AEM.02512-07; Taylor P, 2001, STRUCTURE, V9, P431, DOI 10.1016/S0969-2126(01)00603-7; Viaud MC, 2002, PLANT CELL, V14, P917, DOI 10.1105/tpc.010389; Wang P, 2001, EMBO REP, V2, P511, DOI 10.1093/embo-reports/kve109; WEBER C, 1991, BIOCHEMISTRY-US, V30, P6563, DOI 10.1021/bi00240a029; Zhang XC, 2013, FEBS LETT, V587, P666, DOI 10.1016/j.febslet.2013.01.028; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	79	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157070	10.1371/journal.pone.0157070	http://dx.doi.org/10.1371/journal.pone.0157070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276069	Green Published, Green Accepted, gold			2022-12-27	WOS:000377561700066
J	Sekercioglu, N; Thabane, L; Martinez, JPD; Nesrallah, G; Longo, CJ; Busse, JW; Akhtar-Danesh, N; Agarwal, A; Al-Khalifah, R; Iorio, A; Guyatt, GH				Sekercioglu, Nigar; Thabane, Lehana; Martinez, Juan Pablo Diaz; Nesrallah, Gihad; Longo, Christopher J.; Busse, Jason W.; Akhtar-Danesh, Noori; Agarwal, Arnav; Al-Khalifah, Reem; Iorio, Alfonso; Guyatt, Gordon H.			Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							CORONARY-ARTERY CALCIFICATION; LANTHANUM CARBONATE; HEMODIALYSIS-PATIENTS; VASCULAR CALCIFICATION; FERRIC CITRATE; DOUBLE-BLIND; SEVELAMER HYDROCHLORIDE; AORTIC CALCIFICATION; CALCIUM-CARBONATE; SERUM PHOSPHORUS	Background Chronic kidney disease-mineral and bone disorder (CKD-MBD) has been linked to poor health outcomes, including diminished quality and length of life. This condition is characterized by high phosphate levels and requires phosphate-lowering agents-phosphate binders. The objective of this systematic review is to compare the effects of available phosphate binders on patient-important outcomes in patients with CKD-MBD. Methods Data sources included MEDLINE and EMBASE Trials from 1996 to February 2016. We also searched the Cochrane Register of Controlled Trials up to April 2016. Teams of two reviewers, independently and in duplicate, screened titles and abstracts and potentially eligible full text reports to determine eligibility, and subsequently abstracted data and assessed risk of bias in eligible randomized controlled trials (RCTs). Eligible trials enrolled patients with CKD-MBD, randomized them to receive calcium (delivered as calcium acetate, calcium citrate or calcium carbonate), non-calcium-based phosphate binders (NCBPB) (sevelamer hydrochloride, sevelamer carbonate, lanthanum carbonate, sucroferric oxyhydroxide and ferric citrate), phosphorus restricted diet, placebo or no treatment, and reported effects on all-cause mortality, cardiovascular mortality or hospitalization at >= 4 weeks follow-up. We performed network meta-analyses (NMA) for all cause-mortality for individual agents (seven-node analysis) and conventional meta-analysis of calcium vs. NCBPBs for all-cause mortality, cardiovascular mortality and hospitalization. In the NMAs, we calculated the effect estimates for direct, indirect and network meta-analysis estimates; for both NMA and conventional meta-analysis, we pooled treatment effects as risk ratios (RR) and calculated 95% confidence intervals (CIs) using random effect models. We used the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to rate the quality of evidence for each paired comparison. Results Our search yielded 1190 citations, of which 71 RCTs were retrieved for full review and 15 proved eligible. With 13 eligible studies from a prior review, we included 28 studies with 8335 participants; 25 trials provided data for our quantitative synthesis. Results suggest higher mortality with calcium than either sevelamer (NMA RR, 1.89 [95% CI, 1.02 to 3.50], moderate quality evidence) or NCBPBs (conventional meta-analysis RR, 1.76 [95% CI, 1.21 to 2.56, moderate quality evidence). Conventional meta-analysis suggested no difference in cardiovascular mortality between calcium and NCBPBs (RR, 2.54 [95% CI, 0.67 to 9.62 low quality evidence). Our results suggest higher hospitalization, although non-significant, with calcium than NCBPBs (RR, 1.293 [95% CI, 0.94 to 1.74, moderate quality evidence). Discussion/Conclusions Use of calcium results in higher mortality than either sevelamer in particular and NCBPBs in general (moderate quality evidence). Our results raise questions about whether administration of calcium as an intervention for CKD-MBD remains ethical. Further research is needed to explore the effects of different types of phosphate binders, including novel agents such as iron, on quality and quantity of life.	[Sekercioglu, Nigar; Thabane, Lehana; Martinez, Juan Pablo Diaz; Busse, Jason W.; Akhtar-Danesh, Noori; Iorio, Alfonso; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Pediat & Anesthesia, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare, Ctr Evaluat Med, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada; [Thabane, Lehana] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Nesrallah, Gihad] Humber River Hosp, Toronto, ON, Canada; [Nesrallah, Gihad] Univ Toronto, Dept Med, Toronto, ON, Canada; [Longo, Christopher J.] DeGroote Sch Business, 4350 South Serv Rd, Burlington, ON, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Busse, Jason W.] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Agarwal, Arnav] Univ Toronto, Fac Med, Toronto, ON, Canada; [Al-Khalifah, Reem] King Saud Univ, Div Pediat Endocrinol, Riyadh, Saudi Arabia; [Iorio, Alfonso; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; Population Health Research Institute; University of Toronto; McMaster University; McMaster University; University of Toronto; King Saud University; McMaster University	Sekercioglu, N (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	nigars2003@yahoo.com	SEKERCIOGLU, Nigar/AFR-0250-2022; Agarwal, Arnav/J-1553-2014; Khalifah, Reem/H-6486-2019; Busse, Jason/CAH-3696-2022; Nesrallah, Gihad/AAY-7534-2020; Iorio, Alfonso/B-9478-2013	SEKERCIOGLU, Nigar/0000-0001-6461-8801; Agarwal, Arnav/0000-0002-0931-7851; Khalifah, Reem/0000-0002-5304-3528; Busse, Jason/0000-0002-0178-8712; Iorio, Alfonso/0000-0002-3331-8766				[Anonymous], 2013, USRDS 2013 ANN DAT R; [Anonymous], 2015, AM J KIDNEY DIS OFFI, V20, P00633; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Barreto DV, 2008, NEPHRON CLIN PRACT, V110, pC273, DOI 10.1159/000170783; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Block GA, 2015, AM J KIDNEY DIS, V65, P728, DOI 10.1053/j.ajkd.2014.10.014; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Bolland MJ, 2013, THER ADV DRUG SAF, V4, P199, DOI 10.1177/2042098613499790; Cernaro V, 2016, INT J NEPHROL RENOV, V9, P11, DOI 10.2147/IJNRD.S78040; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Chan CT, 2009, NEPHROL DIAL TRANSPL, V24, P3867, DOI 10.1093/ndt/gfp495; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Cosmai L, 2015, J NEPHROL, V28, P647, DOI 10.1007/s40620-015-0226-9; Cozzolino M, 2014, CURR DRUG METAB, V15, P953; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; de Francisco ALM, 2010, NEPHROL DIAL TRANSPL, V25, P3707, DOI 10.1093/ndt/gfq292; Di Iorio B, 2013, AM J KIDNEY DIS, V62, P771, DOI 10.1053/j.ajkd.2013.03.023; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI 10.2215/CJN.03820411; Floege J, 2014, KIDNEY INT, V86, P638, DOI 10.1038/ki.2014.58; Granata A, 2016, EUR J INTERN MED, V30, P1, DOI 10.1016/j.ejim.2016.02.019; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; IBELS LS, 1979, AM J MED, V66, P790, DOI 10.1016/0002-9343(79)91118-5; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Jono S, 1997, ARTERIOSCL THROM VAS, V17, P1135, DOI 10.1161/01.ATV.17.6.1135; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kakuta T, 2011, AM J KIDNEY DIS, V57, P422, DOI 10.1053/j.ajkd.2010.10.055; Kooienga L, 2007, SEMIN DIALYSIS, V20, P342, DOI 10.1111/j.1525-139X.2007.00304.x; Lee CT, 2015, J NEPHROL, V28, P105, DOI 10.1007/s40620-014-0108-6; Lee WH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002917; Lee YK, 2013, CLIN NEPHROL, V79, P136, DOI 10.5414/CN107362; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lewis JB, 2015, J AM SOC NEPHROL, V26, P493, DOI 10.1681/ASN.2014020212; Locatelli F, 2014, EXPERT OPIN DRUG SAF, V13, P551, DOI 10.1517/14740338.2014.907791; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moe SM, 2006, EUR J CLIN INVEST, V36, P51, DOI 10.1111/j.1365-2362.2006.01665.x; NG KP, 2015, J RENIN-ANGIO-ALDO S, V16, P599, DOI DOI 10.1177/1470320315575849; O'Seaghdha CM, 2011, NEPHROL DIAL TRANSPL, V26, P2885, DOI 10.1093/ndt/gfq808; Ohtake T, 2013, J CARDIOVASC PHARM T, V18, P439, DOI 10.1177/1074248413486355; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Qunibi W, 2008, AM J KIDNEY DIS, V51, P952, DOI 10.1053/j.ajkd.2008.02.298; Rebic D, 2015, REN FAIL, V19, P1; Russo D, 2007, KIDNEY INT, V72, P1255, DOI 10.1038/sj.ki.5002518; Sadek T, 2003, NEPHROL DIAL TRANSPL, V18, P582, DOI 10.1093/ndt/18.3.582; Sanchez-Perales C, 2015, NEFROLOGIA, V35, P157, DOI 10.1016/j.nefro.2015.05.017; Schwarz S, 2006, CLIN J AM SOC NEPHRO, V1, P825, DOI 10.2215/CJN.02101205; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Spasovski G, 2015, EXPERT OPIN PHARMACO, V16, P2589, DOI 10.1517/14656566.2015.1092521; Suki WN, 2008, J RENAL NUTR, V18, P91, DOI 10.1053/j.jrn.2007.10.019; Tagawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114678; Takahara Y, 2014, CLIN NEPHROL, V82, P181, DOI 10.5414/CN108269; Takei T, 2008, NEPHRON CLIN PRACT, V108, pC278, DOI 10.1159/000127361; Toussaint Nigel, 2006, Hemodial Int, V10, P280, DOI 10.1111/j.1542-4758.2006.00109.x; Toussaint ND, 2011, NEPHROLOGY, V16, P290, DOI 10.1111/j.1440-1797.2010.01412.x; Urena-Torres P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-71; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wada K, 2014, THER APHER DIAL, V18, P353, DOI 10.1111/1744-9987.12153; Wilkieson Trevor J, 2015, Can J Kidney Health Dis, V2, P29, DOI 10.1186/s40697-015-0065-6; Wilson R, 2009, CURR MED RES OPIN, V25, P3021, DOI 10.1185/03007990903399398; Wu HC, 2015, RENAL FAILURE, V37, P343, DOI 10.3109/0886022X.2015.1087862; Wuthrich RP, 2013, CLIN J AM SOC NEPHRO, V8, P280, DOI 10.2215/CJN.08230811; Xu J, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-29; Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x; Yokoyama K, 2014, NEPHROL DIAL TRANSPL, V29, P1053, DOI 10.1093/ndt/gft483; Yokoyama K, 2014, CLIN J AM SOC NEPHRO, V9, P543, DOI 10.2215/CJN.05170513; Zhai CJ, 2015, INT UROL NEPHROL, V47, P527, DOI 10.1007/s11255-014-0876-x; 2012, KIDNEY INT S, V2013, P1	74	48	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156891	10.1371/journal.pone.0156891	http://dx.doi.org/10.1371/journal.pone.0156891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276077	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700045
J	Perland, E; Lekholm, E; Eriksson, MM; Bagchi, S; Arapi, V; Fredriksson, R				Perland, Emelie; Lekholm, Emilia; Eriksson, Mikaela M.; Bagchi, Sonchita; Arapi, Vasiliki; Fredriksson, Robert			The Putative SLC Transporters Mfsd5 and Mfsd11 Are Abundantly Expressed in the Mouse Brain and Have a Potential Role in Energy Homeostasis	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; AMINO-ACID; GENE-EXPRESSION; PROTEINS; SYSTEM; IDENTIFICATION; AMYGDALA; NEURONS; GROWTH; SENSOR	Background Solute carriers (SLCs) are membrane bound transporters responsible for the movement of soluble molecules such as amino acids, ions, nucleotides, neurotransmitters and oligopeptides over cellular membranes. At present, there are 395 SLCs identified in humans, where about 40% are still uncharacterized with unknown expression and/or function(s). Here we have studied two uncharacterized atypical SLCs that belong to the Major Facilitator Superfamily Pfam clan, Major facilitator superfamily domain 5 (MFSD5) and Major facilitator superfamily domain 11 (MFSD11). We provide fundamental information about the histology in mice as well as data supporting their disposition to regulate expression levels to keep the energy homeostasis. Results In mice subjected to starvation or high-fat diet, the mRNA expression of Mfsd5 was significantly down-regulated (P<0.001) in food regulatory brain areas whereas Mfsd11 was significantly up-regulated in mice subjected to either starvation (P<0.01) or high-fat diet (P< 0.001). qRT-PCR analysis on wild type tissues demonstrated that both Mfsd5 and Mfsd11 have a wide central and peripheral mRNA distribution, and immunohistochemistry was utilized to display the abundant protein expression in the mouse embryo and the adult mouse brain. Both proteins are expressed in excitatory and inhibitory neurons, but not in astrocytes. Conclusions Mfsd5 and Mfsd11 are both affected by altered energy homeostasis, suggesting plausible involvement in the energy regulation. Moreover, the first histological mapping of MFSD5 and MFSD11 shows ubiquitous expression in the periphery and the central nervous system of mice, where the proteins are expressed in excitatory and inhibitory mouse brain neurons.	[Perland, Emelie; Lekholm, Emilia] Uppsala Univ, Dept Neurosci, Unit Funct Pharmacol, Uppsala, Sweden; [Eriksson, Mikaela M.; Bagchi, Sonchita; Arapi, Vasiliki; Fredriksson, Robert] Uppsala Univ, Dept Pharmaceut Biosci, Unit Mol Neuropharmacol, Uppsala, Sweden	Uppsala University; Uppsala University	Fredriksson, R (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Unit Mol Neuropharmacol, Uppsala, Sweden.	Robert.Fredriksson@farmbio.uu.se		Fredriksson, Robert/0000-0002-2810-3226; Lekholm, Emilia/0000-0001-8135-9127; Ceder, Mikaela/0000-0002-9681-5129; Perland, Emelie/0000-0001-6672-2442	Swedish Research Council; Swedish Brain Foundation; Swedish Society for Medical Research; Novo Nordisk foundation; Ahlens foundation; Engkvist Foundation; Thurings Foundation for metabolic research; Gunvor and Josef Aners foundation; Tore Nilssons foundation; Science for Life Lab BioVis Platform, Uppsala	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Swedish Society for Medical Research; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Ahlens foundation; Engkvist Foundation; Thurings Foundation for metabolic research; Gunvor and Josef Aners foundation; Tore Nilssons foundation; Science for Life Lab BioVis Platform, Uppsala	This study was supported by the Swedish Research Council, The Swedish Brain Foundation, The Swedish Society for Medical Research, The Novo Nordisk foundation, Ahlens foundation, Engkvist Foundation, Thurings Foundation for metabolic research, Gunvor and Josef Aners foundation and Tore Nilssons foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have received funding from the Novo Nordisk Fondation, which is not a commercial source, but a non-profit foundation.; We wish to express special thanks to Mona Bushra and Johanna Lundgren for their assistance with preparations of the experiments and to Matyas Molnar for his microscopy expertise. Imaging was performed with support of the Science for Life Lab BioVis Platform, Uppsala. Further, we wish to thank Michael J. Williams for critically reading the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Bagchi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095438; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; BioParadigms, 2016, SLC TABL; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Cellier Mathieu F M, 2013, Biology (Basel), V2, P233, DOI 10.3390/biology2010233; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hellsten SV, 2016, THESIS ACTA U UPSALI; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KIZER JS, 1976, BRAIN RES, V108, P363, DOI 10.1016/0006-8993(76)90192-X; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Liao XH, 2008, AMINO ACIDS, V35, P761, DOI 10.1007/s00726-008-0100-3; Manns ID, 2001, NEUROSCIENCE, V107, P249, DOI 10.1016/S0306-4522(01)00302-5; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palii SS, 2009, AMINO ACIDS, V37, P79, DOI 10.1007/s00726-008-0199-2; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paxinos G., 2007, MOUSE BRAIN STEREOTA, V3rd Edn; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Qian ZHANG, 2011, [Frontiers in Biology, 生物学前沿], V6, P82; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sreedharan S, 2011, GENE, V478, P11, DOI 10.1016/j.gene.2010.10.011; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taka S, 2013, INFECT GENET EVOL, V17, P8, DOI 10.1016/j.meegid.2013.03.033; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Van der Gucht E, 2003, BRAIN RES, V988, P29, DOI 10.1016/S0006-8993(03)03332-8; van Zessen R, 2012, P NUTR SOC, V71, P435, DOI 10.1017/S0029665112000614; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	51	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156912	10.1371/journal.pone.0156912	http://dx.doi.org/10.1371/journal.pone.0156912			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272503	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561000047
J	Ristivojevic, P; Dimkic, I; Trifkovic, J; Beric, T; Vovk, I; Milojkovic-Opsenica, D; Stankovic, S				Ristivojevic, Petar; Dimkic, Ivica; Trifkovic, Jelena; Beric, Tanja; Vovk, Irena; Milojkovic-Opsenica, Dusanka; Stankovic, Slavisa			Antimicrobial Activity of Serbian Propolis Evaluated by Means of MIC, HPTLC, Bioautography and Chemometrics	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; CHEMICAL-COMPOSITION; PHENOLIC-COMPOUNDS; IMAGE-ANALYSIS; BACTERIA; GROWTH; REGIONS; ACIDS	New information has come to light about the biological activity of propolis and the quality of natural products which requires a rapid and reliable assessment method such as High Performance Thin-Layer Chromatography (HPTLC) fingerprinting. This study investigates chromatographic and chemometric approaches for determining the antimicrobial activity of propolis of Serbian origin against various bacterial species. A linear multivariate calibration technique, using Partial Least Squares, was used to extract the relevant information from the chromatographic fingerprints, i.e. to indicate peaks which represent phenolic compounds that are potentially responsible for the antimicrobial capacity of the samples. In addition, direct bioautography was performed to localize the antibacterial activity on chromatograms. The biological activity of the propolis samples against various bacterial species was determined by a minimum inhibitory concentration assay, confirming their affiliation with the European poplar type of propolis and revealing the existence of two types (blue and orange) according to botanical origin. The strongest antibacterial activity was exhibited by sample 26 against Staphylococcus aureus, with a MIC value of 0.5 mg/mL, and Listeria monocytogenes, with a MIC as low as 0.1 mg/mL, which was also the lowest effective concentration observed in our study. Generally, the orange type of propolis shows higher antimicrobial activity compared to the blue type. PLS modelling was performed on the HPTLC data set and the resulting models might qualitatively indicate compounds that play an important role in the activity exhibited by the propolis samples. The most relevant peaks influencing the antimicrobial activity of propolis against all bacterial strains were phenolic compounds at RF values of 0.37, 0.40, 0.45, 0.51, 0.60 and 0.70. The knowledge gained through this study could be important for attributing the antimicrobial activity of propolis to specific chemical compounds, as well as the verification of HPTLC fingerprinting as a reliable method for the identification of compounds that are potentially responsible for antimicrobial activity. This is the first report on the activity of Serbian propolis as determined by several combined methods, including the modelling of antimicrobial activity by HPTLC fingerprinting.	[Ristivojevic, Petar] Univ Belgrade, Innovat Ctr, Fac Chem Ltd, Belgrade, Serbia; [Dimkic, Ivica; Beric, Tanja; Stankovic, Slavisa] Univ Belgrade, Fac Biol, Dept Microbiol, Belgrade, Serbia; [Trifkovic, Jelena; Milojkovic-Opsenica, Dusanka] Univ Belgrade, Fac Chem, Dept Analyt Chem, Belgrade, Serbia; [Vovk, Irena] Natl Inst Chem, Food Chem Lab, Ljubljana, Slovenia	University of Belgrade; University of Belgrade; University of Belgrade; National Institute of Chemistry - Slovenia	Stankovic, S (corresponding author), Univ Belgrade, Fac Biol, Dept Microbiol, Belgrade, Serbia.	slavisas@bio.bg.ac.rs	Stanković, Slaviša/S-6273-2018; Dimkić, Ivica/AAE-1508-2019; Milojkovic-Opsenica, Dusanka/M-5726-2013; Trifković, Jelena/Q-3985-2016; Ristivojevic, Petar/R-6512-2016; Beric, Tanja/GLR-4901-2022; Dimkic, Ivica/GWR-2445-2022	Stanković, Slaviša/0000-0003-0527-8741; Milojkovic-Opsenica, Dusanka/0000-0001-6274-4222; Trifković, Jelena/0000-0002-8866-1991; Ristivojevic, Petar/0000-0001-6106-1454; Dimkic, Ivica/0000-0002-0425-5938; Beric, Tanja/0000-0002-4860-2225	Ministry of Education, Science and Technological Development of Serbia [172017, 173026]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia, Grants No. 172017 and 173026, http://www.mpn.gov.rs/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boisard S, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/319240; Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244; Choma IM, 2011, J CHROMATOGR A, V1218, P2684, DOI 10.1016/j.chroma.2010.12.069; D'Souza L, 2010, INDIAN J MAR SCI, V39, P294; Darwish RM, 2010, AFR J BIOTECHNOL, V9, P5966; Drago L, 2000, J CHEMOTHERAPY, V12, P390, DOI 10.1179/joc.2000.12.5.390; Du Toit K, 2009, S AFR J SCI, V105, P470; Dumarey M, 2008, J CHROMATOGR A, V1192, P81, DOI 10.1016/j.chroma.2008.03.052; Gatto MT, 2002, BIOORGAN MED CHEM, V10, P269, DOI 10.1016/S0968-0896(01)00275-9; Gomez-Caravaca AM, 2006, J PHARMACEUT BIOMED, V41, P1220, DOI 10.1016/j.jpba.2006.03.002; Kalogeropoulos N, 2009, FOOD CHEM, V116, P452, DOI 10.1016/j.foodchem.2009.02.060; Kareem AA, 2015, J CONTEMP MED SCI, V1, P6; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; Lou ZX, 2012, FOOD CONTROL, V25, P550, DOI 10.1016/j.foodcont.2011.11.022; Lu Jing, 2013, Acta Hydrobiologica Sinica, V37, P1128; Mercan N, 2006, ANN MICROBIOL, V56, P373, DOI 10.1007/BF03175035; Merkl R, 2010, CZECH J FOOD SCI, V28, P275, DOI 10.17221/132/2010-CJFS; Mirzoeva OK, 1997, MICROBIOL RES, V152, P239, DOI 10.1016/S0944-5013(97)80034-1; Morlock GE, 2014, J CHROMATOGR A, V1328, P104, DOI 10.1016/j.chroma.2013.12.053; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Nikaido H., 1996, ESCHERICHIA COLI SAL, P29; Pepeljnjak S, 2004, FEMS MICROBIOL LETT, V240, P111, DOI 10.1016/j.femsle.2004.09.018; PLESIAT P, 1992, MOL MICROBIOL, V6, P1323, DOI 10.1111/j.1365-2958.1992.tb00853.x; Prasad VGNV, 2014, ASIAN PAC J TROP DIS, V4, P326, DOI DOI 10.1016/S2222-1808(14)60464-3; Ristivojevic P, 2015, NAT PROD COMMUN, V10, P1869; Ristivojevic P, 2015, PHYTOCHEM ANALYSIS, V26, P127, DOI 10.1002/pca.2544; Ristivojevic P, 2014, J CHEMOMETR, V28, P301, DOI 10.1002/cem.2592; Vaquero MJR, 2007, FOOD CONTROL, V18, P587, DOI 10.1016/j.foodcont.2006.02.005; Vaquero MJR, 2011, FOOD TECHNOL BIOTECH, V49, P83; Salatino A, 2011, NAT PROD REP, V28, P925, DOI 10.1039/c0np00072h; Sanpa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126886; Sarbu C, 2011, TALANTA, V85, P1112, DOI 10.1016/j.talanta.2011.05.030; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Shan SM, 2014, J PHARMACEUT BIOMED, V89, P76, DOI 10.1016/j.jpba.2013.10.030; Stepanovic S, 2003, MICROBIOL RES, V158, P353, DOI 10.1078/0944-5013-00215; Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08; Temiz A, 2011, TURK J BIOL, V35, P503, DOI 10.3906/biy-0908-22; Tistaert C, 2009, ANAL CHIM ACTA, V652, P189, DOI 10.1016/j.aca.2009.08.024; Tiwari BK, 2009, J AGR FOOD CHEM, V57, P5987, DOI 10.1021/jf900668n; Tukmechi A, 2010, BRAZ J MICROBIOL, V41, P1086, DOI [10.1590/S1517-83822010000400030, 10.1590/S1517-838220100004000030]; Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034; Vijay Kothari, 2011, Research in Biotechnology, V2, P20	43	49	49	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157097	10.1371/journal.pone.0157097	http://dx.doi.org/10.1371/journal.pone.0157097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272728	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000064
J	Al-Nahari, A; Mohamad, MM				Al-Nahari, Abdulaziz; Mohamad, Mohd Murtadha			Receiver-Based Ad Hoc On Demand Multipath Routing Protocol for Mobile Ad Hoc Networks	PLOS ONE			English	Article							ALGORITHM	Decreasing the route rediscovery time process in reactive routing protocols is challenging in mobile ad hoc networks. Links between nodes are continuously established and broken because of the characteristics of the network. Finding multiple routes to increase the reliability is also important but requires a fast update, especially in high traffic load and high mobility where paths can be broken as well. The sender node keeps re-establishing path discovery to find new paths, which makes for long time delay. In this paper we propose an improved multipath routing protocol, called Receiver-based ad hoc on demand multipath routing protocol (RB-AOMDV), which takes advantage of the reliability of the state of the art ad hoc on demand multipath distance vector (AOMDV) protocol with less re-established discovery time. The receiver node assumes the role of discovering paths when finding data packets that have not been received after a period of time. Simulation results show the delay and delivery ratio performances are improved compared with AOMDV.	[Al-Nahari, Abdulaziz; Mohamad, Mohd Murtadha] Univ Teknol Malaysia, Fac Comp, PCRG, Johor Baharu, Malaysia; [Al-Nahari, Abdulaziz] Sanaa Community Coll, Div Appl Sci, Dept Programming, Sanaa, Yemen	Universiti Teknologi Malaysia	Al-Nahari, A (corresponding author), Univ Teknol Malaysia, Fac Comp, PCRG, Johor Baharu, Malaysia.; Al-Nahari, A (corresponding author), Sanaa Community Coll, Div Appl Sci, Dept Programming, Sanaa, Yemen.	azizynh@gmail.com	AL-NAHARI, ABDULAZIZ/AHA-9115-2022; Mohamad, Mohd Murtadha/C-9887-2011	Mohamad, Mohd Murtadha/0000-0002-1478-0138	Fundamental Research Grant Scheme (FRGS) [R. J130000.7828.4F644]; Ministry of Higher Education (MOHE), Malaysia	Fundamental Research Grant Scheme (FRGS); Ministry of Higher Education (MOHE), Malaysia	The study was supported by Fundamental Research Grant Scheme (FRGS) No. R. J130000.7828.4F644. and Ministry of Higher Education (MOHE), Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburumman A, 2015, L N INST COMP SCI SO, V153, P267, DOI 10.1007/978-3-319-23802-9_21; Ahmad SJ, 2015, EXPERT SYST APPL, V42, P6819, DOI 10.1016/j.eswa.2015.04.027; Al-Nahari A, 2015, P ICRIL INT C INN SC; Al-Nahari A, 2013, INT SYST DES APPL IS; Alghamdi Saleh A, 2015, EURASIP J WIREL COMM, P1; Alwadiyeh ES, 2013, 22 NAT C AUSTR SOC O; Alwadiyeh ES, 2013, LOC COMP NETW WORKSH; Amin SH, 2014, COMPUT NETW, V62, P162, DOI 10.1016/j.bjp.2013.11.015; [Anonymous], AD HOC ON DEMAND DIS; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen Z, 2012, HIGH PERF COMP COMM; Clausen T., 2003, EXPERIMENTAL; Di Caro G, 2005, EUR T TELECOMMUN, V16, P443, DOI 10.1002/ett.1062; Huang SC, 2015, COMPUT J, V58, P338, DOI 10.1093/comjnl/bxu042; Kim C, 2006, LECT NOTES COMPUT SC, V4097, P522; Kim S, 2012, WIRELESS PERS COMMUN, V66, P739, DOI 10.1007/s11277-011-0361-0; Liu JW, 2009, 2009 5TH INTERNATIONAL CONFERENCE ON WIRELESS COMMUNICATIONS, NETWORKING AND MOBILE COMPUTING, VOLS 1-8, P2713; Liu S, 2013, AASRI PROC, V5, P21, DOI 10.1016/j.aasri.2013.10.054; Ma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19066; Macharla P, 2008, COMM SYST SOFTW MIDD; Marina MK, 2006, WIREL COMMUN MOB COM, V6, P969, DOI 10.1002/wcm.432; Memon S, WIRELESS PERS COMMUN, P1; Naseem M, 2015, WIRELESS PERS COMMUN, V84, P2955, DOI 10.1007/s11277-015-2775-6; Perkins C. E., 1994, Computer Communication Review, V24, P234, DOI 10.1145/190809.190336; Prabha R., 2015, EURASIP J WIREL COMM, V9, P1; Quispe LE, 2014, EXPERT SYST APPL, V41, P2565, DOI 10.1016/j.eswa.2013.10.004; Radwan AAA, 2011, EGYPT INFORM J, V12, P95, DOI 10.1016/j.eij.2011.04.001; Sambasivam P., 2004, P 3 ANN MED AD HOC N; Seo W. J., 2015, P 11 INT C SEC PRIV, P649, DOI DOI 10.1007/978-3-319-28865-9_43; Shijie L, 2012, SIGN PROC ICSP 2012; Sihai Zheng, 2012, Journal of Networks, V7, P691, DOI 10.4304/jnw.7.4.691-698; Smail O, 2014, EURASIP J WIREL COMM, V2014, P1; Su YW, 2015, WIRELESS PERS COMMUN, V83, P1867, DOI 10.1007/s11277-015-2486-z; Wu ZY, 2010, COMPUT J, V53, P166, DOI 10.1093/comjnl/bxn007; Yang JS, 2008, IEEE WCNC, P2247	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156670	10.1371/journal.pone.0156670	http://dx.doi.org/10.1371/journal.pone.0156670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258013	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700099
J	Balsorano, P; Romagnoli, S; Evans, SK; Ricci, Z; De Gaudio, AR				Balsorano, Paolo; Romagnoli, Stefano; Evans, Samuel Kagan; Ricci, Zaccaria; De Gaudio, Angelo Raffaele			Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; BIOMARKERS; AKI; BLOOD; TIME; RISK	Introduction The kidneys play a crucial role in the regulation of electrolytes and acid-base homeostasis. Urinary Strong Ion Difference (SIDu = NaU + KU-ClU) represents an important aspect of renal acid-base regulation. We evaluated the role of SIDu as a marker of renal dysfunction in critically ill patients. Materials and Methods Patients admitted to the Medical Intensive Care Unit with a diagnosis of AKI for whom concomitant urinary samples available for SIDu calculation were retrospectively reviewed and staged according to KDIGO criteria for 3 days from inclusion. Patients were classified as Recovered (R-AKI) or Persistent-AKI (P-AKI) whether they exited KDIGO criteria within the 3-day observation period or not. A control group with normal renal function and normal serum acid-base and electrolytes was prospectively recruited in order to identify reference SIDu values. Results One-hundred-and-forty-three patients with a diagnosis of AKI were included: 77 with R-AKI, and 66 with P-AKI. Thirty-six controls were recruited. Patients with P-AKI had more severe renal dysfunction and higher mortality than patients with R-AKI (SCr 2.23(IQR: 1.68-3.45) and 1.81(IQR1.5-2.5) mg/dl respectively, p<0.001; 24-h UO 1297(950) and 2100(1094) ml respectively, p = 0.003); 30-d mortality, 39% and 13% respectively; p<0.001). SIDu significantly differed between groups, with rising values from controls to P-AKI groups (16.4(12), 30(24) and 47.3(21.5) mEq/l respectively, p<0.001). Discussion SIDu may be a simple and inexpensive tool in AKI patients' evaluation. Further research is needed to evaluate the ability of SIDu to identify patients with renal dysfunction before derangements in serum creatinine or urine output are observed.	[Balsorano, Paolo; Romagnoli, Stefano; De Gaudio, Angelo Raffaele] Univ Florence, Dept Hlth Sci, Sect Anaesthesiol Intens Care & Pain Med, Florence, Italy; [Evans, Samuel Kagan] Rhode Isl Hosp, Dept Pulm & Crit Care Med, Providence, RI USA; [Ricci, Zaccaria] Bambino Gesu Pediat Hosp, IRCCS, Dept Cardiol & Cardiac Surg, Pediat Cardiac Intens Care Unit, Rome, Italy	University of Florence; Lifespan Health Rhode Island; Rhode Island Hospital; IRCCS Bambino Gesu	Balsorano, P (corresponding author), Univ Florence, Dept Hlth Sci, Sect Anaesthesiol Intens Care & Pain Med, Florence, Italy.	paolobal84@gmail.com	Balsorano, Paolo/AAG-3245-2019; Ricci, Zaccaria/J-2944-2012	ricci, zaccaria/0000-0001-8916-0569				Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P695, DOI 10.1053/j.ajkd.2006.07.017; Bagshaw SM, 2010, CAN J ANESTH, V57, P985, DOI 10.1007/s12630-010-9375-4; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Cruz DN, 2009, CRIT CARE, V13, DOI 10.1186/cc7759; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gattinoni L, 2006, CRIT CARE, V10, DOI 10.1186/cc4890; GOLDSTEIN MB, 1986, AM J MED SCI, V292, P198, DOI 10.1097/00000441-198610000-00003; Hall IE, 2011, CLIN J AM SOC NEPHRO, V6, P2740, DOI 10.2215/CJN.04960511; Honore PM, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-24; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Maciel Alexandre Toledo, 2013, Rev. bras. ter. intensiva, V25, P184, DOI 10.5935/0103-507X.20130032; Maciel AT, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-31; Masevicius FD, 2010, CRIT CARE RESUSC, V12, P248; Masevicius Fabio Daniel, 2013, Rev. bras. ter. intensiva, V25, P197, DOI 10.5935/0103-507X.20130035; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Moviat M, 2012, J CRIT CARE, V27, P255, DOI 10.1016/j.jcrc.2011.05.028; Ronco C, 2013, CRIT CARE, V17, DOI 10.1186/cc12488; Ronco C, 2012, CRIT CARE, V16, DOI 10.1186/cc11240; SARTORIUS OW, 1949, J CLIN INVEST, V28, P423; Sood MM, 2014, J CRIT CARE, V29, P711, DOI 10.1016/j.jcrc.2014.04.003; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Zazzeron L, 2013, CRITICAL CARE, V17, pP415	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156941	10.1371/journal.pone.0156941	http://dx.doi.org/10.1371/journal.pone.0156941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258049	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700161
J	Nakajima, M; Hiraoka, T; Yamamoto, T; Takagi, S; Hirohara, Y; Oshika, T; Mihashi, T				Nakajima, Masashi; Hiraoka, Takahiro; Yamamoto, Toshiya; Takagi, Seiu; Hirohara, Yoko; Oshika, Tetsuro; Mihashi, Toshifumi			Differences of Longitudinal Chromatic Aberration (LCA) between Eyes with Intraocular Lenses from Different Manufacturers	PLOS ONE			English	Article							HIGHER-ORDER ABERRATIONS; OCULAR ABERRATIONS; WAVELENGTH; DISPERSION; MODEL; AGE	Several researchers have studied the longitudinal chromatic aberration (LCA) of eyes implanted with an intraocular lens (IOL). We investigated the LCA of eyes implanted with yellow-colored IOLs from three different manufacturers: Alcon Inc., HOYA Corp., and AMO Inc. The number of subjects was 11, 16, and 16, respectively. The LCA of eyes implanted with SN60WF and SN60AT (Alcon Inc.), and with XY-1 (HOYA Corp.), was the same as that of phakic eyes. The LCA of eyes with ZCB00V (AMO Inc.) was smaller than that of phakic eyes. The LCA of eyes implanted with Alcon's and HOYA's IOLs, but not the LCA of eyes implanted with AMO's IOLs, was positively correlated with the powers of the IOLs. We also performed simulations to verify the impacts of LCA on visual performance for 4-mm pupil diameter; the simulations were a polychromatic modulation transfer function (MTF) and a visual Strehl ratio computed on the basis of an optical transfer function (VSOTF). We concluded that the differences between the LCA of different manufacturers do not affect visual performances when some extent of higher-order aberration (HOA) exists. The smaller HOA of AMO IOLs may enhance visual performance.	[Nakajima, Masashi] Tokyo Inst Technol, Dept Informat Proc, Tokyo, Kanagawa 152, Japan; [Nakajima, Masashi; Hirohara, Yoko] TOPCON, Eye Care Co, Dev Engn Dept, Tokyo, Japan; [Hiraoka, Takahiro; Takagi, Seiu; Oshika, Tetsuro; Mihashi, Toshifumi] Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Tsukuba, Ibaraki 305, Japan; [Yamamoto, Toshiya] Ushiku Aiwa Gen Hosp, Dept Ophthalmol, Ibaraki, Japan	Tokyo Institute of Technology; Topcon Corporation; University of Tsukuba	Mihashi, T (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Ophthalmol, Tsukuba, Ibaraki 305, Japan.	mihashi@md.tsukuba.ac.jp			Topcon corp.	Topcon corp.	Topcon corp. supported in the form of research funding and providing optical instruments for T. Mihashi. The funder also provided support in the form of salaries for authors [M. Nakajima and Y. Hirohara], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal P, 2010, OPT EXPRESS, V18, P1637, DOI 10.1364/OE.18.001637; Atchison DA, 2005, J OPT SOC AM A, V22, P29, DOI 10.1364/JOSAA.22.000029; BEDFORD RE, 1957, J OPT SOC AM, V47, P564; Campbell CE, 2008, J REF SURG, P24; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; CHARMAN WN, 1976, VISION RES, V16, P999, DOI 10.1016/0042-6989(76)90232-7; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Fernandez EJ, 2005, OPT EXPRESS, V13, P400, DOI 10.1364/OPEX.13.000400; Fernandez EJ, 2008, OPT EXPRESS, V16, P21199, DOI 10.1364/OE.16.021199; He YQ, 2013, BIOMED OPT EXPRESS, V4, P667, DOI 10.1364/BOE.4.000667; HOFFER KJ, 1980, AM J OPHTHALMOL, V90, P360, DOI 10.1016/S0002-9394(14)74917-7; HOWARTH PA, 1988, J OPT SOC AM A, V5, P2087, DOI 10.1364/JOSAA.5.002087; Kingslake R, 2010, LENS DESIGN FUNDAMENTALS, 2ND EDITION, P1, DOI 10.1016/B978-0-12-374301-5.00005-X; Koh S, 2002, AM J OPHTHALMOL, V134, P115, DOI 10.1016/S0002-9394(02)01430-7; Koh S, 2006, INVEST OPHTH VIS SCI, V47, P3318, DOI 10.1167/iovs.06-0018; Le Grand Y., 1967, FORM AND SPACE VISIO; Llorente L, 2003, OPTOMETRY VISION SCI, V80, P26, DOI 10.1097/00006324-200301000-00005; Manzanera S, 2008, OPT EXPRESS, V16, P7748, DOI 10.1364/OE.16.007748; Marcos S, 1999, VISION RES, V39, P4309, DOI 10.1016/S0042-6989(99)00145-5; Millodot M., 1976, ALBRECHT V GRAEFES A, P198; MORDI JA, 1985, AM J OPTOM PHYS OPT, V62, P864; Nagata Toyofumi, 1999, Nippon Ganka Gakkai Zasshi, V103, P237; Nakajima M, 2015, BIOMED OPT EXPRESS, V6, P2676, DOI 10.1364/BOE.6.002676; NAVARRO R, 1985, J OPT SOC AM A, V2, P1273, DOI 10.1364/JOSAA.2.001273; Perez-Merino P, 2013, INVEST OPHTH VIS SCI, V54, P2654, DOI 10.1167/iovs.13-11912; Polack A, 1923, B SOC OPHTHALMOL FRA, P9; R Core Team, 2021, R LANGUAGE ENV STAT; Ravikumar S, 2008, J OPT SOC AM A, V25, P2395, DOI 10.1364/JOSAA.25.002395; SCHIEBENER P, 1990, J PHYS CHEM REF DATA, V19, P677, DOI 10.1063/1.555859; SELBERG LA, 1992, OPT ENG, V31, P1961, DOI 10.1117/12.59905; Sharpe LT, 2005, J VISION, V5, P948, DOI 10.1167/5.11.3; Siedlecki D, 2013, OPTOMETRY VISION SCI, V91, P240; Siedlecki D, 2007, OPTOMETRY VISION SCI, V84, P984, DOI 10.1097/OPX.0b013e318157ac82; SIVAK JG, 1982, VISION RES, V22, P997, DOI 10.1016/0042-6989(82)90036-0; Thibos LN, 2004, J VISION, V4, P329, DOI 10.1167/4.4.9; THIBOS LN, 1992, APPL OPTICS, V31, P3594, DOI 10.1364/AO.31.003594; Vinas M, 2015, BIOMED OPT EXPRESS, V6, P948, DOI 10.1364/BOE.6.000948; WALD G, 1947, J OPT SOC AM, V37, P321, DOI 10.1364/JOSA.37.000321; WARE C, 1982, GRAEF ARCH CLIN EXP, V218, P39, DOI 10.1007/BF02134100; Zhao H, 2007, BRIT J OPHTHALMOL, V91, P1225, DOI 10.1136/bjo.2007.118745	41	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156227	10.1371/journal.pone.0156227	http://dx.doi.org/10.1371/journal.pone.0156227			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258141	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700042
J	Pfister, R; Lee, S; Kuhr, K; Baer, F; Fehske, W; Hoepp, HW; Baldus, S; Michels, G				Pfister, Roman; Lee, Samuel; Kuhr, Kathrin; Baer, Frank; Fehske, Wolfgang; Hoepp, Hans-Wilhelm; Baldus, Stephan; Michels, Guido			Impact of the Type of First Medical Contact within a Guideline-Conform ST-Elevation Myocardial Infarction Network: A Prospective Observational Registry Study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; PRIMARY ANGIOPLASTY; PRIMARY PCI; MORTALITY; STRATEGIES; OUTCOMES; IMPLEMENTATION; ASSOCIATION; MANAGEMENT	Aims The impact of type of first medical contact (FMC) in the setting of a guideline conform metropolitan ST-elevation myocardial infarction (STEMI) network providing obligatory primary percutaneous coronary intervention (PCI) is unclear. Methods and Results 3,312 patients were prospectively included between 2006 and 2012 into a registry accompanying the "Cologne Infarction Model" STEMI network, with 68.4% primarily presenting to emergency medical service (EMS), 17.6% to non-PCI-capable hospitals, and 14.0% to PCI-capable hospitals. Median contact-to-balloon time differed significantly by FMC with 89 minutes (IQR 72-115) for EMS, 107 minutes (IQR 85-148) for non-PCI- and 65 minutes (IQR 48-91) for PCI-capable hospitals (p < 0.001). TIMI-flow grade III and in-hospital mortality were 75.7% and 10.4% in EMS, 70.3% and 8.6% in non-PCI-capable hospital and 84.4% and 5.6% in PCI-capable hospital presenters, respectively (p both < 0.01). The association of FMC with in-hospital mortality was not significant after adjustment for baseline characteristics, but risk of TIMI-flow grade < III remained significantly increased in patients presenting to non-PCI-capable hospitals. Conclusion Despite differences in treatment delay by type of FMC in-hospital mortality did not differ significantly. The increased risk of TIMI-flow grade < III in patients presenting to non PCI-capable hospitals needs further study.	[Pfister, Roman; Lee, Samuel; Hoepp, Hans-Wilhelm; Baldus, Stephan; Michels, Guido] Univ Cologne, Dept Internal Med 3, D-50931 Cologne, Germany; [Kuhr, Kathrin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Baer, Frank] St Antonius Hosp, Cologne, Germany; [Fehske, Wolfgang] St Vinzenz Hosp, Cologne, Germany	University of Cologne; University of Cologne; Saint Antonius Hospital	Pfister, R (corresponding author), Univ Cologne, Dept Internal Med 3, D-50931 Cologne, Germany.	roman.pfister@uk-koeln.de	Baer, Frank M/AAI-8957-2021	Lee, Samuel/0000-0001-6768-7079	KIM registered association	KIM registered association	The KIM registry is funded by the KIM registered association (http://www.koelner-infarktmodell.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Bray JE, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001927; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Flesch M, 2008, CIRC-CARDIOVASC INTE, V1, P95, DOI 10.1161/CIRCINTERVENTIONS.108.768176; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; Garberich RF, 2014, CIRCULATION, V129, P1225, DOI 10.1161/CIRCULATIONAHA.113.005568; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Huber K, 2014, EUR HEART J, V35, P1526, DOI 10.1093/eurheartj/ehu125; Kalla K, 2006, CIRCULATION, V113, P2398, DOI 10.1161/CIRCULATIONAHA.105.586198; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Koul S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000486; Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102; Liebetrau C, 2011, CLIN RES CARDIOL, V100, P217, DOI 10.1007/s00392-010-0231-x; Mathews R, 2011, CIRCULATION, V124, P154, DOI 10.1161/CIRCULATIONAHA.110.002345; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Pinto DS, 2011, CIRCULATION, V124, P2512, DOI 10.1161/CIRCULATIONAHA.111.018549; Scholz KH, 2012, JACC-CARDIOVASC INTE, V5, P848, DOI 10.1016/j.jcin.2012.04.012; Schoos MM, 2012, EUR HEART J-ACUTE CA, V1, P200, DOI 10.1177/2048872612455143; Silvain J, 2012, ARCH CARDIOVASC DIS, V105, P639, DOI 10.1016/j.acvd.2012.07.007; So DYF, 2006, AM J CARDIOL, V97, P458, DOI 10.1016/j.amjcard.2005.08.069; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tartan Z, 2008, NUTR METAB CARDIOVAS, V18, P441, DOI 10.1016/j.numecd.2007.02.015; Thilo C, 2013, CLIN RES CARDIOL, V102, P905, DOI 10.1007/s00392-013-0608-8; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Tsao NW, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.012; Wang TY, 2011, JAMA-J AM MED ASSOC, V305, P2540, DOI 10.1001/jama.2011.862; Wilson BH, 2013, JACC-CARDIOVASC INTE, V6, P1064, DOI 10.1016/j.jcin.2013.05.018; Windecker S, 2013, LANCET, V382, P644, DOI 10.1016/S0140-6736(13)61452-X; Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156769	10.1371/journal.pone.0156769	http://dx.doi.org/10.1371/journal.pone.0156769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258655	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700124
J	Wei, WD; Jiang, JJ; Liang, H; Gao, L; Liang, BY; Huang, JG; Zang, N; Liao, YY; Yu, J; Lai, JZ; Qin, FX; Su, JM; Ye, L; Chen, H				Wei, Wudi; Jiang, Junjun; Liang, Hao; Gao, Lian; Liang, Bingyu; Huang, Jiegang; Zang, Ning; Liao, Yanyan; Yu, Jun; Lai, Jingzhen; Qin, Fengxiang; Su, Jinming; Ye, Li; Chen, Hui			Application of a Combined Model with Autoregressive Integrated Moving Average (ARIMA) and Generalized Regression Neural Network (GRNN) in Forecasting Hepatitis Incidence in Heng County, China	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SPRING FESTIVAL; RENAL SYNDROME; VIRUS; TRANSMISSION; PREDICTION; RISK	Background Hepatitis is a serious public health problem with increasing cases and property damage in Heng County. It is necessary to develop a model to predict the hepatitis epidemic that could be useful for preventing this disease. Methods The autoregressive integrated moving average (ARIMA) model and the generalized regression neural network (GRNN) model were used to fit the incidence data from the Heng County CDC (Center for Disease Control and Prevention) from January 2005 to December 2012. Then, the ARIMA-GRNN hybrid model was developed. The incidence data from January 2013 to December 2013 were used to validate the models. Several parameters, including mean absolute error (MAE), root mean square error (RMSE), mean absolute percentage error (MAPE) and mean square error (MSE), were used to compare the performance among the three models. Results The morbidity of hepatitis from Jan 2005 to Dec 2012 has seasonal variation and slightly rising trend. The ARIMA(0,1,2)(1,1,1)(12) model was the most appropriate one with the residual test showing a white noise sequence. The smoothing factor of the basic GRNN model and the combined model was 1.8 and 0.07, respectively. The four parameters of the hybrid model were lower than those of the two single models in the validation. The parameters values of the GRNN model were the lowest in the fitting of the three models. Conclusions The hybrid ARIMA-GRNN model showed better hepatitis incidence forecasting in Heng County than the single ARIMA model and the basic GRNN model. It is a potential decision-supportive tool for controlling hepatitis in Heng County.	[Wei, Wudi; Jiang, Junjun; Liang, Hao; Liang, Bingyu; Huang, Jiegang; Zang, Ning; Liao, Yanyan; Yu, Jun; Lai, Jingzhen; Qin, Fengxiang; Su, Jinming; Ye, Li] Guangxi Med Univ, Sch Publ Hlth, Guangxi Key Lab AIDS Prevent & Treatment, Nanning 530021, Guangxi, Peoples R China; [Wei, Wudi; Jiang, Junjun; Liang, Hao; Liang, Bingyu; Huang, Jiegang; Zang, Ning; Liao, Yanyan; Yu, Jun; Lai, Jingzhen; Qin, Fengxiang; Su, Jinming; Ye, Li] Guangxi Med Univ, Sch Publ Hlth, Guangxi Univ Key Lab Prevent & Control Highly Pre, Nanning 530021, Guangxi, Peoples R China; [Gao, Lian] Ctr Dis Control & Prevent, Heng Cty 530300, Guangxi, Peoples R China; [Liang, Hao; Zang, Ning; Liao, Yanyan; Ye, Li] Guangxi Med Univ, Guangxi Collaborat Innovat Ctr Biomed, Guangxi Med Res Ctr, Nanning 530021, Guangxi, Peoples R China; [Chen, Hui] Guangxi Med Univ, Geriatr Digest Dept Internal Med, Affiliated Hosp 1, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Chinese Center for Disease Control & Prevention; Guangxi Medical University; Guangxi Medical University	Ye, L (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Guangxi Key Lab AIDS Prevent & Treatment, Nanning 530021, Guangxi, Peoples R China.; Ye, L (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Guangxi Univ Key Lab Prevent & Control Highly Pre, Nanning 530021, Guangxi, Peoples R China.; Ye, L (corresponding author), Guangxi Med Univ, Guangxi Collaborat Innovat Ctr Biomed, Guangxi Med Res Ctr, Nanning 530021, Guangxi, Peoples R China.	yeli@gxmu.edu.cn; chenhui680804@163.com	Jiang, Junjun/AAH-9095-2020	Wei, Wudi/0000-0001-6703-4529	National Natural Science Foundation of China [81271851, 31360033, 81460511, 81460305]; Guangxi scientific research and technology development program fund [14124003-1]; Guangxi Natural Science Foundation [2013GXNSFCB019004]; Scientific Research Foundation of the Higher Education Institutions of Guangxi Province, China [YB2014062, 2013ZD012]; Guangxi Universities "100-Talent" Program, Guangxi, China; Guangxi Universities Innovation Research Team and Outstanding Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi scientific research and technology development program fund; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Scientific Research Foundation of the Higher Education Institutions of Guangxi Province, China; Guangxi Universities "100-Talent" Program, Guangxi, China; Guangxi Universities Innovation Research Team and Outstanding Scholar Program	The study was supported by National Natural Science Foundation of China (81271851, 31360033, 81460511, and 81460305), Guangxi scientific research and technology development program fund (Gui Ke Gong NO.14124003-1), Guangxi Natural Science Foundation (2013GXNSFCB019004), Scientific Research Foundation of the Higher Education Institutions of Guangxi Province, China (YB2014062, 2013ZD012), Guangxi Universities "100-Talent" Program, Guangxi, China (to LY), and Guangxi Universities Innovation Research Team and Outstanding Scholar Program (to LY).	Box G. E. P., 1994, J MARKETING RES, V14; BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Claeskens G, 2008, MODEL SELECTION MODE, P561; Dai X, 2013, EMERG INFECT DIS, V19, P1528, DOI 10.3201/eid1909.130013; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; Haider S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144490; Han Qin, 2012, Modern Preventive Medicine, V39, P1337; Han YN, 2009, J INT MED RES, V37, P1952, DOI 10.1177/147323000903700633; Hou LQ, 2014, CHRONIC PATHEMATHOL, V15, P344; Hu J, 2016, COMPUT BIOL CHEM, V60, P59, DOI 10.1016/j.compbiolchem.2015.11.007; Jiang ZhiHua, 2015, China Tropical Medicine, V15, P1057; Jing H, 2014, ENVIRON POLLUT, V192, P204, DOI 10.1016/j.envpol.2014.06.003; Kong SF, 2015, SCI TOTAL ENVIRON, V520, P59, DOI [10.1016/j.scitotenv.2015.03.001, 10.1016/j.scitote]; Leung MT, 2009, INTELL SYST ACCOUNT, V16, P257, DOI 10.1002/isaf.308; Leung MT, 2000, FORECASTING EXCHANGE; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Liao GY., 2015, AGR ARCHAEOL, V03, P225; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Longatti A, 2015, VIRUSES-BASEL, V7, P6707, DOI 10.3390/v7122967; Lu MF, 2012, CHINESE PRIMARY HLTH, V26, P49; Lu YH, 2013, EPIDEMIOL INFECT, V141, P2403, DOI 10.1017/S0950268813000113; Mou HX, 2009, HEILONGJIANG MED PHA, V32, P94; Naghibi SA, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-5049-6; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Purwanto, 2012, APPL INTELL, V37, P511, DOI 10.1007/s10489-012-0344-1; Qina G, 1997, CANC LETT, V121, P203; Sharma N, 2015, J THROID RES, V2015, DOI 10.1155/2015/517173; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Tang XY, 2009, CHINESE J HLTH STAT, P114; Walker CM, 2015, CURR OPIN VIROL, V11, P7, DOI 10.1016/j.coviro.2015.01.003; Wang Dingming, 2015, J Med Case Rep, V9, P109, DOI 10.1186/s13256-015-0580-1; Wang YJ, 2006, CHINESE J VECTOR BIO, V17, P333; Wu J, 2013, GENET TEST MOL BIOMA, V17, P595, DOI 10.1089/gtmb.2013.0031; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang G, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, DOI 10.1371/journal.pone.0080969]; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; [张国良 Zhang Guoliang], 2013, [中国卫生统计, Chinese Journal of Health Statistics], V30, P480; Zhao N, 1994, ZHONGHUA LIU XING BI, V15; Zhao P, 2016, CONTEMP CLIN TRIALS, V47, P85, DOI 10.1016/j.cct.2015.12.012; Zheng YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116832; Zhu FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087154	47	45	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156768	10.1371/journal.pone.0156768	http://dx.doi.org/10.1371/journal.pone.0156768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258555	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700123
J	Dietz, J; Rupp, D; Susser, S; Vermehren, J; Peiffer, KH; Filmann, N; Bon, D; Kuntzen, T; Mauss, S; Grammatikos, G; Perner, D; Berkowski, C; Herrmann, E; Zeuzem, S; Bartenschlager, R; Sarrazin, C				Dietz, Julia; Rupp, Daniel; Susser, Simone; Vermehren, Johannes; Peiffer, Kai-Henrik; Filmann, Natalie; Bon, Dimitra; Kuntzen, Thomas; Mauss, Stefan; Grammatikos, Georgios; Perner, Dany; Berkowski, Caterina; Herrmann, Eva; Zeuzem, Stefan; Bartenschlager, Ralf; Sarrazin, Christoph			Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HEPATITIS-C; BASE-LINE; TELAPREVIR; BOCEPREVIR; GENOTYPE; MUTATIONS; LEDIPASVIR/SOFOSBUVIR; MONOTHERAPY; PREVALENCE	Triple therapy of chronic hepatitis C virus (HCV) infection with boceprevir (BOC) or telaprevir (TVR) leads to virologic failure in many patients which is often associated with the selection of resistance-associated variants (RAVs). These resistance profiles are of importance for the selection of potential rescue treatment options. In this study, we sequenced baseline NS3 RAVs population-based and investigated the sensitivity of NS3 phenotypes in an HCV replicon assay together with clinical factors for a prediction of treatment response in a cohort of 165 German and Swiss patients treated with a BOC or TVR-based triple therapy. Overall, the prevalence of baseline RAVs was low, although the frequency of RAVs was higher in patients with virologic failure compared to those who achieved a sustained virologic response (SVR) (7% versus 1%, P = 0.06). The occurrence of RAVs was associated with a resistant NS3 quasispecies phenotype (P < 0.001), but the sensitivity of phenotypes was not associated with treatment outcome (P = 0.2). The majority of single viral and host predictors of SVR was only weakly associated with treatment response. In multivariate analyses, low AST levels, female sex and an IFNL4 CC genotype were independently associated with SVR. However, a combined analysis of negative predictors revealed a significantly lower overall number of negative predictors in patients with SVR in comparison to individuals with virologic failure (P < 0.0001) and the presence of 2 or less negative predictors was indicative for SVR. These results demonstrate that most single baseline viral and host parameters have a weak influence on the response to triple therapy, whereas the overall number of negative predictors has a high predictive value for SVR.	[Dietz, Julia; Susser, Simone; Vermehren, Johannes; Peiffer, Kai-Henrik; Grammatikos, Georgios; Perner, Dany; Berkowski, Caterina; Zeuzem, Stefan; Sarrazin, Christoph] Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Rupp, Daniel; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Filmann, Natalie; Bon, Dimitra; Herrmann, Eva] Goethe Univ Frankfurt, Inst Biostat & Math Modeling, D-60054 Frankfurt, Germany; [Kuntzen, Thomas] Univ Spital Zurich, Klin Gastroenterol & Hepatol, Zurich, Switzerland; [Mauss, Stefan] Zentrum HIV & Hepatogastroenterol, Dusseldorf, Germany; [Bartenschlager, Ralf] Heidelberg Univ, German Ctr Infect Res, Heidelberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Ruprecht Karls University Heidelberg; Goethe University Frankfurt; University of Zurich; University Zurich Hospital; German Center for Infection Research; Ruprecht Karls University Heidelberg	Sarrazin, C (corresponding author), Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Bartenschlager, Ralf/L-2582-2015	Filmann, Natalie/0000-0003-0424-2317	DZIF (Deutsches Zentrum fur Infektionsforschung) [TTU 05.902]; Janssen-Cilag GmbH	DZIF (Deutsches Zentrum fur Infektionsforschung); Janssen-Cilag GmbH	This study was funded by a DZIF (Deutsches Zentrum fur Infektionsforschung, http://www.dzif.de/forschung/hepatitis/) grant entitled "Geno- & phenotypic NS3, NS5A and NS5B inhibitor resistance analysis" to Christoph Sarrazin and Stefan Zeuzem (TTU 05.902) and by Janssen-Cilag GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ashgar H, 2009, ANN SAUDI MED, V29, P4, DOI 10.4103/0256-4947.51816; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Barnard RJO, 2013, VIROLOGY, V444, P329, DOI 10.1016/j.virol.2013.06.029; Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; De Meyer S, 2012, HEPATOLOGY, V56, P2106, DOI 10.1002/hep.25962; Dierynck I, 2014, J INFECT DIS, V210, P1871, DOI 10.1093/infdis/jiu340; Dietz J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134395; Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12; Esser-Nobis K, 2013, HEPATOLOGY, V57, P953, DOI 10.1002/hep.26260; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Friebe P, 2001, J VIROL, V75, P12047, DOI 10.1128/JVI.75.24.12047-12057.2001; Grammatikos G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087974; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hoffmann L, 2015, BBA CLIN, V3, P146, DOI 10.1016/j.bbacli.2015.01.004; Howe AYM, 2015, ANTIVIR RES, V113, P71, DOI 10.1016/j.antiviral.2014.10.010; Howe JA, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu078; Jacobson IM, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2012.01590.x; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Kieffer TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034372; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11; Peiffer KH, 2016, HEPATOLOGY, V63, P63, DOI 10.1002/hep.28255; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Qi X, 2009, ANTIVIR RES, V81, P166, DOI 10.1016/j.antiviral.2008.11.002; Sarrazin C, 2015, J HEPATOL, V62, pS620, DOI 10.1016/S0168-8278(15)30976-4; Sarrazin C, 2012, Z GASTROENTEROL, V50, P57, DOI 10.1055/s-0031-1282015; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Sarrazin C, 2014, HEPATOLOGY, V60, p1128A; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Stross C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19526; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Susser S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112592; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156731	10.1371/journal.pone.0156731	http://dx.doi.org/10.1371/journal.pone.0156731			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281344	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000042
J	Dobing, S; Frolova, N; McAlister, F; Ringrose, J				Dobing, Selina; Frolova, Natalia; McAlister, Finlay; Ringrose, Jennifer			Sleep Quality and Factors Influencing Self-Reported Sleep Duration and Quality in the General Internal Medicine Inpatient Population	PLOS ONE			English	Article								Background Sleep quality in hospitalized Canadian General Internal Medicine patients is not well characterized. Our goals were to characterize hospital sleep quality in this population and identify potentially modifiable barriers to good sleep. Methods GIM inpatients at a quaternary centre in Edmonton, Canada completed a survey, including the Verran-Snyder Halpern (VSH) questionnaire, to characterize the previous night's sleep within 48 hours prior to discharge. A chart review was also completed to assess comorbidities, discharge diagnoses, and pharmaceutical sleep aid use. Results Patients reported significantly worse nighttime sleep duration in hospital compared with home (mean 5.5 versus 7.0 hours per night, p < 0.0001). Sleep quality was poor, as measured by the VSH disturbance (mean 371), effectiveness (190), and supplementation (115) subscales. Variables independently associated with poorer sleep duration in multivariable regression include prior diagnosis of sleep disorder and multi-patient occupancy rooms. Age, sex, admitting diagnosis, length of stay, frequency of vital checks, and use of sleep pharmaceuticals during the index hospitalization were not associated with sleep duration. The most frequently reported reasons for poor sleep included noise (59%), nursing interruptions (30%), uncomfortable beds (18%), bright lights (16%), unfamiliar surroundings (14%), and pain (9%). Conclusions Sleep quality for GIM inpatients is significantly worse in hospital than at home. There is a need to test non-pharmacologic interventions to address the most frequently identified factors causing poor sleep hygiene for GIM inpatients.	[Dobing, Selina] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Frolova, Natalia; McAlister, Finlay; Ringrose, Jennifer] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada	University of Alberta; University of Alberta	Ringrose, J (corresponding author), Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada.	jennifer.ringrose@ualberta.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341	Alberta Health Services Quality Improvement Grant; Alberta Health Services	Alberta Health Services Quality Improvement Grant; Alberta Health Services	Funded by Alberta Health Services Quality Improvement Grant 2014 (JR SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank nursing staff at the University of Alberta Hospital for support of this project, and Erik Youngson for statistical assistance. Funding for this study was generously provided by Alberta Health Services.	Arora VM, 2011, J AM GERIATR SOC, V59, P2185, DOI 10.1111/j.1532-5415.2011.03644.x; Bartick Melissa C, 2010, J Hosp Med, V5, pE20, DOI 10.1002/jhm.549; Bonnet MH, 2006, SLEEP MED CLIN, V1, P351, DOI 10.1016/j.jsmc.2006.06.004; Calev H, 2015, J HOSP MED, V10, P439, DOI 10.1002/jhm.2364; Frighetto L, 2010, HLTH QUAL LIFE OUT, V24, P2; Hoey LM, 2014, INT J NURS STUD, V51, P1281, DOI 10.1016/j.ijnurstu.2014.02.001; Knauert MP, 2014, SEMIN RESP CRIT CARE, V35, P582, DOI 10.1055/s-0034-1390080; Kokras N, 2011, GEN HOSP PSYCHIAT, V33, P78, DOI 10.1016/j.genhosppsych.2010.12.003; Missildine K, 2010, GERIATR NURS, V31, P263, DOI 10.1016/j.gerinurse.2010.02.013; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; SNYDERHALPERN R, 1987, RES NURS HEALTH, V10, P155, DOI 10.1002/nur.4770100307; Tranmer Joan E, 2003, Clin Nurs Res, V12, P159, DOI 10.1177/1054773803012002004; Young JS, 2009, J HOSP MED, V4, P50, DOI 10.1002/jhm.397	14	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156735	10.1371/journal.pone.0156735	http://dx.doi.org/10.1371/journal.pone.0156735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280292	Green Submitted, gold, Green Published			2022-12-27	WOS:000377563000043
J	Birch, SEP; Miracle, PT; Stevens, RE; O'Connell, TC				Birch, Suzanne E. Pilaar; Miracle, Preston T.; Stevens, Rhiannon E.; O'Connell, Tamsin C.			Late Pleistocene/Early Holocene Migratory Behavior of Ungulates Using Isotopic Analysis of Tooth Enamel and Its Effects on Forager Mobility	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; AFFECTING C-13/C-12 RATIOS; ELK CERVUS-ELAPHUS; SEASONAL MIGRATION; CLIMATIC OSCILLATIONS; INLAND HALOPHYTES; STABLE ISOTOPES; OXYGEN ISOTOPES; BONE PHOSPHATE; SOUTH-AFRICA	Zooarchaeological and paleoecological investigations have traditionally been unable to reconstruct the ethology of herd animals, which likely had a significant influence on the mobility and subsistence strategies of prehistoric humans. In this paper, we reconstruct the migratory behavior of red deer (Cervus elaphus) and caprids at the Pleistocene-Holocene transition in the northeastern Adriatic region using stable oxygen isotope analysis of tooth enamel. The data show a significant change in delta O-18 values from the Pleistocene into the Holocene, as well as isotopic variation between taxa, the case study sites, and through time. We then discuss the implications of seasonal faunal availability as determining factors in human mobility patterns.	[Birch, Suzanne E. Pilaar] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Birch, Suzanne E. Pilaar] Univ Georgia, Dept Geog, Athens, GA 30602 USA; [Miracle, Preston T.; O'Connell, Tamsin C.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Stevens, Rhiannon E.] UCL, Inst Archaeol, London, England; [O'Connell, Tamsin C.] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Cambridge; University of London; University College London; University of Cambridge	Birch, SEP (corresponding author), Univ Georgia, Dept Anthropol, Athens, GA 30602 USA.; Birch, SEP (corresponding author), Univ Georgia, Dept Geog, Athens, GA 30602 USA.	sepbirch@uga.edu		O'Connell, Tamsin/0000-0002-4744-0332; Stevens, Rhiannon Elisabeth/0000-0002-6140-4549; Pilaar Birch, Suzanne/0000-0003-1544-5881	Gates Cambridge Trust; University of Oxford Radiocarbon Accelerator Unit/Natural Environment Research Council [2011/2/12]; NRCF grant [2011/2/12]	Gates Cambridge Trust; University of Oxford Radiocarbon Accelerator Unit/Natural Environment Research Council; NRCF grant	The Gates Cambridge Trust provided funding for SEPB's PhD, of which this research was a part, as well as substantial support for laboratory preparation and stable isotope analysis of the samples. Radiocarbon dates on samples were provided by a University of Oxford Radiocarbon Accelerator Unit/Natural Environment Research Council Grant, #2011/2/12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SEPB would like to thank Darko Komso and the Museum of Archaeology, Pula, Croatia, for access to archaeological material. Thanks to Louise Butterworth and Catherine Kneale at the Dorothy Garrod Laboratory for valuable research assistance, and thanks to Mike Hall and James Rolfe at the Godwin Laboratory, Cambridge for assistance with the isotopic analyses. SEPB and PTM also thank the University of Oxford Radiocarbon Accelerator Unit/ Natural Environment Research Council (NERC) for providing dates on sampled material, funded by NRCF grant #2011/2/12. Penny Higgins and an anonymous reviewer are thanked for their helpful comments on a previous version of this paper. Funding support for the isotopic analysis of samples was provided by the Gates Cambridge Trust.	Alados C.L., 1985, P204; Andric M, 2008, PALAEOGEOGR PALAEOCL, V270, P150, DOI 10.1016/j.palaeo.2008.09.008; Asioli A, 2001, QUATERNARY SCI REV, V20, P1201, DOI 10.1016/S0277-3791(00)00147-5; Bailey GN., 1994, PALAEO LITHIC ARCHAE, V3, P159; Balasse M, 2012, ARCHAEOMETRY, V54, P349, DOI 10.1111/j.1475-4754.2011.00624.x; Balasse M, 2003, J ARCHAEOL SCI, V30, P205, DOI 10.1006/jasc.2002.0833; Balasse M, 2002, J ARCHAEOL SCI, V29, P917, DOI 10.1006/jasc.2001.0787; Balasse M, 2002, INT J OSTEOARCHAEOL, V12, P155, DOI 10.1002/oa.601; Balbo AL, 2006, GEOLOGIA CROATICA, V59, P107; Binford L.R., 2001, CONSTRUCTING FRAMES; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Birch SEP, 2015, ENVIRON ARCHAEOL, V20, P30, DOI 10.1179/174963104Y.0000000051; Blockley SPE, 2004, J QUATERNARY SCI, V19, P159, DOI 10.1002/jqs.820; Bocherens H, 2001, CR ACAD SCI II A, V332, P67, DOI 10.1016/S1251-8050(00)01488-9; Boessneck J., 1964, KUHN ARCHIV, V78, P1; Boschian G, 2007, BAR INT SER, V1716, P15; BOYCE MS, 1991, APPL ANIM BEHAV SCI, V29, P239, DOI 10.1016/0168-1591(91)90251-R; Britton K, 2009, J ARCHAEOL SCI, V36, P1163, DOI 10.1016/j.jas.2009.01.003; BROWN WAB, 1991, J ZOOL, V225, P85, DOI 10.1111/j.1469-7998.1991.tb03803.x; CHAPMAN J, 1990, ANTIQUITY, V64, P127, DOI 10.1017/S0003598X00077371; Choisy P, 1994, IBEX J MOUNTAIN ECOL, P15; Clark G.A., 1983, HUNTER GATHERER EC P, P131; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Clutton-Brock T.H., 1982, BEHAV ECOLOGY 2 SEXE; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; Craighead JJ, 1972, WILDLIFE MONOGR, V29, P3; DANSGAARD W, 1964, TELLUS, V16, P436; Favaretto S, 2008, QUATERN INT, V190, P89, DOI 10.1016/j.quaint.2008.04.005; FERRARI C, 1988, Z SAUGETIERKD, V53, P170; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Fricke HC, 1998, GEOCHIM COSMOCHIM AC, V62, P1839, DOI 10.1016/S0016-7037(98)00114-8; GALLIZIA VUERICH L., 1994, QUATERNARIO, V7, P569; GUY RD, 1986, CAN J BOT, V64, P2700, DOI 10.1139/b86-356; GUY RD, 1986, CAN J BOT, V64, P2693, DOI 10.1139/b86-355; Hammer O, PALAEONTOLOGIA ELECT, V4, P9; Hebblewhite M, 2006, WILDLIFE SOC B, V34, P1280, DOI 10.2193/0091-7648(2006)34[1280:ITMBOM]2.0.CO;2; Hedges REM, 2003, INT J OSTEOARCHAEOL, V13, P66, DOI 10.1002/oa.660; Helmer D., 1994, FICHES OSTEOLOGIE B; Higgs ES., 1968, P PREHIST SOC, V33, P1, DOI [10.1017/S0079497X00014018, DOI 10.1017/S0079497X00014018]; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V206, P355, DOI 10.1016/j.palaeo.2004.01.012; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; Jochim MA, 1998, SE GERMANY LATE PALE; KELLY RL, 1983, J ANTHROPOL RES, V39, P277, DOI 10.1086/jar.39.3.3629672; KELLY RL, 1992, ANNU REV ANTHROPOL, V21, P43, DOI 10.1146/annurev.an.21.100192.000355; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; Kleine D, INTEGRATION APPL NET; KOCH PL, 1989, GEOLOGY, V17, P515, DOI 10.1130/0091-7613(1989)017<0515:OIVITT>2.3.CO;2; Kohn MJ, 2007, REV MINERAL GEOCHEM, V66, P119, DOI 10.2138/rmg.2007.66.5; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P3889, DOI 10.1016/0016-7037(96)00248-7; Kohn MJ, 2004, GEOCHIM COSMOCHIM AC, V68, P403, DOI 10.1016/S0016-7037(03)00443-5; Kohn MJ, 1998, CHEM GEOL, V152, P97, DOI 10.1016/S0009-2541(98)00099-0; Komso D., 2006, OPUSCULA ARCHAEOLOGI, V35, P55; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; KORNER C, 1988, OECOLOGIA, V74, P623, DOI 10.1007/BF00380063; KRATOCHVIL Z, 1969, Acta Veterinaria Brno, V38, P483; Lambeck K, 2004, QUATERNARY SCI REV, V23, P1567, DOI 10.1016/j.quascirev.2004.02.009; LAND LS, 1980, PALAEOGEOGR PALAEOCL, V32, P143, DOI 10.1016/0031-0182(80)90037-1; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; LINCOLN GA, 1970, J REPROD FERTIL S, V11, P71, DOI DOI 10.1530/JRF.0.0250041; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; MAJOUBE M, 1971, J CHIM PHYS PCB, V68, P1423, DOI 10.1051/jcp/1971681423; MARSHALL JD, 1994, ECOLOGY, V75, P1887, DOI 10.2307/1941593; MIRACLE P, 1991, J ARCHAEOL SCI, V18, P89, DOI 10.1016/0305-4403(91)90080-9; Miracle P., 1995, THESIS U MICHIGAN; Miracle P., 2002, CONSUMING PASSIONS P, P65; Miracle P., 2000, EUR J ARCHAEOL, V3, P293, DOI 10.1177/; Miracle P., 1997, POROCILO RAZISKOVANJ, V24, P43; Miracle P., 2001, DOCUMENTA PRAEHISTOR, V26, P177, DOI DOI 10.4312/DP.28.10; Miracle P. T., 2006, ARCHAEOLOGY PUPICINA, V1; Miracle P, 2007, BAR INT SER, V1716, P41; Mlekuz D., 2003, DOCUMENTA PRAEHISTOR, VXXX, P139, DOI [10.4312/dp.30.8, DOI 10.4312/DP.30.8]; Mysterud A, 1999, J ZOOL, V247, P479, DOI 10.1111/j.1469-7998.1999.tb01011.x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Pellegrini M, 2008, RAPID COMMUN MASS SP, V22, P1714, DOI 10.1002/rcm.3521; Pilaar Birch SE, 2013, ARCHAEOL ANTHROP SCI, V5, P1; Pilaar Birch SE, CLIMATE CHANGE PAST; Pilaar Birch SE, 2012, THESIS U CAMBRIDGE; Plug I., 2002, P 9 C INT COUNC ARCH, P64; PRUMMEL W, 1986, J ARCHAEOL SCI, V13, P567, DOI 10.1016/0305-4403(86)90041-5; Ramanzin M, 2007, CAN J ZOOL, V85, P280, DOI 10.1139/Z06-210; Reade H, 2015, CHEM GEOL, V404, P126, DOI 10.1016/j.chemgeo.2015.03.026; RICHARDHANSEN C, 1992, Z SAUGETIERKD, V57, P351; Schmidt Roland, 2000, Journal of Limnology, V59, P113; SHANK CC, 1985, Z SAUGETIERKD, V50, P117; SMITH BN, 1973, PLANT CELL PHYSIOL, V14, P177, DOI 10.1104/pp.14.1.177; SPITZ F, 1990, ACTA THERIOL, V35, P129, DOI 10.4098/AT.arch.90-14; Spitz F., 1986, Pig News and Information, V7, P171; Stevens RE, 2011, PALAEOGEOGR PALAEOCL, V301, P64, DOI 10.1016/j.palaeo.2010.12.021; Suric M, 2005, MAR GEOL, V214, P163, DOI 10.1016/j.margeo.2004.10.030; Trutmann C, 2009, THESIS U ZURICH; van Groenigen JW, 2002, SOIL SCI SOC AM J, V66, P489, DOI 10.2136/sssaj2002.0489; van Vuure C, 2005, RETRACING AUROCHS HI; Vita-Finzi C, 1966, P PREHIST SOC, V32, P1; Voytek B, 2011, J WORLD PREHIST, V24, P189, DOI 10.1007/s10963-011-9044-8; WAHLSTROM LK, 1995, J ZOOL, V235, P455, DOI 10.1111/j.1469-7998.1995.tb01762.x; White PJ, 2010, J MAMMAL, V91, P827, DOI 10.1644/08-MAMM-A-252.1; WILLIS KJ, 1994, QUATERNARY SCI REV, V13, P769, DOI 10.1016/0277-3791(94)90104-X; YAKIR D, 1995, GEOCHIM COSMOCHIM AC, V59, P2149, DOI 10.1016/S0016-7037(99)80010-6; Zazzo A, 2005, GEOCHIM COSMOCHIM AC, V69, P3631, DOI 10.1016/j.gca.2005.02.031; Zazzo A, 2006, J ARCHAEOL SCI, V33, P1177, DOI 10.1016/j.jas.2005.12.006; Zeder MA, 2010, J ARCHAEOL SCI, V37, P2887, DOI 10.1016/j.jas.2010.06.032; Zeder MA, 2010, J ARCHAEOL SCI, V37, P225, DOI 10.1016/j.jas.2009.10.002	105	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155714	10.1371/journal.pone.0155714	http://dx.doi.org/10.1371/journal.pone.0155714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275784	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700007
J	Papin-Michault, C; Bonnetaud, C; Dufour, M; Almairac, F; Coutts, M; Patouraux, S; Virolle, T; Darcourt, J; Burel-Vandenbos, F				Papin-Michault, Caroline; Bonnetaud, Christelle; Dufour, Maxime; Almairac, Fabien; Coutts, Mickael; Patouraux, Stephanie; Virolle, Thierry; Darcourt, Jacques; Burel-Vandenbos, Fanny			Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers	PLOS ONE			English	Article							TRANSPORTER 1 EXPRESSION; PROGNOSTIC-SIGNIFICANCE; RADIATION NECROSIS; CD98 EXPRESSION; F-18-FDOPA PET; LUNG-CANCER; HEAVY-CHAIN; LIGHT-CHAIN; TUMOR; RECURRENT	Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be promising in distinguishing between recurrent tumour and radionecrosis in the follow-up of brain metastasis (BM). The amino acid transporter LAT1 and its cofactor CD98, which are involved in AA uptake, have never been investigated in BM. The aim of our study was to determine and compare the expression of LAT1 and CD98 in BM and in non-tumoral brain tissue (NT). The expression of LAT1 and CD98 were studied by immunohistochemistry in 67 BM, including 18 BM recurrences after radiotherapy, in 53 NT, and in 13 cases of patients with previously irradiated brain tumor and investigated by [18F] FDOPA-PET. LAT1 and CD98 expression were detected in 98.5% and 59.7% of BM respectively and were significantly associated with BM tissue as compared to NT (p<0.001). LAT1 expression in recurrent BM was significantly increased as compared to newly occurring BM. Ten cases investigated by [18F] FDOPA-PET corresponding to recurrent BM displayed significant [18F] FDOPA uptake and LAT1 overexpression whereas three cases corresponding to radionecrosis showed no or low uptake and LAT1 expression. LAT1 expression level and [18F] FDOPA uptake were significantly correlated. In conclusion, we hypothesized that BM may overexpress the AA transporter LAT1. We have shown that LAT1 overexpression was common in BM and was specific for BM as compared to healthy brain. These results could explain the specific BM uptake on PET-AA.	[Papin-Michault, Caroline; Coutts, Mickael; Patouraux, Stephanie; Burel-Vandenbos, Fanny] Univ Hosp, Dept Pathol, Nice, France; [Bonnetaud, Christelle] Univ Hosp, Dept Expt Pathol, Nice, France; [Dufour, Maxime; Darcourt, Jacques] Ctr Antoine Lacassagne, Dept Nucl Med, 36 Voie Romaine, F-06054 Nice, France; [Dufour, Maxime; Darcourt, Jacques] Univ Med, TIRO UMR E 4320, Nice, France; [Almairac, Fabien] Univ Hosp, Dept Neurosurg, Nice, France; [Virolle, Thierry; Burel-Vandenbos, Fanny] Univ Sci, Inst Biol Valrose, UMR CNRS 7277, UMR INSERM 1091, Nice, France	CHU Nice; CHU Nice; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Burel-Vandenbos, F (corresponding author), Univ Hosp, Dept Pathol, Nice, France.; Burel-Vandenbos, F (corresponding author), Univ Sci, Inst Biol Valrose, UMR CNRS 7277, UMR INSERM 1091, Nice, France.	burel-vandenbos.f@chu-nice.fr	Virolle, Thierry/E-5838-2016	patouraux, stephanie/0000-0001-6004-7685				Campbell WA, 2001, J BIOL CHEM, V276, P16877, DOI 10.1074/jbc.M008248200; Chen W, 2007, J NUCL MED, V48, P1468, DOI 10.2967/jnumed.106.037689; Chen W, 2006, J NUCL MED, V47, P904; Cicone F, 2015, EUR J NUCL MED MOL I, V42, P103, DOI 10.1007/s00259-014-2886-4; Ebara T, 2010, ANTICANCER RES, V30, P4223; Furuya M, 2012, CANCER SCI, V103, P382, DOI 10.1111/j.1349-7006.2011.02151.x; Galldiks N, 2012, J NUCL MED, V53, P1367, DOI 10.2967/jnumed.112.103325; Gulyas B, 2012, Q J NUCL MED MOL IM, V56, P173; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Imai H, 2009, HISTOPATHOLOGY, V54, P804, DOI 10.1111/j.1365-2559.2009.03300.x; Kageyama T, 2000, NEUROREPORT, V11, P3663, DOI 10.1097/00001756-200011270-00015; Kageyama T, 2000, BRAIN RES, V879, P115, DOI 10.1016/S0006-8993(00)02758-X; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kaira K, 2012, BRIT J CANCER, V107, P632, DOI 10.1038/bjc.2012.310; Kaira K, 2007, CLIN CANCER RES, V13, P6369, DOI 10.1158/1078-0432.CCR-07-1294; Kaira K, 2011, ANTICANCER RES, V31, P3775; Kaira K, 2010, EXP THER MED, V1, P799, DOI 10.3892/etm.2010.117; Kaira K, 2008, CANCER SCI, V99, P2380, DOI 10.1111/j.1349-7006.2008.00969.x; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kickingereder P, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-52; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Li J, 2013, TUMOR BIOL, V34, P2977, DOI 10.1007/s13277-013-0861-5; Lizarraga KJ, 2014, J NUCL MED, V55, P30, DOI 10.2967/jnumed.113.121418; Nussbaum ES, 1996, CANCER-AM CANCER SOC, V78, P1781, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.3.CO;2-Z; Ohkame H, 2001, J SURG ONCOL, V78, P265, DOI 10.1002/jso.1165; Oka S, 2014, MOL IMAGING BIOL, V16, P322, DOI 10.1007/s11307-013-0693-0; Ono M, 2013, BRAIN RES, V1535, P24, DOI 10.1016/j.brainres.2013.08.037; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Terakawa Y, 2008, J NUCL MED, V49, P694, DOI 10.2967/jnumed.107.048082; Tsuyuguchi N, 2003, J NEUROSURG, V98, P1056, DOI 10.3171/jns.2003.98.5.1056; Wiriyasermkul P, 2012, J NUCL MED, V53, P1253, DOI 10.2967/jnumed.112.103069; Xu G, 2012, J NUCL MED; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yanagisawa N, 2012, J CLIN PATHOL, V65, P1019, DOI 10.1136/jclinpath-2012-200826; Youland RS, 2013, J NEURO-ONCOL, V111, P11, DOI 10.1007/s11060-012-0986-1; Yu WP, 2015, NUCL MED BIOL, V42, P8, DOI 10.1016/j.nucmedbio.2014.07.002; Yu WP, 2010, J MED CHEM, V53, P876, DOI 10.1021/jm900556s	37	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157139	10.1371/journal.pone.0157139	http://dx.doi.org/10.1371/journal.pone.0157139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276226	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700073
J	Vejrik, L; Matejickova, I; Sed'a, J; Blabolil, P; Juza, T; Vasek, M; Ricard, D; Matena, J; Frouzova, J; Kubecka, J; Riha, M; Cech, M				Vejrik, Lukas; Matejickova, Ivana; Sed'a, Jaromir; Blabolil, Petr; Juza, Tomas; Vasek, Mojmir; Ricard, Daniel; Matena, Josef; Frouzova, Jaroslava; Kubecka, Jan; Riha, Milan; Cech, Martin			Who Is Who: An Anomalous Predator-Prey Role Exchange between Cyprinids and Perch	PLOS ONE			English	Article							ROACH RUTILUS-RUTILUS; CORMORANT PHALACROCORAX-CARBO; BLEAK ALBURNUS-ALBURNUS; UPPER NIAGARA RIVER; SCARDINIUS-ERYTHROPHTHALMUS; ABRAMIS-BRAMA; ZOOPLANKTON CONSUMPTION; FORAGING EFFICIENCY; EUROPEAN RESERVOIR; INVASIVE CYPRINID	Piscivory in cyprinids (Cyprinidae) is extremely rare. Specifically, common bream (Abramis brama) and common carp (Cyprinus carpio) are zooplanktivorous fish in deep lentic waters. Nevertheless, we observed predation by these two cyprinids under natural conditions in the Vir Reservoir, Czech Republic. We conducted diet analysis for cyprinids caught by trawling and gillnets and the large amount of young-of-the-year (YOY) perch (Perca fluviatilis), with sizes of 37-52 mm standard length, were found in their digestive tracts. In 2010, a large amount of YOY perch caused a significant decrease in Daphnia spp. size and abundance in the reservoir. Hence, a food deficit was induced for the cyprinids, apparent also from the poor nutritional condition of common bream which was much worse than the condition of those in similar reservoirs. Common carp and common bream shifted to forced piscivory, and they utilized the YOY perch as an alternative food source. In contrast, smaller species, such as roach (Rutilus rutilus) and bleak (Alburnus alburnus), widely utilized planktonic cyanobacteria. In the following year, YOY perch occurred in significantly lower numbers and conversely, Daphnia spp. size and abundance were significantly higher. The forced piscivory was not observed. Our results indicate a switch to forced piscivory by cyprinids, which was caused by a shortage of their natural food source. Moreover, this phenomenon presents an effective mechanism for reduction in the numbers of YOY perch, ensuring the stability of the ecosystem.	[Vejrik, Lukas; Matejickova, Ivana; Sed'a, Jaromir; Blabolil, Petr; Juza, Tomas; Vasek, Mojmir; Ricard, Daniel; Matena, Josef; Frouzova, Jaroslava; Kubecka, Jan; Riha, Milan; Cech, Martin] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Na Sadkach 7, Ceske Budejovice 37005, Czech Republic; [Vejrik, Lukas; Matejickova, Ivana; Blabolil, Petr] Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Ricard, Daniel] Fisheries & Oceans Canada, Gulf Fisheries Ctr, 343 Ave Univ,CP 5030, Moncton, NB E1C 9B6, Canada	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Fisheries & Oceans Canada	Vejrik, L (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Na Sadkach 7, Ceske Budejovice 37005, Czech Republic.; Vejrik, L (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	vejrik.lukas@seznam.cz	Riha, Milan/G-1065-2014; Juza, Tomas/G-3159-2014; Ricard, Daniel/G-1814-2014; Seda, Jaromir/F-9072-2014; Frouzova, Jaroslava/F-8518-2014; Vejřík, Lukáš/E-1607-2017; Kubecka, Jan/A-8230-2011; Vejříková, Ivana/K-4697-2016; Riha, Milan/AAF-9819-2019; Blabolil, Petr/N-8719-2019; Vasek, Mojmir/C-5839-2014; Blabolil, Petr/K-9548-2015; Čech, Martin/C-5797-2014; Vejříková, Ivana/E-1624-2017	Riha, Milan/0000-0002-3930-420X; Frouzova, Jaroslava/0000-0003-4876-4985; Vejřík, Lukáš/0000-0001-8911-9128; Kubecka, Jan/0000-0001-9203-4854; Blabolil, Petr/0000-0003-1344-9627; Vasek, Mojmir/0000-0001-6386-4015; Čech, Martin/0000-0003-1350-4286; Vejříková, Ivana/0000-0001-9113-2815	Ministry of Education, Youth and Sports [CZ.1.07/2.3.00/20.0204]; Czech Science Foundation [206/09/P266, 15-24309S]; Grant Agency of University of South Bohemia [159/2013/P]; Postdok BIOGLOBE - European Social Fund [CZ.1.07/2.3.00/30.0032]; state budget of the Czech Republic; Norwegian Financial Mechanism [7F14316, MSMT-28477/2014]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of University of South Bohemia; Postdok BIOGLOBE - European Social Fund; state budget of the Czech Republic; Norwegian Financial Mechanism	The study was supported by projects no. CZ.1.07/2.3.00/20.0204 (CEKOPOT) of the Ministry of Education, Youth and Sports (http://www.msmt.cz/), 7F14316 of the Norwegian Financial Mechanism 2009-2014 under contract number MSMT-28477/2014 (http://nfm.mjs.bg/NFMs/EN/SitePages/Home.aspx), 206/09/P266 and 15-24309S of the Czech Science Foundation (http://www.udu.cas.cz/en/), and 159/2013/P of the Grant Agency of University of South Bohemia (http://www.jcu.cz/). D. Ricard was supported by project no. CZ.1.07/2.3.00/30.0032 of the Postdok BIOGLOBE co-financed by the European Social Fund and the state budget of the Czech Republic (http://alfa.bc.cas.cz/Postdok-BIOGLOBE/ (http://alfa.bc.cas.cz/Postdok-BIOGLOBE/)).	[Anonymous], 2005, EN14757; Auguie B, 2017, GRIDEXTRA MISCELLANE; Benzie AH, 2005, GUIDES IDENTIFICATIO, V21, P1; Borcherding J, 2000, ECOL FRESHW FISH, V9, P236, DOI 10.1111/j.1600-0633.2000.eff090406.x; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031707; Britton JR, 2010, BIOL INVASIONS, V12, P1533, DOI 10.1007/s10530-009-9566-5; Cech M, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012026; Cech M, 2008, WATERBIRDS, V31, P438; Cech M, 2011, FOLIA ZOOL, V60, P129; CERNY K, 1973, Vestnik Ceskoslovenske Spolecnosti Zoologicke, V37, P1; de Graaf M, 2008, MAR FRESHWATER RES, V59, P391, DOI 10.1071/MF07123; de Graaf M, 2010, AFR ZOOL, V45, P32, DOI 10.3377/004.045.0117; DIEHL S, 1988, OIKOS, V53, P207, DOI 10.2307/3566064; Eklov P, 1997, J FISH AQUAT SCI, V7, P1520; Flossner D, 2000, HAPLOPODA CALDOCERA; Frankiewicz P, 1996, ANN ZOOL FENN, V33, P321; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Garcia-Berthou E, 2001, AQUAT SCI, V63, P466, DOI 10.1007/s00027-001-8045-6; Guinan ME, 2015, AQUAT INVASIONS, V10, P217, DOI 10.3391/ai.2015.10.2.10; HARTMAN KJ, 1993, J FISH BIOL, V43, P109, DOI 10.1006/jfbi.1993.1113; Jarolim O, 2010, HYDROBIOLOGIA, V654, P253, DOI 10.1007/s10750-010-0398-1; Johansson L., 1986, P237; Juza T, 2007, FISH RES, V85, P285, DOI 10.1016/j.fishres.2007.03.001; Juza T, 2015, HYDROBIOLOGIA, V762, P169, DOI 10.1007/s10750-015-2346-6; Kapuscinski KL, 2012, HYDROBIOLOGIA, V693, P169, DOI 10.1007/s10750-012-1106-0; Kratochvil M, 2010, J LIMNOL, V69, P305, DOI 10.4081/jlimnol.2010.305; McCauley E., 1984, IBP HDB, P228; Mehner T, 1999, ENVIRON BIOL FISH, V56, P169, DOI 10.1023/A:1007532720226; Mittelbach GG, 1998, CAN J FISH AQUAT SCI, V55, P1454, DOI 10.1139/f98-041; MULLER M, 1984, Transactions of the Zoological Society of London, V37, P51; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Okun N, 2005, ECOL FRESHW FISH, V14, P139, DOI 10.1111/j.1600-0633.2005.00087.x; Olin M, 2010, J FISH BIOL, V76, P1277, DOI 10.1111/j.1095-8649.2010.02559.x; Olin M, 2002, J FISH BIOL, V60, P593, DOI 10.1006/jfbi.2002.1876; OLSON MH, 1995, ECOLOGY, V76, P1758, DOI 10.2307/1940708; Persson A, 1999, CAN J FISH AQUAT SCI, V56, P70, DOI 10.1139/cjfas-56-1-70; Persson A, 2002, OIKOS, V97, P271, DOI 10.1034/j.1600-0706.2002.970213.x; Persson L., 1988, P203; PERSSON L, 1995, ECOLOGY, V76, P70, DOI 10.2307/1940632; PERSSON L, 1991, BEHAV ECOL SOCIOBIOL, V28, P101; PERSSON L, 1993, OIKOS, V68, P12, DOI 10.2307/3545304; Petrusek A, 2008, PHILOS T R SOC B, V363, P2931, DOI 10.1098/rstb.2008.0026; Petrusek A, 2012, LIMNOL OCEANOGR, V57, P1838, DOI 10.4319/lo.2012.57.6.1838; Prchalova M, 2011, FISH RES, V107, P201, DOI 10.1016/j.fishres.2010.10.021; Rahman MM, 2010, ECOL RES, V25, P303, DOI 10.1007/s11284-009-0657-7; RINGELBERG J, 1991, ARCH HYDROBIOL, V121, P129; Ringelberg J, 2010, DIEL VERTICAL MIGRATION OF ZOOPLANKTON IN LAKES AND OCEANS: CAUSAL EXPLANATIONS AND ADAPTIVE SIGNIFICANCES, P1, DOI 10.1007/978-90-481-3093-1; RINGELBERG J, 1991, J PLANKTON RES, V13, P17, DOI 10.1093/plankt/13.1.17; Seda J, 2007, HYDROBIOLOGIA, V594, P47, DOI 10.1007/s10750-007-9075-4; Seda J, 2007, J PLANKTON RES, V29, P619, DOI 10.1093/plankt/fbm044; Sibbing FA, 2001, REV FISH BIOL FISHER, V10, P393; Smejkal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122437; Specziar A, 1998, ITAL J ZOOL, V65, P331, DOI 10.1080/11250009809386842; Specziar A, 2009, J FISH BIOL, V75, P247, DOI 10.1111/j.1095-8649.2009.02283.x; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Tesch FW., 1971, METHODS ASSESSMENT F, V1, P98; Van Wassenbergh S, 2011, ZOOLOGY, V114, P46, DOI 10.1016/j.zool.2010.10.001; Vasek M, 2016, ECOL INDIC, V63, P219, DOI 10.1016/j.ecolind.2015.11.061; Vasek M, 2004, FOLIA ZOOL, V53, P203; Vasek M, 2011, J FISH BIOL, V78, P953, DOI 10.1111/j.1095-8649.2011.02901.x; Vasek M, 2008, FOLIA ZOOL, V57, P324; Vasek M, 2006, INT REV HYDROBIOL, V91, P178, DOI 10.1002/iroh.200510835; Vejrik L, 2016, FRESHWATER BIOL, V61, P899, DOI 10.1111/fwb.12753; VOLLESTAD LA, 1985, HOLARCTIC ECOL, V8, P88; WINEMILLER KO, 1994, J FISH BIOL, V45, P211; WINFIELD IJ, 1986, J FISH BIOL, V29, P37, DOI 10.1111/j.1095-8649.1986.tb04997.x	67	5	5	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156430	10.1371/journal.pone.0156430	http://dx.doi.org/10.1371/journal.pone.0156430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276078	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700024
J	Kurczab, R; Canale, V; Zajdel, P; Bojarski, AJ				Kurczab, Rafal; Canale, Vittorio; Zajdel, Pawel; Bojarski, Andrzej J.			An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity	PLOS ONE			English	Article							SEROTONIN 5-HT7 RECEPTOR; MACHINE LEARNING-METHODS; FREE-ENERGY CALCULATIONS; ACID AMIDE FRAGMENTS; SUBTYPE SELECTIVITY; BIOLOGICAL-ACTIVITY; IN-VIVO; ANTAGONISTS; BINDING; MODELS	A computational procedure to search for selective ligands for structurally related protein targets was developed and verified for serotonergic 5-HT7/5-HT1A receptor ligands. Starting from a set of compounds with annotated activity at both targets (grouped into four classes according to their activity: selective toward each target, not-selective and not-selective but active) and with an additional set of decoys (prepared using DUD methodology), the SVM (Support Vector Machines) models were constructed using a selective subset as positive examples and four remaining classes as negative training examples. Based on these four component models, the consensus classifier was then constructed using a data fusion approach. The combination of two approaches of data representation (molecular fingerprints vs. structural interaction fingerprints), different training set sizes and selection of the best SVM component models for consensus model generation, were evaluated to determine the optimal settings for the developed algorithm. The results showed that consensus models with molecular fingerprints, a larger training set and the selection of component models based on MCC maximization provided the best predictive performance.	[Kurczab, Rafal; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, 12 Smetna St, PL-31343 Krakow, Poland; [Canale, Vittorio; Zajdel, Pawel] Jagiellonian Univ, Coll Med, Dept Med Chem, 9 Med St, PL-30688 Krakow, Poland	Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Kurczab, R (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Med Chem, 12 Smetna St, PL-31343 Krakow, Poland.	kurczab@if-pan.krakow.pl	Bojarski, Andrzej/GSO-0213-2022; Kurczab, Rafał/AAD-4526-2020	Kurczab, Rafał/0000-0002-9555-3905; Bojarski, Andrzej/0000-0003-1417-6333; Zajdel, Pawel/0000-0002-6192-8721; Canale, Vittorio/0000-0001-7940-9500	Polish-Norwegian Research Programme [Pol-Nor/198887/73/2013]; National Science Center [DEC-2012/05/B/N27/03076]	Polish-Norwegian Research Programme; National Science Center(National Science Centre, Poland)	The study was partially supported by the Polish-Norwegian Research Programme operated by the National Centre for Research and Development under the Norwegian Financial Mechanism 2009-2014 in the frame of Project PLATFORMex (Pol-Nor/198887/73/2013) and by the National Science Center grant no. DEC-2012/05/B/N27/03076.	Abbas AI, 2009, PSYCHOPHARMACOLOGY, V205, P119, DOI 10.1007/s00213-009-1521-8; Alvarsson J, 2014, J CHEM INF MODEL, V54, P2647, DOI 10.1021/ci500361u; [Anonymous], 2015, SMALL MOL DRUG DISC; [Anonymous], 2015, SCHROD REL 2015 4 EP; [Anonymous], 2015, SCHRODINGER RELEASE; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bonaventure P, 2002, J PHARMACOL EXP THER, V302, P240, DOI 10.1124/jpet.302.1.240; Bonaventure P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020210; Canale V, 2015, EUR J MED CHEM, V92, P202, DOI 10.1016/j.ejmech.2014.12.041; Canale V, 2014, EUR J MED CHEM, V78, P10, DOI 10.1016/j.ejmech.2014.03.005; Chuaqui C, 2005, J MED CHEM, V48, P121, DOI 10.1021/jm049312t; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00065; Di Pilato P, 2014, REV NEUROSCIENCE, V25, P401, DOI 10.1515/revneuro-2014-0009; Fang L, 2008, J CHEM INF MODEL, V48, P2030, DOI 10.1021/ci800104s; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hiroaki Y, 2015, PACKAGE ENRICHVS; Huang YY, 2013, J CHEM INF MODEL, V53, P3044, DOI 10.1021/ci400458z; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; Kalliokoski T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061007; Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479; Kurczab R, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-32; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; Leopoldo M, 2010, EXPERT OPIN THERP PA, V20, P739; Leopoldo M, 2007, J MED CHEM, V50, P4214, DOI 10.1021/jm070487n; Lovell PJ, 2000, J MED CHEM, V43, P342, DOI 10.1021/jm991151j; Ma C, 2013, J CHEM INF MODEL, V53, P11, DOI 10.1021/ci3003914; Medina RA, 2014, J MED CHEM, V57, P6879, DOI 10.1021/jm500880c; Medina RA, 2009, J MED CHEM, V52, P2384, DOI 10.1021/jm8014553; Mordalski S, 2011, BIOORG MED CHEM LETT, V21, P6816, DOI 10.1016/j.bmcl.2011.09.027; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Naumenko VS, 2014, CNS NEUROSCI THER, V20, P582, DOI 10.1111/cns.12247; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; Nikiforuk A, 2015, CNS DRUGS, V29, P265, DOI 10.1007/s40263-015-0236-0; Nikiforuk A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066695; Ning X, 2012, J CHEM INF MODEL, V52, P38, DOI 10.1021/ci200346b; Perez-Garcia GS, 2005, BEHAV BRAIN RES, V163, P136, DOI 10.1016/j.bbr.2005.04.014; R Core Team, 2018, R LANG ENV STAT COMP; Renner U, 2012, J CELL SCI, V125, P2486, DOI 10.1242/jcs.101337; Ruocco LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083003; Sabbah DA, 2012, J CHEM INF MODEL, V52, P3213, DOI 10.1021/ci3003057; Salerno L, 2014, EUR J MED CHEM, V85, P716, DOI 10.1016/j.ejmech.2014.08.023; Sciabola S, 2008, J CHEM INF MODEL, V48, P1851, DOI 10.1021/ci800138n; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smusz S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-17; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Viguier F, 2013, EUR J PHARMACOL, V716, P8, DOI 10.1016/j.ejphar.2013.01.074; Volk B, 2008, J MED CHEM, V51, P2522, DOI 10.1021/jm070279v; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Wang XS, 2008, J CHEM INF MODEL, V48, P997, DOI 10.1021/ci700404c; Warszycki D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084510; Wassermann AM, 2009, J CHEM INF MODEL, V49, P582, DOI 10.1021/ci800441c; Willett P, 2006, QSAR COMB SCI, V25, P1143, DOI 10.1002/qsar.200610084; Witek J, 2014, BIOORG MED CHEM LETT, V24, P580, DOI 10.1016/j.bmcl.2013.12.017; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zajdel P, 2015, MEDCHEMCOMM, V6, P1272, DOI 10.1039/c5md00166h; Zajdel P, 2012, EUR J MED CHEM, V56, P348, DOI 10.1016/j.ejmech.2012.07.043; Zajdel P, 2011, BIOORGAN MED CHEM, V19, P6750, DOI 10.1016/j.bmc.2011.09.044; Zajdel P, 2009, BIOORG MED CHEM LETT, V19, P4827, DOI 10.1016/j.bmcl.2009.06.038	61	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156986	10.1371/journal.pone.0156986	http://dx.doi.org/10.1371/journal.pone.0156986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271158	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000056
J	Tiveron, MC; Beurrier, C; Ceni, C; Andriambao, N; Combes, A; Koehl, M; Maurice, N; Gatti, E; Abrous, DN; Kerkerian-Le Goff, L; Pierre, P; Cremer, H				Tiveron, Marie-Catherine; Beurrier, Corinne; Ceni, Claire; Andriambao, Naly; Combes, Alexis; Koehl, Muriel; Maurice, Nicolas; Gatti, Evelina; Abrous, Dhoher Nora; Kerkerian-Le Goff, Lydia; Pierre, Philippe; Cremer, Harold			LAMP5 Fine-Tunes GABAergic Synaptic Transmission in Defined Circuits of the Mouse Brain	PLOS ONE			English	Article							CLATHRIN-COATED VESICLES; PLUS-MAZE; BAD-LAMP; NEUROGENESIS; ANXIETY; TRANSPORTER; NEURONS; CELLS; MODEL	LAMP5 is member of the LAMP family of membrane proteins. In contrast to the canonical members of this protein family, LAMP1 and LAMP2, which show widespread expression in many tissues, LAMP 5 is brain specific in mice. In C. elegans, the LAMP5 ortholog UNC-46 has been suggested to act a trafficking chaperone, essential for the correct targeting of the nematode vesicular GABA-transporter UNC-47. We show here that in the mouse brain LAMP5 is expressed in subpopulations of GABAergic forebrain neurons in the striato-nigral system and the olfactory bulb. The protein was present at synaptic terminals, overlapping with the mammalian vesicular GABA-transporter VGAT. In LAMP5-deficient mice localization of the transporter was unaffected arguing against a conserved role in VGAT trafficking. Electrophysiological analyses in mutants showed alterations in short term synaptic plasticity suggesting that LAMP5 is involved in controlling the dynamics of evoked GABAergic transmission. At the behavioral level, LAMP5 mutant mice showed decreased anxiety and deficits in olfactory discrimination. Altogether, this work implicates LAMP5 function in GABAergic neurotransmission in defined neuronal subpopulations.	[Tiveron, Marie-Catherine; Beurrier, Corinne; Ceni, Claire; Andriambao, Naly; Maurice, Nicolas; Kerkerian-Le Goff, Lydia; Cremer, Harold] Aix Marseille Univ, CNRS, IBDM, Dev Biol Inst Marseille,UMR 7288, F-13009 Marseille, France; [Combes, Alexis; Gatti, Evelina; Pierre, Philippe] Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy, INSERM, U1104,CNRS UMR7280, F-13288 Marseille, France; [Koehl, Muriel; Abrous, Dhoher Nora] NeuroCtr Magendie, INSERM, U862, Neurogenesis & Physiopathol Grp, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Tiveron, MC (corresponding author), Aix Marseille Univ, CNRS, IBDM, Dev Biol Inst Marseille,UMR 7288, F-13009 Marseille, France.	marie-catherine.tiveron@univ-amu.fr	Koehl, Muriel/ABI-2043-2020; Abrous, Nora-Djoher/N-6977-2017; Koehl, Muriel/C-3698-2011; Gatti, Evelina/B-7941-2012; TIVERON, Marie-Catherine/AAR-1142-2020	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; Gatti, Evelina/0000-0002-0667-0799; pierre, philippe/0000-0003-0863-8255; Kerkerian-Le Goff, Lydia/0000-0002-7951-3479; Combes, Alexis/0000-0002-9110-6542; abrous, nora/0000-0002-8589-305X; Cremer, Harold/0000-0002-8673-5176	Agence National pour la Recherche (ANR BadLampLayers); ARC Subvention libre "BAD-LAMP function in multiple myeloma"; A*MIDEX project - "Investissements d'Avenir" French government program [ANR-11-IDEX-0001-02]; France-BioImaging/PICsL infrastructure facility [ANR-10-INSB-04-01]; IBDM animal facility	Agence National pour la Recherche (ANR BadLampLayers)(French National Research Agency (ANR)); ARC Subvention libre "BAD-LAMP function in multiple myeloma"; A*MIDEX project - "Investissements d'Avenir" French government program(French National Research Agency (ANR)); France-BioImaging/PICsL infrastructure facility(French National Research Agency (ANR)); IBDM animal facility	HC and PP received funding from Agence National pour la Recherche (ANR BadLampLayers), and EG from ARC Subvention libre "BAD-LAMP function in multiple myeloma" and A*MIDEX project ANR-11-IDEX-0001-02 funded by the "Investissements d'Avenir" French government program.; The authors thank C. Beclin, and A. de Chevigny for critical reading of the manuscript. V. Camosseto, P. Delage and A. Defays for expert technical assistance, B. Gasnier for anti VGAT antibody. We acknowledge support by the the France-BioImaging/PICsL infrastructure (ANR-10-INSB-04-01) and the IBDM animal facilities.	Beurrier C, 2009, NEUROSCIENCE, V158, P1608, DOI 10.1016/j.neuroscience.2008.11.018; Beurrier C, 2009, FASEB J, V23, P3619, DOI 10.1096/fj.09-131789; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Boulay D, 2000, EUR J PHARMACOL, V391, P63, DOI 10.1016/S0014-2999(99)00916-4; Boulay D, 2000, PROG NEURO-PSYCHOPH, V24, P39, DOI 10.1016/S0278-5846(99)00079-2; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Burk K, 2012, J NEUROSCI, V32, P3759, DOI 10.1523/JNEUROSCI.4906-11.2012; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; David A, 2007, J CELL SCI, V120, P353, DOI 10.1242/jcs.03316; Defays A, 2011, BLOOD, V118, P609, DOI 10.1182/blood-2010-11-319699; Dumoulin A, 1999, J CELL SCI, V112, P811; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Poudel KR, 2014, CURR OPIN CELL BIOL, V26, P28, DOI 10.1016/j.ceb.2013.09.001; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Saftig P, 2001, TRENDS MOL MED, V7, P37, DOI 10.1016/S1471-4914(00)01868-2; Saheki A, 2012, INT J PHARMACEUT, V422, P489, DOI 10.1016/j.ijpharm.2011.10.060; Saheki T, 2012, MOL GENET METAB, V107, P322, DOI 10.1016/j.ymgme.2012.07.021; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Schuske K, 2007, NAT NEUROSCI, V10, P846, DOI 10.1038/nn1920; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SUDHOF T, 2011, COLD SPRING HARB PER, V3; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	33	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157052	10.1371/journal.pone.0157052	http://dx.doi.org/10.1371/journal.pone.0157052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272053	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000059
J	Eyking, A; Reis, H; Frank, M; Gerken, G; Schmid, KW; Cario, E				Eyking, Annette; Reis, Henning; Frank, Magdalena; Gerken, Guido; Schmid, Kurt W.; Cario, Elke			MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; DIFFERENTIATION; MICRORNA; PROLIFERATION; INFLAMMATION; PROGNOSIS; ADENOCARCINOMA; MODULATION; CARCINOMA	Mucinous adenocarcinoma (MAC) represents a distinct histopathological entity of colorectal cancer (CRC), which is associated with disease progression and poor prognosis. Here, we found that expression levels of miR-205 and miR-373 were specifically upregulated only in patients with mucinous colon cancers, but not in CRC that lack mucinous components. To investigate the effects of miR-205 and miR-373 on intestinal epithelial cell (IEC) biology by gain-and loss-of-function experiments in a proof-of-concept approach, we chose previously established in-vitro human Caco-2-based models of differentiated, non-invasive (expressing TLR4 wild-type; termed Caco-2[WT]) versus undifferentiated, invasive (expressing TLR4 mutant D299G; termed Caco-2[D299G]) IEC. Enterocyte-like Caco-2[WT] showed low levels of miR-205 and miR-373 expression, while both miRNAs were significantly upregulated in colorectal carcinoma-like Caco-2[D299G], thus resembling the miRNA expression pattern of paired normal versus tumor samples from MAC patients. Using stable transfection, we generated miR-205-or miR-373-expressing and miR-205-or miR-373-inhibiting subclones of these IEC lines. We found that introduction of miR-205 into Caco-2 [WT] led to expansion of mucus-secreting goblet cell-like cells, which was associated with induction of KLF4, MUC2 and TGF beta 1 expression. Activation of miR-205 in Caco-2[WT] induced chemoresistance, while inhibition of miR-205 in Caco-2[D299G] promoted chemosensitivity. Caco-2[WT] overexpressing miR-373 showed mitotic abnormalities and underwent morphologic changes (loss of epithelial polarity, cytoskeletal reorganization, and junctional disruption) associated with epithelial-mesenchymal transition and progression to inflammation-associated colonic carcinoma, which correlated with induction of phosphorylated STAT3 and N-CADHERIN expression. Functionally, introduction of miR-373 into Caco-2[WT] mediated loss of cell-cell adhesion and increased proliferation and invasion. Reversely, inhibition of miR-373 allowed mesenchymal IEC to regain epithelial properties, which correlated with absence of neoplastic progression. Using xenografts in mice demonstrated miR-373-mediated acceleration of malignant intestinal tumor growth. In conclusion, our results provide first evidence that miR-205 and miR-373 may differentially contribute to the aggressive phenotype of MAC in CRC.	[Eyking, Annette; Frank, Magdalena; Gerken, Guido; Cario, Elke] Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Reis, Henning; Schmid, Kurt W.] Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Cario, E (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany.	elke.cario@uni-due.de	Reis, Henning/AAX-9545-2020	Reis, Henning/0000-0003-1373-5295	Deutsche Forschungsgemeinschaft [CA226/4-3]; Interne Forschungsforderung Essen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interne Forschungsforderung Essen	This study was supported by the Deutsche Forschungsgemeinschaft (Grant CA226/4-3 to E.C.) and intramural funding (Interne Forschungsforderung Essen to E.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson AM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-336; Bosman F. T., 2010, WHO CLASSIFICATION O; Bu XD, 2011, TISSUE CELL, V43, P201, DOI 10.1016/j.tice.2011.03.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cario E, 2006, J IMMUNOL, V176, P4258, DOI 10.4049/jimmunol.176.7.4258; Cario E, 2013, CURR OPIN GASTROEN, V29, P85, DOI 10.1097/MOG.0b013e32835a670e; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Chao CH, 2014, J CLIN INVEST, V124, P3093, DOI 10.1172/JCI73351; Chen D, 2015, ONCOTARGET, V6, P32701, DOI 10.18632/oncotarget.4702; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; DAHIYA R, 1992, CANCER RES, V52, P4655; Debunne H, 2013, ACTA CHIR BELG, V113, P385, DOI 10.1080/00015458.2013.11680951; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Farmer DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076634; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; HANSKI C, 1995, BRIT J CANCER, V72, P1350, DOI 10.1038/bjc.1995.514; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; Hugen N, 2016, NAT REV CLIN ONCOL, V13, P361, DOI 10.1038/nrclinonc.2015.140; Hugen N, 2014, ANN SURG ONCOL, V21, P2963, DOI 10.1245/s10434-014-3706-6; Ivanov AI, 2008, J CELL SCI, V121, P1803, DOI 10.1242/jcs.015842; Kara M, 2015, GENE, V567, P81, DOI 10.1016/j.gene.2015.04.065; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kelemen LE, 2011, LANCET ONCOL, V12, P1071, DOI 10.1016/S1470-2045(11)70058-4; Klaewsongkram J, 2007, J IMMUNOL, V179, P4679, DOI 10.4049/jimmunol.179.7.4679; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Leowardi C, 2015, ANN SURG ONCOL, V14, P14; Low D, 2015, ONCOTARGET, V6, P36535, DOI 10.18632/oncotarget.5440; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; Mekenkamp LJM, 2012, EUR J CANCER, V48, P501, DOI 10.1016/j.ejca.2011.12.004; Melis M, 2010, DIS COLON RECTUM, V53, P936, DOI 10.1007/DCR.0b013e3181d320c4; Orang AV, 2014, ASIAN PAC J CANCER P, V15, P4033, DOI 10.7314/APJCP.2014.15.9.4033; Park JS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000658; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sierko E, 2010, THROMB HAEMOSTASIS, V103, P198, DOI 10.1160/TH09-06-0416; Song GA, 2005, INT J ONCOL, V26, P745; Stewart BW, 2014, WORLD CANCER REPORT; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tanaka T, 2011, ONCOL REP, V26, P1329, DOI 10.3892/or.2011.1401; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TIBBETTS LM, 1988, CANCER RES, V48, P3751; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Vosgha H, 2014, CURR CANCER DRUG TAR, V14, P621, DOI 10.2174/156800961407140926105634; Walia V, 2010, STEM CELLS DEV, V19, P1175, DOI 10.1089/scd.2009.0430; Walsh MD, 2013, MODERN PATHOL, V26, P1642, DOI 10.1038/modpathol.2013.101; Wang DM, 2013, NAT CELL BIOL, V15, P1153, DOI 10.1038/ncb2827; Wei FR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0523-z; Xuan Y, 2015, CANCER LETT, V360, P89, DOI 10.1016/j.canlet.2014.11.051; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou AD, 2012, ONCOGENE, V31, P2968, DOI 10.1038/onc.2011.461; Zhou YN, 2014, MOL BIOL CELL, V25, P2882, DOI 10.1091/mbc.E14-05-0998	58	54	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156871	10.1371/journal.pone.0156871	http://dx.doi.org/10.1371/journal.pone.0156871			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271572	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200024
J	Jeong, JH; Resop, JP; Mueller, ND; Fleisher, DH; Yun, K; Butler, EE; Timlin, DJ; Shim, KM; Gerber, JS; Reddy, VR; Kim, SH				Jeong, Jig Han; Resop, Jonathan P.; Mueller, Nathaniel D.; Fleisher, David H.; Yun, Kyungdahm; Butler, Ethan E.; Timlin, Dennis J.; Shim, Kyo-Moon; Gerber, James S.; Reddy, Vangimalla R.; Kim, Soo-Hyung			Random Forests for Global and Regional Crop Yield Predictions	PLOS ONE			English	Article							RANGE SHIFTS; CORN YIELDS; REGRESSION; CLASSIFICATION; TEMPERATURE; MODELS; RESPONSES; BIOMASS	Accurate predictions of crop yield are critical for developing effective agricultural and food policies at the regional and global scales. We evaluated a machine-learning method, Random Forests (RF), for its ability to predict crop yield responses to climate and biophysical variables at global and regional scales in wheat, maize, and potato in comparison with multiple linear regressions (MLR) serving as a benchmark. We used crop yield data from various sources and regions for model training and testing: 1) gridded global wheat grain yield, 2) maize grain yield from US counties over thirty years, and 3) potato tuber and maize silage yield from the northeastern seaboard region. RF was found highly capable of predicting crop yields and outperformed MLR benchmarks in all performance statistics that were compared. For example, the root mean square errors (RMSE) ranged between 6 and 14% of the average observed yield with RF models in all test cases whereas these values ranged from 14% to 49% for MLR models. Our results show that RF is an effective and versatile machine-learning method for crop yield predictions at regional and global scales for its high accuracy and precision, ease of use, and utility in data analysis. RF may result in a loss of accuracy when predicting the extreme ends or responses beyond the boundaries of the training data.	[Jeong, Jig Han; Yun, Kyungdahm; Kim, Soo-Hyung] Univ Washington, Sch Environm & Forest Sci, Coll Environm, Box 354115, Seattle, WA 98195 USA; [Resop, Jonathan P.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Resop, Jonathan P.; Fleisher, David H.; Timlin, Dennis J.; Reddy, Vangimalla R.] USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD 20705 USA; [Mueller, Nathaniel D.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Mueller, Nathaniel D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Butler, Ethan E.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Shim, Kyo-Moon] RDA, Climate Change & Agroecol Div, Natl Inst Agr Sci, Suwon, South Korea; [Gerber, James S.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); Harvard University; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; Rural Development Administration (RDA), Republic of Korea; University of Minnesota System; University of Minnesota Twin Cities	Kim, SH (corresponding author), Univ Washington, Sch Environm & Forest Sci, Coll Environm, Box 354115, Seattle, WA 98195 USA.	soohkim@uw.edu	Resop, Jonathan Patrick/AAH-5537-2019; Kim, Soo-Hyung/A-3012-2009; Butler, Ethan/AAG-2034-2019; Mueller, Nathan D/E-5864-2010	Resop, Jonathan Patrick/0000-0002-9534-2518; Kim, Soo-Hyung/0000-0003-3879-4080; Mueller, Nathan D/0000-0003-1857-5104; Fleisher, Dave/0000-0002-0631-3986; Gerber, James/0000-0002-6890-0481; Timlin, Dennis/0000-0003-4883-4664	Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea [PJ01000707]; University of Washington [58-1265-1-074]; USDA-ARS [58-1265-1-074]; USDA-ARS Headquarters Postdoctoral Research Associate Program; USDA-NIFA-AFRI [2011-68004-30057]; USDA AFRI fellowship [2016-67012-25208]; NSF Hydrological Sciences grant [1521210]; Packard Foundation; NERC [NE/M021327/1] Funding Source: UKRI; Directorate For Geosciences [1540195] Funding Source: National Science Foundation; Natural Environment Research Council [NE/M021327/1] Funding Source: researchfish	Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea; University of Washington(University of Washington); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-ARS Headquarters Postdoctoral Research Associate Program(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); USDA AFRI fellowship; NSF Hydrological Sciences grant; Packard Foundation(The David & Lucile Packard Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by a Cooperative Research Program for Agricultural Science and Technology Development (Project No. PJ01000707), Rural Development Administration, Republic of Korea (SHK; KMS). Additional support was provided in part by a Specific Cooperative Agreement: 58-1265-1-074 between University of Washington and USDA-ARS (SHK; VRR), the USDA-ARS Headquarters Postdoctoral Research Associate Program (DHF), the USDA-NIFA-AFRI Grant no. 2011-68004-30057: Enhancing Food Security of Underserved Populations in the Northeast through Sustainable Regional Food Systems (DHF), the USDA AFRI fellowship 2016-67012-25208 (NDM), the NSF Hydrological Sciences grant 1521210 (NDM), and the Packard Foundation (EEB).	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Butler EE, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034009; Butler EE, 2013, NAT CLIM CHANGE, V3, P68, DOI [10.1038/NCLIMATE1585, 10.1038/nclimate1585]; CARLSON RE, 1990, J PROD AGRIC, V3, P293, DOI 10.2134/jpa1990.0293; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; ESRI, 2011, ARCGIS DESKT REL 10; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fukuda S, 2013, AGR WATER MANAGE, V116, P142, DOI 10.1016/j.agwat.2012.07.003; Gromping U, 2009, AM STAT, V63, P308, DOI 10.1198/tast.2009.08199; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Kim SH, 2012, AGRON J, V104, P1523, DOI 10.2134/agronj2011.0321; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Kucharik CJ, 2005, EARTH INTERACT, V9, DOI 10.1175/EI098.1; Landau S, 2000, AGR FOREST METEOROL, V101, P151, DOI 10.1016/S0168-1923(99)00166-5; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Mutanga O, 2012, INT J APPL EARTH OBS, V18, P399, DOI 10.1016/j.jag.2012.03.012; NASS, 2011, 2010 CROPL DAT LAYER; NASS, 2015, CENS AGR; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANGUAGE ENV STAT; Resop JP, 2014, AGRON J, V106, P43, DOI 10.2134/agronj2013.0277; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Segal M.R., 2004, INT C BIOINF, DOI DOI 10.2307/2404188; Sheehy JE, 2006, FIELD CROP RES, V98, P151, DOI 10.1016/j.fcr.2006.01.001; Svetnik V, 2004, LECT NOTES COMPUT SC, V3077, P334; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; United States Department of Agriculture National Agricultural Statistics Service (NASS), 2009, CENS AGR; Venables WN., 2002, MODERN APPL STAT S, V4; Villareal R, 1985, S WHEATS MOR TROP EN; Vincenzi S, 2011, ECOL MODEL, V222, P1471, DOI 10.1016/j.ecolmodel.2011.02.007; Wallach D, 2014, WORKING WITH DYNAMIC CROP MODELS: METHODS, TOOLS AND EXAMPLES FOR AGRICULTURE AND ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/C2011-0-06987-9; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]	49	183	188	17	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156571	10.1371/journal.pone.0156571	http://dx.doi.org/10.1371/journal.pone.0156571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257967	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700078
J	Lin, C; Yuan, Y; Courtman, DW				Lin, Clifford; Yuan, Yifan; Courtman, David W.			Differentiation of Murine Bone Marrow-Derived Smooth Muscle Progenitor Cells Is Regulated by PDGF-BB and Collagen	PLOS ONE			English	Article							GROWTH FACTOR-BB; MESENCHYMAL STEM-CELLS; NEOINTIMAL FORMATION; IN-VITRO; FIBRILLAR COLLAGEN; KNOCKOUT MICE; TGF-BETA; ATHEROSCLEROSIS; PROLIFERATION; PROGRESSION	Smooth muscle cells (SMCs) are key regulators of vascular disease and circulating smooth muscle progenitor cells may play important roles in vascular repair or remodelling. We developed enhanced protocols to derive smooth muscle progenitors from murine bone marrow and tested whether factors that are increased in atherosclerotic plaques, namely platelet-derived growth factor-BB (PDGF-BB) and monomeric collagen, can influence the smooth muscle specific differentiation, proliferation, and survival of mouse bone marrow-derived progenitor cells. During a 21 day period of culture, bone marrow cells underwent a marked increase in expression of the SMC markers alpha-SMA (1.93 +/- 0.15 vs. 0.0008 +/- 0.0003 (ng/ng GAPDH) at 0 d), SM22-alpha (1.50 +/- 0.27 vs. 0.005 +/- 0.001 (ng/ng GAPDH) at 0 d) and SM-MHC (0.017 +/- 0.004 vs. 0.001 +/- 0.001 (ng/ng GAPDH) at 0 d). Bromodeoxyuridine (BrdU) incorporation experiments showed that in early culture, the smooth muscle progenitor subpopulation could be identified by high proliferative rates prior to the expression of smooth muscle specific markers. Culture of fresh bone marrow or smooth muscle progenitor cells with PDGF-BB suppressed the expression of alpha-SMA and SM22-alpha, in a rapidly reversible manner requiring PDGF receptor kinase activity. Progenitors cultured on polymerized collagen gels demonstrated expression of SMC markers, rates of proliferation and apoptosis similar to that of cells on tissue culture plastic; in contrast, cells grown on monomeric collagen gels displayed lower SMC marker expression, lower growth rates (319 +/- 36 vs. 635 +/- 97 cells/mm(2)), and increased apoptosis (5.3 +/- 1.6% vs. 1.0 +/- 0.5% (Annexin 5 staining)). Our data shows that the differentiation and survival of smooth muscle progenitors are critically affected by PDGF-BB and as well as the substrate collagen structure.	[Yuan, Yifan; Courtman, David W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Lin, Clifford] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Ottawa; Ottawa Hospital Research Institute; Oregon Health & Science University	Courtman, DW (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	dcourtman@ohri.ca	Yuan, Yifan/H-6569-2019	Yuan, Yifan/0000-0001-8645-3112	Ontario Graduate Scholarship; NSERC	Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We are grateful to Ontario Graduate Scholarship for financial support to Y.Y. and NSERC for financial support to C.L.	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Akhtar S, 2013, ARTERIOSCL THROM VAS, V33, P679, DOI 10.1161/ATVBAHA.112.301162; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Banai S, 1998, CIRCULATION, V97, P1960, DOI 10.1161/01.CIR.97.19.1960; Bentzon JF, 2007, CIRCULATION, V116, P2053, DOI 10.1161/CIRCULATIONAHA.107.722355; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Bentzon JF, 2010, VASC PHARMACOL, V52, P11, DOI 10.1016/j.vph.2009.11.005; Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202; CAMPBELL JH, 1989, ARTERIOSCLEROSIS, V9, P633, DOI 10.1161/01.ATV.9.5.633; Canavan HE, 2005, J BIOMED MATER RES A, V75A, P1, DOI 10.1002/jbm.a.30297; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Chou MT, 2010, BIOMATERIALS, V31, P4367, DOI 10.1016/j.biomaterials.2010.02.011; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Daniel JM, 2011, J MOL CELL CARDIOL, V50, P273, DOI 10.1016/j.yjmcc.2010.10.030; Dorafshar AH, 2003, J SURG RES, V114, P179, DOI 10.1016/S0022-4804(03)00254-3; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Fassett J, 2006, MOL BIOL CELL, V17, P345, DOI 10.1091/mbc.E05-09-0871; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Guildford AL, 2011, J R SOC INTERFACE, V8, P641, DOI 10.1098/rsif.2010.0532; Josh F, 2013, J NIPPON MED SCH, V80, P140, DOI 10.1272/jnms.80.140; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Kruzliak P, 2016, ACTA HISTOCHEM, V118, P413, DOI 10.1016/j.acthis.2016.04.005; Kubota K, 2003, J SURG RES, V109, P43, DOI 10.1016/S0022-4804(02)00037-9; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Merkulova-Rainon T, 2012, CARDIOVASC RES, V95, P205, DOI 10.1093/cvr/cvs097; Metharom P, 2010, ARTERIOSCL THROM VAS, V30, P533, DOI 10.1161/ATVBAHA.109.200097; Orlandi A, 2010, BIOCHEM PHARMACOL, V79, P1706, DOI 10.1016/j.bcp.2010.01.027; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park HS, 2013, BIOCHEM BIOPH RES CO, V431, P326, DOI 10.1016/j.bbrc.2012.12.099; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Pyle AL, 2010, AM J PATHOL, V177, P4, DOI 10.2353/ajpath.2010.090615; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Solchaga LA, 2013, CLIN DRUG INVEST, V33, P143, DOI 10.1007/s40261-013-0053-5; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Zhao Y, 2014, J RECEPT SIG TRANSD, V34, P254, DOI 10.3109/10799893.2014.908915; Zoll J, 2008, CARDIOVASC RES, V77, P471, DOI 10.1093/cvr/cvm034; Zou SL, 2016, ANN THORAC SURG, V101, P2085, DOI 10.1016/j.athoracsur.2016.01.026	48	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156935	10.1371/journal.pone.0156935	http://dx.doi.org/10.1371/journal.pone.0156935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258003	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700159
J	Rasnick, R; Standifird, T; Reinbolt, JA; Cates, HE; Zhang, SN				Rasnick, Robert; Standifird, Tyler; Reinbolt, Jeffrey A.; Cates, Harold E.; Zhang, Songning			Knee Joint Loads and Surrounding Muscle Forces during Stair Ascent in Patients with Total Knee Replacement	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEASURED IN-VIVO; DYNAMIC SIMULATIONS; FUNCTIONAL MOBILITY; OLDER-PEOPLE; CROUCH GAIT; ARTHROPLASTY; WALKING; OSTEOARTHRITIS; BIOMECHANICS	Total knee replacement (TKR) is commonly used to correct end-stage knee osteoarthritis. Unfortunately, difficulty with stair climbing often persists and prolongs the challenges of TKR patents. Complete understanding of loading at the knee is of great interest in order to aid patient populations, implant manufacturers, rehabilitation, and future healthcare research. Musculoskeletal modeling and simulation approximates joint loading and corresponding muscle forces during a movement. The purpose of this study was to determine if knee joint loadings following TKR are recovered to the level of healthy individuals, and determine the differences in muscle forces causing those loadings. Data from five healthy and five TKR patients were selected for musculoskeletal simulation. Variables of interest included knee joint reaction forces (JRF) and the corresponding muscle forces. A paired samples t-test was used to detect differences between groups for each variable of interest (p<0.05). No differences were observed for peak joint compressive forces between groups. Some muscle force compensatory strategies appear to be present in both the loading and push-off phases. Evidence from knee extension moment and muscle forces during the loading response phase indicates the presence of deficits in TKR in quadriceps muscle force production during stair ascent. This result combined with greater flexor muscle forces resulted in similar compressive JRF during loading response between groups.	[Rasnick, Robert; Zhang, Songning] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN 37996 USA; [Standifird, Tyler] Utah Valley Univ, Dept Exercise Sci & Outdoor Recreat, Orem, UT USA; [Reinbolt, Jeffrey A.] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN USA; [Cates, Harold E.] Tennessee Orthoped Clin, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; Utah System of Higher Education; Utah Valley University; University of Tennessee System; University of Tennessee Knoxville	Zhang, SN (corresponding author), Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN 37996 USA.	szhang@utk.edu		Zhang, Songning/0000-0002-3712-9129	Div Of Chem, Bioeng, Env, & Transp Sys [1253317] Funding Source: National Science Foundation	Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Berti L, 2006, CLIN BIOMECH, V21, P610, DOI 10.1016/j.clinbiomech.2006.01.002; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bruyere O, 2012, ARCH ORTHOP TRAUM SU, V132, P1583, DOI 10.1007/s00402-012-1583-7; Catani F, 2003, CLIN BIOMECH, V18, P410, DOI 10.1016/S0268-0033(03)00044-5; Catani F, 2009, J ORTHOP RES, V27, P1569, DOI 10.1002/jor.20941; D'Lima DD, 2007, J BIOMECH, V40, pS11, DOI 10.1016/j.jbiomech.2007.03.004; D'Lima DD, 2006, J ARTHROPLASTY, V21, P255, DOI 10.1016/j.arth.2005.07.011; D'Lima DD, 2005, CLIN ORTHOP RELAT R, P45, DOI 10.1097/01.blo.0000186559.62942.8c; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; DeMers MS, 2014, J ORTHOP RES, V32, P769, DOI 10.1002/jor.22601; Dickstein R, 1998, GERONTOLOGY, V44, P204, DOI 10.1159/000022011; Fantozzi S, 2003, GAIT POSTURE, V17, P225, DOI 10.1016/S0966-6362(02)00096-6; Ghafari AS, 2009, P I MECH ENG H, V223, P863, DOI 10.1243/09544119JEIM578; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Heinlein B, 2009, CLIN BIOMECH, V24, P315, DOI 10.1016/j.clinbiomech.2009.01.011; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Kim HJ, 2009, J ORTHOP RES, V27, P1326, DOI 10.1002/jor.20876; Ko Y, 2011, VALUE HEALTH, V14, P322, DOI 10.1016/j.jval.2010.08.005; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Kumar D, 2013, OSTEOARTHR CARTILAGE, V21, P298, DOI 10.1016/j.joca.2012.11.008; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Lundberg HJ, 2012, J BIOMECH, V45, P990, DOI 10.1016/j.jbiomech.2012.01.015; Mandeville D, 2007, CLIN BIOMECH, V22, P787, DOI 10.1016/j.clinbiomech.2007.04.002; Mundermann A, 2008, J ORTHOP RES, V26, P1167, DOI 10.1002/jor.20655; Paquette MR, 2014, KNEE, V21, P676, DOI 10.1016/j.knee.2014.02.020; Paquette MR, EFFECTS OF INCREASED; Petterson SC, 2008, MED SCI SPORT EXER, V40, P422, DOI [10.1249/mss.0b013e31815ef285, 10.1249/MSS.0b013e31815ef285]; Piazza SJ, 2001, J BIOMECH ENG-T ASME, V123, P599, DOI 10.1115/1.1406950; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Richards C, 2010, J BIOMECH, V43, P2595, DOI 10.1016/j.jbiomech.2010.05.006; Rouston RL., 2010, THESIS OHIO STATE U; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Scuderi GR, 2012, CLIN ORTHOP RELAT R, V470, P3, DOI 10.1007/s11999-011-2135-0; Songning Zhang TS, 2014, 7TH WORLD CONGRESS O; Standifird TW, 2014, J ARTHROPLASTY, V29, P1857, DOI 10.1016/j.arth.2014.03.040; Startzell JK, 2000, J AM GERIATR SOC, V48, P567, DOI 10.1111/j.1532-5415.2000.tb05006.x; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; Taylor WR, 2004, J ORTHOP RES, V22, P625, DOI 10.1016/j.orthres.2003.09.003; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; WATKINS MA, 1991, PHYS THER, V71, P90, DOI 10.1093/ptj/71.2.90	47	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156282	10.1371/journal.pone.0156282	http://dx.doi.org/10.1371/journal.pone.0156282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258086	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700051
J	Serra, L; Cercignani, M; Bruschini, M; Cipolotti, L; Mancini, M; Silvestri, G; Petrucci, A; Bucci, E; Antonini, G; Licchelli, L; Spano, B; Giacanelli, M; Caltagirone, C; Meola, G; Bozzali, M				Serra, Laura; Cercignani, Mara; Bruschini, Michela; Cipolotti, Lisa; Mancini, Matteo; Silvestri, Gabriella; Petrucci, Antonio; Bucci, Elisabetta; Antonini, Giovanni; Licchelli, Loretta; Spano, Barbara; Giacanelli, Manlio; Caltagirone, Carlo; Meola, Giovanni; Bozzali, Marco			"I Know that You Know that I Know": Neural Substrates Associated with Social Cognition Deficits in DM1 Patients	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; ASPERGER-SYNDROME; MIND IMPAIRMENT; CTG REPEAT; BRAIN; PERSONALITY; EXPANSION; NETWORKS; CHILDREN	Myotonic dystrophy type-1 (DM1) is a genetic multi-systemic disorder involving several organs including the brain. Despite the heterogeneity of this condition, some patients with non-congenital DM1 can present with minimal cognitive impairment on formal testing but with severe difficulties in daily-living activities including social interactions. One explanation for this paradoxical mismatch can be found in patients' dysfunctional social cognition, which can be assessed in the framework of the Theory of Mind (ToM). We hypothesize here that specific disease driven abnormalities in DM1 brains may result in ToM impairments. We recruited 20 DM1 patients who underwent the "Reading the Mind in the Eyes" and the ToM-story tests. These patients, together with 18 healthy controls, also underwent resting-state functional MRI. A composite Theory of Mind score was computed for all recruited patients and correlated with their brain functional connectivity. This analysis provided the patients' "Theory of Mind-network", which was compared, for its topological properties, with that of healthy controls. We found that DM1 patients showed deficits in both tests assessing ToM. These deficits were associated with specific patterns of abnormal connectivity between the left inferior temporal and fronto-cerebellar nodes in DM1 brains. The results confirm the previous suggestions of ToM dysfunctions in patients with DM1 and support the hypothesis that difficulties in social interactions and personal relationships are a direct consequence of brain abnormalities, and not a reaction symptom. This is relevant not only for a better pathophysiological comprehension of DM1, but also for non-pharmacological interventions to improve clinical aspects and impact on patients' success in life.	[Serra, Laura; Cercignani, Mara; Bruschini, Michela; Mancini, Matteo; Spano, Barbara; Bozzali, Marco] IRCCS Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Cercignani, Mara] Univ Sussex, Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England; [Cipolotti, Lisa] Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, Queen Sq, London WC1N 3BG, England; [Mancini, Matteo] Univ Rome, Dept Engn, Rome, Italy; [Silvestri, Gabriella] Univ Cattolica Sacro Cuore, Dept Geriatr Orthopaed & Neurosci, Inst Neurol, I-00168 Rome, Italy; [Petrucci, Antonio; Giacanelli, Manlio] S Camillo Forlanini Hosp, Neuromuscular & Neurol Rare Dis Ctr, Rome, Italy; [Bucci, Elisabetta; Antonini, Giovanni; Licchelli, Loretta] Univ Roma La Sapienza, Fac Med & Psychol, Dept Neurol Mental Hlth & Sensory Organs NESMOS, Rome, Italy; [Caltagirone, Carlo] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Meola, Giovanni] Univ Milan, Dept Neurol, IRCCS Policlin San Donato, Milan, Italy	IRCCS Santa Lucia; University of Brighton; University of Sussex; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; IRCCS Santa Lucia; University of Rome Tor Vergata; IRCCS Policlinico San Donato; University of Milan	Bozzali, M (corresponding author), IRCCS Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy.	m.bozzali@hsantalucia.it	Silvestri, Gabriella/J-8713-2018; Meola, Giovanni/K-4775-2016; Bozzali, Marco/AAC-1031-2022; Serra, Laura/K-5637-2016; Antonini, Giovanni/AAC-6698-2022; Mancini, Matteo/K-6627-2016; Spano', Barbara/K-9535-2016	Silvestri, Gabriella/0000-0002-1950-1468; Meola, Giovanni/0000-0001-6396-717X; Serra, Laura/0000-0002-2717-1286; Mancini, Matteo/0000-0001-7194-4568; cipolotti, lisa/0000-0001-5838-3647; petrucci, antonio/0000-0001-7950-4970; Cercignani, Mara/0000-0002-4550-2456; ANTONINI, Giovanni/0000-0002-7519-7739; Spano', Barbara/0000-0002-5291-0984; Bozzali, Marco/0000-0002-0568-2026	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The Neuroimaging Laboratory is in part supported by grants obtained by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; BARONCOHEN S, 1994, CAH PSYCHOL COGN, V13, P724; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carluer L, 2015, CORTEX, V65, P19, DOI 10.1016/j.cortex.2014.12.010; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cheng S, 1996, HUM MUTAT, V7, P304, DOI 10.1002/(SICI)1098-1004(1996)7:4<304::AID-HUMU3>3.0.CO;2-8; Dai ZJ, 2014, NEUROSCI BULL, V30, P217, DOI 10.1007/s12264-013-1421-0; DMello AM, 2015, NEUROIMAGE-CLIN, V7, P631, DOI 10.1016/j.nicl.2015.02.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gonzalez I, 2000, NEUROLOGY, V54, P1218; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; JOHNSON ER, 1995, AM J PHYS MED REHAB, V74, pS104; Kobayakawa M, 2012, NEUROSCI RES, V72, P341, DOI 10.1016/j.neures.2012.01.005; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Meola G, 2015, BBA-MOL BASIS DIS, V1852, P594, DOI 10.1016/j.bbadis.2014.05.019; Minnerop M, 2011, BRAIN, V134, P3527, DOI 10.1093/brain/awr299; Modoni A, 2008, J NEUROL, V255, P1737, DOI 10.1007/s00415-008-0017-5; Mothersill O, 2015, CEREBELLUM; Orsini A., 1997, WAIS R CONTRIBUTO TA; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Prior M., 2003, COGNIZIONE SOCIALE C; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Serafin M, 2004, GIORNALE ITALIANO PS, V4, P839, DOI DOI 10.1421/18849; Serra L, 2015, FUNCT NEUROL, V30, P21; Serra L, 2014, JAMA NEUROL, V71, P603, DOI 10.1001/jamaneurol.2014.130; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2007, PSYCHIAT RES, V149, P11, DOI 10.1016/j.psychres.2005.10.018; Sistiaga A, 2010, PSYCHOL MED, V40, P487, DOI 10.1017/S0033291709990602; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Wechsler D WAIS-R, 1997, SCAL INT WECHSL ADUL; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Winblad Stefan, 2006, Behav Brain Funct, V2, P16, DOI 10.1186/1744-9081-2-16; Wozniak JR, 2011, NEUROMUSCULAR DISORD, V21, P89, DOI 10.1016/j.nmd.2010.11.013; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yeh ZT, 2015, J CLIN EXP NEUROPSYC, V37, P128, DOI 10.1080/13803395.2014.992864; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	45	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156901	10.1371/journal.pone.0156901	http://dx.doi.org/10.1371/journal.pone.0156901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258100	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000377369700151
J	Garonzik, SM; Lenhard, JR; Forrest, A; Holden, PN; Bulitta, JB; Tsuji, BT				Garonzik, Samira M.; Lenhard, Justin R.; Forrest, Alan; Holden, Patricia N.; Bulitta, Jurgen B.; Tsuji, Brian T.			Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach	PLOS ONE			English	Article							PARTICULARLY TISSUE PENETRATION; PROTEIN-BINDING; BACTERICIDAL ACTIVITY; PSEUDOMONAS-AERUGINOSA; BETA-LACTAMS; MODEL; VANCOMYCIN; SUSCEPTIBILITY; CIPROFLOXACIN; CEFTAZIDIME	Our objective was to study the pharmacodynamics of daptomycin in the presence of varying concentrations of human serum (HS) in vitro to quantify the fraction of daptomycin that is 'active'. Time kill experiments were performed with daptomycin (0 to 256 mg/L) against two MRSA strains at log-phase growth, in the presence of HS (0%, 10%, 30%, 50%, 70%) combined with Mueller-Hinton broth. Daptomycin >= 2 mg/L achieved 99.9% kill within 8 h at all HS concentrations; early killing activity was slightly attenuated at higher HS concentrations. After 1 h, bacterial reduction of USA300 upon exposure to daptomycin 4 mg/L ranged from -3.1 to -0.5 log(10)CFU/mL in the presence of 0% to 70% HS, respectively. Bactericidal activity was achieved against both strains at daptomycin >= 4 mg/L for all fractions of HS exposure. A mechanism-based mathematical model (MBM) was developed to estimate the active daptomycin fraction at each %HS, comprising 3 bacterial subpopulations differing in daptomycin susceptibility. Time-kill data were fit with this MBM with excellent precision (r(2) > 0.95). The active fraction of daptomycin was estimated to range from 34.6% to 25.2% at HS fractions of 10% to 70%, respectively. Despite the reported low unbound fraction of daptomycin, the impact of protein binding on the activity of daptomycin was modest. The active fraction approach can be utilized to design in vitro experiments and to optimize therapeutic regimens of daptomycin in humans.	[Garonzik, Samira M.; Lenhard, Justin R.; Forrest, Alan; Holden, Patricia N.; Bulitta, Jurgen B.; Tsuji, Brian T.] Sch Pharm & Pharmaceut Sci Buffalo, Lab Antimicrobial Pharmacodynam, Buffalo, NY USA; [Lenhard, Justin R.; Holden, Patricia N.; Tsuji, Brian T.] Univ Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA; [Forrest, Alan] Univ N Carolina, Sch Pharm, Dept Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Bulitta, Jurgen B.] Univ Florida, Coll Pharm, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA; [Garonzik, Samira M.] Bristol Myers Squibb Co, Jersey City, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; Bristol-Myers Squibb	Tsuji, BT (corresponding author), Sch Pharm & Pharmaceut Sci Buffalo, Lab Antimicrobial Pharmacodynam, Buffalo, NY USA.; Tsuji, BT (corresponding author), Univ Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY USA.	btsuji@buffalo.edu	Lenhard, Justin/M-6681-2018; Bulitta, Jurgen B/P-3355-2018	Lenhard, Justin/0000-0002-2570-7593; Bulitta, Jurgen B/0000-0001-7352-3097	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI111990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111990] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Cubist Pharmaceuticals provided the daptomycin for the experiments; however, Cubist Pharmaceuticals had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BT's and JL's participation was supported by research grants from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI111990 (description at: http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=8826683). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. NIH did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulitta JB, 2010, ANTIMICROB AGENTS CH, V54, P2051, DOI 10.1128/AAC.00881-09; Bulitta JB, 2009, ANTIMICROB AGENTS CH, V53, P46, DOI 10.1128/AAC.00489-08; Cafini E, 2007, J ANTIMICROB CHEMOTH, V59, P1185, DOI 10.1093/jac/dkm078; Cha R, 2004, J ANTIMICROB CHEMOTH, V54, P259, DOI 10.1093/jac/dkh259; CRAIG WA, 1977, CLIN PHARMACOKINET, V2, P252, DOI 10.2165/00003088-197702040-00002; DUDLEY MN, 1987, AM J MED, V82, P363; Eisenstein BI, 2004, EXPERT OPIN INV DRUG, V13, P1159, DOI 10.1517/13543784.13.9.1159; GARRISON MW, 1990, ANTIMICROB AGENTS CH, V34, P1925, DOI 10.1128/AAC.34.10.1925; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Jung D, 2008, CHEM PHYS LIPIDS, V154, P120, DOI 10.1016/j.chemphyslip.2008.04.004; Meagher AK, 2004, ANTIMICROB AGENTS CH, V48, P2061, DOI 10.1128/AAC.48.6.2061-2068.2004; Moise PA, 2009, LANCET INFECT DIS, V9, P617, DOI 10.1016/S1473-3099(09)70200-2; Mouton JW, 1997, ANTIMICROB AGENTS CH, V41, P733, DOI 10.1128/AAC.41.4.733; Smith PF, 2006, DIAGN MICR INFEC DIS, V56, P379, DOI 10.1016/j.diagmicrobio.2006.06.019; Treyaprasert W, 2007, INT J ANTIMICROB AG, V29, P263, DOI 10.1016/j.ijantimicag.2006.08.049; Tsuji BT, 2008, DIAGN MICR INFEC DIS, V60, P441, DOI 10.1016/j.diagmicrobio.2007.11.011; Tsuji BT, 2008, ANTIMICROB AGENTS CH, V52, P1533, DOI 10.1128/AAC.01254-07; WISE R, 1983, J ANTIMICROB CHEMOTH, V12, P1, DOI 10.1093/jac/12.1.1; WISE R, 1983, J ANTIMICROB CHEMOTH, V12, P105, DOI 10.1093/jac/12.2.105; WISE R, 1978, LANCET, V2, P431; WISE R, 1985, J ANTIMICROB CHEMOTH, V15, P77, DOI 10.1093/jac/15.suppl_A.77; WISE R, 1986, CLIN PHARMACOKINET, V11, P470, DOI 10.2165/00003088-198611060-00004; Zeitlinger MA, 2011, ANTIMICROB AGENTS CH, V55, P3067, DOI 10.1128/AAC.01433-10	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156131	10.1371/journal.pone.0156131	http://dx.doi.org/10.1371/journal.pone.0156131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284923	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000008
J	Li, SJ; Guo, PF; Zou, Q; He, FX; Xu, F; Tan, LP				Li, Shaojun; Guo, Pengfei; Zou, Qing; He, Fuxiang; Xu, Feng; Tan, Liping			Efficacy and Safety of Plastic Wrap for Prevention of Hypothermia after Birth and during NICU in Preterm Infants: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							HEAT-LOSS PREVENTION; RANDOMIZED CONTROLLED-TRIAL; NEONATAL HYPOTHERMIA; POLYETHYLENE; MORTALITY; DELIVERY; HELP; BAGS	Objective This meta-analysis aimed to investigate the efficacy and safety of plastic wrap applied after birth and during NICU in preterm infants for prevention of heat loss in preterm infants. Study Methods The Medline (1950 to August 2015), the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 7, 2015), CINAHL (1982 to August 2015) and the Embase (1974 to August 2015) databases were searched for randomized controlled trials (RCTs) or quasi-RCTs with main outcomes related to the core temperature (baseline temperature and/or post-stabilization temperature), hypothermia, mortality rate and hyperthermia. Result The included studies were of low to moderate quality. Compared with unwrapped infants, plastic wrap was associated with a significantly higher baseline temperature and post-stabilization temperature both in infants < 28 weeks of gestation (mean difference [MD] = 0.62, 95% CI 0.38 to 0.85; MD = 0.41, 95% CI 0.33 to 0.50, respectively), and in infants between 28 to 34 weeks of gestation (MD = 0.54, 95% CI 0.21 to 0.87; MD = 0.64, 95% CI 0.45 to 0.82, respectively). Use of plastic wrap was associated with lower incidence of hypothermia (relative risk [RR] = 0.70, 95% CI 0.63 to 0.78). However, use of plastic wrap in preterm infants was not associated with decrease in mortality (RR: 0.88, 95% CI 0.70 to 1.12, P = 0.31). Incidence of hyperthermia was significantly higher in the plastic wrap group as compared to that in the control group (RR = 2.55, 95% CI: 1.56 to 4.15, P = 0.0002). Hyperthermia in the plastic wrap group was resolved within one or two hours after unwrapping the babies. Conclusion Plastic wrap can be considered an effective and safe additional intervention to prevent hypothermia in preterm infants. However, its cost-effectiveness and long-term effect on mortality needs to be ascertained by conducting well-designed studies with longer follow-up period.	[Li, Shaojun; Guo, Pengfei; Tan, Liping] Chongqing Med Univ, Childrens Hosp, Dept Emergency, Chongqing, Peoples R China; [Li, Shaojun; Zou, Qing; Tan, Liping] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Guo, Pengfei; He, Fuxiang; Xu, Feng] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Xu, Feng] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China	Chongqing Medical University	Tan, LP (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Emergency, Chongqing, Peoples R China.; Tan, LP (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.	tanlp0825@hotmail.com	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019					Belsches TC, 2013, PEDIATRICS, V132, pE656, DOI 10.1542/peds.2013-0172; de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Caglar S, 2014, JOGNN-J OBST GYN NEO, V43, P216, DOI 10.1111/1552-6909.12291; Chantaroj Songkiat, 2011, J Med Assoc Thai, V94 Suppl 7, pS32; Cooper BM, 2012, JOGNN-J OBST GYN NEO, V41, P774, DOI 10.1111/j.1552-6909.2012.01401.x; Department of Reproductive Health and Research (RHR) WHO, 1997, WHORHTMSM972 RHR; Doglioni N, 2014, J PEDIATR-US, V165, P261, DOI 10.1016/j.jpeds.2014.04.010; Duman N, 2006, PEDIATR INT, V48, P29, DOI 10.1111/j.1442-200X.2006.02155.x; Flamant C, 2013, J GYNECOL OBST BIO R, V42, P985, DOI 10.1016/j.jgyn.2013.09.020; Harms K, 1994, Z GEBURTSH PERINATOL, V198, P126; HAZAN J, 1991, AM J OBSTET GYNECOL, V164, P111, DOI 10.1016/0002-9378(91)90638-8; Hoehn T, 2008, RESUSCITATION, V78, P7, DOI 10.1016/j.resuscitation.2008.04.027; Kaushal M, 2005, ANN TROP PAEDIATR, V25, P111, DOI 10.1179/146532805X45700; Knobel Robin B, 2005, J Perinatol, V25, P304, DOI 10.1038/sj.jp.7211289; Leadford AE, 2013, PEDIATRICS, V132, pE128, DOI 10.1542/peds.2012-2030; Lunze K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-24; Mannan M A, 2012, Mymensingh Med J, V21, P639; McCall EM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004210.pub3; Nuntnarumit P, 2013, AM J PERINAT, V30, P839, DOI 10.1055/s-0033-1333670; Prasad S, 2013, DM-DIS MON, V59, P196, DOI 10.1016/j.disamonth.2013.03.005; Reilly MC, 2015, J PEDIATR-US, V166, P262, DOI 10.1016/j.jpeds.2014.09.068; Rohana J, 2011, PEDIATR INT, V53, P468, DOI 10.1111/j.1442-200X.2010.03295.x; Simon P, 2011, J PERINATOL, V31, P33, DOI 10.1038/jp.2010.56; Smith J, 2013, NEONATAL NETW, V32, P235, DOI [10.1891/0730-0832.32.4.235, 10.1891/0730-0832.32.1.16]; Trevisanuto D, 2010, J PEDIATR-US, V156, P914, DOI 10.1016/j.jpeds.2009.12.021; Vohra S, 2004, J PEDIATR-US, V145, P750, DOI 10.1016/j.jpeds.2004.07.036; Vohra S, 1999, J PEDIATR-US, V134, P547, DOI 10.1016/S0022-3476(99)70238-6	27	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156960	10.1371/journal.pone.0156960	http://dx.doi.org/10.1371/journal.pone.0156960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281027	gold, Green Submitted, Green Published			2022-12-27	WOS:000377563000060
J	Comblain, F; Dubuc, JE; Lambert, C; Sanchez, C; Lesponne, I; Serisier, S; Henrotin, Y				Comblain, Fanny; Dubuc, Jean-Emile; Lambert, Cecile; Sanchez, Christelle; Lesponne, Isabelle; Serisier, Samuel; Henrotin, Yves			Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract	PLOS ONE			English	Article							CHONDROCYTE HYPERTROPHY; KNEE OSTEOARTHRITIS; ARTICULAR-CARTILAGE; CELLS; MICE; INTERLEUKIN-1-BETA; ANGIOGENESIS; EXPRESSION; MMP-13; GENES	Objective We have previously demonstrated that a mixture of curcuminoids extract, hydrolyzed collagen and green tea extract (COT) inhibited inflammatory and catabolic mediator's synthesis by osteoarthritic human chondrocytes. The objective of this study was to identify new targets of COT using genomic and proteomic approaches. Design Cartilage specimens were obtained from 12 patients with knee osteoarthritis. Primary human chondrocytes were cultured in monolayer until confluence and then incubated for 24 or 48 hours in the absence or in the presence of human interleukin(IL)-1 beta (10(-11)M) and with or without COT, each compound at the concentration of 4 mu g/ml. Microarray gene expression profiling between control, COT, IL-1 beta and COT IL-1 beta conditions was performed. Immunoassays were used to confirm the effect of COT at the protein level. Results More than 4000 genes were differentially expressed between conditions. The key regulated pathways were related to inflammation, cartilage metabolism and angiogenesis. The IL-1 beta stimulated chemokine ligand 6, matrix metalloproteinase-beta, bone morphogenetic protein-2 and stanniocalcin1 gene expressions and protein productions were down-regulated by COT. COT significantly decreased stanniocalcin1 production in basal condition. Serpin E1 gene expression and protein production were down-regulated by IL-1 beta. COT reversed the inhibitory effect of IL-1 beta. Serpin E1 gene expression was up-regulated by COT in control condition. Conclusion The COT mixture has beneficial effect on osteoarthritis physiopathology by regulating the synthesis of key catabolic, inflammatory and angiogenesis factors. These findings give a scientific rationale for the use of these natural ingredients in the management of osteoarthritis.	[Comblain, Fanny; Lambert, Cecile; Sanchez, Christelle; Henrotin, Yves] Univ Liege, Arthropole Liege, Bone & Cartilage Res Unit, CHU Sart Tilman, Liege, Belgium; [Dubuc, Jean-Emile] Clin Univ St Luc, Dept Orthoped, B-1200 Brussels, Belgium; [Lesponne, Isabelle; Serisier, Samuel] Royal Canin Res Ctr, Aimargues, France; [Henrotin, Yves] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Vivalia, Marche En Famen, Belgium	University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Henrotin, Y (corresponding author), Univ Liege, Arthropole Liege, Bone & Cartilage Res Unit, CHU Sart Tilman, Liege, Belgium.; Henrotin, Y (corresponding author), Princess Paola Hosp, Phys Therapy & Rehabil Dept, Vivalia, Marche En Famen, Belgium.	yhenrotin@ulg.ac.be	Serisier, Samuel/AAI-4608-2020	Serisier, Samuel/0000-0002-5702-1350; Henrotin, Yves/0000-0003-1073-449X; sanchez, christelle/0000-0002-1005-8172	Royal Canin SAS	Royal Canin SAS	The research leading to these results was supported by a grant of Royal Canin SAS. Royal Canin SAS gave final approval of the version to be published. FC received her PhD fellow from Royal Canin SAS. IL and SS are employed by Royal Canin SAS. The funder revised the manuscript critically for important intellectual content. The funder gave final approval of the version to be published.	Carter GT, 2014, PHYS MED REH CLIN N, V25, P457, DOI 10.1016/j.pmr.2014.01.007; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Comblain F, 2015, J VET PHARM THER; Comblain F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121654; Davidson ENB, 2015, ANN RHEUM DIS, V74, P1257, DOI 10.1136/annrheumdis-2013-204528; De Ceuninck F, 2004, BIOCHEM BIOPH RES CO, V323, P960, DOI 10.1016/j.bbrc.2004.08.184; EFSA, 2005, EUROPEAN FOOD SAFETY, V174, P1; Hashimoto S, 2013, J BONE JOINT SURG AM, V95A, P1457, DOI 10.2106/JBJS.L.00497; He LF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-39; Henrotin Y, 2011, OSTEOARTHR CARTILAGE, V19, P1, DOI 10.1016/j.joca.2010.10.017; Henrotin Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-56; Henrotin Y, 2014, MATURITAS, V78, P184, DOI 10.1016/j.maturitas.2014.04.015; Henrotin Y, 2014, THER ADV MUSCULOSKEL, V6, P20, DOI 10.1177/1759720X13514669; Henrotin Y, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0361-z; Hochberg MC, 2012, OSTEOARTHR CARTILAGE, V20, P1465, DOI 10.1016/j.joca.2012.07.022; Ko FC, 2016, J ORTHOP RES; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lambert C, 2013, ARTHRITIS RHEUM; Law AYS, 2013, MOL CELL ENDOCRINOL, V374, P73, DOI 10.1016/j.mce.2013.04.024; Leblanc KT, 2015, J CELL PHYSIOL, V230, P440, DOI 10.1002/jcp.24727; Li NG, 2011, CURR MED CHEM, V18, P977, DOI 10.2174/092986711794940905; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Liu Y, 2015, MED SCI MONITOR, V21, P363, DOI 10.12659/MSM.892160; Madej W, 2014, OSTEOARTHR CARTILAGE, V22, P1018, DOI 10.1016/j.joca.2014.04.024; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Mathy-Hartert M, 2008, OSTEOARTHR CARTILAGE, V16, P756, DOI 10.1016/j.joca.2007.10.009; Mathy-Hartert M, 2009, INFLAMM RES, V58, P899, DOI 10.1007/s00011-009-0063-1; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Mobasheri A, 2012, INT J MOL SCI, V13, P4202, DOI 10.3390/ijms13044202; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Ohara H, 2010, BIOSCI BIOTECH BIOCH, V74, P2096, DOI 10.1271/bbb.100193; Pecchi E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4443; Pesesse L, 2014, OSTEOARTHR CARTILAGE, V22, P547, DOI 10.1016/j.joca.2014.01.010; Pesesse L, 2013, OSTEOARTHR CARTILAGE, V21, P1913, DOI 10.1016/j.joca.2013.08.018; Ramos YFM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0528-x; Reynard LN, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.4; Sandell LJ, 2008, OSTEOARTHR CARTILAGE, V16, P1560, DOI 10.1016/j.joca.2008.04.027; Scaife S, 2004, RHEUMATOLOGY, V43, P1346, DOI 10.1093/rheumatology/keh347; Schadow S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053955; Sherwood J, 2014, ANN RHEUM DIS; Walrand S, 2008, J AGR FOOD CHEM, V56, P7790, DOI 10.1021/jf800691f; Wu JB, 2015, ARTERIOSCL THROM VAS, V35, P111, DOI 10.1161/ATVBAHA.114.304554; Wuyts A, 2003, LAB INVEST, V83, P23, DOI 10.1097/01.LAB.0000048719.53282.00; Xu J, 2014, IN VITRO CELL DEV BI; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007	46	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156902	10.1371/journal.pone.0156902	http://dx.doi.org/10.1371/journal.pone.0156902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275599	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700047
J	Mantel, HTJ; Westerkamp, AC; Adam, R; Bennet, WF; Seehofer, D; Settmacher, U; Sanchez-Bueno, F; Prous, JF; Boleslawski, E; Friman, S; Porte, RJ				Mantel, Hendrik T. J.; Westerkamp, Andrie C.; Adam, Rene; Bennet, William F.; Seehofer, Daniel; Settmacher, Utz; Sanchez-Bueno, Francisco; Prous, Joan Fabregat; Boleslawski, Emmanuel; Friman, Styrbjorn; Porte, Robert J.		European Liver Intestine Transplan	Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival	PLOS ONE			English	Article							PERIHILAR CHOLANGIOCARCINOMA; RESECTION; OUTCOMES	Liver transplantation for hilar cholangiocarcinoma (hCCA) has regained attention since the Mayo Clinic reported their favorable results with the use of a neo-adjuvant chemoradiation protocol. However, debate remains whether the success of the protocol should be attributed to the neo-adjuvant therapy or to the strict selection criteria that are being applied. The aim of this study was to investigate the value of patient selection alone on the outcome of liver transplantation for hCCA. In this retrospective study, patients that were transplanted for hCCA between 1990 and 2010 in Europe were identified using the European Liver Transplant Registry (ELTR). Twenty-one centers reported 173 patients (69%) of a total of 249 patients in the ELTR. Twenty-six patients were wrongly coded, resulting in a study group of 147 patients. We identified 28 patients (19%) who met the strict selection criteria of the Mayo Clinic protocol, but had not undergone neo-adjuvant chemoradiation therapy. Five-year survival in this subgroup was 59%, which is comparable to patients with pretreatment pathological confirmed hCCA that were transplanted after completion of the chemoradiation protocol at the Mayo Clinic. In conclusion, although the results should be cautiously interpreted, this study suggests that with strict selection alone, improved survival after transplantation can be achieved, approaching the Mayo Clinic experience.	[Mantel, Hendrik T. J.; Westerkamp, Andrie C.; Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreaticobiliary Surg & Liver Transp, Groningen, Netherlands; [Adam, Rene] Univ Paris 11, Hop Paul Brousse, Dept Hepatobiliary Surg, Villejuif, France; [Bennet, William F.; Friman, Styrbjorn] Univ Gothenburg, Sahlgrenska Univ Hosp, Transplant Inst, Gothenburg, Sweden; [Bennet, William F.; Friman, Styrbjorn] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Seehofer, Daniel] Charite Campus Virchow, Dept Gen Visceral & Transplantat Surg, Berlin, Germany; [Settmacher, Utz] Univ Jena, Dept Gen Visceral & Vasc Surg, Jena, Germany; [Sanchez-Bueno, Francisco] Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg & Liver & Pancreas Transplantat, Murcia, Spain; [Prous, Joan Fabregat] Univ Barcelona, Univ Hosp Bellvitge, Dept Hepatopancreaticobiliary Surg & Liver Transp, Barcelona, Spain; [Boleslawski, Emmanuel] Univ Lille Nord France, Lille Univ Med Ctr, Dept Digest Surg & Transplantat, Lille, France	University of Groningen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; Hospital Clinico Universitario Virgen de la Arrixaca; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Porte, RJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreaticobiliary Surg & Liver Transp, Groningen, Netherlands.	r.j.porte@umcg.nl	Mazzaferro, Vincenzo/C-2726-2017; Citterio, Davide/AAA-6590-2020; Boleslawski, Emmanuel/AAB-9039-2019; Seehofer, Daniel/X-1933-2019; Laurent, Alexis/O-3657-2016; muscari, fabrice/T-1086-2018	Mazzaferro, Vincenzo/0000-0002-4013-8085; Citterio, Davide/0000-0002-0708-8733; Laurent, Alexis/0000-0003-1372-0843; muscari, fabrice/0000-0001-6754-1686				Bismuth H, 2000, LIVER TRANSPLANT, V6, P317, DOI 10.1053/lv.2000.6809; Darwish Murad S, 2012, J AM COLL SURGEONS, V215, DOI [10.1016/1. jarncollsu /8.2012.03.014, DOI 10.1016/1.JARNCOLLSU/8.2012.03.014]; Darwish Murad S, 2012, J AM COLL SURGEONS, V215, P38, DOI [10.1016/1. /8.2012.03.014, DOI 10.1016/1.JARNCOLLSU/8.2012.03.014]; Dinant S, 2006, ANN SURG ONCOL, V13, P872, DOI 10.1245/ASO.2006.05.053; Duignan S, 2014, HPB, V16, P91, DOI 10.1111/hpb.12082; Gleeson FC, 2008, GASTROINTEST ENDOSC, V67, P438, DOI 10.1016/j.gie.2007.07.018; Gomez D, 2014, EJSO-EUR J SURG ONC, V40, P77, DOI 10.1016/j.ejso.2013.10.009; Gores GJ, 2013, DIGEST DIS, V31, P126, DOI 10.1159/000347207; Hassoun Ziad, 2002, Surg Oncol Clin N Am, V11, P909; Heimbach JK, 2004, LIVER TRANSPLANT, V10, pS65, DOI 10.1002/lt.20266; Heimbach JK, 2004, SEMIN LIVER DIS, V24, P201, DOI 10.1055/s-2004-828896; IJitsma AJC, 2004, J GASTROINTEST SURG, V8, P686, DOI 10.1016/j.gassur.2004.04.006; Kipp BR, 2004, AM J GASTROENTEROL, V99, P1675, DOI 10.1111/j.1572-0241.2004.30281.x; Mantel HTJ, 2007, LIVER TRANSPLANT, V13, P1372, DOI 10.1002/lt.21107; Matsuo K, 2012, J AM COLL SURGEONS, V215, P343, DOI 10.1016/j.jamcollsurg.2012.05.025; Meyer CG, 2000, TRANSPLANTATION, V69, P1633; Murakami Y, 2011, ANN SURG ONCOL, V18, P651, DOI 10.1245/s10434-010-1325-4; Neuhaus P, 2012, ANN SURG ONCOL, V19, P1602, DOI 10.1245/s10434-011-2077-5; Nimura Y, 2000, J Hepatobiliary Pancreat Surg, V7, P155, DOI 10.1007/s005340050170; Rea DJ, 2005, ANN SURG, V242, P451, DOI 10.1097/01.sla.0000179678.13285.fa; Salgia RJ, 2014, DIGEST DIS SCI, V59, P1048, DOI 10.1007/s10620-013-2626-9; Sudan D, 2002, AM J TRANSPLANT, V2, P774, DOI 10.1034/j.1600-6143.2002.20812.x; Thelen A, 2007, J HEPATO-BILIARY-PAN, V14, P469, DOI 10.1007/s00534-006-1196-z	23	49	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156127	10.1371/journal.pone.0156127	http://dx.doi.org/10.1371/journal.pone.0156127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276221	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700018
J	Shapira, S; Pleban, S; Kazanov, D; Tirosh, P; Arber, N				Shapira, Shiran; Pleban, Shlomo; Kazanov, Diana; Tirosh, Peter; Arber, Nadir			Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers	PLOS ONE			English	Article							TEA TREE OIL; PERILLYL ALCOHOL; GENE-THERAPY; CD24; COMPONENT; CELLS; L.	Background Terpinen-4-ol, a naturally occurring monoterpene is the main bioactive component of tea-tree oil and has been shown to have many biological activities. Aim To study the antitumor effects of terpinen-4-ol and its mechanism of action in prostate and GI malignancies, alone and in combination with chemotherapeutic and biological agents. Methods Terpinen-4-ol was administrated alone or combined with standard chemotherapy (Oxaliplatin, Fluorouracil, Gemcitabine, Tarceva) and biological agent (Cetuximab). It was also combined with humanized anti-CD24 mAbs (was developed by us). Killing effects were measured qualitatively by light microscopy and quantitatively using the MTT and FACS analysis, following treatment of colorectal, pancreatic, gastric and prostate cancer cells. Terpinen-4-ol effect on tumor development was evaluated in xenograft model. Results Terpinen-4-ol induces a significant growth inhibition of colorectal, pancreatic, prostate and gastric cancer cells in a dose-dependent manner (10-90% in 0.005-0.1%). Terpinen-4-ol and various anti-cancer agents (0.2 mu M oxaliplatin and 0.5 mu M fluorouracil) demonstrated a synergistic inhibitory effect (83% and 91%, respectively) on cancer cell proliferation. In KRAS mutated colorectal cancer cells, which are resistant to anti-EGFR therapy, combining of terpinen-4-ol with cetuximab (1 mu M) resulted in impressive efficacy of 80-90% growth inhibition. Sub-toxic concentrations of terpinen-4-ol potentiate anti-CD24 mAb (150 mu g/ml)-induced growth inhibition (90%). Considerable reduction in tumor volume was seen following terpinen-4-ol (0.2%) treatment alone and with cetuximab (10mg/kg) (40% and 63%, respectively) as compare to the control group. Conclusion Terpinen-4-ol significantly enhances the effect of several chemotherapeutic and biological agents. The possible molecular mechanism for its activity involves induction of cell-death rendering this compound as a potential anti-cancer drug alone and in combination in the treatment of numerous malignancies. Terpinen-4-ol restores the activity of cetuximab in cancers with mutated KRAS.	[Shapira, Shiran; Kazanov, Diana; Arber, Nadir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Mol Biol,Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel; [Pleban, Shlomo; Tirosh, Peter] EMERALD BIO LABS LTD, Netanya, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Arber, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Mol Biol,Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel.	nadir@tlvmc.gov.il		Arber, Nadir/0000-0001-5283-6991	EMERALD BIO-LABS LTD	EMERALD BIO-LABS LTD	EMERALD BIO-LABS LTD provided support in the form of salaries for authors SP & PT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arweiler N B, 2000, Clin Oral Investig, V4, P70, DOI 10.1007/s007840050118; Astani A, 2010, PHYTOTHER RES, V24, P673, DOI 10.1002/ptr.2955; Barra A, 2007, J AGR FOOD CHEM, V55, P7093, DOI 10.1021/jf071129w; Calcabrini A, 2004, J INVEST DERMATOL, V122, P349, DOI 10.1046/j.0022-202X.2004.22236.x; Cha JD, 2007, PHYTOTHER RES, V21, P295, DOI 10.1002/ptr.1864; Da Fonseca CO, 2006, SURG NEUROL, V66, P611, DOI 10.1016/j.surneu.2006.02.034; da Fonseca CO, 2008, SURG NEUROL, V70, P259, DOI 10.1016/j.surneu.2007.07.040; Dryden MS, 2004, J HOSP INFECT, V56, P283, DOI 10.1016/j.jhin.2004.01.008; Dvory-Sobol H, 2005, BIOMED PHARMACOTHER, V59, pS370, DOI 10.1016/S0753-3322(05)80081-2; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gould MN, 1997, ENVIRON HEALTH PERSP, V105, P977, DOI 10.2307/3433313; Greay SJ, 2010, CANCER CHEMOTH PHARM, V65, P877, DOI 10.1007/s00280-009-1093-7; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lim SC, 2005, PATHOL RES PRACT, V201, P479, DOI 10.1016/j.prp.2005.05.004; Lisiansky V, 2012, CANCER GENE THER, V19, P862, DOI 10.1038/cgt.2012.73; Loughlin R, 2008, LETT APPL MICROBIOL, V46, P428, DOI 10.1111/j.1472-765X.2008.02334.x; Martin KW, 2004, MYCOSES, V47, P87, DOI 10.1046/j.1439-0507.2003.00951.x; Mertas A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/590470; Mondello F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-158; Naumov I, 2012, EXP CELL RES, V318, P160, DOI 10.1016/j.yexcr.2011.09.015; Pino JA, 2003, J AGR FOOD CHEM, V51, P3836, DOI 10.1021/jf020733y; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Sagiv Eyal, 2008, Expert Rev Gastroenterol Hepatol, V2, P125, DOI 10.1586/17474124.2.1.125; Shapira S, 2011, GASTROENTEROLOGY, V140, P935, DOI 10.1053/j.gastro.2010.12.004; Sobral Marianna Vieira X AL, 2014, SCI WORLD J, V2014; Suzuki T, 2001, J IMMUNOL, V166, P5567, DOI 10.4049/jimmunol.166.9.5567; Wagner KH, 2003, ANN NUTR METAB, V47, P95, DOI 10.1159/000070030; Wu CS, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/818261	28	44	47	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156540	10.1371/journal.pone.0156540	http://dx.doi.org/10.1371/journal.pone.0156540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275783	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700028
J	van der Lee, A; de Haan, L; Beekman, A				van der Lee, Arnold; de Haan, Lieuwe; Beekman, Aartjan			Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs	PLOS ONE			English	Article							ASSERTIVE COMMUNITY TREATMENT; SEVERE MENTAL-ILLNESS; UNITED-STATES; HEALTH-CARE; SERVICE USE; ADULTS; DISORDERS; ANTIPSYCHOTICS; PEOPLE; RISK	Background Patients with schizophrenia need continuous elective medical care which includes psychiatric treatment, antipsychotic medication and somatic health care. The objective of this study is to assess whether continuous elective psychiatric is associated with less health care costs due to less inpatient treatment. Methods Data concerning antipsychotic medication and psychiatric and somatic health care of patients with schizophrenia in the claims data of Agis Health Insurance were collected over 2008-2011 in the Netherlands. Included were 7,392 patients under 70 years of age with schizophrenia in 2008, insured during the whole period. We assessed the relationship between continuous elective psychiatric care and the outcome measures: acute treatment events, psychiatric hospitalization, somatic care and health care costs. Results Continuous elective psychiatric care was accessed by 73% of the patients during the entire three year follow-up period. These patients received mostly outpatient care and accessed more somatic care, at a total cost of (sic)36,485 in three years, than those without continuous care. In the groups accessing fewer or no years of elective care 34%-68% had inpatient care and acute treatment events, while accessing less somatic care at average total costs of medical care from (sic)33,284 to (sic)64,509. Conclusions Continuous elective mental and somatic care for 73% of the patients with schizophrenia showed better quality of care at lower costs. Providing continuous elective care to the remaining patients may improve health while reducing acute illness episodes.	[van der Lee, Arnold] Zilveren Kruis Achmea, Kennisctr, Leusden, Netherlands; [van der Lee, Arnold; Beekman, Aartjan] VUmc Univ Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [van der Lee, Arnold; Beekman, Aartjan] GGZIngeest, Amsterdam, Netherlands; [de Haan, Lieuwe] UvA, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	van der Lee, A (corresponding author), Zilveren Kruis Achmea, Kennisctr, Leusden, Netherlands.; van der Lee, A (corresponding author), VUmc Univ Med Ctr, Dept Psychiat, Amsterdam, Netherlands.; van der Lee, A (corresponding author), GGZIngeest, Amsterdam, Netherlands.	Arnold.van.der.lee@zilverenkruis.nl			Kenniscentrum, Zilveren Kruis Achmea	Kenniscentrum, Zilveren Kruis Achmea	The funder, "Kenniscentrum, Zilveren Kruis Achmea", provided support in the form of salaries for author AL and data, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111882; Bak M, 2007, SOC PSYCH PSYCH EPID, V42, P125, DOI 10.1007/s00127-006-0147-y; Barkhof E, 2012, EUR PSYCHIAT, V27, P9, DOI 10.1016/j.eurpsy.2011.02.005; Bond GR, 2007, COMMUNITY MENT HLT J, V43, P435, DOI 10.1007/s10597-007-9091-x; Bond GR, 2001, DIS MANAG HEALTH OUT, V9, P141, DOI 10.2165/00115677-200109030-00003; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Burns T, 2009, PSYCHOL MED, V39, P313, DOI 10.1017/S0033291708003747; Chung W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-263; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN P, 1984, ARCH GEN PSYCHIAT, V41, P1178; Correll CU, 2015, WORLD PSYCHIATRY, V14, P119, DOI 10.1002/wps.20204; Couwenberg C, 2014, CROSSING BRIDGE NATL; Crawford MJ, 2004, SOC PSYCH PSYCH EPID, V39, P265, DOI 10.1007/s00127-004-0732-x; Daley C, 2013, HEALTHCARE SYSTEMS N; Dixon L, 1999, PSYCHIATR SERV, V50, P233, DOI 10.1176/ps.50.2.233; Drake R, 2009, SCHIZOPHRENIA B; Drake RE, 2001, PSYCHIATR SERV, V52, P179, DOI 10.1176/appi.ps.52.2.179; Drake RE, 2008, COMMUNITY MENT HLT J, V44, P75, DOI 10.1007/s10597-007-9120-9; Drukker M, 2011, EPIDEMIOL PSYCH SCI, V20, P273, DOI 10.1017/S2045796011000369; Drukker M, 2014, COMMUNITY MENT HLT J, V50, P454, DOI 10.1007/s10597-013-9652-0; Drukker Marjan, 2013, Clin Pract Epidemiol Ment Health, V9, P202, DOI 10.2174/1745017901309010202; Drukker M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-93; Essock SM, 2006, PSYCHIAT SERV, V57, P185, DOI 10.1176/appi.ps.57.2.185; Falloon I, 2004, WORLD PSYCHIAT OFFIC, V3; Fiander M, 2003, BRIT J PSYCHIAT, V182, P248, DOI 10.1192/bjp.182.3.248; Fontanella CA, 2014, ADM POLICY MENT HLTH, V41, P572, DOI 10.1007/s10488-013-0500-x; Garcia-Cabeza I, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-7; Guada JM, 2010, SCHIZOPHR RES, V117, P407, DOI 10.1016/j.schres.2010.02.745; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hastrup LH, 2015, NORD J PSYCHIAT, V69, P110, DOI 10.3109/08039488.2014.936500; Hermes EDA, 2013, PSYCHIAT SERV, V64, P238, DOI 10.1176/appi.ps.201200183; Hoertel N, 2014, EUR PSYCHIAT, V29, P358, DOI 10.1016/j.eurpsy.2013.12.001; Hoertel N, 2014, J CLIN PSYCHIAT, V75, P231, DOI 10.4088/JCP.13m08424; Ising H, 2014, COST EFFECTIVENESS P, DOI [10.1017/S0033291714002530, DOI 10.1017/S0033291714002530]; Johnson S, 1997, SOC PSYCH PSYCH EPID, DOI [10.1007/BF00794612, DOI 10.1007/BF00794612]; Katon W, 2001, GEN HOSP PSYCHIAT, V23, P138, DOI 10.1016/S0163-8343(01)00136-0; Kilbourne AM, 2014, CONTEMP CLIN TRIALS, V39, P74, DOI 10.1016/j.cct.2014.07.007; Laan W, 2010, PHARMACOPSYCHIATRY, V43, P221, DOI 10.1055/s-0030-1254090; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P11, DOI 10.1093/oxfordjournals.schbul.a033303; Linszen D, 2008, SCHIZOPHR RES, V102, P258, DOI [10.1016/S0920-9964(08)70776-X, DOI 10.1016/S0920-9964(08)70776-X]; Ministry of Public Health Welfare and Sport, 2016, HEALTHC NETH; Mojtabai R, 2005, AM J PUBLIC HEALTH, V95, P2009, DOI 10.2105/AJPH.2003.037630; Mojtabai R, 2011, PSYCHOL MED, V41, P1751, DOI 10.1017/S0033291710002291; Morken G, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-32; Mueser KT, 2003, BEHAV MODIF, V27, P387, DOI 10.1177/0145445503027003007; Norden Tommy, 2012, Clin Pract Epidemiol Ment Health, V8, P144, DOI 10.2174/1745017901208010144; Obradovic M, 2007, INT J CLIN PRACT, V61, P1979, DOI 10.1111/j.1742-1241.2007.01431.x; Raucher-Chene D, 2015, INT PSYCHOGERIATR, V27, P1749, DOI 10.1017/S1041610215001064; Reilly S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009531.pub2; Reilly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036468; Sareen J, 2007, PSYCHIAT SERV, V58, P357, DOI 10.1176/appi.ps.58.3.357; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Sernyak MJ, 2008, PSYCHIAT SERV, V59, P567, DOI 10.1176/ps.2008.59.5.567; Singer SJ, 2011, MED CARE RES REV, V68, P112, DOI 10.1177/1077558710371485; Smeets HM, 2011, J CLIN EPIDEMIOL, V64, P424, DOI 10.1016/j.jclinepi.2010.04.023; Sytema S, 2007, ACTA PSYCHIAT SCAND, V116, P105, DOI 10.1111/j.1600-0447.2007.01021.x; Tenback D, 2012, J CLIN PSYCHOPHARM, V32, P31, DOI 10.1097/JCP.0b013e31823f3c43; Termorshuizen F, 2012, SCHIZOPHR RES, V138, P268, DOI 10.1016/j.schres.2012.03.035; Thornicroft G, 2004, BRIT J PSYCHIAT; Van Duin D, 2013, INT J QUAL HEALTH C, V25, P626, DOI 10.1093/intqhc/mzt072; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; Viron M, 2010, PSYCHOSOMATICS; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Westra D, 2016, HEALTH POLICY, V120, P345, DOI 10.1016/j.healthpol.2016.02.014; Wiersma D, 1998, SCHIZOPHRENIA BULL, V24, P75, DOI 10.1093/oxfordjournals.schbul.a033315; Wunderink L, 2007, J CLIN PSYCHIAT, V68, P654, DOI 10.4088/JCP.v68n0502	68	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157150	10.1371/journal.pone.0157150	http://dx.doi.org/10.1371/journal.pone.0157150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27275609	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700075
J	Chen, YP; Cossman, J; Jayasuriya, CT; Li, X; Guan, YJ; Fonseca, V; Yang, K; Charbonneau, C; Yu, HC; Kanbe, K; Ma, P; Darling, E; Chen, Q				Chen, Yupeng; Cossman, Jack; Jayasuriya, Chathuraka T.; Li, Xin; Guan, Yingjie; Fonseca, Vera; Yang, Kun; Charbonneau, Cherie; Yu, Hongchuan; Kanbe, Katsuaki; Ma, Peter; Darling, Eric; Chen, Qian			Deficient Mechanical Activation of Anabolic Transcripts and Post-Traumatic Cartilage Degeneration in Matrilin-1 Knockout Mice	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; MATRIX PROTEIN; CHONDROCYTE DIFFERENTIATION; COLLAGEN-II; IN-SITU; OSTEOARTHRITIS; ORGANIZATION; PROGRESSION; MATURATION; AGGRECAN	Matrilin-1 (Matn1), a cartilage-specific peri-cellular and extracellular matrix (ECM) protein, has been hypothesized to regulate ECM interactions and transmit mechanical signals in cartilage. Since Matn1 knock-out (Matn1(-/-)) mice exhibit a normal skeleton, its function in vivo is unclear. In this study, we found that the anabolic Acan and Col2a transcript levels were significantly higher in wildtype (Matn1(+/+)) mouse cartilage than that of MATN1(-/-) mice in vivo. However, such difference was not observed between Matn1(+/+) and MATN1(-/-) chondrocytes cultured under stationary conditions in vitro. Cyclic loading significantly stimulated Acan and Col2a transcript levels in Matn1(+/+) but not in MATN1(-/-) chondrocytes. This suggests that, while Matn1(+/+) chondrocytes increase their anabolic gene expression in response to mechanical loading, the MATN1(-/-) chondrocytes fail to do so because of the deficiency in mechanotransduction. We also found that altered elastic modulus of cartilage matrix in Matn1(-/-) mice, suggesting the mechanotransduction has changed due to the deficiency of Matn1. To understand the impact of such deficiency on joint disease, mechanical loading was altered in vivo by destabilization of medial meniscus. While Matn1(+/+) mice exhibited superficial fissures and clefts consistent with mechanical damage to the articular joint, Matn1(-/-) mice presented more severe cartilage lesions characterized by proteoglycan loss and disorganization of cells and ECM. This suggests that Matn1 deficiency affects pathogenesis of post-traumatic osteoarthritis by failing to up-regulate anabolic gene expression. This is the first demonstration of Matn1 function in vivo, which suggests its protective role in cartilage degeneration under altered mechanical environment.	[Chen, Yupeng; Yu, Hongchuan; Chen, Qian] Xi An Jiao Tong Univ, Bone & Joint Res Ctr, Affiliated Hosp 1, Xian 710061, Peoples R China; [Chen, Yupeng; Yu, Hongchuan; Chen, Qian] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710061, Peoples R China; [Chen, Yupeng; Cossman, Jack; Jayasuriya, Chathuraka T.; Li, Xin; Guan, Yingjie; Yang, Kun; Charbonneau, Cherie; Yu, Hongchuan; Darling, Eric; Chen, Qian] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02903 USA; [Chen, Yupeng; Cossman, Jack; Jayasuriya, Chathuraka T.; Li, Xin; Guan, Yingjie; Yang, Kun; Charbonneau, Cherie; Yu, Hongchuan; Darling, Eric; Chen, Qian] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA; [Fonseca, Vera; Darling, Eric] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Kanbe, Katsuaki] Tokyo Womens Med Univ, Dept Orthopaed Surg, Med Ctr East, Tokyo, Japan; [Ma, Peter] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Darling, Eric] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Tokyo Women's Medical University; University of Michigan System; University of Michigan; Brown University	Chen, YP; Chen, Q (corresponding author), Xi An Jiao Tong Univ, Bone & Joint Res Ctr, Affiliated Hosp 1, Xian 710061, Peoples R China.; Chen, YP; Chen, Q (corresponding author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710061, Peoples R China.; Chen, YP; Chen, Q (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02903 USA.; Chen, YP; Chen, Q (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA.	Yupeng_Chen@Brown.edu; Qian_Chen@Brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; Jayasuriya, Chathuraka/0000-0002-2705-0679; LI, XIN/0000-0003-0003-8554; Darling, Eric/0000-0002-3932-8623	NIH [P20 GM104937, P30GM103410]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR069383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937, P30GM103410] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH (P20 GM104937, P30GM103410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Chen ZJ, 2009, EUR J HUM GENET, V17, P525, DOI 10.1038/ejhg.2008.203; Coles JM, 2008, J BIOMECH, V41, P541, DOI 10.1016/j.jbiomech.2007.10.013; Darling EM, 2010, BIOPHYS J, V98, P2848, DOI 10.1016/j.bpj.2010.03.037; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Fleming BC, 2015, KNEE SURG SPORT TR A, V23, P1161, DOI 10.1007/s00167-014-2932-6; Fresquet M, 2010, J BIOL CHEM, V285, P34048, DOI 10.1074/jbc.M110.154443; Fujisawa T, 1999, J BIOCHEM-TOKYO, V125, P966, DOI 10.1093/oxfordjournals.jbchem.a022376; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; Kanbe K, 2007, J BONE MINER RES, V22, P318, DOI 10.1359/JBMR.061104; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Natoli RM, 2009, BIORHEOLOGY, V46, P451, DOI 10.3233/BIR-2009-0554; Neacsu CD, 2014, J BIOL CHEM, V289, P1505, DOI 10.1074/jbc.M113.529933; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; Nordenvall R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104681; Okimura A, 1997, ARTHRITIS RHEUM, V40, P1029, DOI 10.1002/art.1780400606; PAULSSON M, 1982, BIOCHEM J, V207, P207, DOI 10.1042/bj2070207; Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Yang Xu, 2006, J Orthop Surg Res, V1, P15, DOI 10.1186/1749-799X-1-15	29	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156676	10.1371/journal.pone.0156676	http://dx.doi.org/10.1371/journal.pone.0156676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270603	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000028
J	Durnez, W; Van Damme, S				Durnez, Wouter; Van Damme, Stefaan			No Evidence for Threat-Induced Spatial Prioritization of Somatosensory Stimulation during Pain Control Using a Synchrony Judgment Paradigm	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENTS; CATASTROPHIZING SCALE; ATTENTION	Topical research efforts on attention to pain often take a critical look at the modulatory role of top-down factors. For instance, it has been shown that the fearful expectation of pain at a location of the body directs attention towards that body part. In addition, motivated attempts to control this pain were found to modulate this prioritization effect. Such studies have often used a temporal order judgment task, requiring participants to judge the order in which two stimuli are presented by indicating which one they perceived first. As this constitutes a forced-choice response format, such studies may be subject to response bias. The aim of the current study was to address this concern. We used a ternary synchrony judgment paradigm, in which participants judged the order in which two somatosensory stimuli occurred. Critically, participants now also had the option to give a `simultaneous' response when they did not perceive a difference. This way we eliminated the need for guessing, and thus reduced the risk of response bias. One location was threatened with the possibility of pain in half of the trials, as predicted by an auditory cue. Additionally, half of the participants (pain control group) were encouraged to avoid pain stimuli by executing a quick button press. The other half (comparison group) performed a similar action, albeit unrelated to the occurrence of pain. Our data did not support threat-induced spatial prioritization, nor did we find evidence that pain control attempts influenced attention in any way.	[Durnez, Wouter; Van Damme, Stefaan] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Van Damme, S (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Stefaan.VanDamme@UGent.be	Van Damme, Stefaan/D-3500-2012	Van Damme, Stefaan/0000-0003-0347-1855; Durnez, Wouter/0000-0001-8045-8801	Research Foundation Flanders (FWO) [3G005611]; Ghent University (Special Research Fund) [BOF11/STA/004]	Research Foundation Flanders (FWO)(FWO); Ghent University (Special Research Fund)(Ghent University)	This work was supported by Research Foundation Flanders (FWO; Grant 3G005611) and by Ghent University (Special Research Fund; Grant BOF11/STA/004).	Alcala-Quintana R, 2013, BEHAV RES METHODS, V45, P972, DOI 10.3758/s13428-013-0325-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bulcke CV, 2014, ACTA PSYCHOL, V153, P113, DOI 10.1016/j.actpsy.2014.09.014; De Paepe AL, 2014, NEUROPSYCHOLOGIA, V56, P219, DOI 10.1016/j.neuropsychologia.2014.01.016; De Ruddere L, 2013, PAIN, V154, P669, DOI 10.1016/j.pain.2012.12.018; Durnez W, 2017, PSYCHOL RES-PSYCH FO, V81, P309, DOI 10.1007/s00426-015-0712-7; Durnez W, 2015, J PAIN, V16, P135, DOI 10.1016/j.jpain.2014.10.012; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; HOLM S, 1979, SCAND J STAT, V6, P65; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; Notebaert L, 2011, PAIN, V152, P1068, DOI 10.1016/j.pain.2011.01.020; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Schrooten MGS, 2012, PAIN MANAG, V2, P141, DOI [10.2217/PMT.12.2, 10.2217/pmt.12.2]; Spence C, 2003, PERCEPT PSYCHOPHYS, V65, P318, DOI 10.3758/BF03194803; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Van Damme S, 2012, PAIN, V153, P1226, DOI 10.1016/j.pain.2012.02.027; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Van Damme S, 2009, BRAIN RES, V1253, P100, DOI 10.1016/j.brainres.2008.11.072; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; Van Hulle L, 2015, PERCEPT MOTOR SKILL, V120, P219, DOI 10.2466/24.PMS.120v13x1; Van Hulle L, 2013, EXP BRAIN RES, V224, P295, DOI 10.1007/s00221-012-3311-5; Vanden Bulcke C, 2013, PAIN, V154, P1464, DOI 10.1016/j.pain.2013.05.009; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; WEINSTEIN SIDNEY, 1968, P195; Wiech K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00046; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zampini M, 2007, NEUROSCI LETT, V414, P75, DOI 10.1016/j.neulet.2006.12.006	32	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156648	10.1371/journal.pone.0156648	http://dx.doi.org/10.1371/journal.pone.0156648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27270456	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000027
J	Hughes, RCE; Williman, J; Gullam, JE				Hughes, R. C. E.; Williman, J.; Gullam, J. E.			Universal HbA1c Measurement in Early Pregnancy to Detect Type 2 Diabetes Reduces Ethnic Disparities in Antenatal Diabetes Screening: A Population-Based Observational Study	PLOS ONE			English	Article							MELLITUS; HBA(1C); WOMEN; RISK	In response to the type 2 diabetes epidemic, measuring HbA1c with the first-antenatal blood screen was recently recommended in NZ. This would enable prompt treatment of women with unrecognised type 2 diabetes, who may otherwise go undetected until the gestational diabetes (GDM) screen. We compare inter-ethnic antenatal screening practices to examine whether the HbA1c test would be accessed by ethnicities most at risk of diabetes, and we determined the prevalence of unrecognised type 2 diabetes and prediabetes in our pregnant population. This is an observational study of pregnancies in Christchurch NZ during 2008-2010. Utilising electronic databases, we matched maternal characteristics to first-antenatal bloods, HbA1c, and GDM screens (glucose challenge tests and oral glucose tolerance tests). Overall uptake of the first-antenatal bloods versus GDM screening was 83.1% and 53.8% respectively in 11,580 pregnancies. GDM screening was lowest in Maori 39.3%, incidence proportion ratio (IPR) 0.77 (0.71, 0.84) compared with Europeans. By including HbA1c with the first-antenatal bloods, the number screened for diabetes increases by 28.5% in Europeans, 40.0% in Maori, 28.1% in Pacific People, and 26.7% in 'Others' (majority of Asian descent). The combined prevalence of unrecognised type 2 diabetes and prediabetes by NZ criteria, HbA1c >= 5.9% (41mmol/mol), was 2.1% in Europeans, Maori 4.7% IPR 2.59 (1.71, 3.93), Pacific People 9.5% IPR 4.76 (3.10, 7.30), and 'Others' 6.2% IPR 2.99 (2.19, 4.07). Applying these prevalence data to 2013 NZ national births data, routine antenatal HbA1c testing could have identified type 2 diabetes in 0.44% and prediabetes in 3.96% of women. Routine HbA1c measurement in early pregnancy is an ideal screening opportunity, particularly benefitting vulnerable groups, reducing ethnic disparities in antenatal diabetes screening. This approach is likely to have world-wide relevance and applicability. Further research is underway to establish whether, as for type 2 diabetes, prompt treatment of prediabetes improves pregnancy and neonatal outcomes.	[Hughes, R. C. E.; Gullam, J. E.] Univ Otago, Dept Obstet & Gynaecol, Christchurch Womens Hosp, Christchurch, New Zealand; [Williman, J.] Univ Otago, Christchurch Sch Med, Biostat & Computat Biol Unit, Christchurch, New Zealand	University of Otago; University of Otago	Hughes, RCE (corresponding author), Univ Otago, Dept Obstet & Gynaecol, Christchurch Womens Hosp, Christchurch, New Zealand.	Ruth.Hughes@cdhb.health.nz	Williman, Jonathan/E-8206-2016	Williman, Jonathan/0000-0001-5080-4435				[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Best Practice Advocacy Centre New Zealand, 2014, ANT TEST PREGN; Blatt AJ, 2011, OBSTET GYNECOL, V117, P61, DOI 10.1097/AOG.0b013e3181fe424b; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; Donovan LE, 2016, DIABETES CARE, V39, P55, DOI 10.2337/dc15-1421; Hughes RCE, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0698-y; Hughes RCE, 2014, DIABETES CARE, V37, P2953, DOI 10.2337/dc14-1312; International Diabetes Federation, 2015, INT DIAB FED DIAB AT; Jefferies Craig, 2012, Pediatr Diabetes, V13, P294, DOI 10.1111/j.1399-5448.2012.00851.x; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; McGrath NM, 2014, DIABETIC MED, V31, P1277, DOI 10.1111/dme.12519; New Zealand Ministry of Health, 2014, SCREEN DIAGN MAN GES; Ninth Annual Report of the Perinatal and Maternal Mortality Review Committee, 2015, 9 ANN REP PER MAT MO; Perinatal and Maternal Mortality Review Committee, 2013, EX SUMM 9 ANN REP PE; R Core Team, 2013, R LANG ENV STAT COMP; Rowan JA, 2016, DIABETIC MED, V33, P25, DOI 10.1111/dme.12812; Tierney M, 2015, DIABETOLOGIA, V58, P2486, DOI 10.1007/s00125-015-3713-6; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yapa M, 2000, DIABETES RES CLIN PR, V48, P217, DOI 10.1016/S0168-8227(99)00150-3; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	20	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156926	10.1371/journal.pone.0156926	http://dx.doi.org/10.1371/journal.pone.0156926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272760	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000049
J	Tiruneh, YM; Galarraga, O; Genberg, B; Wilson, IB				Tiruneh, Yordanos M.; Galarraga, Omar; Genberg, Becky; Wilson, Ira B.			Retention in Care among HIV-Infected Adults in Ethiopia, 2005-2011: A Mixed-Methods Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PATIENT RETENTION; TREATMENT PROGRAM; HERBAL MEDICINE; EARLY MORTALITY; FOLLOW-UP; ADHERENCE; BARRIERS; PREDICTORS; INITIATION	Background Poor retention in HIV care challenges the success of antiretroviral therapy (ART). This study assessed how well patients stay in care and explored factors associated with retention in the context of an initial ART rollout in Sub-Saharan Africa. Methods We conducted a mixed-methods study at a teaching hospital in Addis Ababa, Ethiopia. A cohort of 385 patients was followed for a median of 4.6 years from ART initiation to lost-to-follow- up (LTFU-missing appointments for more than three months after last scheduled visit or administrative censoring). We used Kaplan-Meier plots to describe LTFU over time and Cox-regression models to identify factors associated with being LTFU. We held six focus group discussions, each with 6-11 patients enrolled in care; we analyzed data inductively informed by grounded theory. Results Patients in the cohort were predominantly female (64%) and the median age was 34 years. Thirty percent were LTFU by study's end; the median time to LTFU was 1,675 days. Higher risk of LTFU was associated with baseline CD4 counts <100 and >200 cells/mu L (HR = 1.62; 95% CI: 1.03-2.55; and HR = 2.06; 95% CI: 1.15-3.70, respectively), compared with patients with baseline CD4 counts of 100-200 cells/mu L. Bedridden participants at ART initiation (HR = 2.05; 95% CIs [1.11-3.80]) and those with no or only primary education (HR = 1.50; 95% CIs [1.00-2.24]) were more likely to be LTFU. Our qualitative data revealed that fear of stigma, care dissatisfaction, use of holy water, and economic constraints discouraged retention in care. Social support and restored health and functional ability motivated retention. Conclusion Complex socio-cultural, economic, and health-system factors inhibit optimum patient retention. Better tracking, enhanced social support, and regular adherence counseling addressing stigma and alternative healing options are needed. Intervention strategies aimed at changing clinic routines and improving patient-provider communication could address many of the identified barriers.	[Tiruneh, Yordanos M.; Galarraga, Omar; Genberg, Becky; Wilson, Ira B.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA	Brown University	Tiruneh, YM (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA.	yordanos_tiruneh@brown.edu	Galarraga, Omar/N-1622-2019	Galarraga, Omar/0000-0002-9985-9266; Genberg, Becky/0000-0002-9450-5311; Tiruneh, Yordanos/0000-0001-9296-9908	department of Sociology; Graduate School of Northwestern University; Agency for Healthcare Research and Quality [T32HS000011]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH092242, K01MH099966] Funding Source: NIH RePORTER	department of Sociology; Graduate School of Northwestern University; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the department of Sociology and The Graduate School of Northwestern University, and by grant number T32HS000011 from the Agency for Healthcare Research and Quality.	Abdulwadud O, 2011, ETHIOP J HEALTH DEV, V25, P110; Ahmed I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-867; Alvarez-Uria G, 2013, FACTORS ASS ATTRITIO, P6; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Assefa Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-45; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Balcha TT, 2011, J INT ASS PHYS AIDS; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Bezabhe WM, 2014, BARRIERS FACILITATOR; Bhatta L, 2006, BMC INFECT DIS; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Buchberg MK, 2015, AIDS PATIENT CARE ST, V29, P126, DOI 10.1089/apc.2014.0227; Catz SL, 1999, AIDS CARE, V11, P361, DOI 10.1080/09540129947983; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; Dessalegn M., 2015, J AIDS HIV RES, V7, P1, DOI DOI 10.5897/JAHR2014.0315; Edwards JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102305; Federal Ministry of Health, 2007, GUID PREV MOTH TO CH; Federal Ministry of Health, 2008, GUID MAN OPP INF ANT; Federal Ministry of Health (F-MOH), 2007, GUID IMPL ANT THER P; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Holtzman CW, 2015, AIDS CARE, V27, P817, DOI 10.1080/09540121.2015.1009362; Hsiao AF, 2003, JAIDS-J ACQ IMM DEF, V33, P157, DOI 10.1097/00126334-200306010-00007; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jones DL, 2013, J ASSOC NURSE AIDS C, V24, pE1, DOI 10.1016/j.jana.2012.06.009; Kalichman SC, 2011, ANN BEHAV MED, V42, P111, DOI 10.1007/s12160-011-9271-3; Kloos H, 2013, ETHIOP J HEALTH DEV, V27, P141; Kulkarni S, 2015, J INT ASS PROVIDERS; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Levinson W, 2010, HEALTH AFFAIR, V29, P1310, DOI 10.1377/hlthaff.2009.0450; Lifson Alan R, 2013, J Int Assoc Provid AIDS Care, V12, P32, DOI 10.1177/1545109712456428; Mallinson RK, 2007, AIDS PATIENT CARE ST, V21, pS77, DOI 10.1089/apc.2007.9984; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Mugisha V, 2014, PLOS ONE, V9; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Namuddu B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-855; Rao Kavitha C, 2013, J Int Assoc Provid AIDS Care, V12, P178, DOI 10.1177/2325957412472058; Rathert C, 2012, MED CARE RES REV; Relf MV, 2015, J ASSOC NURSE AIDS C, V26, P36, DOI 10.1016/j.jana.2014.03.003; Robinson JH, 2008, J AM ACAD NURSE PRAC, V20, P600, DOI 10.1111/j.1745-7599.2008.00360.x; Sabin LL, 2008, AIDS CARE, V20, P1242, DOI 10.1080/09540120801918651; Schoni-Affolter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027919; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Strauss A., 1998, BASICS QUALITATIVE R; Tadele A., 2014, J AIDS CLIN RES; Tiruneh YM., 2012, INTERNATIONAL PUBLIC, V4, P403; Tsegaye E, 2011, ETHIOPIAN J HLTH DEV, V25; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629; WUBSHET M, 2012, AIDS, V2012, P1, DOI DOI 10.5402/2012/721720; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197; Yang GLL, 2015, ASIA-PAC J PUBLIC HE, V27, p86S, DOI 10.1177/1010539514548758; Yehia BR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0990-0	67	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156619	10.1371/journal.pone.0156619	http://dx.doi.org/10.1371/journal.pone.0156619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272890	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000024
J	Huang, LF; Lin, KH; He, SL; Chen, JL; Jiang, JZ; Chen, BH; Hou, YS; Chen, RS; Hong, CY; Ho, SL				Huang, Li-Fen; Lin, Kuan-Hung; He, Siou-Luan; Chen, Jyh-Lang; Jiang, Jian-Zhi; Chen, Bo-Hong; Hou, Yi-Syuan; Chen, Ruey-Shyang; Hong, Chwan-Yang; Ho, Shin-Lon			Multiple Patterns of Regulation and Overexpression of a Ribonuclease-Like Pathogenesis-Related Protein Gene, OsPR10a, Conferring Disease Resistance in Rice and Arabidopsis	PLOS ONE			English	Article							STARVATION-INDUCED RIBONUCLEASE; DEFENSE-RELATED PROTEINS; BIRCH POLLEN ALLERGEN; AMINO-ACID-SEQUENCE; BET V 1; PHOSPHATE-STARVATION; PROTEOMIC ANALYSIS; MOLECULAR CHARACTERIZATION; SELF-INCOMPATIBILITY; DISULFIDE BONDS	An abundant 17 kDa RNase, encoded by OsPR10a (also known as PBZ1), was purified from Pi-starved rice suspension-cultured cells. Biochemical analysis showed that the range of optimal temperature for its RNase activity was 40-70 degrees C and the optimum pH was 5.0. Disulfide bond formation and divalent metal ion Mg2+ were required for the RNase activity. The expression of OsPR10a::GUS in transgenic rice was induced upon phosphate (Pi) starvation, wounding, infection by the pathogen Xanthomonas oryzae pv. oryzae (Xoo), leaf senescence, anther, style, the style-ovary junction, germinating embryo and shoot. We also provide first evidence in whole-plant system, demonstrated that OsPR10a-overexpressing in rice and Arabidopsis conferred significant level of enhanced resistance to infection by the pathogen Xoo and Xanthomona campestris pv. campestris (Xcc), respectively. Transgenic rice and Arabidopsis overexpressing OsPR10a significantly increased the length of primary root under phosphate deficiency (-P-i) condition. These results showed that OsPR10a might play multiple roles in phosphate recycling in phosphate-starved cells and senescing leaves, and could improve resistance to pathogen infection and/or against chewing insect pests. It is possible that Pi acquisition or homeostasis is associated with plant disease resistance. Our findings suggest that gene regulation of OsPR10a could act as a good model system to unravel the mechanisms behind the correlation between Pi starvation and plant-pathogen interactions, and also provides a potential application in crops disease resistance.	[Huang, Li-Fen] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Jhongli, Taiwan; [Lin, Kuan-Hung] Chinese Culture Univ, Dept Hort & Biotechnol, Taipei, Taiwan; [He, Siou-Luan] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Chen, Jyh-Lang] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Jiang, Jian-Zhi; Chen, Bo-Hong; Ho, Shin-Lon] Natl Chiayi Univ, Dept Agron, Chiayi 60004, Taiwan; [Hou, Yi-Syuan] Natl Chiayi Univ, Dept Plant Med, Chiayi 60004, Taiwan; [Chen, Ruey-Shyang] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 60004, Taiwan; [Hong, Chwan-Yang] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan; [Chen, Jyh-Lang] Taipei Municipal Dazhi High Sch, Taipei, Taiwan	Yuan Ze University; Chinese Culture University; National Taiwan University; National Taiwan Normal University; National Chiayi University; National Chiayi University; National Chiayi University; National Taiwan University	Ho, SL (corresponding author), Natl Chiayi Univ, Dept Agron, Chiayi 60004, Taiwan.	slho@mail.ncyu.edu.tw	Hong, Chwan-Yang/AAI-6999-2020		Ministry of Science and Technology of the Republic of China [NSC-93-2311-B-415-002, MOST-104-2313-B-415-003]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from the Ministry of Science and Technology of the Republic of China (https://www.most.gov.tw/). The grant numbers are NSC-93-2311-B-415-002 and MOST-104-2313-B-415-003. Both grants' recipient is: Dr. Shin-Lon Ho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1987, PLANTA, V172, P71, DOI 10.1007/BF00403030; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Chakraborty J, 2011, J BIOMOL STRUCT DYN, V29, P67, DOI 10.1080/07391102.2011.10507375; Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037654; Chen Z, 2004, PLANT MOL BIOL, V55, P83, DOI 10.1007/s11103-004-0438-1; Cheng ZY, 2015, NATURE, V521, P213, DOI 10.1038/nature14243; Choi C, 2015, NEW PHYTOL, V208, P846, DOI 10.1111/nph.13516; Choi DS, 2012, PLANT CELL, V24, P1675, DOI 10.1105/tpc.112.095869; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; DICKINSON H G, 1990, Bioessays, V12, P155, DOI 10.1002/bies.950120403; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gallie DR, 2002, PLANT CELL TISS ORG, V68, P163, DOI 10.1023/A:1013818117026; Graham MY, 2003, PHYSIOL MOL PLANT P, V63, P141, DOI 10.1016/j.pmpp.2003.11.002; HARING V, 1990, SCIENCE, V250, P937, DOI 10.1126/science.2237440; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; Ho SL, 2013, PLANT MOL BIOL, V81, P347, DOI 10.1007/s11103-012-0006-z; Ho SL, 2000, PLANT PHYSIOL, V122, P57, DOI 10.1104/pp.122.1.57; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Hwang SH, 2008, PLANTA, V227, P1141, DOI 10.1007/s00425-007-0687-8; JOST W, 1991, EUR J BIOCHEM, V198, P1, DOI 10.1111/j.1432-1033.1991.tb15978.x; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kim ST, 2008, J PROTEOME RES, V7, P1750, DOI 10.1021/pr700878t; Kim ST, 2008, PLANT CELL REP, V27, P593, DOI 10.1007/s00299-007-0485-6; Klaas M, 2011, ANN BOT-LONDON, V108, P677, DOI 10.1093/aob/mcr186; Kock M, 1998, PLANTA, V204, P404, DOI 10.1007/s004250050273; Kock M, 2006, J EXP BOT, V57, P3717, DOI 10.1093/jxb/erl124; Lebel S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-184; Lei Mingguang, 2011, Plant Physiol, V156, P1116, DOI 10.1104/pp.110.171736; Liu JJ, 2005, PLANTA, V221, P159, DOI 10.1007/s00425-004-1428-x; Liu JJ, 2003, PHYSIOL PLANTARUM, V119, P544, DOI 10.1046/j.1399-3054.2003.00200.x; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; LOFFLER A, 1993, EUR J BIOCHEM, V214, P627, DOI 10.1111/j.1432-1033.1993.tb17962.x; LOFFLER A, 1992, PLANT PHYSIOL, V98, P1472, DOI 10.1104/pp.98.4.1472; Ma JF, 2001, PLANT PHYSIOL, V127, P1773, DOI 10.1104/pp.010271; MASCARENHAS JP, 1993, PLANT CELL, V5, P1303, DOI 10.1105/tpc.5.10.1303; McGhee JD, 2001, MOL PLANT MICROBE IN, V14, P877, DOI 10.1094/MPMI.2001.14.7.877; Midoh N, 1996, PLANT CELL PHYSIOL, V37, P9, DOI 10.1093/oxfordjournals.pcp.a028918; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashita H, 2002, PLANT CELL PHYSIOL, V43, P823, DOI 10.1093/pcp/pcf097; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Ravichandran S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-107; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; SIMPSON RB, 1990, MOL PLANT MICROBE IN, V3, P233, DOI 10.1094/MPMI-3-233; Singer SD, 2012, PLANT CELL REP, V31, P13, DOI 10.1007/s00299-011-1167-y; Takeuchi K, 2011, PLANT CELL PHYSIOL, V52, P1686, DOI 10.1093/pcp/pcr105; Tanaka N, 2000, J MOL BIOL, V298, P859, DOI 10.1006/jmbi.2000.3707; Tran HT, 2008, PROTEOMICS, V8, P4317, DOI 10.1002/pmic.200800292; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Tsay YG, 2005, ANAL BIOCHEM, V339, P83, DOI 10.1016/j.ab.2004.12.031; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; WILSON CM, 1975, ANNU REV PLANT PHYS, V26, P187, DOI 10.1146/annurev.pp.26.060175.001155; Xie YR, 2010, J PLANT PHYSIOL, V167, P121, DOI 10.1016/j.jplph.2009.07.004; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067413; Yan QJ, 2008, PLANT PHYSIOL BIOCH, V46, P93, DOI 10.1016/j.plaphy.2007.10.002; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Zhou XJ, 2002, PLANT SCI, V162, P629, DOI 10.1016/S0168-9452(02)00002-X	75	26	27	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156414	10.1371/journal.pone.0156414	http://dx.doi.org/10.1371/journal.pone.0156414			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258121	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700062
J	Inskip, M; Mavros, Y; Sachdev, PS; Singh, MAF				Inskip, Michael; Mavros, Yorgi; Sachdev, Perminder S.; Singh, Maria A. Fiatarone			Exercise for Individuals with Lewy Body Dementia: A Systematic Review	PLOS ONE			English	Review							MINIMAL DETECTABLE CHANGE; DISEASE RATING-SCALE; PARKINSONS-DISEASE; COGNITIVE IMPAIRMENT; PEOPLE; GAIT; BODIES; RELIABILITY; VALIDATION; GUIDELINES	Background Individuals with Lewy body Dementia (LBD), which encompasses both Parkinson disease dementia (PDD) and Dementia with Lewy Bodies (DLB) experience functional decline through Parkinsonism and sedentariness exacerbated by motor, psychiatric and cognitive symptoms. Exercise may improve functional outcomes in Parkinson's disease (PD), and Alzheimer's disease (AD). However, the multi-domain nature of the LBD cluster of symptoms (physical, cognitive, psychiatric, autonomic) results in vulnerable individuals often being excluded from exercise studies evaluating physical function in PD or cognitive function in dementia to avoid confounding results. This review evaluated existing literature reporting the effects of exercise interventions or physical activity (PA) exposure on cluster symptoms in LBD. Methods A high-sensitivity search was executed across 19 databases. Full-length articles of any language and quality, published or unpublished, that analysed effects of isolated exercise/physical activity on indicative Dementia with Lewy Bodies or PD-dementia cohorts were evaluated for outcomes inclusive of physical, cognitive, psychiatric, physiological and quality of life measures. The protocol for this review (Reg. #:CRD42015019002) is accessible at http://www.crd.york.ac.uk/PROSPERO/. Results 111,485 articles were initially retrieved; 288 full articles were reviewed and 89.6% subsequently deemed ineligible due to exclusion of participants with co-existence of dementia and Parkinsonism. Five studies (1 uncontrolled trial, 1 randomized controlled trial and 3 case reports) evaluating 16 participants were included. Interventions were diverse and outcome homogeneity was low. Habitual gait speed outcomes were measured in 13 participants and increased (0.18m/s, 95% CI -0.02, 0.38m/s), exceeding moderate important change (0.14m/s) for PD cohorts. Other outcomes appeared to improve modestly in most participants. Discussion Scarce research investigating exercise in LBD exists. This review confirms exercise studies in PD and dementia consistently exclude LBD participants. Results in this cohort must be treated with caution until robustly designed, larger studies are commissioned to explore exercise efficacy, feasibility and clinical relevance.	[Inskip, Michael; Mavros, Yorgi; Singh, Maria A. Fiatarone] Univ Sydney, Exercise Hlth & Performance Fac Res Grp, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, CHeBA Ctr Hlth Brain Ageing, Randwick, NSW 2031, Australia; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW 2031, Australia; [Singh, Maria A. Fiatarone] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Singh, Maria A. Fiatarone] Hebrew SeniorLife, Roslindale, MA 02131 USA; [Singh, Maria A. Fiatarone] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Boston, MA 02155 USA	University of Sydney; University of New South Wales Sydney; University of Sydney; Harvard University; Hebrew SeniorLife; Tufts University; United States Department of Agriculture (USDA)	Inskip, M (corresponding author), Univ Sydney, Exercise Hlth & Performance Fac Res Grp, Fac Hlth Sci, Lidcombe, NSW 2141, Australia.	michael.inskip@sydney.edu.au	Inskip, Michael/AAE-5628-2022; Mavros, Yorgi/I-2274-2019; Sachdev, Perminder/ABC-1137-2020	Mavros, Yorgi/0000-0002-2588-0425; Sachdev, Perminder/0000-0002-9595-3220; Inskip, Michael John/0000-0001-5150-8582				Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Australian Institute of Health and Welfare, 2012, DEM AUSTR; Bartlett H, 2006, DEMENTIA RES MAPPING; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Ciro CA, 2013, AM J OCCUP THER, V67, P556, DOI 10.5014/ajot.2013.008227; Collin C, 1988, Int Disabil Stud, V10, P61; Dal Bello-Haas V, 2011, PHYSIOTHER CAN, V63, P47, DOI 10.3138/ptc.2009-08; Dawley C, CASE REPORT PAPERS; Dawley C., 2014, USE PARKINSONS DIS S; Duncan RP, 2013, PHYS THER, V93, P542, DOI 10.2522/ptj.20120302; Figari-Jordan R, 2012, NEUROLOGY, V78; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gagnier JJ, 2013, DTSCH ARZTEBL INT, V110, P603, DOI [10.7453/gahmj.2013.008, 10.3238/arztebl.2013.0603, 10.1186/1752-1947-7-223, 10.1136/bcr-2013-201554]; Gill DP, 2011, ALZ DIS ASSOC DIS, V25, P17, DOI 10.1097/WAD.0b013e3182037edf; Goodwin LS, 2014, REV CLIN GERONTOL, V24, P122, DOI 10.1017/S0959259813000257; Goodwin VA, 2008, MOVEMENT DISORD, V23, P631, DOI 10.1002/mds.21922; Hanyu H, 2009, EUR J NEUROL, V16, P212, DOI 10.1111/j.1468-1331.2008.02388.x; Hass CJ, 2014, J NEUROL PHYS THER, V38, P233, DOI 10.1097/NPT.0000000000000055; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Huang SL, 2011, PHYS THER, V91, P114, DOI 10.2522/ptj.20090126; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Jones SAV, 2014, PSYCHOL MED, V44, P673, DOI 10.1017/S0033291713000494; Komatsu Taiki, 2013, Clin Calcium, V23, P731, DOI CliCa1305731738; Lewy body dementia association, 2015, TREATM; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Medicare Learning Network, 2013, QUICK REF CHART SHOR; Merory JR, 2007, GAIT POSTURE, V26, P414, DOI 10.1016/j.gaitpost.2006.10.006; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mosimann UP, 2004, NEUROLOGY, V63, P2091, DOI 10.1212/01.WNL.0000145764.70698.4E; Murman DL, 2003, NEUROLOGY, V61, P944, DOI 10.1212/WNL.61.7.944; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Rochester L, 2009, MOVEMENT DISORD, V24, P839, DOI 10.1002/mds.22400; Schrag A, 2006, MOVEMENT DISORD, V21, P1200, DOI 10.1002/mds.20914; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Stubendorff K, 2011, DEMENT GERIATR COGN, V32, P408, DOI 10.1159/000335364; Tabak R, 2013, J NEUROL PHYS THER, V37, P58, DOI 10.1097/NPT.0b013e31829219bc; Telenius EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126102; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Yamane Y, 2011, PSYCHOGERIATRICS, V11, P157, DOI 10.1111/j.1479-8301.2011.00368.x	44	22	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156520	10.1371/journal.pone.0156520	http://dx.doi.org/10.1371/journal.pone.0156520			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258533	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000377369700073
J	Kito, M; Maeda, D; Kudo-Asabe, Y; Sato, N; Shih, IM; Wang, TL; Tanaka, M; Terada, Y; Goto, A				Kito, Masahiko; Maeda, Daichi; Kudo-Asabe, Yukitsugu; Sato, Naoki; Shih, Ie-Ming; Wang, Tian-Li; Tanaka, Masamitsu; Terada, Yukihiro; Goto, Akiteru			Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube	PLOS ONE			English	Article							INTRAEPITHELIAL CARCINOMA; SEROUS CARCINOMA; REGULATOR; DIAGNOSIS; PATHWAY	There is a growing body of evidence regarding cell competition between normal and mutant mammalian cells, which suggest that it may play a defensive role in the early phase of carcinogenesis. In vitro study in the past has shown that overexpression of vimentin in normal epithelial cells at the contact surface with transformed cells is essential for the cell competition involved in epithelial defense against cancer. In this study, we attempted to examine cell competition in human tissue in vivo by investigating surgically resected human fallopian tubes that contain p53 signatures and serous tubal intraepithelial lesions (STILs), a linear expansion of p53-immunopositive/TP53 mutant tubal epithelial cells that are considered as precursors of pelvic high grade serous carcinoma. Immunofluorescence double staining for p53 and the cell competition marker vimentin was performed in 21 sections of human fallopian tube tissue containing 17 p53 signatures and 4 STILs. The intensities of vimentin expression at the interface between p53-positive cells at the end of the p53 signature/STIL and adjacent p53-negative normal tubal epithelial cells were compared with the background tubal epithelium. As a result, the average vimentin intensity at the interfaces relative to the background intensity was 1.076 (95% CI, 0.9412 - 1.211 for p53 signature and 0.9790 (95% CI, 0.7206 - 1.237) for STIL. Thus, it can be concluded that overexpression of the cell competition marker vimentin are not observed in human tissue with TP53 alterations.	[Kito, Masahiko; Maeda, Daichi; Kudo-Asabe, Yukitsugu; Goto, Akiteru] Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita 010, Japan; [Kito, Masahiko; Sato, Naoki; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Pathol Oncol & Gynecol & Obstet, Baltimore, MD 21205 USA; [Tanaka, Masamitsu] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita 010, Japan	Akita University; Akita University; Johns Hopkins University; Johns Hopkins Medicine; Akita University	Maeda, D (corresponding author), Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita 010, Japan.	maeda-tky@umin.ac.jp	Goto, Akiteru/P-5775-2014; sdsd, shihieih/ABE-6190-2020	Goto, Akiteru/0000-0001-8776-9004	Japan Society for the Promotion of Science [26870129]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science. Grant number: 26870129.	Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Jarboe E, 2008, INT J GYNECOL PATHOL, V27, P1, DOI 10.1097/pgp.0b013e31814b191f; Kajita M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5428; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kobayashi Y, 2015, CLIN CANCER RES, V21, P4652, DOI 10.1158/1078-0432.CCR-14-3368; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levayer R, 2015, NATURE, V524, P476, DOI 10.1038/nature14684; Mamada H, 2015, J CELL SCI, V128, P790, DOI 10.1242/jcs.163675; Miyoshi I, 2002, MOL REPROD DEV, V63, P168, DOI 10.1002/mrd.10175; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Ohoka A, 2015, J CELL SCI, V128, P781, DOI 10.1242/jcs.163113; Petrova Evgeniya, 2011, Commun Integr Biol, V4, P171, DOI 10.4161/cib.4.2.14232; Portela M, 2010, DEV CELL, V19, P562, DOI 10.1016/j.devcel.2010.09.004; Sherman-Baust CA, 2014, J PATHOL, V233, P228, DOI 10.1002/path.4353; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Vang R, 2012, INT J GYNECOL PATHOL, V31, P243, DOI 10.1097/PGP.0b013e31823b8831; Visvanathan K, 2011, AM J SURG PATHOL, V35, P1766, DOI 10.1097/PAS.0b013e31822f58bc; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156069	10.1371/journal.pone.0156069	http://dx.doi.org/10.1371/journal.pone.0156069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258067	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700031
J	Trachana, SP; Pilalis, E; Gavalas, NG; Tzannis, K; Papadodima, O; Liontos, M; Rodolakis, A; Vlachos, G; Thomakos, N; Haidopoulos, D; Lykka, M; Koutsoukos, K; Kostouros, E; Terpos, E; Chatziioannou, A; Dimopoulos, MA; Bamias, A				Trachana, Sofia-Paraskevi; Pilalis, Eleftherios; Gavalas, Nikos G.; Tzannis, Kimon; Papadodima, Olga; Liontos, Michalis; Rodolakis, Alexandros; Vlachos, Georgios; Thomakos, Nikolaos; Haidopoulos, Dimitrios; Lykka, Maria; Koutsoukos, Konstantinos; Kostouros, Efthimios; Terpos, Evagelos; Chatziioannou, Aristotelis; Dimopoulos, Meletios-Athanasios; Bamias, Aristotelis			The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLATINUM RESISTANCE; POOR-PROGNOSIS; CELLS; EXPRESSION; CARCINOMA; CHEMOTHERAPY; PROGRESSION; RECURRENCE; CISPLATIN	Advanced ovarian cancer (AOC) is one of the leading lethal gynecological cancers in developed countries. Based on the important role of angiogenesis in ovarian cancer oncogenesis and expansion, we hypothesized that the development of an "angiogenic signature" might be helpful in prediction of prognosis and efficacy of anti-angiogenic therapies in this disease. Sixty-nine samples of ascitic fluid-35 from platinum sensitive and 34 from platinum resistant patients managed with cytoreductive surgery and 1st-line carboplatin-based chemotherapy- were analyzed using the Proteome Profiler (TM) Human Angiogenesis Array Kit, screening for the presence of 55 soluble angiogenesis-related factors. A protein profile based on the expression of a subset of 25 factors could accurately separate resistant from sensitive patients with a success rate of approximately 90%. The protein profile corresponding to the "sensitive" subset was associated with significantly longer PFS (8 [95% Confidence Interval {CI}: 8-9] vs. 20 months [95% CI: 15-28]; Hazard ratio {HR}: 8.3, p< 0.001) and OS (20.5 months [95% CI: 13.5-30] vs. 74 months [95% CI: 36-not reached]; HR: 5.6 [95% CI: 2.8-11.2]; p< 0.001). This prognostic performance was superior to that of stage, histology and residual disease after cytoreductive surgery and the levels of vascular endothelial growth factor (VEGF) in ascites. In conclusion, we developed an "angiogenic signature" for patients with AOC, which can be used, after appropriate validation, as a prognostic marker and a tool for selection for anti-angiogenic therapies.	[Trachana, Sofia-Paraskevi; Gavalas, Nikos G.; Tzannis, Kimon; Liontos, Michalis; Lykka, Maria; Koutsoukos, Konstantinos; Kostouros, Efthimios; Terpos, Evagelos; Dimopoulos, Meletios-Athanasios; Bamias, Aristotelis] Univ Athens, Alexandra Gen Hosp, Sch Med, Dept Clin Therapeut, Athens 11528, Greece; [Pilalis, Eleftherios; Papadodima, Olga; Chatziioannou, Aristotelis] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Metab Engn & Bioinformat Program, Athens, Greece; [Rodolakis, Alexandros; Vlachos, Georgios; Thomakos, Nikolaos; Haidopoulos, Dimitrios] Univ Athens, Sch Med, Alexandra Gen Hosp, Dept Obstet & Gynecol 1, Athens 11528, Greece	Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; National Hellenic Research Foundation; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens	Trachana, SP (corresponding author), Univ Athens, Alexandra Gen Hosp, Sch Med, Dept Clin Therapeut, Athens 11528, Greece.	sp.voula@yahoo.com	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Papadodima, Olga/AAU-6664-2021; Terpos, Evangelos/AAD-3667-2019; Koutsoukos, Konstantinos/AAE-8238-2019; Liontos, Michalis/ABA-7587-2020; Liontos, Michalis/AAF-1965-2019	Liontos, Michalis/0000-0001-7192-4575; Pilalis, Eleftherios/0000-0002-5253-5256; Papadodima, Olga/0000-0003-3896-4270; Dimopoulos, Meletios/0000-0001-8990-3254	Hellenic Society of Medical Oncology (HeSMO)	Hellenic Society of Medical Oncology (HeSMO)	This work was supported by an educational grant of the Hellenic Society of Medical Oncology (HeSMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai S, 2007, MOL CANCER THER, V6, P101, DOI 10.1158/1535-7163.MCT-06-0367; Bamberger ES, 2002, J CLIN PATHOL-MOL PA, V55, P348, DOI 10.1136/mp.55.6.348; Bamias A, 2007, GYNECOL ONCOL, V106, P75, DOI 10.1016/j.ygyno.2007.02.029; Bamias A, 2012, CRIT REV ONCOL HEMAT, V84, P314, DOI 10.1016/j.critrevonc.2012.04.002; Bamias A, 2008, GYNECOL ONCOL, V108, P421, DOI 10.1016/j.ygyno.2007.10.018; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Biroccio A, 2000, FASEB J, V14, P652, DOI 10.1096/fasebj.14.5.652; Bonneau C, 2015, GYNECOL ONCOL, V136, P112, DOI 10.1016/j.ygyno.2014.10.024; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Chen Y, 2012, INT J MOL SCI, V13, P13264, DOI 10.3390/ijms131013264; Cheng C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055309, DOI 10.1371/JOURNAL.PONE.0055309]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Davidson B, 2006, CLIN CANCER RES, V12, P791, DOI 10.1158/1078-0432.CCR-05-2516; Del Bufalo D, 2002, MOL PHARMACOL, V61, P524, DOI 10.1124/mol.61.3.524; Eckstein N, 2008, J BIOL CHEM, V283, P739, DOI 10.1074/jbc.M706287200; Gan Y, 2006, PHARM RES, V6, P1324; Gourley C, 2014, P AN M AM SOC CLIN, V32, P5502, DOI [10.1200/jco.2014.32.15_suppl.5502, DOI 10.1200/jco.2014.32.15_suppl.5502]; Hata K, 2004, CANCER CHEMOTH PHARM, V53, P68, DOI 10.1007/s00280-003-0693-x; Howlader N., 2016, SEER CANC STAT REV; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kim W, 2012, J BREAST CANCER, V15, P230, DOI 10.4048/jbc.2012.15.2.230; Korampalli TS, 2011, INT J ONCOL, V39, P1033, DOI 10.3892/ijo.2011.1117; Lloyd KL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1101-8; Lose F, 2010, GYNECOL ONCOL, V119, P479, DOI 10.1016/j.ygyno.2010.08.014; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; Matei D, 2007, CANCER BIOL THER, V6, P1951, DOI 10.4161/cbt.6.12.4976; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Meirelles K, 2012, P NATL ACAD SCI USA, V109, P2358, DOI 10.1073/pnas.1120733109; Michaelis M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-80; Miyamoto S, 2011, CLIN CANCER RES, V10, P1058; Monk BJ, 2014, LANCET ONCOL, V15, P799, DOI 10.1016/S1470-2045(14)70244-X; Morimoto Yukiko, 2004, Gan To Kagaku Ryoho, V31, P2195; Niero EL, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-37; Obermayr E, 2013, GYNECOL ONCOL, V128, P15, DOI 10.1016/j.ygyno.2012.09.021; Peterson VM, 2013, P NATL ACAD SCI USA, V110, pE4978, DOI 10.1073/pnas.1315370110; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ray KC, 2009, GASTROENTEROLOGY, V137, P1785, DOI 10.1053/j.gastro.2009.07.067; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Salani R, 2011, AM J OBSTET GYNECOL, V204, P466, DOI 10.1016/j.ajog.2011.03.008; Sallinen H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-696; Secord AA, 2014, GYNECOL ONCOL, V135, P349, DOI 10.1016/j.ygyno.2014.08.033; Su Y, 2003, BIOINFORMATICS, V19, P1578, DOI 10.1093/bioinformatics/btg179; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Taylor DD, 2009, GYNECOL ONCOL, V115, P112, DOI 10.1016/j.ygyno.2009.06.031; Tran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015625; Tu SP, 2005, GASTROENTEROLOGY, V128, P361, DOI 10.1053/j.gastro.2004.11.058; Watanabe Y, 2003, CANCER LETT, V200, P173, DOI 10.1016/S0304-3835(03)00413-0; Yang H, 2013, INT J GYNECOL CANCER, V23, P2, DOI 10.1097/IGC.0b013e3182749139	51	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156403	10.1371/journal.pone.0156403	http://dx.doi.org/10.1371/journal.pone.0156403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258020	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700059
J	Yang, RP; Mo, YL; Liu, CM; Wang, YQ; Ma, JX; Zhang, Y; Li, H; Zhang, X				Yang, Ruiping; Mo, Yanling; Liu, Changming; Wang, Yongqi; Ma, Jianxiang; Zhang, Yong; Li, Hao; Zhang, Xian			The Effects of Cattle Manure and Garlic Rotation on Soil under Continuous Cropping of Watermelon (Citrullus lanatus L.)	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; FUSARIUM-WILT; AEROBIC RICE; PLANT; MANAGEMENT; YIELD; AMENDMENTS; FERTILIZER; DISEASE; SYSTEM	Continuous cropping of watermelon (Citrullus lanatus L.) can lead to reduced yield and quality. We aimed to determine the effects of cattle manure addition and rotation with green garlic to improve yield and reduce disease incidence in watermelon and to examine the effects on the biological and chemical characteristics of the soil. Field experiments were performed during 2012-2014 on land previously under two years of continuous watermelon cropping in northwest China. We examined three treatment combinations: watermelon and garlic rotation, cattle manure application before watermelon planting, and combined cattle manure addition and crop rotation. Watermelon monoculture was retained as a control. Watermelon yield was significantly higher and disease incidence was lower in the treatments than the control. The populations of soil bacteria and actinomycetes and the bacteria/fungi ratio increased significantly and soil enzyme activities were generally enhanced under treatments. Available nutrients and soil organic matter contents were much higher under experimental treatments than the control. Results suggest both cattle manure application and garlic rotation can ameliorate the negative effects of continuous cropping. The combined treatment of cattle manure addition and green garlic rotation was optimal to increase yield, reduce disease incidence and enhance soil quality.	[Yang, Ruiping; Mo, Yanling; Wang, Yongqi; Ma, Jianxiang; Zhang, Yong; Li, Hao; Zhang, Xian] Northwest A&F Univ, Coll Hort, Yangling, Peoples R China; [Liu, Changming] Shangluo Univ, Coll Biol Pharm & Food Engn, Shangluo, Peoples R China; [Wang, Yongqi] Hanzhong City Agrotechnol Extens Ctr, Hanzhong, Peoples R China	Northwest A&F University - China; Shangluo University	Zhang, X (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Peoples R China.	zhangxian098@126.com	Zhang, Kevin/F-5215-2010		Modern Agro-industry Technology Research System of China [CARS-26-18]; county key technology project in Shaanxi province, China [2012XY-27]	Modern Agro-industry Technology Research System of China; county key technology project in Shaanxi province, China	This study was supported by the Modern Agro-industry Technology Research System of China (CARS-26-18), and the county key technology project in Shaanxi province, China (No. 2012XY-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim MF, 2012, CROP PROT, V32, P41, DOI 10.1016/j.cropro.2011.10.011; Abo-Elyousr KAM, 2009, PLANT PATHOLOGY J, V25, P189, DOI 10.5423/PPJ.2009.25.2.189; Ahmad I, 2013, PAK J BOT, V45, P695; Alburquerque JA, 2012, EUR J AGRON, V43, P119, DOI 10.1016/j.eja.2012.06.001; Alvey S, 2001, PLANT SOIL, V231, P45, DOI 10.1023/A:1010386800937; Antonious GF, 2003, J ENVIRON SCI HEAL B, V38, P479, DOI 10.1081/PFC-120021667; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; BAO SD, 2000, AGR SOIL ANAL, P39; BARBER SA, 1990, PLANT SOIL, V124, P183, DOI 10.1007/BF00009257; Borges CD, 2013, ARCH AGRON SOIL SCI, V59, P1471, DOI 10.1080/03650340.2012.725938; BREMNER JM, 1983, COMMUN SOIL SCI PLAN, V14, P905, DOI 10.1080/00103628309367418; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Chen X, 1993, WATERMELON PLANT DIS; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P103, DOI 10.1016/j.compag.2004.11.002; Dai XQ, 2013, FIELD CROP RES, V149, P141, DOI 10.1016/j.fcr.2013.04.027; Davis JR, 2001, AM J POTATO RES, V78, P291, DOI 10.1007/BF02875694; Dick WA, 2000, SOIL BIOL BIOCHEM, V32, P1915, DOI 10.1016/S0038-0717(00)00166-8; Eivazi F., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P686; ElTarabily KA, 1996, PLANT SOIL, V183, P279, DOI 10.1007/BF00011443; Fumagalli P, 2014, J ENVIRON MANAGE, V145, P35, DOI 10.1016/j.jenvman.2014.06.001; Gong B, 2013, SCI HORTICULTURAE, V1161, P49; Guan Y. M, 1986, SOIL ENZYMES RES MET; Huang LF, 2013, J CHEM ECOL, V39, P232, DOI 10.1007/s10886-013-0244-9; Jia ZH, 2011, ALLELOPATHY J, V27, P87; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kapkiyai JJ, 1999, SOIL BIOL BIOCHEM, V31, P1773, DOI 10.1016/S0038-0717(99)00088-7; Khan MA, 2010, PAK J BOT, V42, P4353; Larney FJ, 1996, AGRON J, V88, P921, DOI 10.2134/agronj1996.00021962003600060012x; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liu L- L, 2015, PLOS ONE, V10; Liu SuHui, 2010, Scientia Agricultura Sinica, V43, P1000; Michel VV, 1998, PHYTOPATHOLOGY, V88, P300, DOI 10.1094/PHYTO.1998.88.4.300; Mkhabela MS, 2005, AGR ECOSYST ENVIRON, V106, P57, DOI 10.1016/j.agee.2004.07.014; Moreira A, 2015, COMMUN SOIL SCI PLAN, V46, P1157, DOI 10.1080/00103624.2015.1033542; Naramabuye FX, 2008, AGR ECOSYST ENVIRON, V124, P136, DOI 10.1016/j.agee.2007.08.005; Nie LX, 2007, PLANT SOIL, V300, P185, DOI 10.1007/s11104-007-9402-6; Ren LX, 2008, SOIL BIOL BIOCHEM, V40, P834, DOI 10.1016/j.soilbio.2007.11.003; Sradnick A, 2013, APPL SOIL ECOL, V63, P23, DOI 10.1016/j.apsoil.2012.09.011; Sui N, 2015, FIELD CROP RES, V172, P132, DOI 10.1016/j.fcr.2014.11.011; Tejada M, 2006, J ENVIRON QUAL, V35, P1010, DOI 10.2134/jeq2005.0460; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Whalen JK, 2002, CAN J SOIL SCI, V82, P227, DOI 10.4141/S01-030; Wu FengZhi, 2006, Plant Nutrition and Fertilizer Science, V12, P554; Xiao XM, 2012, ACTA AGR SCAND B-S P, V62, P696, DOI 10.1080/09064710.2012.697571; Xu WH, 2015, PHYSIOL MOL PLANT P, V90, P12, DOI 10.1016/j.pmpp.2015.02.003; Xu WH, 2015, EUR J PLANT PATHOL, V141, P209, DOI 10.1007/s10658-014-0528-0; Xue JiCheng, 1995, Journal of Nanjing Agricultural University, V18, P53; Yang YuHong, 2011, Acta Agronomica Sinica, V37, P105; Yao HY, 2007, SCIENTIFIC, P185; Zhou KQ, 2015, FIELD CROP RES, V171, P138, DOI 10.1016/j.fcr.2014.10.017	50	13	24	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156515	10.1371/journal.pone.0156515	http://dx.doi.org/10.1371/journal.pone.0156515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258145	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700071
J	Hsu, YH; Yu, HY; Chen, HJ; Li, TC; Hsu, CC; Kao, CH				Hsu, Yueh-Han; Yu, Hui-Yi; Chen, Hsuan-Ju; Li, Tsai-Chung; Hsu, Chih-Cheng; Kao, Chia-Hung			The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANKLE-BRACHIAL INDEX; HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; SECONDARY HYPERPARATHYROIDISM; CARDIOVASCULAR-DISEASE; BONE TURNOVER; VITAMIN-D; HORMONE; CALCIFICATION	Purpose The changes of the risk of peripheral arterial disease (PAD) in patients with end-stage renal disease after parathyroidectomy are scant. Methods We used a nationwide health insurance claims database to select all dialysis-dependent patients with end-stage renal disease aged 18 years and older for the study population in 2000 to 2006. Of the patients with end-stage renal disease, we selected 947 patients who had undergone parathyroidectomy as the parathyroidectomy group and frequency matched 3746 patients with end-stage renal disease by sex, age, years since the disease diagnosis, and the year of index date as the non-parathyroidectomy group. We used a multivariate Cox proportional hazards regression analysis with the use of a robust sandwich covariance matrix estimate, accounting for the intra-cluster dependence of hospitals or clinics, to measure the risk of peripheral arterial disease for the parathyroidectomy group compared with the non-parathyroidectomy group after adjusting for sex, age, premium-based income, urbanization, and comorbidity. Results The mean post-op follow-up periods were 5.08 and 4.52 years for the parathyroidectomy and non-parathyroidectomy groups, respectively; the incidence density rate of PAD in the PTX group was 12.26 per 1000 person-years, significantly lower than the data in the non-PTX group (24.09 per 1000 person-years, adjusted HR = 0.66, 95% CI = 0.46-0.94). Conclusion Parathyroidectomy is associated with reduced risk of peripheral arterial disease in patients with end-stage renal disease complicated with severe secondary hyperparathyroidism.	[Hsu, Yueh-Han; Hsu, Chih-Cheng] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Hsu, Yueh-Han] Ditmanson Med Fdn Chia Yi Christian Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Hsu, Yueh-Han] Min Hwei Jr Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Yu, Hui-Yi] Ditmanson Med Fdn Chia Yi Christian Hosp, Div Endocrinol & Metab, Dept Internal Med, Chia Yiy, Taiwan; [Yu, Hui-Yi] Chia Nan Univ Pharm & Sci, Dept Sports Management, Tainan, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan; [Hsu, Chih-Cheng] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.	10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abou-Hassan N, 2015, KIDNEY INT, V87, P195, DOI 10.1038/ki.2014.187; Anderson JL, 2011, AM HEART J, V162, P331, DOI 10.1016/j.ahj.2011.05.005; Bleyer AJ, 2005, AM J KIDNEY DIS, V46, P464, DOI 10.1053/j.ajkd.2005.04.035; Bover J, 2014, SEMIN NEPHROL, V34, P626, DOI 10.1016/j.semnephrol.2014.09.008; Chang TI, 2016, J HUM HYPERTENS, V30, P204, DOI 10.1038/jhh.2015.56; Chen YJ, 2014, ANGIOLOGY, V65, P396, DOI 10.1177/0003319713480842; Coen G, 2007, NEPHROL DIAL TRANSPL, V22, P3262, DOI 10.1093/ndt/gfm370; Conzo G, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S4; Eggers PW, 1999, KIDNEY INT, V56, P1524, DOI 10.1046/j.1523-1755.1999.00668.x; Eguchi M, 2000, AM J NEPHROL, V20, P278, DOI 10.1159/000013601; FOWKES FGR, 1992, AM J EPIDEMIOL, V135, P331; Fukagawa M, 2013, EXPERT OPIN PHARMACO, V14, P863, DOI 10.1517/14656566.2013.783017; Ghimire M, 2014, Kathmandu Univ Med J (KUMJ), V12, P181; Goldenstein PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068870; Hojs R, 2000, ARTIF ORGANS, V24, P691, DOI 10.1046/j.1525-1594.2000.06466.x; Hsu YH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000936; Hsu YH, 2015, J HEPATOL, V62, P519, DOI 10.1016/j.jhep.2014.09.022; Hyun Suzanne, 2014, J Vasc Surg, V60, P390, DOI 10.1016/j.jvs.2014.02.008; Ishani A, 2015, CLIN J AM SOC NEPHRO, V10, P90, DOI 10.2215/CJN.03520414; Ishii H, 2012, DIABETOLOGIA, V55, P1304, DOI 10.1007/s00125-012-2473-9; Iwamoto N, 2012, J NEPHROL, V25, P755, DOI 10.5301/jn.5000056; Jiajue R, 2014, OSTEOPOROSIS INT, V25, P1999, DOI 10.1007/s00198-014-2714-5; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Komaba H, 2015, KIDNEY INT, V88, P350, DOI 10.1038/ki.2015.72; Kuwahara M, 2014, THER APHER DIAL, V18, P9, DOI 10.1111/1744-9987.12055; LAZARUS JM, 1975, KIDNEY INT, V7, pS167; Lee MY, 2010, KIDNEY BLOOD PRESS R, V33, P352, DOI 10.1159/000317524; Lepantalo M, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2233; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; London GM, 2015, J AM SOC NEPHROL, V26, P476, DOI 10.1681/ASN.2014020169; Lorenzo V, 2001, AM J KIDNEY DIS, V37, P1260, DOI 10.1053/ajkd.2001.24532; Ma TL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/639587; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497; Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x; Otsubo S, 2012, INT UROL NEPHROL, V44, P569, DOI 10.1007/s11255-010-9883-8; Rostand SG, 1999, KIDNEY INT, V56, P383, DOI 10.1046/j.1523-1755.1999.00575.x; Selvin E, 2004, CIRCULATION; Sharma J, 2012, J AM COLL SURGEONS, V214, P400, DOI 10.1016/j.jamcollsurg.2011.12.046; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006254; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tsuchihashi K, 2000, NEPHRON, V84, P13, DOI 10.1159/000045533; Usdin TB, 1996, ENDOCRINOLOGY, V137, P4285, DOI 10.1210/en.137.10.4285	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156863	10.1371/journal.pone.0156863	http://dx.doi.org/10.1371/journal.pone.0156863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284924	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000026
J	Silberstein, E; Ulitzky, L; Lima, LA; Cehan, N; Teixeira-Carvalho, A; Roingeard, P; Taylor, DR				Silberstein, Erica; Ulitzky, Laura; Lima, Livia Alves; Cehan, Nicoleta; Teixeira-Carvalho, Andrea; Roingeard, Philippe; Taylor, Deborah R.			HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; LIVER FIBROSIS; CELL-DEATH; SMMC-7721 CELLS; GAMBOGIC ACID; INFECTION; REPLICATION; CASPASE	Chronic Hepatitis C Virus (HCV) infection is associated with progressive liver injury and subsequent development of fibrosis and cirrhosis. The death of hepatocytes results in the release of cytokines that induce inflammatory and fibrotic responses. The mechanism of liver damage is still under investigation but both apoptosis and immune-mediated processes may play roles. By observing the changes in gene expression patterns in HCV-infected cells, both markers and the causes of HCV-associated liver injury may be elucidated. HCV genotype 1b virus from persistently infected VeroE6 cells induced a strong cytopathic effect when used to infect Huh7.5 hepatoma cells. To determine if this cytopathic effect was a result of apoptosis, ultrastructural changes were observed by electron microscopy and markers of programmed cell death were surveyed. Screening of a human PCR array demonstrated a gene expression profile that contained upregulated markers of apoptosis, including tumor necrosis factor, caspases and caspase activators, Fas, Bcl2-interacting killer (BIK) and tumor suppressor protein, p53, as a result of HCV genotype 1b infection. The genes identified in this study should provide new insights into understanding viral pathogenesis in liver cells and may possibly help to identify novel antiviral and antifibrotic targets.	[Silberstein, Erica; Ulitzky, Laura; Lima, Livia Alves; Cehan, Nicoleta; Teixeira-Carvalho, Andrea; Taylor, Deborah R.] CBER FDA, Off Blood Res & Review, Div Emerging Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20903 USA; [Roingeard, Philippe] Univ Tours, INSERM U966, Tours, France; [Roingeard, Philippe] CHRU Tours, Tours, France; [Lima, Livia Alves] Univ Fed Mato Grosso do Sul, Campo Grande, Brazil; [Cehan, Nicoleta] EMLab P&K, Fairfax, VA 22030 USA; [Teixeira-Carvalho, Andrea] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Fundacao Lab Biomarcadores Diagnost & Monitoracao, Grp Integrado Pesquisas Biomarcadores, Belo Horizonte, MG, Brazil	US Food & Drug Administration (FDA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universidade Federal de Mato Grosso do Sul; Fundacao Oswaldo Cruz	Taylor, DR (corresponding author), CBER FDA, Off Blood Res & Review, Div Emerging Transfus Transmitted Dis, Lab Emerging Pathogens, Silver Spring, MD 20903 USA.	Deborah.Taylor@fda.hhs.gov	Guedes, Livia Stêfania Alves Lima/U-8748-2017	Guedes, Livia Stêfania Alves Lima/0000-0002-1071-0351				Ahmad W, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-41; Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Aizaki H, 2002, HEPATOLOGY, V36, P1431, DOI 10.1053/jhep.2002.36937; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Aweya JJ, 2015, VIROLOGY, V474, P41, DOI 10.1016/j.virol.2014.10.027; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bartenschlager R, 2010, J HEPATOL, V53, P583, DOI 10.1016/j.jhep.2010.04.015; Basu A, 2006, VIROLOGY, V349, P347, DOI 10.1016/j.virol.2006.02.023; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Chu VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028551; Ciccaglione AR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-309; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Duan DZ, 2014, FREE RADICAL BIO MED, V69, P15, DOI 10.1016/j.freeradbiomed.2013.12.027; El-Bassiouni A, 2006, APMIS, V114, P420, DOI 10.1111/j.1600-0463.2006.apm_323.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Ferraris P, 2013, CELL MOL LIFE SCI, V70, P1297, DOI 10.1007/s00018-012-1213-0; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Ghavami S, 2005, MED SCI MONITOR, V11, pRA337; Gogela NA, 2015, CURR HIV-AIDS REP, V12, P68, DOI 10.1007/s11904-014-0243-7; Guo QL, 2006, LIFE SCI, V78, P1238, DOI 10.1016/j.lfs.2005.06.046; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lee MH, 2014, INT J CANCER, V135, P1119, DOI 10.1002/ijc.28753; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Ma Yan-bin, 2011, Virologica Sinica, V26, P366, DOI 10.1007/s12250-011-3218-5; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Poenisch M, 2010, SEMIN LIVER DIS, V30, P333, DOI 10.1055/s-0030-1267535; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roingeard P, 2013, J VIRAL HEPATITIS, V20, P77, DOI 10.1111/jvh.12035; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sebastiani G, 2014, WORLD J GASTROENTERO, V20, P11033, DOI 10.3748/wjg.v20.i32.11033; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Silberstein E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000910; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wang Y, 2012, EUR REV MED PHARMACO, V16, P995; Zekri ARN, 2007, J VIRAL HEPATITIS, V14, P468, DOI 10.1111/j.1365-2893.2006.00832.x; Zekri Abdel-Rahman N, 2011, Comp Hepatol, V10, P4, DOI 10.1186/1476-5926-10-4; Zhao P, 2012, VIRUS RES	53	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155708	10.1371/journal.pone.0155708	http://dx.doi.org/10.1371/journal.pone.0155708			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280444	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000005
J	Visioli, G; Galieni, A; Stagnari, F; Bonas, U; Speca, S; Faccini, A; Pisante, M; Marmiroli, N				Visioli, Giovanna; Galieni, Angelica; Stagnari, Fabio; Bonas, Urbana; Speca, Stefano; Faccini, Andrea; Pisante, Michele; Marmiroli, Nelson			Proteomics of Durum Wheat Grain during Transition to Conservation Agriculture	PLOS ONE			English	Article							STORAGE PROTEIN-COMPOSITION; WINTER-WHEAT; NITROGEN-FERTILIZATION; HIGH-TEMPERATURE; QUALITY; YIELD; SOIL; TILLAGE; STRESS; EFFICIENCY	Nitrogen management in combination with sustainable agronomic techniques can have a great impact on the wheat grain proteome influencing its technological quality. In this study, proteomic analyses were used to document changes in the proportion of prolamins in mature grains of the newly released Italian durum wheat cv Achille. Such an approach was applied to wheat fertilized with urea (UREA) and calcium nitrate (NITRATE), during the transition to no-till Conservation Agriculture (CA) practice in a Mediterranean environment. Results obtained in a two-years field experiment study suggest low molecular weight glutenins (LMW-GS) as the fraction particularly inducible regardless of the N-form. Quantitative analyses of LMW-GS by 2D-GE followed by protein identification by LC-ESI-MS/MS showed that the stable increase was principally due to C-type LMW-GS. The highest accumulation resulted from a physiologically healthier state of plants treated with UREA and NITRATE. Proteomic analysis on the total protein fraction during the active phase of grain filling was also performed. For both N treatments, but at different extent, an up-regulation of different classes of proteins was observed: i) enzymes involved in glycolysis and citric acid cycles which contribute to an enhanced source of energy and carbohydrates, ii) stress proteins like heat shock proteins (HSPs) and antioxidant enzymes, such as peroxidases and superoxide dismutase which protect the grain from abiotic stress during starch and storage protein synthesis. In conclusion N inputs, which combined rate with N form gave high yield and improved quality traits in the selected durum wheat cultivar. The specific up-regulation of some HSPs, antioxidant enzymes and defense proteins in the early stages of grain development and physiological indicators related to fitness traits, could be useful bio-indicators, for wheat genotype screening under more sustainable agronomic conditions, like transition phase to no-till CA in Mediterranean environments.	[Visioli, Giovanna; Bonas, Urbana; Marmiroli, Nelson] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Galieni, Angelica; Stagnari, Fabio; Speca, Stefano; Pisante, Michele] Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Teramo, Italy; [Faccini, Andrea] Univ Parma, Interdept Measure Ctr Giuseppe Casnati, I-43100 Parma, Italy; [Marmiroli, Nelson] Reg Emilia Romagna SITEIA, PARMA Technopole, Parma, Italy	University of Parma; University of Teramo; University of Parma	Visioli, G (corresponding author), Univ Parma, Dept Life Sci, I-43100 Parma, Italy.	giovanna.visioli@unipr.it	visioli, giovanna/C-1016-2015; PISANTE, MICHELE/J-4589-2019	visioli, giovanna/0000-0001-9712-3223; PISANTE, MICHELE/0000-0001-5851-3704; Galieni, Angelica/0000-0002-0971-796X	Progetto AGER [2010-C21J10000660002]; Regione Emilia-Romagna (IT) SITEIA. PARMA Technopole (POR FESR)	Progetto AGER; Regione Emilia-Romagna (IT) SITEIA. PARMA Technopole (POR FESR)	This work was supported by Progetto AGER, grant n.2010-C21J10000660002, and by Regione Emilia-Romagna (IT) SITEIA. PARMA Technopole (POR FESR 2007-2013).	Almeselmani M., 2009, Acta Agronomica Hungarica, V57, P1, DOI 10.1556/AAgr.57.2009.1.1; Altenbach SB, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-46; Apan A., 2006, INT J GEOINFORMATICS, V2, P93; Barraclough PB, 2010, EUR J AGRON, V33, P1, DOI 10.1016/j.eja.2010.01.005; Bencze S, 2004, CEREAL RES COMMUN, V32, P75; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; De Sanctis G, 2012, EUR J AGRON, V40, P18, DOI 10.1016/j.eja.2012.02.002; Derpsch R, 2008, NO TILL FARMING SYST, V3, P7; Dupont FM, 2003, J CEREAL SCI, V38, P133, DOI 10.1016/S0733-5210(03)00030-4; Farooq M, 2011, SOIL TILL RES, V117, P172, DOI 10.1016/j.still.2011.10.001; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galieni A, 2016, ITAL J AGRON, V11, P12, DOI 10.4081/ija.2016.662; Gallardo K, 2003, PLANT PHYSIOL, V133, P664, DOI 10.1104/pp.103.025254; Garrido-Lestache E, 2004, FIELD CROP RES, V85, P213, DOI 10.1016/S0378-4290(03)00167-9; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P494, DOI 10.1016/S0176-1617(96)80284-7; Grahmann K, 2014, FIELD CROP RES, V164, P166, DOI 10.1016/j.fcr.2014.05.002; Gruber S, 2011, SOIL TILL RES, V115, P80, DOI 10.1016/j.still.2011.07.001; Hurkman WJ, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-8; Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7; Jiang SS, 2012, INT J MOL SCI, V13, P16065, DOI 10.3390/ijms131216065; Johansson E, 2001, CEREAL CHEM, V78, P19, DOI 10.1094/CCHEM.2001.78.1.19; Kihara A, 2011, BIOSCI BIOTECH BIOCH, V75, P1740, DOI 10.1271/bbb.110285; Kindred DR, 2008, J CEREAL SCI, V48, P46, DOI 10.1016/j.jcs.2007.07.010; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Lemaire G, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P171, DOI 10.1016/B978-0-12-374431-9.00008-6; Marcus JP, 1999, PLANT J, V19, P699, DOI 10.1046/j.1365-313x.1999.00569.x; Matsunaka T, 1997, SOIL SCI PLANT NUTR, V43, P127, DOI 10.1080/00380768.1997.10414721; Melero S, 2011, SOIL TILL RES, V114, P97, DOI 10.1016/j.still.2011.04.007; Muccilli V, 2010, J CEREAL SCI, V51, P134, DOI 10.1016/j.jcs.2009.11.003; Osipova SV, 2012, J AGR FOOD CHEM, V60, P12065, DOI 10.1021/jf303513m; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; Penuelas J, 1997, INT J REMOTE SENS, V18, P2869, DOI 10.1080/014311697217396; PENUELAS J, 1995, NEW PHYTOL, V131, P291, DOI 10.1111/j.1469-8137.1995.tb03064.x; Pimstein A, 2011, FIELD CROP RES, V121, P125, DOI 10.1016/j.fcr.2010.12.001; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; R Core Team, 2021, R LANGUAGE ENV STAT; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Saint Pierre C, 2008, J CEREAL SCI, V47, P407, DOI 10.1016/j.jcs.2007.05.007; Sassa H, 2000, GENE, V250, P61, DOI 10.1016/S0378-1119(00)00190-6; Schleicher TD, 2001, 2001 ASAE ANN INT M; SINGH NK, 1991, J CEREAL SCI, V14, P203, DOI 10.1016/S0733-5210(09)80039-8; Skylas DJ, 2002, J CEREAL SCI, V35, P175, DOI 10.1006/jcrs.2001.0410; Stagnari F, 2013, PLANT BREEDING, V132, P266, DOI 10.1111/pbr.12044; Tang L, 2008, TRANSGENIC RES, V17, P705, DOI 10.1007/s11248-007-9155-2; Tea I, 2004, CEREAL CHEM, V81, P759, DOI 10.1094/CCHEM.2004.81.6.759; Tenuta M, 2003, CAN J SOIL SCI, V83, P521, DOI 10.4141/S02-062; Velthof GL, 2003, BIOL FERT SOILS, V37, P221, DOI 10.1007/s00374-003-0589-2; Vensel WH, 2005, PROTEOMICS, V5, P1594, DOI 10.1002/pmic.200401034; Vinje MA, 2011, PLANTA, V233, P1001, DOI 10.1007/s00425-011-1348-5; Visioli G, 2016, FOOD ANAL METHOD, V9, P469, DOI 10.1007/s12161-015-0218-3; Wan YF, 2013, J EXP BOT, V64, P161, DOI 10.1093/jxb/ers318; Wang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102914; Wang ZJ, 2004, FIELD CROP RES, V90, P311, DOI 10.1016/j.fcr.2004.04.004; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang JH, 2010, SCI CHINA TECHNOL SC, V53, P1159, DOI 10.1007/s11431-010-0131-3; Zhang N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00735; Zhao CX, 2009, CR BIOL, V332, P759, DOI 10.1016/j.crvi.2009.03.003; Zhao H, 2008, J AGRON CROP SCI, V194, P47, DOI 10.1111/j.1439-037X.2007.00283.x	60	15	15	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156007	10.1371/journal.pone.0156007	http://dx.doi.org/10.1371/journal.pone.0156007			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281174	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000011
J	Walitt, B; Katz, RS; Bergman, MJ; Wolfe, F				Walitt, Brian; Katz, Robert S.; Bergman, Martin J.; Wolfe, Frederick			Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview Survey	PLOS ONE			English	Article							DISTRESS	Objectives Although fibromyalgia criteria have been in effect for decades, little is known about how the fibromyalgia diagnosis is applied and understood by clinicians and patients. We used the National Health Interview Survey (NHIS) to determine the prevalence of self-reported clinician diagnosed fibromyalgia and then compared demographics, symptoms, disability and medical utilization measures of persons with a clinical diagnosis of fibromyalgia that did not meet diagnostic criteria (false-positive or prior [F/P] fibromyalgia) to persons with and without criteria-positive fibromyalgia. Methods The National Health Interview Survey (NHIS) collected information about both clinical diagnosis and symptoms of fibromyalgia that was appropriately weighted to represent 225,726,257 US adults. Surrogate NHIS diagnostic criteria for fibromyalgia were developed based on the level of polysymptomatic distress (PSD) as characterized in the 2011 modified American College of Rheumatology criteria (ACR) for fibromyalgia. Persons with F/P fibromyalgia were compared with persons who do not have fibromyalgia and those meeting surrogate NHIS fibromyalgia criteria. Results Of the 1.78% of persons reporting a clinical diagnosis, 73.5% did not meet NHIS fibromyalgia criteria. The prevalence of F/P fibromyalgia is 1.3%. F/P fibromyalgia is associated with a mild degree of polysymptomatic distress (NHIS PSD score 6.2) and characterized by frequent but not widespread pain and insomnia. Measures of work disability and medical utilization in F/P fibromyalgia were equal to that seen with NHIS criteria positive fibromyalgia and were 6-7x greater in F/P fibromyalgia than in non-fibromyalgia persons. F/P fibromyalgia was best predicted by being female (Odds Ratio [OR] 8.81), married (OR 3.27), and white (OR 1.96). In contrast, being a white, married woman was only modestly predictive of NHIS (criteria positive) fibromyalgia (OR 2.1). Conclusions The majority of clinically diagnosed fibromyalgia cases in the US do not reach levels of severity necessary and sufficient for diagnosis. The clinical diagnosis of fibromyalgia is disproportionally dependent on demographic and social factors rather than the symptoms themselves. Diagnostic criteria for fibromyalgia appear to be used as a vague guide by clinicians and patients, and allow for substantial diagnostic expansion of fibromyalgia.	[Walitt, Brian] Georgetown Univ, Washington, DC USA; [Katz, Robert S.] Rush Univ, Med Ctr, Dept Rheumatol, Chicago, IL 60612 USA; [Bergman, Martin J.] Drexel Univ, Coll Med, Dept Rheumatol, Philadelphia, PA 19104 USA; [Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS USA	Georgetown University; Rush University; Drexel University; National Data Bank for Rheumatic Diseases	Walitt, B (corresponding author), Georgetown Univ, Washington, DC USA.	Brian.walitt@nih.gov		Wolfe, Frederick/0000-0002-2801-6413				Association A. P., 2013, DIAGN STAT MAN MENT, V5th, P991; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; CDC, 2013, VIT SIGNS PRESCR PAI; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Conrad P, 2010, SOC SCI MED, V70, P1943, DOI 10.1016/j.socscimed.2010.02.019; Corporation S., 2013, STAT STAT SOFTW REL; Furedi F, 2006, SOCIETY, V43, P14, DOI 10.1007/BF02698479; GARFIELD SR, 1970, SCI AM, V222, P15, DOI 10.1038/scientificamerican0470-15; Gupta A, 2007, RHEUMATOLOGY, V46, P666, DOI 10.1093/rheumatology/kel363; Hauser W, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4441; Hauser W, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010292; Mease P, 2009, J RHEUMATOL, V36, P2318, DOI 10.3899/jrheum.090367; Nakamura I, 2014, ARTHRIT CARE RES, V66, P1093, DOI 10.1002/acr.22277; National Condidential Enquiry into Patient Outcome and Death (UK), 2013, MOD SHAL GAS DEV US, P1; Petzke F, 2003, J RHEUMATOL, V30, P567; Robinson RL, 2013, PAIN MED, V14, P1400, DOI 10.1111/pme.12168; Skaer TL, 2014, PHARMACOECONOMICS, V32, P457, DOI 10.1007/s40273-014-0137-y; SMYTHE H A, 1977, Bulletin on the Rheumatic Diseases, V28, P928; Szabo RM, 2000, J BONE JOINT SURG AM, V82A, P1314, DOI 10.2106/00004623-200009000-00012; Uceyler N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010782; Walitt B, 2015, PREVALENCE CHARACTER; Walitt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138024; Walitt B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011735; Walitt B, 2011, J RHEUMATOL, V38, P2238, DOI 10.3899/jrheum.110026; Wolfe F, 1997, ANN RHEUM DIS, V56, P268, DOI 10.1136/ard.56.4.268; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2015, J RHEUMATOL, V42, P1494, DOI 10.3899/jrheum.141519; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolinsky H, 2005, EMBO REP, V6, P612, DOI 10.1038/sj.embor.7400476	32	51	51	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157235	10.1371/journal.pone.0157235	http://dx.doi.org/10.1371/journal.pone.0157235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281286	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000112
J	Davis, MP; Sparks, JS; Smith, WL				Davis, Matthew P.; Sparks, John S.; Smith, W. Leo			Repeated and Widespread Evolution of Bioluminescence in Marine Fishes	PLOS ONE			English	Article							PONYFISHES TELEOSTEI LEIOGNATHIDAE; DEEP-SEA; DIVERSIFICATION; PHYLOGENY; AULOPIFORMES; RADIATIONS; DIVERSITY; LIGHT	Bioluminescence is primarily a marine phenomenon with 80% of metazoan bioluminescent genera occurring in the world's oceans. Here we show that bioluminescence has evolved repeatedly and is phylogenetically widespread across ray-finned fishes. We recover 27 independent evolutionary events of bioluminescence, all among marine fish lineages. This finding indicates that bioluminescence has evolved many more times than previously hypothesized across fishes and the tree of life. Our exploration of the macroevolutionary patterns of bioluminescent lineages indicates that the present day diversity of some inshore and deep-sea bioluminescent fish lineages that use bioluminescence for communication, feeding, and reproduction exhibit exceptional species richness given clade age. We show that exceptional species richness occurs particularly in deep-sea fishes with intrinsic bioluminescent systems and both shallow water and deep-sea lineages with luminescent systems used for communication.	[Davis, Matthew P.] St Cloud State Univ, St Cloud, MN 56301 USA; [Sparks, John S.] Amer Museum Nat Hist, New York, NY 10024 USA; [Smith, W. Leo] Univ Kansas, Lawrence, KS 66045 USA	Minnesota State Colleges & Universities; Saint Cloud State University; American Museum of Natural History (AMNH); University of Kansas	Davis, MP (corresponding author), St Cloud State Univ, St Cloud, MN 56301 USA.	mpdavis@stcloudstate.edu			National Science Foundation grants (DEB) [1543654, 1258141, 0444842, 1257555, 1060869]; Dalio Family Foundation; KU; SCSU; Direct For Biological Sciences [1543654] Funding Source: National Science Foundation	National Science Foundation grants (DEB); Dalio Family Foundation; KU; SCSU; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by National Science Foundation grants (DEB) to M.P.D. (1543654, 1258141), J.S.S. (0444842, 1257555), and W.L.S. (1060869, 1258141), with support from the Dalio Family Foundation, KU, and SCSU.; We thank the following people and institutions for providing specimens and tissue loans: A. Bentley (KU), H.J. Walker (SIO), K. Hartel and A. Williston (MCZ), C. McMahan, S. Mochel, and K. Swagel (FMNH), C. Baldwin (USNM), A. Graham (CSIRO), and M. Miya (CBM). Financial support was provided by National Science Foundation grants (DEB) to M.P.D. (1543654, 1258141), J.S.S. (0444842, 1257555), and W.L.S. (1060869, 1258141), with support from the Dalio Family Foundation, KU, and SCSU.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Branham MA, 1996, NATURE, V381, P745, DOI 10.1038/381745b0; Chakrabarty P, 2011, MOL ECOL, V20, P2818, DOI 10.1111/j.1365-294X.2011.05112.x; Chakrabarty P, 2011, J MORPHOL, V272, P704, DOI 10.1002/jmor.10941; Claes JM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150219; Davis MP, 2014, MAR BIOL, V161, P1139, DOI 10.1007/s00227-014-2406-x; Davis MP, 2010, MOL PHYLOGENET EVOL, V57, P1194, DOI 10.1016/j.ympev.2010.09.003; DeVaney SC, 2008, THESIS U KANSAS; Dikow RB, 2011, CLADISTICS, V27, P9, DOI 10.1111/j.1096-0031.2010.00312.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunlap PV, 2007, CLADISTICS, V23, P507, DOI 10.1111/j.1096-0031.2007.00157.x; Eschmeyer W. N., 2014, CATALOG FISHES; Gerlach T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0787; Ghedotti MJ, 2015, J MORPHOL, V276, P310, DOI 10.1002/jmor.20341; Haddock SHD, 2001, P NATL ACAD SCI USA, V98, P11148, DOI 10.1073/pnas.201329798; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASTINGS JW, 1971, SCIENCE, V173, P1016, DOI 10.1126/science.173.4001.1016; Herring P.J., 1987, Journal of Bioluminescence and Chemiluminescence, V1, P147, DOI 10.1002/bio.1170010303; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kronstrom J, 2010, ACTA ZOOL-STOCKHOLM, V91, P474, DOI 10.1111/j.1463-6395.2009.00438.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2012, MOL PHYLOGENET EVOL, V63, P388, DOI 10.1016/j.ympev.2012.01.011; Niemiller ML, 2013, EVOLUTION, V67, P732, DOI 10.1111/j.1558-5646.2012.01822.x; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Sparks JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083259; Straube N, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0446-6; Straube N, 2010, MOL PHYLOGENET EVOL, V56, P905, DOI 10.1016/j.ympev.2010.04.042; Thacker CE, 2009, MOL PHYLOGENET EVOL, V52, P735, DOI 10.1016/j.ympev.2009.05.017; Velez-Zuazo X, 2011, MOL PHYLOGENET EVOL, V58, P207, DOI 10.1016/j.ympev.2010.11.018; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Wiley EO, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.2946.1.4; Zwickl DJ., 2006, THESIS	38	59	59	13	225	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155154	10.1371/journal.pone.0155154	http://dx.doi.org/10.1371/journal.pone.0155154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276229	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700004
J	Buonocore, JJ; Lambert, KF; Burtraw, D; Sekar, S; Driscoll, CT				Buonocore, Jonathan J.; Lambert, Kathleen F.; Burtraw, Dallas; Sekar, Samantha; Driscoll, Charles T.			An Analysis of Costs and Health Co-Benefits for a US Power Plant Carbon Standard	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; FINE PARTICULATE MATTER; TERM CLIMATE-CHANGE; FUTURE AIR-QUALITY; POLLUTION; OZONE; POLICY; METAANALYSIS; MITIGATION; LIFE	Reducing carbon dioxide (CO2) emissions from power plants can have important "co-benefits" for public health by reducing emissions of air pollutants. Here, we examine the costs and health co-benefits, in monetary terms, for a policy that resembles the U.S. Environmental Protection Agency's Clean Power Plan. We then examine the spatial distribution of the co-benefits and costs, and the implications of a range of cost assumptions in the implementation year of 2020. Nationwide, the total health co-benefits were $29 billion 2010 USD (95% CI: $2.3 to $68 billion), and net co-benefits under our central cost case were $12 billion (95% CI: -$15 billion to $51 billion). Net co-benefits for this case in the implementation year were positive in 10 of the 14 regions studied. The results for our central case suggest that all but one region should experience positive net benefits within 5 years after implementation.	[Buonocore, Jonathan J.] Harvard Univ, Ctr Hlth & Global Environm, TH Chan Sch Publ Hlth, Boston, MA 02215 USA; [Lambert, Kathleen F.] Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; [Burtraw, Dallas; Sekar, Samantha] Resources Future Inc, Washington, DC 20036 USA; [Driscoll, Charles T.] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; [Sekar, Samantha] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Palo Alto, CA 94305 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Resources for the Future; Syracuse University; Stanford University	Buonocore, JJ (corresponding author), Harvard Univ, Ctr Hlth & Global Environm, TH Chan Sch Publ Hlth, Boston, MA 02215 USA.	jbuonocore@mail.harvard.edu	Driscoll, Charles/F-9832-2014	Driscoll, Charles/0000-0003-2692-2890	William and Flora Hewlett Foundation [2013-9458, 2014-1413]; Grantham Foundation for the Protection of the Environment through Harvard University [271065]; Mistra's Indigo research program; FORMAS Human Cooperation to Manage Natural Resources; Division Of Environmental Biology [1633026] Funding Source: National Science Foundation	William and Flora Hewlett Foundation; Grantham Foundation for the Protection of the Environment through Harvard University; Mistra's Indigo research program; FORMAS Human Cooperation to Manage Natural Resources; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by grants from the William and Flora Hewlett Foundation (Foundation Grant #s: 2013-9458 and 2014-1413) and the Grantham Foundation for the Protection of the Environment (Harvard Internal # 271065) through Harvard University, and by Mistra's Indigo research program and the FORMAS Human Cooperation to Manage Natural Resources through support to Resources for the Future. A listing of the known relevant funding sources and other relationships of the authors of this paper are below. The study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit for publication was solely conducted by the authors.	*AG HEALTHC RES QU, 2007, HEALTHC COST UT PROJ; Aldy JE, 1999, SOC NATUR RESOUR, V12, P93, DOI 10.1080/089419299279777; Allcott H, 2014, REV ECON STAT, V96, P779, DOI 10.1162/REST_a_00419; Allcott H, 2011, AM ECON REV, V101, P98, DOI 10.1257/aer.101.3.98; Anenberg SC, 2012, ENVIRON HEALTH PERSP, V120, P831, DOI 10.1289/ehp.1104301; [Anonymous], 2010, CARBON IWG SC TECHNI, P1; Arimura TH, 2012, ENERG J, V33, P63, DOI 10.5547/01956574.33.2.4; Arrow K, 2013, SCIENCE, V341, P349, DOI 10.1126/science.1235665; Buonocore JJ, 2016, NAT CLIM CHANGE, V6, P100, DOI [10.1038/NCLIMATE2771, 10.1038/nclimate2771]; Burtraw D, 2015, ENVIRON RESOUR ECON, V62, P217, DOI 10.1007/s10640-015-9963-4; Burtraw D, 2014, AM ECON REV, V104, P557, DOI 10.1257/aer.104.5.557; Byun D.W., 1999, SCI ALGORITHMS EPA M; COLBECK I, 1984, SCI TOTAL ENVIRON, V34, P87, DOI 10.1016/0048-9697(84)90043-3; Cropper ML, 2000, VALUING ENV BENEFITS; Luke C, 2006, ENVIRON INT, V32, P815, DOI 10.1016/j.envint.2006.03.012; Driscoll CT, 2015, NAT CLIM CHANGE, V5, P535, DOI 10.1038/nclimate2598; Eisenstein EL, 2001, MED CARE, V39, P824, DOI 10.1097/00005650-200108000-00008; Epstein PR, 2011, ANN NY ACAD SCI, V1219, P73, DOI 10.1111/j.1749-6632.2010.05890.x; Garcia-Menendez F, 2015, ENVIRON SCI TECHNOL, V49, P7580, DOI 10.1021/acs.est.5b01324; GDS Associates I, 2013, MICH EL NAT GAS EN E; Gerarden Todd D, 2015, ASSESSING ENERGY EFF; Gillingham K, 2014, REV ENV ECON POLICY, V8, P18, DOI 10.1093/reep/ret021; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Huynh M, 2006, PAEDIATR PERINAT EP, V20, P454, DOI 10.1111/j.1365-3016.2006.00759.x; ICF International, 2013, INT PLANN MOD; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Ji M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024006; Levy JI, 2012, AM J EPIDEMIOL, V175, P1091, DOI 10.1093/aje/kwr457; Louis MES, 2008, AM J PREV MED, V35, P527, DOI 10.1016/j.amepre.2008.08.023; Mills D, 2014, CLIM CHANGE; Moore FC, 2015, NAT CLIM CHANGE, V5, P127, DOI [10.1038/NCLIMATE2481, 10.1038/nclimate2481]; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nemet GF, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014007; Plachinski SD, 2014, ATMOS ENVIRON, V94, P180, DOI 10.1016/j.atmosenv.2014.03.028; Roman HA, 2012, RISK ANAL, V32, P2133, DOI 10.1111/j.1539-6924.2012.01826.x; Shin HH, 2014, EPIDEMIOLOGY, V25, P835, DOI 10.1097/EDE.0000000000000162; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Shindell DT, 2015, CLIMATIC CHANGE, V130, P313, DOI 10.1007/s10584-015-1343-0; Talbott EO, 2015, ENVIRON RES, V140, P414, DOI 10.1016/j.envres.2015.04.021; Thompson TM, 2014, NAT CLIM CHANGE, V4, P917, DOI [10.1038/nclimate2342, 10.1038/NCLIMATE2342]; U. S. Energy Information, 2013, DOEEIA0383, V1, P1; U. S. Environmental Protection Agency, 2015, REG IMP AN CLEAN POW; U.S. Environmental Protection Agency, 2015, CARB POLL EM GUID EX, P1560; U.S. Environmental Protection Agency, 2015, BENMAP; U.S. Environmental Protection Agency Office of Air Quality Planning and Standards Health and Environmental Impacts Division, 2011, REG IMP AN FIN MERC; US EPA, 2015, TECHN SUPP DOC SOC C, P1, DOI [10.1017/CBO9781107415324.004.SW-846, DOI 10.1017/CBO9781107415324.004.SW-846]; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/nclimate2009, 10.1038/NCLIMATE2009]; Williams RC, 2002, J ENVIRON ECON MANAG, V44, P261, DOI 10.1006/jeem.2001.1237; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58	51	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156308	10.1371/journal.pone.0156308	http://dx.doi.org/10.1371/journal.pone.0156308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27270222	Green Published, gold			2022-12-27	WOS:000377561000011
J	Devarajan, K				Devarajan, Kadambari			The Antsy Social Network: Determinants of Nest Structure and Arrangement in Asian Weaver Ants	PLOS ONE			English	Article							OECOPHYLLA-SMARAGDINA; PLANT MUTUALISM; HYMENOPTERA; COMPETITION	Asian weaver ants (Oecophylla smaragdina) are arboreal ants that are known to form mutualistic complexes with their host trees. They are eusocial ants that build elaborate nests in the canopy in tropical areas. A colony comprises of multiple nests, usually on multiple trees, and the boundaries of the colony may be difficult to identify. However, they provide the ideal model for studying group living in invertebrates since there are a definite number of nests for a given substrate, the tree. Here, we briefly examine the structure of the nests and the processes involved in the construction and maintenance of these nests. We have described the spatial arrangement of weaver ant nests on trees in two distinct tropical clusters, a few hundred kilometres apart in India. Measurements were made for 13 trees with a total of 71 nests in the two field sites. We have considered a host of biotic and abiotic factors that may be crucial in determining the location of the nesting site by Asian weaver ants. Our results indicate that tree characteristics and architecture followed by leaf features help determine nest location in Asian weaver ants. While environmental factors may not be as influential to nest arrangement, they seem to be important determinants of nest structure. The parameters that may be considered in establishing the nests could be crucial in picking the evolutionary drivers for colonial living in social organisms.	[Devarajan, Kadambari] Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Post Grad Programme Wildlife Biol & Conservat, Bengaluru, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Devarajan, K (corresponding author), Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Post Grad Programme Wildlife Biol & Conservat, Bengaluru, India.	kadambari.devarajan@gmail.com			National Centre for Biological Sciences	National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the National Centre for Biological Sciences (URL: http://ncbs.res.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bluthgen N, 2002, J ANIM ECOL, V71, P793, DOI 10.1046/j.1365-2656.2002.00647.x; Bochynek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095112; BRADSHAW JWS, 1975, NATURE, V258, P230, DOI 10.1038/258230a0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; COLE AC, 1948, AM MIDL NAT, V39, P641, DOI 10.2307/2421529; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dlussky GM, 2008, ACTA PALAEONTOL POL, V53, P615, DOI 10.4202/app.2008.0406; Dunn RR, 2007, EVOL ECOL RES, V9, P1349; Edwards DP, 2006, P ROY SOC B-BIOL SCI, V273, P595, DOI 10.1098/rspb.2005.3273; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; HOLLDOBLER B, 1977, P NATL ACAD SCI USA, V74, P2072, DOI 10.1073/pnas.74.5.2072; Holldobler B, 1977, SCI AM, P237; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; JAISSON P, 1980, NATURE, V286, P388, DOI 10.1038/286388a0; Jander R, 1998, ETHOLOGY, V104, P743, DOI 10.1111/j.1439-0310.1998.tb00108.x; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Lach L, 2011, OIKOS, V120, P9, DOI 10.1111/j.1600-0706.2010.18803.x; Mele PV, 2008, INT J PEST MANAGE, V55, P57, DOI [10.1080/09670870802450276, DOI 10.1080/09670870802450276]; Newey PS, 2010, ECOLOGY, V91, P2366, DOI 10.1890/09-0561.1; Palmer TM, 2003, ECOLOGY, V84, P2843, DOI 10.1890/02-0528; Peng RK, 2011, AGR FOREST ENTOMOL, V13, P165, DOI 10.1111/j.1461-9563.2010.00514.x; Peng RK, 1998, AUST J ENTOMOL, V37, P249, DOI 10.1111/j.1440-6055.1998.tb01579.x; Ramachandran P, 2011, COMPUT SCI ENG, V13, P40, DOI 10.1109/MCSE.2011.35; Reh D, 1906, SCI AM S, V1575, P25241; Santos JC, 2005, SOCIOBIOLOGY, V46, P27; Schluns EA, 2009, MOL ECOL, V18, P156, DOI 10.1111/j.1365-294X.2008.04020.x; Sribandit W, 2008, ASIAN MYRMECOL, V2, P129; Stanton ML, 1999, NATURE, V401, P578, DOI 10.1038/44119; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; Van Mele P, 2008, AGR FOREST ENTOMOL, V10, P13, DOI 10.1111/j.1461-9563.2007.00350.x; WAY MJ, 1951, NATURE, V168, P302, DOI 10.1038/168302b0; WILSON EDWARD O., 1964, PSYCHE, V71, P93, DOI 10.1155/1964/17612	33	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156681	10.1371/journal.pone.0156681	http://dx.doi.org/10.1371/journal.pone.0156681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271037	Green Published, gold			2022-12-27	WOS:000377561000031
J	Jiang, T; Nogales, A; Baker, SF; Martinez-Sobrido, L; Turner, DH				Jiang, Tian; Nogales, Aitor; Baker, Steven F.; Martinez-Sobrido, Luis; Turner, Douglas H.			Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture	PLOS ONE			English	Article							SECONDARY STRUCTURE; COAXIAL STACKING; AVIAN INFLUENZA; UNITED-STATES; VIRUS-VACCINE; NS1 PROTEIN; SEQUENCE; DOMAIN; CHILDREN; EFFICACY	Influenza A virus is a significant public health threat, but little is understood about the viral RNA structure and function. Current vaccines and therapeutic options to control influenza A virus infections are mostly protein-centric and of limited effectiveness. Here, we report using an ensemble defect approach to design mutations to misfold regions of conserved mRNA structures in influenza A virus segments 7 and 8. Influenza A mutant viruses inhibit pre-mRNA splicing and attenuate viral replication in cell culture, thus providing evidence for functions of the targeted regions. Targeting these influenza A viral RNA regions provides new possibilities for designing vaccines and therapeutics against this important human respiratory pathogen. The results also demonstrate that the ensemble defect approach is an efficient way to test for function of RNA sequences.	[Jiang, Tian; Turner, Douglas H.] Univ Rochester, Dept Chem, Rochester, NY USA; [Nogales, Aitor; Baker, Steven F.; Martinez-Sobrido, Luis] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA	University of Rochester; University of Rochester	Turner, DH (corresponding author), Univ Rochester, Dept Chem, Rochester, NY USA.	turner@chem.rochester.edu	NOGALES, AITOR/AAY-1590-2020; Martinez-Sobrido, Luis/ACJ-7853-2022; NOGALES, AITOR/W-3948-2017	NOGALES, AITOR/0000-0002-2424-7900; Martinez-Sobrido, Luis/0000-0001-7084-0804; Baker, Steven/0000-0001-8379-283X	National Institutes of Health [GM22939]; University of Rochester Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM22939 (DHT) and a 2014 University of Rochester Research Award (LMS) (http://www.nih.gov/) (http://www.rochester.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2012, EUR J CLIN MICROBIOL, V31, P2549, DOI 10.1007/s10096-012-1595-9; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Belshe RB, 2008, VACCINE, V26, pD10, DOI 10.1016/j.vaccine.2008.06.083; Belshe RB, 2007, VACCINE, V25, P6755, DOI 10.1016/j.vaccine.2007.06.066; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Carrillo B, 2014, J VIROL, V88, P4113, DOI 10.1128/JVI.03692-13; CDC, 2015, LIV ATT INFL VACC LA; CDC, 2015, IN INFL VACC INF STA; Chen JL, 2012, BIOCHEMISTRY-US, V51, P3508, DOI 10.1021/bi3002709; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Cho KJ, 2015, J VIROL, V89, P3700, DOI 10.1128/JVI.02576-14; Cox A, 2015, J VIROL, V89, P3421, DOI 10.1128/JVI.02636-14; COX NJ, 1988, VIROLOGY, V167, P554, DOI 10.1016/S0042-6822(88)90118-3; Cross TA, 2012, CURR OPIN VIROL, V2, P128, DOI 10.1016/j.coviro.2012.01.005; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Govorkova EA, 2013, CURR TOP MICROBIOL, V370, P273, DOI 10.1007/82_2011_198; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; Gu M, 2012, J VIROL, V86, P12463, DOI 10.1128/JVI.02315-12; Gultyaev AP, 2007, BIOINFORMATICS, V23, P272, DOI 10.1093/bioinformatics/btl559; Gultyaev AP, 2014, RNA BIOL, V11, P942, DOI 10.4161/rna.29730; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Jiang T, 2014, BIOCHEMISTRY-US, V53, P5236, DOI 10.1021/bi500611j; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lommer BS, 2002, J BIOL CHEM, V277, P7108, DOI 10.1074/jbc.M109045200; MAASSAB HF, 1967, NATURE, V213, P612, DOI 10.1038/213612a0; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Martinez-Sobrido L, 2010, J VISUALIZED EXPT; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Moss WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038323; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Safo MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109510; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shtykova EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082431; SNYDER MH, 1988, J VIROL, V62, P488, DOI 10.1128/JVI.62.2.488-495.1988; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Tyagi R, 2007, RNA, V13, P939, DOI 10.1261/rna.305307; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; WALTER AE, 1994, BIOCHEMISTRY-US, V33, P12715, DOI 10.1021/bi00208a024; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786	55	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156906	10.1371/journal.pone.0156906	http://dx.doi.org/10.1371/journal.pone.0156906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272307	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000046
J	Watson, CM; Crinnion, LA; Harrison, SM; Lascelles, C; Antanaviciute, A; Carr, IM; Bonthron, DT; Sheridan, E				Watson, Christopher M.; Crinnion, Laura A.; Harrison, Sally M.; Lascelles, Carolina; Antanaviciute, Agne; Carr, Ian M.; Bonthron, David T.; Sheridan, Eamonn			A Chromosome 7 Pericentric Inversion Defined at Single-Nucleotide Resolution Using Diagnostic Whole Genome Sequencing in a Patient with Hand-Foot-Genital Syndrome	PLOS ONE			English	Article							HOXA13; PERFORMANCE; EXPRESSION; ALIGNMENT; DELETION; REVEALS; CLUSTER	Next generation sequencing methodologies are facilitating the rapid characterisation of novel structural variants at nucleotide resolution. These approaches are particularly applicable to variants initially identified using alternative molecular methods. We report a child born with bilateral postaxial syndactyly of the feet and bilateral fifth finger clinodactyly. This was presumed to be an autosomal recessive syndrome, due to the family history of consanguinity. Karyotype analysis revealed a homozygous pericentric inversion of chromosome 7 (46, XX,inv(7)(p15q21)x2) which was confirmed to be heterozygous in both unaffected parents. Since the resolution of the karyotype was insufficient to identify any putatively causative gene, we undertook medium-coverage whole genome sequencing using paired-end reads, in order to elucidate the molecular breakpoints. In a two-step analysis, we first narrowed down the region by identifying discordant read-pairs, and then determined the precise molecular breakpoint by analysing the mapping locations of "soft-clipped" breakpoint-spanning reads. PCR and Sanger sequencing confirmed the identified breakpoints, both of which were located in intergenic regions. Significantly, the 7p15 break-point was located 523 kb upstream of HOXA13, the locus for hand-foot-genital syndrome. By inference from studies of HOXA locus control in the mouse, we suggest that the inversion has delocalised a HOXA13 enhancer to produce the phenotype observed in our patient. This study demonstrates how modern genetic diagnostic approach can characterise structural variants at nucleotide resolution and provide potential insights into functional regulation.	[Watson, Christopher M.; Crinnion, Laura A.; Bonthron, David T.; Sheridan, Eamonn] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [Watson, Christopher M.; Crinnion, Laura A.; Harrison, Sally M.; Lascelles, Carolina; Antanaviciute, Agne; Carr, Ian M.; Bonthron, David T.; Sheridan, Eamonn] Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; Saint James's University Hospital; University of Leeds	Watson, CM (corresponding author), St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England.; Watson, CM (corresponding author), Univ Leeds, St Jamess Univ Hosp, Sch Med, Leeds LS9 7TF, W Yorkshire, England.	c.m.watson@leeds.ac.uk		Antanaviciute, Agne/0000-0002-9019-2215; Watson, Christopher Mark/0000-0003-2371-1844	MRC [MR/L01629X/1, MR/M009084/1] Funding Source: UKRI; Medical Research Council [MR/M009084/1, MR/L01629X/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Devriendt K, 1999, AM J HUM GENET, V65, P249, DOI 10.1086/302452; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Hayes JL, 2013, GENOMICS, V102, P174, DOI 10.1016/j.ygeno.2013.04.006; Innis JW, 2004, HUM MOL GENET, V13, P2841, DOI 10.1093/hmg/ddh306; Innis JW, 2006, GENEREVIEWS; Jun KR, 2011, AM J MED GENET A, V155A, P642, DOI 10.1002/ajmg.a.33860; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lehoczky JA, 2004, EVOL DEV, V6, P423, DOI 10.1111/j.1525-142X.2004.04050.x; Lehoczky JA, 2008, EVOL DEV, V10, P421, DOI 10.1111/j.1525-142X.2008.00253.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Morgan JE, 2010, HUM MUTAT, V31, P484, DOI 10.1002/humu.21216; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Perez WD, 2010, DEV DYNAM, V239, P446, DOI 10.1002/dvdy.22183; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Watson CM, 2014, AM J MED GENET A, V164, P2649, DOI 10.1002/ajmg.a.36679; Watson CM, 2014, HUM MUTAT, V35, P434, DOI 10.1002/humu.22490	22	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157075	10.1371/journal.pone.0157075	http://dx.doi.org/10.1371/journal.pone.0157075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272187	Green Published, gold			2022-12-27	WOS:000377561000060
J	Ghanbarian, H; Wagner, N; Polo, B; Baudouy, D; Kiani, J; Michiels, JF; Cuzin, F; Rassoulzadegan, M; Wagner, KD				Ghanbarian, Hossein; Wagner, Nicole; Polo, Beatrice; Baudouy, Delphine; Kiani, Jafar; Michiels, Jean-Francois; Cuzin, Francois; Rassoulzadegan, Minoo; Wagner, Kay-Dietrich			Dnmt2/Trdmt1 as Mediator of RNA Polymerase II Transcriptional Activity in Cardiac Growth	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; METHYLTRANSFERASE DNMT2; B2 RNA; P-TEFB; HYPERTROPHY; METHYLATION; COMPLEXES; MOUSE; DNA; INHERITANCE	Dnmt2/Trdmt1 is a methyltransferase, which has been shown to methylate tRNAs. Deficient mutants were reported to exhibit various, seemingly unrelated, defects in development and RNA-mediated epigenetic heredity. Here we report a role in a distinct developmental regulation effected by a noncoding RNA. We show that Dnmt2-deficiency in mice results in cardiac hypertrophy. Echocardiographic measurements revealed that cardiac function is preserved notwithstanding the increased dimensions of the organ due to cardiomyocyte enlargement. Mechanistically, activation of the P-TEFb complex, a critical step for cardiac growth, results from increased dissociation of the negatively regulating Rn7sk non-coding RNA component in Dnmt2-deficient cells. Our data suggest that Dnmt2 plays an unexpected role for regulation of cardiac growth by modulating activity of the P-TEFb complex.	[Ghanbarian, Hossein] Shahid Beheshti Univ Med Sci, Dept Biotechnol, Sch Adv Technol Med, Tehran, Iran; [Wagner, Nicole; Baudouy, Delphine; Michiels, Jean-Francois; Wagner, Kay-Dietrich] Univ Nice Sophia Antipolis, IRCAN, Fac Med, CNRS UMR7284,INSERM U1081, F-06100 Nice, France; [Wagner, Nicole; Polo, Beatrice; Baudouy, Delphine; Cuzin, Francois; Rassoulzadegan, Minoo; Wagner, Kay-Dietrich] Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, F-06100 Nice, France; [Michiels, Jean-Francois] CHU Nice, Dept Pathol, F-06202 Nice, France; [Kiani, Jafar] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran, Iran	Shahid Beheshti University Medical Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Iran University of Medical Sciences	Wagner, KD (corresponding author), Univ Nice Sophia Antipolis, IRCAN, Fac Med, CNRS UMR7284,INSERM U1081, F-06100 Nice, France.; Rassoulzadegan, M; Wagner, KD (corresponding author), Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, F-06100 Nice, France.	minoo@unice.fr; kwagner@unice.fr	Ghanbarian, Hossein/P-6082-2019; Wagner, Kay-Dietrich/E-6119-2016; Rassoulzadegan, Minoo/O-7939-2016	Wagner, Kay-Dietrich/0000-0001-5483-7760; Wagner, Nicole/0000-0002-2746-0707; Kiani, Jafar/0000-0002-5907-5846	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE program [ANR-11-LABX-0028-01]; Association pour la Recherche sur le Cancer; Fondation de France; Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche France [ANR-08-GENOPAT-011 Epipath-Parapath]; Shahid Beheshti University of Medical Sciences, Iran	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE program(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation de France(Fondation de France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche France(French National Research Agency (ANR)); Shahid Beheshti University of Medical Sciences, Iran	This work was supported by the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE program (reference ANR-11-LABX-0028-01), the Association pour la Recherche sur le Cancer and Fondation de France (KDW), the Ligue Nationale Contre le Cancer and Agence Nationale de la Recherche France (ANR-08-GENOPAT-011 Epipath-Parapath) (MR). HG was the recipient of a scholarship from Shahid Beheshti University of Medical Sciences, Iran.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Cherrier T, 2013, P NATL ACAD SCI USA, V110, P12655, DOI 10.1073/pnas.1220136110; Coelho OR, 2013, CIRCULATION, V128, P1225, DOI 10.1161/CIRCULATIONAHA.112.000438; DANIELS GR, 1985, NATURE, V317, P819, DOI 10.1038/317819a0; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Kulkarni PA, 2004, RECENT PROG HORM RES, V59, P125, DOI 10.1210/rp.59.1.125; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Tuorto F, 2015, EMBO J, V34, P2350, DOI 10.15252/embj.201591382; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wagner KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6852; Yadlapalli S, 2013, NATURE, V498, P251, DOI 10.1038/nature12106; Yakovchuk P, 2011, TRANSCR-AUSTIN, V2, P45, DOI 10.4161/trns.2.1.14306; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	30	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156953	10.1371/journal.pone.0156953	http://dx.doi.org/10.1371/journal.pone.0156953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270731	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200027
J	Cusimano, MD; Ilie, G; Mullen, SJ; Pauley, CR; Stulberg, JR; Topolovec-Vranic, J; Zhang, S				Cusimano, Michael D.; Ilie, Gabriela; Mullen, Sarah J.; Pauley, Christopher R.; Stulberg, Jennifer R.; Topolovec-Vranic, Jane; Zhang, Stanley			Aggression, Violence and Injury in Minor League Ice Hockey: Avenues for Prevention of Injury	PLOS ONE			English	Article							BODY-CHECKING; BRAIN-INJURY; CONCUSSION EDUCATION; BAYESIAN NETWORK; YOUTH HOCKEY; RISK-FACTORS; SPORT; PSYCHOLOGY; BEHAVIOR; PLAYERS	Background In North America, more than 800,000 youth are registered in organized ice hockey leagues. Despite the many benefits of involvement, young players are at significant risk for injury. Body-checking and aggressive play are associated with high frequency of game-related injury including concussion. We conducted a qualitative study to understand why youth ice hockey players engage in aggressive, injury-prone behaviours on the ice. Methods Semi-structured interviews were conducted with 61 minor ice hockey participants, including male and female players, parents, coaches, trainers, managers and a game official. Players were aged 13-15 playing on competitive body checking teams or on non-body checking teams. Interviews were manually transcribed, coded and analyzed for themes relating to aggressive play in minor ice hockey. Results Parents, coaches, teammates and the media exert a large influence on player behavior. Aggressive behavior is often reinforced by the player's social environment and justified by players to demonstrate loyalty to teammates and especially injured teammates by seeking revenge particularly in competitive, body-checking leagues. Among female and male players in non-body checking organizations, aggressive play is not reinforced by the social environment. These findings are discussed within the framework of social identity theory and social learning theory, in order to understand players' need to seek revenge and how the social environment reinforces aggressive behaviors. Conclusion This study provides a better understanding of the players' motivations and environmental influences around aggressive and violent play which may be conducive to injury. The findings can be used to help design interventions aimed at reducing aggression and related injuries sustained during ice hockey and sports with similar cultures and rules.	[Cusimano, Michael D.; Mullen, Sarah J.; Pauley, Christopher R.; Zhang, Stanley] St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Stulberg, Jennifer R.] Univ Toronto, Family & Community Med, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med, Occupat Sci & Occupat Therapy, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Dalhousie University; University of Toronto; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca	Cusimano, Michael/GWR-1025-2022; Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212	Canadian Institutes of Health Research Strategic Team Grant [TIR-103946]; Ontario Neurotrauma Foundation; St. Michael's Hospital Foundation	Canadian Institutes of Health Research Strategic Team Grant; Ontario Neurotrauma Foundation; St. Michael's Hospital Foundation	This research was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation (http://onf.org), as well as the St. Michael's Hospital Foundation (http://www.stmichaelsfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PL, 2014, REV PSICOL DEPORTE, V23, P395; Anderson E., 2010, SPORT THEORY AND SOC; [Anonymous], 2012, CULTURE; Arnold E, 2002, WHOSE PUCK IS IT ANY; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bawa H BM, 2004, SPORTS RELATED INJUR; Beddoes-Jones F., 2004, TRAINING JOURNAL, V16; Bortoli L, 2012, PSYCHOL SPORT EXERC, V13, P397, DOI 10.1016/j.psychsport.2012.01.001; Bronfenbrenner U., 1988, PERSONS CONTEXT DEV, P25; Bruner MW, 2015, J APPL SPORT PSYCHOL, V27, P351, DOI 10.1080/10413200.2015.1010661; Bruner MW, 2013, GROUP DYN-THEOR RES, V17, P30, DOI 10.1037/a0030114; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Carron AV, 1982, JOURNAL OF SPORT PSY; Celozzi MJ, 1981, JOURNAL OF SPORT BEH; Chalabaev A, 2013, PSYCHOL SPORT EXERC, V14, P136, DOI 10.1016/j.psychsport.2012.10.005; Chapman J., 2006, MANAGE DECIS, V44, P1391, DOI [DOI 10.1108/00251740610715713, 10.1108/00251740610715713.]; Chicau Borrego C, 2012, J HUMAN KINETICS, V34, P119; Cohen J, 1977, STATISTICAL POWER AN; Cope CJ, 2011, INT J SPORT EXERC PS, V9, P19, DOI 10.1080/1612197X.2011.563124; Cusimano MD, 2012, CANADIAN MEDICAL ASS; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Cusimano Michael D, 2011, Open Med, V5, pe57; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ford DW, 2012, JOURNAL OF SPORT ADM, V4; Frederick EL, 2013, CONTRACT NO 1; Freedman J, 1970, AGGRESSION SOCIAL PS, P101; Fu T, 2015, CANADIAN JOURNAL OF, V42; Fuster-Parra P, 2015, HUM MOVEMENT SCI, V40, P98, DOI 10.1016/j.humov.2014.12.005; Fuster-Parra P, 2014, QUAL QUANT, V48, P1473, DOI 10.1007/s11135-013-9848-y; Gillis C., 2014, HOW PARENTS AND THEI; Gould D, 2006, BRIT J SPORT MED, V40, P632, DOI 10.1136/bjsm.2005.024927; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Hancock B, 1998, AN INTRODUCTION TO Q; Hardy J, 2005, SMALL GR RES, V36, P166, DOI 10.1177/1046496404266715; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Ilie G, 2014, JOURNAL OF NEUROTRAU; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Janis IL., 1997, GROUPTHINK; Jeffery-Tosoni S, 2015, J SPORT BEHAV, V38, P3; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kimmel M., 1987, THE LIFE OF A MANS S, P53; Kirker B, 2000, RES Q EXERCISE SPORT, V71, P373, DOI 10.1080/02701367.2000.10608920; Kleiber DA, 1981, JOURNAL OF SPORT PSY, V3; Lacey A, 2001, TRENT FOCUS FOR RESE; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Loughead TM, 2001, JOURNAL OF SPORT BEH; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Mageau GA, 2003, J SPORT SCI, V21, P883, DOI 10.1080/0264041031000140374; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; MARCOTTE G, 1993, ASTM STP, V1212, P103, DOI DOI 10.1520/STP13128S; Mugno D A, 1985, Can J Appl Sport Sci, V10, P26; NASH JE, 1981, YOUTH SOC, V13, P229, DOI 10.1177/0044118X8101300202; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pediatrics AAo, 2000, PEDIATRICS PT 1, V105, P657; Perry JL, 2013, ATHLETIC INSIGHT, V5, P197; R M. The Bertuzzi Incident, 2004, GLOBE MAIL; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Rothe J. P., 2000, UNDERTAKING QUALITAT; Rutten EA, 2007, J YOUTH ADOLESCENCE, V36, P255, DOI 10.1007/s10964-006-9085-y; Schwandt T. A., 2007, THE SAGE DICTIONARY; Shah C.P., 2003, PUBLIC HEALTH AND PR; Sheldon JP, 2001, RES Q EXERCISE SPORT, V72, P304, DOI 10.1080/02701367.2001.10608965; Shirazi M, 2015, CANADIAN JOURNAL OF, P42; Smith MD, 1979, CANADIAN JOURNAL OF, P105; Sports C., 2015, NHL HOCKEY INJURIES; Steinfeldt JA, PSYCHOLOGY OF MEN MA, V12, P324; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Surveillance Epidemiology Division CfCDPPHAoC, 2014, CHRONIC DISEASES AND, V34, P272; Tajfel H, 2004, THE SOCIAL IDENTITY; Taylor S J, 1981, Monogr Am Assoc Ment Defic, P71; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Traclet A, 2015, AGGRESSIVE BEHAV, V41, P123, DOI 10.1002/ab.21561; TUCKMAN BW, 1965, PSYCHOL BULL, V63, P384, DOI 10.1037/h0022100; Villani S, 2001, J AM ACAD CHILD PSY, V40, P392, DOI 10.1097/00004583-200104000-00007; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wiese-Bjornstal DM, 2014, REV PSICOL DEPORTE, V23, P411; Wojtys EM, 2015, SPORTS HEALTH, V7, P108, DOI 10.1177/1941738115572986	89	12	13	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156683	10.1371/journal.pone.0156683	http://dx.doi.org/10.1371/journal.pone.0156683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258426	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700103
J	Jeong, BY; Uddin, MJ; Park, JH; Lee, JH; Lee, HB; Miyata, T; Ha, H				Jeong, Bo Yeong; Uddin, Md Jamal; Park, Jong Hee; Lee, Jung Hwa; Lee, Hi Bahl; Miyata, Toshio; Ha, Hunjoo			Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model	PLOS ONE			English	Article							RENAL INTERSTITIAL FIBROSIS; SMALL-MOLECULE INHIBITOR; OBSTRUCTIVE NEPHROPATHY; URETERAL OBSTRUCTION; DEFICIENCY; PAI-1; DISEASE; MICE; BENEFITS	Diabetic nephropathy is the leading cause of end-stage renal disease worldwide, but no effective therapeutic strategy is available. Because plasminogen activator inhibitor-1 (PAI-1) is increasingly recognized as a key factor in extracellular matrix (ECM) accumulation in diabetic nephropathy, this study examined the renoprotective effects of TM5275 and TM5441, two novel orally active PAI-1 inhibitors that do not trigger bleeding episodes, in streptozotocin (STZ)-induced diabetic mice. TM5275 (50 mg/kg) and TM5441 (10 mg/kg) were administered orally for 16 weeks to STZ-induced diabetic and age-matched control mice. Relative to the control mice, the diabetic mice showed significantly increased (p < 0.05) plasma glucose and creatinine levels, urinary albumin excretion, kidney-to-body-weight ratios, glomerular volume, and fractional mesangial area. Markers of fibrosis and inflammation along with PAI-1 were also upregulated in the kidney of diabetic mice, and treatment with TM5275 and TM5441 effectively inhibited albuminuria, mesangial expansion, ECM accumulation, and macrophage infiltration in diabetic kidneys. Furthermore, in mouse proximal tubular epithelial (mProx24) cells, both TM5275 and TM5441 effectively inhibited PAI-1-induced mRNA expression of fibrosis and inflammation markers and also reversed PAI-1-induced inhibition of plasmin activity, which confirmed the efficacy of the TM compounds as PAI-1 inhibitors. These data suggest that TM compounds could be used to prevent diabetic kidney injury.	[Jeong, Bo Yeong; Uddin, Md Jamal; Park, Jong Hee; Lee, Jung Hwa; Ha, Hunjoo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, 52 Ewhayeodae Gil, Seoul 120750, South Korea; [Lee, Hi Bahl] Kims Clin & Dialysis Unit, Myrang, South Korea; [Miyata, Toshio] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Res, Sendai, Miyagi 980, Japan	Ewha Womans University; Tohoku University	Ha, H (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	hha@ewha.ac.kr	Miyata, Toshio/A-4872-2010; Uddin, Md Jamal/W-3434-2017	Uddin, Md Jamal/0000-0003-2911-3255; Ha, Hunjoo/0000-0002-5601-1265	NRF [NRF-2014R1A2A1A11050945]; NST - Korean Government [DRC-2014-1-KBSI]	NRF; NST - Korean Government	It is noted that this work was supported by NRF-2014R1A2A1A11050945 from an NRF grant (www.nrf.re.kr) and DRC-2014-1-KBSI from an NST grant (www.nst.re.kr) funded by the Korean Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Collins SJ, 2006, NEPHRON EXP NEPHROL, V104, pE23, DOI 10.1159/000093673; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Edgtton KL, 2004, KIDNEY INT, V66, P68, DOI 10.1111/j.1523-1755.2004.00707.x; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Huang WT, 2012, AM J RESP CELL MOL, V46, P87, DOI 10.1165/rcmb.2011-0139OC; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Hwang I, 2012, DIABETES, V61, P728, DOI 10.2337/db11-0584; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Kobayashi N, 2015, AM J PHYSIOL-RENAL, V308, pF614, DOI 10.1152/ajprenal.00616.2014; LANE PH, 1993, KIDNEY INT, V43, P661, DOI 10.1038/ki.1993.95; Mao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092686; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Pelisch N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124510; Peters H, 2004, KIDNEY INT, V66, P1434, DOI 10.1111/j.1523-1755.2004.00906.x; Placencio VR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133786; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Vaughan DE, 2007, CURR DRUG TARGETS, V8, P962, DOI 10.2174/138945007781662364; Weisberg AD, 2005, ARTERIOSCL THROM VAS, V25, P365, DOI 10.1161/01.ATV.0000152356.85791.52	35	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157012	10.1371/journal.pone.0157012	http://dx.doi.org/10.1371/journal.pone.0157012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258009	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700169
J	Li, YK; Liu, QC; Liu, F; Zhu, PF; Zhang, LC; Zhou, XJ; Sun, CY; Cheng, YH				Li, Yukui; Liu, Qingchuan; Liu, Fei; Zhu, Pengfei; Zhang, Lichao; Zhou, Xiujie; Sun, Chongyu; Cheng, Yunhuan			Effects of Different Ratios of Sewage Sludge and Cattle Manure on Growth and Propagation of Eisenia Fetida	PLOS ONE			English	Article							PERIONYX-EXCAVATUS; VERMISTABILIZATION; REPRODUCTION; OLIGOCHAETA; STABILIZATION; REQUIREMENTS; NUTRIENT; INDUSTRY; DENSITY; WASTES	Domestic sewage sludge and cattle manure are rich in nutrition elements, but without proper disposal, are harmful to the environment. Here with an indoor culture method, we used Eisenia fetida to dispose different ratios of sewage sludge and cattle manure, and thereby investigated the effects and acting rules of these sludge-manure mixtures on the growth and reproduction of E. fetida. We find these mixtures are food sources for E. fetida, and their physiochemical properties are significantly changed after disposal by earthworms. Paired samples t-test shows the average change after different treatments is -20.37% for total organic carbon, 85.71% for total Kjeldahl N, -6.67% for total P, 8.33% for pH, -24.78% for EC (ms.cm(-1)), and -57.10% for C/N ratio. The average growth rate after treatment CD-70 is 9.20 mg.worm(-1).day(-1); the average growth rates of E. fetida on day 0-28, day 29-56, and day 57-91 are 9.33, 11.90 and 6.95 mg.worm(-1).day(-1), respectively, indicating a trend of "rapid-rapidest-slow" growth. Other treatments all show this trend. Though all earthworms developed reproductive rings during the test periods, the appearing time and the cocoon production time both differed among these treatments. The cocoon production amount is maximized to 233 after treatment CD-70. The cocoon production rates are significantly different among these treatments, and the maximum and mean are 0.32 and 0.17-.32, cocoons.worm(-1).day(-1), respectively. E. fetida can modestly enrich Cd, but is not very effective over Sb or other heavy metals. E. fetida can remove a part of heavy metals from sewage sludge and cattle manure. Generally, the mixtures of sewage sludge and cattle manure can largely affect the growth and propagation of E. fetida in a ratio-dependent way.	[Li, Yukui; Liu, Fei; Zhu, Pengfei; Zhang, Lichao; Zhou, Xiujie; Sun, Chongyu; Cheng, Yunhuan] Huaibei Normal Univ, Sch Environm Sci, Huaibei, Anhui, Peoples R China; [Liu, Qingchuan] Hefei Univ Technol, Coll Food Sci, Hefei, Anhui, Peoples R China	Huaibei Normal University; Hefei University of Technology	Liu, F (corresponding author), Huaibei Normal Univ, Sch Environm Sci, Huaibei, Anhui, Peoples R China.	liufei66@mail.ahnu.edu.cn		LIU, Fei/0000-0003-4378-5007	National Science Foundation of China [41371444]; China Spark Program [2014GA710040]; Anhui Provincial Natural Science Project [KJ2013ZD07, 1301ZC04064]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Spark Program; Anhui Provincial Natural Science Project	This work was financially supported by the National Science Foundation of China (Project No. 41371444), the China Spark Program (2014GA710040); and Anhui Provincial Natural Science Project (No. KJ2013ZD07, No. 1301ZC04064;). Talent Cultivation Plan of Huaibei City: 20130306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2000, BIORESOURCE TECHNOL, V73, P95, DOI 10.1016/S0960-8524(99)00173-X; Bettinelli M, 2000, ANAL CHIM ACTA, V424, P289, DOI 10.1016/S0003-2670(00)01123-5; Bhat SA, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-014-0780-y; Bhat SA, 2014, ENVIRON SCI POLLUT R, V21, P8112, DOI 10.1007/s11356-014-2758-2; Chauhan H. K., 2012, World Journal of Zoology, V7, P23; Cynthia J. M., 2012, Advances in Applied Science Research, V3, P1092; Dominguez J, 2000, PEDOBIOLOGIA, V44, P24, DOI 10.1078/S0031-4056(04)70025-6; Dominguez J, 1997, PEDOBIOLOGIA, V41, P566; Dominguez-Crespo MA, 2012, WATER AIR SOIL POLL, V223, P915, DOI 10.1007/s11270-011-0913-7; Edwards Clive A., 1998, P327; Garg V. K., 2006, Environmentalist, V26, P269, DOI 10.1007/s10669-006-8641-z; Hait S, 2011, BIORESOURCE TECHNOL, V102, P2812, DOI 10.1016/j.biortech.2010.10.031; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; International Standard Organisation (ISO), 1995, 112611995 ISO; Molina MJ, 2013, BIORESOURCE TECHNOL, V137, P88, DOI 10.1016/j.biortech.2013.03.029; KALE RD, 1982, PEDOBIOLOGIA, V23, P419; KAPLAN DL, 1980, SOIL BIOL BIOCHEM, V12, P347, DOI 10.1016/0038-0717(80)90008-5; Karmegam Natchimuthu, 2009, Environmentalist, V29, P287, DOI 10.1007/s10669-008-9195-z; Khare NSA, 2005, APPL ECOL ENV RES, V4, P85; Khwairakpam M, 2009, J HAZARD MATER, V161, P948, DOI 10.1016/j.jhazmat.2008.04.088; Kirchberger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123465; Kizilkaya R, 2004, ECOL ENG, V22, P141, DOI 10.1016/j.ecoleng.2004.04.002; Kumar D. S., 2013, Annual Review and Research in Biology, V3, P574; Kumar J. I. Nirmal, 2010, International Journal of Environment and Waste Management, V5, P379, DOI 10.1504/IJEWM.2010.032015; LEE KE, 1992, SOIL BIOL BIOCHEM, V24, P1765, DOI 10.1016/0038-0717(92)90185-Z; Liu F, 2013, J MATER CYCLES WASTE, V15, P482, DOI 10.1007/s10163-013-0157-2; Loh TC, 2005, BIORESOURCE TECHNOL, V96, P111, DOI 10.1016/j.biortech.2003.03.001; Lv BY, 2013, BIORESOURCE TECHNOL, V132, P320, DOI 10.1016/j.biortech.2013.01.006; Ministry of Environmental Protection of the People's Republic of China, 6322011 HJ MIN ENV P; Ndegwa PM, 2000, BIORESOURCE TECHNOL, V71, P5, DOI 10.1016/S0960-8524(99)00055-3; NEUHAUSER EF, 1980, OIKOS, V35, P93, DOI 10.2307/3544730; Rajpal A, 2014, J MATER CYCLES WASTE, V16, P219, DOI 10.1007/s10163-013-0167-0; REINECKE AJ, 1992, SOIL BIOL BIOCHEM, V24, P1295, DOI 10.1016/0038-0717(92)90109-B; SATCHELL JE, 1984, SOIL BIOL BIOCHEM, V16, P191, DOI 10.1016/0038-0717(84)90111-1; Siddique Jaweria, 2005, Pakistan Journal of Zoology, V37, P211; Singh D, 2012, BIORESOURCE TECHNOL, V112, P179, DOI 10.1016/j.biortech.2012.02.101; Singh J, 2010, ECOTOX ENVIRON SAFE, V73, P430, DOI 10.1016/j.ecoenv.2009.08.019; Singh KC HK., 2012, WORLD J ZOOL, V7, P23; Suthar Surindra, 2008, International Journal of Environment and Waste Management, V2, P84, DOI 10.1504/IJEWM.2008.016994; Suthar Surindra, 2008, International Journal of Environment and Waste Management, V2, P584, DOI 10.1504/IJEWM.2008.021862; Suthar S, 2009, J HAZARD MATER, V163, P199, DOI 10.1016/j.jhazmat.2008.06.106; Suthar S, 2010, ECOL ENG, V36, P703, DOI 10.1016/j.ecoleng.2009.12.016; Tripathi G, 2004, BIORESOURCE TECHNOL, V92, P275, DOI 10.1016/j.biortech.2003.09.005; Xie D, 2016, ENV SCI POLLUT R, P1; Zirbes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032564	45	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156492	10.1371/journal.pone.0156492	http://dx.doi.org/10.1371/journal.pone.0156492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257977	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700068
J	Liang, LN; Sun, H; Zhang, W; Zhang, MD; Yang, X; Kuang, R; Zheng, H				Liang, Lining; Sun, Hao; Zhang, Wei; Zhang, Mengdan; Yang, Xiao; Kuang, Rui; Zheng, Hui			Meta-Analysis of EMT Datasets Reveals Different Types of EMT	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; CELL-ADHESION MOLECULES; DIRECT CONVERSION; STEM-CELLS; EPITHELIAL TRANSITION; SIGNALING PATHWAY; NEURONAL CELLS; RETINOIC ACID; CANCER; FIBROBLASTS	As a critical process during embryonic development, cancer progression and cell fate conversions, epithelial-mesenchymal transition (EMT) has been extensively studied over the last several decades. To further understand the nature of EMT, we performed meta-analysis of multiple microarray datasets to identify the related generic signature. In this study, 24 human and 17 mouse microarray datasets were integrated to identify conserved gene expression changes in different types of EMT. Our integrative analysis revealed that there is low agreement among the list of the identified signature genes and three other lists in previous studies. Since removing the datasets with weakly-induced EMT from the analysis did not significantly improve the overlapping in the signature-gene lists, we hypothesized the existence of different types of EMT. This hypothesis was further supported by the grouping of 74 human EMT-induction samples into five distinct clusters, and the identification of distinct pathways in these different clusters of EMT samples. The five clusters of EMT-induction samples also improves the understanding of the characteristics of different EMT types. Therefore, we concluded the existence of different types of EMT was the possible reason for its complex role in multiple biological processes.	[Liang, Lining; Sun, Hao; Zhang, Mengdan; Yang, Xiao; Zheng, Hui] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Wei; Kuang, Rui] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN USA	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Minnesota System; University of Minnesota Twin Cities	Zheng, H (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Guangdong, Peoples R China.	zheng_hui@gibh.ac.cn		Zhang, Wei/0000-0003-3605-9373; Zheng, Hui/0000-0001-6801-0529	National Natural Science Foundation of China [31422032, 31421004, 91519305]; Guangdong Natural Science Foundation [2014A030308002]; Guangdong Science and Technology Planning Project [2013B010404040]; Guangzhou Health Care Collaborative Innovation Program [201508020250]; Guangdong special support program [2014TQ01R157]; National Science Foundation of United States [III 1117153]; Direct For Computer & Info Scie & Enginr [1149697] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Science and Technology Planning Project; Guangzhou Health Care Collaborative Innovation Program; Guangdong special support program; National Science Foundation of United States(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Natural Science Foundation of China (31422032, 31421004, 91519305), the Guangdong Natural Science Foundation (2014A030308002), the Guangdong Science and Technology Planning Project (2013B010404040), the Guangzhou Health Care Collaborative Innovation Program (201508020250), and the Guangdong special support program (2014TQ01R157). H.Z. received the funding. This work was also partially supported by National Science Foundation of United States (III 1117153). R. K. received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaku-Saraste EHA, 1996, DEV BIOL, V180, P16; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Cheng L, 2015, CELL RES, V25, P1269, DOI 10.1038/cr.2015.120; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Farahani E, 2014, CARCINOGENESIS, V35, P747, DOI 10.1093/carcin/bgu045; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Garg M, 2013, WORLD J STEM CELLS, V5, P8; Groger CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051136; Guan F, 2010, FASEB J, V24, P4889, DOI 10.1096/fj.10-162107; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Guan KM, 2001, CELL TISSUE RES, V305, P171, DOI 10.1007/s004410100416; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hayashida T, 2011, J ONCOL, V2011, DOI 10.1155/2011/591427; He Songwei, 2015, Cell Regen, V4, P12, DOI 10.1186/s13619-015-0027-6; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Huntsman DG, 1998, CYTOGENET CELL GENET, V83, P82, DOI 10.1159/000015134; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Li N, 2014, J CELL MOL MED, V18, P1975, DOI 10.1111/jcmm.12331; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Liu XP, 2013, NAT CELL BIOL, V15, P829, DOI 10.1038/ncb2765; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miskiewicz A, 2015, ARCH IMMUNOL THER EX, V63, P485, DOI 10.1007/s00005-015-0355-9; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Ouyang GL, 2010, CELL MOL LIFE SCI, V67, P2605, DOI 10.1007/s00018-010-0338-2; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Priglinger CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146887; Rawluszko-Wieczorek AA, 2015, CRIT REV ONCOL HEMAT, V96, P425, DOI 10.1016/j.critrevonc.2015.07.008; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rhodes JMCBJ, 2002, CELL, V8, P7; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Sheng C, 2012, CELL RES; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tang JXL, 2016, ONCOL REP, V35, P10; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P173, DOI 10.1016/S1357-2725(03)00243-7; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Yagi T, 2000, GENE DEV, V14, P1169; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu WH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015613; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459; Zheng H, 2014, CELL RES, V24, P1162, DOI 10.1038/cr.2014.93; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhu FY, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0729-9	74	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156839	10.1371/journal.pone.0156839	http://dx.doi.org/10.1371/journal.pone.0156839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258544	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700144
J	Wilson, MR; Brown, E; Keys, C; Strain, E; Luo, Y; Muruvanda, T; Grim, C; Beaubrun, JJG; Jarvis, K; Ewing, L; Gopinath, G; Hanes, D; Allard, MW; Musser, S				Wilson, Mark R.; Brown, Eric; Keys, Chris; Strain, Errol; Luo, Yan; Muruvanda, Tim; Grim, Christopher; Beaubrun, Junia Jean-Gilles; Jarvis, Karen; Ewing, Laura; Gopinath, Gopal; Hanes, Darcy; Allard, Marc W.; Musser, Steven			Whole Genome DNA Sequence Analysis of Salmonella subspecies enterica serotype Tennessee obtained from related peanut butter foodborne outbreaks	PLOS ONE			English	Article							LIMITED GENETIC DIVERSITY; ESCHERICHIA-COLI; ENTERITIDIS; TYPHIMURIUM; SCHEME; EVOLUTION; VIRULENCE; STRAINS	Establishing an association between possible food sources and clinical isolates requires discriminating the suspected pathogen from an environmental background, and distinguishing it from other closely-related foodborne pathogens. We used whole genome sequencing (WGS) to Salmonella subspecies enterica serotype Tennessee (S. Tennessee) to describe genomic diversity across the serovar as well as among and within outbreak clades of strains associated with contaminated peanut butter. We analyzed 71 isolates of S. Tennessee from disparate food, environmental, and clinical sources and 2 other closely-related Salmonella serovars as outgroups (S. Kentucky and S. Cubana), which were also shot-gun sequenced. A whole genome single nucleotide polymorphism (SNP) analysis was performed using a maximum likelihood approach to infer phylogenetic relationships. Several monophyletic lineages of S. Tennessee with limited SNP variability were identified that recapitulated several food contamination events. S. Tennessee clades were separated from outgroup salmonellae by more than sixteen thousand SNPs. Intra-serovar diversity of S. Tennessee was small compared to the chosen outgroups (1,153 SNPs), suggesting recent divergence of some S. Tennessee clades. Analysis of all 1,153 SNPs structuring an S. Tennessee peanut butter outbreak cluster revealed that isolates from several food, plant, and clinical isolates were very closely related, as they had only a few SNP differences between them. SNP-based cluster analyses linked specific food sources to several clinical S. Tennessee strains isolated in separate contamination events. Environmental and clinical isolates had very similar whole genome sequences; no markers were found that could be used to discriminate between these sources. Finally, we identified SNPs within variable S. Tennessee genes that may be useful markers for the development of rapid surveillance and typing methods, potentially aiding in traceback efforts during future outbreaks. Using WGS can delimit contamination sources for foodborne illnesses across multiple outbreaks and reveal otherwise undetected DNA sequence differences essential to the tracing of bacterial pathogens as they emerge.	[Wilson, Mark R.] US FDA, CFSAN, College Pk, MD USA; [Brown, Eric; Keys, Chris; Strain, Errol; Luo, Yan; Muruvanda, Tim; Grim, Christopher; Allard, Marc W.; Musser, Steven] Battelle Mem Inst, Crystal City, VA 22202 USA; [Grim, Christopher; Beaubrun, Junia Jean-Gilles; Jarvis, Karen; Ewing, Laura; Gopinath, Gopal; Hanes, Darcy] US FDA, DVA, VMB, CFSAN,OARSA, Laurel, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Allard, MW (corresponding author), Battelle Mem Inst, Crystal City, VA 22202 USA.	marc.allard@fda.hhs.gov		Holloway, Courtney Jean/0000-0003-3661-1957				Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P521; [Anonymous], 1993, JAMA, V270, P432; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Beaubrun JJG, 2014, FOOD MICROBIOL, V42, P181, DOI 10.1016/j.fm.2014.02.008; Bell C, 2002, SALMONELLA PRACTICAL; Botteldoorn N, 2010, ZOONOSES PUBLIC HLTH, V57, P345, DOI 10.1111/j.1863-2378.2008.01216.x; Centers for Disease Control and Prevention, 2009, MORB MORTAL WKLY REP; Centers for Disease Control and Prevention (CDC), SALM STRAINS TABL OU; Cheng CM, 2008, J FOOD PROTECT, V71, P2436, DOI 10.4315/0362-028X-71.12.2436; Chin C., 2010, NEW ENGL J MED, V364, p[1, 33]; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; den Bakker HC, 2011, APPL ENVIRON MICROB, V77, P8648, DOI 10.1128/AEM.06538-11; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gilmour MW, 2004, PLASMID, V52, P182, DOI 10.1016/j.plasmid.2004.06.006; Guard Jean, 2011, BMC Res Notes, V4, P369, DOI 10.1186/1756-0500-4-369; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Karberg KA, 2011, P NATL ACAD SCI USA, V108, P20154, DOI 10.1073/pnas.1109451108; Kim M, 2012, J VIROL, V86, P10894, DOI 10.1128/JVI.01796-12; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Lee JH, 2012, J VIROL, V86, P3404, DOI 10.1128/JVI.07226-11; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-88; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Louie K. K., 1993, Morbidity and Mortality Weekly Report, V42, P516; Mattick KL, 2000, APPL ENVIRON MICROB, V66, P4921, DOI 10.1128/AEM.66.11.4921-4925.2000; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Nguyen C. H., 2013, Journal of Biology, Agriculture and Healthcare, V3, P36; Nguyen CH, 2013, AGRICULTURE, V3, DOI [10.3390/agriculture30x000x, DOI 10.3390/AGRICULTURE30X000X]; Nielsen Newswire, 2009, NIELSEN NEWSWIRE; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Olson AB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-87; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P2166, DOI 10.1128/AAC.05796-11; Saeed AM, 2006, J AOAC INT, V89, P504; Shachar D, 2006, J FOOD PROTECT, V69, P2687, DOI 10.4315/0362-028X-69.11.2687; Shah DH, 2012, FOODBORNE PATHOG DIS, V9, P258, DOI 10.1089/fpd.2011.1009; Shin H, 2012, J VIROL, V86, P1284, DOI 10.1128/JVI.06696-11; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; STANLEY J, 1992, FEMS MICROBIOL LETT, V90, P153, DOI [10.1111/j.1574-6968.1992.tb05143.x, 10.1016/0378-1097(92)90620-4]; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Timme RE, 2012, J BACTERIOL, V194, P5994, DOI 10.1128/JB.01289-12; WARD LR, 1987, EPIDEMIOL INFECT, V99, P291, DOI 10.1017/S0950268800067765; Wise MG, 2009, J MICROBIOL METH, V76, P18, DOI 10.1016/j.mimet.2008.09.006; World Health Organization, DRUG RES SALM; Xi ML, 2008, J FOOD PROTECT, V71, P2067, DOI 10.4315/0362-028X-71.10.2067; Zheng J, 2007, EMERG INFECT DIS, V13, P1932, DOI 10.3201/eid1312.070185; Zwickl DJ., 2006, GENETIC ALGORITHM AP	51	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0146929	10.1371/journal.pone.0146929	http://dx.doi.org/10.1371/journal.pone.0146929			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258142	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700002
J	Xu, PP; Zang, AP; Chen, HY; Cai, WM				Xu, Peipei; Zang, Aiping; Chen, Haiying; Cai, Weiming			The Small G Protein AtRAN1 Regulates Vegetative Growth and Stress Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							GTP-BINDING PROTEIN; COLD-STRESS; IMPORTIN BETA; CELL-CYCLE; TRANSCRIPTIONAL ACTIVATOR; OSMOTIC-STRESS; PLANT-GROWTH; ORYZA-SATIVA; RAN-GTPASE; RICE	The evolutionarily conserved small G-protein Ran plays important role in nuclear translocation of proteins, cell cycle regulation, and nuclear envelope maintenance in mammalian cells and yeast. Arabidopsis Ran proteins are encoded by a family of four genes and are highly conserved at the protein level. However, their biological functions are poorly understood. We report here that AtRAN1 plays an important role in vegetative growth and the molecular improvement of stress tolerance in Arabidopsis. AtRAN1 overexpression promoted vegetative growth and enhanced abiotic tolerance, while the atran1 atran3 double mutant showed higher freezing sensitivity than WT. The AtRAN1 gene is ubiquitously expressed in plants, and the expression levels are higher in the buds, flowers and siliques. Subcellular localization results showed that AtRAN1 is mainly localized in the nucleus, with some present in the cytoplasm. AtRAN1 could maintain cell division and cell cycle progression and promote the formation of an intact nuclear envelope, especially under freezing conditions.	[Xu, Peipei; Zang, Aiping; Chen, Haiying; Cai, Weiming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, WM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	wmcai@sibs.ac.cn	xu, peipei/AAS-4967-2021	xu, peipei/0000-0002-8944-3339	Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences [XDA04020202-15, XDA04020415]; National Natural Science Foundation of China [31570859, 31500236, 31070237, 90917009]; China Manned Space Flight Technology Project	Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Manned Space Flight Technology Project	This work was supported by the Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences (grant No. XDA04020202-15, XDA04020415), the National Natural Science Foundation of China (No. 31570859, No. 31500236, No. 31070237 and No. 90917009) and the China Manned Space Flight Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences (grant No. XDA04020202-15, XDA04020415), the National Natural Science Foundation of China (No. 31570859, No. 31500236, No. 31070237 and No. 90917009) and the China Manned Space Flight Technology Project.	ACH RA, 1994, P NATL ACAD SCI USA, V91, P5863, DOI 10.1073/pnas.91.13.5863; Chen N, 2011, PLANT CELL ENVIRON, V34, P52, DOI 10.1111/j.1365-3040.2010.02225.x; Chinnusamy V, 2008, CURR TOP MICROBIOL, V326, P235; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Di Fiore B, 2004, CELL CYCLE, V3, P305; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Haizel T, 1997, PLANT J, V11, P93, DOI 10.1046/j.1365-313X.1997.11010093.x; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Imin N, 2004, PROTEOMICS, V4, P1873, DOI 10.1002/pmic.200300738; Kim Young-Hwa, 2013, Journal of Plant Biotechnology, V40, P9, DOI 10.5010/JPB.2013.40.1.009; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Liu PW, 2014, MOL PLANT, V7, P1316, DOI 10.1093/mp/ssu041; Luo YJ, 2013, PLANT J, V75, P377, DOI 10.1111/tpj.12207; Ma L, 2008, PLANT PHYSIOL, V148, P223, DOI 10.1104/pp.108.120527; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Miche L, 2006, MOL PLANT MICROBE IN, V19, P502, DOI 10.1094/MPMI-19-0502; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; Rose A, 2001, P NATL ACAD SCI USA, V98, P15377, DOI 10.1073/pnas.261459698; Sazer S, 2000, J CELL SCI, V113, P1111; Sinha VB, 2014, MOL BIOL REP, V41, P5989, DOI 10.1007/s11033-014-3476-z; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Thalhammer A, 2014, METHODS MOL BIOL, V1166, P15, DOI 10.1007/978-1-4939-0844-8_3; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Verslues PE, 2006, PLANT J, V47, P776, DOI 10.1111/j.1365-313X.2006.02833.x; Wang X, 2006, PLANT PHYSIOL, V140, P91, DOI 10.1104/pp.105.071670; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu PP, 2014, J EXP BOT, V65, P3277, DOI 10.1093/jxb/eru178; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Yano A, 2006, ANN BOT-LONDON, V98, P1179, DOI 10.1093/aob/mcl211; Yasuda Y, 2006, EXP CELL RES, V312, P512, DOI 10.1016/j.yexcr.2005.11.017; Ying L, 2014, PLANT PHYSIOL BIOCH, V79, P77, DOI 10.1016/j.plaphy.2014.03.004; Zang AP, 2010, J EXP BOT, V61, P777, DOI 10.1093/jxb/erp341; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7; Zhao JF, 2007, PLANT CELL, V19, P3805, DOI 10.1105/tpc.106.048900; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101	50	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154787	10.1371/journal.pone.0154787	http://dx.doi.org/10.1371/journal.pone.0154787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258048	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700010
J	Zhang, QY; Zhao, Y; Zhang, RY; Wei, YY; Yi, HG; Shao, F; Chen, F				Zhang, Qiuyi; Zhao, Yang; Zhang, Ruyang; Wei, Yongyue; Yi, Honggang; Shao, Fang; Chen, Feng			A Comparative Study of Five Association Tests Based on CpG Set for Epigenome-Wide Association Studies	PLOS ONE			English	Article							DIFFERENTIALLY METHYLATED LOCI; DNA METHYLATION; CLASSIFICATION; CHALLENGES; REGRESSION; REDUCTION; SURVIVAL	An epigenome-wide association study (EWAS) is a large-scale study of human disease-associated epigenetic variation, specifically variation in DNA methylation. High throughput technologies enable simultaneous epigenetic profiling of DNA methylation at hundreds of thousands of CpGs across the genome. The clustering of correlated DNA methylation at CpGs is reportedly similar to that of linkage-disequilibrium (LD) correlation in genetic single nucleotide polymorphisms (SNP) variation. However, current analysis methods, such as the t-test and rank-sum test, may be underpowered to detect differentially methylated markers. We propose to test the association between the outcome (e.g case or control) and a set of CpG sites jointly. Here, we compared the performance of five CpG set analysis approaches: principal component analysis (PCA), supervised principal component analysis (SPCA), kernel principal component analysis (KPCA), sequence kernel association test (SKAT), and sliced inverse regression (SIR) with Hotelling's T-2 test and t-test using Bonferroni correction. The simulation results revealed that the first six methods can control the type I error at the significance level, while the t-test is conservative. SPCA and SKAT performed better than other approaches when the correlation among CpG sites was strong. For illustration, these methods were also applied to a real methylation dataset.	[Zhang, Qiuyi; Zhao, Yang; Zhang, Ruyang; Wei, Yongyue; Yi, Honggang; Shao, Fang; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing 211166, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn	zhao, yang/GXF-4424-2022; Wei, Yongyue/GYV-5660-2022	Wei, Yongyue/0000-0002-1132-1796; Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [81530088, 81473070, 81373102, 81402763, 81402764, 81202283]; Jiangsu Natural Science Foundation [BK20140907]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [14KJA310002]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [TAPP: PPZY2015A067]; Qing-lan Project of Jiangsu Province; Excellent Young Teacher Project of Nanjing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; Qing-lan Project of Jiangsu Province; Excellent Young Teacher Project of Nanjing Medical University	This work was supported by National Natural Science Foundation of China (No. 81530088, 81473070, 81373102, 81402763, 81402764, 81202283), Jiangsu Natural Science Foundation (No. BK20140907), Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 14KJA310002), the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD) and Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP: PPZY2015A067). The work was also supported by the Qing-lan Project of Jiangsu Province and the Excellent Young Teacher Project of Nanjing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Cai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062495; Chen X, 2008, BIOINFORMATICS, V24, P2474, DOI 10.1093/bioinformatics/btn458; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Chen Y, 2014, GENET EPIDEMIOL, V38, P42, DOI 10.1002/gepi.21774; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Jolliffe I.T, 2002, PRINCIPAL COMPONENTS, V2nd, P487; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LI KC, 1991, J AM STAT ASSOC, V86, P316, DOI 10.2307/2290563; Liu Y, 2014, AM J HUM GENET, V94, P485, DOI 10.1016/j.ajhg.2014.02.011; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Liu ZQ, 2005, J BIOMED BIOTECHNOL, P155, DOI 10.1155/JBB.2005.155; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mika S, 1998, KERNEL PCA AND DE NO, P7; Miller J, 2002, RANDGEN A PROGRAM FO; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Saadati M, 2014, STAT MED, V33, P5347, DOI 10.1002/sim.6251; Scholkopf B., 1997, Artificial Neural Networks - ICANN '97. 7th International Conference Proceedings, P583, DOI 10.1007/BFb0020217; Thomas M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-137; Wang S, 2011, GENET EPIDEMIOL, V35, P686, DOI 10.1002/gepi.20619; Wang Xuexia, 2009, BMC Proc, V3 Suppl 7, pS28; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu HY, 2013, GENET EPIDEMIOL, V37, P377, DOI 10.1002/gepi.21726; Yi HG, 2015, J BIOMED RES, V29, P298, DOI 10.7555/JBR.29.20140043; Yip WK, 2014, GENET EPIDEMIOL, V38, P714, DOI 10.1002/gepi.21851; Zeng P, 2015, J BIOMED RES, V29, P285, DOI 10.7555/JBR.29.20140007; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044978	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156895	10.1371/journal.pone.0156895	http://dx.doi.org/10.1371/journal.pone.0156895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258058	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700150
J	Abuogi, LL; Smith, C; McFarland, EJ				Abuogi, Lisa L.; Smith, Christiana; McFarland, Elizabeth J.			Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review	PLOS ONE			English	Review							FOLLOW-UP; TREATMENT OUTCOMES; CLINICAL-OUTCOMES; TREATMENT PROGRAM; SOUTH-AFRICA; MORTALITY; CARE; INITIATION; INFANTS; SUCCESS	Current UNAIDS goals aimed to end the AIDS epidemic set out to ensure that 90% of all people living with HIV know their status, 90% initiate and continue life-long anti-retroviral therapy (ART), and 90% achieve viral load suppression. In 2014 there were an estimated 2.6 million children under 15 years of age living with HIV, of which only one-third were receiving ART. Little literature exists describing retention of HIV-infected children in the first year on ART. We conducted a systematic search for English language publications reporting on retention of children with median age at ART initiation less than ten years in resource limited settings. The proportion of children retained in care on ART and predictors of attrition were identified. Twelve studies documented retention at one year ranging from 71-95% amongst 31877 African children. Among the 5558 children not retained, 4082 (73%) were reported as lost to follow up (LFU) and 1476 (27%) were confirmed to have died. No studies confirmed the outcomes of children LFU. Predictors of attrition included younger age, shorter duration of time on ART, and severe immunosuppression. In conclusion, significant attrition occurs in children in the first 12 months after ART initiation, the majority attributed to LFU, although true outcomes of children labeled as LFU are unknown. Focused efforts to ensure retention and minimize early mortality are needed as universal ART for children is scaled up.	[Abuogi, Lisa L.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Abuogi, Lisa L.; Smith, Christiana; McFarland, Elizabeth J.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Abuogi, Lisa L.] Univ Colorado, Sch Med, Sch Publ Hlth, Ctr Global Hlth, Aurora, CO 80045 USA; [Smith, Christiana; McFarland, Elizabeth J.] Univ Colorado, Sch Med, Dept Pediat Infect Dis, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Abuogi, LL (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA.; Abuogi, LL (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.; Abuogi, LL (corresponding author), Univ Colorado, Sch Med, Sch Publ Hlth, Ctr Global Hlth, Aurora, CO 80045 USA.	lisa.abuogi@ucdenver.edu	Smith, Christiana/AAK-7917-2020					Ahoua L, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-67; Alvarez-Uria G, 2014, PEER J, V2014; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Asfawesen GY, 2011, ACTA PAEDIATR, V100, P1164, DOI 10.1111/j.1651-2227.2011.02243.x; Auld AF, 2014, PEDIATR INFECT DIS J, V33, P1134, DOI 10.1097/INF.0000000000000457; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Barth RE, 2011, PEDIATR INFECT DIS J, V30, P52, DOI 10.1097/INF.0b013e3181ed2af3; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Catalani Caricia, 2013, Open AIDS J, V7, P17, DOI 10.2174/1874613620130812003; Davies MA, 2015, J INT AIDS SOC, V18, P1, DOI 10.7448/IAS.18.7.20745; Ditekemena J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113877; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-519; Eley B, 2006, SAMJ S AFR MED J, V96, P988; Essajee S, 2015, J INT AIDS SOC, V18, P14, DOI 10.7448/IAS.18.7.20299; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE60, DOI 10.1097/QAI.0b013e3182303c7e; Fayorsey RN, 2013, JAIDS-J ACQ IMM DEF, V62, pE124, DOI 10.1097/QAI.0b013e3182869558; Fox MP, 2015, AIDS, V29, P493, DOI 10.1097/QAD.0000000000000559; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; George E, 2007, J INFECT DIS, V195, P1411, DOI 10.1086/514823; Hagstromer O, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22274; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Innes S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18914; Isaakidis P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-11; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Jaspan HB, 2008, PEDIATR INFECT DIS J, V27, P993, DOI 10.1097/INF.0b013e31817acf7b; Joint United Nations Programme on HIV/AIDS, 2014, 909090 UNAIDS JOINT; Joseph-Davey D, 2013, 7 INT AIDS SOC C HIV; Kabue MM, 2012, PEDIATRICS, V130, pE591, DOI 10.1542/peds.2011-1187; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Koye DN, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-161; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Leroy V, 2013, JAIDS-J ACQ IMM DEF, V62, P208, DOI 10.1097/QAI.0b013e31827b70bf; Lourenco L, 2013, 7 INT AIDS SOC C HIV; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Massavon W, 2014, ISRN AIDS, V2014, P852489, DOI 10.1155/2014/852489; McConnell MS, 2010, JAIDS-J ACQ IMM DEF, V54, P423, DOI 10.1097/QAI.0b013e3181dc5eb0; McNairy M, RETENTION PAEDIAT AG; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; Meyer-Rath G, 2013, AIDS, V27, P243, DOI 10.1097/QAD.0b013e32835a5b92; Mugglin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056446; Odeny TA, 2013, 7 INT AIDS SOC C HIV; Ojikutu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100039; Organization WH, 2012, RET HIV PROGR DEF CH; Phelps BR, 2013, AIDS, V27, pS207, DOI 10.1097/QAD.0000000000000095; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Scott CA, 2013, PLOS ONE, V8; Sengayi M, 2013, GLOBAL HEALTH ACTION, V6, P169, DOI 10.3402/gha.v6i0.19248; Tene G, 2013, PEDIATR INFECT DIS J, V32, pE341, DOI 10.1097/INF.0b013e31828c2744; The Coalition for Children Affected by AIDS, 2014, 7 INT AIDS SOC C HIV; UNAIDS, 2015, AIDS CHANG EV MDG6 1; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; Vermund SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110116; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Weigel R, 2010, TROP MED INT HEALTH, V15, P934, DOI 10.1111/j.1365-3156.2010.02561.x; Wells G.A., NEWCASTLE OTTAWA SCA; World Bank website, 2014, COUNTR LEND GROUPS; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, TEST NEW DIR TREATM; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706; Zhao Y, 2013, CLIN INFECT DIS, V56, P735, DOI 10.1093/cid/cis941	66	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156506	10.1371/journal.pone.0156506	http://dx.doi.org/10.1371/journal.pone.0156506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280404	gold, Green Published			2022-12-27	WOS:000377563000034
J	Eckelman, MJ; Sherman, J				Eckelman, Matthew J.; Sherman, Jodi			Environmental Impacts of the US Health Care System and Effects on Public Health	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; AIR-POLLUTION; CLIMATE-CHANGE; BURDEN	The U.S. health care sector is highly interconnected with industrial activities that emit much of the nation's pollution to air, water, and soils. We estimate emissions directly and indirectly attributable to the health care sector, and potential harmful effects on public health. Negative environmental and public health outcomes were estimated through economic input-output life cycle assessment (EIOLCA) modeling using National Health Expenditures (NHE) for the decade 2003-2013 and compared to national totals. In 2013, the health care sector was also responsible for significant fractions of national air pollution emissions and impacts, including acid rain (12%), greenhouse gas emissions (10%), smog formation (10%) criteria air pollutants (9%), stratospheric ozone depletion (1%), and carcinogenic and non-carcinogenic air toxics (1-2%). The largest contributors to impacts are discussed from both the supply side (EIOLCA economic sectors) and demand side (NHE categories), as are trends over the study period. Health damages from these pollutants are estimated at 470,000 DALYs lost from pollution-related disease, or 405,000 DALYs when adjusted for recent shifts in power generation sector emissions. These indirect health burdens are commensurate with the 44,000-98,000 people who die in hospitals each year in the U.S. as a result of preventable medical errors, but are currently not attributed to our health system. Concerted efforts to improve environmental performance of health care could reduce expenditures directly through waste reduction and energy savings, and indirectly through reducing pollution burden on public health, and ought to be included in efforts to improve health care quality and safety.	[Eckelman, Matthew J.] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Sherman, Jodi] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA	Northeastern University; Yale University	Eckelman, MJ (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.	m.eckelman@neu.edu		sherman, jodi/0000-0003-4157-9728	Anesthesia Patient Safety Foundation	Anesthesia Patient Safety Foundation	MJE received no specific funding for this work. JS was supported by the Anesthesia Patient Safety Foundation, awarded in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andel Charles, 2012, J Health Care Finance, V39, P39; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], WRI CAIT 2 0 CLIM AN; Bare J, 2006, ENVIRON SCI TECHNOL, V40, P5108, DOI 10.1021/es052494b; Bare J, 2011, CLEAN TECHNOL ENVIR, V13, P687, DOI 10.1007/s10098-010-0338-9; BARE JC, 2003, J IND ECOLOGY, V0006; Berwick DM, 2008, HLTH AFF MILLWOOD, V27, P759; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Caiazzo F, 2013, ATMOS ENVIRON, V79, P198, DOI 10.1016/j.atmosenv.2013.05.081; Carnegie Mellon University Green Design Institute, EC INP OUTP LIF CYCL; Chung JW, 2009, JAMA-J AM MED ASSOC, V302, P1970, DOI 10.1001/jama.2009.1610; Connor A, 2011, HEMODIAL INT, V15, P39, DOI 10.1111/j.1542-4758.2010.00523.x; Eckelman M, 2012, ANESTH ANALG, V114, P1067, DOI 10.1213/ANE.0b013e31824f6959; Energy Information Administration, EL DAT; Energy Information Administration, 2012, 2012 COMM BUILD EN C; Fann N, 2013, ENVIRON SCI TECHNOL, V47, P3580, DOI 10.1021/es304831q; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361; Hendrickson CT, 2006, ENV LIFE CYCLE ASSES; Institute for Health Metrics and Evaluation, 2013, STAT US HLTH INN INS; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine Roundtable, 2013, PUBL HLTH LINK SUST; ISO, 2006, 140442006 ISO, DOI [10.1136/bmj.332.7550.1107, DOI 10.1016/J.ECOLIND.2011.01.007]; Jaramillo P, 2016, ENERG POLICY, V90, P202, DOI DOI 10.1016/J.ENP0L.2015.12.035; Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Lautier A, 2010, SCI TOTAL ENVIRON, V409, P33, DOI 10.1016/j.scitotenv.2010.09.016; Leffall L, 2010, REDUCING ENVIRONMENT; Mccoy D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2351; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; NHS Sustainable Development Unit, NHS ENGL CARB FOOTPR; OECD, 2015, HLTH STAT; Pizzol M, 2011, J CLEAN PROD, V19, P646, DOI 10.1016/j.jclepro.2010.05.007; Ryberg M, 2014, CLEAN TECHNOL ENVIR, V16, P329, DOI 10.1007/s10098-013-0629-z; Sherman J, 2012, ANESTH ANALG, V114, P1086, DOI 10.1213/ANE.0b013e31824f6940; Thiel CL, 2015, ENVIRON SCI TECHNOL, V49, P1779, DOI 10.1021/es504719g; US Environmental Protection Agency, NAT EM IN V NEI AIR; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2015, PROM HLTH WHIL MIT C; World Health Organization, 2014, BURD DIS AMB AIR POL	42	309	310	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157014	10.1371/journal.pone.0157014	http://dx.doi.org/10.1371/journal.pone.0157014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280706	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000067
J	Gao, JJ; Qiu, XP; Wang, XB; Peng, CY; Zheng, F				Gao, Jiajia; Qiu, Xueping; Wang, Xuebin; Peng, Chunyan; Zheng, Fang			Associations of ChREBP and Global DNA Methylation with Genetic and Environmental Factors in Chinese Healthy Adults	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; GENOMIC DNA; POLYMORPHISMS; MULTIPLE; TISSUE; RISK; AGE; METHYLTRANSFERASE; 5-METHYLCYTOSINE	Age, gender, diet, gene and lifestyle have been reported to affect metabolic status and disease susceptibility through epigenetic pathway. But it remains indistinct that which factors account for certain epigenetic modifications. Our aim was to identify the influencing factors on inter-individual DNA methylation variations of carbohydrate response element binding protein (ChREBP) and global genome in peripheral blood leucocytes (PBLs). ChREBP DNA methylation was determined by bisulfite sequencing, and genomic 5mdC contents were quantified by capillary hydrophilic-interaction liquid chromatography/in-source fragmentation/tandem mass spectrometry system in about 300 healthy individuals. Eleven single nucleotide polymorphisms (SNPs) spanning ChREBP and DNA methyltransferase 1 (DNMT1) were genotyped by high resolution melting or PCR-restriction fragment length polymorphism. DNMT1 mRNA expression was analyzed by quantitative PCR. We found ChREBP DNA methylation levels were statistically associated with age (Beta (B) = 0.028, p = 0.006) and serum total cholesterol concentrations (TC) (B = 0.815, p = 0.010), independent of sex, concentrations of triglyceride, high density lipoprotein cholesterol, low density lipoprotein cholesterol (LDL-C), fasting blood glucose and systolic blood pressure, diastolic blood pressure, PBLs counts and classifications. The DNMT1 haplotypes were related to ChREBP (odds ratio (OR) = 0.668, p = 0.029) and global (OR = 0.450, p = 0.015) DNA methylation as well as LDL-C, but not DNMT1 expression. However, only the relation to LDL-C was robust to correction for multiple testing (ORFDR = 1.593, p(FDR) = 0.013). These results indicated that the age and TC were independent influential factors of ChREBP methylation and DNMT1 variants could probably influence LDLC to further modify ChREBP DNA methylation. Certainly, sequential comprehensive analysis of the interactions between genetic variants and blood lipid levels on ChREBP and global DNA methylation was required.	[Gao, Jiajia; Qiu, Xueping; Wang, Xuebin; Peng, Chunyan; Zheng, Fang] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China; [Gao, Jiajia] Huazhong Univ Sci & Technol, Tongji Med Coll, Clin Immunol Lab, Wuhan Hosp 1, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Zheng, F (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Peoples R China.	zhengfang@whu.edu.cn			National Natural Science Foundation of China [81270365, 81071420]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China with grants 81270365 and 81071420 (http://www.nsfc.gov.cn/).	Ahmet I, 2005, CIRCULATION, V112, P3115, DOI 10.1161/CIRCULATIONAHA.105.563817; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2014, NUTRIENTS, V6, P4625, DOI 10.3390/nu6104625; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Chettier R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117708; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Fang MZ, 2003, CANCER RES, V63, P7563; Fiorito G, 2014, NUTR METAB CARDIOVAS, V24, P483, DOI 10.1016/j.numecd.2013.10.026; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gillberg L, 2014, METABOLISM, V63, P263, DOI 10.1016/j.metabol.2013.10.003; Guo SR, 2011, CLIN CHIM ACTA, V412, P1854, DOI 10.1016/j.cca.2011.06.024; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kim SO, 2013, INT J ONCOL, V42, P349, DOI 10.3892/ijo.2012.1686; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Lakshmi SVV, 2013, MOL CELL BIOCHEM, V374, P203, DOI 10.1007/s11010-012-1520-7; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Maestri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139681; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Peng CY, 2014, INT J MOL SCI, V15, P22694, DOI 10.3390/ijms151222694; Potter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076506; Saad MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131960; Sarter B, 2005, HUM GENET, V117, P402, DOI 10.1007/s00439-005-1317-9; Sauder KA, 2015, METABOLISM, V64, P1521, DOI 10.1016/j.metabol.2015.07.021; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Singal R, 2005, ONCOL REP, V14, P569; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Smith AK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-145; Sun JL, 2008, PROSTATE, V68, P1257, DOI 10.1002/pros.20793; Tra J, 2002, MECH AGEING DEV, V123, P1487, DOI 10.1016/S0047-6374(02)00080-5; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yang N, 2014, CLIN LAB, V60, P125, DOI 10.7754/Clin.Lab.2013.130108; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	45	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157128	10.1371/journal.pone.0157128	http://dx.doi.org/10.1371/journal.pone.0157128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281235	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000092
J	Hesketh, KR; Law, C; Bedford, H; Hope, S				Hesketh, Kathryn R.; Law, Catherine; Bedford, Helen; Hope, Steven			Co-Occurrence of Health Conditions during Childhood: Longitudinal Findings from the UK Millennium Cohort Study (MCS)	PLOS ONE			English	Article							COMORBIDITY; CHILDREN; STRENGTHS; EDUCATION; RHINITIS; ECZEMA; ASTHMA	Aims To identify patterns of stability and change in co-occurrence in children between 5-11 years, and to assess if they vary by socio-demographic factors. Methods Data from 9548 singleton children from the UK Millennium Cohort Study (MCS) were assessed for co-occurrence of five common adverse conditions: wheeze; longstanding illness; unfavorable weight; injury; and socio-emotional difficulties. We summed adverse conditions (0-5) for each child at ages 5, 7, and 11 and identified co-occurrence (>= 2 conditions). Using multinomial regression, we explored associations between co-occurrence trajectories and child's sex and ethnicity, maternal education, and income quintile. Results 45.6% of children experienced co-occurrence between 5-11 years (7% experienced constant co-occurrence). More children moved into co-occurrence than moved out (16.9 vs. 11.9%). Mutually-adjusted relative risk ratios (aRRR) showed a gradient by maternal education: compared to children with no co-occurrence whose mothers had a higher/degree, children whose mothers had no qualifications were more likely to move into (aRRR = 1.32(95% CI: 1.02,1.70)), out of (1.74(1.34,2.26)), have fluctuating (1.52(1.09,2.10)) or constant co-occurrence (2.58(1.76,3.80)). The same gradient (high vs. low) was evident for income quintiles. Girls were less likely to experience co-occurrence. Conclusions Co-occurrence of adverse conditions is common during childhood, and trajectories are socially patterned. Child-focused care for lower-income children and boys early in life may prevent and reduce co-occurrence in later childhood.	[Hesketh, Kathryn R.; Law, Catherine; Bedford, Helen; Hope, Steven] UCL Inst Child Hlth, Guilford St, London, England	University of London; University College London	Hesketh, KR (corresponding author), UCL Inst Child Hlth, Guilford St, London, England.	Kathryn.hesketh@ucl.ac.uk		Law, Catherine/0000-0002-1777-9386; Hesketh, Kathryn/0000-0003-3963-9189; Hope, Steven/0000-0001-6759-6927	Department of Health through Children's Policy Research Unit [10090001]; Department of Health; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Economic and Social Research Council	Department of Health through Children's Policy Research Unit; Department of Health; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	All authors have support from a grant from the Department of Health (funded through the Children's Policy Research Unit; funder reference 10090001) for the submitted work. This is an independent piece of research commissioned and funded by the Department of Health. The views expressed are not necessarily those of the Department. Research at the UCL Institute of Child Health and Great Ormond Street Hospital for Children receives a proportion of the funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The Millennium Cohort Study is funded by grants to former and current directors of the study from the Economic and Social Research Council (Professor Heather Joshi, Professor Lucinda Platt and Professor Emla Fitzsimons) and a consortium of government funders. The study sponsors played no part in the design, data analysis and interpretation of this study; the writing of the manuscript or the decision to submit the paper for publication, and the authors' work was independent of their funders.	Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Case A, 2006, FUTURE CHILD, V16, P151, DOI 10.1353/foc.2006.0014; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Connelly R, 2014, INT J EPIDEMIOL, P1; Cummings P, 2005, INJURY PREV, V11, P43, DOI 10.1136/ip.2004.006833; Department of Health, 2013, ANN REP CHIEF MED OF; Department of Health, 2013, NHS OUTC FRAM 2014 2; Department of Health, 1999, SAV LIV OUR HLTH NAT; Department of Health, 2004, CHOOS HLTH MAK HLTH; FOWLER MG, 1992, PEDIATRICS, V90, P939; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Griffiths LJ, 2011, INT J PEDIATR OBES, V6, pE423, DOI 10.3109/17477166.2010.526221; Hale DR, 2015, PEDIATRICS, V136, P128, DOI 10.1542/peds.2014-2105; Hargreaves DS, 2013, ARCH DIS CHILD, V98, P850, DOI 10.1136/archdischild-2012-303403; Hillemeier MM, 2013, MATERN CHILD HLTH J, V17, P1852, DOI 10.1007/s10995-012-1205-6; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Lewis I., 2012, REPORT CHILDREN YOUN; McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Plewis I., 2007, MILLENNIUM COHORT ST; Public Health England, 2012, PUBL HLTH OUTC FRAM; Public Health England, 2012, HLTH LIV HLTH PEOPL; Public Health England, 2014, CHILDR YOUNG PEOPL H; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sidora-Arcoleo K, 2005, INJURY VIOLENCE AM M; StataCorp LP, 2013, STATA 13 SE; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sweeting H, 1998, ARCH DIS CHILD, V78, P427, DOI 10.1136/adc.78.5.427; The Marmot Review Team, 2011, STRAT REV HLTH IN EN; von Mutius E, 2011, J ALLERGY CLIN IMMUN, V127, P1513, DOI 10.1016/j.jaci.2011.04.026; West P, 1997, SOC SCI MED, V44, P833, DOI 10.1016/S0277-9536(96)00188-8	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156868	10.1371/journal.pone.0156868	http://dx.doi.org/10.1371/journal.pone.0156868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27281228	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000051
J	Stanifer, JW; Turner, EL; Egger, JR; Thielman, N; Karia, F; Maro, V; Kilonzo, K; Patel, UD; Yeates, K				Stanifer, John W.; Turner, Elizabeth L.; Egger, Joseph R.; Thielman, Nathan; Karia, Francis; Maro, Venance; Kilonzo, Kajiru; Patel, Uptal D.; Yeates, Karen			Knowledge, Attitudes, and Practices Associated with Chronic Kidney Disease in Northern Tanzania: A Community-Based Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SUB-SAHARAN AFRICA; DIABETES-MELLITUS; MEDICINAL-PLANTS; HEALTH LITERACY; BURDEN; EPIDEMIOLOGY; RISK	Background Non-communicable diseases (NCDs) are a leading cause of death among adults in sub-Saharan Africa, and chronic kidney disease (CKD) is a growing public health threat. Understanding knowledge, attitudes, and practices associated with NCDs is vital to informing optimal policy and public health responses in the region, but few community-based assessments have been performed for CKD. To address this gap, we conducted a cross-sectional survey of adults in northern Tanzania using a validated instrument. Methods Between January and June 2014, we administered a structured survey to a random sample of adults from urban and rural communities. The validated instrument consisted of 25 items designed to measure knowledge, attitudes, and practices associated with kidney disease. Participants were also screened for CKD, diabetes, hypertension, and human immunodeficiency virus. Results We enrolled 606 participants from 431 urban and rural households. Knowledge of the etiologies, symptoms, and treatments for kidney disease was low (mean score 3.28 out of 10; 95% CI 2.94, 3.63). There were no significant differences by CKD status. Living in an urban setting and level of education had the strongest independent associations with knowledge score. Attitudes were characterized by frequent concern about the health (27.3%; 20.2, 36.0%), economic (73.1%; 68.2, 77.5%), and social impact (25.4%; 18.6, 33.6%) of kidney disease. Practices included the use of traditional healers (15.2%; 9.1, 24.5%) and traditional medicines (33.8%; 25.0, 43.9%) for treatment of kidney disease as well as a willingness to engage with mobile-phone technology in CKD care (94.3%; 90.1, 96.8%). Conclusions Community-based adults in northern Tanzania have limited knowledge of kidney disease. However, there is a modest knowledge base upon which to build public health programs to expand awareness and understanding of CKD, but these programs must also consider the variety of means by which adults in this population meet their healthcare needs. Finally, our assessment of local attitudes suggested that such public health efforts would be well-received.	[Stanifer, John W.; Thielman, Nathan; Patel, Uptal D.] Duke Univ, Dept Med, DUMC Box 3182, Durham, NC 27710 USA; [Stanifer, John W.; Turner, Elizabeth L.; Egger, Joseph R.; Thielman, Nathan; Patel, Uptal D.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Stanifer, John W.; Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, DUMC Box 3646, Durham, NC 27710 USA; [Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, DUMC Box 2721, Durham, NC 27710 USA; [Karia, Francis; Maro, Venance; Kilonzo, Kajiru] Kilimanjaro Christian Med Coll, Sokoine Rd, Moshi, Tanzania; [Yeates, Karen] Queens Univ, Dept Med, 76 Stuart St, Kingston, ON K7L 2VL, Canada	Duke University; Duke University; Duke University; Duke University; Queens University - Canada	Stanifer, JW (corresponding author), Duke Univ, Dept Med, DUMC Box 3182, Durham, NC 27710 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Clin Res Inst, DUMC Box 3646, Durham, NC 27710 USA.	john.stanifer@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879	National Institutes of Health Research Training Grant - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER	National Institutes of Health Research Training Grant - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by an National Institutes of Health Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology Global Outreach Committee; and a Master's of Science research stipend from the Duke Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2013, 2012 POP HOUS CENS; Bagnis CI, 2004, AM J KIDNEY DIS, V44, P1, DOI 10.1053/j.ajkd.2004.02.009; Bloomfield GS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-49; Boaduo NKK, 2014, PHARM BIOL, V52, P756, DOI 10.3109/13880209.2013.869828; Booysen HL, 2016, J HYPERTENS, V34, P1178, DOI 10.1097/HJH.0000000000000924; Cavanaugh KL, 2010, J AM SOC NEPHROL, V21, P1979, DOI 10.1681/ASN.2009111163; Colson CRD, 2005, ADV CHRONIC KIDNEY D, V12, P261, DOI 10.1016/j.ackd.2005.03.006; DeVellis R., 2017, SCALE DEV THEORY APP, V4; Devraj R, 2009, AM J KIDNEY DIS, V53, P884, DOI 10.1053/j.ajkd.2008.12.028; GOLD CH, 1980, CLIN NEPHROL, V14, P128; Green JA, 2015, ADV CHRONIC KIDNEY D, V22, P24, DOI 10.1053/j.ackd.2014.07.004; Gurman TA, 2012, J HEALTH COMMUN, V17, P82, DOI 10.1080/10810730.2011.649160; Hoy W, 2005, ADV CHRONIC KIDNEY D, V12, P64, DOI 10.1053/j.ackd.2004.10.004; International Telecommunication Union, 2013, WORLD 2013 ICT FACTS; Karou SD, 2011, PHARM BIOL, V49, P1286, DOI 10.3109/13880209.2011.621959; Kokwaro J.O., 1976, MED PLANTS E AFRICA; Krenzke T, 2006, P AM SOC ASS SURV RE; Luyckx VA, 2002, AM J KIDNEY DIS, V39, DOI 10.1053/ajkd.2002.31424; Mani MK, 2005, KIDNEY INT, V67, pS75, DOI 10.1111/j.1523-1755.2005.09419.x; Musabayane CT, 2012, CARDIOVASC J AFR, V23, P462, DOI 10.5830/CVJA-2012-025; Naicker S, 2010, CLIN NEPHROL, V74, pS13; Sharma SK, 2010, AM J KIDNEY DIS, V56, P915, DOI 10.1053/j.ajkd.2010.06.022; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122638; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121722; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; United Republic of Tanzania, 2011, ED SECT PERF REP 201; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601	29	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156336	10.1371/journal.pone.0156336	http://dx.doi.org/10.1371/journal.pone.0156336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280584	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000026
J	Wei, CC; Yen, PL; Chang, ST; Cheng, PL; Lo, YC; Liao, VHC				Wei, Chia-Cheng; Yen, Pei-Ling; Chang, Shang-Tzen; Cheng, Pei-Ling; Lo, Yi-Chen; Liao, Vivian Hsiu-Chuan			Antioxidative Activities of Both Oleic Acid and Camellia tenuifolia Seed Oil Are Regulated by the Transcription Factor DAF-16/FOXO in Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; OLIVE OIL; MEDITERRANEAN DIET; BETA-SITOSTEROL; LONGEVITY; RESISTANCE; GENE; IDENTIFICATION; COMPONENTS	Background Tea seed oil is a high quality edible oil, yet lacking sufficient scientific evidences to support the nutritional and medical purposes. We identified major and minor components in Camellia tenuifolia seed oil and investigated the antioxidative activity and its underlying mechanisms in Caenorhabditis elegans. Principal Findings The results showed that the major constitutes in C. tenuifolia seed oil were unsaturated fatty acids (similar to 78.4%). Moreover, two minor compounds, beta-amyrin and beta-sitosterol, were identified and their antioxidative activity was examined. We found that oleic acid was the major constitute in C. tenuifolia seed oil and plays a key role in the antioxidative activity of C. tenuifolia seed oil in C. elegans. Conclusions This study found evidences that the transcription factor DAF-16/FOXO was involved in both oleic acid- and C. tenuifolia seed oil-mediated oxidative stress resistance in C. elegans. This study suggests the potential of C. tenuifolia seed oil as nutrient or functional foods.	[Wei, Chia-Cheng; Liao, Vivian Hsiu-Chuan] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Yen, Pei-Ling; Chang, Shang-Tzen] Natl Taiwan Univ, Dept Forestry & Resource Conservat, Taipei 10764, Taiwan; [Cheng, Pei-Ling; Lo, Yi-Chen] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Liao, VHC (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	vivianliao@ntu.edu.tw		Wei, Chia-Cheng/0000-0002-0694-7284; Liao, Vivian/0000-0002-4676-9953	research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) - Taiwan Agriculture Research Institute, Council of Agriculture; NIH National Center for Research Resources	research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) - Taiwan Agriculture Research Institute, Council of Agriculture; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded in parts by the research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) supported by the Taiwan Agriculture Research Institute, Council of Agriculture (http://www.tari.gov.tw/) to VL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All nematodes strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources. This study was funded in parts by the research grant (Health benefits of camellia oil-Study on in vivo anti-oxidative activity (II), 105 Agriculture Sciences-15.3.1-Food-Z1) supported by the Taiwan Agriculture Research Institute, Council of Agriculture (http://www.tari.gov.tw/) to V. H.-C. Liao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BAST A, 1989, PHARM WEEKBLAD, V11, P199, DOI 10.1007/BF01959411; Boskou D., 2005, Current Topics in Nutraceutical Research, V3, P125; BRENNER S, 1974, GENETICS, V77, P71; Bulotta S, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0219-9; Carrillo C, 2012, NUTR HOSP, V27, P1860, DOI 10.3305/nh.2012.27.6.6010; Cheng SC, 2014, J AGR FOOD CHEM, V62, P4159, DOI 10.1021/jf500842v; Cicerale S, 2012, CURR OPIN BIOTECH, V23, P129, DOI 10.1016/j.copbio.2011.09.006; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Feas X, 2013, MOLECULES, V18, P4573, DOI 10.3390/molecules18044573; Frankel EN, 2011, J AGR FOOD CHEM, V59, P785, DOI 10.1021/jf103813t; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Guha S, 2013, AGE, V35, P1559, DOI 10.1007/s11357-012-9459-x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Horikawa M, 2010, MOL CELL ENDOCRINOL, V323, P183, DOI 10.1016/j.mce.2010.03.004; Johnston AD, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/546915; Kalua CM, 2007, FOOD CHEM, V100, P273, DOI 10.1016/j.foodchem.2005.09.059; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Krishnan K, 2014, INFLAMMOPHARMACOLOGY, V22, P373, DOI 10.1007/s10787-014-0218-8; Labuschagne CF, 2013, AGEING RES REV, V12, P918, DOI 10.1016/j.arr.2013.09.003; Li H, 2011, J MED PLANTS RES, V5, P485; Li WH, 2014, MOL NUTR FOOD RES, V58, P863, DOI 10.1002/mnfr.201300404; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Martelanc M, 2009, J CHROMATOGR A, V1216, P6662, DOI 10.1016/j.chroma.2009.07.038; Moreno JJ, 2003, FREE RADICAL BIO MED, V35, P1073, DOI 10.1016/S0891-5849(03)00465-9; Morgan KL, 2010, TOXICOL SCI, V118, P530, DOI 10.1093/toxsci/kfq273; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; OKEEFE SF, 1993, J AM OIL CHEM SOC, V70, P489, DOI 10.1007/BF02542581; Paniagua-Perez R, 2008, ARCH TOXICOL, V82, P615, DOI 10.1007/s00204-007-0277-3; Sahari MA, 2004, J AM OIL CHEM SOC, V81, P585, DOI 10.1007/s11746-006-0945-0; Saul N, 2008, MECH AGEING DEV, V129, P611, DOI 10.1016/j.mad.2008.07.001; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Shao P, 2015, EUR J LIPID SCI TECH, V117, P355, DOI 10.1002/ejlt.201400259; Shi YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039515; Shi YC, 2012, FREE RADICAL BIO MED, V52, P109, DOI 10.1016/j.freeradbiomed.2011.09.034; Sin O, 2014, BBA-MOL BASIS DIS, V1842, P1951, DOI 10.1016/j.bbadis.2014.01.015; Su MH, 2014, FOOD CHEM, V156, P369, DOI 10.1016/j.foodchem.2014.02.016; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sunil C, 2014, IND CROP PROD, V61, P510, DOI 10.1016/j.indcrop.2014.07.005; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Trichopoulou A, 2000, CANCER EPIDEM BIOMAR, V9, P869; Tripoli E, 2005, NUTR RES REV, V18, P98, DOI 10.1079/NRR200495; Uylaser V, 2014, CRIT REV FOOD SCI, V54, P1092, DOI 10.1080/10408398.2011.626874; Vivancos M, 2005, FREE RADICAL BIO MED, V39, P91, DOI 10.1016/j.freeradbiomed.2005.02.025; Wan Y, 2015, J SCI FOOD AGR, V95, P2571, DOI 10.1002/jsfa.7035; Wei CC, 2014, J AGR FOOD CHEM, V62, P10701, DOI 10.1021/jf503192x; Yu CW, 2014, J AGR FOOD CHEM, V62, P6159, DOI 10.1021/jf500417y	53	25	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157195	10.1371/journal.pone.0157195	http://dx.doi.org/10.1371/journal.pone.0157195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275864	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700084
J	Amann, J; Zanini, C; Rubinelli, S				Amann, Julia; Zanini, Claudia; Rubinelli, Sara			What Online User Innovation Communities Can Teach Us about Capturing the Experiences of Patients Living with Chronic Health Conditions. A Scoping Review	PLOS ONE			English	Article							SOURCE SOFTWARE-DEVELOPMENT; WORLD-WIDE-WEB; SOCIAL MEDIA; PRODUCT DEVELOPMENT; CO-CREATION; VIRTUAL COMMUNITIES; SUPPORT GROUPS; DIFFERENT FORMS; PUBLIC-SECTOR; INTERNET USE	Background In order to adapt to societal changes, healthcare systems need to switch from a disease orientation to a patient-centered approach. Virtual patient networks are a promising tool to favor this switch and much can be learned from the open and user innovation literature where the involvement of online user communities in the innovation process is well-documented. Objectives The objectives of this study were 1) to describe the use of online communities as a tool to capture and harness innovative ideas of end users or consumers; and 2) to point to the potential value and challenges of these virtual platforms to function as a tool to inform and promote patient-centered care in the context of chronic health conditions. Methods A scoping review was conducted. A total of seven databases were searched for scientific articles published in English between 1995 and 2014. The search strategy was refined through an iterative process. Results A total of 144 studies were included in the review. Studies were coded inductively according to their research focus to identify groupings of papers. The first set of studies focused on the interplay of factors related to user roles, motivations, and behaviors that shape the innovation process within online communities. Studies of the second set examined the role of firms in online user innovation initiatives, identifying different organizational strategies and challenges. The third set of studies focused on the idea selection process and measures of success with respect to online user innovation initiatives. Finally, the findings from the review are presented in the light of the particularities and challenges discussed in current healthcare research. Conclusion The present paper highlights the potential of virtual patient communities to inform and promote patient-centered care, describes the key challenges involved in this process, and makes recommendations on how to address them.	[Amann, Julia; Zanini, Claudia; Rubinelli, Sara] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Lucerne Nottwil, Switzerland; [Amann, Julia; Zanini, Claudia; Rubinelli, Sara] Swiss Parapleg Res, Lucerne Nottwil, Switzerland; [Amann, Julia; Zanini, Claudia; Rubinelli, Sara] Swiss Parapleg Res, Nottwil, Switzerland	Swiss Paraplegic Research; Swiss Paraplegic Research	Amann, J (corresponding author), Univ Lucerne, Dept Hlth Sci & Hlth Policy, Lucerne Nottwil, Switzerland.; Amann, J (corresponding author), Swiss Parapleg Res, Lucerne Nottwil, Switzerland.; Amann, J (corresponding author), Swiss Parapleg Res, Nottwil, Switzerland.	julia.amann@paraplegie.ch	Amann, Julia/AAA-4127-2019	Amann, Julia/0000-0003-2155-5286	Swiss Paraplegic Research (Nottwil, Switzerland)	Swiss Paraplegic Research (Nottwil, Switzerland)	The study was funded internally by Swiss Paraplegic Research as part of the regular research activity (Nottwil, Switzerland), http://www.paraplegie.ch/en/pub/spf.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkafi N, 2009, MANAGE DECIS, V47, P1610, DOI 10.1108/00251740911004718; Adams SA, 2010, INT J MED INFORM, V79, P391, DOI 10.1016/j.ijmedinf.2010.01.006; Alam I., 2002, J SERV MARK, V16, P515, DOI [10.1108/08876040210443391, DOI 10.1108/08876040210443391]; Amann J., 2015, EUR J HEALTH PSYCHOL, V17, P286; An LC, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1018; [Anonymous], 2015, BMC HLTH SERVICES RE; Antikainen M, 2010, EUR J INNOV MANAG, V13, P100, DOI 10.1108/14601061011013258; Antorini YM, 2013, RES TECHNOL MANAGE, V56, P21, DOI 10.5437/08956308X5603931; Antorini YM, 2012, MIT SLOAN MANAGE REV, V53, P73; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Armstrong N, 2012, HEALTH-LONDON, V16, P347, DOI 10.1177/1363459311425514; Balka K, 2014, J PROD INNOVAT MANAG, V31, P392, DOI 10.1111/jpim.12102; Barcellini F, 2009, INT J IND ERGONOM, V39, P533, DOI 10.1016/j.ergon.2008.10.013; Battistella C, 2012, INFORM RES, V17; Battistella C, 2012, INNOV-ORGAN MANAG, V14, P557, DOI 10.5172/impp.2012.14.4.557; Battistella C, 2013, PROD PLAN CONTROL, V24, P226, DOI 10.1080/09537287.2011.647876; Bayus BL, 2013, MANAGE SCI, V59, P226, DOI 10.1287/mnsc.1120.1599; Bianchi AJ, 2012, ORGAN SCI, V23, P341, DOI 10.1287/orsc.1100.0580; Birkinshaw J, 2011, MIT SLOAN MANAGE REV, V52, P43; Blohm Ivo, 2011, International Journal of Networking and Virtual Organisations, V9, P106, DOI 10.1504/IJNVO.2011.042413; Boon W, 2010, NEUROMUSCULAR DISORD, V20, P148, DOI 10.1016/j.nmd.2009.10.012; Bothos E, 2009, INTERNET RES, V19, P26, DOI 10.1108/10662240910927803; Boudreau KJ, 2012, ORGAN SCI, V23, P1409, DOI 10.1287/orsc.1110.0678; Boudreau KJ, 2011, MANAGE SCI, V57, P843, DOI 10.1287/mnsc.1110.1322; Brabham DC, 2010, INFORM COMMUN SOC, V13, P1122, DOI 10.1080/13691181003624090; Broom A, 2005, QUAL HEALTH RES, V15, P325, DOI 10.1177/1049732304272916; Bullinger AC, 2012, HEALTH POLICY, V105, P165, DOI 10.1016/j.healthpol.2012.02.009; Cheng CCJ, 2013, INNOV-MANAG POLICY P, V15, P83, DOI 10.5172/impp.2013.15.1.83; Cheng JL, 2008, PERFORM IMPROV Q, V21, P43, DOI 10.1002/piq.20030; Chesbrough H., 2006, OPEN INNOVATION RES, P1, DOI DOI 10.1016/J.JENGTECMAN.2004.05.003; Christensen Martin, 2006, Br J Nurs, V15, P695; Chu KM, 2009, INTERNET RES, V19, P496, DOI 10.1108/10662240910998887; Chua AYK, 2013, J KNOWL MANAG, V17, P237, DOI 10.1108/13673271311315196; Colombo MG, 2014, RES POLICY, V43, P891, DOI 10.1016/j.respol.2013.08.015; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Cromie J, 2008, INT J MARKET RES, V50, P631, DOI 10.2501/S1470785308200079; Dahlander L, 2007, IND CORP CHANGE, V16, P913, DOI 10.1093/icc/dtm026; Dahlander L, 2014, RES POLICY, V43, P812, DOI 10.1016/j.respol.2013.06.006; Dahlander L, 2012, ORGAN SCI, V23, P988, DOI 10.1287/orsc.1110.0673; Davis K, 2009, INT J NURS STUD, V46, P1386, DOI 10.1016/j.ijnurstu.2009.02.010; De Toni AF, 2012, LEARN ORGAN, V19, P335, DOI 10.1108/09696471211226699; Martinez-Torres MD, 2014, ASIAN J TECHNOL INNO, V22, P114, DOI 10.1080/19761597.2014.912577; Demiris G, 2006, PATIENT EDUC COUNS, V62, P178, DOI 10.1016/j.pec.2005.10.003; Di Gangi PM, 2010, MIS Q EXEC, V9, P213; Di Gangi PM, 2009, DECIS SUPPORT SYST, V48, P303, DOI 10.1016/j.dss.2009.04.004; Divajeva D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-456; Djelassi S, 2013, IND MARKET MANAG, V42, P683, DOI 10.1016/j.indmarman.2013.05.006; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Edwards SJL, 2000, J MED ETHICS, V26, P179, DOI 10.1136/jme.26.3.179; Edwards T, 2008, CURR CLIN UROL, P325, DOI 10.1007/978-1-60327-126-4_22; Evans-Cowley J, 2010, PLAN PRACT RES, V25, P397, DOI 10.1080/02697459.2010.503432; Eysenbach G, 2002, BMJ-BRIT MED J, V324, P573, DOI 10.1136/bmj.324.7337.573; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; Eysenbach G, 2004, BMJ-BRIT MED J, V328, P1166, DOI 10.1136/bmj.328.7449.1166; Fagerholm F, 2014, IEEE SOFTWARE, V31, P54, DOI 10.1109/MS.2014.107; Ferguson T, 2000, BRIT MED J, V321, P1129, DOI 10.1136/bmj.321.7269.1129; Ferrand E, 2003, AM J RESP CRIT CARE, V167, P1310, DOI 10.1164/rccm.200207-752OC; Filieri R, 2013, MARK INTELL PLAN, V31, P40, DOI 10.1108/02634501311292911; Fleming L, 2007, ORGAN SCI, V18, P165, DOI 10.1287/orsc.1060.0242; Franke N, 2014, J PROD INNOVAT MANAG, V31, P1214, DOI 10.1111/jpim.12137; Franke N, 2013, ORGAN SCI, V24, P1495, DOI 10.1287/orsc.1120.0794; Fuller J, 2007, J BUS RES, V60, P60, DOI 10.1016/j.jbusres.2006.09.019; Fuller J, 2014, J MANAGE INFORM SYST, V31, P273, DOI 10.2753/MIS0742-1222310111; Fuller J, 2012, CREAT INNOV MANAG, V21, P247, DOI 10.1111/j.1467-8691.2012.00650.x; Fuller J, 2011, R&D MANAGE, V41, P259, DOI 10.1111/j.1467-9310.2011.00640.x; Fuller J, 2009, J MANAGE INFORM SYST, V26, P71, DOI 10.2753/MIS0742-1222260303; Gagliardi A, 2002, BMJ-BRIT MED J, V324, P569, DOI 10.1136/bmj.324.7337.569; Ghazawneh Ahmad, 2011, International Journal of Networking and Virtual Organisations, V9, P140, DOI 10.1504/IJNVO.2011.042415; Grabher G, 2008, ECON GEOGR, V84, P253; Grabher G, 2014, J ECON GEOGR, V14, P97, DOI 10.1093/jeg/lbt014; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Guenduez AA, 2014, INT PUBLIC MANAG J, V15, P58; Guimaraes ALS, 2013, J ELECTRON COMMER RE, V14, P167; Habicht H., 2013, UNTERNEHMUNG, V66, P277, DOI DOI 10.5771/0042-059X-2012-3-277; Hajli MN, 2014, J STRAT MARKET, P1; Hann IH, 2013, INFORM SYST RES, V24, P520, DOI 10.1287/isre.2013.0474; Hartmann M, 2010, OPEN INNOVATION HEAL, P102; Hennala L, 2011, EUR J INNOV MANAG, V14, P364, DOI 10.1108/14601061111148843; Henttonen Katja, 2012, Journal of Technology Management & Innovation, V7, P135, DOI 10.4067/S0718-27242012000300012; Henwood F, 2003, SOCIOL HEALTH ILL, V25, P589, DOI 10.1111/1467-9566.00360; Herxheimer A, 2003, BRIT MED J, V326, P1208, DOI 10.1136/bmj.326.7400.1208; Hess J, 2013, INT J HUM-COMPUT ST, V71, P570, DOI 10.1016/j.ijhcs.2013.01.003; Heyduck K, 2014, J CLIN PSYCHOL MED S, V21, P267, DOI 10.1007/s10880-014-9405-4; Hildebrand C, 2013, INFORM SYST RES, V24, P14, DOI 10.1287/isre.1120.0455; Househ M, 2014, HEALTH INFORM J, V20, P50, DOI 10.1177/1460458213476969; Houston TK, 2002, AM J PSYCHIAT, V159, P2062, DOI 10.1176/appi.ajp.159.12.2062; Hoybye MT, 2010, BRIT J CANCER, V102, P1348, DOI 10.1038/sj.bjc.6605646; Huang Y, 2014, MANAGE SCI, V60, P2138, DOI 10.1287/mnsc.2013.1879; Huizingh EKRE, 2011, TECHNOVATION, V31, P2, DOI 10.1016/j.technovation.2010.10.002; Hutter K, 2011, CREAT INNOV MANAG, V20, P3, DOI 10.1111/j.1467-8691.2011.00589.x; Jarvenpaa SL, 2013, MIS Q EXEC, V12, P125; Jeppesen LB, 2006, ORGAN SCI, V17, P45, DOI 10.1287/orsc.1050.0156; Jespersen KR, 2011, INT J INNOV MANAG, V15, P1141, DOI 10.1142/S1363919611003684; Jespersen KR, 2010, INT J INNOV MANAG, V14, P471, DOI 10.1142/S136391961000274X; Jin B, 2010, WHAT MAKES ONLINE CO, P587; Johnston AC, 2013, INFORM TECHNOL PEOPL, V26, P213, DOI 10.1108/ITP-02-2013-0040; Juell-Skielse Gustaf, 2014, Information Polity, V19, P247, DOI 10.3233/IP-140346; Kaicker J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-59; Kanstrup AM, 2015, HEALTH INF MANAG J, V44, P12, DOI 10.1177/183335831504400102; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Khan Z, 2014, TRANSFORM GOV-PEOPLE, V8, P205, DOI 10.1108/TG-09-2013-0030; Kim JH, 2008, INT J INNOV MANAG, V12, P357, DOI 10.1142/S1363919608002011; King A, 2013, MIT SLOAN MANAGE REV, V55, P41; Koch S., 2004, ELECTRON MARK, V14, P77, DOI [10.1080/10196780410001675031, DOI 10.1080/10196780410001675031]; Kohler T, 2009, TECHNOVATION, V29, P395, DOI 10.1016/j.technovation.2008.11.004; Kosonen M, 2014, INT J INNOV MANAG, V18, DOI 10.1142/S1363919614500315; Kosonen M, 2013, INT J INNOV MANAG, V17, DOI 10.1142/S1363919613400100; Kuenne CW, 2013, ONLINE INNOVATION IN; Lampel J, 2012, ACAD MANAGE PERSPECT, V26, P71, DOI 10.5465/amp.2010.0068; Lasker Judith N, 2005, J Med Internet Res, V7, pe10, DOI 10.2196/jmir.7.1.e10; Latusek-Jurczak, 2014, J EC MANAG, V17, P47; Latzko-Toth G, 2014, CAN J COMMUN, V39, P577; Lavis J, 2013, BRIDGING WORLDS RES, V4, P5; Lavis JN, 2009, ISSUE BRIEF ENGAGING; Lee H, 2014, ELECTRON COMMER R A, V13, P205, DOI 10.1016/j.elerap.2014.02.001; Lee SM, 2012, MANAGE DECIS, V50, P147, DOI 10.1108/00251741211194921; Leimeister JM, 2009, J MANAGE INFORM SYST, V26, P197, DOI 10.2753/MIS0742-1222260108; Lerner J, 2006, AM ECON REV, V96, P114, DOI 10.1257/000282806777211874; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levine SS, 2014, ORGAN SCI, V25, P1414, DOI 10.1287/orsc.2013.0872; Lichtenthaler U, 2009, R&D MANAGE, V39, P38, DOI 10.1111/j.1467-9310.2008.00522.x; Liu HX, 2014, INFORM TECHNOL MANAG, V15, P255, DOI 10.1007/s10799-014-0199-8; Luders M, 2014, J COMPUT-MEDIAT COMM, V19, P446, DOI 10.1111/jcc4.12047; MacCormack A, 2013, MIT SLOAN MANAGE REV, V55, P25; Magnezi R, 2015, INFORM HEALTH SOC CA, V40, P125, DOI 10.3109/17538157.2013.879147; Malhotra A, 2014, CALIF MANAGE REV, V56, P103, DOI 10.1525/cmr.2014.56.4.103; Mallapragada G, 2012, MARKET SCI, V31, P474, DOI 10.1287/mksc.1110.0690; Malone M, 2004, FAM PRACT, V21, P189, DOI 10.1093/fampra/cmh215; Maloney-Krichmar D., 2005, ACM Transactions on Computer-Human Interaction, V12, P201, DOI 10.1145/1067860.1067864; Marchi G, 2011, TECHNOVATION, V31, P350, DOI 10.1016/j.technovation.2011.04.005; Martinez-Torres MR, 2014, TECHNOL ANAL STRATEG, V26, P435, DOI 10.1080/09537325.2013.851378; Martinez-Torres MR, 2013, EXPERT SYST APPL, V40, P2503, DOI 10.1016/j.eswa.2012.10.070; Martinez-Torres MR, 2010, INTERNET RES, V20, P72, DOI 10.1108/10662241011020842; Martini A, 2014, BUS HORIZONS, V57, P425, DOI 10.1016/j.bushor.2014.02.003; Martini A, 2013, INFORM ORGAN-UK, V23, P198, DOI 10.1016/j.infoandorg.2013.07.001; Martins CS, 2013, J SERV MANAGE, V24, P567, DOI 10.1108/JOSM-04-2013-0112; May C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-148; McNichol E, 2012, INT J HEALTHCARE MAN, V5, P216, DOI 10.1179/2047971912Y.0000000020; Medury, 2012, J TARGETING MEASUREM, V20, P35, DOI [DOI 10.1057/JT.2012.3, 10.1057/jt.2012.3]; Misra R, 2008, INT J PHARM HEALTHC, V2, P321, DOI 10.1108/17506120810922358; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morahan-Martin JM, 2004, CYBERPSYCHOL BEHAV, V7, P497, DOI 10.1089/1094931042403082; Mortara L, 2013, TECHNOL FORECAST SOC, V80, P1563, DOI 10.1016/j.techfore.2013.01.008; Mount M, 2014, CALIF MANAGE REV, V56, P124, DOI 10.1525/cmr.2014.56.4.124; Muller-Seitz G, 2010, TECHNOVATION, V30, P627, DOI 10.1016/j.technovation.2010.07.006; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Nambisan S, 2008, MIT SLOAN MANAGE REV, V49, P53; Nambisan S, 2010, ORGAN SCI, V21, P554, DOI 10.1287/orsc.1090.0460; Natti S, 2014, J BUS IND MARK, V29, P173, DOI 10.1108/JBIM-08-2013-0167; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Nicolajsen HW, 2011, J BUS IND MARK, V26, P368, DOI 10.1108/08858621111144424; Ogawa S, 2006, MIT SLOAN MANAGE REV, V47, P65; Ogawa S, 2013, RES TECHNOL MANAGE, V56, P41, DOI 10.5437/08956308X5603088; Oliveira P, 2014, ORPHANET J RARE DIS, V9, pO33, DOI DOI 10.1186/1750-1172-9-S1-O33; Omachonu V., 2010, INNOV J, V15, P1; Parekh AK, 2014, JAMA-J AM MED ASSOC, V312, P1199, DOI 10.1001/jama.2014.10181; Parjanen S, 2012, INNOV-ORGAN MANAG, V14, P363, DOI 10.5172/impp.2012.14.3.363; Patel V, 2011, INT J MED INFORM, V80, P171, DOI 10.1016/j.ijmedinf.2010.11.008; Paulini M, 2013, CODESIGN, V9, P90, DOI 10.1080/15710882.2012.716850; Piller FT, 2006, R&D MANAGE, V36, P307, DOI 10.1111/j.1467-9310.2006.00432.x; Poetz MK, 2012, J PROD INNOVAT MANAG, V29, P245, DOI 10.1111/j.1540-5885.2011.00893.x; Raasch C, 2013, MIT SLOAN MANAGE REV, V55, P33; Raasch C, 2011, INT J INNOV TECHNOL, V8, P557, DOI 10.1142/S021987701100260X; Raasch C, 2009, R&D MANAGE, V39, P382, DOI 10.1111/j.1467-9310.2009.00567.x; Reay T, 2009, ORGAN STUD, V30, P629, DOI 10.1177/0170840609104803; Reinhardt R, 2015, OPEN INNOVATION HLTH, P237; Richardson CR, 2010, J MED INTERNET RES, V12, P138, DOI 10.2196/jmir.1338; Riedl C, 2013, INT J ELECTRON COMM, V17, P7, DOI 10.2753/JEC1086-4415170301; Roberts D, 2014, EUR J MARKETING, V48, P147, DOI 10.1108/EJM-12-2010-0637; Roberts DL, 2014, J PROD INNOVAT MANAG, V31, P105, DOI 10.1111/jpim.12195; Roberts N, 2012, J MANAGE INFORM SYST, V28, P231, DOI 10.2753/MIS0742-1222280409; ROSENBERG W, 1995, BMJ-BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122; Rossi C, 2011, MEAS BUS EXCELL, V15, P46, DOI 10.1108/13683041111161157; Rubinelli S, 2009, INT J PUBLIC HEALTH, V54, P307, DOI 10.1007/s00038-009-0052-8; Russo-Spena T, 2012, J SERV MANAGE, V23, P527, DOI 10.1108/09564231211260404; Ryzhkova N, 2012, INNOV-ORGAN MANAG, V14, P416, DOI 10.5172/impp.2012.14.3.416; Saldanha FP, 2014, TECHNOL INNOV MANAG, P28; Sarkar S, 2008, TRENDS FOOD SCI TECH, V19, P574, DOI 10.1016/j.tifs.2008.09.006; Sasinovskaya O, 2011, J BRAND MANAG, V19, P33, DOI 10.1057/bm.2011.31; Saxton GD, 2013, INFORM SYST MANAGE, V30, P2, DOI 10.1080/10580530.2013.739883; Schlagwein D, 2014, J ASSOC INF SYST, V15, P754; Schroeder EB, 2015, INTERACT J MED RES, V4, P35, DOI 10.2196/ijmr.3856; Schulz PJ, 2013, PATIENT EDUC COUNS, V90, P4, DOI 10.1016/j.pec.2012.09.006; Schulz PJ, 2010, J COMPUT-MEDIAT COMM, V15, P625, DOI 10.1111/j.1083-6101.2009.01509.x; Schumacher KR, 2014, PEDIATRICS, V133, pE1345, DOI 10.1542/peds.2013-2966; Schweitzer FM, 2012, RES TECHNOL MANAGE, V55, P32, DOI 10.5437/08956308X5503055; Scupola A, 2013, INT J E-BUS RES, V9, P27, DOI 10.4018/jebr.2013070102; Scupola A, 2010, LIBR MANAGE, V31, P304, DOI 10.1108/01435121011046362; Seltzer E, 2013, J PLAN LIT, V28, P3, DOI 10.1177/0885412212469112; Setia P, 2012, INFORM SYST RES, V23, P144, DOI 10.1287/isre.1100.0311; Shen C, 2011, WHO CONNECTS WHOM SO, P39; Sigala M, 2012, INT J CONTEMP HOSP M, V24, P966, DOI 10.1108/09596111211258874; Singh PV, 2010, ACM T SOFTW ENG METH, V20; Smits REHM, 2008, DRUG DISCOV TODAY, V13, P353, DOI 10.1016/j.drudis.2007.12.006; Son J, 2012, J RES INTERACT MARK, V6, P180, DOI 10.1108/17505931211274660; Spaeth S, 2010, INT J TECHNOL MANAGE, V52, P411, DOI 10.1504/IJTM.2010.035983; Spiliotopoulou L, 2014, TRANSFORM GOV-PEOPLE, V8, P545, DOI 10.1108/TG-01-2014-0002; Spyropoulou GA, 2009, J PLAST RECONSTR AES, V62, pE353, DOI 10.1016/j.bjps.2008.01.043; Stam W, 2009, RES POLICY, V38, P1288, DOI 10.1016/j.respol.2009.06.004; Stewart D, 2005, AM SOCIOL REV, V70, P823, DOI 10.1177/000312240507000505; Teigland R, 2014, INFORM ORGAN-UK, V24, P25, DOI 10.1016/j.infoandorg.2014.01.001; Terwiesch C, 2008, MANAGE SCI, V54, P1529, DOI 10.1287/mnsc.1080.0884; Thorne SE, 2000, INT J NURS STUD, V37, P303, DOI 10.1016/S0020-7489(00)00007-9; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Toral SL, 2009, BEHAV INFORM TECHNOL, V28, P405, DOI 10.1080/01449290903121394; Toral SL, 2009, J UNIVERS COMPUT SCI, V15, P648; Toubia O, 2007, MARKET SCI, V26, P342, DOI 10.1287/mksc.1070.0273; Tuckermann H., 2014, MULTIRATIONAL MANAGE, P71; van Dijk J, 2014, INT J CONSUM STUD, V38, P110, DOI 10.1111/ijcs.12071; Villarroel JA, 2013, COMPUT MATH ORGAN TH, V19, P42, DOI 10.1007/s10588-012-9137-7; von Hippel E., 2005, DEMOCRATIZING INNOVA; Wald HS, 2007, PATIENT EDUC COUNS, V68, P218, DOI 10.1016/j.pec.2007.05.016; Wallace DJ, 2008, SEMIN ARTHRITIS RHEU, V37, P256, DOI 10.1016/j.semarthrit.2007.04.008; Wallin MW, 2010, ORGAN DYN, V39, P145, DOI 10.1016/j.orgdyn.2010.01.010; Wearden A, 2008, BRIT J HEALTH PSYCH, V13, P189, DOI 10.1348/135910708X295613; Weeks LC, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-43; Wei W, 2013, INNOV-ORGAN MANAG, V15, P69, DOI 10.5172/impp.2013.15.1.69; Weiber R, 2014, TOTAL QUAL MANAG BUS, V25, P1105, DOI 10.1080/14783363.2013.782972; Weitzman ER, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1356; West J, 2010, CONTRASTING INNOVATI; West J, 2008, IND INNOV, V15, P145, DOI 10.1080/13662710801970142; Wicks P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1549; Williams RL, 2000, SLOAN MANAGE REV, V41, P81; Xu B, 2011, J DATABASE MANAGE, V22, P26, DOI 10.4018/jdm.2011010102; Xu B, 2009, INFORM MANAGE-AMSTER, V46, P151, DOI 10.1016/j.im.2008.12.005; Yucesan E, 2013, IIE TRANS, V45, P751, DOI 10.1080/0740817X.2012.757679; Zanini C, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0374-6; Zhang C, 2013, INFORM SYST RES, V24, P1112, DOI 10.1287/isre.2013.0485; Zhao YC, 2014, ONLINE INFORM REV, V38, P896, DOI 10.1108/OIR-08-2014-0188; Zheng HC, 2014, J ELECTRON COMMER RE, V15, P212; Zrebiec JF, 2001, DIABETIC MED, V18, P154, DOI 10.1046/j.1464-5491.2001.00443.x	231	17	17	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156175	10.1371/journal.pone.0156175	http://dx.doi.org/10.1371/journal.pone.0156175			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272912	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000009
J	Porch, CE; Lauretta, MV				Porch, Clay E.; Lauretta, Matthew V.			On Making Statistical Inferences Regarding the Relationship between Spawners and Recruits and the Irresolute Case of Western Atlantic Bluefin Tuna (Thunnus thynnus)	PLOS ONE			English	Article							STOCK; FISH; AGE	Forecasts of the future abundance of western Atlantic bluefin tuna (Thunnus thynnus) have, for nearly two decades, been based on two competing views of future recruitment potential: (1) a "low" recruitment scenario based on hockey-stick (two-line) curve where the expected level of recruitment is set equal to the geometric mean of the recruitment estimates for the years after a supposed regime-shift in 1975, and (2) a "high" recruitment scenario based on a Beverton-Holt curve fit to the time series of spawner-recruit pairs beginning in 1970. Several investigators inferred the relative plausibility of these two scenarios based on measures of their ability to fit estimates of spawning biomass and recruitment derived from stock assessment outputs. Typically, these comparisons have assumed the assessment estimates of spawning biomass are known without error. It is shown here that ignoring error in the spawning biomass estimates can predispose model-choice approaches to favor the regime-shift hypothesis over the Beverton-Holt curve with higher recruitment potential. When the variance of the observation error approaches that which is typically estimated for assessment outputs, the same model-choice approaches tend to favor the single Beverton-Holt curve. For this and other reasons, it is argued that standard model-choice approaches are insufficient to make the case for a regime shift in the recruitment dynamics of western Atlantic bluefin tuna. A more fruitful course of action may be to move away from the current high/low recruitment dichotomy and focus instead on adopting biological reference points and management procedures that are robust to these and other sources of uncertainty.	[Porch, Clay E.; Lauretta, Matthew V.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA	Porch, CE (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA.	Clay.Porch@noaa.gov						Anonymous, 2015, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V71, P1863; [Anonymous], 2002, ICCAT REPORT BIENN 1, V2; Boettiger C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1631; Brooks EN, 2014, CAN J FISH AQUAT SCI, V72, P1; Brown Craig A., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P953; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Fromentin JM, 2014, FISH OCEANOGR, V23, P147, DOI 10.1111/fog.12050; Gilbert DJ, 1997, CAN J FISH AQUAT SCI, V54, P969, DOI 10.1139/cjfas-54-4-969; He X, 2014, FISH RES, V165, P54; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; ICCAT, 2013, INT COMM CONS ATL CO, V69, P1; Kehler DG, 2002, CAN J FISH AQUAT SCI, V59, P854, DOI 10.1139/F02-060; Kendall M.G., 1973, ADV THEORY STAT, V2; KERR LA, 2013, INT COMM CONS ATL CO, V69, P742; Klaer NL, 2015, FISH RES, V168, P49, DOI 10.1016/j.fishres.2015.03.021; LUDWIG D, 1981, CAN J FISH AQUAT SCI, V38, P711, DOI 10.1139/f81-094; Maunder MN, 2003, CAN J FISH AQUAT SCI, V60, P1204, DOI 10.1139/F03-104; McAllister M, 2001, COL VOL SCI PAP ICCA, V52, P1078; Myers RA, 1996, FISH B-NOAA, V94, P707; Porch CE, 2015, MAR COAST FISH, V7, P233, DOI 10.1080/19425120.2015.1040567; Porch CE, 2005, B MAR SCI, V76, P363; Porch CE, 2014, INT COMM CONS ATL CO, V70, P639; Porch Clay E., 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P1022; Report of the Meeting of the Standing Committee on Research and Statistics (SCRS), 1993, M STAND COMM RES S 2; Report of the Standing Committee on Research and Statistics (SCRS), 2014, ICCAT REPORT BIENN 1, V2; Rosenberg A, 2013, INT COMM CONS ATL CO, V69, P1016; SCRS, 2001, COL VOL SCI PAP ICCA, V54, P895; Su ZM, 2012, ECOL MODEL, V224, P76, DOI 10.1016/j.ecolmodel.2011.11.001; Szuwalski C, 2013, P NATL ACAD SCI USA, V110, pE1436, DOI 10.1073/pnas.1301759110; Szuwalski CS, 2015, FISH FISH, V16, P633, DOI 10.1111/faf.12083; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Vert Pre K. A, 2013, P NATL ACAD SCI USA, V110, P1779, DOI [10.1073/pnas.1214879110, DOI 10.1073/PNAS.1214879110]; 2015, COL VOL SCI PAP ICCA, V71, P692	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156767	10.1371/journal.pone.0156767	http://dx.doi.org/10.1371/journal.pone.0156767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272215	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000035
J	Tabrizi, SN; Tan, LY; Walker, S; Twin, J; Poljak, M; Bradshaw, CS; Fairley, CK; Bissessor, M; Mokany, E; Todd, AV; Garland, SM				Tabrizi, Sepehr N.; Tan, Lit Y.; Walker, Samantha; Twin, Jimmy; Poljak, Marin; Bradshaw, Catriona S.; Fairley, Christopher K.; Bissessor, Melanie; Mokany, Elisa; Todd, Alison V.; Garland, Suzanne M.			Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; NONGONOCOCCAL URETHRITIS; AZITHROMYCIN FAILURE; CLINICAL SPECIMENS; MNAZYME QPCR; ASSOCIATION; DISCRIMINATION; REGIMENS; DNA; PCR	Mycoplasma genitalium is a cause of non-gonoccocal urethritis (NGU) in men and cervicitis and pelvic inflammatory disease in women. Recent international data also indicated that the first line treatment, 1 gram stat azithromycin therapy, for M. genitalium is becoming less effective, with the corresponding emergence of macrolide resistant strains. Increasing failure rates of azithromycin for M. genitalium has significant implications for the presumptive treatment of NGU and international clinical treatment guidelines. Assays able to predict macrolide resistance along with detection of M. genitalium will be useful to enable appropriate selection of antimicrobials to which the organism is susceptible and facilitate high levels of rapid cure. One such assay recently developed is the MG 23S assay, which employs novel PlexZyme (TM) and PlexPrime (TM) technology. It is a multiplex assay for detection of M. genitalium and 5 mutations associated with macrolide resistance. The assay was evaluated in 400 samples from 254 (186 males and 68 females) consecutively infected participants, undergoing tests of cure. Using the MG 23S assay, 83% (331/440) of samples were positive, with 56% of positives carrying a macrolide resistance mutation. Comparison of the MG 23S assay to a reference qPCR method for M. genitalium detection and high resolution melt analysis (HRMA) and sequencing for detection of macrolide resistance mutations, resulted in a sensitivity and specificity for M. genitalium detection and for macrolide resistance of 99.1/98.5% and 97.4/100%, respectively. The MG 23S assay provides a considerable advantage in clinical settings through combined diagnosis and detection of macrolide resistance.	[Tabrizi, Sepehr N.; Twin, Jimmy; Poljak, Marin; Garland, Suzanne M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia; [Tabrizi, Sepehr N.; Twin, Jimmy; Poljak, Marin; Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic 3010, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Tan, Lit Y.; Walker, Samantha; Mokany, Elisa; Todd, Alison V.] SpeeDx Pty Ltd, Sydney, NSW, Australia; [Bradshaw, Catriona S.; Fairley, Christopher K.; Bissessor, Melanie] Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia; [Bradshaw, Catriona S.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Clayton, Vic 3800, Australia	University of Melbourne; Murdoch Children's Research Institute; Monash University	Tabrizi, SN (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Parkville, Vic, Australia.; Tabrizi, SN (corresponding author), Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic 3010, Australia.; Tabrizi, SN (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	sepehr.tabrizi@thewomens.org.au		bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	SpeedX	SpeedX	In regards to the funding statement the authors would like to confirm that the funder (SpeedX) provided support in the form of salaries for authors (LT, SW, EM, AT). The funder did not have any role in the clinical evaluation including data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bissessor M, 2015, CLIN INFECT DIS, V60, P1228, DOI 10.1093/cid/ciu1162; Bradshaw CS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003618; Bradshaw CS, 2006, EMERG INFECT DIS, V12, P1149, DOI 10.3201/eid1207.051558; Cohen CR, 2002, LANCET, V359, P765, DOI 10.1016/S0140-6736(02)07848-0; Deguchi T, 2002, J UROLOGY, V167, P1210, DOI 10.1016/S0022-5347(05)65268-8; Horner PJ, 2011, SEX TRANSM INFECT, V87, P38, DOI 10.1136/sti.2010.044487; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2012, METHODS MOL BIOL, V903, P129, DOI 10.1007/978-1-61779-937-2_8; Jensen JS, 2004, J EUR ACAD DERMATOL, V18, P1, DOI 10.1111/j.1468-3083.2004.00923.x; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Manhart LE, 2008, J INFECT DIS, V197, P733, DOI 10.1086/526501; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; Mavedzenge SN, 2012, AIDS, V26, P617, DOI 10.1097/QAD.0b013e32834ff690; Mokany E, 2013, METHODS MOL BIOL, V1039, P31, DOI 10.1007/978-1-62703-535-4_3; Mokany E, 2013, CLIN CHEM, V59, P419, DOI 10.1373/clinchem.2012.192930; Mokany E, 2010, J AM CHEM SOC, V132, P1051, DOI 10.1021/ja9076777; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Shahmanesh M, 2009, INT J STD AIDS, V20, P458, DOI 10.1258/ijsa.2009.009143; Taylor-Robinson D, 2002, INT J STD AIDS, V13, P145, DOI 10.1258/0956462021924776; Touati A, 2014, J CLIN MICROBIOL, V52, P1549, DOI 10.1128/JCM.03318-13; TULLY JG, 1981, LANCET, V1, P1288; Twin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035593; Twin J, 2011, J CLIN MICROBIOL, V49, P1140, DOI 10.1128/JCM.02328-10; Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49; Uuskula A, 2002, INT J STD AIDS, V13, P79, DOI 10.1258/0956462021924695; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	26	52	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156740	10.1371/journal.pone.0156740	http://dx.doi.org/10.1371/journal.pone.0156740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271704	Green Submitted, gold, Green Published			2022-12-27	WOS:000377560200013
J	Yano, T; Takeda, H; Uematsu, A; Yamanaka, S; Nomura, S; Nemoto, K; Iwasaki, T; Takahashi, H; Sawasaki, T				Yano, Tomoya; Takeda, Hiroyuki; Uematsu, Atsushi; Yamanaka, Satoshi; Nomura, Shunsuke; Nemoto, Keiichirou; Iwasaki, Takahiro; Takahashi, Hirotaka; Sawasaki, Tatsuya			AGIA Tag System Based on a High Affinity Rabbit Monoclonal Antibody against Human Dopamine Receptor D1 for Protein Analysis	PLOS ONE			English	Article							NF-KAPPA-B; FUNCTIONAL ANNOTATION; CELL; PURIFICATION; EXPRESSION; PEPTIDE; PHOSPHORYLATION; PHOSPHATASE; EFFICIENT; EPITOPE	Polypeptide tag technology is widely used for protein detection and affinity purification. It consists of two fundamental elements: a peptide sequence and a binder which specifically binds to the peptide tag. In many tag systems, antibodies have been used as binder due to their high affinity and specificity. Recently, we obtained clone Ra48, a high-affinity rabbit monoclonal antibody (mAb) against dopamine receptor D1 (DRD1). Here, we report a novel tag system composed of Ra48 antibody and its epitope sequence. Using a deletion assay, we identified EEAAGIARP in the C-terminal region of DRD1 as the minimal epitope of Ra48 mAb, and we named this sequence the "AGIA" tag, based on its central sequence. The tag sequence does not include the four amino acids, Ser, Thr, Tyr, or Lys, which are susceptible to post-translational modification. We demonstrated performance of this new tag system in biochemical and cell biology applications. SPR analysis demonstrated that the affinity of the Ra48 mAb to the AGIA tag was 4.90 x 10(-9) M. AGIA tag showed remarkably high sensitivity and specificity in immunoblotting. A number of AGIA-fused proteins overexpressed in animal and plant cells were detected by anti-AGIA antibody in immunoblotting and immunostaining with low background, and were immunoprecipitated efficiently. Furthermore, a single amino acid substitution of the second Glu to Asp (AGIA/E2D) enabled competitive dissociation of AGIA/E2D-tagged protein by adding wild-type AGIA peptide. It enabled one-step purification of AGIA/E2D-tagged recombinant proteins by peptide competition under physiological conditions. The sensitivity and specificity of the AGIA system makes it suitable for use in multiple methods for protein analysis.	[Yano, Tomoya; Takeda, Hiroyuki; Uematsu, Atsushi; Yamanaka, Satoshi; Nomura, Shunsuke; Nemoto, Keiichirou; Iwasaki, Takahiro; Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan	Ehime University	Sawasaki, T (corresponding author), Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	sawasaki@ehime-u.ac.jp		Sawasaki, Tatsuya/0000-0002-7952-0556	Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI Grant [24710251, 25117719, 25290077, 26640130, 26750375]; Grants-in-Aid for Scientific Research [15J03774] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (T.S.). This work was also partially supported by JSPS KAKENHI Grant Numbers 24710251 (H. Takeda), 25117719 (T.S.), 25290077 (T.S.), 26640130 (T.S.), and 26750375 (H. Takeda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht FE, 1996, J CLIN INVEST, V97, P2283, DOI 10.1172/JCI118670; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; De Ceuninck L, 2013, J CELL SCI, V126, P3770, DOI 10.1242/jcs.131250; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FUXE K, 1985, DOPAMINE NEUROENDOCR, P11, DOI DOI 10.1007/978-3-642-69948-1_2; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hopp TP, 1988, NATURE BIOTECHNOLOGY; Iwasaki T, 2013, MOL BIOL CELL, V24, P748, DOI 10.1091/mbc.E11-08-0740; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Knorre DG, 2009, ACTA NATURAE, V1, P29, DOI 10.32607/20758251-2009-1-3-29-51; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Krueger KE, 2006, MOL CELL PROTEOMICS, V5, P1799, DOI 10.1074/mcp.R600009-MCP200; Liguori MJ, 2001, HYBRIDOMA, V20, P189, DOI 10.1089/027245701750293529; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Malhotra A, 2009, METHOD ENZYMOL, V463, P239, DOI 10.1016/S0076-6879(09)63016-0; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Molestina RE, 2003, J CELL SCI, V116, P4359, DOI 10.1242/jcs.00683; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nemoto K, 2015, J BIOL CHEM, V290, P16665, DOI 10.1074/jbc.M114.617274; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ozawa T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0052383, DOI 10.1371/J0URNAL.P0NE.0052383]; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Schmidt PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037779; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Tadokoro D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.65; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Takeda H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11333; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Uchinomiya S, 2014, INORG CHEM, V53, P1816, DOI 10.1021/ic401612z; Ullman EF, 1996, CLIN CHEM, V42, P1518; User N., 2003, MASS SPECTROMETRY BA, P1; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Xu Y., 2015, CURR TOP MED CHEM; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	47	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156716	10.1371/journal.pone.0156716	http://dx.doi.org/10.1371/journal.pone.0156716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271343	Green Submitted, gold, Green Published			2022-12-27	WOS:000377560200012
J	Dipaola, M; Pavan, EE; Cattaneo, A; Frazzitta, G; Pezzoli, G; Cavallari, P; Frigo, CA; Isaias, IU				Dipaola, Mariangela; Pavan, Esteban E.; Cattaneo, Andrea; Frazzitta, Giuseppe; Pezzoli, Gianni; Cavallari, Paolo; Frigo, Carlo A.; Isaias, Ioannis U.			Mechanical Energy Recovery during Walking in Patients with Parkinson Disease	PLOS ONE			English	Article							CENTER-OF-MASS; REHABILITATION TREATMENT; GAIT; WORK; BIOMECHANICS; PARAMETERS; DISABILITY; COST	The mechanisms of mechanical energy recovery during gait have been thoroughly investigated in healthy subjects, but never described in patients with Parkinson disease (PD). The aim of this study was to investigate whether such mechanisms are preserved in PD patients despite an altered pattern of locomotion. We consecutively enrolled 23 PD patients (mean age 64 +/- 9 years) with bilateral symptoms (H&Y >= II) if able to walk unassisted in medication-off condition (overnight suspension of all dopaminergic drugs). Ten healthy subjects (mean age 62 +/- 3 years) walked both at their 'preferred' and 'slow' speeds, to match the whole range of PD velocities. Kinematic data were recorded by means of an optoelectronic motion analyzer. For each stride we computed spatio-temporal parameters, time-course and range of motion (ROM) of hip, knee and ankle joint angles. We also measured kinetic (W-k), potential (W-p), total (W-totCM) energy variations and the energy recovery index (ER). Along with PD progression, we found a significant correlation of W-totCM and W-p with knee ROM and in particular with knee extension in terminal stance phase. W-k and ER were instead mainly related to gait velocity. In PD subjects, the reduction of knee ROM significantly diminished both W-p and W-totCM. Rehabilitation treatments should possibly integrate passive and active mobilization of knee to prevent a reduction of gait-related energetic components.	[Dipaola, Mariangela; Cattaneo, Andrea; Cavallari, Paolo] Univ Milan, Human Physiol Sect, Dept Pathophysiol & Transplantat, Milan, Italy; [Dipaola, Mariangela; Pavan, Esteban E.; Frigo, Carlo A.] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Movement Biomech & Motor Control Lab, I-20133 Milan, Italy; [Cattaneo, Andrea; Isaias, Ioannis U.] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Cattaneo, Andrea; Isaias, Ioannis U.] Univ Wurzburg, D-97070 Wurzburg, Germany; [Frazzitta, Giuseppe] Moriggia Pelascini Hosp, Gravedona, Germany; [Frazzitta, Giuseppe] Moriggia Pelascini Hosp, Uniti, Germany; [Pezzoli, Gianni; Isaias, Ioannis U.] Pini CTO Ex ICP, Parkinson Inst, Milan, Italy; [Isaias, Ioannis U.] FERB Onlus, Milan, Italy	University of Milan; Polytechnic University of Milan; University of Wurzburg; University of Wurzburg	Isaias, IU (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany.; Isaias, IU (corresponding author), Univ Wurzburg, D-97070 Wurzburg, Germany.; Isaias, IU (corresponding author), Pini CTO Ex ICP, Parkinson Inst, Milan, Italy.; Isaias, IU (corresponding author), FERB Onlus, Milan, Italy.	Isaias_I@ukw.de	Pavan, Esteban Enrique/A-7272-2010; Cavallari, Paolo/C-5145-2012; Frigo, Carlo Albino/AAA-7060-2021; Isaias, Ioannis Ugo/F-4492-2014	Pavan, Esteban Enrique/0000-0001-9628-9694; Cavallari, Paolo/0000-0003-3160-9030; Frigo, Carlo Albino/0000-0003-0948-6089; Isaias, Ioannis Ugo/0000-0002-3552-5144; Frazzitta, Giuseppe/0000-0002-5555-4145; Pezzoli, Gianni/0000-0003-4665-6710	Fondazione Grigioni per la Malattia di Parkinson; Fondazione Europea Ricerca Biomedica FERB - ONLUS; Interdisziplinares Zentrum fur Klinische Forschung of the University Hospital Wurzburg [IZKF F-255]	Fondazione Grigioni per la Malattia di Parkinson; Fondazione Europea Ricerca Biomedica FERB - ONLUS; Interdisziplinares Zentrum fur Klinische Forschung of the University Hospital Wurzburg	The study was funded in part by the Fondazione Grigioni per la Malattia di Parkinson (IUI), Fondazione Europea Ricerca Biomedica FERB - ONLUS (IUI, GF), and the Interdisziplinares Zentrum fur Klinische Forschung (IZKF F-255) of the University Hospital Wurzburg (MD, EEP, AC, IUI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpinella I, 2007, IEEE T NEUR SYS REH, V15, P543, DOI 10.1109/TNSRE.2007.908933; Carpinella I, 2010, EUR J APPL PHYSIOL, V108, P71, DOI 10.1007/s00421-009-1168-5; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Christiansen CL, 2009, MOVEMENT DISORD, V24, P1481, DOI 10.1002/mds.22621; Delval A, 2008, GAIT POSTURE, V28, P495, DOI 10.1016/j.gaitpost.2008.03.003; Dietz V, 1995, ELECTROMYOGR MOTOR C, V97, P408, DOI 10.1016/0924-980X(95)00109-X; DuffRaffaele M, 1996, AM J PHYS MED REHAB, V75, P375, DOI 10.1097/00002060-199609000-00014; Ferrarin M, 2005, EXP BRAIN RES, V160, P517, DOI 10.1007/s00221-004-2036-5; Ferrarin M, 2002, GAIT POSTURE, V16, P135, DOI 10.1016/S0966-6362(01)00204-1; Fisher NM, 1997, DISABIL REHABIL, V19, P47, DOI 10.3109/09638289709166827; Frazzitta G, 2015, NEUROREHAB NEURAL RE, V29, P123, DOI 10.1177/1545968314542981; Frazzitta G, 2009, MOVEMENT DISORD, V24, P1139, DOI 10.1002/mds.22491; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Inman V., 1981, HUMAN WALKING; INMAN VT, 1966, CAN MED ASSOC J, V94, P1047; Isaias IU, 2010, MOVEMENT DISORD, V25, P679, DOI 10.1002/mds.22870; Kimmeskamp S, 2001, CLIN BIOMECH, V16, P806, DOI 10.1016/S0268-0033(01)00069-9; Maggioni MA, 2012, NEUROL SCI, V33, P779, DOI 10.1007/s10072-011-0827-6; Margaria R., 1976, BIOMECHANICS ENERGET; Mehrholz J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007830.pub2; Mitoma H, 2000, J NEUROL SCI, V174, P22, DOI 10.1016/S0022-510X(99)00329-9; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Morris ME, 2001, CLIN BIOMECH, V16, P459, DOI 10.1016/S0268-0033(01)00035-3; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; MORRIS ME, 1994, J NEUROL NEUROSUR PS, V57, P1532, DOI 10.1136/jnnp.57.12.1532; Morris ME, 1999, HUM MOVEMENT SCI, V18, P461, DOI 10.1016/S0167-9457(99)00020-2; Neptune RR, 2004, J BIOMECH, V37, P817, DOI 10.1016/j.jbiomech.2003.11.001; Perry Jacquelin, 1992, J PEDIATR ORTHOPED, P4, DOI [DOI 10.1097/01241398-199211000-00023, 10.1097/01241398-199211000-00023]; Shulman LM, 2008, MOVEMENT DISORD, V23, P790, DOI 10.1002/mds.21879; Sparling TL, 2014, OSTEOARTHR CARTILAGE, V22, P747, DOI 10.1016/j.joca.2014.04.004; STAUFFER RN, 1977, CLIN ORTHOP RELAT R, P246; Vieregge P, 1997, J NEURAL TRANSM, V104, P237, DOI 10.1007/BF01273184; Zatsiorsky V., 1983, BIOMECHANICS 8 B, V56, P1152	35	25	25	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156420	10.1371/journal.pone.0156420	http://dx.doi.org/10.1371/journal.pone.0156420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258183	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700063
J	Prodan, A; Brand, H; Imangaliyev, S; Tsivtsivadze, E; van der Weijden, F; de Jong, A; Paauw, A; Crielaard, W; Keijser, B; Veerman, E				Prodan, Andrei; Brand, Henk; Imangaliyev, Sultan; Tsivtsivadze, Evgeni; van der Weijden, Fridus; de Jong, Ad; Paauw, Armand; Crielaard, Wim; Keijser, Bart; Veerman, Enno			A Study of the Variation in the Salivary Peptide Profiles of Young Healthy Adults Acquired Using MALDI-TOF MS	PLOS ONE			English	Article							PROLINE-RICH PROTEIN; PROTEOMICS; ADHESION	A cross-sectional observational study was conducted to evaluate the inter-individual variation in the MALDI-TOF MS peptide profiles of unstimulated whole saliva in a population of 268 systemically healthy adults aged 18-30 yr (150 males and 118 females) with no apparent caries lesions or periodontal disease. Using Spectral Clustering, four subgroups of individuals were identified within the study population. These subgroups were delimited by the pattern of variation in 9 peaks detected in the 2-15 kDa m/z range. An Unsupervised Feature Selection algorithm showed that P-C peptide, a 44 residue-long salivary acidic proline-rich protein, and three of its fragments (Fr. 1-25, Fr. 15-35 and Fr. 15-44) play a central role in delimiting the subgroups. Significant differences were found in the salivary biochemistry of the subgroups with regard to lysozyme and chitinase, two enzymes that are part of the salivary innate defense system (p < 0.001). These results suggest that MALDI-TOF MS salivary peptide profiles may relate information on the underlying state of the oral ecosystem and may provide a useful reference for salivary disease biomarker discovery studies.	[Prodan, Andrei; Brand, Henk; Imangaliyev, Sultan; Crielaard, Wim; Keijser, Bart] Top Inst Food & Nutr, Wageningen, Netherlands; [Prodan, Andrei; Brand, Henk; Veerman, Enno] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Biochem, Amsterdam, Netherlands; [Prodan, Andrei; Brand, Henk; van der Weijden, Fridus; Crielaard, Wim; Veerman, Enno] Free Univ Amsterdam, Amsterdam, Netherlands; [Imangaliyev, Sultan; Tsivtsivadze, Evgeni; Keijser, Bart] Netherlands Org Appl Sci Res TNO, MSB Grp, Zeist, Netherlands; [van der Weijden, Fridus] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol, Amsterdam, Netherlands; [de Jong, Ad; Paauw, Armand] Netherlands Org Appl Sci Res TNO, Dept CBRN Protect, Rijswijk, Netherlands; [Crielaard, Wim] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Prevent Dent, Amsterdam, Netherlands	Top Institute Food & Nutrition; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Prodan, A (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Prodan, A (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Biochem, Amsterdam, Netherlands.; Prodan, A (corresponding author), Free Univ Amsterdam, Amsterdam, Netherlands.	a.prodan@acta.nl	Brand, Henk/GOP-2332-2022	Brand, Henk/0000-0002-7829-9116; Prodan, Andrei/0000-0003-2789-7789	TI Food and Nutrition	TI Food and Nutrition	The project was funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The public partners were responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The private partners contributed to the project through regular discussion. The funder provided support in the form of salaries for authors A. Prodan, WC and BK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. http://www.tifn.nl/	Albrethsen J, 2011, J PROTEOMICS, V74, P765, DOI 10.1016/j.jprot.2011.02.027; Amerongen AV, 2007, ANN NY ACAD SCI, V1098, P1, DOI 10.1196/annals.1384.033; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Bakry R, 2011, ANAL CHIM ACTA, V690, P26, DOI 10.1016/j.aca.2011.01.044; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNICK A, 1983, ARCH ORAL BIOL, V28, P19, DOI 10.1016/0003-9969(83)90022-5; Blankenvoorde MFJ, 1997, J PERIODONTAL RES, V32, P583, DOI 10.1111/j.1600-0765.1997.tb00935.x; Bonne NJ, 2012, GENOME MED, V4, DOI 10.1186/gm383; Cabras T, 2014, BIOANALYSIS, V6, P563, DOI 10.4155/bio.13.349; Cabras T, 2010, MOL CELL PROTEOMICS, V9, P2099, DOI 10.1074/mcp.M110.001057; Cai KH, 2004, ARCH ORAL BIOL, V49, P871, DOI 10.1016/j.archoralbio.2004.05.004; Castagnola M, 2012, J MATERN-FETAL NEO M, V25, P27, DOI 10.3109/14767058.2012.714647; Castagnola M, 2012, EXPERT REV PROTEOMIC, V9, P33, DOI [10.1586/EPR.11.77, 10.1586/epr.11.77]; Chaiyarit P, 2014, CLIN ORAL INVEST, P1; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009; Fabian TK, 2012, INT J MOL SCI, V13, P4295, DOI 10.3390/ijms13044295; GIBBONS RJ, 1991, INFECT IMMUN, V59, P2948, DOI 10.1128/IAI.59.9.2948-2954.1991; Gomez SM, 2001, J CLIN PERIODONTOL, V28, P970; Halgand F, 2010, J AM SOC MASS SPECTR, V21, P868, DOI 10.1016/j.jasms.2010.01.026; HAY DI, 1994, J DENT RES, V73, P1717, DOI 10.1177/00220345940730110701; HAY DI, 1979, INORG PERSPECT BIOL, V2, P271; Helmerhorst EJ, 2008, J BIOL CHEM, V283, P19957, DOI 10.1074/jbc.M708282200; Hoek GH, 2002, EUR J ORAL SCI, V110, P480, DOI 10.1034/j.1600-0722.2002.21370.x; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Huq NL, 2007, INT J PEPT RES THER, V13, P547, DOI 10.1007/s10989-007-9109-9; Inzitari R, 2005, PROTEOMICS, V5, P805, DOI 10.1002/pmic.200401156; Levine M, 2011, INT J DENT, V2011, DOI 10.1155/2011/953412; Liu J, 2012, ORAL ONCOL; Lu Y, 1998, ARCH ORAL BIOL, V43, P717, DOI 10.1016/S0003-9969(98)00040-5; Lupi A., 2003, European Journal of Morphology, V41, P99; Messana I, 2004, J PROTEOME RES, V3, P792, DOI 10.1021/pr049953c; Messana I, 2008, J SEP SCI, V31, P1948, DOI 10.1002/jssc.200800100; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; Morzel M, 2012, J PROTEOMICS, V75, P3665, DOI 10.1016/j.jprot.2012.04.028; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Prodan A, 2015, EUR J ORAL SCI, V125; ROBINSON R, 1989, BIOCHEM J, V263, P497, DOI 10.1042/bj2630497; RUDNEY JD, 1995, CRIT REV ORAL BIOL M, V6, P343, DOI 10.1177/10454411950060040501; Soares S, 2011, J AGR FOOD CHEM, V59, P5535, DOI 10.1021/jf104975d; ter Braak CJF, 2009, COMPUT STAT DATA AN, V53, P3183, DOI 10.1016/j.csda.2008.10.004; Trindade F, 2015, J PROTEOMICS, V115, P49, DOI 10.1016/j.jprot.2014.12.004; Tsivtsivadze E, 2014, MACHINE LEARNING COM; Tsivtsivadze E, 2013, LECT NOTES ARTIF INT, V8193, P80, DOI 10.1007/978-3-642-40705-5_8; Van Steijn GJ, 2002, J PERIODONTAL RES, V37, P245, DOI 10.1034/j.1600-0765.2002.00330.x; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang QH, 2015, CLIN CHIM ACTA, V438, P214, DOI 10.1016/j.cca.2014.08.037; Wei P, 2013, BIOSCIENCE REP, V33, P567, DOI 10.1042/BSR20130022; Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513; WONG RSC, 1980, J BIOL CHEM, V255, P5943	52	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156707	10.1371/journal.pone.0156707	http://dx.doi.org/10.1371/journal.pone.0156707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258023	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700110
J	Qu, WN; Dai, MN; Zhao, WG; Zhang, K; Ge, Y				Qu, Weina; Dai, Mengnuo; Zhao, Wenguo; Zhang, Kan; Ge, Yan			Expressing Anger Is More Dangerous than Feeling Angry when Driving	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; DRIVERS; BEHAVIOR; ROAD; SCALE; AGGRESSION; INVENTORY; PROPENSITY; MODEL	Anger is an emotion that drivers often feel and express while driving, and it is believed by researchers to be an important cause of dangerous driving behavior. In this study, the relationships between driving trait anger, driving anger expression, and dangerous driving behaviors were analyzed. The Driving Anger Scale (DAS) was used to measure driving trait anger, whereas the Driving Anger Expression (DAX) Inventory was used to measure expressions of driving anger. A sample of 38 drivers completed the DAS, DAX, and a driving simulation session on a simulator where their driving behaviors were recorded. Correlation analysis showed that the higher scores on the DAS were associated with longer durations of speeding in the simulator. The more participants expressed their anger in verbal and physical ways, the more likely they were to crash the virtual vehicle during the simulation. Regression analyses illustrated the same pattern. The findings suggest that, although trait anger is related to speeding, the passive expression of anger is the real factor underling traffic accidents. This study extends findings about the predictive effects of self-report scales of driving behaviors to behaviors recorded on a simulator. Thus, if in traffic safety propaganda, guiding drivers to use positive ways to cope with driving anger is recommended by our findings.	[Qu, Weina; Dai, Mengnuo; Zhao, Wenguo; Zhang, Kan; Ge, Yan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Dai, Mengnuo; Zhao, Wenguo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ge, Y (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	gey@psych.ac.cn		Ge, Yan/0000-0002-4701-6144	National Natural Science Foundation of China [31100750, 31400886]; Basic Project of National Science and Technology of China [2009FY110100]; NSFC [31100750, 31400886]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Project of National Science and Technology of China; NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Grants No. 31100750,31400886), the Basic Project of National Science and Technology of China (No. 2009FY110100). YG received NSFC 31100750, WQ received NSFC 31400886, KZ received 2009FY110100. The URL of the National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The URL of the Basic Project of National Science and Technology of China is http://www.most.gov.cn/kjjh/gjkjjh/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150227; Chai J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147083; Dahlen ER, 2004, J SAFETY RES, V35, P557, DOI 10.1016/j.jsr.2004.09.002; DEFFENBACHER JL, 1992, J COUNS PSYCHOL, V39, P158, DOI 10.1037/0022-0167.39.2.158; DEFFENBACHER JL, 1994, PSYCHOL REP, V74, P83, DOI 10.2466/pr0.1994.74.1.83; Deffenbacher JL, 2003, BEHAV RES THER, V41, P333, DOI 10.1016/S0005-7967(02)00014-1; Deffenbacher JL, 2002, BEHAV RES THER, V40, P717, DOI 10.1016/S0005-7967(01)00063-8; Deffenbacher JL, 2001, PERS INDIV DIFFER, V31, P1321, DOI 10.1016/S0191-8869(00)00226-9; Esiyok B, 2007, TURK PSIKIYATR DERG, V18, P231; Fernandez DH., 2011, TRANSPORT RES F-TRAF, V14, P324; Garrity RD, 2001, J ADULT DEV, V8, P109, DOI 10.1023/A:1026446002317; Li F, 2014, PERS INDIV DIFFER, V68, P130, DOI 10.1016/j.paid.2014.04.018; Matthews G., 2002, THEOR ISS ERGON SCI, V3, P195, DOI [10.1080/14639220210124120, DOI 10.1080/14639220210124120]; Mei CQ, 2014, ACTA PHYS SIN-CH ED, V63, DOI 10.7498/aps.63.038901; Mesken J, 2007, TRANSPORT RES F-TRAF, V10, P458, DOI 10.1016/j.trf.2007.05.001; Parker D, 2002, ACCIDENT ANAL PREV, V34, P229, DOI 10.1016/S0001-4575(01)00018-5; Sarbescu P, 2012, TRANSPORT RES F-TRAF, V15, P556, DOI 10.1016/j.trf.2012.05.009; Sharma S, 2015, PHYSICA A, V421, P401, DOI 10.1016/j.physa.2014.11.003; Sohu, 2008, SURV RES 60 PERC MOT; Stephens AN, 2014, TRANSPORT RES F-TRAF, V22, P140, DOI 10.1016/j.trf.2013.11.005; Stephens AN, 2011, COGNITION EMOTION, V25, P1423, DOI 10.1080/02699931.2010.551184; Stephens AN, 2009, TRANSPORT RES F-TRAF, V12, P29, DOI 10.1016/j.trf.2008.06.005; Sullman MJM, 2015, TRANSPORT RES F-TRAF, V29, P70, DOI 10.1016/j.trf.2015.01.006; Sullman MJM, 2015, SAFETY SCI, V72, P153, DOI 10.1016/j.ssci.2014.08.013; Sullman MJM, 2013, ACCIDENT ANAL PREV, V58, P88, DOI 10.1016/j.aap.2013.05.002; Sullman MJM, 2013, ACCIDENT ANAL PREV, V56, P42, DOI 10.1016/j.aap.2013.03.013; Sullman MJM, 2006, TRANSPORT RES F-TRAF, V9, P173, DOI 10.1016/j.trf.2005.10.003; Tang TQ, 2015, TRANSPORT RES D-TR E, V41, P423, DOI 10.1016/j.trd.2015.10.016; Tang TQ, 2014, PHYSICA A, V413, P583, DOI 10.1016/j.physa.2014.07.035; Tang TQ, 2012, COMMUN THEOR PHYS, V58, P583, DOI 10.1088/0253-6102/58/4/24; Underwood G., 1999, TRANSP RES F, V2, P55, DOI [10.1016/S1369-8478(99)00006-6, DOI 10.1016/S1369-8478(99)00006-6]	31	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156948	10.1371/journal.pone.0156948	http://dx.doi.org/10.1371/journal.pone.0156948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258144	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700163
J	Smith, DK; Mendoza, MCB; Stryker, JE; Rose, CE				Smith, Dawn K.; Mendoza, Maria C. B.; Stryker, Jo Ellen; Rose, Charles E.			PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS PREP; HIV-INFECTION; ANTIRETROVIRAL PROPHYLAXIS; HEALTH-CARE; KNOWLEDGE; RISK; PREVENTION; MEN; SEX; IMPLEMENTATION	Objectives As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure prophylaxis (PrEP) for the prevention of HIV infection, there was a clear need to understand the evolution of knowledge of, and attitudes toward, PrEP among primary care clinicians. Methods Physicians and nurse practitioners were surveyed in 2009 (n = 1500), 2010 (n = 1504), 2012 (n = 1503), 2013 (n = 1507), 2014 (n = 1508) and 2015 (n = 1501) to assess their awareness of PrEP, willingness to prescribe PrEP, and whether they support use of public funds to pay for PrEP. Pharmacists (n = 251) were surveyed about PrEP in 2012 only. Descriptive statistics were computed for physician demographics and PrEP- related questions. Prevalence ratios for willingness to prescribe PrEP were computed using Poisson regression analysis. Results Awareness of PrEP was low among clinicians (2009: 24%, 2010: 29%) but increased after trials reported effectiveness (2012: 49%, 2013: 51%, 2014: 61%, 2015: 66%). Following a description of PrEP with an estimated effectiveness of 75%, across 6 of the study years 91% of clinicians indicated a willingness to prescribe PrEP to at least one group at high risk of HIV acquisition. A smaller majority of clinicians indicated support for public funding of PrEP in 2009: 59%, 2010: 53%, and 2013: 63%. Conclusions In surveys conducted before and after the release of PrEP trial results, primary care clinicians were largely unaware of PrEP. They indicated high levels of willingness to prescribe it for patients at high risk of HIV acquisition and expressed interest in education about how to deliver this new clinical HIV prevention method. It will be important to continue monitoring clinician knowledge, attitudes, and practices as the use of PrEP increases in the US.	[Smith, Dawn K.; Mendoza, Maria C. B.; Stryker, Jo Ellen; Rose, Charles E.] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent DHAP, Natl Ctr HIV Viral Hepatitis STD & TB Prevent NCH, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Smith, DK (corresponding author), Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent DHAP, Natl Ctr HIV Viral Hepatitis STD & TB Prevent NCH, Atlanta, GA 30333 USA.	dsmith1@cdc.gov						Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Blumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-z; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI, P1; Centers for Disease Control and Prevention, 2013, HIV SURV SUPPL REP; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Khawcharoenporn T, 2012, AIDS PATIENT CARE ST, V26, P222, DOI 10.1089/apc.2011.0202; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Laws RA, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-66; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Mullins TLK, 2015, AIDS PATIENT CARE ST, V29, P193, DOI 10.1089/apc.2014.0273; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Rahangdale Lisa, 2014, J AIDS Clin Res, V5, P1000307; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Spector AY, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/1747-597X-10-1; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thrun MW, 2014, LGBT HEALTH, V1, P75, DOI 10.1089/lgbt.2014.0007; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; Voetsch AC, 2007, JAIDS-J ACQ IMM DEF, V46, P378, DOI 10.1097/QAI.0b013e3181576874; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; Whiteside YO, 2011, AIDS PATIENT CARE ST, V25, P365, DOI 10.1089/apc.2010.0224; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7	27	115	115	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156592	10.1371/journal.pone.0156592	http://dx.doi.org/10.1371/journal.pone.0156592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258374	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700084
J	Ba, K; Thiaw, M; Lazar, N; Sarr, A; Brochier, T; Ndiaye, I; Faye, A; Sadio, O; Panfili, J; Thiaw, OT; Brehmer, P				Ba, Kamarel; Thiaw, Modou; Lazar, Najih; Sarr, Alassane; Brochier, Timothee; Ndiaye, Ismaila; Faye, Alioune; Sadio, Oumar; Panfili, Jacques; Thiaw, Omar Thiom; Brehmer, Patrice			Resilience of Key Biological Parameters of the Senegalese Flat Sardinella to Overfishing and Climate Change	PLOS ONE			English	Article							POINTE-NOIRE REGION; MADERENSIS LOWE; EBA VAL; MATURITY; LENGTH; AGE; AURITA; GROWTH; POPULATIONS; PATTERNS	The stock of the Senegalese flat sardinella, Sardinella maderensis, is highly exploited in Senegal, West Africa. Its growth and reproduction parameters are key biological indicators for improving fisheries management. This study reviewed these parameters using landing data from small-scale fisheries in Senegal and literature information dated back more than 25 years. Age was estimated using length-frequency data to calculate growth parameters and assess the growth performance index. With global climate change there has been an increase in the average sea surface temperature along the Senegalese coast but the length-weight parameters, sex ratio, size at first sexual maturity, period of reproduction and condition factor of S. maderensis have not changed significantly. The above parameters of S. maderensis have hardly changed, despite high exploitation and fluctuations in environmental conditions that affect the early development phases of small pelagic fish in West Africa. This lack of plasticity of the species regarding of the biological parameters studied should be considered when planning relevant fishery management plans.	[Ba, Kamarel; Thiaw, Modou; Brochier, Timothee; Brehmer, Patrice] ISRA, CRODT, Dakar, Senegal; [Ba, Kamarel; Sarr, Alassane; Ndiaye, Ismaila; Faye, Alioune; Thiaw, Omar Thiom] UCAD, IUPA, Dakar, Senegal; [Lazar, Najih] Univ Rhode Isl East Farm, Dept Fisheries, Kingston, RI USA; [Brochier, Timothee; Sadio, Oumar; Brehmer, Patrice] IRD, UMR Lemar 195, Dakar, Senegal; [Panfili, Jacques] Univ Montpellier 2, UMR Marbec, IRD, Montpellier 5, France	University Cheikh Anta Diop Dakar; University of Rhode Island; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Thiaw, OT (corresponding author), UCAD, IUPA, Dakar, Senegal.	thiawo@hotmail.com	Brehmer, Patrice/K-2285-2016; PANFILI, JACQUES/J-9397-2016	Brehmer, Patrice/0000-0001-8949-9095; PANFILI, JACQUES/0000-0003-0504-2384; SADIO, Oumar/0000-0002-6621-2490; Ba, Kamarel/0000-0002-2741-5148	USAID/COMFISH project	USAID/COMFISH project(United States Agency for International Development (USAID))	The study was supported by the USAID/COMFISH project, that was implemented by the University of Rhode Island in the United States and Senegalese partners including the University of Dakar (UCAD) within the Institute of Fisheries and Aquaculture of Senegal (Institut Universitaire de Peche et d'Aquaculture, IUPA).	[Anonymous], ICLARM FISHBYTE; [Anonymous], 2010, RESULTATS GENERAUX P; Belhabib D, 2014, FISH RES, V151, P1, DOI 10.1016/j.fishres.2013.12.006; Boely T., 1980, THESIS; Brochier T, 2014, 4 C MAR SCI JUN 11 1, P458; Camarena-Luhrs T., 1987, Oceanographie Tropicale, V21, P143; Conand F, 1971, CAHIER ORSTOM SERIE, V10, P293, DOI [10.1046/j.1439-0426.1999.00111.x, DOI 10.1046/J.1439-0426.1999.00111.X]; Cury P, 1988, AQUAT LIVING RESOUR, V1, P165, DOI 10.1051/alr:1988018; Demarcq H, 2000, OCEANOL ACTA, V23, P391, DOI 10.1016/S0399-1784(00)01113-0; DIOUF P.S., 1996, THESIS; Djama T, 1989, ICLARM FISHBYTE, V7, P13; Djama T, 1989, FISHBYTE, V7, P8; Dobo A., 2009, THESIS; Ecoutin JM, 2005, FISH RES, V72, P347, DOI 10.1016/j.fishres.2004.10.007; Ernande B, 2004, P ROY SOC B-BIOL SCI, V271, P415, DOI 10.1098/rspb.2003.2519; Etim L, 1998, FISH RES, V38, P211, DOI 10.1016/S0165-7836(98)00161-1; FAO, 1987, COPACE PACE SER, V86, P101; FAO, 2013, REP FAO WORK GROUP A; FAO, 1979, 791832 FAO COPACETEC; FAO, 1988, FAO FISHERIES REPORT; Faure V., 2002, POULPE OCTOPUS VULGA, P129; FONTANA A, 1969, CAH ORSTOM OCEANOGR, V7, P101; Freon P., 1986, REPONSES ADAPTATIONS; Froese R, 2004, FISH FISH, V5, P86, DOI 10.1111/j.1467-2979.2004.00144.x; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; GABCHE CE, 1995, FISH RES, V24, P331, DOI 10.1016/0165-7836(95)00371-7; Garcia S., 2012, FAO FISHERIES AQUACU, V18; GHENO Y, 1968, CAH ORSTOM OCEANOGR, V6, P69; Kromer JL, 1994, RIO GRANDE BUBA BIOE; Lawal H.S., 1988, CONTRIBUTION ETUDE R; Le Bec C., 1985, REV TRAVAUX I PECHES, V47, P181; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; MARCHAL E, 1993, ENV RESSOURCES AQUAT, V1, P237; Marcus O., 1989, J SCI, V23, P1; Mbaye BC, 2015, FISH OCEANOGR, V24, P69, DOI 10.1111/fog.12094; McDonald J.H., 2009, HDB BIOL STAT; Nisbet RM, 2000, J ANIM ECOL, V69, P913, DOI 10.1046/j.1365-2656.2000.00448.x; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Pascual-Alayon P, 2012, SCI MANAGEMENT SMALL; PAULY D, 1995, FISH RES, V22, P197, DOI 10.1016/0165-7836(94)00323-O; Pauly D., 1983, FAO FISHERIES TECHNI, P52; Pineiro C, 2003, ICES J MAR SCI, V60, P1086, DOI 10.1016/S1054-3139(03)00086-9; Postel E., 1955, RESUME CONNAISSANCES, V137, P7; Quaatey SNK, 1999, J APPL ICHTHYOL, V15, P63, DOI 10.1046/j.1439-0426.1999.00111.x; Rossignol N., 1955, PREMIERE OBSERVATION, V137, P17; Roy C., 1989, Aquatic Living Resources, V2, P21, DOI 10.1051/alr:1989003; Rueda M, 1999, FISH RES, V42, P155, DOI 10.1016/S0165-7836(99)00033-8; Samb B., 1988, FAO FISHERIES REPORT, V389, P257; Showers PAT, 1996, NAGA ICLARM Q, V19, P42; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Somers I.F., 1988, FISHBYTE, V6, P8; Sow F, 2010, RESOURCES SCI, V32, P620; Thiaw M., 2010, THESIS; Valenzuela N, 2003, AM NAT, V161, P676, DOI 10.1086/368292; van der Lingen CD, 2010, AFRICAN J MARINE SCI, V32, P271, DOI [10.2989/1814232X.2010.501581, DOI 10.2989/1814232X.2010.501581]; Wetherall J. A., 1986, FISHBYTE, V4, P12; YOUMBI JT, 1991, J APPL ICHTHYOL, V7, P60, DOI 10.1111/j.1439-0426.1991.tb00595.x; Zar JH, 1999, BIOSTATISTICAL ANAL	59	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156143	10.1371/journal.pone.0156143	http://dx.doi.org/10.1371/journal.pone.0156143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280629	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000017
J	Hanski, L; Ausbacher, D; Tiirola, TM; Strom, MB; Vuorela, PM				Hanski, Leena; Ausbacher, Dominik; Tiirola, Terttu M.; Strom, Morten B.; Vuorela, Pia M.			Amphipathic beta(2,2)-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae	PLOS ONE			English	Article							IN-VITRO ACTIVITY; ANTIMICROBIAL PEPTIDES; CHLAMYDOPHILA-PNEUMONIAE; DEVELOPMENTAL CYCLE; TRACHOMATIS; PROTEINS; GROWTH; CHARGE; DRUGS; CELLS	We demonstrate in the current work that small cationic antimicrobial beta(2,2)-amino acid derivatives (Mw < 500 Da) are highly potent against Chlamydia pneumoniae at clinical relevant concentrations (< 5 mu M, i.e. < 3.4 mu g/mL). C. pneumoniae is an atypical respiratory pathogen associated with frequent treatment failures and persistent infections. This gram-negative bacterium has a biphasic life cycle as infectious elementary bodies and proliferating reticulate bodies, and efficient treatment is challenging because of its long and obligate intracellular replication cycle within specialized inclusion vacuoles. Chlamydicidal effect of the beta(2,2)-amino acid derivatives in infected human epithelial cells was confirmed by transmission electron microscopy. Images of infected host cells treated with our lead derivative A2 revealed affected chlamydial inclusion vacuoles 24 hours post infection. Only remnants of elementary and reticulate bodies were detected at later time points. Neither the EM studies nor resazurin-based cell viability assays showed toxic effects on uninfected host cells or cell organelles after A2 treatment. Besides the effects on early intracellular inclusion vacuoles, the ability of these beta(2,2)-amino acid derivatives to suppress Chlamydia pneumoniae infectivity upon treatment of elementary bodies suggested also a direct interaction with bacterial membranes. Synthetic beta(2,2)-amino acid derivatives that target C. pneumoniae represent promising lead molecules for development of antimicrobial agents against this hard-totreat intracellular pathogen.	[Hanski, Leena; Tiirola, Terttu M.; Vuorela, Pia M.] Univ Helsinki UHEL, Fac Pharm, Div Pharmaceut Biosci, Pharmaceut Design & Discovery Res Grp, Helsinki, Finland; [Ausbacher, Dominik; Strom, Morten B.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, Nat Prod & Med Chem Res Grp, Tromso, Norway	University of Helsinki; UiT The Arctic University of Tromso	Vuorela, PM (corresponding author), Univ Helsinki UHEL, Fac Pharm, Div Pharmaceut Biosci, Pharmaceut Design & Discovery Res Grp, Helsinki, Finland.	pia.vuorela@helsinki.fi	Hanski, Leena/AAD-5096-2019	Hanski, Leena/0000-0002-3121-8542; Strom, Morten B./0000-0003-1973-0778	Academy of Finland [252216, 272266]; Tor, Joe och Pentti Borgs minnesfond; Faculty of Health Sciences, UiT-The Arctic University of Norway; Research Council of Norway [214493/F20]	Academy of Finland(Academy of Finland); Tor, Joe och Pentti Borgs minnesfond; Faculty of Health Sciences, UiT-The Arctic University of Norway; Research Council of Norway(Research Council of Norway)	Academy of Finland (grant 252216 to LH and 272266 to PMV) and Tor, Joe och Pentti Borgs minnesfond are acknowledged for the financial support. The project was further supported by the transition grant of the Faculty of Health Sciences, UiT-The Arctic University of Norway (DA) and the Research Council of Norway, "Fellesloftet", Grant-214493/F20 (MBS). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Alvesalo J, 2006, BIOCHEM PHARMACOL, V71, P735, DOI 10.1016/j.bcp.2005.12.006; Ausbacher D, 2014, BIOFOULING, V30, P81, DOI 10.1080/08927014.2013.847924; Ausbacher D, 2012, BBA-BIOMEMBRANES, V1818, P2917, DOI 10.1016/j.bbamem.2012.07.005; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Chotikanatis K, 2014, ANTIMICROB AGENTS CH, V58, P1800, DOI 10.1128/AAC.02263-13; Chu HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126390; Donati M, 2005, ANTIMICROB AGENTS CH, V49, P1201, DOI 10.1128/AAC.49.3.1201-1202.2005; EKMAN MR, 1993, CLIN INFECT DIS, V17, P420, DOI 10.1093/clinids/17.3.420; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Hansen T, 2012, EUR J MED CHEM, V58, P22, DOI 10.1016/j.ejmech.2012.09.048; Hansen T, 2011, J MED CHEM, V54, P858, DOI 10.1021/jm101327d; Hanski L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115115; Hanski L, 2014, EXPERT OPIN DRUG DIS, V9, P791, DOI 10.1517/17460441.2014.915309; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hatch TP, 1996, J BACTERIOL, V178, P1; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Karlsson D, 2012, EUR J PHARM SCI, V47, P190, DOI 10.1016/j.ejps.2012.05.014; Kern JM, 2009, FEMS IMMUNOL MED MIC, V55, P131, DOI 10.1111/j.1574-695X.2008.00514.x; Kohlhoff SA, 2015, EXPERT OPIN PHARMACO, V16, P205, DOI 10.1517/14656566.2015.999041; Kohlhoff SA, 2014, ANTIMICROB AGENTS CH, V58, P7595, DOI 10.1128/AAC.03920-14; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; Kuo C-C, 1999, CHLAMYDIA PNEUMONIAE, P9; KUO CC, 1990, J INFECT DIS, V162, P755, DOI 10.1093/infdis/162.3.755; Lazarev VN, 2013, ARCH MICROBIOL, V195, P173, DOI 10.1007/s00203-012-0863-5; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Nguyen BD, 2011, P NATL ACAD SCI USA, V108, P10284, DOI 10.1073/pnas.1107478108; Park N, 2009, J ANTIMICROB CHEMOTH, V63, P115, DOI 10.1093/jac/dkn436; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Roblin PM, 2010, ANTIMICROB AGENTS CH, V54, P1358, DOI 10.1128/AAC.01343-09; Ronzone E, 2012, MANIPULATION HOST VE, P45; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Salin O, 2011, J AGR FOOD CHEM, V59, P12836, DOI 10.1021/jf2032473; Salin O, 2010, BIOCHEM PHARMACOL, V80, P1141, DOI 10.1016/j.bcp.2010.06.051; Siewert K, 2005, ANTIMICROB AGENTS CH, V49, P1852, DOI 10.1128/AAC.49.5.1852-1856.2005; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Vila-Corcoles A, 2009, RESP MED, V103, P309, DOI 10.1016/j.rmed.2008.08.006; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157306	10.1371/journal.pone.0157306	http://dx.doi.org/10.1371/journal.pone.0157306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280777	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000118
J	Tomar, RSS; Tiwari, S; Vinod; Naik, BK; Chand, S; Deshmukh, R; Mallick, N; Singh, S; Singh, NK; Tomar, SMS				Tomar, Ram Sewak Singh; Tiwari, Sushma; Vinod; Naik, Bhojaraja K.; Chand, Suresh; Deshmukh, Rupesh; Mallick, Niharika; Singh, Sanjay; Singh, Nagendra Kumar; Tomar, S. M. S.			Molecular and Morpho-Agronomical Characterization of Root Architecture at Seedling and Reproductive Stages for Drought Tolerance in Wheat	PLOS ONE			English	Article							GENETIC DIVERSITY; TRITICUM-AESTIVUM; GRAIN-YIELD; DURUM-WHEAT; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; TRAITS; WATER; GROWTH; POLYMORPHISM	Water availability is a major limiting factor for wheat (Triticum aestivum L.) production in rain-fed agricultural systems worldwide. Root architecture is important for water and nutrition acquisition for all crops, including wheat. A set of 158 diverse wheat genotypes of Australian (72) and Indian (86) origin were studied for morpho-agronomical traits in field under irrigated and drought stress conditions during 2010-11 and 2011-12. Out of these 31 Indian wheat genotypes comprising 28 hexaploid (Triticum aestivum L.) and 3 tetraploid (T. durum) were characterized for root traits at reproductive stage in polyvinyl chloride (PVC) pipes. Roots of drought tolerant genotypes grew upto137cm (C306) as compared to sensitive one of 63cm with a mean value of 94.8cm. Root architecture traits of four drought tolerant (C306, HW2004, HD2888 and NI5439) and drought sensitive (HD2877, HD2012, HD2851 and MACS2496) genotypes were also observed at 6 and 9 days old seedling stage. The genotypes did not show any significant variation for root traits except for longer coleoptiles and shoot and higher absorptive surface area in drought tolerant genotypes. The visible evaluation of root images using WinRhizo Tron root scanner of drought tolerant genotype HW2004 indicated compact root system with longer depth while drought sensitive genotype HD2877 exhibited higher horizontal root spread and less depth at reproductive stage. Thirty SSR markers were used to study genetic variation which ranged from 0.12 to 0.77 with an average value of 0.57. The genotypes were categorized into three subgroups as highly tolerant, sensitive, moderately sensitive and tolerant as intermediate group based on UPGMA cluster, STRUCTURE and principal coordinate analyses. The genotypic clustering was positively correlated to grouping based on root and morpho-agronomical traits. The genetic variability identified in current study demonstrated these traits can be used to improve drought tolerance and association mapping.	[Tomar, Ram Sewak Singh; Tiwari, Sushma; Singh, Nagendra Kumar] Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi 110012, India; [Vinod; Naik, Bhojaraja K.; Mallick, Niharika; Tomar, S. M. S.] Indian Agr Res Inst, Div Genet, Pusa Campus, New Delhi 110012, India; [Chand, Suresh] Devi Ahilya Vishwa Vidyalaya, Sch Iife Sci, Khandwa Rd, Indore 452017, India; [Tomar, Ram Sewak Singh; Deshmukh, Rupesh] Univ Laval, Dept Phytol, Quebec City, PQ G1V0A6, Canada; [Singh, Sanjay] Directorate Wheat Res, Karnal 132001, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Devi Ahilya University; Laval University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research	Vinod (corresponding author), Indian Agr Res Inst, Div Genet, Pusa Campus, New Delhi 110012, India.	vinod.genetics@gmail.com	Deshmukh, Rupesh Kailasrao/C-6479-2012; TOMAR, RAM SEWAK SINGH/AAF-5619-2021; Mallick, Niharika/GVT-7629-2022; Singh, Nouratan/N-9377-2017	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; TOMAR, RAM SEWAK SINGH/0000-0001-9959-4395; Singh, Nouratan/0000-0002-8063-8375	Indian Council of Agricultural Research [NPTC 21/19-3008]	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	Funding for the current study was provided by Indian Council of Agricultural Research funded project "Transgenics in crops" (Grant number - NPTC 21/19-3008). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna TLB, 2007, PLANT SOIL, V301, P135, DOI 10.1007/s11104-007-9428-9; Ahmadizadeh M, 2011, AFR J BIOTECHNOL, V10, P19771, DOI 10.5897/AJB11.2371; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Atta B. M., 2013, Australian Journal of Crop Science, V7, P2108; Barrett BA, 1998, CROP SCI, V38, P1261, DOI 10.2135/cropsci1998.0011183X003800050025x; Bazzaz F. A., 2000, Seeds: the ecology of regeneration in plant communities, P1, DOI 10.1079/9780851994321.0001; Bharti S, 2014, INT J AGR SCI, V4, P214; Cane MA, 2014, MOL BREEDING, V34, P1629, DOI 10.1007/s11032-014-0177-1; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Cooper M, 2001, FIELD CROP RES, V69, P47, DOI 10.1016/S0378-4290(00)00131-3; Dadbakhsh A., 2011, Advances in Environmental Biology, V5, P1804; De Loose M, 1995, IDENTIFICATION METHO; Dhanda SS, 2004, J AGRON CROP SCI, V190, P6, DOI 10.1111/j.1439-037X.2004.00592.x; Dreisigacker S, 2004, CROP SCI, V44, P381, DOI 10.2135/cropsci2004.0381; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehdaie B, 2003, CROP SCI, V43, P710, DOI 10.2135/cropsci2003.0710; FAO & WFP, 2014, STAT FOOD INS WORLD; FISCHER RA, 1996, INCREASING YIELD POT, P150; Hai L, 2007, GENETICA, V130, P213, DOI 10.1007/s10709-006-9008-6; Hammer GL, 2005, AUST J AGR RES, V56, P947, DOI 10.1071/AR05157; Hao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024598; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; HURD EA, 1964, CAN J PLANT SCI, V44, P240, DOI 10.4141/cjps64-046; INNES P, 1985, J AGR SCI, V105, P543, DOI 10.1017/S0021859600059438; Kazemi M, 2009, 1 NAT C TOM PROD PRO; Khan AS, 2010, INT J AGRIC BIOL, V12, P247; Kinyua M. G., 2003, International Journal of Agriculture and Rural Development, V4, P9; Kirigwi FM, 2007, MOL BREEDING, V20, P401, DOI 10.1007/s11032-007-9100-3; Liao MT, 2006, AUST J AGR RES, V57, P1097, DOI 10.1071/AR05439; Liao MT, 2004, FUNCT PLANT BIOL, V31, P121, DOI 10.1071/FP03060; Liu K, 2004, POWER MARKER NEW GEN; LIU YG, 1991, JPN J GENET, V66, P617, DOI 10.1266/jjg.66.617; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; Manifesto MM, 2001, CROP SCI, V41, P682, DOI 10.2135/cropsci2001.413682x; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Manske G. G. B., 2002, Plant roots: the hidden half, P249; McDonald GK, 2012, CROP PASTURE SCI, V63, P1043, DOI 10.1071/CP12244; Mishra HS, 1999, IRRIGATION SCI, V18, P117, DOI 10.1007/s002710050052; MONYO JH, 1970, J AGR SCI-CAMBRIDGE, V74, P329, DOI 10.1017/S0021859600022954; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nezhadahmadi Arash, 2013, ScientificWorldJournal, V2013, P610721, DOI 10.1155/2013/610721; OBRIEN L, 1979, AUST J AGR RES, V30, P587, DOI 10.1071/AR9790587; OTOOLE JC, 1987, ADV AGRON, V41, P91, DOI 10.1016/S0065-2113(08)60803-2; Passioura J, 2006, AGR WATER MANAGE, V80, P176, DOI 10.1016/j.agwat.2005.07.012; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Placido DF, 2013, PLANT PHYSIOL, V161, P1806, DOI 10.1104/pp.113.214262; Plaut Z, 2004, FIELD CROP RES, V86, P185, DOI 10.1016/j.fcr.2003.08.005; Prasad M, 2000, THEOR APPL GENET, V100, P584, DOI 10.1007/s001229900102; Pritchard JK, 2000, GENETICS, V155, P945; Rebetzke GJ, 1999, AUST J AGR RES, V50, P291, DOI 10.1071/A98125; Reynolds M., 2001, APPL PHYSL WHEAT BRE; Richards RA, 2007, EUPHYTICA, V154, P409, DOI 10.1007/s10681-006-9286-1; Roder MS, 1998, GENOME, V41, P278, DOI 10.1139/gen-41-2-278; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Royo C, 2010, FIELD CROP RES, V119, P91, DOI 10.1016/j.fcr.2010.06.020; SADHU D, 1984, Z ACKER PFLANZENBAU, V153, P216; Sharma S, 2009, THEOR APPL GENET, V119, P783, DOI 10.1007/s00122-009-1088-0; SLAFER GA, 1991, EUPHYTICA, V58, P37, DOI 10.1007/BF00035338; Tahar Boutraa, 2010, Journal of Agronomy, V9, P1, DOI 10.3923/ja.2010.1.8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomar RS, 2012, INDIAN J GENET PL BR, V72, P195; Tomar RSS, 2014, PLANT BREEDING, V133, P12, DOI 10.1111/pbr.12116; Xue Q, 2003, PLANT SOIL, V257, P151, DOI 10.1023/A:1026230527597; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004; [No title captured]	68	13	13	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156528	10.1371/journal.pone.0156528	http://dx.doi.org/10.1371/journal.pone.0156528			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280445	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000035
J	Daniel, B; Wallner, S; Steiner, B; Oberdorfer, G; Kumar, P; van der Graaff, E; Roitsch, T; Sensen, CW; Gruber, K; Macheroux, P				Daniel, Bastian; Wallner, Silvia; Steiner, Barbara; Oberdorfer, Gustav; Kumar, Prashant; van der Graaff, Eric; Roitsch, Thomas; Sensen, Christoph W.; Gruber, Karl; Macheroux, Peter			Structure of a Berberine Bridge Enzyme-Like Enzyme with an Active Site Specific to the Plant Family Brassicaceae	PLOS ONE			English	Article							COVALENTLY ATTACHED FAD; OXIDATION; IDENTIFICATION; FLAVOPROTEINS; METABOLISM; SYNTHASE; GENES	Berberine bridge enzyme-like (BBE-like) proteins form a multigene family (pfam 08031), which is present in plants, fungi and bacteria. They adopt the vanillyl alcohol-oxidase fold and predominantly show bi-covalent tethering of the FAD cofactor to a cysteine and histidine residue, respectively. The Arabidopsis thaliana genome was recently shown to contain genes coding for 28 BBE-like proteins, while featuring four distinct active site compositions. We determined the structure of a member of the AtBBE-like protein family (termed AtBBE-like 28), which has an active site composition that has not been structurally and biochemically characterized thus far. The most salient and distinguishing features of the active site found in AtBBE-like 28 are a mono-covalent linkage of a histidine to the 8 alpha-position of the flavin-isoalloxazine ring and the lack of a second covalent linkage to the 6-position, owing to the replacement of a cysteine with a histidine. In addition, the structure reveals the interaction of a glutamic acid (Glu426) with an aspartic acid (Asp369) at the active site, which appear to share a proton. This arrangement leads to the delocalization of a negative charge at the active site that may be exploited for catalysis. The structure also indicates a shift of the position of the isoalloxazine ring in comparison to other members of the BBE-like family. The dioxygen surrogate chloride was found near the C(4a) position of the isoalloxazine ring in the oxygen pocket, pointing to a rapid reoxidation of reduced enzyme by dioxygen. A TDNA insertional mutant line for AtBBE-like 28 results in a phenotype, that is characterized by reduced biomass and lower salt stress tolerance. Multiple sequence analysis showed that the active site composition found in AtBBE-like 28 is only present in the Brassicaceae, suggesting that it plays a specific role in the metabolism of this plant family.	[Daniel, Bastian; Wallner, Silvia; Steiner, Barbara; Macheroux, Peter] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Oberdorfer, Gustav; Kumar, Prashant; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [van der Graaff, Eric; Roitsch, Thomas] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Roitsch, Thomas] Czech Globe AS CR, Global Change Res Ctr, Vvi, Drasov 470, CZ-66424 Drasov, Czech Republic; [Sensen, Christoph W.] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria	Graz University of Technology; University of Graz; University of Copenhagen; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Graz University of Technology	Macheroux, P (corresponding author), Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.	peter.macheroux@tugraz.at	Sensen, Christoph W./C-1798-2013; Macheroux, Peter/AAB-5157-2019; Gruber, Karl/GPP-6706-2022; Roitsch, Thomas/H-4347-2014	Sensen, Christoph W./0000-0001-9604-8962; Macheroux, Peter/0000-0002-0242-454X; Gruber, Karl/0000-0002-3485-9740; Roitsch, Thomas/0000-0001-7109-3134; Wallner, Silvia/0000-0002-3608-4029; Daniel, Bastian/0000-0001-9210-7136; Oberdorfer, Gustav/0000-0002-6144-9114	Austrian Science Foundation (FWF) [W908, P28678]; Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I) [LO1415]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Foundation (FWF) ( Doctoral program "Molecular Enzymology" W908 and P28678) to KG and PM; and the Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I), grant number LO1415, to T.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a grant from the Austrian Science Foundation (FWF) (Doctoral program "Molecular Enzymology" W908 and P28678) KG and PM and the Czech Ministry of Education, Youth and Sports within the National Sustainability Program I (NPU I), grant number LO1415, to T.R.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Attila C, 2008, MICROB BIOTECHNOL, V1, P17, DOI 10.1111/j.1751-7915.2007.00002.x; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V1000, P213, DOI DOI 10.1016/0926.6569(63)90227-X; Coram TE, 2010, FUNCT INTEGR GENOMIC, V10, P383, DOI 10.1007/s10142-009-0148-5; Daniel B, 2015, J BIOL CHEM, V290, P18770, DOI 10.1074/jbc.M115.659631; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; do Amaral AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049904; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Gonzalez-Candelas L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-194; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hyun TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112946; Ishida M, 2014, BREEDING SCI, V64, P48, DOI 10.1270/jsbbs.64.48; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kopacz MM, 2014, BIOORGAN MED CHEM, V22, P5621, DOI 10.1016/j.bmc.2014.05.051; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Lin HC, 2015, ANGEW CHEM INT EDIT, V54, P3004, DOI 10.1002/anie.201411297; Liu YC, 2011, NAT CHEM BIOL, V7, P304, DOI 10.1038/nchembio.556; Lorenz N, 2010, APPL ENVIRON MICROB, V76, P1822, DOI 10.1128/AEM.00737-09; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; Massey V., 1992, CELL BIOCHEM FUNCT, DOI [10.1002/cbf.290100117, DOI 10.1002/CBF.290100117]; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raffaele S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-637; Rambaut A, 2009, FIGTREE V1 3 1; Schrittwieser JH, 2011, J ORG CHEM, V76, P6703, DOI 10.1021/jo201056f; Seidl MF, 2011, PLANT PHYSIOL, V155, P628, DOI 10.1104/pp.110.167841; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Winkler A, 2009, J BIOL CHEM, V284, P19993, DOI 10.1074/jbc.M109.015727; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zafred D, 2015, FEBS J, V282, P3060, DOI 10.1111/febs.13212; Zafred D, 2013, J ALLERGY CLIN IMMUN, V132, P696, DOI 10.1016/j.jaci.2013.03.021	51	20	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156892	10.1371/journal.pone.0156892	http://dx.doi.org/10.1371/journal.pone.0156892			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276217	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700046
J	Simmons, R; Malyuta, R; Chentsova, N; Karnets, I; Murphy, G; Medoeva, A; Kruglov, Y; Yurchenko, A; Copas, A; Porter, K				Simmons, Ruth; Malyuta, Ruslan; Chentsova, Nelli; Karnets, Iryna; Murphy, Gary; Medoeva, Antonia; Kruglov, Yuri; Yurchenko, Alexander; Copas, Andrew; Porter, Kholoud		CASCADE Collaboration EuroCoord	HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL LOAD; HETEROSEXUAL TRANSMISSION; HIV/AIDS SURVEILLANCE; UNITED-STATES; IMMUNOASSAY; INFECTION; SEROCONVERSION; POPULATIONS	Objective To estimate HIV incidence and highlight the characteristics of persons at greatest risk of HIV in the Ukraine capital, Kiev. Method Residual samples from newly-diagnosed persons attending the Kiev City AIDS Centre were tested for evidence of recent HIV infection using an avidity assay. Questions on possible risk factors for HIV acquisition and testing history were introduced. All persons (>= 16yrs) presenting for an HIV test April' 13-March' 14 were included. Rates per 100,000 population were calculated using region-specific denominators. Results During the study period 6370 individuals tested for HIV. Of the 467 individuals newly-diagnosed with HIV, 21 had insufficient samples for LAg testing. Of the remaining 446, 39 (8.7%) were classified as recent with an avidity index <1.5ODn, 10 were reclassified as long-standing as their viral load was <1000 copies/mL, resulting in 29 (6.5%) recent HIV infections. The only independent predictor for a recent infection was probable route of exposure, with MSM more likely to present with a recent infection compared with heterosexual contact [Odds Ratio 8.86; 95% CI 2.65-29.60]. We estimated HIV incidence at 21.5 per 100,000 population, corresponding to 466 new infections. Using population estimates for MSM and PWID, incidence was estimated to be between 2289.6 and 6868.7/100,000 MSM, and 350.4 for PWID. Conclusion A high proportion of persons newly-infected remain undiagnosed, with MSM disproportionally affected with one in four newly-HIV-diagnosed and one in three recently-HIV-infected. Our findings should be used for targeted public health interventions and health promotion.	[Simmons, Ruth; Copas, Andrew; Porter, Kholoud] UCL, London, England; [Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Chentsova, Nelli; Karnets, Iryna; Medoeva, Antonia; Yurchenko, Alexander] Kyiv City AIDS Ctr, Kiev, Ukraine; [Murphy, Gary] Publ Hlth England, London, England; [Kruglov, Yuri] Inst Epidemiol, Kiev, Ukraine	University of London; University College London; Public Health England; National Academy of Medical Sciences of Ukraine; L. V. Gromashevsky Institute of Epidemiology & Infectious Diseases of the National Academy of Medical Sciences of Ukraine	Porter, K (corresponding author), UCL, London, England.	kholoud.porter@ucl.ac.uk	Rosińska, Magdalena/K-5857-2019	Rosińska, Magdalena/0000-0002-6256-7809; Copas, Andrew/0000-0001-8968-5963; Porter, Kholoud/0000-0002-9226-6206	European Union [260694]; Medical Research Council [MC_UU_12023/15] Funding Source: researchfish; MRC [MC_UU_12023/15] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was conducted on behalf of a CASCADE Collaboration in EuroCoord, funded from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no. 260694.	AIDS Alliance, 2010, AN REPORT BAS SOC ST; AIDS Alliance, 2014, MARP COV 2012; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Chiu J, 2011, PUNITIVE DRUG LAW RI; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; European Centre for Disease Prevention and Control/World Health Organization Regional Office for Europe, 2013, HIV AIDS SURV EUR 20; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Mammone A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-65; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-919; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ragni MV, 1998, J ACQ IMMUN DEF SYND, V17, P42, DOI 10.1097/00042560-199801010-00006; Scheer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055002; Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343; Sedia Biosciences Corporation, 2013, SEDIA HIV 1 LIM ANT; Simmons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137062; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; Tovanabutra S, 2002, J ACQ IMMUN DEF SYND, V29, P275, DOI 10.1097/00126334-200203010-00008; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wilson KM, 2004, AIDS, V18, P2253, DOI 10.1097/00002030-200411190-00005; World Health Organisation UNAIDS, 2014, WHO UNAIDS TECHN UPD; World Health Organization, 2013, HIV AIDS TREATM CAR	32	8	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157179	10.1371/journal.pone.0157179	http://dx.doi.org/10.1371/journal.pone.0157179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276170	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700081
J	Busa, MA; Lim, J; van Emmerik, REA; Hamill, J				Busa, Michael A.; Lim, Jongil; van Emmerik, Richard E. A.; Hamill, Joseph			Head and Tibial Acceleration as a Function of Stride Frequency and Visual Feedback during Running	PLOS ONE			English	Article							SHOCK ATTENUATION; IMPACT SHOCK; WALKING; LENGTH; PELVIS	Individuals regulate the transmission of shock to the head during running at different stride frequencies although the consequences of this on head-gaze stability remain unclear. The purpose of this study was to examine if providing individuals with visual feedback of their head-gaze orientation impacts tibial and head accelerations, shock attenuation and headgaze motion during preferred speed running at different stride frequencies. Fifteen strides from twelve recreational runners running on a treadmill at their preferred speed were collected during five stride frequencies (preferred, +/- 10% and +/- 20% of preferred) in two visual task conditions (with and without real-time visual feedback of head-gaze orientation). The main outcome measures were tibial and head peak accelerations assessed in the time and frequency domains, shock attenuation from tibia to head, and the magnitude and velocity of head-gaze motion. Decreasing stride frequency resulted in greater vertical accelerations of the tibia (p<0.01) during early stance and at the head (p<0.01) during early and late stance; however, for the impact portion the increase in head acceleration was only observed for the slowest stride frequency condition. Visual feedback resulted in reduced head acceleration magnitude (p<0.01) and integrated power spectral density in the frequency domain (p<0.01) in late stance, as well as overall of head-gaze motion (p<0.01). When running at preferred speed individuals were able to stabilize head acceleration within a wide range of stride frequencies; only at a stride frequency 20% below preferred did head acceleration increase. Furthermore, impact accelerations of the head and tibia appear to be solely a function of stride frequency as no differences were observed between feedback conditions. Increased visual task demands through head gaze feedback resulted in reductions in head accelerations in the active portion of stance and increased head-gaze stability.	[Busa, Michael A.; Lim, Jongil; Hamill, Joseph] Univ Massachusetts, Dept Kinesiol, Biomech Lab, Amherst, MA 01003 USA; [Busa, Michael A.; Lim, Jongil; van Emmerik, Richard E. A.] Univ Massachusetts, Dept Kinesiol, Motor Control Lab, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lim, J (corresponding author), Univ Massachusetts, Dept Kinesiol, Biomech Lab, Amherst, MA 01003 USA.; Lim, J (corresponding author), Univ Massachusetts, Dept Kinesiol, Motor Control Lab, Amherst, MA 01003 USA.	jongil@kin.umass.edu						Boyer KA, 2004, J BIOMECH, V37, P1583, DOI 10.1016/j.jbiomech.2004.01.002; CAVAGNA GA, 1963, J APPL PHYS, V18, P1; CAVANAGH PR, 1982, MED SCI SPORT EXER, V14, P30, DOI 10.1249/00005768-198201000-00006; Crowell HP, 2010, J ORTHOP SPORT PHYS, V40, P206, DOI 10.2519/jospt.2010.3166; Derrick TR, 2004, MED SCI SPORT EXER, V36, P830, DOI 10.1249/01.MSS.0000125728.92536.54; Derrick TR, 1998, MED SCI SPORT EXER, V30, P128, DOI 10.1097/00005768-199801000-00018; Edwards WB, 2012, J APPL BIOMECH, V28, P502, DOI 10.1123/jab.28.5.502; Fajen BR, 2007, ECOL PSYCHOL, V19, P383, DOI 10.1080/10407410701557877; Fajen BR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00085; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Gibson J.J., 1966, SENSES CONSIDERED PE; Gruber AH, 2014, J SPORT HEALTH SCI, V3, P113, DOI 10.1016/j.jshs.2014.03.004; HAMILL J, 1995, HUM MOVEMENT SCI, V14, P45, DOI 10.1016/0167-9457(95)00004-C; HENNIG EM, 1991, INT J SPORT BIOMECH, V7, P303, DOI 10.1123/ijsb.7.3.303; HOLT KG, 1991, MED SCI SPORT EXER, V23, P491; HOLT KG, 1990, HUM MOVEMENT SCI, V9, P55, DOI 10.1016/0167-9457(90)90035-C; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Matthis JS, 2014, J EXP PSYCHOL HUMAN, V40, P106, DOI 10.1037/a0033101; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Mercer JA, 2003, MED SCI SPORT EXER, V35, P307, DOI 10.1249/01.MSS.0000048837.81430.E7; Mercer JA, 2002, EUR J APPL PHYSIOL, V87, P403, DOI 10.1007/s00421-002-0646-9; SHORTEN MR, 1992, INT J SPORT BIOMECH, V8, P288, DOI 10.1123/ijsb.8.4.288; Smeathers JE, 1981, P I MECH ENG H, V203, P181; Valiant GA., 1987, BIOMECHANICS X, P937; Warren WH, 2008, UNDERST COMPLEX SYST, P45, DOI 10.1007/978-3-540-74479-5_3; Wood CM, 2014, J BIOMECH, V47, P1739, DOI 10.1016/j.jbiomech.2014.03.008; WOSK J, 1981, J BIOMECH, V14, P261, DOI 10.1016/0021-9290(81)90071-3; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	28	16	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157297	10.1371/journal.pone.0157297	http://dx.doi.org/10.1371/journal.pone.0157297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271850	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000070
J	Foster, AC; Farnsworth, J; Lind, GE; Li, YX; Yang, JY; Dang, V; Penjwini, M; Viswanath, V; Staubli, U; Kavanaugh, MP				Foster, Alan C.; Farnsworth, Jill; Lind, Genevieve E.; Li, Yong-Xin; Yang, Jia-Ying; Dang, Van; Penjwini, Mahmud; Viswanath, Veena; Staubli, Ursula; Kavanaugh, Michael P.			D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures	PLOS ONE			English	Article							NEUROMODULATOR D-SERINE; D-ASPARTATE RECEPTOR; INTELLECTUAL DISABILITY; MOUSE-BRAIN; NEURONS; GLUTAMATE; RACEMASE; ASCT2; MUTATIONS; OXIDASE	N-methyl-D-aspartate (NMDA) receptors play critical roles in synaptic transmission and plasticity. Activation of NMDA receptors by synaptically released L-glutamate also requires occupancy of co-agonist binding sites in the tetrameric receptor by either glycine or D-serine. Although D-serine appears to be the predominant co-agonist at synaptic NMDA receptors, the transport mechanisms involved in D-serine homeostasis in brain are poorly understood. In this work we show that the SLC1 amino acid transporter family members SLC1A4 (ASCT1) and SLC1A5 (ASCT2) mediate homo-and hetero-exchange of D-serine with physiologically relevant kinetic parameters. In addition, the selectivity profile of D-serine uptake in cultured rat hippocampal astrocytes is consistent with uptake mediated by both ASCT1 and ASCT2. Together these data suggest that SLC1A4 (ASCT1) may represent an important route of Na-dependent D-serine flux in the brain that has the ability to regulate extracellular D-serine and thereby NMDA receptor activity.	[Foster, Alan C.; Li, Yong-Xin; Yang, Jia-Ying; Dang, Van; Penjwini, Mahmud; Viswanath, Veena; Staubli, Ursula] Allergan Pharmaceut Inc, Dept Biol Sci, 2525 Dupont Dr, Irvine, CA 92612 USA; [Farnsworth, Jill; Lind, Genevieve E.; Kavanaugh, Michael P.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	AbbVie; Allergan; University of Montana System; University of Montana	Foster, AC; Li, YX (corresponding author), Allergan Pharmaceut Inc, Dept Biol Sci, 2525 Dupont Dr, Irvine, CA 92612 USA.; Kavanaugh, MP (corresponding author), Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA.	AFoster@otonomy.com; li_yongxin@allergan.com; Michael.Kavanaugh@mso.umt.edu			NIH [R15 GM110690]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The following authors were employees of Allergan, Inc. at the time of the conduct of this study: ACF, Y-XL, JY, VD, MP, VV, and US. Allergan provided support in the form of salaries for authors ACF, Y-XL, JY, VD, MP, VV, and US, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JF,GEL, and MPK were supported by a grant from NIH (R15 GM110690).	ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 1999, J NEUROCHEM, V73, P2184; Damseh N, 2015, J MED GENET, V52, P541, DOI 10.1136/jmedgenet-2015-103104; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Gliddon CM, 2009, J NEUROCHEM, V108, P372, DOI 10.1111/j.1471-4159.2008.05767.x; Grewer C, 2004, J PHYSIOL-LONDON, V557, P747, DOI 10.1113/jphysiol.2004.062521; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; Heimer G, 2015, CLIN GENET, V88, P327, DOI 10.1111/cge.12637; Helboe L, 2003, EUR J NEUROSCI, V18, P2227, DOI 10.1046/j.1460-9568.2003.02966.x; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Kantrowitz JT, 2015, LANCET PSYCHIAT, V2, P403, DOI 10.1016/S2215-0366(15)00098-X; Kasai Y, 2011, J NEUROCHEM, V118, P304, DOI 10.1111/j.1471-4159.2011.07313.x; Martineau Magalie, 2014, Front Synaptic Neurosci, V6, P12, DOI 10.3389/fnsyn.2014.00012; Maucler C, 2013, ACS CHEM NEUROSCI, V4, P772, DOI 10.1021/cn4000549; Meunier CNJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151233; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Miyoshi Y, 2012, AMINO ACIDS, V43, P1919, DOI 10.1007/s00726-012-1398-4; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; O'Brien KB, 2005, NEUROSCI LETT, V385, P58, DOI 10.1016/j.neulet.2005.05.009; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Panizzutti R, 2014, CURR PHARM DESIGN, V20, P5160, DOI 10.2174/1381612819666140110121139; Pinilia-Tenas J, 2003, J MEMBRANE BIOL, V195, P27, DOI 10.1007/s00232-003-2041-9; Potier B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.001.2010; Radzishevsky I, 2013, CURR OPIN CLIN NUTR, V16, P72, DOI 10.1097/MCO.0b013e32835a3466; Ribeiro CS, 2002, BRAIN RES, V929, P202, DOI 10.1016/S0006-8993(01)03390-X; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Sacchi S, 2012, AMINO ACIDS, V43, P1833, DOI 10.1007/s00726-012-1345-4; Sason H., 2016, CEREB CORTEX; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Shao ZJ, 2009, J NEUROSCI RES, V87, P2520, DOI 10.1002/jnr.22086; Smith Sean M, 2010, Open Med Chem J, V4, P3, DOI 10.2174/1874104501004020003; Srour M, 2015, CLIN GENET, V88, pE1, DOI 10.1111/cge.12605; Sun W, 2014, NEUROCHEM INT, V73, P146, DOI 10.1016/j.neuint.2014.04.007; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2013, BIOCHEM SOC T, V41, P1546, DOI 10.1042/BST20130220; Yamamori H, 2014, NEUROSCI LETT, V582, P93, DOI 10.1016/j.neulet.2014.08.052; Yamamoto T, 2004, NEUROSCI RES, V49, P101, DOI 10.1016/j.neures.2004.02.004; Yamamoto T, 2003, FEBS LETT, V548, P69, DOI 10.1016/S0014-5793(03)00742-7; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991	47	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156551	10.1371/journal.pone.0156551	http://dx.doi.org/10.1371/journal.pone.0156551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272177	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000019
J	Hanifa, Y; Fielding, KL; Chihota, VN; Adonis, L; Charalambous, S; Karstaedt, A; McCarthy, K; Nicol, MP; Ndlovu, NT; Sahid, F; Churchyard, GJ; Grant, AD				Hanifa, Yasmeen; Fielding, Katherine L.; Chihota, Violet N.; Adonis, Lungiswa; Charalambous, Salome; Karstaedt, Alan; McCarthy, Kerrigan; Nicol, Mark P.; Ndlovu, Nontobeko T.; Sahid, Faieza; Churchyard, Gavin J.; Grant, Alison D.			Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; SPUTUM	Background We assessed the diagnostic accuracy of Determine TB-LAM (LF-LAM) to screen for tuberculosis among ambulatory adults established in HIV care in South Africa. Methods A systematic sample of adults attending for HIV care, regardless of symptomatology, were enrolled in the XPHACTOR study, which tested a novel algorithm for prioritising investigation with Xpert MTB/RIF. In this substudy, restricted to participants with enrolment CD4<200x10(6)/l, urine was stored at enrolment for later testing with LF-LAM. Sputum was sent for immediate Xpert MTB/RIF if any of: current cough, fever >= 3 weeks, body mass index (BMI)<18.5kg/m(2), CD4<100x10(6)/l (or <200x10(6)/l if pre-ART), weight loss >= 10% or strong clinical suspicion were present; otherwise, sputum was stored for Xpert testing at study completion. Participants were reviewed monthly, with reinvestigation if indicated, to 3 months, when sputum and blood were taken for mycobacterial culture. We defined tuberculosis as "confirmed" if Xpert, line probe assay or culture for M. tuberculosis within six months of enrolment were positive, and "clinical" if tuberculosis treatment started without microbiological confirmation. Results Amongst 424 participants, 61% were female and 57% were taking ART (median duration 22 months); median age, CD4 and BMI were 39 years, 111x10(6)/l, and 23 kg/m(2). 56/424 (13%) participants had tuberculosis (40 confirmed, 16 clinical). 24/424 (5.7%) vs. 8/424 (1.9%) were LAM-positive using grade 1 vs. grade 2 cut-off. Using grade 1 cut-off, sensitivity for confirmed TB (all clinical TB excluded) was 12.5% (95% CI 4.2%, 26.8%) and in CD4<100x10(6)/l vs. CD4 >= 100x10(6)/l was 16.7% (95% CI 4.7%, 37.4%) vs. 6.3% (95% CI 0.2%, 30.2%). Specificity was > 95% irrespective of diagnostic reference standard, CD4 stratum, or whether grade 1 or grade 2 cut-off was used. Conclusion Sensitivity of LF-LAM is too low to recommend as part of intensified case finding in ambulatory patients established in HIV care.	[Hanifa, Yasmeen; Fielding, Katherine L.; Churchyard, Gavin J.; Grant, Alison D.] London Sch Hyg & Trop Med, London WC1, England; [Chihota, Violet N.; Charalambous, Salome; McCarthy, Kerrigan; Ndlovu, Nontobeko T.; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Chihota, Violet N.; Charalambous, Salome; Karstaedt, Alan; Sahid, Faieza; Churchyard, Gavin J.; Grant, Alison D.] Univ Witwatersrand, Johannesburg, South Africa; [Adonis, Lungiswa] Mamelodi Hosp, Pretoria, South Africa; [Karstaedt, Alan; Sahid, Faieza] Chris Hani Baragwanath Hosp, Dept Med, Johannesburg, South Africa; [Nicol, Mark P.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Nicol, Mark P.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Churchyard, Gavin J.] South African Med Res Council Collaborating Ctr H, Adv Care & Treatment ACT TB HIV, Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; National Health Laboratory Service; University of Cape Town	Hanifa, Y (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	yasmeen.hanifa@lshtm.ac.uk	Nicol, Mark/W-4149-2019; Chihota, Violet/DWH-9372-2022	Nicol, Mark/0000-0002-1366-4805; Charalambous, Salome/0000-0001-7143-1009; McCarthy, Kerrigan/0000-0001-8958-9795; HANIFA, YASMEEN/0000-0002-1677-0697; Fielding, Katherine/0000-0002-6524-3754; Chihota, Violet/0000-0003-1444-9266; Churchyard, Gavin/0000-0002-4269-3699	Bill and Melinda Gates Foundation [OPP1034523]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge funding from the Bill and Melinda Gates Foundation (Grant No. OPP1034523; http://www.gatesfoundation.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere Ltd, 2015, AL DET TB LAM PACK I; [Anonymous], 2015, US LAT FLOW UR LIP A; Balcha TT, 2014, TROP MED INT HEALTH, V19, P734, DOI 10.1111/tmi.12308; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Drain PK, 2015, JAIDS-J ACQ IMM DEF, V68, P274, DOI 10.1097/QAI.0000000000000436; Drain PK, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-110; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Manabe YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101459; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0967-z; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Shah M, 2014, AIDS, V28, P1307, DOI 10.1097/QAD.0000000000000264; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; World Health Organization, 2015, GLOB TUB REP 2014; World Health Organization, 2013, WHO POL COLL TB HIV	16	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156866	10.1371/journal.pone.0156866	http://dx.doi.org/10.1371/journal.pone.0156866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271432	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000377561000042
J	Li, WF; Liu, HZ; Yang, P; Xie, W				Li, Wenfa; Liu, Hongzhe; Yang, Peng; Xie, Wei			Supporting Regularized Logistic Regression Privately and Efficiently	PLOS ONE			English	Article							PRIVACY; GENE; ANONYMITY; NETWORK; SHARE	As one of the most popular statistical and machine learning models, logistic regression with regularization has found wide adoption in biomedicine, social sciences, information technology, and so on. These domains often involve data of human subjects that are contingent upon strict privacy regulations. Concerns over data privacy make it increasingly difficult to coordinate and conduct large-scale collaborative studies, which typically rely on cross-institution data sharing and joint analysis. Our work here focuses on safeguarding regularized logistic regression, a widely-used statistical model while at the same time has not been investigated from a data security and privacy perspective. We consider a common use scenario of multi-institution collaborative studies, such as in the form of research consortia or networks as widely seen in genetics, epidemiology, social sciences, etc. To make our privacy- enhancing solution practical, we demonstrate a non-conventional and computationally efficient method leveraging distributing computing and strong cryptography to provide comprehensive protection over individual-level and summary data. Extensive empirical evaluations on several studies validate the privacy guarantee, efficiency and scalability of our proposal. We also discuss the practical implications of our solution for large-scale studies and applications from various disciplines, including genetic and biomedical studies, smart grid, network analysis, etc.	[Li, Wenfa; Liu, Hongzhe; Yang, Peng] Beijing Union Univ, Beijing Key Lab Informat Serv Engn, Beijing 100101, Peoples R China; [Xie, Wei] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA	Beijing Union University; Vanderbilt University	Xie, W (corresponding author), Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37232 USA.	wei.xie@vanderbilt.edu		Xie, Wei/0000-0002-1871-6846; Liu, Hongzhe/0000-0003-2314-5272	National Nature Science Foundation of China [61300078]; The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD20130320, CITTCD201504039]; Funding Project for Academic Human Resources Development in Beijing Union University [Zk80201403, Rk100201510]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Funding Project for Academic Human Resources Development in Beijing Union University	This work was partly supported by The National Nature Science Foundation of China (No. 61300078), and The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD20130320, CIT&TCD201504039), and Funding Project for Academic Human Resources Development in Beijing Union University (Zk80201403, Rk100201510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe EA, 2012, AM ECON REV, V102, P65, DOI 10.1257/aer.102.3.65; Almquist ZW, 2014, SOCIOL METHODOL, V44, P273, DOI 10.1177/0081175013520159; [Anonymous], 2003, COMP NUMERICAL OPTIM; Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Beimel Amos, 2011, Coding and Cryptology. Proceedings of the Third International Workshop, IWCC 2011, P11, DOI 10.1007/978-3-642-20901-7_2; boyd d., 2008, CONVERGENCE-US, V14, P13, DOI [DOI 10.1177/1354856507084416, 10.1177/1354856507084416]; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Chaudhuri K., 2009, ADV NEURAL INFORM PR, P289; Dai C, 2014, P VLDB ENDOWMENT, V7, DOI 10.14778/2733004.2733080; Daries JP, 2014, COMMUN ACM, V57, P56, DOI 10.1145/2643132; Dasgupta A, 2011, GENET EPIDEMIOL, V35, pS5, DOI 10.1002/gepi.20642; Du WL, 2004, SIAM PROC S, P222; Dwork, 2011, ENCY CRYPTOGRAPHY SE, P338, DOI DOI 10.1007/978-1-4419-5906-5_752; El Emam K, 2013, J AM MED INFORM ASSN, V20, P453, DOI 10.1136/amiajnl-2011-000735; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; Federal Trade Commission, PREL FTC STAFF REP P; Goldreich O., 2009, FDN CRYPTOGRAPHY, V2; GREEN PJ, 1984, J R STAT SOC B, V46, P149; Hall R, 2011, J OFF STAT, V27, P669; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kantarcioglu M, 2008, IEEE T INF TECHNOL B, V12, P606, DOI 10.1109/TITB.2007.908465; Kosinski M, 2013, P NATL ACAD SCI USA, V110, P5802, DOI 10.1073/pnas.1218772110; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lee S.-I., 2006, EFFICIENT L1 REGULAR, V1, P401; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Liu M, 2012, J AM MED INFORM ASSN, V19, pE28, DOI 10.1136/amiajnl-2011-000699; Liu Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-384; Malo N, 2008, AM J HUM GENET, V82, P375, DOI 10.1016/j.ajhg.2007.10.012; Masuda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062262; McDaniel P, 2009, IEEE SECUR PRIV, V7, P75, DOI 10.1109/MSP.2009.76; Nardi Y, 2012, J PRIVACY CONFIDENTI, V4, P9; Nikolaenko V, 2013, P IEEE S SECUR PRIV, P334, DOI 10.1109/SP.2013.30; O'Keefe CM, 2013, INT STAT REV, V81, P426, DOI 10.1111/insr.12021; Office for Civil Rights HHS, 2002, Fed Regist, V67, P53181; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Richardson M., 2007, P 16 INT C WORLD WID, P521, DOI [DOI 10.1145/1242572.1242643, 10.1145/1242572.1242643]; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Shen X, 2013, GENETICS, V193, P1255, DOI 10.1534/genetics.112.146720; Sparks R, 2008, COMPUT METH PROG BIO, V91, P208, DOI 10.1016/j.cmpb.2008.04.001; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; van der Putten P., 2000, COIL CHALLENGE 2000; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wasserman L, 2011, ALL STAT; Wolfson M, 2010, INT J EPIDEMIOL; Wu Yuan, 2012, AMIA Annu Symp Proc, V2012, P1450; Xie W, 2014, BIOINFORMATICS, V30, P3334, DOI 10.1093/bioinformatics/btu561; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	50	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156479	10.1371/journal.pone.0156479	http://dx.doi.org/10.1371/journal.pone.0156479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271738	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200010
J	Baumgarten, TJ; Oeltzschner, G; Hoogenboom, N; Wittsack, H; Schnitzler, A; Lange, J				Baumgarten, Thomas J.; Oeltzschner, Georg; Hoogenboom, Nienke; Wittsack, Hansoejrg; Schnitzler, Alfons; Lange, Joachim			Beta Peak Frequencies at Rest Correlate with Endogenous GABA plus /Cr Concentrations in Sensorimotor Cortex Areas	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; EDITED MR SPECTROSCOPY; OSCILLATORY ACTIVITY; MOTOR CORTEX; NETWORK OSCILLATIONS; HAND REPRESENTATION; GAMMA FREQUENCY; MOVEMENT; ASYMMETRY; AMPLITUDE	Neuronal oscillatory activity in the beta band (15-30 Hz) is a prominent signal within the human sensorimotor cortex. Computational modeling and pharmacological modulation studies suggest an influence of GABAergic interneurons on the generation of beta band oscillations. Accordingly, studies in humans have demonstrated a correlation between GABA concentrations and power of beta band oscillations. It remains unclear, however, if GABA concentrations also influence beta peak frequencies and whether this influence is present in the sensorimotor cortex at rest and without pharmacological modulation. In the present study, we investigated the relation between endogenous GABA concentration (measured by magnetic resonance spectroscopy) and beta oscillations (measured by magnetoencephalography) at rest in humans. GABA concentrations and beta band oscillations were measured for left and right sensorimotor and occipital cortex areas. A significant positive linear correlation between GABA concentration and beta peak frequency was found for the left sensorimotor cortex, whereas no significant correlations were found for the right sensorimotor and the occipital cortex. The results show a novel connection between endogenous GABA concentration and beta peak frequency at rest. This finding supports previous results that demonstrated a connection between oscillatory beta activity and pharmacologically modulated GABA concentration in the sensorimotor cortex. Furthermore, the results demonstrate that for a predominantly right-handed sample, the correlation between beta band oscillations and endogenous GABA concentrations is evident only in the left sensorimotor cortex.	[Baumgarten, Thomas J.; Oeltzschner, Georg; Hoogenboom, Nienke; Schnitzler, Alfons; Lange, Joachim] Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Oeltzschner, Georg] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Oeltzschner, Georg] Kennedy Krieger Inst, FM Kirby Ctr Funct Brain Imaging, Baltimore, MD USA; [Oeltzschner, Georg; Wittsack, Hansoejrg] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Fac Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Johns Hopkins University; Kennedy Krieger Institute; Heinrich Heine University Dusseldorf	Baumgarten, TJ (corresponding author), Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	Thomas.Baumgarten@med.uni-duesseldorf.de	Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/Q-5520-2019; Baumgarten, Thomas J/AAV-3608-2021; Oeltzschner, Georg/X-9520-2019	Schnitzler, Alfons/0000-0002-6414-7939; Baumgarten, Thomas J/0000-0001-8544-1048; Oeltzschner, Georg/0000-0003-3083-9811	Deutsche Forschungsgemeinschaft [SFB974 B07, LA 2400/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (SFB974 B07, Grant LA 2400/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi O, 2015, J NEUROSCIENCE METHO; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Baumgarten TJ, 2015, P NATL ACAD SCI USA, V112, P12187, DOI 10.1073/pnas.1501438112; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buzsaki G., 2006, RHYTHMS BRAIN; Cousijn H, 2014, P NATL ACAD SCI USA, V111, P9301, DOI 10.1073/pnas.1321072111; Durst CR, 2015, MAGN RESON IMAGING, V33, P611, DOI 10.1016/j.mri.2015.02.015; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Haegens S, 2011, P NATL ACAD SCI USA, V108, P10708, DOI 10.1073/pnas.1107297108; Hall SD, 2011, NEUROIMAGE, V56, P1506, DOI 10.1016/j.neuroimage.2011.02.025; Hall SD, 2010, HUM BRAIN MAPP, V31, P581, DOI 10.1002/hbm.20889; Harris AD, 2014, MAGN RESON MED, V72, P941, DOI 10.1002/mrm.25009; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Kilavik BE, 2012, CEREB CORTEX, V22, P2148, DOI 10.1093/cercor/bhr299; Lange J, 2012, CEREB CORTEX, V22, P2564, DOI 10.1093/cercor/bhr329; Liu ZM, 2012, NEUROIMAGE, V59, P2073, DOI 10.1016/j.neuroimage.2011.10.042; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Muthukumaraswamy SD, 2013, NEUROIMAGE, V66, P36, DOI 10.1016/j.neuroimage.2012.10.054; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Near J, 2015, MAGN RESON MED, V73, P44, DOI 10.1002/mrm.25094; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Oeltzschner G., 2015, METABOLIC BRAIN DIS, P1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Puts NAJ, 2011, J NEUROSCI, V31, P16556, DOI 10.1523/JNEUROSCI.4489-11.2011; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Soros P, 1999, NEUROSCI LETT, V271, P89, DOI 10.1016/S0304-3940(99)00528-5; Stagg CJ, 2014, NEUROIMAGE, V86, P19, DOI 10.1016/j.neuroimage.2013.01.009; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Steingruber H.J., 2011, HAND DOMINANZ TEST; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; van Dijk H, 2010, P NATL ACAD SCI USA, V107, P900, DOI 10.1073/pnas.0908821107; van Ede F, 2010, NEUROIMAGE, V51, P867, DOI 10.1016/j.neuroimage.2010.02.053; Volkmann J, 1998, J NEUROPHYSIOL, V79, P2149, DOI 10.1152/jn.1998.79.4.2149; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	46	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156829	10.1371/journal.pone.0156829	http://dx.doi.org/10.1371/journal.pone.0156829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258089	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700141
J	Ertl, NG; O'Connor, WA; Papanicolaou, A; Wiegand, AN; Elizur, A				Ertl, Nicole G.; O'Connor, Wayne A.; Papanicolaou, Alexie; Wiegand, Aaron N.; Elizur, Abigail			Transcriptome Analysis of the Sydney Rock Oyster, Saccostrea glomerata: Insights into Molluscan Immunity	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; FRESH-WATER MUSSEL; CRASSOSTREA-GIGAS; PACIFIC OYSTER; ANTIOXIDANT ENZYMES; SIGNALING PATHWAYS; INNATE IMMUNITY; EASTERN OYSTER; MOLECULAR-CLONING	Background Oysters have important ecological functions in their natural environment, acting as global carbon sinks and improving water quality by removing excess nutrients from the water column. During their life-time oysters are exposed to a variety of pathogens that can cause severe mortality in a range of oyster species. Environmental stressors encountered in their habitat can increase the susceptibility of oysters to these pathogens and in general have been shown to impact on oyster immunity, making immune parameters expressed in these marine animals an important research topic. Results Paired-end Illumina high throughput sequencing of six S. glomerata tissues exposed to different environmental stressors resulted in a total of 484,121,702 paired-end reads. When reads and assembled transcripts were compared to the C. gigas genome, an overall low level of similarity at the nucleotide level, but a relatively high similarity at the protein level was observed. Examination of the tissue expression pattern showed that some transcripts coding for cathepsins, heat shock proteins and antioxidant proteins were exclusively expressed in the haemolymph of S. glomerata, suggesting a role in innate immunity. Furthermore, analysis of the S. glomerata ORFs showed a wide range of genes potentially involved in innate immunity, from pattern recognition receptors, components of the Toll-like signalling and apoptosis pathways to a complex antioxidant defence mechanism. Conclusions This is the first large scale RNA-Seq study carried out in S. glomerata, showing the complex network of innate immune components that exist in this species. The results confirmed that many of the innate immune system components observed in mammals are also conserved in oysters; however, some, such as the TLR adaptors MAL, TRIF and TRAM are either missing or have been modified significantly. The components identified in this study could help explain the oysters' natural resilience against pathogenic microorganisms encountered in their natural environment.	[Ertl, Nicole G.; O'Connor, Wayne A.; Wiegand, Aaron N.; Elizur, Abigail] Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia; [Ertl, Nicole G.] Australian Seafood Cooperat Res Ctr, Bedford Pk, SA, Australia; [O'Connor, Wayne A.] Dept Primary Ind, Taylors Beach, NSW, Australia; [Papanicolaou, Alexie] Commonwealth Sci & Ind Res Org CSIRO Ecosyst Sci, Black Mt Labs, Canberra, ACT, Australia	University of the Sunshine Coast; NSW Department of Primary Industries; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Elizur, A (corresponding author), Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia.	AElizur@usc.edu.au	Papanicolaou, Alexie/A-1618-2011; O'Connor, Wayne/AAL-8097-2020	Papanicolaou, Alexie/0000-0002-3635-6848; O'Connor, Wayne/0000-0002-0972-4668; Elizur, Abigail/0000-0002-2960-302X; ERTL, Nicole/0000-0002-0442-3882	Fisheries Research & Development Corporation (FRDC); Australian Seafood Cooperative Research Centre (CRC) [2011/718]; University of the Sunshine Coast, Australia; Australian Seafood CRC; University of the Sunshine Coast scholarship; Queensland Education and Training International (QETI)	Fisheries Research & Development Corporation (FRDC)(Fisheries R&D Corp); Australian Seafood Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast, Australia; Australian Seafood CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast scholarship; Queensland Education and Training International (QETI)	This project was funded by the Fisheries Research & Development Corporation (FRDC - http://frdc.com.au/), the Australian Seafood Cooperative Research Centre (CRC - http://www.seafoodcrc.com/) (2011/718 to NGE, AE and WAO), and the University of the Sunshine Coast, Australia. NGE was supported by an Australian Seafood CRC and University of the Sunshine Coast scholarship, as well as a scholarship from Queensland Education and Training International (QETI). The funding parties had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEMA CM, 1993, J LEUKOCYTE BIOL, V54, P379, DOI 10.1002/jlb.54.5.379; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ashe PC, 2003, PROG NEURO-PSYCHOPH, V27, P199, DOI 10.1016/S0278-5846(03)00016-2; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; BACHERE E, 1995, AQUACULTURE, V132, P17, DOI 10.1016/0044-8486(94)00389-6; Balakrishnan A, 2013, INNATE IMMUN-LONDON, V19, P339, DOI 10.1177/1753425912465098; Bebianno MJ, 2005, AQUAT TOXICOL, V75, P354, DOI 10.1016/j.aquatox.2005.08.013; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berthe FCJ, 2004, AQUAT LIVING RESOUR, V17, P433, DOI 10.1051/alr:2004051; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bhandari T, 2014, INFECT DIS THER; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butt D, 2006, AQUACULTURE, V251, P159, DOI 10.1016/j.aquaculture.2005.05.045; Butt D, 2007, MAR FRESHWATER RES, V58, P213, DOI 10.1071/MF06080; Cantacessi C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002284; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Cheriyath V, 2011, J INTERF CYTOK RES, V31, P173, DOI 10.1089/jir.2010.0105; Cherkasov AS, 2007, J THERM BIOL, V32, P162, DOI 10.1016/j.jtherbio.2007.01.005; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Choi SH, 2013, FISH SHELLFISH IMMUN, V35, P476, DOI 10.1016/j.fsi.2013.05.001; CHU FLE, 1994, MAR ENVIRON RES, V38, P243, DOI 10.1016/0141-1136(94)90026-4; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conner JR, 2010, P NATL ACAD SCI USA, V107, P11477, DOI 10.1073/pnas.1006894107; CONTE A, 1995, FEBS LETT, V365, P120, DOI 10.1016/0014-5793(95)00439-G; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cordeiro Q, 2009, REV BRAS PSIQUIATR, V31, P131, DOI 10.1590/S1516-44462009000200009; Creese A, 2014, AQUACULTURE PRODUCTI; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Dang C, 2011, FISH SHELLFISH IMMUN, V31, P1034, DOI 10.1016/j.fsi.2011.09.003; Deng Y, 2014, BIOSCI BIOTECH BIOCH, P1; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Edge KJ, 2012, ECOTOXICOLOGY, V21, P1415, DOI 10.1007/s10646-012-0895-2; Ellis RP, 2011, FISH SHELLFISH IMMUN, V30, P1209, DOI 10.1016/j.fsi.2011.03.017; Fang Y, 2013, COMP BIOCHEM PHYS C, V157, P54, DOI 10.1016/j.cbpc.2012.10.002; Feng Y, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/170352; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Ge H, 2012, GENE, V506, P417, DOI 10.1016/j.gene.2012.06.038; Glick BR, 2003, MOL BIOTECHNOLOGY PR, P23; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gourdon I, 2001, NITRIC OXIDE-BIOL CH, V5, P1, DOI 10.1006/niox.2000.0327; Green TJ, 2010, MAR ECOL PROG SER, V402, P161, DOI 10.3354/meps08430; Green TJ, 2009, FISH SHELLFISH IMMUN, V26, P799, DOI 10.1016/j.fsi.2009.03.003; Guha S, 2008, INDIAN J BIOCHEM BIO, V45, P75; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Harris AJ, 2014, HYPOXIA, V2, P47, DOI 10.2147/HP.S50269; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Higgins CB, 2011, J ENVIRON QUAL, V40, P271, DOI 10.2134/jeq2010.0203; Ho KKY, 2014, MAR POLLUT BULL, V85, P499, DOI 10.1016/j.marpolbul.2014.02.023; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hook SE, 2014, MAR GENOM, V18, P109, DOI 10.1016/j.margen.2014.08.003; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Hu XJ, 2014, FISH SHELLFISH IMMUN, V40, P446, DOI 10.1016/j.fsi.2014.07.005; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Huang BY, 2014, MOL BIOL REP, V41, P6481, DOI 10.1007/s11033-014-3531-9; Hughes FM, 2010, FISH SHELLFISH IMMUN, V29, P247, DOI 10.1016/j.fsi.2010.03.003; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jantsch J, 2011, J LEUKOCYTE BIOL, V90, P551, DOI 10.1189/jlb.1210683; Jenny MJ, 2002, MAR BIOTECHNOL, V4, P81, DOI 10.1007/s10126-001-0072-8; Jo PG, 2008, COMP BIOCHEM PHYS C, V147, P460, DOI 10.1016/j.cbpc.2008.02.001; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kawabe S, 2012, MAR BIOTECHNOL, V14, P106, DOI 10.1007/s10126-011-9394-3; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Kiss T, 2010, APOPTOSIS, V15, P313, DOI 10.1007/s10495-009-0446-3; Kohchi C, 2009, ANTICANCER RES, V29, P817; Kuchel RP, 2012, AQUACULTURE, V362, P33, DOI 10.1016/j.aquaculture.2012.07.027; Kuchel RP, 2010, FISH SHELLFISH IMMUN, V29, P930, DOI 10.1016/j.fsi.2010.07.033; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kutikhin AG, 2013, GENOMICS PATTERN REC, P1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee Youngdeuk, 2014, Journal of Coastal Life Medicine, V2, P447; Leite RB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-741; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu L, 2011, DEV COMP IMMUNOL, V35, P227, DOI 10.1016/j.dci.2010.09.010; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Malagoli D, 2007, FISH SHELLFISH IMMUN, V23, P171, DOI 10.1016/j.fsi.2006.10.004; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Meng XL, 2014, FISH SHELLFISH IMMUN, V38, P287, DOI 10.1016/j.fsi.2014.03.009; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nell JA, 2006, AQUAC RES, V37, P693, DOI 10.1111/j.1365-2109.2006.01482.x; Niu DH, 2014, DEV COMP IMMUNOL, V46, P241, DOI 10.1016/j.dci.2014.04.012; Niu DH, 2013, DEV COMP IMMUNOL, V41, P94, DOI 10.1016/j.dci.2013.04.014; Niyogi S, 2001, SCI TOTAL ENVIRON, V281, P237, DOI 10.1016/S0048-9697(01)00850-6; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Palumbo A, 2005, COMP BIOCHEM PHYS A, V142, P241, DOI 10.1016/j.cbpb.2005.05.043; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paul-Pont I, 2014, AQUACULTURE, V422, P146, DOI 10.1016/j.aquaculture.2013.12.009; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Peters R, 2003, AQUACULTURE, V223, P29, DOI 10.1016/S0044-8486(03)00169-8; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Piontkivska H, 2011, COMP BIOCHEM PHYS D, V6, P103, DOI 10.1016/j.cbd.2010.10.003; Poole AZ, 2014, DEV COMP IMMUNOL, V46, P480, DOI 10.1016/j.dci.2014.06.002; Prentis PJ, 2014, MAR GENOM, V18, P113, DOI 10.1016/j.margen.2014.08.004; Rauta PR, 2014, IMMUNOL LETT, V158, P14, DOI 10.1016/j.imlet.2013.11.013; Ren Q, 2014, DEV COMP IMMUNOL, V42, P286, DOI 10.1016/j.dci.2013.09.012; Ren Q, 2013, FISH SHELLFISH IMMUN, V34, P1287, DOI 10.1016/j.fsi.2013.02.014; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Taylor JM, 2008, NUCLEIC ACIDS RES, V36, P4845, DOI 10.1093/nar/gkn444; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Toubiana M, 2013, DEV COMP IMMUNOL, V40, P158, DOI 10.1016/j.dci.2013.02.006; Trevisan R, 2012, AQUAT TOXICOL, V108, P85, DOI 10.1016/j.aquatox.2011.09.023; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Wang LL, 2013, DEV COMP IMMUNOL, V39, P2, DOI 10.1016/j.dci.2012.06.014; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wu BJ, 2011, DEV COMP IMMUNOL, V35, P764, DOI 10.1016/j.dci.2011.02.009; Wu D, 2013, FISH SHELLFISH IMMUN, V34, P1033, DOI 10.1016/j.fsi.2012.12.009; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xiang ZM, 2014, FISH SHELLFISH IMMUN, V40, P514, DOI 10.1016/j.fsi.2014.08.006; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Yu ZN, 2006, AQUACULTURE, V254, P160, DOI 10.1016/j.aquaculture.2005.10.016; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang LL, 2012, AQUAC RES, V43, P1071, DOI 10.1111/j.1365-2109.2011.02910.x; Zhang T, 2014, DEV COMP IMMUNOL, V45, P141, DOI 10.1016/j.dci.2014.02.015; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025; Zhao JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013480; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3	141	36	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156649	10.1371/journal.pone.0156649	http://dx.doi.org/10.1371/journal.pone.0156649			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258386	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700094
J	Faraji-Dana, Z; Tam, F; Chen, JJ; Graham, SJ				Faraji-Dana, Zahra; Tam, Fred; Chen, J. Jean; Graham, Simon J.			Suppressing Respiration Effects when Geometric Distortion Is Corrected Dynamically by Phase Labeling for Additional Coordinate Encoding (PLACE) during Functional MRI	PLOS ONE			English	Article							ECHO-PLANAR IMAGES; FMRI TIME-SERIES; MOTION CORRECTION; SUSCEPTIBILITY ARTIFACTS; RETROSPECTIVE CORRECTION; HUMAN BRAIN; EPI; TRACKING; ACQUISITION; SIGNAL	Echo planar imaging (EPI) suffers from geometric distortions caused by magnetic field inhomogeneities, which can be time-varying as a result of small amounts of head motion that occur over seconds and minutes during fMRI experiments, also known as "dynamic geometric distortion". Phase Labeling for Additional Coordinate Encoding (PLACE) is a promising technique for geometric distortion correction without reduced temporal resolution and in principle can be used to correct for motion-induced dynamic geometric distortion. PLACE requires at least two EPI images of the same anatomy that are ideally acquired with no variation in the magnetic field inhomogeneities. However, head motion and lung ventilation during the respiratory cycle can cause changes in magnetic field inhomogeneities within the EPI pair used for PLACE. In this work, we exploited dynamic off-resonance in k-space (DORK) and averaging to correct the within EPI pair magnetic field inhomogeneities; and hence proposed a combined technique (DORK+PLACE+averaging) to mitigate dynamic geometric distortion in EPI-based fMRI while preserving the temporal resolution. The performance of the combined DORK, PLACE and averaging technique was characterized through several imaging experiments involving test phantoms and six healthy adult volunteers. Phantom data illustrate reduced temporal standard deviation of fMRI signal intensities after use of combined dynamic PLACE, DORK and averaging compared to the standard processing and static geometric distortion correction. The combined technique also substantially improved the temporal standard deviation and activation maps obtained from human fMRI data in comparison to the results obtained by standard processing and static geometric distortion correction, highlighting the utility of the approach.	[Faraji-Dana, Zahra; Chen, J. Jean; Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Faraji-Dana, Zahra; Tam, Fred; Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Chen, J. Jean] Baycrest Hlth Sci Ctr, Rotman Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Baycrest	Faraji-Dana, Z (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Faraji-Dana, Z (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	zfarajid@sri.utoronto.ca	Chen, Jean/A-2846-2013	Chen, Jean/0000-0001-5469-7542	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors received funding from Natural Sciences and Engineering Research Council of Canada for this work.	Aksoy M, 2011, MAGN RESON MED, V66, P366, DOI 10.1002/mrm.22787; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Arnold S, 2009, EVALUATION EPI GEOME, V57, P4633; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boegle R, 2010, MAGN RESON MATER PHY, V23, P263, DOI 10.1007/s10334-010-0225-8; Chavez S, 2010, P INT SOC MAG RESON, P5064; Chen NK, 1999, MAGNET RESON MED, V41, P1206, DOI 10.1002/(SICI)1522-2594(199906)41:6<1206::AID-MRM17>3.0.CO;2-L; Cheng H, 2010, MAGN RESON IMAGING, V28, P574, DOI 10.1016/j.mri.2009.12.014; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Faraji-Dana Z, 2015, P 21 ANN M ORG HUM B; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gorno-Tempini ML, 2002, NEUROIMAGE, V15, P136, DOI 10.1006/nimg.2001.0967; Hagberg GE, 2008, MAGN RESON IMAGING, V26, P1026, DOI 10.1016/j.mri.2008.01.010; Hagberg GE, 2012, NEUROIMAGE, V59, P3748, DOI 10.1016/j.neuroimage.2011.10.095; HAJNAL JV, 1994, MAGNET RESON MED, V31, P283, DOI 10.1002/mrm.1910310307; Heid O, 2000, US Patent, Patent No. [6,043,651, 6043651]; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kwongt KK, 1992, DYNAMIC MAGNETIC RES, V89, P5675; Mansfield P., 1977, MULTIPLANAR IMAGE FO, V10, P55; MCCULLAGH P, 1984, EUR J OPER RES, V16, P285, DOI 10.1016/0377-2217(84)90282-0; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Ooi MB, 2013, MAGN RESON MED, V69, P803, DOI 10.1002/mrm.24285; Pfeuffer J, 2002, MAGN RESON MED, V47, P344, DOI 10.1002/mrm.10065; Pfeuffer J, 2011, P INT SOC MAG RESON, V19, P4577; Raj D, 2001, PHYS MED BIOL, V46, P3331, DOI 10.1088/0031-9155/46/12/318; Reber PJ, 1998, MAGNET RESON MED, V39, P328, DOI 10.1002/mrm.1910390223; Robson MD, MEASUREMENT POINT SP; Rotenberg D, 2013, MAGN RESON MED, V69, P734, DOI 10.1002/mrm.24309; Speck O, 2006, MAGN RESON MATER PHY, V19, P55, DOI 10.1007/s10334-006-0027-1; Sutton BP, 2004, MAGN RESON MED, V51, P1194, DOI 10.1002/mrm.20079; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Van de Moortele PF, 2002, MAGNET RESON MED, V47, P888, DOI 10.1002/mrm.10145; Vogler M, 2008, P 14 ANN M ORG HUM B; Xiang QS, 2007, MAGN RESON MED, V57, P731, DOI 10.1002/mrm.21187; Zaitsev M, 2006, NEUROIMAGE, V31, P1038, DOI 10.1016/j.neuroimage.2006.01.039; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261; Zeller M, 2014, MAGN RESON MED, V71, P1117, DOI 10.1002/mrm.24737	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156750	10.1371/journal.pone.0156750	http://dx.doi.org/10.1371/journal.pone.0156750			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258194	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700121
J	Khatri, I; Sharma, S; Ramya, TNC; Subramanian, S				Khatri, Indu; Sharma, Shailza; Ramya, T. N. C.; Subramanian, Srikrishna			Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DIFFICILE-INDUCED COLITIS; ORIGINAL RESEARCH; RAPID ANNOTATION; COG DATABASE; BACTERIOCINS; SPORES; STRAIN; GENES; IDENTIFICATION	Several spore-forming strains of Bacillus are marketed as probiotics due to their ability to survive harsh gastrointestinal conditions and confer health benefits to the host. We report the complete genomes of two commercially available probiotics, Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, and compare them with the genomes of other Bacillus and Lactobacillus. The taxonomic position of both organisms was established with a maximum-likelihood tree based on twenty six housekeeping proteins. Analysis of all probiotic strains of Bacillus and Lactobacillus reveal that the essential sporulation proteins are conserved in all Bacillus probiotic strains while they are absent in Lactobacillus spp. We identified various antibiotic resistance, stress-related, and adhesion-related domains in these organisms, which likely provide support in exerting probiotic action by enabling adhesion to host epithelial cells and survival during antibiotic treatment and harsh conditions.	[Khatri, Indu; Sharma, Shailza; Ramya, T. N. C.; Subramanian, Srikrishna] CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ramya, TNC; Subramanian, S (corresponding author), CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India.	ramya@imtech.res.in; krishna@imtech.res.in	Khatri, Indu/Y-2429-2018; subramanian, srikrishna/N-3018-2019; Chakravarthy, Ramya T. N./AAJ-7507-2021	Khatri, Indu/0000-0002-7993-1953; subramanian, srikrishna/0000-0002-3263-1048; Sharma, Shailza/0000-0001-5746-1447	Council of Scientific Research (CSIR) Network project on Man as a super-organism: Understanding the Human Microbiome [HUM-CSIR-BSC0119]; University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR)	Council of Scientific Research (CSIR) Network project on Man as a super-organism: Understanding the Human Microbiome; University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific Research (CSIR) Network project on Man as a super-organism: Understanding the Human Microbiome (HUM-CSIR-BSC0119). IK and SS acknowledge the University Grants Commission (UGC) and Council of Scientific and Industrial Research (CSIR), respectively, for their research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baron M, 2009, POSTGRAD MED, V121, P114, DOI 10.3810/pgm.2009.03.1971; Cavazzoni V, 1998, BRIT POULTRY SCI, V39, P526, DOI 10.1080/00071669888719; Chen CC, 2010, PEDIATR INFECT DIS J, V29, P135, DOI 10.1097/INF.0b013e3181b530bf; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; D'Arienzo R, 2006, RES MICROBIOL, V157, P891, DOI 10.1016/j.resmic.2006.06.001; De Clerck E, 2004, SYST APPL MICROBIOL, V27, P50, DOI 10.1078/0723-2020-00250; De Vecchi E., 2006, INT J PROBIOT PREBIO, V1, P3; Dolin BJ, 2009, METHOD FIND EXP CLIN, V31, P655, DOI 10.1358/mf.2009.31.10.1441078; Duc LH, 2004, APPL ENVIRON MICROB, V70, P2161, DOI 10.1128/AEM.70.4.2161-2171.2004; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endres JR, 2011, FOOD CHEM TOXICOL, V49, P1174, DOI 10.1016/j.fct.2011.02.012; Endres JR, 2009, FOOD CHEM TOXICOL, V47, P1231, DOI 10.1016/j.fct.2009.02.018; Fitzpatrick LR, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-13; Fitzpatrick LR, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-16; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gueimonde M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00202; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Hoa TT, 2001, APPL ENVIRON MICROB, V67, P3819, DOI 10.1128/AEM.67.9.3819-3823.2001; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002; Hun L, 2009, POSTGRAD MED, V121, P119, DOI 10.3810/pgm.2009.03.1984; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4; La Ragione RM, 2001, VET MICROBIOL, V79, P133, DOI 10.1016/S0378-1135(00)00350-3; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Le Marrec C, 2000, APPL ENVIRON MICROB, V66, P5213, DOI 10.1128/AEM.66.12.5213-5220.2000; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Minot S. S., 2015, ONE CODEX SENSITIVE, DOI [10.1101/027607, DOI 10.1101/027607]; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Natale DA, 2000, GENETICA, V108, P9, DOI 10.1023/A:1004031323748; Natarajan P, 2015, J GENET GENOMICS, V42, P43, DOI 10.1016/j.jgg.2014.07.002; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Patel AK, 2010, APPL BIOCHEM BIOTECH, V160, P140, DOI 10.1007/s12010-009-8583-2; Payot T, 1999, ENZYME MICROB TECH, V24, P191, DOI 10.1016/S0141-0229(98)00098-2; Pinchuk IV, 2001, ANTIMICROB AGENTS CH, V45, P3156, DOI 10.1128/AAC.45.11.3156-3161.2001; Riazi S, 2009, J APPL MICROBIOL, V106, P1370, DOI 10.1111/j.1365-2672.2008.04105.x; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rogha Mehran, 2014, Gastroenterol Hepatol Bed Bench, V7, P156; Sanders M E, 2003, Compr Rev Food Sci Food Saf, V2, P101, DOI 10.1111/j.1541-4337.2003.tb00017.x; Saneian Hossein, 2015, Gastroenterol Hepatol Bed Bench, V8, P56; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Sharma P, 2014, FOOD RES INT, V57, P176, DOI 10.1016/j.foodres.2014.01.025; Sonenshein AL, 1993, BACILLUS SUBTILIS OT; Sorokulova I, 2013, J PROB HLTH, V1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sudha MR, 2012, INDIAN J MICROBIOL, V52, P396, DOI 10.1007/s12088-011-0233-z; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Zheng GL, 2000, J BACTERIOL, V182, P3266, DOI 10.1128/JB.182.11.3266-3273.2000	64	31	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156745	10.1371/journal.pone.0156745	http://dx.doi.org/10.1371/journal.pone.0156745			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258038	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700119
J	Wang, R; Gong, L; Xue, XL; Qin, X; Ma, R; Luo, HY; Zhang, YJ; Yao, B; Su, XY				Wang, Rong; Gong, Li; Xue, Xianli; Qin, Xing; Ma, Rui; Luo, Huiying; Zhang, Yongjie; Yao, Bin; Su, Xiaoyun			Identification of the C-Terminal GH5 Domain from CbCel9B/Man5A as the First Glycoside Hydrolase with Thermal Activation Property from a Multimodular Bifunctional Enzyme	PLOS ONE			English	Article							BACTERIUM CALDICELLULOSIRUPTOR-BESCII; THERMOPHILIC BETA-MANNANASE; PLANT BIOMASS; DEGRADING ENZYMES; PICHIA-PASTORIS; GENE-CLUSTER; DSM 6725; CLONING; EXPRESSION; ENDO-1,4-BETA-MANNOSIDASE	Caldicellulosiruptor bescii encodes at least six unique multimodular glycoside hydrolases crucial for plant cell wall polysaccharides degradation, with each having two catalytic domains separated by two to three carbohydrate binding modules. Among the six enzymes, three have one N- or C-terminal GH5 domain with identical amino acid sequences. Despite a few reports on some of these multimodular enzymes, little is known about how the conserved GH5 domains behave, which are believed to be important due to the gene duplication. We thus cloned a representative GH5 domain from the C-terminus of a multimodular protein, i.e. the bifunctional cellulase/mannanase CbCel9B/Man5A which has been reported, and expressed it in Escherichia coli. Without any appending CBMs, the recombinant CbMan5A was still able to hydrolyze a variety of mannan substrates with different backbone linkages or side-chain decorations. While CbMan5A displayed the same pH optimum as CbCel9B/Man5A, it had an increased optimal temperature (90 degrees C) and moreover, was activated by heating at 70 degrees C and 80 degrees C, a property not ever reported for the full-length protein. The turnover numbers of CbMan5A on mannan substrates were, however, lower than those of CbCel9B/Man5A. These data suggested that evolution of CbMan5A and the other domains into a single polypeptide is not a simple assembly; rather, the behavior of one module may be affected by the other ones in the full-length enzyme. The differential scanning calorimetry analysis further indicated that heating CbMan5A was not a simple transition state process. To the best knowledge of the authors, CbMan5A is the first glycoside hydrolase with thermal activation property identified from a multimodular bifunctional enzyme.	[Wang, Rong; Gong, Li; Xue, Xianli; Qin, Xing; Ma, Rui; Luo, Huiying; Yao, Bin; Su, Xiaoyun] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Wang, Rong; Zhang, Yongjie] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Shanxi, Peoples R China; [Gong, Li] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Shanxi University; Zhejiang University	Zhang, YJ (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Shanxi, Peoples R China.	zhangyj2008@sxu.edu.cn; binyao@caas.cn; suxiaoyun@caas.cn	Zhang, Yong-Jie/B-9054-2009	Zhang, Yong-Jie/0000-0002-6331-2189	Elite Youth Program of Chinese Academy of Agricultural Sciences; National Natural Science Foundation of China [31400067]; Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences [2015ZL045]; National High Technology Research, and Development Program of China 863 program [2012AA022208]; China Modern Agriculture Research System [CARS-42]	Elite Youth Program of Chinese Academy of Agricultural Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences; National High Technology Research, and Development Program of China 863 program(National High Technology Research and Development Program of China); China Modern Agriculture Research System	1. Elite Youth Program of Chinese Academy of Agricultural Sciences. Grant number: n/a. http://www.caas.net.cn/kjcxgczl/zytz/237653.shtml 2. National Natural Science Foundation of China (31400067). http://www.nsfc.gov.cn/ 3. Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences (2015ZL045). http://www.caas.cn 4. National High Technology Research, and Development Program of China 863 program (no. 2012AA022208), http://www.863.gov.cn/ 5. China Modern Agriculture Research System (CARS-42), http://www.moa.gov.cn/; This research was supported by the Elite Youth Program of Chinese Academy of Agricultural Sciences, the National Natural Science Foundation of China (31400067), and the Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences (2015ZL045), the National High Technology Research, and Development Program of China 863 program (no. 2012AA022208), and the China Modern Agriculture Research System (CARS-42).	Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Chen XL, 2007, J BIOTECHNOL, V128, P452, DOI 10.1016/j.jbiotec.2006.11.003; Chung D, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0147-1; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Do BC, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-59; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Hsiao YM, 2010, J AGR FOOD CHEM, V58, P1653, DOI 10.1021/jf903637s; KLUMP H, 1992, J BIOL CHEM, V267, P22681; Kong FS, 2014, PROCESS BIOCHEM, V49, P775, DOI 10.1016/j.procbio.2014.02.008; Liang D, 2015, BIOCHEM BIOPH RES CO, V467, P334, DOI 10.1016/j.bbrc.2015.09.156; Lu HQ, 2014, APPL MICROBIOL BIOT, V98, P2155, DOI 10.1007/s00253-013-5112-6; Lu HQ, 2013, APPL MICROBIOL BIOT, V97, P8121, DOI 10.1007/s00253-012-4656-1; Luo HY, 2012, J IND MICROBIOL BIOT, V39, P547, DOI 10.1007/s10295-011-1067-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moon YH, 2011, APPL ENVIRON MICROB, V77, P5157, DOI 10.1128/AEM.00353-11; Rathi P, 2000, BIOTECHNOL LETT, V22, P495, DOI 10.1023/A:1005604617440; Soysal C, 2008, J FOOD PROCESS PRES, V32, P1034, DOI 10.1111/j.1745-4549.2008.00298.x; STUTZENBERGER F, 1986, ENZYME MICROB TECH, V8, P205, DOI 10.1016/0141-0229(86)90088-8; Su XY, 2013, APPL ENVIRON MICROB, V79, P1481, DOI 10.1128/AEM.03265-12; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Summpunn P, 2011, J MICROBIOL, V49, P86, DOI 10.1007/s12275-011-0357-1; Velikodvorskaia G A, 2013, Mol Biol (Mosk), V47, P667; Wang CH, 2015, APPL MICROBIOL BIOT, V99, P1217, DOI 10.1007/s00253-014-5979-x; Yang H, 2015, FOOD CHEM, V173, P283, DOI 10.1016/j.foodchem.2014.10.022; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172; Young J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0142-6; Yu S, 2015, BIOTECHNOL LETT; Zhang YL, 2008, ACTA CRYSTALLOGR F, V64, P209, DOI 10.1107/S1744309108002832	29	11	11	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156802	10.1371/journal.pone.0156802	http://dx.doi.org/10.1371/journal.pone.0156802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258548	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700132
J	Zeng, NF; Mancuso, JE; Zivkovic, AM; Smilowitz, JT; Ristenpart, WD				Zeng, Nancy F.; Mancuso, Jordan E.; Zivkovic, Angela M.; Smilowitz, Jennifer T.; Ristenpart, William D.			Red Blood Cells from Individuals with Abdominal Obesity or Metabolic Abnormalities Exhibit Less Deformability upon Entering a Constriction	PLOS ONE			English	Article							INSULIN-RESISTANCE; MICROFLUIDIC DEVICE; ASSOCIATION; VISCOSITY; RELEASE; PROFILE; RISK; ATP	Abdominal obesity and metabolic syndrome (MS) are multifactorial conditions associated with increased risk of cardiovascular disease and type II diabetes mellitus. Previous work has demonstrated that the hemorheological profile is altered in patients with abdominal obesity and MS, as evidenced for example by increased whole blood viscosity. To date, however, no studies have examined red blood cell (RBC) deformability of blood from individuals with obesity or metabolic abnormalities under typical physiological flow conditions. In this study, we pumped RBCs through a constriction in a microfluidic device and used high speed video to visualize and track the mechanical behavior of similar to 8,000 RBCs obtained from either healthy individuals (n = 5) or obese participants with metabolic abnormalities (OMA) (n = 4). We demonstrate that the OMA+ cells stretched on average about 25% less than the healthy controls. Furthermore, we examined the effects of ingesting a high-fat meal on RBC mechanical dynamics, and found that the postprandial period has only a weak effect on the stretching dynamics exhibited by OMA+ cells. The results suggest that chronic rigidification of RBCs plays a key role in the increased blood pressure and increased whole blood viscosity observed in OMA individuals and was independent of an acute response triggered by consumption of a high-fat meal.	[Zeng, Nancy F.; Mancuso, Jordan E.; Ristenpart, William D.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA; [Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Smilowitz, Jennifer T.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ristenpart, WD (corresponding author), Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.	wdristenpart@ucdavis.edu	Ristenpart, William/AAG-4462-2021	Zivkovic, Angela/0000-0002-2828-7862	National Science Foundation Biomechanics and Mechanobiology grant [1201245]; National Institute of Health [T32-GM008799]; NSF [1201245]; NIGMS-NIH [T32-GM008799]; Div Of Civil, Mechanical, & Manufact Inn [1201245] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008799] Funding Source: NIH RePORTER	National Science Foundation Biomechanics and Mechanobiology grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIGMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Science Foundation Biomechanics and Mechanobiology grant # 1201245; National Institute of Health grant # T32-GM008799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Primary support for this research was provided by NSF grant number 1201245 (Biomechanics and Mechanobiology, CMMI). Partial support for this research was provided by grant number T32-GM008799 from NIGMS-NIH. The authors would like to thank the Foods for Health Institute at UC Davis, the USDA, Agricultural Research Service, Western Human Nutrition Research Center and the National Dairy Council (Rosemont, IL) for supplying the blood samples for our experiments.	Ageno W, 2009, J THROMB HAEMOST, V7, P736, DOI 10.1111/j.1538-7836.2009.03327.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aloulou I, 2006, CLIN HEMORHEOL MICRO, V35, P207; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Brun JF, 2004, CLIN HEMORHEOL MICRO, V30, P203; Caimi G, 2001, INT J OBESITY, V25, P1856, DOI 10.1038/sj.ijo.0801824; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DEMMER E, 2016, J NUTR SCI, V5; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ervin RB, 2003, NATL HLTH STAT REPOR, V2009, P1; Faustino V, 2014, BIOCHIP J, V8, P42, DOI 10.1007/s13206-014-8107-1; Forsyth AM, 2010, MICROVASC RES, V80, P37, DOI 10.1016/j.mvr.2010.03.008; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Gyawali P, 2012, CLIN LIPIDOL, V7, P709, DOI 10.2217/CLP.12.65; Helal O, 2011, NUTR METAB CARDIOVAS, V21, P665, DOI 10.1016/j.numecd.2010.01.004; Irace C, 2006, NMCD, V19, P476; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Lee SS, 2009, BIOMED MICRODEVICES, V11, P1021, DOI 10.1007/s10544-009-9319-3; Lo Presti R, 2002, CLIN HEMORHEOL MICRO, V26, P241; Marossy A, 2009, CLIN HEMORHEOL MICRO, V42, P239, DOI 10.3233/CH-2009-1192; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Perez-Martinez P, 2014, EUR J CLIN INVEST, V44, P1053, DOI 10.1111/eci.12339; Price AK, 2004, ANAL CHEM, V76, P4849, DOI 10.1021/ac0495992; Rodrigues RO, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-0014-2; TANGELDER GJ, 1988, AM J PHYSIOL, V254, pH1059, DOI 10.1152/ajpheart.1988.254.6.H1059; Toker S, 2005, DIABETES-METAB RES, V21, P197, DOI 10.1002/dmrr.502; Uyuklu M, 2009, CLIN HEMORHEOL MICRO, V41, P269, DOI 10.3233/CH-2009-1178; Vaya A, 2011, CLIN HEMORHEOL MICRO, V49, P493, DOI 10.3233/CH-2011-1499; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wiernsperger N, 2007, MICROCIRCULATION, V14, P403, DOI 10.1080/10739680701285617; Yaginuma T, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4820414; Zeng NF, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4904058; Zhang L, 2006, INT J CARDIOL, V112, P229, DOI 10.1016/j.ijcard.2005.11.104; Zhao R, 2006, BIORHEOLOGY, V43, P747	38	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156070	10.1371/journal.pone.0156070	http://dx.doi.org/10.1371/journal.pone.0156070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258098	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700032
J	Zhong, XR; Dong, ZW; Dong, H; Li, JY; Peng, ZX; Deng, L; Zhu, XH; Sun, Y; Lu, XS; Shen, FX; Su, XY; Zhang, LY; Gu, Y; Zheng, H				Zhong, Xiaorong; Dong, Zhengwei; Dong, Hua; Li, Jiayuan; Peng, Zuxiang; Deng, Ling; Zhu, Xuehua; Sun, Yun; Lu, Xuesong; Shen, Fuxiao; Su, Xinying; Zhang, Liying; Gu, Yi; Zheng, Hong			Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients	PLOS ONE			English	Article							OVARIAN-CANCER; SOMATIC MUTATIONS; SURVIVAL; CHEMOTHERAPY; CARRIERS; THERAPY; WOMEN; GERMLINE; BRCANESS; OUTCOMES	Background The prevalence of BRCA1/2 variants in Chinese breast cancer patients varies among studies. Germline or somatic BRCA1/2 mutations are associated with sensitivity to poly(ADPribose) polymerase-1 inhibitors and DNA-damaging agents. We aimed to investigate the distribution of both somatic and germline BRCA1/2 variants in unselected Chinese breast cancer patients, and explore their roles in tumor phenotype and disease prognosis. Methods 507 breast cancer patients, unselected for family history of breast cancer or age at diagnosis, were prospectively enrolled from West China Hospital between Feb. 2008 and Feb. 2014. BRCA1/2 variants in the exons/flanking regions were detected in fresh-frozen tumors using next-generation sequencing and confirmed by independent methods. Germline/somatic status was validated by Sanger sequencing in paired blood/normal tissue. Results BRCA1/2 pathogenic or likely pathogenic (P/LP) variants were detected in 50 patients (9.9%), including 40 germline carriers (18 in BRCA1, 22 in BRCA2), 9 patients with somatic variants (3 in BRCA1, 6 in BRCA2), and 1 patient with concurrent germline/somatic variants in BRCA2. The triple-negative (21.4%) and Luminal B (9.7%) subtypes had higher rates of BRCA1/2 variants. In patients with disease stage 0 similar to II, presence of a germline or somatic BRCA1 P/LP variant increased the risk of relapse as compared to non-carriers [univariate hazard ratio (HR): 3.70, P = 0.04]. Germline BRCA1 P/LP variants, which were associated with aggressive tumor phenotypes, predicted worse disease-free survival in the subgroup of stage 0 similar to II (HR: 4.52, P = 0.02) and N0 (HR: 5.4, P = 0.04) compared to non-carriers. Conclusion A high frequency of germline and somatic BRCA1/2 P/LP variants was detected in unselected Chinese breast cancer patients. Luminal B subtype should be considered as a high-risk population of BRCA1/2 mutation, in addition to triple-negative breast cancer. BRCA1 status was associated with aggressive tumor phenotype and worse disease progression in early stage breast cancer patients.	[Zhong, Xiaorong; Peng, Zuxiang; Deng, Ling; Zheng, Hong] Sichuan Univ, Lab Mol Diag Canc, State Key Lab Biotherapy, Natl Collaborat Innovat Ctr Biotherapy,West China, Chengdu 610064, Sichuan, Peoples R China; [Dong, Zhengwei; Dong, Hua; Zhu, Xuehua; Sun, Yun; Lu, Xuesong; Shen, Fuxiao; Su, Xinying; Gu, Yi] AstraZeneca, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Li, Jiayuan] Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu 610064, Sichuan, Peoples R China; [Peng, Zuxiang] Sichuan Univ, Dept Thyroid & Breast Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Liying] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Zheng, Hong] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; AstraZeneca; Sichuan University; Sichuan University; Memorial Sloan Kettering Cancer Center; Sichuan University	Gu, Y (corresponding author), AstraZeneca, Asia & Emerging Markets iMed, Shanghai, Peoples R China.	yigu68@yahoo.com; hzheng@scu.edu.cn	li, jia/GVT-7587-2022		AstraZeneca; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by AstraZeneca (Recipient: ZH). The funder provided support in the form of salaries for authors [ZD, HD, XHZ, YS, XL, FS, XS and YG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; [Anonymous], [No title captured]; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chalasani P, 2013, ONCOLOGIST, V18, P909, DOI 10.1634/theoncologist.2013-0039; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Couch FJ, 2015, J CLIN ONCOL, V33, P304, DOI 10.1200/JCO.2014.57.1414; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Goodwin PJ, 2012, J CLIN ONCOL, V30, P19, DOI 10.1200/JCO.2010.33.0068; Guideline Recommendations for HER2 Detection in Breast Cancer Group, 2014, Zhonghua Bing Li Xue Za Zhi, V43, P262; Guideline Recommendations for Immunohistochemistry Detection in Breast Cancer Group, 2015, Zhonghua Bing Li Xue Za Zhi, V44, P237; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Huzarski T, 2013, J CLIN ONCOL, V31, P3191, DOI 10.1200/JCO.2012.45.3571; Kim H, 2012, BREAST CANCER RES TR, V134, P1315, DOI 10.1007/s10549-012-2159-5; Kim J., 2013, INT J RES STUDIES ED, V2, P15, DOI [DOI 10.4048/JBC.2013.16.4.357, 10.5861/ijrset.2012.170, DOI 10.5861/IJRSET.2012.170]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Maksimenko J, 2014, ONCOL LETT, V7, P278, DOI 10.3892/ol.2013.1684; Melchor L, 2013, HUM GENET, V132, P845, DOI 10.1007/s00439-013-1299-y; Moller P, 2007, INT J CANCER, V121, P1017, DOI 10.1002/ijc.22789; Oza AM, 2015, LANCET ONCOL, V16, P87, DOI 10.1016/S1470-2045(14)71135-0; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Quinn JE, 2003, CANCER RES, V63, P6221; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Suter NM, 2004, CANCER EPIDEM BIOMAR, V13, P181, DOI 10.1158/1055-9965.EPI-03-0196; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wang C, 2015, ANN ONCOL, V26, P523, DOI 10.1093/annonc/mdu559; Yang X, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0005-2; Yu JH, 2014, J BREAST CANCER, V17, P129, DOI 10.4048/jbc.2014.17.2.129; Zhong Q, 2015, CLIN CANCER RES, V21, P211, DOI 10.1158/1078-0432.CCR-14-1816	38	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156789	10.1371/journal.pone.0156789	http://dx.doi.org/10.1371/journal.pone.0156789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257965	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700128
J	Griffiths, ET; Keen, SC; Lanzone, M; Farnsworth, A				Griffiths, Emily T.; Keen, Sara C.; Lanzone, Michael; Farnsworth, Andrew			Can Nocturnal Flight Calls of the Migrating Songbird, American Redstart, Encode Sexual Dimorphism and Individual Identity?	PLOS ONE			English	Article							WOOD-WARBLERS; BIRD SONG; RECOGNITION; AGE; EVOLUTION; VOCALIZATIONS; NEIGHBORS; BEHAVIOR; SYSTEMS; WHALES	Bird species often use flight calls to engage in social behavior, for instance maintain group cohesion and to signal individual identity, kin or social associations, or breeding status of the caller. Additional uses also exist, in particular among migrating songbirds for communication during nocturnal migration. However, our understanding of the information that these vocalizations convey is incomplete, especially in nocturnal scenarios. To examine whether information about signaler traits could be encoded in flight calls we quantified several acoustic characteristics from calls of a nocturnally migrating songbird, the American Redstart. We recorded calls from temporarily captured wild specimens during mist-netting at the Powdermill Avian Research Center in Rector, PA. We measured call similarity among and within individuals, genders, and age groups. Calls from the same individual were significantly more similar to one another than to the calls of other individuals, and calls were significantly more similar among individuals of the same sex than between sexes. Flight calls from hatching-year and after hatching-year individuals were not significantly different. Our results suggest that American Redstart flight calls may carry identifiers of gender and individual identity. To our knowledge, this is the first evidence of individuality or sexual dimorphism in the flight calls of a migratory songbird. Furthermore, our results suggest that flight calls may have more explicit functions beyond simple group contact and cohesion. Nocturnal migration may require coordination among numerous individuals, and the use of flight calls to transmit information among intra-and conspecifics could be advantageous. Applying approaches that account for such individual and gender information may enable more advanced research using acoustic monitoring.	[Griffiths, Emily T.; Keen, Sara C.] Cornell Univ, Bioacoust Res Program, Cornell Lab Ornithol, Ithaca, NY USA; [Lanzone, Michael] Carnegie Museum Nat Hist, Powdermill Avian Res Ctr, Pittsburgh, PA USA; [Farnsworth, Andrew] Cornell Univ, Informat Sci, Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	Griffiths, ET (corresponding author), Cornell Univ, Bioacoust Res Program, Cornell Lab Ornithol, Ithaca, NY USA.	emilytgriffiths@gmail.com		Keen, Sara/0000-0002-2988-8280; Farnsworth, Andrew/0000-0002-9854-4449	National Science Foundation [IIS-1125098]; Department of Defense Legacy Resource Management Program [05-245, 06-245, 07-245, 10-245]; Leon Levy Foundation; Cornell Laboratory of Ornithology; Kenneth L. Harder Trust	National Science Foundation(National Science Foundation (NSF)); Department of Defense Legacy Resource Management Program; Leon Levy Foundation; Cornell Laboratory of Ornithology; Kenneth L. Harder Trust	This project was funded by multiple sources, including the National Science Foundation (IIS-1125098), Department of Defense Legacy Resource Management Program (05-245, 06-245, 07-245, and 10-245), and the Leon Levy Foundation. Private donations, such as the Kenneth L. Harder Trust, the Scott and Karen Harder Family, and several anonymous private donations to the Cornell Laboratory of Ornithology provided additional funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. That being said, though they had no active role, the Harder family's interest and enthusiasm in flight calls helped push this project forward. No additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript was undertaken.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], WHOI9413, DOI DOI 10.1016/j.marpolbul.2017.09.027; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown Eleanor D., 1997, P98, DOI 10.1017/CBO9780511758843.007; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Charif R. A., 2008, RAVEN PRO 1 3 USERS; CHENEY DL, 1982, AM ZOOL, V22, P519; Cortopassi K, 2006, AUTOMATED ROBUST MEA; Cortopassi KA, 2005, 2 INT WORKSH DET LOC; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; EMLEN S T, 1971, Zeitschrift fuer Tierpsychologie, V28, P241; Evans W. R, 2002, FLIGHT CALLS MIGRATO; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Farnsworth A, 2005, AUK, V122, P733, DOI 10.1642/0004-8038(2005)122[0733:FCATVF]2.0.CO;2; Farnsworth A., 2007, THESIS CORNELL U; Farnsworth A, 2008, BIOL J LINN SOC, V94, P155, DOI 10.1111/j.1095-8312.2008.00973.x; Farnsworth A, 2007, WILSON J ORNITHOL, V119, P334, DOI 10.1676/06-070.1; Farnsworth A, 2007, J FIELD ORNITHOL, V78, P279, DOI 10.1111/j.1557-9263.2007.00115.x; Farnsworth A, 2005, J AVIAN BIOL, V36, P337, DOI 10.1111/j.0908-8857.2005.03315.x; FICKEN MS, 1967, WILSON BULL, V79, P188; Fristrup K.M., 1992, WHOI9204; Germain RR, 2012, BEHAV ECOL SOCIOBIOL, V66, P419, DOI 10.1007/s00265-011-1288-x; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; GRIFFIN DR, 1969, Q REV BIOL, V44, P255, DOI 10.1086/406142; HAMILTON WILLIAM J. III, 1962, CONDOR, V64, P390; Herzing DL, 2000, SPR HDB AUD, V12, P225; Hopp SL, 2001, ANIM BEHAV, V62, P297, DOI 10.1006/anbe.2001.1745; Horton KG, 2015, ECOL APPL, V25, P390, DOI 10.1890/14-0279.1; HOWARD RD, 1974, EVOLUTION, V28, P428, DOI 10.1111/j.1558-5646.1974.tb00764.x; James PC, 1985, CALL BULWERS PETREL, P878; Keen S, 2014, ECOL INFORM, V21, P25, DOI 10.1016/j.ecoinf.2014.01.001; Kirschel ANG, 2011, IBIS, V153, P255, DOI 10.1111/j.1474-919X.2011.01102.x; Lanzone M, 2009, AUK, V126, P511, DOI 10.1525/auk.2009.08187; Lebbin DJ, 2007, WILSON J ORNITHOL, V119, P506, DOI 10.1676/06-139.1; LEMON RE, 1994, ANIM BEHAV, V47, P317, DOI 10.1006/anbe.1994.1045; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; MARLER P, 1955, NATURE, V176, P6, DOI 10.1038/176006a0; Marra PP, 1993, TERRITORIAL EXCLUSIO, P565; McDonald PG, 2007, J AVIAN BIOL, V38, P113, DOI 10.1111/j.2007.0908-8857.03753.x; McDonald PG, 2012, BIOL LETTERS, V8, P365, DOI 10.1098/rsbl.2011.1118; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; McKellar AE, 2014, OIKOS, V123, P356, DOI 10.1111/j.1600-0706.2013.00756.x; Mennill DJ, 2011, IBIS, V153, P235, DOI 10.1111/j.1474-919X.2011.01119.x; Mills H., 1995, J ACOUST SOC AM, V97, P3370; Molles LE, 2001, ANIM BEHAV, V61, P119, DOI 10.1006/anbe.2000.1561; Morse D. H., 2013, AM WARBLERS; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; NOWICKI S, 1983, BEHAV ECOL SOCIOBIOL, V12, P317, DOI 10.1007/BF00302899; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parrish JD, 1994, SEXUAL HABITAT SEGRE, P38; Payne RB, 1998, ANIM BEHAV, V55, P1537, DOI 10.1006/anbe.1997.0701; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Price JJ, 1998, P ROY SOC B-BIOL SCI, V265, P497, DOI 10.1098/rspb.1998.0322; R Core Team, 2021, R LANGUAGE ENV STAT; Rendell LE, 2003, P ROY SOC B-BIOL SCI, V270, P225, DOI 10.1098/rspb.2002.2239; Reudink MW, 2014, OECOLOGIA, P1; Saether B.-E., 1990, Current Ornithology, V7, P251; Sanders CE, 2014, CONDOR, V116, P371, DOI 10.1650/CONDOR-13-098.1; SHACKELL NL, 1988, AUK, V105, P609, DOI 10.1093/auk/105.4.609; SHERRY TW, 1989, BEHAV ECOL SOCIOBIOL, V25, P327, DOI 10.1007/BF00302990; Sherry TW, 1997, BIRDS N AM; Singer TL, 1998, AM ZOOL, V38, P394; Smith AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092218; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Sousa-Lima Renata S., 2008, Aquatic Mammals, V34, P109, DOI 10.1578/AM.34.1.2008.109; Staicer CA, 2006, WILSON J ORNITHOL, V118, P439, DOI 10.1676/05-056.1; Stephenson T., 2013, THE WARBLER GUIDE; Stewart RLM, 2002, WILSON BULL, V114, P264, DOI 10.1676/0043-5643(2002)114[0264:ARDTOS]2.0.CO;2; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; Taoka M, 1990, SEXUAL DIFFERENCES F, P571; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tonra CM, 2014, ECOL EVOL, V4, P1222, DOI 10.1002/ece3.994; U. S. Geological Survey (USGS), 2015, USGS SCI CHANG WORLD	76	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156578	10.1371/journal.pone.0156578	http://dx.doi.org/10.1371/journal.pone.0156578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284697	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000016
J	Bergstrom, SH; Nilsson, M; Adamo, H; Thysell, E; Jernberg, E; Stattin, P; Widmark, A; Wikstrom, P; Bergh, A				Bergstrom, Sofia Halin; Nilsson, Maria; Adamo, Hanibal; Thysell, Elin; Jernberg, Emma; Stattin, Par; Widmark, Anders; Wikstrom, Pernilla; Bergh, Anders			Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth	PLOS ONE			English	Article							CANCER CELLS; INFLAMMATION; HOMEOSTASIS; ENVIRONMENT; PROGRESSION; MECHANISMS; CASTRATION; THERAPY; DENSITY; DISEASE	Aggressive tumors induce tumor-supporting changes in the benign parts of the prostate. One factor that has increased expression outside prostate tumors is hemoxygenase-1 (HO-1). To investigate HO-1 expression in more detail, we analyzed samples of tumor tissue and peritumoral normal prostate tissue from rats carrying cancers with different metastatic capacity, and human prostate cancer tissue samples from primary tumors and bone metastases. In rat prostate tumor samples, immunohistochemistry and quantitative RTPCR showed that the main site of HO-1 synthesis was HO-1(+) macrophages that accumulated in the tumor-bearing organ, and at the tumor-invasive front. Small metastatic tumors were considerably more effective in attracting HO-1(+) macrophages than larger non-metastatic ones. In clinical samples, accumulation of HO-1(+) macrophages was seen at the tumor invasive front, almost exclusively in high-grade tumors, and it correlated with the presence of bone metastases. HO-1(+) macrophages, located at the tumor invasive front, were more abundant in bone metastases than in primary tumors. HO-1 expression in bone metastases was variable, and positively correlated with the expression of macrophage markers but negatively correlated with androgen receptor expression, suggesting that elevated HO-1 could be a marker for a subgroup of bone metastases. Together with another recent observation showing that selective knockout of HO-1 in macrophages reduced prostate tumor growth and metastatic capacity in animals, the results of this study suggest that extratumoral HO-1(+) macrophages may have an important role in prostate cancer.	[Bergstrom, Sofia Halin; Nilsson, Maria; Adamo, Hanibal; Thysell, Elin; Jernberg, Emma; Wikstrom, Pernilla; Bergh, Anders] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, Urol, Umea, Sweden; [Widmark, Anders] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden	Umea University; Umea University; Umea University	Bergstrom, SH (corresponding author), Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden.	sofia.halin@umu.se		Halin Bergstrom, Sofia/0000-0003-3475-3230	Swedish Research Council [Co257301]; Swedish Cancer Foundation [130293]; Lion's Cancer Research Foundation; Queen Victorias Freemason Foundation; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Lion's Cancer Research Foundation; Queen Victorias Freemason Foundation; Umea University	This work was supported by grants from the Swedish Research Council (http://www.vr.se/) (AB), grant number Co257301; the Swedish Cancer Foundation, (https://www.cancerfonden.se/) (AB), grant number 130293; the Lion's Cancer Research Foundation, Umea University (http://www.cancerforskningsfonden.se/) (SHB); and the Queen Victorias Freemason Foundation (https://www.frimurarorden.se/organisation/barmhartighetsverksamhet/frimurarstiftelsen/) (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141601; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Blann AD, 2011, PROSTATE CANCER P D, V14, P114, DOI 10.1038/pcan.2010.56; Chau LY, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0128-0; Deng R, 2012, ONCOL RES, V20, P473, DOI 10.3727/096504013X13715991125684; Elguero B, 2012, NEOPLASIA, V14, P1043, DOI 10.1593/neo.121358; Ferrando M, 2011, ANGIOGENESIS, V14, P467, DOI 10.1007/s10456-011-9230-4; Gueron G, 2014, ONCOTARGET, V5, P4087, DOI 10.18632/oncotarget.1826; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2010, NEOPLASIA, V12, P336, DOI 10.1593/neo.92046; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2006, CLIN CANCER RES, V12, P7431, DOI 10.1158/1078-0432.CCR-06-1895; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Herroon MK, 2013, ONCOTARGET, V4, P2108, DOI 10.18632/oncotarget.1482; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hull TD, 2014, ANTIOXID REDOX SIGN, V20, P1770, DOI 10.1089/ars.2013.5673; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Jernberg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077407; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Li YR, 2011, J PATHOL, V224, P90, DOI 10.1002/path.2855; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Lundholm M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15651; Maines MD, 1996, UROLOGY, V47, P727, DOI 10.1016/S0090-4295(96)00010-6; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Nemeth Z, 2015, ONCOTARGET, V6, P33675, DOI 10.18632/oncotarget.5284; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P435, DOI 10.1097/MBC.0000000000000075; Nilsson M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19608; Nilsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140985; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sheehan D.C., 1980, THEORY PRACTICE HIST; Tesfay L, 2015, CANCER RES, V75, P2254, DOI 10.1158/0008-5472.CAN-14-2465; Tidehag V, 2014, EUR J CANCER, V50, P1829, DOI 10.1016/j.ejca.2014.03.278; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Vidal SJ, 2015, CANCER CELL, V27, P223, DOI 10.1016/j.ccell.2014.11.013; Wegiel B, 2013, CANCER RES, V73, P7009, DOI 10.1158/0008-5472.CAN-13-1075; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; Wu ML, 2011, AM J CARDIOVASC DIS, V1, P150; Zhang CG, 2015, PROTEIN CELL, V6, P88, DOI 10.1007/s13238-014-0119-z	50	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157280	10.1371/journal.pone.0157280	http://dx.doi.org/10.1371/journal.pone.0157280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280718	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000117
J	Chatterjee, R; Zelnick, L; Mukamal, KJ; Nettleton, JA; Kestenbaum, BR; Siscovick, DS; Ix, JH; Tracy, R; Hoofnagle, AN; Svetkey, LP; Edelman, D; de Boer, IH				Chatterjee, Ranee; Zelnick, Leila; Mukamal, Kenneth J.; Nettleton, Jennifer A.; Kestenbaum, Bryan R.; Siscovick, David S.; Ix, Joachim H.; Tracy, Russell; Hoofnagle, Andrew N.; Svetkey, Laura P.; Edelman, David; de Boer, Ian H.			Potassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							24-H URINARY SODIUM; EXCRETION; DIETARY; MELLITUS; ADULTS	Background Recent studies have found low-normal potassium (K) to be associated with increased diabetes risk. We sought to verify these associations in a multi-ethnic US cohort; and to determine if these associations extend to US Hispanics and Asian-Americans. Methods We analyzed data from Multi-Ethnic Study of Atherosclerosis (MESA) participants who were free-of-diabetes at baseline. We examined cross-sectional associations between measures of K-serum, dietary, and urine-with fasting glucose and HOMA-IR. We examined longitudinal associations between K and diabetes risk over 8 years. Findings In multivariable models, compared to those with higher serum K (>= 4.5mmol/L), those with lower serum K (<4.0mmol/L) had significantly higher fasting glucose [1.3 mg/dL (95%CI 0.2, 2.4), P-value = 0.03]. Incident diabetes developed in 1281 of 5415 at-risk participants. In minimally-adjusted models, we found inverse associations between serum and dietary K and diabetes risk. Compared to those with higher serum K, those with lower serum K had an HR (95% CI) of incident diabetes of 1.23 (1.04, 1.47), P-value = 0.02. However, these associations were attenuated in fully-adjusted models. We found no significant interaction between potassium and ethnicity. Conclusions In this multi-ethnic cohort, we found a significant inverse association between serum K and fasting glucose but no significant association with longer-term diabetes risk. This inverse association between potassium and glucose must be studied further to understand the physiology and its potential impact on chronic health.	[Chatterjee, Ranee; Svetkey, Laura P.; Edelman, David] Duke Univ, Dept Med, Durham, NC USA; [Zelnick, Leila] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Mukamal, Kenneth J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Nettleton, Jennifer A.] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX 77030 USA; [Kestenbaum, Bryan R.; de Boer, Ian H.] Univ Washington, Dept Med, Seattle, WA USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Ix, Joachim H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Tracy, Russell] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Hoofnagle, Andrew N.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [de Boer, Ian H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Duke University; University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; New York Academy of Medicine; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Vermont; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chatterjee, R (corresponding author), Duke Univ, Dept Med, Durham, NC USA.	ranee.chatterjee@duke.edu	Mukamal, Kenneth/GVR-7978-2022; de Boer, Ian/GYJ-3282-2022	Edelman, David/0000-0001-7112-6151; Zelnick, Leila/0000-0002-8461-5111	National Heart, Lung, and Blood Institute [R01HL096875, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169]; NCRR [UL1-TR-000040, UL1-TR-001079]; NIH/Duke CTSA [KL2TR001115-02]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/Duke CTSA	This research was supported by grant R01HL096875 from the National Heart, Lung, and Blood Institute, which funded potassium measurements, as well as contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. Dr. Chatterjee was supported by the NIH/Duke CTSA KL2TR001115-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 1999, J WOMEN HEALTH GEN-B, V8, P805, DOI 10.1089/152460999319129; Bingham SA, 1997, AM J CLIN NUTR, V65, P1130; Chatterjee R, 2012, DIABETOLOGIA, V55, P1295, DOI 10.1007/s00125-012-2487-3; Chatterjee R, 2015, J GERONTOL A-BIOL, V70, P255, DOI 10.1093/gerona/glu071; Chatterjee R, 2011, AM J CLIN NUTR, V93, P1087, DOI 10.3945/ajcn.110.007286; Chatterjee R, 2010, ARCH INTERN MED, V170, P1745, DOI 10.1001/archinternmed.2010.362; Cogswell ME, 2012, AM J CLIN NUTR, V96, P647, DOI 10.3945/ajcn.112.034413; Heianza Y, 2011, DIABETOLOGIA, V54, P762, DOI 10.1007/s00125-010-2029-9; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Lacher David A, 2010, Natl Health Stat Report, P1; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055106; Meisinger C, 2013, DIABETOLOGIA, V56, P484, DOI 10.1007/s00125-012-2786-8; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Nettleton JA, 2009, BRIT J NUTR, V102, P1220, DOI 10.1017/S0007114509382161; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Panel on Dietary Reference Intakes for Electrolytes and Water, 2004, POT DIET REF INT WAT, P186; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Sebastian-Gambaro MA, 1997, EUR J CLIN CHEM CLIN, V35, P845; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Tasevska N, 2006, J NUTR, V136, P1334, DOI 10.1093/jn/136.5.1334; Team RC, 2015, R LANG ENV STAT COMP	22	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157252	10.1371/journal.pone.0157252	http://dx.doi.org/10.1371/journal.pone.0157252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280455	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000115
J	Choi, SKY; Boyle, E; Cairney, J; Gardner, S; Collins, EJ; Bacon, J; Rourke, SB				Choi, Stephanie K. Y.; Boyle, Eleanor; Cairney, John; Gardner, Sandra; Collins, Evan J.; Bacon, Jean; Rourke, Sean B.		OHTN Cohort Study Grp	Adequacy of Mental Health Services for HIV-Positive Patients with Depression: Ontario HIV Treatment Network Cohort Study	PLOS ONE			English	Article							CANMAT CLINICAL GUIDELINES; ANTIRETROVIRAL THERAPY; CANADIAN NETWORK; RISK BEHAVIOR; CARE; MANAGEMENT; DISORDERS; ACCESS; ADULTS; MOOD	Background Major depression can profoundly impact clinical and quality-of-life outcomes of people living with HIV, and this disease is underdiagnosed and undertreated in many HIV-positive individuals. Here, we describe the prevalence of publicly funded primary and secondary mental health service use and antidepressant use, as well as mental health care for depression in accordance with existing Canadian guidelines for HIV-positive patients with depression in Ontario, Canada. Methods We conducted a prospective cohort study linking data from the Ontario HIV Treatment Network Cohort Study with administrative health databases in the province of Ontario, Canada. Current depression was assessed using the Center for Epidemiologic Depression Scale or the Kessler Psychological Distress Scale. Multivariable regressions were used to characterize prevalence outcomes. Results Of 990 HIV-positive patients with depression, 493 (50%) patients used mental health services; 182 (18%) used primary services (general practitioners); 176 (18%) used secondary services (psychiatrists); and 135 (14%) used both. Antidepressants were used by 407 (39%) patients. Patients who identified as gay, lesbian, or bisexual, as having low income or educational attainment, or as non-native English speakers or immigrants to Canada were less likely to obtain care. Of 493 patients using mental health services, 250 (51%) received mental health care for depression in accordance with existing Canadian guidelines. Conclusions Our results showed gaps in delivering publicly funded mental health services to depressed HIV-positive patients and identified unequal access to these services, particularly among vulnerable groups. More effective mental health policies and better access to mental health services are required to address HIV-positive patient needs and reduce depression's impact on their lives.	[Choi, Stephanie K. Y.; Bacon, Jean; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Choi, Stephanie K. Y.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Boyle, Eleanor] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Boyle, Eleanor; Cairney, John; Gardner, Sandra] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cairney, John] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cairney, John] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cairney, John] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Collins, Evan J.] Univ Hlth Network, Toronto, ON, Canada; [Collins, Evan J.; Rourke, Sean B.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Rourke, Sean B.] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Gardner, Sandra] Baycrest Hlth Sci, Toronto, ON, Canada	University of Toronto; University of Southern Denmark; University of Toronto; McMaster University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Rourke, SB (corresponding author), Ontario HIV Treatment Network, Toronto, ON, Canada.; Rourke, SB (corresponding author), Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada.; Rourke, SB (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	sean.rourke@utoronto.ca	Cairney, John/AAQ-9703-2020; Boyle, Eleanor/G-4567-2016; Evans, Gerald/J-9229-2019	Cairney, John/0000-0003-2856-3967; Boyle, Eleanor/0000-0002-9012-9128; Evans, Gerald/0000-0003-2557-0897; Choi, Stephanie Ka Yee/0000-0003-3019-5729	Ontario HIV Treatment Network (OHTN); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Ontario HIV Treatment Network (OHTN); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the Ontario HIV Treatment Network (OHTN) and the Institute for Clinical Evaluative Sciences, which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings, opinions and conclusions are those of the authors and no endorsement of these by the OHTN, ICES, CIHI, or the MOHLTC is intended or should be inferred.	Albuquerque GA, 2016, BMC INT HEALTH HUM R, V16, DOI 10.1186/s12914-015-0072-9; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2013, STAT SOFTW; Asch SM, 2003, J GEN INTERN MED, V18, P450, DOI 10.1046/j.1525-1497.2003.20938.x; Barua B, 2015, WAITING YOUR TURN; Bess KD, 2013, AIDS PATIENT CARE ST, V27, P171, DOI 10.1089/apc.2012.0406; Bhui K, 2012, CULTURE MENTAL HLTH; Blashill AJ, 2012, AIDS BEHAV, V16, P2251, DOI 10.1007/s10461-011-0056-2; Bousman CA, 2009, J AFFECT DISORDERS, V119, P84, DOI 10.1016/j.jad.2009.04.006; Bradley MV, 2008, PSYCHOSOM MED, V70, P186, DOI 10.1097/PSY.0b013e3181642a1c; Brien S., 2015, TAKING STOCK REPORT; Burnam MA, 2001, ARCH GEN PSYCHIAT, V58, P729, DOI 10.1001/archpsyc.58.8.729; [Canadian Psychiatric Association Canadian Network for Mood and Anxiety Treatments (CANMAT)], 2001, CAN J PSYCHIAT S1, V46, p5S; Choi SKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142706; Cook JA, 2014, AIDS BEHAV, V18, P1094, DOI 10.1007/s10461-013-0679-6; Duhoux A, 2009, SOC PSYCH PSYCH EPID, V44, P385, DOI 10.1007/s00127-008-0444-8; Durbin A, 2012, COMMUNITY MENT HLT J, V48, P662, DOI 10.1007/s10597-011-9469-7; Fleury MJ, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-19; Giacco D, 2014, CURR OPIN PSYCHIATR, V27, P282, DOI 10.1097/YCO.0000000000000065; Goldner EM, 2011, CAN J PSYCHIAT, V56, P474, DOI 10.1177/070674371105600805; Harrell FE, 2001, REGRESSION MODELING; Himelhoch S, 2009, GEN HOSP PSYCHIAT, V31, P538, DOI 10.1016/j.genhosppsych.2009.05.009; Iron K, 2008, LIVING DYING ONTARIO; Jacobs P, 2008, CAN J PSYCHIAT, V53, P306; Katz MH, 1996, AIDS CARE, V8, P433, DOI 10.1080/09540129650125623; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McIntyre J., 2012, CANADIAN J COMMUNITY, V30, P173, DOI [10.7870/cjcmh-2011-0023, DOI 10.7870/CJCMH-2011-0023]; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; Mental Health Commission of Canada, 2012, CHANG DIR; Mood Disorders Society of Canada, 2015, 2015 MENT HLTH CAR S; Patten SB, 2009, J AFFECT DISORDERS, V117, pS5, DOI 10.1016/j.jad.2009.06.044; Ramasubbu R, 2012, ANN CLIN PSYCHIATRY, V24, P82; Reif S, 2006, AIDS CARE, V18, pS10, DOI 10.1080/09540120600838738; Ross LE., 2015, CAN J COMMUNITY MENT, V34, P31, DOI [10.7870/cjcmh-2014-037, DOI 10.7870/CJCMH-2014-037]; Ross LE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0353-3; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Saha S, 2011, PATIENT EDUC COUNS, V85, pE278, DOI 10.1016/j.pec.2011.01.012; Schuster R, 2012, BEHAV MODIF, V36, P123, DOI 10.1177/0145445511425231; Springer SA, 2012, AIDS BEHAV, V16, P2119, DOI 10.1007/s10461-012-0212-3; Standing Senate Committee on Social Affairs Science and Technology, 2006, OUT SHAD LAST TRANSF; Steele LS, 2006, PSYCHIAT SERV, V57, P317, DOI 10.1176/appi.ps.57.3.317; Steele LS, 2004, MED CARE, V42, P960, DOI 10.1097/00005650-200410000-00004; Thomson MS, 2015, J IMMIGR MINOR HEALT, V17, P1895, DOI 10.1007/s10903-015-0175-3; Tyndall Mark W, 2006, Harm Reduct J, V3, P36, DOI 10.1186/1477-7517-3-36; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Vitiello B, 2003, AM J PSYCHIAT, V160, P547, DOI 10.1176/appi.ajp.160.3.547; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wang JL, 2005, CAN J PSYCHIAT, V50, P652, DOI 10.1177/070674370505001012; Weaver MR, 2008, JAIDS-J ACQ IMM DEF, V47, P449, DOI 10.1097/QAI.0b013e3181642244; Zuniga JA, 2016, AIDS PATIENT CARE ST, V30, P34, DOI 10.1089/apc.2015.0214	52	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156652	10.1371/journal.pone.0156652	http://dx.doi.org/10.1371/journal.pone.0156652			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280751	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000038
J	Lin, SYC; Toyoda, H; Kumada, T; Liu, HF				Lin, Serena Y. C.; Toyoda, Hidenori; Kumada, Takashi; Liu, Hsin-Fu			Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CORE GENE; HEPATOCELLULAR-CARCINOMA; GEOGRAPHIC-DISTRIBUTION; POPULATION-DYNAMICS; SELECTION PRESSURE; HBV INFECTION; GENOTYPE-B; INFERENCE; STRAINS	Hepatitis B virus (HBV) is prevalent worldwide and causes liver diseases, including acute and chronic hepatitis. Ten HBV genotypes (A-J) with distinct geographic distributions have been reported. Cases of acute HBV infection with genotype A have increased in Japan nationwide since the 1990s, mainly through sexual transmission. To investigate the molecular evolution and phylodynamics of HBV genotypes, we collected acute HBV isolates acquired in Japan from 1992-2002. Full genomes were obtained for comprehensive phylogenetic and phylodynamic analysis, with other Japanese HBV sequences from GenBank that were isolated during 1991-2010. HBV genotypes were classified using the maximum-likelihood and Bayesian methods. The GMRF Bayesian Skyride was used to estimate the evolution and population dynamics of HBV. Four HBV genotypes (A, B, C, and H) were identified, of which C was the major genotype. The phylodynamic results indicated an exponential growth between the 1960s and early 1990s; this was followed by a population bottleneck after 1995, possibly linked with successful implementation of a nationwide vaccination program. However, HBV/A increased from 1990 to 2003-2004, and then started to decrease. The prevalence of genotype A has increased over the past 10 years. Phylodynamic inference clearly demonstrates a steady population growth compatible with an ongoing subepidemic; this might be due to the loss of immunity to HBV in adolescents and people being born before the vaccination program. This is the first phylodynamic study of HBV infection in Japan and will facilitate understanding the molecular epidemiology and long-term evolutionary dynamics of this virus in Japan.	[Lin, Serena Y. C.; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Lin, Serena Y. C.; Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Gifu, Japan; [Liu, Hsin-Fu] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan	National Taiwan Ocean University; Mackay Memorial Hospital; Ogaki Municipal Hospital; National Taipei University of Nursing & Health Science (NTUNHS)	Liu, HF (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.; Liu, HF (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.; Liu, HF (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan.	hsinfu@mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269	Ministry of Science and Technology, Taiwan [NSC 102-2314-B-195-013-MY2]; Mackay Memorial Hospital, Taiwan [MMH-103-19]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital, Taiwan	This study was supported in part by the Ministry of Science and Technology, Taiwan (grant NSC 102-2314-B-195-013-MY2) and the Mackay Memorial Hospital, Taiwan (grant MMH-103-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WGH, 2012, ANTIVIR RES, V96, P148, DOI 10.1016/j.antiviral.2012.08.007; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Chan HLY, 2011, J GASTROEN HEPATOL, V26, P8, DOI 10.1111/j.1440-1746.2010.06514.x; Chan HLY, 2009, CLIN GASTROENTEROL H, V7, P1361, DOI 10.1016/j.cgh.2009.08.004; Chan HLY, 2003, J CLIN MICROBIOL, V41, P1277, DOI 10.1128/JCM.41.3.1277-1279.2003; Chang MH, 2010, ANTIVIR THER, V15, P463, DOI 10.3851/IMP1555; Chen HL, 2012, GASTROENTEROLOGY, V142, P773, DOI 10.1053/j.gastro.2011.12.035; Chen SJ, 2012, VIRUS RES, V163, P197, DOI 10.1016/j.virusres.2011.09.029; Cho Ji-Hyun, 2009, Korean J Hepatol, V15, P140, DOI 10.3350/kjhep.2009.15.2.140; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-226; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; GUNTHER S, 1995, J VIROL, V69, P5437; Hayashi K, 2007, J MED VIROL, V79, P366, DOI 10.1002/jmv.20824; Kao JH, 2002, J CLIN MICROBIOL, V40, P1207, DOI 10.1128/JCM.40.4.1207-1209.2002; Kao JH, 2002, J CLIN MICROBIOL, V40, P22, DOI 10.1128/JCM.40.1.22-25.2002; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Kiyohara T, 2015, VACCINE, V33, P6037, DOI 10.1016/j.vaccine.2015.08.034; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Lee CM, 2003, SCAND J GASTROENTERO, V38, P95, DOI 10.1080/00365520310000500; Li YR, 2008, J MED VIROL, V80, P1885, DOI 10.1002/jmv.21301; Liu HF, 2001, J PEDIATR GASTR NUTR, V32, P274, DOI 10.1097/00005176-200103000-00008; Liu Y, 2010, J CLIN VIROL, V47, P243, DOI 10.1016/j.jcv.2009.12.013; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; McMahon BJ, 2009, J INFECT DIS, V200, P1390, DOI 10.1086/606119; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Orito E, 2001, HEPATOLOGY, V34, P590, DOI 10.1053/jhep.2001.27221; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Salemi M, 1999, P NATL ACAD SCI USA, V96, P13253, DOI 10.1073/pnas.96.23.13253; Schaefer S, 2005, J VIRAL HEPATITIS, V12, P111, DOI 10.1111/j.1365-2893.2005.00584.x; Szu-Ming C, 2011, J CLIN VIROL, V52, P11, DOI 10.1016/j.jcv.2011.06.012; Takeda Y, 2006, INFECTION, V34, P201, DOI 10.1007/s15010-006-5099-3; Tamada Y, 2012, GUT, V61, P765, DOI 10.1136/gutjnl-2011-300832; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; van de Klundert MAA, 2012, J VIRAL HEPATITIS, V19, pE34, DOI 10.1111/j.1365-2893.2011.01506.x; Warner BG, 2011, J GEN VIROL, V92, P1800, DOI 10.1099/vir.0.030478-0; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Wu TW, 2013, HEPATOLOGY, V57, P38, DOI 10.1002/hep.25988; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	48	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157103	10.1371/journal.pone.0157103	http://dx.doi.org/10.1371/journal.pone.0157103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280441	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000085
J	Mergenthal, K; Beyer, M; Gerlach, FM; Guethlin, C				Mergenthal, Karola; Beyer, Martin; Gerlach, Ferdinand M.; Guethlin, Corina			Sharing Responsibilities within the General Practice Team - A Cross-Sectional Study of Task Delegation in Germany	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE ASSISTANTS; PHYSICIAN ASSISTANTS; CASE-MANAGEMENT; NURSE-PRACTITIONERS; MEDICAL ASSISTANTS; FAMILY PHYSICIANS; SKILL-MIX; DEPRESSION; WORKFORCE	Background Expected growth in the demand for health services has generated interest in the more effective deployment of health care assistants. Programs encouraging German general practitioners (GPs) to share responsibility for care with specially qualified health care assistants in the family practice (VERAHs) have existed for several years. But no studies have been conducted on the tasks German GPs are willing to rely on specially qualified personnel to perform, what they are prepared to delegate to all non-physician practice staff and what they prefer to do themselves. Methods As part of an evaluation study on the deployment of VERAHs in GP-centered health care, we used a questionnaire to ask about task delegation within the practice team. From a list of tasks that VERAHs are specifically trained to carry out, GPs were asked to indicate which they actually delegate. We also asked GPs why they had employed a VERAH in their practice and for their opinions on the benefits and limitations of assigning tasks to VERAHs. The aim of the study was to find out which tasks GPs delegate to their specially qualified personnel, which they permit all HCAs to carry out, and which tasks they do not delegate at all. Results The survey was filled in and returned by 245 GPs (83%). Some tasks were exclusively delegated to VERAHs (e.g. home visits), while others were delegated to all HCAs (e.g. vaccinations). About half the GPs rated the assessment of mental health, as part of the comprehensive assessment of a patient's condition, as the sole responsibility of a GP. The possibility to delegate more complex tasks was the main reason given for employing a VERAH. Doctors said the delegation of home visits provided them with the greatest relief. Conclusions In Germany, where GPs are solely accountable for the health care provided in their practices, experience with the transfer of responsibility to other non-physician health care personnel is still very limited. When HCAs have undergone special training, GPs seem to be prepared to delegate tasks that demand a substantial degree of know-how, such as home visits and case management. This "new" role allocation within the practice may signal a shift in the provision of health care by family practice teams in Germany.	[Mergenthal, Karola; Beyer, Martin; Gerlach, Ferdinand M.; Guethlin, Corina] Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Mergenthal, K (corresponding author), Goethe Univ Frankfurt, Inst Gen Practice, D-60054 Frankfurt, Germany.	mergenthal@allgemeinmedizin.uni-frankfurt.de	Güthlin, Corina/AAP-2322-2020	Güthlin, Corina/0000-0001-8490-467X	AOK Baden Wuerttemberg; Hausaerztliche Vertragsgemeinschaft Baden-Wuerttemberg	AOK Baden Wuerttemberg; Hausaerztliche Vertragsgemeinschaft Baden-Wuerttemberg	The trial was funded by the AOK Baden Wuerttemberg and the Hausaerztliche Vertragsgemeinschaft Baden-Wuerttemberg. The analysis was carried out completely independently. The sponsor had no influence in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2009, AUST FAM PHYSICIAN, V38, P623; Australien Nursing Federation, 2016, ANF COMP STAND REG E; Aylin P, 1996, BRIT MED J, V313, P207, DOI 10.1136/bmj.313.7051.207; Bodenheimer T, 2014, JAMA INTERN MED, V174, P1025, DOI 10.1001/jamainternmed.2014.1319; Bosley S, 2008, BRIT J GEN PRACT, V58, P118, DOI 10.3399/bjgp08X277032; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; Dill MJ, 2013, HEALTH AFFAIR, V32, P1135, DOI 10.1377/hlthaff.2012.1150; Donald Faith, 2010, Nurs Leadersh (Tor Ont), V23 Spec No 2010, P88; Freund T, 2015, INT J NURS STUD, V52, P727, DOI 10.1016/j.ijnurstu.2014.11.014; Freund T, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-163; Gensichen J, 2012, PATIENT EDUC COUNS, V86, P114, DOI 10.1016/j.pec.2011.02.020; Gensichen J, 2009, ANN FAM MED, V7, P513, DOI 10.1370/afm.1037; Gensichen J, 2009, ANN INTERN MED, V151, P369, DOI 10.7326/0003-4819-151-6-200909150-00001; Halter M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-223; Hooker RS, 2011, PUBLIC HEALTH REP, V126, P708, DOI 10.1177/003335491112600513; KEENAN JM, 1992, ARCH INTERN MED, V152, P2025, DOI 10.1001/archinte.152.10.2025; Lizarondo L, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0572-7; Mergenthal K, 2013, Z EVIDENZ FORTBILD Q, V107, P386, DOI 10.1016/j.zefq.2013.07.003; Peters-Klimm F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-56; Peterson LE, 2013, J AM BOARD FAM MED, V26, P244, DOI 10.3122/jabfm.2013.03.120312; Ritchie C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148096; Rosemann Thomas, 2006, BMC Fam Pract, V7, P14, DOI 10.1186/1471-2296-7-14; Rosemann T, 2007, ARTHRIT RHEUM-ARTHR, V57, P1390, DOI 10.1002/art.23080; Ruggiero L, 2014, WESTERN J NURS RES, V36, P1052, DOI 10.1177/0193945914522862; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Taylor MT, 2013, CAN FAM PHYSICIAN, V59, pE507; Theile G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-24; Wen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100603	28	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157248	10.1371/journal.pone.0157248	http://dx.doi.org/10.1371/journal.pone.0157248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280415	Green Published, gold, Green Submitted			2022-12-27	WOS:000377563000114
J	Merten, S; Ntalasha, H; Musheke, M				Merten, Sonja; Ntalasha, Harriet; Musheke, Maurice			Non-Uptake of HIV Testing in Children at Risk in Two Urban and Rural Settings in Zambia: A Mixed-Methods Study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION PROGRAM; INFECTED CHILDREN; PREGNANT-WOMEN; PMTCT PROGRAMS; AIDS STIGMA; FOLLOW-UP; BARRIERS; PREVENTION; HEALTH	This article investigates reasons why children who were considered at risk of HIV were not taken for HIV testing by their caregivers. Qualitative and quantitative data collected in Zambia from 2010-11 revealed that twelve percent of caregivers who stated that they had been suspecting an HIV infection in a child in their custody had not had the child tested. Fears of negative reactions from the family were the most often stated reason for not testing a child. Experience of pre-existing conflicts between the couple or within the family (aOR 1.35, 95% CI 1.00-1.82) and observed stigmatisation of seropositive children in one's own neighbourhood (aOR 1.69, 95% CI 1.20-2.39) showed significant associations for not testing a child perceived at risk of HIV. Although services for HIV testing and treatment of children have been made available through national policies and programmes, some women and children were denied access leading to delayed diagnosis and treatment-not on the side of the health system, but on the household level. Social norms, such as assigning the male household head the power to decide over the use of healthcare services by his wife and children, jeopardize women's bargaining power to claim their rights to healthcare, especially in a conflict-affected relationship. Social norms and customary and statutory regulations that disadvantage women and their children must be addressed at every level-including the community and household-in order to effectively decrease barriers to HIV related care.	[Merten, Sonja] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57, CH-4002 Basel, Switzerland; [Merten, Sonja] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland; [Ntalasha, Harriet] Univ Zambia, Dept Populat Studies, Great East Rd Campus, Lusaka, Zambia; [Musheke, Maurice] Mwaleshi Rd,Olympia Pk, Lusaka, Zambia	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zambia	Merten, S (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57, CH-4002 Basel, Switzerland.; Merten, S (corresponding author), Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland.	sonja.merten@unibas.ch		Merten, Sonja/0000-0003-4115-106X	Swiss National Science Foundation [PMPDP3-123072]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded through a Research grant from the Swiss National Science Foundation, PMPDP3-123072.	Ahmed S, 2013, AIDS, V27, pS235, DOI 10.1097/QAD.0000000000000099; Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Babalola S, 2007, AIDS BEHAV, V11, P759, DOI 10.1007/s10461-006-9189-0; Berendes S, 2011, J ASSOC NURSE AIDS C, V22, P215, DOI 10.1016/j.jana.2010.08.005; Boender TS, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/817506; Brinda EM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1449-3; Buzdugan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053213; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; Daniel O J, 2006, J Obstet Gynaecol, V26, P191, DOI 10.1080/01443610500508196; Davies MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081037; Donahue MC, 2012, AIDS CARE, V24, P1233, DOI 10.1080/09540121.2012.656570; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; EPSTEIN J, 1992, AM IMAGO, V49, P293; Gari S, 2014, AIDS CARE, V26, P1258, DOI 10.1080/09540121.2014.897911; Gari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071922; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hardon A, 2013, SAHARA J-J SOC ASP H, V10, pS1, DOI 10.1080/02664763.2012.755317; Katowa N, 2013, EVALUATION SANCTITY; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kimani-Murage EW, 2013, AIDS CARE, V25, P744, DOI 10.1080/09540121.2012.748865; Kohler PK, 2014, AIDS PATIENT CARE ST, V28, P643, DOI 10.1089/apc.2014.0171; Koku EF, 2011, J COMMUN HEALTH, V36, P289, DOI 10.1007/s10900-010-9310-1; Kranzer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001649; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; McPake B, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-46; Meiberg Annemarie E, 2008, East Afr J Public Health, V5, P49; Meier BM, 2014, PUBLIC HEALTH, V128, P179, DOI 10.1016/j.puhe.2013.08.012; Ministry of Finance, 2014, REV 6 NAT DEV PLAN; Ministry of Health and Community Development Mother and Child Health, 2013, ZAMB CONS GUID TREAT; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Moyer E, 2012, CULT HEALTH SEX, V14, pS67, DOI 10.1080/13691058.2012.662524; Musheke M, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-12; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Mutanga JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029656; Namukwaya Z, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1213-5; National AIDS Council, 2015, ZAMB COUNTR REP MON; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Niehaus I, 2007, J S AFR STUD, V33, P845, DOI 10.1080/03057070701646944; Njunga J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-14; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Onono M., 2015, J AIDS CLIN RES, V6; Parker L, 2014, CULT HEALTH SEX, V16, P792, DOI 10.1080/13691058.2014.905707; Peltzer K, 2010, ACTA PAEDIATR, V99, P590, DOI 10.1111/j.1651-2227.2009.01670.x; Porter M, 2015, JAIDS-J ACQ IMM DEF, V69, P593, DOI 10.1097/QAI.0000000000000683; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Sambisa W, 2010, AIDS CARE, V22, P170, DOI 10.1080/09540120903038374; Schumaker LL, 2008, SOC SCI MED, V67, P2126, DOI 10.1016/j.socscimed.2008.09.006; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087028; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walcott MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1115; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; World Health Organization, 2022, GLOB HLTH OBS; Yeap AD, 2010, AIDS CARE, V22, P1101, DOI 10.1080/09540121003602218; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7	68	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155510	10.1371/journal.pone.0155510	http://dx.doi.org/10.1371/journal.pone.0155510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280282	Green Published, gold, Green Accepted			2022-12-27	WOS:000377563000003
J	Rangel, J; Boroczky, K; Schal, C; Tarpy, DR				Rangel, Juliana; Boroczky, Katalin; Schal, Coby; Tarpy, David R.			Honey Bee (Apis mellifera) Queen Reproductive Potential Affects Queen Mandibular Gland Pheromone Composition and Worker Retinue Response	PLOS ONE			English	Article							MASS-SPECTRAL FRAGMENTATION; EFFECTIVE PATERNITY; HYMENOPTERA; SECRETION; BEHAVIOR; AGE; COMMUNICATION; SUPPRESSION; MODULATION; COMPONENTS	Reproductive division of labor is one of the defining traits of honey bees (Apis mellifera), with non-reproductive tasks being performed by workers while a single queen normally monopolizes reproduction. The decentralized organization of a honey bee colony is maintained in large part by a bouquet of queen-produced pheromones, the distribution of which is facilitated by contact among workers throughout the hive. Previous studies have shown that the developmental fate of honey bee queens is highly plastic, with queens raised from younger worker larvae exhibiting higher measures of reproductive potential compared to queens raised from older worker larvae. We investigated differences in the chemical composition of the mandibular glands and attractiveness to workers of "high-quality" queens (i.e., raised from first instar worker larvae; more queen-like) and "low-quality" queens (i.e., raised from third instar worker larvae; more worker-like). We characterized the chemical profiles of the mandibular glands of high-quality queens and low-quality queens using GCMS and used the worker retinue response as a measure of the attractiveness to workers of high-quality queens vs. low-quality queens. We found that queen quality affected the chemical profiles of mandibular gland contents differently across years, showing significant differences in the production of the queen mandibular pheromone ("QMP") components HVA and 9-HDA in 2010, but no significant differences of any glandular compound in 2012. We also found that workers were significantly more attracted to high-quality queens than to low-quality queens in 2012, possibly because of increased attractiveness of their mandibular gland chemical profiles. Our results indicate that the age at which honey bee larvae enter the "queen-specific" developmental pathway influences the chemical composition of queen mandibular glands and worker behavior. However, these changes are not consistent across years, suggesting that other external factors may play important roles in modulating queen quality.	[Rangel, Juliana; Boroczky, Katalin; Schal, Coby; Tarpy, David R.] N Carolina State Univ, Dept Entomol, Campus Box 7613, Raleigh, NC 27695 USA; [Rangel, Juliana; Boroczky, Katalin; Schal, Coby; Tarpy, David R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Campus Box 7613, Raleigh, NC 27695 USA; Texas A&M Univ, Dept Entomol, 2475 TAMU, College Stn, TX 77843 USA; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Cornell University; Cornell University	Rangel, J (corresponding author), N Carolina State Univ, Dept Entomol, Campus Box 7613, Raleigh, NC 27695 USA.; Rangel, J (corresponding author), N Carolina State Univ, WM Keck Ctr Behav Biol, Campus Box 7613, Raleigh, NC 27695 USA.	jrangel@tamu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Tarpy, David/0000-0001-8601-6094	US National Science Foundation Postdoctoral Research Fellowship in Biology [1002465]; NC Department of Agriculture & Consumer Services; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2007-02281]	US National Science Foundation Postdoctoral Research Fellowship in Biology; NC Department of Agriculture & Consumer Services; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	Funding was provided to JR by the US National Science Foundation Postdoctoral Research Fellowship in Biology (Award number 1002465) and to DRT by the NC Department of Agriculture & Consumer Services and grant number 2007-02281 from the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN M. DELIA, 1957, BRIT JOUR ANIMAL BEHAVIOUR, V5, P81, DOI 10.1016/S0950-5601(57)80001-X; [Anonymous], 1971, INSECT SOC; Apsegaite V., 1999, Pheromones, V6, P27; Babis M, 2014, INSECT SOC, V61, P337, DOI 10.1007/s00040-014-0358-2; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Butler C.G., 1973, Journal apic Res, V12, P159; Butler C. G., 1963, Journal of Apicultural Research London, V2, P14; Crozier R.H., 1996, EVOLUTION SOCIAL INS; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Dedej S, 1998, J APICULT RES, V37, P183, DOI 10.1080/00218839.1998.11100970; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Engels W, 1997, J INSECT PHYSIOL, V43, P307, DOI 10.1016/S0022-1910(96)00110-2; FELL RD, 1984, INSECT SOC, V31, P221, DOI 10.1007/BF02223608; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; Hatch S, 1999, INSECT SOC, V46, P372, DOI 10.1007/s000400050159; HIGO HA, 1992, CAN ENTOMOL, V124, P409, DOI 10.4039/Ent124409-2; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Johnson JN, 2010, J INSECT PHYSIOL, V56, P761, DOI 10.1016/j.jinsphys.2010.01.004; KAMINSKI LA, 1990, J CHEM ECOL, V16, P841, DOI 10.1007/BF01016494; Katzav-Gozansky T, 2004, P ROY SOC B-BIOL SCI, V271, P2065, DOI 10.1098/rspb.2004.2839; Katzav-Gozansky T, 2001, BEHAV ECOL SOCIOBIOL, V51, P76, DOI 10.1007/s002650100406; Katzav-Gozansky T, 2007, NATURWISSENSCHAFTEN, V94, P407, DOI 10.1007/s00114-006-0206-y; Katzav-Gozansky T, 2006, J COMP PHYSIOL A, V192, P737, DOI 10.1007/s00359-006-0110-0; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; Keeling CI, 2001, APIDOLOGIE, V32, P243, DOI 10.1051/apido:2001126; Kocher SD, 2011, J CHEM ECOL, V37, P1263, DOI 10.1007/s10886-011-0036-z; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kraus FB, 2005, INSECT SOC, V52, P1, DOI 10.1007/s00040-004-0766-9; Laidlaw HH., 1997, QUEEN REARING BEE BR; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Maisonnasse A, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-18; Melathopoulos AP, 1996, CAN ENTOMOL, V128, P263, DOI 10.4039/Ent128263-2; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Moritz RFA, 2000, NATURWISSENSCHAFTEN, V87, P395, DOI 10.1007/s001140050748; Moritz RFA, 2004, P ROY SOC B-BIOL SCI, V271, pS98, DOI 10.1098/rsbl.2003.0113; Nino EL, 2012, J INSECT PHYSIOL, V58, P1082, DOI 10.1016/j.jinsphys.2012.04.015; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; PANKIW T, 1995, INSECT SOC, V42, P371, DOI 10.1007/BF01242165; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; Pankiw T, 1996, J CHEM ECOL, V22, P605, DOI 10.1007/BF02033573; PETTIS JS, 1995, INSECT SOC, V42, P113, DOI 10.1007/BF01242447; PETTIS JS, 1995, ANN ENTOMOL SOC AM, V88, P580, DOI 10.1093/aesa/88.4.580; Pettis JS, 1997, INSECT SOC, V44, P311, DOI 10.1007/s000400050053; Pirk C.W.W., 2011, PHEROMONES, P207; Plettner E, 1997, J CHEM ECOL, V23, P363, DOI 10.1023/B:JOEC.0000006365.20996.a2; Rangel J, 2013, INSECT SOC, V60, P65, DOI 10.1007/s00040-012-0267-1; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Rontani JF, 2008, J AM SOC MASS SPECTR, V19, P66, DOI 10.1016/j.jasms.2007.10.014; Rontani JF, 2004, RAPID COMMUN MASS SP, V18, P1889, DOI 10.1002/rcm.1567; Schafer MO, 2006, J COMP PHYSIOL A, V192, P761, DOI 10.1007/s00359-006-0112-y; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1979, BEHAV ECOL SOCIOBIOL, V5, P391, DOI 10.1007/BF00292527; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; SLESSOR KN, 1990, J CHEM ECOL, V16, P851, DOI 10.1007/BF01016495; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Strauss K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1523, DOI 10.1007/s00265-008-0581-9; Tarpy DR, 2011, INSECT SOC, V58, P569, DOI 10.1007/s00040-011-0180-z; Tarpy DR, 2009, ETHOL ECOL EVOL, V21, P147, DOI 10.1080/08927014.2009.9522503; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2000, ANIM BEHAV, V59, P97, DOI 10.1006/anbe.1999.1311; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; VELTHUIS HH, 1970, Z VERGL PHYSIOL, V70, P210, DOI 10.1007/BF00297717; Villar G, 2015, J COMP PHYSIOL A, V201, P731, DOI 10.1007/s00359-015-1006-7; Winston M.L., 1991, BIOL HONEY BEE; WINSTON ML, 1989, INSECT SOC, V36, P15, DOI 10.1007/BF02225877; Wossler TC, 1999, J INSECT BEHAV, V12, P343, DOI 10.1023/A:1020839505622; Woyke J., 1971, J Apic Res, V10, P45; Yusuf AA, 2015, APIDOLOGIE, V46, P559, DOI 10.1007/s13592-014-0346-6	73	15	15	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156027	10.1371/journal.pone.0156027	http://dx.doi.org/10.1371/journal.pone.0156027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281328	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000012
J	Zhang, FH; Peng, B; Chang, HY; Zhang, R; Lu, FG; Wang, FY; Fang, F; Chen, Z				Zhang, Fenghua; Peng, Bo; Chang, Haiyan; Zhang, Ran; Lu, Fangguo; Wang, Fuyan; Fang, Fang; Chen, Ze			Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; T-CELL RESPONSES; AVIAN INFLUENZA; IMMUNE-RESPONSE; CROSS-PROTECTION; VACCINE; LIVE; DNA; HEMAGGLUTININ; INDUCTION	Maternally-derived antibodies (MDAs) can protect offspring against influenza virus infection but may also inhibit active immune responses. To overcome MDA-mediated inhibition, active immunization of offspring with an inactivated H5N1 whole-virion vaccine under the influence of MDAs was explored in mice. Female mice were vaccinated twice via the intraperitoneal (IP) or intranasal (IN) route with the vaccine prior to mating. One week after birth, the offspring were immunized twice via the IP or IN route with the same vaccine and then challenged with a lethal dose of a highly homologous virus strain. The results showed that, no matter which immunization route (IP or IN) was used for mothers, the presence of MDAs severely interfered with the active immune response of the offspring when the offspring were immunized via the IP route. Only via the IN immunization route did the offspring overcome the MDA interference. These results suggest that intranasal immunization could be a suitable inoculation route for offspring to overcome MDA interference in the defense against highly pathogenic H5N1 virus infection. This study may provide references for human and animal vaccination to overcome MDA-induced inhibition.	[Zhang, Fenghua; Peng, Bo; Chang, Haiyan; Fang, Fang; Chen, Ze] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [Zhang, Ran] Hunan Normal Univ, Sch Med, Changsha, Hunan, Peoples R China; [Lu, Fangguo] Hunan Univ Chinese Med, Sch Med, Changsha, Hunan, Peoples R China; [Wang, Fuyan] Cent S Univ, Dept Immunol, Coll Basic Med Sci, Changsha, Hunan, Peoples R China; [Chen, Ze] Shanghai Inst Biol Prod, Shanghai, Peoples R China	Hunan Normal University; Hunan Normal University; Hunan University of Chinese Medicine; Central South University	Fang, F; Chen, Z (corresponding author), Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China.; Chen, Z (corresponding author), Shanghai Inst Biol Prod, Shanghai, Peoples R China.	fangfangc@263.net; chenze2005@263.net			Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]; National Natural Science Foundation of China [30972623]; Open Found of Hunan Provincial Key Laboratory for Molecular Microbiology [2014-04]; General Foundation of Hunan Provincial Science and Technology Department [2013SK3131]; Key Project of Hunan Province Program in the Field of Social Development [2015SK20331]	Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Found of Hunan Provincial Key Laboratory for Molecular Microbiology; General Foundation of Hunan Provincial Science and Technology Department; Key Project of Hunan Province Program in the Field of Social Development	This study was supported by Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (20134486), National Natural Science Foundation of China (30972623), Open Found of Hunan Provincial Key Laboratory for Molecular Microbiology (2014-04), General Foundation of Hunan Provincial Science and Technology Department(2013SK3131), and Key Project of Hunan Province Program in the Field of Social Development (2015SK20331).	Bailhache M, 2011, ARCH PEDIATRIE, V18, P383, DOI 10.1016/j.arcped.2011.01.022; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Block SL, 2008, VACCINE, V26, P4940, DOI 10.1016/j.vaccine.2008.07.013; Bonati M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-873; Chen JJ, 2009, VIRUS GENES, V38, P66, DOI 10.1007/s11262-008-0289-y; Chen JJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-118; Chen QJ, 2009, VIRUS GENES, V38, P30, DOI 10.1007/s11262-008-0305-2; Chiu SS, 2009, VACCINE, V27, P4834, DOI 10.1016/j.vaccine.2009.05.066; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Dickson M, 2011, BJOG-INT J OBSTET GY, V118, P1140, DOI 10.1111/j.1471-0528.2011.02957.x; Endsley JJ, 2003, BIOLOGICALS, V31, P123, DOI 10.1016/S1045-1056(03)00027-7; Enserink M, 2012, SCIENCE, V335, P20, DOI 10.1126/science.335.6064.20; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; HARTE PG, 1984, IMMUNOLOGY, V53, P401; Ichinohe T, 2008, EXPERT REV VACCINES, V7, P1435, DOI 10.1586/14760584.7.9.1435; Ichinohe T, 2010, J MED VIROL, V82, P128, DOI 10.1002/jmv.21670; Jensen TH, 2015, VACCINE, V33, P1375, DOI 10.1016/j.vaccine.2015.01.029; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Klipper E, 2004, VACCINE, V22, P493, DOI 10.1016/j.vaccine.2003.07.011; Kumagai T, 2004, VACCINE, V22, P3404, DOI 10.1016/j.vaccine.2004.02.030; Letson GW, 2004, J PEDIATR-US, V144, P327, DOI 10.1016/j.jpeds.2003.11.030; Lopez-Medina E, 2012, J PEDIATR-US, V160, P626, DOI 10.1016/j.jpeds.2011.09.060; Maas R, 2011, AVIAN PATHOL, V40, P87, DOI 10.1080/03079457.2010.541226; Okamoto S, 2012, CLIN VACCINE IMMUNOL, V19, P979, DOI 10.1128/CVI.00016-12; Oner AF, 2012, CLIN INFECT DIS, V55, P26, DOI 10.1093/cid/cis295; Pertmer TM, 2000, J VIROL, V74, P7787, DOI 10.1128/JVI.74.17.7787-7793.2000; Pomorska-Mol M, 2010, VET MICROBIOL, V144, P450, DOI 10.1016/j.vetmic.2010.01.015; Rauw F, 2009, VACCINE, V27, P3631, DOI 10.1016/j.vaccine.2009.03.068; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Sui ZW, 2010, VACCINE, V28, P7690, DOI 10.1016/j.vaccine.2010.09.019; Sui ZW, 2010, ARCH VIROL, V155, P535, DOI 10.1007/s00705-010-0621-4; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Tamura S, 2010, VACCINE, V28, P6393, DOI 10.1016/j.vaccine.2010.05.019; Trondsen M, 2015, SCAND J IMMUNOL, V81, P305, DOI 10.1111/sji.12288; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; VANMAANEN C, 1992, VET QUART, V14, P13, DOI 10.1080/01652176.1992.9694319; Vincent AL, 2012, J VIROL, V86, P10597, DOI 10.1128/JVI.01439-12; Wesley RD, 2006, VET MICROBIOL, V118, P67, DOI 10.1016/j.vetmic.2006.07.014; Zanetta RAC, 2001, VACCINE, V20, P226, DOI 10.1016/S0264-410X(01)00267-5; Zhang FH, 2013, ARCH VIROL, V158, P1253, DOI 10.1007/s00705-013-1621-y	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157041	10.1371/journal.pone.0157041	http://dx.doi.org/10.1371/journal.pone.0157041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280297	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000073
J	Scheetz, TE; Roos, BR; Solivan-Timpe, F; Miller, K; DeLuca, AP; Stone, EM; Kwon, YH; Alward, WLM; Wang, K; Fingert, JH				Scheetz, Todd E.; Roos, Ben R.; Solivan-Timpe, Frances; Miller, Kathy; DeLuca, Adam P.; Stone, Edwin M.; Kwon, Young H.; Alward, Wallace L. M.; Wang, Kai; Fingert, John H.			SQSTM1 Mutations and Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AMYOTROPHIC-LATERAL-SCLEROSIS; NORMAL-TENSION GLAUCOMA; OPTINEURIN SEQUENCE VARIATIONS; GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATIONS; FRONTOTEMPORAL DEMENTIA; RETINITIS-PIGMENTOSA; AUTOPHAGY; GENE	Glaucoma is the most common cause of irreversible blindness worldwide. One subset of glaucoma, normal tension glaucoma (NTG) occurs in the absence of high intraocular pressure. Mutations in two genes, optineurin (OPTN) and TANK binding kinase 1 (TBK1), cause familial NTG and have known roles in the catabolic cellular process autophagy. TKB1 encodes a kinase that phosphorylates OPTN, an autophagy receptor, which ultimately activates autophagy. The sequestosome (SQSTM1) gene also encodes an autophagy receptor and also is a target of TBK1 phosphorylation. Consequently, we hypothesized that mutations in SQSTM1 may also cause NTG. We tested this hypothesis by searching for glaucoma-causing mutations in a cohort of NTG patients (n = 308) and matched controls (n = 157) using Sanger sequencing. An additional 1098 population control samples were also analyzed using whole exome sequencing. A total of 17 non-synonymous mutations were detected which were not significantly skewed between cases and controls when analyzed separately, or as a group (p > 0.05). These data suggest that SQSTM1 mutations are not a common cause of NTG.	[Scheetz, Todd E.; Roos, Ben R.; Solivan-Timpe, Frances; Miller, Kathy; DeLuca, Adam P.; Stone, Edwin M.; Kwon, Young H.; Alward, Wallace L. M.; Fingert, John H.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Scheetz, Todd E.; Roos, Ben R.; Solivan-Timpe, Frances; Miller, Kathy; DeLuca, Adam P.; Stone, Edwin M.; Kwon, Young H.; Alward, Wallace L. M.; Wang, Kai; Fingert, John H.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Wang, Kai] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Fingert, JH (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA.; Fingert, JH (corresponding author), Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA.	john-fingert@uiowa.edu	Fingert, John/AAX-4750-2021; Fingert, John/F-8787-2012; Alward, Wallace/AAY-4149-2020; DeLuca, Adam/AAO-6291-2021	Fingert, John/0000-0002-0377-0479; Fingert, John/0000-0002-0377-0479; DeLuca, Adam/0000-0001-7798-1538; Scheetz, Todd/0000-0002-1965-5811; Alward, Wallace/0000-0001-6368-9018; Kwon, Young/0000-0002-1116-8250; Stone, Edwin M./0000-0003-3343-4414	National Eye Institute [RO1EY023512]; Research to Prevent Blindness; Marlene S. and Leonard A. Hadley Glaucoma Research Fund; NATIONAL EYE INSTITUTE [R01EY023512] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Marlene S. and Leonard A. Hadley Glaucoma Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Eye Institute RO1EY023512, Research to Prevent Blindness, and Marlene S. and Leonard A. Hadley Glaucoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; [Anonymous], 2008, AUTOPHAGY PATHOGENES, V132, P27, DOI [10.1016/j.cell.2007.12.018, DOI 10.1016/J.CELL.2007.12.018]; Awadalla MS, 2015, AM J OPHTHALMOL, V159, P124, DOI 10.1016/j.ajo.2014.09.044; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; DeLuca AP, 2016, HUM MOL GENET, V25, P44, DOI 10.1093/hmg/ddv446; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; Hirano M, 2013, NEUROLOGY, V80, P458, DOI 10.1212/WNL.0b013e31827f0fe5; Kawase K, 2012, EXP EYE RES, V96, P178, DOI 10.1016/j.exer.2011.12.021; Kwok CT, 2014, EUR J HUM GENET, V22, P492, DOI 10.1038/ejhg.2013.184; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu YT, 2014, INVEST OPHTH VIS SCI, V55, P8251, DOI 10.1167/iovs.14-15712; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nassif M, 2011, AUTOPHAGY, V7, P450, DOI 10.4161/auto.7.4.14700; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ritch R, 2014, JAMA OPHTHALMOL, V132, P544, DOI 10.1001/jamaophthalmol.2014.104; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Shimizu H, 2013, ACTA NEUROPATHOL, V126, P453, DOI 10.1007/s00401-013-1150-5; Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0; Tucker Budd A, 2014, J Stem Cell Res Ther, V3, P161; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wong YC, 2014, NATL ACAD SCI, V111, pE4439, DOI [10.1073/pnas.1405752111, DOI 10.1073/PNAS.1405752111]; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Yang Y, 2015, AMYOTROPH LAT SCL FR, V16, P378, DOI 10.3109/21678421.2015.1009466	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156001	10.1371/journal.pone.0156001	http://dx.doi.org/10.1371/journal.pone.0156001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275741	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700013
J	Dowall, SD; Graham, VA; Rayner, E; Hunter, L; Watson, R; Taylor, I; Rule, A; Carroll, MW; Hewson, R				Dowall, Stuart D.; Graham, Victoria A.; Rayner, Emma; Hunter, Laura; Watson, Robert; Taylor, Irene; Rule, Antony; Carroll, Miles W.; Hewson, Roger			Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses	PLOS ONE			English	Article							M-GENOME SEGMENT; CD8(+) T-CELLS; IMMUNE-RESPONSE; KNOCKOUT MICE; ANDES VIRUS; MOUSE MODEL; LETHAL; INTRAPERITONEAL; PATHOGENESIS; ANTIBODIES	Crimean-Congo Haemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. There is no approved vaccine currently available against CCHF. The most promising candidate, which has previously been shown to confer protection in the small animal model, is a modified Vaccinia Ankara virus vector expressing the CCHF viral glycoprotein (MVA-GP). It has been shown that MVA-GP induces both humoral and cellular immunogenicity. In the present study, sera and T-lymphocytes were passively and adoptively transferred into recipient mice prior to challenge with CCHF virus. Results demonstrated that mediators from both arms of the immune system were required to demonstrate protective effects against lethal challenge.	[Dowall, Stuart D.; Graham, Victoria A.; Rayner, Emma; Hunter, Laura; Watson, Robert; Taylor, Irene; Rule, Antony; Carroll, Miles W.; Hewson, Roger] Publ Hlth England, Salisbury, Wilts, England	Public Health England	Dowall, SD (corresponding author), Publ Hlth England, Salisbury, Wilts, England.	stuart.dowall@phe.gov.uk		Watson, Robert/0000-0003-3146-3457	Public Health England of the United Kingdom	Public Health England of the United Kingdom	This work was funded by a pipeline fund initiative from Public Health England of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Arda B, 2012, J MED ETHICS, V38, P117, DOI 10.1136/medethics-2011-100107; Ascioglu S, 2011, J ANTIMICROB CHEMOTH, V66, P1215, DOI 10.1093/jac/dkr136; Atkinson B, 2012, VECTOR-BORNE ZOONOT, V12, P786, DOI 10.1089/vbz.2011.0770; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; Bhardwaj N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000725; Buttigieg KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091516; Canakoglu N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003579; Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059; Custer DM, 2003, J VIROL, V77, P9894, DOI 10.1128/JVI.77.18.9894-9905.2003; Du XH, 2012, ONCOL REP, V28, P1743, DOI 10.3892/or.2012.2013; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Ghiasi SM, 2011, CLIN VACCINE IMMUNOL, V18, P2031, DOI 10.1128/CVI.05352-11; Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Keshtkar-Jahromi M, 2011, ANTIVIR RES, V90, P85, DOI 10.1016/j.antiviral.2011.02.010; Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48; Matheu Melanie P, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5565; MATTES MJ, 1987, J NATL CANCER I, V79, P855; Mousavi-Jazi M, 2012, VACCINE, V30, P6225, DOI 10.1016/j.vaccine.2012.08.003; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Papa A, 2011, SCAND J INFECT DIS, V43, P225, DOI 10.3109/00365548.2010.540036; Petersen CC, 2006, J IMMUNOTHER, V29, P241, DOI 10.1097/01.cji.0000203078.97493.c3; SCHMALJOHN CS, 1989, VIROLOGY, V170, P184, DOI 10.1016/0042-6822(89)90365-6; SHEPHERD AJ, 1989, REV INFECT DIS, V11, pS801; Shimizu S, 2004, LAB MOUSE, P527, DOI DOI 10.1016/B978-012336425-8/50085-6; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155	35	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156637	10.1371/journal.pone.0156637	http://dx.doi.org/10.1371/journal.pone.0156637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272940	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000025
J	Ren, H; Ferguson, K; Kirkpatrick, G; Vinning, T; Chow, V; Ma, S				Ren, He; Ferguson, Kyle; Kirkpatrick, Gordon; Vinning, Tanya; Chow, Victor; Ma, Sai			Altered Crossover Distribution and Frequency in Spermatocytes of Infertile Men with Azoospermia	PLOS ONE			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; SYNAPTONEMAL COMPLEX LENGTH; STRAND BREAK REPAIR; CHROMOSOME SYNAPSIS; UNSYNAPSED REGIONS; DNA METHYLATION; TELOMERES; MEIOSIS; PROTEIN; SPERM	During meiosis, homologous chromosomes pair to facilitate the exchange of DNA at crossover sites along the chromosomes. The frequency and distribution of crossover formation are tightly regulated to ensure the proper progression of meiosis. Using immunofluorescence techniques, our group and others have studied the meiotic proteins in spermatocytes of infertile men, showing that this population displays a reduced frequency of crossovers compared to fertile men. An insufficient number of crossovers is thought to promote chromosome missegregation, in which case the faulty cell may face meiotic arrest or contribute to the production of aneuploid sperm. Increasing evidence in model organisms has suggested that the distribution of crossovers may also be important for proper chromosome segregation. In normal males, crossovers are shown to be rare near centromeres and telomeres, while frequent in subtelomeric regions. Our study aims to characterize the crossover distribution in infertile men with non-obstructive (NOA) and obstructive azoospermia (OA) along chromosomes 13, 18 and 21. Eight of the 16 NOA men and five of the 21 OA men in our study displayed reduced crossover frequency compared to control fertile men. Seven NOA men and nine OA men showed altered crossover distributions on at least one of the chromosome arms studied compared to controls. We found that although both NOA and OA men displayed altered crossover distributions, NOA men may be at a higher risk of suffering both altered crossover frequencies and distributions compared to OA men. Our data also suggests that infertile men display an increase in crossover formation in regions where they are normally inhibited, specifically near centromeres and telomeres. Finally, we demonstrated a decrease in crossovers near subtelomeres, as well as increased average crossover distance to telomeres in infertile men. As telomere-guided mechanisms are speculated to play a role in crossover formation in subtelomeres, future studies linking crossover distribution with telomere integrity and sperm aneuploidy may provide new insight into the mechanisms underlying male infertility.	[Ren, He; Ferguson, Kyle; Kirkpatrick, Gordon; Vinning, Tanya; Chow, Victor; Ma, Sai] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Ma, S (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada.	sai@mail.ubc.ca			Canadian Institutes of Health Research, Ottawa, Canada [MOP-93801, OBM-101387]	Canadian Institutes of Health Research, Ottawa, Canada(Canadian Institutes of Health Research (CIHR))	This study is funded by the Canadian Institutes of Health Research, Ottawa, Canada, grant numbers MOP-93801 and OBM-101387 to S.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (http://www.cihr-irsc.gc.ca/e/193.html).	Barton AB, 2003, GENETICS, V165, P929; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Cherry SM, 2007, CURR BIOL, V17, P373, DOI 10.1016/j.cub.2006.12.048; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Ferfouri F, 2013, ANDROLOGY-US, V1, P815, DOI 10.1111/j.2047-2927.2013.00117.x; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Ferguson KA, 2009, HUM REPROD, V24, P1313, DOI 10.1093/humrep/dep021; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; HULTEN M, 1970, HEREDITAS-GENETISK A, V65, P285; Joseph I, 2007, CELL MOL LIFE SCI, V64, P125, DOI 10.1007/s00018-006-6464-1; Kirkpatrick G, 2008, HUM REPROD, V23, P1679, DOI 10.1093/humrep/den126; Kniewel R, 2009, EMBO J, V28, P81, DOI 10.1038/emboj.2008.277; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liu L, 2004, P NATL ACAD SCI USA, V101, P6496, DOI 10.1073/pnas.0400755101; Liu L, 2002, EMBO REP, V3, P230, DOI 10.1093/embo-reports/kvf055; Liu L, 2002, DEV BIOL, V249, P74, DOI 10.1006/dbio.2002.0735; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Ma S, 2006, HUM REPROD, V21, P980, DOI 10.1093/humrep/dei428; Mezard C, 2015, TRENDS GENET, V31, P393, DOI 10.1016/j.tig.2015.03.008; MICIC M, 1982, CLIN GENET, V22, P266; Minor A, 2011, REPRODUCTION, V141, P749, DOI 10.1530/REP-11-0008; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099560; Oliver TR, 2009, AM J MED GENET A, V149A, P1685, DOI 10.1002/ajmg.a.32942; Peoples-Holst TL, 2005, GENE DEV, V19, P863, DOI 10.1101/gad.1293605; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Reig-Viader R, 2014, FERTIL STERIL, V102, P728, DOI 10.1016/j.fertnstert.2014.06.005; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Ross LO, 1996, GENETICS, V142, P79; Ruan J, 2012, REPROD SCI, V19, P1190, DOI 10.1177/1933719112446076; Scherthan H, 2007, CELL MOL LIFE SCI, V64, P117, DOI 10.1007/s00018-006-6463-2; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Shibuya H, 2014, NAT CELL BIOL, V16, P145, DOI 10.1038/ncb2896; Su YP, 2000, CHROMOSOMA, V109, P467, DOI 10.1007/s004120000098; Sun F, 2007, CYTOGENET GENOME RES, V119, P27, DOI 10.1159/000109615; Sun F, 2005, HUM MOL GENET, V14, P3013, DOI 10.1093/hmg/ddi332; Sun F, 2007, FERTIL STERIL, V87, P565, DOI 10.1016/j.fertnstert.2006.07.1531; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Thilagavathi J, 2013, ANDROLOGIA, V45, P289, DOI 10.1111/and.12008; Treff NR, 2011, PLOS GENET, V7, DOI DOI 10.1371/JOURNAL.PGEN.1002161; Wu HY, 2006, MOL CELL BIOL, V26, P3683, DOI 10.1128/MCB.26.10.3683-3694.2006; YAMAMOTO M, 1979, GENETICS, V93, P437; Yang F, 2008, J CELL BIOL, V180, P673, DOI 10.1083/jcb.200709057; Yang F, 2015, EMBO MOL MED, V7, P1198, DOI 10.15252/emmm.201404967; Zalenskaya IA, 2002, INT REV CYTOL, V218, P37; Zhang XH, 2015, SYST BIOL REPROD MED, V61, P187, DOI 10.3109/19396368.2015.1027014; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	54	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156817	10.1371/journal.pone.0156817	http://dx.doi.org/10.1371/journal.pone.0156817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27273078	Green Submitted, Green Published, gold			2022-12-27	WOS:000377560200017
J	Amer, M; Cowan, J; Gray, A; Brockway, B; Dummer, J				Amer, Mostafa; Cowan, Jan; Gray, Andrew; Brockway, Ben; Dummer, Jack			Effect of Inhaled beta(2)-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							EOSINOPHILIC AIRWAY INFLAMMATION; LUNG-FUNCTION; EXACERBATIONS; REVERSIBILITY; SPIROMETRY; COPD; NO	The fractional exhaled nitric oxide measured at an expiratory flow of 50mL/s (FE(NO)50) is a marker of airway inflammation, and high levels are associated with greater response to steroid treatment. In asthma, FE(NO)50 increases with bronchodilation and decreases with bronchoconstriction, the latter potentially causing an underestimate of the degree of airway inflammation when asthma worsens. It is unknown whether the same effect occurs in chronic obstructive lung disease (COPD). Likewise, it is not known whether changes in airway calibre in COPD patients alter flow-independent parameters describing pulmonary nitric oxide exchange, such as the maximal flux of nitric oxide (NO) from the proximal airway compartment (J'aw(NO)) and the distal airway/alveolar concentration of NO (CA(NO)). We recruited 24 patients with COPD and performed FENO analysis at multiple expiratory flows before and after treatment with inhaled beta(2)-agonist bronchodilator therapy. For the 21 patients analysed, FE(NO)50 rose from 17.1 (1.4) ppb (geometric mean (geometric SD)) at baseline, to 19.3 (1.3) ppb after bronchodilator therapy, an increase of 2.2 ppb (95% CI, 0.7-3.6; P = 0.005). There were non-significant changes in flow-independent NO parameters. The change in FE(NO)50 correlated positively with the change in J'aw(NO) (r(s) = 0.67, P < 0.001; r(s) = 0.62, P = 0.002 before and after correction for axial back-diffusion respectively) following bronchodilation. Inhaled bronchodilator therapy can increase exhaled nitric oxide measurements in COPD. The standardisation of inhaled bronchodilator therapy before FENO analysis in COPD patients should therefore be considered in both research and clinical settings.	[Amer, Mostafa; Cowan, Jan; Brockway, Ben; Dummer, Jack] Univ Otago, Dept Med, Otago Resp Res Unit, Dunedin, New Zealand; [Gray, Andrew] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago; University of Otago	Dummer, J (corresponding author), Univ Otago, Dept Med, Otago Resp Res Unit, Dunedin, New Zealand.	jack.dummer@otago.ac.nz	Gray, Andrew Robert/L-9161-2015	Gray, Andrew Robert/0000-0003-4299-2194; Dummer, Jack/0000-0003-1581-6857; Amer, Mostafa/0000-0002-6501-7300				Alving K, 2010, EUR RESPIR MONOGR, P1, DOI 10.1183/1025448x.00028509; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnes Neil C, 2007, Prim Care Respir J, V16, P149, DOI 10.3132/pcrj.2007.00038; Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Brindicci C, 2005, EUR RESPIR J, V26, P52, DOI 10.1183/09031936.04.00125304; Cattoni I, 2013, CHEST, V143, P1269, DOI 10.1378/chest.12-1374; Chorley BN, 2006, AM J RESP CELL MOL, V34, P119, DOI 10.1165/rcmb.2005-0338OC; Chou KT, 2014, LUNG, V192, P499, DOI 10.1007/s00408-014-9591-8; Condorelli P, 2007, J APPL PHYSIOL, V102, P417, DOI 10.1152/japplphysiol.00533.2006; de Gouw HWFM, 1998, AM J RESP CRIT CARE, V158, P315, DOI 10.1164/ajrccm.158.1.9703005; Deykin A, 1998, AM J RESP CRIT CARE, V157, P769, DOI 10.1164/ajrccm.157.3.9707114; Doherty DE., 2006, J FAM PRACTICE, V55, pS1; Dummer JF, 2009, AM J RESP CRIT CARE, V180, P846, DOI 10.1164/rccm.200905-0685OC; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Gibson PG, 2009, CLIN EXP ALLERGY, V39, P478, DOI 10.1111/j.1365-2222.2009.03226.x; Haccuria A, 2014, J ALLERGY CLIN IMMUN, V134, P554, DOI 10.1016/j.jaci.2013.12.1070; Hanania NA, 2011, CHEST, V140, P1055, DOI 10.1378/chest.10-2974; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kharitonov SA, 1998, AM J RESP CRIT CARE, V158, P1374, DOI 10.1164/ajrccm.158.5.9707076; Lehtimaki L, 2014, CHEST, V146, pE234, DOI 10.1378/chest.14-1189; Malerba M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/271918; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Papi A, 2000, AM J RESP CRIT CARE, V162, P1773, DOI 10.1164/ajrccm.162.5.9910112; Paredi P, 2014, CHEST, V145, P113, DOI 10.1378/chest.13-0843; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ricciardolo FLM, 2014, CURR OPIN PULM MED, V20, P53, DOI 10.1097/MCP.0000000000000006; Sears MR, 2005, RESP MED, V99, P152, DOI 10.1016/j.rmed.2004.07.003; Silkoff PE, 1999, AM J RESP CRIT CARE, V159, P940, DOI 10.1164/ajrccm.159.3.9805044; Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Tsoukias NM, 1998, J APPL PHYSIOL, V85, P653, DOI 10.1152/jappl.1998.85.2.653; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Zhao HJ, 2017, CLIN RESPIR J, V11, P328, DOI 10.1111/crj.12340	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157019	10.1371/journal.pone.0157019	http://dx.doi.org/10.1371/journal.pone.0157019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258087	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700171
J	Tan, SGD; Kim, S; Hon, JKF; Leo, HL				Tan, Sean Guo-Dong; Kim, Sangho; Hon, Jimmy Kim Fatt; Leo, Hwa Liang			A D-Shaped Bileaflet Bioprosthesis which Replicates Physiological Left Ventricular Flow Patterns	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; VORTEX FORMATION; FLUID-MECHANICS; MITRAL-VALVES; HEART; ECHOCARDIOGRAPHY; HEMODYNAMICS; AXISYMMETRY; MODEL	Prior studies have shown that in a healthy heart, there exist a large asymmetric vortex structure that aids in establishing a steady flow field in the left ventricle. However, the implantation of existing artificial heart valves at the mitral position is found to have a negative effect on this physiological flow pattern. In light of this, a novel D-shaped bileaflet porcine bio-prosthesis (GD valve) has been designed based on the native geometry mitral valve, with the hypothesis that biomimicry in valve design can restore physiological left ventricle flow patterns after valve implantation. An in-vitro experiment using two dimensional particle velocimetry imaging was carried out to determine the hemodynamic performance of the new bileaflet design and then compared to that of the well-established St. Jude Epic valve which functioned as a control in the experiment. Although both valves were found to have similar Reynolds shear stress and Turbulent Kinetic Energy levels, the novel D-shape valve was found to have lower turbulence intensity and greater mean kinetic energy conservation.	[Tan, Sean Guo-Dong; Kim, Sangho; Leo, Hwa Liang] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Block E4,04-08,4 Engn Dr 3, Singapore 117583, Singapore; [Hon, Jimmy Kim Fatt] Natl Univ Singapore, Dept Surg, Yong Loo Lin Sch Med, Kent Ridge Rd, Singapore 119228, Singapore	National University of Singapore; National University of Singapore	Leo, HL (corresponding author), Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Block E4,04-08,4 Engn Dr 3, Singapore 117583, Singapore.	bielhl@nus.edu.sg	Hon, Jimmy/B-5445-2012; Kim, Sangho/I-7032-2012; Leo, Hwa Liang/B-6946-2011	Kim, Sangho/0000-0002-1045-5928; Leo, Hwa Liang/0000-0003-0592-6470				Abe H, 2013, EUR HEART J-CARD IMG, V14, P1049, DOI 10.1093/ehjci/jet049; Bach DS, 1997, PROG CARDIOVASC DIS, V39, P543, DOI 10.1016/S0033-0620(97)80013-8; Charonko JJ, 2013, ANN BIOMED ENG, V41, P1049, DOI 10.1007/s10439-013-0755-0; Elbaz MSM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0078-9; Elbaz MS, 2016, MAGN RESON MED, DOI [10.1002/26129, DOI 10.1002/26129]; Ertesvag IS, 2000, COMBUST SCI TECHNOL, V159, P213, DOI 10.1080/00102200008935784; Falahatpisheh A, 2015, ANN BIOMED ENG, V43, P2349, DOI 10.1007/s10439-015-1302-y; Falahatpisheh A, 2015, EUR J MECH B-FLUID, V49, P264, DOI 10.1016/j.euromechflu.2014.09.003; Faludi R, 2010, J THORAC CARDIOV SUR, V139, P1501, DOI 10.1016/j.jtcvs.2009.07.060; Gharib M, 2006, P NATL ACAD SCI USA, V103, P6305, DOI 10.1073/pnas.0600520103; Jamieson WRE, 2011, J THORAC CARDIOV SUR, V141, P1449, DOI 10.1016/j.jtcvs.2010.05.055; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Kefayati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098209; Kilner PJ, 2000, NATURE, V404, P759, DOI 10.1038/35008075; KIM WY, 1995, J AM COLL CARDIOL, V26, P224, DOI 10.1016/0735-1097(95)00141-L; Le TB, 2012, EUR J MECH B-FLUID, V35, P20, DOI 10.1016/j.euromechflu.2012.01.013; MAGILLIGAN DJ, 1985, J THORAC CARDIOV SUR, V89, P499; Okafor IU, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0154-9; Pedrizzetti G, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108101; Pedrizzetti G, 2015, ANN BIOMED ENG, V43, P26, DOI 10.1007/s10439-014-1101-x; Pedrizzetti G, 2014, NAT REV CARDIOL, V11, P545, DOI 10.1038/nrcardio.2014.75; Pedrizzetti G, 2010, ANN BIOMED ENG, V38, P769, DOI 10.1007/s10439-010-9928-2; Pierrakos O, 2006, J BIOMECH ENG-T ASME, V128, P527, DOI 10.1115/1.2205863; Querzoli G, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3371720; Rodevand O, 1999, J AM SOC ECHOCARDIOG, V12, P500, DOI 10.1016/S0894-7317(99)70087-8; SALLAM AM, 1984, BIORHEOLOGY, V21, P783; Shen M, 2001, ANN THORAC SURG, V71, pS408, DOI 10.1016/S0003-4975(01)02506-1; Sotiropoulos F, 2016, ANNU REV FLUID MECH, V48, P259, DOI 10.1146/annurev-fluid-122414-034314; Valfre C, 2010, EUR J CARDIO-THORAC, V38, P141, DOI 10.1016/j.ejcts.2010.01.046; Wang Q, 2013, ANN BIOMED ENG, V41, P142, DOI 10.1007/s10439-012-0620-6	30	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156580	10.1371/journal.pone.0156580	http://dx.doi.org/10.1371/journal.pone.0156580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258099	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700082
J	Aspord, C; Costa, JB; Jacob, MC; Dufeu-Duchesne, T; Bertucci, I; Pouget, N; Brevot-Lutton, O; Zoulim, F; Bourliere, M; Plumas, J; Leroy, V				Aspord, Caroline; Costa, Juliana Bruder; Jacob, Marie-Christine; Dufeu-Duchesne, Tania; Bertucci, Inga; Pouget, Noelle; Brevot-Lutton, Ophelie; Zoulim, Fabien; Bourliere, Marc; Plumas, Joel; Leroy, Vincent		ANRS HB06 PEGAN Study Grp	Remodeling of B-Cell Subsets in Blood during Pegylated IFN alpha-2 alpha Therapy in Patients with Chronic Hepatitis B Infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON-ALPHA; PEGINTERFERON ALPHA-2A; PERIPHERAL-BLOOD; VIRUS-INFECTION; SOLUBLE CD30; MEMORY B; DIFFERENTIATION; LYMPHOCYTES; COMPARTMENT	The ultimate goal of pegylated interferon-alfa-2a (Peg-IFN-alpha) therapy in chronic hepatitis B (CHB) infection is HBsAg seroconversion. Even though B cells are major mediators of a positive clinical outcome, their modulation during Peg-IFN-alpha therapy has not yet been described. We investigated here the effects of Peg-IFN-alpha on eight circulating B-cell subsets thanks to an original multi-gating approach based on CD19, CD27, IgD, CD10, and CD38 markers in patients with CHB treated with nucleos(t)ide analog alone or in combination with Peg-IFN-alpha. These dynamic changes were analyzed during the 48-weeks of Peg-IFN-alpha therapy and up to 2 years after the cessation of treatment. The CD19(+)CD27(-)IgD(+)CD10(+)CD38(high) transitional B cells and the CD19(+)CD27(+)IgD(-)CD10(-)CD38(high) plasmablasts continuously increased, whereas the CD19(+)CD27(-)IgD(+)CD10(-)CD38(low) naive, CD19(+)CD27(+)IgD(+) natural memory, and CD19(+)CD27(+)IgD(-)CD10(-)CD38(low) post-germinal center B cells decreased during the course of Peg-IFNa treatment. Such modulations correlated with a sustained increase in sCD30 levels and the decrease in plasma HBsAg. However, no seroconversion occurred and all parameters returned to baseline after the stop of the treatment. Peg-IFN-alpha therapy mediates a remodeling of B-cell compartmentalization, without clinical relevance. Our study provides new insights into the immunomodulatory effects of Peg-IFN-alpha on circulating B-cells, and questioned the benefit of the add-on Peg-IFN-alpha treatment in CHB.	[Aspord, Caroline; Costa, Juliana Bruder; Jacob, Marie-Christine; Dufeu-Duchesne, Tania; Plumas, Joel; Leroy, Vincent] Univ Grenoble 1, F-38041 Grenoble, France; [Aspord, Caroline; Costa, Juliana Bruder; Plumas, Joel] INSERM, U823, Immunobiol & Immunotherapy Canc, F-38706 La Tronche, France; [Aspord, Caroline; Plumas, Joel] EFS Rhone Alpes, R&D Lab, F-38701 La Tronche, France; [Costa, Juliana Bruder; Dufeu-Duchesne, Tania; Leroy, Vincent] CHU Grenoble, Michallon Hosp, Hepatogastroenterol Unit, F-38043 Grenoble, France; [Jacob, Marie-Christine] INSERM, U823, CRI, Inst Albert Bonniot, F-38000 Grenoble, France; [Jacob, Marie-Christine] CHU Grenoble, Dept Immunol, F-38000 Grenoble, France; [Dufeu-Duchesne, Tania; Leroy, Vincent] INSERM, U823, Analyt Immunol Chron Pathol, F-38706 La Tronche, France; [Bertucci, Inga] ANRS France REch Nord & Sud Sida Hiv Hepatites FR, Paris, France; [Pouget, Noelle; Brevot-Lutton, Ophelie] Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ IPLES UM, F-75012 Paris, France; [Zoulim, Fabien] CRCL, CNRS 5286, INSERM U1052, Lyon, France; [Zoulim, Fabien] Hosp Civils Lyon, Hepatol Dept, Lyon, France; [Zoulim, Fabien] Univ Lyon, Lyon, France; [Bourliere, Marc] St Joseph Hosp, Hepatogastroenterol Dept, F-13008 Marseille, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); CHU Lyon	Aspord, C (corresponding author), Univ Grenoble 1, F-38041 Grenoble, France.; Aspord, C (corresponding author), INSERM, U823, Immunobiol & Immunotherapy Canc, F-38706 La Tronche, France.; Aspord, C (corresponding author), EFS Rhone Alpes, R&D Lab, F-38701 La Tronche, France.	carolineaspord@yahoo.com	Zoulim, Fabien/ABD-5594-2021; ASPORD, Caroline/AAU-1805-2020; marie-christine, JACOB/G-7322-2014; ASPORD, CAROLINE/N-3179-2013	Zoulim, Fabien/0000-0002-2245-0083; rosa, isabelle/0000-0001-6879-3148; Cales, Paul/0000-0003-4866-5274; Ganne-Carrie, Nathalie/0000-0002-7351-5027; Ratziu, Vlad/0000-0002-6865-3791; ASPORD, CAROLINE/0000-0002-4979-7044	French Blood Service (EFS); ANRS	French Blood Service (EFS); ANRS(ANRSFrench National Research Agency (ANR))	The authors' work was supported by the French Blood Service (EFS) and the study was sponsored and funded by ANRS.	Amu S, 2013, AIDS, V27, P2323, DOI 10.1097/QAD.0b013e328361a427; Boltjes A, 2013, MOL IMMUNOL, V53, P72, DOI 10.1016/j.molimm.2012.06.016; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Fathallah I, 2010, J IMMUNOL, V185, P6439, DOI 10.4049/jimmunol.0903459; Fattovich G, 1996, CLIN EXP IMMUNOL, V103, P105, DOI 10.1046/j.1365-2249.1996.915607.x; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garraud O, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-63; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; Lampertico P, 2013, GUT, V62, P290, DOI 10.1136/gutjnl-2011-301430; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Liu YZ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-274; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Monsalve-de Castillo F, 2002, CLIN DIAGN LAB IMMUN, V9, P1372, DOI 10.1128/CDLI.9.6.1372-1375.2002; Ni JH, 2003, J IMMUNOL, V170, P3429, DOI 10.4049/jimmunol.170.6.3429; Oliviero B, 2011, J HEPATOL, V55, P53, DOI 10.1016/j.jhep.2010.10.016; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Penna A, 2012, J HEPATOL, V56, P1239, DOI 10.1016/j.jhep.2011.12.032; Pensieroso S, 2013, AIDS, V27, P1209, DOI 10.1097/QAD.0b013e32835edc47; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rijckborst V, 2010, AM J GASTROENTEROL, V105, P1762, DOI 10.1038/ajg.2010.186; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Sprinzl MF, 2014, J VIRAL HEPATITIS, V21, P633, DOI 10.1111/jvh.12189; Stelma F, 2015, J INFECT DIS, V212, P1042, DOI 10.1093/infdis/jiv180; Swiecki M, 2011, CURR OPIN VIROL, V1, P463, DOI 10.1016/j.coviro.2011.10.026; Thimme R, 2013, J HEPATOL, V58, P205, DOI 10.1016/j.jhep.2012.11.007; Vincent IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026315; Wehr C, 2004, CLIN IMMUNOL, V113, P161, DOI 10.1016/j.clim.2004.05.010; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156200	10.1371/journal.pone.0156200	http://dx.doi.org/10.1371/journal.pone.0156200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281019	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000020
J	Milojevich, HM; Lukowski, AF				Milojevich, Helen M.; Lukowski, Angela F.			Sleep and Mental Health in Undergraduate Students with Generally Healthy Sleep Habits	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; COLLEGE-STUDENTS; PSYCHIATRIC-DISORDERS; YOUNG-ADULTS; INSOMNIA; QUALITY; DEPRESSION; SYMPTOMS; ANXIETY; DISTURBANCES	Whereas previous research has indicated that sleep problems tend to co-occur with increased mental health issues in university students, relatively little is known about relations between sleep quality and mental health in university students with generally healthy sleep habits. Understanding relations between sleep and mental health in individuals with generally healthy sleep habits is important because (a) student sleep habits tend to worsen over time and (b) even time-limited experience of sleep problems may have significant implications for the onset of mental health problems. In the present research, 69 university students with generally healthy sleep habits completed questionnaires about sleep quality and mental health. Although participants did not report clinically concerning mental health issues as a group, global sleep quality was associated with mental health. Regression analyses revealed that nighttime sleep duration and the frequency of nighttime sleep disruptions were differentially related to total problems and clinically-relevant symptoms of psychological distress. These results indicate that understanding relations between sleep and mental health in university students with generally healthy sleep habits is important not only due to the large number of undergraduates who experience sleep problems and mental health issues over time but also due to the potential to intervene and improve mental health outcomes before they become clinically concerning.	[Milojevich, Helen M.; Lukowski, Angela F.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA	University of California System; University of California Irvine	Lukowski, AF (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA.	angela.lukowski@uci.edu	Milojevich, Helen/AFG-3672-2022	Milojevich, Helen/0000-0001-5337-7264	University of California-Irvine	University of California-Irvine(University of California System)	This research was funded by start-up money provided by the University of California-Irvine to the second author and by money provided to undergraduate research assistants through the Undergraduate Research Opportunities Program. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2005, J PERS ASSESS, V84, P49, DOI 10.1207/s15327752jpa8401_10; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Barclay NL, 2011, PSYCHOL MED, V41, P1029, DOI 10.1017/S0033291710001741; Bastien CH, 2004, J CONSULT CLIN PSYCH, V72, P653, DOI 10.1037/0022-006X.72.4.653; Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brown FC, 2006, J AM COLL HEALTH, V54, P231, DOI 10.3200/JACH.54.4.231-237; Buboltz WC, 2001, J AM COLL HEALTH, V50, P131, DOI 10.1080/07448480109596017; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caldwell K, 2010, J AM COLL HEALTH, V58, P433, DOI 10.1080/07448480903540481; Chapman DP, 2013, PSYCHIAT SERV, V64, P385, DOI 10.1176/appi.ps.201200226; Concepcion T, 2014, J AM COLL HEALTH, V62, P441, DOI 10.1080/07448481.2014.917652; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Galambos NL, 2011, J RES ADOLESCENCE, V21, P342, DOI 10.1111/j.1532-7795.2010.00679.x; Gao R, 2014, SLEEP BIOL RHYTHMS, V12, P194, DOI 10.1111/sbr.12063; Gau SSF, 2007, J BIOL RHYTHM, V22, P268, DOI 10.1177/0748730406298447; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; Gregory AM, 2011, J PSYCHOSOM RES, V71, P250, DOI 10.1016/j.jpsychores.2011.03.011; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kahn-Greene ET, 2007, SLEEP MED, V8, P215, DOI 10.1016/j.sleep.2006.08.007; Lavigne JV, 1999, J DEV BEHAV PEDIATR, V20, P164, DOI 10.1097/00004703-199906000-00005; Lukowski AF, 2014, BEHAV SLEEP MED, V12, P1; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Means MK, 2000, BEHAV RES THER, V38, P665, DOI 10.1016/S0005-7967(99)00091-1; Morphy H, 2007, SLEEP, V30, P274; Nyer M, 2014, DEPRESS ANXIETY, V30, P1; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Paavonen EJ, 2003, J DEV BEHAV PEDIATR, V24, P307, DOI 10.1097/00004703-200310000-00001; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Ramsawh HJ, 2009, J PSYCHIATR RES, V43, P926, DOI 10.1016/j.jpsychires.2009.01.009; Reid GJ, 2009, J SLEEP RES, V18, P49, DOI 10.1111/j.1365-2869.2008.00692.x; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Scharf R, 2010, J DEV BEHAV PEDIATR, V31, P384; Stein MB, 2008, PSYCHOSOM MED, V70, P913, DOI 10.1097/PSY.0b013e3181871405; Tabachnik G.B., 2007, EXPT DESIGNS USING A; Taras H, 2005, J SCHOOL HEALTH, V75, P248, DOI 10.1111/j.1746-1561.2005.00033.x; Taylor DJ, 2007, BEHAV THER, V38, P49, DOI 10.1016/j.beth.2006.04.002; Taylor DJ, 2011, BEHAV SLEEP MED, V9, P107, DOI 10.1080/15402002.2011.557992; Trockel M, 2011, J CLIN SLEEP MED, V7, P273, DOI 10.5664/JCSM.1072; Urponen H, 1991, SLEEP HLTH RISK, P555; Wong ML, 2013, J PSYCHOSOM RES, V74, P271, DOI 10.1016/j.jpsychores.2012.08.014; Yang CM, 2003, BEHAV MED, V29, P133, DOI 10.1080/08964280309596066; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001	51	65	65	8	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156372	10.1371/journal.pone.0156372	http://dx.doi.org/10.1371/journal.pone.0156372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280714	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000027
J	Azam, MN; Shahjahan, M; Yeasmin, M; Ahmed, NU				Azam, Mohammad Nurul; Shahjahan, Mohammad; Yeasmin, Mahbuba; Ahmed, Nasar U.			Prevalence of Smokeless Tobacco among Low Socioeconomic Populations: A Cross-Sectional Analysis	PLOS ONE			English	Article								Background Cost, social acceptability and non-stringent regulations pertaining to smokeless tobacco (SLT) product sales have made people choose and continue using SLT. If disaggregated data on smokeless forms and smoked practices of tobacco are reviewed, the incidence of SLT remains static. There is a strong positive correlation of SLT intake with the occurrence of adverse cardiovascular disease, particularly in the low socioeconomic populations. Aims To investigate the prevalence of smokeless tobacco, its initiation influence and risk factors associated with the practice among lower socioeconomic populations of Bangladesh. In this study, we explore the utilization of SLT among lower socioeconomic populations in industrialized zone of Bangladesh. Methods A cross-sectional analysis using both quantitative and categorical approaches was employed. Using systematic random sampling method, four focus group discussions (FGDs) were conducted and 459 participants were interviewed. Multiple logistic regression model was applied to distinguish the significant factors among the SLT users. Results Almost fifty percent of the respondents initiated SLT usage at the age of 15-24 years and another 22 percent respondents were smoking and using SLT concurrently. The bulk of the women respondents used SLT during their pregnancy. Nearly twenty five percent of the respondents tried to quit the practice of SLT and one-quarter had a plan to quit SLT in the future. More than twenty percent respondents were suffering from dental decay. A noteworthy correlation was found by gender (p<0.01), sufferings from SLT related disease (p<0.05). The multiple logistic regression analysis suggested that, males were 2.7 times more knowledgeable than that of females (p<0.01) about the adversative health condition of SLT usage. The respondents suffering from SLT related diseases were 3.7 times as more knowledgeable about the effect of the practice of SLT than the respondents without diseases (p<0.01). Regarding the knowledge about the health consequences of the practice of SLT, one participant in the FGD session commented that "although the mouth is the gateway to health, we infected our mouth by using Zarda and Gul". Again, informants opined that peer, family, curiosity and hospitality, culture are influencing factors for SLT initiation. Conclusion counselling on tobacco, including SLT, health hazards have to be emphasized through mass media and it is essential for development of relevant policies and communication messages to make people aware of serious health consequences of SLT usages.	[Azam, Mohammad Nurul] King Saud Univ, Riyadh, Saudi Arabia; [Azam, Mohammad Nurul] Daffodil Int Univ, Dhaka, Bangladesh; [Shahjahan, Mohammad] Daffodil Int Univ, Dept Publ Hlth, Dhaka, Bangladesh; [Yeasmin, Mahbuba] EKRA Inst, Melbourne, Vic, Australia; [Ahmed, Nasar U.] Florida Int Univ, Dept Epidemiol, Miami, FL 33199 USA	King Saud University; Daffodil International University; Daffodil International University; State University System of Florida; Florida International University	Azam, MN (corresponding author), King Saud Univ, Riyadh, Saudi Arabia.; Azam, MN (corresponding author), Daffodil Int Univ, Dhaka, Bangladesh.	mazamd@gmail.com			King Saud University, KSA [RG-1435-028]; Deanship of Scientific Research at King Saud University, KSA [RG-1435-028]	King Saud University, KSA(King Saud University); Deanship of Scientific Research at King Saud University, KSA	This work was supported by the King Saud University, KSA, research grant (No. RG-1435-028). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thankfully recognize the commitment of the examination group who worked hard to gather quality information in an auspicious way. At last, we are thankful to the study members for their time and help. The first author extends his sincere appreciation to the Deanship of Scientific Research at King Saud University, KSA, for funding his research (No. RG-1435-028). The KSU had no part in information gathering and investigation, choice to distribute, or planning of the work.	Abdullah A, 2011, INT J ENV RES PUB HE, V8, P842, DOI 10.3390/ijerph8030842; Anchorage AK, 2008, ASSESSMENT FACTORS R; [Anonymous], 2008, REP GLOB TOB EP; [Anonymous], WHY TOB IS PUBL HLTH; [Anonymous], 1999, CURBING EPIDEMIC GOV; [Anonymous], MILL DEV GOALS TOB C; Bangladesh Bureau of Statistics, 2010, REP HOUS INC EXP SUR; Bartal M, 2001, Monaldi Arch Chest Dis, V56, P545; Choudhury K, 2007, J HEALTH POPUL NUTR, V25, P456; Ezzati M, 2004, TOB CONTROL, V13, P388, DOI 10.1136/tc.2003.005215; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Forster JL, 1998, AM J PUBLIC HEALTH, V88, P1193, DOI 10.2105/AJPH.88.8.1193; Gilani SI, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-16; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Hossain MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084470; Kalaiselvi S, 2014, NJRCM, V3, P217; Khawaja Muhammad RizwanulHaq, 2006, Asian Pac J Cancer Prev, V7, P95; Lumukana Robson, 2003, Pac Health Dialog, V10, P41; Lynch BS., 1994, GROWING TOBACCO FREE; MEHTA FS, 1969, CANCER, V24, P832, DOI 10.1002/1097-0142(196910)24:4<832::AID-CNCR2820240427>3.0.CO;2-U; Rahman MA, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2197, DOI 10.1177/1010539512446957; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Rooban T, 2010, Indian J Cancer, V47 Suppl 1, P91, DOI 10.4103/0019-509X.63865; Subba S H, 2011, Indian J Community Med, V36, P128, DOI 10.4103/0970-0218.84132; Sultana P, 2016, J BIOMETRICS ITS APP, V1, P1, DOI [DOI 10.15744/2455-765X.1.102, 10.15744/2455-765X.1.102]; UDDIN G, 2009, BANGLADESH MED J, V38, P48, DOI DOI 10.3329/BMJ.V38I2.3573; World Bank, 2003, EC TOB S AS REG; World Health Organization, 2008, GUID IMPL ART 13 WHO; World Health Organization, 2011, TOB FACT SHEET; World Health Organization, 2009, GLOB AD TOB SURV BAN; World Health Organization (WHO), 2013, S E AS 90 SMOK TOB U; World Health Organization (WHO), 2009, BANGL GLOB AD TOB SU; Zaman M. M., 2007, IMPACT TOBACCO RELAT	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156887	10.1371/journal.pone.0156887	http://dx.doi.org/10.1371/journal.pone.0156887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275870	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700043
J	Baab, KL; Brown, P; Falk, D; Richtsmeier, JT; Hildebolt, CF; Smith, K; Jungers, W				Baab, Karen L.; Brown, Peter; Falk, Dean; Richtsmeier, Joan T.; Hildebolt, Charles F.; Smith, Kirk; Jungers, William			A Critical Evaluation of the Down Syndrome Diagnosis for LB1, Type Specimen of Homo floresiensis	PLOS ONE			English	Article							LIANG-BUA; LATE PLEISTOCENE; HUMAN OCCUPATION; SOUTHEAST-ASIA; PREMATURE LOSS; CRANIAL BASE; CHILDREN; SKULL; INDIVIDUALS; PREVALENCE	The Liang Bua hominins from Flores, Indonesia, have been the subject of intense scrutiny and debate since their initial description and classification in 2004. These remains have been assigned to a new species, Homo floresiensis, with the partial skeleton LB1 as the type specimen. The Liang Bua hominins are notable for their short stature, small endocranial volume, and many features that appear phylogenetically primitive relative to modern humans, despite their late Pleistocene age. Recently, some workers suggested that the remains represent members of a small-bodied island population of modern Austro-Melanesian humans, with LB1 exhibiting clinical signs of Down syndrome. Many classic Down syndrome signs are soft tissue features that could not be assessed in skeletal remains. Moreover, a definitive diagnosis of Down syndrome can only be made by genetic analysis as the phenotypes associated with Down syndrome are variable. Most features that contribute to the Down syndrome phenotype are not restricted to Down syndrome but are seen in other chromosomal disorders and in the general population. Nevertheless, we re-evaluated the presence of those phenotypic features used to support this classification by comparing LB1 to samples of modern humans diagnosed with Down syndrome and euploid modern humans using comparative morphometric analyses. We present new data regarding neurocranial, brain, and symphyseal shape in Down syndrome, additional estimates of stature for LB1, and analyses of inter- and intralimb proportions. The presence of cranial sinuses is addressed using CT images of LB1. We found minimal congruence between the LB1 phenotype and clinical descriptions of Down syndrome. We present important differences between the phenotypes of LB1 and individuals with Down syndrome, and quantitative data that characterize LB1 as an outlier compared with Down syndrome and non-Down syndrome groups. Homo floresiensis remains a phenotypically unique, valid species with its roots in Plio-Pleistocene Homo taxa.	[Baab, Karen L.] Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, 19555 N 59th Ave, Glendale, AZ 85308 USA; [Brown, Peter] Australian Natl Univ, Sch Archaeol & Anthropol, Bioanthropol, Acton, ACT 2601, Australia; [Falk, Dean] Florida State Univ, Dept Anthropol, Tallahassee, FL 32306 USA; [Falk, Dean] Sch Adv Res, Santa Fe, NM 87505 USA; [Richtsmeier, Joan T.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Hildebolt, Charles F.] Washington Univ, Mallinckrodt Inst Radiol, Dept Radiol, Sch Med, 510 South Kingshighway, St Louis, MO 63110 USA; [Smith, Kirk] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA; [Jungers, William] SUNY Stony Brook, Dept Anat Sci, Sch Med, Stony Brook, NY 11794 USA; [Jungers, William] Assoc Vahatra, BP 3972, Antananarivo 101, Madagascar	Midwestern University; Australian National University; State University System of Florida; Florida State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Washington University (WUSTL); University of Arkansas System; University of Arkansas Medical Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Baab, KL (corresponding author), Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, 19555 N 59th Ave, Glendale, AZ 85308 USA.	kbaab@midwestern.edu	Baab, Karen/I-4019-2019; Falk, Dean/C-6400-2019	Baab, Karen/0000-0002-6434-3681; Falk, Dean/0000-0003-1654-0469	National Science Foundation [BCS 04-24262]; L.S.B. Leakey Foundation; Sigma Xi Foundation; National Institutes of Health [R01-HD038384]; NSF [BCS 04-24262]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD078233, R01HD038384] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); L.S.B. Leakey Foundation; Sigma Xi Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Grant support was provided to KLB by the National Science Foundation (BCS 04-24262; http://www.nsf.gov/), the L.S.B. Leakey Foundation (http://www.leakeyfoundation.org/), and the Sigma Xi Foundation (https://www.sigmaxi.org/). JTR was supported in part by a National Institutes of Health grant (R01-HD038384; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank Campbell Rolian, University of Calgary, for phalangeal data. We appreciate comments on an earlier version of this manuscript by Roger Reeves, Johns Hopkins University. We thank ARKENAS for access to the LB1 stereolithic model and the many institutions that permitted us to collect the comparative modern human datasets. PB would like to thank Dr. Tony Djubiantono, Arkeologi Nasional, Jakarta, for permission to examine the Liang Bua skeletal material. PB's research would not have been possible without the joint Indonesian-Australian excavations at Liang Bua directed by the late Radien Soejono (Arkeologi Nasional) and the late Mike Morwood (University of New England), with field and laboratory direction by Thomas Sutikna, Jatmiko, E. Wayhu Saptomo, and Rokhus Due Awe. Grant support was provided to KLB by NSF (BCS 04-24262), the L.S.B. Leakey Foundation, and the Sigma Xi Foundation. JTR was supported in part by R01-HD038384.	Aiello LC, 2010, AM J PHYS ANTHROPOL, V142, P167, DOI 10.1002/ajpa.21255; Aksakalli S, 2012, EUROPEAN J GEN DENT, V1, P58; Al-Shawaf R., 2011, KING SAUD U J DENT S, V2, P17, DOI [10.1016/j.ksujds.2010.12.001, DOI 10.1016/J.KSUJDS.2010.12.001]; Alam MK, 2014, PLOS ONE, V9, DOI [10. 1371/journal.pone.0101157, DOI 10.1371/J0URNAL.P0NE.0101157]; Alio JJ, 2008, AM J ORTHOD DENTOFAC, V133, P729, DOI 10.1016/j.ajodo.2006.03.036; Alpoz A R, 1997, J Clin Pediatr Dent, V22, P37; Andersson EMM, 2014, EUR J ORTHODONT, V36, P414, DOI 10.1093/ejo/cjt063; Argue D, 2009, J HUM EVOL, V57, P623, DOI 10.1016/j.jhevol.2009.05.002; Argue D, 2014, AAA ASHA ANN C CAIRN; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Aylward EH, 1997, ARCH NEUROL-CHICAGO, V54, P209, DOI 10.1001/archneur.1997.00550140077016; Baab KL, 2008, J HUM EVOL, V54, P827, DOI 10.1016/j.jhevol.2007.11.003; Baab KL, 2016, J ANTHROPOL SCI, V94, P5, DOI [10.4436/jass.94024, 10.4436/JASS.94024]; Baab KL, 2015, AM J PHYS ANTHROPOL, V156, P74; Baab KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069119; Baab KL, 2009, J HUM EVOL, V57, P608, DOI 10.1016/j.jhevol.2008.08.011; Bailleul-Forestier I, 2008, EUROPEAN J MED GENET, V51, P283; Balzeau A, 2016, J HUM EVOL, V93, P12, DOI 10.1016/j.jhevol.2015.12.008; BARDEN HS, 1983, HUM BIOL, V55, P539; BARDEN HS, 1980, AM J PHYS ANTHROPOL, V52, P169, DOI 10.1002/ajpa.1330520203; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Bauer D, 2012, INT J DENT, V2012, DOI 10.1155/2012/872367; Benda CE, 1941, J PEDIATR-US, V19, P800, DOI 10.1016/S0022-3476(41)80106-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOLGER WE, 1990, OTOLARYNG HEAD NECK, V103, P759, DOI 10.1177/019459989010300516; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; BROTHWELL DR, 1960, ANN HUM GENET, V24, P141; Brown Barbara, 1993, P161; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brown P, 2012, J HUM EVOL, V62, P201, DOI 10.1016/j.jhevol.2011.10.011; Brown P, 2009, J HUM EVOL, V57, P571, DOI 10.1016/j.jhevol.2009.06.002; Chen H, 2015, SYNDROME DIFFERENTIA; Concolino D, 2006, ACTA PAEDIATR, V95, P17, DOI 10.1080/08035250500325108; Crevecoeur I, 2012, AM J PHYS ANTHROPOL, V147, P121; CROME L, 1966, J MENT DEFIC RES, V10, P69; Czarnetzki A, 2003, LANCET, V362, P1000, DOI 10.1016/S0140-6736(03)14384-X; DAVIDSON RG, 1988, PEDIATRICS, V81, P857; Dayal RS, 1958, INDIAN J CHILD HLTH, V7, P960; De Coster PJ, 2009, J ORAL PATHOL MED, V38, P1, DOI 10.1111/j.1600-0714.2008.00699.x; Moraes Mari Eli Leonelli de, 2007, Braz. Dent. J., V18, P346, DOI 10.1590/S0103-64402007000400014; Dembo M, 2015, P ROY SOC B-BIOL SCI, V282, P133, DOI 10.1098/rspb.2015.0943; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Desai SS, 1999, ANGLE ORTHOD, V69, P85; Dingwall HL, 2014, AM J PHYS ANTHROPOL, V153, P106; Down J. T., 1866, LONDON HOSP REPORTS, V3, P259; Eckhardt RB, 2014, P NATL ACAD SCI USA, V111, P11961, DOI 10.1073/pnas.1407385111; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2007, P NATL ACAD SCI USA, V104, P2513, DOI 10.1073/pnas.0609185104; Falk D, 2009, AM J PHYS ANTHROPOL, V140, P52, DOI 10.1002/ajpa.21035; FISCHERBRANDIES H, 1988, EUR J ORTHODONT, V10, P255; FORT P, 1984, J PEDIATR-US, V104, P545, DOI 10.1016/S0022-3476(84)80544-2; Gauld SC, 1996, AM J PHYS ANTHROPOL, V100, P411; Gorlin RJ., 2001, SYNDROMES HEAD NECK, DOI 10.17245/jdapm.2019.19.5.261; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grabowski M, 2015, J HUM EVOL, V85, P75, DOI 10.1016/j.jhevol.2015.05.005; Groves C., 2007, HAYATI J BIOSCI, V14, P123, DOI DOI 10.4308/hjb.14.4.123; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Haier RJ, 2008, NEUROIMAGE, V39, P1324, DOI 10.1016/j.neuroimage.2007.09.064; HALL B, 1964, ACTA PAEDIATR, V53, P478, DOI 10.1111/j.1651-2227.1964.tb07254.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henneberg M., 2010, HOBBIT TRAP NEW SPEC; Henneberg M, 2014, P NATL ACAD SCI USA, V111, P11967, DOI 10.1073/pnas.1407382111; Hershkovitz I, 2007, AM J PHYS ANTHROPOL, V134, P198, DOI 10.1002/ajpa.20655; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; JASPERS MT, 1981, ORAL SURG ORAL MED O, V51, P632, DOI 10.1016/S0030-4220(81)80014-X; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P529, DOI 10.1001/archneur.1990.00530050049011; Juj H, 2009, J PEDIATR-US, V154, P234, DOI 10.1016/j.jpeds.2008.07.056; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Jungers William L., 2009, P93, DOI 10.1007/978-1-4020-9980-9_9; JUNGERS WL, 1988, AM J PHYS ANTHROPOL, V76, P227, DOI 10.1002/ajpa.1330760211; Kaifu Y, 2015, ANTHROPOL SCI, V123, P129, DOI 10.1537/ase.150501; Kaifu Y, 2011, J HUM EVOL, V61, P644, DOI 10.1016/j.jhevol.2011.08.008; Kaifu Y, 2009, AM J PHYS ANTHROPOL, V140, P177, DOI 10.1002/ajpa.21066; King K, 2014, IRISH J MED SCI, V183, P1, DOI 10.1007/s11845-013-0994-y; Kisling E, 1966, CRANIAL MORPHOLOGY S; Kliewer MA, 1996, RADIOLOGY, V201, P681, DOI 10.1148/radiology.201.3.8939215; Konigsberg LW, 1998, AM J PHYS ANTHROPOL, V107, P97, DOI 10.1002/(SICI)1096-8644(199809)107:1<97::AID-AJPA8>3.3.CO;2-S; Korayem MA, 2014, ANGLE ORTHOD, V84, P30, DOI 10.2319/030813-195.1; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; Kumasaka S, 1997, Spec Care Dentist, V17, P137, DOI 10.1111/j.1754-4505.1997.tb00884.x; Larson SG, 2009, J HUM EVOL, V57, P555, DOI 10.1016/j.jhevol.2008.06.007; Leonelli de Moraes ME, 2007, BRAZ DENT J, V18, P346, DOI [10.1590/ 50103 64402007000400014, DOI 10.1590/50103]; LESTREL PE, 1976, GROWTH, V40, P385; Lestrel PE, 1979, PROC 1ST INT CONG AU, V1, P108; Mann R. W., 2005, PHOTOGRAPHIC REGIONA; Margvelashvili A, 2013, P NATL ACAD SCI USA, V110, P17278, DOI 10.1073/pnas.1316052110; McKinney CM, 2009, PAEDIATR PERINAT EP, V23, P332, DOI 10.1111/j.1365-3016.2009.01038.x; MILLER JDR, 1986, J CAN ASSOC RADIOL, V37, P85; MIYAMOTO W, 1976, J DENT RES, V55, P584, DOI 10.1177/00220345760550040601; Moosa S, 2013, SAMJ S AFR MED J, V103, P966, DOI [10.7196/samj.7111, 10.7196/SAMJ.7111]; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Obendorf PJ, 2008, P ROY SOC B-BIOL SCI, V275, P1287, DOI 10.1098/rspb.2007.1488; Orr CM, 2013, J HUM EVOL, V64, P109, DOI 10.1016/j.jhevol.2012.10.003; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Oxnard C, 2012, HOMO, V63, P407, DOI 10.1016/j.jchb.2012.09.005; Oxnard C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013018; PEDERSEN J, 1978, COMMUNITY DENT ORAL, V6, P204, DOI 10.1111/j.1600-0528.1978.tb01151.x; Prasher V, 2011, J INTELL DISABIL RES, V55, P392, DOI 10.1111/j.1365-2788.2011.01384.x; Prasher V, 1994, DOWNS SYNDROME RES P, V2, P59, DOI 10.3104/reports.31; Quintanilla JS, 2002, PEDIATR RADIOL, V32, P635, DOI 10.1007/s00247-002-0703-x; Reuland-Bosma W, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.032; Richards GD, 2006, J EVOLUTION BIOL, V19, P1744, DOI 10.1111/j.1420-9101.2006.01179.x; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Rivollat M, 2014, INT J PALEOPATHOL, V7, P8, DOI 10.1016/j.ijpp.2014.05.004; ROBERTS GM, 1980, CLIN RADIOL, V31, P475, DOI 10.1016/S0009-9260(80)80199-1; ROCHE AF, 1961, AMER J ROENTGENOL RA, V85, P659; ROCHE AF, 1966, ACTA NEUROL SCAND, V42, P62, DOI 10.1111/j.1600-0404.1966.tb05985.x; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Roizen NJ, 2014, J PEDIATR-US, V164, P871, DOI 10.1016/j.jpeds.2013.11.032; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Ross C, 2011, J PROSTHET ORTHOT, V23, P149, DOI DOI 10.1097/JPO.0B013E318227285E; Scheid RC., 2010, WOELFELS DENT ANATOM; SEWARD FS, 1961, AMER J ROENTGENOL RA, V85, P653; Shapira J, 2000, ANGLE ORTHOD, V70, P290; Shimizu T, 2009, JPN DENT SCI REV, V45, P52, DOI 10.1016/j.jdsr.2008.12.001; Smith BA, 2008, GAIT POSTURE, V28, P448, DOI 10.1016/j.gaitpost.2008.02.002; SPITZER R, 1961, CAN MED ASSOC J, V84, P567; SPITZER R, 1955, BRIT J RADIOL, V28, P117, DOI 10.1259/0007-1285-28-327-117; SPITZER R, 1958, BRIT J RADIOL, V31, P596, DOI 10.1259/0007-1285-31-371-596; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Stevenson RE., 2006, HUMAN MALFORMATIONS; Subrata Dey, 2011, PRENATAL DIAGNOSIS S, P59; Suri S, 2011, ANGLE ORTHOD, V81, P260, DOI 10.2319/070910-391.1; Suri S, 2010, ANGLE ORTHOD, V80, P861, DOI 10.2319/111709-650.1; Sutikna T, 2016, NATURE, V532, P366, DOI 10.1038/nature17179; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Tuysuz B, 2012, AM J MED GENET A, V158A, P2656, DOI 10.1002/ajmg.a.35710; van Heteren AH, 2013, GENE, V528, P12, DOI 10.1016/j.gene.2013.06.010; Vannucci RC, 2011, P NATL ACAD SCI USA, V108, P14043, DOI 10.1073/pnas.1105585108; Walker PL, 1991, AM J PHYS ANTHR S12, V34, P179; WALLACE JA, 1977, AM J PHYS ANTHROPOL, V46, P483, DOI 10.1002/ajpa.1330460315; Westaway KE, 2007, QUAT GEOCHRONOL, V2, P337, DOI 10.1016/j.quageo.2006.03.015; Westaway MC, 2015, P NATL ACAD SCI USA, V112, pE604, DOI 10.1073/pnas.1418997112	138	6	6	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155731	10.1371/journal.pone.0155731	http://dx.doi.org/10.1371/journal.pone.0155731			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275928	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700008
J	Conroy-Beam, D; Buss, DM				Conroy-Beam, Daniel; Buss, David M.			How Are Mate Preferences Linked with Actual Mate Selection? Tests of Mate Preference Integration Algorithms Using Computer Simulations and Actual Mating Couples	PLOS ONE			English	Article							SEX-DIFFERENCES; EVOLUTIONARY	Prior mate preference research has focused on the content of mate preferences. Yet in real life, people must select mates among potentials who vary along myriad dimensions. How do people incorporate information on many different mate preferences in order to choose which partner to pursue? Here, in Study 1, we compare seven candidate algorithms for integrating multiple mate preferences in a competitive agent-based model of human mate choice evolution. This model shows that a Euclidean algorithm is the most evolvable solution to the problem of selecting fitness-beneficial mates. Next, across three studies of actual couples (Study 2: n = 214; Study 3: n = 259; Study 4: n = 294) we apply the Euclidean algorithm toward predicting mate preference fulfillment overall and preference fulfillment as a function of mate value. Consistent with the hypothesis that mate preferences are integrated according to a Euclidean algorithm, we find that actual mates lie close in multidimensional preference space to the preferences of their partners. Moreover, this Euclidean preference fulfillment is greater for people who are higher in mate value, highlighting theoretically-predictable individual differences in who gets what they want. These new Euclidean tools have important implications for understanding real-world dynamics of mate selection.	[Conroy-Beam, Daniel; Buss, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Conroy-Beam, D (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.	Dconroybeam@utexas.edu		Buss, David/0000-0002-4467-7019				Aktipis CA, 2011, HUM ECOL, V39, P131, DOI 10.1007/s10745-010-9364-9; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Christensen HT, 1947, MARRIAGE FAM LIVING, V9, P85, DOI 10.2307/347505; Conroy-Beam D, 2015, PERSONALITY SOCIAL P; DAWKINS R, 1979, Z TIERPSYCHOL, V51, P184; Eastwick PW, 2013, PREDICTIVE VALIDITY; Gangestad SW, 2006, PSYCHOL INQ, V17, P75, DOI 10.1207/s15327965pli1702_1; Gildersleeve K, 2014, PSYCHOL BULL, V140, P1205, DOI 10.1037/a0035438; Goldberg L, 1983, MAGICAL NUMBER 5 PLU; Hitsch GJ, 2010, QME-QUANT MARK ECON, V8, P393, DOI 10.1007/s11129-010-9088-6; KENRICK DT, 1992, BEHAV BRAIN SCI, V15, P75, DOI 10.1017/S0140525X00067595; KENRICK DT, 1993, J PERS SOC PSYCHOL, V64, P951, DOI 10.1037/0022-3514.64.6.951; Krasnow MM, 2015, GROUP COOPERATION GR; Kurzban R, 2005, EVOL HUM BEHAV, V26, P227, DOI 10.1016/j.evolhumbehav.2004.08.012; Lewis DM, 2015, EVOLUTION HUMAN BEHA; Li N.P., 2015, EVOLUTIONARY BEHAV S, V9, P89, DOI [DOI 10.1037/EBS0000036, 10.1037/ebs0000036]; Li NP, 2013, J PERS SOC PSYCHOL, V105, P757, DOI 10.1037/a0033777; Li NP, 2011, PERS INDIV DIFFER, V50, P291, DOI 10.1016/j.paid.2010.10.005; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; Norman P. Li, 2007, [心理学报, Acta Psychologica Sinica], V39, P528; Rozin P., 2015, EVOLUTIONARY PSYCHOL; Ryan Michael J., 2009, P137; Shackelford TK, 2005, COGNITION EMOTION, V19, P1262, DOI 10.1080/02699930500215249; Sugiyama L.S., 2005, HDB EVOLUTIONARY PSY, P292; Vazire S, 2010, J PERS SOC PSYCHOL, V98, P281, DOI 10.1037/a0017908	28	25	27	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156078	10.1371/journal.pone.0156078	http://dx.doi.org/10.1371/journal.pone.0156078			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27276030	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700016
J	Kirkwood, JS; Miranda, CL; Bobe, G; Maier, CS; Stevens, JF				Kirkwood, Jay S.; Miranda, Cristobal L.; Bobe, Gerd; Maier, Claudia S.; Stevens, Jan F.			O-18-Tracer Metabolomics Reveals Protein Turnover and CDP-Choline Cycle Activity in Differentiating 3T3-L1 Pre-Adipocytes	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; HEME OXYGENASE; MATRIX METALLOPROTEINASES; PROLINE-OXIDASE; CELL-CYCLE; ADIPOGENESIS; PHOSPHATIDYLCHOLINE; OBESITY; OVEREXPRESSION; SPERMIDINE	The differentiation of precursor cells into mature adipocytes (adipogenesis) has been an area of increased focus, spurred by a rise in obesity rates. Though our understanding of adipogenesis and its regulation at the cellular level is growing, many questions remain, especially regarding the regulation of the metabolome. The 3T3-L1 cell line is the most well characterized cellular model of adipogenesis. Using a time course metabolomics approach, we show that the 3T3-L1 preadipocyte metabolome is greatly altered during the first 48 hours of differentiation, where cells go through about two rounds of cell division, a process known as mitotic clonal expansion. Short-chain peptides were among several small molecules that were increased during mitotic clonal expansion. Additional indicators of protein turnover were also increased, including bilirubin, a degradation product of heme-containing proteins, and 3-methylhistidine, a post-translationally modified amino acid that is not reutilized for protein synthesis. To study the origin of the peptides, we treated differentiating pre-adipocytes with O-18 labeled water and found that O-18 was incorporated into the short chain peptides, confirming them, at least in part, as products of hydrolysis. Inhibitors of the proteasome or matrix metalloproteinases affected the peptide levels during differentiation, but inhibitors of autophagy or peptidases did not. O-18 was also incorporated into several choline metabolites including cytidine 5'-diphosphocholine (CDP-choline), glycerophosphocholine, and several phosphatidylcholine species, indicative of phosphatidylcholine synthesis/degradation and of flux through the CDP-choline cycle, a hallmark of proliferating cells. O-18-Tracer metabolomics further showed metabolic labeling of glutamate, suggestive of glutaminolysis, also characteristic of proliferating cells. Together, these results highlight the utility of O-18 isotope labeling in combination with metabolomics to uncover changes in cellular metabolism that are not detectable by time-resolved metabolomics.	[Kirkwood, Jay S.; Miranda, Cristobal L.; Bobe, Gerd; Maier, Claudia S.; Stevens, Jan F.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Maier, Claudia S.] Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Stevens, JF (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.; Stevens, JF (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	fred.stevens@oregonstate.edu		Maier, Claudia S./0000-0003-0743-8956; Stevens, Jan Frederik/0000-0002-6348-9347	National Institutes of Health [S10RR027878, P30ES000120]; College of Pharmacy, Oregon State University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Pharmacy, Oregon State University	National Institutes of Health (Grants S10RR027878 to JFS; P30ES000120 Core to CSM) and the College of Pharmacy, Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; Bauters D, 2015, BBA-GEN SUBJECTS, V1850, P1449, DOI 10.1016/j.bbagen.2015.04.003; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Brenner S, 2015, J BIOL CHEM, V290, P27384, DOI 10.1074/jbc.M115.686980; Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Cheong LY, 2015, J CELL BIOCHEM, V116, P1361, DOI 10.1002/jcb.25093; Chutkow WA, 2011, J BIOL CHEM, V286, P29139, DOI 10.1074/jbc.M111.267666; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Dasuri K, 2011, FREE RADICAL BIO MED, V51, P1727, DOI 10.1016/j.freeradbiomed.2011.08.001; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Gao Y, 2014, ADIPOCYTE, V3, P160, DOI 10.4161/adip.28307; Gavin KM, 2016, FASEB J, V30, P1096, DOI 10.1096/fj.15-278994; Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6; Goldman S, 2010, AUTOPHAGY, V6, P179, DOI 10.4161/auto.6.1.10814; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Hyvonen MT, 2013, BIOCHEM J, V453, P467, DOI 10.1042/BJ20130263; Ishii I, 2012, AMINO ACIDS, V42, P619, DOI 10.1007/s00726-011-1037-5; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kirkwood JS, 2013, J BIOL CHEM, V288, P19000, DOI 10.1074/jbc.M112.445452; Kirkwood JS, 2013, CURR PROTOC TOXICOL; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee J, 2012, J BIOL CHEM, V287, P8839, DOI 10.1074/jbc.M111.263434; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; Pajonk F, 2002, FREE RADICAL BIO MED, V32, P536, DOI 10.1016/S0891-5849(02)00743-8; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Phang JM, 2008, PPAR RES, V2008, DOI 10.1155/2008/542694; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TERCE F, 1994, J LIPID RES, V35, P2130; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; VREMAN HJ, 1993, PEDIATR RES, V33, P195; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Yeo GSH, 2014, MOL CELL ENDOCRINOL, V397, P34, DOI 10.1016/j.mce.2014.09.012; YOUNG VR, 1973, METABOLISM, V22, P1429, DOI 10.1016/0026-0495(73)90257-6; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhang HJ, 2002, J BIOL CHEM, V277, P20919, DOI 10.1074/jbc.M109801200; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	58	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157118	10.1371/journal.pone.0157118	http://dx.doi.org/10.1371/journal.pone.0157118			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275782	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700070
J	Wang, SY; Yang, BJ; Yang, QC; Lu, LL; Wang, XY; Peng, YY				Wang, Siyuan; Yang, Bojuan; Yang, Qichun; Lu, Linlin; Wang, Xiaoyue; Peng, Yaoyao			Temporal Trends and Spatial Variability of Vegetation Phenology over the Northern Hemisphere during 1982-2012	PLOS ONE			English	Article							SATELLITE-DERIVED PHENOLOGY; LAND-SURFACE PHENOLOGY; TERRESTRIAL VEGETATION; SPRING PHENOLOGY; PLANT PHENOLOGY; TIBETAN PLATEAU; CLIMATE-CHANGE; TIME-SERIES; RESPONSES; AVHRR	Satellite-derived vegetation phenology has been recognized as a key indicator for detecting changes in the terrestrial biosphere in response to global climate change. However, multi-decadal changes and spatial variation of vegetation phenology over the Northern Hemisphere and their relationship to climate change have not yet been fully investigated. In this article, we investigated the spatial variability and temporal trends of vegetation phenology over the Northern Hemisphere by calibrating and analyzing time series of the satellite-derived normalized difference vegetation index (NDVI) during 1982-2012, and then further examine how vegetation phenology responds to climate change within different ecological zones. We found that during the period from 1982 to 2012 most of the high latitude areas experienced an increase in growing period largely due to an earlier beginning of vegetation growing season (BGS), but there was no significant trend in the vegetation growing peaks. The spatial pattern of phenology within different eco-zones also experienced a large variation over the past three decades. Comparing the periods of 1982-1992, 1992-2002 with 2002-2012, the spatial pattern of change rate of phenology shift (RPS) shows a more significant trend in advancing of BGS, delaying of EGS (end of growing season) and prolonging of LGS (length of growing season) during 2002-2012, overall shows a trend of accelerating change. Temperature is a major determinant of phenological shifts, and the response of vegetation phenology to temperature varied across different eco-zones.	[Wang, Siyuan; Yang, Bojuan; Lu, Linlin; Wang, Xiaoyue; Peng, Yaoyao] Chinese Acad Sci, Key Lab Digital Earth, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Yang, Qichun] Auburn Univ, Sch Forestry & Wildlife Sci, Ecosyst Dynam & Global Ecol Lab, Auburn, AL 36849 USA	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Auburn University System; Auburn University	Wang, SY (corresponding author), Chinese Acad Sci, Key Lab Digital Earth, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	w_siyuan@126.com	Lu, Linlin/P-9200-2018	Lu, Linlin/0000-0003-1647-1950; Yang, Qichun/0000-0002-8689-2550	Natural Science Foundation of China [41271426, 41428103, 91547107]; National Basic Research Program of China [2011CB707100]; Chinese Academy of Sciences	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Natural Science Foundation of China (Grant No. 41271426, No. 41428103 and 91547107), National Basic Research Program of China (No. 2011CB707100), and "1-3-5 Project" of Chinese Academy of Sciences.	[Anonymous], 1999, MODIS VEGETATION IND; Barber VA, 2000, NATURE, V405, P668, DOI 10.1038/35015049; Basler D, 2012, AGR FOREST METEOROL, V165, P73, DOI 10.1016/j.agrformet.2012.06.001; Broich M, 2014, BIOGEOSCIENCES, V11, P5181, DOI 10.5194/bg-11-5181-2014; Broich M, 2015, ENVIRON MODELL SOFTW, V64, P191, DOI 10.1016/j.envsoft.2014.11.017; Buus-Hinkler J, 2006, REMOTE SENS ENVIRON, V105, P237, DOI 10.1016/j.rse.2006.06.016; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; de Beurs KM, 2008, J CLIMATE, V21, P4257, DOI 10.1175/2008JCLI2074.1; de Beurs KM, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P177, DOI 10.1007/978-90-481-3335-2_9; de Beurs KM, 2005, GLOBAL CHANGE BIOL, V11, P779, DOI 10.1111/j.1365-2486.2005.00949.x; Delbart N, 2006, REMOTE SENS ENVIRON, V101, P52, DOI 10.1016/j.rse.2005.11.012; FAO, 2000, WORKSH CAMBR 28 30 J, P26; Fisher JI, 2007, REMOTE SENS ENVIRON, V109, P261, DOI 10.1016/j.rse.2007.01.004; Fontana F, 2008, SENSORS-BASEL, V8, P2833, DOI 10.3390/s8042833; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Geerken RA, 2009, ISPRS J PHOTOGRAMM, V64, P422, DOI 10.1016/j.isprsjprs.2009.03.001; Gong DY, 2003, J GEOPHYS RES-ATMOS, V108; GOWARD SN, 1985, VEGETATIO, V64, P3, DOI 10.1007/BF00033449; Hansen M., 1998, UMD GLOBAL LAND COVE, P1981; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Holdridge L. R., 1967, Life zone ecology.; Horion S, 2013, INT J APPL EARTH OBS, V20, P20, DOI 10.1016/j.jag.2011.12.010; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; Ide R, 2013, ECOL INFORM, V16, P25, DOI 10.1016/j.ecoinf.2013.04.003; Ivits E, 2013, ECOL INDIC, V26, P49, DOI 10.1016/j.ecolind.2012.10.012; Ivits E, 2012, GLOBAL PLANET CHANGE, V88-89, P85, DOI 10.1016/j.gloplacha.2012.03.010; Jeganathan C, 2014, REMOTE SENS ENVIRON, V143, P154, DOI 10.1016/j.rse.2013.11.020; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jin ZN, 2013, CLIMATIC CHANGE, V119, P435, DOI 10.1007/s10584-013-0722-7; Kaduk J, 1996, CLIMATE RES, V6, P1, DOI 10.3354/cr006001; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Krishnaswamy J, 2014, GLOBAL CHANGE BIOL, V20, P203, DOI 10.1111/gcb.12362; Lesica P, 2010, J ARID ENVIRON, V74, P1013, DOI 10.1016/j.jaridenv.2010.02.002; LLOYD D, 1990, INT J REMOTE SENS, V11, P2269, DOI 10.1080/01431169008955174; Odland A., 2011, ALPINE ENV GEOLOGY E, P85; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Prieto P, 2008, ANN BOT-LONDON, V102, P275, DOI 10.1093/aob/mcn090; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Shen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087977; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Shutova E, 2006, INT J BIOMETEOROL, V51, P155, DOI 10.1007/s00484-006-0042-y; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockli R, 2004, INT J REMOTE SENS, V25, P3303, DOI 10.1080/01431160310001618149; Stockli R, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001545; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Tucker CJ, 2004, NA94APR15BN116G U MA; Verstraete MM, 2008, ADV SPACE RES, V41, P1773, DOI 10.1016/j.asr.2007.05.066; Vitasse Y, 2013, EUR J FOREST RES, V132, P1, DOI 10.1007/s10342-012-0661-2; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Wielgolaski F.E., 2013, PHENOLOGY INTEGRATIV, P225; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zeng HQ, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045508; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang XY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031447; Zhang XY, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000217; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	69	40	40	14	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157134	10.1371/journal.pone.0157134	http://dx.doi.org/10.1371/journal.pone.0157134			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276082	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700072
J	Yang, F; Cao, HB; Xiao, QY; Guo, XQ; Zhuang, Y; Zhang, CY; Wang, TC; Lin, HY; Song, YL; Hu, GL; Liu, P				Yang, Fei; Cao, Huabin; Xiao, Qingyang; Guo, Xiaoquan; Zhuang, Yu; Zhang, Caiying; Wang, Tiancheng; Lin, Huayuan; Song, Yalu; Hu, Guoliang; Liu, Ping			Transcriptome Analysis and Gene Identification in the Pulmonary Artery of Broilers with Ascites Syndrome	PLOS ONE			English	Article							RIGHT-VENTRICULAR FAILURE; NITRIC-OXIDE; HYPERTENSION; EXPRESSION; CHICKENS; HYPOXIA; GROWTH; SUSCEPTIBILITY; PROTEIN; LUNGS	Background Pulmonary arterial hypertension, also known as Ascites syndrome (AS), remains a clinically challenging disease with a large impact on both humans and broiler chickens. Pulmonary arterial remodeling presents a key step in the development of AS. The precise molecular mechanism of pulmonary artery remodeling regulating AS progression remains unclear. Methodology/Principal Findings We obtained pulmonary arteries from two positive AS and two normal broilers for RNA sequencing (RNA-seq) analysis and pathological observation. RNA-seq analysis revealed a total of 895 significantly differentially expressed genes (DEGs) with 437 up-regulated and 458 down-regulated genes, which were significantly enriched to 12 GO (Gene Ontology) terms and 4 KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways (Padj<0.05) regulating pulmonary artery remodeling and consequently occurrence of AS. These GO terms and pathways include ribosome, Jak-STAT and NOD-like receptor signaling pathways which regulate pulmonary artery remodeling through vascular smooth cell proliferation, inflammation and vascular smooth cell proliferation together. Some notable DEGs within these pathways included downregulation of genes like RPL 5, 7, 8, 9, 14; upregulation of genes such as IL-6, K60, STAT3, STAT5 Pim1 and SOCS3; IKK alpha, I kappa B, P38, five cytokines IL-6, IL8, IL-1 beta, IL-18, and MIP-1 beta. Six important regulators of pulmonary artery vascular remodeling and construction like CYP1B1, ALDH7A1, MYLK, CAMK4, BMP7 and INOS were upregulated in the pulmonary artery of AS broilers. The pathology results showed that the pulmonary artery had remodeled and become thicker in the disease group. Conclusions/Significance Our present data suggested some specific components of the complex molecular circuitry regulating pulmonary arterial remodeling underlying AS progression in broilers. We revealed some valuable candidate genes and pathways that involved in pulmonary artery remodeling further contributing to the AS progression.	[Yang, Fei; Cao, Huabin; Xiao, Qingyang; Guo, Xiaoquan; Zhuang, Yu; Zhang, Caiying; Wang, Tiancheng; Lin, Huayuan; Song, Yalu; Hu, Guoliang; Liu, Ping] JiangXi Agr Univ, Inst Anim Populat Hlth, Coll Anim Sci & Technol, NO 1101,Zhimin Ave, Nanchang 330045, Peoples R China	Jiangxi Agricultural University	Hu, GL; Liu, P (corresponding author), JiangXi Agr Univ, Inst Anim Populat Hlth, Coll Anim Sci & Technol, NO 1101,Zhimin Ave, Nanchang 330045, Peoples R China.	hgljx@163.com; PingLiujx@163.com	liu, ping/T-8380-2019	Guo, Xiaoquan/0000-0001-6041-8765	National Natural Science Foundation of China [31402266]; Natural Science Foundation of Jiangxi Province [GJJ14311]; Technology R & D Program of Jiangxi Province [20141BBF60035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Technology R & D Program of Jiangxi Province	Funding provided by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) awarded to PL (No. 31402266), the Natural Science Foundation of Jiangxi Province (http://www.11467.com/nanchang/co/58361.htm) awarded to PL (No. GJJ14311); the Technology R & D Program of Jiangxi Province (http://www.jxstc.gov.cn/) awarded to PL (No. 20141BBF60035).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babcock HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101782; Bai H, 2014, PLOS ONE, P1; Behrooj N, 2012, BRIT POULTRY SCI, V53, P658, DOI 10.1080/00071668.2012.727082; Chen S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-82; Cheng NL, 2015, AGING CELL, V14, P200, DOI 10.1111/acel.12294; Church AC, 2015, AM J PHYSIOL-LUNG C, V309, pL333, DOI 10.1152/ajplung.00038.2015; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Das M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096043; Deng H, 2010, AM J PHYSIOL-LUNG C, V298, pL793, DOI 10.1152/ajplung.00108.2009; Dominguez-Avila N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/190382; Druyan S, 2007, POULTRY SCI, V86, P621, DOI 10.1093/ps/86.4.621; Fernandez Ruby A, 2012, J Signal Transduct, V2012, P951497, DOI 10.1155/2012/951497; Gore B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100310; Hamal KR, 2012, AVIAN PATHOL, V41, P211, DOI 10.1080/03079457.2012.663077; Hamal KR, 2010, AM J PHYSIOL-REG I, V298, pR235, DOI 10.1152/ajpregu.00451.2009; Hassanpour H, 2013, BRIT POULTRY SCI, V54, P581, DOI 10.1080/00071668.2013.828151; Hassanpour H, 2009, BRIT POULTRY SCI, V50, P725, DOI 10.1080/00071660903141005; JULIAN RJ, 1992, CAN VET J, V33, P382; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; JULIAN RJ, 1989, AVIAN PATHOL, V18, P675, DOI 10.1080/03079458908418641; JULIAN RJ, 1993, AVIAN PATHOL, V22, P419, DOI 10.1080/03079459308418934; Kalmar ID, 2013, VET J, V197, P169, DOI 10.1016/j.tvjl.2013.03.011; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lee TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117356; Li Y, 2013, AVIAN PATHOL, V42, P335, DOI 10.1080/03079457.2013.804903; Liongue Clifford, 2013, JAKSTAT, V2, pe22756, DOI 10.4161/jkst.22756; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullen LM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0645-y; Nain S, 2009, RES VET SCI, V86, P479, DOI 10.1016/j.rvsc.2008.08.008; Palenski TL, 2013, LAB INVEST, V93, P646, DOI 10.1038/labinvest.2013.55; Paulin Roxane, 2012, JAKSTAT, V1, P223, DOI 10.4161/jkst.22366; Qiao LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051514; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; RATH NC, 1995, AVIAN DIS, V39, P382, DOI 10.2307/1591883; Shi SR, 2014, MOL BIOSYST, V10, P2984, DOI 10.1039/c4mb00360h; Smolock EM, 2012, CIRCULATION, V126, P2418, DOI 10.1161/CIRCULATIONAHA.112.125971; Stenmark KR, 2015, J APPL PHYSIOL, V119, P1164, DOI 10.1152/japplphysiol.00283.2015; Tan X, 2007, AVIAN PATHOL, V36, P261, DOI 10.1080/03079450701460765; Wang J, 2007, J VET MED A, V54, P564, DOI 10.1111/j.1439-0442.2007.00988.x; Wideman RF, 2013, POULTRY SCI, V92, P64, DOI 10.3382/ps.2012-02745; Wideman RF, 2001, WORLD POULTRY SCI J, V57, P289, DOI 10.1079/WPS20010021; Yamauchi S, 2010, P NATL ACAD SCI USA, V107, P11924, DOI 10.1073/pnas.0913179107; Yang Y, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/352371; Yang Y, 2007, EUR J PHARMACOL, V561, P137, DOI 10.1016/j.ejphar.2007.01.036; Yang Y, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-28; Yang Y, 2010, ANIM SCI J, V81, P494, DOI 10.1111/j.1740-0929.2010.00762.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang JJ, 2013, POULTRY SCI, V92, P2044, DOI 10.3382/ps.2013-03097; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112695; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014; Zoranovic Tamara, 2013, JAKSTAT, V2, pe25408, DOI 10.4161/jkst.25408	56	22	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156045	10.1371/journal.pone.0156045	http://dx.doi.org/10.1371/journal.pone.0156045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275925	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700015
J	Yang, ST; Liao, Y; Cong, L; Lu, XL; Yang, RY				Yang, Suteng; Liao, Yong; Cong, Lin; Lu, Xuelian; Yang, Rongya			In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahii	PLOS ONE			English	Article							CANDIDA-ALBICANS BIOFILMS; AMPHOTERICIN-B; ACETYLSALICYLIC-ACID; FUNGAL BIOFILMS; INFECTIONS; RESISTANCE; FLUCONAZOLE; IBUPROFEN; COMBINATIONS; VORICONAZOLE	Increasing drug resistance has brought enormous challenges to the management of Trichosporon spp. infections. The in vitro antifungal activities of non-steroidal anti-inflammatory drugs (NSAIDs) against Candida spp. and Cryptococcus spp. were recently discovered. In the present study, the in vitro interactions between three NSAIDs (aspirin, ibuprofen and diclofenac sodium) and commonly used antifungal agents (fluconazole, itraconazole, voriconazole, caspofungin and amphotericin B) against planktonic and biofilm cells of T. asahii were evaluated using the checkerboard microdilution method. The spectrophotometric method and the XTT reduction assay were used to generate data on biofilm cells. The fractional inhibitory concentration index (FICI) and the.E model were compared to interpret drug interactions. Using the FICI, the highest percentages of synergistic effects against planktonic cells (86.67%) and biofilm cells (73.33%) were found for amphotericin B/ibuprofen, and caspofungin/ibuprofen showed appreciable percentages (73.33% for planktonic form and 60.00% for biofilm) as well. We did not observe antagonism. The.E model gave consistent results with FICI (86.67%). Our findings suggest that amphotericin B/ibuprofen and caspofungin/ibuprofen combinations have potential effects against T. asahii. Further in vivo and animal studies to investigate associated mechanisms need to be conducted.	[Yang, Suteng; Liao, Yong; Cong, Lin; Lu, Xuelian; Yang, Rongya] Gen Hosp Beijing Mil Command, Dept Dermatol, Beijing, Peoples R China; [Yang, Suteng; Liao, Yong] Second Mil Med Univ Peoples Liberat Army, Clin Med Coll Beijing Mil Reg, Shanghai, Peoples R China	Seventh Medical Center of Chinese PLA General Hospital; Naval Medical University	Yang, RY (corresponding author), Gen Hosp Beijing Mil Command, Dept Dermatol, Beijing, Peoples R China.	yangrya_l@sina.com		Yang, Rongya/0000-0002-4490-4007	National Natural Science Foundation of China [81301410]; Beijing Natural Science Foundation [7163225]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (No. 81301410) (http://www.nsfc.gov.cn/) and Beijing Natural Science Foundation (NO. 7163225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0; Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004; Amir M, 2008, EUR J MED CHEM, V43, P2056, DOI 10.1016/j.ejmech.2007.09.025; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Bink A, 2012, J INFECT DIS, V206, P1790, DOI 10.1093/infdis/jis594; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Costa de Oliveira S, 2015, ANTIMICROB AGENTS CH; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Deva R, 2001, FEMS MICROBIOL LETT, V198, P37, DOI 10.1111/j.1574-6968.2001.tb10616.x; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Falk R, 2003, J CLIN MICROBIOL, V41, P911, DOI 10.1128/JCM.41.2.911.2003; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; GRAUER ME, 1994, INFECTION, V22, P283, DOI 10.1007/BF01739918; Hatipoglu N, 2013, EXPERT REV ANTI-INFE, V11, P523, DOI [10.1586/ERI.13.29, 10.1586/eri.13.29]; HOY J, 1986, REV INFECT DIS, V8, P959; Hynninen VV, 2006, ANTIMICROB AGENTS CH, V50, P1967, DOI 10.1128/AAC.01483-05; Kontoyiannis DP, 2004, SCAND J INFECT DIS, V36, P564, DOI 10.1080/00365540410017563; Kushima H, 2012, FEMS YEAST RES, V12, P662, DOI 10.1111/j.1567-1364.2012.00816.x; Leeuw NJ, 2007, ANTON LEEUW INT J G, V91, P393, DOI 10.1007/s10482-006-9124-4; Liao Y, 2014, ANTIMICROB AGENTS CH, V58, P7615, DOI 10.1128/AAC.03817-14; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Maligie MA, 2005, ANTIMICROB AGENTS CH, V49, P2851, DOI 10.1128/AAC.49.7.2851-2856.2005; Meletiadis J, 2003, ANTIMICROB AGENTS CH, V47, P106, DOI 10.1128/AAC.47.1.106-117.2003; Niwa T, 2014, CURR DRUG METAB, V15, P651; Oliveira Dos Santos C, 2016, BMC INFECT DIS, V16, P148, DOI [10.1186/s12879-016-1477-3, DOI 10.1186/S12879-016-1477-3]; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Pina-Vaz C, 2005, J ANTIMICROB CHEMOTH, V56, P678, DOI 10.1093/jac/dki264; Ricardo E, 2009, FEMS YEAST RES, V9, P618, DOI 10.1111/j.1567-1364.2009.00504.x; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Rodriguez-Tudela JL, 2005, ANTIMICROB AGENTS CH, V49, P4026, DOI 10.1128/AAC.49.10.4026-4034.2005; Ruan SY, 2009, CLIN INFECT DIS, V49, pE11, DOI 10.1086/599614; SCOTT EM, 1995, ANTIMICROB AGENTS CH, V39, P2610, DOI 10.1128/AAC.39.12.2610; Sebolai OM, 2008, CAN J MICROBIOL, V54, P111, DOI 10.1139/w07-116; Stepanovic S, 2004, J CHEMOTHER; Sun W, 2012, J MED MICROBIOL, V61, P1750, DOI 10.1099/jmm.0.049817-0; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Tsai MS, 2012, MYCOPATHOLOGIA, V174, P121, DOI 10.1007/s11046-012-9525-z; Vitale RG, 2005, METH MOLEC MED, V118, P143; WALSH TJ, 1990, J CLIN MICROBIOL, V28, P1616, DOI 10.1128/JCM.28.7.1616-1622.1990; Wolf DG, 2001, J CLIN MICROBIOL, V39, P4420, DOI 10.1128/JCM.39.12.4420-4425.2001; Yucesoy M, 2000, J CHEMOTHER; Zhou YB, 2012, ANTIMICROB AGENTS CH, V56, P3250, DOI 10.1128/AAC.06082-11	46	35	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157047	10.1371/journal.pone.0157047	http://dx.doi.org/10.1371/journal.pone.0157047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275608	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700061
J	Huus, K; Akerman, L; Raustorp, A; Ludvigsson, J				Huus, Karina; Akerman, Linda; Raustorp, Anders; Ludvigsson, Johnny			Physical Activity, Blood Glucose and C-Peptide in Healthy School-Children, a Longitudinal Study	PLOS ONE			English	Article							BODY-MASS INDEX; ACCELERATOR HYPOTHESIS; RISK-FACTORS; WEIGHT-GAIN; INSULIN-SECRETION; CHILDHOOD; CHILDREN; OBESITY; ADOLESCENTS; OVERWEIGHT	Aim To further elucidate the relationship between physical activity and several risk factors for development of diabetes (glucose, C-peptide and obesity) over time. Methods A prospective longitudinal study where physical activity was measured on 199 children from Kalmar and Linkoping at age 8, and the same 107 children from Linkoping again at age 12. Anthropometric data was collected and blood was analyzed for C-peptide and f-glucose. The children in the study were representative for the general Swedish child population, and on an average lean. Results High physical activity was related to lower C-peptide at age 8 and 12. This correlation was especially pronounced in boys, who also were more physically active than girls at both time points. The association seen at 8 years of age was similar at age 12 in most children. Children with higher BMI Z-Score had a higher fasting C-peptide (age 12) but linear regression showed that children with more steps per day were less likely to have a higher fasting C-peptide irrespective of BMI. Longitudinal follow-up showed that a decrease in physical activity increased insulin resistance and beta-cell load. Conclusions Already in young children, physical activity improves insulin sensitivity and decreases the need of C-peptide over time. This seems to become even more pronounced with increasing age when children are followed longitudinally. Low physical activity increases the load on insulin producing beta-cells, might increase the risk for both type 1- and 2 diabetes.	[Huus, Karina] Sch Hlth & Welf, CHILD Res Grp, Dept Nursing, SE-55111 Jonkoping, Sweden; [Akerman, Linda] Linkoping Univ, Dept Clin & Expt Med, Div Pediat, SE-58185 Linkoping, Sweden; [Raustorp, Anders] Linnaeus Univ, Sch Sport Sci, SE-39182 Kalmar, Sweden; [Raustorp, Anders] Univ Gothenburg, Dept Nutr & Sport Sci, SE-40530 Gothenburg, Sweden; [Ludvigsson, Johnny] Linkoping Univ, Dept Clin & Expt Med, Div Pediat, SE-58185 Linkoping, Sweden; [Ludvigsson, Johnny] Cty Council, Pediat Clin, SE-58185 Linkoping, Sweden	Linkoping University; Linnaeus University; University of Gothenburg; Linkoping University	Huus, K (corresponding author), Sch Hlth & Welf, CHILD Res Grp, Dept Nursing, SE-55111 Jonkoping, Sweden.	karina.huus@ju.se	Ludvigsson, Johnny/AAI-2051-2020	Ludvigsson, Johnny/0000-0003-1695-5234	Swedish Child Diabetes Foundation (Barndiabetesfonden); Novo Nordisk Foundation; Research Council of South-east Sweden (FORSS); Swedish Research Council [K2005-72X-11242-11A]; ALF/County Council of Ostergotland	Swedish Child Diabetes Foundation (Barndiabetesfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Council of South-east Sweden (FORSS); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF/County Council of Ostergotland	This study as a part of the ABIS project was supported by the Swedish Child Diabetes Foundation (Barndiabetesfonden), Novo Nordisk Foundation, The Research Council of South-east Sweden (FORSS), Swedish Research Council K2005-72X-11242-11A, and ALF/County Council of Ostergotland.	AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Beets MW, 2010, AM J PREV MED, V38, P208, DOI 10.1016/j.amepre.2009.09.045; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; BJORK E, 1992, DIABETOLOGIA, V35, P490, DOI 10.1007/BF02342450; CAPRIO S, 1993, HORM RES, V39, P112, DOI 10.1159/000182796; CAPRIO S, 1989, J PEDIATR-US, V114, P963, DOI 10.1016/S0022-3476(89)80438-X; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dahlquist G, 2006, DIABETOLOGIA, V49, P20, DOI 10.1007/s00125-005-0076-4; Danielsen YS, 2011, ACTA PAEDIATR, V100, P253, DOI 10.1111/j.1651-2227.2010.02098.x; Duncan MJ, 2010, INT J PEDIATR OBES, V5, P445, DOI 10.3109/17477160903568421; Eisenmann JC, 2005, EUR J APPL PHYSIOL, V93, P440, DOI 10.1007/s00421-004-1227-x; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Flodmark CE, 2004, INT J OBESITY, V28, P1189, DOI 10.1038/sj.ijo.0802787; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Froberg A, 2014, EUROPEAN J PEDIAT, P1; Hjorth MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104677; Huus K, 2007, ACTA PAEDIATR, V96, P1315, DOI 10.1111/j.1651-2227.2007.00408.x; Hypponen E, 1999, DIABETES CARE, V22, P1961, DOI 10.2337/diacare.22.12.1961; JOHANSSON C, 1994, DIABETOLOGIA, V37, P91; Kibirige M, 2003, DIABETES CARE, V26, P2865, DOI 10.2337/diacare.26.10.2865; Kim Y, 2012, J SCI MED SPORT, V15, P311, DOI 10.1016/j.jsams.2011.12.001; Larsson C, 2011, ACTA PAEDIATR, V100, P102, DOI 10.1111/j.1651-2227.2010.01969.x; Ljungkrantz M, 2008, PEDIATR DIABETES, V9, P50, DOI 10.1111/j.1399-5448.2007.00360.x; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Ludvigsson J, 2006, ANN NY ACAD SCI, V1079, P374, DOI 10.1196/annals.1375.058; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Raustorp A, 2004, ACTA PAEDIATR, V93, P400, DOI 10.1080/08035250310007484; Raustorp A, 2007, PEDIATR EXERC SCI, V19, P228, DOI 10.1123/pes.19.2.228; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sjoberg A, 2011, OBES REV, V12, P305, DOI 10.1111/j.1467-789X.2010.00838.x; Soldin OP, 2008, CLIN BIOCHEM, V41, P937, DOI 10.1016/j.clinbiochem.2008.04.025; Telford RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047438; The Oxford Centre for Diabetes EM, 2007, HOMA2 CALC V2 2; Tudor-Locke C, 2004, PREV MED, V38, P857, DOI 10.1016/j.ypmed.2003.12.018; Tudor-Locke C, 2004, FIELD METHOD, V16, P422; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-78; Vincent SD, 2003, MED SCI SPORT EXER, V35, P1367, DOI 10.1249/01.MSS.0000079024.40014.91; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wilkin TJ, 2002, DIABETES, V51, P3468, DOI 10.2337/diabetes.51.12.3468; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548	41	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156401	10.1371/journal.pone.0156401	http://dx.doi.org/10.1371/journal.pone.0156401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270732	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000012
J	Land, WM				Land, William M.			Action Effects and Task Knowledge: The Influence of Anticipatory Priming on the Identification of Task-Related Stimuli in Experts	PLOS ONE			English	Article							CHOICE REACTION-TIMES; ATTENTIONAL FOCUS; EXTERNAL FOCUS; AUTOMATIC INTEGRATION; TALENT IDENTIFICATION; MUSIC PERFORMANCE; AUDITORY-FEEDBACK; SKILL; EXECUTION; REPRESENTATION	The purpose of the present study was to examine the extent to which anticipation of an action's perceptual effect primes identification of task-related stimuli. Specifically, skilled (n = 16) and novice (n = 24) tennis players performed a choice-reaction time (CRT) test in which they identified whether the presented stimulus was a picture of a baseball bat or tennis racket. Following their response, auditory feedback associated with either baseball or tennis was presented. The CRT test was performed in blocks in which participants predictably received the baseball sound or tennis sound irrespective of which stimulus picture was displayed. Results indicated that skilled tennis players responded quicker to tennis stimuli when the response was predictably followed by the tennis auditory effect compared to the baseball auditory effect. These findings imply that, within an individual's area of expertise, domain-relevant knowledge is primed by anticipation of an action's perceptual effect, thus allowing the cognitive system to more quickly identify environmental information. This finding provides a more complete picture of the influence that anticipation can have on the cognitive-motor system. No differences existed for novices.	[Land, William M.] Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Land, WM (corresponding author), Univ Texas San Antonio, Dept Kinesiol Hlth & Nutr, San Antonio, TX USA.	William.land@utsa.edu		Land, William/0000-0003-3244-1348				Beckers T, 2002, PSYCHOL RES-PSYCH FO, V66, P166, DOI 10.1007/s00426-002-0090-9; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Blasing BE, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01008, 10.3389/fpsyg.2014.01500]; Castaneda B, 2007, J SPORT EXERCISE PSY, V29, P60, DOI 10.1123/jsep.29.1.60; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Fagioli S, 2007, PSYCHOL RES-PSYCH FO, V71, P22, DOI 10.1007/s00426-005-0033-3; Fischer MH, 1997, J EXP PSYCHOL HUMAN, V23, P404, DOI 10.1037/0096-1523.23.2.404; Fischman MG, 2003, RES Q EXERCISE SPORT, V74, P17, DOI 10.1080/02701367.2003.10609060; Flach R, 2006, ACTA PSYCHOL, V122, P11, DOI 10.1016/j.actpsy.2005.09.001; Ford P, 2007, J MOTOR BEHAV, V39, P481, DOI 10.3200/JMBR.39.6.481-490; Foster J, 2007, SOCIAL PSYCHOL HDB B, P201; Gray R, 2004, J EXP PSYCHOL-APPL, V10, P42, DOI 10.1037/1076-898X.10.1.42; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; Hommel B, 2008, OXFORD HDB HUMAN ACT, P369; Jackson RC, 2006, J SPORT EXERCISE PSY, V28, P49, DOI 10.1123/jsep.28.1.49; James W., 1890, PRINCIPLES PSYCHOL, V2; Keller PE, 2008, Q J EXP PSYCHOL, V61, P275, DOI 10.1080/17470210601160864; Kornblum S, 2002, ATTENTION PERFORM, V19, P9; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Kunde W, 2004, PSYCHOL RES-PSYCH FO, V68, P199, DOI 10.1007/s00426-003-0156-3; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Land WM, 2014, PSYCHOL SPORT EXERC, V15, P30, DOI 10.1016/j.psychsport.2013.09.006; Land WM, 2013, ACTA PSYCHOL, V144, P298, DOI 10.1016/j.actpsy.2013.06.002; Land WM, 2013, J SPORT EXERCISE PSY, V35, P250, DOI 10.1123/jsep.35.3.250; Luria A. R., 1961, ROLE SPEECH REGULATI, P50; LURIA AR, 1959, WORD, V15, P341, DOI 10.1080/00437956.1959.11659703; Lu┬tze R.H., 1852, MED PSYCHOL ODER PHY; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; MOWBRAY GH, 1960, Q J EXP PSYCHOL, V12, P193, DOI 10.1080/17470216008416726; MOWBRAY GH, 1959, Q J EXP PSYCHOL, V11, P16, DOI 10.1080/17470215908416282; Musseler J, 1997, J EXP PSYCHOL HUMAN, V23, P861, DOI 10.1037/0096-1523.23.3.861; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Nitsch JR., 2004, Z SPORTPSYCHOL, V11, P10, DOI [DOI 10.1026/1612-5010.11.1.10, 10.1026/1612-5010.11.1.10]; Pfordresher PQ, 2005, J EXP PSYCHOL HUMAN, V31, P1331, DOI 10.1037/0096-1523.31.6.1331; Pfordresher PQ, 2003, J EXP PSYCHOL HUMAN, V29, P949, DOI 10.1037/0096-1523.29.5.949; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1007/978-3-642-75348-0_7; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; ROSENBAUM DA, 1990, ATTENTION PERFORM, P321; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; Rosenbaum DA, 2006, MOTOR CONTROL AND LEARNING, P9, DOI 10.1007/0-387-28287-4_2; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Schack T., 2004, J SPORT EXERCISE PSY, V2, P403, DOI [10.1080/1612197x.2004.9671753, DOI 10.1080/1612197X.2004.9671753, 10.1080/1612197X.2004.9671753]; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shin YK, 2010, PSYCHOL BULL, V136, P943, DOI 10.1037/a0020541; Short MW, 1999, ACTA PSYCHOL, V100, P243, DOI 10.1016/S0001-6918(98)00020-1; Ste-marie D., 2003, EXPERT PERFORMANCE S, P169; Wenke D, 2007, PSYCHOL RES-PSYCH FO, V71, P92, DOI 10.1007/s00426-005-0038-y; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Williams A.M., 2007, HDB SPORT PSYCHOL, P203, DOI DOI 10.1002/9781118270011.CH9; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Williams AM., 2003, EXPERT PERFORMANCE S, P219; Wohlschlager A, 2000, VISION RES, V40, P925, DOI 10.1016/S0042-6989(99)00239-4; Wulf G, 2000, RES Q EXERCISE SPORT, V71, P229, DOI 10.1080/02701367.2000.10608903; Wulf G, 1998, J MOTOR BEHAV, V30, P169, DOI 10.1080/00222899809601334; Wulf G., 2007, ATTENTION MOTOR SKIL; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035; Ziessler M, 2004, PSYCHOL RES-PSYCH FO, V68, P163, DOI 10.1007/s00426-003-0153-6	59	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156928	10.1371/journal.pone.0156928	http://dx.doi.org/10.1371/journal.pone.0156928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272987	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000050
J	Patel, T; Chang, F; Mohammed, HT; Raman-Wilms, L; Jurcic, J; Khan, A; Sproule, B				Patel, Tejal; Chang, Feng; Mohammed, Heba Tallah; Raman-Wilms, Lalitha; Jurcic, Jane; Khan, Ayesha; Sproule, Beth			Knowledge, Perceptions and Attitudes toward Chronic Pain and Its Management: A Cross-Sectional Survey of Frontline Pharmacists in Ontario, Canada	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; PRIMARY-CARE; COMMUNITY PHARMACISTS; DIABETIC-NEUROPATHY; OPIOIDS; EPIDEMIOLOGY; PREVALENCE; PHYSICIANS; PATTERNS; BELIEFS	The treatment of chronic pain consumes a significant share of primary care. Community and family health team pharmacists frequently see patients with chronic pain, thus have the opportunity to improve their care. To assess the knowledge, perceptions, and attitudes of Ontario pharmacists, we invited 5,324 Ontario pharmacists, to participate in an online survey we developed using Qualtrics. The 31-question survey gathered demographic information, assessed pharmacists' knowledge of three chronic pain conditions; chronic lower back pain (CLBP, eight true/false statements); chronic headache disorder (CHD, eight true/false statements) and painful diabetic neuropathy (PDN, seven true/false statements), and their attitudes toward and perceptions of patients with these conditions, and knowledge, attitudes, and perceptions of opioids in pain management. We received 688 responses (12.9%) and 392 pharmacists completed the survey. The mean age of respondents was 48.5 years and 48.5% were male. More than 50% of respondents were in practice for more than 20 years and 58.7% worked 25-40 hours per week. The mean knowledge scores were 4.5/8, 5.5/8, and 5.3/8 for CBLP, CHD, and PDN respectively. While 95% of respondents were aware of the increasing death rates due to opioid use, only half were familiar with the Canadian guideline for safe opioid prescribing for non-cancer use. Responses were compared based on gender, time in practice and location of practice. Pharmacists with more than ten years of experience scored significantly higher than those with less experience. Fewer differences were found in comparisons of gender and location of practice. Safe and effective care of chronic pain patients, particularly with opioids, will require additional pharmacist education.	[Patel, Tejal; Chang, Feng; Mohammed, Heba Tallah; Khan, Ayesha] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada; [Patel, Tejal] Ctr Family Med, Family Hlth Team, Kitchener, ON, Canada; [Patel, Tejal; Jurcic, Jane] McMaster Univ, Dept Family Med, DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada; [Chang, Feng] Gateway Ctr Excellence Rural Hlth, Seaforth, ON, Canada; [Mohammed, Heba Tallah] Aim Shams Univ, Dept Community Med, Cairo, Egypt; [Raman-Wilms, Lalitha; Sproule, Beth] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Sproule, Beth] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Waterloo; McMaster University; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Patel, T (corresponding author), Univ Waterloo, Sch Pharm, Kitchener, ON, Canada.; Patel, T (corresponding author), Ctr Family Med, Family Hlth Team, Kitchener, ON, Canada.; Patel, T (corresponding author), McMaster Univ, Dept Family Med, DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada.	t5patel@uwaterloo.ca	Patel, Tejal/ABG-6213-2021; Mohammed, Heba/AAF-8484-2020	Sproule, Beth/0000-0001-7960-3696	government of Ontario [06674]	government of Ontario	This study was supported by a grant from the government of Ontario (Ministry grant no. 06674).	ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; [Anonymous], 2013, 1 DO NO HARM RESP CA; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boulanger A, 2007, PAIN RES MANAG, V12, P39, DOI 10.1155/2007/762180; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Canadian Council for Accreditation of Pharmacy Programs (CCAPP), CCAPP PHARM TECHN PR; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Duby JJ, 2004, AM J HEALTH-SYST PH, V61, P160, DOI 10.1093/ajhp/61.2.160; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Fine PG, 2011, PAIN MED, V12, P996, DOI 10.1111/j.1526-4637.2011.01187.x; Furlan AD, 2010, CAN MED ASSOC J, V182, P923, DOI 10.1503/cmaj.100187; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; Gilson AM, 2010, J PAIN SYMPTOM MANAG, V40, P599, DOI 10.1016/j.jpainsymman.2010.02.011; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Grahmann Paula H, 2004, J Pain Palliat Care Pharmacother, V18, P7; Greenwald BD, 1999, J PAIN SYMPTOM MANAG, V17, P369, DOI 10.1016/S0885-3924(99)00010-X; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Iyer S, 2013, EXPERT OPIN PHARMACO, V14, P1765, DOI 10.1517/14656566.2013.811490; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Joranson D E, 2001, J Am Pharm Assoc (Wash), V41, P213; Jouini G, 2014, J PAIN RES, V7, P163, DOI 10.2147/JPR.S56884; Kahan M, 2006, CAN FAM PHYSICIAN, V52, P1091; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Labianca R, 2012, CLIN DRUG INVEST, V32, P53, DOI 10.2165/11630080-000000000-00000; Lalonde L, 2014, PAIN RES MANAG, V19, P241, DOI 10.1155/2014/760145; Laurent S., 2002, RURAL CANADA ACCESS; Lipton RB, 2004, NEUROLOGY, V62, P1926, DOI 10.1212/WNL.62.11.1926; Martin BA, 2010, RES SOC ADMIN PHARM, V6, P155, DOI 10.1016/j.sapharm.2010.05.001; National Association of Pharmacy Regulatory Authorities (NAPRA), MOD STAND PRACT CAN, P2009; Office of National Drug Control Policy / The White House, 2011, PERSCR DRUG AB PREV; Passmore C, 2002, FAM MED, V34, P281; Phillips CJ, 2008, CHRONIC PAIN HLTH PO, P41, DOI DOI 10.1002/9783527622665.CH4; Prefontaine K, 2013, BRIT J OCCUP THER, V76, P280, DOI 10.4276/030802213X13706169932905; Reitsma ML, 2011, CHRON DIS INJ CAN, V31, P157; Roth CS, 2007, J REHABIL RES DEV, V44, P263, DOI 10.1682/JRRD.2006.05.0055; SCHMIDT FL, 1986, J APPL PSYCHOL, V71, P432, DOI 10.1037/0021-9010.71.3.432; Schopflocher D, 2011, PAIN RES MANAG, V16, P445, DOI 10.1155/2011/876306; Schrader Susan L, 2005, S D J Med, V58, P423; Silcock J, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-10; Sproule BA, 1999, J CLIN PSYCHOPHARM, V19, P367, DOI 10.1097/00004714-199908000-00014; Sproule B, 2009, CAN FAM PHYSICIAN, V55, P68; Sproule BA, 2011, DRUG ALCOHOL REV, V30, P327, DOI 10.1111/j.1465-3362.2010.00270.x; Tousignant-Laflamme Y, 2012, PAIN RES MANAG, V17, P341, DOI 10.1155/2012/506352; Veves A, 2008, PAIN MED, V9, P660, DOI 10.1111/j.1526-4637.2007.00347.x; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; Wenghofer EF, 2011, CAN FAM PHYSICIAN, V57, P324; Wenzel RG, 2005, HEADACHE, V45, P47, DOI 10.1111/j.1526-4610.2005.05010.x; Wenzel RG, 2002, ANN PHARMACOTHER, V36, P612; Wolfert MZ, 2010, PAIN MED, V11, P425, DOI 10.1111/j.1526-4637.2009.00761.x	51	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157151	10.1371/journal.pone.0157151	http://dx.doi.org/10.1371/journal.pone.0157151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27270723	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561000068
J	Callaghan, B; Lydon, H; Roelants, SLKW; Van Bogaert, INA; Marchant, R; Banat, IM; Mitchell, CA				Callaghan, Breedge; Lydon, Helen; Roelants, Sophie L. K. W.; Van Bogaert, Inge N. A.; Marchant, Roger; Banat, Ibrahim M.; Mitchell, Christopher A.			Lactonic Sophorolipids Increase Tumor Burden in Apc(min+/-) Mice	PLOS ONE			English	Article							CANCER CELLS; MICROBIAL-PRODUCTION; IGE PRODUCTION; FOOD-INDUSTRY; APC GENE; BIOSURFACTANTS; APOPTOSIS; SEPSIS; MOUSE; MODEL	Sophorolipids (SL) are amphiphilic biosurfactant molecules consisting of a disaccharide sophorose with one fatty acid at the C1 position and optional acetylation at the C6' and C6 '' positions. They exist in a closed ring lactonic (LSL) or open acidic (ASL) structure Sophorolipids are produced in crude mixtures in economically viable amounts by the yeast Starmerella bombicola and used in a variety of consumer products. Varying levels of antiproliferative and anti-cancer activity of crude sophorolipid mixtures are described in a number of tumor cell lines in vitro. However, significant inter-study variation exists in the composition of sophorolipid species as well as other biologically active compounds in these mixtures, which makes interpretation of in vitro and in vivo studies difficult. We produced a 96% pure C18:1 lactonic sophorolipid that dose-dependently reduces the viability of colorectal cancer, as well as normal human colonic and lung cell lines in vitro. Oral administration of vehicle-only; or lactonic sophorolipids (50 mg/kg for 70 days), to Apcmin(+/-) mice resulted in an increase in the number (55.5 +/- 3.3 vs 70.50 +/- 7.8: p < 0.05) and size (modal size 2mm vs 4mm) of intestinal polyps. Lactonic administration resulted in a systematic effect via reduced hematocrit (49.5 +/- 1.0 vs 28.2 +/- 2.0 vs: p<0.03) and splenomegaly (0.56 +/- 0.03g vs 0.71 +/- 0.04g; p<0.01) confirming exacerbation of disease progression in this model.	[Callaghan, Breedge; Lydon, Helen; Marchant, Roger; Banat, Ibrahim M.; Mitchell, Christopher A.] Univ Ulster, Ctr Mol Biosci, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Roelants, Sophie L. K. W.; Van Bogaert, Inge N. A.] Univ Ghent, Fac Biosci Engn, Ctr Ind Biotechnol & Biocatalysis InBio Be, Coupure Links 653, B-9000 Ghent, Belgium	Ulster University; Ghent University	Mitchell, CA (corresponding author), Univ Ulster, Ctr Mol Biosci, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland.	ca.mitchell@ulster.ac.uk	Mitchell, Christopher/ABH-1426-2020	Mitchell, Christopher/0000-0002-4422-7499; Banat, Ibrahim/0000-0001-8964-2840; Van Bogaert, Inge/0000-0001-8144-6466	European FP7 Project Biosurfing [289219]	European FP7 Project Biosurfing	This research was funded by the European FP7 Project Biosurfing, Grant number 289219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0; Bluth MH, 2008, J ALLERGY CLIN IMMUN, V121, pS2, DOI 10.1016/j.jaci.2007.12.011; Bluth MH, 2006, CRIT CARE MED, V34, P188, DOI 10.1097/01.CCM.0000196212.56885.50; Bognolo G, 1999, COLLOID SURFACE A, V152, P41, DOI 10.1016/S0927-7757(98)00684-0; Casteleyn C, 2010, LAB ANIM-UK, V44, P176, DOI 10.1258/la.2009.009112; Cavalero DA, 2003, J BIOTECHNOL, V103, P31, DOI 10.1016/S0168-1656(03)00067-1; Chen J, 2006, APPL MICROBIOL BIOT, V72, P52, DOI 10.1007/s00253-005-0243-z; CROSBY WH, 1959, BLOOD, V14, P399, DOI 10.1182/blood.V14.4.399.399; de Oliveira MR, REV SOPHOROLIPIDS PR; Finnerty William R., 1994, Current Opinion in Biotechnology, V5, P291, DOI 10.1016/0958-1669(94)90031-0; Fracchia L, 2012, BIOMEDICAL SCI ENG T, P325; Fracchia L., 2012, BIOMEDICAL SCI ENG T, P326; Fracchia L, 2015, AIMS BIOENG, V2, P144, DOI 10.3934/bioeng.2015.3.144; Fu SL, 2008, J SURG RES, V148, P77, DOI 10.1016/j.jss.2008.03.005; Goodlad RA, 2006, CARCINOGENESIS, V27, P2133, DOI 10.1093/carcin/bgl113; Hagler M, 2007, J ALLERGY CLIN IMMUN, V119, pS263, DOI 10.1016/j.jaci.2006.12.399; Hardin R, 2007, J SURG RES, V142, P314, DOI 10.1016/j.jss.2007.04.025; Isoda H, 1997, BIOSCI BIOTECH BIOCH, V61, P609, DOI 10.1271/bbb.61.609; Jing C, 2006, ENZYME MICROB TECH, V39, P501, DOI 10.1016/j.enzmictec.2005.12.022; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Kralova I, 2009, J DISPER SCI TECHNOL, V30, P1363, DOI 10.1080/01932690902735561; Kumar V., 2012, ROBBINS BASIC PATHOL, V14, P928; Lang S, 1999, APPL MICROBIOL BIOT, V51, P22, DOI 10.1007/s002530051358; Levin Jacquelyn, 2011, J Clin Aesthet Dermatol, V4, P31; Li JS, 2016, APPL MICROBIOL BIOT, V100, P1307, DOI 10.1007/s00253-015-7091-2; Ma XJ, 2012, J COLLOID INTERF SCI, V376, P165, DOI 10.1016/j.jcis.2012.03.007; Manzke C, 1999, PROZESSABHA NGIGE AU; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Montoneri E, 2009, WASTE MANAGE, V29, P383, DOI 10.1016/j.wasman.2008.01.011; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009; Napolitano LM, 2006, CRIT CARE MED, V34, P258, DOI 10.1097/01.CCM.0000196082.26483.F0; Nitschke M, 2007, TRENDS FOOD SCI TECH, V18, P252, DOI 10.1016/j.tifs.2007.01.002; Nunez A, 2001, CHROMATOGRAPHIA, V53, P673, DOI 10.1007/BF02493019; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Petroianu A, 2007, EXPERT OPIN DRUG SAF, V6, P199, DOI 10.1517/14740338.6.2.199; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Ribeiro IAC, 2015, J MOL RECOGNIT, V28, P155, DOI 10.1002/jmr.2403; Rodrigues LR, 2010, ADV EXP MED BIOL, V672, P75; Roelants SL, 2015, BIOTECHNOLOGY BIOENG; Shah V, 2005, ANTIMICROB AGENTS CH, V49, P4093, DOI 10.1128/AAC.49.10.4093-4100.2005; Shao LJ, 2012, J SURG RES, V173, P286, DOI 10.1016/j.jss.2010.09.013; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; You SJ, 2006, INT J EXP PATHOL, V87, P227, DOI 10.1111/j.1365-2613.2006.00477.x	47	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156845	10.1371/journal.pone.0156845	http://dx.doi.org/10.1371/journal.pone.0156845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271048	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200021
J	Ma, ZH; Huang, BL; Xu, SS; Chen, Y; Cao, GQ; Ding, GC; Lin, SZ				Ma, Zhihui; Huang, Binlong; Xu, Shanshan; Chen, Yu; Cao, Guangqiu; Ding, Guochang; Lin, Sizu			Ion Flux in Roots of Chinese Fir (Cunninghamia lanceolata (Lamb.) Hook) under Aluminum Stress	PLOS ONE			English	Article							COMPETITIVE AL-3+ INHIBITION; NET MG-2+ UPTAKE; OXALIC-ACID; TOXICITY; RESISTANCE; CALCIUM; H+; POTASSIUM; TOLERANCE; SECRETION	Chinese fir is a tall, fast-growing species that is unique to southern China. In Chinese fir plantations, successive plantings have led to a decline in soil fertility, and aluminum toxicity is thought to be one of the main reasons for this decline. In this study, Non-invasive Microtest Technology was used to study the effect of aluminum stress on the absorption of 4 different ions in the roots of the Chinese fir clone FS01. The results are as follows: with increased aluminum concentration and longer periods of aluminum stress, the H+ ion flow gradually changed from influx into efflux; there was a large variation in the K+ efflux, which gradually decreased with increasing duration of aluminum stress; and 1 h of aluminum stress uniformly resulted in Ca2+ influx, but it changed from influx to efflux after a longer period of aluminum stress. Changes in the different concentrations of aluminum had the largest influence on Mg2+.	[Ma, Zhihui] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Ma, Zhihui; Huang, Binlong; Xu, Shanshan; Chen, Yu; Cao, Guangqiu; Ding, Guochang; Lin, Sizu] State Forestry Adm Engn Res Ctr Chinese Fir, Fuzhou, Fujian, Peoples R China; [Huang, Binlong] Fujian Prov Forestry Survey & Design Inst, Fuzhou, Fujian, Peoples R China; [Xu, Shanshan; Chen, Yu; Cao, Guangqiu; Ding, Guochang; Lin, Sizu] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, SZ (corresponding author), State Forestry Adm Engn Res Ctr Chinese Fir, Fuzhou, Fujian, Peoples R China.; Lin, SZ (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China.	szlin53@126.com			local special program "Chinese fir plantations in colleges and universities cultivate innovative team building" [6213c0111]	local special program "Chinese fir plantations in colleges and universities cultivate innovative team building"	Funding for this work was provided by central financial support from the local special program "Chinese fir plantations in colleges and universities cultivate innovative team building" (6213c0111).; Funding for this work was provided by central financial support from the local special program "Chinese fir plantations in colleges and universities cultivate innovative team building" (6213c0111). We thank the Center for Genomics and Biotechnology, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University for providing the ultra-thin semiautomatic microtome. We also thank AJE (American Journal Experts) for editing our manuscript for grammar, punctuation, diction and spelling.	BARCELO J, 1990, J PLANT NUTR, V13, P1, DOI 10.1080/01904169009364057; Bose J, 2013, PLANT CELL PHYSIOL, V54, P1093, DOI 10.1093/pcp/pct064; Cao YP, 2011, MOL BIOL REP, V38, P4839, DOI 10.1007/s11033-010-0618-9; Chen L, 2012, PLANTA, V235, P375, DOI 10.1007/s00425-011-1514-9; Chen Q, 2015, PLANT CELL PHYSL; CUMMING JR, 1985, CAN J BOT, V63, P1099, DOI 10.1139/b85-151; Facanha AR, 2002, PLANT PHYSIOL, V129, P1763, DOI 10.1104/pp.001651; FOY CD, 1988, COMMUN SOIL SCI PLAN, V19, P959, DOI 10.1080/00103628809367988; KASAI M, 1992, PLANT CELL PHYSIOL, V33, P1035; Kawano T, 2003, BIOCHEM BIOPH RES CO, V308, P35, DOI 10.1016/S0006-291X(03)01286-5; Kinraide TB, 2003, EUR J SOIL SCI, V54, P323, DOI 10.1046/j.1365-2389.2003.00538.x; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; LAZOF DB, 1994, PLANT PHYSIOL, V106, P1107, DOI 10.1104/pp.106.3.1107; Li J, 2014, PLANT AN GEN 22 C; Liu K, 2001, PLANT CELL, V13, P1453, DOI 10.1105/tpc.13.6.1453; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; [马丽 Ma Li], 2010, [海洋科学, Marine Sciences], V34, P41; Ma QF, 2002, ANN BOT-LONDON, V89, P241, DOI 10.1093/aob/mcf017; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; MATSUMOTO H, 1991, DEV PLANT SOIL SCI, V45, P825; NICHOL BE, 1993, PLANT PHYSIOL, V101, P1263, DOI 10.1104/pp.101.4.1263; OLIVETTI GP, 1995, PLANT PHYSIOL, V109, P123; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; Qing Y, 2000, CHINESE J OIL CROP S, V122, P68; Rengel Z, 1996, NEW PHYTOL, V134, P389, DOI 10.1111/j.1469-8137.1996.tb04356.x; RENGEL Z, 1990, PLANT PHYSIOL, V93, P1261, DOI 10.1104/pp.93.3.1261; RENGEL Z, 1989, PLANT PHYSIOL, V91, P1407, DOI 10.1104/pp.91.4.1407; RENGEL Z, 1989, PLANT SOIL, V116, P223, DOI 10.1007/BF02214551; RYAN PR, 1993, PLANT PHYSIOL, V102, P975, DOI 10.1104/pp.102.3.975; RYAN PR, 1994, PLANTA, V192, P98; Shen H, 2005, PLANT PHYSIOL, V138, P287, DOI 10.1104/pp.104.058065; ULRICH B, 1980, SOIL SCI, V130, P193, DOI 10.1097/00010694-198010000-00005; Wang CY, 2013, J PROTEOMICS, V78, P281, DOI 10.1016/j.jprot.2012.09.035; Wang H, 2015, NEW PHYTOL, V205, P273, DOI 10.1111/nph.13011; Zhang ZY, 2011, PLANT CELL REP, V30, P1701, DOI 10.1007/s00299-011-1078-y; ZHAO XJ, 1987, PLANT PHYSIOL, V83, P159, DOI 10.1104/pp.83.1.159; Zheng SJ, 1998, PLANT PHYSIOL, V117, P745, DOI 10.1104/pp.117.3.745	38	8	8	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156832	10.1371/journal.pone.0156832	http://dx.doi.org/10.1371/journal.pone.0156832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270726	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200020
J	Abu-Madi, M; Behnke, JM; Sharma, A; Bearden, R; Al-Banna, N				Abu-Madi, Marawan; Behnke, Jerzy M.; Sharma, Aarti; Bearden, Rebecca; Al-Banna, Nadia			Prevalence of Virulence/Stress Genes in Campylobacter jejuni from Chicken Meat Sold in Qatari Retail Outlets	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; HOSPITALIZED CHILDREN; RAW CHICKEN; IDENTIFICATION; CARCASSES; SPP.; COLI; PCR; GASTROENTERITIS; INFECTIONS	Chicken meat from the shelves of supermarkets in Qatar was tested for the presence of Campylobacter spp. and the presence of five virulence genes (htrB, cdtB, clpP, cadF and ciaB) was assessed in isolates. Forty eight percent of the chickens provided for supermarkets by Saudi (53%) and Qatari (45.9%) producers were found to be contaminated and the most important factor affecting the overall prevalence of contaminated chickens was the store from which chicken samples originated. Variation in prevalence of Campylobacter in chicken meat from different stores was evident even when the same producer supplied the three stores in our survey. Differences in the prevalence and in the combinations of virulence genes in isolates that can and cannot grow in a classic maintenance medium (Karmali) were identified, providing a starting point for linking presence/absence of particular virulence genes with actual in vivo virulence and pathogenicity. Because of the relatively low infective doses of Campylobacter that are required to initiate infection in humans, it will be important to explore further the relationships we identified between certain Campylobacter virulence genes and their capacity for survival in poultry meat, and hence their contribution to the incidence of campylobacteriosis.	[Abu-Madi, Marawan; Sharma, Aarti; Bearden, Rebecca] Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Biomed Res Ctr, POB 2713, Doha, Qatar; [Behnke, Jerzy M.] Univ Nottingham, Sch Life Sci, Univ Pk, Nottingham NG7 2RD, England; [Al-Banna, Nadia] Qatar Univ, Coll Med, POB 2713, Doha, Qatar	Qatar University; University of Nottingham; Qatar University	Abu-Madi, M (corresponding author), Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Biomed Res Ctr, POB 2713, Doha, Qatar.	abumadi@qu.edu.qa	Bearden, Rebecca/AAO-1851-2021	Bearden, Rebecca/0000-0001-9342-5304; Abu-Madi, Marawan/0000-0001-7843-1255	National Priority Research Program from the Qatar National Research Fund a member of Qatar Foundation [NPRP4-164-4-001]	National Priority Research Program from the Qatar National Research Fund a member of Qatar Foundation(Qatar National Research Fund (QNRF))	This publication was made possible by a National Priority Research Program grant number NPRP4-164-4-001 from the Qatar National Research Fund (http://www.qnrf.org/), a member of Qatar Foundation. The statements made herein are solely the responsibility of the authors. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acke E, 2009, VET REC, V164, P44, DOI 10.1136/vr.164.2.44; AKHTER J, 1994, J INT MED RES, V22, P47, DOI 10.1177/030006059402200106; Al-Mahmeed A, 2006, J MED MICROBIOL, V55, P839, DOI 10.1099/jmm.0.46500-0; Al-Shaikh Sana A., 2007, Acta Microbiologica et Immunologica Hungarica, V54, P139, DOI 10.1556/AMicr.54.2007.2.4; ALFREIHI H, 1993, E AFR MED J, V70, P267; Ansari-Lari M, 2011, INT J FOOD MICROBIOL, V144, P475, DOI 10.1016/j.ijfoodmicro.2010.11.003; Chaisowwong W, 2012, J VET MED SCI, V74, P43, DOI 10.1292/jvms.11-0305; Chansiripornchai N, 2009, J VET MED SCI, V71, P839, DOI 10.1292/jvms.71.839; COVER TL, 1990, FEMS MICROBIOL LETT, V70, P301, DOI 10.1016/S0378-1097(05)80012-6; Datta S, 2003, J MED MICROBIOL, V52, P345, DOI 10.1099/jmm.0.05056-0; Denis M, 2001, J APPL MICROBIOL, V91, P255, DOI 10.1046/j.1365-2672.2001.01380.x; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Ghazwan J, 2006, THESIS ARABIAN GULF, V66; Ghunaim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119268; GRIFFITHS PL, 1990, J APPL BACTERIOL, V69, P281, DOI 10.1111/j.1365-2672.1990.tb01519.x; Habib I, 2008, FOOD MICROBIOL, V25, P65, DOI 10.1016/j.fm.2007.07.010; Horrocks SM, 2009, ANAEROBE, V15, P18, DOI 10.1016/j.anaerobe.2008.09.001; Ismaeel AY, 2002, SAUDI MED J, V23, P1064; Jain D, 2008, J MED MICROBIOL, V57, P267, DOI 10.1099/jmm.0.47317-0; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Jorgensen F, 2002, INT J FOOD MICROBIOL, V76, P151, DOI 10.1016/S0168-1605(02)00027-2; Josefsen MH, 2010, APPL ENVIRON MICROB, V76, P5097, DOI 10.1128/AEM.00411-10; Jumaa PA, 2005, J CHEMOTHERAPY, V17, P376, DOI 10.1179/joc.2005.17.4.376; KARMALI MA, 1986, J CLIN MICROBIOL, V23, P743, DOI 10.1128/JCM.23.4.743-747.1986; Keener KM, 2004, COMPR REV FOOD SCI F, V3, P105, DOI 10.1111/j.1541-4337.2004.tb00060.x; Konkel ME, 1998, INFECT IMMUN, V66, P3666, DOI 10.1128/IAI.66.8.3666-3672.1998; Konkel ME, 1999, J CLIN MICROBIOL, V37, P510, DOI 10.1128/JCM.37.3.510-517.1999; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Oliver JD, 2005, J MICROBIOL, V43, P93; Oyarzabal OA, 2007, J MICROBIOL METH, V69, P129, DOI 10.1016/j.mimet.2006.12.011; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Rahimi E, 2010, POULTRY SCI, V89, P1015, DOI 10.3382/ps.2009-00090; Rahimi E, 2010, AFR J MICROBIOL RES, V4, P1620; Rohlf F.J., 1995, STAT TABLES; Rozynek E, 2005, J MED MICROBIOL, V54, P615, DOI 10.1099/jmm.0.45988-0; SAHA SK, 1991, APPL ENVIRON MICROB, V57, P3388, DOI 10.1128/AEM.57.11.3388-3389.1991; SETHI SK, 1989, PEDIATR INFECT DIS J, V8, P593, DOI 10.1097/00006454-198909000-00005; Son I, 2007, INT J FOOD MICROBIOL, V113, P16, DOI 10.1016/j.ijfoodmicro.2006.06.033; Stern NJ, 2003, EPIDEMIOL INFECT, V130, P23, DOI 10.1017/S0950268802007914; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Szymanski CM, 2012, GUT MICROBES, V3, P135, DOI 10.4161/gmic.19488; Taremi M, 2006, INT J FOOD MICROBIOL, V108, P401, DOI 10.1016/j.ijfoodmicro.2005.12.010; Tauxe R V, 1988, MMWR CDC Surveill Summ, V37, P1; Vellinga A, 2002, EMERG INFECT DIS, V8, P19, DOI 10.3201/eid0801.010129; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Yehia HM, 2014, INT J FOOD CONTAMINA, V1, P2, DOI [10.1186/s40550-014-0002-y, DOI 10.1186/S40550-014-0002-Y]; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	50	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156938	10.1371/journal.pone.0156938	http://dx.doi.org/10.1371/journal.pone.0156938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258021	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700160
J	Kondratick, CM; Boehm, EM; Dieckman, LM; Powers, KT; Sanchez, JC; Mueting, SR; Washington, MT				Kondratick, Christine M.; Boehm, Elizabeth M.; Dieckman, Lynne M.; Powers, Kyle T.; Sanchez, Julio C.; Mueting, Samuel R.; Washington, M. Todd			Identification of New Mutations at the PCNA Subunit Interface that Block Translesion Synthesis	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; FAMILY DNA-POLYMERASES; XERODERMA-PIGMENTOSUM; DAMAGE TOLERANCE; POL-ETA; REPLICATION; PROTEIN; BYPASS; REPAIR; ROLES	Proliferating cell nuclear antigen (PCNA) plays an essential role in DNA replication and repair by interacting with a large number of proteins involved in these processes. Two amino acid substitutions in PCNA, both located at the subunit interface, have previously been shown to block translesion synthesis (TLS), a pathway for bypassing DNA damage during replication. To better understand the role of the subunit interface in TLS, we used random mutagenesis to generate a set of 33 PCNA mutants with substitutions at the subunit interface. We assayed the full set of mutants for viability and sensitivity to ultraviolet (UV) radiation. We then selected a subset of 17 mutants and measured their rates of cell growth, spontaneous mutagenesis, and UV-induced mutagenesis. All except three of these 17 mutants were partially or completely defective in induced mutagenesis, which indicates a partial or complete loss of TLS. These results demonstrate that the integrity of the subunit interface of PCNA is essential for efficient TLS and that even conservative substitutions have the potential to disrupt this process.	[Kondratick, Christine M.; Boehm, Elizabeth M.; Powers, Kyle T.; Sanchez, Julio C.; Mueting, Samuel R.; Washington, M. Todd] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Dieckman, Lynne M.] Creighton Univ, Dept Chem, Omaha, NE 68178 USA	University of Iowa; Creighton University	Washington, MT (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	todd-washington@uiowa.edu		Washington, Todd/0000-0001-8680-2992; Mueting, Samuel/0000-0001-7476-5186; Powers, Kyle/0000-0003-3240-6534	National Institute of General Medicine [TGM081433, GM108027]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108027, R01GM081433] Funding Source: NIH RePORTER	National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by TGM081433 and GM108027 from the National Institute of General Medicine to MTW.	Amin NS, 1996, GENETICS, V144, P479; Dieckman LM, 2013, DNA REPAIR, V12, P367, DOI 10.1016/j.dnarep.2013.02.007; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Freudenthal BD, 2011, J MOL BIOL, V406, P9, DOI 10.1016/j.jmb.2010.12.015; Freudenthal BD, 2009, ACTA CRYSTALLOGR D, V65, P560, DOI 10.1107/S0907444909011329; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lehmann AR, 2003, CELL CYCLE, V2, P300, DOI 10.4161/cc.2.4.407; Lehmann AR, 2005, FEBS LETT, V579, P873, DOI 10.1016/j.febslet.2004.11.029; LuCore SD, 2015, BIOPHYS J, V109, P816, DOI 10.1016/j.bpj.2015.06.062; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Washington MT, 2010, BBA-PROTEINS PROTEOM, V1804, P1113, DOI 10.1016/j.bbapap.2009.07.004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Zhang HS, 2006, GENETICS, V173, P1983, DOI 10.1534/genetics.106.058545; Zhuang ZH, 2008, P NATL ACAD SCI USA, V105, P5361, DOI 10.1073/pnas.0801310105	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157023	10.1371/journal.pone.0157023	http://dx.doi.org/10.1371/journal.pone.0157023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258147	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700172
J	Park, KM; Im, SI; Kim, EK; Lee, SC; Park, SJ; Kim, JS; On, YK				Park, Kyoung-min; Im, Sung Il; Kim, Eun Kyoung; Lee, Sang-chol; Park, Seung-jung; Kim, June Soo; On, Young Keun			Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?	PLOS ONE			English	Article							CLINICAL-COURSE; OBSTRUCTION; POPULATION; SEVERITY; EXERCISE; AFFIRM; STROKE; MARKER; VOLUME; IMPACT	Hypertrophic cardiomyopathy (HCM) is a cardiac disease associated with a high incidence of atrial fibrillation (AF). Recent studies have suggested that interventricular septum thickness may influence the risk stratification of patients with AF. We evaluated the effects of septal hypertrophy on morbidity and mortality in patients with HCM. Patients were followed for a median of 6.1 years and were divided into two groups according to the extent of septal hypertrophy. A total of 1,360 HCM patients were enrolled: 482(33%) apical or apicoseptal, 415(28%) asymmetric septal, 388(27%) basal septal, 38(2.6%) concentric, and 37(2.5%) diffuse and mixed type. Ninety-two all-cause deaths and 21 cardiac deaths occurred. The total event rates were significantly higher for patients with HCM with more extensive septal hypertrophy (group A) compared to those with HCM +/- focal septal hypertrophy (group B), regardless of type (p<0.001). Arrhythmias occurred in 502 patients, with a significantly higher incidence in group A than in group B (p<0.001). Among patients with arrhythmias, the incidence of AF was significantly higher in group A than group B (p<0.001). In univariate Cox analysis, a greater extent of septal hypertrophy (p<0.001), E/E' ratio (p = 0.011), and mitral regurgitation grade (p = 0.003) were significantly associated with developing AF. In multivariate Cox analyses, a greater extent of septal hypertrophy [ odds ratio (OR) 5.44 (2.29-12.92), p<0.001] in patients with HCM was significantly associated with developing AF. In conclusion, a greater extent of septal hypertrophy is an independent predictor of progression to AF in patients with HCM.	[Park, Kyoung-min; Kim, Eun Kyoung; Lee, Sang-chol; Park, Seung-jung; Kim, June Soo; On, Young Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul 135710, South Korea; [Im, Sung Il] Kosin Univ, Coll Med, Kosin Univ Gospel Hosp, Div Cardiol,Dept Internal Med, Busan 602702, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	On, YK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul 135710, South Korea.	yk.on@samsung.com						Apostolakis S, 2014, INT J CARDIOL, V170, P303, DOI 10.1016/j.ijcard.2013.11.002; Autore C, 2005, J AM COLL CARDIOL, V45, P1076, DOI 10.1016/j.jacc.2004.12.067; Avegliano G, 2014, J CARDIOVASC MED, V15, P207, DOI 10.2459/JCM.0b013e3283638093; BONOW RO, 1985, CIRCULATION, V72, P853, DOI 10.1161/01.CIR.72.4.853; Doi Y, 2001, J Cardiol, V37 Suppl 1, P133; Geske JB, 2013, J AM COLL CARDIOL, V61, P2456, DOI 10.1016/j.jacc.2013.04.004; Kim SH, 2013, INT HEART J, V54, P207, DOI 10.1536/ihj.54.207; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; Kubo T, 2009, CIRC J, V73, P1599, DOI 10.1253/circj.CJ-09-0140; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; MARON BJ, 1994, AM J CARDIOL, V73, P577, DOI 10.1016/0002-9149(94)90337-9; Maron MS, 2009, J AM COLL CARDIOL, V54, P866, DOI 10.1016/j.jacc.2009.04.072; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Olshansky B, 2005, J AM COLL CARDIOL, V45, P2026, DOI 10.1016/j.jacc.2005.03.020; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; Yang H, 2005, J AM SOC ECHOCARDIOG, V18, P1074, DOI 10.1016/j.echo.2005.06.011	20	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156410	10.1371/journal.pone.0156410	http://dx.doi.org/10.1371/journal.pone.0156410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258035	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700060
J	Spexoto, MCB; Serrano, SV; Halliday, V; Maroco, J; Campos, JADB				Bernardes Spexoto, Maria Claudia; Serrano, Sergio Vicente; Halliday, Vanessa; Maroco, Joao; Duarte Bonini Campos, Juliana Alvares			Cancer Appetite and Symptom Questionnaire (CASQ) for Brazilian Patients: Cross-Cultural Adaptation and Validation Study	PLOS ONE			English	Article							WEIGHT-LOSS; NUTRITIONAL ASSESSMENT; ANOREXIA; MALNUTRITION; CACHEXIA; MANAGEMENT; INDICATOR	Background Appetite and symptoms, conditions generally reported by the patients with cancer, are somewhat challenging for professionals to measure directly in clinical routine (latent conditions). Therefore, specific instruments are required for this purpose. This study aimed to perform a cultural adaptation of the Cancer Appetite and Symptom Questionnaire (CASQ), into Portuguese and evaluate its psychometric properties on a sample of Brazilian cancer patients. Methods This is a validation study with Brazilian cancer patients. The face, content, and construct (factorial and convergent) validities of the Cancer Appetite and Symptom Questionnaire, the study tool, were estimated. Further, a confirmatory factor analysis (CFA) was conducted. The ratio of chi-square and degrees of freedom (chi(2)/df), comparative fit index (CFI), goodness of fit index (GFI) and root mean square error of approximation (RMSEA) were used for fit model assessment. In addition, the reliability of the instrument was estimated using the composite reliability (CR) and Cronbach's alpha coefficient (a), and the invariance of the model in independent samples was estimated by a multigroup analysis (Delta chi(2)). Results Participants included 1,140 cancer patients with a mean age of 53.95 (SD = 13.25) years; 61.3% were women. After the CFA of the original CASQ structure, 2 items with inadequate factor weights were removed. Four correlations between errors were included to provide adequate fit to the sample (chi(2)/df = 8.532, CFI = .94, GFI = .95, and RMSEA = .08). The model exhibited a low convergent validity (AVE = .32). The reliability was adequate (CR = .82 a = .82). The refined model showed strong invariance in two independent samples (Delta chi(2):lambda: p = .855; i: p = .824; Res: p = .390). A weak stability was obtained between patients undergoing chemotherapy and radiotherapy (Delta chi(2):lambda: p = .155; i: p < .001; Res: p < .001), and between patients undergoing chemotherapy combined with radiotherapy and palliative care (Delta chi(2):lambda: p = .058; i: p < .001; Res: p < .001). Conclusion The Portuguese version of the CASQ had good face and construct validity and reliability. However, the CASQ still presented invariance in independent samples of Brazilian patients with cancer. However, the tool has low convergent validity and weak invariance in samples with different treatments.	[Bernardes Spexoto, Maria Claudia] Univ Estadual Paulista, Dept Alimentos & Nutr, Fac Ciencias Farmaceut Araraquara, UNESP, Rod Araraqura Jau,Km 01, Sao Paulo, Brazil; [Serrano, Sergio Vicente] Fundacao Pio XII Barretos, Barretos Canc Hosp, Sao Paulo, Brazil; [Halliday, Vanessa] Univ Sheffield, Sch Hlth & Related Res, Publ Hlth, Sheffield, S Yorkshire, England; [Maroco, Joao] ISPA IU, Dept Ciencias Psicol, Rua Jardim Tabaco 34, P-1149041 Lisbon, Portugal; [Maroco, Joao] ISPA IU, Unidade Invest Psicol & Saude, Rua Jardim Tabaco 34, P-1149041 Lisbon, Portugal; [Duarte Bonini Campos, Juliana Alvares] Univ Estadual Paulista, UNESP, Dept Alimentos & Nutr, Fac Ciencias Farmaceut Araraquara, Rod Araraquara Jau,Km 01, Sao Paulo, Brazil	Universidade Estadual Paulista; Hospital de Cancer de Barretos; University of Sheffield; Instituto Superior Psicologia Aplicada (ISPA); Instituto Superior Psicologia Aplicada (ISPA); Universidade Estadual Paulista	Campos, JADB (corresponding author), Univ Estadual Paulista, UNESP, Dept Alimentos & Nutr, Fac Ciencias Farmaceut Araraquara, Rod Araraquara Jau,Km 01, Sao Paulo, Brazil.	jucampos@fcfar.unesp.br	Marôco, João/H-3622-2019; Marôco, João P./A-5729-2010; Campos, Juliana Alvares Duarte Bonini/AAD-6383-2020	Marôco, João/0000-0001-9214-5378; Marôco, João P./0000-0001-9214-5378; Campos, Juliana Alvares Duarte Bonini/0000-0001-7123-5585; Spexoto, Maria Claudia Bernardes/0000-0001-7681-1422	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation) [2011/22620-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation), grant number 2011/22620-5 to JADBC (http://www.fapesp.br/en/) and by a scholarship for MCBS from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA ERA Education NCOMI, 1999, STAND ED PSYCH TEST; Associacao Brasileira de Empresas de Pesquisa, 2018, CRIT CLASS EC BRAS; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bovio G, 2014, AM J HOSP PALLIAT ME, V31, P20, DOI 10.1177/1049909112474713; Bozzetti F, 2013, CRIT REV ONCOL HEMAT, V87, P172, DOI 10.1016/j.critrevonc.2013.03.006; Bozzetti F, 2009, JPEN-PARENTER ENTER, V33, P361, DOI 10.1177/0148607108325076; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Campos JADB, 2013, REV BRAS BIOM, V31, P327; Davis MP, 2000, SUPPORT CARE CANCER, V8, P180, DOI 10.1007/s005200050282; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Campos JADB, 2012, REV SAUDE PUBL, V46, P816, DOI 10.1590/S0034-89102012000500008; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gioulbasanis I, 2011, ANN ONCOL, V22, P835, DOI 10.1093/annonc/mdq440; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hair Jf, 2005, MULTIVARIATE DATA AN; Halliday V, 2012, J HUM NUTR DIET, V25, P217, DOI 10.1111/j.1365-277X.2012.01233.x; Kaplan D., 2009, STRUCTURAL EQUATION, V2; Kline RB, PRINCIPLES IN PRESS; Kruizenga HM, 2005, CLIN NUTR, V24, P75, DOI 10.1016/j.clnu.2004.07.015; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Loh KW, 2012, NETH J MED, V70, P365; Marco J., 2014, ANALISE EQUACOES EST; Maroco J., 2006, LAB PSICOL, V4, P65, DOI [https://doi.org/10.14417/lp.763, DOI 10.14417/LP.763]; Mathey M F, 2001, J Nutr Health Aging, V5, P22; Mercadante S, 2000, J PAIN SYMPTOM MANAG, V20, P104, DOI 10.1016/S0885-3924(00)00160-3; Muliawati Yanti, 2012, Acta Med Indones, V44, P154; Nicolini A, 2013, BIOMED PHARMACOTHER, V67, P807, DOI 10.1016/j.biopha.2013.08.005; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Ribaudo JM, 2000, QUAL LIFE RES, V9, P1137, DOI 10.1023/A:1016670403148; Shragge JE, 2007, PALLIATIVE MED, V21, P227, DOI 10.1177/0269216307077172; Shragge JE, 2006, PALLIATIVE MED, V20, P623, DOI 10.1177/0269216306070322; Teixeira C, 2013, REV ELECT ESPACO TEO, V7; Tisdale M J, 2001, Nutrition, V17, P438, DOI 10.1016/S0899-9007(01)00506-8; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074; Yavuzsen T, 2009, SUPPORT CARE CANCER, V17, P1531, DOI 10.1007/s00520-009-0623-5	35	5	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156288	10.1371/journal.pone.0156288	http://dx.doi.org/10.1371/journal.pone.0156288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TJ	27275947	Green Published, gold, Green Accepted			2022-12-27	WOS:000377561700022
J	Ghosal, R; Xiong, PX; Sorensen, PW				Ghosal, Ratna; Xiong, Peter X.; Sorensen, Peter W.			Invasive Bighead and Silver Carps Form Different Sized Shoals that Readily Intermix	PLOS ONE			English	Article							DENSITY-DEPENDENT PREDATION; SELFISH HERD; FISH SCHOOLS; MISSISSIPPI RIVER; COMMON CARP; ASIAN CARP; BEHAVIOR; AGGREGATION; GROWTH; PREY	Two species of congeneric filter-feeding microphagous carps from Asia, the bighead and the silver carp, were recently introduced to North America and have become highly invasive. These species of carp have similar food habits but the silver carp has the unique habit of jumping when disturbed. Both species have complex but poorly understood social behaviors and while both are thought to aggregate (form groups) and shoal (form tight social groups), this possibility has not yet been examined in these species. The present study examined the grouping tendencies of these species in the laboratory and the effects of fish density and species identity on it. Using nearest neighbor distance (NND) as a metric, we showed that both juvenile bighead and juvenile silver carp grouped (aggregate) strongly (P<0.05) but to different extents, and that fish density had no effect (P>0.05) on this behavior. Within aggregations, bighead carp tended to form a single large shoal while silver carp formed shoals of 2-3 individuals. Further, when tested as mixed-species groups, bighead and silver carp readily shoaled with each other but not with the common carp, which is from Eurasia and a member of another feeding guild. Due to their similar feeding strategies, we speculate that the bighead and silver carp tend to aggregate and shoal to facilitate both their foraging efforts and to avoid predation, while the differences in the size of the shoals they form may seemingly reflect their different anti-predation strategies. These complex shoaling behaviors likely influence Asian carp distribution in rivers, and thus how they might be sampled and managed.	[Ghosal, Ratna; Xiong, Peter X.; Sorensen, Peter W.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ghosal, R (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	rghosal@umn.edu	GHOSAL, RATNA/AAB-9470-2020	Sorensen, Peter/0000-0003-0321-1279; Ghosal, RATNA/0000-0002-2295-453X	Minnesota Environment; Natural Resources Trust Fund; Minnesota Aquatic Invasive Species Research Centre	Minnesota Environment; Natural Resources Trust Fund; Minnesota Aquatic Invasive Species Research Centre	Funding for this project was provided by the Minnesota Environment and Natural Resources Trust Fund in association with Minnesota Aquatic Invasive Species Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRCC, 2015, AS CARP CONTR STRAT; Bajer PG, 2011, FISHERIES MANAG ECOL, V18, P497, DOI 10.1111/j.1365-2400.2011.00805.x; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; BOHNSACK JA, 1989, B MAR SCI, V44, P631; Brierley AS, 2010, CURR BIOL, V20, P1758, DOI 10.1016/j.cub.2010.08.041; CHRISTENSEN B, 1993, BEHAV ECOL SOCIOBIOL, V32, P1; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Cuddington K, 2014, BIOL INVASIONS, V16, P903, DOI 10.1007/s10530-013-0547-3; Degrandchamp KL, 2008, T AM FISH SOC, V137, P45, DOI 10.1577/T06-116.1; Dempster T, 2010, ESTUAR COAST SHELF S, V86, P271, DOI 10.1016/j.ecss.2009.11.007; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; GREEN BW, 1984, AQUACULTURE, V37, P87, DOI 10.1016/0044-8486(84)90046-2; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hansen A, 2014, J EXP BIOL, V217, P3945, DOI 10.1242/jeb.107870; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Kolar C.S., 2005, ASIAN CARPS GENUS HY; Kolar CS, 2007, AM FISH SOC, V33; KRAUSE J, 1993, ANIM BEHAV, V45, P1019, DOI 10.1006/anbe.1993.1119; Krause J, 2000, BIOL REV, V75, P477; Lamer JT, 2010, N AM J FISH MANAGE, V30, P1452, DOI 10.1577/M10-053.1; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LUBINSKI KS, 1986, HYDROBIOLOGIA, V136, P141, DOI 10.1007/BF00051511; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; MORSE DH, 1977, BIOSCIENCE, V27, P332, DOI 10.2307/1297632; OATEN A, 1977, AM NAT, V111, P1061, DOI 10.1086/283238; PARRISH JK, 1989, ENVIRON BIOL FISH, V26, P79, DOI 10.1007/BF00001024; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Patil JG, 2015, GEN COMP ENDOCR, V221, P173, DOI 10.1016/j.ygcen.2015.03.005; PITCHER TJ, 1983, ANIM BEHAV, V31, P546, DOI 10.1016/S0003-3472(83)80078-5; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Pitcher TJ, 1993, BEHAV TELEOST FISHES, V7, P294; Robinson CJ, 2007, J FISH BIOL, V71, P200, DOI 10.1111/j.1095-8649.2007.01484.x; RYER CH, 1995, ANIM BEHAV, V49, P411, DOI 10.1006/anbe.1995.0054; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; Sandin SA, 2005, ECOLOGY, V86, P1520, DOI 10.1890/03-0654; Sorensen PW, 2015, FISH PHEROMONES AND RELATED CUES, P1; Ward AJW, 2003, P ROY SOC B-BIOL SCI, V270, P1157, DOI 10.1098/rspb.2003.2337; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Williamson CJ, 2005, T AM FISH SOC, V134, P1423, DOI 10.1577/T04-106.1	42	10	10	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157174	10.1371/journal.pone.0157174	http://dx.doi.org/10.1371/journal.pone.0157174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276024	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700079
J	Goncalves, AB; Souza, S; da Silva, GG; Cereda, MP; Pott, A; Naka, MH; Pistori, H				Goncalves, Ariadne Barbosa; Souza, Junior Silva; da Silva, Gercina Goncalves; Cereda, Marney Pascoli; Pott, Arnildo; Naka, Marco Hiroshi; Pistori, Hemerson			Feature Extraction and Machine Learning for the Classification of Brazilian Savannah Pollen Grains	PLOS ONE			English	Article								The classification of pollen species and types is an important task in many areas like forensic palynology, archaeological palynology and melissopalynology. This paper presents the first annotated image dataset for the Brazilian Savannah pollen types that can be used to train and test computer vision based automatic pollen classifiers. A first baseline human and computer performance for this dataset has been established using 805 pollen images of 23 pollen types. In order to access the computer performance, a combination of three feature extractors and four machine learning techniques has been implemented, fine tuned and tested. The results of these tests are also presented in this paper.	[Goncalves, Ariadne Barbosa; Naka, Marco Hiroshi; Pistori, Hemerson] Univ Catolica Dom Bosco, INOVISAO, Dept Biotechnol, Campo Grande, MG, Brazil; [Souza, Junior Silva; Pistori, Hemerson] Univ Fed Mato Grosso do Sul, Dept Comp Sci, Campo Grande, MG, Brazil; [da Silva, Gercina Goncalves; Cereda, Marney Pascoli; Pistori, Hemerson] Univ Catolica Dom Bosco, Dept Environm Sci & Agr Sustainabil, Campo Grande, MG, Brazil; [Pott, Arnildo] Univ Fed Mato Grosso do Sul, Lab Bot, Campo Grande, MG, Brazil; [Naka, Marco Hiroshi] Fed Inst Mato Grosso Sul, Direct Res Extens & Inst, Sci & Technol, Campo Grande, MG, Brazil	Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Mato Grosso do Sul; Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Mato Grosso do Sul; Instituto Federal de Mato Grosso do Sul	Goncalves, AB (corresponding author), Univ Catolica Dom Bosco, INOVISAO, Dept Biotechnol, Campo Grande, MG, Brazil.	ariadne.gon@gmail.com	Naka, Marco H/M-4287-2013; Cereda, Marney Pascoli/F-4439-2019; Pistori, Hemerson/G-3933-2012; Cereda, Marney Pascoli/AAH-9571-2020	Naka, Marco H/0000-0002-1440-8985; Cereda, Marney Pascoli/0000-0002-8181-7754; Pistori, Hemerson/0000-0001-8181-760X; Pott, Arnildo/0000-0002-8599-9276; BARBOSA GONCALVES, ARIADNE/0000-0003-2496-5723	Dom Bosco Catholic University, UCDB; Development of Education, Science and Technology; State of Mato Grosso do Sul, FUNDECT; Brazilian National Council of Technological and Scientific Development; CNPq; Coordination for the Improvement of Higher Education Personnel, CAPES	Dom Bosco Catholic University, UCDB; Development of Education, Science and Technology; State of Mato Grosso do Sul, FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Brazilian National Council of Technological and Scientific Development; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has received financial support from the Dom Bosco Catholic University, UCDB and the Foundation for the Support and Development of Education, Science and Technology from the State of Mato Grosso do Sul, FUNDECT. Some of the authors have been awarded with Scholarships from the the Brazilian National Council of Technological and Scientific Development, CNPq and the Coordination for the Improvement of Higher Education Personnel, CAPES.	Andrade WT, 2012, 25 C GRAPH PATT IM, P108; Bhargava N., 2013, PROC INT J ADV RES C, V3, P1114; Boucher Alain, 2002, Aerobiologia, V18, P195, DOI 10.1023/A:1021322813565; Chica M, 2012, J FOOD ENG, V112, P50, DOI 10.1016/j.jfoodeng.2012.03.028; del Pozo-Banos M, 2012, BIODIVERSITY ENRICHMENT IN A DIVERSE WORLD, P493, DOI 10.5772/47527; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; France I, 2000, QUATERNARY SCI REV, V19, P537, DOI 10.1016/S0277-3791(99)00021-9; Goncalves AB, 2011, 41 INT AP C BUEN AIR; Goncalves AB, 2013, CADERNOS AGROECOLOGI, V8, P14634; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; LANGFORD M, 1990, REV PALAEOBOT PALYNO, V64, P197, DOI 10.1016/0034-6667(90)90133-4; Lee H.-C., 2005, INTRO COLOR IMAGING; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Lozano-Vega G, 2013, LECT NOTES COMPUT SC, V8156, P712; Malik S., 2003, CSC2503F U TOR DEP C; Mateos I, 2008, 5 JORN TECN HABL BIL; Platt J., 1991, ADV KERNEL METHODS S, P185; Quinta LNB, 2013, VISAO COMPUTACIONAL; R Core Team, 2014, LANG ENV STAT COMP; Rodriguez-Damian M, 2006, IEEE T SYST MAN CY C, V36, P531, DOI 10.1109/TSMCC.2005.855426; Silva D. S. da, 2014, African Journal of Agricultural Research, V9, P908; Silva-Coiado DG, 2010, CARACTERIZACAO SETOR; Tuytelaars T., 2006, EUR C COMP VIS, V1, P404, DOI DOI 10.1007/11744023_32; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Witten I. H., 2005, DATA MINING PRACTICA; Yang J., 2007, P INT WORKSH MULT IN, P197, DOI DOI 10.1145/1290082.1290111; Zhang CH, 2013, PROCEDIA COMPUT SCI, V17, P1083, DOI 10.1016/j.procs.2013.05.137	28	40	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157044	10.1371/journal.pone.0157044	http://dx.doi.org/10.1371/journal.pone.0157044			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27276196	gold, Green Submitted, Green Published			2022-12-27	WOS:000377561700059
J	Marti-Fabregas, J; Prats-Sanchez, L; Martinez-Domeno, A; Camps-Renom, P; Marin, R; Jimenez-Xarrie, E; Fuentes, B; Dorado, L; Purroy, F; Arias-Rivas, S; Delgado-Mederos, R				Marti-Fabregas, Joan; Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Marin, Rebeca; Jimenez-Xarrie, Elena; Fuentes, Blanca; Dorado, Laura; Purroy, Francisco; Arias-Rivas, Susana; Delgado-Mederos, Raquel			The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; STROKE; GUIDELINES; MANAGEMENT; SYSTEM; RISK; CT	Background and Purpose There are no generally accepted criteria for the etiologic classification of intracerebral hemorrhage (ICH). For this reason, we have developed a set of etiologic criteria and have applied them to a large number of patients to determine their utility. Methods The H-ATOMIC classification includes 7 etiologic categories: Hypertension, cerebral Amyloid angiopathy, Tumour, Oral anticoagulants, vascular Malformation, Infrequent causes and Cryptogenic. For each category, the etiology is scored with three degrees of certainty: Possible(3), Probable(2) and Definite(1). Our aim was to perform a basic study consisting of neuroimaging, blood tests, and CT-angio when a numerical score (SICH) suggested an underlying structural abnormality. Combinations of > 1 etiologic category for an individual patient were acceptable. The criteria were evaluated in a multicenter and prospective study of consecutive patients with spontaneous ICH. Results Our study included 439 patients (age 70.8 +/- 14.5 years; 61.3% were men). A definite etiology was achieved in 176 (40.1% of the patients: Hypertension 28.2%, cerebral Amyloid angiopathy 0.2%, Tumour 0.2%, Oral anticoagulants 2.2%, vascular Malformation 4.5%, Infrequent causes 4.5%). A total of 7 patients (1.6%) were cryptogenic. In the remaining 58.3% of the patients, ICH was attributable to a single (n = 56, 12.7%) or the combination of >= 2 (n = 200, 45.5%) possible/probable etiologies. The most frequent combinations of etiologies involved possible hypertension with possible CAA (H(3)A(3), n = 38) or with probable CAA (H(3)A(2), n = 29), and probable hypertension with probable OA (H2O2, n = 27). The most frequent category with any degree of certainty was hypertension (H1+2+3 = 80.6%) followed by cerebral amyloid angiopathy (A(1+2+3) = 30.9%). Conclusions According to our etiologic criteria, only about 40% patients received a definite diagnosis, while in the remaining patients ICH was attributable to a single possible/probable etiology or to more than one possible/ probable etiology. The use of these criteria would likely help in the management of patients with ICH.	[Marti-Fabregas, Joan; Prats-Sanchez, Luis; Martinez-Domeno, Alejandro; Camps-Renom, Pol; Marin, Rebeca; Jimenez-Xarrie, Elena; Delgado-Mederos, Raquel] Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Neurol, Stroke Unit, Barcelona, Spain; [Fuentes, Blanca] Hosp Univ La Paz, Dept Neurol, Madrid, Spain; [Dorado, Laura] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Purroy, Francisco] Hosp Arnau Vilanova, Lleida, Spain; [Arias-Rivas, Susana] Complejo Hosp Univ Santiago, Santiago De Compostela, Spain	Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; Hospital Germans Trias i Pujol; University Hospital Arnau de Vilanova; Complexo Hospitalario Universitario de Santiago de Compostela	Marti-Fabregas, J (corresponding author), Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Neurol, Stroke Unit, Barcelona, Spain.	jmarti@santpau.cat	Purroy, Francisco/D-4538-2009; Fuentes, Blanca/I-2114-2019; Martí-Fàbregas, Joan/I-5933-2019	Purroy, Francisco/0000-0002-1808-5968; Fuentes, Blanca/0000-0002-0363-862X; Martí-Fàbregas, Joan/0000-0001-9229-8649; CAMPS-RENOM, POL/0000-0001-6587-6271; Martinez-Domeno, Alejandro/0000-0002-9933-3192	Ministery of Health-Instituto de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS [RD012/0014]; FEDER (Fondo Europeo de Desarrollo Regional)	Ministery of Health-Instituto de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission)	This work was supported by Ministery of Health-Instituto de Salud Carlos III: RETICS (Redes tematicas de Investigacion Cooperativa) INVICTUS RD012/0014 (JM-F, PC-R, AM-D, LP-S, RD-M), FEDER (Fondo Europeo de Desarrollo Regional). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; Almandoz JED, 2010, AM J NEURORADIOL, V31, P1653, DOI 10.3174/ajnr.A2156; Almandoz JED, 2009, AM J NEURORADIOL, V30, P1213, DOI 10.3174/ajnr.A1546; Amarenco P, 2009, CEREBROVASC DIS, V27, P502, DOI 10.1159/000210433; Bejot Y, 2013, BRAIN, V136, P658, DOI 10.1093/brain/aws349; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Cordonnier C, 2010, STROKE, V41, P685, DOI 10.1161/STROKEAHA.109.572495; Fiebach JB, 2004, STROKE, V35, P502, DOI 10.1161/01.STR.0000114203.75678.88; Flaherty ML, 2007, NEUROLOGY, V68, P116, DOI 10.1212/01.wnl.0000250340.05202.8b; Flaherty ML, 2010, SEMIN NEUROL, V30, P565, DOI 10.1055/s-0030-1268866; Greenberg SM, 2014, LANCET NEUROL, V13, P419, DOI 10.1016/S1474-4422(14)70003-1; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Macellari F, 2014, STROKE, V45, P903, DOI 10.1161/STROKEAHA.113.003701; Meretoja A, 2012, STROKE, V43, P2592, DOI 10.1161/STROKEAHA.112.661603; Ritter MA, 2005, NEUROLOGY, V64, P1233, DOI 10.1212/01.WNL.0000156522.93403.C3; Rodrigue KM, 2013, JAMA NEUROL, V70, P600, DOI 10.1001/jamaneurol.2013.1342; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503	25	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156992	10.1371/journal.pone.0156992	http://dx.doi.org/10.1371/journal.pone.0156992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275863	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561700056
J	Shimamura, Y; Aoki, N; Sugiyama, Y; Tanaka, T; Murata, M; Masuda, S				Shimamura, Yuko; Aoki, Natsumi; Sugiyama, Yuka; Tanaka, Takashi; Murata, Masatsune; Masuda, Shuichi			Plant-Derived Polyphenols Interact with Staphylococcal Enterotoxin A and Inhibit Toxin Activity	PLOS ONE			English	Article							FOOD; PROANTHOCYANIDINS; HEALTH; SUPERANTIGENS; METABOLITES; OUTBREAK; EXTRACTS; TANNINS; LEAVES; COLI	This study was performed to investigate the inhibitory effects of 16 different plant-derived polyphenols on the toxicity of staphylococcal enterotoxin A (SEA). Plant-derived polyphenols were incubated with the cultured Staphylococcus aureus C-29 to investigate the effects of these samples on SEA produced from C-29 using Western blot analysis. Twelve polyphenols (0.1-0.5 mg/mL) inhibited the interaction between the anti-SEA antibody and SEA. We examined whether the polyphenols could directly interact with SEA after incubation of these test samples with SEA. As a result, 8 polyphenols (0.25 mg/mL) significantly decreased SEA protein levels. In addition, the polyphenols that interacted with SEA inactivated the toxin activity of splenocyte proliferation induced by SEA. Polyphenols that exerted inhibitory effects on SEA toxic activity had a tendency to interact with SEA. In particular, polyphenol compounds with 1 or 2 hexahydroxydiphenoyl groups and/or a galloyl group, such as eugeniin, castalagin, punicalagin, pedunculagin, corilagin and geraniin, strongly interacted with SEA and inhibited toxin activity at a low concentration. These polyphenols may be used to prevent S. aureus infection and staphylococcal food poisoning.	[Shimamura, Yuko; Aoki, Natsumi; Sugiyama, Yuka; Masuda, Shuichi] Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Tanaka, Takashi] Nagasaki Univ, Grad Sch Biochem Sci, 1-14 Bukyo Machi, Nagasaki 8528521, Japan; [Murata, Masatsune] Ochanomizu Univ, Dept Nutr & Food Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan	University of Shizuoka; Nagasaki University; Ochanomizu University	Masuda, S (corresponding author), Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	masudas@u-shizuoka-ken.ac.jp		Tanaka, Takashi/0000-0001-7762-7432	JSPS KAKENHI Grant [24700806]; Japan Food Chemical Research Foundation; Charitable Trust Fund for Home Economics Research; Japan Cassis Association	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Food Chemical Research Foundation(Japan Food Chemical Research Foundation); Charitable Trust Fund for Home Economics Research; Japan Cassis Association	This study was supported in part by JSPS KAKENHI Grant Number 24700806, a grant from the Japan Food Chemical Research Foundation, Charitable Trust Fund for Home Economics Research and Japan Cassis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao T, 2003, EPIDEMIOL INFECT, V130, P33, DOI 10.1017/S0950268802007951; Balaban N, 2000, INT J FOOD MICROBIOL, V61, P1, DOI 10.1016/S0168-1605(00)00377-9; Cos P, 2004, CURR MED CHEM, V11, P1345, DOI 10.2174/0929867043365288; EVENSON ML, 1988, INT J FOOD MICROBIOL, V7, P311, DOI 10.1016/0168-1605(88)90057-8; Feldman KS, 2005, PHYTOCHEMISTRY, V66, P1984, DOI 10.1016/j.phytochem.2004.11.015; Friedman M, 2013, J FOOD SCI, V78, pM270, DOI 10.1111/1750-3841.12021; Friedman M, 2011, J FOOD SCI, V76, pM558, DOI 10.1111/j.1750-3841.2011.02365.x; Hagerman AE, 1998, J AGR FOOD CHEM, V46, P2590, DOI 10.1021/jf971097k; Holtfreter S, 2005, ARCH IMMUNOL THER EX, V53, P13; Huang YL, 2011, PHYTOCHEMISTRY, V72, P2006, DOI 10.1016/j.phytochem.2011.07.007; Ito H, 2011, PLANTA MED, V77, P1110, DOI 10.1055/s-0030-1270749; Lee YA, 2007, J NUTR SCI VITAMINOL, V53, P287, DOI 10.3177/jnsv.53.287; Lina G, 2004, J INFECT DIS, V189, P2334, DOI 10.1086/420852; Maina EK, 2012, PEPTIDES, V38, P1, DOI 10.1016/j.peptides.2012.08.013; Maisch T, 2004, PHOTOCH PHOTOBIO SCI, V3, P907, DOI 10.1039/b407622b; Matsuo Y, 2010, FOOD CHEM, V121, P1073, DOI 10.1016/j.foodchem.2010.01.052; Mulaudzi RB, 2012, J ETHNOPHARMACOL, V143, P185, DOI 10.1016/j.jep.2012.06.022; Omoe K, 2013, INFECT IMMUN, V81, P3627, DOI 10.1128/IAI.00550-13; Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Rasooly A, 1998, INT J FOOD MICROBIOL, V41, P205, DOI 10.1016/S0168-1605(98)00050-6; Rasooly R, 2012, FOOD COMPOUNDS INHIB, P387; Rasooly R, 2010, J AGR FOOD CHEM, V58, P5421, DOI 10.1021/jf904021b; Shimamura Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1571, DOI 10.1271/bbb.50617; Shimamura Y, 2014, J FOOD SCI, V79, pM2294, DOI 10.1111/1750-3841.12566; Shimamura Y, 2008, FOOD SCI TECHNOL RES, V14, P513, DOI 10.3136/fstr.14.513; Taguri T, 2004, BIOL PHARM BULL, V27, P1965, DOI 10.1248/bpb.27.1965; Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226; Tajchakavit S, 2001, FOOD RES INT, V34, P431, DOI 10.1016/S0963-9969(00)00188-5; TANAKA T, 1986, CHEM PHARM BULL, V34, P650; TANAKA T, 1986, J CHEM SOC PERK T 1, P369, DOI 10.1039/p19860000369; Tanaka T, 2003, J NAT PROD, V66, P759, DOI 10.1021/np020608g; TANAKA T, 1985, J CHEM RES, P176; Tanaka T, 1996, CHEM PHARM BULL, V44, P2236, DOI 10.1248/cpb.44.2236; Taniguchi S, 2005, YAKUGAKU ZASSHI, V125, P499, DOI 10.1248/yakushi.125.499; Trombley JD, 2011, ANAL BIOANAL CHEM, V401, P1523, DOI 10.1007/s00216-011-4846-1; Verhelst R, 2013, VET MICROBIOL, V163, P319, DOI 10.1016/j.vetmic.2012.12.039	37	10	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157082	10.1371/journal.pone.0157082	http://dx.doi.org/10.1371/journal.pone.0157082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272505	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000062
J	Erhart, J; Unger, E; Schefzig, P; Varga, P; Trulson, I; Gormasz, A; Trulson, A; Reschl, M; Hagmann, M; Vecsei, V; Mayr, W				Erhart, Jochen; Unger, Ewald; Schefzig, Philip; Varga, Peter; Trulson, Inga; Gormasz, Anna; Trulson, Alexander; Reschl, Martin; Hagmann, Michael; Vecsei, Vilmos; Mayr, Winfried			Rotational Stability of Scaphoid Osteosyntheses: An In Vitro Comparison of Small Fragment Cannulated Screws to Novel Bone Screw Sets	PLOS ONE			English	Article							BIOMECHANICAL ASSESSMENT; FIXATION; WAIST; FRACTURES; NONUNION; COMPRESSION; SHEAR	Background The current standard of care for operative repair of scaphoid fractures involves reduction and internal fixation with a single headless compression screw. However, a compression screw in isolation does not necessarily control rotational stability at a fracture or nonunion site. The single screw provides rotational control through friction and bone interdigitation from compression at the fracture site. We hypothesize that osteosyntheses with novel bone screw sets (BSS) equipped with anti-rotational elements provide improved rotational stability. Methods Stability of osteosynthesis under increasing cyclic torsional loading was investigated on osteotomized cadaveric scaphoids. Two novel prototype BSS, oblique type (BSS-obl.) and longitudinal type (BSS-long.) were compared to three conventional screws: Acutrak2 (R) mini, HCS (R) 3.0 and Twinfix (R). Biomechanical tests were performed on scaphoids from single donors in paired comparison and analyzed by balanced incomplete random block design. Loading was increased by 50 mNm increments with 1,000 cycles per torque level and repeated until a rotational clearance of 10 degrees. Primary outcome measure was the number of cycles to 10 degrees clearance, secondary outcome measure was the maximum rotational clearance for each torque level. Findings BSS-obl. performed significantly better than Acutrak2 (R) mini and HCS (R) (p = 0.015, p < 0.0001). BSS-long. performed significantly better than HCS (R) (p = 0.010). No significant difference in performance between BSS-obl. and BSS-long. (p = 0.361), between BSS obl. and Twinfix (R) (p = 0.50) and BSS long. and Twinfix (R) (p = 0.667) was detected. Within the torque range up to 200 mNm, four of 21 (19%) BSS-long. and four of 21 (19%) BSS-obl. preparations showed early failure. The same loading led to early failure in four (29%) Twinfix (R), seven (50%) Acutrak2 (R) mini and 10 (71%) HCS (R) of 14 screw samples, respectively. Conclusions For both BSS and to a lesser extent for Twinfix (R) (as dual-component screw), higher rotational stabilities were identified in comparison to single component headless compression screws.	[Erhart, Jochen; Schefzig, Philip; Trulson, Inga; Gormasz, Anna; Reschl, Martin; Vecsei, Vilmos] Med Univ Vienna, Dept Trauma Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Unger, Ewald; Mayr, Winfried] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Varga, Peter] AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland; [Trulson, Alexander] BG Clin Tuebingen, Schnarrenbergstr 95, D-72076 Tubingen, Germany; [Hagmann, Michael] Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Spitalgasse 23, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Erhart, J (corresponding author), Med Univ Vienna, Dept Trauma Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	jochen.erhart@meduniwien.ac.at	Varga, Peter/H-6181-2012	Varga, Peter/0000-0003-2738-6436; Unger, Ewald/0000-0003-0275-9988	FWF (Austrian Scientific Fund) [L613-N14]	FWF (Austrian Scientific Fund)(Austrian Science Fund (FWF))	This work was funded by FWF (Austrian Scientific Fund) L613-N14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson L, 2001, J HAND SURG-BRIT EUR, V26, P192, DOI 10.1054/jhsb.2001.0558; Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Beadel GP, 2004, J HAND SURG-AM, V29A, P273, DOI 10.1016/j.jhsa.2003.12.006; Berger RA, 2001, HAND CLIN, V17, P525; Bishop NE, 2006, CLIN ORTHOP RELAT R, P307, DOI 10.1097/01.blo.0000191272.34786.09; Crawford LA, 2012, J HAND SURG-AM, V37A, P255, DOI 10.1016/j.jhsa.2011.10.021; Den Boer F., 2002, OSTEOSYNTH TRAUMA CA, V10, P1, DOI [10.1055/s-2002-30627, DOI 10.1055/S-2002-30627]; Dodds SD, 2006, J HAND SURG-AM, V31A, P405, DOI 10.1016/j.jhsa.2005.09.014; Egol KA, 2004, J ORTHOP TRAUMA, V18, P488, DOI 10.1097/00005131-200409000-00003; Filan SL, 1996, J BONE JOINT SURG BR, V78B, P519, DOI 10.1302/0301-620X.78B4.0780519; Grewal R, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-27; Gruszka DS, 2012, J HAND SURG-AM, V37A, P1142, DOI 10.1016/j.jhsa.2012.03.018; Ikeda K, 2008, J TRAUMA, V65, P1453, DOI 10.1097/TA.0b013e31805824f3; Koh IH, 2015, INJURY, V46, P638, DOI 10.1016/j.injury.2015.01.018; Leixnering M, 2011, J TRAUMA, V71, P933, DOI 10.1097/TA.0b013e3181f65721; McCallister WV, 2003, J BONE JOINT SURG AM, V85A, P72, DOI 10.2106/00004623-200301000-00012; McQueen MM, 2008, J BONE JOINT SURG BR, V90B, P66, DOI 10.1302/0301-620X.90B1.19767; Oka K, 2005, J HAND SURG-AM, V30A, P1136, DOI 10.1016/j.jhsa.2005.08.004; Pahr DH, 2009, COMPUT METHOD BIOMEC, V12, P45, DOI [10.1080/10255840802144105, 10.1080/10255840903065399]; Ramaswamy R, 2010, INJURY, V41, P179, DOI 10.1016/j.injury.2009.08.015; Sauerbier M GG, 2004, EUR J TRAUMA, V30, P80; Slade JF, 2006, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000205886.66081.9d; Sugathan HK, 2012, INJURY, V43, P205, DOI 10.1016/j.injury.2011.07.011; Toby EB, 1997, J BONE JOINT SURG AM, V79A, P1190, DOI 10.2106/00004623-199708000-00011; Trumble TE, 1996, J BONE JOINT SURG AM, V78A, P1829, DOI 10.2106/00004623-199612000-00005; Varga P, 2016, MED ENG PHYS, V38, P131, DOI 10.1016/j.medengphy.2015.11.006; Varga P, 2013, J BIOMECH, V46, P984, DOI 10.1016/j.jbiomech.2012.11.053; Wheeler DL, 1998, CLIN ORTHOP RELAT R, P237; Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156080	10.1371/journal.pone.0156080	http://dx.doi.org/10.1371/journal.pone.0156080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258387	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000377369700034
J	Gomaa, MR; Kandeil, A; Kayed, AS; Elabd, MA; Zaki, SA; Abu Zeid, D; El Rifay, AS; Mousa, AA; Farag, MM; McKenzie, PP; Webby, RJ; Ali, MA; Kayali, G				Gomaa, Mokhtar R.; Kandeil, Ahmed; Kayed, Ahmed S.; Elabd, Mona A.; Zaki, Shaimaa A.; Abu Zeid, Dina; El Rifay, Amira S.; Mousa, Adel A.; Farag, Mohamed M.; McKenzie, Pamela P.; Webby, Richard J.; Ali, Mohamed A.; Kayali, Ghazi			Serological Evidence of Human Infection with Avian Influenza A H7virus in Egyptian Poultry Growers	PLOS ONE			English	Article							RISK-FACTORS; HUMAN-BEINGS; VIRUS; H5N1; TRANSMISSION; PROTEINS; WORKERS; H7	Avian influenza viruses circulate widely in birds, with occasional human infections. Poultry-exposed individuals are considered to be at high risk of infection with avian influenza viruses due to frequent exposure to poultry. Some avian H7 viruses have occasionally been found to infect humans. Seroprevalence of neutralizing antibodies against influenza A/H7N7 virus among poultry-exposed and unexposed individuals in Egypt were assessed during a three-years prospective cohort study. The seroprevalence of antibodies ( titer, >= 80) among exposed individuals was 0%, 1.9%, and 2.1% annually while the seroprevalence among the control group remained 0% as measured by virus microneutralization assay. We then confirmed our results using western blot and immunofluorescence assays. Although human infection with H7 in Egypt has not been reported yet, our results suggested that Egyptian poultry growers are exposed to avian H7 viruses. These findings highlight the need for surveillance in the people exposed to poultry to monitor the risk of zoonotic transmission of avian influenza viruses.	[Gomaa, Mokhtar R.; Kandeil, Ahmed; Kayed, Ahmed S.; Elabd, Mona A.; Zaki, Shaimaa A.; Abu Zeid, Dina; El Rifay, Amira S.; Ali, Mohamed A.] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza, Egypt; [Mousa, Adel A.; Farag, Mohamed M.] Al Azhar Univ, Fac Sci, Dept Bot & Microbiol, Cairo, Egypt; [McKenzie, Pamela P.; Webby, Richard J.; Kayali, Ghazi] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kayali, Ghazi] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Kayali, Ghazi] Human Link, Hazmieh, Lebanon	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Al Azhar University; St Jude Children's Research Hospital; University of Texas System; University of Texas Health Science Center Houston	Ali, MA (corresponding author), Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza, Egypt.; Kayali, G (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.; Kayali, G (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.; Kayali, G (corresponding author), Human Link, Hazmieh, Lebanon.	mohamedahmedali2004@yahoo.com; ghazi@human-link.org	Kandeil, Ahmed Mohamed/B-3345-2016; Ali, Mohamed A/N-8768-2017; Webby, Richard J/N-5657-2018; Kandeil, Ahmed/N-5473-2019; Gomaa, Mokhtar Rizk/N-9125-2018; Refay, Amira El/I-6183-2019	Kandeil, Ahmed Mohamed/0000-0003-3253-6961; Ali, Mohamed A/0000-0002-5615-3212; Kandeil, Ahmed/0000-0003-3253-6961; sayed, amira/0000-0002-6181-1072; Gomaa, Mokhtar/0000-0001-7947-3609; Kayed, Ahmed/0000-0002-0439-3476; Abu Zeid, Dina/0000-0002-3671-3067; Elabd, Mona/0000-0002-1417-8307; Zaki, Shaimaa/0000-0002-3761-5581	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400006C]; Egyptian Science and Technology Development Fund [5175]; American Lebanese Syrian Associated Charities (ALSAC)	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Egyptian Science and Technology Development Fund(Science and Technology Development Fund (STDF)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN272201400006C, the Egyptian Science and Technology Development Fund, under contract number 5175, and supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN272201400006C, the Egyptian Science and Technology Development Fund, under contract number 5175, and supported by the American Lebanese Syrian Associated Charities (ALSAC).	Afifi MAA, 2013, TROP ANIM HEALTH PRO, V45, P687, DOI 10.1007/s11250-012-0243-9; Ahad A, 2014, PREV VET MED, V117, P610, DOI 10.1016/j.prevetmed.2014.10.007; Di Trani L, 2012, AVIAN DIS, V56, P1068, DOI 10.1637/10184-041012-ResNote.1; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gerloff NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068522; Gomaa MR, 2015, J INFECT DIS, V211, P1399, DOI 10.1093/infdis/jiu529; Kandeil A, 2013, ARCH VIROL, V158, P619, DOI 10.1007/s00705-012-1529-y; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kayali G, 2014, EMERG INFECT DIS, V20, P542, DOI 10.3201/eid2004.131295; Kayali G, 2011, EMERG INFECT DIS, V17, P2306, DOI 10.3201/eid1712.110683; Kayali G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-685; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Meleigy M, 2007, LANCET, V370, P553, DOI 10.1016/S0140-6736(07)61274-4; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Puzelli S, 2014, EMERG INFECT DIS, V20, P1745, DOI 10.3201/eid2010.140512; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Toner ES, 2013, CLIN INFECT DIS, V56, P1206, DOI 10.1093/cid/cit047; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; WEBSTER RG, 1981, NEW ENGL J MED, V304, P911; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2015, AV INFL A H5N1 EG; Zhang T, 2014, EMERG INFECT DIS, V20, P2076, DOI 10.3201/eid2012.140911	26	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155294	10.1371/journal.pone.0155294	http://dx.doi.org/10.1371/journal.pone.0155294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258357	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700013
J	Ip, P; Ho, FKW; So, HK; Chan, DFY; Ho, M; Tso, W; Nelson, EAS				Ip, Patrick; Ho, Frederick Ka Wing; So, Hung-Kwan; Chan, Dorothy Fung-ying; Ho, Matthew; Tso, Winnie; Nelson, E. Anthony S.			Socioeconomic Gradient in Childhood Obesity and Hypertension: A Multilevel Population-Based Study in a Chinese Community	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; BLOOD-PRESSURE; ADOLESCENTS; OVERWEIGHT; CHILDREN; ASSOCIATIONS; PREVALENCE; EPIDEMIC; WEIGHT	Background This study aims to assess evidence for any socioeconomic gradients in childhood obesity and hypertension in a population-representative sample in Hong Kong, China. Methods The data of a stratified random sampled growth survey collected in 2005-2006 was matched with a population by-census. Obesity was defined using the International Obesity Task Force standard and hypertension was defined using the Hong Kong norm table. Family socioeconomic status (SES) was measured by maternal education level. Neighbourhood SES was measured by median household income of the neighbourhood. Multilevel Poisson regression models with robust standard error were used to test the association. Body mass indices of children's parents were included as potential confounders. Intra-school/neighbourhood correlations were adjusted using random factors. Results Totally 14842 children (age 6-19 years) included in the analysis, in which 16.6% of them were overweight or obese. Children whose mother only completed secondary school or below had higher risk of childhood obesity (RR 1.41, 95% CI 1.13-1.76, p = 0.003) and hypertension (RR 1.18, 95% CI 1.01-1.36, p = 0.03). Meanwhile, children in the lowest neighbourhood SES group had higher risk of childhood underweight (RR 1.61, 95% CI 1.04-2.49, p = 0.03), overweight (RR 1.35, 95% CI 1.05-1.72, p = 0.02), and obesity (RR 2.07, 95% CI 1.11-3.88, p = 0.02). Conclusions Socioeconomic gradient in childhood obesity and hypertension existed in Hong Kong, one of the most developed cities in China. These results have implications for policymakers and public health experts and highlight the need to monitor trends in other parts of China.	[Ip, Patrick; Ho, Frederick Ka Wing; Ho, Matthew; Tso, Winnie] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [So, Hung-Kwan; Chan, Dorothy Fung-ying; Nelson, E. Anthony S.] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Chan, DFY (corresponding author), Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	dorothychan@cuhk.edu.hk	Ho, Matthew/ACZ-8423-2022; Ho, Frederick/M-6407-2017; Ho, Frederick/AAS-2647-2021; Nelson, E Anthony S/ABF-4238-2020; Tso, Wan Yee Winnie/C-4751-2009	Ho, Frederick/0000-0001-7190-9025; Ho, Frederick/0000-0001-7190-9025; Nelson, E Anthony S/0000-0002-2521-3403; Tso, Wan Yee Winnie/0000-0002-5859-015X; So, Hung-kwan/0000-0002-6188-7587	Hong Kong Paediatric Society	Hong Kong Paediatric Society	This original growth survey was supported by Department funds and the Hong Kong Paediatric Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Arnett DK, 2001, AM J HYPERTENS, V14, P200, DOI 10.1016/S0895-7061(00)01262-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boles M, 2004, J OCCUP ENVIRON MED, V46, P737, DOI 10.1097/01.jom.0000131830.45744.97; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Census and Statistics Department of Hong Kong SAR Government, 2007, BAS TABL TERT PLANN; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Due P, 2009, INT J OBESITY, V33, P1084, DOI 10.1038/ijo.2009.128; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Guldan GS, 2014, HONG KONG MED J, V20, P30; Hui LL, 2003, INT J OBESITY, V27, P1411, DOI 10.1038/sj.ijo.0802423; Hui S., 2001, HLTH PHYS ACTIVITY H; Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414; Ip P, J PEDIAT IN PRESS; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; LAUER RM, 1989, PEDIATRICS, V84, P633; Leung LCK, 2011, ARCH DIS CHILD, V96, P804, DOI 10.1136/adc.2010.202770; MacKinnon DP, 2008, ENCY CLIN PSYCHOL; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; National High Blood Pressure Education Program, 1996, PEDIATRICS, V98, P649, DOI DOI 10.1542/PEDS.98.4.649; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; SALLIS JF, 1994, PEDIATR EXERC SCI, V6, P302; Sanders Lee M, 2009, Pediatrics, V124 Suppl 3, pS306, DOI 10.1542/peds.2009-1162G; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; So HK, 2011, BRIT J NUTR, V106, P742, DOI 10.1017/S0007114511000754; So HK, 2010, J HUM HYPERTENS, V24, P646, DOI 10.1038/jhh.2009.117; So HK, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-320; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Sung RYT, 2008, J HYPERTENS, V26, P678, DOI 10.1097/HJH.0b013e3282f42270; The HKSAR Government, 2013, HALF YEARL EC REP 20; Tingley D, 2014, J STAT SOFTW, V59; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Yin H Shonna, 2009, Pediatrics, V124 Suppl 3, pS289, DOI 10.1542/peds.2009-1162E; Yu ZJ, 2000, B WORLD HEALTH ORGAN, V78, P1296; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156945	10.1371/journal.pone.0156945	http://dx.doi.org/10.1371/journal.pone.0156945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258094	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000377369700162
J	Saksens, NTM; Lechanteur, YTE; Verbakel, SK; Groenewoud, JMM; Daha, MR; Schick, T; Fauser, S; Boon, CJF; Hoyng, CB; den Hollander, AI				Saksens, Nicole T. M.; Lechanteur, Yara T. E.; Verbakel, Sanne K.; Groenewoud, Joannes M. M.; Daha, Mohamed R.; Schick, Tina; Fauser, Sascha; Boon, Camiel J. F.; Hoyng, Carel B.; den Hollander, Anneke I.			Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; CHOROIDAL NEOVASCULARIZATION; COMPONENT 3; FACTOR-B; GENE; ASSOCIATION; VARIANT; CFH; METAANALYSIS; AGGREGATION	Aims Age-related macular degeneration (AMD) is a multifactorial disease, in which complement-mediated inflammation plays a pivotal role. A positive family history is an important risk factor for developing AMD. Certain lifestyle factors are shown to be significantly associated with AMD in non-familial cases, but not in familial cases. This study aimed to investigate whether the contribution of common genetic variants and complement activation levels differs between familial and sporadic cases with AMD. Methods and Results 1216 AMD patients (281 familial and 935 sporadic) and 1043 controls (143 unaffected members with a family history of AMD and 900 unrelated controls without a family history of AMD) were included in this study. Ophthalmic examinations were performed, and lifestyle and family history were documented with a questionnaire. Nine single nucleotide polymorphisms (SNPs) known to be associated with AMD were genotyped, and serum concentrations of complement components C3 and C3d were measured. Associations were assessed in familial and sporadic individuals. The association with risk alleles of the age-related maculopathy susceptibility 2 (ARMS2) gene was significantly stronger in sporadic AMD patients compared to familial cases (p = 0.017 for all AMD stages and p = 0.003 for advanced AMD, respectively). ARMS2 risk alleles had the largest effect in sporadic cases but were not significantly associated with AMD in densely affected families. The C3d/C3 ratio was a significant risk factor for AMD in sporadic cases and may also be associated with familial cases. In patients with a densely affected family this effect was particularly strong with ORs of 5.37 and 4.99 for all AMD and advanced AMD respectively. Conclusion This study suggests that in familial AMD patients, the common genetic risk variant in ARMS2 is less important compared to sporadic AMD. In contrast, factors leading to increased complement activation appear to play a larger role in patients with a positive family history compared to sporadic patients. A better understanding of the different contributions of risk factors in familial compared to non-familial AMD will aid the development of reliable prediction models for AMD, and may provide individuals with more accurate information regarding their individual risk for AMD. This information is especially important for individuals who have a positive family history for AMD.	[Saksens, Nicole T. M.; Lechanteur, Yara T. E.; Verbakel, Sanne K.; Boon, Camiel J. F.; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Groenewoud, Joannes M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Daha, Mohamed R.] Leiden Univ, Nijmegen Med Ctr, Dept Nephrol, Leiden, Netherlands; [Schick, Tina; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Boon, Camiel J. F.] Leiden Univ, Med Ctr, Dept Ophthalmol, Albinusdreef 2, Leiden, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; University of Cologne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Lehtimäki, Terho/AAD-1094-2022; Hollander, Anneke den/N-4911-2014; Lechanteur, Yara/ABB-6875-2020; Verbakel, Sanne K/P-8160-2015; Groenewoud, Hans JMM/R-3588-2017; Boon, CJF/P-7534-2014	Lehtimäki, Terho/0000-0002-2555-4427; Lechanteur, Yara/0000-0003-0951-4625; Verbakel, Sanne K/0000-0002-0187-379X; Groenewoud, Hans JMM/0000-0002-4974-150X; Boon, CJF/0000-0002-6737-7932	Foundation Fighting Blindness USA [C-GE-0811-0548-RAD04]; Salentein fellowship part of the 'Diana-Hermes foundation'; MD Fonds; Nederlandse Oogonderzoek Stichting; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Nederlands Oogheelkundig Onderzoek; Gelderse Blindenstichting	Foundation Fighting Blindness USA; Salentein fellowship part of the 'Diana-Hermes foundation'; MD Fonds; Nederlandse Oogonderzoek Stichting; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Nederlands Oogheelkundig Onderzoek; Gelderse Blindenstichting	This work was supported by: Foundation Fighting Blindness USA (grant C-GE-0811-0548-RAD04; received by Anneke den Hollander); Salentein fellowship part of the 'Diana-Hermes foundation' (received by Carel Hoyng); Anneke den Hollander and Carel Hoyng received: MD Fonds, Nederlandse Oogonderzoek Stichting, Oogfonds, Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Stichting Nederlands Oogheelkundig Onderzoek, and Gelderse Blindenstichting. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar L, 2014, GENET MED, V16, P231, DOI 10.1038/gim.2013.115; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Chakravarthy U, 2013, OPHTHALMOLOGY, V120, P342, DOI 10.1016/j.ophtha.2012.08.004; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Duvvari MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094165; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Howard KP, 2014, INVEST OPHTH VIS SCI, V55, P2592, DOI 10.1167/iovs.13-13763; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein B E, 2001, Ophthalmic Epidemiol, V8, P251, DOI 10.1076/opep.8.4.251.1612; KLEIN ML, 1994, ARCH OPHTHALMOL-CHIC, V112, P932, DOI 10.1001/archopht.1994.01090190080025; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MEYERS SM, 1995, AM J OPHTHALMOL, V120, P757, DOI 10.1016/S0002-9394(14)72729-1; Mokwa NF, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/385915; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ristau T, 2014, INVEST OPHTH VIS SCI, V55, P210, DOI 10.1167/iovs.13-13248; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Saksens NTM, 2014, INVEST OPHTH VIS SCI, V55, P7085, DOI 10.1167/iovs.14-14659; Saksens NTM, 2014, PROG RETIN EYE RES, V39, P23, DOI 10.1016/j.preteyeres.2013.11.001; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Shahid H, 2012, BRIT J OPHTHALMOL, V96, P427, DOI 10.1136/bjophthalmol-2011-300193; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Sobrin L, 2010, EUR J HUM GENET, V18, P496, DOI 10.1038/ejhg.2009.185; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; van de Ven JPH, 2012, ARCH OPHTHALMOL-CHIC, V130, P1038, DOI 10.1001/archophthalmol.2012.265; van de Ven JPH, 2012, MOL VIS, V18, P2271; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2014, HUM MOL GEN IN PRESS; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0144367	10.1371/journal.pone.0144367	http://dx.doi.org/10.1371/journal.pone.0144367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258093	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700001
J	Lepping, RJ; Atchley, RA; Chrysikou, E; Martin, LE; Clair, AA; Ingram, RE; Simmons, WK; Savage, CR				Lepping, Rebecca J.; Atchley, Ruth Ann; Chrysikou, Evangelia; Martin, Laura E.; Clair, Alicia A.; Ingram, Rick E.; Simmons, W. Kyle; Savage, Cary R.			Neural Processing of Emotional Musical and Nonmusical Stimuli in Depression	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BORDERLINE PERSONALITY-DISORDER; CIRCUMPLEX MODEL; MOOD INDUCTION; WORD VALENCE; HUMAN BRAIN; CONNECTIVITY; RESPONSES; THERAPY; STRESS	Background Anterior cingulate cortex (ACC) and striatum are part of the emotional neural circuitry implicated in major depressive disorder (MDD). Music is often used for emotion regulation, and pleasurable music listening activates the dopaminergic system in the brain, including the ACC. The present study uses functional MRI (fMRI) and an emotional nonmusical and musical stimuli paradigm to examine how neural processing of emotionally provocative auditory stimuli is altered within the ACC and striatum in depression. Method Nineteen MDD and 20 never-depressed (ND) control participants listened to standardized positive and negative emotional musical and nonmusical stimuli during fMRI scanning and gave subjective ratings of valence and arousal following scanning. Results ND participants exhibited greater activation to positive versus negative stimuli in ventral ACC. When compared with ND participants, MDD participants showed a different pattern of activation in ACC. In the rostral part of the ACC, ND participants showed greater activation for positive information, while MDD participants showed greater activation to negative information. In dorsal ACC, the pattern of activation distinguished between the types of stimuli, with ND participants showing greater activation to music compared to nonmusical stimuli, while MDD participants showed greater activation to nonmusical stimuli, with the greatest response to negative nonmusical stimuli. No group differences were found in striatum. Conclusions These results suggest that people with depression may process emotional auditory stimuli differently based on both the type of stimulation and the emotional content of that stimulation. This raises the possibility that music may be useful in retraining ACC function, potentially leading to more effective and targeted treatments.	[Lepping, Rebecca J.; Martin, Laura E.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA; [Atchley, Ruth Ann; Chrysikou, Evangelia; Ingram, Rick E.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA; [Martin, Laura E.] Univ Kansas, Med Ctr, Dept Prevent Med, Kansas City, KS 66103 USA; [Clair, Alicia A.] Univ Kansas, Dept Mus Educ & Mus Therapy, Lawrence, KS 66045 USA; [Simmons, W. Kyle] Laureate Inst Brain Res, Tulsa, OK USA; [Simmons, W. Kyle] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Savage, Cary R.] Univ Kansas, Med Ctr, Ctr Hlth Behav Neurosci, Kansas City, KS 66103 USA; [Savage, Cary R.] Univ Kansas, Med Ctr, Dept Psychiat, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; Laureate Institute for Brain Research, Inc.; University of Tulsa; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Lepping, RJ (corresponding author), Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA.	rlepping@kumc.edu	Simmons, W. Kyle/V-6846-2019	Simmons, W. Kyle/0000-0002-0399-9003	Society for Education, Music and Psychology Research (SEMPRE: Arnold Bentley New Initiatives Fund); University of Kansas Doctoral Student Research Fund; Hoglund Brain Imaging Center; National Institutes of Health [UL1 TR000001]	Society for Education, Music and Psychology Research (SEMPRE: Arnold Bentley New Initiatives Fund); University of Kansas Doctoral Student Research Fund; Hoglund Brain Imaging Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding to RL from The Society for Education, Music and Psychology Research (SEMPRE: Arnold Bentley New Initiatives Fund), and the University of Kansas Doctoral Student Research Fund. MR imaging was provided by pilot funding from the Hoglund Brain Imaging Center. The Hoglund Brain Imaging Center is supported by a generous gift from Forrest and Sally Hoglund and funding from the National Institutes of Health (UL1 TR000001). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or any individual institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU; Aselton P, 2012, J CHILD ADOL PS NURS, V25, P119, DOI 10.1111/j.1744-6171.2012.00341.x; Atchley RA, 2003, BRAIN LANG, V84, P105, DOI 10.1016/S0093-934X(02)00523-0; Beck A.T., 1990, MANUAL BECK ANXIETY; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Brattico E, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00676; Bryant FB, 1996, J RES PERS, V30, P223, DOI 10.1006/jrpe.1996.0015; Buchheim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033745; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carlson E, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00466; CLARK DM, 1983, ADV BEHAV RES THER, V5, P27, DOI 10.1016/0146-6402(83)90014-0; CLARK DM, 1983, B PSYCHONOMIC SOC, V21, P175; CLARK DM, 1985, J PERS SOC PSYCHOL, V48, P1595, DOI 10.1037/0022-3514.48.6.1595; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dichter GS, 2009, BIOL PSYCHIAT, V66, P886, DOI 10.1016/j.biopsych.2009.06.021; DIENER E, 1985, J PERS SOC PSYCHOL, V48, P1253, DOI 10.1037/0022-3514.48.5.1253; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Duval ER, 2013, PSYCHIAT RES-NEUROIM, V214, P459, DOI 10.1016/j.pscychresns.2013.09.005; Enloe AA, 2001, BRAIN COGNITION, V46, P129, DOI 10.1016/S0278-2626(01)80049-X; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Erkkila J, 2011, BRIT J PSYCHIAT, V199, P132, DOI 10.1192/bjp.bp.110.085431; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; First MB, 2002, STRUCTURED CLIN INTE; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Guetin S, 2009, DEMENT GERIATR COGN, V28, P36, DOI 10.1159/000229024; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Heller W, 1997, COGNITION EMOTION, V11, P637, DOI 10.1080/026999397379845a; Hevner K, 1936, AM J PSYCHOL, V48, P246, DOI 10.2307/1415746; Hilliard RE, 2001, J PALLIAT CARE, V17, P161; Holzinger A, 2012, INT J SOC PSYCHIATR, V58, P343, DOI 10.1177/0020764010397262; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Ilardi SS, 2007, COGNITIVE THER RES, V31, P175, DOI 10.1007/s10608-006-9113-y; INGRAM RE, 1984, COGNITIVE THER RES, V8, P139, DOI 10.1007/BF01173040; Jackson ME, 2001, J NEUROSCI, V21, P676, DOI 10.1523/JNEUROSCI.21-02-00676.2001; Juslin PN, 2001, MUSIC EMOTION THEORY, pviii; Kakolewski KE, 1999, INT J PSYCHOPHYSIOL, V34, P283, DOI 10.1016/S0167-8760(99)00085-9; Koelsch S, 2010, MUSIC PERCEPT, V27, P307, DOI 10.1525/MP.2010.27.4.307; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Lai CH, 2013, PSYCHIAT RES-NEUROIM, V211, P37, DOI 10.1016/j.pscychresns.2012.06.006; Leino S, 2007, BRAIN RES, V1142, P169, DOI 10.1016/j.brainres.2007.01.049; Lepping RJ, 2016, PSYCHOL MUSIC, V44, P1012, DOI 10.1177/0305735615604509; Lepping RJ, 2013, SOC BIOL PSYCH ANN S; Lepping RJ, 2012, PSYCH SOC ANN M 2012; Lepping RJ, 2012, SOC NEUR ANN M 2012; Lepping RJ, 2013, SOC AFF NEUR SOC ANN; Maratos A, 2011, BRIT J PSYCHIAT, V199, P92, DOI 10.1192/bjp.bp.110.087494; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; McFerran KS, 2014, ART PSYCHOTHER, V41, P89, DOI 10.1016/j.aip.2013.11.007; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Minzenberg MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P231, DOI 10.1016/j.pscychresns.2007.03.006; Mobbs D, 2010, P NATL ACAD SCI USA, V107, P20582, DOI 10.1073/pnas.1009076107; Mussorgsky MP, 1995, PICTURES EXHIBITION; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Niida A, 2012, INT J GEN MED, V5, P667, DOI 10.2147/IJGM.S34093; Osuch EA, 2009, NEUROREPORT, V20, P1204, DOI 10.1097/WNR.0b013e32832f4da3; Peltola H, 2015, 50 SHADES BLUE CLASS; Pereira CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027241; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; PIGNATIELLO MF, 1986, J ABNORM PSYCHOL, V95, P295, DOI 10.1037/0021-843X.95.3.295; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Quide Y, 2012, NEUROSCI BIOBEHAV R, V36, P626, DOI 10.1016/j.neubiorev.2011.09.004; Reeve J, 2009, UNDERSTANDING MOTIVA; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; SUTHERLAND G, 1982, BRIT J MED PSYCHOL, V55, P127, DOI 10.1111/j.2044-8341.1982.tb01491.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Thaut M., 2005, RHYTHM MUSIC BRAIN S, px; Van den Tol AJM, 2013, PSYCHOL MUSIC, V41, P440, DOI 10.1177/0305735611430433; Vastfjall D, 2001, MUSIC SCI, V5, P173; Vuoskoski JK, 2012, MUSIC PERCEPT, V29, P311, DOI 10.1525/MP.2012.29.3.311; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672	93	24	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156859	10.1371/journal.pone.0156859	http://dx.doi.org/10.1371/journal.pone.0156859			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284693	Green Published, gold			2022-12-27	WOS:000377564000025
J	Ambrosi, C; Ren, C; Spagnol, G; Cavin, G; Cone, A; Grintsevich, EE; Sosinsky, GE; Sorgen, PL				Ambrosi, Cinzia; Ren, Cynthia; Spagnol, Gaelle; Cavin, Gabriel; Cone, Angela; Grintsevich, Elena E.; Sosinsky, Gina E.; Sorgen, Paul L.			Connexin43 Forms Supramolecular Complexes through Non-Overlapping Binding Sites for Drebrin, Tubulin, and ZO-1	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; CARBOXYL-TERMINAL DOMAIN; DENDRITIC SPINE PROTEIN; BLOOD-BRAIN-BARRIER; ACTIN-BINDING; ALZHEIMERS-DISEASE; ZONULA OCCLUDENS-1; F-ACTIN; NEOCORTICAL DEVELOPMENT; STRUCTURAL-CHANGES	Gap junctions are membrane specialization domains identified in most tissue types where cells abut each other. The connexin channels found in these membrane domains are conduits for direct cell-to-cell transfer of ions and molecules. Connexin43 (Cx43) is the most ubiquitous connexin, with critical roles in heart, skin, and brain. Several studies described the interaction between Cx43 and the cytoskeleton involving the actin binding proteins Zonula occludens (ZO-1) and drebrin, as well as with tubulin. However, a direct interaction has not been identified between drebrin and Cx43. In this study, co-IP and NMR experiments were used to demonstrate that the Cx43-CT directly interacts with the highly conserved N-terminus region of drebrin. Three Cx43-CT areas were found to be involved in drebrin binding, with residues 264-275 being critical for the interaction. Mimicking Src phosphorylation within this region (Y265) significantly disrupted the interaction between the Cx43-CT and drebrin. Immunofluorescence showed colocalization of Cx43, drebrin, and F-actin in astrocytes and Vero cells membrane, indicating that Cx43 forms a submembrane protein complex with cytoskeletal and scaffolding proteins. The co-IP data suggest that Cx43 indirectly interacts with F-actin through drebrin. Along with the known interaction of the Cx43-CT with ZO-1 and tubulin, the data presented here for drebrin indicate non-overlapping and separated binding sites for all three proteins for which simultaneous binding could be important in regulating cytoskeleton rearrangements, especially for neuronal migration during brain development.	[Ambrosi, Cinzia; Ren, Cynthia; Cavin, Gabriel; Cone, Angela; Sosinsky, Gina E.] Univ Calif La Jolla, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA USA; [Sosinsky, Gina E.] Univ Calif La Jolla, Dept Neurosci, La Jolla, CA USA; [Grintsevich, Elena E.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Spagnol, Gaelle; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of Nebraska System; University of Nebraska Medical Center	Ambrosi, C (corresponding author), Univ Calif La Jolla, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, La Jolla, CA USA.; Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.	cinziambro@gmail.com; psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM065937, GM072881, GMGM072631]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM065937, R01GM072881, R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants GM065937 (awarded to GES), GM072881 (awarded to GES) and GMGM072631 (awarded to PLS).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bittman K, 1997, J NEUROSCI, V17, P7037; Brikci-Nigassa AS, 2012, BIOCHEMISTRY-US, V51, P4331, DOI 10.1021/bi201806j; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Cina C, 2007, J COMP NEUROL, V504, P298, DOI 10.1002/cne.21426; Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; Counts SE, 2012, NEURODEGENER DIS, V10, P216, DOI 10.1159/000333122; Danesh-Meyer HV, 2008, J CLIN NEUROSCI, V15, P1253, DOI 10.1016/j.jocn.2008.08.002; del Valle J, 2012, J ALZHEIMERS DIS, V32, P233, DOI 10.3233/JAD-2012-120718; DEWEY MM, 1962, SCIENCE, V137, P670, DOI 10.1126/science.137.3531.670-a; Duffy HS, 2002, J PHYSIOL-PARIS, V96, P243, DOI 10.1016/S0928-4257(02)00012-8; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533, DOI 10.14670/HH-25.533; Dunn CA, 2014, J CELL SCI, V127, P455, DOI 10.1242/jcs.142497; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Giepmans BNG, 2001, CELL COMMUN ADHES, V8, P219, DOI 10.3109/15419060109080727; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grintsevich EE, 2010, J MOL BIOL, V398, P542, DOI 10.1016/j.jmb.2010.03.039; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi T, 2009, J CELL SCI, V122, P1005, DOI 10.1242/jcs.028175; Homma N, 1998, CIRC RES, V83, P27, DOI 10.1161/01.RES.83.1.27; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Jin MH, 2002, GENOMICS, V79, P686, DOI 10.1006/geno.2002.6764; Julien C, 2008, J NEUROSCI RES, V86, P2292, DOI 10.1002/jnr.21667; Keller A, 2002, TRENDS NEUROSCI, V25, P541, DOI 10.1016/S0166-2236(02)02260-9; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; Kobayashi R, 2004, NEUROSCI RES, V49, P205, DOI 10.1016/j.neures.2004.02.014; KOJIMA N, 1993, MOL BRAIN RES, V19, P101, DOI 10.1016/0169-328X(93)90154-H; Kojima N, 1988, Brain Res, V464, P207; Kojima N, 2010, NEUROSCIENCE, V165, P138, DOI 10.1016/j.neuroscience.2009.10.016; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; Lewis Alberts, 2002, MOL BIOL CELL; Li HJ, 2014, J CELL SCI, V127, P3269, DOI 10.1242/jcs.145193; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Majoul I, 2007, HISTOCHEM CELL BIOL, V127, P355, DOI 10.1007/s00418-007-0273-y; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Mizu T, 2005, MOL CELL NEUROSCI, V30, P149, DOI 10.1016/j.mcn.2005.06.008; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; Palatinus JA, 2011, AM J PHYSIOL-HEART C, V300, pH583, DOI 10.1152/ajpheart.00999.2010; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Peitsch WK, 2005, J INVEST DERMATOL, V125, P761, DOI 10.1111/j.0022-202X.2005.23793.x; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; SHIRAO T, 1988, MOL BRAIN RES, V4, P71, DOI 10.1016/0169-328X(88)90020-4; SHIRAO T, 1994, EXP CELL RES, V215, P145, DOI 10.1006/excr.1994.1326; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Spagnol G, 2016, J BIOL CHEM, V291, P7637, DOI 10.1074/jbc.M115.701417; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; TODA M, 1993, BIOCHEM BIOPH RES CO, V196, P468, DOI 10.1006/bbrc.1993.2273; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Worth DC, 2013, J CELL BIOL, V202, P793, DOI 10.1083/jcb.201303005; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033	92	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157073	10.1371/journal.pone.0157073	http://dx.doi.org/10.1371/journal.pone.0157073			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280719	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000077
J	Auderset, L; Cullen, CL; Young, KM				Auderset, Loic; Cullen, Carlie L.; Young, Kaylene M.			Low Density Lipoprotein-Receptor Related Protein 1 Is Differentially Expressed by Neuronal and Glial Populations in the Developing and Mature Mouse Central Nervous System	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; PLASMINOGEN-ACTIVATOR; LRP1; CELLS; OLIGODENDROCYTES; PHOSPHORYLATION; TRANSCRIPTOME; PROGENITORS; METABOLISM; ASTROCYTES	The low density lipoprotein-receptor related protein 1 (LRP1) is a large endocytic cell surface receptor that is known to interact with a variety of ligands, intracellular adaptor proteins and other cell surface receptors to regulate cellular behaviours ranging from proliferation to cell fate specification, migration, axon guidance, and lipid metabolism. A number of studies have demonstrated that LRP1 is expressed in the brain, yet it is unclear which central nervous system cell types express LRP1 during development and in adulthood. Herein we undertake a detailed study of LRP1 expression within the mouse brain and spinal cord, examining a number of developmental stages ranging from embryonic day 13.5 to postnatal day 60. We report that LRP1 expression in the brain peaks during postnatal development. On a cellular level, LRP1 is expressed by radial glia, neuroblasts, microglia, oligodendrocyte progenitor cells (OPCs), astrocytes and neurons, with the exception of parvalbumin(+) interneurons in the cortex. Most cell populations exhibit stable expression of LRP1 throughout development; however, the proportion of OPCs that express LRP1 increases significantly from similar to 69% at E15.5 to similar to 99% in adulthood. We also report that LRP1 expression is rapidly lost as OPCs differentiate, and is absent from all oligodendrocytes, including newborn oligodendrocytes. While LRP1 function has been primarily examined in mature neurons, these expression data suggest it plays a more critical role in glial cell regulation where expression levels are much higher.	[Auderset, Loic; Cullen, Carlie L.; Young, Kaylene M.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia	University of Tasmania; Menzies Institute for Medical Research	Young, KM (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia.	kaylene.young@utas.edu.au	Cullen, Carlie/J-7706-2014	Cullen, Carlie/0000-0001-6929-6258; Young, Kaylene/0000-0002-1686-3463	National Health and Medical Research Council of Australia [1066025, 1045240]; University of Tasmania Research Enhancement Grant Scheme; Menzies Institute for Medical Research Development Grant Scheme; Multiple Sclerosis Research Australia [15054]; Morrell Family Trust Scholarship in Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Tasmania Research Enhancement Grant Scheme; Menzies Institute for Medical Research Development Grant Scheme; Multiple Sclerosis Research Australia; Morrell Family Trust Scholarship in Medical Research	This study was supported by the National Health and Medical Research Council of Australia (KMY applications 1066025 and 1045240), the University of Tasmania Research Enhancement Grant Scheme (CC), the Menzies Institute for Medical Research Development Grant Scheme (KMY and CC), Multiple Sclerosis Research Australia (CC 15054) and the Morrell Family Trust Scholarship in Medical Research (LA).; Work in the authors' laboratory was supported by the National Health and Medical Research Council of Australia, the University of Tasmania Research Enhancement Grant Scheme, the Menzies Institute for Medical Research Development Grant Scheme and Multiple Sclerosis Research Australia. Mr Loic Auderset was supported by the Morrell Family Trust Scholarship in Medical Research.	An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630; [Anonymous], 2015, J BIOL CHEM AM SOC B; Auderset L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2108495; Bu G., 2013, MOL NEURODEGENER, V8, DOI [10. 1186/1750-1326-8-s1-p33, DOI 10.1186/1750-1326-8-S1-P33]; BU GJ, 1994, J BIOL CHEM, V269, P18521; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Casse F, 2012, J NEUROSCI, V32, P5186, DOI 10.1523/JNEUROSCI.5296-11.2012; Chanas-Sacre G, 2000, DEV DYNAM, V219, P514, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1078>3.0.CO;2-0; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Craig J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070432; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113237; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Hennen E, 2013, J BIOL CHEM, V288, P16538, DOI 10.1074/jbc.M112.419812; Jeon H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-149; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Maier W, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-25; Marzolo MP, 2000, J NEUROSCI RES, V60, P401, DOI 10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.3.CO;2-C; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Nakajima C, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444364; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Pi XC, 2012, CIRC RES, V111, P564, DOI 10.1161/CIRCRESAHA.112.274597; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Ramanathan A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00136; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Uden E, 1999, MOL CELL NEUROSCI, V14, P129, DOI 10.1006/mcne.1999.0772; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Wang S., 2013, SEL TOP SIGNAL PROCE, V1, P1, DOI DOI 10.1016/J.SUSC0M.2010.10.002.(AVAILABLE; WOLF BB, 1992, AM J PATHOL, V141, P37; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	58	32	32	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155878	10.1371/journal.pone.0155878	http://dx.doi.org/10.1371/journal.pone.0155878			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280679	gold, Green Submitted, Green Published			2022-12-27	WOS:000377563000007
J	Castilla, AR; Pope, N; Jaffe, R; Jha, S				Castilla, Antonio R.; Pope, Nathaniel; Jaffe, Rodolfo; Jha, Shalene			Elevation, Not Deforestation, Promotes Genetic Differentiation in a Pioneer Tropical Tree	PLOS ONE			English	Article							FOREST FRAGMENTATION; MICROSATELLITE LOCI; MICONIA-CALVESCENS; RAIN-FOREST; HABITAT FRAGMENTATION; REPRODUCTIVE-BIOLOGY; SEED DISPERSAL; MATING SYSTEM; INVASIVE TREE; DIVERSITY	The regeneration of disturbed forest is an essential part of tropical forest ecology, both with respect to natural disturbance regimes and large-scale human-mediated logging, grazing, and agriculture. Pioneer tree species are critical for facilitating the transition from deforested land to secondary forest because they stabilize terrain and enhance connectivity between forest fragments by increasing matrix permeability and initiating disperser community assembly. Despite the ecological importance of early successional species, little is known about their ability to maintain gene flow across deforested landscapes. Utilizing highly polymorphic microsatellite markers, we examined patterns of genetic diversity and differentiation for the pioneer understory tree Miconia affinis across the Isthmus of Panama. Furthermore, we investigated the impact of geographic distance, forest cover, and elevation on genetic differentiation among populations using circuit theory and regression modeling within a landscape genetics framework. We report marked differences in historical and contemporary migration rates and moderately high levels of genetic differentiation in M. affinis populations across the Isthmus of Panama. Genetic differentiation increased significantly with elevation and geographic distance among populations; however, we did not find that forest cover enhanced or reduced genetic differentiation in the study region. Overall, our results reveal strong dispersal for M. affinis across human-altered landscapes, highlighting the potential use of this species for reforestation in tropical regions. Additionally, this study demonstrates the importance of considering topography when designing programs aimed at conserving genetic diversity within degraded tropical landscapes.	[Castilla, Antonio R.; Pope, Nathaniel; Jha, Shalene] Univ Texas Austin, Dept Integrat Biol, Biol Labs 401, Austin, TX 78712 USA; [Jaffe, Rodolfo] Vale Inst Technol Sustainable Dev, Rua Boaventura da Silva 955, BR-66055090 Belem, Para, Brazil; [Jaffe, Rodolfo] Univ Sao Paulo, Dept Ecol, Rua Matao 321, BR-05508090 Sao Paulo, SP, Brazil	University of Texas System; University of Texas Austin; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade de Sao Paulo	Jha, S (corresponding author), Univ Texas Austin, Dept Integrat Biol, Biol Labs 401, Austin, TX 78712 USA.	sjha@austin.utexas.edu	Jaffé, Rodolfo/K-3230-2013; Castilla, Antonio R./A-3877-2019	Jaffé, Rodolfo/0000-0002-2101-5282; Castilla, Antonio R./0000-0002-4124-738X	University of Texas at Austin; National Science Foundation [NSF DEB 0908661, NSF DEB 1110007]; FAPESP [23661-2]; U.S. National Science Foundation	University of Texas at Austin; National Science Foundation(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); U.S. National Science Foundation(National Science Foundation (NSF))	This study was supported by the University of Texas at Austin and the National Science Foundation (S.J.: NSF DEB 0908661). N.P. is funded by a predoctoral fellowship from the National Science Foundation (NSF DEB 1110007) and R.J. was funded by a FAPESP Grant (23661-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Herbario Universidad de Panama, J. Wright, R. Condit, J. Hall, A. Espinosa, N. Gottdenker, and R. A. Perez for their invaluable help in locating the M. affinis populations. We thank J. A. Ramirez, E. Sanchez, M. Urena, A. G. Castillo, and numerous volunteers for their help in the collection of leaf material. The BCI forest dynamics research project was founded by S.P. Hubbell and R.B. Foster and is now managed by R. Condit, S. Lao and R. Perez under the Center for Tropical Forest Science and the Smithsonian Tropical Research Institute in Panama. Numerous organizations have provided funding, principally the U.S. National Science Foundation, and hundreds of field workers have contributed to the project. Finally, we would also like to thank the Jha lab, Edgardo Ortiz, and three anonymous reviewers for helpful feedback on the analyses and manuscript.	Aragao DV, 2005, AM J BOT, V92, P456, DOI 10.3732/ajb.92.3.456; Banks SC, 2013, TRENDS ECOL EVOL, V28, P670, DOI 10.1016/j.tree.2013.08.005; Barton K., 2015, MUMIN MULTIMODEL INF; BEALS EW, 1969, SCIENCE, V165, P981, DOI 10.1126/science.165.3897.981; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Blignaut J, 2014, ECOL ENG, V65, P54, DOI 10.1016/j.ecoleng.2013.09.003; Breed MF, 2015, HEREDITY, V115, P100, DOI 10.1038/hdy.2012.72; Breed MF, 2015, HEREDITY, V115, P108, DOI 10.1038/hdy.2013.48; Brito VLG, 2012, PLANT SYST EVOL, V298, P1271, DOI 10.1007/s00606-012-0633-5; BROKAW NVL, 1987, J ECOL, V75, P9, DOI 10.2307/2260533; Byrne M, 2011, J APPL ECOL, V48, P1365, DOI 10.1111/j.1365-2664.2011.02045.x; Castilla AR, 2016, ANN BOT-LONDON, V117, P319, DOI 10.1093/aob/mcv170; Castilla AR, 2011, ACTA OECOL, V37, P269, DOI 10.1016/j.actao.2011.02.011; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Ciofi C, 1999, MOL ECOL, V8, pS17, DOI 10.1046/j.1365-294X.1999.00734.x; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Collevatti RG, 2001, MOL ECOL, V10, P349, DOI 10.1046/j.1365-294x.2001.01226.x; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Condit R, 2001, BIOSCIENCE, V51, P389, DOI 10.1641/0006-3568(2001)051[0389:TSOTPC]2.0.CO;2; Croat T.B., 1978, FLORA BARRO COLORADO; CRUDEN RW, 1972, SCIENCE, V176, P1439, DOI 10.1126/science.176.4042.1439; Dalsgaard B, 2009, OECOLOGIA, V159, P757, DOI 10.1007/s00442-008-1255-z; Davies SJ, 2015, HEREDITY, V115, P125, DOI 10.1038/hdy.2013.95; DIAMOND JM, 1976, P NATL ACAD SCI USA, V73, P2160, DOI 10.1073/pnas.73.6.2160; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fox J., 2011, R COMPANION APPL REG, DOI [10.1177/0049124105277200, DOI 10.1177/0049124105277200]; Gallagher MK, 2016, J APPL ECOL, V53, P251, DOI 10.1111/1365-2664.12564; Garen EJ, 2011, FOREST ECOL MANAG, V261, P1684, DOI 10.1016/j.foreco.2010.10.011; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gauzere J, 2013, MOL ECOL, V22, P5001, DOI 10.1111/mec.12435; Goldenberg R, 2008, INT J PLANT SCI, V169, P963, DOI 10.1086/589697; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hall JS, 2011, FOREST ECOL MANAG, V261, P1553, DOI 10.1016/j.foreco.2010.12.011; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hardesty B. D., 2010, Tropical Plant Biology, V3, P28, DOI 10.1007/s12042-010-9044-3; Herrera CM, 2008, HEREDITY, V100, P275, DOI 10.1038/sj.hdy.6801072; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Jaffe R, 2016, CONSERV GENET, V17, P267, DOI 10.1007/s10592-015-0779-0; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Jha S, 2015, MOL ECOL, V24, P993, DOI 10.1111/mec.13090; Jha S, 2009, MOL ECOL RESOUR, V9, P344, DOI 10.1111/j.1755-0998.2008.02428.x; Jha S, 2010, P NATL ACAD SCI USA, V107, P13760, DOI 10.1073/pnas.1002490107; Jha S, 2008, CURR BIOL, V18, pR1126, DOI 10.1016/j.cub.2008.11.017; Jones FA, 2013, J BIOGEOGR, V40, P720, DOI 10.1111/jbi.12037; Jordano P, 2000, MOL ECOL, V9, P1293, DOI 10.1046/j.1365-294x.2000.01009.x; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Le Roux JJ, 2008, DIVERS DISTRIB, V14, P935, DOI 10.1111/j.1472-4642.2008.00504.x; Le Roux JJ, 2008, MOL ECOL RESOUR, V8, P961, DOI 10.1111/j.1755-0998.2008.02102.x; Lemes MR, 2003, MOL ECOL, V12, P2875, DOI 10.1046/j.1365-294X.2003.01950.x; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lowe A, 2004, ANAL APPL OXFORD BLA; Lowe AJ, 2015, HEREDITY, V115, P97, DOI 10.1038/hdy.2015.40; Luck GW, 2003, ECOL APPL, V13, P235, DOI 10.1890/1051-0761(2003)013[0235:TCBARC]2.0.CO;2; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meyer JY, 1998, BIOTROPICA, V30, P609, DOI 10.1111/j.1744-7429.1998.tb00101.x; MONTAGNINI F, 1990, AMBIO, V19, P386; Montoya D, 2008, SCIENCE, V320, P1502, DOI 10.1126/science.1158404; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Parrotta JA, 2001, ECOL ENG, V17, P219, DOI 10.1016/S0925-8574(00)00141-5; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PELLMYR O, 1986, OECOLOGIA, V68, P304, DOI 10.1007/BF00384804; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pinheiro JJS, 2013, HUMAN SUPP, P1, DOI 10.14195/978-989-721-034-1; Primmer CR, 2006, MOL ECOL, V15, P653, DOI 10.1111/j.1365-294X.2005.02844.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RENNER SS, 1993, NORD J BOT, V13, P519, DOI 10.1111/j.1756-1051.1993.tb00096.x; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Schroder R, 2013, RESTOR ECOL, V21, P793, DOI 10.1111/rec.12018; SCHUSTER WS, 1989, AM J BOT, V76, P1395, DOI 10.2307/2444563; Shi MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021302; STILES FG, 1978, AM ZOOL, V18, P715; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; van Breugel M, 2011, FOREST ECOL MANAG, V261, P1580, DOI 10.1016/j.foreco.2010.08.019; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Wilson GA, 2003, GENETICS, V163, P1177; Wishnie MH, 2007, FOREST ECOL MANAG, V243, P39, DOI 10.1016/j.foreco.2007.02.001; Wright S, 1943, GENETICS, V28, P114; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	98	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156694	10.1371/journal.pone.0156694	http://dx.doi.org/10.1371/journal.pone.0156694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280872	Green Submitted, gold, Green Published			2022-12-27	WOS:000377563000039
J	Demarez, C; Hubert, C; Sempoux, C; Lemaigre, FP				Demarez, Celine; Hubert, Catherine; Sempoux, Christine; Lemaigre, Frederic P.			Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							CELL; MICRORNAS; PROGNOSIS; GROWTH; RNA; YAP	The differentiation status of tumor cells, defined by histomorphological criteria, is a prognostic factor for survival of patients affected with intrahepatic cholangiocarcinoma (ICC). To strengthen the value of morphological differentiation criteria, we wished to correlate histopathological differentiation grade with expression of molecular biliary differentiation markers and of microRNAs previously shown to be dysregulated in ICC. We analysed a series of tumors that were histologically classified as well, moderately or poorly differentiated, and investigated the expression of cytokeratin 7, 19 and 903 (CK7, CK19, CK903), SRY-related HMG box transcription factors 4 and 9 (SOX4, SOX9), osteopontin (OPN), Hepatocyte Nuclear Factor-1 beta (HNF1 beta), Yes-associated protein (YAP), Epithelial cell adhesion molecule (EPCAM), Mucin 1 (MUC1) and N-cadherin (NCAD) by qRT-PCR and immunostaining, and of miR-31, miR-135b, miR-132, miR-200c, miR-221 and miR-222. Unexpectedly, except for subcellular location of SOX9 and OPN, no correlation was found between the expression levels of these molecular markers and histopathological differentiation grade. Therefore, our data point toward necessary caution when investigating the evolution and prognosis of ICC on the basis of cell differentiation criteria.	[Demarez, Celine; Lemaigre, Frederic P.] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Hubert, Catherine] Catholic Univ Louvain, Clin Univ St Luc, Dept Abdominal Surg & Transplantat, Div Hepatobiliary & Pancreat Surg, Ave Hippocrate 10, B-1200 Brussels, Belgium; [Sempoux, Christine] Univ Lausanne, Serv Pathol Clin, CHU Vaudois, CH-1011 Lausanne, Switzerland	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lemaigre, FP (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	frederic.lemaigre@uclouvain.be		Lemaigre, Frederic/0000-0002-3609-434X; Hubert, Catherine/0000-0001-6837-2511; Sempoux, Christine/0000-0003-1375-3979	FRS-FNRS (Belgium) [T.0072.14]; Interuniversity Attraction Pole Programme (Belgian Science Policy BELSPO) [PVII-47]; Televie (Belgium) [7.4597.14-F]	FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole Programme (Belgian Science Policy BELSPO); Televie (Belgium)	The work was supported by the FRS-FNRS (Belgium; grant T.0072.14; http://www.fnrs.be), the Interuniversity Attraction Pole Programme (Belgian Science Policy BELSPO; grant PVII-47; http://www.belspo.be/). CD held a fellowship from Televie (Belgium; grant 7.4597.14-F; http://www.fnrs.be/index.php/mecenat-prix/l-operation-televie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2002, MODERN PATHOL, V15, P1181, DOI 10.1097/01.MP.0000032537.82380.69; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Braicu C, 2009, GASTROENTEROL RES, V2, P132, DOI 10.4021/gr2009.06.1299; Chakravarty G, 2011, CANCER BIOL THER, V11, P71, DOI 10.4161/cbt.11.1.13952; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Fan LN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-320; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Hyder O, 2014, JAMA SURG, V149, P432, DOI 10.1001/jamasurg.2013.5168; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Kawahigashi Yutaka, 2009, Journal of Nippon Medical School, V76, P188; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Matsushima H, 2015, DIGEST LIVER DIS, V47, P1067, DOI 10.1016/j.dld.2015.08.003; Mazur PK, 2012, AM J GASTROENTEROL, V107, P126, DOI 10.1038/ajg.2011.305; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mosnier JF, 2009, MODERN PATHOL, V22, P182, DOI 10.1038/modpathol.2008.123; Munoz-Garrido P, 2012, WORLD J GASTROENTERO, V18, P6189, DOI 10.3748/wjg.v18.i43.6189; Papaconstantinou I, 2012, EUR J GASTROEN HEPAT, V24, P223, DOI 10.1097/MEG.0b013e3283505063; Pei TM, 2015, ONCOTARGET, V6, P17206, DOI 10.18632/oncotarget.4043; Plieskatt J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1270-5; Plieskatt JL, 2014, J HEPATOL, V61, P850, DOI 10.1016/j.jhep.2014.05.035; Poncy A, 2015, DEV BIOL, V404, P136, DOI 10.1016/j.ydbio.2015.05.012; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Razumilava N, 2013, CLIN GASTROENTEROL H, V11, P13, DOI 10.1016/j.cgh.2012.09.009; Sirica AE, 2009, CLIN GASTROENTEROL H, V7, pS68, DOI 10.1016/j.cgh.2009.08.023; Sulpice L, 2014, J SURG RES, V192, P117, DOI 10.1016/j.jss.2014.05.017; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Terashi T, 2004, LIVER INT, V24, P38, DOI 10.1111/j.1478-3231.2004.00886.x; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wadsworth CA, 2013, HEPATOL INT, V7, P377, DOI 10.1007/s12072-012-9407-y; Wang WS, 2014, BIOCHEM BIOPH RES CO, V452, P614, DOI 10.1016/j.bbrc.2014.08.124; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Yu DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13319; Zhang MY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1067-6	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157140	10.1371/journal.pone.0157140	http://dx.doi.org/10.1371/journal.pone.0157140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280413	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000094
J	Erdem, O; Van Lenthe, FJ; Prins, RG; Voorham, TAJJ; Burdorf, A				Erdem, Ozcan; Van Lenthe, Frank J.; Prins, Rick G.; Voorham, Toon A. J. J.; Burdorf, Alex			Socioeconomic Inequalities in Psychological Distress among Urban Adults: The Moderating Role of Neighborhood Social Cohesion	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIOR; MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; COLLECTIVE EFFICACY; MAJOR DEPRESSION; SCREENING SCALES; DISORDERS; ASSOCIATION; PREVALENCE; DIVERSITY	Background Various studies have reported socioeconomic inequalities in mental health among urban residents. This study aimed at investigating whether neighborhood social cohesion influences the associations between socio-economic factors and psychological distress. Methods Cross-sectional questionnaire study on a random sample of 18,173 residents aged 16 years and older from 211 neighborhoods in the four largest cities in the Netherlands. Psychological distress was the dependent variable (scale range 10-50). Neighborhood social cohesion was measured by five statements and aggregated to the neighborhood level using ecometrics methodology. Multilevel linear regression analyses were used to investigate cross-level interactions, adjusted for neighborhood deprivation, between individual characteristics and social cohesion with psychological distress. Results The mean level of psychological distress among urban residents was 17.2. Recipients of disability, social assistance or unemployment benefits reported higher psychological distress (beta = 5.6, 95% CI 5.2 to 5.9) than those in paid employment. Persons with some or great financial difficulties reported higher psychological distress (beta = 3.4, 95% CI 3.2 to 3.6) than those with little or no financial problems. Socio-demographic factors were also associated with psychological distress, albeit with much lower influence. Living in a neighborhood with high social cohesion instead of low social cohesion was associated with a lower psychological distress of 22% among recipients of disability, social assistance or unemployment benefits and of 13% among citizens with financial difficulties. Conclusions Residing in socially cohesive neighborhoods may reduce the influence of lack of paid employment and financial difficulties on psychological distress among urban adults. Urban policies aimed at improving neighborhood social cohesion may contribute to decreasing socio-economic inequalities in mental health.	[Erdem, Ozcan; Van Lenthe, Frank J.; Prins, Rick G.; Burdorf, Alex] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Erdem, Ozcan] Municipal Rotterdam, Dept Res & Business Intelligence, Rotterdam, Netherlands; [Voorham, Toon A. J. J.] Municipal Rotterdam, Dept Hlth Author, Rotterdam, Netherlands; [Voorham, Toon A. J. J.] Univ Appl Sci, Dept Primary Hlth Care, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Erdem, O (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.; Erdem, O (corresponding author), Municipal Rotterdam, Dept Res & Business Intelligence, Rotterdam, Netherlands.	o.erdem@rotterdam.nl	Burdorf, Alex/A-2226-2008	Burdorf, Alex/0000-0003-3129-2862				Abada T, 2007, SOC SCI MED, V65, P2004, DOI 10.1016/j.socscimed.2007.06.030; Ahern J, 2011, AM J EPIDEMIOL, V173, P1453, DOI 10.1093/aje/kwr030; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; [Anonymous], 2008, HLTH LIFESTYLE MED C; Bijl R, 2010, SOCIAL STATE NETHERL; Bleije B, 2009, WONEN OVERWOGEN RESU; Cramm JM, 2013, GERONTOLOGIST, V53, P142, DOI 10.1093/geront/gns052; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Donker T, 2010, PSYCHIAT RES, V176, P45, DOI 10.1016/j.psychres.2009.01.012; Echeverria S, 2008, HEALTH PLACE, V14, P853, DOI 10.1016/j.healthplace.2008.01.004; Erdem O, 2015, EUR J PUBLIC HEALTH, V25, P995, DOI 10.1093/eurpub/ckv120; Fone D, 2007, INT J EPIDEMIOL, V36, P338, DOI 10.1093/ije/dym004; Fryers Tom, 2005, Clin Pract Epidemiol Ment Health, V1, P14; Hanson S, 2015, BRIT J SPORT MED, V49, P710, DOI 10.1136/bjsports-2014-094157; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Kandula NR, 2009, AM J PUBLIC HEALTH, V99, P885, DOI 10.2105/AJPH.2007.131854; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, V174, P290; Kennedy M, 2001, DEALING NEIGHBORHOD; Kessler R., 1994, FINAL VERSIONS OUR N; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Kruijshaar ME, 2003, J AFFECT DISORDERS, V77, P53, DOI 10.1016/S0165-0327(02)00099-X; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Mair C, 2015, HEALTH PLACE, V32, P93, DOI 10.1016/j.healthplace.2015.01.003; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mennis J, 2013, ENVIRON PLANN A, V45, P2176, DOI 10.1068/a45428; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Mohnen SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-116; Mohnen SM, 2011, SOC SCI MED, V72, P660, DOI 10.1016/j.socscimed.2010.12.004; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Netherlands S., 2012, NED SAM 2012; Netherlands S, 2000, HOE DOET CBS DAT NOU, P24; Paykel ES, 2005, EUR NEUROPSYCHOPHARM, V15, P411, DOI 10.1016/j.euroneuro.2005.04.008; Peyrot WJ, 2013, J AFFECT DISORDERS, V146, P91, DOI 10.1016/j.jad.2012.08.044; Poortinga W, 2012, HEALTH PLACE, V18, P286, DOI 10.1016/j.healthplace.2011.09.017; Prins RG, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-90; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Reupert AE, 2012, MED J AUSTRAL S 0416, V1, P7, DOI [10.5694/mjao11.11200, DOI 10.5694/MJAO11.11200]; Rios R, 2012, ANN BEHAV MED, V43, P50, DOI 10.1007/s12160-011-9306-9; Robinette JW, 2013, SOC SCI MED, V96, P174, DOI 10.1016/j.socscimed.2013.07.027; Stafford M, 2008, HEALTH PLACE, V14, P394, DOI 10.1016/j.healthplace.2007.08.006; Stansfeld SA, 2003, J EPIDEMIOL COMMUN H, V57, P361, DOI 10.1136/jech.57.5.361; Twigg L, 2010, ENVIRON PLANN A, V42, P1421, DOI 10.1068/a42287; van Bergen APL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098680; van Lenthe FJ, 2007, HEALTH PLACE, V13, P123, DOI 10.1016/j.healthplace.2005.09.013; Veelen Jv, 2009, G4 GEZONDHEID UITGEM; Volker B, 2007, EUR SOCIOL REV, V23, P99, DOI 10.1093/esr/jc1022	51	34	34	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157119	10.1371/journal.pone.0157119	http://dx.doi.org/10.1371/journal.pone.0157119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TW	27280601	Green Published, gold			2022-12-27	WOS:000377563000087
J	Kayad, AG; Al-Gaadi, KA; Tola, E; Madugundu, R; Zeyada, AM; Kalaitzidis, C				Kayad, Ahmed G.; Al-Gaadi, Khalid A.; Tola, ElKamil; Madugundu, Rangaswamy; Zeyada, Ahmed M.; Kalaitzidis, Chariton			Assessing the Spatial Variability of Alfalfa Yield Using Satellite Imagery and Ground-Based Data	PLOS ONE			English	Article							LEAF-AREA INDEX; VEGETATION INDEX; BIOMASS; NDVI; AGRICULTURE	Understanding the temporal and spatial variability in a crop yield is viewed as one of the key steps in the implementation of precision agriculture practices. Therefore, a study on a center pivot irrigated 23.5 ha field in Saudi Arabia was conducted to assess the variability in alfalfa yield using Landsat-8 imagery and a hay yield monitor data. In addition, the study was designed to also explore the potential of predicting the alfalfa yield using vegetation indices. A calibrated yield monitor mounted on a large rectangular hay baler was used to measure the actual alfalfa yield for four alfalfa harvests performed in the period from October 2013 to May 2014. A total of 18 Landsat-8 images, representing different crop growth stages, were used to derive different vegetation indices (VIs). Data from the yield monitor was used to generate yield maps, which illustrated a definite spatial variation in alfalfa yield across the experimental field for the four studied harvests as indicated by the high spatial correlation values (0.75 to 0.97) and the low P-values (4.7E-103 to 8.9E-27). The yield monitor-measured alfalfa actual yield was compared to the predicted yield form the Vis. Results of the study showed that there was a correlation between actual and predicted yield. The highest correlations were observed between actual yield and the predicted using NIR reflectance, SAVI and NDVI with maximum correlation coefficients of 0.69, 0.68 and 0.63, respectively.	[Kayad, Ahmed G.; Al-Gaadi, Khalid A.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Kayad, Ahmed G.; Al-Gaadi, Khalid A.; Tola, ElKamil; Madugundu, Rangaswamy; Zeyada, Ahmed M.] King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia; [Kayad, Ahmed G.] Agr Res Ctr, Agr Engn Res Inst AEnRI, Giza, Egypt; [Kalaitzidis, Chariton] Mediterranean Agron Inst Chania MAICh, Dept Geoinformat Environm Management, Khania, Greece	King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; CIHEAM; CIHEAM IAM Chania	Kayad, AG (corresponding author), King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia.; Kayad, AG (corresponding author), King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia.; Kayad, AG (corresponding author), Agr Res Ctr, Agr Engn Res Inst AEnRI, Giza, Egypt.	akaiad@ksu.edu.sa	Tola, ElKamil/AAX-8777-2021; Kayad, Ahmed/E-7601-2017; Tola, ElKamil/E-8523-2017; Madugundu, Rangaswamy/N-9214-2013; Kalaitzidis, Chariton/D-6763-2012	Kayad, Ahmed/0000-0003-3396-938X; Tola, ElKamil/0000-0003-0927-9688; Madugundu, Rangaswamy/0000-0002-5326-4785; Kalaitzidis, Chariton/0000-0001-5217-7164	King Saud University, Vice Deanship of Research Chairs; Precision Agriculture Research Chair	King Saud University, Vice Deanship of Research Chairs; Precision Agriculture Research Chair	This study was financially supported by King Saud University, Vice Deanship of Research Chairs (http://chairs.ksu.edu.sa/en). The author who received the fund is KA (Precision Agriculture Research Chair Director). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 2010, ISPRS P INT CAL OR W; Asner GP, 1998, REMOTE SENS ENVIRON, V64, P234, DOI 10.1016/S0034-4257(98)00014-5; Blackmore S., 2003, THESIS; Borowik T, 2013, EUR J WILDLIFE RES, V59, P675, DOI 10.1007/s10344-013-0720-0; Buick RD, 1997, PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, P176; Calvao T, 2004, INT J REMOTE SENS, V25, P3113, DOI 10.1080/01431160310001654978; Childs C., 2004, ARCUSER, V3235, P32, DOI DOI 10.1007/978-0-387-35973-1_369; Ferencz C, 2004, INT J REMOTE SENS, V25, P4113, DOI 10.1080/01431160410001698870; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Hancock DW., THESIS U KENTUCKY; Hanna MM., 1999, GEOCARTO INT, V14, P89, DOI [DOI 10.1080/10106049908542121, 10.1080/10106049908542121]; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Isaaks EH, 1989, APPL GEOSTATISTICS; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Jurgens C, 1997, INT J REMOTE SENS, V18, P3583, DOI 10.1080/014311697216810; Kastens JH, 2005, REMOTE SENS ENVIRON, V99, P341, DOI 10.1016/j.rse.2005.09.010; Kayad A. G., 2015, American-Eurasian Journal of Agricultural & Environmental Sciences, V15, P1025; Lambert D.M., 2004, ADOPTION PROFITABILI; LIU HQ, 1995, IEEE T GEOSCI REMOTE, V33, P457, DOI 10.1109/36.377946; Lu DS, 2005, PHOTOGRAMM ENG REM S, V71, P967, DOI 10.14358/PERS.71.8.967; Masek J, 2011, ENG RUR DEV INT C P; Maselli F, 2001, PHOTOGRAMM ENG REM S, V67, P593; Noureldin NA, 2013, EGYPT J REMOTE SENS, V16, P125, DOI 10.1016/j.ejrs.2013.04.005; Pan G, 2009, ENVIRON MODELL SOFTW, V24, P510, DOI 10.1016/j.envsoft.2008.09.014; Panda SS, 2010, REMOTE SENS-BASEL, V2, P673, DOI 10.3390/rs2030673; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Radovic J., 2009, Biotechnology in Animal Husbandry, V25, P465; Ross KW, 2008, APPL ENG AGRIC, V24, P309; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Schellberg J, 2008, EUR J AGRON, V29, P59, DOI 10.1016/j.eja.2008.05.005; Schmierer J. L., 2004, Proceedings of the 7th International Conference on Precision Agriculture and Other Precision Resources Management, Hyatt Regency, Minneapolis, MN, USA, 25-28 July, 2004, P2083; Schut AGT, 2003, GRASS FORAGE SCI, V58, P276, DOI 10.1046/j.1365-2494.2003.00379.x; Toulios L, 1998, P WORLD COTT RES C 2, P534; TRANGMAR BB, 1985, ADV AGRON, V38, P45; Trotter T., 2008, 9 INT C PREC AGR ICP; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Wang FM, 2007, RICE SCI, V14, P195, DOI 10.1016/S1672-6308(07)60027-4; Yang YJ, 2011, MATH COMPUT MODEL, V54, P1138, DOI 10.1016/j.mcm.2010.11.046	39	27	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157166	10.1371/journal.pone.0157166	http://dx.doi.org/10.1371/journal.pone.0157166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281189	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000101
J	Malarkey, CS; Gustafson, CE; Saifee, JF; Torres, RM; Churchill, MEA; Janoff, EN				Malarkey, Christopher S.; Gustafson, Claire E.; Saifee, Jessica F.; Torres, Raul M.; Churchill, Mair E. A.; Janoff, Edward N.			Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; HIGH BINDING-AFFINITY; NF-KAPPA-B; INFLAMMATORY RESPONSES; BACTERIAL-DNA; CIRCULAR-DICHROISM; NUCLEIC-ACIDS; FACTOR-I; ACTIVATION; PROTEIN	Mitochondrial transcription factor A (TFAM) had previously been shown to act as a damage associated molecular pattern with the ability to enhance CpG-A phosphorothioate oligodeoxynucleotide (ODN)-mediated stimulation of IFN alpha production from human plasmacytoid dendritic cells. Examination of the mechanism by which TFAM might influence CpG ODN mediated innate immune responses revealed that TFAM binds directly, tightly and selectively to the structurally related CpG-A, -B, and -C ODN. TFAM also modulated the ability of the CpG-B or -C to stimulate the production of antibodies from human B cells. TFAM showed a dose-dependent modulation of CpG-B, and -C -induced antibody production from human B cells in vitro, with enhancement of high dose and inhibition of low doses of CpG stimulation. This effect was linked to the ability of TFAM to directly inhibit the binding of CpG ODNs to B cells, in a manner consistent with the relative binding affinities of TFAM for the ODNs. These data suggest that TFAM alters the free concentration of the CpG available to stimulate B cells by sequestering this ODN in a TFAM-CpG complex. Thus, TFAM has the potential to decrease the pathogenic consequences of exposure to natural CpG-like hypomethylated DNA in vivo, as well as such as that found in traumatic injury, infection, autoimmune disease and during pregnancy.	[Malarkey, Christopher S.; Saifee, Jessica F.; Churchill, Mair E. A.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Malarkey, Christopher S.; Saifee, Jessica F.; Churchill, Mair E. A.] Univ Colorado, Sch Med, Program Struct Biol & Biochem, Aurora, CO 80045 USA; [Gustafson, Claire E.; Janoff, Edward N.] Univ Colorado, Sch Med, Mucosal & Vaccine Res Program Colorado MAVRC, Dept Med, Aurora, CO 80045 USA; [Gustafson, Claire E.; Janoff, Edward N.] Univ Colorado, Sch Med, Program Immunol, Aurora, CO 80045 USA; [Gustafson, Claire E.; Janoff, Edward N.] Denver Vet Affairs Med Ctr, Denver, CO 80220 USA; [Torres, Raul M.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Malarkey, Christopher S.] Regis Univ, Sch Pharm, Dept Pharmaceut Sci, 3333 Regis Blvd,H-28, Denver, CO 80221 USA; [Gustafson, Claire E.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Saifee, Jessica F.] 33 Dover Rd, Wellesley, MA 02482 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; Regis University; Stanford University	Churchill, MEA (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	Mair.Churchill@ucdenver.edu	Churchill, Mair E. A./C-5549-2014; Malarkey, Chris/V-2557-2019	Churchill, Mair E. A./0000-0003-0862-235X; Saifee, Jessica/0000-0002-7796-3572; Malarkey, Christopher/0000-0002-2384-2476	University of Colorado Cancer Center Support Grant [P30CA046934]; Veterans Affairs Research Service; Mucosal and Vaccine Research Program Colorado (MAVRC); University of Colorado Cancer Center [P30CA046934]; National Institutes of Health [T32AI052066, R01AI108479, R01GM111902]; American Heart Association [13POST16330009, 11GRNT7380064]; Gerber Foundation; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052066, R01AI052157, R01AI108479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111902] Funding Source: NIH RePORTER	University of Colorado Cancer Center Support Grant; Veterans Affairs Research Service(US Department of Veterans Affairs); Mucosal and Vaccine Research Program Colorado (MAVRC); University of Colorado Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gerber Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The University of Colorado Cancer Center Support Grant (P30CA046934) partially supported the usage of core facilities. National Institutes of Health [T32AI052066 to C.E.G., R01AI108479 to E.N.J., R01GM111902 to M.E.A.C.]; American Heart Association [13POST16330009 to C.S.M., 11GRNT7380064 to M.E.A.C.]; Gerber Foundation [to C.E.G.].; We appreciate the ongoing support of the Veterans Affairs Research Service and the Mucosal and Vaccine Research Program Colorado (MAVRC). The University of Colorado Cancer Center Support Grant (P30CA046934) partially supported the usage of core facilities. This work was supported by the National Institutes of Health [T32AI052066 to C.E.G., R01AI108479 to E.N.J., R01GM111902 to M.E.A.C.]; American Heart Association [13POST16330009 to C.S.M., 11GRNT7380064 to M.E.A.C.]; Gerber Foundation [to C.E.G.].	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959; CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hanagata N, 2012, INT J NANOMED, V7, P2181, DOI 10.2147/IJN.S30197; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Hayashi T, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.12.028; Hopkins RJ, 2013, VACCINE, V31, P3051, DOI 10.1016/j.vaccine.2013.04.063; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jahrsdorfer Bernd, 2008, Update Cancer Ther, V3, P27, DOI 10.1016/j.uct.2007.11.003; JOHNSON S, 1992, J INFECT DIS, V166, P1287, DOI 10.1093/infdis/166.6.1287; Julian MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072354; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Klein DCG, 2010, ULTRAMICROSCOPY, V110, P689, DOI 10.1016/j.ultramic.2010.02.033; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lamphier MS, 2006, ANN NY ACAD SCI, V1082, P31, DOI 10.1196/annals.1348.005; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lim EJ, 2007, EXP MOL MED, V39, P239, DOI 10.1038/emm.2007.27; Little JP, 2014, MOL CELL NEUROSCI, V60, P88, DOI 10.1016/j.mcn.2014.04.003; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Malarkey CS, 2012, NUCLEIC ACIDS RES, V40, P614, DOI 10.1093/nar/gkr787; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P4034, DOI 10.1021/bi952555q; Mou TC, 2002, NUCLEIC ACIDS RES, V30, P749, DOI 10.1093/nar/30.3.749; Mou TC, 2001, BIOCHEMISTRY-US, V40, P2267, DOI 10.1021/bi002136f; Muller S, 2001, BIOCHEMISTRY-US, V40, P10254, DOI 10.1021/bi0100900; Ngo HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4077; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Polewicz M, 2013, VACCINE, V31, P3148, DOI 10.1016/j.vaccine.2013.05.008; Redford TW, 1998, J IMMUNOL, V161, P3930; Rosa M, 2005, BIOMACROMOLECULES, V6, P2164, DOI 10.1021/bm050137n; Scharfe-Nugent A, 2012, J IMMUNOL, V188, P5706, DOI 10.4049/jimmunol.1103454; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Sursal T, 2013, SHOCK, V39, P55, DOI 10.1097/SHK.0b013e318276f4ca; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Wagner M, 2004, J IMMUNOL, V172, P954, DOI 10.4049/jimmunol.172.2.954; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yi AK, 1996, J IMMUNOL, V156, P558; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	58	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157157	10.1371/journal.pone.0157157	http://dx.doi.org/10.1371/journal.pone.0157157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280778	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000098
J	Pinchoff, J; Chaponda, M; Shields, TM; Sichivula, J; Muleba, M; Mulenga, M; Kobayashi, T; Curriero, FC; Moss, WJ				Pinchoff, Jessie; Chaponda, Mike; Shields, Timothy M.; Sichivula, James; Muleba, Mbanga; Mulenga, Modest; Kobayashi, Tamaki; Curriero, Frank C.; Moss, William J.		Southern Africa Int Ctr Excellence	Individual and Household Level Risk Factors Associated with Malaria in Nchelenge District, a Region with Perennial Transmission: A Serial Cross-Sectional Study from 2012 to 2015	PLOS ONE			English	Article							CONTROL INTERVENTIONS; PATTERNS; CHILDREN; AFRICA; BURDEN	Background The scale-up of malaria control interventions has resulted in substantial declines in transmission in some but not all regions of sub-Saharan Africa. Understanding factors associated with persistent malaria transmission despite control efforts may guide targeted interventions to high-risk areas and populations. Methods Household malaria surveys were conducted in Nchelenge District, Luapula Province, in northern Zambia. Structures that appeared to be households were enumerated from a high-resolution satellite image and randomly sampled for enrollment. Households were enrolled into cross-sectional (single visit) or longitudinal (visits every other month) cohorts but analyses were restricted to cross-sectional visits and the first visit to longitudinal households. During study visits, a questionnaire was administered to adults and caretakers of children and a blood sample was collected for a malaria rapid diagnostic test (RDT) from all household residents. Characteristics associated with RDT positivity were analyzed using multi-level models. Results A total of 2,486 individuals residing within 742 households were enrolled between April 2012 and July 2015. Over this period, 51% of participants were RDT positive. Forty-three percent of all RDT positive individuals were between the ages of 5 and 17 years although this age group comprised only 30% of study participants. In a multivariable model, the odds being RDT positive were highest in 5-17 year olds and did not vary by season. Children 5-17 years of age had 8.83 higher odds of being RDT positive compared with those >18 years of age (95% CI: 6.13, 12.71); there was an interaction between age and report of symptoms, with an almost 50% increased odds of report of symptoms with decreasing age category (OR = 1.49; 95% CI 1.11, 2.00). Conclusions Children and adolescents between the ages of 5 and 17 were at the highest risk of malaria infection throughout the year. School-based programs may be effective at targeting this high-risk group.	[Pinchoff, Jessie; Shields, Timothy M.; Kobayashi, Tamaki; Curriero, Frank C.; Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chaponda, Mike; Sichivula, James; Muleba, Mbanga; Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pinchoff, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	jpinchoff@gmail.com			Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research [U19 AI089680]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089680] Funding Source: NIH RePORTER	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation; Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Johns Hopkins Malaria Research Institute, the Bloomberg Family Foundation and the Division of Microbiology and Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health as part of the International Centers of Excellence for Malaria Research (U19 AI089680).	Alonso P. L., 2011, PLOS MED, V8; Ardiet DL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-199; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Das S, 2016, AM J TROPICAL MED HY; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Greenwood BM, 2008, TRENDS PARASITOL, V24, P449, DOI 10.1016/j.pt.2008.07.002; Guillebaud J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-379; Hiwat H, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-10; Kamuliwo M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-437; Kanyangarara M, AM J TROPIC IN PRESS; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Kyabayinze DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-221; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Lin J, 2014, TRENDS PARASITOLOGY, V30; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Mabaso MLH, 2007, AM J TROP MED HYG, V76, P33, DOI 10.4269/ajtmh.2007.76.33; malERA, 2011, PLOS MED, V8; Mharakurwa S, 2011, ACTA TROPICA; MOH, 2015, ZAMB NAT MAL IND SUR; MOH, 2010, ZAMB DEM HLTH SURV 2; Mukonka VM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-153; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; NMCP, 2012, NAT MAL CONTR PROGR; Omukunda E, 2012, J VECTOR DIS, V49, P61; Pinault LL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00059; Pinchoff J, AM J TROPICAL MED HY, V93; Pinchoff J, 2015, AM J TROPICAL MED HY, V93; Pinchoff J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0793-1; Russell T, 2013, MALARIA J, V12; Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396; Townes LR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-407; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, 2 WHO; Zhou G, 2011, PLOS ONE, V6; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	41	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156717	10.1371/journal.pone.0156717	http://dx.doi.org/10.1371/journal.pone.0156717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281028	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000040
J	Smith-Aguilar, SE; Ramos-Fernandez, G; Getz, WM				Smith-Aguilar, Sandra E.; Ramos-Fernandez, Gabriel; Getz, Wayne M.			Seasonal Changes in Socio-Spatial Structure in a Group of Free-Living Spider Monkeys (Ateles geoffroyi)	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; ASSOCIATION PATTERNS; SOCIAL-STRUCTURE; PAN-TROGLODYTES; NATIONAL-PARK; HOME RANGES; GROUP-SIZE; ECOLOGICAL CONSTRAINTS; FEEDING COMPETITION; FEMALE CHIMPANZEES	Ecological and social factors influence individual movement and group membership decisions, which ultimately determine how animal groups adjust their behavior in spatially and temporally heterogeneous environments. The mechanisms behind these behavioral adjustments can be better understood by studying the relationship between association and space use patterns of groups and how these change over time. We examined the socio-spatial patterns of adult individuals in a free-ranging group of spider monkeys (Ateles geoffroyi), a species with high fission-fusion dynamics. Data comprised 4916 subgroup scans collected during 325 days throughout a 20-month period and was used to evaluate changes from fruit-scarce to fruit-abundant periods in individual core-area size, subgroup size and two types of association measures: spatial (core-area overlap) and spatio-temporal (occurrence in the same subgroup) associations. We developed a 3-level analysis framework to distinguish passive associations, where individuals are mostly brought together by resources of common interest, from active association, where individuals actively seek or avoid certain others. Results indicated a more concentrated use of space, increased individual gregariousness and higher spatio-temporal association rates in the fruit-abundant seasons, as is compatible with an increase in passive associations. Nevertheless, results also suggested active associations in all the periods analyzed, although associations differed across seasons. In particular, females seem to actively avoid males, perhaps prompted by an increased probability of random encounters among individuals, resulting from the contraction of individual core areas. Our framework proved useful in investigating the interplay between ecological and social constraints and how these constraints can influence individual ranging and grouping decisions in spider monkeys, and possibly other species with high fission-fusion dynamics.	[Smith-Aguilar, Sandra E.; Ramos-Fernandez, Gabriel] Inst Politecn Nacl, Ctr Interdisciplinario Invest & Desarrollo Integr, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico; [Ramos-Fernandez, Gabriel] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Ciudad De Mexico, Mexico; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California Berkeley; University of Kwazulu Natal	Smith-Aguilar, SE (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest & Desarrollo Integr, Unidad Oaxaca, Xoxocotlan, Oaxaca, Mexico.	galadrielent@yahoo.com	Smith-Aguilar, Sandra Elizabeth/AAR-2926-2021; Ramos-Fernandez, Gabriel/GQR-1310-2022	Smith-Aguilar, Sandra Elizabeth/0000-0003-2209-5496; Ramos-Fernandez, Gabriel/0000-0001-7175-3905	Consejo Nacional de Ciencia y Tecnologia of Mexico [157656, 207883]; Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia [2014-MZO2015]; Instituto Politecnico Nacional (ECOES)	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Politecnico Nacional; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Politecnico Nacional (ECOES)	Funding for field work was provided by the Consejo Nacional de Ciencia y Tecnologia of Mexico (grant 157656: GRF and scholarship 207883: SESA) and by the Instituto Politecnico Nacional. Part of the analyses was conducted during a research stay by SESA at the Getz Lab, UC Berkeley supported by the Consejo Nacional de Ciencia y Tecnologia (scholarship 2014-MZO2015) and the Instituto Politecnico Nacional (ECOES grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Archie EA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1261; Asensio N, 2012, J ZOOL, V287, P250, DOI 10.1111/j.1469-7998.2012.00911.x; Asensio N, 2008, BEHAVIOUR, V145, P983, DOI 10.1163/156853908784089234; Asensio N, 2015, AM J PRIMATOL, V77, P777, DOI 10.1002/ajp.22400; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2006, AM J PHYS ANTHROPOL, V131, P486, DOI 10.1002/ajpa.20451; Aureli F, 2012, BEHAV ECOL, V23, P1308, DOI 10.1093/beheco/ars122; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Best EC, 2014, ANIM BEHAV, V89, P1, DOI 10.1016/j.anbehav.2013.12.011; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Bonilla-Moheno M., 2008, THESIS; Busia L, 2016, BEHAVIOUR, V153, P107, DOI 10.1163/1568539X-00003329; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Canty A., 2015, BOOT BOOTSTRAP R S P; CHAPMAN C, 1988, PRIMATES, V29, P177, DOI 10.1007/BF02381121; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; CHAPMAN CA, 1990, BEHAV ECOL SOCIOBIOL, V26, P409; Chapman CA, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P24; Chapman CA, 2009, PRIMATES, V50, P12, DOI 10.1007/s10329-008-0123-0; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Connor R, 2005, ANIM BEHAV, V69, P127, DOI 10.1016/j.anbehav.2004.02.022; Connor RC, 2000, CETACEAN SOCIETIES, P91; Conradt L, 2000, P ROY SOC B-BIOL SCI, V267, P2213, DOI 10.1098/rspb.2000.1271; Couzin ID, 2006, CURR BIOL, V16, pR169, DOI 10.1016/j.cub.2006.02.042; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; CROOK JH, 1976, ANIM BEHAV, V24, P261, DOI 10.1016/S0003-3472(76)80035-8; Cross PC, 2005, ANIM BEHAV, V69, P499, DOI 10.1016/j.anbehav.2004.08.006; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; FEDIGAN L M, 1984, Primates, V25, P279, DOI 10.1007/BF02382267; FEDIGAN LM, 1988, AM J PRIMATOL, V16, P19, DOI 10.1002/ajp.1350160104; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2012, PHILOS T R SOC B, V367, P1802, DOI 10.1098/rstb.2011.0214; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fury CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052987; Garcia-Frapolli E, 2007, LANDSCAPE URBAN PLAN, V83, P137, DOI 10.1016/j.landurbplan.2007.03.007; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; GINSBERG JR, 1992, ANIM BEHAV, V44, P377, DOI 10.1016/0003-3472(92)90042-8; Godde S, 2013, ANIM BEHAV, V85, P553, DOI 10.1016/j.anbehav.2012.12.010; Grove M, 2012, ANIM BEHAV, V83, P411, DOI 10.1016/j.anbehav.2011.11.011; Hartwell KS, 2014, INT J PRIMATOL, V35, P425, DOI 10.1007/s10764-013-9746-0; Hemelrijk CK, 2000, LEARN BEH WORKSH 2 I, P11; HEMELRIJK CK, 1998, COM ADAP SY, P307; Henzi SP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1015, DOI 10.1007/s00265-009-0720-y; Henzi SP, 2007, ADV STUD BEHAV, V37, P43, DOI 10.1016/S0065-3454(07)37002-2; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Holme P, 2007, PHYSICA A, V373, P821, DOI 10.1016/j.physa.2006.04.066; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Ilany A, 2015, ECOL LETT, V18, P687, DOI 10.1111/ele.12447; Isbell LA, 1998, BEHAV ECOL SOCIOBIOL, V42, P123, DOI 10.1007/s002650050420; Jose-Dominguez JM, 2015, AM J PRIMATOL, V77, P841, DOI 10.1002/ajp.22409; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Koenig A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0348; Lehmann J, 2003, BEHAV ECOL, V14, P642, DOI 10.1093/beheco/arg047; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lyons AJ, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-2; Miller JA, 2014, ANIM BEHAV, V87, P147, DOI 10.1016/j.anbehav.2013.10.023; Murray CM, 2008, CURR BIOL, V18, P20, DOI 10.1016/j.cub.2007.11.044; Murray CM, 2007, ANIM BEHAV, V74, P1795, DOI 10.1016/j.anbehav.2007.03.024; Murray CM, 2006, BEHAV ECOL, V17, P1020, DOI 10.1093/beheco/arl042; Newton-Fisher NE, 1999, BEHAVIOUR, V136, P705, DOI 10.1163/156853999501531; Pinacho Guendulain B, 2010, THESIS; Popa-Lisseanu AG, 2008, ANIM BEHAV, V75, P471, DOI 10.1016/j.anbehav.2007.05.011; Powell RA, 2000, METH C CONS, P65; Puga-Gonzalez I, 2015, BEHAV ECOL SOCIOBIOL, V69, P383, DOI 10.1007/s00265-014-1850-4; Ramos-Fernandez G, 2005, INT J PRIMATOL, V26, P1077, DOI 10.1007/s10764-005-6459-z; Ramos-Fernandez G, 2009, AM J PRIMATOL, V71; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Ramos-Fernandez Gabriel, 2003, Neotropical Primates, V11, P155; Ramos-Fernandez G, 2014, BEHAV ECOL SOCIOBIOL, V68, P1225, DOI 10.1007/s00265-014-1733-8; Ramos-Fernandez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062813; Ramos-Fernandez G, 2008, CAM S BIO EVOL ANTHR, V55, P220; Ramos-Fernandez G, 2009, BEHAV ECOL SOCIOBIOL, V63, P999, DOI 10.1007/s00265-009-0719-4; Romera Valero Angel, 2004, THESIS; Ryan SJ, 2008, INT J PRIMATOL, V29, P405, DOI 10.1007/s10764-007-9172-2; SAMUEL MD, 1985, J ANIM ECOL, V54, P711, DOI 10.2307/4373; Schaffner CM, 2012, INT J PRIMATOL, V33, P922, DOI 10.1007/s10764-012-9621-4; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Shimooka Y, 2003, PRIMATES, V44, P83, DOI 10.1007/s10329-002-0028-2; Shimooka Y, 2005, INT J PRIMATOL, V26, P385, DOI 10.1007/s10764-005-2930-0; Shimooka Y, 2008, CAM S BIO EVOL ANTHR, V55, P329; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Slater KY, 2007, ANIM BEHAV, V74, P455, DOI 10.1016/j.anbehav.2006.11.026; Slater KY, 2009, AM J PRIMATOL, V71, P21, DOI 10.1002/ajp.20618; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; SMN, 2015, NOMRALES CLIMATOLGIE, P1; Spehar SN, 2010, AM J PRIMATOL, V72, P129, DOI 10.1002/ajp.20763; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; SUGARDJITO J, 1987, INT J PRIMATOL, V8, P17, DOI 10.1007/BF02737112; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; SYMINGTON MM, 1990, INT J PRIMATOL, V11, P47, DOI 10.1007/BF02193695; te Boekhorst I, 1994, ARTIF LIFE, P119; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Thompson ME, 2006, DEV PRIMATOL, P209; Valero A, 2007, ANIM COGN, V10, P305, DOI 10.1007/s10071-006-0066-z; Valero A, 2006, AM J PRIMATOL, V68, P732, DOI 10.1002/ajp.20263; van der Post DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117027; VanderWaal KL, 2014, BEHAV ECOL, V25, P17, DOI 10.1093/beheco/art061; VANSCHAIK CP, 1983, BEHAVIOUR, V85, P91, DOI 10.1163/156853983X00057; Wakefield ML, 2013, ANIM BEHAV, V85, P1303, DOI 10.1016/j.anbehav.2013.03.019; Wallace RB, 2006, AM J PRIMATOL, V68, P313, DOI 10.1002/ajp.20227; WHITE FJ, 1988, BEHAVIOUR, V105, P148, DOI 10.1163/156853988X00494; White FJ, 1998, INT J PRIMATOL, V19, P1013, DOI 10.1023/A:1020374220004; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1991, BEHAV ECOL SOCIOBIOL, V29, P385, DOI 10.1007/BF00165964; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H., 2008, ANAL ANIMAL SOC; Whitehead H., 2005, ANIM BEHAV, V69, pE1, DOI [10.1016/j.anbehav.2004.11.004, DOI 10.1016/J.ANBEHAV.2004.11.004]; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Wiszniewski J, 2012, J MAMMAL, V93, P239, DOI 10.1644/10-MAMM-A-366.1; Wittemyer G, 2007, BEHAV ECOL SOCIOBIOL, V61, P1919, DOI 10.1007/s00265-007-0432-0; Wittemyer G, 2007, ANIM BEHAV, V73, P671, DOI 10.1016/j.anbehav.2006.10.008; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wolf JBW, 2007, ANIM BEHAV, V74, P1293, DOI 10.1016/j.anbehav.2007.02.024	127	20	21	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157228	10.1371/journal.pone.0157228	http://dx.doi.org/10.1371/journal.pone.0157228			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280800	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000109
J	Soprano, M; Sorriento, D; Rusciano, MR; Maione, AS; Limite, G; Forestieri, P; D'Angelo, D; D'Alessio, M; Campiglia, P; Formisano, P; Iaccarino, G; Bianco, R; Illario, M				Soprano, Maria; Sorriento, Daniela; Rusciano, Maria Rosaria; Maione, Angela Serena; Limite, Gennaro; Forestieri, Pietro; D'Angelo, Dario; D'Alessio, Matteo; Campiglia, Pietro; Formisano, Pietro; Iaccarino, Guido; Bianco, Roberto; Illario, Maddalena			Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells	PLOS ONE			English	Article							HIV PROTEASE INHIBITORS; ENDOPLASMIC-RETICULUM STRESS; PHASE-I TRIAL; NF-KAPPA-B; SUPEROXIDE-DISMUTASE; INSULIN-RESISTANCE; TRANSCRIPTION FACTORS; AKT PHOSPHORYLATION; REDOX REGULATION; CYCLE ARREST	The discovery of the anti-proliferative activity of nelfinavir in HIV-free models has encouraged its investigation as anticancer drug. Although the molecular mechanism by which nelfinavir exerts antitumor activity is still unknown, its effects have been related to Akt inhibition. Here we tested the effects of nelfinavir on cell proliferation, viability and death in two human breast cancer cell lines and in human normal primary breast cells. To identify the mechanism of action of nelfinavir in breast cancer, we evaluated the involvement of the Akt pathway as well as the effects of nelfinavir on reactive oxygen species (ROS) production and ROS-related enzymes activities. Nelfinavir reduced breast cancer cell viability by inducing apoptosis and necrosis, without affecting primary normal breast cells. The antitumor activity of nelfinavir was related to alterations of the cell redox state, coupled with an increase of intracellular ROS production limited to cancer cells. Nelfinavir treated tumor cells also displayed a downregulation of the Akt pathway due to disruption of the Akt-HSP90 complex, and subsequent degradation of Akt. These effects resulted to be ROS dependent, suggesting that ROS production is the primary step of nelfinavir anticancer activity. The analysis of ROS-producers and ROS-detoxifying enzymes revealed that nelfinavir-mediated ROS production was strictly linked to flavoenzymes activation. We demonstrated that ROS enhancement represents the main molecular mechanism required to induce cell death by nelfinavir in breast cancer cells, thus supporting the development of new and more potent oxidizing molecules for breast cancer therapy.	[Soprano, Maria; Rusciano, Maria Rosaria; Maione, Angela Serena; Formisano, Pietro; Illario, Maddalena] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Sorriento, Daniela] Italian Natl Res Council CNR, IBB, Naples, Italy; [Limite, Gennaro; Forestieri, Pietro] Univ Naples Federico II, Breast Unit, Dept Clin Med & Surg, Naples, Italy; [D'Angelo, Dario; D'Alessio, Matteo] Hosp Ctr A Cardarelli, Plast Surg Operat Unit, Dept Emergency & Recept, Naples, Italy; [Campiglia, Pietro] Univ Salerno, Dept Pharm, I-84100 Salerno, Italy; [Iaccarino, Guido] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Bianco, Roberto] Univ Naples Federico II, Div Oncol, Dept Clin Med & Surg, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Istituto di Neuroscienze (IN-CNR); University of Naples Federico II; Antonio Cardarelli Hospital; University of Salerno; University of Salerno; University of Naples Federico II	Illario, M (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	illario@unina.it	Iaccarino, Guido/D-4540-2009; Rusciano, Maria Rosaria/W-1958-2019; Maione, Angela Serena/H-3123-2018; Campiglia, Pietro/J-5625-2018; Formisano, Pietro/J-4237-2018; IACCARINO, Guido/A-7702-2010	Iaccarino, Guido/0000-0002-8997-835X; Maione, Angela Serena/0000-0003-1460-7033; IACCARINO, Guido/0000-0002-8997-835X; Formisano, Pietro/0000-0001-7020-6870; Campiglia, Pietro/0000-0002-1069-2181	Campania Bioscience [PON03PE_00060_8]	Campania Bioscience	This study was supported by the Campania Bioscience, grant PON03PE_00060_8.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Beck R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040795; Ben-Romano R, 2006, ANTIVIR THER, V11, P1051; Bernstein WB, 2008, CURR OPIN HIV AIDS, V3, P666, DOI 10.1097/COH.0b013e328313915d; Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Brown NS, 2000, CANCER RES, V60, P6298; Bruning A, 2009, CANCER BIOL THER, V8, P222; Bruning A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2602; Buijsen J, 2013, RADIOTHER ONCOL, V107, P184, DOI 10.1016/j.radonc.2013.03.023; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Chakravarty G, 2016, BIOCHIMIE, V124, P53, DOI 10.1016/j.biochi.2016.01.014; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chow WA, 2006, ANTI-CANCER DRUG, V17, P891, DOI 10.1097/01.cad.0000224448.08706.76; Conklin KA, 2004, J NUTR, V134, p3201S, DOI 10.1093/jn/134.11.3201S; Cuneo KC, 2007, CANCER RES, V67, P4886, DOI 10.1158/0008-5472.CAN-06-3684; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dean RT, 1997, BIOCHEM J, V324, P1; Deeks SG, 1997, JAMA-J AM MED ASSOC, V277, P145, DOI 10.1001/jama.277.2.145; Deng W, 2010, J MOL CELL CARDIOL, V49, P746, DOI 10.1016/j.yjmcc.2010.08.013; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Forman HJ, 2007, FREE RADICAL BIO MED, V42, P926, DOI 10.1016/j.freeradbiomed.2007.01.011; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Goldenberg MM, 1999, CLIN THER, V21, P309, DOI 10.1016/S0149-2918(00)88288-0; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Gupta AK, 2005, CANCER RES, V65, P8256, DOI 10.1158/0008-5472.CAN-05-1220; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Gupte A, 2009, CANCER TREAT REV, V35, P32, DOI 10.1016/j.ctrv.2008.07.004; Hoyt MT, 2011, INVEST NEW DRUG, V29, P562, DOI 10.1007/s10637-010-9390-x; Hsieh TC, 2005, BIOCHEM BIOPH RES CO, V337, P224, DOI 10.1016/j.bbrc.2005.09.040; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Iaccarino G, 2006, CLIN PHARMACOL THER, V80, P633, DOI 10.1016/j.clpt.2006.09.006; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Jareno EJ, 2002, FREE RADICAL RES, V36, P341, DOI 10.1080/10715760290019363; Jiang ZB, 2007, CANCER RES, V67, P4467, DOI 10.1158/0008-5472.CAN-06-3398; Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Kronenwett U, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-8; LaBarge MA, 2013, JOVE-J VIS EXP, DOI 10.3791/50011; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005; Manoharan S, 2004, CELL MOL BIOL LETT, V9, P699; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McEligot AJ, 2005, ANNU REV NUTR, V25, P261, DOI 10.1146/annurev.nutr.25.050304.092633; Meitzler JL, 2014, ANTIOXID REDOX SIGN, V20, P2873, DOI 10.1089/ars.2013.5603; Monini P, 2003, J ANTIMICROB CHEMOTH, V51, P207, DOI 10.1093/jac/dkg086; Moskowitz R, 1999, Congest Heart Fail, V5, P153; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; OBERLEY LW, 1979, CANCER RES, V39, P1141; Oberley TD, 2004, ANTIOXID REDOX SIGN, V6, P537, DOI 10.1089/152308604773934297; Olumi AF, 1999, CANCER RES, V59, P5002; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Pajonk F, 2002, CANCER RES, V62, P5230; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plastaras JP, 2008, CANCER BIOL THER, V7, P628; Pore N, 2006, CANCER RES, V66, P9252, DOI 10.1158/0008-5472.CAN-06-1239; Portakal O, 2000, CLIN BIOCHEM, V33, P279, DOI 10.1016/S0009-9120(00)00067-9; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reliene R, 2006, DNA REPAIR, V5, P852, DOI 10.1016/j.dnarep.2006.05.003; Rengan R, 2012, J THORAC ONCOL, V7, P709, DOI 10.1097/JTO.0b013e3182435aa6; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Ridnour LA, 2004, ANTIOXID REDOX SIGN, V6, P501, DOI 10.1089/152308604773934260; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rudich A, 2005, ACTA PHYSIOL SCAND, V183, P75, DOI 10.1111/j.1365-201X.2004.01383.x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarkar S, 2013, INT J CANCER, V132, P695, DOI 10.1002/ijc.27687; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shim JS, 2012, JNCI-J NATL CANCER I, V104, P1576, DOI 10.1093/jnci/djs396; Sinha R. J., 2009, Indian Journal of Cancer, V46, P146; Sorriento D, 2015, BRIT J CANCER, V112, P77, DOI 10.1038/bjc.2014.577; Sorriento D, 2013, FEBS LETT, V587, P3487, DOI 10.1016/j.febslet.2013.09.002; Sorriento D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-97; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tebas P, 2000, Expert Opin Pharmacother, V1, P1429, DOI 10.1517/14656566.1.7.1429; Thomas S, 2012, CANCER LETT, V325, P63, DOI 10.1016/j.canlet.2012.05.030; Toschi E, 2011, INT J CANCER, V128, P82, DOI 10.1002/ijc.25550; Touzet O, 2010, AIDS, V24, P1437, DOI 10.1097/QAD.0b013e32833a6114; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsurutani J, 2007, LUNG CANCER, V55, P115, DOI 10.1016/j.lungcan.2006.09.026; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang XW, 2007, AM J PATHOL, V171, P304, DOI 10.2353/ajpath.2007.060965; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiang T, 2015, CANCER LETT, V364, P79, DOI 10.1016/j.canlet.2015.04.027; Yang Y, 2006, BRIT J CANCER, V95, P1653, DOI 10.1038/sj.bjc.6603435; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	96	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0155970	10.1371/journal.pone.0155970	http://dx.doi.org/10.1371/journal.pone.0155970			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280849	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000009
J	Young, KH; Baird, JR; Savage, T; Cottam, B; Friedman, D; Bambina, S; Messenheimer, DJ; Fox, B; Newell, P; Bahjat, KS; Gough, MJ; Crittenden, MR				Young, Kristina H.; Baird, Jason R.; Savage, Talicia; Cottam, Benjamin; Friedman, David; Bambina, Shelly; Messenheimer, David J.; Fox, Bernard; Newell, Pippa; Bahjat, Keith S.; Gough, Michael J.; Crittenden, Marka R.			Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy	PLOS ONE			English	Article							ANTITUMOR IMMUNITY; LOCAL RADIATION; BREAST-CANCER; MOUSE MODEL; RADIOTHERAPY; OX40; INFILTRATION; EXPRESSION; METASTASES; ANTIBODIES	The anecdotal reports of promising results seen with immunotherapy and radiation in advanced malignancies have prompted several trials combining immunotherapy and radiation. However, the ideal timing of immunotherapy with radiation has not been clarified. Tumor bearing mice were treated with 20Gy radiation delivered only to the tumor combined with either anti-CTLA4 antibody or anti-OX40 agonist antibody. Immunotherapy was delivered at a single timepoint around radiation. Surprisingly, the optimal timing of these therapies varied. Anti-CTLA4 was most effective when given prior to radiation therapy, in part due to regulatory T cell depletion. Administration of anti-OX40 agonist antibody was optimal when delivered one day following radiation during the post-radiation window of increased antigen presentation. Combination treatment of anti-CTLA4, radiation, and anti-OX40 using the ideal timing in a transplanted spontaneous mammary tumor model demonstrated tumor cures. These data demonstrate that the combination of immunotherapy and radiation results in improved therapeutic efficacy, and that the ideal timing of administration with radiation is dependent on the mechanism of action of the immunotherapy utilized.	[Young, Kristina H.; Baird, Jason R.; Savage, Talicia; Cottam, Benjamin; Friedman, David; Bambina, Shelly; Messenheimer, David J.; Fox, Bernard; Bahjat, Keith S.; Gough, Michael J.; Crittenden, Marka R.] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, 4805 NE Glisan St, Portland, OR 97213 USA; [Young, Kristina H.; Newell, Pippa; Crittenden, Marka R.] Oregon Clin, Portland, OR 97213 USA; [Newell, Pippa] Providence Portland Med Ctr, Providence Hepatobiliary & Pancreat Canc Program, 4805 NE Glisan St, Portland, OR 97213 USA	Providence Portland Medical Center; Providence Portland Medical Center	Young, KH (corresponding author), Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, 4805 NE Glisan St, Portland, OR 97213 USA.; Young, KH (corresponding author), Oregon Clin, Portland, OR 97213 USA.	kristina.young@providence.org	Gough, Michael/AAY-3419-2020	Gough, Michael/0000-0002-5575-0074; Young, Kristina/0000-0002-3363-0063; Friedman, David/0000-0002-1295-1562	RSNA Research and Education Foundation; NIH [HHSN272201300006C]; RSNA RE Foundation; NATIONAL CANCER INSTITUTE [R01CA182311] Funding Source: NIH RePORTER	RSNA Research and Education Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RSNA RE Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KHY received an RSNA Research and Education Foundation Research Resident Grant.; We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of MHC tetramers. This study was funded, in part, by an RSNA R&E Foundation Research Resident Grant to KHY.	Barker CA, 2013, CANCER IMMUNOL RES, V1, P92, DOI 10.1158/2326-6066.CIR-13-0082; Belcaid Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101764; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; BRATTAIN MG, 1980, CANCER RES, V40, P2142; Crittenden MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069527; Crittenden MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039295; Curti BD, 2013, CANCER RES, V73, P7189, DOI 10.1158/0008-5472.CAN-12-4174; Demaria S, 2005, CLIN CANCER RES, V11, P728; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Evans DE, 2001, J IMMUNOL, V167, P6804, DOI 10.4049/jimmunol.167.12.6804; Filatenkov A, 2015, CLIN CANCER RES, V21, P3727, DOI 10.1158/1078-0432.CCR-14-2824; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Gough MJ, 2012, IMMUNOTHERAPY-UK, V4, P125, DOI [10.2217/IMT.11.157, 10.2217/imt.11.157]; Gough MJ, 2010, J IMMUNOTHER, V33, P798, DOI 10.1097/CJI.0b013e3181ee7095; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hiniker SM, 2012, TRANSL ONCOL, V5, P404, DOI 10.1593/tlo.12280; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang RR, 2011, CLIN CANCER RES, V17, P4101, DOI 10.1158/1078-0432.CCR-11-0407; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Liang H, 2013, J IMMUNOL, V190, P5874, DOI 10.4049/jimmunol.1202612; Pilones KA, 2009, CLIN CANCER RES, V15, P597, DOI 10.1158/1078-0432.CCR-08-1277; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Redmond WL, 2014, CANCER IMMUNOL RES, V2, P142, DOI 10.1158/2326-6066.CIR-13-0031-T; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Seung SK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003649; Sharabi AB, 2015, CANCER IMMUNOL RES, V3, P345, DOI 10.1158/2326-6066.CIR-14-0196; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Stein WD, 2011, CLIN CANCER RES, V17, P907, DOI 10.1158/1078-0432.CCR-10-1762; Thibault I, 2014, J NEUROSURG-SPINE, V21, P711, DOI 10.3171/2014.7.SPINE13895; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Videtic GMM, 2014, INT J RADIAT ONCOL, V90, P203, DOI 10.1016/j.ijrobp.2014.05.017; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Yokouchi H, 2008, CANCER SCI, V99, P361, DOI 10.1111/j.1349-7006.2007.00664.x; Young KH, 2014, CANCER IMMUNOL RES, V2, P1011, DOI 10.1158/2326-6066.CIR-13-0207; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	39	177	183	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157164	10.1371/journal.pone.0157164	http://dx.doi.org/10.1371/journal.pone.0157164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281029	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000100
J	Zhang, Y; Deng, WC; Xie, XB; Jiao, NZ				Zhang, Yao; Deng, Wenchao; Xie, Xiabing; Jiao, Nianzhi			Differential Incorporation of Carbon Substrates among Microbial Populations Identified by Field-Based, DNA Stable-Isotope Probing in South China Sea	PLOS ONE			English	Article							MAJOR BACTERIAL GROUPS; DISSOLVED ORGANIC-MATTER; MARINE-BACTERIA; BIOMASS PRODUCTION; SARGASSO SEA; TIME-SERIES; DIVERSITY; PACIFIC; ASSEMBLAGES; METABOLISM	To determine the adapted microbial populations to variant dissolved organic carbon (DOC) sources in the marine environment and improve the understanding of the interaction between microorganisms and marine DOC pool, field-based incubation experiments were carried out using supplemental C-13-labeled typical substrates D-glucose and D-glucosamine (D-Glc and D-GlcN, respectively), which are two important components in marine DOC pool in the South China Sea. C-13- and C-12-DNA were then fractionated by ultracentrifugation and the microbial community was analyzed by terminal-restriction fragment length polymorphism and 454 pyrosequencing of 16S rRNA gene. C-12-DNA-based communities showed relatively high similarities with their corresponding in situ communities, and their bacterial diversities were generally higher than C-13-DNA-based counterparts. Distinct differences in community composition were found between C-13- and C-12-DNA-based communities and between two substrate-supplemented C-13-DNA-based communities; these differences distinctly varied with depth and site. In most cases, there were more genera with relative abundances of >0.1% in D-Glc-incorporating communities than in D-GlcN-incorporating communities. The Roseobacter clade was one of the prominent actively substrate-incorporating bacterial populations in all C-13-DNA-based communities. Vibrio was another prominent actively D-GlcN-incorporating bacterial population in most incubations. However notably, different OTUs dominated this clade or genus in different treatments at different depths. Altogether, these results suggested that there were taxa-specific differences in DOC assimilations and, moreover, their differences varied among the typical water masses, which could have been caused by the variant compositions of original bacterial communities from different hydrological environments. This implies that ecologically, the levels of labile or recalcitrance of DOC can be maintained only in a specific environmental context with specific bacterial community composition.	[Zhang, Yao; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361101, Peoples R China; Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen 361101, Peoples R China	Xiamen University; Xiamen University	Zhang, Y; Jiao, NZ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361101, Peoples R China.	yaozhang@xmu.edu.cn; jiao@xmu.edu.cn			973 program [2013CB955700]; NSFC [41422603, 91428308]; SOA [GASI-03-01-02-03, GASI-03-01-02-05];  [973 CHOICE-C II 2015CB954000]	973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); SOA; 	This research was funded by the 973 program 2013CB955700, the NSFC projects 41422603 and 91428308, the SOA projects GASI-03-01-02-03 and GASI-03-01-02-05. The cruise was supported by 973 CHOICE-C II 2015CB954000.	Alonso C, 2006, ENVIRON MICROBIOL, V8, P2022, DOI 10.1111/j.1462-2920.2006.01082.x; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Birnie G. D., 1978, CENTRIFUGAL SEPARATI; Clarke K., 2001, PRIMER V5 USER MANUA; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Dumont MG, 2011, ENVIRON MICROBIOL, V13, P1153, DOI 10.1111/j.1462-2920.2010.02415.x; Hertkorn N, 2006, GEOCHIM COSMOCHIM AC, V70, P2990, DOI 10.1016/j.gca.2006.03.021; Hu J, 2000, J OCEANOGR, V56, P607, DOI DOI 10.1023/A:1011117531252; Hutchens E, 2004, ENVIRON MICROBIOL, V6, P111, DOI 10.1046/j.1462-2920.2003.00543.x; Jiao N, 2014, BIOGEOSCIENCES, V11, P5285, DOI 10.5194/bg-11-5285-2014; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Jiao NZ, 2011, APPL ENVIRON MICROB, V77, P7439, DOI 10.1128/AEM.05640-11; Kaiser K, 2012, J GEOPHYS RES-OCEANS, P117; Kaiser K, 2009, MAR CHEM, V113, P63, DOI 10.1016/j.marchem.2008.12.004; Kirchman DL, 2005, LIMNOL OCEANOGR, V50, P1697, DOI 10.4319/lo.2005.50.5.1697; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee SH, 2010, SCI TOTAL ENVIRON, V408, P1349, DOI 10.1016/j.scitotenv.2009.10.061; Lennon JT, 2007, APPL ENVIRON MICROB, V73, P2799, DOI 10.1128/AEM.02674-06; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Mou X, 2005, NATURE, V451, P708; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Neufeld JD, 2007, ISME J, V1, P480, DOI 10.1038/ismej.2007.65; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Quast C., 2012, NUCLEIC ACIDS RES, V41, pD590, DOI DOI 10.1093/NAR/GKS1219; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Rich J, 1997, DEEP-SEA RES PT II, V44, P1645, DOI 10.1016/S0967-0645(97)00058-1; Rich JH, 1996, LIMNOL OCEANOGR, V41, P595, DOI 10.4319/lo.1996.41.4.0595; Riemann L, 2002, APPL ENVIRON MICROB, V68, P5554, DOI 10.1128/AEM.68.11.5554-5562.2002; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SUTTLE CA, 1991, MAR ECOL PROG SER, V70, P189, DOI 10.3354/meps070189; Tada Y, 2011, APPL ENVIRON MICROB, V77, P4055, DOI 10.1128/AEM.02952-10; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Uhlik O, 2009, SCI TOTAL ENVIRON, V407, P3611, DOI 10.1016/j.scitotenv.2008.05.012; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wong GTF, 2007, DEEP-SEA RES PT II, V54, P1434, DOI 10.1016/j.dsr2.2007.05.012; Zhang Y, 2006, AQUAT MICROB ECOL, V43, P233, DOI 10.3354/ame043233; Zhang Y, 2016, APPL ENVIRON MICROB, V82, P2100, DOI 10.1128/AEM.03678-15; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044593; Zhang Y, 2011, RES MICROBIOL, V162, P320, DOI 10.1016/j.resmic.2010.12.006; Zhang Y, 2009, AQUAT MICROB ECOL, V56, P65, DOI 10.3354/ame01324; Zubkov MV, 2008, J PLANKTON RES, V30, P211, DOI 10.1093/plankt/fbm091	49	7	7	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157178	10.1371/journal.pone.0157178	http://dx.doi.org/10.1371/journal.pone.0157178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280442	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000105
J	Marques, CMD; MacNeil, S				de Godoy Marques, Claudia Mirian; MacNeil, Sheila			Use of a Tissue Engineered Human Skin Model to Investigate the Effects of Wounding and of an Anti-Inflammatory on Melanoma Cell Invasion	PLOS ONE			English	Article							RECONSTRUCTED HUMAN SKIN; NECROSIS-FACTOR-ALPHA; STIMULATING HORMONE; CYCLOOXYGENASE-2 INHIBITOR; TUMOR-GROWTH; CANCER; FIBROBLASTS; INFLAMMATION; EXPRESSION; MIGRATION	An increasing number of studies suggest inflammation stimulates tumour invasion. In melanoma, despite recent advances in targeted therapy and immunomodulatory therapies, this cancer remains difficult to treat. Our previous studies show melanoma cells interact with skin cells in their invasion into tissue engineered skin and suggest inflammation stimulates invasion. The aim of this study was to investigate the use of an anti-inflammatory on melanoma invasion. To do this we developed a wounded and inflamed in vitro 3D melanoma model in which to investigate the use of an anti-inflammatory on melanoma invasion. The tissue engineered skin model was based on human de-epidermised acellular dermis to which keratinocytes, fibroblasts and three different melanoma cell lines were added in various combinations. A simple incisional wound was made in the model and TNF-alpha and fibrin were added to simulate conditions of inflammation. Topical ibuprofen in a hydrogel was added and the extent of melanoma invasion into the dermis was assessed under the various conditions. The results showed that penetration of two of the cell lines (HBL and A375SM) into the tissue engineered skin was exacerbated by wounding and ibuprofen significantly decreased invasion of A375SM cells and slightly reduced invasion of HBL cells. A third cell line, C8161, was aggressively invasive under all conditions to an extent that was not influenced by wounding, TNF-alpha or the addition of ibuprofen. In summary, the results for one these cell lines (and a trend for a second cell line) support the hypothesis that a wound environment is conducive to melanoma invasion but the local addition of an anti-inflammatory drug such as ibuprofen may attenuate invasion.	[de Godoy Marques, Claudia Mirian] Santa Catarina State Univ, Dept Hlth Sci, Florianopolis, SC, Brazil; [MacNeil, Sheila] Univ Sheffield, Dept Mat Sci & Engn, Kroto Res Inst, Sheffield, S Yorkshire, England	Universidade do Estado de Santa Catarina; University of Sheffield	MacNeil, S (corresponding author), Univ Sheffield, Dept Mat Sci & Engn, Kroto Res Inst, Sheffield, S Yorkshire, England.	s.macneil@sheffield.ac.uk			CAPES Foundation (Brazilian Government) [BEX 2475/04-9]	CAPES Foundation (Brazilian Government)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge the CAPES Foundation (Brazilian Government) (Grant Number BEX 2475/04-9) for the support of CMGM's PhD research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the CAPES Foundation (Brazilian Government) for the support of Claudia MG Marques PhD research work.	Aliperti LA, 2011, ANN SURG ONCOL, V18, P603, DOI 10.1245/s10434-010-1442-0; [Anonymous], 2010, SEER STAT DAT INC SE; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bogden AE, 1997, BRIT J CANCER, V75, P1021, DOI 10.1038/bjc.1997.175; BREGMAN MD, 1983, PROSTAGLANDINS, V26, P449, DOI 10.1016/0090-6980(83)90179-X; Briggs M, 2012, COCHRANE DB SYST REV, V11; Canton I, 2003, J INVEST DERMATOL, V121, P557, DOI 10.1046/j.1523-1747.2003.12417.x; Chakrabarty KH, 1999, BRIT J DERMATOL, V141, P811, DOI 10.1046/j.1365-2133.1999.03153.x; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Edward M, 2005, CARCINOGENESIS, V26, P1215, DOI 10.1093/carcin/bgi064; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Eves P, 2003, CLIN EXP METASTAS, V20, P685, DOI 10.1023/B:CLIN.0000006824.41376.b0; Eves P, 2000, BRIT J DERMATOL, V142, P210, DOI 10.1046/j.1365-2133.2000.03287.x; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Flach EH, 2011, MOL PHARMACEUT, V8, P2039, DOI 10.1021/mp200421k; GHANEM GE, 1988, INT J CANCER, V41, P248, DOI 10.1002/ijc.2910410216; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goldbrunner RH, 1996, ANTICANCER RES, V16, P3679; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Katerinaki E, 2006, MELANOMA RES, V16, P11, DOI 10.1097/01.cmr.0000195698.58013.53; Kim E, 2013, CANCER RES, V73, P6874, DOI 10.1158/0008-5472.CAN-13-1720; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Lejeune FJ, 2006, MELANOMA RES, V16, P263, DOI 10.1097/01.cmr.0000205020.17774.ae; Lewis DA, 2011, AGING-US, V3, P407, DOI 10.18632/aging.100318; Li J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150247; Little EG, 2012, DERMATOL CLIN, V30, P355, DOI 10.1016/j.det.2012.04.001; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Olszanski AJ, 2014, J MANAG CARE SPEC PH, V20, P346, DOI 10.18553/jmcp.2014.20.4.346; Redpath M, 2009, BRIT J DERMATOL, V161, P25, DOI 10.1111/j.1365-2133.2009.09220.x; Reed KB, 2012, MAYO CLIN PROC, V87, P328, DOI 10.1016/j.mayocp.2012.01.010; Reichle A, 2004, CANCER-AM CANCER SOC, V101, P2247, DOI 10.1002/cncr.20574; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Rizzi SC, 2010, EXPERT REV MED DEVIC, V7, P143, DOI [10.1586/erd.09.57, 10.1586/ERD.09.57]; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Spieth K, 2003, CANCER CHEMOTH PHARM, V52, P377, DOI 10.1007/s00280-003-0678-9; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tiago M, 2014, TISSUE ENG PT A, V20, P2412, DOI [10.1089/ten.tea.2013.0473, 10.1089/ten.TEA.2013.0473]; Veierod Marit B, 2015, Tidsskr Nor Laegeforen, V135, P450, DOI 10.4045/tidsskr.14.1109; Woo KY, 2008, INT WOUND J, V5, P1, DOI 10.1111/j.1742-481X.2008.00474.x; Yorucu C, 2016, APPL SPECTROSC REV, V51, P243, DOI 10.1080/05704928.2015.1126840; Zhou LL, 2015, J CANCER, V6, P717, DOI 10.7150/jca.10865; Zhu NW, 2002, J INVEST DERMATOL, V119, P1165, DOI 10.1046/j.1523-1747.2002.19516.x	47	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156931	10.1371/journal.pone.0156931	http://dx.doi.org/10.1371/journal.pone.0156931			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270229	Green Published, gold, Green Accepted			2022-12-27	WOS:000377561000051
J	Girard, D; Tardif, JC; Demarble, JB; D'Antono, B				Girard, Dominique; Tardif, Jean-Claude; Demarble, Julie Boisclair; D'Antono, Bianca			Trait Hostility and Acute Inflammatory Responses to Stress in the Laboratory	PLOS ONE			English	Article							ACUTE PSYCHOLOGICAL STRESS; CORONARY-ARTERY-DISEASE; PHYSIOLOGICAL-RESPONSES; DEPRESSIVE SYMPTOMS; BLOOD-PRESSURE; INTERPERSONAL STRESS; PSYCHOSOCIAL FACTORS; CYTOKINE PRODUCTION; SOCIAL SUPPORT; HEALTHY-MEN	Hostility has been associated with higher basal levels of inflammation. The present study evaluated the association of hostility with acute stress-induced changes in inflammatory activity. One hundred and ninety-nine healthy men and women, aged 19-64 years, were exposed to a stress protocol involving four interpersonal stressors. Participants completed the Cook-Medley Hostility questionnaire and provided two blood samples for the measurement of inflammatory biomarkers (CRP, II-6, MPO, TNF-alpha, MCP-1, II-8, II-10, and II-18), prior to and following exposure to a standardized stress protocol. In univariate analyses, hostility was associated with significantly higher TNF-alpha, but lower II-8 and II-18 values post-stress, though only II-8 remained significant after controlling for baseline differences. In multivariate analyses, a significant Age by Hostility interaction emerged for II-6, while sex moderated the relation between hostility and II-10 reactivity. Following stress, hostility was associated with greater pro-inflammatory II-6 activity among younger individuals and to decreased anti-inflammatory II-10 activity in women. Future research is needed to replicate these findings and to evaluate their implication for disease.	[Girard, Dominique; Tardif, Jean-Claude; Demarble, Julie Boisclair; D'Antono, Bianca] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Girard, Dominique] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Tardif, Jean-Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Demarble, Julie Boisclair; D'Antono, Bianca] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Quebec; University of Quebec Montreal; Universite de Montreal; Universite de Montreal	D'Antono, B (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.; D'Antono, B (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	bianca.d.antono@umontreal.ca		Girard, Dominique/0000-0001-7822-8724	Canadian Institutes of Health Research (CIHR) [79456, 111017]; Montreal Heart Institute Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Montreal Heart Institute Foundation	This study was supported by grants awarded to Dr D'Antono by the Canadian Institutes of Health Research (CIHR; MOP #79456 and #111017) and the Montreal Heart Institute Foundation. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	al'Absi M, 2000, INT J PSYCHOPHYSIOL, V37, P257, DOI 10.1016/S0167-8760(00)00108-2; BAREFOOT JC, 1983, PSYCHOSOM MED, V45, P59, DOI 10.1097/00006842-198303000-00008; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Bobjer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061466; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Brummett BH, 2010, PSYCHOSOM MED, V72, P333, DOI 10.1097/PSY.0b013e3181d2f104; Bruun JM, 2003, HORM METAB RES, V35, P142, DOI 10.1055/s-2003-39074; Brydon L, 2010, J PSYCHOSOM RES, V68, P109, DOI 10.1016/j.jpsychores.2009.06.007; Bunde J, 2006, HEALTH PSYCHOL, V25, P493, DOI 10.1037/0278-6133.25.4.493; Buske-Kirschbaum A, 2007, BRAIN BEHAV IMMUN, V21, P92, DOI 10.1016/j.bbi.2006.03.006; Buske-Kirschbaum A, 2002, J NEUROIMMUNOL, V129, P161, DOI 10.1016/S0165-5728(02)00168-6; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Chida Y, 2010, HYPERTENSION, V55, P1026, DOI 10.1161/HYPERTENSIONAHA.109.146621; Coccaro EF, 2006, J PSYCHIAT RES, V40, P460, DOI 10.1016/j.jpsychires.2005.04.005; Connor TJ, 2005, J NEUROIMMUNOL, V159, P119, DOI 10.1016/j.jneuroim.2004.10.016; Cook W. W., 1954, PROPOSED HOSTILITY P, DOI [10.1037/h0060667, DOI 10.1037/H0060667]; Curtin NM, 2009, BRAIN BEHAV IMMUN, V23, P371, DOI 10.1016/j.bbi.2008.12.010; CUTOLO M, 1995, MEDIAT INFLAMM, V4, P138, DOI 10.1155/S096293519500024X; Czajkowski SM, 1997, AM J CARDIOL, V79, P1017, DOI 10.1016/S0002-9149(97)00040-4; D'Antono B, 2005, J BEHAV MED, V28, P267, DOI 10.1007/s10865-005-4663-0; D'Antono B, 2013, J PSYCHOSOM RES, V75, P262, DOI 10.1016/j.jpsychores.2013.05.010; Demarble JB, 2014, J PSYCHOSOM RES, V76, P384, DOI 10.1016/j.jpsychores.2014.02.010; Deschamps A, 2013, J CARDIOTHOR VASC AN, V27, P485, DOI 10.1053/j.jvca.2012.07.016; Dragomir AI, 2014, PSYCHOPHYSIOLOGY, V51, P921, DOI 10.1111/psyp.12231; Elovainio M, 2011, BIOL PSYCHOL, V87, P234, DOI 10.1016/j.biopsycho.2011.03.002; Everson SA, 1996, HYPERTENSION, V27, P1059, DOI 10.1161/01.HYP.27.5.1059; Feinstein DL, 2002, NEUROCHEM INT, V41, P357, DOI 10.1016/S0197-0186(02)00049-9; Gentile C, 2015, ANN BEHAV MED, V49, P112, DOI 10.1007/s12160-014-9639-2; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Gordon JL, 2012, PSYCHOPHYSIOLOGY, V49, P1082, DOI 10.1111/j.1469-8986.2012.01397.x; Graham JE, 2006, BRAIN BEHAV IMMUN, V20, P389, DOI 10.1016/j.bbi.2005.11.002; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hackett RA, 2015, PSYCHOSOM MED, V77, P458, DOI 10.1097/PSY.0000000000000172; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heesen C, 2002, BRAIN BEHAV IMMUN, V16, P282, DOI 10.1006/brbi.2001.0628; Heneka MT, 2002, J NEUROSCI, V22, P2434, DOI 10.1523/JNEUROSCI.22-07-02434.2002; Janicki-Deverts D, 2010, BRAIN BEHAV IMMUN, V24, P58, DOI 10.1016/j.bbi.2009.07.009; Juster RP, 2013, STRESS, V16, P616, DOI 10.3109/10253890.2013.835395; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; Kinzenbaw DA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.149; Lavretsky H, 2012, AM J GERIAT PSYCHIAT, V20, P729, DOI 10.1097/JGP.0b013e31826573cf; Levesque K, 2010, PSYCHOPHYSIOLOGY, V47, P332, DOI 10.1111/j.1469-8986.2009.00943.x; Levesque K, 2009, BIOL PSYCHOL, V80, P354, DOI 10.1016/j.biopsycho.2008.12.003; Loria V, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/135625; Lutgendorf SK, 2004, BRAIN BEHAV IMMUN, V18, P55, DOI 10.1016/S0889-1591(03)00090-4; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Maes M, 2000, NEUROENDOCRINOL LETT, V21, P375; Maruyama Y, 2004, J NEPHROL, V17, pS72; Mezuk B, 2010, BRAIN BEHAV IMMUN, V24, P1294, DOI 10.1016/j.bbi.2010.06.006; Miller GE, 2003, J BEHAV MED, V26, P501, DOI 10.1023/A:1026273817984; Miller TQ, 1996, PSYCHOL BULL, V119, P322, DOI 10.1037/0033-2909.119.2.322; Mwendwa DT, 2013, BRAIN BEHAV IMMUN, V28, P72, DOI 10.1016/j.bbi.2012.10.019; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; OLWEUS D, 1980, PSYCHOSOM MED, V42, P253, DOI 10.1097/00006842-198003000-00003; Peters ML, 1999, PSYCHOSOM MED, V61, P513, DOI 10.1097/00006842-199907000-00016; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Prather AA, 2009, BRAIN BEHAV IMMUN, V23, P622, DOI 10.1016/j.bbi.2008.11.004; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Rappaport LM, 2014, J COUNS PSYCHOL, V61, P253, DOI 10.1037/a0035625; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sherwood A, 2002, PSYCHOSOM MED, V64, P247, DOI 10.1097/00006842-200203000-00007; Smith TW, 2004, J PERS, V72, P1217, DOI 10.1111/j.1467-6494.2004.00296.x; SMITH TW, 1994, IRISH J PSYCHOL, V15, P8, DOI 10.1080/03033910.1994.10557991; SMITH TW, 1985, HEALTH PSYCHOL, V4, P503, DOI 10.1037/0278-6133.4.6.503; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Stewart JC, 2008, PSYCHOSOM MED, V70, P197, DOI 10.1097/PSY.0b013e3181642a0b; Suarez EC, 2003, PSYCHOSOM MED, V65, P523, DOI 10.1097/01.PSY.0000062530.94551.EA; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Suarez EC, 1998, PSYCHOSOM MED, V60, P78, DOI 10.1097/00006842-199801000-00017; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Tikkanen P., 1999, CHARACTERIZATION APP; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang YC, 2014, SOC SCI MED, V107, P124, DOI 10.1016/j.socscimed.2014.02.013; Yao Y, 2013, INT REV IMMUNOL, V32, P324, DOI 10.3109/08830185.2012.762361	79	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156329	10.1371/journal.pone.0156329	http://dx.doi.org/10.1371/journal.pone.0156329			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270459	Green Published, gold, Green Submitted			2022-12-27	WOS:000377560200007
J	Helft, L; Thompson, M; Bent, AF				Helft, Laura; Thompson, Mikayla; Bent, Andrew F.			Directed Evolution of FLS2 towards Novel Flagellin Peptide Recognition	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; BACTERIAL ELICITOR FLAGELLIN; DISEASE-RESISTANCE GENE; PLANT IMMUNE-RESPONSES; ELONGATION-FACTOR TU; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; RECEPTOR EFR; NICOTIANA-BENTHAMIANA	Microbe-associated molecular patterns (MAMPs) are molecules, or domains within molecules, that are conserved across microbial taxa and can be recognized by a plant or animal immune system. Although MAMP receptors have evolved to recognize conserved epitopes, the MAMPs in some microbial species or strains have diverged sufficiently to render them unrecognizable by some host immune systems. In this study, we carried out in vitro evolution of the Arabidopsis thaliana flagellin receptor FLAGELLIN-SENSING 2 (FLS2) to isolate derivatives that recognize one or more flagellin peptides from bacteria for which the wildtype Arabidopsis FLS2 confers little or no response. A targeted approach generated amino acid variation at FLS2 residues in a region previously implicated in flagellin recognition. The primary screen tested for elevated response to the canonical flagellin peptide from Pseudomonas aeruginosa, flg22. From this pool, we then identified five alleles of FLS2 that confer modest (quantitatively partial) recognition of an Erwinia amylovora flagellin peptide. Use of this Erwinia-based flagellin peptide to stimulate Arabidopsis plants expressing the resulting FLS2 alleles did not lead to a detectable reduction of virulent P. syringae pv. tomato growth. However, combination of two identified mutations into a single allele further increased FLS2-mediated responses to the E. amylovora flagellin peptide. These studies demonstrate the potential to raise the sensitivity of MAMP receptors toward particular targets.	[Helft, Laura; Thompson, Mikayla; Bent, Andrew F.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Helft, Laura] Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI USA; [Helft, Laura] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Thompson, Mikayla] Yale Univ, New Haven, CT 06520 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Yale University	Bent, AF (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	afbent@wisc.edu	Bent, Andrew/E-5391-2016	Bent, Andrew/0000-0001-6610-9525	U.S. Department of Energy [DE-FG02-02ER15342]; NSF Predoctoral Fellowship	U.S. Department of Energy(United States Department of Energy (DOE)); NSF Predoctoral Fellowship(National Science Foundation (NSF))	This research was funded by the U.S. Department of Energy (http://science.energy.gov/bes/csgb/, Contract No. DE-FG02-02ER15342) to AFB and an NSF Predoctoral Fellowship (https://www.nsfgrfp.org) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; Albert M, 2010, EUR J CELL BIOL, V89, P200, DOI 10.1016/j.ejcb.2009.11.015; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Aslam SN, 2009, MOL PLANT PATHOL, V10, P375, DOI [10.1111/j.1364-3703.2009.00537.x, 10.1111/J.1364-3703.2009.00537.X]; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Beck M, 2012, CURR OPIN PLANT BIOL, V15, P367, DOI 10.1016/j.pbi.2012.05.004; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chapman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110158; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Clarke CR, 2013, NEW PHYTOL, V200, P847, DOI 10.1111/nph.12408; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Deng L, 2013, ANNU REV BIOPHYS, V42, P191, DOI 10.1146/annurev-biophys-083012-130422; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Faulkner C, 2013, P NATL ACAD SCI USA, V110, P9166, DOI 10.1073/pnas.1203458110; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Forsyth A, 2010, MOL PLANT MICROBE IN, V23, P1545, DOI 10.1094/MPMI-02-10-0047; Giannakopoulou A, 2015, MOL PLANT MICROBE IN, V28, P1316, DOI 10.1094/MPMI-07-15-0147-R; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Helft L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021614; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Jehle AK, 2013, PLANT CELL, V25, P2330, DOI 10.1105/tpc.113.110833; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kishimoto K, 2010, PLANT J, V64, P343, DOI 10.1111/j.1365-313X.2010.04328.x; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koller T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111185; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lane MD, 2014, CURR OPIN CHEM BIOL, V22, P129, DOI 10.1016/j.cbpa.2014.09.013; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Minshull J, 2004, METHODS, V32, P416, DOI 10.1016/j.ymeth.2003.10.004; Miya A, 2007, P NATL ACAD SCI US; Mueller K, 2012, PLANT CELL, V24, P2213, DOI 10.1105/tpc.112.096073; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nicaise V, 2013, EMBO J, V32, P701, DOI 10.1038/emboj.2013.15; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Pel MJC, 2014, MOL PLANT MICROBE IN, V27, P603, DOI 10.1094/MPMI-02-14-0032-R; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Pfund C, 2004, MOL PLANT MICROBE IN, V17, P696, DOI 10.1094/MPMI.2004.17.6.696; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Robatzek S, 2013, PROTOPLASMA, V250, P671, DOI 10.1007/s00709-012-0459-6; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Stirnweis D, 2014, MOL PLANT MICROBE IN, V27, P265, DOI 10.1094/MPMI-10-13-0297-FI; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Takakura Y, 2008, MOL PLANT PATHOL, V9, P525, DOI 10.1111/J.1364-3703.2008.00477.X; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tintor N, 2013, P NATL ACAD SCI USA, V110, P6211, DOI 10.1073/pnas.1216780110; Trda L, 2014, NEW PHYTOL, V201, P1371, DOI 10.1111/nph.12592; Vetter MM, 2012, MOL BIOL EVOL, V29, P1655, DOI 10.1093/molbev/mss011; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang SZ, 2015, MOL PLANT, V8, P1024, DOI 10.1016/j.molp.2015.01.012; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zhang Z, 2013, J INTEGR PLANT BIOL, V55, P1212, DOI 10.1111/jipb.12080; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	94	10	10	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157155	10.1371/journal.pone.0157155	http://dx.doi.org/10.1371/journal.pone.0157155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270917	Green Published, Green Submitted, gold			2022-12-27	WOS:000377560200033
J	Sahoo, B; Arduini, I; Drombosky, KW; Kodali, R; Sanders, LH; Greenamyre, JT; Wetzel, R				Sahoo, Bankanidhi; Arduini, Irene; Drombosky, Kenneth W.; Kodali, Ravindra; Sanders, Laurie H.; Greenamyre, J. Timothy; Wetzel, Ronald			Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; NEURONAL INTRANUCLEAR INCLUSIONS; POLYGLUTAMINE-EXPANSION; AGGREGATION BEHAVIOR; DISEASE PATHOLOGY; DNA-DAMAGE; IN-VITRO; PROTEIN; LENGTH; CELLS	Expansion of the polyglutamine (polyQ) track of the Huntingtin (HTT) protein above 36 is associated with a sharply enhanced risk of Huntington's disease (HD). Although there is general agreement that HTT toxicity resides primarily in N-terminal fragments such as the HTT exon1 protein, there is no consensus on the nature of the physical states of HTT exon1 that are induced by polyQ expansion, nor on which of these states might be responsible for toxicity. One hypothesis is that polyQ expansion induces an alternative, toxic conformation in the HTT exon1 monomer. Alternative hypotheses posit that the toxic species is one of several possible aggregated states. Defining the nature of the toxic species is particularly challenging because of facile interconversion between physical states as well as challenges to identifying these states, especially in vivo. Here we describe the use of fluorescence correlation spectroscopy (FCS) to characterize the detailed time and repeat length dependent self-association of HTT exon1-like fragments both with chemically synthesized peptides in vitro and with cell-produced proteins in extracts and in living cells. We find that, in vitro, mutant HTT exon1 peptides engage in polyQ repeat length dependent dimer and tetramer formation, followed by time dependent formation of diffusible spherical and fibrillar oligomers and finally by larger, sedimentable amyloid fibrils. For expanded polyQ HTT exon1 expressed in PC12 cells, monomers are absent, with tetramers being the smallest molecular form detected, followed in the incubation time course by small, diffusible aggregates at 6-9 hours and larger, sedimentable aggregates that begin to build up at 12 hrs. In these cell cultures, significant nuclear DNA damage appears by 6 hours, followed at later times by caspase 3 induction, mitochondrial dysfunction, and cell death. Our data thus defines limits on the sizes and concentrations of different physical states of HTT exon1 along the reaction profile in the context of emerging cellular distress. The data provide some new candidates for the toxic species and some new reservations about more well-established candidates. Compared to other known markers of HTT toxicity, nuclear DNA damage appears to be a relatively early pathological event.	[Sahoo, Bankanidhi; Arduini, Irene; Drombosky, Kenneth W.; Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Sahoo, Bankanidhi; Arduini, Irene; Drombosky, Kenneth W.; Kodali, Ravindra; Sanders, Laurie H.; Greenamyre, J. Timothy; Wetzel, Ronald] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Sanders, Laurie H.; Greenamyre, J. Timothy] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wetzel, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.; Wetzel, R (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.	rwetzel@pitt.edu	Wetzel, Ronald/G-7453-2011; Sahoo, Bankanidhi/C-2295-2017	Greenamyre, J. Timothy/0000-0003-3468-7878; Sahoo, Bankanidhi/0000-0002-3633-1616	National Institutes of Health [R01 AG019322, R01 ES020718]; Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by National Institutes of Health (http://www.nih.gov/) R01 AG019322 to RW (supported BS, IA, KWD, RK and RW); National Institutes of Health (http://www.nih.gov/) R01 ES020718 to JTG (supported LS and JTG); Hereditary Disease Foundation (http://hdfoundation.org/) research contract to RW (supported IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Arndt JR, 2015, BIOCHEMISTRY-US, V54, P4285, DOI 10.1021/acs.biochem.5b00478; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Bates G. P., 2002, HUNTINGTONS DIS, P429; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Brock R, 1999, P NATL ACAD SCI USA, V96, P10123, DOI 10.1073/pnas.96.18.10123; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Chemuru S, 2016, J MOL BIOL, V428, P274, DOI 10.1016/j.jmb.2015.06.008; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Duim WC, 2014, ACS CHEM BIOL, V9, P2767, DOI 10.1021/cb500335w; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Garai K, 2007, BIOPHYS J, V92, pL55, DOI 10.1529/biophysj.106.101485; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Hoop CL, 2016, P NATL ACAD SCI USA, V113, P1546, DOI 10.1073/pnas.1521933113; Huang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121055; Hughes A, 2014, HUNTINGTONS DIS, P323; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kheterpal I, 2003, BIOCHEMISTRY-US, V42, P14092, DOI 10.1021/bi0357816; Klein FAC, 2013, HUM MOL GENET, V22, P4215, DOI 10.1093/hmg/ddt273; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Li SH, 2000, HUM MOL GENET, V9, P2859, DOI 10.1093/hmg/9.19.2859; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; Marcellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044457; McCampbell A, 2001, NAT MED, V7, P528, DOI 10.1038/87842; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Monsellier E, 2015, J BIOL CHEM, V290, P2560, DOI 10.1074/jbc.M114.603332; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Owens GE, 2015, J MOL BIOL, V427, P2507, DOI 10.1016/j.jmb.2015.05.023; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Sahl SJ, 2016, Q REV BIOPHYS, V49, P1, DOI [10.1017/S0033583515000219, DOI 10.1017/S0033583515000219]; Sahoo B, 2016, METHODS MOL BIOL, V1345, P67, DOI 10.1007/978-1-4939-2978-8_5; Sahoo B, 2014, BIOCHEMISTRY-US, V53, P3897, DOI 10.1021/bi500300c; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Sapp E, 2012, J BIOL CHEM, V287, P13487, DOI 10.1074/jbc.M111.286609; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Snowden J., 2014, HUNTINGTONS DIS, P36; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Vitalis A, 2008, J MOL BIOL, V384, P279, DOI 10.1016/j.jmb.2008.09.026; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wetzel R., 2014, HUNTINGTONS DIS, P274; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Yano H, 2014, NAT NEUROSCI, V17, P822, DOI 10.1038/nn.3721; Youker RT, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.090801	70	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0155747	10.1371/journal.pone.0155747	http://dx.doi.org/10.1371/journal.pone.0155747			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271685	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000377560200003
J	Whitin, JC; Yu, TTS; Ling, XB; Kanegaye, JT; Burns, JC; Cohen, HJ				Whitin, John C.; Yu, Tom To-Sang; Ling, Xuefeng Bruce; Kanegaye, John T.; Burns, Jane C.; Cohen, Harvey J.			A Novel Truncated Form of Serum Amyloid A in Kawasaki Disease	PLOS ONE			English	Article							ELEVATED LEVELS; ACUTE-PHASE; A-PROTEIN; DIAGNOSIS; BIOMARKER; MATRIX-METALLOPROTEINASE-9; DEGRADATION; PROTEOLYSIS; EXPRESSION; DISCOVERY	Background Kawasaki disease (KD) is an acute vasculitis in children that can cause coronary artery abnormalities. Its diagnosis is challenging, and many cytokines, chemokines, acute phase reactants, and growth factors have failed evaluation as specific biomarkers to distinguish KD from other febrile illnesses. We performed protein profiling, comparing plasma from children with KD with febrile control (FC) subjects to determine if there were specific proteins or peptides that could distinguish the two clinical states. Materials and Methods Plasma from three independent cohorts from the blood of 68 KD and 61 FC subjects was fractionated by anion exchange chromatography, followed by surface-enhanced laser desorption ionization (SELDI) mass spectrometry of the fractions. The mass spectra of KD and FC plasma samples were analyzed for peaks that were statistically significantly different. Results A mass spectrometry peak with a mass of 7,860 Da had high intensity in acute KD subjects compared to subacute KD (p = 0.0003) and FC (p = 7.9 x 10(-10)) subjects. We identified this peak as a novel truncated form of serum amyloid A with N-terminal at Lys-34 of the circulating form and validated its identity using a hybrid mass spectrum immunoassay technique. The truncated form of serum amyloid A was present in plasma of KD subjects when blood was collected in tubes containing protease inhibitors. This peak disappeared when the patients were examined after their symptoms resolved. Intensities of this peptide did not correlate with KD-associated laboratory values or with other mass spectrum peaks from the plasma of these KD subjects. Conclusions Using SELDI mass spectrometry, we have discovered a novel truncated form of serum amyloid A that is elevated in the plasma of KD when compared with FC subjects. Future studies will evaluate its relevance as a diagnostic biomarker and its potential role in the pathophysiology of KD.	[Whitin, John C.; Yu, Tom To-Sang; Cohen, Harvey J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Ling, Xuefeng Bruce] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Kanegaye, John T.; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kanegaye, John T.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA	Stanford University; Stanford University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Cohen, HJ (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	punko@Stanford.edu		Whitin, John/0000-0002-6229-4628; Ling, Bruce/0000-0002-5386-3884	National Institutes of Health (US) [HL69413, HL086835]	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (US) award HL69413 to JCB; and National Institutes of Health (US) award HL086835 to HJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1824; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cabana VG, 1997, PEDIATR RES, V42, P651, DOI 10.1203/00006450-199711000-00017; Carlson SM, 2007, PROTEOMICS, V7, P1037, DOI 10.1002/pmic.200600514; Chua PK, 2003, CLIN DIAGN LAB IMMUN, V10, P308, DOI 10.1128/CDLI.10.2.308-314.2003; DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776; Fung ET, 2005, INT J CANCER, V115, P783, DOI 10.1002/ijc.20928; Gavin PJ, 2003, ARTERIOSCL THROM VAS, V23, P576, DOI 10.1161/01.ATV.0000065385.47152.FD; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kawasaki T, 1967, Arerugi, V16, P178; Kiernan UA, 2003, FEBS LETT, V537, P166, DOI 10.1016/S0014-5793(03)00097-8; Kiernan UA, 2006, J PROTEOME RES, V5, P2928, DOI 10.1021/pr060062+; Ling XB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-130; Ling XB, 2009, BIOINFORMATICS, V25, P1461, DOI 10.1093/bioinformatics/btp176; Madan A, 2007, PEDIATR RES, V61, P215, DOI 10.1203/pdr.0b013e31802d776d; Minich LL, 2007, PEDIATRICS, V120, pE1434, DOI 10.1542/peds.2007-0815; Mitani Y, 2005, CIRCULATION, V111, P38, DOI 10.1161/01.CIR.0000151311.38708.29; MIWATA H, 1993, ARCH DIS CHILD, V68, P210, DOI 10.1136/adc.68.2.210; MORENS DM, 1978, HOSP PRACT, V13, P109, DOI 10.1080/21548331.1978.11707402; NASH MC, 1995, CLIN EXP IMMUNOL, V101, P13; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Niederkofler EE, 2003, J LIPID RES, V44, P630, DOI 10.1194/jlr.D200034-JLR200; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; SALO E, 1993, SCAND J INFECT DIS, V25, P497, DOI 10.3109/00365549309008532; SCHILLER B, 1995, ACTA PAEDIATR, V84, P769, DOI 10.1111/j.1651-2227.1995.tb13753.x; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; Stix B, 2001, AM J PATHOL, V159, P561, DOI 10.1016/S0002-9440(10)61727-0; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Takeshita S, 1997, CLIN EXP IMMUNOL, V108, P446, DOI 10.1046/j.1365-2249.1997.3852128.x; TAUBERT KA, 1994, PEDIATR INFECT DIS J, V13, P704, DOI 10.1097/00006454-199408000-00005; Terai M, 1999, AM J CARDIOL, V83, P337, DOI 10.1016/S0002-9149(98)00864-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weiss PF, 2012, PEDIATR CLIN N AM, V59, P407, DOI 10.1016/j.pcl.2012.03.013; Whitin John C, 2013, BMC Res Notes, V6, P358, DOI 10.1186/1756-0500-6-358; Whitin JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049724; Wong M, 1997, J RHEUMATOL, V24, P1179; YAMADA T, 1995, SCAND J IMMUNOL, V41, P94, DOI 10.1111/j.1365-3083.1995.tb03538.x; YAMADA T, 1995, SCAND J IMMUNOL, V41, P570, DOI 10.1111/j.1365-3083.1995.tb03609.x; Yanagawa H, 1996, J Epidemiol, V6, P148; Yang Q, 2009, PEDIATR RES, V66, P11, DOI 10.1203/PDR.0b013e3181a207e3	42	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157024	10.1371/journal.pone.0157024	http://dx.doi.org/10.1371/journal.pone.0157024			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271757	gold, Green Submitted, Green Published			2022-12-27	WOS:000377560200029
J	Wiecek, W; Karcher, H				Wiecek, Witold; Karcher, Helene			Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma	PLOS ONE			English	Article							EVEROLIMUS; MODEL; VALIDATION	Renal-cell carcinoma (RCC) affects over 330,000 new patients every year, of whom 1/3 present with metastatic RCC (mRCC) at diagnosis. Most mRCC patients treated with a first-line agent relapse within 1 year and need second-line therapy. The present study aims to compare overall survival (OS) between nivolumab and cabozantinib from two recent pivotal studies comparing, respectively, each one of the two emerging treatments against everolimus in patients who relapse following first-line treatment. Comparison is traditionally carried out using the Bucher method, which assumes proportional hazard. Since OS curves intersected in one of the pivotal studies, models not assuming proportional hazards were also considered to refine the comparison. Four Bayesian parametric survival network meta-analysis models were implemented on overall survival (OS) data digitized from the Kaplan-Meier curves reported in the studies. Three models allowing hazard ratios (HR) to vary over time were assessed against a fixed-HR model. The Bucher method favored cabozantinib, with a fixed HR for OS vs. nivolumab of 1.09 (95% confidence interval: [0.77, 1.54]). However, all models with time-varying HR showed better fits than the fixed-HR model. The log-logistic model fitted the data best, exhibiting a HR for OS initially favoring cabozantinib, the trend inverting to favor nivolumab after month 5 (95% credible interval <1 from 10 months). The initial probability of cabozantinib conferring superior OS was 54%, falling to 41.5% by month 24. Numerical differences in study-adjusted OS estimates between the two treatments remained small. This study evidences that HR for OS of nivolumab vs. cabozantinib varies over time, favoring cabozantinib in the first months of treatment but nivolumab afterwards, a possible indication that patients with poor prognosis benefit more from cabozantinib in terms of survival, nivolumab benefiting patients with better prognosis. More evidence, including real-world observational data, is needed to compare effectiveness between cabozantinib and nivolumab.	[Wiecek, Witold; Karcher, Helene] LASER Analyt, Halton House,20-23 Holborn, London EC1N 2JD, England		Karcher, H (corresponding author), LASER Analyt, Halton House,20-23 Holborn, London EC1N 2JD, England.	Helene.Karcher@la-ser.com			LASER Analytica	LASER Analytica	This study was funded by LASER Analytica. LASER Analytica has no commercial interests in any of the products studied. Members of the LASER Analytica network have no interest in a drug or other factors studied. Authors consult or currently participate in studies sponsored by virtually all pharmaceutical companies. The funder provided support in the form of salaries for authors HK and WW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; COX DR, 1972, J R STAT SOC B, V34, P187; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fisher R, 2013, SEMIN CANCER BIOL, V23, P38, DOI 10.1016/j.semcancer.2012.06.004; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hess G, 2013, CLIN GENITOURIN CANC, V11, P161, DOI 10.1016/j.clgc.2012.10.003; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ko JJ, 2015, LANCET ONCOL, V16, P293, DOI 10.1016/S1470-2045(14)71222-7; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Ouwens MJNM, 2010, RES SYNTH METHODS, V1, P258, DOI 10.1002/jrsm.25; Quinn DI, 2015, NEW ENGL J MED, V373, P1872, DOI 10.1056/NEJMe1511252; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353	20	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0155389	10.1371/journal.pone.0155389	http://dx.doi.org/10.1371/journal.pone.0155389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271250	gold, Green Submitted, Green Published			2022-12-27	WOS:000377560200001
J	Zhunussova, A; Vitol, EA; Polyak, B; Tuleukhanov, S; Brooks, AD; Sensenig, R; Friedman, G; Orynbayeva, Z				Zhunussova, Aigul; Vitol, Elina A.; Polyak, Boris; Tuleukhanov, Sultan; Brooks, Ari D.; Sensenig, Richard; Friedman, Gary; Orynbayeva, Zulfiya			Mitochondria-Mediated Anticancer Effects of Non-Thermal Atmospheric Plasma	PLOS ONE			English	Article							PRESSURE PLASMA; COMPLEX II; CELLS; ROS; STERILIZATION; SUPEROXIDE; GENERATION; INHIBITORS; SUCCINATE	Non-thermal atmospheric pressure plasma has attracted great interest due to its multiple potential biomedical applications with cancer treatment being among the most urgent. To realize the clinical potential of non-thermal plasma, the exact cellular and molecular mechanisms of plasma effects must be understood. This work aimed at studying the prostate cancer specific mechanisms of non-thermal plasma effects on energy metabolism as a central regulator of cell homeostasis and proliferation. It was found that cancer cells with higher metabolic rate initially are more resistant to plasma treated phosphate-buffered saline (PBS) since the respiratory and calcium sensitive signaling systems were not responsive to plasma exposure. However, dramatic decline of cancer oxidative phosphorylation developed over time resulted in significant progression of cell lethality. The normal prostate cells with low metabolic activity immediately responded to plasma treated PBS by suppression of respiratory functions and sustained elevation of cytosolic calcium. However, over time the normal cells start recovering their mitochondria functions, proliferate and restore the cell population. We found that the non-thermal plasma induced increase in intracellular ROS is of primarily non-mitochondrial origin. The discriminate non-thermal plasma effects hold a promise for clinical cancer intervention.	[Zhunussova, Aigul; Polyak, Boris; Orynbayeva, Zulfiya] Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA; [Zhunussova, Aigul; Tuleukhanov, Sultan] Al Farabi Kazakh Natl Univ, Dept Biophys & Biomed, Alma Ata, Kazakhstan; [Vitol, Elina A.; Friedman, Gary] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Brooks, Ari D.; Sensenig, Richard] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Vitol, Elina A.] ECOLAB, RD&E, Global Sensor Syst Engn, Naperville, IL USA	Drexel University; Al-Farabi Kazakh National University; Drexel University; University of Pennsylvania; Ecolab Inc.	Orynbayeva, Z (corresponding author), Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA.	zorynbay@drexelmed.edu	Vitol, Elina/U-5228-2019; Tuleuhanov, Sultan/O-1218-2014	Tuleukhanov, Sultan/0000-0002-9898-0507	Cornelius Beukenkamp endowment for studies of prostate cancer; Mary DeWitt Pettit Foundation	Cornelius Beukenkamp endowment for studies of prostate cancer; Mary DeWitt Pettit Foundation	This work was supported by Cornelius Beukenkamp endowment for studies of prostate cancer and the Mary DeWitt Pettit Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Cornelius Beukenkamp endowment for studies of prostate cancer. The support of Mary DeWitt Pettit Foundation is appreciated.	Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Burts ML, 2009, AM J INFECT CONTROL, V37, P729, DOI 10.1016/j.ajic.2009.03.010; De Geyter N, 2012, ANNU REV BIOMED ENG, V14, P255, DOI 10.1146/annurev-bioeng-071811-150110; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Ercan UK, 2013, PLASMA PROCESS POLYM, V10, P544, DOI 10.1002/ppap.201200104; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; FRIDMAN A, 2008, PLASMA CHEM; Fridman A, 2004, PLASMA PHYS ENG; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Gnaiger E., 2008, MITOCHONDRIAL DYSFUN, P27; Haertel B, 2014, BIOMOL THER, V22, P477, DOI 10.4062/biomolther.2014.105; Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Howlader N. N. A., 2015, SEER CANC STAT REV; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kostov KG, 2010, SURF COAT TECH, V204, P2954, DOI 10.1016/j.surfcoat.2010.01.052; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Panngom K, CELL DEATH CENTRAL; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Panov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072078; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Schmidt A, 2015, J BIOL CHEM, V290, P6731, DOI 10.1074/jbc.M114.603555; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tuhvatulin AI, 2012, ACTA NATURAE, V4, P82, DOI 10.32607/20758251-2012-4-3-82-87; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Zhang W, 2015, INT J BIOL SCI, V11, P1160, DOI 10.7150/ijbs.11439; Zhunussova A, 2015, AM J CANCER RES, V5, P1665	40	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156818	10.1371/journal.pone.0156818	http://dx.doi.org/10.1371/journal.pone.0156818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270230	gold, Green Submitted, Green Published			2022-12-27	WOS:000377560200018
J	Abay, S; Addissie, A; Davey, G; Farsides, B; Addissie, T				Abay, Serebe; Addissie, Adamu; Davey, Gail; Farsides, Bobbie; Addissie, Thomas			Rapid Ethical Assessment on Informed Consent Content and Procedure in Hintalo-Wajirat, Northern Ethiopia: A Qualitative Study	PLOS ONE			English	Article							THERAPEUTIC MISCONCEPTION; PARTICIPATE; DECISION; NIGERIA; CANCER; TRIAL	Background Informed consent is a key component of bio-medical research involving human participants. However, obtaining informed consent is challenging in low literacy and resource limited settings. Rapid Ethical Assessment (REA) can be used to contextualize and simplify consent information within a given study community. The current study aimed to explore the effects of social, cultural, and religious factors during informed consent process on a proposed HPV-serotype prevalence study. Methodology A qualitative community-based REA was conducted in Adigudom and Mynebri Kebeles, Northern Ethiopia, from July to August 2013. Data were collected by a multi-disciplinary team using open ended questions concerning informed consent components in relation to the parent study. The team conducted one-to-one In-Depth Interviews (IDI) and Focus Group Discussions (FGDs) with key informants and community members to collect data based on the themes of the study. Tape recorded data were transcribed in Tigrigna and then translated into English. Data were categorized and thematically analyzed using open coding and content analysis based on pre-defined themes. Results The REA study revealed a number of socio-cultural issues relevant to the proposed study. Low community awareness about health research, participant rights and cervical cancer were documented. Giving a vaginal sample for testing was considered to be highly embarrassing, whereas giving a blood sample made participants worry that they might be given a result without the possibility of treatment. Verbal consent was preferred to written consent for the proposed study. Conclusion This rapid ethical assessment disclosed important socio-cultural issues which might act as barriers to informed decision making. The findings were important for contextual modification of the Information Sheet, and to guide the best consent process for the proposed study. Both are likely to have enabled participants to understand the informed consent better and consequently to comply with the study.	[Abay, Serebe] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Addissie, Adamu; Davey, Gail; Farsides, Bobbie] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Addissie, Adamu; Addissie, Thomas] Univ Addis Ababa, Addis Ababa, Ethiopia	University of Brighton; University of Sussex; Addis Ababa University	Abay, S (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	serebeabay@yahoo.com	Gebrie, Serebe/AAL-1800-2020; Gebrie, Serebe Abay/AAL-7475-2021	Gebrie, Serebe/0000-0003-0194-3652; Farsides, Bobbie/0000-0002-5477-0612	Wellcome Trust [089769]; Tigray Regional Health Bureau; Hintalo-Wajirat district	Wellcome Trust(Wellcome TrustEuropean Commission); Tigray Regional Health Bureau; Hintalo-Wajirat district	This work was supported by the Wellcome Trust (grant 089769), http://www.wellcome.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our special gratitude goes to all our study participants and members of the multidisciplinary team. We acknowledge the Tigray Regional Health Bureau and Hintalo-Wajirat district for their support and community facilitating for the study.	Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; [Anonymous], 2014, NAT RES ETH REV GUID; Assefa M, 2013, HPV WOMEN ETHIOPIA A; Association of Clinical Research Professionals, 2018, ACRP CERT; Bhan A, 2006, MED ETHICS, V3, P36; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; Bricki N., 2007, MED SANS FRONTIERES; Bull S, 2012, J EMPIR RES HUM RES, V7, P37, DOI 10.1525/jer.2012.7.1.37; Campbell B., 2013, INFORM CONSENT DEV C, P1; Cole CL, 2002, FQS, V3, P199; Corneli AL, 2006, J EMPIR RES HUM RES, V1, P45, DOI 10.1525/jer.2006.1.4.45; de Melo-Martin I, 2008, J MED ETHICS, V34, P202, DOI 10.1136/jme.2006.019406; Escobedo C., 2007, BIOETHICS, V1, P1; Hanrahan D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133394; Hepple B, 2004, ETHICS RES RELATED H; Kengne-Ouafo J a, 2015, INT HLTH, P20; Kengne-Ouafo JA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1026; Kennedy I, 1999, ETHICS RES RELATED H; Krogstad DJ, 2010, AM J TROP MED HYG, V83, P743, DOI 10.4269/ajtmh.2010.10-0014; Legesse B, 2014, KNOWLEDGE BREAST CAN, V4, P32; Lidz CW, 2006, BEHAV SCI LAW, V24, P535, DOI 10.1002/bsl.700; Lobato L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1156; Marshall Patrica A, 2007, SOCIAL EC BEHAV RES; Marshall PA, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-38; Mayer Karl Fortes, 2002, Nurs Times, V98, P30; McAdam Keith, 2002, NUFF COUNC BIOETH, P49; Ndebele PM, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-29; Negussie H, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0818-7; Nijhawan LP, 2013, J ADV PHARM TECHNOL, V4, P134, DOI 10.4103/2231-4040.116779; Osamor PE, 2012, DEV WORLD BIOETH, V12, P87, DOI 10.1111/j.1471-8847.2012.00326.x; Sanchez S, 2001, BIOETHICS, V15, P398, DOI 10.1111/1467-8519.00250; Seidel J V., 1998, ETHNOGRAPH V6 0, P1; Strauss A, 1998, OPEN CODING QUALITAT; Tekola F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000482; Tindana P, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-15; WHO, 2002, B MED ETH; WHO, 2011, STAND OPR GUID ETH R; Zekaria S, 2007, POPULATION CENSUS RE	38	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157056	10.1371/journal.pone.0157056	http://dx.doi.org/10.1371/journal.pone.0157056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258537	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700174
J	Jackson, CA; Dobson, AJ; Tooth, LR; Mishra, GD				Jackson, Caroline A.; Dobson, Annette J.; Tooth, Leigh R.; Mishra, Gita D.			Lifestyle and Socioeconomic Determinants of Multimorbidity Patterns among Mid-Aged Women: A Longitudinal Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CIGARETTE-SMOKING; PRIMARY-CARE; HEALTH; POPULATION; DISEASE; OBESITY; INEQUALITIES; RELIABILITY; OVERWEIGHT	Background Little is known about patterns of associative multimorbidity and their aetiology. We aimed to identify patterns of associative multimorbidity among mid-aged women and the lifestyle and socioeconomic factors associated with their development. Methods Participants were from the Australian Longitudinal Study on Women's Health. We included 4896 women born 1946-51, without multimorbidity in 1998. We identified multimorbidity patterns at survey 6 (2010) using factor analysis, and related these patterns to baseline lifestyle and socioeconomic factors using logistic regression. We dichotomised factor scores and determined odds ratios (ORs) with 95% confidence intervals (CIs) for associations between characteristics and odds of a high versus low factor score. Results We identified five multimorbidity patterns: psychosomatic; musculoskeletal; cardiometabolic; cancer; and respiratory. Overweight and obesity were respectively associated with increased odds of having a high score for the musculoskeletal (adjusted ORs 1.45 [95% CI 1.23, 1.70] and 2.14 [95% CI 1.75, 2.60]) and cardiometabolic (adjusted ORs 1.53 [95% CI 1.31, 1.79] and 2.46 [95% CI 2.02, 2.98]) patterns. Physical inactivity was associated with increased odds of a high score for the psychosomatic, musculoskeletal and cancer patterns (adjusted ORs 1.41 [95% CI 1.13, 1.76]; 1.39 [95% CI 1.11, 1.74]; and 1.35 [95% CI 1.08, 1.69]). Smoking was associated with increased odds of a high score for the respiratory pattern. Education and ability to manage on income were associated with increased odds of a high score for the psychosomatic pattern (adjusted ORs 1.34 [95% CI 1.03, 1.75] and 1.73 [95% CI 1.37, 1.28], respectively) and musculoskeletal pattern (adjusted ORs 1.43 [95% CI 1.10, 1.87] and 1.38 [1.09, 1.75], respectively). Conclusions Distinct multimorbidity patterns can be identified among mid-aged women. Social inequality, physical activity and BMI are risk factors common to multiple patterns and are appropriate targets for reducing the risk of specific multimorbidity groups in mid-life women.	[Jackson, Caroline A.; Dobson, Annette J.; Tooth, Leigh R.; Mishra, Gita D.] Univ Queensland, Sch Populat Hlth, Ctr Longitudinal & Life Course Res, Herston Rd, Herston, Qld 4006, Australia; [Jackson, Caroline A.] Usher Inst Populat Hlth Sci & Informat, 9 Edinburgh Bioquarter,9 Little France Rd, Edinburgh EH16 4UX, Midlothian, Scotland	University of Queensland	Jackson, CA (corresponding author), Univ Queensland, Sch Populat Hlth, Ctr Longitudinal & Life Course Res, Herston Rd, Herston, Qld 4006, Australia.; Jackson, CA (corresponding author), Usher Inst Populat Hlth Sci & Informat, 9 Edinburgh Bioquarter,9 Little France Rd, Edinburgh EH16 4UX, Midlothian, Scotland.	caroline.jackson@ed.ac.uk	Tooth, Leigh/F-2769-2010; Jackson, Caroline/B-5954-2012	Tooth, Leigh/0000-0002-1569-934X; Jackson, Caroline/0000-0002-2067-2811	Australian Commonwealth Department of Health; Australian National Health and Medical Research Council [APP1000986]; Australian Research Council Future Fellowship [FT120100812]	Australian Commonwealth Department of Health; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	The Australian Commonwealth Department of Health funded the Australian Longitudinal Study on Women's Health. CAJ was supported by the Australian National Health and Medical Research Council (grant number: APP1000986). GDM was funded by the Australian Research Council Future Fellowship (FT120100812).r The research on which this paper is based was conducted as part of the Australian Longitudinal Study on Women's Health, at the University of Newcastle and the University of Queensland. We are grateful to the women who provided the survey data. The Australian Commonwealth Department of Health funded the Australian Longitudinal Study on Women's Health. CAJ was supported by the Australian National Health and Medical Research Council (grant number: APP1000986). GDM was funded by the Australian Research Council Future Fellowship (FT120100812).	Anandacoomarasamy A, 2008, INT J OBESITY, V32, P211, DOI 10.1038/sj.ijo.0803715; Australian National Health and Medical Research Council, 2001, AUSTR ALC GUID HLTH; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bize R, 2007, PREV MED, V45, P401, DOI 10.1016/j.ypmed.2007.07.017; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Burton NW, 2010, AUST NZ J PUBL HEAL, V34, P620, DOI 10.1111/j.1753-6405.2010.00618.x; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Dobson AJ, 2015, INT J EPIDEMIOL, V30, P987; Friedenreich CM, 2001, CANCER EPIDEM BIOMAR, V10, P287; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Hamilton L. C., 2013, STAT STATA UPDATED V, V8th; Hansen H, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-39; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Laaksonen E, 2007, INT J EPIDEMIOL, V36, P776, DOI 10.1093/ije/dym074; Langhammer A, 2000, J EPIDEMIOL COMMUN H, V54, P917, DOI 10.1136/jech.54.12.917; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Marmot M, 1997, SOC SCI MED, V44, P901, DOI 10.1016/S0277-9536(96)00194-3; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Peeters G, 2014, J PHYS ACT HEALTH, V11, P966, DOI 10.1123/jpah.2012-0275; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Tang JY, 2013, CANC EPIDEMIOL BIOMA, V22, DOI 2010.1158/1055-9965.EPI-2013-0647.; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Teychenne M, 2008, PREV MED, V46, P397, DOI 10.1016/j.ypmed.2008.01.009; TROISI RJ, 1995, CHEST, V108, P1557, DOI 10.1378/chest.108.6.1557; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	41	32	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156804	10.1371/journal.pone.0156804	http://dx.doi.org/10.1371/journal.pone.0156804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258649	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700133
J	Kashima, H; Momose, F; Umehara, H; Miyoshi, N; Ogo, N; Muraoka, D; Shiku, H; Harada, N; Asai, A				Kashima, Hajime; Momose, Fumiyasu; Umehara, Hiroshi; Miyoshi, Nao; Ogo, Naohisa; Muraoka, Daisuke; Shiku, Hiroshi; Harada, Naozumi; Asai, Akira			Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity	PLOS ONE			English	Article							FACTOR-KAPPA-B; NUCLEAR-FACTOR; EFFECTOR FUNCTIONS; ANTITUMOR-ACTIVITY; CARCINOMA; IMMUNOTHERAPY; DOXORUBICIN; ACTIVATION; INSIGHTS; ANALOGS	Forkhead box protein p3 (Foxp3) is crucial to the development and suppressor function of regulatory T cells (Tregs) that have a significant role in tumor-associated immune suppression. Development of small molecule inhibitors of Foxp3 function is therefore considered a promising strategy to enhance anti-tumor immunity. In this study, we developed a novel cell-based assay system in which the NF-kappa B luciferase reporter signal is suppressed by the co-expressed Foxp3 protein. Using this system, we screened our chemical library consisting of approximately 2,100 compounds and discovered that a cancer chemotherapeutic drug epirubicin restored the Foxp3-inhibited NF-kappa B activity in a concentration-dependent manner without influencing cell viability. Using immunoprecipitation assay in a Treg-like cell line Karpas-299, we found that epirubicin inhibited the interaction between Foxp3 and p65. In addition, epirubicin inhibited the suppressor function of murine Tregs and thereby improved effector T cell stimulation in vitro. Administration of low dose epirubicin into tumor-bearing mice modulated the function of immune cells at the tumor site and promoted their IFN-gamma production without direct cytotoxicity. In summary, we identified the novel action of epirubicin as a Foxp3 inhibitor using a newly established luciferase-based cellular screen. Our work also demonstrated our screen system is useful in accelerating discovery of Foxp3 inhibitors.	[Kashima, Hajime; Umehara, Hiroshi; Miyoshi, Nao; Ogo, Naohisa; Muraoka, Daisuke; Asai, Akira] Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan; [Momose, Fumiyasu] Mie Univ, Grad Sch Med, Dept Immunogene Therapy, Tsu, Mie 5148507, Japan; [Shiku, Hiroshi; Harada, Naozumi] Mie Univ, Ctr Comprehens Canc Immunotherapy, Tsu, Mie 5148507, Japan	University of Shizuoka; Mie University; Mie University	Asai, A (corresponding author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 4228526, Japan.; Harada, N (corresponding author), Mie Univ, Ctr Comprehens Canc Immunotherapy, Tsu, Mie 5148507, Japan.	nharada@clin.medic.mie-u.ac.jp; aasai@u-shizuoka-ken.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Pharma Valley Center (PVC) Shizuoka, Japan	Pharma Valley Center (PVC) Shizuoka, Japan	This work was supported by Pharma Valley Center (PVC) Shizuoka, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa K, 2004, BIOCHEM PHARMACOL, V67, P353, DOI 10.1016/j.bcp.2003.08.039; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bottero V, 2001, CANCER RES, V61, P7785; Carson BD, 2006, FRONT BIOSCI-LANDMRK, V11, P1607, DOI 10.2741/1908; Casares N, 2010, J IMMUNOL, V185, P5150, DOI 10.4049/jimmunol.1001114; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Ihenetu K, 2008, INFLAMM RES, V57, P519, DOI 10.1007/s00011-008-7249-9; Kwon HK, 2008, MOL IMMUNOL, V45, P3205, DOI 10.1016/j.molimm.2008.02.021; Larmonier N, 2008, J IMMUNOL, V181, P6955, DOI 10.4049/jimmunol.181.10.6955; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Li LF, 2013, ASIAN PAC J CANCER P, V14, P1721, DOI 10.7314/APJCP.2013.14.3.1721; Liu WM, 2010, BRIT J CANCER, V102, P115, DOI 10.1038/sj.bjc.6605465; Lozano T, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00294; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nishikawa H, 2001, P NATL ACAD SCI USA, V98, P14571, DOI 10.1073/pnas.251547298; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Schlecht U, 2012, P NATL ACAD SCI USA, V109, P9213, DOI 10.1073/pnas.1204952109; Shaul P, 2013, ACS MED CHEM LETT, V4, P323, DOI 10.1021/ml3002852; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; WEISS RB, 1986, CANCER CHEMOTH PHARM, V18, P185; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wolke C, 2006, INT J MOL MED, V17, P275; Zhou ZC, 2008, IMMUNOL RES, V42, P19, DOI 10.1007/s12026-008-8029-x; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	35	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156643	10.1371/journal.pone.0156643	http://dx.doi.org/10.1371/journal.pone.0156643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284967	gold, Green Published, Green Submitted			2022-12-27	WOS:000377564000018
J	Ohno, T; Adachi, S; Okuno, M; Horibe, Y; Goto, N; Iwama, M; Yamauchi, O; Kojima, T; Saito, K; Ibuka, T; Yasuda, I; Araki, H; Moriwaki, H; Shimizu, M				Ohno, Tomohiko; Adachi, Seiji; Okuno, Mitsuru; Horibe, Yohei; Goto, Naoe; Iwama, Midori; Yamauchi, Osamu; Kojima, Takao; Saito, Koshiro; Ibuka, Takashi; Yasuda, Ichiro; Araki, Hiroshi; Moriwaki, Hisataka; Shimizu, Masahito			Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study	PLOS ONE			English	Article							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; CANCER-RISK; ALCOHOL-CONSUMPTION; FOLLOW-UP; MORTALITY; POLYPS; METAANALYSIS; PREVENTION; GUIDELINES; ASPIRIN	Objective The purpose of this study was to develop a novel scoring system to screen subjects who have a high risk for colorectal neoplasia. Study Design and Setting We retrospectively analyzed 1061 subjects undergoing total colonoscopy (TCS) for the first time at Gihoku Kosei Hospital. The characteristics and habits of the subjects were analyzed using a multivariate logistic regression analysis. The risk score was established according to each odds ratio of the individual risk factors, and the correlations between the sum of the risk scores and the prevalence of colorectal neoplasia for each individual were evaluated. Results Age 45-59 (risk score: 2 points) and >= 60 (3 points), male gender (1 point), and habitual alcohol consumption >= 21g daily (1 point) were extracted as the significant risk factors for colorectal neoplasia. When the risk groups were determined by summing up these risk scores, the prevalence rates of colorectal neoplasia were 8.8% for the low risk group (0-2 points), 30.5% for the low-moderate risk group (3 points), 39.1% for the high-moderate risk group (4 points), and 57.6% for the high risk group (5 points). In comparison with the low risk group, the odds ratio of the low-moderate risk, the high-moderate risk, and the high risk groups were 4.6, 6.7, and 14.1 folds, respectively. Conclusion Our scoring system, which linearly correlates with the prevalence rate of colorectal neoplasia, may be an effective tool for screening the subjects who have a high risk for colorectal neoplasia. These subjects, therefore, should be recommended to undergo TCS.	[Ohno, Tomohiko; Adachi, Seiji; Okuno, Mitsuru; Horibe, Yohei; Goto, Naoe; Iwama, Midori; Yamauchi, Osamu; Kojima, Takao; Saito, Koshiro] Gihoku Kosei Hosp, Dept Gastroenterol Internal Med, Yamagata 5012105, Japan; [Ibuka, Takashi; Yasuda, Ichiro] Gifu Univ, Grad Sch Med, Div Reg Canc Control, Gifu 5011194, Japan; [Ibuka, Takashi; Araki, Hiroshi; Moriwaki, Hisataka; Shimizu, Masahito] Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu 5011194, Japan	Gifu University; Gifu University	Adachi, S (corresponding author), Gihoku Kosei Hosp, Dept Gastroenterol Internal Med, Yamagata 5012105, Japan.	sadachi-gif@umin.ac.jp						Ahlawat SK, 2011, J CLIN GASTROENTEROL, V45, P347, DOI 10.1097/MCG.0b013e3181f3a2e0; Aldridge AJ, 2001, EUR J SURG, V167, P777; Atkin WS, 2012, ENDOSCOPY, V44, pSE151, DOI 10.1055/s-0032-1309821; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Bu WJ, 2014, BRIT J CLIN PHARMACO, V78, P301, DOI 10.1111/bcp.12350; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Cardel M, 2014, CANCER MED-US, V3, P1458, DOI 10.1002/cam4.306; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; Colucci Philomena M, 2003, Clin Med Res, V1, P261; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Galiatsatos P, 2006, AM J GASTROENTEROL, V101, P385, DOI 10.1111/j.1572-0241.2006.00375.x; Heitman SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000370; HIWATASHI N, 1993, JPN J CANCER RES, V84, P1110, DOI 10.1111/j.1349-7006.1993.tb02809.x; Hoffmeister M, 2007, INT J CANCER, V121, P1325, DOI 10.1002/ijc.22796; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Kaminski MF, 2014, GUT, V63, P1112, DOI 10.1136/gutjnl-2013-304965; Kedika R, 2011, J CLIN GASTROENTEROL, V45, pE12, DOI 10.1097/MCG.0b013e3181ea1044; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Limburg PJ, 2006, AM J GASTROENTEROL, V101, P1872, DOI 10.1111/j.1572-0241.2006.00725.x; Limsui D, 2010, JNCI-J NATL CANCER I, V102, P1012, DOI 10.1093/jnci/djq201; Makar GA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt374; Nishihara R, 2015, EUR J EPIDEMIOL, V30, P1129, DOI 10.1007/s10654-015-0088-4; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Saito H, 2000, ONCOL REP, V7, P815; SAITO H, 1995, INT J CANCER, V61, P465, DOI 10.1002/ijc.2910610406; Sakamoto T, 2013, COLORECTAL DIS, V15, pE295, DOI 10.1111/codi.12210; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Steffen A, 2014, CANCER EPIDEM BIOMAR, V23, P2543, DOI 10.1158/1055-9965.EPI-14-0206; Tsugane S, 1999, AM J EPIDEMIOL, V150, P1201, DOI 10.1093/oxfordjournals.aje.a009946; van Duijnhoven Franzel J B, 2011, Gut, V60, P1094, DOI 10.1136/gut.2010.225011; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168; Zappa M, 1999, EUR J CANCER, V35, P326; Zappa M, 1998, EUR J CANCER, V34, P773; Zhu JZ, 2014, ALIMENT PHARM THER, V40, P325, DOI 10.1111/apt.12841	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157269	10.1371/journal.pone.0157269	http://dx.doi.org/10.1371/journal.pone.0157269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284907	Green Published, Green Submitted, gold			2022-12-27	WOS:000377564000053
J	Dalmasso, M; Strain, R; Neve, H; Franz, CMAP; Cousin, FJ; Ross, RP; Hill, C				Dalmasso, Marion; Strain, Ronan; Neve, Horst; Franz, Charles M. A. P.; Cousin, Fabien J.; Ross, R. Paul; Hill, Colin			Three New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage Therapy	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SHIGELLA-SONNEI; BACTERIOPHAGE; COCKTAIL; GENERATION; VOLUNTEERS; BIOCONTROL; O157-H7; BLAST	With the emergence of multi-drug resistant bacteria the use of bacteriophages (phages) is gaining renewed interest as promising anti-microbial agents. The aim of this study was to isolate and characterize phages from human fecal samples. Three new coliphages, phi APCEc01, phi APCEc02 and phi APCEc03, were isolated. Their phenotypic and genomic characteristics, and lytic activity against biofilm, and in combination with ciprofloxacin, were investigated. All three phages reduced the growth of E. coli strain DPC6051 at multiplicity of infection (MOI) between 10(-3) and 10(5). A cocktail of all three phages completely inhibited the growth of E. coli. The phage cocktail also reduced biofilm formation and prevented the emergence of phage-resistant mutants which occurred with single phage. When combined with ciprofloxacin, phage alone or in cocktail inhibited the growth of E. coli and prevented the emergence of resistant mutants. These three new phages are promising biocontrol agents for E. coli infections.	[Dalmasso, Marion; Strain, Ronan; Cousin, Fabien J.; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Dalmasso, Marion; Strain, Ronan; Cousin, Fabien J.; Ross, R. Paul; Hill, Colin] Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [Neve, Horst; Franz, Charles M. A. P.] Max Rubner Inst, Dept Microbiol & Biotechnol, Kiel, Germany; [Ross, R. Paul] TEAGASC, Ctr Biotechnol, Moorepk Food Res Ctr, Fermoy, Cork, Ireland; [Dalmasso, Marion] Normandie Univ, UNICAEN, ABTE EA4651, F-14032 Caen, France	University College Cork; University College Cork; Teagasc; Universite de Caen Normandie	Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.; Hill, C (corresponding author), Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland.	c.hill@ucc.ie	Hill, Colin/A-5611-2012; Ross, Paul/A-7584-2015	Hill, Colin/0000-0002-8527-1445; Ross, Paul/0000-0003-4876-8839; Cousin, Fabien/0000-0001-6874-387X; Strain, Ronan/0000-0003-2465-4626; Dalmasso, Marion/0000-0003-1875-2748	Science Foundation Ireland [SFI/12/RC/2273]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors received financial support from Science Foundation Ireland (http://www.sfi.ie/) under Grant Number SFI/12/RC/2273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0059-2; Baron F, 2006, LAIT, V86, P251, DOI 10.1051/lait:2006005; Brussow H, 2012, VIROLOGY, V434, P138, DOI 10.1016/j.virol.2012.09.015; Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Casey E, 2015, APPL ENVIRON MICROB, V81, P1319, DOI 10.1128/AEM.03413-14; Cha SB, 2012, J VET MED SCI, V74, P1037, DOI 10.1292/jvms.11-0556; Chang HW, 2011, J MICROBIOL, V49, P927, DOI 10.1007/s12275-011-1577-0; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Comeau AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000799; Coulter LB, 2014, VIRUSES-BASEL, V6, P3778, DOI 10.3390/v6103778; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Cusack S, 2013, GERONTOLOGY, V59, P114, DOI 10.1159/000343158; Dalmasso M, 2014, TRENDS MICROBIOL, V22, P399, DOI 10.1016/j.tim.2014.02.010; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Denou E, 2009, VIROLOGY, V388, P21, DOI 10.1016/j.virol.2009.03.009; Dufour N, 2015, CRIT CARE MED, V43, pE190, DOI 10.1097/CCM.0000000000000968; Endersen L, 2014, ANNU REV FOOD SCI T, V5, P327, DOI 10.1146/annurev-food-030713-092415; Field D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119684; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hejnova J, 2005, MICROBIOL-SGM, V151, P385, DOI 10.1099/mic.0.27469-0; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Hoyles L, 2014, RES MICROBIOL, V165, P803, DOI 10.1016/j.resmic.2014.10.006; Hu J, 2015, CLIN MICROBIOL INFEC, V21, P729, DOI 10.1016/j.cmi.2015.01.015; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jeffery IB, 2016, ISME J, V10, P170, DOI 10.1038/ismej.2015.88; Kamal F, 2015, APPL ENVIRON MICROB, V81, P1132, DOI 10.1128/AEM.02850-14; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Kropinski AM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-76; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Lu ZJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00067; Ly-Chatain MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00051; Mahony J, 2011, CURR OPIN BIOTECH, V22, P157, DOI 10.1016/j.copbio.2010.10.008; Maura D, 2012, ANTIMICROB AGENTS CH, V56, P6235, DOI 10.1128/AAC.00602-12; Mirzaei MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118557; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murphy J, 2013, J DAIRY SCI, V96, P4945, DOI 10.3168/jds.2013-6748; O'Flaherty S, 2005, J BACTERIOL, V187, P7161, DOI 10.1128/JB.187.20.7161-7164.2005; O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parasion S, 2014, POL J MICROBIOL, V63, P137; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Rahmani R, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.17744; Sarker SA, 2012, VIROLOGY, V434, P222, DOI 10.1016/j.virol.2012.09.002; Subramanian S, 2008, INFLAMM BOWEL DIS, V14, P162, DOI 10.1002/ibd.20296; Tang F, 2012, J VIROL, V86, P13871, DOI 10.1128/JVI.02698-12; TARR PI, 1995, CLIN INFECT DIS, V20, P1, DOI 10.1093/clinids/20.1.1; Truncaite L, 2012, ARCH VIROL, V157, P2431, DOI 10.1007/s00705-012-1449-x; Tsonos J, 2014, VET MICROBIOL, V171, P470, DOI 10.1016/j.vetmic.2013.10.021; Tunney MM, 2004, ANTIMICROB AGENTS CH, V48, P1879, DOI 10.1128/AAC.48.5.1879-1881.2004; Viertel TM, 2014, J ANTIMICROB CHEMOTH, V69, P2326, DOI 10.1093/jac/dku173; Wittebole X, 2014, VIRULENCE, V5, P226, DOI 10.4161/viru.25991; Yap ML, 2014, FUTURE MICROBIOL, V9, P1319, DOI 10.2217/fmb.14.91	60	42	44	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156773	10.1371/journal.pone.0156773	http://dx.doi.org/10.1371/journal.pone.0156773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280590	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000046
J	DeGregorio, GA; Bradford, LS; Manga, S; Tih, PM; Wamai, R; Ogembo, R; Sando, Z; Liu, YX; Schwaiger, C; Rao, SR; Kalmakis, K; Sheldon, LK; Nulah, K; Welty, E; Welty, T; Ogembo, JG				DeGregorio, Geneva A.; Bradford, Leslie S.; Manga, Simon; Tih, Pius M.; Wamai, Richard; Ogembo, Rebecca; Sando, Zacharie; Liu, Yuxin; Schwaiger, Constance; Rao, Sowmya R.; Kalmakis, Karen; Sheldon, Lisa Kennedy; Nulah, Kathleen; Welty, Edith; Welty, Thomas; Ogembo, Javier Gordon			Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon	PLOS ONE			English	Article							VISUAL INSPECTION; ACETIC-ACID; SINGLE-VISIT; CRYOTHERAPY; ACCEPTABILITY; FEASIBILITY; WOMEN; INFECTIONS; SAFETY; SEE	Background In 2007, the Cameroon Baptist Convention Health Services (CBCHS) implemented a screen-and-treat cervical cancer prevention program using visual inspection with acetic acid enhanced by digital cervicography (VIA-DC). Methods We retrospectively analyzed 46,048 medical records of women who received care through the CBCHS Women's Health Program from 2007 through 2014 to determine the prevalence and predictors of positive VIA-DC, rates of same day treatment, and cohort prevalence of invasive cervical cancer (ICC). Results Of the 44,979 women who were screened for cervical cancer, 9.0% were VIA-DC-positive, 66.8% were VIA-DC-negative, 22.0% were VIA-DC-inadequate (normal ectocervix, but portions of the transformation zone were obscured), and 2.2% were VIA-DC-uncertain (cervical abnormalities confounding VIA-DC interpretation). Risk factors significantly associated with VIA-DC-positive screen were HIV-positivity, young age at sexual debut, higher lifetime number of sexual partners, low education status and higher gravidity. In 2014, 31.1% of women eligible for cryotherapy underwent same day treatment. Among the 32,788 women screened from 2007 through 2013, 201 cases of ICC were identified corresponding to a cohort prevalence of 613 per 100,000. Conclusions High rate of VIA-DC-positive screens suggests a significant burden of potential cervical cancer cases and highlights the need for expansion of cervical cancer screening and prevention throughout the 10 regions of Cameroon. VIA-DC-inadequate rates were also high, especially in older women, and additional screening methods are needed to confirm whether these results are truly negative. In comparison to similar screening programs in sub-Saharan Africa there was low utilization of same day cryotherapy treatment. Further studies are required to characterize possible program specific barriers to treatment, for example cultural demands, health system challenges and cost of procedure. The prevalence of ICC among women who presented for screening was high and requires further investigation.	[DeGregorio, Geneva A.; Bradford, Leslie S.] Univ Massachusetts, Sch Med, Dept Obstet & Gynecol, Worcester, MA USA; [Manga, Simon; Tih, Pius M.; Nulah, Kathleen; Welty, Edith; Welty, Thomas] Cameroon Baptist Convent Hlth Serv, Bamenda, North West Regi, Cameroon; [Wamai, Richard] Northeastern Univ, Dept African Amer Studies, Boston, MA 02115 USA; [Ogembo, Rebecca] Univ Massachusetts, Sch Med, Grad Sch Nursing, Worcester, MA USA; [Sando, Zacharie] Yaounde Gynecoobstet & Pediat Hosp, Yaounde, Centre Region, Cameroon; [Liu, Yuxin] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Schwaiger, Constance; Kalmakis, Karen] Univ Massachusetts, Sch Nursing, Amherst, MA 01003 USA; [Rao, Sowmya R.] Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA; [Sheldon, Lisa Kennedy] Univ Massachusetts, Dept Nursing, Boston, MA 02125 USA; [Ogembo, Javier Gordon] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; Northeastern University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst; Boston University; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Worcester	Ogembo, JG (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.	jogembo@coh.org	liu, yuxin/GRY-3592-2022	Ogembo, Javier Gordon/0000-0001-6949-8693; Sheldon, Lisa Kennedy/0000-0002-5958-8529	Cameroon Health and Education Fund; Elizabeth Glaser Pediatric AIDS Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [UL1TR000161]; NATIONAL CANCER INSTITUTE [K01CA184388] Funding Source: NIH RePORTER	Cameroon Health and Education Fund; Elizabeth Glaser Pediatric AIDS Foundation; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The WHP has received financial support from the Cameroon Health and Education Fund (http://cameroonhealthandeducationfund.com/chef) and the Elizabeth Glaser Pediatric AIDS Foundation (www.pedaids.org) to provide the services described in this paper. This evaluation and quality improvement project was supported in part by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under award number UL1TR000161. The content is solely the responsibility of the authors and does not necessarily represent official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adefuye PO, 2015, INT J GYNECOL OBSTET, V129, P62, DOI 10.1016/j.ijgo.2014.10.032; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Blumenthal P. D., 2007, AM J OBSTET GYNECOL, V196, P407; Central Statistical Office [Zambia] MoHMZ and ICF International, 2014, ZAMB DEM HLTH SUV 20; Chumworathayi B, 2010, J OBSTET GYNAECOL RE, V36, P79, DOI 10.1111/j.1447-0756.2009.01089.x; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Crocker-Buque T, 2015, J ROY SOC MED, V108, P57, DOI 10.1177/0141076814554671; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; Doh AS, 2005, INT J GYNECOL OBSTET, V89, P167, DOI 10.1016/j.ijgo.2004.12.040; Ferlay J, 2013, IARC CANCERBASE; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; Institut National de la Statistiq et ICF, 2012, ENQ DEM SANT IND MUL; Joint United National Programme on HIV/AIDS, 2014, THE GAP REP; Joint United National Programme on HIV/AIDS, 2013, GLOB REP 2013 UNAIDS; Kim YM, 2013, J OBSTET GYNAECOL RE, V39, P1190, DOI 10.1111/jog.12052; Kuhn L, 2010, AIDS, V24, P2545, DOI 10.1097/QAD.0b013e32833e163e; Luciani S, 2011, INT J GYNECOL OBSTET, V115, P53, DOI 10.1016/j.ijgo.2011.05.014; Manga S, 2015, J LOW GENIT TRACT DI, V19, P288, DOI 10.1097/LGT.0000000000000133; Martin CE, 2014, J OBSTET GYNAECOL RE, V40, P1707, DOI 10.1111/jog.12366; Murillo R, 2010, INT J GYNECOL OBSTET, V109, P230, DOI 10.1016/j.ijgo.2010.01.019; Mwanahamuntu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074607; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Nessa A, 2010, INT J GYNECOL OBSTET, V111, P115, DOI 10.1016/j.ijgo.2010.06.004; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Ntembe A., 2009, INT REV BUSINESS RES, V5, P33; Ogembo JG, 2014, VACCINE, V32, P4399, DOI 10.1016/j.vaccine.2014.06.064; Parham GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122169; Parkin DM, 2014, CANCER EPIDEM BIOMAR, V23, P953, DOI 10.1158/1055-9965.EPI-14-0281; Pergialiotis V, 2015, J LOW GENIT TRACT DI, V19, P257, DOI 10.1097/LGT.0000000000000066; Phongsavan K, 2011, INT J GYNECOL OBSTET, V114, P268, DOI 10.1016/j.ijgo.2011.03.009; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; Richart R M, 1973, Pathol Annu, V8, P301; Sankaranarayanan R, 2007, BRIT J CANCER, V96, P738, DOI 10.1038/sj.bjc.6603633; Sankaranarayanan R, 2003, TESTING REPORTING RE; Senkomago V, 2015, J INFECT DIS, V211, P811, DOI 10.1093/infdis/jiu535; Tebeu PM, 2015, INT J CANCER, V136, pE743, DOI 10.1002/ijc.29250; Tobian AAR, 2011, INT J CANCER, V129, P2970, DOI 10.1002/ijc.25957; Vedantham H, 2010, CANCER EPIDEM BIOMAR, V19, P1373, DOI 10.1158/1055-9965.EPI-09-1282; WHO, 2014, COMPR CERV CANC CONT; World Health Organization, 2013, GUID SCREEN TREATM P	46	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157319	10.1371/journal.pone.0157319	http://dx.doi.org/10.1371/journal.pone.0157319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280882	gold, Green Submitted, Green Published			2022-12-27	WOS:000377563000119
J	Mavoko, HM; Kalabuanga, M; Delgado-Ratto, C; Maketa, V; Mukele, R; Fungula, B; da Luz, RI; Rosanas-Urgell, A; Lutumba, P; Van Geertruyden, JP				Mavoko, Hypolite Muhindo; Kalabuanga, Marion; Delgado-Ratto, Christopher; Maketa, Vivi; Mukele, Rodin; Fungula, Blaise; da Luz, Raquel Inocencio; Rosanas-Urgell, Anna; Lutumba, Pascal; Van Geertruyden, Jean-Pierre			Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; SUB-SAHARAN AFRICA; GENETIC DIVERSITY; ARTEMISININ RESISTANCE; TRANSMISSION; KINSHASA; COMPLEXITY; HAPLOTYPES; CHILDREN	Background In the Democratic Republic of Congo, artesunate-amodiaquine (ASAQ) is the first-line medication recommended for uncomplicated malaria treatment. We conducted a study in Kinshasa to describe the clinical features of the disease and assess the efficacy of ASAQ and its impact on the multiplicity of infection in children with uncomplicated malaria. Methods Children aged 12 to 59 months with uncomplicated P. falciparum malaria were treated with ASAQ and followed up passively for 42 days. To distinguish new infections from recrudescent parasites, samples were genotyped using a stepwise strategy with three molecular markers (GLURP, MSP2 and MSP1). We then assessed PCR-corrected and -uncorrected day-42 cure rates and multiplicity of infection (MOI). Results In total, 2,796 patients were screened and 865 enrolled in the study. Clinical features were characterized by history of fever (100%), coryza (59.9%) and weakness (59.4%). The crude and PCR-corrected efficacies of ASAQ were 55.3% (95% CI: 51.8-58.8) and 92.8% (95% CI: 91.0-94.6) respectively, as 83.6% (95% CI: 79.1-87.2) of the recurrences were new infections. Compared to monoclonal infections, polyclonal infections were more frequent at enrollment (88.1%) and in recurrences (80.1%; p = 0.005; OR: 1.8, 95%CI: 1.20-2.8). The median MOI at enrollment (MOI = 3.7; IQR: 0.7-6.7) decreased to 3 (IQR: 1-5) in the recurrent samples (p<0.001). Patients infected with a single haplotype on day 0 had no recrudescence; the risk of recrudescence increased by 28% with each additional haplotype (HR: 1.3, 95%CI: 1.24-1.44). Conclusion The PCR-corrected efficacy of ASAQ at day 42 was 92.8%, but crude efficacy was relatively poor due to high reinfection rates. Treatment outcomes were positively correlated with MOI. Continued monitoring of the efficacy of ACTs-ASAQ, in this case-is paramount.	[Mavoko, Hypolite Muhindo; Maketa, Vivi; Mukele, Rodin; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Fac Med, Kinshasa, DEM REP CONGO; [Mavoko, Hypolite Muhindo; Delgado-Ratto, Christopher; Maketa, Vivi; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Global Hlth Inst, B-2020 Antwerp, Belgium; [Kalabuanga, Marion; Fungula, Blaise] Lisungi Hlth Ctr, Outpatients Dept, Kinshasa, DEM REP CONGO; [Rosanas-Urgell, Anna] Inst Trop Med, B-2000 Antwerp, Belgium	Universite de Kinshasa; University of Antwerp; Institute of Tropical Medicine (ITM)	Mavoko, HM (corresponding author), Univ Kinshasa, Dept Trop Med, Fac Med, Kinshasa, DEM REP CONGO.; Mavoko, HM (corresponding author), Univ Antwerp, Global Hlth Inst, B-2020 Antwerp, Belgium.	mavoko@yahoo.com	Inocencio da Luz, Raquel/ABE-8206-2021; da Luz, Raquel A Inocencio/L-9676-2016; Van geertruyden, Jean-Pierre/K-6425-2014; Van geertruyden, Jean-Pierre/S-3254-2019	Inocencio da Luz, Raquel/0000-0002-2870-0311; da Luz, Raquel A Inocencio/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Delgado-Ratto, Christopher/0000-0003-2300-5181	Fonds Wetenschappelijk Onderzoek (FWO) [G.078.11]; Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS) [ZRDC2012MP076]; European and Developing Countries Clinical Trials Partnership (EDCTP) Grant [MS.2010.10800.004]; Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC) [FEE/06/12]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS); European and Developing Countries Clinical Trials Partnership (EDCTP) Grant; Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC)	This work was funded by Fonds Wetenschappelijk Onderzoek (FWO, Grant reference G.078.11 to JPVg), Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS, Grant reference ZRDC2012MP076 to JPVg, PL), European and Developing Countries Clinical Trials Partnership (EDCTP, Grant reference MS.2010.10800.004 to JPVg) and the Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC, Grant reference FEE/06/12 to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Adjuik MA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0301-z; [Anonymous], 2003, ASS MON ANT DRUG EFF; Antonia AL, 2014, AM J TROP MED HYG, V90, P1094, DOI 10.4269/ajtmh.13-0378; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Arnot David E, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS131, DOI 10.1016/S0035-9203(02)90064-7; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Barry AE, 2013, AM J TROP MED HYG, V88, P718, DOI 10.4269/ajtmh.12-0056; Bartoloni A, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.026; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bonnet M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-192; Branch OH, 2001, INFECT IMMUN, V69, P7783, DOI 10.1128/IAI.69.12.7783-7792.2001; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; Delgado-Ratto C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-8; Espie E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-174; Etiaba E, 2015, NIGER J CLIN PRACT, V18, P22, DOI 10.4103/1119-3077.146974; Ghansah A, 2014, SCIENCE, V345, P1297, DOI 10.1126/science.1259423; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Kariuki SK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-295; Kiwanuka GN, 2009, J VECTOR DIS, V46, P1; Kyabayinze DJ, 2008, AFR HEALTH SCI, V8, P200; Lee SA, 2006, J INFECT DIS, V193, P1160, DOI 10.1086/501473; Maketa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0595-5; Mavoko HM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-307; McKenzie FE, 2008, ADV PARASIT, V66, P1, DOI 10.1016/S0065-308X(08)00201-7; Muhindo HM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-224; Mvumbi DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0892-z; Mvumbi DM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-459; Onyamboko MA, 2014, ANTIMICROB AGENTS CH, V58, P5528, DOI 10.1128/AAC.02682-14; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PNLP, 2010, DIR NAT TRAIT PAL RE; PNLP, 2014, RAPP ANN ACT LUTT PA; Talisuna AO, 2002, T ROY SOC TROP MED H, V96, P310, DOI 10.1016/S0035-9203(02)90108-2; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Zwang J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-114	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157074	10.1371/journal.pone.0157074	http://dx.doi.org/10.1371/journal.pone.0157074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280792	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000078
J	Rowland, IJ; Goodman, WG				Rowland, Ian J.; Goodman, Walter G.			Magnetic Resonance Imaging of Alimentary Tract Development in Manduca sexta	PLOS ONE			English	Article							PUPAL-ADULT DEVELOPMENT; TOBACCO HORNWORM; ECDYSTEROID TITER; NMR MICROSCOPY; INSECT BRAIN; BOMBYX-MORI; 3D MRI; METAMORPHOSIS; MIDGUT; LARVAL	Non-invasive 3D magnetic resonance imaging techniques were used to investigate metamorphosis of the alimentary tract of Manduca sexta from the larval to the adult stage. The larval midgut contracts in volume immediately following cessation of feeding and then greatly enlarges during the late pharate pupal period. Magnetic resonance imaging revealed that the foregut and hindgut of the pharate pupa undergo ecdysis considerably earlier than the external exoskeleton. Expansion of air sacs in the early pupa and development of flight muscles several days later appear to orient the midgut into its adult position in the abdomen. The crop, an adult auxiliary storage organ, begins development as a dorsal outgrowth of the foregut. This coincides with a reported increase in pupal ecdysteroid titers. An outgrowth of the hindgut, the rectal sac, appears several days later and continues to expand until it nearly fills the dorsal half of the abdominal cavity. This development correlates with a second rise in pupal ecdysteroid titers. In the pharate pupa, the presence of paramagnetic species renders the silk glands hyperintense.	[Rowland, Ian J.; Goodman, Walter G.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Rowland, IJ (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	irowland@wisc.edu		Rowland, Ian/0000-0001-8738-4550				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alleyne M, 2007, J INSECT SCI, V7, P2; BAHADUR J, 1971, International Journal of Insect Morphology and Embryology, V1, P21, DOI 10.1016/0020-7322(71)90005-5; BAKER FC, 1987, INSECT BIOCHEM, V17, P989, DOI 10.1016/0020-1790(87)90108-9; Baldwin K. M., 1996, P31; Barbehenn RV, 2004, J INSECT PHYSIOL, V50, P783, DOI 10.1016/j.jinsphys.2004.05.012; BOLLENBACHER WE, 1981, GEN COMP ENDOCR, V44, P302, DOI 10.1016/0016-6480(81)90005-8; CIOFFI M, 1979, TISSUE CELL, V11, P467, DOI 10.1016/0040-8166(79)90057-0; CONNER WE, 1988, EXPERIENTIA, V44, P11, DOI 10.1007/BF01960223; CORNELL JC, 1983, J EXP BIOL, V107, P501; Davis NT, 2006, ARTHROPOD STRUCT DEV, V35, P15, DOI 10.1016/j.asd.2005.07.001; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Dow JAT, 1986, INSECT MIDGUT FUNCTI, P187; EATON JL, 1982, INT J INSECT MORPHOL, V11, P355, DOI 10.1016/0020-7322(82)90024-1; Eaton JL, 1988, LEPIDOPTERAN ANATOMY; GOODMAN BA, 1995, J INSECT PHYSIOL, V41, P419, DOI 10.1016/0022-1910(94)00115-W; GOODMAN WG, 1985, ANN ENTOMOL SOC AM, V78, P70, DOI 10.1093/aesa/78.1.70; Gorman MJ, 2000, J INVERTEBR PATHOL, V75, P296, DOI 10.1006/jipa.2000.4930; Grant JB, 2006, J EXP BIOL, V209, P3018, DOI 10.1242/jeb.02335; GRAY JOHN, 1931, ANN ENT SOC AMERICA, V24, P45; Haddad D, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.7; HAKIM RS, 1976, DEV BIOL, V49, P369, DOI 10.1016/0012-1606(76)90181-0; Hallock KJ, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.1001; Hart AG, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.5; HENSON H, 1946, BIOL REV, V21, P1, DOI 10.1111/j.1469-185X.1946.tb00449.x; Henson H, 1929, Q J MICROSC SCI, V73, P87; Ihara F, 2008, JPN J APPL ENTOMOL Z, V52, P123, DOI 10.1303/jjaez.2008.123; Jasanoff A, 2002, J MAGN RESON, V158, P79, DOI 10.1016/S1090-7807(02)00063-0; JUDY K, 1970, J MORPHOL, V131, P277, DOI 10.1002/jmor.1051310304; JUDY KJ, 1969, ANN ENTOMOL SOC AM, V62, P1438, DOI 10.1093/aesa/62.6.1438; Kaneko J, 2010, APPL ENTOMOL ZOOL, V45, P253, DOI 10.1303/aez.2010.253; Kayser H, 2006, ARCH BIOCHEM BIOPHYS, V453, P179, DOI 10.1016/j.abb.2006.07.001; Konig H, 2006, J APPL MICROBIOL, V101, P620, DOI 10.1111/j.1365-2672.2006.02914.x; LEVENBOOK L, 1971, J INSECT PHYSIOL, V17, P1321, DOI 10.1016/0022-1910(71)90197-1; Lowe Tristan, 2013, Journal of the Royal Society Interface, V10, P1; Mapelli M, 1997, MAGN RESON IMAGING, V15, P693, DOI 10.1016/S0730-725X(97)00006-4; Meme S, 2013, MAGN RESON IMAGING, V31, P109, DOI 10.1016/j.mri.2012.06.019; Michaelis T, 2005, NEUROIMAGE, V24, P596, DOI 10.1016/j.neuroimage.2004.08.048; Mietchen D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003826; Null B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002817; Peterson Alvah, 1912, Annals of the Entomological Society of America, V5; Plotkin Marian, 2006, Physiological Chemistry and Physics and Medical NMR, V38, P43; Reynolds S, 2013, ENDOCRINE SYSTEM, P675; RIDDIFORD LM, 1976, NATURE, V259, P115, DOI 10.1038/259115a0; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; RUSSELL VW, 1991, ARCH INSECT BIOCHEM, V17, P67, DOI 10.1002/arch.940170202; RYERSE JS, 1992, TISSUE CELL, V24, P751, DOI 10.1016/0040-8166(92)90047-B; Sehnal F., 1996, P55; SKIBBE U, 1995, MAGN RESON IMAGING, V13, P471, DOI 10.1016/0730-725X(94)00116-K; Stringer Richard P., 2000, Metamorphosis, V11, P132; Suzuki T, 2010, PESTIC BIOCHEM PHYS, V97, P199, DOI 10.1016/j.pestbp.2010.01.005; Suzuki T, 2009, J INSECT PHYSIOL, V55, P250, DOI 10.1016/j.jinsphys.2008.11.014; Tomanek B, 1996, J APICULT RES, V35, P3, DOI 10.1080/00218839.1996.11100907; WAKU Y, 1971, TISSUE CELL, V3, P127, DOI 10.1016/S0040-8166(71)80035-6; WARREN JT, 1986, INSECT BIOCHEM, V16, P65, DOI 10.1016/0020-1790(86)90080-6; Watanabe T, 2006, J NEUROSCI METH, V158, P50, DOI 10.1016/j.jneumeth.2006.05.012; Wecker S, 2002, MAGN RESON IMAGING, V20, P105, DOI 10.1016/S0730-725X(01)00445-3; Young JK, 2003, MOL CELL ENDOCRINOL, V208, P41, DOI 10.1016/S0303-7207(03)00259-4	59	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157124	10.1371/journal.pone.0157124	http://dx.doi.org/10.1371/journal.pone.0157124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280776	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000089
J	Andrew, ME; Ruthrof, KX; Matusick, G; Hardy, GES				Andrew, Margaret E.; Ruthrof, Katinka X.; Matusick, George; Hardy, Giles E. St. J.			Spatial Configuration of Drought Disturbance and Forest Gap Creation across Environmental Gradients	PLOS ONE			English	Article							INDUCED TREE MORTALITY; DIE-OFF; CANOPY GAPS; DYNAMICS; PATTERNS; VEGETATION; RECOVERY; DIEBACK; SENSITIVITY; LANDSCAPE	Climate change is increasing the risk of drought to forested ecosystems. Although drought impacts are often anecdotally noted to occur in discrete patches of high canopy mortality, the landscape effects of drought disturbances have received virtually no study. This study characterized the landscape configuration of drought impact patches and investigated the relationships between patch characteristics, as indicators of drought impact intensity, and environmental gradients related to water availability to determine factors influencing drought vulnerability. Drought impact patches were delineated from aerial surveys following an extreme drought in 2011 in southwestern Australia, which led to patchy canopy dieback of the Northern Jarrah Forest, a Mediterranean forest ecosystem. On average, forest gaps produced by drought-induced dieback were moderate in size (6.6 +/- 9.7 ha, max = 85.7 ha), compact in shape, and relatively isolated from each other at the scale of several kilometers. However, there was considerable spatial variation in the size, shape, and clustering of forest gaps. Drought impact patches were larger and more densely clustered in xeric areas, with significant relationships observed with topographic wetness index, meteorological variables, and stand height. Drought impact patch clustering was more strongly associated with the environmental factors assessed (R-2 = 0.32) than was patch size (R-2 = 0.21); variation in patch shape remained largely unexplained (R-2 = 0.02). There is evidence that the xeric areas with more intense drought impacts are ` chronic disturbance patches' susceptible to recurrent drought disturbance. The spatial configuration of drought disturbances is likely to influence ecological processes including forest recovery and interacting disturbances such as fire. Regime shifts to an alternate, non-forested ecosystem may occur preferentially in areas with large or clustered drought impact patches. Improved understanding of drought impacts and their patterning in space and time will expand our knowledge of forest ecosystems and landscape processes, informing management of these dynamic systems in an uncertain future.	[Andrew, Margaret E.; Ruthrof, Katinka X.; Hardy, Giles E. St. J.] Murdoch Univ, Sch Vet & Life Sci, Environm & Conservat Sci, Murdoch, WA 6150, Australia; [Ruthrof, Katinka X.; Matusick, George; Hardy, Giles E. St. J.] Murdoch Univ, Ctr Excellence Climate Change Woodland & Forest H, Murdoch, WA 6150, Australia; [Matusick, George] Nature Conservancy, Georgia Chapter, Ft Benning, GA 31905 USA	Murdoch University; Murdoch University; Nature Conservancy	Andrew, ME (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Environm & Conservat Sci, Murdoch, WA 6150, Australia.	m.andrew@murdoch.edu.au		Andrew, Margaret/0000-0003-3285-3684; Ruthrof, Katinka/0000-0003-2038-2264; Hardy, Giles/0000-0001-7419-5064	State Centre of Excellence for Climate Change, Woodland and Forest Health, a partnership between private industry, community groups, Universities; Government of Western Australia	State Centre of Excellence for Climate Change, Woodland and Forest Health, a partnership between private industry, community groups, Universities; Government of Western Australia	The authors received no specific funding for this work. It analyzed pre-existing data, the development of which was funded by the State Centre of Excellence for Climate Change, Woodland and Forest Health, a partnership between private industry, community groups, Universities, and the Government of Western Australia.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Angelini C, 2012, ECOLOGY, V93, P101, DOI 10.1890/11-0557.1; [Anonymous], 2011, 1 2 SRTM DERIVED DIG; [Anonymous], 2011, MODIS VEGETATION CON; Asner GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060875; ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P301, DOI 10.1016/0378-1127(94)90115-5; Bailey RM, 2011, P ROY SOC B-BIOL SCI, V278, P1064, DOI 10.1098/rspb.2010.1750; Bates BC, 2008, CLIMATIC CHANGE, V89, P339, DOI 10.1007/s10584-007-9390-9; Bennett JM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1238, DOI 10.1111/geb.12083; Blackburn GA, 2014, J VEG SCI, V25, P1341, DOI 10.1111/jvs.12201; Bowker MA, 2012, J ARID ENVIRON, V76, P9, DOI 10.1016/j.jaridenv.2011.08.012; Boyd DS, 2013, ECOL APPL, V23, P1588, DOI 10.1890/12-0371.1; Bradshaw F. J., 1999, Australian Forestry, V62, P255; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brouwers NC, 2015, FORESTRY, V88, P454, DOI 10.1093/forestry/cpv014; Brouwers N, 2013, LANDSCAPE ECOL, V28, P69, DOI 10.1007/s10980-012-9815-3; Burrows ND, 2008, FOREST ECOL MANAG, V255, P2394, DOI 10.1016/j.foreco.2008.01.009; Burrows N. D., 1995, Australian Forestry, V58, P7; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CLINTON BD, 1993, ECOLOGY, V74, P1551, DOI 10.2307/1940082; Collins BM, 2007, LANDSCAPE ECOL, V22, P545, DOI 10.1007/s10980-006-9047-5; Collins BM, 2010, LANDSCAPE ECOL, V25, P927, DOI 10.1007/s10980-010-9470-5; Croton JT, 2014, SUSTAINABLE FOREST M; Curzon MT, 2010, CAN J FOREST RES, V40, P13, DOI 10.1139/X09-157; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Fensham RJ, 2007, J VEG SCI, V18, P71, DOI 10.1111/j.1654-1103.2007.tb02517.x; Fensham RJ, 1999, J APPL ECOL, V36, P1035, DOI 10.1046/j.1365-2664.1999.00460.x; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Gallant J, 2012, DATA COLLECTION, DOI [10.4225/08/50A9DF3968422, DOI 10.4225/08/50A9DF3968422]; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; Greenwood DL, 2008, FOREST ECOL MANAG, V255, P2129, DOI 10.1016/j.foreco.2007.12.048; Guarin A, 2005, FOREST ECOL MANAG, V218, P229, DOI 10.1016/j.foreco.2005.07.014; Hartmann H, 2011, GLOBAL CHANGE BIOL, V17, P642, DOI 10.1111/j.1365-2486.2010.02248.x; Hessburg PF, 1999, ECOL APPL, V9, P1232, DOI 10.1890/1051-0761(1999)009[1232:DCIFSP]2.0.CO;2; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Hughes JD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050797; Hytteborn H, 2014, J VEG SCI, V25, P100, DOI 10.1111/jvs.12057; *IOCI, 2002, CLIM VAR CHANG S W W; Lozano FJ, 2012, INT J WILDLAND FIRE, V21, P666, DOI 10.1071/WF10072; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Suarez ML, 2010, J ECOL, V98, P1023, DOI 10.1111/j.1365-2745.2010.01698.x; Laurance WF, 2011, BIOL CONSERV, V144, P1472, DOI 10.1016/j.biocon.2011.01.016; Lloret F, 2004, GLOBAL CHANGE BIOL, V10, P2092, DOI 10.1111/j.1365-2486.2004.00870.x; MacGregor SD, 2002, AUSTRAL ECOL, V27, P385, DOI 10.1046/j.1442-9993.2002.01192.x; Matusick G, 2012, OPEN J FOR, V2, P183; Matusick G, 2016, J VEG SCI, V27, P493, DOI 10.1111/jvs.12378; Matusick G, 2014, TREES-STRUCT FUNCT, V28, P1449, DOI 10.1007/s00468-014-1048-4; Matusick G, 2013, EUR J FOREST RES, V132, P497, DOI 10.1007/s10342-013-0690-5; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2006, ECOL APPL, V16, P1164, DOI 10.1890/1051-0761(2006)016[1164:HMOPPG]2.0.CO;2; McGarigal K., 1995, SPATIAL PATTERN ANAL; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Miller JD, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00158.1; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; O'Donnell AJ, 2011, J BIOGEOGR, V38, P112, DOI 10.1111/j.1365-2699.2010.02381.x; Olano JM, 2003, FOREST ECOL MANAG, V174, P139, DOI 10.1016/S0378-1127(02)00033-6; Oliver TH, 2013, ECOGRAPHY, V36, P579, DOI 10.1111/j.1600-0587.2012.07665.x; Parisien MA, 2006, INT J WILDLAND FIRE, V15, P361, DOI 10.1071/WF06009; Petrone KC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043102; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Raupach MR, 2009, 3 CTR AUSTR WEATH CL; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Roberts S. L., 2008, Fire Ecology, V4, P83; RUPRECHT JK, 1993, J HYDROL, V150, P369, DOI 10.1016/0022-1694(93)90117-R; Ruthrof KX, 2016, INT J WILDLAND FIRE, V25, P819, DOI 10.1071/WF15028; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schulte LA, 2005, ECOLOGY, V86, P431, DOI 10.1890/03-4065; Shearer BL, 2007, AUST J BOT, V55, P225, DOI 10.1071/BT06019; Simard M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001708; Starzomski BM, 2007, OIKOS, V116, P690, DOI 10.1111/j.2007.0030-1299.15547.x; Suarez ML, 2004, J ECOL, V92, P954, DOI 10.1111/j.1365-2745.2004.00941.x; Torimaru T, 2012, FOREST ECOL MANAG, V284, P1, DOI 10.1016/j.foreco.2012.07.044; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Turner MG, 1997, ECOL MONOGR, V67, P411, DOI 10.1890/0012-9615(1997)067[0411:EOFSAP]2.0.CO;2; Twidwell D, 2014, APPL VEG SCI, V17, P42, DOI 10.1111/avsc.12044; Vepakomma U, 2012, J ECOL, V100, P1257, DOI 10.1111/j.1365-2745.2012.01996.x; Vesk PA, 2004, J ECOL, V92, P310, DOI 10.1111/j.0022-0477.2004.00871.x; Wang WF, 2012, ENVIRON REV, V20, P109, DOI [10.1139/A2012-004, 10.1139/a2012-004]; Western Australia Climate Services Center, 2010, VER DRY YEAR SO FAR; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Williams K., 2001, BIODIVERSITY AUDIT W, P369; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; Worrall JJ, 2005, J ECOL, V93, P178, DOI 10.1111/j.1365-2745.2004.00937.x	92	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0157154	10.1371/journal.pone.0157154	http://dx.doi.org/10.1371/journal.pone.0157154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275744	gold, Green Published, Green Submitted			2022-12-27	WOS:000377561700076
J	Bicart-See, A; Rottman, M; Cartwright, M; Seiler, B; Gamini, N; Rodas, M; Penary, M; Giordano, G; Oswald, E; Super, M; Ingber, DE				Bicart-See, A.; Rottman, M.; Cartwright, M.; Seiler, B.; Gamini, N.; Rodas, M.; Penary, M.; Giordano, G.; Oswald, E.; Super, M.; Ingber, D. E.			Rapid Isolation of Staphylococcus aureus Pathogens from Infected Clinical Samples Using Magnetic Beads Coated with Fc-Mannose Binding Lectin	PLOS ONE			English	Article							COMPLEMENT-MEDIATED OPSONOPHAGOCYTOSIS; INNATE IMMUNITY; SYNOVIAL-FLUID; PROTEIN-A; ACID; DIAGNOSIS; BACTERIA; THERAPY; ASSAY	Here we describe how Staphylococcus aureus bacteria can be rapidly isolated from clinical samples of articular fluid and synovial tissue using magnetic beads coated with the engineered chimeric human opsonin protein, Fc-mannose-binding lectin (FcMBL). The FcMBL-beads were used to capture and magnetically remove bacteria from purified cultures of 12 S. aureus strains, and from 8 articular fluid samples and 4 synovial tissue samples collected from patients with osteoarthritis or periprosthetic infections previously documented by positive S. aureus cultures. While the capture efficiency was high (85%) with purified S. aureus strains grown in vitro, direct FcMBL-bead capture from the clinical samples was initially disappointing (< 5% efficiency). Further analysis revealed that inhibition of FcMBL binding was due to coating of the bacteria by immunoglobulins and immune cells that masked FcMBL binding sites, and to the high viscosity of these complex biological samples. Importantly, capture of pathogens using the FcMBL-beads was increased to 76% efficiency by pretreating clinical specimens with hypotonic washes, hyaluronidase and a protease cocktail. Using this approach, S. aureus bacteria could be isolated from infected osteoarthritic tissues within 2 hours after sample collection. This FcMBL-enabled magnetic method for rapid capture and concentration of pathogens from clinical samples could be integrated upstream of current processes used in clinical microbiology laboratories to identify pathogens and perform antibiotic sensitivity testing when bacterial culture is not possible or before colonies can be detected.	[Bicart-See, A.; Rottman, M.; Cartwright, M.; Seiler, B.; Gamini, N.; Rodas, M.; Super, M.; Ingber, D. E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Bicart-See, A.; Giordano, G.] Hosp Joseph Ducuing, Toulouse, France; [Rottman, M.] Univ Versailles, St Quentin en Yvelines, France; [Penary, M.; Oswald, E.] INSERM 1043, Toulouse, France; [Ingber, D. E.] Harvard Univ, Sch Med, Boston, MA USA; [Ingber, D. E.] Boston Childrens Hosp, Boston, MA USA; [Ingber, D. E.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Boston, MA USA.; Ingber, DE (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	don.ingber@wyss.harvard.edu	Rottman, Martin/AAD-9075-2021; Ingber, Donald E/AAC-5894-2019; Super, Michael/AAW-7952-2021; Rottman, Martin/I-3005-2012	Rottman, Martin/0000-0001-5953-3344; Oswald, Eric/0000-0002-3017-0081	Defense Advanced Research Projects Agency (DARPA) [N66001-11-1-4180]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by grants N66001-11-1-4180 from the Defense Advanced Research Projects Agency (DARPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEUNG AL, 1987, INFECT IMMUN, V55, P843, DOI 10.1128/IAI.55.4.843-847.1987; CHEUNG AL, 1988, INFECT IMMUN, V56, P1061, DOI 10.1128/IAI.56.5.1061-1065.1988; de Prost N, 2013, CRIT CARE, V17, DOI 10.1186/cc13022; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Didar TF, 2015, BIOMATERIALS, V67, P382, DOI 10.1016/j.biomaterials.2015.07.046; Douglas IS, 2015, AM J RESP CRIT CARE, V191, P566, DOI 10.1164/rccm.201408-1468OC; Dubouix-Bourandy A, 2011, J CLIN MICROBIOL, V49, P4225, DOI 10.1128/JCM.00334-11; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Guenther LE, 2014, P I MECH ENG H, V228, P127, DOI 10.1177/0954411913517880; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Jayadev C, 2012, J IMMUNOL METHODS, V386, P22, DOI 10.1016/j.jim.2012.08.012; Jung DJ, 2012, J IMMUNOL, V189, P4951, DOI 10.4049/jimmunol.1201294; Kang JH, 2014, NAT MED, V20, P1211, DOI 10.1038/nm.3640; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Kurokawa K, 2013, J BIOL CHEM, V288, P30956, DOI 10.1074/jbc.M113.509893; Lee W, 2014, ANAL CHEM, V86, P6683, DOI 10.1021/ac501436d; LINDMARK R, 1983, J IMMUNOL METHODS, V62, P1, DOI 10.1016/0022-1759(83)90104-7; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Michelow IC, 2011, J INFECT DIS, V203, P175, DOI 10.1093/infdis/jiq025; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Roux AL, 2011, CLIN MICROBIOL INFEC, V17, P447, DOI 10.1111/j.1469-0691.2010.03359.x; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; SUPER M, 1989, LANCET, V2, P1236; Takahashi K, 2005, CLIN INFECT DIS, V41, pS440, DOI 10.1086/431987; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588	25	21	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156287	10.1371/journal.pone.0156287	http://dx.doi.org/10.1371/journal.pone.0156287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275840	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561700021
J	Fekri, F; Delos Santos, RC; Karshafian, R; Antonescu, CN				Fekri, Farnaz; Delos Santos, Ralph Christian; Karshafian, Raffi; Antonescu, Costin N.			Ultrasound Microbubble Treatment Enhances Clathrin-Mediated Endocytosis and Fluid-Phase Uptake through Distinct Mechanisms	PLOS ONE			English	Article							PLASMA-MEMBRANE REPAIR; DRUG-DELIVERY; EXOCYTOSIS; CERAMIDE; GROWTH; SPHINGOMYELINASE; PRESSURE; DYNAMIN; SYSTEM; TUMORS	Drug delivery to tumors is limited by several factors, including drug permeability of the target cell plasma membrane. Ultrasound in combination with microbubbles (USMB) is a promising strategy to overcome these limitations. USMB treatment elicits enhanced cellular uptake of materials such as drugs, in part as a result of sheer stress and formation of transient membrane pores. Pores formed upon USMB treatment are rapidly resealed, suggesting that other processes such as enhanced endocytosis may contribute to the enhanced material uptake by cells upon USMB treatment. How USMB regulates endocytic processes remains incompletely understood. Cells constitutively utilize several distinct mechanisms of endocytosis, including clathrin-mediated endocytosis (CME) for the internalization of receptor-bound macromolecules such as Transferrin Receptor (TfR), and distinct mechanism(s) that mediate the majority of fluid-phase endocytosis. Tracking the abundance of TfR on the cell surface and the internalization of its ligand transferrin revealed that USMB acutely enhances the rate of CME. Total internal reflection fluorescence microscopy experiments revealed that USMB treatment altered the assembly of clathrin-coated pits, the basic structural units of CME. In addition, the rate of fluid-phase endocytosis was enhanced, but with delayed onset upon USMB treatment relative to the enhancement of CME, suggesting that the two processes are distinctly regulated by USMB. Indeed, vacuolin-1 or desipramine treatment prevented the enhancement of CME but not of fluid phase endocytosis upon USMB, suggesting that lysosome exocytosis and acid sphingomyelinase, respectively, are required for the regulation of CME but not fluid phase endocytosis upon USMB treatment. These results indicate that USMB enhances both CME and fluid phase endocytosis through distinct signaling mechanisms, and suggest that strategies for potentiating the enhancement of endocytosis upon USMB treatment may improve targeted drug delivery.	[Fekri, Farnaz; Delos Santos, Ralph Christian; Antonescu, Costin N.] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Karshafian, Raffi] Ryerson Univ, Dept Med Phys, Toronto, ON, Canada; [Fekri, Farnaz; Delos Santos, Ralph Christian; Karshafian, Raffi; Antonescu, Costin N.] Ryerson Univ, Grad Program Mol Sci, Toronto, ON, Canada; [Karshafian, Raffi] Inst Biomed Engn Sci & Technol, Toronto, ON, Canada; [Karshafian, Raffi; Antonescu, Costin N.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada	Toronto Metropolitan University; Toronto Metropolitan University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Antonescu, CN (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.; Karshafian, R (corresponding author), Ryerson Univ, Dept Med Phys, Toronto, ON, Canada.; Karshafian, R; Antonescu, CN (corresponding author), Ryerson Univ, Grad Program Mol Sci, Toronto, ON, Canada.; Karshafian, R (corresponding author), Inst Biomed Engn Sci & Technol, Toronto, ON, Canada.; Karshafian, R; Antonescu, CN (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	karshafian@ryerson.ca; cantonescu@ryerson.ca		Antonescu, Costin/0000-0001-9192-6340	Canadian Institutes of Health Research (CIHR) [125854]; Natural Sciences and Engineering Research Council (of Canada); Canadian Institutes of Health Research [125854]; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funded by Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca/e/193.html), an Operating Grant to CNA (grant number 125854), and Natural Sciences and Engineering Research Council (of Canada), a Discovery Grant to R.K. (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research was provided by an Operating Grant from the Canadian Institutes of Health Research to C.N.A. (grant no. 125854) and by a Discovery Grant from the Natural Sciences and Engineering Research Council to R.K.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Antonescu CN, 2013, COLD SPRING IN PRESS; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Bae YH, 2011, J CONTROL RELEASE, V153, P198, DOI 10.1016/j.jconrel.2011.06.001; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen H, 2013, J THER ULTRASOUND, V1, DOI 10.1186/2050-5736-1-10; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Corrotte M, 2012, TRAFFIC, V13, P483, DOI 10.1111/j.1600-0854.2011.01323.x; Czarnota GJ, 2012, P NATL ACAD SCI USA, V109, pE2033, DOI 10.1073/pnas.1200053109; De Cock I, 2015, J CONTROL RELEASE, V197, P20, DOI 10.1016/j.jconrel.2014.10.031; Derieppe M, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/046010; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Garay C, 2015, MOL BIOL CELL, V26, P3504, DOI 10.1091/mbc.E14-09-1412; Goertz DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052307; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Hilgemann DW, 2013, ELIFE, V2, DOI 10.7554/eLife.01293; Hilgemann DW, 2011, J GEN PHYSIOL, V137, P155, DOI 10.1085/jgp.201010470; Ho CM, 2005, CELL SIGNAL, V17, P837, DOI 10.1016/j.cellsig.2004.11.005; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Holopainen JM, 1997, CHEM PHYS LIPIDS, V88, P1, DOI 10.1016/S0009-3084(97)00040-6; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Ibsen S, 2013, ULTRASONICS, V53, P178, DOI 10.1016/j.ultras.2012.05.006; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; Johnston I, 2008, BBA-BIOMEMBRANES, V1778, P185, DOI 10.1016/j.bbamem.2007.09.021; Karshafian R, 2010, ULTRASONICS, V50, P691, DOI 10.1016/j.ultras.2010.01.009; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Kiessling F, 2012, J NUCL MED, V53, P345, DOI 10.2967/jnumed.111.099754; Kim HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102343; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Loerke D, 2011, TRAFFIC; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meijering BDM, 2009, CIRC RES, V104, P679, DOI 10.1161/CIRCRESAHA.108.183806; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Nomikou N, 2010, CANCER LETT, V288, P94, DOI 10.1016/j.canlet.2009.06.028; Pakkanen K, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046004; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ross E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128013; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaughnessy R, 2014, FEBS J, V281, P2172, DOI 10.1111/febs.12770; Silva L, 2006, MOL MEMBR BIOL, V23, P137, DOI 10.1080/09687860500439474; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sot J, 2005, BIOPHYS J, V88, P3368, DOI 10.1529/biophysj.104.057851; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Tardoski S, 2015, ULTRASOUND MED BIOL, V41, P2740, DOI 10.1016/j.ultrasmedbio.2015.06.006; Todorova M, 2013, INT J CANCER, V132, P2956, DOI 10.1002/ijc.27977; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yang F, 2008, J CONTROL RELEASE, V131, P205, DOI 10.1016/j.jconrel.2008.07.038; Zeghimi A, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066007	64	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0156754	10.1371/journal.pone.0156754	http://dx.doi.org/10.1371/journal.pone.0156754			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275866	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561700035
J	Chen, XL; Chen, YH; Wiggs, JL; Pasquale, LR; Sun, XH; Fan, BJ				Chen, Xueli; Chen, Yuhong; Wiggs, Janey L.; Pasquale, Louis R.; Sun, Xinghuai; Fan, Bao Jian			Association of Matrix Metalloproteinase-9 (MMP9) Variants with Primary Angle Closure and Primary Angle Closure Glaucoma	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MATRIX METALLOPROTEASE-9 GENE; RISK ALLELE; POPULATION; SUSCEPTIBILITY; PREVALENCE; WORLDWIDE; LINKAGE; CHINA	Shorter axial length observed in patients with primary angle closure glaucoma (PACG) might be due to altered matrix metalloproteinase-9 (MMP9) activity resulting in ECM remodeling during eye growth and development. This study aimed to evaluate common variants in MMP9 for association with PACG. Six tag SNPs of MMP9 were genotyped in a Chinese sample of 1,030 cases, including 572 PACG and 458 primary angle closure (PAC), and 499 controls. None of 6 SNPs were significantly associated with overall PAC/PACG (P > 0.07) or with PAC/PACG subgroups (P-c > 0.18). Meta-analysis of two non-Chinese studies revealed significant association between rs17576 and PACG (ORs = 0.56, P < 0.0001); however, meta-analysis of our dataset with 4 Chinese datasets did not replicate this association (ORs = 1.23, P = 0.29). Prior significant association for rs3918249 in one Caucasian study (OR = 0.63, P = 0.006) was not replicated in meta-analysis of 3 Chinese studies including this study (ORs = 0.91, P = 0.13). Significant heterogeneity between non-Chinese and Chinese datasets precluded overall meta-analysis for rs17576 and rs3918249 (Q = 0.001 and 0.04 respectively). rs17577 was nominally associated with PACG in one Caucasian study (OR = 1.71, P = 0.02), but not in 3 Chinese studies including our study (ORs = 1.20, P = 0.07). Overall meta-analysis revealed nominal association for rs17577 and PAC/PACG (ORs = 1.26, P-c = 0.05). Meta-analysis did not show significant association between the other SNPs and PAC/PACG (P > 0.47). The largest association study to date did not find significant association between MMP9 and PAC/PACG in Chinese; meta-analysis with other Chinese datasets did not produce significant association. In most instances combination with non-Chinese datasets was not possible except for one variant showing nominally significant association. More work is needed to define the role of MMP9 variants in PACG.	[Chen, Xueli; Chen, Yuhong; Sun, Xinghuai] Fudan Univ, Shanghai Med Coll, Eye & Ear Nose Throat Hosp, Dept Ophthalmol & Vis Sci, Shanghai 200433, Peoples R China; [Chen, Xueli; Wiggs, Janey L.; Pasquale, Louis R.; Fan, Bao Jian] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA; [Pasquale, Louis R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Sun, Xinghuai] Fudan Univ, State Key Lab Med Neurobiol, Inst Brain Sci, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Key Lab Myopia, Minist Hlth, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai 200433, Peoples R China	Fudan University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fudan University; Fudan University; Fudan University; Fudan University	Sun, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & Ear Nose Throat Hosp, Dept Ophthalmol & Vis Sci, Shanghai 200433, Peoples R China.; Fan, BJ (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA USA.; Sun, XH (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Inst Brain Sci, Shanghai 200433, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200433, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Key Lab Myopia, Minist Hlth, Shanghai 200433, Peoples R China.; Sun, XH (corresponding author), Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai 200433, Peoples R China.	xhsun@shmu.edu.cn; baojian_fan@meei.harvard.edu		Fan, Baojian/0000-0002-6851-2737	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [81020108017]; National Natural Science Foundation of China [81570887]; Harvard Medical School Ophthalmology Distinguished Scholar Award	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harvard Medical School Ophthalmology Distinguished Scholar Award	This work was supported in part by the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (81020108017) (XS) and National Natural Science Foundation of China (81570887) (YC). A Harvard Medical School Ophthalmology Distinguished Scholar Award supports LRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsagoff Z, 2000, OPHTHALMOLOGY, V107, P2300, DOI 10.1016/S0161-6420(00)00385-7; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amerasinghe N, 2011, OPHTHALMOLOGY, V118, P480, DOI 10.1016/j.ophtha.2010.06.043; Aung T, 2008, J GLAUCOMA, V17, P257, DOI 10.1097/IJG.0b013e31815c3aa5; Awadalla MS, 2011, MOL VIS, V17, P1420; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cheng JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103222; Cong YH, 2009, MOL VIS, V15, P1412; Day AC, 2012, BRIT J OPHTHALMOL, V96, P1162, DOI 10.1136/bjophthalmol-2011-301189; Dubey SK, 2014, JAMA OPHTHALMOL, V132, P949, DOI 10.1001/jamaophthalmol.2014.845; Fan BJ, 2010, INVEST OPHTH VIS SCI, V51, P4110, DOI 10.1167/iovs.09-4974; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gao XJ, 2014, INT J OPHTHALMOL-CHI, V7, P397, DOI 10.3980/j.issn.2222-3959.2014.03.02; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lee KYC, 2007, BRIT J OPHTHALMOL, V91, P1059, DOI 10.1136/bjo.2006.113779; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; LOWE RF, 1972, BRIT J OPHTHALMOL, V56, P13, DOI 10.1136/bjo.56.1.13; Micheal S, 2013, MOL VIS, V19, P441; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2001, BRIT J OPHTHALMOL, V85, P1271, DOI 10.1136/bjo.85.11.1271; R Core Team, 2013, R LANG ENV STAT COMP; Rong SS, 2016, OPHTHALMOLOGY, V123, P1211, DOI 10.1016/j.ophtha.2015.12.027; Shi HH, 2013, MOL VIS, V19, P128; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang IJ, 2006, MOL VIS, V12, P1223; Wang L, 2016, J GLAUCOMA, V25, P62, DOI 10.1097/IJG.0000000000000128; Williams SEI, 2010, MOL VIS, V16, P705; Zhang BP, 1999, HUM GENET, V105, P418, DOI 10.1007/s004390051124	32	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157093	10.1371/journal.pone.0157093	http://dx.doi.org/10.1371/journal.pone.0157093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272641	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000063
J	Yang, FC; Lin, TY; Chen, HJ; Lee, JT; Lin, CC; Kao, CH				Yang, Fu-Chi; Lin, Te-Yu; Chen, Hsuan-Ju; Lee, Jiunn-Tay; Lin, Chun-Chieh; Kao, Chia-Hung			Increased Risk of Dementia in Patients with Tension-Type Headache: A Nationwide Retrospective Population-Based Cohort Study	PLOS ONE			English	Article							COGNITIVE DECLINE; ALZHEIMERS-DISEASE; PRIMARY-CARE; MIGRAINE; COMORBIDITY; PREVALENCE; STRESS; HEALTH; IMPAIRMENT; STROKE	Purpose The association between primary headaches, including tension-type headache (TTH) as one of the most common primary headache disorders, and dementia remains controversial. In this nationwide, population-based, retrospective, cohort study, we explored the potential association between TTH and dementia and examined sex, age, and comorbidities as risk factors for dementia. Methods Using the Taiwan National Health Insurance Research Database (NHIRD) claims data, the sample included 13908 subjects aged >= 20 years with newly-diagnosed TTH in 2000-2006. The non-TTH group included 55632 randomly selected sex-and age-matched TTH-free individuals. All subjects were followed until dementia diagnosis, death, or the end of 2011. Patients with dementia, including vascular and non-vascular (including Alzheimer's) subtypes, were identified using International Classification of Diseases Ninth Revision, Clinical Modification codes. Multivariate Cox proportional hazards regression models were used to assess the risk of dementia and dementia-associated risk factors, such as migraine and other medical comorbidities. Results During the average follow-up of 8.14 years, the incidence density rates of dementia were 5.30 and 3.68/1,000 person-years in the TTH and non-TTH groups, respectively. Compared with the non-TTH group, the risks of dementia were 1.25 (95% confidence interval [CI], 1.11-1.42) and 1.13 (95% CI, 1.01-1.27) times higher in the women and >65-year-old TTH group, respectively. TTH patients with comorbidities had a higher risk of dementia. TTH patients had a greater risk of non-vascular dementia (hazard ratio, 1.21; 95% CI, 1.09-1.34) than the non-TTH group. Conclusion TTH patients have a future risk of dementia, indicating a potentially linked disease pathophysiology that warrants further study. The association between TTH and dementia is greater in women, older adults, and with comorbidities. Clinicians should be aware of potential dementia comorbidity in TTH patients.	[Yang, Fu-Chi; Lee, Jiunn-Tay; Lin, Chun-Chieh] Natl Def Med Ctr, Triserv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Te-Yu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.	d10040@mail.cmuh.org.tw		Yang, Fu-Chi/0000-0001-6831-3634	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005, MOST 104-2325-B-039-005]; Tri-Service General Hospital [TSGH-C101-159]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tri-Service General Hospital; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tri-Service General Hospital [TSGH-C101-159], Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tri-Service General Hospital [TSGH-C101-159], Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alzheimer's Association, 2013, ALZHEIMERS DEMENT, V9, P110, DOI [10.1016/j.jalz.2013.02.003, DOI 10.1016/J.JALZ.2013.02.003]; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Baars MAE, 2010, HEADACHE, V50, P176, DOI 10.1111/j.1526-4610.2009.01572.x; Bell BD, 1999, ARCH CLIN NEUROPSYCH, V14, P389, DOI 10.1016/S0887-6177(98)00020-1; Caselli RJ, 2003, SEMIN NEUROL, V23, P231; Chai N.C., 2012, TECH REG ANESTH PAIN, V16, P4, DOI DOI 10.1053/J.TRAP.2012.11.001; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chuang CS, 2013, NEUROEPIDEMIOLOGY, V41, P139, DOI 10.1159/000353559; Crystal SC, 2010, CURR PAIN HEADACHE R, V14, P449, DOI 10.1007/s11916-010-0146-2; Erol R, 2015, WOMEN AND DEMENTIA A; Fereshtehnejad SM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0065-2; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gaist D, 2005, NEUROLOGY, V64, P600, DOI 10.1212/01.WNL.0000151858.15482.66; Hagen K, 2014, CEPHALALGIA, V34, P327, DOI 10.1177/0333102413513181; Hagen K, 2010, J HEADACHE PAIN, V11, P67, DOI 10.1007/s10194-009-0174-7; Jensen Rigmor, 2003, Curr Pain Headache Rep, V7, P455, DOI 10.1007/s11916-003-0061-x; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kalaydjian A, 2007, NEUROLOGY, V68, P1417, DOI 10.1212/01.wnl.0000268250.10171.b3; Kohler S, 2015, J AM GERIATR SOC, V63, P692, DOI 10.1111/jgs.13357; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P243, DOI 10.1007/s10654-004-6519-2; Morris JC, 2003, ALZ DIS ASSOC DIS, V17, P245, DOI 10.1097/00002093-200310000-00010; Payne JD, 2007, LEARN MEMORY, V14, P861, DOI 10.1101/lm.743507; Poblador-Plou B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-84; Puca F, 1999, CEPHALALGIA, V19, P159, DOI 10.1046/j.1468-2982.1999.1903159.x; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Ringman JM, 2008, DEMENT GERIATR COGN, V25, P380, DOI 10.1159/000121986; Rist PM, 2013, HEADACHE, V53, P589, DOI 10.1111/head.12046; Rist PM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5027; Rist PM, 2011, CEPHALALGIA, V31, P1291, DOI 10.1177/0333102411417466; Rottereng AKS, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0573-x; Rusanen M, 2013, CURR ALZHEIMER RES, V10, P549, DOI 10.2174/1567205011310050011; Sacco S, 2011, CURR PAIN HEADACHE R, V15, P438, DOI 10.1007/s11916-011-0222-2; Sahathevan R, 2012, INT J STROKE, V7, P61, DOI 10.1111/j.1747-4949.2011.00731.x; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; TAKESHIMA T, 1990, HEADACHE, V30, P735, DOI 10.1111/j.1526-4610.1990.hed3011735.x; van Straaten ECW, 2008, J NEUROL, V255, P1302, DOI 10.1007/s00415-008-0874-y; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066	41	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156097	10.1371/journal.pone.0156097	http://dx.doi.org/10.1371/journal.pone.0156097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27272332	Green Published, gold, Green Submitted			2022-12-27	WOS:000377561000007
J	Pinkenburg, O; Meyer, T; Bannert, N; Norley, S; Bolte, K; Czudai-Matwich, V; Herold, S; Gessner, A; Schnare, M				Pinkenburg, Olaf; Meyer, Torben; Bannert, Norbert; Norley, Steven; Bolte, Kathrin; Czudai-Matwich, Volker; Herold, Susanne; Gessner, Andre; Schnare, Markus			The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; HUMAN ALPHA-DEFENSINS; REPLICATION; MECHANISMS; LL-37; SUBTYPES; PEPTIDE	In addition to their well-known antibacterial activity some antimicrobial peptides and proteins (AMPs) display also antiviral effects. A 27 aa peptide from the N-terminal part of human bactericidal/permeability-increasing protein (BPI) previously shown to harbour antibacterial activity inhibits the infectivity of multiple Influenza A virus strains (H1N1, H3N2 and H5N1) the causing agent of the Influenza pneumonia. In contrast, the homologous murine BPI-peptide did not show activity against Influenza A virus. In addition human BPI-peptide inhibits the activation of immune cells mediated by Influenza A virus. By changing the human BPI-peptide to the sequence of the mouse homologous peptide the antiviral activity was completely abolished. Furthermore, the human BPI-peptide also inhibited the pathogenicity of the Vesicular Stomatitis Virus but failed to interfere with HIV and measles virus. Electron microscopy indicate that the human BPI-peptide interferes with the virus envelope and at high concentrations was able to destroy the particles completely.	[Pinkenburg, Olaf; Meyer, Torben; Schnare, Markus] Univ Marburg, Inst Immunol, Robert Koch Str 17, D-35032 Marburg, Germany; [Bannert, Norbert; Norley, Steven] Robert Koch Inst, Dept HIV & Other Retroviruses, Berlin, Germany; [Bolte, Kathrin] Univ Marburg, Cell Biol Lab, Marburg, Germany; [Czudai-Matwich, Volker] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Herold, Susanne] Univ Giessen, Dept Internal Med 2, Lung Ctr, D-35390 Giessen, Germany; [Herold, Susanne] German Ctr Lung Res, Giessen, Germany; [Gessner, Andre] Univ Regensburg, Inst Clin Microbiol & Hyg, D-93053 Regensburg, Germany	Philipps University Marburg; Robert Koch Institute; Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; University of Regensburg	Schnare, M (corresponding author), Univ Marburg, Inst Immunol, Robert Koch Str 17, D-35032 Marburg, Germany.	markus.schnare@staff.uni-marburg.de		Herold, Susanne/0000-0001-6343-0911	DFG [SCHN635/4-1]; von-Behring-Rontgen Stiftung Giessen and Marburg [61-0053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); von-Behring-Rontgen Stiftung Giessen and Marburg; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by DFG grant SCHN635/4-1 (http://www.dfg.de), von-Behring-Rontgen Stiftung Giessen and Marburg (grant number 61-0053 to MS)(http://www.br-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele D, 2006, INFECT IMMUN, V74, P4708, DOI 10.1128/IAI.02066-05; AIR GM, 1981, P NATL ACAD SCI-BIOL, V78, P7639, DOI 10.1073/pnas.78.12.7639; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Benincasa M, 2003, PEPTIDES, V24, P1723, DOI 10.1016/j.peptides.2003.07.025; Bergman P, 2007, CURR HIV RES, V5, P410; Bingle CD, 2011, BIOCHEM SOC T, V39, P961, DOI 10.1042/BST0390961; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10311, DOI 10.1021/bi970177e; Wittmann I, 2008, J IMMUNOL, V180, P7546, DOI 10.4049/jimmunol.180.11.7546; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; YEWDELL JW, 1981, ANNU REV MICROBIOL, V35, P185, DOI 10.1146/annurev.mi.35.100181.001153	32	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156929	10.1371/journal.pone.0156929	http://dx.doi.org/10.1371/journal.pone.0156929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27273104	Green Submitted, Green Published, gold			2022-12-27	WOS:000377560200026
J	Chen, ZF; Zhang, L; Tang, AM; Callahan, C; Pristatsky, P; Swoyer, R; Cejas, P; Nahas, D; Galli, J; Cosmi, S; DiStefano, D; Hoang, V; Bett, A; Casimiro, D; Vora, KA				Chen, Zhifeng; Zhang, Lan; Tang, Aimin; Callahan, Cheryl; Pristatsky, Pavlo; Swoyer, Ryan; Cejas, Pedro; Nahas, Debbie; Galli, Jennifer; Cosmi, Scott; DiStefano, Daniel; Hoang, Van M.; Bett, Andrew; Casimiro, Danilo; Vora, Kalpit A.			Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; FUSION GLYCOPROTEIN; IN-VITRO; PROTEIN; NEUTRALIZATION; LIBRARIES; INFECTION; RECOGNITION; SELECTION; EPITOPES	Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants, the elderly and in immunosuppressed populations. The vast majority of neutralizing antibodies isolated from human subjects target the RSV fusion (F) glycoprotein, making it an attractive target for the development of vaccines and therapeutic antibodies. Currently, Synagis (R) (palivizumab) is the only FDA approved antibody drug for the prevention of RSV infection, and there is a great need for more effective vaccines and therapeutics. Phage display is a powerful tool in antibody discovery with the advantage that it does not require samples from immunized subjects. In this study, Morphosys HuCAL GOLD (R) phage libraries were used for panning against RSV prefusion and postfusion F proteins. Panels of human monoclonal antibodies (mAbs) against RSV F protein were discovered following phage library panning and characterized. Antibodies binding specifically to prefusion or postfusion F proteins and those binding both conformations were identified. 3B1 is a prototypic postfusion F specific antibody while 2E1 is a prototypic prefusion F specific antibody. 2E1 is a potent broadly neutralizing antibody against both RSV A and B strains. Epitope mapping experiments identified a conformational epitope spanning across three discontinuous sections of the RSV F protein, as well as critical residues for antibody interaction.	[Chen, Zhifeng; Zhang, Lan; Tang, Aimin; Callahan, Cheryl; Swoyer, Ryan; Cejas, Pedro; Nahas, Debbie; Galli, Jennifer; DiStefano, Daniel; Bett, Andrew; Casimiro, Danilo; Vora, Kalpit A.] Merck & Co Inc, Merck Res Labs, Dept Infect Dis & Vaccines Res, West Point, PA USA; [Pristatsky, Pavlo; Hoang, Van M.] Merck & Co Inc, Merck Res Labs, Vaccine Bioproc Res & Dev, West Point, PA USA; [Cosmi, Scott] Eurofins Lancaster Labs Profess Sci Serv, Lancaster, PA USA	Merck & Company; Merck & Company	Vora, KA (corresponding author), Merck & Co Inc, Merck Res Labs, Dept Infect Dis & Vaccines Res, West Point, PA USA.	kalpit.vora@merck.com		Galli, Jennifer/0000-0001-8577-4790; Chen, Zhifeng/0000-0002-9390-6527	Merck and Co., Inc.	Merck and Co., Inc.(Merck & Company)	The research was fully funded by Merck and Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1988, J VIROL, V62, P4232, DOI 10.1128/JVI.62.11.4232-4238.1988; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14; Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Homaira Nusrat, 2014, Int J Pediatr, V2014, P571609, DOI 10.1155/2014/571609; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Huang RYC, 2014, ANAL BIOANAL CHEM, V406, P6541, DOI 10.1007/s00216-014-7924-3; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Krebs B, 2001, J IMMUNOL METHODS, V254, P67, DOI 10.1016/S0022-1759(01)00398-2; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lopez JA, 1998, J VIROL, V72, P6922; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2015, CURR OPIN VIROL, V11, P70, DOI 10.1016/j.coviro.2015.03.002; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nixon AE, 2014, MABS-AUSTIN, V6, P73, DOI 10.4161/mabs.27240; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; SANNA PP, 1995, P NATL ACAD SCI USA, V92, P6439, DOI 10.1073/pnas.92.14.6439; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Whimbey E, 2000, CURR CLIN TOPICS INF, V20, P232; Williams JV, 2007, J VIROL, V81, P8315, DOI 10.1128/JVI.00106-07; Wu SJ, 2007, J GEN VIROL, V88, P2719, DOI 10.1099/vir.0.82753-0	36	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156798	10.1371/journal.pone.0156798	http://dx.doi.org/10.1371/journal.pone.0156798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258388	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700131
J	Haycocks, JRJ; Grainger, DC				Haycocks, James R. J.; Grainger, David C.			Unusually Situated Binding Sites for Bacterial Transcription Factors Can Have Hidden Functionality	PLOS ONE			English	Article							POLYMERASE ALPHA-SUBUNIT; CRP-DEPENDENT PROMOTERS; AMP RECEPTOR PROTEIN; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; RNA-POLYMERASE; ACTIVATION; SEQUENCE; GENOME; TARGETS	A commonly accepted paradigm of molecular biology is that transcription factors control gene expression by binding sites at the 5' end of a gene. However, there is growing evidence that transcription factor targets can occur within genes or between convergent genes. In this work, we have investigated one such target for the cyclic AMP receptor protein (CRP) of enterotoxigenic Escherichia coli. We show that CRP binds between two convergent genes. When bound, CRP regulates transcription of a small open reading frame, which we term aatS, embedded within one of the adjacent genes. Our work demonstrates that non-canonical sites of transcription factor binding can have hidden functionality.	[Haycocks, James R. J.; Grainger, David C.] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Birmingham	Grainger, DC (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	d.grainger@bham.ac.uk		Grainger, David/0000-0003-3375-5154	Wellcome Trust [WT085092MA]; BBSRC [BB/N005961/1]; Biotechnology and Biological Sciences Research Council [1363809, BB/N005961/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust Award Number WT085092MA to DCG and BBSRC Award Number BB/N005961/1 to DCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2002, INFECT IMMUN, V70, P2915, DOI 10.1128/IAI.70.6.2915-2925.2002; BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BUSBY S, 1983, J MOL BIOL, V167, P259, DOI 10.1016/S0022-2836(83)80335-0; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Efromovich S, 2008, METHOD ENZYMOL, V437, P211, DOI 10.1016/S0076-6879(07)37012-2; Ellis JC, 2003, TRENDS BIOCHEM SCI, V28, P521, DOI 10.1016/j.tibs.2003.08.002; Feltens R, 2003, P NATL ACAD SCI USA, V100, P5724, DOI 10.1073/pnas.0931462100; GASTON K, 1990, CELL, V62, P733, DOI 10.1016/0092-8674(90)90118-X; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Haycocks JRJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004605; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Islam MS, 2012, BIOCHEM J, V441, P247, DOI 10.1042/BJ20110912; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lloyd GS, 2008, FEMS MICROBIOL LETT, V288, P250, DOI 10.1111/j.1574-6968.2008.01365.x; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nishi J, 2003, J BIOL CHEM, V278, P45680, DOI 10.1074/jbc.M306413200; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Rhodius VA, 1997, NUCLEIC ACIDS RES, V25, P326, DOI 10.1093/nar/25.2.326; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; Savery NJ, 2002, J BACTERIOL, V184, P2273, DOI 10.1128/JB.184.8.2273-2280.2002; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Waldminghaus T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-414; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Yamamoto K, 2011, J BACTERIOL, V193, P1477, DOI 10.1128/JB.01230-10	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157016	10.1371/journal.pone.0157016	http://dx.doi.org/10.1371/journal.pone.0157016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258043	Green Published, gold			2022-12-27	WOS:000377369700170
J	Melberg, A; Diallo, AH; Ruano, AL; Tylleskar, T; Moland, KM				Melberg, Andrea; Diallo, Abdoulaye Hama; Ruano, Ana Lorena; Tylleskar, Thorkild; Moland, Karen Marie			Reflections on the Unintended Consequences of the Promotion of Institutional Pregnancy and Birth Care in Burkina Faso	PLOS ONE			English	Article							RURAL HEALTH FACILITIES; MATERNAL MORTALITY; PERCEIVED QUALITY; PERFORMANCE; STRATEGIES; SERVICES; TANZANIA; CONTEXT; GHANA; USER	The policy of institutional delivery has been the cornerstone of actions aimed at monitoring and achieving MDG 5. Efforts to increase institutional births have been implemented worldwide within different cultural and health systems settings. This paper explores how communities in rural Burkina Faso perceive the promotion and delivery of facility pregnancy and birth care, and how this promotion influences health-seeking behaviour. A qualitative study was conducted in South-Western Burkina Faso between September 2011 and January 2012. A total of 21 in-depth interviews and 8 focus group discussions with women who had given birth recently and community members were conducted. The data were analyzed using qualitative content analysis and interpreted through Merton's concept of unintended consequences of purposive social action. The study found that community members experienced a strong pressure to give birth in a health facility and perceived health workers to define institutional birth as the only acceptable option. Women and their families experienced verbal, economic and administrative sanctions if they did not attend services and adhered to health worker recommendations, and reported that they felt incapable of questioning health workers' knowledge and practices. Women who for social and economic reasons had limited access to health facilities found that the sanctions came with increased cost for health services, led to social stigma and acted as additional barriers to seek skilled care at birth. The study demonstrates how the global and national policy of skilled pregnancy and birth care can occur in unintentional ways in local settings. The promotion of institutional care during pregnancy and at birth in the study area compromised health system trust and equal access to care. The pressure to use facility care and the sanctions experienced by women not complying may further marginalize women with poor access to facility care and contribute to worsened health outcomes.	[Melberg, Andrea; Ruano, Ana Lorena; Tylleskar, Thorkild; Moland, Karen Marie] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Diallo, Abdoulaye Hama] Minist Sante, Ctr MURAZ, Bobo Dioulasso, Burkina Faso; [Diallo, Abdoulaye Hama] Univ Ouagadougou, Dept Publ Hlth, UFR SDS, Ouagadougou, Burkina Faso; [Ruano, Ana Lorena] Ctr Study Equity & Governance Hlth Syst, Guatamala City, Guatemala; [Moland, Karen Marie] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Bergen, Norway	University of Bergen; Centre Muraz; University of Bergen	Melberg, A (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	andrea.melberg@uib.no	Tylleskär, Thorkild/S-5529-2017; Ruano, Ana Lorena/AAA-1656-2021	Tylleskär, Thorkild/0000-0003-4801-4324; Ruano, Ana Lorena/0000-0003-3913-4228	Medical Students Research Program/the Norwegian Research Council	Medical Students Research Program/the Norwegian Research Council	This study was funded through the Medical Students Research Program/the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Austveg B, 2011, REPROD HEALTH MATTER, V19, P26, DOI 10.1016/S0968-8080(11)38583-7; Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Behague DP, 2008, SOCIOL HEALTH ILL, V30, P489, DOI 10.1111/j.1467-9566.2007.01070.x; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chimhutu V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-23; De Allegri M, 2011, HEALTH POLICY, V99, P210, DOI 10.1016/j.healthpol.2010.10.010; Diallo AH, 2011, J PERINATOL, V31, P656, DOI 10.1038/jp.2011.6; Direction generale de l'information et des statistiques sanitaires, 2012, ANNUAIRE STATISTIQUE; District sanitaire de Banfora, 2011, PLAN DACTION 2012 DU; District sanitaire de Mangodara, 2011, PLAN DACTION 2012 DU; Douglas M, 1992, RISK AND BLAME ESSAY; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P534, DOI 10.1111/tmi.12076; Duysburgh E, 2013, TROP MED INT HEALTH, V18, P1498, DOI 10.1111/tmi.12214; Farmer P., 1997, SOCIAL SUFFERING; Goetz Annemarie, 2003, NO SHORTCUTS POWER A; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Kabakian-Khasholian T, 2000, SOC SCI MED, V51, P103, DOI 10.1016/S0277-9536(99)00443-8; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kleinman A, 1997, SOCIAL SUFFERING; Kleinman A, 2015, LANCET, V386, P240, DOI 10.1016/S0140-6736(15)61271-5; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kvernflaten B, 2013, REPROD HEALTH MATTER, V21, P32, DOI 10.1016/S0968-8080(13)42728-3; Magrath P, 2012, SOC SCI MED, V75, P1778, DOI 10.1016/j.socscimed.2012.07.025; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Metcalfe R, 2013, INT HEALTH, V5, P96, DOI 10.1093/inthealth/ihs001; Ministere de la Sante, 2006, PLAN DACCELERATION D; Ng SK, 2014, BMC PREGNANCY CHILDB, V14, DOI [10.1186/1471-2393-14-314, 10.1186/1471-2393-14-323]; Nikiema L, 2010, J HEALTH POPUL NUTR, V28, P67, DOI 10.3329/jhpn.v28i1.4525; Philibert A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-120; RIDDE V, 2011, HLTH POLICY PLAN S2, V26, P30, DOI DOI 10.1093/HEAPOL/CZR060; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Shayo EH, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-30; Some TD, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-3; Storeng KT, 2014, MED ANTHROPOL Q, V28, P260, DOI 10.1111/maq.12072; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations Department of Economic and Social Affairs, 2012, MILL DEV GOALS REP 2; World Health Organization, 2004, MAKING PREGNANCY SAF	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156503	10.1371/journal.pone.0156503	http://dx.doi.org/10.1371/journal.pone.0156503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258012	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700069
J	Dobierzewska, A; Palominos, M; Sanchez, M; Dyhr, M; Helgert, K; Venegas-Araneda, P; Tong, S; Illanes, SE				Dobierzewska, Aneta; Palominos, Macarena; Sanchez, Marianela; Dyhr, Michael; Helgert, Katja; Venegas-Araneda, Pia; Tong, Stephen; Illanes, Sebastian E.			Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia	PLOS ONE			English	Article							TROPHOBLAST DIFFERENTIATION; SPHINGOLIPID METABOLISM; SPHINGOSINE-1-PHOSPHATE; HYPOXIA; EXPRESSION; KINASE; 1-PHOSPHATE; CONTRIBUTES; INHIBITION; PROLIFERATION	Preeclampsia (PE), is a serious pregnancy disorder characterized in the early gestation by shallow trophoblast invasion, impaired placental neo-angiogenesis, placental hypoxia and ischemia, which leads to maternal and fetal morbidity and mortality. Here we hypothesized that angiogenic sphingosine kinase-1 (SPHK1)/sphingosine-1-phosphate (S1P) receptors pathway is impaired in PE. We found that SPHK1 mRNA and protein expression are downregulated in term placentae and term chorionic villous explants from patients with PE or severe PE (PES), compared with controls. Moreover, mRNA expression of angiogenic S1PR1 and S1PR3 receptors were decreased in placental samples of PE and PES patients, whereas anti-angiogenic S1PR2 was up-regulated in chorionic villous tissue of PES subjects, pointing to its potential atherogenic and inflammatory properties. Furthermore, in in vitro (JAR cells) and ex vivo (chorionic villous explants) models of placental hypoxia, SPHK1 mRNA and protein were strongly up-regulated under low oxygen tension (1% O-2). In contrast, there was no change in SPHK1 expression under the conditions of placental physiological hypoxia (8% O-2). In both models, nuclear protein levels of HIF1A were increased at 1% O-2 during the time course, but there was no up-regulation at 8% O-2, suggesting that SPHK1 and HIF1A might be the part of the same canonical pathway during hypoxia and that both contribute to placental neovascularization during early gestation. Taken together, this study suggest the SPHK1 pathway may play a role in the human early placentation process and may be involved in the pathogenesis of PE.	[Dobierzewska, Aneta; Palominos, Macarena; Sanchez, Marianela; Dyhr, Michael; Helgert, Katja; Venegas-Araneda, Pia; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Dept Obstet & Gynecol, Santiago, Chile; [Dobierzewska, Aneta; Palominos, Macarena; Sanchez, Marianela; Dyhr, Michael; Helgert, Katja; Venegas-Araneda, Pia; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Reprod Biol Lab, Santiago, Chile; [Tong, Stephen] Univ Melbourne, Dept Obstet & Gynecol, Translat Obstet Grp, Mercy Hosp Women, Heidelberg, Vic, Australia; [Illanes, Sebastian E.] Clin Davila, Dept Maternal Fetal Med, Santiago, Chile	Universidad de los Andes - Chile; Universidad de los Andes - Chile; University of Melbourne; Clinica Davila	Dobierzewska, A (corresponding author), Univ Los Andes, Fac Med, Dept Obstet & Gynecol, Santiago, Chile.	adobierzewska@uandes.cl		Tong, Stephen/0000-0002-2319-0586; Illanes, Sebastian/0000-0001-5433-9315	FAI Inicacion grant (Fondo de Ayuda a la Investigacion of Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) [1140119]; International DAAD-Rise scholarships [CL-BI-330, CL-ME-1454]	FAI Inicacion grant (Fondo de Ayuda a la Investigacion of Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia"; Fondecyt (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); International DAAD-Rise scholarships	This work was supported by FAI Inicacion grant (Fondo de Ayuda a la Investigacion of Universidad de los Andes) "Imbalance of bioactive sphingolipids rheostat in patients with preeclampsia" to AD and Fondecyt Regular 1140119 (Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile) to SEI. (http://www.conicyt.cl/fondecyt). MD and KH were supported by International DAAD-Rise scholarships (CL-BI-330 and CL-ME-1454) "Search for sphingolipids-related biomarkers of pregnancy disease: preeclampsia" to conduct internships in our laboratory (http://www.daad.de/rise). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chauvin S, 2015, J CLIN ENDOCR METAB, V100, pE986, DOI 10.1210/jc.2015-1288; De Marco CS, 2002, PLACENTA, V23, pS58, DOI 10.1053/plac.2002.0809; Dobierzewska A, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.124644; Dunlap KA, 2010, BIOL REPROD, V82, P876, DOI 10.1095/biolreprod.109.081604; Egerman RS, 1999, CLIN OBSTET GYNECOL, V42, P381, DOI 10.1097/00003081-199906000-00022; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Fayyad AM, 2005, EARLY HUM DEV, V81, P865, DOI 10.1016/j.earlhumdev.2005.09.005; French KJ, 2003, CANCER RES, V63, P5962; Heringdorf DM, 1999, FEBS LETT, V461, P217, DOI 10.1016/S0014-5793(99)01463-5; Heringdorf DMZ, 2001, EUR J PHARMACOL, V414, P145, DOI 10.1016/S0014-2999(01)00789-0; Inoki I, 2006, BIOCHEM BIOPH RES CO, V346, P293, DOI 10.1016/j.bbrc.2006.05.119; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kihara A, 2008, BIOCHIM BIOPHYS ACTA, V1781, P483; Kono M, 2004, J BIOL CHEM; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Lanoix D, 2012, PLACENTA, V33, P151, DOI 10.1016/j.placenta.2011.12.008; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Singh AT, 2012, REPROD BIOMED ONLINE, V24, P224, DOI 10.1016/j.rbmo.2011.10.012; Skaznik-Wikiel ME, 2006, BIOL REPROD, V74, P569, DOI 10.1095/biolreprod.105.046714; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Takuwa Yoh, 2010, World J Biol Chem, V1, P298, DOI 10.4331/wjbc.v1.i10.298; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Tao R, 2007, CARDIOVASC RES, V74, P56, DOI 10.1016/j.cardiores.2007.01.015; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yang WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106725; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zhang H, 2012, CELL PROLIFERAT, V45, P167, DOI 10.1111/j.1365-2184.2012.00807.x; Zhang JH, 2013, HUM REPROD, V28, P3026, DOI 10.1093/humrep/det339; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhao J, 2015, CURR ATHEROSCLER REP, V17, P1	45	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157221	10.1371/journal.pone.0157221	http://dx.doi.org/10.1371/journal.pone.0157221			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284992	Green Published, gold			2022-12-27	WOS:000377564000045
J	Malm, CB; Khoo, NS; Granlund, I; Lindstedt, E; Hult, A				Malm, Christer B.; Khoo, Nelson S.; Granlund, Irene; Lindstedt, Emilia; Hult, Andreas			Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate Statistics	PLOS ONE			English	Article							RECOMBINANT ERYTHROPOIETIN; HEMOGLOBIN CONCENTRATION; CENTRAL CIRCULATION; MAXIMAL EXERCISE; TRANSFUSION; ANEMIA; SOCCER; ERYTHROCYTHEMIA; POLYCYTHEMIA; REINFUSION	The discovery of erythropoietin (EPO) simplified blood doping in sports, but improved detection methods, for EPO has forced cheating athletes to return to blood transfusion. Autologous blood transfusion with cryopreserved red blood cells (RBCs) is the method of choice, because no valid method exists to accurately detect such event. In endurance sports, it can be estimated that elite athletes improve performance by up to 3% with blood doping, regardless of method. Valid detection methods for autologous blood doping is important to maintain credibility of athletic performances. Recreationalmale (N = 27) and female (N = 11) athletes served as Transfusion (N = 28) and Control (N = 10) subjects in two different transfusion settings. Hematological variables and physical performance were measured before donation of 450 or 900 mL whole blood, and until four weeks after re-infusion of the cryopreserved RBC fraction. Blood was analyzed for transferrin, iron, Hb, EVF, MCV, MCHC, reticulocytes, leucocytes and EPO. Repeated measures multivariate analysis of variance (MANOVA) and pattern recognition using Principal Component Analysis (PCA) and Orthogonal Projections of Latent Structures (OPLS) discriminant analysis (DA) investigated differences between Control and Transfusion groups over time. Significant increase in performance (15 +/- 8%) and VO2max (17 +/- 10%) (mean +/- SD) could be measured 48 h after RBC re-infusion, and remained increased for up to four weeks in some subjects. In total, 533 blood samples were included in the study (Clean = 220, Transfused = 313). In response to blood transfusion, the largest change in hematological variables occurred 48 h after blood donation, when Control and Transfused groups could be separated with OPLS-DA (R-2 = 0.76/Q(2) = 0.59). RBC re-infusion resulted in the bestmodel (R-2 = 0.40/Q(2) = 0.10) at the first sampling point (48 h), predicting one false positive and one false negative. Over all, a 25% and 86% false positives ratio was achieved in two separate trials. In conclusions, autologous re-infusion of RBCs increased VO2max and performance as hypothesized, but hematological profiling by multivariate statistics could not reach the WADA stipulated false positive ratio of <0.001% at any time point investigated. A majority of samples remained within limits of normal individual variation at all times.	[Malm, Christer B.; Khoo, Nelson S.; Granlund, Irene; Lindstedt, Emilia; Hult, Andreas] Umea Univ, Sports Med Unit, Umea, Sweden; [Malm, Christer B.] Winternet, Boden, Sweden	Umea University	Malm, CB (corresponding author), Umea Univ, Sports Med Unit, Umea, Sweden.; Malm, CB (corresponding author), Winternet, Boden, Sweden.	Christer.malm@umu.se	Malm, Christer/O-3458-2014	Malm, Christer/0000-0002-8436-2476; Hult, Andreas/0000-0002-4341-1745	World Anti Doping Agency (WADA) [R07A1CM, 08C06CM]; Sweden's innovation agency (VINNOVA) [2009-00462]; Centrum for Idrottsforskning (CIF) [2008 88/08]; Umea Biotech Incubator	World Anti Doping Agency (WADA); Sweden's innovation agency (VINNOVA)(Vinnova); Centrum for Idrottsforskning (CIF); Umea Biotech Incubator	This work was funded by World Anti Doping Agency (WADA) R07A1CM and 08C06CM (www.wada-ama.org), Sweden's innovation agency (VINNOVA) 2009-00462 (www.vinnova.se), Centrum for Idrottsforskning (CIF) 2008 88/08 (http://centrumforidrottsforskning.se), and Umea Biotech Incubator (www.ubi.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, pR899, DOI 10.1152/ajpregu.2000.279.3.R899; BANGSBO J, 1992, INT J SPORTS MED, V13, P125, DOI 10.1055/s-2007-1021243; Barrero A, 2014, INT J SPORTS MED, V35, P1170, DOI 10.1055/s-0034-1374601; Bejder J, 2016, SCAND J MED SCI SPOR, V26, P338, DOI 10.1111/sms.12438; Berglund B, 2007, SCAND J MED SCI SPOR, V17, P292, DOI 10.1111/j.1600-0838.2006.00550.x; BERGLUND B, 1988, SPORTS MED, V5, P127, DOI 10.2165/00007256-198805020-00004; BERGLUND B, 1989, MED SCI SPORT EXER, V21, P637, DOI 10.1249/00005768-198912000-00002; BERGLUND B, 1987, INT J SPORTS MED, V8, P231, DOI 10.1055/s-2008-1025661; BERGLUND B, 1991, J INTERN MED, V229, P125, DOI 10.1111/j.1365-2796.1991.tb00319.x; BERGLUND B, 1987, INT J SPORTS MED, V8, P66, DOI 10.1055/s-2008-1025643; Birkeland KI, 2000, MED SCI SPORT EXER, V32, P1238, DOI 10.1097/00005768-200007000-00009; BRIEN AJ, 1987, JAMA-J AM MED ASSOC, V257, P2761, DOI 10.1001/jama.257.20.2761; BUICK FJ, 1980, J APPL PHYSIOL, V48, P636, DOI 10.1152/jappl.1980.48.4.636; Bylesjo M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-207; Carlsson M, 2014, EUR J APPL PHYSIOL, V114, P2587, DOI 10.1007/s00421-014-2980-0; CELSING F, 1986, EUR J APPL PHYSIOL, V55, P74, DOI 10.1007/BF00422897; CELSING F, 1986, J APPL PHYSIOL, V61, P1358, DOI 10.1152/jappl.1986.61.4.1358; CELSING F, 1987, ACTA PHYSIOL SCAND, V129, P47, DOI 10.1111/j.1748-1716.1987.tb08038.x; CHATARD JC, 1990, INT J SPORTS MED, V11, P156, DOI 10.1055/s-2007-1024782; CHRISTENSEN T, 1978, EUR J APPL PHYSIOL O, V39, P17, DOI 10.1007/BF00429675; COYLE EF, 1991, MED SCI SPORT EXER, V23, P93; Damsgaard R, 2006, HAEMATOL-HEMATOL J, V91, P1006; DUCHE P, 1993, EUR J APPL PHYSIOL O, V66, P467, DOI 10.1007/BF00599623; EKBLOM B, 1976, J APPL PHYSIOL, V40, P379, DOI 10.1152/jappl.1976.40.3.379; EKBLOM B, 1975, J APPL PHYSIOL, V39, P71, DOI 10.1152/jappl.1975.39.1.71; EKBLOM B, 1972, J APPL PHYSIOL, V33, P175, DOI 10.1152/jappl.1972.33.2.175; Ekblom BT, 2000, BEST PRACT RES CL EN, V14, P89, DOI 10.1053/beem.2000.0056; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; Gore CJ, 2003, HAEMATOLOGICA, V88, P333; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; GRIMBY G, 1966, J APPL PHYSIOL, V21, P1150, DOI 10.1152/jappl.1966.21.4.1150; Hult A., 2015, DETAILED UNDERSTANDI; Hult A, 2015, PHAGOCYTOSIS L UNPUB; Hult A, 2013, TRANSFUSION, V53, P28, DOI 10.1111/j.1537-2995.2012.03710.x; Jelkmann W, 2011, BLOOD, V118, P2395, DOI 10.1182/blood-2011-02-303271; Jones M, 1989, Br J Sports Med, V23, P84; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; KNOWLTON RG, 1980, MED SCI SPORT EXER, V12, P164; Lamberts RP, 2014, INT J SPORTS MED, V35, P217, DOI 10.1055/s-0033-1349139; Lasne F, 2000, NATURE, V405, P635, DOI 10.1038/35015164; Leuenberger N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066309; Lindberg AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118945; Lindberg AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068047; Malcovati L, 2003, HAEMATOLOGICA, V88, P570; McCormack WP, 2014, J STRENGTH COND RES, V28, P964, DOI 10.1519/JSC.0000000000000359; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; Morkeberg J, 2009, INT J SPORTS MED, V30, P285, DOI 10.1055/s-0028-1105938; Morkeberg J, 2012, TRANSFUS MED REV, V26, P199, DOI 10.1016/j.tmrv.2011.09.007; Nelson M, 2003, HAEMATOLOGICA, V88, P1284; PACE N, 1947, AM J PHYSIOL, V148, P152, DOI 10.1152/ajplegacy.1947.148.1.152; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; Pialoux V, 2009, INT J HEMATOL, V89, P714, DOI 10.1007/s12185-009-0330-5; Pohjanen E, 2007, J PROTEOME RES, V6, P2113, DOI 10.1021/pr070007g; Pottgiesser T, 2009, VOX SANG, V96, P333, DOI 10.1111/j.1423-0410.2009.01169.x; Pottgiesser T, 2011, TRANSFUSION, V51, P1707, DOI 10.1111/j.1537-2995.2011.03076.x; ROBERTSON RJ, 1984, J APPL PHYSIOL, V57, P568, DOI 10.1152/jappl.1984.57.2.568; ROBINSON BF, 1966, CIRC RES, V19, P26, DOI 10.1161/01.RES.19.1.26; Sallet P, 2008, INT J HEMATOL, V88, P362, DOI 10.1007/s12185-008-0182-4; Schmidt W, 2010, EXERC SPORT SCI REV, V38, P68, DOI 10.1097/JES.0b013e3181d4957a; Segura J, 2012, DRUG TEST ANAL, V4, P876, DOI 10.1002/dta.405; Sharpe K, 2002, HAEMATOLOGICA, V87, P1248; SPRIET LL, 1986, J APPL PHYSIOL, V61, P1942, DOI 10.1152/jappl.1986.61.5.1942; TANAKA K, 1982, ANN HUM BIOL, V9, P473, DOI 10.1080/03014468200006001; Thomsen JJ, 2007, EUR J APPL PHYSIOL, V101, P481, DOI 10.1007/s00421-007-0522-8; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van Straten AHM, 2010, INTERACT CARDIOV TH, V10, P37, DOI 10.1510/icvts.2009.214551; Vardhandboken, 2006, TRANSF BLODK, V18; WADA, 2015, PROH LIST 2015; Wells CM, 2012, J SPORT MED PHYS FIT, V52, P245; WIDE L, 1995, MED SCI SPORT EXER, V27, P1569; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Yu JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105330	72	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0156157	10.1371/journal.pone.0156157	http://dx.doi.org/10.1371/journal.pone.0156157			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1UG	27284981	Green Submitted, gold, Green Published			2022-12-27	WOS:000377564000009
J	Arinder, P; Johannesson, P; Karlsson, I; Borch, E				Arinder, Pernilla; Johannesson, Par; Karlsson, Ingela; Borch, Elisabeth			Transfer and Decontamination of S. aureus in Transmission Routes Regarding Hands and Contact Surfaces	PLOS ONE			English	Article							BACTERIAL CROSS-CONTAMINATION; QUANTITATIVE EXPOSURE MODEL; STAPHYLOCOCCUS-AUREUS; LISTERIA-MONOCYTOGENES; RISK; ENVIRONMENT; NOROVIRUS; EFFICACY; CARE	Hand hygiene, cleaning and disinfection are pre-requirements for hygiene management in hospital settings and the food industry. In order to facilitate risk management, different contamination scenarios and interventions need to be evaluated. In the present study data on transfer rates and reductions of Staphylococcus aureus were provided in an experimental set-up using artificial skin. Using this methodology, test persons were not exposed with pathogenic bacteria. An exposure assessment model was developed and applied to evaluate different contamination routes and hygiene interventions. The transfer rates of S. aureus from inoculated VITRO-SKIN1 to fomites were calculated from blotting series. The VITRO-SKIN (R) was more prone to spread bacteria than fomites. When different surfaces were cleaned, the reduction of S. aureus varied between < 1 and 7 log CFU. It could not be concluded that a certain coupon material, cleaning agent, cleaning wipe, soiling or humidity consistently resulted in a high or low reduction of S. aureus. The reduction of S. aureus and E. coli during hand washing was evaluated on artificial skin, VITRO-SKIN (R). The reduction of E. coli on VITRO-SKIN (R) was similar to the log reduction obtained when washing human hands. The S. aureus count on a human hand was both calculated in different scenarios describing different contamination routes starting from a contaminated hand using the exposure assessment model, and measured on an experimental setup using VITRO-SKIN (R) for validation. A linear relationship was obtained between the analysed level of S. aureus and the calculated level. However, the calculated levels of S. aureus on the VITRO-SKIN (R) in the scenarios were 1-1.5 log lower than the analysed level. One of the scenarios was used to study the effect of interventions like hand washing and cleaning of surfaces.	[Arinder, Pernilla; Borch, Elisabeth] SP Tech Res Inst Sweden, Food & Biosci, Lund, Sweden; [Johannesson, Par] SP Tech Res Inst Sweden, Mech Res, Boras, Sweden; [Karlsson, Ingela] SP Tech Res Inst Sweden, Food & Biosci, Gothenburg, Sweden	SP Technical Research Institute of Sweden; SP Technical Research Institute of Sweden; SP Technical Research Institute of Sweden	Borch, E (corresponding author), SP Tech Res Inst Sweden, Food & Biosci, Lund, Sweden.	elisabeth.borch@sp.se		Johannesson, Par/0000-0002-6730-0214	Bo Rydin Foundation	Bo Rydin Foundation	Bo Rydin Foundation funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, J HOSP INFECT, V80, P192, DOI 10.1016/j.jhin.2011.12.005; Berendt AE, 2011, AM J INFECT CONTROL, V39, P442, DOI 10.1016/j.ajic.2010.08.014; Bloomfield SF, 1997, J APPL MICROBIOL, V83, P1, DOI 10.1046/j.1365-2672.1997.00199.x; Caous JS., 2011, THESIS; Chen YH, 2001, J FOOD PROTECT, V64, P72, DOI 10.4315/0362-028X-64.1.72; Dancer SJ, 2011, EUR J CLIN MICROBIOL, V30, P1473, DOI 10.1007/s10096-011-1250-x; Desai R, 2011, AM J INFECT CONTROL, V39, P219, DOI 10.1016/j.ajic.2010.07.005; Diab-Elschahawi M, 2010, AM J INFECT CONTROL, V38, P289, DOI 10.1016/j.ajic.2009.09.006; Doncaster CP, 2007, ANALYSIS OF VARIANCE AND COVARIANCE: HOW TO CHOOSE AND CONSTRUCT MODELS FOR THE LIFE SCIENCES, P1, DOI 10.1017/CBO9780511611377; Garrood MJ, 2004, APPL ENVIRON MICROB, V70, P3558, DOI 10.1128/AEM.70.6.3558-3565.2004; Haas CN, 2005, INT J HYG ENVIR HEAL, V208, P461, DOI 10.1016/j.ijheh.2005.04.009; Huss HH, 2004, ASSESSMENT MANAGEMEN, P101; Jerrmann R, 2002, INT J COSMETIC SCI, V24, P35, DOI [10.1046/j.0412-5463.2001.00123.x, DOI 10.1046/J.0412-5463.2001.00123.X]; Johannesson P, 2013, QUAL RELIAB ENG INT, V29, P17, DOI 10.1002/qre.1294; Johansson P, 2006, QUAL RELIAB ENG INT, V22, P865, DOI 10.1002/qre.773; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Mokhtari A, 2009, INT J FOOD MICROBIOL, V133, P38, DOI 10.1016/j.ijfoodmicro.2009.04.021; Montville R, 2003, APPL ENVIRON MICROB, V69, P7188, DOI 10.1128/AEM.69.12.7188-7193.2003; Montville R, 2002, INT J FOOD MICROBIOL, V73, P305, DOI 10.1016/S0168-1605(01)00666-3; Oie S, 2005, BIOL PHARM BULL, V28, P120, DOI 10.1248/bpb.28.120; Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004; Perez-Rodriguez F, 2008, TRENDS FOOD SCI TECH, V19, P131, DOI 10.1016/j.tifs.2007.08.003; Perez-Rodriguez F, 2006, J FOOD PROTECT, V69, P2384, DOI 10.4315/0362-028X-69.10.2384; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; Rusin P, 2002, J APPL MICROBIOL, V93, P585, DOI 10.1046/j.1365-2672.2002.01734.x; Stals A, 2015, INT J FOOD MICROBIOL, V196, P126, DOI 10.1016/j.ijfoodmicro.2014.12.004; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04; WHO, 2015, PAT SAF SOL, V1; WHO, 2009, WHO GUID HAND HYG HL	29	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156390	10.1371/journal.pone.0156390	http://dx.doi.org/10.1371/journal.pone.0156390			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280772	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000028
J	Czyzewska, U; Siemionow, K; Zareba, I; Miltyk, W				Czyzewska, Urszula; Siemionow, Katarzyna; Zareba, Ilona; Miltyk, Wojciech			Proapoptotic Activity of Propolis and Their Components on Human Tongue Squamous Cell Carcinoma Cell Line (CAL-27)	PLOS ONE			English	Article							ORAL-CANCER; CHEMICAL-COMPOSITION; MASS-SPECTROMETRY; TEA POLYPHENOLS; CAFFEIC ACID; COLON-CANCER; NECK-CANCER; IN-VITRO; APOPTOSIS; FLAVONOIDS	Propolis has been used since ancient times in folk medicine. It is a popular medicine possessing a broad spectrum of biological activities. This material is one of the richest sources of polyphenolic compounds such as flavonoids and phenolic acids. The ethanolic extract of propolis (EEP) evokes antibacterial, antiviral, antifungal and anticancer properties. Due to pharmacological properties it is used in the commercial production of nutritional supplements. In this study, gas chromatography coupled with mass spectrometry (GC-MS) was used to quantify main polyphenols in EEPs. The effect of EEPs, individual EEPs components (chrysin, galangin, pinocembrin, caffeic acid, p-coumaric acid, ferulic acid) and their mixture on viability of human tongue squamous cell carcinoma cell line (CAL-27) as well as the molecular mechanisms of the process were examined. The results of MTTs assay demonstrated that EEP, polyphenols and mixture of polyphenolic compounds were cytotoxic for CAL-27 cells in a dose dependent manner. The mechanism of cytotoxicity induced by these components undergoes through apoptosis as detected by flow cytometry. The ethanolic extracts of propolis activated caspases -3, -8, -9. Mixture of polyphenols was found as the most potent inducer of apoptosis thorough both intrinsic and extrinsic pathway. Therefore, we suggest that anticancer properties of propolis is related to synergistic activity of its main components.	[Czyzewska, Urszula; Siemionow, Katarzyna; Miltyk, Wojciech] Med Univ Bialystok, Dept Pharmaceut Anal, Bialystok, Poland; [Zareba, Ilona] Med Univ Bialystok, Dept Med Chem, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok	Czyzewska, U (corresponding author), Med Univ Bialystok, Dept Pharmaceut Anal, Bialystok, Poland.	urszula.czyzewska@umb.edu.pl	Frazao, Maria/O-4407-2016; Miltyk, Wojciech/P-6937-2018; Zareba, Ilona/T-6930-2018	Miltyk, Wojciech/0000-0001-5150-6093; Zareba, Ilona/0000-0002-7934-6973	Medical University of Bialystok as part of the OP DEP [POPW.01.03.00-20-008/09]; Medical University of Bialystok, Poland (KNOW) [124/KNOW/15]	Medical University of Bialystok as part of the OP DEP; Medical University of Bialystok, Poland (KNOW)	This study was conducted with the use of equipment purchased by Medical University of Bialystok as part of the OP DEP 2007-2013, Priority Axis I.3, contract No. POPW.01.03.00-20-008/09 and financially supported by the Medical University of Bialystok, Poland (KNOW Project No. 124/KNOW/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIG 2015; [Anonymous], CANC POL 2012; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Barlak Y, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-74; Barnes L, 2005, PATHLOGY GENETICS HE; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chang YC, 2012, J AGR FOOD CHEM, V60, P8395, DOI 10.1021/jf302223g; Chen ZY, 2013, BANGL J PHARMACOL, V8, P255, DOI 10.3329/bjp.v8i3.14795; Czyzewska U, 2015, J MED FOOD, V18, P584, DOI 10.1089/jmf.2014.0069; Watanabe MAE, 2011, J PHARM PHARMACOL, V63, P1378, DOI 10.1111/j.2042-7158.2011.01331.x; Fan MJ, 2015, NUTR CANCER, V67, P327, DOI 10.1080/01635581.2015.990576; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Galeone C, 2015, INT J CANCER, V136, P904, DOI 10.1002/ijc.29044; Gardana C, 2007, J PHARMACEUT BIOMED, V45, P390, DOI 10.1016/j.jpba.2007.06.022; Gazzani G, 2012, CURR OPIN BIOTECH, V23, P153, DOI 10.1016/j.copbio.2011.09.003; Gomez-Caravaca AM, 2006, J PHARMACEUT BIOMED, V41, P1220, DOI 10.1016/j.jpba.2006.03.002; Guo SJ, 2011, ADV BIOM ENG, P98; Hashim YZHY, 2008, INT J CANCER, V122, P495, DOI 10.1002/ijc.23148; Iriti M, 2013, NUTRIENTS, V5, P2564, DOI 10.3390/nu5072564; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kasala ER, 2015, TOXICOL LETT, V233, P214, DOI 10.1016/j.toxlet.2015.01.008; Kim JW, 2010, CANCER PREV RES, V3, P900, DOI 10.1158/1940-6207.CAPR-09-0131; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Kubina R, 2015, ADV CLIN EXP MED, V24, P203, DOI 10.17219/acem/31792; Kuntz S, 1999, EUR J NUTR, V38, P133, DOI 10.1007/s003940050054; Lin CL, 2012, INT J MOL SCI, V13, P6236, DOI 10.3390/ijms13056236; Lin J.-K., 2006, FLAVONOIDS NUTRACEUT; Mangalath U, 2014, J INT SOC PREV COMMU, V4, pS131, DOI 10.4103/2231-0762.149018; Markiewicz-Zukowska R, 2012, ADV MED SCI-POLAND, V57, P208, DOI 10.2478/v10039-012-0042-6; Prasad NR, 2011, MOL CELL BIOCHEM, V349, P11, DOI 10.1007/s11010-010-0655-7; Premratanachai Pongsathon, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P337, DOI 10.12980/APJTB.4.2014C1262; Rasul A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379850; Roleira FMF, 2015, FOOD CHEM, V183, P235, DOI 10.1016/j.foodchem.2015.03.039; Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.5603/FHC.2012.0004, 10.2478/18693]; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Toreti VC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/697390; Torkin R, 2005, MOL CANCER THER, V4, P1; Turan I, 2015, TROP J PHARM RES, V14, P777, DOI 10.4314/tjpr.v14i5.5; Walle T, 2007, BIOCHEM PHARMACOL, V73, P1288, DOI 10.1016/j.bcp.2006.12.028	39	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157091	10.1371/journal.pone.0157091	http://dx.doi.org/10.1371/journal.pone.0157091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281369	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000082
J	Eybpoosh, S; Bahrampour, A; Karamouzian, M; Azadmanesh, K; Jahanbakhsh, F; Mostafavi, E; Zolala, F; Haghdoost, AA				Eybpoosh, Sana; Bahrampour, Abbas; Karamouzian, Mohammad; Azadmanesh, Kayhan; Jahanbakhsh, Fatemeh; Mostafavi, Ehsan; Zolala, Farzaneh; Haghdoost, Ali Akbar			Spatio-Temporal History of HIV-1 CRF35_AD in Afghanistan and Iran	PLOS ONE			English	Article							INJECTING DRUG-USERS; MOLECULAR EPIDEMIOLOGY; MIDDLE-EAST; EVOLUTIONARY HISTORY; POPULATION-DYNAMICS; TYPE-1 SUBTYPE; NORTH-AFRICA; PHYLODYNAMICS; INFECTION; TRANSMISSION	HIV-1 Circulating Recombinant Form 35_AD (CRF35_AD) has an important position in the epidemiological profile of Afghanistan and Iran. Despite the presence of this clade in Afghanistan and Iran for over a decade, our understanding of its origin and dissemination patterns is limited. In this study, we performed a Bayesian phylogeographic analysis to reconstruct the spatio-temporal dispersion pattern of this clade using eligible CRF35_AD gag and pol sequences available in the Los Alamos HIV database (432 sequences available from Iran, 16 sequences available from Afghanistan, and a single CRF35_AD-like pol sequence available from USA). Bayesian Markov Chain Monte Carlo algorithm was implemented in BEAST v1.8.1. Between-country dispersion rates were tested with Bayesian stochastic search variable selection method and were considered significant where Bayes factor values were greater than three. The findings suggested that CRF35_AD sequences were genetically similar to parental sequences from Kenya and Uganda, and to a set of subtype A1 sequences available from Afghan refugees living in Pakistan. Our results also showed that across all phylogenies, Afghan and Iranian CRF35_AD sequences formed a monophyletic cluster (posterior clade credibility> 0.7). The divergence date of this cluster was estimated to be between 1990 and 1992. Within this cluster, a bidirectional dispersion of the virus was observed across Afghanistan and Iran. We could not clearly identify if Afghanistan or Iran first established or received this epidemic, as the root location of this cluster could not be robustly estimated. Three CRF35_AD sequences from Afghan refugees living in Pakistan nested among Afghan and Iranian CRF35_AD branches. However, the CRF35_AD-like sequence available from USA diverged independently from Kenyan subtype A1 sequences, suggesting it not to be a true CRF35_AD lineage. Potential factors contributing to viral exchange between Afghanistan and Iran could be injection drug networks and mass migration of Afghan refugees and labours to Iran, which calls for extensive preventive efforts.	[Eybpoosh, Sana; Karamouzian, Mohammad; Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Eybpoosh, Sana; Karamouzian, Mohammad; Haghdoost, Ali Akbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Bahrampour, Abbas; Zolala, Farzaneh] Kerman Univ Med Sci, Inst Futures Studies Hlth, Modeling Hlth Res Ctr, Kerman, Iran; [Karamouzian, Mohammad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Azadmanesh, Kayhan; Jahanbakhsh, Fatemeh] Pasteur Inst Iran, Dept Virol, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Emerging & Reemerging Infect Dis Res Ctr, Kabudar Ahang, Hamadan, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Kerman University of Medical Sciences; University of British Columbia; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Haghdoost, AA (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran.; Haghdoost, AA (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran.	ahaghdoost@kmu.ac.ir	Mostafavi, Ehsan/A-7627-2011; Haghdoost, Ali Akbar/C-2823-2009; Bahrampour, Abbas/B-7260-2011; Karamouzian, Mohammad/C-9277-2018; Eybpoosh, Sana/K-4836-2017; Zolala, Farzaneh/S-7088-2016; Azadmanesh, Kayhan/W-2445-2017	Mostafavi, Ehsan/0000-0002-1997-517X; Haghdoost, Ali Akbar/0000-0003-4628-4849; Bahrampour, Abbas/0000-0002-8950-2925; Karamouzian, Mohammad/0000-0002-5631-4469; Eybpoosh, Sana/0000-0002-2304-8352; Zolala, Farzaneh/0000-0002-1848-183X; Azadmanesh, Kayhan/0000-0002-7165-9043	Kerman University of Medical Sciences; Pasteur Institute of Iran [92-10-8-29690]	Kerman University of Medical Sciences; Pasteur Institute of Iran	This project was supported by Kerman University of Medical Sciences and Pasteur Institute of Iran (Grant No. 92-10-8-29690). The grant was received by AAH and EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi-Shavazi MJ, 2005, RETURN AFGHANISTAN S; Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Al Rifai R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007703; [Anonymous], 2014, AFGH AIDS PROGR REP; [Anonymous], 2004, BITT SWEET HARV AFGH; Ansari AS, 2011, AIDS, V25, P1427, DOI 10.1097/QAD.0b013e32834800e7; Apetrei C, LOS ALAMOS HIV DATAB; Baesi K, 2012, IRAN J BIOTECHNOL, V10, P1; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bozicevic I, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18962; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Chen JJ, 2011, MOD SIMUL ENG, V2011, DOI 10.1155/2011/259401; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Garcia V, 2007, J RURAL HEALTH, V23, P61, DOI 10.1111/j.1748-0361.2007.00125.x; Gokengin D, 2016, INT J INFECT DIS, V44, P66, DOI 10.1016/j.ijid.2015.11.008; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Hamkar R, 2010, AIDS ACTION, V2, pS85; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hu Wei-Shau, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006882; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Inciardi JA, 1999, SUBST USE MISUSE, V34, P653, DOI 10.3109/10826089909037236; Jahanbakhsh F, 2013, AIDS RES HUM RETROV, V29, P198, DOI [10.1089/AID.2012.0186, 10.1089/aid.2012.0186]; Jahanbakhsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061864; Khan S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-164; Khanani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022449; Koepke B., 2011, SITUATION AFGHANS IS; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Lemey P, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P362; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li Yanrui, 2010, J Biomed Biotechnol, V2010, P716515, DOI 10.1155/2010/716515; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Memarnejadian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126955; Mumtaz G, 2011, SEX TRANSM INFECT, V87, P101, DOI 10.1136/sti.2010.043711; Mumtaz GR, 2014, CURR OPIN HIV AIDS, V9, P183, DOI 10.1097/COH.0000000000000038; Murillo W, 2013, J VIROL, V87, P7463, DOI 10.1128/JVI.01602-12; MZ K, 2004, IRANIAN EC RES J, P57; Naderi H R, 2006, Infect Agent Cancer, V1, P4, DOI 10.1186/1750-9378-1-4; Pagan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069218; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pourhossein B, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015002; Pyne MT, 2013, J CLIN MICROBIOL, V51, P2662, DOI 10.1128/JCM.00880-13; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2002, TREEANNOTATOR V1 8 1; Rambaut A, 2002, LOGCOMBINER V1 8 1; Rambaut A, FIGTREE V1 4 TREE FI; Ray SC, 1999, SIMPLOT V2 5 0; Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; Sanders-Buell E, 2010, AIDS RES HUM RETROV, V26, P605, DOI 10.1089/aid.2009.0226; Sarrami-Forooshani R, 2006, J MED VIROL, V78, P853, DOI 10.1002/jmv.20634; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Soheilli ZS, 2009, AIDS RES HUM RETROV, V25, P123, DOI 10.1089/aid.2008.0199; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Tagliamonte M, 2007, AIDS RES HUM RETROV, V23, P1569, DOI 10.1089/aid.2007.0169; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; United Nations Office on Drugs and Crime (UNODC), 2018, WORLD DRUG REPORT 20; UNODC United Nations Office on Drugs and Crime Vienna, 2010, WORLD DRUG REP 2010; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yebra G, 2015, J GEN VIROL, V96, P1890, DOI 10.1099/vir.0.000107; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	72	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0156499	10.1371/journal.pone.0156499	http://dx.doi.org/10.1371/journal.pone.0156499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280293	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000033
J	Nagai-Okatani, C; Minamino, N				Nagai-Okatani, Chiaki; Minamino, Naoto			Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure	PLOS ONE			English	Article							MUSCLE LIM PROTEIN; BRAIN NATRIURETIC PEPTIDE; GROWTH-FACTOR RECEPTOR; SALT-SENSITIVE RATS; O-GLYCOSYLATION; POSTTRANSLATIONAL MODIFICATIONS; HUMAN GLYCOME; CORE FUCOSE; LECTIN; GLYCOPROTEIN	Targeted proteomics focusing on post-translational modifications, including glycosylation, is a useful strategy for discovering novel biomarkers. To apply this strategy effectively to cardiac hypertrophy and resultant heart failure, we aimed to characterize glycosylation profiles in the left ventricle and plasma of rats with cardiac hypertrophy. Dahl salt-sensitive hypertensive rats, a model of hypertension-induced cardiac hypertrophy, were fed a high-salt (8% NaCl) diet starting at 6 weeks. As a result, they exhibited cardiac hypertrophy at 12 weeks and partially impaired cardiac function at 16 weeks compared with control rats fed a low-salt (0.3% NaCl) diet. Gene expression analysis revealed significant changes in the expression of genes encoding glycosyltransferases and glycosidases. Glycoproteome profiling using lectin microarrays indicated upregulation of mucin-type O-glycosylation, especially disialyl-T, and downregulation of core fucosylation on N-glycans, detected by specific interactions with Amaranthus caudatus and Aspergillus oryzae lectins, respectively. Upregulation of plasma a-L-fucosidase activity was identified as a biomarker candidate for cardiac hypertrophy, which is expected to support the existing marker, atrial natriuretic peptide and its related peptides. Proteomic analysis identified cysteine and glycine-rich protein 3, a master regulator of cardiac muscle function, as an O-glycosylated protein with altered glycosylation in the rats with cardiac hypertrophy, suggesting that alternations in O-glycosylation affect its oligomerization and function. In conclusion, our data provide evidence of significant changes in glycosylation pattern, specifically mucin-type O-glycosylation and core defucosylation, in the pathogenesis of cardiac hypertrophy and heart failure, suggesting that they are potential biomarkers for these diseases.	[Nagai-Okatani, Chiaki; Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Res Inst, Suita, Osaka, Japan; [Nagai-Okatani, Chiaki] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Glycosci & Glycotechnol Res Grp, Tsukuba, Ibaraki, Japan; [Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr, Om Res Ctr, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Cerebral & Cardiovascular Center - Japan	Minamino, N (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Res Inst, Suita, Osaka, Japan.; Minamino, N (corresponding author), Natl Cerebral & Cardiovasc Ctr, Om Res Ctr, Suita, Osaka, Japan.	minamino@ncvc.go.jp	Nagai-Okatani, Chiaki/L-2883-2018	Nagai-Okatani, Chiaki/0000-0003-4084-3128	Intramural Research Fund of the National Cerebral and Cardiovascular Center of Japan [22-1-4, 25-6-16, 27-1-5]; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation of Japan [10-44]; Ministry of Education, Culture, Sports, Science and Technology, Japan [24890306]	Intramural Research Fund of the National Cerebral and Cardiovascular Center of Japan; Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was from the Intramural Research Fund of the National Cerebral and Cardiovascular Center of Japan (http://www.ncvc.go.jp/english/), 22-1-4, 25-6-16, and 27-1-5; the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation of Japan (http://www.nibio.go.jp/english/), 10-44; and KAKENHI Grant-in-Aid for Research Activity Start-up of the Ministry of Education, Culture, Sports, Science and Technology, Japan (https://www.jsps.go.jp/english/), 24890306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABURAYA M, 1989, BIOCHEM BIOPH RES CO, V165, P880, DOI 10.1016/S0006-291X(89)80048-8; Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Boateng SY, 2009, J MOL CELL CARDIOL, V47, P426, DOI 10.1016/j.yjmcc.2009.04.006; Chowdhury P, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0372-4; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Doi R, 2000, J HYPERTENS, V18, P111, DOI 10.1097/00004872-200018010-00016; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Hirabayashi J, 2013, CHEM SOC REV, V42, P4443, DOI 10.1039/c3cs35419a; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Kasper BT, 2014, BIOCHEM BIOPH RES CO, V445, P774, DOI 10.1016/j.bbrc.2014.01.034; Katafuchi T, 2003, J BIOL CHEM, V278, P12046, DOI 10.1074/jbc.M207970200; Kessler EL, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00482; Kuno A, 2008, J PROTEOM BIOINFORM, V1, P68, DOI DOI 10.4172/JPB.1000011; Kuzmanov U, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-31; Liddy KA, 2013, GENOME MED, V5, DOI 10.1186/gm424; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Nagai C, 2014, ANAL BIOCHEM, V461, P10, DOI 10.1016/j.ab.2014.05.022; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Nishikimi T, 2003, HYPERTENSION, V42, P1034, DOI 10.1161/01.HYP.0000097604.64716.D2; Nishikimi T, 2011, J CARDIOL, V57, P131, DOI 10.1016/j.jjcc.2011.01.002; Ogihara T, 2002, HYPERTENSION, V40, P83, DOI 10.1161/01.HYP.0000022880.45113.C9; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; RINDERLE SJ, 1989, J BIOL CHEM, V264, P16123; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stefaniuk P, 2010, WORLD J GASTROENTERO, V16, P418, DOI 10.3748/wjg.v16.i4.418; Tateno H, 2010, METHOD ENZYMOL, V478, P181, DOI 10.1016/S0076-6879(10)78008-3; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Vafiadaki E, 2015, GENE, V566, P1, DOI 10.1016/j.gene.2015.04.077; Van Eyk JE, 2011, CIRC RES, V108, P490, DOI 10.1161/CIRCRESAHA.110.226894; van Kimmenade RRJ, 2012, CLIN CHEM, V58, P127, DOI 10.1373/clinchem.2011.165720; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; WOOD S, 1975, CLIN CHIM ACTA, V58, P251, DOI 10.1016/0009-8981(75)90444-1; Yu HJ, 2012, J PROTEOME RES, V11, P5277, DOI 10.1021/pr300484j; Zhao YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094536	55	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0150210	10.1371/journal.pone.0150210	http://dx.doi.org/10.1371/journal.pone.0150210			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27281159	Green Published, Green Submitted, gold			2022-12-27	WOS:000377563000001
J	Poirier, S; Hamouda, HA; Villeneuve, L; Demers, A; Mayer, G				Poirier, Steve; Hamouda, Hocine Ait; Villeneuve, Louis; Demers, Annie; Mayer, Gaetan			Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PROPROTEIN CONVERTASE PCSK9; PRECURSOR-LIKE PROTEIN-2; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; SECRETED PCSK9; PCSK9-MEDIATED DEGRADATION; HEPG2 CELLS; CHOLESTEROL	PCSK9 is a secreted ligand and negative post-translational regulator of low-density lipoprotein receptor (LDLR) in hepatocytes. Gain-of-function (GOF) or loss-of-function (LOF) mutations in PCSK9 are directly correlated with high or low plasma LDL-cholesterol levels, respectively. Therefore, PCSK9 is a prevailing lipid-lowering target to prevent coronary heart diseases and stroke. Herein, we fused monomeric fluorescent proteins to PCSK9 and LDLR to visualize their intra-and extracellular trafficking dynamics by live confocal microscopy. Fluorescence recovery after photobleaching (FRAP) showed that PCSK9 LOF R46L mutant and GOF mutations S127R and D129G, but not the LDLR high-affinity mutant D374Y, significantly accelerate PCSK9 exit from the endoplasmic reticulum (ER). Quantitative analysis of inverse FRAP revealed that only R46L presented a much slower trafficking from the trans-Golgi network (TGN) to the plasma membrane and a lower mobile fraction likely suggesting accumulation or delayed exit at the TGN as an underlying mechanism. While not primarily involved in LDLR binding, PCSK9 C-terminal domain (CTD) was found to be essential to induce LDLR degradation both upon its overexpression in cells or via the extracellular pathway. Our data revealed that PCSK9 CTD is required for the localization of PCSK9 at the TGN and increases its LDLR-mediated endocytosis. Interestingly, intracellular lysosomal targeting of PCSK9-Delta CTD was able to rescue its capacity to induce LDLR degradation emphasizing a role of the CTD in the sorting of PCSK9-LDLR complex towards late endocytic compartments. Finally, we validated our dual fluorescence system as a cell based-assay by preventing PCSK9 internalization using a PCSK9-LDLR blocking antibody, which may be expended to identify protein, peptide or small molecule inhibitors of PCSK9.	[Poirier, Steve; Hamouda, Hocine Ait; Villeneuve, Louis; Demers, Annie; Mayer, Gaetan] Montreal Heart Inst Res Ctr, Mol Cell Biol Lab, Montreal, PQ, Canada; [Poirier, Steve; Hamouda, Hocine Ait; Mayer, Gaetan] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Mayer, Gaetan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Mayer, G (corresponding author), Montreal Heart Inst Res Ctr, Mol Cell Biol Lab, Montreal, PQ, Canada.; Mayer, G (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.; Mayer, G (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	gaetan.mayer@icm-mhi.org			Canadian Institutes of Health Research (CIHR - Institute of Nutrition, Metabolism and Diabetes) [MOP133598]; Heart and Stroke Foundation of Canada; Fonds de Recherche du Quebec - Sante; Montreal Heart Institute Foundation	Canadian Institutes of Health Research (CIHR - Institute of Nutrition, Metabolism and Diabetes)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Montreal Heart Institute Foundation	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR - Institute of Nutrition, Metabolism and Diabetes; MOP133598), the Heart and Stroke Foundation of Canada, the Fonds de Recherche du Quebec - Sante and the Montreal Heart Institute Foundation to G.M.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; BENDAYAN M, 1995, PROG HISTOCHEM CYTOC, V29, P1; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Bergeron N, 2015, CIRCULATION, V132, P1648, DOI 10.1161/CIRCULATIONAHA.115.016080; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Demers A, 2015, ARTERIOSCL THROM VAS, V35, P2517, DOI 10.1161/ATVBAHA.115.306032; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nguyen MA, 2014, J LIPID RES, V55, P266, DOI 10.1194/jlr.M044156; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Poirier S, 2014, J BIOL CHEM, V289, P18736, DOI 10.1074/jbc.M114.563650; Poirier S, 2013, DRUG DES DEV THER, V7, P1135, DOI 10.2147/DDDT.S36984; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; Tveten K, 2013, J LIPID RES, V54, P1560, DOI 10.1194/jlr.M034371; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	61	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157230	10.1371/journal.pone.0157230	http://dx.doi.org/10.1371/journal.pone.0157230			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280970	gold, Green Published, Green Submitted			2022-12-27	WOS:000377563000110
J	Vacaflores, A; Chapman, NM; Harty, JT; Richer, MJ; Houtman, JCD				Vacaflores, Aldo; Chapman, Nicole M.; Harty, John T.; Richer, Martin J.; Houtman, Jon C. D.			Exposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism	PLOS ONE			English	Article							INTERFERON-GAMMA; IFN-GAMMA; EFFECTOR FUNCTION; GENE-EXPRESSION; DENDRITIC CELLS; INTERLEUKIN-12; KINASE; PHOSPHORYLATION; ACTIVATION; PLASTICITY	Human CD4 T cells are constantly exposed to IL-12 during infections and certain autoimmune disorders. The current paradigm is that IL-12 promotes the differentiation of naive CD4 T cells into Th1 cells, but recent studies suggest IL-12 may play a more complex role in T cell biology. We examined if exposure to IL-12 alters human CD4 T cell responses to subsequent TCR stimulation. We found that IL-12 pretreatment increased TCR-induced IFN-gamma, TNF-alpha, IL-13, IL-4 and IL-10 production. This suggests that prior exposure to IL-12 potentiates the TCR-induced release of a range of cytokines. We observed that IL-12 mediated its effects through both transcriptional and post-transcriptional mechanisms. IL-12 pretreatment increased the phosphorylation of AKT, p38 and LCK following TCR stimulation without altering other TCR signaling molecules, potentially mediating the increase in transcription of cytokines. In addition, the IL-12-mediated enhancement of cytokines that are not transcriptionally regulated was partially driven by increased oxidative metabolism. Our data uncover a novel function of IL-12 in human CD4 T cells; specifically, it enhances the release of a range of cytokines potentially by altering TCR signaling pathways and by enhancing oxidative metabolism.	[Vacaflores, Aldo; Chapman, Nicole M.; Harty, John T.; Houtman, Jon C. D.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Harty, John T.; Richer, Martin J.; Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Chapman, Nicole M.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Richer, Martin J.] McGill Univ, Dept Microbiol & Immunol, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada	University of Iowa; University of Iowa; University of Iowa; University of Iowa; St Jude Children's Research Hospital; McGill University	Houtman, JCD (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA.; Houtman, JCD (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.; Houtman, JCD (corresponding author), Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA.	jon-houtman@uiowa.edu		Houtman, Jon/0000-0002-5307-9854; Harty, John/0000-0001-7266-2802	National Cancer Institute at the National Institutes of Health [CA136729]; American Heart Association [11PRE7390070]; NIH [T32 AI007485, AI42767, AI085515, AI95178, AI100527, AI106776]; Canadian Institutes of Health Research from American Heart Association Midwest Affiliate; Holden Comprehensive Cancer Center [P30CA086862]; NATIONAL CANCER INSTITUTE [R01CA136729, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research from American Heart Association Midwest Affiliate; Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The JCDH laboratory was supported by the National Cancer Institute at the National Institutes of Health (CA136729). NMC was supported by the American Heart Association Predoctoral (11PRE7390070) and the NIH Predoctoral Training Grant in Immunology (T32 AI007485). MJR was supported by a Canadian Institutes of Health Research fellowship and a fellowship from the American Heart Association Midwest Affiliate. The JTH laboratory is supported by NIH grants (AI42767, AI085515, AI95178, AI100527, AI106776). The ESR Facility (Seahorse experiments) is supported in part by the Holden Comprehensive Cancer Center (P30CA086862).	Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Athie-M V, 2000, EUR J IMMUNOL, V30, P1425, DOI 10.1002/(SICI)1521-4141(200005)30:5<1425::AID-IMMU1425>3.0.CO;2-Q; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Bellanger AP, 2013, CLIN VACCINE IMMUNOL, V20, P1133, DOI 10.1128/CVI.00043-13; Bilal MY, 2015, IMMUNOL CELL BIOL, V93, P896, DOI 10.1038/icb.2015.59; Bright JJ, 1998, J NEUROIMMUNOL, V82, P22, DOI 10.1016/S0165-5728(97)00184-7; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chehimi J, 1995, RES IMMUNOL, V146, P605, DOI 10.1016/0923-2494(96)83038-0; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Cruz-Orcutt N, 2014, CELL SIGNAL, V26, P797, DOI 10.1016/j.cellsig.2013.12.022; Cruz-Orcutt N, 2009, MOL IMMUNOL, V46, P2274, DOI 10.1016/j.molimm.2009.04.006; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; El-Shabrawi Y, 1998, OPHTHALMOLOGY, V105, P1659, DOI 10.1016/S0161-6420(98)99035-2; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; JUNE CH, 1990, J IMMUNOL, V144, P1591; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kim C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004137; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lee TS, 1999, ARTERIOSCL THROM VAS, V19, P734, DOI 10.1161/01.ATV.19.3.734; Ley Klaus, 2014, F1000Res, V3, P37, DOI 10.12688/f1000research.3-37.v1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhumitha H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-1; Martinez-Pomar N, 2006, CLIN EXP IMMUNOL, V144, P233, DOI 10.1111/j.1365-2249.2006.03063.x; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Meyaard L, 1996, J IMMUNOL, V156, P2776; Mingari MC, 1996, EUR J IMMUNOL, V26, P1083, DOI 10.1002/eji.1830260519; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pope RM, 2013, NAT REV RHEUMATOL, V9, P252, DOI 10.1038/nrrheum.2012.170; Portielje JEA, 2003, CLIN CANCER RES, V9, P76; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Renner K, 2015, EUR J IMMUNOL, V45, P2504, DOI 10.1002/eji.201545473; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Tokano Y, 1999, CLIN EXP IMMUNOL, V116, P169; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Tremblay MM, 2015, J IMMUNOL METHODS, V416, P137, DOI 10.1016/j.jim.2014.11.009; Tremblay MM, 2014, MOL IMMUNOL, V57, P161, DOI 10.1016/j.molimm.2013.09.002; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tugues S, 2015, CELL DEATH DIFFER, V22, P237, DOI 10.1038/cdd.2014.134; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Wagner BA, 2011, FREE RADICAL BIO MED, V51, P700, DOI 10.1016/j.freeradbiomed.2011.05.024; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Windhagen A, 1996, J IMMUNOL, V157, P1127; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	62	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2016	11	6							e0157175	10.1371/journal.pone.0157175	http://dx.doi.org/10.1371/journal.pone.0157175			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TW	27280403	Green Submitted, Green Published, gold			2022-12-27	WOS:000377563000104
J	Thanos, PK; Kim, R; Delis, F; Ananth, M; Chachati, G; Rocco, MJ; Masad, I; Muniz, JA; Grant, SC; Gold, MS; Cadet, JL; Volkow, ND				Thanos, Panayotis K.; Kim, Ronald; Delis, Foteini; Ananth, Mala; Chachati, George; Rocco, Mark J.; Masad, Ihssan; Muniz, Jose A.; Grant, Samuel C.; Gold, Mark S.; Cadet, Jean Lud; Volkow, Nora D.			Chronic Methamphetamine Effects on Brain Structure and Function in Rats	PLOS ONE			English	Article							HIGH-DOSE METHAMPHETAMINE; MICROGLIAL ACTIVATION; DOPAMINE TRANSPORTERS; NEUROTROPHIC FACTOR; METABOLISM; RECEPTORS; GLUTAMATE; STRIATUM; ABUSERS; INDUCE	Methamphetamine (MA) addiction is a growing epidemic worldwide. Chronic MA use has been shown to lead to neurotoxicity in rodents and humans. Magnetic resonance imaging (MRI) studies in MA users have shown enlarged striatal volumes and positron emission tomography (PET) studies have shown decreased brain glucose metabolism (BGluM) in the striatum of detoxified MA users. The present study examines structural changes of the brain, observes microglial activation, and assesses changes in brain function, in response to chronic MA treatment. Rats were randomly split into three distinct treatment groups and treated daily for four months, via i.p. injection, with saline (controls), or low dose (LD) MA (4 mg/kg), or high dose (HD) MA (8 mg/kg). Sixteen weeks into the treatment period, rats were injected with a glucose analog, [F-18] fluorodeoxyglucose (FDG), and their brains were scanned with micro-PET to assess regional BGluM. At the end of MA treatment, magnetic resonance imaging at 21T was performed on perfused rats to determine regional brain volume and in vitro [H-3]PK 11195 autoradiography was performed on fresh-frozen brain tissue to measure microglia activation. When compared with controls, chronic HD MA-treated rats had enlarged striatal volumes and increases in [H-3]PK 11195 binding in striatum, the nucleus accumbens, frontal cortical areas, the rhinal cortices, and the cerebellar nuclei. FDG microPET imaging showed that LD MA-treated rats had higher BGluM in insular and somatosensory cortices, face sensory nucleus of the thalamus, and brainstem reticular formation, while HD MA-treated rats had higher BGluM in primary and higher order somatosensory and the retrosplenial cortices, compared with controls. HD and LD MA-treated rats had lower BGluM in the tail of the striatum, rhinal cortex, and subiculum and HD MA also had lower BGluM in hippocampus than controls. These results corroborate clinical findings and help further examine the mechanisms behind MA-induced neurotoxicity.	[Thanos, Panayotis K.; Chachati, George; Rocco, Mark J.] Univ Buffalo, Behav Neuropharmacol & Neuroimaging Lab Addict, Res Inst Addict, Buffalo, NY USA; [Kim, Ronald] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Delis, Foteini] Univ Ioannina, Sch Med, Dept Pharmacol, GR-45110 Ioannina, Greece; [Ananth, Mala] SUNY Stony Brook, Dept Neurosci, Stony Brook, NY 11794 USA; [Masad, Ihssan; Muniz, Jose A.; Grant, Samuel C.] Natl High Magnet Field Lab, Tallahassee, FL USA; [Gold, Mark S.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cadet, Jean Lud] NIDA, Mol Neuropsychiat Res Branch, NIH, Dept Hlth & Human Serv, Baltimore, MD USA; [Volkow, Nora D.] NIAAA, Lab Neuroimaging, NIH, Dept Hlth & Human Serv, Bethesda, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; University of Ioannina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; Florida State University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Thanos, PK (corresponding author), Univ Buffalo, Behav Neuropharmacol & Neuroimaging Lab Addict, Res Inst Addict, Buffalo, NY USA.	pthanos@ria.buffalo.edu	Grant, Samuel Colles/D-8744-2013	Grant, Samuel Colles/0000-0001-7738-168X; Kim, Ronald/0000-0001-7078-0995; Ananth, Mala/0000-0003-1736-2350	National Institutes of Health; National Institute on Alcohol and Alcoholism [AA11034]; Research Foundation of New York [RIAQ094]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Research Foundation of New York; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by National Institutes of Health; National Institute on Alcohol and Alcoholism, AA11034; and Research Foundation of New York, RIAQ094.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Berman SM, 2008, MOL PSYCHIATR, V13, P897, DOI 10.1038/sj.mp.4002107; Burrows KB, 1999, NEUROSCIENCE, V90, P833, DOI 10.1016/S0306-4522(98)00506-5; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Chang L, 2005, BIOL PSYCHIAT, V57, P967, DOI 10.1016/j.biopsych.2005.01.039; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chin KM, 2006, CHEST, V130, P1657, DOI 10.1378/chest.130.6.1657; Chung YA, 2010, DRUG ALCOHOL DEPEN, V111, P155, DOI 10.1016/j.drugalcdep.2010.04.005; Churchwell JC, 2012, DEV NEUROSCI-BASEL, V34, P310, DOI 10.1159/000337724; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Escubedo E, 1998, BRAIN RES, V814, P120, DOI 10.1016/S0006-8993(98)01065-8; Ferrucci M, 2013, CURR NEUROPHARMACOL, V11, P80, DOI 10.2174/157015913804999522; Fujita S, 2010, NEUROSCIENCE, V165, P278, DOI 10.1016/j.neuroscience.2009.09.073; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Grobler Sias R, 2011, ISRN Dent, V2011, P974768, DOI 10.5402/2011/974768; Groman SM, 2013, PSYCHOPHARMACOLOGY, V229, P527, DOI 10.1007/s00213-013-3159-9; Halpin LE, 2014, LIFE SCI, V97, P37, DOI 10.1016/j.lfs.2013.07.014; Hoffman W, 2008, PSYCHOPHARMACOLOGY, V201, P183, DOI 10.1007/s00213-008-1261-1; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Huang YH, 1999, NEUROPSYCHOPHARMACOL, V21, P427, DOI 10.1016/S0893-133X(99)00029-9; Isgor C, 2015, NEUROSCIENCE, V288, P10, DOI 10.1016/j.neuroscience.2014.12.036; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; Jan RK, 2012, BRAIN SCI, V2, P553, DOI 10.3390/brainsci2040553; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; Kim R, 2011, METHAMPHETAMINE EFFE; Kobayashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021736; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krubitzer LPJ., 2008, ENCYCLOPEDIC REFEREN, P1225; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; LaVoie MJ, 2004, EXP NEUROL, V187, P47, DOI 10.1016/j.expneurol.2004.01.010; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Marks GA, 2008, NEUROSCIENCE, V156, P1, DOI 10.1016/j.neuroscience.2008.06.067; Marshall JF, 2007, ADDICTION, V102, P61, DOI 10.1111/j.1360-0443.2006.01780.x; Michaelides M, 2010, EUR J NEUROSCI, V32, P668, DOI 10.1111/j.1460-9568.2010.07319.x; MITLER MM, 1993, SLEEP, V16, P306; MITLER MM, 1994, SLEEP, V17, pS103, DOI 10.1093/sleep/17.suppl_8.S103; MYERS R, 1991, J CEREBR BLOOD F MET, V11, P314, DOI 10.1038/jcbfm.1991.64; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; O'Dell SJ, 2005, SYNAPSE, V55, P137, DOI 10.1002/syn.20098; O'Dell SJ, 2002, SYNAPSE, V43, P122, DOI 10.1002/syn.10016; Paxinos G., 2007, THE RAT BRAIN IN STE; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Pfefferbaum A, 2011, CEREB CORTEX, V21, P233, DOI 10.1093/cercor/bhq090; Polesskaya O, 2011, BRAIN RES, V1373, P91, DOI 10.1016/j.brainres.2010.12.017; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Royal Pharmaceutical Society of Great Britain, 1999, MARTINDALE THE COMPL; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Thanos PK, 2013, J NEUROSCI, V33, P6343, DOI 10.1523/JNEUROSCI.4997-12.2013; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; Thrash B, 2009, PHARMACOL REP, V61, P966, DOI 10.1016/S1734-1140(09)70158-6; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Volkow ND, 2001, AM J PSYCHIAT, V158, P383, DOI 10.1176/appi.ajp.158.3.383; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Volkow ND, 2015, NEUROIMAGE, V121, P20, DOI 10.1016/j.neuroimage.2015.07.035; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015269; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Wang GJ, 2004, AM J PSYCHIAT, V161, P242, DOI 10.1176/appi.ajp.161.2.242; Watson CJ, 2011, J NEUROCHEM, V118, P571, DOI 10.1111/j.1471-4159.2011.07350.x; Winslow BT, 2007, AM FAM PHYSICIAN, V76, P1169	75	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2016	11	6							e0155457	10.1371/journal.pone.0155457	http://dx.doi.org/10.1371/journal.pone.0155457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TJ	27275601	Green Published, gold			2022-12-27	WOS:000377561700005
J	Abu Bakar, SA; Nadarajah, S; Adzhar, ZAABSLK; Mohamed, I				Abu Bakar, Shaiful Anuar; Nadarajah, Saralees; Adzhar, Zahrul Azmir A. B. S. L. Kamarul; Mohamed, Ibrahim			Gendist: An R Package for Generated Probability Distribution Models	PLOS ONE			English	Article							SKEW-CAUCHY DISTRIBUTION; STUDENT GOOD MODELS; INSURANCE CLAIMS; MIXTURE-MODELS; FINITE MIXTURE; TAIL	In this paper, we introduce the R package gendist that computes the probability density function, the cumulative distribution function, the quantile function and generates random values for several generated probability distribution models including the mixture model, the composite model, the folded model, the skewed symmetric model and the arc tan model. These models are extensively used in the literature and the R functions provided here are flexible enough to accommodate various univariate distributions found in other R packages. We also show its applications in graphing, estimation, simulation and risk measurements.	[Abu Bakar, Shaiful Anuar; Adzhar, Zahrul Azmir A. B. S. L. Kamarul; Mohamed, Ibrahim] Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia; [Nadarajah, Saralees] Univ Manchester, Sch Math, Manchester, Lancs, England	Universiti Malaya; University of Manchester	Abu Bakar, SA (corresponding author), Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia.	saab@um.edu.my	Abu Bakar, Shaiful Anuar/B-9729-2010; BIN MOHAMED, IBRAHIM/B-8643-2010	Abu Bakar, Shaiful Anuar/0000-0003-4747-1742; BIN MOHAMED, IBRAHIM/0000-0001-5518-4132; ABSL KAMARUL ADZHAR, ZAHRUL AZMIR/0000-0002-8011-8644	Fundamental Research Grant Scheme (FRGS) [FP050-2014A]; Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia [FP050-2014A]	Fundamental Research Grant Scheme (FRGS); Fundamental Research Grant Scheme (FRGS), Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	SAAB is funded by Fundamental Research Grant Scheme (FRGS) with grant number FP050-2014A.r The authors greatly thank the Academic Editor and the anonymous reviewer for carefully reading the paper and their valuable comments. This research was supported by Fundamental Research Grant Scheme (FRGS FP050-2014A), Ministry of Higher Education Malaysia.	Abu Bakar SA, 2015, INSUR MATH ECON, V61, P146, DOI 10.1016/j.insmatheco.2014.08.008; Ali MM, 2010, BRAZ J PROBAB STAT, V24, P1, DOI 10.1214/08-BJPS100; [Anonymous], 2006, SOOCHOW J MATH; [Anonymous], 1994, CONTINUOUS UNIVARIAT; [Anonymous], 2014, R LANG ENV STAT COMP; Ardia D, 2009, J STAT SOFTW, V29, P1; Arnold BC, 2000, STAT PROBABIL LETT, V49, P285, DOI 10.1016/S0167-7152(00)00059-6; Aryal G, 2005, J INFORM OPTIM SCI, V26, P205, DOI 10.1080/02522667.2005.10699644; AZZALINI A, 1985, SCAND J STAT, V12, P171; Azzalini A, 2015, PACKAGE SN; Benaglia T, 2009, J STAT SOFTW, V32, P1; Brazauskas V, 2011, SCAND ACTUAR J, P59, DOI 10.1080/03461230903424199; Calderin-Ojeda E, 2016, SCAND ACTUAR J, P817, DOI 10.1080/03461238.2015.1034763; Carta JA, 2007, RENEW ENERG, V32, P518, DOI 10.1016/j.renene.2006.05.005; Cooray K, 2006, COMMUN STAT-THEOR M, V35, P385, DOI 10.1080/03610920500476234; Cooray K., 2005, SCAND ACTUAR J, P321, DOI 10.1080/03461230510009763; Davis C, 2015, SGT SKEWED GEN T DIS; Dutang C, 2014, CRAN TASK VIEW PROBA; Dutang C, 2008, J STAT SOFTW, V25, P1; Eling M, 2014, INSUR MATH ECON, V59, P45, DOI 10.1016/j.insmatheco.2014.08.004; Eling M, 2012, INSUR MATH ECON, V51, P239, DOI 10.1016/j.insmatheco.2012.04.001; Feldmann A, 1997, IEEE INFOCOM SER, P1096, DOI 10.1109/INFCOM.1997.631130; Gomez-Deniz E, 2015, ASTIN BULL, V45, P639, DOI 10.1017/asb.2015.9; Huang WJ, 2007, STAT PROBABIL LETT, V77, P1137, DOI 10.1016/j.spl.2007.02.006; King R, 2012, SKEWT SKEWED STUDENT; Kocovic J, 2015, SCAND ACTUAR J, V2015, P49, DOI 10.1080/03461238.2013.775665; Lee D, 2012, INSUR MATH ECON, V51, P538, DOI 10.1016/j.insmatheco.2012.07.008; Lee SCK, 2010, N AM ACTUAR J, V14, P107, DOI 10.1080/10920277.2010.10597580; Machler M, 2015, NOR1MIX NORMAL 1 D M; Nadarajah S, 2015, COMMUN STAT-THEOR M, V44, P4408, DOI 10.1080/03610926.2013.793348; Nadarajah S, 2014, SCAND ACTUAR J, V2014, P180, DOI 10.1080/03461238.2012.695748; Nadarajah S, 2013, R J, V5, P98; Nadarajah S, 2015, NEWDISTNS COMPUTES P; Pearson K., 1894, Philosophical Transactions, V185a, P71, DOI 10.1098/rsta.1894.0003; Preda V, 2006, ROMANIAN J EC FORECA, V3; PSARAKIS S, 1990, COMMUN STAT THEORY, V19, P2717, DOI 10.1080/03610929008830342; ROST J, 1991, BRIT J MATH STAT PSY, V44, P75, DOI 10.1111/j.2044-8317.1991.tb00951.x; Scollnik D.P.M., 2007, SCAND ACTUAR J, P20, DOI 10.1080/03461230601110447; Scollnik DPM, 2012, N AM ACTUAR J, V16, P260, DOI 10.1080/10920277.2012.10590640; Scott D., 2015, SKEWHYPERBOLIC SKEW; Seabra JC, 2011, IEEE T BIO-MED ENG, V58, P1314, DOI 10.1109/TBME.2011.2106498; Stasinopoulos M, 2015, GAMLSS DIST DISTRIBU; Teodorescu S, 2009, ROM J ECON FORECAST, V12, P82; Venturini S, GSM GAMMA SHAPE MIXT; Wahed AS., 2001, J STAT RES, V35, P71; Webb AR, 2000, PATTERN RECOGN, V33, P2045, DOI 10.1016/S0031-3203(99)00195-8; Yan J, 2007, J STAT SOFTW, V21, P1; Yang MH, 1998, PROC SPIE, V3656, P458, DOI 10.1117/12.333865; Zhang LJ, 2001, CAN J FOREST RES, V31, P1654, DOI 10.1139/x01-086	50	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156537	10.1371/journal.pone.0156537	http://dx.doi.org/10.1371/journal.pone.0156537			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272043	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000018
J	Brown, NJL; MacDonald, DA; Samanta, MP; Friedman, HL; Coyne, JC				Brown, Nicholas J. L.; MacDonald, Douglas A.; Samanta, Manoj P.; Friedman, Harris L.; Coyne, James C.			More Questions than Answers: Continued Critical Reanalysis of Fredrickson et al.'s Studies of Genomics and Well-Being	PLOS ONE			English	Article								We critically re-examine Fredrickson et al.'s renewed claims concerning the differential relationship between hedonic and eudaimonic forms of well-being and gene expression, namely that people who experience a preponderance of eudaimonic well-being have gene expression profiles that are associated with more favorable health outcomes. By means of an extensive reanalysis of their data, we identify several discrepancies between what these authors claimed and what their data support; we further show that their different analysis models produce mutually contradictory results. We then show how Fredrickson et al.'s most recent article on this topic not only fails to adequately address our previously published concerns about their earlier related work, but also introduces significant further problems, including inconsistency in their hypotheses. Additionally, we demonstrate that regardless of which statistical model is used to analyze their data, Fredrickson et al.'s method can be highly sensitive to the inclusion (or exclusion) of data from a single subject. We reiterate our previous conclusions, namely that there is no evidence that Fredrickson et al. have established a reliable empirical distinction between their two delineated forms of well-being, nor that eudaimonic well-being provides any overall health benefits over hedonic well-being.	[Brown, Nicholas J. L.; Coyne, James C.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [MacDonald, Douglas A.] Univ Detroit Mercy, Detroit, MI 48221 USA; [Samanta, Manoj P.] Systemix Inst, Redmond, WA USA; [Friedman, Harris L.] Goddard Coll, Plainfield, VT USA; [Friedman, Harris L.] Univ Florida, Gainesville, FL USA	University of Groningen; University of Detroit Mercy; State University System of Florida; University of Florida	Brown, NJL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	nick.brown@free.fr	Brown, Nicholas/F-2238-2017; MacDonald, Douglas A./Y-4796-2019	Brown, Nicholas/0000-0003-1579-0730; MacDonald, Douglas A./0000-0002-2100-1526				Barr DJ, 2014, ANATOMY STAT ARTIFAC; Brown NJL, 2014, P NATL ACAD SCI USA, V111, P12705, DOI 10.1073/pnas.1407057111; Brown NJL, 2014, SUPPORTING INFORM CR; Disabato DJ, 2016, PSYCHOL ASSESSMENT, V28, P471, DOI 10.1037/pas0000209; Fredrickson BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121839; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; Fredrickson BL, PLOS ONE IN PRESS; Neuroskeptic, 2014, NEUROSKEPTIC FALSE P; Osborne J.W., 2019, PRACT ASSESS RES EVA, V9, P11, DOI [DOI 10.7275/QF69-7K43, 10.7275/ktzq-jq66]; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Walker JA, 2016, PEERJ UNPUB, DOI 10	11	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156415	10.1371/journal.pone.0156415	http://dx.doi.org/10.1371/journal.pone.0156415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270924	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000013
J	Qualai, J; Cantero, J; Li, LX; Carrascosa, JM; Cabre, E; Dern, O; Sumoy, L; Requena, G; McSorley, SJ; Genesca, M				Qualai, Jamal; Cantero, Jon; Li, Lin-Xi; Manuel Carrascosa, Jose; Cabre, Eduard; Dern, Olga; Sumoy, Lauro; Requena, Gerard; McSorley, Stephen J.; Genesca, Meritxell			Adhesion Molecules Associated with Female Genital Tract Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; CHLAMYDIA-TRACHOMATIS INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; INFLAMMATORY-BOWEL-DISEASE; RESIDENT MEMORY; MEDIATED PROTECTION; BACTERIAL VAGINOSIS; IMMUNE-RESPONSE; IN-VIVO; EXPRESSION	Efforts to develop vaccines that can elicit mucosal immune responses in the female genital tract against sexually transmitted infections have been hampered by an inability to measure immune responses in these tissues. The differential expression of adhesion molecules is known to confer site-dependent homing of circulating effector T cells to mucosal tissues. Specific homing molecules have been defined that can be measured in blood as surrogate markers of local immunity (e.g. alpha 4 beta 7 for gut). Here we analyzed the expression pattern of adhesion molecules by circulating effector T cells following mucosal infection of the female genital tract in mice and during a symptomatic episode of vaginosis in women. While CCR2, CCR5, CXCR6 and CD11c were preferentially expressed in a mouse model of Chlamydia infection, only CCR5 and CD11c were clearly expressed by effector T cells during bacterial vaginosis in women. Other homing molecules previously suggested as required for homing to the genital mucosa such as alpha 4 beta 1 and alpha 4 beta 7 were also differentially expressed in these patients. However, CD11c expression, an integrin chain rarely analyzed in the context of T cell immunity, was the most consistently elevated in all activated effector CD8(+) T cell subsets analyzed. This molecule was also induced after systemic infection in mice, suggesting that CD11c is not exclusive of genital tract infection. Still, its increase in response to genital tract disorders may represent a novel surrogate marker of mucosal immunity in women, and warrants further exploration for diagnostic and therapeutic purposes.	[Qualai, Jamal; Cantero, Jon; Genesca, Meritxell] AIDS Res Inst IrsiCaixa HIVACAT, Inst Invest Ciencies Salut Germans Trias & Pujol, Mucosal Immunol Unit, Can Ruti Campus, Badalona, Spain; [Li, Lin-Xi] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Manuel Carrascosa, Jose] Univ Autonoma Barcelona, Univ Hosp Germans Trias & Pujol, Dept Dermatol, Badalona, Spain; [Cabre, Eduard] Univ Hosp Germans Trias & Pujol, Dept Gastroenterol, Can Ruti Campus, Badalona, Catalonia, Spain; [Cabre, Eduard] CIBERehd, Madrid, Spain; [Dern, Olga] Ctr Atencio Primaria CAP St Felix, ASSIR, ICS, Sabadell, Spain; [Sumoy, Lauro] Inst Predict & Personalized Med Canc IMPPC, Genom & Bioinformat Grp, Can Ruti Campus, Badalona, Spain; [Requena, Gerard] Inst Invest Ciencies Salut Germans Trias & Pujol, Flow Cytometry Unit, Badalona, Spain; [McSorley, Stephen J.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Ctr Comparat Med, Davis, CA 95616 USA	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University of Arkansas System; University of Arkansas Medical Sciences; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); University of California System; University of California Davis	Genesca, M (corresponding author), AIDS Res Inst IrsiCaixa HIVACAT, Inst Invest Ciencies Salut Germans Trias & Pujol, Mucosal Immunol Unit, Can Ruti Campus, Badalona, Spain.	mgenesca@igtp.cat	Genescà, Meritxell/AFT-2336-2022; Genescà, Meritxell/AAF-9074-2020; Requena, Gerard/R-4814-2019; Sumoy, Lauro/AGZ-3186-2022; Sumoy, Lauro/K-1680-2013	Genescà, Meritxell/0000-0001-6413-3812; Sumoy, Lauro/0000-0003-0005-4618; Sumoy, Lauro/0000-0003-0005-4618; Li, Lin-Xi/0000-0002-5526-8966; Cantero, Jon/0000-0003-4844-6143; McSorley, Stephen/0000-0002-6363-3222	European Commission; Proyecto de Investigacion en Salud from the Spanish Instituto de Salud Carlos III [PI14/01235]; Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117303, R01AI103422] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Proyecto de Investigacion en Salud from the Spanish Instituto de Salud Carlos III; Dexeus foundation for women's health research; Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Marie Curie Career Integration Grant (CIG) from the European Commission, a Proyecto de Investigacion en Salud from the Spanish Instituto de Salud Carlos III (PI14/01235) and a fellowship award from the Dexeus foundation for women's health research. MG is currently supported by a Ramon y Cajal contract from the Spanish Ministry for Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2015, J CLIN INVEST, V125, P1827, DOI 10.1172/JCI77990; Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Anton G, 2008, INFECTION, V36, P147, DOI 10.1007/s15010-007-7152-2; Beyer M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-70; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Chen ZB, 2013, J IMMUNOL, V190, P6145, DOI 10.4049/jimmunol.1300060; Cooney LA, 2013, INFECT IMMUN, V81, P4171, DOI 10.1128/IAI.00871-13; Davila SJ, 2014, J IMMUNOL, V192, P4284, DOI 10.4049/jimmunol.1303238; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Ferguson AR, 2010, J IMMUNOL, V184, P4079, DOI 10.4049/jimmunol.0901903; Ferran M, 2008, EUR J DERMATOL, V18, P647, DOI 10.1684/ejd.2008.0513; Fujiwara D, 2011, AM J PHYSIOL-GASTR L, V300, pG939, DOI 10.1152/ajpgi.00032.2010; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Genesca M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103924; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Goodsell A, 2008, IMMUNOLOGY, V123, P378, DOI 10.1111/j.1365-2567.2007.02702.x; Hladik F, 1999, J IMMUNOL, V163, P2306; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Joag VR, 2016, MUCOSAL IMMUNOL, V9, P1, DOI 10.1038/mi.2015.28; Johansson EL, 1999, IMMUNOLOGY, V96, P272; Kelly KA, 2009, AM J REPROD IMMUNOL, V61, P436, DOI 10.1111/j.1600-0897.2009.00704.x; Koelle DM, 2002, J CLIN INVEST, V110, P537, DOI [10.1172/JCI200215537, 10.1172/JCI0215537]; Kubota K, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00026; Kuka M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2223; Lewis DA, 2007, SEX TRANSM INFECT, V83, P508, DOI 10.1136/sti.2007.028142; Lewis DJM, 2014, J VIROL, V88, P11648, DOI 10.1128/JVI.01621-14; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Marelli-Berg FM, 2010, IMMUNOLOGY, V130, P158, DOI 10.1111/j.1365-2567.2010.03278.x; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mitchell C, 2014, AM J REPROD IMMUNOL, V71, P555, DOI 10.1111/aji.12264; Miyairi I, 2010, J INFECT DIS, V201, pS96, DOI 10.1086/652393; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Shannon B, 2014, J IMMUNOL, V192, P5074, DOI 10.4049/jimmunol.1302916; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Teraki Y, 2004, CLIN EXP DERMATOL, V29, P658, DOI 10.1111/j.1365-2230.2004.01638.x; Youn H, 2008, BIOMARKERS, V13, P257, DOI [10.1080/13547500701843338, 10.1080/13547500701843338 ]	47	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156605	10.1371/journal.pone.0156605	http://dx.doi.org/10.1371/journal.pone.0156605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272720	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000023
J	Warda, AK; Siezen, RJ; Boekhorst, J; Wells-Bennik, MHJ; de Jong, A; Kuipers, OP; Groot, MNN; Abee, T				Warda, Alicja K.; Siezen, Roland J.; Boekhorst, Jos; Wells-Bennik, Marjon H. J.; de Jong, Anne; Kuipers, Oscar P.; Groot, Masja N. Nierop; Abee, Tjakko			Linking Bacillus cereus Genotypes and Carbohydrate Utilization Capacity	PLOS ONE			English	Article							COMPARATIVE GENOME ANALYSIS; ALPHA-L-FUCOSIDASE; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; LACTOBACILLUS-PLANTARUM; L-FUCOSE; EXTRACELLULAR 1,2-ALPHA-L-FUCOSIDASE; STREPTOCOCCUS-PNEUMONIAE; LISTERIA-MONOCYTOGENES; BIOFILM FORMATION	We characterised carbohydrate utilisation of 20 newly sequenced Bacillus cereus strains isolated from food products and food processing environments and two laboratory strains, B. cereus ATCC 10987 and B. cereus ATCC 14579. Subsequently, genome sequences of these strains were analysed together with 11 additional B. cereus reference genomes to provide an overview of the different types of carbohydrate transporters and utilization systems found in B. cereus strains. The combined application of API tests, defined growth media experiments and comparative genomics enabled us to link the carbohydrate utilisation capacity of 22 B. cereus strains with their genome content and in some cases to the panC phylogenetic grouping. A core set of carbohydrates including glucose, fructose, maltose, trehalose, N-acetyl-glucosamine, and ribose could be used by all strains, whereas utilisation of other carbohydrates like xylose, galactose, and lactose, and typical host-derived carbohydrates such as fucose, mannose, N-acetyl-galactosamine and inositol is limited to a subset of strains. Finally, the roles of selected carbohydrate transporters and utilisation systems in specific niches such as soil, foods and the human host are discussed.	[Warda, Alicja K.; Siezen, Roland J.; Boekhorst, Jos; Wells-Bennik, Marjon H. J.; de Jong, Anne; Kuipers, Oscar P.; Groot, Masja N. Nierop; Abee, Tjakko] TI Food & Nutr, Wageningen, Netherlands; [Warda, Alicja K.; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Warda, Alicja K.; Groot, Masja N. Nierop] Wageningen UR Food & Biobased Res, Wageningen, Netherlands; [Siezen, Roland J.; Boekhorst, Jos] RadboudUMC, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Siezen, Roland J.] Microbial Bioinformat, Ede, Netherlands; [Boekhorst, Jos; Wells-Bennik, Marjon H. J.] NIZO Food Res BV, Ede, Netherlands; [de Jong, Anne; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; Radboud University Nijmegen; NIZO Food Research; University of Groningen	Abee, T (corresponding author), TI Food & Nutr, Wageningen, Netherlands.; Abee, T (corresponding author), Wageningen Univ, Food Microbiol Lab, NL-6700 AP Wageningen, Netherlands.	tjakko.abee@wur.nl	warda, Alicja/ABF-2403-2020; Siezen, Roland J/P-5745-2015; Kuipers, Oscar/B-6752-2009	warda, Alicja/0000-0001-8317-6455; Boekhorst, Jos/0000-0002-4807-7838; Kuipers, Oscar/0000-0001-5596-7735	TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition; TIFN	TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition; TIFN	The project is funded by TI Food and Nutrition (TIFN), a public-private partnership on precompetitive research in food and nutrition. The public partners are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The private partners have contributed to the project through regular discussion. TIFN provided support in the form of salaries for authors (AKW, RJS, JB, MHJWB, AdJ, OPK, MNNG, TA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. NIZO food research (http://www.nizo.com) is a contract research organization. NIZO was paid by TIFN to provide input on experimental design, bioinformatics analysis and data interpretation (i.e., the salary of JB and MHJWB was indirectly paid by TIFN). NIZO has no financial interest in any specific outcome of the study. Food & Biobased Research (FBR) is a contract research organization, part of Wageningen University and Research centre. FBR was paid by TIFN to provide input on experimental design, data generation, data interpretation, preparation of the manuscript (salary of MNNG, AKW). FBR has no financial interest in any specific outcome of the study. TIFN financed subcontracting to Microbial Bioinformatics (RJS) for input on experimental design, data interpretation and preparation of the manuscript. Microbial Bioinformatics has no financial interest in any specific outcome of the study.	Abee T, 2011, FOOD MICROBIOL, V28, P199, DOI 10.1016/j.fm.2010.03.015; Abranches J, 2004, APPL ENVIRON MICROB, V70, P6047, DOI 10.1128/AEM.70.10.6047-6052.2004; Abranches J, 2006, J BACTERIOL, V188, P3748, DOI 10.1128/JB.00169-06; Anderson I, 2005, FEMS MICROBIOL LETT, V250, P175, DOI 10.1016/j.femsle.2005.07.008; Andersson A, 1995, INT J FOOD MICROBIOL, V28, P145, DOI 10.1016/0168-1605(95)00053-4; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Aymerich T, 2003, APPL ENVIRON MICROB, V69, P4583, DOI 10.1128/AEM.69.8.4583-4594.2003; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Becerra JE, 2015, APPL ENVIRON MICROB, V81, P3880, DOI 10.1128/AEM.00260-15; Borneman AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-373; Brehm K, 1999, J BACTERIOL, V181, P5024, DOI 10.1128/JB.181.16.5024-5032.1999; Brumm PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00430; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Ceapa C, 2015, APPL ENVIRON MICROB, V81, P5458, DOI 10.1128/AEM.00851-15; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; CHEN YM, 1987, J BACTERIOL, V169, P3712, DOI 10.1128/jb.169.8.3712-3719.1987; CHEN YM, 1987, J BACTERIOL, V169, P3289, DOI 10.1128/jb.169.7.3289-3294.1987; CHEN YM, 1987, MOL GEN GENET, V210, P331, DOI 10.1007/BF00325702; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Vries YP, 2004, APPL ENVIRON MICROB, V70, P2514, DOI 10.1128/AEM.70.4.2514-2519.2004; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dierick K, 2005, J CLIN MICROBIOL, V43, P4277, DOI 10.1128/JCM.43.8.4277-4279.2005; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Federhen S, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0134-1; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; FLOREZ LA, 2009, COMMUNITY CURATED CO; FOUET A, 1987, P NATL ACAD SCI USA, V84, P8773, DOI 10.1073/pnas.84.24.8773; Giffel MCT, 1997, INT J FOOD MICROBIOL, V34, P307, DOI 10.1016/S0168-1605(96)01204-4; Guillemet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055085; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; Hayrapetyan H, 2016, GENOME ANNO IN PRESS; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Higgins MA, 2014, J MOL BIOL, V426, P1469, DOI 10.1016/j.jmb.2013.12.006; Hooper LV, 2001, GLYCOBIOLOGY, V11, p1R, DOI 10.1093/glycob/11.2.1R; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Krawczyk AO, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01480-15; KRUGER S, 1995, J BACTERIOL, V177, P5590; KURIMURA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P589, DOI 10.1271/bbb.59.589; LOGAN NA, 1985, J MED MICROBIOL, V20, P75, DOI 10.1099/00222615-20-1-75; LOGAN NA, 1984, J GEN MICROBIOL, V130, P1871; Luo YE, 2014, BIOTECHNOL ADV, V32, P905, DOI 10.1016/j.biotechadv.2014.04.009; Manzoor I, 2015, J MOL MICROB BIOTECH, V25, P120, DOI 10.1159/000377724; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Miura T, 2005, J BIOSCI BIOENG, V99, P629, DOI 10.1263/jbb.99.629; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Mols M, 2007, ENVIRON MICROBIOL, V9, P2933, DOI 10.1111/j.1462-2920.2007.01404.x; Neves AR, 2010, APPL ENVIRON MICROB, V76, P7048, DOI 10.1128/AEM.01195-10; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; PARK SF, 1993, MOL MICROBIOL, V8, P653, DOI 10.1111/j.1365-2958.1993.tb01609.x; Plumbridge J, 2015, J MOL MICROB BIOTECH, V25, P154, DOI 10.1159/000369583; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; REIZER A, 1991, MOL MICROBIOL, V5, P1081, DOI 10.1111/j.1365-2958.1991.tb01880.x; Reizer J, 1999, MICROBIOL-UK, V145, P3419, DOI 10.1099/00221287-145-12-3419; Rodionov DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-494; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Saier MH, 2002, J MOL MICROB BIOTECH, V4, P37; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Setlow B, 2004, ARCH MICROBIOL, V181, P60, DOI 10.1007/s00203-003-0628-2; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Siezen RJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S3; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Song FP, 2014, GUT MICROBES, V5, P58, DOI 10.4161/gmic.27092; Song FP, 2012, FASEB J, V26, P3336, DOI 10.1096/fj.11-197681; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; TSUJI Y, 1990, J BIOCHEM-TOKYO, V108, P235, DOI 10.1093/oxfordjournals.jbchem.a123186; TSUJI Y, 1990, J BIOCHEM-TOKYO, V107, P324, DOI 10.1093/oxfordjournals.jbchem.a123046; Vetting MW, 2015, BIOCHEMISTRY-US, V54, P909, DOI 10.1021/bi501388y; Wu MC, 2012, INFECT IMMUN, V80, P2464, DOI 10.1128/IAI.06247-11; Ymele-Leki P, 2013, APPL ENVIRON MICROB, V79, P4675, DOI 10.1128/AEM.01184-13; Zeng L, 2012, APPL ENVIRON MICROB, V78, P5597, DOI 10.1128/AEM.01393-12; Zhang HM, 2015, MICROBIOLOGYOPEN, V4, P983, DOI 10.1002/mbo3.307	79	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156796	10.1371/journal.pone.0156796	http://dx.doi.org/10.1371/journal.pone.0156796			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27272929	Green Published, Green Submitted, gold			2022-12-27	WOS:000377561000039
J	Chen, QX; Hua, BZ				Chen, Qing-Xiao; Hua, Bao-Zhen			Ultrastructure and Morphology of Compound Eyes of the Scorpionfly Panorpa dubia (Insecta: Mecoptera: Panorpidae)	PLOS ONE			English	Article							FINE-STRUCTURE; COLOR-VISION; CHAOBORUS-CRYSTALLINUS; SUPERPOSITION EYE; OPTIC LOBES; LARVAL EYE; EVOLUTION; DORSAL; DIPTERA; LEPIDOPTERA	Mecoptera are unique in holometabolous insects in that their larvae have compound eyes. In the present study the cellular organisation and morphology of the compound eyes of adult individuals of the scorpionfly Panorpa dubia in Mecoptera were investigated by light, scanning electron, and transmission electron microscopy. The results showed that the compound eyes of adult P. dubia are of the apposition type, each eye comprising more than 1200 ommatidia. The ommatidium consists of a cornea, a crystalline cone made up of four cone cells, eight photoreceptors, two primary pigment cells, and 18 secondary pigment cells. The adult ommatidium has a fused rhabdom with eight photoreceptors. Seven photoreceptors extend from the proximal end of the crystalline cone to the basal matrix, whereas the eighth photoreceptor is shorter, extending from the middle level of the photoreceptor cluster to the basal matrix. The fused rhabdom is composed of the rhabdomeres of different photoreceptors at different levels. The adult ommatidia have the same cellular components as the larval ommatidia, but the tiering scheme is different.	[Chen, Qing-Xiao; Hua, Bao-Zhen] Northwest A&F Univ, Entomol Museum, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Chen, Qing-Xiao] Henan Univ Sci & Technol, Coll Forestry, Luoyang, Henan, Peoples R China	Northwest A&F University - China; Henan University of Science & Technology	Hua, BZ (corresponding author), Northwest A&F Univ, Entomol Museum, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huabzh@nwsuaf.edu.cn			National Natural Science Foundation of China [31172125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 31172125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 1977, Proceedings of the Japanese Society for Systematic Zoology, VNo. 13, P81; Belusic G, 2013, J EXP BIOL, V216, P2081, DOI 10.1242/jeb.084194; Bierbrodt Erika, 1942, ZOOL JAHRB ABT ANAI U ONTOG TIERE, V68, P49; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2001, MOL BIOL EVOL, V18, P2270, DOI 10.1093/oxfordjournals.molbev.a003773; Buchner E, 1984, PLENUM, P561, DOI DOI 10.1007/978-1-4613-2743-1_16; Burkhardt D., 1972, Information processing in the visual systems of arthropods. Symposium, Zurich, 1972. Editor R. Wehner., P147; Buschbeck EK, 2014, J EXP BIOL, V217, P2818, DOI 10.1242/jeb.085365; Buschbeck Elke K., 2008, Evolution Education and Outreach, V1, P448, DOI 10.1007/s12052-008-0086-z; BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; Chapman RF, 2013, J CHEM INF MODEL, V5th; Chen QX, 2014, MICRON, V59, P8, DOI 10.1016/j.micron.2013.12.004; Chen QX, 2013, MICROSC RES TECHNIQ, V76, P862, DOI 10.1002/jemt.22240; Chen QX, 2012, MICRON, V43, P893, DOI 10.1016/j.micron.2012.03.006; Chen QX, 2012, J MORPHOL, V273, P561, DOI 10.1002/jmor.20001; CHOU I, 1981, Entomotaxonomia, V3, P1; EGUCHI E, 1971, Z VERGL PHYSIOL, V71, P201, DOI 10.1007/BF00297978; Friedrich M, 2011, J EXP ZOOL PART B, V316B, P484, DOI 10.1002/jez.b.21424; HARDIE RC, 1986, TRENDS NEUROSCI, V9, P419, DOI 10.1016/0166-2236(86)90136-0; Horridge G.A., 1975, P255; HORRIDGE GA, 1972, PROC R SOC SER B-BIO, V182, P457, DOI 10.1098/rspb.1972.0088; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; KOLB G, 1977, ZOOMORPHOLOGIE, V87, P123, DOI 10.1007/BF01007602; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAUGHLIN S, 1978, CELL TISSUE RES, V188, P427; MCLEAN M, 1977, TISSUE CELL, V9, P653, DOI 10.1016/0040-8166(77)90033-7; MEINECKE CC, 1981, CELL TISSUE RES, V216, P333; MELZER RR, 1991, ZOOMORPHOLOGY, V110, P227, DOI 10.1007/BF01633007; MELZER RR, 1994, INT J INSECT MORPHOL, V23, P261, DOI 10.1016/0020-7322(94)90023-X; MELZER RR, 1994, CELL TISSUE RES, V275, P283, DOI 10.1007/BF00319426; MELZER RR, 1994, ACTA ZOOL-STOCKHOLM, V75, P201, DOI 10.1111/j.1463-6395.1994.tb01207.x; MEYER EP, 1993, CELL TISSUE RES, V272, P17, DOI 10.1007/BF00323566; Mishra M, 2008, INSECT SCI, V15, P179, DOI 10.1111/j.1744-7917.2008.00199.x; Narendra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076015; Nilsson D.-E., 1989, P30; Oakley TH, 2003, INTEGR COMP BIOL, V43, P522, DOI 10.1093/icb/43.4.522; OGRADY GE, 1987, CAN J ZOOL, V65, P1454, DOI 10.1139/z87-228; Olberg RM, 2007, J COMP PHYSIOL A, V193, P685, DOI 10.1007/s00359-007-0223-0; Paulus H.F., 1979, P299; Paulus HF, 2000, J ZOOL SYST EVOL RES, V38, P189, DOI 10.1046/j.1439-0469.2000.383152.x; RIBI WA, 1978, CELL TISSUE RES, V191, P57; Rottmar B., 1966, Zoologische Jahrbuecher (Anatomie), V83, P497; Sakura M, 2003, ZOOL SCI, V20, P833, DOI 10.2108/zsj.20.833; Stavenga DG, 1995, PROG RETIN EYE RES, V15, P231, DOI 10.1016/1350-9462(95)00011-9; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; Suzuki N., 1989, P ARTHROPOD EMBRYOL, V24, P27; WARRANT EJ, 1990, J COMP PHYSIOL A, V167, P785; Wehner R, 2006, P NATL ACAD SCI USA, V103, P12575, DOI 10.1073/pnas.0604430103; Wei Y, 2010, MICRON, V41, P953, DOI 10.1016/j.micron.2010.07.005; WILLIAMS DS, 1982, CELL TISSUE RES, V225, P595; WILSON M, 1978, CELL TISSUE RES, V195, P205	56	8	9	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156970	10.1371/journal.pone.0156970	http://dx.doi.org/10.1371/journal.pone.0156970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258365	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700164
J	Zhang, C; Chen, M; Wang, GZ; Fang, W; Ye, C; Hu, HH; Fa, ZZ; Yi, J; Liao, WQ				Zhang, Chao; Chen, Mei; Wang, Guizhen; Fang, Wei; Ye, Chen; Hu, Hanhua; Fa, Zhenzong; Yi, Jiu; Liao, Wan-qing			Pd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal Effect	PLOS ONE			English	Article							SILVER NANOPARTICLES; ANTIFUNGAL ACTIVITY; ESCHERICHIA-COLI; ANTIBACTERIAL; FLUCONAZOLE; RESISTANCE; MENINGITIS; EPIDEMIOLOGY; NEOFORMANS; AGENTS	Silver nanoparticles have received considerable interest as new "nanoantibiotics" with the potential to kill drug-resistant microorganisms. Recently, a class of new core-shell nanostructures, Pd@Ag nanosheets (Pd@Ag NSs), were created using deposition techniques and demonstrated excellent inhibitory effects on various bacteria in vitro. In this study, we evaluated the antifungal activity of Pd@Ag NSs against common invasive fungal pathogens. Among these organisms, Cryptococcus neoformans complex species was most susceptible to Pd@Ag NSs, which exhibited potent antifungal activity against various molecular types or sources of cryptococcal strains including fluconazole-resistant isolates. The anticryptococcal activity of Pd@Ag NSs was significantly greater than fluconazole and similar to that of amphotericin B (AmB). At relatively high concentrations, Pd@Ag NSs exhibited fungicidal activity against Cryptococcus spp., which can likely be attributed to the disruption of cell integrity, intracellular protein synthesis, and energy metabolism. Intriguingly, Pd@Ag NSs also exhibited strong synergistic anti-cryptococcal fungicidal effects at low concentrations in combination with AmB but exhibitedmuch better safety in erythrocytes than AmB, even at the minimal fungicidal concentration. Therefore, Pd@Ag NSs may be a promising adjunctive agent for treating cryptococcosis, and further investigation for clinical applications is required.	[Zhang, Chao; Yi, Jiu; Liao, Wan-qing] Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Zhang, Chao; Fang, Wei; Fa, Zhenzong] Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China; [Chen, Mei] Xiamen Univ, Coll Chem & Chem Engn, Collaborat Innovat Ctr Chem Energy Mat, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China; [Chen, Mei] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China; [Wang, Guizhen] Urumuqi Army Gen Hosp, ICU Dept, Urumqi, Xinjiang, Peoples R China; [Ye, Chen] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Hu, Hanhua] Xinjiang Med Univ, UEM Dept, Urumqi, Xinjiang, Peoples R China	Naval Medical University; Naval Medical University; Xiamen University; Xiamen University; Naval Medical University; Xinjiang Medical University	Liao, WQ (corresponding author), Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.; Fang, W (corresponding author), Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China.	weifang081782@163.com; liaowanqing@sohu.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Key Basic Research Programs of China [2013CB531601]; National Natural Science Foundation of China [81401651, 81471926, 31170139]; Shanghai Municipal Natural Science Foundation [12JC1411000, 12ZR1454400, 14495800500]; Shanghai Key Laboratory of Molecular Medical Mycology [14DZ2272900]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Key Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Shanghai Key Laboratory of Molecular Medical Mycology; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by the National Key Basic Research Programs of China (2013CB531601), the National Natural Science Foundation of China (81401651, 81471926, and 31170139), the Shanghai Municipal Natural Science Foundation (12JC1411000, 12ZR1454400, and 14495800500), and the Shanghai Key Laboratory of Molecular Medical Mycology (14DZ2272900).	AbuSalah KM, 1996, BRIT J BIOMED SCI, V53, P122; Ajesh K, 2013, J APPL MICROBIOL, V115, P1287, DOI 10.1111/jam.12324; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Chowdhary A, 2011, J MED MICROBIOL, V60, P961, DOI 10.1099/jmm.0.029025-0; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; CLSI, 2008, M27A3 CLSI; Despax B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/17/175101; Fang W, 2015, FUNGAL GENET BIOL, V78, P7, DOI 10.1016/j.fgb.2014.10.017; Fang WJ, 2012, SMALL, V8, P3816, DOI 10.1002/smll.201200962; Fang WJ, 2012, ADV FUNCT MATER, V22, P842, DOI 10.1002/adfm.201101960; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fortun J, 2011, ENFERM INFEC MICR CL, V29, P38, DOI 10.1016/S0213-005X(11)70042-8; Friese G, 2001, AIDS, V15, P2344, DOI 10.1097/00002030-200111230-00026; Georgopapadakou NH, 1998, CURR OPIN MICROBIOL, V1, P547, DOI 10.1016/S1369-5274(98)80087-8; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P316, DOI 10.1128/AAC.4.3.316; Huang XQ, 2011, ADV MATER, V23, P3420, DOI 10.1002/adma.201100905; Huang XQ, 2011, NAT NANOTECHNOL, V6, P28, DOI 10.1038/NNANO.2010.235; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Ishida K, 2014, MEM I OSWALDO CRUZ, V109, P220, DOI 10.1590/0074-0276130269; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Jebali A, 2014, MED MYCOL, V52, P65, DOI 10.3109/13693786.2013.822996; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2; Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103442; Lortholary O, 2007, CLIN INFECT DIS, V45, P81, DOI 10.1086/518583; Manfredi R, 2006, AIDS PATIENT CARE ST, V20, P227, DOI 10.1089/apc.2006.20.227; Mares D, 1998, MED MYCOL, V36, P379, DOI 10.1080/02681219880000601; Mdodo R, 2010, East Afr Med J, V87, P481; Mo SG, 2015, J MATER CHEM B, V3, P6255, DOI 10.1039/c5tb00830a; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Niazi JH, 2011, APPL BIOCHEM BIOTECH, V164, P1278, DOI 10.1007/s12010-011-9212-4; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Osumi M, 1998, MICRON, V29, P207; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Richardson M, 2008, CLIN MICROBIOL INFEC, V14, P5, DOI 10.1111/j.1469-0691.2008.01978.x; Roling EE, 2002, DIAGN MICR INFEC DIS, V43, P13, DOI 10.1016/S0732-8893(02)00361-9; Sar B, 2004, J ANTIMICROB CHEMOTH, V54, P563, DOI 10.1093/jac/dkh361; Selvaraj M, 2014, APPL BIOCHEM BIOTECH, V173, P55, DOI 10.1007/s12010-014-0782-9; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sifuentes-Osornio J, 2012, CURR FUNGAL INFECT R, V6, P23, DOI 10.1007/s12281-011-0081-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Tang SH, 2014, SMALL, V10, P3139, DOI 10.1002/smll.201303631; Vazquez-Munoz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108876; Xu Y, 2013, J OCUL PHARMACOL TH, V29, P270, DOI 10.1089/jop.2012.0155; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhao ZX, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/28/285701	69	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157000	10.1371/journal.pone.0157000	http://dx.doi.org/10.1371/journal.pone.0157000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27611217	Green Submitted, Green Published, gold			2022-12-27	WOS:000377561000058
J	Zhang, N; Becares, L; Chandola, T				Zhang, Nan; Becares, Laia; Chandola, Tarani			Patterns and Determinants of Double-Burden of Malnutrition among Rural Children: Evidence from China	PLOS ONE			English	Article							LEFT-BEHIND CHILDREN; DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; RISK-FACTORS; PARENTAL MIGRATION; PHYSICAL-ACTIVITY; GROWTH STANDARDS; OLDER CHILDREN; HEALTH-STATUS; LIFE-COURSE	Chinese children are facing dual burden of malnutrition-coexistence of under-and overnutrition. Little systematic evidence exists for explaining the simultaneous presence of under-and over-nutrition. This study aims to explore underlying mechanisms of under-and over-nutrition among children in rural China. This study used a nationwide longitudinal data-set of children (N = 5,017) from 9 provinces across China, with four exclusively categories of nutritional outcomes including under-nutrition (stunting and underweight), over-nutrition (overweight only including obesity), paradox (stunted overweight), with normal nutrition as reference. Multinomial logit models (Level-1: occasions; Level-2: children; Level-3: villages) were fitted which corrected for non-independence of observations due to geographic clustering and repeated observations of individuals. A mixture of risk factors at the individual, household and neighbourhood levels predicted under-and over-nutrition among children in rural China. Improved socioeconomic status and living in more urbanised villages reduced the risk of stunted overweight among rural children in China. Young girls appeared to have higher risk of under-nutrition, and the risk decreased with age more markedly than for boys up to age 5. From age 5 onwards, boys tended to have higher risk of under-nutrition than girls. Girls aged around 12 and older were less likely to suffer from under-nutrition, while boys' higher risk of under-nutrition persisted throughout adolescence. Children were less likely to suffer from over-nutrition compared to normal nutrition. Boys tended to have an even lower risk of over-nutrition than girls and the gender difference widened with age until adolescence. Our results have important policy implications that improving household economic status, in particular, maternal education and health insurance for children, and living environment are important to enhance rural children's nutritional status in China. Investments in early years of childhood can be effective to reduce gender inequality in nutritional health in rural China.	[Zhang, Nan; Becares, Laia; Chandola, Tarani] Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England; [Becares, Laia] Univ Manchester, Ctr Dynam Ethn CoDE, Sch Social Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Zhang, N (corresponding author), Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England.	nancytju@gmail.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	ESRC; National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre [5 R24 HD050924]; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R24 HD050924, R01-HD38700]; Fogarty International Centre, NIH; China-Japan Friendship Hospital, Ministry of Health; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); China-Japan Friendship Hospital, Ministry of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supporting by an ESRC postgraduate scholarship to NZ. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an ESRC postgraduate scholarship to NZ. We use data from China Health and Nutrition Survey (CHNS), which is available for public use from http://www.cpc.unc.edu/projects/china/data. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009.	All-China Women's Federation, 2013, RES REP RUR LEFT CHI; [Anonymous], 2000, MODERNISATION SON PR; ASTRUP A, 1994, AM J PHYSIOL, V266, pE592, DOI 10.1152/ajpendo.1994.266.4.E592; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1998, MOTHERS BABIES HLTH; Berk LE., 2013, CHILD DEV; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Bredenkamp C, 2006, INCOME CHILD NUTR ST; Brown J, 2007, NUTR LIFE CYCLE; Browne W.J., 2015, MCMC ESTIMATION MLWI; Chang S, 2000, Wei Sheng Yan Jiu, V29, P270; Chang Suying, 2006, Wei Sheng Yan Jiu, V35, P768; Chen CM, 2011, BIOMED ENVIRON SCI, V24, P321, DOI 10.3967/0895-3988.2011.04.001; Dang SN, 2014, J CHILD HEALTH CARE, V18, P358, DOI 10.1177/1367493513496669; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Ge XJ, 2001, SOC PSYCHOL QUART, V64, P363, DOI 10.2307/3090160; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Harris NS, 2001, NEW ENGL J MED, V344, P341, DOI 10.1056/NEJM200102013440504; He W, 2014, AM J PUBLIC HEALTH, V104, pE14, DOI 10.2105/AJPH.2013.301669; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Hui L, 2003, HEALTH PLACE, V9, P371, DOI 10.1016/S1353-8292(03)00049-2; Jia X-y, 2012, CHINESE J PUBLIC HLT, V1; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Jiang Y, 2015, CHILD CARE HLTH DEV, V41, P45, DOI 10.1111/cch.12148; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li YP, 2009, BIOMED ENVIRON SCI, V22, P130, DOI 10.1016/S0895-3988(09)60035-0; Liu Y, 2007, ECON BULL, V15; Luo JY, 2008, PUBLIC HEALTH REP, V123, P382; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Morgan SL, 2000, CHINA J, V44, P1, DOI 10.2307/2667475; Mu R, 2015, J POPUL ECON, V28, P631, DOI 10.1007/s00148-015-0550-3; Na Zhang, 2015, 2015 Visual Communications and Image Processing (VCIP), P1, DOI 10.1109/VCIP.2015.7457813; Ning MX, 2013, AGR ECON-CZECH, V59, P467, DOI 10.17221/19/2013-AGRICECON; Pei LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-121; Piernas C, 2015, EUROPEAN J CLIN NUTR; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Poskitt EME, 2009, ANN TROP PAEDIATR, V29, P1, DOI 10.1179/146532809X401971; Rasbash J, 2013, MLWIN VERSION 2 28; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Ren WW, 2014, CHINA ECON REV, V31, P145, DOI 10.1016/j.chieco.2014.09.001; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Shen TF, 1996, NEW ENGL J MED, V335, P400, DOI 10.1056/NEJM199608083350606; Shetty P, 2013, INDIAN J PEDIATR, V80, pS21, DOI 10.1007/s12098-013-0971-5; Shi ZM, 2005, J ADOLESCENT HEALTH, V37, P313, DOI 10.1016/j.jadohealth.2004.10.013; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Strauss J, 1998, J ECON LIT, V36, P766; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tan C, 2010, PUBLIC HEALTH NUTR, V13, P1663, DOI 10.1017/S1368980010000078; Tassoni P., 2007, CHILD DEV 6 16 YEARS; United Nations Children's Fund, 1998, STAT WORLDS CHILDR 1; United Nations Children's Fund, 1990, STRAT IMPR NUTR STAT; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Wang Y, 1998, EUR J CLIN NUTR, V52, P908, DOI 10.1038/sj.ejcn.1600664; Wang Y., 2012, HDB ANTHROPOMETRY PH, V1, P29, DOI DOI 10.1007/978-1-4419-1788-1_2; Wang YF, 2003, PUBLIC HEALTH NUTR, V6, P549, DOI 10.1079/PHN2003470; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Wei SG, 2011, AUSTRALAS MED J, V4, P123, DOI 10.4066/AMJ.2011.584; Zhang J, 2011, ASIA PAC J CLIN NUTR, V20, P584; Zhang N, 2016, PARENTAL MIGRATION I; Zhang N, 2015, APPETITE, V95, P484, DOI 10.1016/j.appet.2015.08.024; Zhang N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2296-y; Zhang YX, 2014, INT J CARDIOL, V176, P1212, DOI 10.1016/j.ijcard.2014.07.222; Zong XN, 2014, B WORLD HEALTH ORGAN, V92, P555, DOI 10.2471/BLT.13.126243; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	91	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158119	10.1371/journal.pone.0158119	http://dx.doi.org/10.1371/journal.pone.0158119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27611217	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000380005400031
J	Zhang, MH; Xin, M				Zhang, Miaohui; Xin, Ming			Human Detection Using Random Color Similarity Feature and Random Ferns Classifier	PLOS ONE			English	Article								We explore a novel approach for human detection based on random color similarity feature (RCS) and random ferns classifier which is also known as semi-naive Bayesian classifier. In contrast to other existing features employed by human detection, color-based features are rarely used in vision-based human detection because of large intra-class variations. In this paper, we propose a novel color-based feature, RCS feature, which is yielded by simple color similarity computation between image cells randomly picked in still images, and can effectively characterize human appearances. In addition, a histogram of oriented gradient based local binary feature (HOG-LBF) is also introduced to enrich the human descriptor set. Furthermore, random ferns classifier is used in the proposed approach because of its faster speed in training and testing than traditional classifiers such as SupportVector Machine (SVM) classifier, without a loss in performance. Finally, the proposed method is conducted in public datasets and achieves competitive detection results.	[Zhang, Miaohui] Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China; [Xin, Ming] Beihang Univ, Sch Comp Sci & Engn, Beijing Key Lab Digital Media, Beijing, Peoples R China	Henan University; Beihang University	Zhang, MH (corresponding author), Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China.	zhmh@henu.edu.cn	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Natural Science Foundation of China [61305042, 61503250, 61503173]; Science and Technology Research Key Project of Education Department of Henan Province [152102210057]; Postdoctoral Science Fund of China [2015M582182]; Henan University Fund [2012YBZR005]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Key Project of Education Department of Henan Province; Postdoctoral Science Fund of China(China Postdoctoral Science Foundation); Henan University Fund; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by the National Natural Science Foundation of China (No. 61305042, No. 61503250, No. 61503173), the Science and Technology Research Key Project of Education Department of Henan Province (No. 152102210057), the Postdoctoral Science Fund of China (No. 2015M582182), Henan University Fund (2012YBZR005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng WC, 2013, ENG APPL ARTIF INTEL, V26, P1016, DOI 10.1016/j.engappai.2012.08.013; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dalal N, 2006, LECT NOTES COMPUT SC, V3952, P428, DOI 10.1007/11744047_33; Everingham P. M., 2009, P INT C COMP VIS KYO; Kalal Z., 2010, P COMP VIS PATT REC; Kong KK, 2015, PATTERN RECOGN LETT, V68, P63, DOI 10.1016/j.patrec.2015.07.043; Laptev I, 2006, BMVC, V3, P949; Liu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142820; Luo P, 2014, IEEE C CVPR; Maji S, 2008, PROC CVPR IEEE, P2245; Mikolajczyk K, 2004, LECT NOTES COMPUT SC, V3021, P69; Mohan A, 2001, IEEE T PATTERN ANAL, V23, P349, DOI 10.1109/34.917571; Ozuysal M, 2010, IEEE T PATTERN ANAL, V32, P448, DOI 10.1109/TPAMI.2009.23; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Schwartz W.R., 2009, P INT C COMP VIS KYO; Tuzel O., 2007, CVPR, V1; Villamizar M., 2010, CVPR; WALK S, 2010, PROC CVPR IEEE, P1030, DOI DOI 10.1109/CVPR.2010.5540102; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Winn J., 2006, CVPR; Wu B, 2005, IEEE I CONF COMP VIS, P90; Wu B., 2008, P IEEE COMP SOC C CO; Yao SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134242; Zhang M., 2011, OPTICAL ENG, V9; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhao Y, 2013, IEEE INTELLIGENT TRA, V7, P459	30	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162830	10.1371/journal.pone.0162830	http://dx.doi.org/10.1371/journal.pone.0162830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611217	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255900174
